PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA
J	Zollner, S; Pritchard, JK				Zollner, Sebastian; Pritchard, Jonathan K.			Overcoming the winner's curse: Estimating penetrance parameters from case-control data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRO12ALA POLYMORPHISM; GENETIC ASSOCIATION; DIABETES-MELLITUS; BIAS; GAMMA; SUBSTITUTION; GENOMEWIDE; OBESITY; RISK	Genomewide association studies are now a widely used approach in the search for loci that affect complex traits. After detection of significant association, estimates of penetrance and allele-frequency parameters for the associated variant indicate the importance of that variant and facilitate the planning of replication studies. However, when these estimates are based on the original data used to detect the variant, the results are affected by an ascertainment bias known as the "winner's curse." The actual genetic effect is typically smaller than its estimate. This overestimation of the genetic effect may cause replication studies to fail because the necessary sample size is underestimated. Here, we present an approach that corrects for the ascertainment bias and generates an estimate of the frequency of a variant and its penetrance parameters. The method produces a point estimate and confidence region for the parameter estimates. We study the performance of this method using simulated data sets and show that it is possible to greatly reduce the bias in the parameter estimates, even when the original association study had low power. The uncertainty of the estimate decreases with increasing sample size, independent of the power of the original test for association. Finally, we show that application of the method to case-control data can improve the design of replication studies considerably.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA		Zollner, S (corresponding author), Univ Michigan, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	szoellne@umich.edu			NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG002772, R01 HG002772-05, HG002772, R01 HG002772-01, R01 HG002772-03, R01 HG002772-04, R01 HG002772-02] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL084729, U01 HL084729] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL084729] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002772] Funding Source: NIH RePORTER		Allison DB, 2002, AM J HUM GENET, V70, P575, DOI 10.1086/339273; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; CAPEN EC, 1971, J PETROL TECHNOL, V23, P641, DOI 10.2118/2993-PA; Clement K, 2000, INT J OBESITY, V24, P391, DOI 10.1038/sj.ijo.0801191; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mancini FP, 1999, DIABETES, V48, P1466, DOI 10.2337/diabetes.48.7.1466; Meirhaeghe A, 2000, INT J OBESITY, V24, P195, DOI 10.1038/sj.ijo.0801112; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Ringel J, 1999, BIOCHEM BIOPH RES CO, V254, P450, DOI 10.1006/bbrc.1998.9962; Siegmund D, 2002, AM J HUM GENET, V71, P1183, DOI 10.1086/343819; Sun L, 2005, GENET EPIDEMIOL, V28, P352, DOI 10.1002/gepi.20068; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; [No title captured]	21	270	274	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					605	615		10.1086/512821			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	WOS:000245465200003	17357068	Green Published, Bronze			2022-01-24	
J	Rollins, RA; Haghighi, F; Edwards, JR; Das, R; Zhang, MQ; Ju, JY; Bestor, TH				Rollins, RA; Haghighi, F; Edwards, JR; Das, R; Zhang, MQ; Ju, JY; Bestor, TH			Large-scale structure of genomic methylation patterns	GENOME RESEARCH			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; TRANSCRIPTION; REPLICATION; ELEMENTS; WIDE	The mammalian genome depends on patterns of methylated cytosines for normal function, but the relationship between genomic methylation patterns and the underlying sequence is unclear. We have characterized the methylation landscape of the human genome by global analysis of patterns of CpG depletion and by direct sequencing of 3073 unmethylated domains and 2565 methylated domains from human brain DNA. The genome was found to consist of short (< 4 kb) unmethylated domains embedded in a matrix of long methylated domains. Unmethylated domains were enriched in promoters, CpG islands, and first exons, while methylated domains comprised interspersed and tandem-repeated sequences, exons other than first exons, and non-annotated single-copy sequences that are depleted in the CpG dinucleotide. The enrichment of regulatory sequences in the relatively small unmethylated compartment suggests that cytosine methylation constrains the effective size of the genome through the selective exposure of regulatory sequences. This buffers regulatory networks against changes in total genome size and provides an explanation for the C value paradox, which concerns the wide variations in genome size that scale independently of gene number. This Suggestion is compatible with the finding that cytosine methylation is universal among large-genome eukaryotes, while many eukaryotes with genome sizes < 5 x 10(8) bp do not methylate their DNA.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ, Dept Chem Engn, New York, NY 10032 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA		Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	THB12@Columbia.edu	Rollins, Robert/R-2978-2019				Aerts S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-34; ANTEQUERA F, 1989, CELL, V58, P509, DOI 10.1016/0092-8674(89)90431-5; Bestor TH, 2003, TRENDS GENET, V19, P185, DOI 10.1016/S0168-9525(03)00049-0; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Jojic V, 2004, BIOINFORMATICS, V20, P161, DOI 10.1093/bioinformatics/bth917; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; Oda M, 1998, J MOL BIOL, V276, P571, DOI 10.1006/jmbi.1997.1564; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P3418, DOI 10.1073/pnas.79.11.3418; THOMAS CA, 1971, ANNU REV GENET, V5, P237, DOI 10.1146/annurev.ge.05.120171.001321; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; TYKOCINSKI ML, 1984, NUCLEIC ACIDS RES, V12, P4385, DOI 10.1093/nar/12.10.4385; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; WIGLER M, 1981, CELL, V24, P33, DOI 10.1016/0092-8674(81)90498-0; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	36	270	287	1	10	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2006	16	2					157	163		10.1101/gr.4262006			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	009OP	WOS:000235122000002	16365381				2022-01-24	
J	Curran, JE; Jowett, JBM; Elliott, KS; Gao, Y; Gluschenko, K; Wang, JM; Azim, DMA; Cai, GW; Mahaney, MC; Comuzzie, AG; Dyer, TD; Walder, KR; Zimmet, P; MacCluer, JW; Collier, GR; Kissebah, AH; Blangero, J				Curran, JE; Jowett, JBM; Elliott, KS; Gao, Y; Gluschenko, K; Wang, JM; Azim, DMA; Cai, GW; Mahaney, MC; Comuzzie, AG; Dyer, TD; Walder, KR; Zimmet, P; MacCluer, JW; Collier, GR; Kissebah, AH; Blangero, J			Genetic variation in selenoprotein S influences inflammatory response	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; 15Q26 IDDM3; PROTEIN; POPULATION; COMPLEX; RISK; SUSCEPTIBILITY; POLYMORPHISM; METABOLISM; EXPRESSION	Chronic inflammation has a pathological role in many common diseases and is influenced by both genetic and environmental factors. Here we assess the role of genetic variation in selenoprotein S (SEPS1, also called SELS or SELENOS), a gene involved in stress response in the endoplasmic reticulum and inflammation control. After resequencing SEPS1, we genotyped 13 SNPs in 522 individuals from 92 families. As inflammation biomarkers, we measured plasma levels of IL-6, IL-1 beta and TNF-alpha. Bayesian quantitative trait nucleotide analysis identified associations between SEPS1 polymorphisms and all three proinflammatory cytokines. One promoter variant, -105G-->A, showed strong evidence for an association with each cytokine (multivariate P = 0.0000002). Functional analysis of this polymorphism showed that the A variant significantly impaired SEPS1 expression after exposure to endoplasmic reticulum stress agents (P = 0.00006). Furthermore, suppression of SEPS1 by short interfering RNA in macrophage cells increased the release of IL-6 and TNF-alpha. To investigate further the significance of the observed associations, we genotyped -105G-->A in 419 Mexican American individuals from 23 families for replication. This analysis confirmed a significant association with both TNF-alpha (P = 0.0049) and IL- 1 beta (P = 0.0101). These results provide a direct mechanistic link between SEPS1 and the production of inflammatory cytokines and suggest that SEPS1 has a role in mediating inflammation.	SW Fdn Biomed Res, San Antonio, TX 78227 USA; Int Diabet Inst, Caulfield, Vic, Australia; ChemGenex Pharmaceut, Geelong, Vic, Australia; Deakin Univ, Sch Hlth Sci, Metab Res Unit, Waurn Ponds, Vic, Australia		Blangero, J (corresponding author), SW Fdn Biomed Res, San Antonio, TX 78227 USA.	john@darwin.sfbr.org	Zimmet, Paul/O-8486-2019; Jowett, Jeremy/A-3809-2009; Blangero, John/ABA-7175-2021	Zimmet, Paul/0000-0003-0627-0776; Curran, Joanne/0000-0002-6898-155X			Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Arthur JR, 2003, P NUTR SOC, V62, P393, DOI 10.1079/PNS2003254; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blangero J, 2003, J THROMB HAEMOST, V1, P1391, DOI 10.1046/j.1538-7836.2003.00310.x; BLANGERO J, IN PRESS HUM BIOL; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Caspersen C, 2000, J BIOL CHEM, V275, P22363, DOI 10.1074/jbc.M001569200; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; de Maat MPM, 2004, ARTERIOSCL THROM VAS, V24, P2168, DOI 10.1161/01.ATV.0000143856.01669.e7; Ferencik M, 2003, FOLIA MICROBIOL, V48, P417, DOI 10.1007/BF02931378; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Gao Y, 2003, DIABETES, V52, P929, DOI 10.2337/diabetes.52.4.929; Karlsson HKR, 2004, DIABETES, V53, P1424, DOI 10.2337/diabetes.53.6.1424; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Long AD, 1998, GENETICS, V149, P999; MacCluer JW, 1999, NUTR REV, V57, pS59, DOI 10.1111/j.1753-4887.1999.tb01790.x; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Pantsulaia I, 2002, CYTOKINE, V19, P138, DOI 10.1006/cyto.2002.1959; Phillips PC, 1999, TRENDS GENET, V15, P6, DOI 10.1016/S0168-9525(98)01622-9; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Saadeddin Salam M, 2002, Med Sci Monit, V8, pRA5; Stengard JH, 2002, AM J HUM GENET, V71, P501, DOI 10.1086/342217; Susi M, 2001, SCAND J GASTROENTERO, V36, P372, DOI 10.1080/003655201300051153; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Williams-Blangero S, 2004, HUM BIOL, V76, P515, DOI 10.1353/hub.2004.0062; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zamani M, 1996, HUM GENET, V98, P491, DOI 10.1007/s004390050245	35	270	283	3	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1234	1241		10.1038/ng1655			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	WOS:000233045200023	16227999	Green Published			2022-01-24	
J	Burgard, AP; Nikolaev, EV; Schilling, CH; Maranas, CD				Burgard, AP; Nikolaev, EV; Schilling, CH; Maranas, CD			Flux coupling analysis of genome-scale metabolic network reconstructions	GENOME RESEARCH			English	Article							HAEMOPHILUS-INFLUENZAE RD; IN-SILICO MODELS; ESCHERICHIA-COLI; PATHWAY ANALYSIS; SYSTEMS PROPERTIES; MUTANTS; CAPABILITIES; ORGANIZATION; DEFINITION; REDUNDANCY	In this paper, we introduce the Flux Coupling Finder (FCF) framework for elucidating the topological and flux connectivity features of genome-scale metabolic networks. The framework is demonstrated on genome-scale metabolic reconstructions of Helicobacter pylori, Escherichia coli, and Saccharomyces cerevisiae. The analysis allows one to determine whether any two metabolic fluxes, v(1) and v(2), are (1) directionally coupled, if a non-zero flux for v(1) implies a non-zero flux for v(2) but not necessarily the reverse; (2) partially coupled, if a non-zero flux for v(1) implies a non-zero, though variable, flux for v(2) and vice versa; or (3) fully coupled, if a non-zero flux for v(1) implies not only a non-zero but also a fixed flux for v(2) and vice versa. Flux coupling analysis also enables the global identification of blocked reactions, which are all reactions incapable of carrying flux under a certain condition; equivalent knockouts, defined as the set of all possible reactions whose deletion forces the flux through a particular reaction to zero; and sets of affected reactions denoting all reactions whose fluxes are forced to zero if a particular reaction is deleted. The FCF approach thus provides a novel and versatile tool for aiding metabolic reconstructions and guiding genetic manipulations.	Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; Genomat Inc, San Diego, CA 92121 USA		Maranas, CD (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398; Nikolaev, Evgeni/0000-0001-6594-5580			Badarinarayana V, 2001, NAT BIOTECHNOL, V19, P1060, DOI 10.1038/nbt1101-1060; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880; Burgard AP, 2001, BIOTECHNOL BIOENG, V74, P364, DOI 10.1002/bit.1127; Carlson R, 2002, BIOTECHNOL BIOENG, V79, P121, DOI 10.1002/bit.10305; Covert MW, 2003, J THEOR BIOL, V221, P309, DOI 10.1006/jtbi.2003.3071; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 1999, J BIOL CHEM, V274, P17410, DOI 10.1074/jbc.274.25.17410; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; GOLUB G. H., 2013, MATRIX COMPUTATIONS, V4th; Gruer MJ, 1997, MICROBIOL-UK, V143, P1837, DOI 10.1099/00221287-143-6-1837; Heinrich R., 1996, REGULATION CELLULAR; HELLING RB, 1971, J BACTERIOL, V105, P1224, DOI 10.1128/JB.105.3.1224-1226.1971; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KHOLODENKO BN, 1995, FEBS LETT, V368, P1, DOI 10.1016/0014-5793(95)00562-N; Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3; Klamt S, 2003, BIOINFORMATICS, V19, P261, DOI 10.1093/bioinformatics/19.2.261; Klamt S, 2002, MOL BIOL REP, V29, P233, DOI 10.1023/A:1020390132244; LAKSHMI TM, 1976, J BACTERIOL, V127, P76, DOI 10.1128/JB.127.1.76-83.1976; Palsson BO, 2003, TRENDS BIOTECHNOL, V21, P195, DOI 10.1016/S0167-7799(03)00080-5; Papin JA, 2002, J THEOR BIOL, V215, P67, DOI 10.1006/jtbi.2001.2499; Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251; PHARKYA P, 2004, IN PRESS BIOTECHNOL; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Price ND, 2002, GENOME RES, V12, P760, DOI 10.1101/gr.218002; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; REEDJL, 2003, GENOME BIOL, V4, pR54; Rohwer JM, 1996, J THEOR BIOL, V179, P213, DOI 10.1006/jtbi.1996.0062; Salgado H, 2001, NUCLEIC ACIDS RES, V29, P72, DOI 10.1093/nar/29.1.72; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 2002, BIOINFORMATICS, V18, P351, DOI 10.1093/bioinformatics/18.2.351; SCHUTZ EA, 1994, SPORTS MED ARTHROSC, V2, P165; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; VARMA A, 1993, APPL ENVIRON MICROB, V59, P2465, DOI 10.1128/AEM.59.8.2465-2473.1993; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711	44	270	279	0	14	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2004	14	2					301	312		10.1101/gr.1926504			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	771XR	WOS:000188811800012	14718379	Green Published, Bronze			2022-01-24	
J	Rey, MW; Ramaiya, P; Nelson, BA; Brody-Karpin, SD; Zaretsky, EJ; Tang, M; de Leon, AL; Xiang, H; Gusti, V; Clausen, IG; Olsen, PB; Rasmussen, MD; Andersen, JT; Jorgensen, PL; Larsen, TS; Sorokin, A; Bolotin, A; Lapidus, A; Galleron, N; Ehrlich, SD; Berka, RM				Rey, MW; Ramaiya, P; Nelson, BA; Brody-Karpin, SD; Zaretsky, EJ; Tang, M; de Leon, AL; Xiang, H; Gusti, V; Clausen, IG; Olsen, PB; Rasmussen, MD; Andersen, JT; Jorgensen, PL; Larsen, TS; Sorokin, A; Bolotin, A; Lapidus, A; Galleron, N; Ehrlich, SD; Berka, RM			Complete genome sequence of the industrial bacterium Bacillus licheniformis and comparisons with closely related Bacillus species	GENOME BIOLOGY			English	Article							PROTEIN FAMILIES; STRAINS; SUBTILIS; IDENTIFICATION; TRANSFORMATION; PREDICTION; INITIATION; RESOURCE; DATABASE; PROGRAM	Background: Bacillus licheniformis is a Gram-positive, spore-forming soil bacterium that is used in the biotechnology industry to manufacture enzymes, antibiotics, biochemicals and consumer products. This species is closely related to the well studied model organism Bacillus subtilis, and produces an assortment of extracellular enzymes that may contribute to nutrient cycling in nature. Results: We determined the complete nucleotide sequence of the B. licheniformis ATCC 14580 genome which comprises a circular chromosome of 4,222,336 base-pairs ( bp) containing 4,208 predicted protein-coding genes with an average size of 873 bp, seven rRNA operons, and 72 tRNA genes. The B. licheniformis chromosome contains large regions that are colinear with the genomes of B. subtilis and Bacillus halodurans, and approximately 80% of the predicted B. licheniformis coding sequences have B. subtilis orthologs. Conclusions: Despite the unmistakable organizational similarities between the B. licheniformis and B. subtilis genomes, there are notable differences in the numbers and locations of prophages, transposable elements and a number of extracellular enzymes and secondary metabolic pathway operons that distinguish these species. Differences include a region of more than 80 kilobases (kb) that comprises a cluster of polyketide synthase genes and a second operon of 38 kb encoding plipastatin synthase enzymes that are absent in the B. licheniformis genome. The availability of a completed genome sequence for B. licheniformis should facilitate the design and construction of improved industrial strains and allow for comparative genomics and evolutionary studies within this group of Bacillaceae.	Novozymes Biotech Inc, Davis, CA 95616 USA; Novozymes AS, DK-2880 Bagsvaerd, Denmark; INRA, F-75007 Paris, France; AstraZeneca Int, SE-22187 Lund, Sweden; Joint Genome Inst, Walnut Creek, CA 94598 USA		Berka, RM (corresponding author), Novozymes Biotech Inc, 1445 Drew Ave, Davis, CA 95616 USA.	ramb@novozymes.com	Bolotine, Alexandre/AAW-1156-2020; Lapidus, Alla L/I-4348-2013; Ehrlich, S./Y-2423-2019; Sorokin, Alexei/AAV-4666-2020	Bolotine, Alexandre/0000-0002-5878-8270; Lapidus, Alla L/0000-0003-0427-8731; Ehrlich, S./0000-0002-7563-4046; Sorokin, Alexei/0000-0002-8653-9896			Agata N., 2002, Abstracts of the General Meeting of the American Society for Microbiology, V102, P374; Alexander M., 1977, Introduction to soil microbiology.; Altena K, 2000, APPL ENVIRON MICROB, V66, P2565, DOI 10.1128/AEM.66.6.2565-2571.2000; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Christensen BB, 1999, J BACTERIOL, V181, P2683, DOI 10.1128/JB.181.9.2683-2688.1999; De Clerck E, 2004, FEMS MICROBIOL LETT, V231, P91, DOI 10.1016/S0378-1097(03)00935-2; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Erickson RJ, 1976, MICROBIOLOGY 1976, P406; EVELEIGH DE, 1981, SCI AM, V245, P155; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; GHERNA R, 1989, AM TYPE CULTURE COLL; Grangemard I, 2001, APPL BIOCHEM BIOTECH, V90, P199, DOI 10.1385/ABAB:90:3:199; GWINN DD, 1964, J BACTERIOL, V87, P519, DOI 10.1128/JB.87.3.519-526.1964; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hoffmann A, 2002, FARMACO, V57, P685, DOI 10.1016/S0014-827X(02)01208-9; Ishihara H, 2002, CURR MICROBIOL, V45, P18, DOI 10.1007/s00284-001-0041-5; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; KATZ E, 1977, BACTERIOL REV, V41, P449, DOI 10.1128/MMBR.41.2.449-474.1977; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KOONIN EV, 2002, SEQUENCE EVOLUTION F; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lapidus A, 2002, FEMS MICROBIOL LETT, V209, P23, DOI 10.1111/j.1574-6968.2002.tb11104.x; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; LOGAN NA, 1981, AEROBIC ENDOSPORE FO, P106; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Majka J, 1999, EUR J BIOCHEM, V260, P325, DOI 10.1046/j.1432-1327.1999.00168.x; Manachini PL, 1998, SYST APPL MICROBIOL, V21, P520, DOI 10.1016/S0723-2020(98)80064-7; Neyra C, 1996, CAHIERS OPT MED, V31, P447; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; ODONNELL AG, 1980, INT J SYST BACTERIOL, V30, P448, DOI 10.1099/00207713-30-2-448; Pag U, 2002, CURR PHARM DESIGN, V8, P815, DOI 10.2174/1381612023395439; Pedersen PB, 2002, REGUL TOXICOL PHARM, V36, P155, DOI 10.1006/rtph.2002.1574; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rocha EPC, 1999, NUCLEIC ACIDS RES, V27, P3567, DOI 10.1093/nar/27.17.3567; Salkinoja-Salonen MS, 1999, APPL ENVIRON MICROB, V65, P4637; Schiex T, 2003, NUCLEIC ACIDS RES, V31, P3738, DOI 10.1093/nar/gkg610; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; SONNENSHEIN AL, 1993, BACILLUS SUBTILIS OT; Soong CL, 1999, APPL ENVIRON MICROB, V65, P1459; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Takahashi S, 2002, J INFECT DIS, V186, P1034, DOI 10.1086/342950; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THORNE CB, 1966, J BACTERIOL, V91, P1012, DOI 10.1128/JB.91.3.1012-1020.1966; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Wilson RK, 1997, GENOME ANAL, V1, P397; Wu CH, 2002, NUCLEIC ACIDS RES, V30, P35, DOI 10.1093/nar/30.1.35; Xu D, 2003, INT J SYST EVOL MICR, V53, P695, DOI 10.1099/ijs.0.02346-0; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	56	270	853	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2004	5	10							R77	10.1186/gb-2004-5-10-r77			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	859DS	WOS:000224243400010	15461803	Green Published, hybrid			2022-01-24	
J	Leegwater, PAJ; Vermeulen, G; Konst, AAM; Naidu, S; Mulders, J; Visser, A; Kersbergen, P; Mobach, D; Fonds, D; van Berkel, CGM; Lemmers, RJLF; Frants, RR; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS				Leegwater, PAJ; Vermeulen, G; Konst, AAM; Naidu, S; Mulders, J; Visser, A; Kersbergen, P; Mobach, D; Fonds, D; van Berkel, CGM; Lemmers, RJLF; Frants, RR; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS			Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter	NATURE GENETICS			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; GLYCOGEN-SYNTHASE KINASE-3; SIGNAL-TRANSDUCTION; EPSILON-SUBUNIT; IDENTIFICATION; EIF2B-EPSILON; INACTIVATION; DOMAINS; INSULIN; YEAST	Leukoencephalopathy with vanishing white matter (VWM) is an inherited brain disease that occurs mainly in children. The course is chronic-progressive with additional episodes of rapid deterioration following febrile infection or minor head trauma. We have identified mutations in EIF2B5 and EIF2B2, encoding the epsilon- and beta -subunits of the translation initiation factor eIF2B and located on chromosomes 3q27 and 14q24, respectively, as causing VWM. We found 16 different mutations in EIF2B5 in 29 patients from 23 families. We also found two distantly related individuals who were homozygous with respect to a missense mutation in EIF2B2, affecting a conserved amino acid. Three other patients also had mutations in EIF2B2. As eIF2B has an essential role in the regulation of translation under different conditions, including stress, this may explain the rapid deterioration of people with VWM under stress. Mutant translation initiation factors have not previously been implicated in disease.	Free Univ Amsterdam, Med Ctr, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Clin Chem, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1081 BT Amsterdam, Netherlands; Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA; Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands		Pronk, JC (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Human Genet, Van Der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.			Leegwater, Peter/0000-0002-4100-015X			Anthony TG, 2000, BBA-GENE STRUCT EXPR, V1492, P56, DOI 10.1016/S0167-4781(00)00062-2; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; Clemens MJ, 1996, TRANSLATIONAL CONTRO, V30, P139; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; HANEFELD F, 1993, NEUROPEDIATRICS, V24, P244, DOI 10.1055/s-2008-1071551; HINNEBUSCH AG, 1996, TRANSLATIONAL CONTRO, P194; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Price NT, 1996, BIOCHEM J, V318, P637, DOI 10.1042/bj3180637; Quevedo C, 2000, J BIOL CHEM, V275, P19192, DOI 10.1074/jbc.M000238200; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Scheper GC, 1997, J BIOL CHEM, V272, P26850, DOI 10.1074/jbc.272.43.26850; Scheper GC, 1998, BIOCHEM J, V334, P463, DOI 10.1042/bj3340463; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Singh LP, 1996, BIOCHEMISTRY-US, V35, P3206, DOI 10.1021/bi9522099; van der Knaap MS, 1998, NEUROLOGY, V51, P540, DOI 10.1212/WNL.51.2.540; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; YOUSSOUFIAN H, 1986, NATURE, V324, P380, DOI 10.1038/324380a0	23	270	283	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					383	388		10.1038/ng764			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	WOS:000172507500012	11704758				2022-01-24	
J	Wang, JB; Mager, J; Chen, YJ; Schneider, E; Cross, JC; Nagy, A; Magnuson, T				Wang, JB; Mager, J; Chen, YJ; Schneider, E; Cross, JC; Nagy, A; Magnuson, T			Imprinted X inactivation maintained by a mouse Polycomb group gene	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; DROSOPHILA; EMBRYOS; COMPLEX; EED; DIFFERENTIATION; MAINTENANCE; ACETYLATION	In mammals, dosage compensation of X-linked genes is achieved by the transcriptional silencing of one X chromosome in the female (reviewed in ref. 1). This process, called X inactivation, is usually random in the embryo proper. In marsupials and the extra-embryonic region of the mouse, however, X inactivation is imprinted: the paternal X chromosome is preferentially inactivated whereas the maternal X is always active. Having more than one active X chromosome is deleterious to extra-embryonic development in the mouse(2). Here we show that the gene eed (embryonic ectoderm development)(3,4), a member of the mouse Polycomb group (Pc-G) of genes, is required for primary and secondary trophoblast giant cell development in female embryos. Results from mice carrying a paternally inherited X-linked green fluorescent protein (GFP) transgene implicate eed in the stable maintenance of imprinted X inactivation in extra-embryonic tissues. Based on the recent finding that the Eed protein interacts with histone deacetylases, we suggest that this maintenance activity involves hypoacetylation of the inactivated paternal X chromosome in the extra-embryonic tissues.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ Calgary, Dept Biochem & Mol Biol, Genes & Dev Res Grp, Calgary, AB, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada		Magnuson, T (corresponding author), Univ N Carolina, Dept Genet, CB 7264,102 Mason Farm Rd, Chapel Hill, NC 27599 USA.		Cross, James/F-4814-2011; Cross, James/AAU-2973-2020; Nagy, Andras/G-6465-2013	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378; Nagy, Andras/0000-0003-4311-0413			BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Faust C, 1998, DEVELOPMENT, V125, P4495; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hansen RS, 1996, HUM MOL GENET, V5, P1345, DOI 10.1093/hmg/5.9.1345; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Keohane AM, 1998, DEV GENET, V22, P65, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;65::AID-DVG7&gt;3.0.CO;2-5; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MIGEON BR, 1988, NATURE, V335, P93, DOI 10.1038/335093a0; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; O'Neill LP, 1999, EMBO J, V18, P2897, DOI 10.1093/emboj/18.10.2897; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; RINCHIK EM, 1993, MAMM GENOME, V4, P349, DOI 10.1007/BF00360583; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; STRUHL G, 1985, EMBO J, V4, P3259, DOI 10.1002/j.1460-2075.1985.tb04075.x; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; Tie F, 1998, DEVELOPMENT, V125, P3483; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	28	270	275	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					371	375		10.1038/ng574			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	WOS:000170174800019	11479595				2022-01-24	
J	Nelson, MR; Kardia, SLR; Ferrell, RE; Sing, CF				Nelson, MR; Kardia, SLR; Ferrell, RE; Sing, CF			A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation	GENOME RESEARCH			English	Article							LDL RECEPTOR GENE; APOLIPOPROTEIN-E PHENOTYPE; LIPOPROTEIN-LIPASE; DNA POLYMORPHISM; PLASMA-LIPIDS; B GENE; COMPLEX; AGE; POPULATION; VARIANCES	Recent advances in genome research have accelerated the process of locating candidate genes and the variable sites within them and have simplified the task of genotype measurement. The development of statistical and computational strategies to utilize information on hundreds - soon thousands - of variable loci to investigate the relationships between genome variation and phenotypic variation has not kept pace, particularly for quantitative traits that do not follow simple Mendelian patterns of inheritance. We present here the combinatorial partitioning method (CPM) that examines multiple genes, each containing multiple variable loci, to identify partitions of multilocus genotypes that predict interindividual variation in quantitative trait levels. We illustrate this method with an application to plasma triglyceride levels collected on 188 males, ages 20-60 yr, ascertained without regard to health status, from Rochester, Minnesota. Genotype information included measurements at 18 diallelic loci in six coronary heart disease-candidate susceptibility gene regions: APOA1-C3-A4, APOB, APOE, LDLR, LPL, and PON1. To illustrate the CPM, we evaluated all possible partitions of two-locus genotypes into two to nine partitions (similar to 10(6) evaluations). We found that many combinations of loci are involved in sets of genotypic partitions that predict triglyceride variability and that the most predictive sets show nonadditivity. These results suggest that traditional methods of building multilocus models that rely on statistically significant marginal, single-locus effects, may fail to identify combinations of loci that best predict trait variability. The CPM offers a strategy for exploring the high-dimensional genotype state space so as to predict the quantitative trait variation in the population at large that does not require the conditioning of the analysis on a prespecified genetic model.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA		Sing, CF (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	csing@umich.edu		Sing, Charles/0000-0001-5872-7956	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL039107, HL58240, HL39107] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL039107, R01HL058240] Funding Source: NIH RePORTER		BERG K, 1986, P NATL ACAD SCI USA, V83, P7367, DOI 10.1073/pnas.83.19.7367; BOERWINKLE E, 1986, AM J HUM GENET, V39, P137; BOERWINKLE E, 1989, NUCLEIC ACIDS RES, V17, P4003, DOI 10.1093/nar/17.10.4003; Breiman L., 1984, CLASSIFICATION REGRE CLASSIFICATION REGRE; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; COBB MM, 1992, CIRCULATION, V86, P849, DOI 10.1161/01.CIR.86.3.849; COLEMAN RT, 1986, MOL BIOL MED, V3, P213; Comtet L., 1974, ADV COMBINATORICS AR; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; FRANKLIN I, 1970, GENETICS, V65, P707; FUNKE H, 1988, NUCLEIC ACIDS RES, V16, P2741, DOI 10.1093/nar/16.6.2741; Goldberg D. E., 1989, GENETIC ALGORITHMS S; HEIZMANN C, 1987, NUCLEIC ACIDS RES, V15, P6763; HOBBS HH, 1987, NUCLEIC ACIDS RES, V15, P379, DOI 10.1093/nar/15.1.379; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Jarvik GP, 1997, AM J HUM GENET, V61, P171, DOI 10.1086/513902; KESSLING AM, 1985, CLIN GENET, V28, P296; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Knuth DE, 1997, ART COMPUTER PROGRAM, V1; Kohavi R., 1995, P 14 INT C ART INT M, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; KOTZE MJ, 1986, S AFR MED J, V70, P77; LEITERSDORF E, 1987, NUCLEIC ACIDS RES, V15, P2782, DOI 10.1093/nar/15.6.2782; Lewontin Richard C., 1992, P137; LI SR, 1988, NUCLEIC ACIDS RES, V16, P2358, DOI 10.1093/nar/16.5.2358; Lussier-Cacan S, 1999, AM J EPIDEMIOL, V150, P1229, DOI 10.1093/oxfordjournals.aje.a009950; Nelson MR, 1999, ANN HUM GENET, V63, P311, DOI 10.1046/j.1469-1809.1999.6340311.x; NILSSONEHLE H, 1909, KREUZUNGUNTERSUCHUNG; *OMIM, 2000, CTR MED GEN; PRIESTLEY L, 1985, NUCLEIC ACIDS RES, V13, P6792, DOI 10.1093/nar/13.18.6792; RALL SC, 1982, J BIOL CHEM, V257, P4171; REES A, 1983, LANCET, V1, P444; REILLY SL, 1992, AM J HUM GENET, V51, P1311; REILLY SL, 1991, AM J HUM GENET, V49, P1155; RIPLEY BD, 1998, PATTERN RECOGNITION; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SHOULDERS CC, 1985, ATHEROSCLEROSIS, V58, P277, DOI 10.1016/0021-9150(85)90073-5; Sing CF, 1996, CIBA F SYMP, V197, P211; Stone M., 1978, Mathematische Operationsforschung und Statistik, Series Statistics, V9, P127, DOI 10.1080/02331887808801414; Taimela S, 1996, METABOLISM, V45, P797, DOI 10.1016/S0026-0495(96)90149-3; TEMPLETON AR, 1976, GENETICS, V82, P349; TEMPLETON AR, 2000, EPISTASIS EVOLUTIONA; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; TURNER ST, 1989, HYPERTENSION, V13, P378, DOI 10.1161/01.HYP.13.4.378; Wijsman EM, 2001, HUM HERED, V51, P145, DOI 10.1159/000053335; WRIGHT S, 1923, P 6 INT C GEN, V1, P356; YAMAKAWA K, 1987, NUCLEIC ACIDS RES, V15, P7659, DOI 10.1093/nar/15.18.7659; Zerba KE, 1996, GENETICS, V143, P463; Zerba KE, 1998, HUM GENET, V103, P346, DOI 10.1007/s004390050828; Zerba KE, 2000, HUM GENET, V107, P466, DOI 10.1007/s004390000394	51	270	277	4	8	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAR	2001	11	3					458	470		10.1101/gr.172901			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	407DG	WOS:000167255700016	11230170	Green Published, Bronze			2022-01-24	
J	Lai, CH; Chou, CY; Ch'ang, LY; Liu, CS; Lin, WC				Lai, CH; Chou, CY; Ch'ang, LY; Liu, CS; Lin, WC			Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics	GENOME RESEARCH			English	Article							HUMAN-GENOME-PROJECT; EXPRESSED SEQUENCE TAGS; INTEGRATED RESOURCE; CODING REGIONS; YEAST GENOME; DISCOVERY; DATABASES; PROTEINS; INFORMATION; FAMILY	Modern biomedical research greatly benefits from large-scale genome-sequencing projects ranging from studies of viruses, bacteria, and yeast to multicellular organisms, like Caenorhabditis elegans. Comparative genomic studies offer a vast array of prospects for identification and functional annotation of human ortholog genes. We presented a novel comparative proteomic approach for assembling human gene contigs and assisting gene discovery. The C. elegans proteome was used as an alignment template to assist in novel human gene identification from human EST nucleotide databases. Among the available 18,452 C. elegans protein sequences, our results indicate that at least 83% (15,344 sequences) of C. elegans proteome has human homologous genes, with 7,954 records of C. elegans proteins matching known human gene transcripts. Only 11% or less of C. elegans proteome contains nematode-specific genes. We Found that the remaining 7,390 sequences might lead to discoveries of novel human genes, and over 150 putative Full-length human gene transcripts were assembled upon Further database analyses.	Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; Chung Yuan Christian Univ, Dept Informat Engn, Chungli, Taiwan		Lin, WC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	wenlin@ibms.sinica.edu.tw	Lin, Wen-chang/B-3100-2011; Lin, Wen-chang/ABH-7976-2020	Lin, Wen-chang/0000-0003-0194-1745; Lin, Wen-chang/0000-0003-0194-1745			Aaronson JS, 1996, GENOME RES, V6, P829, DOI 10.1101/gr.6.9.829; ADAMS MD, 1995, NATURE, V377, P3; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Andrade MA, 1997, YEAST, V13, P1363, DOI 10.1002/(SICI)1097-0061(199711)13:14<1363::AID-YEA182>3.0.CO;2-8; Bailey LC, 1998, GENOME RES, V8, P362, DOI 10.1101/gr.8.4.362; Banfi S, 1997, HUM MOL GENET, V6, P1745, DOI 10.1093/hmg/6.10.1745; Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Burke J, 1998, GENOME RES, V8, P276, DOI 10.1101/gr.8.3.276; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Claverie JM, 1997, HUM MOL GENET, V6, P1735, DOI 10.1093/hmg/6.10.1735; COLLINS F, 1993, SCIENCE, V262, P43, DOI 10.1126/science.8211127; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Greller LD, 1999, GENOME RES, V9, P282; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Lin JS, 1998, J BIOMED SCI, V5, P101, DOI 10.1159/000025319; Lin WC, 1999, BIOCHEM BIOPH RES CO, V264, P789, DOI 10.1006/bbrc.1999.1594; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; Marra M, 1999, NAT GENET, V21, P191, DOI 10.1038/5976; Miller G, 1997, GENOME RES, V7, P1027, DOI 10.1101/gr.7.10.1027; Murakami K, 1998, BIOINFORMATICS, V14, P665, DOI 10.1093/bioinformatics/14.8.665; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; OLSON MV, 1993, P NATL ACAD SCI USA, V90, P4338, DOI 10.1073/pnas.90.10.4338; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Pietu G, 1999, GENOME RES, V9, P195; Rawlings CJ, 1997, CURR OPIN GENET DEV, V7, P416, DOI 10.1016/S0959-437X(97)80158-X; Rossi DL, 1997, J IMMUNOL, V158, P1033; Schuler GD, 1997, J MOL MED, V75, P694, DOI 10.1007/s001090050155; Sluder AE, 1999, GENOME RES, V9, P103; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wasinger VC, 1998, FEMS MICROBIOL LETT, V169, P375, DOI 10.1111/j.1574-6968.1998.tb13343.x; WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665; White O, 1996, METHOD ENZYMOL, V266, P27; Wu CH, 1998, BIOINFORMATICS, V14, P223, DOI 10.1093/bioinformatics/14.2.223; Yuan YP, 1998, BIOINFORMATICS, V14, P285, DOI 10.1093/bioinformatics/14.3.285	46	270	435	3	50	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2000	10	5					703	713		10.1101/gr.10.5.703			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	314UZ	WOS:000087077100013	10810093	Green Published, Bronze			2022-01-24	
J	Hayashi, YK; Chou, FL; Engvall, E; Ogawa, M; Matsuda, C; Hirabayashi, S; Yokochi, K; Ziober, BL; Kramer, RH; Kaufman, SJ; Ozawa, E; Goto, Y; Nonaka, I; Tsukahara, T; Wang, JZ; Hoffman, EP; Arahata, K				Hayashi, YK; Chou, FL; Engvall, E; Ogawa, M; Matsuda, C; Hirabayashi, S; Yokochi, K; Ziober, BL; Kramer, RH; Kaufman, SJ; Ozawa, E; Goto, Y; Nonaka, I; Tsukahara, T; Wang, JZ; Hoffman, EP; Arahata, K			Mutations in the integrin alpha 7 gene cause congenital myopathy	NATURE GENETICS			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; CYTOPLASMIC DOMAINS; NERVOUS-SYSTEM; CHAIN GENE; EXPRESSION; LAMININ; MEROSIN; DEFICIENCY	The basal lamina of muscle fibers plays a crucial role in the of development and function of skeletal muscle. An important laminin receptor in muscle is integrin alpha 7 beta 1D. Integrin beta 1 is expressed throughout the body, while integrin alpha 7 is more muscle-specific(1-5). To address the role of integrin alpha 7 in human muscle disease, we determined alpha 7 protein expression in muscle biopsies from 117 patients with unclassified congenital myopathy and congenital muscular dystrophy by immunocytochemistry. We found three unrelated patients with integrin alpha 7 deficiency and normal laminin alpha 2 chain expression. To determine nine if any of these three patients had mutations of the integrin alpha 7 gene, ITGA7, we cloned and sequenced the full-length human ITGA7 cDNA, and screened the patients for mutations. One patient had splice mutations on both alleles; one causing a 21-bp insertion in the conserved cysteine-rich region, and the other causing a 98-bp deletion, A second patient was a compound heterozygote for the same 98-bp deletion, and had a l-bp frame-shift deletion on the other allele. A third showed marked deficiency of ITGA7 mRNA, Clinically, these patients showed congenital myopathy with delayed motor milestones, Our results demonstrate that mutations in ITGA7 are involved in a form of congenital myopathy.	Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 187, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Cell Biol, Kodaira, Tokyo 187, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 187, Japan; Univ Pittsburgh, Sch Med, Dept Human Genet, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; La Jolla Canc Res Ctr, Burnham Inst, La Jolla, CA 92037 USA; Agcy Ind Sci & Technol, Natl Inst Biosci & Human Technol, Dept Biomol Engn, Oho, Ibaraki 305, Japan; Nagano Childrens Hosp, Dept Pediat, Nagano 399, Japan; Seirei Mikatabara Hosp, Dept Neuropediat, Shizuoka 433, Japan; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA		Arahata, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 187, Japan.	arahata@ncnaxp.ncnp.go.jp		Hoffman, Eric/0000-0001-6470-5139	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG014632] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 14632] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R01 29525] Funding Source: Medline		ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; BANKER BQ, 1994, MYOLOGY, P1275; COLLO G, 1993, J BIOL CHEM, V268, P19019; DUBOWITZ V, 1989, COLOR ATLAS MUSCLE D, P52; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Guicheney P, 1997, NEUROMUSCULAR DISORD, V7, P180, DOI 10.1016/S0960-8966(97)00460-4; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hodges BL, 1997, J CELL SCI, V110, P2873; Kil SH, 1996, INT J DEV NEUROSCI, V14, P181, DOI 10.1016/0736-5748(96)00006-8; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; MIZUNO Y, 1994, MUSCLE NERVE, V17, P206, DOI 10.1002/mus.880170212; Nagano A, 1996, NAT GENET, V12, P254, DOI 10.1038/ng0396-254; PHILPOT J, 1995, NEUROMUSCULAR DISORD, V5, P301, DOI 10.1016/0960-8966(94)00069-L; Pulkkinen L, 1997, HUM MOL GENET, V6, P669, DOI 10.1093/hmg/6.5.669; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; SONG WK, 1993, J CELL SCI, V106, P1139; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; VACHON P, 1997, J CLIN INVEST, V100, P170; Velling T, 1996, DEV DYNAM, V207, P355, DOI 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G; VIDAL F, 1995, GENOMICS, V30, P273, DOI 10.1006/geno.1995.9877; VONDERMARK H, 1991, J BIOL CHEM, V266, P23593; WANG W, 1995, GENOMICS, V26, P56; YOSHIDA M, 1993, J BIOCHEM-TOKYO, V114, P634, DOI 10.1093/oxfordjournals.jbchem.a124229; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773; [No title captured]	30	270	274	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					94	97		10.1038/ng0598-94			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	WOS:000073346700027	9590299				2022-01-24	
J	FitzGerald, MG; Bean, JM; Hegde, SR; Unsal, H; MacDonald, DJ; Harkin, DP; Finkelstein, DM; Isselbacher, KJ; Haber, DA				FitzGerald, MG; Bean, JM; Hegde, SR; Unsal, H; MacDonald, DJ; Harkin, DP; Finkelstein, DM; Isselbacher, KJ; Haber, DA			Heterozygous ATM mutations do not contribute to early onset of breast cancer	NATURE GENETICS			English	Article							ATAXIA-TELANGIECTASIA GENE; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; NORMAL DONORS; RADIOSENSITIVITY; FAMILIES; LYMPHOCYTES; PRODUCT; PROTEIN; HOMOLOG	Ataxia telangiectasia (AT) is a recessive syndrome, including cerebellar degeneration, immunologic defects and cancer predisposition(1,2), attributed to mutations in the recently isolated ATM (ataxia telangiectasia, mutated) gene(3). AT is diagnosed in 1/40,000 to 1/100,000 live births, with carriers calculated to comprise similar to 1% of the population. Studies of AT families have suggested that female relatives presumed to be carriers have a 5 to 8-fold increased risk for developing breast cancer(4,5), raising the possibility that germline ATM mutations may account for similar to 5% of all breast cancer cases. The increased risk for breast cancer reported for AT family members has been most evident among younger women, leading to an age-specific relative risk model predicting that 8% of breast cancer in women under age 40 arises in AT carriers, compared with 2% of cases between 40-59 years(6). To test this hypothesis, we undertook a germ-line mutational analysis of the ATM gene in a population of women with early onset of breast cancer, using a protein truncation (PTT) assay to detect chain-terminating mutations, which account for 90% of mutations identified in children with AT(7-11). We detected a heterozygous ATM mutation in 2/202 (1%) controls, consistent with the frequency of AT carriers predicted from epidemiologic studies. ATM mutations were present in only 2/401 (0.5%) women with early onset of breast cancer (P = 0.6). We conclude that heterozygous ATM mutations do not confer genetic predisposition to early onset of breast cancer.	MASSACHUSETTS GEN HOSP, CTR CANC, CTR CANC RISK ANAL, CHARLESTOWN, MA 02129 USA; MASSACHUSETTS GEN HOSP, CTR CANC, DEPT BIOSTAT, CHARLESTOWN, MA 02129 USA; HARVARD UNIV, SCH MED, CHARLESTOWN, MA 02129 USA					Bean, James/0000-0001-6733-5794			Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baumer A, 1996, HUM GENET, V98, P246, DOI 10.1007/s004390050202; BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; BORRESEN AL, 1990, GENE CHROMOSOME CANC, V2, P339, DOI 10.1002/gcc.2870020412; Byrd PJ, 1996, HUM MOL GENET, V5, P145, DOI 10.1093/hmg/5.1.145; COLE J, 1988, INT J RADIAT BIOL, V54, P929, DOI 10.1080/09553008814552331; CUNLIFFE PN, 1975, BRIT J RADIOL, V48, P374, DOI 10.1259/0007-1285-48-569-374; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HOULDSWORTH J, 1980, NUCLEIC ACIDS RES, V8, P3709, DOI 10.1093/nar/8.16.3709; Jorgensen TJ, 1996, INT J RADIAT BIOL, V69, P527, DOI 10.1080/095530096145535; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHANNA KK, 1993, ONCOGENE, V8, P3307; MORRELL D, 1986, J NATL CANCER I, V77, P89; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; PIPPARD EC, 1988, CANCER RES, V48, P2929; Ramsay J, 1996, LANCET, V347, P1627, DOI 10.1016/S0140-6736(96)91114-9; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; SHILOH Y, 1995, EUR J HUM GENET, V3, P116; STINE GJ, 1989, NEW HUMAN GENETICS, P393; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Telatar M, 1996, AM J HUM GENET, V59, P40; Thacker J, 1994, INT J RADIAT BIOL, V66, P587; Vorechovsky I, 1996, CANCER RES, V56, P4130; Vorechovsky I, 1996, CANCER RES, V56, P2726; WEST CML, 1995, INT J RADIAT BIOL, V68, P197, DOI 10.1080/09553009514551101; WOOSTER R, 1993, HUM GENET, V92, P91, DOI 10.1007/BF00216153; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8	39	270	272	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					307	310		10.1038/ng0397-307			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	WOS:A1997WK38600025	9054948				2022-01-24	
J	KOBAYASHI, T; HIRAYAMA, Y; KOBAYASHI, E; KUBO, Y; HINO, O				KOBAYASHI, T; HIRAYAMA, Y; KOBAYASHI, E; KUBO, Y; HINO, O			A GERMLINE INSERTION IN THE TUBEROUS SCLEROSIS (TSC2) GENE GIVES RISE TO THE EKER RAT MODEL OF DOMINANTLY INHERITED CANCER	NATURE GENETICS			English	Article								The Eker rat hereditary renal carcinoma (RC) is an excellent example of a mendelian dominant predisposition to a specific cancer in an experimental animal. We have previously established a new conserved linkage group on rat chromosome 10q and human chromosome 16p13.3, and shown that the Eker mutation is tightly linked to the tuberous sclerosis (Tsc2) gene. We now describe a germline mutation in the gene encoding Tsc2 caused by the insertion of an approximately 5 kilobase DNA fragment in the Eker rat, resulting in aberrant RNA expression from the mutant allele. The phenotype of tuberous sclerosis in humans differs from that of the Eker rat, except for the occurence of renal tumours. The Eker rat may therefore provide insights into species-specific differences in tumourigenesis and/or phenotype-specific mutations.	JAPANESE FDN CANC RES, INST CANC, DEPT EXPTL PATHOL, TOKYO 170, JAPAN								EKER R, 1961, NATURE, V189, P858, DOI 10.1038/189858b0; EVERITT JI, 1992, J UROLOGY, V148, P1932, DOI 10.1016/S0022-5347(17)37087-8; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HINO O, 1993, P NATL ACAD SCI USA, V90, P327, DOI 10.1073/pnas.90.1.327; HINO O, 1993, JPN J CANCER RES, V84, P1106, DOI 10.1111/j.1349-7006.1993.tb02808.x; HINO O, 1994, BIOCHEM BIOPH RES CO, V203, P1302, DOI 10.1006/bbrc.1994.2324; HINO O, 1993, P NATL ACAD SCI USA, V90, P730, DOI 10.1073/pnas.90.2.730; HINO O, 1985, INT J CANCER, V35, P5, DOI 10.1002/ijc.2910350103; HINO O, 1993, CANCER RES, V53, P5856; HINO O, 1994, CANCER LETT, V83, P117, DOI 10.1016/0304-3835(94)90307-7; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; KUBO Y, 1994, CANCER RES, V54, P2633; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; NELLIST M, 1993, CELL, V75, P1305; WARD CJ, 1994, CELL, V77, P881; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; YEUNG RS, 1993, P NATL ACAD SCI USA, V90, P8038, DOI 10.1073/pnas.90.17.8038	19	270	271	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1995	9	1					70	74		10.1038/ng0195-70			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	WOS:A1995PZ91300017	7704028				2022-01-24	
J	ZEMEL, S; BARTOLOMEI, MS; TILGHMAN, SM				ZEMEL, S; BARTOLOMEI, MS; TILGHMAN, SM			PHYSICAL LINKAGE OF 2 MAMMALIAN IMPRINTED GENES, H19 AND INSULIN-LIKE GROWTH FACTOR-II	NATURE GENETICS			English	Article							WIEDEMANN-BECKWITH SYNDROME; EARLY MOUSE EMBRYOGENESIS; FACTOR-II GENE; DOMINANT INHERITANCE; BETA-GLOBIN; EXPRESSION; YEAST; MICE; CHROMOSOME-11; GENOME	Parental imprinting is a phenomenon in mammals whereby the maternal and paternal alleles of a gene are differentially expressed. Three murine genes have been shown to display this type of allele-specific expression. Two of them, insulin-like growth factor-2 (Igf-2) and H19, map to the distal end of mouse chromosome 7, but are imprinted in opposite directions. Pulsed-field gel electrophoresis and large-fragment DNA cloning were utilized to establish a physical map that includes H19 and Igf-2. Igf-2 lies approximately 90 kilobases of DNA 5' to H19, in the same transcriptional orientation. This physical proximity is conserved in humans, based on pulsed-field gel analysis. We conclude that H19 and Igf-2 constitute an imprinted domain.	PRINCETON UNIV,HOWARD HUGHES MED INST,PRINCETON,NJ 08544; PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544								ALECK KA, 1989, AM J MED GENET, V33, P155, DOI 10.1002/ajmg.1320330202; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BELL GI, 1985, P NATL ACAD SCI USA, V82, P6450, DOI 10.1073/pnas.82.19.6450; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1982, MOUSE NEWS LETT, V66, P62; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DECHIARA TM, 1991, CELL, V64; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LEE JE, 1990, DEVELOPMENT, V110, P151; LUBINSKY M, 1974, LANCET, V1, P983; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; NICKOL JM, 1988, P NATL ACAD SCI USA, V85, P2548, DOI 10.1073/pnas.85.8.2548; NIIKAWA N, 1986, AM J MED GENET, V24, P41, DOI 10.1002/ajmg.1320240107; OMALLEY KL, 1988, NUCLEIC ACIDS RES, V16, P4437; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; PING AJ, 1989, AM J HUM GENET, V44, P720; POIRIER F, 1991, DEVELOPMENT, V113, P1105; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROSSI JM, 1992, P NATL ACAD SCI USA, V89, P2456, DOI 10.1073/pnas.89.6.2456; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SOARES MB, 1986, J MOL BIOL, V192, P737, DOI 10.1016/0022-2836(86)90025-2; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	41	270	274	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					61	65		10.1038/ng0992-61			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	WOS:A1992JM64600018	1303252				2022-01-24	
J	HORAI, S; HAYASAKA, K				HORAI, S; HAYASAKA, K			INTRASPECIFIC NUCLEOTIDE-SEQUENCE DIFFERENCES IN THE MAJOR NONCODING REGION OF HUMAN MITOCHONDRIAL-DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HORAI, S (corresponding author), NATL INST GENET,DEPT HUMAN GENET,YATA 1111,MISHIMA,SHIZUOKA 411,JAPAN.						ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; AQUADRO CF, 1983, GENETICS, V103, P287; BIBB MJ, 1981, CELL, V6, P43; BLANC H, 1983, AM J HUM GENET, V35, P167; BREGA A, 1986, AM J HUM GENET, V39, P502; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BROWN WM, 1979, ICN UCLA S, P485; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CANTATORE P, 1980, NUCLEIC ACIDS RES, V8, P2605, DOI 10.1093/nar/8.12.2605; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P6319, DOI 10.1073/pnas.78.10.6319; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GILES RE, 1980, P NATL ACAD SCI USA, V77, P715; GOJOBORI T, 1982, J MOL EVOL, V18, P414, DOI 10.1007/BF01840889; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1986, JPN J GENET, V61, P271, DOI 10.1266/jjg.61.271; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1987, HUM GENET, P177; HORAI S, 1989, IN PRESS P CIRCUM PA; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEI M, 1985, POPULATION GENETICS, P421; POTTER SS, 1975, P NATL ACAD SCI USA, V72, P4496, DOI 10.1073/pnas.72.11.4496; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sokal R. R., 1963, PRINCIPLES NUMERICAL; STONEKING M, 1989, COLONIZATION PACIFIC, P215; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; [No title captured]	35	270	285	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					828	842					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	WOS:A1990CW54900023	2316527				2022-01-24	
J	LOWDEN, JA; OBRIEN, JS				LOWDEN, JA; OBRIEN, JS			SIALIDOSIS - REVIEW OF HUMAN NEURAMINIDASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											LOWDEN, JA (corresponding author), UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093, USA.						ANDERSON B, 1958, AM J OPHTHALMOL, V45, P23, DOI 10.1016/0002-9394(58)90219-8; ARONSON NN, 1968, J BIOL CHEM, V243, P4564; BERARD M, 1968, Pathologia Europaea, V3, P172; BERMAN ER, 1974, CLIN CHIM ACTA, V52, P115; BIGNAMI A, 1969, ACTA NEUROPATHOL, V12, P50, DOI 10.1007/BF00685310; CANTZ M, 1977, BIOCHEM BIOPH RES CO, V74, P732, DOI 10.1016/0006-291X(77)90363-1; CHAMPION MJ, 1977, AM J HUM GENET, V29, P149; DERRY DM, 1968, NEUROLOGY, V18, P340, DOI 10.1212/WNL.18.4.340; DURAND P, 1977, HELV PAEDIATR ACTA, V32, P391; ENGEL J, 1977, EPILEPSIA, V18, P73, DOI 10.1111/j.1528-1157.1977.tb05589.x; FUKUNAGA H, 1976, CLIN NEUROL TOKYO, V16, P566; GALJAARD H, 1975, NATURE, V257, P60, DOI 10.1038/257060a0; GAUZZI GC, 1973, ACTA NEUROL NAPOLI, V28, P542; GLASGOW GAVIN L., 1957, AUSTRALASIAN ANN MED, V6, P295; GOLDBERG MF, 1971, ARCH INTERN MED, V128, P387, DOI 10.1001/archinte.128.3.387; Goldstein M L, 1974, Trans Am Neurol Assoc, V99, P110; GONATAS NK, 1963, J NEUROPATH EXP NEUR, V22, P557, DOI 10.1097/00005072-196310000-00001; HAMBERT O, 1970, ACTA NEUROL SCAND, V46, P149, DOI 10.1111/j.1600-0404.1970.tb05614.x; HICKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P992, DOI 10.1016/0006-291X(72)90310-5; HOLMES E, ANAL BIOCH; HOROUPIAN DS, 1977, CAN J NEUROL SCI, V4, P67, DOI 10.1017/S0317167100120438; HORVAT A, 1968, J BIOL CHEM, V243, P4380; JERVIS GA, 1952, J NEUROPATH EXP NEUR, V11, P4, DOI 10.1097/00005072-195201000-00002; JUSTICE RM, 1977, PEDIATR RES, V11, P407; KELLY TE, 1977, AM J MED GENET, V1, P31, DOI 10.1002/ajmg.1320010105; KISHORE GS, 1975, J BIOL CHEM, V250, P2655; KRESS BC, 1978, BIOCHEM BIOPH RES CO, V81, P756, DOI 10.1016/0006-291X(78)91416-X; KURIYAMA M, 1975, CLIN NEUROL TOKYO, V15, P580; LEROY JG, 1972, PEDIATR RES, V6, P752, DOI 10.1203/00006450-197210000-00002; LOONEN MCB, 1974, LANCET, V2, P785; LOWDEN JA, UNPUBLISHED; MONTREUIL J, 1975, PURE APPL CHEM, V42, P431, DOI 10.1351/pac197542030431; NISHIGAK.M, 1974, BIOCHEM BIOPH RES CO, V59, P638, DOI 10.1016/S0006-291X(74)80027-6; OBRIEN JS, 1975, CLIN GENET, V8, P303; OBRIEN JS, 1977, AM J HUM GENET, V29, P184; OBRIEN JS, 1978, CLIN GENET, V14, P55; OBRIEN JS, 1977, BIOCHEM BIOPH RES CO, V79, P1136, DOI 10.1016/0006-291X(77)91124-X; OBRIEN JS, AM J HUM GENET; OBRIEN JS, 1978, INHERITED BASIS META, P841; OHMAN R, 1970, BIOCHEMISTRY-US, V9, P3774, DOI 10.1021/bi00821a017; OKADA S, 1978, CLIN CHIM ACTA, V86, P159, DOI 10.1016/0009-8981(78)90129-8; ORII T, 1972, TOHOKU J EXP MED, V107, P303, DOI 10.1620/tjem.107.303; RAPIN I, 1978, ANN NEUROL, V3, P234, DOI 10.1002/ana.410030309; SCHENGRUND CL, 1972, J BIOL CHEM, V247, P2742; SHAUER R, 1976, HOPPESEYLERS Z PHYSL, V357, P559; SOGG RL, AM J OPTHALMOL; SPRANGER J, 1977, AM J MED GENET, V1, P21, DOI 10.1002/ajmg.1320010104; SPRANGER J, 1968, Z KINDERHEILKD, V103, P285, DOI 10.1007/BF00439910; SPRANGER JW, 1970, HUMANGENETIK, V9, P113, DOI 10.1007/BF00278928; STRECKER G, 1977, EUR J BIOCHEM, V75, P391, DOI 10.1111/j.1432-1033.1977.tb11540.x; STRECKER G, 1976, BIOMED EXPRESS, V25, P238; SUZUKI Y, 1977, ARCH NEUROL-CHICAGO, V34, P157, DOI 10.1001/archneur.1977.00500150043008; SUZUKI Y, 1977, HUM GENET, V36, P219, DOI 10.1007/BF00273261; SYMONDS C, 1954, MED J AUSTRALIA, V1, P765; TARENTINO AL, 1976, J BIOL CHEM, V251, P6537; THOMAS GH, 1976, BIOCHEM BIOPH RES CO, V71, P188, DOI 10.1016/0006-291X(76)90267-9; THOMAS GH, 1973, PEDIATR RES, V7, P751, DOI 10.1203/00006450-197309000-00004; THOMAS GH, 1978, CLIN GENET, V13, P369; THOMAS JJ, 1978, ANAL BIOCHEM, V88, P461, DOI 10.1016/0003-2697(78)90445-1; TITTARELLI R, 1966, BRIT J OPHTHALMOL, V50, P414, DOI 10.1136/bjo.50.7.414; TULSIANI DR, 1970, J BIOL CHEM, V245, P1821; TUPPY H, 1969, FEBS LETT, V3, P72, DOI 10.1016/0014-5793(69)80100-6; VENERANDO B, 1975, BIOCHIM BIOPHYS ACTA, V403, P461, DOI 10.1016/0005-2744(75)90074-1; VLADUTIU GD, 1975, BIOCHEM BIOPH RES CO, V67, P956, DOI 10.1016/0006-291X(75)90768-8; VLADUTIU GD, 1977, AM J HUM GENET, V29, pA110; WEISMANN UN, 1974, PEDIATR RES, V8, P865; WENGER DA, 1978, BIOCHEM BIOPH RES CO, V82, P589, DOI 10.1016/0006-291X(78)90915-4; WYNBURNMASON R, 1943, BRIT J OPHTHALMOL, V27, P193; YAMAMOTO A, 1974, ARCH INTERN MED, V134, P627, DOI 10.1001/archinte.134.4.627; YEH AK, 1971, J LAB CLIN MED, V78, P771	70	270	271	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					1	18					18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR115	WOS:A1979GR11500001	107795				2022-01-24	
J	Warren, HR; Evangelou, E; Cabrera, CP; Gao, H; Ren, MX; Mifsud, B; Ntalla, I; Surendran, P; Liu, CY; Cook, JP; Kraja, AT; Drenos, F; Loh, M; Verweij, N; Marten, J; Karaman, I; Lepe, MPS; O'Reilly, PF; Knight, J; Snieder, H; Kato, N; He, J; Tai, ES; Said, MA; Porteous, D; Alver, M; Poulter, N; Farrall, M; Gansevoort, RT; Padmanabhan, S; Magi, R; Stanton, A; Connell, J; Bakker, SJL; Metspalu, A; Shields, DC; Thom, S; Brown, M; Sever, P; Esko, T; Hayward, C; van der Harst, P; Saleheen, D; Chowdhury, R; Chambers, JC; Chasman, DI; Chakravarti, A; Newton-Cheh, C; Lindgren, CM; Levy, D; Kooner, JS; Keavney, B; Tomaszewski, M; Samani, NJ; Howson, JMM; Tobin, MD; Munroe, PB; Ehret, GB; Wain, LV; Barnes, MR; Tzoulaki, J; Caulfield, MJ; Elliott, P; Wain, LV; Vaez, A; Jansen, R; Joehanes, R; van der Most, PJ; Erzurumluoglu, AM; O'Reilly, P; Cabrera, CP; Warren, HR; Rose, LM; Verwoert, GC; Hottenga, JJ; Strawbridge, RJ; Esko, T; Arking, DE; Hwang, SJ; Guo, XQ; Kutalik, Z; Trompet, S; Shrine, N; Teumer, A; Ried, JS; Bis, JC; Smith, AV; Amin, N; Nolte, IM; Lyytikainen, LP; Mahajan, A; Wareham, NJ; Hofer, E; Joshi, PK; Kristiansson, K; Traglia, M; Havulinna, AS; Goel, A; Nalls, MA; Sober, S; Vuckovic, D; Luan, JA; Del Greco, F; Ayers, KL; Marrugat, J; Ruggiero, D; Lopez, LM; Niiranen, T; Enroth, S; Jackson, AU; Nelson, CP; Huffman, JE; Zhang, WH; Marten, J; Gandin, I; Harris, SE; Zemonik, T; Lu, YC; Evangelou, E; Shah, N; de Borst, MH; Mangino, M; Prins, BP; Campbell, A; Li-Gao, RF; Chauhan, G; Oldmeadow, C; Abecasis, G; Abedi, M; Barbieri, CM; Barnes, MR; Batini, C; Blake, T; Boehnke, M; Bottinger, EP; Braund, PS; Brown, M; Brumat, M; Campbell, H; Chambers, JC; Cocca, M; Collins, F; Connell, J; Cordell, HJ; Damman, JJ; Davies, G; de Geus, EJ; de Mutsert, R; Deelen, J; Demirkale, Y; Doney, ASF; Dorr, M; Farrall, M; Ferreira, T; Franberg, M; Gao, H; Giedraitis, V; Gieger, C; Giulianini, F; Gow, AJ; Hamsten, A; Harris, TB; Hofman, A; Holliday, EG; Jarvelin, MR; Johansson, A; Johnson, AD; Jousilahti, P; Jula, A; Kahonen, M; Kathiresan, S; Khaw, KT; Kolcic, I; Koskinen, S; Langenberg, C; Larson, M; Launer, LJ; Lehne, B; Liewald, DCM; Lin, L; Lind, L; Mach, F; Mamasoula, C; Menni, C; Mifsud, B; Milaneschi, Y; Morgan, A; Morris, AD; Morrison, AC; Munson, PJ; Nandakumar, P; Nguyen, QT; Nutile, T; Oldehinkel, AJ; Oostra, BA; Org, E; Padmanabhan, S; Palotie, A; Pare, G; Pattie, A; Penninx, BWJH; Poulter, N; Pramstaller, PP; Raitakari, OT; Ren, MX; Rice, K; Ridker, PM; Riese, H; Ripatti, S; Robino, A; Rotter, JI; Rudan, I; Saba, Y; Saint Pierre, A; Sala, CF; Sarin, AP; Schmidt, R; Scott, R; Seelen, MA; Shields, DC; Siscovick, D; Sorice, R; Stanton, A; Stott, DJ; Sundstrom, J; Swertz, M; Taylor, KD; Thom, S; Tzoulaki, I; Tzourio, C; Uitterlinden, AG; Volker, U; Vollenweider, P; Wild, S; Willemsen, G; Wright, AF; Yao, J; Theriault, S; Conen, D; John, A; Sever, P; Debette, S; Mook-Kanamori, DO; Zeggini, E; Spector, TD; van der Harst, P; Palmer, CNA; Vergnaud, AC; Loos, RJF; Polasek, O; Starr, JM; Girotto, G; Hayward, C; Kooner, JS; Lindgren, CM; Vitart, V; Samani, NJ; Tuomilehto, J; Gyllensten, U; Knekt, P; Deary, IJ; Ciullo, M; Elosua, R; Keavney, BD; Hicks, AA; Scott, RA; Gasparini, P; Laan, M; Liu, YM; Watkins, H; Hartman, CA; Salomaa, V; Toniolo, D; Perola, M; Wilson, JF; Schmidt, H; Zhao, JH; Lehtimaki, T; van Duijn, CM; Gudnason, V; Psaty, BM; Peters, A; Rettig, R; James, A; Jukema, JW; Strachan, DP; Palmas, W; Metspalu, A; Ingelsson, E; Boomsma, DI; Franco, OH; Bochud, M; Newton-Cheh, C; Munroe, PB; Elliott, P; Chasman, DI; Chakravarti, A; Knight, J; Morris, AP; Levy, D; Tobin, MD; Snieder, H; Caulfield, MJ; Ehret, GB				Warren, Helen R.; Evangelou, Evangelos; Cabrera, Claudia P.; Gao, He; Ren, Meixia; Mifsud, Borbala; Ntalla, Ioanna; Surendran, Praveen; Liu, Chunyu; Cook, James P.; Kraja, Aldi T.; Drenos, Fotios; Loh, Marie; Verweij, Niek; Marten, Jonathan; Karaman, Ibrahim; Lepe, Marcelo P. Segura; O'Reilly, Paul F.; Knight, Joanne; Snieder, Harold; Kato, Norihiro; He, Jiang; Tai, E. Shyong; Said, M. Abdullah; Porteous, David; Alver, Maris; Poulter, Neil; Farrall, Martin; Gansevoort, Ron T.; Padmanabhan, Sandosh; Magi, Reedik; Stanton, Alice; Connell, John; Bakker, Stephan J. L.; Metspalu, Andres; Shields, Denis C.; Thom, Simon; Brown, Morris; Sever, Peter; Esko, Tonu; Hayward, Caroline; van der Harst, Pim; Saleheen, Danish; Chowdhury, Rajiv; Chambers, John C.; Chasman, Daniel I.; Chakravarti, Aravinda; Newton-Cheh, Christopher; Lindgren, Cecilia M.; Levy, Daniel; Kooner, Jaspal S.; Keavney, Bernard; Tomaszewski, Maciej; Samani, Nilesh J.; Howson, Joanna M. M.; Tobin, Martin D.; Munroe, Patricia B.; Ehret, Georg B.; Wain, Louise V.; Barnes, Michael R.; Tzoulaki, Joanna; Caulfield, Mark J.; Elliott, Paul; Wain, Louise V.; Vaez, Ahmad; Jansen, Rick; Joehanes, Roby; van der Most, Peter J.; Erzurumluoglu, A. Mesut; O'Reilly, Paul; Cabrera, Claudia P.; Warren, Helen R.; Rose, Lynda M.; Verwoert, Germaine C.; Hottenga, Jouke-Jan; Strawbridge, Rona J.; Esko, Tonu; Arking, Dan E.; Hwang, Shih-Jen; Guo, Xiuqing; Kutalik, Zoltan; Trompet, Stella; Shrine, Nick; Teumer, Alexander; Ried, Janina S.; Bis, Joshua C.; Smith, Albert V.; Amin, Najaf; Nolte, Ilja M.; Lyytikainen, Leo-Pekka; Mahajan, Anubha; Wareham, Nicholas J.; Hofer, Edith; Joshi, Peter K.; Kristiansson, Kati; Traglia, Michela; Havulinna, Aki S.; Goel, Anuj; Nalls, Mike A.; Sober, Siim; Vuckovic, Dragana; Luan, Jian'an; Del Greco M, Fabiola; Ayers, Kristin L.; Marrugat, Jaume; Ruggiero, Daniela; Lopez, Lorna M.; Niiranen, Teemu; Enroth, Stefan; Jackson, Anne U.; Nelson, Christopher P.; Huffman, Jennifer E.; Zhang, Weihua; Marten, Jonathan; Gandin, Ilaria; Harris, Sarah E.; Zemonik, Tatijana; Lu, Yingchang; Evangelou, Evangelos; Shah, Nabi; de Borst, Martin H.; Mangino, Massimo; Prins, Bram P.; Campbell, Archie; Li-Gao, Ruifang; Chauhan, Ganesh; Oldmeadow, Christopher; Abecasis, Goncalo; Abedi, Maryam; Barbieri, Caterina M.; Barnes, Michael R.; Batini, Chiara; Blake, Tineka; Boehnke, Michael; Bottinger, Erwin P.; Braund, Peter S.; Brown, Morris; Brumat, Marco; Campbell, Harry; Chambers, John C.; Cocca, Massimiliano; Collins, Francis; Connell, John; Cordell, Heather J.; Damman, Jeffrey J.; Davies, Gail; de Geus, Eco J.; de Mutsert, Renee; Deelen, Joris; Demirkale, Yusuf; Doney, Alex S. F.; Dorr, Marcus; Farrall, Martin; Ferreira, Teresa; Franberg, Mattias; Gao, He; Giedraitis, Vilmantas; Gieger, Christian; Giulianini, Franco; Gow, Alan J.; Hamsten, Anders; Harris, Tamara B.; Hofman, Albert; Holliday, Elizabeth G.; Jarvelin, Marjo-Riitta; Johansson, Asa; Johnson, Andrew D.; Jousilahti, Pekka; Jula, Antti; Kahonen, Mika; Kathiresan, Sekar; Khaw, Kay-Tee; Kolcic, Ivana; Koskinen, Seppo; Langenberg, Claudia; Larson, Marty; Launer, Lenore J.; Lehne, Benjamin; Liewald, David C. M.; Lin, Li; Lind, Lars; Mach, Francois; Mamasoula, Chrysovalanto; Menni, Cristina; Mifsud, Borbala; Milaneschi, Yuri; Morgan, Anna; Morris, Andrew D.; Morrison, Alanna C.; Munson, Peter J.; Nandakumar, Priyanka; Quang Tri Nguyen; Nutile, Teresa; Oldehinkel, Albertine J.; Oostra, Ben A.; Org, Elin; Padmanabhan, Sandosh; Palotie, Aarno; Pare, Guillaume; Pattie, Alison; Penninx, Brenda W. J. H.; Poulter, Neil; Pramstaller, Peter P.; Raitakari, Olli T.; Ren, Meixia; Rice, Kenneth; Ridker, Paul M.; Riese, Harriette; Ripatti, Samuli; Robino, Antonietta; Rotter, Jerome I.; Rudan, Igor; Saba, Yasaman; Saint Pierre, Aude; Sala, Cinzia F.; Sarin, Antti-Pekka; Schmidt, Reinhold; Scott, Rodney; Seelen, Marc A.; Shields, Denis C.; Siscovick, David; Sorice, Rossella; Stanton, Alice; Stott, David J.; Sundstrom, Johan; Swertz, Morris; Taylor, Kent D.; Thom, Simon; Tzoulaki, Ioanna; Tzourio, Christophe; Uitterlinden, Andre G.; Volker, Uwe; Vollenweider, Peter; Wild, Sarah; Willemsen, Gonneke; Wright, Alan F.; Yao, Jie; Theriault, Sebastien; Conen, David; John, Attia; Sever, Peter; Debette, Stephanie; Mook-Kanamori, Dennis O.; Zeggini, Eleftheria; Spector, Tim D.; van der Harst, Pim; Palmer, Colin N. A.; Vergnaud, Anne-Claire; Loos, Ruth J. F.; Polasek, Ozren; Starr, John M.; Girotto, Giorgia; Hayward, Caroline; Kooner, Jaspal S.; Lindgren, Cecila M.; Vitart, Veronique; Samani, Nilesh J.; Tuomilehto, Jaakko; Gyllensten, Ulf; Knekt, Paul; Deary, Ian J.; Ciullo, Marina; Elosua, Roberto; Keavney, Bernard D.; Hicks, Andrew A.; Scott, Robert A.; Gasparini, Paolo; Laan, Maris; Liu, YongMei; Watkins, Hugh; Hartman, Catharina A.; Salomaa, Veikko; Toniolo, Daniela; Perola, Markus; Wilson, James F.; Schmidt, Helena; Zhao, Jing Hua; Lehtimaki, Terho; van Duijn, Cornelia M.; Gudnason, Vilmundur; Psaty, Bruce M.; Peters, Annette; Rettig, Rainer; James, Alan; Jukema, J. Wouter; Strachan, David P.; Palmas, Walter; Metspalu, Andres; Ingelsson, Erik; Boomsma, Dorret I.; Franco, Oscar H.; Bochud, Murielle; Newton-Cheh, Christopher; Munroe, Patricia B.; Elliott, Paul; Chasman, Daniel I.; Chakravarti, Aravinda; Knight, Joanne; Morris, Andrew P.; Levy, Daniel; Tobin, Martin D.; Snieder, Harold; Caulfield, Mark J.; Ehret, Georg B.		Int Consortium Blood Pressure ICBP; CHD Exome Consortium; ExomeBP Consortium; T2D-GENES Consortium; GoT2D Genes Consortium; CHARGE BP Exome Consortium; iGEN-BP Consortium; UK Biobank CardioMetab Consortium; BIOS Consortium; Lifelines Cohort Study; Understanding Soc Sci Grp	Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; ENDOTHELIAL-CELL; NEUROTROPHIC FACTOR; KEY ROLE; HYPERTENSION; COMMON; GENE; NOX4; METAANALYSIS; INHIBITION	Elevated blood pressure is the leading heritable risk factor for cardiovascular disease worldwide. We report genetic association of blood pressure (systolic, diastolic, pulse pressure) among UK Biobank participants of European ancestry with independent replication in other cohorts, and robust validation of 107 independent loci. We also identify new independent variants at 11 previously reported blood pressure loci. In combination with results from a range of in silico functional analyses and wet bench experiments, our findings highlight new biological pathways for blood pressure regulation enriched for genes expressed in vascular tissues and identify potential therapeutic targets for hypertension. Results from genetic risk score models raise the possibility of a precision medicine approach through early lifestyle intervention to offset the impact of blood pressure-raising genetic variants on future cardiovascular disease risk.	[Warren, Helen R.; Cabrera, Claudia P.; Ren, Meixia; Mifsud, Borbala; Ntalla, Ioanna; Barnes, Michael R.; Caulfield, Mark J.; Cabrera, Claudia P.; Warren, Helen R.; Barnes, Michael R.; Mifsud, Borbala; Ren, Meixia; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Warren, Helen R.; Cabrera, Claudia P.; Ren, Meixia; Barnes, Michael R.; Caulfield, Mark J.; Cabrera, Claudia P.; Warren, Helen R.; Barnes, Michael R.; Caulfield, Mark J.] Queen Mary Univ London, Barts Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, London, England; [Evangelou, Evangelos; Gao, He; Loh, Marie; Karaman, Ibrahim; Lepe, Marcelo P. Segura; Chambers, John C.; Tzoulaki, Joanna; Elliott, Paul; Zhang, Weihua; Evangelou, Evangelos; Chambers, John C.; Gao, He; Lehne, Benjamin; Tzoulaki, Ioanna; Vergnaud, Anne-Claire] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Evangelou, Evangelos; Tzoulaki, Joanna; Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece; [Gao, He; Tzoulaki, Joanna; Elliott, Paul; Jarvelin, Marjo-Riitta; Elliott, Paul] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England; [Surendran, Praveen; Chowdhury, Rajiv; Howson, Joanna M. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Liu, Chunyu; Levy, Daniel; Levy, Daniel] NHLBI, Populat Sci Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Liu, Chunyu] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Liu, Chunyu; Levy, Daniel; Joehanes, Roby; Johnson, Andrew D.; Larson, Marty] NHLBI, Framingham Heart Study, Framingham, MA USA; [Cook, James P.; Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Kraja, Aldi T.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [Kraja, Aldi T.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Drenos, Fotios] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Drenos, Fotios] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [Loh, Marie] ASTAR, Translat Lab Genet Med, Singapore, Singapore; [Verweij, Niek; Said, M. Abdullah; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Verweij, Niek; Esko, Tonu; Newton-Cheh, Christopher; Lindgren, Cecilia M.; Kathiresan, Sekar; Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Verweij, Niek; Newton-Cheh, Christopher; Kathiresan, Sekar; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Verweij, Niek; Newton-Cheh, Christopher; Kathiresan, Sekar; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Marten, Jonathan; Hayward, Caroline; Huffman, Jennifer E.; Wright, Alan F.; Hayward, Caroline; Vitart, Veronique; Wilson, James F.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Lepe, Marcelo P. Segura] Bayer Pharma, Berlin, Germany; [O'Reilly, Paul F.; O'Reilly, Paul] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Knight, Joanne] Univ Lancaster, Data Sci Inst, Lancaster, England; [Snieder, Harold; Vaez, Ahmad; van der Most, Peter J.; Nolte, Ilja M.; Damman, Jeffrey J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Kato, Norihiro] Natl Ctr Global Hlth & Med, Res Inst, Dept Gene Diagnost & Therapeut, Tokyo, Japan; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Hlth Syst, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Porteous, David; Harris, Sarah E.; Campbell, Archie] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Alver, Maris; Magi, Reedik; Metspalu, Andres; Esko, Tonu; Esko, Tonu; Org, Elin] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; Imperial Coll London, Sch Publ Hlth, Imperial Clin Trials Unit, London, England; [Farrall, Martin] Univ Oxford, Radcliffe Dept Med, Wellcome Trust Ctr Human Genet, Div Cardiovasc Med, Oxford, England; [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Padmanabhan, Sandosh; Stott, David J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Stanton, Alice] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin, Ireland; [Connell, John] Univ Dundee, Ninewells Hosp & Med Sch, Dundee, Scotland; [Bakker, Stephan J. L.; de Borst, Martin H.; Seelen, Marc A.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Shields, Denis C.] Univ Coll Dublin, Conway Inst, Sch Med, Dublin, Ireland; [Thom, Simon; Sever, Peter; Kooner, Jaspal S.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Saleheen, Danish] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommun Dis, Karachi, Pakistan; [Saleheen, Danish; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Chambers, John C.] Ealing Hosp Natl Hlth Serv NHS Trust, Southall, Middx, England; [Chambers, John C.; Kooner, Jaspal S.; Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London, England; [Chambers, John C.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Rose, Lynda M.; Giulianini, Franco; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Ridker, Paul M.] Harvard Med Sch, Boston, MA USA; [Chakravarti, Aravinda; Arking, Dan E.; Nandakumar, Priyanka] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Lindgren, Cecilia M.; Mahajan, Anubha; Goel, Anuj; Farrall, Martin; Ferreira, Teresa; Lindgren, Cecila M.; Watkins, Hugh; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lindgren, Cecilia M.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Kooner, Jaspal S.; Zhang, Weihua; Chambers, John C.; Kooner, Jaspal S.] Ealing Hosp NHS Trust, Dept Cardiol, Southall, Middx, England; [Kooner, Jaspal S.] Imperial Coll London, Cardiovasc Sci, Natl Heart & Lung Inst, Hammersmith Campus, London, England; [Keavney, Bernard; Tomaszewski, Maciej; Keavney, Bernard D.] Univ Manchester, Fac Biol Med & Hlth, Div Cardiovasc Sci, Manchester, Lancs, England; [Keavney, Bernard; Tomaszewski, Maciej] Cent Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Div Med, Manchester, Lancs, England; [Nelson, Christopher P.; Braund, Peter S.] Univ Leicester, Glenfield Hosp, BHF Cardiovasc Res Ctr, Dept Cardiovasc Sci, Leicester, Leics, England; [Nelson, Christopher P.; Braund, Peter S.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Tobin, Martin D.; Wain, Louise V.; Erzurumluoglu, A. Mesut; Shrine, Nick; Batini, Chiara; Blake, Tineka] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Lin, Li; Mach, Francois] Univ Hosp Geneva, Dept Med, Cardiol, Geneva, Switzerland; [Vaez, Ahmad] Isfahan Univ Med Sci, Res Inst Primordial Prevent Noncommun Dis, Esfahan, Iran; [Jansen, Rick] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Joehanes, Roby] Harvard Med Sch, Hebrew SeniorLife, Boston, MA USA; [Verwoert, Germaine C.; Hofman, Albert; Uitterlinden, Andre G.; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hottenga, Jouke-Jan; de Geus, Eco J.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ, Dept Biol Psychol, Amsterdam, Netherlands; [Hottenga, Jouke-Jan; de Geus, Eco J.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Strawbridge, Rona J.; Franberg, Mattias; Hamsten, Anders] Karolinska Inst, Dept Med Solna, Cardiovasc Med Unit, Stockholm, Sweden; [Strawbridge, Rona J.; Franberg, Mattias; Hamsten, Anders] Karolinska Univ Sjukhuset, Ctr Mol Med, Solna, Sweden; [Esko, Tonu] Childrens Hosp, Div Endocrinol, 300 Longwood Ave, Boston, MA 02115 USA; [Esko, Tonu; Lindgren, Cecila M.; Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Cambridge, England; [Hwang, Shih-Jen] NHLBI, Populat Sci Branch, US NIH, Bldg 10, Bethesda, MD 20892 USA; [Hwang, Shih-Jen; Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Guo, Xiuqing; Rotter, Jerome I.; Yao, Jie] Harbor UCLA Med Ctr, LABioMed, Dept Pediat, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Kutalik, Zoltan; Bochud, Murielle] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Teumer, Alexander] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Teumer, Alexander; Dorr, Marcus; Volker, Uwe] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Ried, Janina S.; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Amin, Najaf; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, Tampere, Finland; [Wareham, Nicholas J.; Luan, Jian'an; Langenberg, Claudia; Scott, Robert A.; Zhao, Jing Hua] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England; [Hofer, Edith; Schmidt, Reinhold; Loos, Ruth J. F.] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Joshi, Peter K.; Campbell, Harry; Rudan, Igor; Wild, Sarah; Perola, Markus; Wilson, James F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland; [Kristiansson, Kati; Havulinna, Aki S.; Niiranen, Teemu; Jousilahti, Pekka; Jula, Antti; Koskinen, Seppo; Knekt, Paul; Salomaa, Veikko] Natl Inst Hlth & Welf THL, Dept Hlth, Helsinki, Finland; [Traglia, Michela; Barbieri, Caterina M.; Sala, Cinzia F.; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, Milan, Italy; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Nalls, Mike A.] NIA, Neurogenet Lab, US NIH, Bethesda, MD 20892 USA; [Nalls, Mike A.] Kelly Serv, Rockville, MD USA; [Sober, Siim; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Res Grp, Tartu, Estonia; [Vuckovic, Dragana; Girotto, Giorgia; Gasparini, Paolo] Sidra Med & Res Ctr, Expt Genet Div, Doha, Qatar; [Vuckovic, Dragana; Gandin, Ilaria; Brumat, Marco; Cocca, Massimiliano; Morgan, Anna; Girotto, Giorgia; Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Del Greco M, Fabiola; Pramstaller, Peter P.; Saint Pierre, Aude; Hicks, Andrew A.] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Del Greco M, Fabiola; Pramstaller, Peter P.; Saint Pierre, Aude; Hicks, Andrew A.] Univ Lubeck, Lubeck, Germany; [Ayers, Kristin L.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Marrugat, Jaume; Elosua, Roberto; Int Consortium Blood Pressure ICBP] IMIM, Cardiovasc Epidemiol & Genet, Barcelona, Spain; [Ruggiero, Daniela; Nutile, Teresa; Sorice, Rossella; Ciullo, Marina] CNR, Inst Genet & Biophys Buzzati Traverso, Naples, Italy; [Lopez, Lorna M.; Harris, Sarah E.; Davies, Gail; Gow, Alan J.; Liewald, David C. M.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.] Beaumont Hosp, Educ & Res Ctr, Royal Coll Surg Ireland, Dept Psychiat, Dublin, Ireland; [Lopez, Lorna M.] UCD, Ctr Proteome Res, UCD Conway Inst, Dublin, Ireland; [Enroth, Stefan; Johansson, Asa; Gyllensten, Ulf] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Zemonik, Tatijana] Univ Split, Fac Med, Dept Biol, Split, Croatia; [Lu, Yingchang; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Shah, Nabi; Doney, Alex S. F.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee, Scotland; [Shah, Nabi] COMSATS Inst Informat Technol, Dept Pharm, Abbottabad, Pakistan; [Mangino, Massimo; Menni, Cristina; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Mangino, Massimo] Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Prins, Bram P.; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [Campbell, Archie; Padmanabhan, Sandosh; Hayward, Caroline] Univ Edinburgh, Ctr Genom & Expt Med, Generat Scotland, Edinburgh, Midlothian, Scotland; [Li-Gao, Ruifang; de Mutsert, Renee; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Chauhan, Ganesh; Tzourio, Christophe; Debette, Stephanie] Bordeaux Populat Hlth Ctr, INSERM, U1219, Bordeaux, France; [Chauhan, Ganesh; Tzourio, Christophe; Debette, Stephanie] Bordeaux Univ, Bordeaux, France; [Oldmeadow, Christopher; Holliday, Elizabeth G.; Scott, Rodney; John, Attia] Hunter Med Res Inst, New Lambton, NSW, Australia; [Abecasis, Goncalo] SPH II, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI USA; [Abedi, Maryam] Isfahan Univ Med Sci, Dept Genet & Mol Biol, Esfahan, Iran; [Collins, Francis] NHGRI, Med Genom & Metab Genet Branch, US NIH, Bethesda, MD 20892 USA; [Cordell, Heather J.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Damman, Jeffrey J.] Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Davies, Gail; Liewald, David C. M.; Pattie, Alison; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Deelen, Joris] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Demirkale, Yusuf; Munson, Peter J.; Quang Tri Nguyen] US NIH, Ctr Informat Technol, Bethesda, MD USA; [Dorr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Franberg, Mattias] Stockholm Univ, Dept Numer Anal & Comp Sci, Stockholm, Sweden; [Giedraitis, Vilmantas] Dept Publ Hlth & Caring Sci, Geriatr, Uppsala, Sweden; [Gieger, Christian] Helmholtz Zentrum Munchen, Deutsch Forsch Zentrum Gesundheit & Umwelt, Neuherberg, Germany; [Gow, Alan J.] Heriot Watt Univ, Sch Life Sci, Dept Psychol, Edinburgh, Midlothian, Scotland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Johnson, Andrew D.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Bldg 10, Bethesda, MD 20892 USA; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, Tampere, Finland; [Kolcic, Ivana; Polasek, Ozren] Univ Split, Fac Med, Dept Publ Hlth, Split, Croatia; [Lind, Lars; Sundstrom, Johan] Uppsala Univ, Cardiovasc Epidemiol, Dept Med Sci, Uppsala, Sweden; [Mamasoula, Chrysovalanto] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Milaneschi, Yuri; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Psychiat, Amsterdam, Netherlands; [Morris, Andrew D.] Univ Edinburgh, Sch Med, Sch Mol Genet & Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Oldehinkel, Albertine J.; Riese, Harriette; Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Padmanabhan, Sandosh] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Palotie, Aarno; Ripatti, Samuli; Sarin, Antti-Pekka; Perola, Markus] Univ Helsinki, FIMM, Helsinki, Finland; [Pare, Guillaume; Theriault, Sebastien] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Ren, Meixia] Fujian Med Univ, Fujian Prov Hosp, Dept Cardiol, Fuzhou, Peoples R China; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Robino, Antonietta] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Rotter, Jerome I.] Harbor UCLA Med Ctr, LABioMed, Dept Med, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Saba, Yasaman; Schmidt, Helena] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; [Saint Pierre, Aude] Etab Francais Sang, INSERM, U1078, Brest, France; [Scott, Rodney; John, Attia] Univ Newcastle, Fac Hlth, Callaghan, NSW, Australia; [Scott, Rodney; John, Attia] John Hunter Hosp, Sch Biomed Sci & Pharm, New Lambton, NSW, Australia; [Siscovick, David] New York Acad Med, New York, NY USA; [Sorice, Rossella; Ciullo, Marina] IRCCS Neuromed, Pozzilli, Italy; [Swertz, Morris] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Taylor, Kent D.] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Taylor, Kent D.] Harbor UCLA Med Ctr, Dept Pediat, Div Genet Outcomes, Torrance, CA 90509 USA; [Thom, Simon] Imperial Coll London, Int Ctr Circulatory Hlth, London, England; [Tzourio, Christophe] Bordeaux Univ Hosp, Dept Publ Hlth, Bordeaux, France; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Volker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Gen, Greifswald, Germany; [Vollenweider, Peter] CHU Vaudois, Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland; [Conen, David] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Debette, Stephanie] Bordeaux Univ Hosp, Dept Neurol, Bordeaux, France; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth Dev Inst, New York, NY 10029 USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] South Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] Hosp Univ La Paz, Red RECAVA Grp RD06 0014 0015, Madrid, Spain; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Laan, Maris] Univ Tartu, Inst Biomed & Translat Med, Tartu, Estonia; [Liu, YongMei] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Perola, Markus] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Schmidt, Helena] Med Univ Graz, Dept Neurol, Graz, Austria; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, Karlsburg, Germany; [James, Alan] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep, Nedlands, WA, Australia; [James, Alan] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Strachan, David P.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Palmas, Walter] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA		Caulfield, MJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.; Caulfield, MJ (corresponding author), Queen Mary Univ London, Barts Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, London, England.; Elliott, P (corresponding author), Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England.	p.elliott@imperial.ac.uk; m.j.caulfield@qmul.ac.uk	Tzourio, christophe/B-4015-2009; Stanton, Alice V/F-4697-2012; Tzoulaki, Ioanna/ABE-6269-2020; Doney, Alexander SF/P-7437-2017; Lopez, Lorna/AAR-4912-2020; Franco, Oscar H./ABE-2305-2020; Org, Elin/AAJ-9631-2021; Magi, Reedik/AAJ-9679-2021; Campbell, Archie/AAZ-1757-2021; Laan, Maris/A-4100-2011; Vaez, Ahmad/B-4336-2018; Deelen, Joris/H-3201-2019; Schmidt, Reinhold/E-1137-2014; Enroth, Stefan/C-7396-2009; Gandin, Ilaria/B-2634-2017; Loos, Ruth J F/Q-2862-2016; Toniolo, Daniela/AAE-2969-2019; Johansson, Asa/AAG-6799-2021; Jukema, J. Wouter/ABD-6503-2021; Kolcic, Ivana/E-2713-2017; Peters, Annette/A-6117-2011; Mifsud, Borbala/AAB-5379-2020; Palmer, Colin NA/C-7053-2008; Deary, Ian J/C-6297-2009; Tzourio, christophe/L-6344-2019; Havulinna, Aki/AAM-4769-2021; Shah, Nabi/AAG-7378-2021; Evangelou, Evangelos/C-3033-2013; Khaw, Kay-Tee/AAZ-3209-2021; de Geus, Eco J.C./M-9318-2015; Wilson, James F/A-5704-2009; He, Jiang/AAF-5303-2020; Boomsma, Dorret I/AAX-4470-2020; Campbell, Harry/E-2959-2010; Rotter, Jerome/AAY-6598-2021; Sundstrom, Johan/R-2139-2019; Dorr, Marcus/F-1919-2010; Verweij, Niek/ABC-6249-2021; Study, GoDARTS/K-9448-2016; Raitakari, Olli/AAQ-7389-2021; Teumer, Alexander/S-7438-2019; Pare, Guillaume/T-9631-2018; Sundstrom, Johan/A-6286-2009; Shah, Nabi/Q-1008-2016; Ruggiero, Daniela/K-5638-2016; Sala, Cinzia Felicita/AAN-1900-2020; Morgan, Anna/K-2238-2018; EHRET, Georg B/A-9532-2009; Hicks, Andrew Anthony/E-9518-2017; Gudnason, Vilmundur/AAE-7126-2019; Gasparini, Paolo/B-6173-2014; CHAUHAN, GANESH/AAI-5110-2021; Ciullo, Marina/AAE-3041-2020; Debette, Stephanie/T-4946-2019; Li-Gao, Ruifang/B-7172-2018; Colaus, PsyColaus/K-6607-2013; Johansson, Asa/G-5270-2011; Johnson, Andrew D/G-6520-2013; Levy, Daniel/ABF-6873-2021; Riese, Harriette/E-7234-2012; Porteous, David/AAA-3446-2021; Gow, Alan J/A-6070-2009; Levy, Daniel/ABB-2752-2021; Polasek, Ozren/B-6002-2011; Cocca, Massimiliano/J-2951-2018; Rudan, Igor/I-1467-2012; Erzurumluoglu, A Mesut/E-4445-2018; Traglia, Michela/AAX-5816-2020; Scott, Rodney/B-2827-2013; Niiranen, Teemu/R-1507-2017; Girotto, Giorgia/I-9452-2018; Smith, Albert Vernon/K-5150-2015; Charchar, Fadi/I-6656-2017; Robino, Antonietta/K-9398-2016	Tzourio, christophe/0000-0002-6517-2984; Tzoulaki, Ioanna/0000-0002-4275-9328; Doney, Alexander SF/0000-0002-6210-5620; Lopez, Lorna/0000-0002-0241-9783; Franco, Oscar H./0000-0002-4606-4929; Laan, Maris/0000-0002-8519-243X; Vaez, Ahmad/0000-0001-9048-3795; Deelen, Joris/0000-0003-4483-3701; Enroth, Stefan/0000-0002-5056-9137; Gandin, Ilaria/0000-0003-3196-2491; Loos, Ruth J F/0000-0002-8532-5087; Toniolo, Daniela/0000-0001-9545-6032; Johansson, Asa/0000-0002-2915-4498; Jukema, J. Wouter/0000-0002-3246-8359; Kolcic, Ivana/0000-0001-7918-6052; Peters, Annette/0000-0001-6645-0985; Palmer, Colin NA/0000-0002-6415-6560; Deary, Ian J/0000-0002-1733-263X; Tzourio, christophe/0000-0002-6517-2984; Shah, Nabi/0000-0003-2764-3615; Evangelou, Evangelos/0000-0002-5488-2999; de Geus, Eco J.C./0000-0001-6022-2666; Wilson, James F/0000-0001-5751-9178; He, Jiang/0000-0002-8286-9652; Campbell, Harry/0000-0002-6169-6262; Sundstrom, Johan/0000-0003-2247-8454; Dorr, Marcus/0000-0001-7471-475X; Verweij, Niek/0000-0002-4303-7685; Teumer, Alexander/0000-0002-8309-094X; Pare, Guillaume/0000-0002-6795-4760; Sundstrom, Johan/0000-0003-2247-8454; Shah, Nabi/0000-0003-2764-3615; Ruggiero, Daniela/0000-0003-3898-7827; Morgan, Anna/0000-0001-6290-445X; EHRET, Georg B/0000-0002-5730-0675; Hicks, Andrew Anthony/0000-0001-6320-0411; Gudnason, Vilmundur/0000-0001-5696-0084; Ciullo, Marina/0000-0002-9621-9984; Debette, Stephanie/0000-0001-8675-7968; Li-Gao, Ruifang/0000-0003-0650-1351; Johansson, Asa/0000-0002-2915-4498; Johnson, Andrew D/0000-0001-6369-5178; Levy, Daniel/0000-0003-1843-8724; Riese, Harriette/0000-0003-3661-3151; Porteous, David/0000-0003-1249-6106; Gow, Alan J/0000-0002-3320-4531; Polasek, Ozren/0000-0002-5765-1862; Cocca, Massimiliano/0000-0002-1127-7596; Rudan, Igor/0000-0001-6993-6884; Erzurumluoglu, A Mesut/0000-0003-1322-8138; Scott, Rodney/0000-0001-7724-3404; Wain, Louise/0000-0003-4951-1867; Magi, Reedik/0000-0002-2964-6011; Lindgren, Cecilia/0000-0002-4903-9374; Oldmeadow, Christopher/0000-0001-6104-1322; Shrine, Nick/0000-0003-3641-4371; Marten, Jonathan/0000-0001-6916-2014; Kahonen, Mika/0000-0002-4510-7341; De Borst, Martin/0000-0002-4127-8733; O'Reilly, Paul/0000-0001-7515-0845; Niiranen, Teemu/0000-0002-7394-7487; Jansen, Rick/0000-0002-3333-6737; Knight, Joanne/0000-0002-7148-1660; Girotto, Giorgia/0000-0003-4507-6589; Smith, Albert Vernon/0000-0003-1942-5845; Tai, E Shyong/0000-0003-2929-8966; Tobin, Martin/0000-0002-3596-7874; Van Duijn, Cornelia/0000-0002-2374-9204; Charchar, Fadi/0000-0002-6164-9941; Barnes, Michael/0000-0001-9097-7381; Willemsen, Gonneke/0000-0003-3755-0236; Joshi, Peter/0000-0002-6361-5059; Vuckovic, Dragana/0000-0001-9343-6142; Drenos, Fotios/0000-0003-2469-5516; Said, M. Abdullah/0000-0003-2920-7745; Palotie, Aarno/0000-0002-2527-5874; Shields, Denis/0000-0003-4015-2474; Amin, Najaf/0000-0002-8944-1771; Cordell, Heather/0000-0002-1879-5572; Caulfield, Mark/0000-0001-9295-3594; Robino, Antonietta/0000-0003-2152-2353; Morrison, Alanna/0000-0001-6381-4296; ELOSUA, ROBERTO/0000-0001-8235-0095; Pramstaller, Peter P/0000-0002-9831-8302; Org, Elin/0000-0001-8688-9717; Padmanabhan, Sandosh/0000-0003-3869-5808; Keavney, Bernard/0000-0001-9573-0812; Vitart, Veronique/0000-0002-4991-3797; Mifsud, Borbala/0000-0003-3429-3094; Loh, Marie/0000-0003-3626-8466; Tomaszewski, Maciej/0000-0001-8215-6567; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Howson, Joanna/0000-0001-7618-0050; Gasparini, Paolo/0000-0002-0859-0856; Karaman, Ibrahim/0000-0001-9341-8155; NUTILE, TERESA/0000-0001-7062-8352; Elliott, Paul/0000-0002-7511-5684; Stanton, Alice/0000-0002-4961-165X	National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Unit at Barts and The London School of Medicine and Dentistry; NIHR Imperial College Health Care NHS Trust and Imperial College London Biomedical Research Centre; China Scholarship CouncilChina Scholarship Council [2011632047]; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800270, MR/N015746/1]; British Heart FoundationBritish Heart Foundation [SP/09/002, SP/13/2/30111]; UK National Institute for Health Research Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); European Research CouncilEuropean Research Council (ERC)European Commission [268834]; European Commission Framework Programme 7 [HEALTH-F2-2012-279233]; MRC Unit at the University of BristolUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12013/1-9]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL113933, HL124262, HL128782, HL086694]; ZonMwNetherlands Organization for Health Research and Development [90.700.441]; Marie Sklodowska-Curie GF [H2020-MSCA-IF-2014, 661395]; Marie Sklodowska-Curie GF grant [661395]; ICIN-NHI; UK National Institute for Health Research Biomedical Research Centre at Imperial College Healthcare NHS Trust; NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; Wellcome TrustWellcome TrustEuropean Commission [109863/Z/15/Z]; EU PhenoMeNal project (Horizon) [654241]; Wellcome Trust core awardWellcome Trust [090532/Z/09/Z]; BHF Centre of Research Excellence, Oxford [RE/13/1/30181]; MRC core grant for QTL in Health and Disease programmeUK Research & Innovation (UKRI)Medical Research Council UK (MRC); NIHR Health Protection Research Unit in Health Impact of Environmental Hazards [HPRU-2012-10141]; Public Health England [MR/L01341X/1]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/L01632X/1];  [MR/L016311/1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL124262, R01HL086694, R01HL128782, R01HL113933] Funding Source: NIH RePORTER; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600237, MC_UU_12013/3, MR/N015746/1, MC_UU_12015/1, G0800270, MR/L003120/1, MR/L01341X/1, MC_PC_U127561128, MR/L016311/1, MR/L01632X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1] Funding Source: researchfish; British Heart FoundationBritish Heart Foundation [PG/16/49/32176, RG/15/12/31616, RG/08/014/24067] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_qA137853, MC_PC_U127561128, MR/L01341X/1, MR/L016311/1, MR/K006584/1, MR/N015746/1, MC_UU_12015/1, G0600237, G0800270, MC_UU_12013/3, MR/L003120/1, MR/K026992/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10113, NF-SI-0611-10170, NF-SI-0507-10228, NF-SI-0513-10059, NF-SI-0611-10136, NF-SI-0512-10165, NF-SI-0514-10027] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4] Funding Source: researchfish	H.R.W., C.P.C., M.R., M.R.B., P.B.M., M.B. and M.J.C. were funded by the National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Unit at Barts and The London School of Medicine and Dentistry. H.G. was funded by the NIHR Imperial College Health Care NHS Trust and Imperial College London Biomedical Research Centre. M.R. was a recipient of a grant from the China Scholarship Council (2011632047). B.M. holds an MRC eMedLab Medical Bioinformatics Career Development Fellowship, funded from award MR/L016311/1. J.M.M.H. was funded by the UK Medical Research Council (G0800270), British Heart Foundation (SP/09/002), UK National Institute for Health Research Cambridge Biomedical Research Centre, European Research Council (268834) and European Commission Framework Programme 7 (HEALTH-F2-2012-279233). B.K. holds a British Heart Foundation Personal Chair (CH/13/2/30154). N.J.S. holds a chair funded by the British Heart Foundation and is an NIHR Senior Investigator. F.D. was funded by the MRC Unit at the University of Bristol (MC_UU_12013/1-9). P. Surendran was funded by the UK Medical Research Council (G0800270). C.L. and A.K. were funded by NHLBI intramural funding. C.N.-C. was funded by the National Institutes of Health (HL113933, HL124262). P.v.d.H. was funded by ZonMw grant 90.700.441, Marie Sklodowska-Curie GF (call, H2020-MSCA-IF-2014; project ID, 661395). N.V. was supported by a Marie Sklodowska-Curie GF grant (661395) and ICIN-NHI. N.P. received funding from the UK National Institute for Health Research Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London and also from his Senior Investigator Award. P. Sever was supported by the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London. S.T. was supported by the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London. P.F.O'R. received funding from the UK Medical Research Council (MR/N015746/1) and the Wellcome Trust (109863/Z/15/Z). I.K. was supported by the EU PhenoMeNal project (Horizon 2020, 654241). A.C. was funded by the National Institutes of Health (HL128782, HL086694). M.F. was supported by a Wellcome Trust core award (090532/Z/09/Z) and the BHF Centre of Research Excellence, Oxford (RE/13/1/30181). C.H. was funded by an MRC core grant for QTL in Health and Disease programme. Some of this work used the ALICE and SPECTRE High-Performance Computing Facilities at the University of Leicester. M.J.C. is a National Institute for Health Research (NIHR) senior investigator. P.E. is a National Institute for Health Research (NIHR) senior investigator and acknowledges support from the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London, and the NIHR Health Protection Research Unit in Health Impact of Environmental Hazards (HPRU-2012-10141). As director of the MRC-PHE Centre for Environment and Health, P.E. acknowledges support from the Medical Research Council and Public Health England (MR/L01341X/1). This work used the computing resources of the UK Medical Bioinformatics partnership-aggregation, integration, visualisation and analysis of large, complex data (UK MED-BIO), which is supported by the Medical Research Council (MR/L01632X/1). This research was supported by the British Heart Foundation (grant SP/13/2/30111).; Project title: Large-Scale Comprehensive Genotyping of UK Biobank for Cardiometabolic Traits and Diseases: UK CardioMetabolic Consortium (UKCMC). This research has been conducted using the UK Biobank Resource under application number 236.	Akashi M, 2011, BIOCHEM BIOPH RES CO, V413, P224, DOI 10.1016/j.bbrc.2011.08.073; Cabrera CP, 2015, WIRES SYST BIOL MED, V7, P73, DOI 10.1002/wsbm.1290; Cakstina I, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-10; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Chan EC, 2013, BIOCHEM BIOPH RES CO, V430, P918, DOI 10.1016/j.bbrc.2012.11.138; Chan Q, 2016, J ATHEROSCLER THROMB, V23, P276, DOI 10.5551/jat.30000; Chan SHH, 2010, CIRC RES, V107, P1127, DOI 10.1161/CIRCRESAHA.110.225573; Crespo K, 2016, CLIN EXP HYPERTENS, V38, P533, DOI 10.3109/10641963.2016.1163373; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; DeStefano AL, 1998, AM J HUM GENET, V63, P1425, DOI 10.1086/302096; Dietrich T, 2007, BASIC RES CARDIOL, V102, P298, DOI 10.1007/s00395-007-0652-5; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Erdos B, 2015, AM J PHYSIOL-HEART C, V308, pH612, DOI 10.1152/ajpheart.00776.2014; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Hamilton CA, 2001, HYPERTENSION, V37, P529, DOI 10.1161/01.HYP.37.2.529; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; Hong X, 2007, METHOD FIND EXP CLIN, V29, P3, DOI 10.1358/mf.2007.29.1.1063490; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kazenwadel J, 2012, BLOOD, V119, P1283, DOI 10.1182/blood-2011-08-374363; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; MONGEAU JG, 1986, CLIN EXP HYPERTENS A, V8, P653, DOI 10.3109/10641968609046581; Munoz M, 2016, NAT GENET, V48, P980, DOI 10.1038/ng.3618; Munroe PB, 2013, CIRC RES, V112, P1365, DOI 10.1161/CIRCRESAHA.112.300387; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oliver JJ, 2006, HYPERTENSION, V48, P622, DOI 10.1161/01.HYP.0000239816.13007.c9; Perez NG, 2007, HYPERTENSION, V49, P1095, DOI 10.1161/HYPERTENSIONAHA.107.087759; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012; Raffler J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005487; Ray R, 2011, ARTERIOSCL THROM VAS, V31, P1368, DOI 10.1161/ATVBAHA.110.219238; Rizzoni D, 2012, INTERN EMERG MED, V7, P205, DOI 10.1007/s11739-011-0548-0; Ronaldson PT, 2015, BRAIN RES, V1623, P39, DOI 10.1016/j.brainres.2015.03.018; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Steppan J, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/263585; Stoynev N, 2014, J CARDIOVASC MED, V15, P702, DOI 10.2459/JCM.0b013e32835dbcc8; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Takimoto E, 2002, FASEB J, V16, DOI 10.1096/fj.01-0735com; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tian X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018136; Touyz RM, 2012, CIRC RES, V110, P1159, DOI 10.1161/CIRCRESAHA.112.269068; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; van Setten J, 2013, ATHEROSCLEROSIS, V228, P400, DOI 10.1016/j.atherosclerosis.2013.02.039; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012; Watanabe Y, 2010, HYPERTENS RES, V33, P129, DOI 10.1038/hr.2009.193; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.551; Yndestad A, 2009, J APPL PHYSIOL, V106, P1356, DOI 10.1152/japplphysiol.90719.2008	62	269	277	7	128	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2017	49	3					403	415		10.1038/ng.3768			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL9CU	WOS:000394917800014	28135244	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Gaunt, TR; Shihab, HA; Hemani, G; Min, JL; Woodward, G; Lyttleton, O; Zheng, J; Duggirala, A; McArdle, WL; Ho, KR; Ring, SM; Evans, DM; Smith, GD; Relton, CL				Gaunt, Tom R.; Shihab, Hashem A.; Hemani, Gibran; Min, Josine L.; Woodward, Geoff; Lyttleton, Oliver; Zheng, Jie; Duggirala, Aparna; McArdle, Wendy L.; Ho, Karen; Ring, Susan M.; Evans, David M.; Smith, George Davey; Relton, Caroline L.			Systematic identification of genetic influences on methylation across the human life course	GENOME BIOLOGY			English	Article						Methylation quantitative trait loci; mQTL; Cohort; Genetic association; DNA methylation	DNA METHYLATION; INTERINDIVIDUAL VARIATION; EXPRESSION; VARIANTS; DISCOVERY; TISSUES	Background: The influence of genetic variation on complex diseases is potentially mediated through a range of highly dynamic epigenetic processes exhibiting temporal variation during development and later life. Here we present a catalogue of the genetic influences on DNA methylation (methylation quantitative trait loci (mQTL)) at five different life stages in human blood: children at birth, childhood, adolescence and their mothers during pregnancy and middle age. Results: We show that genetic effects on methylation are highly stable across the life course and that developmental change in the genetic contribution to variation in methylation occurs primarily through increases in environmental or stochastic effects. Though we map a large proportion of the cis-acting genetic variation, a much larger component of genetic effects influencing methylation are acting in trans. However, only 7 % of discovered mQTL are trans-effects, suggesting that the trans component is highly polygenic. Finally, we estimate the contribution of mQTL to variation in complex traits and infer that methylation may have a causal role consistent with an infinitesimal model in which many methylation sites each have a small influence, amounting to a large overall contribution. Conclusions: DNA methylation contains a significant heritable component that remains consistent across the lifespan. Our results suggest that the genetic component of methylation may have a causal role in complex traits. The database of mQTL presented here provide a rich resource for those interested in investigating the role of methylation in disease.	[Gaunt, Tom R.; Shihab, Hashem A.; Hemani, Gibran; Min, Josine L.; Woodward, Geoff; Zheng, Jie; Ring, Susan M.; Evans, David M.; Smith, George Davey; Relton, Caroline L.] Univ Bristol, MRC, Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England; [Gaunt, Tom R.; Shihab, Hashem A.; Hemani, Gibran; Min, Josine L.; Woodward, Geoff; Zheng, Jie; Ring, Susan M.; Evans, David M.; Smith, George Davey; Relton, Caroline L.] Univ Bristol, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England; [Lyttleton, Oliver; Duggirala, Aparna; McArdle, Wendy L.; Ho, Karen; Ring, Susan M.] Univ Bristol, Avon Longitudinal Study Parents & Children ALSPAC, Oakfield House, Bristol BS8 2BN, Avon, England; [Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia; [Relton, Caroline L.] Newcastle Univ, Dept Genet Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England		Gaunt, TR (corresponding author), Univ Bristol, MRC, Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England.; Gaunt, TR (corresponding author), Univ Bristol, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.	tom.gaunt@bristol.ac.uk	Gaunt, Tom R/O-3918-2014; Relton, Caroline/AAC-5904-2019; Evans, David M/H-6325-2013; Davey Smith, George/A-7407-2013; Duggirala, Aparna/ABA-2994-2020; Duggirala, Aparna/AAX-9684-2021	Gaunt, Tom R/0000-0003-0924-3247; Evans, David M/0000-0003-0663-4621; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Duggirala, Aparna/0000-0002-5311-0663; Relton, Caroline/0000-0003-2052-4840; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Zheng, Jie/0000-0002-6623-6839; Hemani, Gibran/0000-0003-0920-1055; Ho, Karen/0000-0003-3478-9751	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1000427]; UK BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I025751/1, BB/I025263/1]; Wellcome TrustWellcome TrustEuropean Commission [102215/2/13/2]; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I025263/1, BB/I025751/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12013/4, G1001799, MR/N01104X/1, MC_UU_12013/2, MC_UU_12013/1, MC_UU_12013/8] Funding Source: UKRI; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I025263/1, BB/I025751/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1001799, MC_UU_12013/4, MC_PC_15018, MC_UU_12013/1, MC_UU_12013/2, G1000427, MR/N01104X/1, MC_UU_12013/8] Funding Source: researchfish	Work was carried out in the MRC Integrative Epidemiology Unit (MC_UU_12013/2, MC_UU_12013/8) with additional support from MRC project G1000427, National Health and Medical Research Council (APP1085130) and European Union Framework 7 (GEoCoDE). Methylation data in the ALSPAC cohort were generated as part of the UK BBSRC funded (BB/I025751/1 and BB/I025263/1) Accessible Resource for Integrated Epigenomic Studies (ARIES, http://www.ariesepigenomics.org.uk). The UK Medical Research Council and the Wellcome Trust (grant reference 102215/2/13/2) and the University of Bristol provide core support for ALSPAC.	Teh AL, 2014, GENOME RES, V24, P1064, DOI 10.1101/gr.171439.113; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; Heyn H, 2013, GENOME RES, V23, P1363, DOI 10.1101/gr.154187.112; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Kaplow IM, 2015, GENOME RES, V25, P907, DOI 10.1101/gr.183749.114; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lemire M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7326; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Naeem H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-51; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Relton CL, 2015, INT J EPIDEMIOL, V44, P1181, DOI 10.1093/ije/dyv072; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shah S, 2014, GENOME RES, V24, P1725, DOI 10.1101/gr.176933.114; Shi JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4365; Smith AK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-145; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Touleimat N, 2012, EPIGENOMICS-UK, V4, P325, DOI [10.2217/EPI.12.21, 10.2217/epi.12.21]; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113	44	269	272	4	28	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	MAR 31	2016	17								61	10.1186/s13059-016-0926-z			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	DI0NE	WOS:000373192500003	27036880	Green Published, gold	Y	N	2022-01-24	
J	Ounit, R; Wanamaker, S; Close, TJ; Lonardi, S				Ounit, Rachid; Wanamaker, Steve; Close, Timothy J.; Lonardi, Stefano			CLARK: fast and accurate classification of metagenomic and genomic sequences using discriminative k-mers	BMC GENOMICS			English	Article						Metagenomics; Genomics; Arm/chromosome assignments; Discriminative k-mers; Sequence-specific k-mers; Chromosome arm; Centromere	IDENTIFICATION	Background: The problem of supervised DNA sequence classification arises in several fields of computational molecular biology. Although this problem has been extensively studied, it is still computationally challenging due to size of the datasets that modern sequencing technologies can produce. Results: We introduce CLARK a novel approach to classify metagenomic reads at the species or genus level with high accuracy and high speed. Extensive experimental results on various metagenomic samples show that the classification accuracy of CLARK is better or comparable to the best state-of-the-art tools and it is significantly faster than any of its competitors. In its fastest single-threaded mode CLARK classifies, with high accuracy, about 32 million metagenomic short reads per minute. CLARK can also classify BAC clones or transcripts to chromosome arms and centromeric regions. Conclusions: CLARK is a versatile, fast and accurate sequence classification method, especially useful for metagenomics and genomics applications. It is freely available at http://clark.cs.ucr.edu/.	[Ounit, Rachid; Lonardi, Stefano] Univ Calif Riverside, Dept Comp Sci & Engn, Riverside, CA 92521 USA; [Wanamaker, Steve; Close, Timothy J.] Univ Calif Riverside, Dept Plant & Bot Sci, Riverside, CA 92521 USA		Lonardi, S (corresponding author), Univ Calif Riverside, Dept Comp Sci & Engn, 900 Univ Ave, Riverside, CA 92521 USA.	stelo@cs.ucr.edu	Ounit, Rachid/H-3632-2019	Ounit, Rachid/0000-0003-1803-261X; Lonardi, Stefano/0000-0002-2696-7274	USDA, "Advancing the Barley Genome" [2009-65300-05645]; NSFNational Science Foundation (NSF) [DBI-1062301, IIS-1302134]; Direct For Computer & Info Scie & EnginrNational Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE) [1302134] Funding Source: National Science Foundation	This project was funded in part by USDA, "Advancing the Barley Genome" (2009-65300-05645) and by NSF, "ABI Innovation: Barcoding-Free Multiplexing: Leveraging Combinatorial Pooling for High-Throughput Sequencing" (DBI-1062301), and "III: Algorithms and Software Tools for Epigenetics Research" (IIS-1302134). We are thankful to the authors of NBC and KRAKEN for their useful advice on running their tools. We thank Dr. Gail Rosen and the anonymous reviewers for constructive comments on the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Benson DA, NUCL ACIDS RES; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Close Timothy J., 2007, V406, P161; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Dolezel J, 2012, FUNCT INTEGR GENOMIC, V12, P397, DOI 10.1007/s10142-012-0293-0; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koslicki D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091784; Liu B, 2011, BMC GENOMICS S2, V12, P4, DOI DOI 10.1186/1471-2164-12-S2-S4; Lonardi S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003010; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magoc T, 2013, BIOINFORMATICS, V29, P1718, DOI 10.1093/bioinformatics/btt273; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Said HS, DNA RES; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/nmeth.2066, 10.1038/NMETH.2066]; Tu QC, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku138; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	31	269	274	11	37	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAR 25	2015	16								236	10.1186/s12864-015-1419-2			13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	CH7UA	WOS:000354240900001	25879410	Green Published, gold			2022-01-24	
J	Tilgner, H; Knowles, DG; Johnson, R; Davis, CA; Chakrabortty, S; Djebali, S; Curado, J; Snyder, M; Gingeras, TR; Guigo, R				Tilgner, Hagen; Knowles, David G.; Johnson, Rory; Davis, Carrie A.; Chakrabortty, Sudipto; Djebali, Sarah; Curado, Joao; Snyder, Michael; Gingeras, Thomas R.; Guigo, Roderic			Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for IncRNAs	GENOME RESEARCH			English	Article							SITE SELECTION; EXONS; ELONGATION; GENES	Splicing remains an incompletely understood process. Recent findings suggest that chromatin structure participates in its regulation. Here, we analyze the RNA from subcellular fractions obtained through RNA-seq in the cell line K562. We show that in the human genome, splicing occurs predominantly during transcription. We introduce the coSI measure, based on RNA-seq reads mapping to exon junctions and borders, to assess the degree of splicing completion around internal exons. We show that, as expected, splicing is almost fully completed in cytosolic polyA+ RNA. In chromatin-associated RNA (which includes the RNA that is being transcribed), for 5.6% of exons, the removal of the surrounding introns is fully completed, compared with 0.3% of exons for which no intron-removal has occurred. The remaining exons exist as a mixture of spliced and fewer unspliced molecules, with a median coSI of 0.75. Thus, most RNAs undergo splicing while being transcribed: "co-transcriptional splicing." Consistent with co-transcriptional spliceosome assembly and splicing, we have found significant enrichment of spliceosomal snRNAs in chromatin-associated RNA compared with other cellular RNA fractions and other nonspliceosomal snRNAs. CoSI scores decrease along the gene, pointing to a "first transcribed, first spliced" rule, yet more downstream exons carry other characteristics, favoring rapid, co-transcriptional intron removal. Exons with low coSI values, that is, in the process of being spliced, are enriched with chromatin marks, consistent with a role for chromatin in splicing during transcription. For alternative exons and long noncoding RNAs, splicing tends to occur later, and the latter might remain unspliced in some cases.	[Tilgner, Hagen; Knowles, David G.; Johnson, Rory; Djebali, Sarah; Curado, Joao; Guigo, Roderic] Ctr Genom Regulat CRG, E-08003 Barcelona, Spain; [Tilgner, Hagen; Knowles, David G.; Johnson, Rory; Djebali, Sarah; Curado, Joao; Guigo, Roderic] UPF, E-08003 Barcelona, Spain; [Davis, Carrie A.; Chakrabortty, Sudipto; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tilgner, Hagen; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA		Guigo, R (corresponding author), Ctr Genom Regulat CRG, E-08003 Barcelona, Spain.	roderic.guigo@crg.cat	Johnson, Rory/H-2961-2015; Guigo, Roderic/D-1303-2010; Johnson, Rory/ABE-2503-2021; Djebali, Sarah/O-9817-2014	Johnson, Rory/0000-0003-4607-2782; Guigo, Roderic/0000-0002-5738-4477; Johnson, Rory/0000-0003-4607-2782; Djebali, Sarah/0000-0002-0599-1267; Gingeras, Thomas/0000-0001-9106-3573; Curado, Joao/0000-0003-3916-0936	Spanish Ministry of ScienceSpanish Government [RD07/0067/0012, BIO2006-03380, CSD2007-00050]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U54HG004557-01, 1U54HG004555-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG004555, U54HG004557] Funding Source: NIH RePORTER	We thank Juan Valcarcel and Tobias Warnecke from the CRG for useful discussions. This work has been carried out under grants RD07/0067/0012, BIO2006-03380, and CSD2007-00050 from the Spanish Ministry of Science, and grants 1U54HG004557-01 and 1U54HG004555-01 from the National Institutes of Health.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2010, RNA, V16, P904, DOI 10.1261/rna.1993510; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE IN PRESS; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kundaje A, 2012, GENOME RES, V22, P1735, DOI 10.1101/gr.136366.111; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; O'Mullane L, 1998, MOL CELL BIOL, V18, P7510, DOI 10.1128/MCB.18.12.7510; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010	36	269	275	0	24	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	SEP	2012	22	9			SI		1616	1625		10.1101/gr.134445.111			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	998XD	WOS:000308272800004	22955974	Green Submitted, hybrid, Green Published			2022-01-24	
J	Vandin, F; Upfal, E; Raphael, BJ				Vandin, Fabio; Upfal, Eli; Raphael, Benjamin J.			De novo discovery of mutated driver pathways in cancer	GENOME RESEARCH			English	Article							MARKOV-CHAINS; MUTATIONS; GENE; ALGORITHMS; PTEN; EGFR	Next-generation DNA sequencing technologies are enabling genome-wide measurements of somatic mutations in large numbers of cancer patients. A major challenge in the interpretation of these data is to distinguish functional "driver mutations" important for cancer development from random "passenger mutations." A common approach for identifying driver mutations is to find genes that are mutated at significant frequency in a large cohort of cancer genomes. This approach is confounded by the observation that driver mutations target multiple cellular signaling and regulatory pathways. Thus, each cancer patient may exhibit a different combination of mutations that are sufficient to perturb these pathways. This mutational heterogeneity presents a problem for predicting driver mutations solely from their frequency of occurrence. We introduce two combinatorial properties, coverage and exclusivity, that distinguish driver pathways, or groups of genes containing driver mutations, from groups of genes with passenger mutations. We derive two algorithms, called Dendrix, to find driver pathways de novo from somatic mutation data. We apply Dendrix to analyze somatic mutation data from 623 genes in 188 lung adenocarcinoma patients, 601 genes in 84 glioblastoma patients, and 238 known mutations in 1000 patients with various cancers. In all data sets, we find groups of genes that are mutated in large subsets of patients and whose mutations are approximately exclusive. Our Dendrix algorithms scale to whole-genome analysis of thousands of patients and thus will prove useful for larger data sets to come from The Cancer Genome Atlas (TCGA) and other large-scale cancer genome sequencing projects.	[Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA		Raphael, BJ (corresponding author), Brown Univ, Dept Comp Sci, Providence, RI 02912 USA.	braphael@cs.brown.edu		Upfal, Eli/0000-0002-9321-9460	NSFNational Science Foundation (NSF) [IIS-1016648]; Department of DefenseUnited States Department of Defense; Alfred P. Sloan FoundationAlfred P. Sloan Foundation; Susan G. Komen FoundationSusan G. Komen Breast Cancer Foundation; Burroughs Wellcome FundBurroughs Wellcome Fund	We thank the anonymous reviewers for helpful suggestions that improved the manuscript. This work is supported by NSF grant IIS-1016648, the Department of Defense Breast Cancer Research Program, the Alfred P. Sloan Foundation, and the Susan G. Komen Foundation. B.J.R. is also supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Backlund LM, 2003, CLIN CANCER RES, V9, P4151; Bansal V, 2008, GENOME RES, V18, P1336, DOI 10.1101/gr.077065.108; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Boca SM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r112; Bradley JR, 2009, J APPL STAT, V36, P1307, DOI 10.1080/02664760802582306; Bubley R, 1997, ANN IEEE SYMP FOUND, P223, DOI 10.1109/SFCS.1997.646111; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chehab NH, 2000, GENE DEV, V14, P278; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conde E, 2006, CLIN CANCER RES, V12, P710, DOI 10.1158/1078-0432.CCR-05-1362; Deguchi K, 2002, LEUKEMIA, V16, P740, DOI 10.1038/sj.leu.2402500; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dom M, 2006, LECT NOTES COMPUT SC, V4059, P339; Efroni S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014437; Garey Michael R., 1990, COMPUTERS INTRACTABI; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Gilks W, 1998, MARKOV CHAIN MONTE C; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ikeda T, 2000, ONCOL REP, V7, P567; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kim YA, 2010, LECT N BIOINFORMAT, V6044, P263; Kuhn F, 2005, LECT NOTES COMPUT SC, V3595, P188; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; McCormick F, 1999, TRENDS BIOCHEM SCI, V24, pM53, DOI 10.1016/S0968-0004(99)01480-2; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Meyer IM, 2007, PLOS COMPUT BIOL, V3, P1441, DOI 10.1371/journal.pcbi.0030149; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mitzenmacher M., 2005, PROBABILITY COMPUTIN; Murali T M, 2003, Pac Symp Biocomput, P77; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Randall D, 2006, COMPUT SCI ENG, V8, P30, DOI 10.1109/MCSE.2006.30; Segal E, 2003, Pac Symp Biocomput, P89; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Ulitsky I, 2008, LECT N BIOINFORMAT, V4955, P347; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wikman H, 2005, GENE CHROMOSOME CANC, V42, P193, DOI 10.1002/gcc.20122; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985	51	269	274	1	28	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2012	22	2					375	385		10.1101/gr.120477.111			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	883BA	WOS:000299606400020	21653252	Green Published, Bronze			2022-01-24	
J	Andolfatto, P; Davison, D; Erezyilmaz, D; Hu, TT; Mast, J; Sunayama-Morita, T; Stern, DL				Andolfatto, Peter; Davison, Dan; Erezyilmaz, Deniz; Hu, Tina T.; Mast, Joshua; Sunayama-Morita, Tomoko; Stern, David L.			Multiplexed shotgun genotyping for rapid and efficient genetic mapping	GENOME RESEARCH			English	Article							QUANTITATIVE TRAIT LOCI; DROSOPHILA-MELANOGASTER; RECOMBINATION; CROSSOVERS; MUTATIONS; SIMULANS; YEAST	We present a new approach to genotyping based on multiplexed shotgun sequencing that can identify recombination breakpoints in a large number of individuals simultaneously at a resolution sufficient for most mapping purposes, such as quantitative trait locus (QTL) mapping and mapping of induced mutations. We first describe a simple library construction protocol that uses just 10 ng of genomic DNA per individual and makes the approach accessible to any laboratory with standard molecular biology equipment. Sequencing this library results in a large number of sequence reads widely distributed across the genomes of multiplexed bar-coded individuals. We develop a Hidden Markov Model to estimate ancestry at all genomic locations in all individuals using these data. We demonstrate the utility of the approach by mapping a dominant marker allele in D. simulans to within 105 kb of its true position using 96 F1-backcross individuals genotyped in a single lane on an Illumina Genome Analyzer. We further demonstrate the utility of our method by genetically mapping more than 400 previously unassembled D. simulans contigs to linkage groups and by evaluating the quality of targeted introgression lines. At this level of multiplexing and divergence between strains, our method allows estimation of recombination breakpoints to a median of 38-kb intervals. Our analysis suggests that higher levels of multiplexing and/or use of strains with lower levels of divergence are practicable.	[Andolfatto, Peter; Erezyilmaz, Deniz; Hu, Tina T.; Mast, Joshua; Sunayama-Morita, Tomoko; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Andolfatto, Peter; Davison, Dan; Hu, Tina T.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Davison, Dan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Erezyilmaz, Deniz; Mast, Joshua; Sunayama-Morita, Tomoko; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA		Andolfatto, P (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	pandolfa@princeton.edu		Stern, David/0000-0002-1847-6483; Andolfatto, Peter/0000-0003-3393-4574	National Research Service AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIGMS Center of ExcellenceUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50 GM071508]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM063622-06A1]; National Science FoundationNational Science Foundation (NSF) [IOS-0640339, DEB-0946398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM071508, R01GM063622] Funding Source: NIH RePORTER	We thank Amy Caudy, Josh Shapiro, and Molly Przeworski for helpful advice during the development of this project, as well as Ana Faigon, Gretchen Kappes, Ryan Kuzmickas, and Serge Picard for technical assistance. Thanks to Leonid Kruglyak and three anonymous reviewers for comments on the manuscript. This research was partly supported by funding from a National Research Service Award (D. E.), a NIGMS Center of Excellence grant P50 GM071508 (P. A.), and funding from the National Institutes of Health Grant GM063622-06A1 and National Science Foundation Grants IOS-0640339 (D. L. S.) and DEB-0946398 (P. A.)	Ashburner M., 1989, DROSOPHILA LAB HDB; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Chen B, 1998, GENETICS, V149, P157; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Edenberg HJ, 2009, COLD SPRING HARB PRO, V2009, P1, DOI DOI 10.1101/PDB.TOP62; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Falush D, 2003, GENETICS, V164, P1567; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Kliman RM, 2000, GENETICS, V156, P1913; LACHAISE D, 1986, EVOLUTION, V40, P262, DOI 10.1111/j.1558-5646.1986.tb00468.x; Lai CQ, 2007, NAT METHODS, V4, P839, DOI 10.1038/NMETH1084; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martin SG, 2001, GENOME BIOL, V2; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ragoussis J, 2009, ANNU REV GENOM HUM G, V10, P117, DOI 10.1146/annurev-genom-082908-150116; Wang H, 2010, GENOME RES, V20, P981, DOI 10.1101/gr.102921.109; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107	26	269	283	0	110	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	APR	2011	21	4					610	617		10.1101/gr.115402.110			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	744BN	WOS:000289067800011	21233398	Green Published, Bronze			2022-01-24	
J	Borg, J; Papadopoulos, P; Georgitsi, M; Gutierrez, L; Grech, G; Fanis, P; Phylactides, M; Verkerk, AJMH; van der Spek, PJ; Scerri, CA; Cassar, W; Galdies, R; van IJcken, W; Ozgur, Z; Gillemans, N; Hou, J; Bugeja, M; Grosveld, FG; von Lindern, M; Felice, AE; Patrinos, GP; Philipsen, S				Borg, Joseph; Papadopoulos, Petros; Georgitsi, Marianthi; Gutierrez, Laura; Grech, Godfrey; Fanis, Pavlos; Phylactides, Marios; Verkerk, Annemieke J. M. H.; van der Spek, Peter J.; Scerri, Christian A.; Cassar, Wilhelmina; Galdies, Ruth; van IJcken, Wilfred; Ozgur, Zeliha; Gillemans, Nynke; Hou, Jun; Bugeja, Marisa; Grosveld, Frank G.; von Lindern, Marieke; Felice, Alex E.; Patrinos, George P.; Philipsen, Sjaak			Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin	NATURE GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; EFFICIENT GENE DELIVERY; SICKLE-CELL-DISEASE; KRUPPEL-LIKE FACTOR; BETA-THALASSEMIA; LINKAGE ANALYSIS; CHROMOSOME 6Q23; GAMMA-GLOBIN; IN-VIVO; DNA	Hereditary persistence of fetal hemoglobin (HPFH) is characterized by persistent high levels of fetal hemoglobin (HbF) in adults. Several contributory factors, both genetic and environmental, have been identified(1) but others remain elusive. HPFH was found in 10 of 27 members from a Maltese family. We used a genome-wide SNP scan followed by linkage analysis to identify a candidate region on chromosome 19p13.12-13. Sequencing revealed a nonsense mutation in the KLF1 gene, p.K288X, which ablated the DNA-binding domain of this key erythroid transcriptional regulator(2). Only family members with HPFH were heterozygous carriers of this mutation. Expression profiling on primary erythroid progenitors showed that KLF1 target genes were downregulated in samples from individuals with HPFH. Functional assays suggested that, in addition to its established role in regulating adult globin expression, KLF1 is a key activator of the BCL11A gene, which encodes a suppressor of HbF expression(3). These observations provide a rationale for the effects of KLF1 haploinsufficiency on HbF levels.	[Borg, Joseph; Grech, Godfrey; Scerri, Christian A.; Cassar, Wilhelmina; Galdies, Ruth; Bugeja, Marisa; Felice, Alex E.] Univ Malta, Dept Physiol & Biochem, Mol Genet Lab, Msida, Malta; [Borg, Joseph; Grech, Godfrey; Scerri, Christian A.; Cassar, Wilhelmina; Galdies, Ruth; Felice, Alex E.] Mater Dei Hosp, Thalassaemia Clin, Sect Pathol, Msida, Malta; [Papadopoulos, Petros; Gutierrez, Laura; Fanis, Pavlos; Gillemans, Nynke; Hou, Jun; Grosveld, Frank G.; Philipsen, Sjaak] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Georgitsi, Marianthi; Patrinos, George P.] Univ Patras, Dept Pharm, Patras, Greece; [Phylactides, Marios] Cyprus Inst Neurol & Genet, Nicosia, Cyprus; [Verkerk, Annemieke J. M. H.; van der Spek, Peter J.] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [van IJcken, Wilfred; Ozgur, Zeliha] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [Hou, Jun; Grosveld, Frank G.; Philipsen, Sjaak] Netherlands Consortium Syst Biol, Rotterdam, Netherlands; [Grosveld, Frank G.] Ctr Biomed Genet, Rotterdam, Netherlands; [von Lindern, Marieke] Erasmus MC, Dept Hematol, Rotterdam, Netherlands		Felice, AE (corresponding author), Univ Malta, Dept Physiol & Biochem, Mol Genet Lab, Msida, Malta.	alex.felice@um.edu.mt; gpatrinos@upatras.gr; j.philipsen@erasmusmc.nl	Grech, Godfrey/AAD-1303-2020; Scerri, Christian/D-3077-2012; Grech, Godfrey/A-4684-2013; Papadopoulos, Petros/B-1913-2015; van ijcken, willem/N-9805-2018; von Lindern, Marieke/AAH-2350-2020; Gutierrez, Laura/P-9367-2019; Gutierrez, Laura/B-3780-2016	Grech, Godfrey/0000-0003-4502-8237; Scerri, Christian/0000-0002-6499-234X; Grech, Godfrey/0000-0003-4502-8237; Papadopoulos, Petros/0000-0002-8342-329X; van ijcken, willem/0000-0002-0421-8301; Gutierrez, Laura/0000-0001-8443-900X; Georgitsi, Marianthi/0000-0002-0354-0913; Fanis, Pavlos/0000-0003-4590-4778; Felice, Alex/0000-0003-0015-3923; Borg, Joseph/0000-0002-2220-5651	University of Malta; Mater Dei Hospital; Malta Government; European Molecular Biology OrganizationEuropean Molecular Biology Organization (EMBO); Netherlands Scientific Organization [VENI 863.09.012, DN 82-294, 912-07-019]; Netherlands Genomics Initiative, Erasmus MC [296088]; Landsteiner Foundation for Blood Transfusion Research [0615]; Centre for Biomedical Genetics; European Commission, EuTRACC consortiumEuropean CommissionEuropean Commission Joint Research Centre [037445]; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HL073455]; Research Promotion Foundation of Cyprus [PiDeltaE046_02]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [200754]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL073455] Funding Source: NIH RePORTER	We thank the family members for their cooperation; T. van Gent for help with statistical analysis; T. van Dijk for expertise in lentiviral technology; N. Papazian for preparation of human fetal liver samples; and M. Pizzuto for administrative support. The population samples from Malta were obtained from the Malta BioBank (EuroBioBank). Recombinant human erythropoietin (Epo) was a kind gift from Ortho-Biotech, and recombinant human Stem Cell Factor (SCF) was a kind gift from Amgen. Supported by the University of Malta and Mater Dei Hospital (A. E. F.); the Malta Government (J.B.); the European Molecular Biology Organization (J.B., P. P.); the Netherlands Scientific Organization (VENI 863.09.012 to L. G. and DN 82-294 and 912-07-019 to S. P.); the Netherlands Genomics Initiative, Erasmus MC (MRace; 296088 to S. P.); the Landsteiner Foundation for Blood Transfusion Research (0615 to S. P.); the Centre for Biomedical Genetics (F. G. G.); the European Commission FP6 EuTRACC consortium (037445 to F. G. G.); the US National Institutes of Health (NIH) (R01-HL073455 to F. G. G.); the Research Promotion Foundation of Cyprus (Pi Delta E046_02 to G. P. P.); and the European Commission FP7 GEN2PHEN (200754 to G. P. P).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Antoniou M, 1991, Methods Mol Biol, V7, P421, DOI 10.1385/0-89603-178-0:421; Bieker JJ, 2005, MT SINAI J MED, V72, P333; Bottardi S, 2006, EMBO J, V25, P3586, DOI 10.1038/sj.emboj.7601232; Close J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-33; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; CRAIG JE, 1994, BLOOD, V83, P1673, DOI 10.1182/blood.V83.6.1673.1673; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; FENG WC, 1994, J BIOL CHEM, V269, P1493; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; Garner C, 1998, AM J HUM GENET, V62, P1468, DOI 10.1086/301859; GILMAN JG, 1985, BLOOD, V66, P783; Higgs DR, 2008, P NATL ACAD SCI USA, V105, P11595, DOI 10.1073/pnas.0806633105; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Leberbauer C, 2005, BLOOD, V105, P85, DOI 10.1182/blood-2004-03-1002; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Leykin I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-7; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serjeant GR, 2001, DISORDERS HEMOGLOBIN, P895; Singleton BK, 2008, BLOOD, V112, P2081, DOI 10.1182/blood-2008-03-145672; STAMATOYANNOPOU.G, 2001, MOL BASIS BLOOD DIS, P135; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; TRIFILLIS P, 1991, BLOOD, V78, P3298; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; Zhou DW, 2006, J BIOL CHEM, V281, P16052, DOI 10.1074/jbc.M601182200; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	38	269	275	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					801	U100		10.1038/ng.630			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	WOS:000281388400019	20676099	Green Accepted, Green Published			2022-01-24	
J	Veeriah, S; Taylor, BS; Meng, S; Fang, F; Yilmaz, E; Vivanco, I; Janakiraman, M; Schultz, N; Hanrahan, AJ; Pao, W; Ladanyi, M; Sander, C; Heguy, A; Holland, EC; Paty, PB; Mischel, PS; Liau, L; Cloughesy, TF; Mellinghoff, IK; Solit, DB; Chan, TA				Veeriah, Selvaraju; Taylor, Barry S.; Meng, Shasha; Fang Fang; Yilmaz, Emrullah; Vivanco, Igor; Janakiraman, Manickam; Schultz, Nikolaus; Hanrahan, Aphrothiti J.; Pao, William; Ladanyi, Marc; Sander, Chris; Heguy, Adriana; Holland, Eric C.; Paty, Philip B.; Mischel, Paul S.; Liau, Linda; Cloughesy, Timothy F.; Mellinghoff, Ingo K.; Solit, David B.; Chan, Timothy A.			Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies	NATURE GENETICS			English	Article							UBIQUITIN-PROTEIN LIGASE; TUMOR-SUPPRESSOR GENE; RECESSIVE JUVENILE PARKINSONISM; CYCLIN-E; FHIT GENE; CANCER; CARCINOMA; EXPRESSION; OVARIAN; SUBUNIT	Mutation of the gene PARK2, which encodes an E3 ubiquitin ligase, is the most common cause of early-onset Parkinson's disease(1-3). In a search for multisite tumor suppressors, we identified PARK2 as a frequently targeted gene on chromosome 6q25.2-q27 in cancer. Here we describe inactivating somatic mutations and frequent intragenic deletions of PARK2 in human malignancies. The PARK2 mutations in cancer occur in the same domains, and sometimes at the same residues, as the germline mutations causing familial Parkinson's disease. Cancer-specific mutations abrogate the growth-suppressive effects of the PARK2 protein. PARK2 mutations in cancer decrease PARK2's E3 ligase activity, compromising its ability to ubiquitinate cyclin E and resulting in mitotic instability. These data strongly point to PARK2 as a tumor suppressor on 6q25.2-q27. Thus, PARK2, a gene that causes neuronal dysfunction when mutated in the germline, may instead contribute to oncogenesis when altered in non-neuronal somatic cells.	[Veeriah, Selvaraju; Meng, Shasha; Fang Fang; Yilmaz, Emrullah; Vivanco, Igor; Janakiraman, Manickam; Hanrahan, Aphrothiti J.; Pao, William; Ladanyi, Marc; Heguy, Adriana; Mellinghoff, Ingo K.; Solit, David B.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Taylor, Barry S.; Schultz, Nikolaus; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Pao, William; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Paty, Philip B.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Mischel, Paul S.; Liau, Linda; Cloughesy, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA		Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	solitd@mskcc.org; chant@mskcc.org	Schultz, Nikolaus/ABE-6347-2020; Ladanyi, Marc/AAG-8585-2019; Solit, David B./AAC-5309-2019; Chan, Timothy A/ABD-5850-2021; Meng, Shasha/AAR-3936-2020; Yilmaz, Emrullah/AAR-6228-2021; Sander, Chris/H-1452-2011; Vivanco, Igor/AAN-8578-2021	Sander, Chris/0000-0001-6059-6270; Liau, Linda/0000-0002-4053-0052; Yilmaz, Emrullah/0000-0003-2308-713X; Schultz, Nikolaus/0000-0002-0131-4904; Vivanco, Igor/0000-0001-6347-9416; Janakiraman, Manickam/0000-0003-4423-6237	Brain Tumors Funders' Collaborative Fund; Cancer Genome Atlas Project; Flight Attendants Medical Research Institute; Louis Gerstner Foundation; Memorial Sloan-Kettering Society; Elsa U. Pardee Foundation; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF); NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA121210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS086875] Funding Source: NIH RePORTER	We thank J. Wongvipat, K. Huberman, I. Dolgalev and S. Thomas for exceptional technical expertise. We thank R. Levine for helpful discussions and comments. B. S. T. is the David H. Koch Fellow in cancer genomics. This work was supported in part by The Brain Tumors Funders' Collaborative Fund (I. K. M.), The Cancer Genome Atlas Project (N. S, C. S.), the Flight Attendants Medical Research Institute (T. A. C.), the Louis Gerstner Foundation (T. A. C.), the Memorial Sloan-Kettering Society (T. A. C.), the Elsa U. Pardee Foundation (T. A. C.) and the Doris Duke Charitable Foundation (T. A.C.)	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corti O, 2005, CR BIOL, V328, P131, DOI 10.1016/j.crvi.2004.10.009; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Courjal F, 1996, INT J CANCER, V69, P247; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; Dachsel JC, 2005, FEBS LETT, V579, P3913, DOI 10.1016/j.febslet.2005.06.003; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Dohm CP, 2008, NEURODEGENER DIS, V5, P321, DOI 10.1159/000119459; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; Ekholm-Reed Susanna, 2004, Cancer Research, V64, P2939; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Keck JM, 2007, J CELL BIOL, V178, P371, DOI 10.1083/jcb.200703202; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2000, MAMM GENOME, V11, P417, DOI 10.1007/s003350010080; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Ledesma MD, 2002, J NEUROCHEM, V83, P1431, DOI 10.1046/j.1471-4159.2002.01253.x; Liu M, 2008, J BIOL CHEM, V283, P35783, DOI 10.1074/jbc.M806860200; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Martinez-Noel G, 2001, EUR J BIOCHEM, V268, P5912, DOI 10.1046/j.0014-2956.2001.02541.x; Mhawech-Fauceglia P, 2008, INT J GYNECOL PATHOL, V27, P539, DOI 10.1097/PGP.0b013e31816bcda4; MOLLER H, 1995, BRIT MED J, V310, P1500, DOI 10.1136/bmj.310.6993.1500; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rankin CA, 2001, J BIOMED SCI, V8, P421; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Sangfelt O, 2008, CELL CYCLE, V7, P1075, DOI 10.4161/cc.7.8.5648; Schlossmacher Michael G., 2005, V301, P351; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Toma MI, 2008, NEOPLASIA, V10, P634, DOI 10.1593/neo.08160; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	62	269	273	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					77	U98		10.1038/ng.491			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	WOS:000273055100020	19946270	Green Accepted, Bronze			2022-01-24	
J	Morrissy, AS; Morin, RD; Delaney, A; Zeng, T; McDonald, H; Jones, S; Zhao, Y; Hirst, M; Marra, MA				Morrissy, A. Sorana; Morin, Ryan D.; Delaney, Allen; Zeng, Thomas; McDonald, Helen; Jones, Steven; Zhao, Yongjun; Hirst, Martin; Marra, Marco A.			Next-generation tag sequencing for cancer gene expression profiling	GENOME RESEARCH			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ANTISENSE TRANSCRIPTS; MICRORNA EXPRESSION; UP-REGULATION; CELL-LINES; STEM-CELLS; GENOME; DNA; DIFFERENTIATION; LONGSAGE	We describe a new method, Tag-seq, which employs ultra high-throughput sequencing of 21 base pair cDNA tags for sensitive and cost-effective gene expression profiling. We compared Tag-seq data to LongSAGE data and observed improved representation of several classes of rare transcripts, including transcription factors, antisense transcripts, and intronic sequences, the latter possibly representing novel exons or genes. We observed increases in the diversity, abundance, and dynamic range of such rare transcripts and took advantage of the greater dynamic range of expression to identify, in cancers and normal libraries, altered expression ratios of alternative transcript isoforms. The strand-specific information of Tag-seq reads further allowed us to detect altered expression ratios of sense and antisense (S-AS) transcripts between cancer and normal libraries. S-AS transcripts were enriched in known cancer genes, while transcript isoforms were enriched in miRNA targeting sites. We found that transcript abundance had a stronger GC-bias in LongSAGE than Tag-seq, such that AT-rich tags were less abundant than GC-rich tags in LongSAGE. Tag-seq also performed better in gene discovery, identifying >98% of genes detected by LongSAGE and profiling a distinct subset of the transcriptome characterized by AT-rich genes, which was expressed at levels below those detectable by LongSAGE. Overall, Tag-seq is sensitive to rare transcripts, has less sequence composition bias relative to LongSAGE, and allows differential expression analysis for a greater range of transcripts, including transcripts encoding important regulatory molecules.	[Morrissy, A. Sorana; Morin, Ryan D.; Delaney, Allen; Zeng, Thomas; McDonald, Helen; Jones, Steven; Zhao, Yongjun; Hirst, Martin; Marra, Marco A.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada		Marra, MA (corresponding author), BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada.	mmarra@bcgsc.ca	Marra, Marco A/B-5987-2008; Hirst, Martin/B-7684-2016; Jones, Steven J/C-3621-2009; Morin, Ryan/AAE-7824-2019; Ding, Cheng-Qiang/B-6287-2011	Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Morin, Ryan/0000-0003-2932-7800; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [N01-SO-12400]; National Cancer Institute Office of Cancer Genomics [27xS053]; Genome Canada/Genome BC MORGEN ProjectGenome Canada; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Health Research Senior Scholar; Young Investigator	We thank Don Riddle and Peter Ruzanov for helpful discussions, Malachi Griffith for providing Affymetrix array data, Asim Siddiqui for insights into GC-bias, and Scott DiGuistini for providing Blue Stain fungus data. We thank Daniela Gerhard for helpful discussions and guidance, and the anonymous reviewers for comments that strengthened the manuscript. This study was funded in part by the National Institutes of Health (contract no. N01-SO-12400), the National Cancer Institute Office of Cancer Genomics (contract no. 27xS053), and the Genome Canada/Genome BC MORGEN Project. A. S. M. is a trainee funded by the Canadian Institutes of Health Research, and M. A. M. is a Michael Smith Foundation for Health Research Senior Scholar and a Terry Fox Young Investigator.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Dahary D, 2005, GENOME RES, V15, P364, DOI 10.1101/gr.3308405; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hanriot L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-418; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; Hirst M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r113; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jiang L, 2008, CANCER RES, V68, P9900, DOI 10.1158/0008-5472.CAN-08-1319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khattra J, 2007, GENOME RES, V17, P108, DOI 10.1101/gr.5488207; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lal A, 1999, CANCER RES, V59, P5403; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nielsen KL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl714; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Peters DG, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e39; Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Siddiqui AS, 2005, P NATL ACAD SCI USA, V102, P18485, DOI 10.1073/pnas.0509455102; Siddiqui AS, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl404; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; von Bubnoff A, 2008, CELL, V132, P721, DOI 10.1016/j.cell.2008.02.028; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382	45	269	294	0	30	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2009	19	10					1825	1835		10.1101/gr.094482.109			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	501NX	WOS:000270389700015	19541910	Green Published, Bronze			2022-01-24	
J	Melzer, S; Lens, F; Gennen, J; Vanneste, S; Rohde, A; Beeckman, T				Melzer, Siegbert; Lens, Frederic; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom			Flowering-time genes modulate meristem determinacy and growth form in Arabidopsis thaliana	NATURE GENETICS			English	Article							FLORAL INDUCTION; FT; ACTIVATION; TRANSITION; EXPRESSION; MORPHOLOGY; FRUITFULL; EVOLUTION; PATHWAYS; SIGNALS	Plants have evolved annual and perennial life forms as alternative strategies to adapt reproduction and survival to environmental constraints. In isolated situations, such as islands, woody perennials have evolved repeatedly from annual ancestors(1). Although the molecular basis of the rapid evolution of insular woodiness is unknown, the molecular difference between perennials and annuals might be rather small, and a change between these life strategies might not require major genetic innovations(2,3). Developmental regulators can strongly affect evolutionary variation(4) and genes involved in meristem transitions are good candidates for a switch in growth habit. We found that the MADS box proteins SUPPRESSOR OF OVEREXPRESSION OF CONSTANS 1 ( SOC1) and FRUITFULL (FUL) not only control flowering time, but also affect determinacy of all meristems. In addition, downregulation of both proteins established phenotypes common to the lifestyle of perennial plants, suggesting their involvement in the prevention of secondary growth and longevity in annual life forms.	[Melzer, Siegbert; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Melzer, Siegbert; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Lens, Frederic] Katholieke Univ Leuven, Inst Bot & Microbiol, Lab Plant Syst, B-3001 Louvain, Belgium; [Lens, Frederic] Nat Herbarium Netherlands, Leiden Univ Branch, NL-2300 RA Leiden, Netherlands		Melzer, S (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	siegbert.melzer@psb.ugent.be	Lens, Frederic/B-8482-2011; Vanneste, Steffen/K-8353-2013; Beeckman, Tom/ABI-1703-2020; Beeckman, Tom/ABA-1164-2020	Lens, Frederic/0000-0002-5001-0149; Vanneste, Steffen/0000-0002-9948-9672; Beeckman, Tom/0000-0001-8656-2060; Melzer, Siegbert/0000-0003-4008-4782	Technology in FlandersInstitute for the Promotion of Innovation by Science and Technology in Flanders (IWT); Research Foundation-Flanders (FWO)FWO	We appreciate the continuous support of K. Apel, D. Inze and E. Smets. We thank J. Chandler and M. De Cock for critical reading of the manuscript. S. V. is indebted to the Institute for the Promotion of Innovation through Science and Technology in Flanders for a predoctoral fellowship. F. L. and A. R. are postdoctoral fellows of the Research Foundation-Flanders (FWO). Seeds of 35S:FT plants were provided by P. Wigge (John Innes Centre), seeds of the soc1-1 allele were provided by G. Coupland (Max Planck Institute for Plant Breeding Research) and seeds of soc1-2 in Col and Ler backgrounds by I. Lee (University of Seoul).	Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Carlquist S., 1974, ISLAND BIOL; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cronk QCB, 2001, NAT REV GENET, V2, P607, DOI 10.1038/35084556; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Poduska B, 2003, GENETICS, V163, P1457; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Sibout R, 2008, CURR BIOL, V18, P458, DOI 10.1016/j.cub.2008.02.070; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Thomas H, 2000, J EXP BOT, V51, P1781, DOI 10.1093/jexbot/51.352.1781; Tooke F, 2005, J EXP BOT, V56, P2587, DOI 10.1093/jxb/eri254; Wang Q, 2007, CURR BIOL, V17, P1513, DOI 10.1016/j.cub.2007.07.059; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	28	269	296	5	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1489	1492		10.1038/ng.253			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	WOS:000261215900028	18997783	Green Submitted, Green Published			2022-01-24	
J	Luedi, PP; Dietrich, FS; Weidman, JR; Bosko, JM; Jirtle, RL; Hartemink, AJ				Luedi, Philippe P.; Dietrich, Fred S.; Weidman, Jennifer R.; Bosko, Jason M.; Jirtle, Randy L.; Hartemink, Alexander J.			Computational and experimental identification of novel human imprinted genes	GENOME RESEARCH			English	Article							SERUM RESPONSE FACTOR; HUMAN GENOME; H19 GENE; METHYLATION; EXPRESSION; GROWTH; DOMAIN; CELLS; DIFFERENTIATION; EVOLUTION	Imprinted genes are essential in embryonic development, and imprinting dysregulation contributes to human disease. We report two new human imprinted genes: KCNK9 is predominantly expressed in the brain, is a known oncogene, and may be involved in bipolar disorder and epilepsy, while DLGAP2 is a candidate bladder cancer tumor suppressor. Both genes lie on chromosome 8, not previously suspected to contain imprinted genes. We identified these genes, along with 154 others, based on the predictions of multiple classification algorithms using DNA sequence characteristics as features. Our findings demonstrate that DNA sequence characteristics, including recombination hot spots, are sufficient to accurately predict the imprinting status of individual genes in the human genome.	Duke Univ, Ctr Bioinformat & Computat Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; Duke Univ, Dept Comp Sci, Durham, NC 27708 USA		Jirtle, RL (corresponding author), Duke Univ, Ctr Bioinformat & Computat Biol, Durham, NC 27708 USA.	jirtle@radonc.duke.edu; amink@cs.duke.edu			NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32 ES007031, ES13053, T32ES07031, ES015165, R01 ES015165, R21 ES013053] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R21ES013053, R01ES015165, T32ES007031] Funding Source: NIH RePORTER		Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bantignies F, 2006, CURR OPIN CELL BIOL, V18, P275, DOI 10.1016/j.ceb.2006.04.003; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; CROUSE HV, 1960, GENETICS, V45, P1429; de Villena FPM, 2000, TRENDS GENET, V16, P573, DOI 10.1016/S0168-9525(00)02134-X; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Furukawa C, 2005, CANCER RES, V65, P7102, DOI 10.1158/0008-5472.CAN-04-1877; Greally JM, 2002, P NATL ACAD SCI USA, V99, P327, DOI 10.1073/pnas.012539199; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hunter P, 2007, EMBO REP, V8, P441, DOI 10.1038/sj.embor.7400965; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kananura C, 2002, AM J MED GENET, V114, P227, DOI 10.1002/ajmg.10201; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Ke XY, 2002, MAMM GENOME, V13, P639, DOI 10.1007/s00335-002-3038-x; Kimura MI, 2004, J HUM GENET, V49, P273, DOI 10.1007/s10038-004-0139-2; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Kwon HE, 2004, ANN NY ACAD SCI, V1034, P1, DOI 10.1196/annals.1335.001; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lee SH, 2001, MAMM GENOME, V12, P157, DOI 10.1007/s003350010247; Levitsky VG, 2001, BIOINFORMATICS, V17, P998, DOI 10.1093/bioinformatics/17.11.998; Li T, 2002, J BIOL CHEM, V277, P13518, DOI 10.1074/jbc.M200458200; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; MILTENBERGER RJ, 1995, MOL CELL BIOL, V15, P2527; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; Muscheck M, 2000, LAB INVEST, V80, P1089, DOI 10.1038/labinvest.3780114; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Niu XP, 1999, PLANT MOL BIOL, V41, P1, DOI 10.1023/A:1006206011502; Okita C, 2003, GENOMICS, V81, P556, DOI 10.1016/S0888-7543(03)00052-1; Patel AJ, 2004, PFLUG ARCH EUR J PHY, V448, P261, DOI 10.1007/s00424-004-1255-8; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Ranta S, 2000, EUR J HUM GENET, V8, P381, DOI 10.1038/sj.ejhg.5200440; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; SAVORY TH, 1970, SCI AM, V223, P102, DOI 10.1038/scientificamerican1270-102; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; VANDROMME M, 1992, J CELL BIOL, V118, P1489, DOI 10.1083/jcb.118.6.1489; Walter J, 2003, HUM MOL GENET, V12, pR215, DOI 10.1093/hmg/ddg296; Witten I. H., 2005, DATA MINING PRACTICA; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	60	269	285	0	15	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2007	17	12					1723	1730		10.1101/gr.6584707			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	237FP	WOS:000251359900003	18055845	Bronze, Green Published			2022-01-24	
J	Edwards, RA; Rodriguez-Brito, B; Wegley, L; Haynes, M; Breitbart, M; Peterson, DM; Saar, MO; Alexander, S; Alexander, EC; Rohwer, F				Edwards, Robert A.; Rodriguez-Brito, Beltran; Wegley, Linda; Haynes, Matthew; Breitbart, Mya; Peterson, Dean M.; Saar, Martin O.; Alexander, Scott; Alexander, E. Calvin, Jr.; Rohwer, Forest			Using pyrosequencing to shed light on deep mine microbial ecology	BMC GENOMICS			English	Article							GENOMIC ANALYSIS; COMMUNITY; METAGENOMICS	Background: Contrasting biological, chemical and hydrogeological analyses highlights the fundamental processes that shape different environments. Generating and interpreting the biological sequence data was a costly and time-consuming process in defining an environment. Here we have used pyrosequencing, a rapid and relatively inexpensive sequencing technology, to generate environmental genome sequences from two sites in the Soudan Mine, Minnesota, USA. These sites were adjacent to each other, but differed significantly in chemistry and hydrogeology. Results: Comparisons of the microbes and the subsystems identified in the two samples highlighted important differences in metabolic potential in each environment. The microbes were performing distinct biochemistry on the available substrates, and subsystems such as carbon utilization, iron acquisition mechanisms, nitrogen assimilation, and respiratory pathways separated the two communities. Although the correlation between much of the microbial metabolism occurring and the geochemical conditions from which the samples were isolated could be explained, the reason for the presence of many pathways in these environments remains to be determined. Despite being physically close, these two communities were markedly different from each other. In addition, the communities were also completely different from other microbial communities sequenced to date. Conclusion: We anticipate that pyrosequencing will be widely used to sequence environmental samples because of the speed, cost, and technical advantages. Furthermore, subsystem comparisons rapidly identify the important metabolisms employed by the microbes in different environments.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; Univ Minnesota, Dept Geol Sci, Nat Resources Res Inst, Duluth, MN 55812 USA; Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN USA		Edwards, RA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	redwards@salmonella.org; beltran.rodriguezbrito@gmail.com; lwegley@gmail.com; mhaynes@projects.sdsu.edu; mya@marine.usf.edu; dpeters1@nrri.umn.edu; saar@tc.umn.edu; alexa017@umn.edu; alexa001@umn.edu; frohwer@sunstroke.sdsu.edu	Breitbart, Mya/B-1366-2009; Edwards, Rob/Q-1691-2019; chen, qi/C-8585-2011; Rohwer, Forest/AAC-5315-2019; Saar, Martin/F-3542-2014	Breitbart, Mya/0000-0003-3210-2899; Saar, Martin/0000-0002-4869-6452			ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Cann AJ, 2005, VIRUS GENES, V30, P151, DOI 10.1007/s11262-004-5624-3; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Klubek B, 1996, MICROBIOS, V88, P223; Margulies M, 2005, NATURE; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Overbeek R, 2004, COMMUN ACM, V47, P46, DOI 10.1145/1029496.1029525; OVERBEEK R, 2005, NUCL ACIDS RES; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; RODRIGUEZBRITO B, 2006, IN PRESS BMC BIOINFO; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turtura GC, 2000, MICROBIOLOGICA, V23, P207; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; SEED; FIG SUBSYSTEM FORUM; RIBOSOMAL DATABASE P	26	269	282	1	66	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAR 20	2006	7								57	10.1186/1471-2164-7-57			13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	058EF	WOS:000238647400001		Green Published, gold			2022-01-24	
J	Stephens, P; Edkins, S; Davies, H; Greenman, C; Cox, C; Hunter, C; Bignell, G; Teague, J; Smith, R; Stevens, C; O'Meara, S; Parker, A; Tarpey, P; Avis, T; Barthorpe, A; Brackenbury, L; Buck, G; Butler, A; Clements, J; Cole, J; Dicks, E; Edwards, K; Forbes, S; Gorton, M; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jones, D; Kosmidou, V; Laman, R; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Shepherd, R; Small, A; Solomon, H; Stephens, Y; Tofts, C; Varian, J; Webb, A; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Green, A; Knowles, M; Leung, SY; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Yuen, ST; Nicholson, AG; Lakhani, S; Easton, DF; Weber, BL; Stratton, MR; Futreal, PA; Wooster, R				Stephens, P; Edkins, S; Davies, H; Greenman, C; Cox, C; Hunter, C; Bignell, G; Teague, J; Smith, R; Stevens, C; O'Meara, S; Parker, A; Tarpey, P; Avis, T; Barthorpe, A; Brackenbury, L; Buck, G; Butler, A; Clements, J; Cole, J; Dicks, E; Edwards, K; Forbes, S; Gorton, M; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jones, D; Kosmidou, V; Laman, R; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Shepherd, R; Small, A; Solomon, H; Stephens, Y; Tofts, C; Varian, J; Webb, A; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Green, A; Knowles, M; Leung, SY; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Yuen, ST; Nicholson, AG; Lakhani, S; Easton, DF; Weber, BL; Stratton, MR; Futreal, PA; Wooster, R			A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME	We examined the coding sequence of 518 protein kinases, similar to 1.3 Mb of DNA per sample, in 25 breast cancers. In many tumors, we detected no somatic mutations. But a few had numerous somatic mutations with distinctive patterns indicative of either a mutator phenotype or a past exposure.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Inst Canc Res, Sutton SM2 5NG, Surrey, England; UCL, Inst Orthopaed, Stanmore, Middx, England; Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England; St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Erasmus Univ, Josephine Nefkens Inst, NL-3015 GE Rotterdam, Netherlands; Univ Penn, Div Urol, Philadelphia, PA 19104 USA; Nazl Tumori & FIRC Inst Mol Oncol, Milan, Italy; Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; Royal Brompton Hosp, London SW3 6NP, England; Inst Canc Res, Chester Beatty Labs, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Strangeways Res Labs, Canc Res UK Genet Epidemiol Grp, Cambridge CB1 4RN, England; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA		Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk	Lakhani, Sunil R/I-1970-2018; Pierotti, Marco Alessandro/AAC-4728-2022; Leung, Suet Yi/C-4340-2009; Yuen, Siu/K-6311-2014; Looijenga, Leendert/B-8145-2019; Leung, Suet Yi/T-9620-2019	Lakhani, Sunil R/0000-0003-4067-2760; Pierotti, Marco Alessandro/0000-0002-7431-8332; Looijenga, Leendert/0000-0002-8146-1911; Hunter, Christopher/0000-0002-1335-0881; Gray, Kristian/0000-0002-7035-7107; Yates, Andrew/0000-0002-8886-4772; Leung, Suet Yi/0000-0001-8614-4619; Teh, Bin Tean/0000-0003-1514-1124; Knowles, Margaret/0000-0002-9363-8657; Buck, Gemma/0000-0001-5289-1050; Laman, Ross/0000-0003-0545-0521; Edkins, Sarah/0000-0003-0717-1972; Green, Anthony/0000-0002-9795-0218; Raine, Keiran/0000-0002-5634-1539; Flanagan, Adrienne/0000-0002-2832-1303			Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Persons DL, 1997, MODERN PATHOL, V10, P720; Wagner E, 2002, J CELL SCI, V115, P3033; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Xiao W, 1999, MUTAT RES-FUND MOL M, V431, P155, DOI 10.1016/S0027-5107(99)00203-1	7	269	278	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2005	37	6					590	592		10.1038/ng1571			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	WOS:000229495300011	15908952				2022-01-24	
J	Descargues, P; Deraison, C; Bonnart, C; Kreft, M; Kishibe, M; Ishida-Yamamoto, A; Elias, P; Barrandon, Y; Zambruno, G; Sonnenberg, A; Hovnanian, A				Descargues, P; Deraison, C; Bonnart, C; Kreft, M; Kishibe, M; Ishida-Yamamoto, A; Elias, P; Barrandon, Y; Zambruno, G; Sonnenberg, A; Hovnanian, A			Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity	NATURE GENETICS			English	Article							SERINE PROTEINASE-INHIBITOR; CORNEUM CHYMOTRYPTIC ENZYME; STRATUM-CORNEUM; BARRIER FUNCTION; PERMEABILITY BARRIER; SUBTILISIN-A; LEKTI; EXPRESSION; SKIN; DESQUAMATION	Mutations in SPINK5, encoding the serine protease inhibitor LEKTI, cause Netherton syndrome, a severe autosomal recessive genodermatosis. Spink5(-/-) mice faithfully replicate key features of Netherton syndrome, including altered desquamation, impaired keratinization, hair malformation and a skin barrier defect. LEKTI deficiency causes abnormal desmosome cleavage in the upper granular layer through degradation of desmoglein 1 due to stratum corneum tryptic enzyme and stratum corneum chymotryptic enzyme-like hyperactivity. This leads to defective stratum corneum adhesion and resultant loss of skin barrier function. Profilaggrin processing is increased and implicates LEKTI in the cornification process. This work identifies LEKTI as a key regulator of epidermal protease activity and degradation of desmoglein 1 as the primary pathogenic event in Netherton syndrome.	Univ Toulouse 3, INSERM, U563, F-31059 Toulouse 3, France; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Dermatol, San Francisco, CA 94121 USA; Swiss Fed Inst Technol, Sch Life Sci, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland; IRCCS, Ist Dermopat Immacolata, Lab Mol & Cell Biol, I-00167 Rome, Italy; Hop Purpan, Dept Med Genet, F-31059 Toulouse 3, France		Hovnanian, A (corresponding author), Univ Toulouse 3, INSERM, U563, Pl Dr Baylac, F-31059 Toulouse 3, France.	alain.hovnanian@toulouse.inserm.fr	BONNART, Chrystelle/A-1309-2011; Hovnanian, Alain/I-4711-2017; deraison, celine/P-6255-2016; Zambruno, Giavanna/K-2933-2018	Hovnanian, Alain/0000-0003-3412-7512; deraison, celine/0000-0002-9013-4592; Zambruno, Giovanna/0000-0002-1295-056X			Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; BARRANDON Y, 1988, J INVEST DERMATOL, V91, P315, DOI 10.1111/1523-1747.ep12475646; Bernard BA, 2003, J AM ACAD DERMATOL, V48, pS120, DOI 10.1067/mjd.2003.279; Bitoun E, 2003, HUM MOL GENET, V12, P2417, DOI 10.1093/hmg/ddg247; Bitoun E, 2002, J INVEST DERMATOL, V118, P352, DOI 10.1046/j.1523-1747.2002.01603.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; COMEL M, 1949, Dermatologica, V98, P133; deWolf K, 1996, DERMATOLOGY, V192, P400, DOI 10.1159/000246431; Ding X, 1999, J INVEST DERMATOL, V112, P739, DOI 10.1046/j.1523-1747.1999.00585.x; Ekholm IE, 2000, J INVEST DERMATOL, V114, P56, DOI 10.1046/j.1523-1747.2000.00820.x; ELIAS PM, 1991, ADV LIPID RES, V24, P1; ELIAS PM, 2004, J INVEST DERMATOL, V122, pR6; Fartasch M, 1999, ARCH DERMATOL, V135, P823, DOI 10.1001/archderm.135.7.823; Franzke CW, 1996, J BIOL CHEM, V271, P21886, DOI 10.1074/jbc.271.36.21886; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; HANSSON L, 1994, J BIOL CHEM, V269, P19420; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hausser I, 1996, PEDIATR DERMATOL, V13, P183, DOI 10.1111/j.1442-200X.1996.tb02615.x; ISHIDAYAMAMOTO A, IN PRESS J INVEST DE; ITO M, 1984, J INVEST DERMATOL, V83, P1, DOI 10.1111/1523-1747.ep12261618; Jayakumar A, 2004, PROTEIN EXPRES PURIF, V35, P93, DOI 10.1016/j.pep.2003.12.004; JUDGE MR, 1994, BRIT J DERMATOL, V131, P615, DOI 10.1111/j.1365-2133.1994.tb04971.x; Kljuic A, 2003, EXP DERMATOL, V12, P20, DOI 10.1034/j.1600-0625.2003.120103.x; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Kreutzmann P, 2004, J CHROMATOGR B, V803, P75, DOI 10.1016/j.jchromb.2003.07.016; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI13563; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Magert HJ, 2002, INT J BIOCHEM CELL B, V34, P573, DOI 10.1016/S1357-2725(01)00179-0; Magert HJ, 2002, EUR J MED RES, V7, P49; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; NETHERTON EW, 1958, ARCH DERMATOL, V78, P483, DOI 10.1001/archderm.1958.01560100059009; Pulkkinen L, 2003, EXP DERMATOL, V12, P11, DOI 10.1034/j.1600-0625.2003.120102.x; Raghunath M, 2004, J INVEST DERMATOL, V123, P474, DOI 10.1111/j.0022-202X.2004.23220.x; RESING KA, 1984, J CELL BIOL, V99, P1372, DOI 10.1083/jcb.99.4.1372; Scheimberg I, 1996, PEDIATR PATHOL LAB M, V16, P359, DOI 10.1080/15513819609168677; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; SMITH DL, 1995, BRIT J DERMATOL, V133, P153; Sprecher E, 2001, J INVEST DERMATOL, V117, P179, DOI 10.1046/j.1523-1747.2001.01389.x; STEVANOVIC DV, 1969, BRIT J DERMATOL, V81, P851, DOI 10.1111/j.1365-2133.1969.tb15956.x; SUZUKI Y, 1994, ARCH DERMATOL RES, V286, P249, DOI 10.1007/BF00387596; TRAUPE H, 1989, ICHTYOSIS GUIDE CLIN; Van Gysel D, 2001, DERMATOLOGY, V202, P99, DOI 10.1159/000051607; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104	50	269	275	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					56	65		10.1038/ng1493			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	WOS:000225997500021	15619623				2022-01-24	
J	Birnby, DA; Link, EM; Vowels, JJ; Tian, H; Colacurcio, PL; Thomas, JH				Birnby, DA; Link, EM; Vowels, JJ; Tian, H; Colacurcio, PL; Thomas, JH			A transmembrane guanylyl cyclase (DAF-11) and Hsp90 (DAF-21) regulate a common set of chemosensory behaviors in Caenorhabditis elegans	GENETICS			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; NUCLEOTIDE-GATED CHANNEL; HEAT-SHOCK-PROTEIN; CONTROLLING DAUER FORMATION; ROD OUTER SEGMENT; N-TERMINAL DOMAIN; C-ELEGANS; IN-VIVO; MOLECULAR CHAPERONES; LARVAL DEVELOPMENT	Caenorhabditis elegans daf-11 and daf-21 mutants share defects in specific chemosensory responses mediated by several classes of sensory neurons, indicating that these two genes have closely related functions in an assortment of chemosensory pathways. We report that daf-11 encodes one of a large family of C. elegans transmembrane guanylyl cyclases (TM-GCs). The cyclic GMP analogue 8-bromo-cCMP rescues a sensory defect in both daf-11 and daf-21 mutants, supporting a role for DAF-11 guanylyl cyclase activity in this process and further suggesting that daf-21 acts at a similar step, daf-11:gfp fusions are expressed in five identified pairs of chemosensory neurons in a pattern consistent with most daf-11 mutant phenotypes. We also show that daf-21 encodes the heat-shock protein 90 (Hsp90), a chaperone with numerous specific protein targets. We show that the viable chemosensory-deficient daf-21 mutation is an unusual allele resulting from a single amino acid substitution and that the daf-21 null phenotype is early larval lethality. These results demonstrate that cGMP is a prominent second messenger in C. elegans chemosensory transduction and suggest a previously unknown role for Hsp90 in regulating cGMP levels.	Univ Washington, Dept Genet, Seattle, WA 98195 USA		Thomas, JH (corresponding author), Univ Washington, Dept Genet, Box 357360, Seattle, WA 98195 USA.	jht@genetics.washington.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007735, R01GM048700] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM-07735, GM-48700] Funding Source: Medline		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BRENNER S, 1974, GENETICS, V77, P71; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caplan AJ, 1999, TRENDS CELL BIOL, V9, P262, DOI 10.1016/S0962-8924(99)01580-9; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen CF, 1996, MOL CELL BIOL, V16, P4691; CHINKERS M, 1994, P NATL ACAD SCI USA, V91, P11075, DOI 10.1073/pnas.91.23.11075; CHINKERS M, 1991, J BIOL CHEM, V266, P4088; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; DALLEY BK, 1992, DEV BIOL, V151, P80, DOI 10.1016/0012-1606(92)90215-3; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOTTLIEB S, 1994, GENETICS, V137, P107; GOY MF, 1991, TRENDS NEUROSCI, V14, P293, DOI 10.1016/0166-2236(91)90140-P; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HORVITZ HR, 1979, MOL GEN GENET, V175, P129, DOI 10.1007/BF00425528; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; HURLEY JB, 1987, ANNU REV PHYSIOL, V49, P793; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; KIMURA Y, 1994, MOL GEN GENET, V242, P517, DOI 10.1007/BF00285275; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Koutalos Y, 1993, Curr Opin Neurobiol, V3, P513, DOI 10.1016/0959-4388(93)90049-5; LIU DWC, 1994, J NEUROSCI, V14, P1953; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Malone EA, 1996, GENETICS, V143, P1193; Mayer MP, 1999, CURR BIOL, V9, pR322, DOI 10.1016/S0960-9822(99)80203-6; Mazzarella R, 1997, GENOMICS, V45, P216, DOI 10.1006/geno.1997.4912; MCNEIL L, 1995, J BIOL CHEM, V270, P7189, DOI 10.1074/jbc.270.13.7189; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meng X, 1996, J CELL SCI, V109, P1677; MIKI N, 1975, J BIOL CHEM, V250, P6320; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; PARKINSON SJ, 1994, J BIOL CHEM, V269, P22683; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Priess J.R., 1997, C ELEGANS 2 1997, P739; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Scheibel T, 1998, BIOCHEM PHARMACOL, V56, P675, DOI 10.1016/S0006-2952(98)00120-8; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schumacher RJ, 1996, BIOCHEMISTRY-US, V35, P14889, DOI 10.1021/bi961825h; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; SONG HY, 1996, J BIOL CHEM, V24, P3574; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; THOMAS JH, 1993, GENETICS, V134, P1105; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VAANDRAGER AB, 1993, J BIOL CHEM, V268, P2174; VAANDRAGER AB, 1993, J BIOL CHEM, V268, P19598; VANDERKEYL H, 1994, DEV DYNAM, V201, P86, DOI 10.1002/aja.1002010109; vanderStraten A, 1997, EMBO J, V16, P1961, DOI 10.1093/emboj/16.8.1961; VOWELS JJ, 1994, GENETICS, V138, P303; VOWELS JJ, 1992, GENETICS, V130, P105; VOWELS JJ, 1994, THESIS U WASHINGTON; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; Waterston Robert H., 1997, Cold Spring Harbor Monograph Series, V33, P23; WEICH H, 1992, NATURE, V358, P169; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wood WB, 1988, NEMATODE CAENORHABDI; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; YUEN PST, 1992, ANNU REV NEUROSCI, V15, P193; Zwaal RR, 1997, GENETICS, V145, P715; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	100	269	304	0	21	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAY	2000	155	1					85	104					20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311DH	WOS:000086869200008	10790386				2022-01-24	
J	de Koning, DJ; Janss, LLG; Rattink, AP; van Oers, PAM; de Vries, BJ; Groenen, MAM; van der Poel, JJ; de Groot, PN; Brascamp, EW; van Arendonk, JAM				de Koning, DJ; Janss, LLG; Rattink, AP; van Oers, PAM; de Vries, BJ; Groenen, MAM; van der Poel, JJ; de Groot, PN; Brascamp, EW; van Arendonk, JAM			Detection of quantitative trait loci for backfat thickness and intramuscular fat content in pigs (Sus scrofa)	GENETICS			English	Article							MEAT QUALITY TRAITS; LARGE WHITE-PIGS; WILD BOAR; POPULATIONS; MEISHAN; CARCASS; GROWTH; GENOME; GENES; MAP	In an experimental cross between Meishan and Dutch Large White and Landrace lines, 619 F-2 animals and their parents were typed for molecular markers covering the entire porcine genome. Associations were studied between these markers and two fatness traits: intramuscular fat content and backfat thickness. Association analyses were performed using interval mapping by regression under two genetic models: (1) an outbred line-cross model where the founder lines were assumed to be fixed for different QTL alleles; and (2) a half-sib model where a unique allele substitution effect was fitted within each of the 19 half-sib families. Both approaches revealed for backfat thickness a highly significant QTL on chromosome 7 and suggestive evidence for a QTL at chromosome 2. Furthermore, suggestive OTL affecting backfat thickness were detected on chromosomes 1 and 6 under the line-cross model. For intramuscular fat content the line-cross approach showed suggestive evidence for QTL on chromosomes 2, 4, and 6, whereas the half-sib analysis showed suggestive linkage for chromosomes 4 and 7. The nature of the QTL effects and assumptions underlying both models could explain discrepancies between the findings under the two models. It is concluded that both approaches can complement each other in the analysis of data from outbred line crosses.	Wageningen Univ Agr, Wageningen Inst Anim Sci, Anim Breeding & Genet Grp, NL-6700 AH Wageningen, Netherlands; DLO, ID, Inst Anim Sci & Hlth, NL-8200 AB Lelystad, Netherlands		de Koning, DJ (corresponding author), Wageningen Univ Agr, Wageningen Inst Anim Sci, Anim Breeding & Genet Grp, POB 338, NL-6700 AH Wageningen, Netherlands.	dirk-jan.deKonig@alg.vf.wau.nl	van Arendonk, Johan/E-2536-2011; Groenen, Martien/D-8408-2012; van der Poel, Jan/E-5104-2012; de Koning, Dirk Jan/F-3399-2013	van Arendonk, Johan/0000-0003-2592-3947; Groenen, Martien/0000-0003-0484-4545; de Koning, Dirk Jan/0000-0001-6343-8155			Alfonso L, 1998, ANIM SCI, V66, P1; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; ARCHIBALD AL, 1995, MAMM GENOME, V6, P157, DOI 10.1007/BF00293008; Bink MCAM, 1999, GENETICS, V151, P409; Carver EA, 1997, GENOME RES, V7, P1123, DOI 10.1101/gr.7.12.1123; CHURCHILL GA, 1994, GENETICS, V138, P963; DEKONING DJ, 1998, P 6 WORLD C GEN APPL, V26, P410; Falconer D. S., 1989, Introduction to quantitative genetics.; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; Geldermann H, 1996, J ANIM BREED GENET, V113, P381, DOI 10.1111/j.1439-0388.1996.tb00629.x; Goureau A, 1996, GENOMICS, V36, P252, DOI 10.1006/geno.1996.0460; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Green P., 1990, DOCUMENTATION CRIMAP; Groenen MAM, 1996, ANIM GENET, V27, P355, DOI 10.1111/j.1365-2052.1996.tb00978.x; HALEY CS, 1994, GENETICS, V136, P1195; HOUDE A, 1993, J ANIM SCI, V71, P1414, DOI 10.2527/1993.7161414x; Hovenier R., 1993, Pig News and Information, V14, p17N; HOVENIER R, 1992, LIVEST PROD SCI, V32, P309, DOI 10.1016/0301-6226(92)90002-L; Janss LLG, 1997, GENETICS, V145, P395; Janss LLG, 1997, J ANIM SCI, V75, P2864; JANSS LLG, 1995, THEOR APPL GENET, V91, P1137, DOI 10.1007/BF00223932; JOHANSSON M, 1995, GENOMICS, V25, P682, DOI 10.1016/0888-7543(95)80011-A; Knott SA, 1998, GENETICS, V149, P1069; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Milan D., 1998, Proceedings of the 6th World Congress on Genetics Applied to Livestock Production, Armidale, Australia, January 11-16, 1998. Volume 26: Quantitative genetic theory; selection theory and experiments; internationalisation of breeding programs; detection of quantitative trait loci; exploitation of quantitative trait loci; quantitative trait loci maps; transgenics; developmental genetics., P414; MOSER G, 1998, P 6 WORLD C GEN APPL, V26, P478; Norman RA, 1997, AM J HUM GENET, V60, P166; Rohrer GA, 1998, J ANIM SCI, V76, P2247; Rohrer GA, 1996, GENOME RES, V6, P371, DOI 10.1101/gr.6.5.371; Rothschild MF, 1995, J ANIM BREED GENET, V112, P341, DOI 10.1111/j.1439-0388.1995.tb00576.x; SERRA JJ, 1992, ANIM PROD, V54, P117, DOI 10.1017/S0003356100020638; Spelman RJ, 1996, GENETICS, V144, P1799; VAIMAN M, 1988, MOL BIOL MAJOR HISTO, P23; van Kaam JBCHM, 1998, LIVEST PROD SCI, V54, P133, DOI 10.1016/S0301-6226(97)00171-1; Vilkki HJ, 1997, J DAIRY SCI, V80, P198, DOI 10.3168/jds.S0022-0302(97)75928-9; WALLING GA, 1998, P 6 WORLD C GEN APPL, V23, P519; WARDEN CH, 1995, J CLIN INVEST, V95, P1545, DOI 10.1172/JCI117827; WARRISS PD, 1990, MEAT SCI, V28, P21, DOI 10.1016/0309-1740(90)90017-Z; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477	40	269	274	0	20	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	AUG	1999	152	4					1679	1690					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224GL	WOS:000081889600039	10430592				2022-01-24	
J	Matthijs, G; Schollen, E; Pardon, E; VeigaDaCunha, M; Jaeken, J; Cassiman, JJ; VanSchaftingen, E				Matthijs, G; Schollen, E; Pardon, E; VeigaDaCunha, M; Jaeken, J; Cassiman, JJ; VanSchaftingen, E			Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)	NATURE GENETICS			English	Article							SERUM TRANSFERRIN	Carbohydrate-deficient glycoprotein syndrome type 1 (CDG1 or Jaeken syndrome) is the prototype of a class of genetic multisystem disorders characterized by defective glycosylation of glycoconjugates(1-4). It is mostly a severe disorder which presents neonatally. There is a severe encephalopathy with axial hypotonia, abnormal eye movements and pronounced psychomotor retardation, as well as a peripheral neuropathy, cerebellar hypoplasia and retinitis pigmentosa. The patients show a peculiar distribution of subcutaneous fat, nipple retraction and hypogonadism. There is a 20% lethality in the first years of life due to severe infections, liver insufficiency or cardiomyopathy(2,3,5). CDG1 shows an autosomal recessive mode of inheritance and has been mapped to chromosome 16p(6,7). Most patients show a deficiency of phosphomannomutase (PMM)(8), an enzyme necessary for the synthesis of GDP-mannose. We have cloned the PMM1 gene, which is on chromosome 22q13 (ref, 9), We now report the identification of a second human PMM gene, PMM2, which is located on 16p13 and which encodes a protein with 66% identity to PMM1. We found eleven different missense mutations in PMM2 in 16 CDG1 patients from different geographical origins and with a documented phosphomannomutase deficiency. Our results give conclusive support to the biochemical finding that the phosphomannomutase deficiency is the basis for CDG1.	INT INST CELLULAR & MOL PATHOL, PHYSIOL CHEM LAB, B-1200 BRUSSELS, BELGIUM; UNIV CATHOLIQUE LOUVAIN, B-1200 BRUSSELS, BELGIUM; KATHOLIEKE UNIV LEUVEN HOSP, DEPT PEDIAT, B-3000 LOUVAIN, BELGIUM		Matthijs, G (corresponding author), CATHOLIC UNIV LEUVEN, CTR HUMAN GENET, CAMPUS GASTHUISBERG, B-3000 LOUVAIN, BELGIUM.		Van+Schaftingen, Emile/AAF-5532-2020	Matthijs, Gert/0000-0001-6710-1912; Van Schaftingen, Emile/0000-0002-6199-7647			CHEN ISY, 1983, NATURE, V305, P502, DOI 10.1038/305502a0; DOGGETT NA, 1995, NATURE, V377, P335; JAEKEN J, 1984, CLIN CHIM ACTA, V144, P245, DOI 10.1016/0009-8981(84)90059-7; JAEKEN J, 1980, PEDIATR RES, V14, P179, DOI 10.1203/00006450-198002000-00117; JAEKEN J, 1993, J INHERIT METAB DIS, V16, P813, DOI 10.1007/BF00714272; Jaeken J, 1997, J MED GENET, V34, P73, DOI 10.1136/jmg.34.1.73; JAEKEN J, IN PRESS J INHER MET; JAEKEN J, IN PRESS EUR J PEDIA; KEPES F, 1988, J BIOL CHEM, V263, P9155; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LONGMIRE JL, 1993, GENET ANAL-BIOMOL E, V10, P69, DOI 10.1016/1050-3862(93)90037-J; MARTINSSON T, 1994, HUM MOL GENET, V3, P2037; Matthijs G, 1996, GENOMICS, V35, P597, DOI 10.1006/geno.1996.0404; Matthijs G, 1997, GENOMICS, V40, P41, DOI 10.1006/geno.1996.4536; Sambrook J., 1989, MOL CLONING LAB MANU; STIBLER H, 1994, J NEUROL NEUROSUR PS, V57, P552, DOI 10.1136/jnnp.57.5.552; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; WADA Y, 1992, BIOCHEM BIOPH RES CO, V189, P832, DOI 10.1016/0006-291X(92)92278-6; YAMASHITA K, 1993, J BIOL CHEM, V268, P5783	19	269	272	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1997	16	1					88	92		10.1038/ng0597-88			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	WOS:A1997WX02400028	9140401				2022-01-24	
J	Cheverud, JM; Routman, EJ; Duarte, FAM; vanSwinderen, B; Cothran, K; Perel, C				Cheverud, JM; Routman, EJ; Duarte, FAM; vanSwinderen, B; Cothran, K; Perel, C			Quantitative trait loci for murine growth	GENETICS			English	Article							MENDELIAN FACTORS; GENETIC-ANALYSIS; MICE; ONTOGENY; EVOLUTION; CHARACTERS; SIZE; MAP	Body size is an archetypal quantitative trait with variation due to the segregation of many gene loci, each of relatively minor effect, and the environment. We examine the effects of quantitative trait loci (QTLs) on age-specific body weights and growth in the F-2 intercross of the LG/J and SM/J strains of inbred mice. Weekly weights (1-10 wk) and 75 microsatellite genotypes were obtained for 535 mice. Interval mapping was used to locate and measure the genotypic effects of QTLs on body weight and growth. QTL effects were detected on 16 of the 19 autosomes with several chromosomes carrying more than one QTL. The number of QTLs for age-specific weights varied from seven at 1 week to 17 at 10 wk. The QTLs were each of relatively minor, subequal effect. QTLs affecting early and late growth were generally distinct, mapping to different chromosomal locations indicating separate genetic and physiological systems for early and later murine growth.	SAN FRANCISCO STATE UNIV, DEPT BIOL, SAN FRANCISCO, CA 94132 USA; UNIV SAO PAULO, DEPT GENET, RIBEIRAO PRETO, SP, BRAZIL		Cheverud, JM (corresponding author), WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, 660 S EUCLID AVE, ST LOUIS, MO 63110 USA.			van Swinderen, Bruno/0000-0001-6552-7418			ATCHLEY WR, 1980, EVOLUTION, V34, P1161, DOI 10.1111/j.1558-5646.1980.tb04061.x; ATCHLEY WR, 1984, EVOLUTION, V38, P1165, DOI 10.1111/j.1558-5646.1984.tb05640.x; CHAI CK, 1956, GENETICS, V41, P165; CHAI CK, 1956, GENETICS, V41, P157; CHAI CK, 1968, GENET RES, V11, P239, DOI 10.1017/S0016672300011447; CHAI CK, 1957, GENETICS, V42, P601; CHAI CK, 1961, GENET RES, V2, P25, DOI 10.1017/S0016672300000513; CHEEK DB, 1975, FETAL POSTNATAL CELL; CHEVERUD JM, 1993, J EVOLUTION BIOL, V6, P463, DOI 10.1046/j.1420-9101.1993.6040463.x; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; CHEVERUD JM, 1983, EVOLUTION, V37, P895, DOI 10.1111/j.1558-5646.1983.tb05619.x; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DERCOLE AJ, 1986, HUMAN GROWTH COMPREH, P327; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Falconer D. S., 1989, Introduction to quantitative genetics.; FALCONER DS, 1978, GENET RES, V31, P287, DOI 10.1017/S0016672300018061; FALCONER DS, 1953, J GENET, V51, P470, DOI 10.1007/BF02982939; Galton F., 1889, NATURAL INHERITANCE; Goodale HD, 1938, J HERED, V29, P101, DOI 10.1093/oxfordjournals.jhered.a104463; Goodale HD, 1941, SCIENCE, V94, P442, DOI 10.1126/science.94.2445.442; GREENSPAN FS, 1994, BASIC CLIN ENDOCRINO; HALL K, 1981, BIOL NORMAL HUMAN GR, P275; Huxley J.S., 1932, PROBLEMS RELATIVE GR; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lander E. S., 1992, CONSTRUCTING GENETIC; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEAMY L, 1984, GROWTH, V48, P339; Leroith Derek, 1995, P181; Lincoln S., 1992, MAPPING GENES CONTRO, P36; MacArthur JW, 1944, AM NAT, V78, P142, DOI 10.1086/281181; *MGD, 1995, MOUS GEN INF PROJ; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; Parks John S., 1995, P473; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; RAPPAPORT R, 1993, PEDIAT ENDOCRINOLOGY, P175; RISKA B, 1984, GENETICS, V107, P79; ROUTMAN E, 1994, MAMM GENOME, V5, P187, DOI 10.1007/BF00352355; Routman E., 1994, Experientia Supplementum (Basel), V69, P593; ROUTMAN EJ, 1995, MAMM GENOME, V6, P401, DOI 10.1007/BF00355640; RUTLEDGE JJ, 1972, J ANIM SCI, V34, P344; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; SARA VR, 1981, BIOL NORMAL HUMAN GR, P241; SIZONENKO PC, 1986, HUMAN GROWTH COMPREH, P339; TANNER JM, 1963, NATURE, V199, P845, DOI 10.1038/199845a0; VANDENBRANDE JL, 1993, PEDIAT ENDOCRINOLOGY, P154; ZENG ZB, 1994, GENETICS, V136, P1457; [No title captured]	50	269	279	1	8	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	1996	142	4					1305	1319					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UD844	WOS:A1996UD84400021	8846907				2022-01-24	
J	HOUWEN, RHJ; BAHARLOO, S; BLANKENSHIP, K; RAEYMAEKERS, P; JUYN, J; SANDKUIJL, LA; FREIMER, NB				HOUWEN, RHJ; BAHARLOO, S; BLANKENSHIP, K; RAEYMAEKERS, P; JUYN, J; SANDKUIJL, LA; FREIMER, NB			GENOME SCREENING BY SEARCHING FOR SHARED SEGMENTS - MAPPING A GENE FOR BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	NATURE GENETICS			English	Article							LINKAGE MAP; DISEQUILIBRIUM; PEDIGREE; TRAITS	It is now feasible to map disease genes by screening the genome for linkage disequilibrium between the disease and marker alleles. This report presents the first application of this approach for a previously unmapped locus. A gene for benign recurrent intrahepatic cholestasis (BRIC) was mapped to chromosome 18 by searching for chromosome segments shared by only three distantly related patients. The screening results were confirmed by identyifying an extended haplotype conserved between the patients. Probability calculations indicate that such segment sharing is unlikely to arise by chance. Searching the genome for segments shared by patients is a powerful empirical method for mapping disease genes. Computer simulations suggest that, in appropriate populations, the approach may be used to localize genes for common diseases.	UNIV CALIF SAN FRANCISCO,NEUROGENET LAB,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CTR NEUROBIOL & PSYCHIAT,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; WILHELMINA CHILDRENS HOSP,UTRECHT,NETHERLANDS; CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,B-3000 LOUVAIN,BELGIUM; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,INST CLIN GENET,ROTTERDAM,NETHERLANDS						NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH00916, MH47563, MH49499] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K21MH000916, R01MH049499] Funding Source: NIH RePORTER		BENHAMIDA C, 1993, NAT GENET, V5, P195; BODMER W, 1994, NAT GENET, V6, P217, DOI 10.1038/ng0394-217; BRENARD R, 1989, J CLIN GASTROENTEROL, V11, P546, DOI 10.1097/00004836-198910000-00011; BUETOW K, 1993, AM J HUM GENET, V53, pA176; COOK JTE, 1993, DIABETES, V42, P1536, DOI 10.2337/diabetes.42.10.1536; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; ELSTON RC, 1984, GENET EPIDEMIOL, V1, P315; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEWONTIN RC, 1988, GENETICS, V120, P849; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; Ott J, 1991, ANAL HUMAN GENETIC L; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; SANDKUYL L, 1989, HUM GENET, V82, P159, DOI 10.1007/BF00284050; SHAPIRO RH, 1963, NEW ENGL J MED, V268, P708; SUMMERSKILL WHJ, 1959, LANCET, V2, P686; VANSOEST S, 1994, GENOMICS, V22, P499, DOI 10.1006/geno.1994.1422; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	27	269	272	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					380	386		10.1038/ng1294-380			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	WOS:A1994PV68200020	7894490	Green Published			2022-01-24	
J	ROBERTSON, A; LERNER, IM				ROBERTSON, A; LERNER, IM			THE HERITABILITY OF ALL-OR-NONE TRAITS - VIABILITY OF POULTRY	GENETICS			English	Article																	Cochran WG, 1936, ANN EUGENIC, V7, P207, DOI 10.1111/j.1469-1809.1936.tb02140.x; DEMPSTER ER, 1947, GENETICS, V32, P567; DEMPSTER ER, 1947, GENETICS, V32, P555; Finney D.J., 1947, PROBIT ANAL; Fisher, 1947, DESIGN EXPT; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; FISHER RA, 1941, STATISTICAL METHODS; KENDALL MG, 1945, ADV THEORY STATISTIC, V1; KORKMAN N, 1948, HEREDITAS, V34, P23; LERNER IM, 1948, POULTRY SCI, V27, P67, DOI 10.3382/ps.0270067; LERNER IM, 1947, GENETICS, V32, P325; LUSH JL, 1948, POULTRY SCI, V27, P375, DOI 10.3382/ps.0270375; SHOFFNER RN, 1946, POULTRY SCI, V25, P412; SNEDECOR GW, 1946, STATISTICAL METHODS; TAYLOR LEWIS W., 1938, CALIFORNIA AGRIC EXP STA BULL, V626, P1; Taylor Lewis W., 1943, POULTRY SCI, V22, P339, DOI 10.3382/ps.0220339; Weinberg W., 1909, Z INDUKT ABSTAMM VER, V1, P440; Weinberg W., 1908, Z INDUKTIVE ABSTAMMU, V1, P377, DOI [10.1007/BF01990605, DOI 10.1007/BF01990605]; Weinberg W., 1909, Z INDUKT ABSTAMM VER, V2, P276; Whatley JA, 1942, J AGRIC RES, V65, P0249; Wright S, 1934, GENETICS, V19, P0537; Wright S, 1921, GENETICS, V6, P111; Wright S, 1934, GENETICS, V19, P0506; Wright S, 1926, J AM STAT ASSOC, V21, P162, DOI 10.2307/2277143; Wright S, 1943, GENETICS, V28, P139; Wright S., 1917, J WASHINGTON ACAD SC, V7, P532	26	269	270	0	7	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1949	34	4					395	411					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW835	WOS:A1949XW83500004	17247323				2022-01-24	
J	van Rheenen, W; Shatunov, A; Dekker, AM; McLaughlin, RL; Diekstra, FP; Pulit, SL; van der Spek, RAA; Vosa, U; de Jong, S; Robinson, MR; Yang, J; Fogh, I; van Doormaal, PTC; Tazelaar, GHP; Koppers, M; Blokhuis, AM; Sproviero, W; Jones, AR; Kenna, KP; van Eijk, KR; Harschnitz, O; Schellevis, RD; Brands, WJ; Medic, J; Menelaou, A; Vajda, A; Ticozzi, N; Lin, K; Rogelj, B; Vrabec, K; Ravnik-Glavac, M; Koritnik, B; Zidar, J; Leonardis, L; Groselj, LD; Millecamps, S; Salachas, F; Meininger, V; de Carvalho, M; Pinto, S; Mora, JS; Rojas-Garcia, R; Polak, M; Chandran, S; Colville, S; Swingler, R; Morrison, KE; Shaw, PJ; Hardy, J; Orrell, RW; Pittman, A; Sidle, K; Fratta, P; Malaspina, A; Topp, S; Petri, S; Abdulla, S; Drepper, C; Sendtner, M; Meyer, T; Ophoff, RA; Staats, KA; Wiedau-Pazos, M; Lomen-Hoerth, C; Van Deerlin, VM; Trojanowski, JQ; Elman, L; McCluskey, L; Basak, AN; Tunca, C; Hanizeiy, H; Parman, Y; Meitinger, T; Lichtner, P; Radivojkov-Blagojevic, M; Andres, CR; Maurel, C; Bensimon, G; Landwehrmeyer, B; Brice, A; Payan, CAM; Saker-Delye, S; Durr, A; Wood, NW; Tittmann, L; Lieb, W; Franke, A; Rietschel, M; Cichon, S; Nothen, MM; Amouyel, P; Tzourio, C; Dartigues, JF; Uitterlinden, AG; Rivadeneira, F; Estrada, K; Hofman, A; Curtis, C; Blauw, HM; van der Kooi, AJ; de Visser, M; Goris, A; Weber, M; Shaw, CE; Smith, BN; Pansarasa, O; Cereda, C; Del Bo, R; Comi, GP; D'Alfonso, S; Bertolin, C; Soraru, G; Mazzini, L; Pensato, V; Gellera, C; Tiloca, C; Ratti, A; Calvo, A; Moglia, C; Brunetti, M; Arcuti, S; Capozzo, R; Zecca, C; Lunetta, C; Penco, S; Riva, N; Padovani, A; Filosto, M; Muller, B; Stuit, RJ; Blair, I; Zhang, K; McCann, EP; Fifita, JA; Nicholson, GA; Rowe, DB; Pamphlett, R; Kiernan, MC; Grosskreutz, J; Witte, OW; Ringer, T; Prell, T; Stubendorff, B; Kurth, I; Hubner, CA; Leigh, PN; Casale, F; Chio, A; Beghi, E; Pupillo, E; Tortelli, R; Logroscino, G; Powell, J; Ludolph, AC; Weishaupt, JH; Robberecht, W; Van Damme, P; Franke, L; Pers, TH; Brown, RH; Glass, JD; Landers, JE; Hardiman, O; Andersen, PM; Corcia, P; Vourc'h, P; Silani, V; Wray, NR; Visscher, PM; de Bakker, PIW; van Es, MA; Pasterkamp, RJ; Lewis, CM; Breen, G; Al-Chalabi, A; van den Berg, LH; Veldink, JH				van Rheenen, Wouter; Shatunov, Aleksey; Dekker, Annelot M.; McLaughlin, Russell L.; Diekstra, Frank P.; Pulit, Sara L.; van der Spek, Rick A. A.; Vosa, Urmo; de Jong, Simone; Robinson, Matthew R.; Yang, Jian; Fogh, Isabella; van Doormaal, Perry T. C.; Tazelaar, Gijs H. P.; Koppers, Max; Blokhuis, Anna M.; Sproviero, William; Jones, Ashley R.; Kenna, Kevin P.; van Eijk, Kristel R.; Harschnitz, Oliver; Schellevis, Raymond D.; Brands, William J.; Medic, Jelena; Menelaou, Androniki; Vajda, Alice; Ticozzi, Nicola; Lin, Kuang; Rogelj, Boris; Vrabec, Katarina; Ravnik-Glavac, Metka; Koritnik, Blazi; Zidar, Janez; Leonardis, Lea; Groselj, Leja Dolenc; Millecamps, Stephanie; Salachas, Francois; Meininger, Vincent; de Carvalho, Mamede; Pinto, Susana; Mora, Jesus S.; Rojas-Garcia, Ricardo; Polak, Meraida; Chandran, Siddharthan; Colville, Shuna; Swingler, Robert; Morrison, Karen E.; Shaw, Pamela J.; Hardy, John; Orrell, Richard W.; Pittman, Alan; Sidle, Katie; Fratta, Pietro; Malaspina, Andrea; Topp, Simon; Petri, Susanne; Abdulla, Susanne; Drepper, Carsten; Sendtner, Michael; Meyer, Thomas; Ophoff, Roel A.; Staats, Kim A.; Wiedau-Pazos, Martina; Lomen-Hoerth, Catherine; Van Deerlin, Vivianna M.; Trojanowski, John Q.; Elman, Lauren; McCluskey, Leo; Basak, A. Nazli; Tunca, Ceren; Hamzeiy, Hamid; Parman, Yesim; Meitinger, Thomas; Lichtner, Peter; Radivojkov-Blagojevic, Milena; Andres, Christian R.; Maurel, Cindy; Bensimon, Gilbert; Landwehrmeyer, Bernhard; Brice, Alexis; Payan, Christine A. M.; Saker-Delye, Safaa; Duerr, Alexandra; Wood, Nicholas W.; Tittmann, Lukas; Lieb, Wolfgang; Franke, Andre; Rietschel, Marcella; Cichon, Sven; Noethen, Markus M.; Amouyel, Philippe; Tzourio, Christophe; Dartigues, Jean-Francois; Uitterlinden, Andre G.; Rivadeneira, Fernando; Estrada, Karol; Hofman, Albert; Curtis, Charles; Blauw, Hylke M.; van der Kooi, Anneke J.; de Visser, Marianne; Goris, An; Weber, Markus; Shaw, Christopher E.; Smith, Bradley N.; Pansarasa, Orietta; Cereda, Cristina; Del Bo, Roberto; Comi, Giacomo P.; D'Alfonso, Sandra; Bertolin, Cinzia; Soraru, Gianni; Mazzini, Letizia; Pensato, Viviana; Gellera, Cinzia; Tiloca, Cinzia; Ratti, Antonia; Calvo, Andrea; Moglia, Cristina; Brunetti, Maura; Arcuti, Simona; Capozzo, Rosa; Zecca, Chiara; Lunetta, Christian; Penco, Silvana; Riva, Nilo; Padovani, Alessandro; Filosto, Massimiliano; Muller, Bernard; Stuit, Robbert Jan; Blair, Ian; Zhang, Katharine; McCann, Emily P.; Fifita, Jennifer A.; Nicholson, Garth A.; Rowe, Dominic B.; Pamphlett, Roger; Kiernan, Matthew C.; Grosskreutz, Julian; Witte, Otto W.; Ringer, Thomas; Prell, Tino; Stubendorff, Beatrice; Kurth, Ingo; Huebner, Christian A.; Leigh, P. Nigel; Casale, Federico; Chio, Adrian; Beghi, Ettore; Pupillo, Elisabetta; Tortelli, Rosanna; Logroscino, Giancarlo; Powell, John; Ludolph, Albert C.; Weishaupt, Jochen H.; Robberecht, Wim; Van Damme, Philip; Franke, Lude; Pers, Tune H.; Brown, Robert H.; Glass, Jonathan D.; Landers, John E.; Hardiman, Orla; Andersen, Peter M.; Corcia, Philippe; Vourc'h, Patrick; Silani, Vincenzo; Wray, Naomi R.; Visscher, Peter M.; de Bakker, Paul I. W.; van Es, Michael A.; Pasterkamp, R. Jeroen; Lewis, Cathryn M.; Breen, Gerome; Al-Chalabi, Ammar; van den Berg, Leonard H.; Veldink, Jan H.		PARALS Registry; SLALOM Grp; SLAP Registry; FALS Sequencing Consortium; SLAGEN Consortium; NNIPPS Study Grp	Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							FRONTOTEMPORAL DEMENTIA; HEXANUCLEOTIDE REPEAT; ALS; SUSCEPTIBILITY; POPULATION; EFFICIENT; PATHWAYS; PITFALLS; SEQUENCE; COMPLEX	To elucidate the genetic architecture of amyotrophic lateral sclerosis (ALS) and find associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced patients with ALS and matched controls (n = 1,861). Through imputation and mixed-model association analysis in 12,577 cases and 23,475 controls, combined with 2,579 cases and 2,767 controls in an independent replication cohort, we fine-mapped a new risk locus on chromosome 21 and identified C21orf2 as a gene associated with ALS risk. In addition, we identified MOBP and SCFD1 as new associated risk loci. We established evidence of ALS being a complex genetic trait with a polygenic architecture. Furthermore, we estimated the SNP-based heritability at 8.5%, with a distinct and important role for low-frequency variants (frequency 1-10%). This study motivates the interrogation of larger samples with full genome coverage to identify rare causal variants that underpin ALS risk.	[van Rheenen, Wouter; Dekker, Annelot M.; Diekstra, Frank P.; van der Spek, Rick A. A.; van Doormaal, Perry T. C.; Tazelaar, Gijs H. P.; Koppers, Max; Blokhuis, Anna M.; van Eijk, Kristel R.; Harschnitz, Oliver; Schellevis, Raymond D.; Brands, William J.; Medic, Jelena; Blauw, Hylke M.; van Es, Michael A.; Al-Chalabi, Ammar; van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands; [Shatunov, Aleksey; Fogh, Isabella; Sproviero, William; Jones, Ashley R.; Lin, Kuang; Topp, Simon; Shaw, Christopher E.; Smith, Bradley N.; Powell, John] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Dept Basic & Clin Neurosci, London, England; [McLaughlin, Russell L.] Trinity Coll Dublin, Smurfit Inst Genet, Populat Genet Lab, Dublin, Ireland; [Pulit, Sara L.; Menelaou, Androniki; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Vosa, Urmo; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [de Jong, Simone; Curtis, Charles; Lewis, Cathryn M.; Breen, Gerome] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England; [de Jong, Simone; Curtis, Charles; Breen, Gerome] Kings Coll London, Maudsley Hosp, NIFIR Biomed Res Ctr Mental Hlth, London, England; [de Jong, Simone; Curtis, Charles; Breen, Gerome] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Robinson, Matthew R.; Yang, Jian; Wray, Naomi R.; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Fogh, Isabella; Ticozzi, Nicola; Tiloca, Cinzia; Ratti, Antonia; Silani, Vincenzo] IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Milan, Italy; [Koppers, Max; Blokhuis, Anna M.; Harschnitz, Oliver; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Kenna, Kevin P.; Brown, Robert H.; Landers, John E.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Vajda, Alice; Hardiman, Orla] Trinity Coll Dublin, Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland; [Vajda, Alice; Hardiman, Orla] Beaumont Hosp, Dept Neurol, Dublin, Ireland; [Ticozzi, Nicola; Ratti, Antonia; Silani, Vincenzo] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Tranplantat, Milan, Italy; [Rogelj, Boris] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia; [Rogelj, Boris] Biomed Res Inst BRIS, Ljubljana, Slovenia; [Vrabec, Katarina; Ravnik-Glavac, Metka] Univ Ljubljana, Fac Med, Inst Pathol, Dept Mol Genet, Ljubljana, Slovenia; [Ravnik-Glavac, Metka] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana, Slovenia; [Koritnik, Blazi; Zidar, Janez; Leonardis, Lea; Groselj, Leja Dolenc] Univ Med Ctr Ljubljana, Ljubljana ALS Ctr, Inst Clin Neurophysiol, Ljubljana, Slovenia; [Millecamps, Stephanie; Salachas, Francois] Univ Paris 06, Sorbonne Univ, Inst Cerveau & Moelle Epiniere, CNRS UMR 7225,INSERM U1127,UMRS 1127, Paris, France; [Salachas, Francois] Hop La Pitie Salpetriere, Ctr Reference Malad Races SLA Ile France, Dept Neurol, Paris, France; [Salachas, Francois] GRC UPMC SEA & Malad Motoneurone, Paris, France; [Meininger, Vincent] Hop Peupliers, Ramsay Gen Sante, Paris, France; [Meininger, Vincent] Reseau SEA Ile France, Paris, France; [de Carvalho, Mamede; Pinto, Susana] Univ Lisbon, Fac Med, Inst Mol Med, Inst Physiol, Lisbon, Portugal; [de Carvalho, Mamede; Pinto, Susana] Hosp Santa Maria CHLN, Dept Neurosci, Lisbon, Portugal; [Mora, Jesus S.] Hosp San Rafael, Dept Neurol, Madrid, Spain; [Rojas-Garcia, Ricardo] Autonomous Univ Barcelona, Hosp Santa Creu & St Pau Barcelona, Dept Neurol, Barcelona, Spain; [Rojas-Garcia, Ricardo] Ctr Invest Red Enfermedades Raras CIBFRFR, Madrid, Spain; [Polak, Meraida; Glass, Jonathan D.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Polak, Meraida; Glass, Jonathan D.] Emory Univ, Sch Med, Emory ALS Ctr, Atlanta, GA USA; [Chandran, Siddharthan; Colville, Shuna; Swingler, Robert] Euan MacDonald Ctr Motor Neuron Dis Res, Edinburgh, Midlothian, Scotland; [Chandran, Siddharthan] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Chandran, Siddharthan; Basak, A. Nazli] Univ Edinburgh, Ctr Regenerat Med, MRC, Edinburgh, Midlothian, Scotland; [Morrison, Karen E.] Univ Southampton, Fac Med, Southampton, Hants, England; [Shaw, Pamela J.] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield, S Yorkshire, England; [Hardy, John; Pittman, Alan] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Orrell, Richard W.; Sidle, Katie] UCL, Inst Neurol, Dept Clin Neurosci, London, England; [Pittman, Alan] UCL, Inst Neurol, Reta Lila Weston Inst, London, England; [Fratta, Pietro] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Malaspina, Andrea] Queen Mary Univ London, Ctr Neurosci & Trauma, Blizard Inst, London, England; [Malaspina, Andrea] North East London & Essex Reg Motor Neuron Dis Ca, London, England; [Petri, Susanne] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Abdulla, Susanne] Univ Magdeburg, Dept Neurol, Magdeburg, Germany; [Drepper, Carsten; Sendtner, Michael] Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Meyer, Thomas] Humboldt Univ, Charite Univ Hosp, Dept Neurol, Berlin, Germany; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Ophoff, Roel A.; Staats, Kim A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Sernel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Wiedau-Pazos, Martina] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Lomen-Hoerth, Catherine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Van Deerlin, Vivianna M.; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Elman, Lauren; McCluskey, Leo] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA USA; [Basak, A. Nazli; Tunca, Ceren; Hamzeiy, Hamid] Bogazici Univ, Neurodegenerat Res Lab, Istanbul, Turkey; [Parman, Yesim] Istanbul Univ, Istanbul Med Sch, Dept Neurol, Istanbul, Turkey; [Meitinger, Thomas; Lichtner, Peter; Radivojkov-Blagojevic, Milena] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Andres, Christian R.; Maurel, Cindy; Corcia, Philippe; Vourc'h, Patrick] Univ Tours, INSERM U930, Tours, France; [Bensimon, Gilbert; Payan, Christine A. M.] Hop La Pitie Salpetriere, AP HP, Dept Clin Pharmacol, Paris, France; [Bensimon, Gilbert] Univ Paris 06, Pharmacol, Paris, France; [Bensimon, Gilbert; Payan, Christine A. M.] CHU Nimes, BESPIM, Nimes, France; [Landwehrmeyer, Bernhard; Ludolph, Albert C.; Weishaupt, Jochen H.; Andersen, Peter M.] Univ Ulm, Dept Neurol, Ulm, Germany; [Brice, Alexis] Hop La Pitie Salpetriere, INSERM U1127, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, CNRS UMR 7225, Paris, France; [Brice, Alexis] Univ Paris 06, Sorbonne Univ, Hop Pitie Salpetriere, UMRS 1127, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Saker-Delye, Safaa] Genethon, CNRS UMR 8587, Evry, France; [Duerr, Alexandra] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Dept Med Genet, Paris, France; [Wood, Nicholas W.] Univ College London, Inst Neurol, Dept Neurogenet, London, England; [Tittmann, Lukas; Lieb, Wolfgang] Christian Albrechts Univ Kiel, PopGen Biobarik, Kiel, Germany; [Tittmann, Lukas; Lieb, Wolfgang] Christian Albrechts Univ Kiel, Inst Epidemiol, Kiel, Germany; [Basak, A. Nazli; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Rietschel, Marcella] Heidelberg Univ, Fac Med Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Heidelberg, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Life & Brain Ctr, Dept Genom, Bonn, Germany; [Cichon, Sven] Univ Basel, Univ Basel Hosp, Div Med Genet, Basel, Switzerland; [Cichon, Sven] Univ Basel, Dept Biomed, Basel, Switzerland; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Amouyel, Philippe] Univ Lille, CHU Lille, INSERM, Inst Pasteur Lille,RID AGE Risk Factor & Mol Dete, Lille, France; [Tzourio, Christophe; Dartigues, Jean-Francois] Univ Bordeaux, ISPED, INSERM U1219, Epidemiol Biostat, Bordeaux, France; [Tzourio, Christophe; Dartigues, Jean-Francois] CHU Bordeaux, CIC 1401, Pole Sante Publ, Bordeaux, France; [Uitterlinden, Andre G.; Rivadeneira, Fernando; Estrada, Karol] Erasmus MC, Dept Internal Med, Genet Lab, Rotterdam, Netherlands; [Uitterlinden, Andre G.; Rivadeneira, Fernando; Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [van der Kooi, Anneke J.; de Visser, Marianne] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Goris, An; Robberecht, Wim; Van Damme, Philip] Katholieke Univ Leuven, Univ Leuven, Leuven Res Inst Neurosci & Dis LIND, Dpet Neurosci Expt Neurol, Leuven, Belgium; [Weber, Markus] Kantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, St Gallen, Switzerland; [Pansarasa, Orietta; Cereda, Cristina] IRCCS C Mondino Natl Inst Neurol Fdn, Lab Expt Neurobiol, Pavia, Italy; [Del Bo, Roberto; Comi, Giacomo P.] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy; [D'Alfonso, Sandra] Univ Piemonte Orientale, Interdisciplinary Res Ctr Autoimmune Dis, Dept Hlth Sci, Novara, Italy; [Bertolin, Cinzia; Soraru, Gianni] Univ Padua, Dept Neurosci, Padua, Italy; [Mazzini, Letizia] Univ Piemonte Orientals, Dept Neurol, Novara, Italy; [Pensato, Viviana; Gellera, Cinzia] Fdn IRCCS Ist Neurol Carlo Besta, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy; [Calvo, Andrea; Moglia, Cristina; Brunetti, Maura; Casale, Federico; Chio, Adrian] Univ Turin, ALS Ctr, Rita Levi Montalcini Dept Neurosci, Turin, Italy; [Calvo, Andrea; Moglia, Cristina; Brunetti, Maura; Chio, Adrian] Azienda Osped Citta Salute & Sci, Turin, Italy; [Arcuti, Simona; Capozzo, Rosa; Zecca, Chiara; Tortelli, Rosanna] Univ Bari A Moro, Dept Clin Res Neurol, Tricase, Italy; [Arcuti, Simona; Capozzo, Rosa; Zecca, Chiara; Tortelli, Rosanna] Pia Fdn Card G Panico, Tricase, Italy; [Lunetta, Christian] Niguarda Ca Granda Hostipal, Serena Onlins Fdn, NEMO Clin Ctr, Milan, Italy; [Penco, Silvana] Osped Niguarda Ca Granda, Dept Lab Med, Med Genet Unit, Milan, Italy; [Riva, Nilo] Ist Sci San Raffaele, Inst Expt Neurol INSPE, Dept Neurol, Div Neurosci, Milan, Italy; [Padovani, Alessandro; Filosto, Massimiliano] Univ Brescia, Dept Clin & Expt Sci, Neurol Unit, Brescia, Italy; [Muller, Bernard; Stuit, Robbert Jan] Project MinE Fdn, Rotterdam, Netherlands; [Blair, Ian; Zhang, Katharine; McCann, Emily P.; Fifita, Jennifer A.; Nicholson, Garth A.; Rowe, Dominic B.] Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, Australia; [Nicholson, Garth A.] Univ Sydney, ANZAC Res Inst, Sydney, NSW, Australia; [Pamphlett, Roger] Univ Sydney, Dept Pathol, Stacey MND Lab, Sydney, NSW, Australia; [Kiernan, Matthew C.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Grosskreutz, Julian; Witte, Otto W.; Ringer, Thomas; Prell, Tino; Stubendorff, Beatrice] Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Germany; [Kurth, Ingo; Huebner, Christian A.] Jena Univ Hosp, Inst Human Genet, Jena, Germany; [Leigh, P. Nigel] Univ Sussex, Trafford Ctr Biomed Res, Brighton & Sussex Med Sch, Dept Neurol, Falmer, England; [Beghi, Ettore; Pupillo, Elisabetta] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Lab Neurol Dis, Milan, Italy; [Logroscino, Giancarlo] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Logroscino, Giancarlo] Univ Bari Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Tricase, Italy; [Robberecht, Wim; Van Damme, Philip] VIB, Vesalius Res Ctr, Neurobiol Lab, Leuven, Belgium; [Robberecht, Wim; Van Damme, Philip] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Pers, Tune H.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Pers, Tune H.] Boston Childrens Hosp, Div Genet, Boston, MA USA; [Pers, Tune H.] Boston Childrens Hosp, Ctr Basic Translat Obes Res, Boston, MA USA; [Pers, Tune H.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Pers, Tune H.] Broad Inst, Program Med & Populat Genet, Carnbridge, MA USA; [Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Corcia, Philippe] CHRU Tours, Ctr SLA, Tours, France; [Corcia, Philippe] LITORALS, Federat Ctr SLA Tours & Limoges, Tours, France; [Visscher, Peter M.] Univ Queensland, Translat Res Inst, Diarnantina Inst, Brisbane, Qld, Australia; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Lewis, Cathryn M.] Kings Coll London, Dept Med & Mol Genet, London, England		Al-Chalabi, A; Veldink, JH (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands.	ammar.al-chalabi@kcl.ac.uk; j.h.veldink@umcutrecht.nl	Moglia, Cristina/AAB-9643-2019; Powell, John F/G-4412-2011; Leigh, Peter/AAD-5638-2019; Hardiman, Orla/Y-3441-2019; CEREDA, CRISTINA/G-8208-2011; Wood, Nicholas W/C-2505-2009; Van Damme, Philip/A-6464-2009; Tzourio, christophe/B-4015-2009; Pinto, Susana/L-8394-2019; Tzourio, christophe/L-6344-2019; Lewis, Cathryn M/A-5225-2010; Rowe, Dominic B/B-6661-2011; Hubner, Christian/A-2950-2017; Prell, Tino/AAE-5492-2020; Pupillo, Elisabetta/AAA-7385-2020; Pensato, Viviana/J-6533-2016; Sendtner, Michael/J-1542-2012; Franke, Andre/B-2151-2010; Visscher, Peter/ABB-6151-2020; Goris, An/L-5852-2019; Silani, Vincenzo/P-4421-2017; McCann, Emily P/A-2563-2016; Goris, An/F-2943-2010; Breen, Gerome D/A-5540-2010; Brice, Alexis/A-2170-2009; Filosto, Massimiliano/S-9446-2019; Millecamps, Stephanie/W-7184-2018; Witte, Otto/P-4127-2018; Pansarasa, Orietta/A-2012-2019; Wray, Naomi/C-8639-2015; CALVO, Andrea/K-4141-2016; brice, alexis/AAE-8275-2019; Vosa, Urmo/AAJ-5928-2020; DARTIGUES, Jean Francois/T-4513-2019; Rogelj, Boris/G-9252-2011; Meitinger, Thomas/O-1318-2015; Pittman, Alan/AAP-2534-2020; Soraro, Gianni/AAB-8891-2019; Weber, Markus/AAI-7138-2020; Beghi, Ettore/AAA-7426-2020; Williams, Kelly L/A-5545-2010; van+Es, Michael/AAC-5772-2021; Cotelli, Maria Sofia/K-4534-2017; Sendtner, Michael/M-8137-2014; de Carvalho, Mamede/I-6295-2019; Yang, Jian/A-5852-2010; moglia, cristina/K-4142-2016; Padovani, Alessandro/ABI-7312-2020; Koritnik, Blaz/N-7487-2019; ravnik-glavac, metka/ABH-8339-2020; Pupillo, Elisabetta/ABD-2698-2020; Hardy, John/C-2451-2009; Ticozzi, Nicola/K-8094-2016; Lewis, Cathryn/M-8766-2019; Lieb, Wolfgang/C-1990-2012; Pittman, Alan M/D-6231-2012; Gellera, Cinzia/J-7887-2016; Capozzo, Rosa/AAC-2716-2019; Breen, Gerome/Y-2706-2019; Kiernan, Matthew C/E-4460-2011; Arcuti, Simona/J-8587-2016; Fratta, Pietro/G-1296-2019; Grosskreutz, Julian/G-2293-2010; Rivadeneira, Fernando/O-5385-2015; Mazzini, Letizia/AAA-2262-2021; Franke, Lude/P-7036-2016; Al-Chalabi, Ammar/E-5361-2010; Tittmann, Lukas/A-7295-2017; Cichon, Sven/B-9618-2014	Moglia, Cristina/0000-0001-7377-7222; Powell, John F/0000-0001-6124-439X; Hardiman, Orla/0000-0003-2610-1291; CEREDA, CRISTINA/0000-0001-9571-0862; Wood, Nicholas W/0000-0002-9500-3348; Van Damme, Philip/0000-0002-4010-2357; Tzourio, christophe/0000-0002-6517-2984; Pinto, Susana/0000-0002-0727-5897; Tzourio, christophe/0000-0002-6517-2984; Lewis, Cathryn M/0000-0002-8249-8476; Rowe, Dominic B/0000-0003-0912-2146; Hubner, Christian/0000-0002-1030-4943; Prell, Tino/0000-0002-6423-3108; Pupillo, Elisabetta/0000-0003-4420-8076; Pensato, Viviana/0000-0001-9798-2669; Sendtner, Michael/0000-0002-4737-2974; Franke, Andre/0000-0003-1530-5811; Visscher, Peter/0000-0002-2143-8760; Goris, An/0000-0002-1276-6682; Silani, Vincenzo/0000-0002-7698-3854; McCann, Emily P/0000-0002-8200-3525; Goris, An/0000-0002-1276-6682; Breen, Gerome D/0000-0003-2053-1792; Filosto, Massimiliano/0000-0002-2852-7512; Millecamps, Stephanie/0000-0002-0745-6735; Witte, Otto/0000-0003-2101-4105; Wray, Naomi/0000-0001-7421-3357; CALVO, Andrea/0000-0002-5122-7243; brice, alexis/0000-0002-0941-3990; Vosa, Urmo/0000-0003-3476-1652; Rogelj, Boris/0000-0003-3898-1943; Pittman, Alan/0000-0002-8112-2987; Beghi, Ettore/0000-0003-2542-0469; Williams, Kelly L/0000-0001-6319-9473; Cotelli, Maria Sofia/0000-0002-7010-2809; Sendtner, Michael/0000-0002-4737-2974; de Carvalho, Mamede/0000-0001-7556-0158; Yang, Jian/0000-0003-2001-2474; moglia, cristina/0000-0001-7377-7222; Padovani, Alessandro/0000-0002-0119-3639; Koritnik, Blaz/0000-0002-5083-8261; Pupillo, Elisabetta/0000-0003-4420-8076; Hardy, John/0000-0002-3122-0423; Ticozzi, Nicola/0000-0001-5963-7426; Lewis, Cathryn/0000-0002-8249-8476; Pittman, Alan M/0000-0002-8112-2987; Gellera, Cinzia/0000-0002-3582-665X; Capozzo, Rosa/0000-0002-7672-8669; Breen, Gerome/0000-0003-2053-1792; Arcuti, Simona/0000-0002-0132-3296; Fratta, Pietro/0000-0002-8762-8188; Grosskreutz, Julian/0000-0001-9525-1424; Rivadeneira, Fernando/0000-0001-9435-9441; Mazzini, Letizia/0000-0003-2479-9120; Franke, Lude/0000-0002-5159-8802; Al-Chalabi, Ammar/0000-0002-4924-7712; Andres, Christian/0000-0002-5062-3156; Curtis, Charles/0000-0002-2992-1941; Nothen, Markus/0000-0002-8770-2464; Smith, Bradley/0000-0002-6980-2453; Staats, Kim/0000-0001-8392-7992; Shatunov, Aleksey/0000-0002-2671-8040; Kiernan, Matthew/0000-0001-9054-026X; van Es, Michael/0000-0002-7709-5883; Tittmann, Lukas/0000-0002-8731-4592; Soraru, Gianni/0000-0001-9691-6328; de Jong, Simone/0000-0002-8002-7195; Amouyel, Philippe/0000-0001-9088-234X; Kurth, Ingo/0000-0002-5642-8378; Cichon, Sven/0000-0002-9475-086X; Nicholson, Garth/0000-0001-9694-066X; Hamzeiy, Hamid/0000-0001-7990-2530; topp, simon/0000-0002-5200-3284; Robinson, Matthew/0000-0001-8982-8813; McLaughlin, Russell/0000-0003-3915-2135; Harschnitz, Oliver/0000-0001-6496-881X; Meitinger, Thomas/0000-0002-8838-8403; Chio, Adriano/0000-0001-9579-5341; Pulit, Sara/0000-0002-2502-3669; Shaw, Pamela/0000-0002-8925-2567; Pers, Tune/0000-0003-0207-4831; Fifita, Jennifer/0000-0002-0814-0118; Sproviero, William/0000-0002-9335-9260; VOURC'H, Patrick/0000-0001-7960-8139; Koppers, Max/0000-0002-7751-1082; Vajda, Alice/0000-0001-9105-6680; Drepper, Carsten/0000-0002-7883-6479; Morrison, Karen/0000-0003-0216-5717; Fogh, Isabella/0000-0002-6266-8933; Blair, Ian/0000-0003-3083-0075; Maurel, Cindy/0000-0003-1487-9987; Shaw, Christopher/0000-0003-0251-0146; Jones, Ashley/0000-0003-0470-0058; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X	governmental and charitable bodies; ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/L008238/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M008606/1, MC_G0901330, MR/K000039/1, G0901254, MC_G1000733, G0600974, G0900688] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG032953, P01AG017586] Funding Source: NIH RePORTER; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/L008238/1] Funding Source: researchfish; Lundbeck FoundationLundbeckfonden [R190-2014-3904] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/M008606/1, MC_G1000733, MR/L501529/1, G0600974, G0901254, MC_G0901330, G0900688, MR/K000039/1] Funding Source: researchfish; Medical Research FoundationUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MRF-060-0003-RG-SMITH] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0513-10064, NF-SI-0507-10376, NF-SI-0512-10082] Funding Source: researchfish; NNF Center for Basic Metabolic ResearchNovo Nordisk Foundation [Pers Group] Funding Source: researchfish; Parkinson&quot;s UKParkinson&apos;s UK [G-1107] Funding Source: researchfish; Motor Neurone Disease Association [Jones/Oct15/958-799, Fratta/Jan15/946-795, McLaughlin/Oct15/957-799, Malaspina/Apr13/817-791] Funding Source: researchfish	The work of the contributing groups was supported by various grants from governmental and charitable bodies. Details are provided in the Supplementary Note.	Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Fang X, 2015, ACTA BIOCH BIOPH SIN, V47, P834, DOI 10.1093/abbs/gmv076; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fogh I, 2014, HUM MOL GENET, V23, P2220, DOI 10.1093/hmg/ddt587; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Irwin DJ, 2014, NEUROLOGY, V83, P502, DOI 10.1212/WNL.0000000000000668; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Krohn K, 1997, BIOCHEM BIOPH RES CO, V238, P806, DOI 10.1006/bbrc.1997.7352; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Ma XX, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-71; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Ramakrishnan NA, 2012, MOL CELL NEUROSCI, V50, P58, DOI 10.1016/j.mcn.2012.03.009; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Shatunov A, 2010, LANCET NEUROL, V9, P986, DOI 10.1016/S1474-4422(10)70197-6; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Veriepe J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8319; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876	32	268	268	2	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1043	+		10.1038/ng.3622			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	WOS:000382398800015	27455348	Green Accepted, Green Submitted, Green Published	Y	N	2022-01-24	
J	Eleveld, TF; Oldridge, DA; Bernard, V; Koster, J; Daage, LC; Diskin, SJ; Schild, L; Bentahar, NB; Bellini, A; Chicard, M; Lapouble, E; Combaret, V; Legoix-Ne, P; Michon, J; Pugh, TJ; Hart, LS; Rader, J; Attiyeh, EF; Wei, JS; Zhang, SL; Naranjo, A; Gastier-Foster, JM; Hogarty, MD; Asgharzadeh, S; Smith, MA; Auvil, JMG; Watkins, TBK; Zwijnenburg, DA; Ebus, ME; van Sluis, P; Hakkert, A; van Wezel, E; van der Schoot, CE; Westerhout, EM; Schulte, JH; Tytgat, GA; Dolman, MEM; Janoueix-Lerosey, I; Gerhard, DS; Caron, HN; Delattre, O; Khan, J; Versteeg, R; Schleiermacher, G; Molenaar, JJ; Maris, JM				Eleveld, Thomas F.; Oldridge, Derek A.; Bernard, Virginie; Koster, Jan; Daage, Leo Colmet; Diskin, Sharon J.; Schild, Linda; Bentahar, Nadia Bessoltane; Bellini, Angela; Chicard, Mathieu; Lapouble, Eve; Combaret, Valerie; Legoix-Ne, Patricia; Michon, Jean; Pugh, Trevor J.; Hart, Lori S.; Rader, JulieAnn; Attiyeh, Edward F.; Wei, Jun S.; Zhang, Shile; Naranjo, Arlene; Gastier-Foster, Julie M.; Hogarty, Michael D.; Asgharzadeh, Shahab; Smith, Malcolm A.; Auvil, Jaime M. Guidry; Watkins, Thomas B. K.; Zwijnenburg, Danny A.; Ebus, Marli E.; van Sluis, Peter; Hakkert, Anne; van Wezel, Esther; van der Schoot, C. Ellen; Westerhout, Ellen M.; Schulte, Johannes H.; Tytgat, Godelieve A.; Dolman, M. Emmy M.; Janoueix-Lerosey, Isabelle; Gerhard, Daniela S.; Caron, Huib N.; Delattre, Olivier; Khan, Javed; Versteeg, Rogier; Schleiermacher, Gudrun; Molenaar, Jan J.; Maris, John M.			Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations	NATURE GENETICS			English	Article							SEQUENCING DATA; CHROMOSOME 1P; ALK MUTATIONS; HUMAN CANCER; THERAPY; COMBINATION; PROGRESSION; ASSOCIATION; SENSITIVITY; CRIZOTINIB	The majority of patients with neuroblastoma have tumors that initially respond to chemotherapy, but a large proportion will experience therapy-resistant relapses. The molecular basis of this aggressive phenotype is unknown. Whole-genome sequencing of 23 paired diagnostic and relapse neuroblastomas showed clonal evolution from the diagnostic tumor, with a median of 29 somatic mutations unique to the relapse sample. Eighteen of the 23 relapse tumors (78%) showed mutations predicted to activate the RAS-MAPK pathway. Seven of these events were detected only in the relapse tumor, whereas the others showed clonal enrichment. In neuroblastoma cell lines, we also detected a high frequency of activating mutations in the RAS-MAPK pathway (11/18; 61%), and these lesions predicted sensitivity to MEK inhibition in vitro and in vivo. Our findings provide a rationale for genetic characterization of relapse neuroblastomas and show that RAS-MAPK pathway mutations may function as a biomarker for new therapeutic approaches to refractory disease.	[Eleveld, Thomas F.; Koster, Jan; Schild, Linda; Zwijnenburg, Danny A.; Ebus, Marli E.; van Sluis, Peter; Hakkert, Anne; Westerhout, Ellen M.; Dolman, M. Emmy M.; Versteeg, Rogier; Molenaar, Jan J.] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Oldridge, Derek A.; Diskin, Sharon J.; Hart, Lori S.; Rader, JulieAnn; Attiyeh, Edward F.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Oldridge, Derek A.; Diskin, Sharon J.; Hart, Lori S.; Rader, JulieAnn; Attiyeh, Edward F.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Oldridge, Derek A.; Diskin, Sharon J.; Attiyeh, Edward F.; Hogarty, Michael D.; Maris, John M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bernard, Virginie; Daage, Leo Colmet; Bentahar, Nadia Bessoltane; Legoix-Ne, Patricia] Inst Curie, ICGEX Platform, Paris, France; [Daage, Leo Colmet; Bellini, Angela; Chicard, Mathieu; Schleiermacher, Gudrun] Inst Curie, Transfer Dept, Lab RTOP, Paris, France; [Lapouble, Eve] Inst Curie, Unite Genet Somat, Paris, France; [Combaret, Valerie] Ctr Leon Berard, Lab Rech Translat Lyon, F-69373 Lyon, France; [Michon, Jean; Schleiermacher, Gudrun] Inst Curie, Dept Pediat, Paris, France; [Pugh, Trevor J.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Pugh, Trevor J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Wei, Jun S.; Zhang, Shile; Khan, Javed] NIH, Pediat Oncol Branch, Oncogen Sect, Ctr Canc Res, Gaithersburg, MD USA; [Naranjo, Arlene] Univ Florida, Dept Biostat, COG, Gainesville, FL USA; [Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Gastier-Foster, Julie M.; Gerhard, Daniela S.] Nationwide Childrens Hosp, Biopathol Ctr, Columbus, OH USA; [Asgharzadeh, Shahab] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Smith, Malcolm A.] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Auvil, Jaime M. Guidry] NCI, Off Canc Genom, Bethesda, MD 20892 USA; [Watkins, Thomas B. K.] Canc Res UK, Translat Canc Therapeut Lab, London, England; [van Wezel, Esther; van der Schoot, C. Ellen] Sanquin Res, Dept Expt Immunohematol, Amsterdam, Netherlands; [van Wezel, Esther; van der Schoot, C. Ellen] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Schulte, Johannes H.] Charite, Dept Pediat Oncol & Hematol, D-13353 Berlin, Germany; [Schulte, Johannes H.] German Consortium Translat Canc Res DKTK, Heidelberg, Germany; [Schulte, Johannes H.] Univ Childrens Hosp Essen, Dept Pediat Oncol & Hematol, Essen, Germany; [Schulte, Johannes H.] Univ Hosp Essen, West German Canc Ctr WTZ, Translat Neurooncol, Essen, Germany; [Tytgat, Godelieve A.; Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands; [Janoueix-Lerosey, Isabelle; Delattre, Olivier; Schleiermacher, Gudrun] Inst Curie, Lab Genet & Biol Canc, INSERM U830, Paris, France		Schleiermacher, G (corresponding author), Inst Curie, Transfer Dept, Lab RTOP, Paris, France.	gudrun.schleiermacher@curie.fr; j.j.molenaar@amc.uva.nl; maris@chop.edu	Schleiermacher, Gudrun/AAN-4711-2021; Eleveld, Thomas/AAA-5416-2021; Versteeg, Rogier/AAQ-1765-2020; tytgat, g/ABF-6481-2020; Khan, Javed/P-9157-2014; Janoueix-Lerosey, Isabelle/G-1758-2018; Koster, Jan/C-5934-2008; Pugh, Trevor/Y-2535-2019; Schulte, Johannes H./V-2474-2018	Schleiermacher, Gudrun/0000-0002-0133-5879; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; Koster, Jan/0000-0002-0890-7585; Pugh, Trevor/0000-0002-8073-5888; Schulte, Johannes Hubertus/0000-0003-0671-1201; Smith, Malcolm/0000-0001-9880-9876; COLMET DAAGE, Leo/0000-0002-5472-4616; Eleveld, Thomas/0000-0001-8580-4822; Dolman, Emmy/0000-0002-0567-5918; delattre, olivier/0000-0002-8730-2276; Versteeg, Rogier/0000-0001-7172-0388; Chicard, Mathieu/0000-0002-0697-8611	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RC1MD004418, HHSN261200800001E]; University of Pennsylvania Genome Frontiers Institute; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); Annenberg Foundation; Nelia and Amadeo Barletta Foundation; SiRIC/INCa [INCa-DGOS-4654]; Comite d'Evaluation et Suivi des Projets de Recherche de Transfert (CEST) of Institut Curie; Associations Enfants et Sante; Association Hubert Gouin Enfance et Cancer; Les Bagouz a Manon; Les Amis de Claire; EQUIPEX Investissements d'Avenir programFrench National Research Agency (ANR) [ANR-10-EQPX-03]; Agence Nationale de le RechercheFrench National Research Agency (ANR) [ANR10-INBS-09-08]; Canceropole Ile-de-FranceRegion Ile-de-France; Villa Joep Foundation; Kinderen Kankervrij Foundation; Netherlands Cancer Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U10CA098543, U10CA098413, F30CA192831, U10CA180886] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [RC1MD004418] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [T32HG000046] Funding Source: NIH RePORTER	The authors would like to thank N. Ross for sample preparation and quality control. This study was supported in part by US National Institutes of Health grants RC1MD004418 to the TARGET consortium and CA98543 and CA98413 to the Children's Oncology Group and was supported in part by a grant throughout the University of Pennsylvania Genome Frontiers Institute. In addition, this project was funded in part with federal funds from the National Cancer Institute, US National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services nor does mention of trade names, commercial products or organizations imply endorsement by the US government. The binimetinib xenograft studies were supported through a research collaborative agreement between the Children's Hospital of Philadelphia and Novartis Pharmaceuticals. In France, this study was supported by the Annenberg Foundation and the Nelia and Amadeo Barletta Foundation. Funding was also obtained from SiRIC/INCa (grant INCa-DGOS-4654) and from the Comite d'Evaluation et Suivi des Projets de Recherche de Transfert (CEST) of Institut Curie. This study was also funded by the Associations Enfants et Sante, Association Hubert Gouin Enfance et Cancer, Les Bagouz a Manon and Les Amis de Claire. Deep sequencing experiments were conducted on the ICGex next-generation sequencing platform at the Institut Curie funded by the EQUIPEX Investissements d'Avenir program (ANR-10-EQPX-03) and ANR10-INBS-09-08 from the Agence Nationale de le Recherche and by the Canceropole Ile-de-France. In the Netherlands, this study was supported by grants from the Villa Joep Foundation, the Kinderen Kankervrij Foundation and the Netherlands Cancer Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Boca SM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r112; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamers F, 2012, EUR J CANCER, V48, P763, DOI 10.1016/j.ejca.2011.10.012; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Moore NF, 2014, ONCOTARGET, V5, P8737, DOI 10.18632/oncotarget.2372; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schleiermacher G, 2014, J CLIN ONCOL, V32, P2727, DOI 10.1200/JCO.2013.54.0674; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Simon T, 2011, PEDIATR BLOOD CANCER, V56, P578, DOI 10.1002/pbc.22693; Taggart D, 2008, Q J NUCL MED MOL IM, V52, P403; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	42	268	273	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					864	+		10.1038/ng.3333			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	WOS:000358674100008	26121087	Green Accepted			2022-01-24	
J	Xu, H; Xiao, TF; Chen, CH; Li, W; Meyer, CA; Wu, Q; Wu, D; Cong, L; Zhang, F; Liu, JS; Brown, M; Liu, XS				Xu, Han; Xiao, Tengfei; Chen, Chen-Hao; Li, Wei; Meyer, Clifford A.; Wu, Qiu; Wu, Di; Cong, Le; Zhang, Feng; Liu, Jun S.; Brown, Myles; Liu, X. Shirley			Sequence determinants of improved CRISPR sgRNA design	GENOME RESEARCH			English	Article							HUMAN-CELLS; ENDONUCLEASE CAS9; CANCER-CELLS; SYSTEM; SPECIFICITY; ACTIVATION; NUCLEASES; SELECTION	The CRISPR/Cas9 system has revolutionized mammalian somatic cell genetics. Genome-wide functional screens using CRISPR/Cas9-mediated knockout or dCas9 fusion-mediated inhibition/activation (CRISPRi/a) are powerful techniques for discovering phenotype-associated gene function. We systematically assessed the DNA sequence features that contribute to single guide RNA (sgRNA) efficiency in CRISPR-based screens. Leveraging the information from multiple designs, we derived a new sequence model for predicting sgRNA efficiency in CRISPR/Cas9 knockout experiments. Our model confirmed known features and suggested new features including a preference for cytosine at the cleavage site. The model was experimentally validated for sgRNA-mediated mutation rate and protein knockout efficiency. Tested on independent data sets, the model achieved significant results in both positive and negative selection conditions and outperformed existing models. We also found that the sequence preference for CRISPRi/a is substantially different from that for CRISPR/Cas9 knockout and propose a new model for predicting sgRNA efficiency in CRISPRi/a experiments. These results facilitate the genome-wide design of improved sgRNA for both knockout and CRISPRi/a studies.	[Xu, Han; Xiao, Tengfei; Li, Wei; Meyer, Clifford A.; Wu, Qiu; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Xu, Han; Xiao, Tengfei; Li, Wei; Meyer, Clifford A.; Wu, Qiu; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Xu, Han; Xiao, Tengfei; Li, Wei; Meyer, Clifford A.; Wu, Qiu; Brown, Myles; Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Xiao, Tengfei; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Xiao, Tengfei; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chen, Chen-Hao] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02215 USA; [Wu, Qiu] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Wu, Di; Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Cong, Le; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Cong, Le; Zhang, Feng] MIT, Dept Biol Engn, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Brown, Myles] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02215 USA		Brown, M (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA.	myles_brown@dfci.harvard.edu; xsliu@jimmy.harvard.edu	Brown, Myles/AAX-5332-2021	Brown, Myles/0000-0002-8213-1658; Liu, Xiaole/0000-0003-4736-7339	National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [U01 CA180980, R01 GM113242-01]; National Science Foundation (NSF)National Science Foundation (NSF) [DMS-1120368]; Claudia Adams Barr Award in Innovative Basic Cancer Research from the Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA180980, P50CA090381] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG008728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM113242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [DP1MH100706, R01MH110049] Funding Source: NIH RePORTER; Division Of Mathematical SciencesNational Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS) [1208771, 1120368] Funding Source: National Science Foundation	We thank Drs. Carl Novina, Tim Wang, David Sabatini, Eric Lander, Ophir Shalem, and Neville Sanjana for providing the data sets and helpful discussions. The project was supported by the National Institute for Health Research (NIHR) grants U01 CA180980 (to X.S.L.), R01 GM113242-01 (to J.S.L.), National Science Foundation (NSF) grant DMS-1120368 (to J.S.L.), and the Claudia Adams Barr Award in Innovative Basic Cancer Research from the Dana-Farber Cancer Institute.	Andersson BS, 1995, LEUKEMIA, V9, P2100; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tikhonov A. N., 1977, SOLUTIONS ILL POSED; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	29	268	283	11	115	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2015	25	8					1147	1157		10.1101/gr.191452.115			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CO2AL	WOS:000358957500007	26063738	Green Published, Green Submitted, hybrid			2022-01-24	
J	Lienert, F; Wirbelauer, C; Som, I; Dean, A; Mohn, F; Schubeler, D				Lienert, Florian; Wirbelauer, Christiane; Som, Indrani; Dean, Ann; Mohn, Fabio; Schuebeler, Dirk			Identification of genetic elements that autonomously determine DNA methylation states	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; CPG ISLANDS; CHROMATIN-STRUCTURE; HISTONE; METHYLTRANSFERASE; NANOG; TRANSCRIPTION; PLURIPOTENT; METHYLOME; PROMOTER	Cytosine methylation is a repressive, epigenetically propagated DNA modification. Although patterns of DNA methylation seem tightly regulated in mammals, it is unclear how these are specified and to what extent this process entails genetic or epigenetic regulation. To dissect the role of the underlying DNA sequence, we sequentially inserted over 50 different DNA elements into the same genomic locus in mouse stem cells. Promoter sequences of approximately 1,000 bp autonomously recapitulated correct DNA methylation in pluripotent cells. Moreover, they supported proper de novo methylation during differentiation. Truncation analysis revealed that this regulatory potential is contained within small methylation-determining regions (MDRs). MDRs can mediate both hypomethylation and de novo methylation in cis, and their activity depends on developmental state, motifs for DNA-binding factors and a critical CpG density. These results demonstrate that proximal sequence elements are both necessary and sufficient for regulating DNA methylation and reveal basic constraints of this regulation.	[Lienert, Florian; Wirbelauer, Christiane; Mohn, Fabio; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Lienert, Florian; Schuebeler, Dirk] Univ Basel, Fac Sci, Basel, Switzerland; [Som, Indrani; Dean, Ann] NIDDKD, Cellular & Dev Biol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA		Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	dirk@fmi.ch		Mohn, Fabio/0000-0001-9889-5225	Boehringer IngelheimBoehringer Ingelheim; National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Novartis Research Foundation; European UnionEuropean Commission [FP7-HEALTH-2010-257082, LSHG-CT-2006-037415]; European Research CouncilEuropean Research Council (ERC)European Commission [ERC-204264]; Swiss initiative in Systems Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [ZIADK015508, ZIADK075033] Funding Source: NIH RePORTER	We are grateful to M. Pietrzak for sequencing. We thank M. Lorincz of the University of British Columbia-Vancouver for providing plasmids for RMCE and S. Fiering for advice. We would also like to thank members of the Schubeler group and S. Gasser for critical comments on the manuscript. F.L. is supported by a PhD fellowship of the Boehringer Ingelheim Fonds. Research in the laboratory of A.D. is supported by the Intramural Program of National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health. Research in the laboratory of D.S. is supported by the Novartis Research Foundation, by the European Union (NoE "EpiGeneSys" FP7-HEALTH-2010-257082, LSHG-CT-2006-037415), the European Research Council (ERC-204264) and by the RTD "Cellplasticity" of the Swiss initiative in Systems Biology (SystemsX.ch).	Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Fromm G, 2009, BIOCHEM CELL BIOL, V87, P781, DOI 10.1139/O09-048; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Horvath GC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-63; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kim M, 2006, J BIOL CHEM, V281, P34288, DOI 10.1074/jbc.M607168200; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lorincz MC, 2002, MOL CELL BIOL, V22, P7572, DOI 10.1128/MCB.22.21.7572-7580.2002; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	51	268	269	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1091	U78		10.1038/ng.946			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	WOS:000296584000012	21964573				2022-01-24	
J	Zhang, HX; Zhai, Y; Hu, ZB; Wu, C; Qian, J; Jia, WH; Ma, FC; Huang, WF; Yu, LX; Yue, W; Wang, ZF; Li, PY; Zhang, Y; Liang, RX; Wei, ZL; Cui, Y; Xie, WM; Cai, M; Yu, XS; Yuan, YF; Xia, X; Zhang, XM; Yang, H; Qiu, W; Yang, JM; Gong, F; Chen, MS; Shen, HB; Lin, DX; Zeng, YX; He, FC; Zhou, GQ				Zhang, Hongxing; Zhai, Yun; Hu, Zhibin; Wu, Chen; Qian, Ji; Jia, Weihua; Ma, Fuchao; Huang, Wenfeng; Yu, Lixia; Yue, Wei; Wang, Zhifu; Li, Peiyao; Zhang, Yang; Liang, Renxiang; Wei, Zhongliang; Cui, Ying; Xie, Weimin; Cai, Mi; Yu, Xinsen; Yuan, Yunfei; Xia, Xia; Zhang, Xiumei; Yang, Hao; Qiu, Wei; Yang, Jingmin; Gong, Feng; Chen, Minshan; Shen, Hongbing; Lin, Dongxin; Zeng, Yi-Xin; He, Fuchu; Zhou, Gangqiao			Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; CHROMOSOME 1P; GENE; UBIQUITIN; CANCER; KIF1B; HEPATOCARCINOGENESIS; NEUROBLASTOMA; MUTATION; RISK	To identify susceptibility variants for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), we conducted a genome-wide association study by genotyping 440,794 SNPs in 355 chronic HBV carriers with HCC and 360 chronic HBV carriers without HCC, all of Chinese ancestry. We identified one intronic SNP (rs17401966) in KIF1B on chromosome 1p36.22 that was highly associated with HBV-related HCC and confirmed this association in five additional independent samples, consisting of 1,962 individuals with HCC, 1,430 control subjects and 159 family trios. Across the six studies, the association with rs17401966 was highly statistically significant (joint odds ratio = 0.61, P = 1.7 x 10(-18)). In addition to KIF1B, the association region tagged two other plausible causative genes, UBE4B and PGD. Our findings provide evidence that the 1p36.22 locus confers susceptibility to HBV-related HCC, and suggest that KIF1B-, UBE4B- or PGD-related pathways might be involved in the pathogenesis of this malignancy.	[Zhang, Hongxing; Zhai, Yun; Yu, Lixia; Yue, Wei; Wang, Zhifu; Li, Peiyao; Zhang, Yang; Cai, Mi; Xia, Xia; Zhang, Xiumei; Yang, Hao; Qiu, Wei; Gong, Feng; He, Fuchu; Zhou, Gangqiao] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Wu, Chen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100037, Peoples R China; [Qian, Ji; Yang, Jingmin] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Qian, Ji; Yang, Jingmin] Fudan Univ, Ctr Evolutionary Biol, Sch Life Sci, Shanghai 200433, Peoples R China; [Qian, Ji; Yang, Jingmin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Jia, Weihua; Yuan, Yunfei; Zeng, Yi-Xin] State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China; [Jia, Weihua; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Fuchao; Huang, Wenfeng; Cui, Ying; Xie, Weimin] Canc Inst Guangxi, Nanning, Guangxi, Peoples R China; [Liang, Renxiang; Wei, Zhongliang] Liver Canc Inst Fusui Cty, Guangxi, Peoples R China; [Chen, Minshan] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China		Zhou, GQ (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	hefc@nic.bmi.ac.cn; zhougq114@gmail.com	Hu, Zhibin/ABB-6910-2021	Huang, Wenfeng/0000-0002-3194-4368; He, Fuchu/0000-0002-8571-2351; Zhou, Gangqiao/0000-0002-4895-5063; Lin, Dongxin/0000-0002-8723-8868; Wu, Chen/0000-0003-4954-1011; Yuan, Yunfei/0000-0003-2467-3683	Chinese National High-tech Program [2006AA02A412]; Chinese Key Project for Infectious Diseases [2008ZX10002-016]; Chinese National Science Fund for Creative Research Groups ProgramScience Fund for Creative Research Groups [30621063]; Beijing Science and Technology NOVA program [2006A54]	We thank the subjects and their families for participating in this study, and the clinicians, nurses and study coordinators for their contributions. This study was supported in part by grants from Chinese National High-tech Program 2006AA02A412 (G.Z.), Chinese Key Project for Infectious Diseases 2008ZX10002-016 (G.Z.), Chinese National Science Fund for Creative Research Groups Program 30621063 (F. H.) and Beijing Science and Technology NOVA program 2006A54 (G.Z.).	Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Benn DE, 2000, CANCER RES, V60, P7048; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chatterjee A, 2008, CELL CYCLE, V7, P1231, DOI 10.4161/cc.7.9.5795; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Dawson SP, 2008, BBA-MOL BASIS DIS, V1782, P775, DOI 10.1016/j.bbadis.2008.08.003; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Houlston RS, 1996, QJM-INT J MED, V89, P737, DOI 10.1093/qjmed/89.10.737; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kim YJ, 2005, INTERVIROLOGY, V48, P10, DOI 10.1159/000082089; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Krona C, 2003, ONCOGENE, V22, P2343, DOI 10.1038/sj.onc.1206324; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Midorikawa Y, 2009, HEPATOLOGY, V49, P513, DOI 10.1002/hep.22698; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nicodemus KK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-130; NOVELLO F, 1968, BIOCHEM J, V107, P775, DOI 10.1042/bj1070775; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234; Turyn J, 2003, HORM METAB RES, V35, P565, DOI 10.1055/s-2003-43500; Yang HW, 2001, ONCOGENE, V20, P5075, DOI 10.1038/sj.onc.1204456; Yeh IT, 2008, HUM GENET, V124, P279, DOI 10.1007/s00439-008-0553-1; Yu MW, 1997, AM J EPIDEMIOL, V145, P1039, DOI 10.1093/oxfordjournals.aje.a009060; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Zhai Y, 2006, GASTROENTEROLOGY, V130, P2001, DOI 10.1053/j.gastro.2006.02.030	34	268	287	2	183	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					755	U39		10.1038/ng.638			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	WOS:000281388400009	20676096				2022-01-24	
J	Silby, MW; Cerdeno-Tarraga, AM; Vernikos, GS; Giddens, SR; Jackson, RW; Preston, GM; Zhang, XX; Moon, CD; Gehrig, SM; Godfrey, SAC; Knight, CG; Malone, JG; Robinson, Z; Spiers, AJ; Harris, S; Challis, GL; Yaxley, AM; Harris, D; Seeger, K; Murphy, L; Rutter, S; Squares, R; Quail, MA; Saunders, E; Mavromatis, K; Brettin, TS; Bentley, SD; Hothersall, J; Stephens, E; Thomas, CM; Parkhill, J; Levy, SB; Rainey, PB; Thomson, NR				Silby, Mark W.; Cerdeno-Tarraga, Ana M.; Vernikos, Georgios S.; Giddens, Stephen R.; Jackson, Robert W.; Preston, Gail M.; Zhang, Xue-Xian; Moon, Christina D.; Gehrig, Stefanie M.; Godfrey, Scott A. C.; Knight, Christopher G.; Malone, Jacob G.; Robinson, Zena; Spiers, Andrew J.; Harris, Simon; Challis, Gregory L.; Yaxley, Alice M.; Harris, David; Seeger, Kathy; Murphy, Lee; Rutter, Simon; Squares, Rob; Quail, Michael A.; Saunders, Elizabeth; Mavromatis, Konstantinos; Brettin, Thomas S.; Bentley, Stephen D.; Hothersall, Joanne; Stephens, Elton; Thomas, Christopher M.; Parkhill, Julian; Levy, Stuart B.; Rainey, Paul B.; Thomson, Nicholas R.			Genomic and genetic analyses of diversity and plant interactions of Pseudomonas fluorescens	GENOME BIOLOGY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; VIVO EXPRESSION TECHNOLOGY; EXPERIMENTAL POPULATIONS; ADAPTIVE DIVERGENCE; BACTERIAL GENOMES; ESCHERICHIA-COLI; SBW25; ACQUISITION; GROWTH; SOIL	Background: Pseudomonas fluorescens are common soil bacteria that can improve plant health through nutrient cycling, pathogen antagonism and induction of plant defenses. The genome sequences of strains SBW25 and Pf0-1 were determined and compared to each other and with P. fluorescens Pf-5. A functional genomic in vivo expression technology (IVET) screen provided insight into genes used by P. fluorescens in its natural environment and an improved understanding of the ecological significance of diversity within this species. Results: Comparisons of three P. fluorescens genomes (SBW25, Pf0-1, Pf-5) revealed considerable divergence: 61% of genes are shared, the majority located near the replication origin. Phylogenetic and average amino acid identity analyses showed a low overall relationship. A functional screen of SBW25 defined 125 plant-induced genes including a range of functions specific to the plant environment. Orthologues of 83 of these exist in Pf0-1 and Pf-5, with 73 shared by both strains. The P. fluorescens genomes carry numerous complex repetitive DNA sequences, some resembling Miniature Inverted-repeat Transposable Elements (MITEs). In SBW25, repeat density and distribution revealed 'repeat deserts' lacking repeats, covering approximately 40% of the genome. Conclusions: P. fluorescens genomes are highly diverse. Strain-specific regions around the replication terminus suggest genome compartmentalization. The genomic heterogeneity among the three strains is reminiscent of a species complex rather than a single species. That 42% of plant-inducible genes were not shared by all strains reinforces this conclusion and shows that ecological success requires specialized and core functions. The diversity also indicates the significant size of genetic information within the Pseudomonas pan genome.	[Cerdeno-Tarraga, Ana M.; Vernikos, Georgios S.; Harris, Simon; Harris, David; Seeger, Kathy; Murphy, Lee; Rutter, Simon; Squares, Rob; Quail, Michael A.; Bentley, Stephen D.; Parkhill, Julian; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Silby, Mark W.; Levy, Stuart B.] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Boston, MA 02111 USA; [Silby, Mark W.; Levy, Stuart B.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Giddens, Stephen R.; Jackson, Robert W.; Preston, Gail M.; Moon, Christina D.; Gehrig, Stefanie M.; Godfrey, Scott A. C.; Knight, Christopher G.; Malone, Jacob G.; Robinson, Zena; Spiers, Andrew J.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Jackson, Robert W.] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England; [Zhang, Xue-Xian; Rainey, Paul B.] Massey Univ, N Shore Mail Ctr, New Zealand Inst Adv Study, Auckland, New Zealand; [Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Yaxley, Alice M.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Saunders, Elizabeth; Brettin, Thomas S.] Los Alamos Natl Lab, Biosci Div, DOE Joint Genome Inst, Los Alamos, NM 87545 USA; [Mavromatis, Konstantinos] Joint Genome Inst, Dept Energys, Genome Biol Program, Walnut Creek, CA 94598 USA; [Hothersall, Joanne; Stephens, Elton; Thomas, Christopher M.] Univ Birmingham, Dept Biosci, Birmingham B15 2TT, W Midlands, England; [Rainey, Paul B.] Massey Univ Auckland, Allan Wilson Ctr Mol Ecol & Evolut, N Shore Mail Ctr, Auckland, New Zealand		Thomson, NR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	nrt@sanger.ac.uk	Harris, Simon R/K-1318-2013; Parkhill, Julian/G-4703-2011; Quail, michael/ABE-6131-2020; Zhang, Xue-Xian/AAP-1415-2020; Knight, Chris/AAM-3228-2020; Spiers, Andrew/I-3535-2012; Rainey, Paul/A-3207-2008; Malone, Jacob/G-8319-2011; Preston, Gail/C-3072-2009; Zhang, Xue-Xian/B-8143-2008; Jackson, Robert W/C-2973-2009; Thomson, Nicholas/P-5988-2014	Harris, Simon R/0000-0003-1512-6194; Parkhill, Julian/0000-0002-7069-5958; Knight, Chris/0000-0001-9815-4267; Spiers, Andrew/0000-0003-0463-8629; Rainey, Paul/0000-0003-0879-5795; Zhang, Xue-Xian/0000-0002-6536-3529; Jackson, Robert W/0000-0002-2042-4105; Moon, Christina/0000-0001-9692-9559; Murphy, Lee/0000-0001-6467-7449; Thomson, Nicholas/0000-0002-4432-8505; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Challis, Gregory/0000-0001-5976-3545; Preston, Gail/0000-0003-3882-4438; Malone, Jacob/0000-0003-1959-6820; Silby, Mark/0000-0002-3092-8008	BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [104/P16729, P15257]; US Department of Energy's Office of Science, Biological and Environmental Research ProgramUnited States Department of Energy (DOE) [DE-AC03-76SF00098]; University of CaliforniaUniversity of California System; Lawrence Livermore National LaboratoryUnited States Department of Energy (DOE) [W-7405-Eng-48]; USDAUnited States Department of Agriculture (USDA) [2006-35604-16673]; New Zealand Foundation for Research Science and TechnologyNew Zealand Foundation for Research, Science and Technology; Natural Environment Research CouncilUK Research & Innovation (UKRI)Natural Environment Research Council (NERC) [NER/T/S/2002/00196] Funding Source: researchfish	We thank the core sequencing and informatics teams at the Sanger Institute for their assistance, The Wellcome Trust for its support of the Sanger Institute Pathogen Genomics and Pathogen Informatics groups, and Andrew Berry and Alex Bateman for their role in the repeat analysis. The P. fluorescens SBW25 work was carried out at The Wellcome Trust Sanger Institute supported by a BBSRC grant ( number 104/P16729) to PBR and CMT. Pf0-1 genome sequencing was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Livermore National Laboratory under contract number W-7405-Eng-48, Lawrence Berkeley National Laboratory under contract number DE-AC03-76SF00098 and Los Alamos National Laboratory under contract number W-7405-ENG-36. The P. fluorescens Pf0-1 work was supported by USDA grant 2006-35604-16673 to SBL. MWS was supported in part by a postdoctoral fellowship from the New Zealand Foundation for Research Science and Technology. JH and ES were supported by BBSRC grant P15257 for studies on mupirocin biosynthesis in P. fluorescens NCIMB10586.	Aranda-Olmedo I, 2002, NUCLEIC ACIDS RES, V30, P1826, DOI 10.1093/nar/30.8.1826; Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Collyn F, 2004, INFECT IMMUN, V72, P4784, DOI 10.1128/IAI.72.8.4784-4790.2004; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; de Bruijn I, 2007, MOL MICROBIOL, V63, P417, DOI 10.1111/j.1365-2958.2006.05525.x; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Gal M, 2003, MOL ECOL, V12, P3109, DOI 10.1046/j.1365-294X.2003.01953.x; Giddens SR, 2007, P NATL ACAD SCI USA, V104, P18247, DOI 10.1073/pnas.0706739104; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haubold B, 1996, MOL ECOL, V5, P747, DOI 10.1111/j.1365-294X.1996.tb00371.x; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Howden AJM, 2009, PLANT J, V57, P243, DOI 10.1111/j.1365-313X.2008.03682.x; Hughes D, 2000, GENOME BIOL, V1; Jackson RW, 2005, J BACTERIOL, V187, P8477, DOI 10.1128/JB.187.24.8477-8488.2005; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lilley AK, 1997, APPL ENVIRON MICROB, V63, P1577, DOI 10.1128/AEM.63.4.1577-1583.1997; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; Moon CD, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-7; Naseby DC, 2001, J APPL MICROBIOL, V90, P421, DOI 10.1046/j.1365-2672.2001.01260.x; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Preston GM, 2001, MOL MICROBIOL, V41, P999, DOI 10.1046/j.1365-2958.2001.02560.x; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; RAINEY PB, 1994, MICROBIOL-UK, V140, P2315, DOI 10.1099/13500872-140-9-2315; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; Rainey PB, 1997, MOL GEN GENET, V256, P84, DOI 10.1007/s004380050548; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Ravel J, 2003, TRENDS MICROBIOL, V11, P195, DOI 10.1016/S0966-842X(03)00076-3; Rediers H, 2003, APPL ENVIRON MICROB, V69, P6864, DOI 10.1128/AEM.69.11.6864-6874.2003; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; Rodriguez F, 1997, PHYTOPATHOLOGY, V87, P614, DOI 10.1094/PHYTO.1997.87.6.614; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Shakhnovich BE, 2006, GENOME RES, V16, P1529, DOI 10.1101/gr.5346206; Silby MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000094; Silby MW, 2004, J BACTERIOL, V186, P7411, DOI 10.1128/JB.186.21.7411-7419.2004; Silby MW, 2004, MICROBIOL-SGM, V150, P518, DOI 10.1099/mic.0.26871-0; Spiers AJ, 2002, GENETICS, V161, P33; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tett A, 2007, ISME J, V1, P331, DOI 10.1038/ismej.2007.47; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; van Passel MWJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-84; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Yang SH, 2004, MOL PLANT MICROBE IN, V17, P999, DOI 10.1094/MPMI.2004.17.9.999; Zhang XX, 2008, ENVIRON MICROBIOL, V10, P3284, DOI 10.1111/j.1462-2920.2008.01720.x; Zhang XX, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-114; Zhang XX, 2006, MICROBIOL-SGM, V152, P1867, DOI 10.1099/mic.0.28731-0; Zhang XX, 2004, FEMS MICROBIOL ECOL, V51, P9, DOI 10.1016/j.femsec.2004.07.006	75	268	1229	21	174	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2009	10	5							R51	10.1186/gb-2009-10-5-r51			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	465RJ	WOS:000267604200010	19432983	Green Published, hybrid, Green Accepted			2022-01-24	
J	Huang, SF; Yuan, SC; Guo, L; Yu, YH; Li, J; Wu, T; Liu, T; Yang, MY; Wu, K; Liu, HL; Ge, J; Yu, YC; Huang, HQ; Dong, ML; Yu, CL; Chen, SW; Xu, AL				Huang, Shengfeng; Yuan, Shaochun; Guo, Lei; Yu, Yanhong; Li, Jun; Wu, Tao; Liu, Tong; Yang, Manyi; Wu, Kui; Liu, Huiling; Ge, Jin; Yu, Yingcai; Huang, Huiqing; Dong, Meiling; Yu, Cuiling; Chen, Shangwu; Xu, Anlong			Genomic analysis of the immune gene repertoire of amphioxus reveals extraordinary innate complexity and diversity	GENOME RESEARCH			English	Article							TOLL-LIKE RECEPTORS; C-TYPE LECTIN; COMPLEMENT-SYSTEM; SEA-URCHIN; BRANCHIOSTOMA-LANCEOLATUM; MOLECULAR-MECHANISMS; CHINESE AMPHIOXUS; EVOLUTION; PROTEINS; IDENTIFICATION	It has been speculated that before vertebrates evolved somatic diversity-based adaptive immunity, the germline-encoded diversity of innate immunity may have been more developed. Amphioxus occupies the basal position of the chordate phylum and hence is an important reference to the evolution of vertebrate immunity. Here we report the first comprehensive genomic survey of the immune gene repertoire of the amphioxus Branchiostoma floridae. It has been reported that the purple sea urchin has a vastly expanded innate receptor repertoire not previously seen in other species, which includes 222 toll-like receptors (TLRs), 203 NOD/NALP-like receptors (NLRs), and 218 scavenger receptors (SRs). We discovered that the amphioxus genome contains comparable expansion with 71 TLR gene models, 118 NLR models, and 270 SR models. Amphioxus also expands other receptor-like families, including 1215 C-type lectin models, 240 LRR and IGcam-containing models, 1363 other LRR-containing models, 75 C1q-like models, 98 ficolin-like models, and hundreds of models containing complement-related domains. The expansion is not restricted to receptors but is likely to extend to intermediate signal transducers because there are 58 TIR adapter-like models, 36 TRAF models, 44 initiator caspase models, and 541 death-fold domain-containing models in the genome. Amphioxus also has a sophisticated TNF system and a complicated complement system not previously seen in other invertebrates. Besides the increase of gene number, domain combinations of immune proteins are also increased. Altogether, this survey suggests that the amphioxus, a species without vertebrate-type adaptive immunity, holds extraordinary innate complexity and diversity.	[Huang, Shengfeng; Yuan, Shaochun; Guo, Lei; Yu, Yanhong; Li, Jun; Wu, Tao; Liu, Tong; Yang, Manyi; Wu, Kui; Liu, Huiling; Ge, Jin; Yu, Yingcai; Huang, Huiqing; Dong, Meiling; Yu, Cuiling; Chen, Shangwu; Xu, Anlong] Sun Yat Sen Zhongshan Univ, Coll Life Sci, State Key Lab Biocontrol, Guangdong Key Lab Pharmaceut Funct Genes, Guangzhou 510275, Guangdong, Peoples R China		Xu, AL (corresponding author), Sun Yat Sen Zhongshan Univ, Coll Life Sci, State Key Lab Biocontrol, Guangdong Key Lab Pharmaceut Funct Genes, Guangzhou 510275, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn	Yu, Cuiling/E-6254-2011	Huang, Shengfeng/0000-0002-0968-1370; Yu, Yanhong/0000-0002-1652-201X; Xu, Anlong/0000-0002-1419-3494			Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; Chung JY, 2002, J CELL SCI, V115, P679; Clow LA, 2004, J EXP BIOL, V207, P2147, DOI 10.1242/jeb.01001; Collette Y, 2003, TRENDS IMMUNOL, V24, P387, DOI 10.1016/S1471-4906(03)00166-2; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Dong ML, 2005, FISH SHELLFISH IMMUN, V19, P165, DOI 10.1016/j.fsi.2004.11.001; Endo Y, 2003, J IMMUNOL, V170, P4701, DOI 10.4049/jimmunol.170.9.4701; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; Gupta G, 2007, BIOESSAYS, V29, P452, DOI 10.1002/bies.20573; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Holland LZ, 2004, METHOD CELL BIOL, V74, P195; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang GH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000206; Huang GH, 2007, DEV COMP IMMUNOL, V31, P1013, DOI 10.1016/j.dci.2007.01.003; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Matsushita M, 2004, P NATL ACAD SCI USA, V101, P10127, DOI 10.1073/pnas.0402180101; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; PUTNAM NH, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE06967; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; RHODES CP, 1982, SCIENCE, V217, P263, DOI 10.1126/science.7089565; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Robertson AJ, 2006, DEV BIOL, V300, P321, DOI 10.1016/j.ydbio.2006.08.053; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Sekine H, 2001, J IMMUNOL, V167, P4504, DOI 10.4049/jimmunol.167.8.4504; Suzuki MM, 2002, J MOL EVOL, V54, P671, DOI 10.1007/s00239-001-0068-z; Yu CL, 2005, J IMMUNOL, V174, P3493, DOI 10.4049/jimmunol.174.6.3493; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Yu YH, 2007, GLYCOBIOLOGY, V17, P774, DOI 10.1093/glycob/cwm044; Yuan SC, 2007, MOL IMMUNOL, V44, P756, DOI 10.1016/j.molimm.2006.04.011; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	55	268	287	0	46	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2008	18	7					1112	1126		10.1101/gr.069674.107			15	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	320QC	WOS:000257249100011	18562681	Green Published, Bronze			2022-01-24	
J	Savage, SA; Giri, N; Baerlocher, GM; Orr, N; Lansdorp, PM; Alter, BP				Savage, Sharon A.; Giri, Neelarn; Baerlocher, Gabriela M.; Orr, Nick; Lansdorp, Peter M.; Alter, Blanche P.			TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REVERSE-TRANSCRIPTASE COMPONENT; STEM-CELL TRANSPLANTATION; APLASTIC-ANEMIA; GENETIC-VARIATION; LINKAGE DISEQUILIBRIUM; MUTATIONS; LENGTH; DISEASE; TERT; RETINOPATHY	Patients with dyskeratosis congenita (DC), a heterogeneous inherited bone marrow failure syndrome, have abnormalities in telomere biology, including very short telomeres and germline mutations in DKC1, TERC, TERT, or NOP10, but similar to 60% of DC patients lack an identifiable mutation. With the very short telomere phenotype and a highly penetrant, rare disease model, a linkage scan was performed on a family with autosomal-dominant DC and no mutations in DKC1, TERC, or TERT Evidence favoring linkage was found at 2p24 and 14q11.2, and this led to the identification of TINF2 (14q11.2) mutations, K280E, in the proband and her five affected relatives and TINF2R282H in three additional unrelated DC probands, including one with Revesz syndrome; a fifth DC proband had a R282S mutation. TINF2 mutations were not present in unaffected relatives, DC probands with mutations in DKC1, TERC, or TERT or 298 control subjects. We demonstrate that a fifth gene, TINF2, is mutated in classical DC and, for the first time, in Revesz syndrome. This represents the first shelterin complex mutation linked to human disease and confirms the role of very short telomeres as a diagnostic test for DC.	[Savage, Sharon A.; Giri, Neelarn; Alter, Blanche P.] NCI, Dept Hlth & Human Serv, NIH, Div Canc Epidemiol & Genet,Clin Genet Branch, Bethesda, MD 20892 USA; [Baerlocher, Gabriela M.] Univ Hosp Bern, Dept Hematol, CH-3010 Bern, Switzerland; [Orr, Nick] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Baerlocher, Gabriela M.; Lansdorp, Peter M.] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada		Savage, SA (corresponding author), NCI, Dept Hlth & Human Serv, NIH, Div Canc Epidemiol & Genet,Clin Genet Branch, Bethesda, MD 20892 USA.	savagesh@mail.nili.gov	Savage, Sharon/AAB-5160-2019; Savage, Sharon A/B-9747-2015	Savage, Sharon/0000-0001-6006-0740; Savage, Sharon A/0000-0001-6006-0740; Lansdorp, Peter/0000-0001-7435-1071	Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA Funding Source: Medline; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [N02CP11019] Funding Source: Medline; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI029524, R21 AI029524, AI29524] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01CP010190, Z01CP010144] Funding Source: NIH RePORTER		Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; Al-Rahawan MM, 2006, INT J HEMATOL, V83, P275, DOI 10.1532/IJH97.06030; Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; Brazzola P, 2005, BONE MARROW TRANSPL, V36, P1103, DOI 10.1038/sj.bmt.1705171; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dror Y, 2003, BONE MARROW TRANSPL, V31, P847, DOI 10.1038/sj.bmt.1703931; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; KAJTAR P, 1994, AM J MED GENET, V49, P374, DOI 10.1002/ajmg.1320490404; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Marrone Anna, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008671; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mason PJ, 2005, CURR MOL MED, V5, P159, DOI 10.2174/1566524053586581; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Ostronoff F, 2007, BIOL BLOOD MARROW TR, V13, P366, DOI 10.1016/j.bbmt.2006.11.015; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; REVESZ T, 1992, J MED GENET, V29, P673, DOI 10.1136/jmg.29.9.673; Savage SA, 2006, EXP HEMATOL, V34, P664, DOI 10.1016/j.exphem.2006.02.008; Savage SA, 2005, HUM MUTAT, V26, P343, DOI 10.1002/humu.20226; Savage SA, 2006, BLOOD CELL MOL DIS, V37, P134, DOI 10.1016/j.bcmd.2006.07.001; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Sznajer Y, 2003, EUR J PEDIATR, V162, P863, DOI 10.1007/s00431-003-1317-5; Tamary H, 2007, PEDIATR HEMAT ONCOL, V24, P87, DOI 10.1080/08880010601123240; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Walne AJ, 2005, INT J HEMATOL, V82, P184, DOI 10.1532/IJH97.05067; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Webb EL, 2005, BIOINFORMATICS, V21, P3060, DOI 10.1093/bioinformatics/bti449; Yabe M, 1997, BONE MARROW TRANSPL, V19, P389, DOI 10.1038/sj.bmt.1700674; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Zhu Y, 2004, CANCER RES, V64, P2251, DOI 10.1158/0008-5472.CAN-03-2800	45	268	281	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					501	509		10.1016/j.ajhg.2007.10.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	WOS:000253223900022	18252230	Green Published, Bronze			2022-01-24	
J	Hudson, G; Carelli, V; Spruijt, L; Gerards, M; Mowbray, C; Achilli, A; Pyle, A; Elson, J; Howell, N; La Morgia, C; Valentino, ML; Huoponen, K; Savontaus, ML; Nikoskelainen, E; Sadun, AA; Salomao, SR; Belfort, R; Griffiths, P; Man, PYW; de Coo, RFM; Horvath, R; Zeviani, M; Smeets, HJT; Torroni, A; Chinnery, PF				Hudson, Gavin; Carelli, Valerio; Spruijt, Liesbeth; Gerards, Mike; Mowbray, Catherine; Achilli, Alessandro; Pyle, Angela; Elson, Joanna; Howell, Neil; La Morgia, Chiara; Valentino, Maria Lucia; Huoponen, Kirsi; Savontaus, Marja-Liisa; Nikoskelainen, Eeva; Sadun, Alfredo A.; Salomao, Solange R.; Belfort, Rubens, Jr.; Griffiths, Philip; Man, Patrick Yu Wai; de Coo, Rene F. M.; Horvath, Rita; Zeviani, Massimo; Smeets, Hubert J. T.; Torroni, Antonio; Chinnery, Patrick F.			Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-B GENE; CHAIN COMPLEX-I; MAMMALIAN MITOCHONDRIA; MUTATION; HAPLOTYPE; PEDIGREE; DISEASE; HETEROPLASMY; PENETRANCE; QUESTIONS	Leber hereditary optic neuropathy (LHON) is due primarily to one of three common point mutations of mitochondrial DNA (mtDNA), but the incomplete penetrance implicates additional genetic or environmental factors in the pathophysiology of the disorder. Both the 11778G -> A and 14484T -> C LHON mutations are preferentially found on a specific mtDNA genetic background, but 3460G -> A is not. However, there is no clear evidence that any background influences clinical penetrance in any of these mutations. By studying 3,613 subjects from 159 LHON-affected pedigrees, we show that the risk of visual failure is greater when the 11778G -> A or 14484T -> C mutations are present in specific subgroups of haplogroup J (J2 for 11778G -> A and J1 for 14484T -> C) and when the 3460G -> A mutation is present in haplogroup K. By contrast, the risk of visual failure is significantly less when 11778G -> A occurs in haplogroup H. Substitutions on MTCYB provide an explanation for these findings, which demonstrate that common genetic variants have a marked effect on the expression of an ostensibly monogenic mtDNA disorder.	Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Ophthalmol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Bologna, Dipartimento Sci Neurol, I-40126 Bologna, Italy; Univ So Calif, Sch Med, Doheny Eye Inst, Los Angeles, CA 90089 USA; Univ Nijmegen, Radboud Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Univ Maastricht, Dept Genet & Cell Biol, Maastricht, Netherlands; Univ Pavia, Dipartiemnto Genet & Microbiol, I-27100 Pavia, Italy; Univ Turku, Dept Med Genet, SF-20500 Turku, Finland; MIGENIX, San Diego, CA USA; Univ Turku, Cent Hosp, Dept Ophthalmol, SF-20500 Turku, Finland; Univ Sao Paulo, Dept Oftalmol, BR-05508 Sao Paulo, Brazil; Erasmus Univ, Med Ctr, Dept Child Neurol, NL-3000 DR Rotterdam, Netherlands; Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; Med Genet Ctr Munich, Munich, Germany; C Besta Neurol Inst, IRCCS, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy		Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@ncl.ac.uk	Mowbray, Catherine/X-6269-2019; Zeviani, Massimo/K-2891-2014; La Morgia, Chiara/H-6765-2012; Salomao, Solange/AAB-3234-2021; Salomao, Solange R/G-9500-2012; Achilli, Alessandro/I-9236-2012; Zeviani, Massimo/AAU-2632-2021; Belfort, Rubens/E-2252-2012; Horvath, Rita/AAY-7042-2020; Spruijt, L./L-4664-2015; Hudson, Gavin/E-7117-2017; Torroni, Antonio/E-1557-2011	Mowbray, Catherine/0000-0001-8234-0276; Salomao, Solange/0000-0002-3436-5599; Salomao, Solange R/0000-0002-3436-5599; Achilli, Alessandro/0000-0001-6871-3451; Zeviani, Massimo/0000-0002-9067-5508; Belfort, Rubens/0000-0002-8422-3898; Torroni, Antonio/0000-0002-4163-4478; CARELLI, VALERIO/0000-0003-4923-6404; de Coo, Irenaeus/0000-0003-0533-7422; /0000-0002-3551-5624; LA MORGIA, Chiara/0000-0002-4639-8929; Horvath, Rita/0000-0002-9841-170X; Chinnery, Patrick/0000-0002-7065-6617; Hudson, Gavin/0000-0001-7210-2733; VALENTINO, MARIA LUCIA/0000-0001-5323-0115	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G90/63] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G90/63] Funding Source: Medline; TelethonFondazione Telethon [GGP06233] Funding Source: Medline		Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Brown MD, 1997, AM J HUM GENET, V60, P381; Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429; BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O; De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; HARDING AE, 1995, AM J HUM GENET, V57, P77; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135; Howell N, 1999, INT REV CYTOL, V186, P49; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6; Man PYW, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011247; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1086/346066; Newman NJ, 2002, J NEURO-OPHTHALMOL, V22, P257, DOI 10.1097/00041327-200212000-00001; NIKOSKELAINEN EK, 1994, CLIN NEUROSCI, V2, P115; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.0.CO;2-I; Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; Torroni A, 1997, AM J HUM GENET, V60, P1107; Torroni A, 1996, AM J HUM GENET, V59, P248; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739	34	268	284	1	20	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					228	233		10.1086/519394			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	WOS:000248540400003	17668373	Bronze, Green Published			2022-01-24	
J	Kulterer, B; Friedl, G; Jandrositz, A; Sanchez-Cabo, F; Prokesch, A; Paar, C; Scheideler, M; Windhager, R; Preisegger, KH; Trajanoski, Z				Kulterer, Birgit; Friedl, Gerald; Jandrositz, Anita; Sanchez-Cabo, Fatima; Prokesch, Andreas; Paar, Christine; Scheideler, Marcel; Windhager, Reinhard; Preisegger, Karl-Heinz; Trajanoski, Zlatko			Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation	BMC GENOMICS			English	Article							LOOP-HELIX PROTEINS; STROMAL CELLS; IN-VITRO; PROGENITOR CELLS; MICROARRAY DATA; ID PROTEINS; DEFECTS; REGENERATION; GROWTH; PROLIFERATION	Background: Human mesenchymal stem cells ( MSC) with the capacity to differentiate into osteoblasts provide potential for the development of novel treatment strategies, such as improved healing of large bone defects. However, their low frequency in bone marrow necessitate ex vivo expansion for further clinical application. In this study we asked if MSC are developing in an aberrant or unwanted way during ex vivo long-term cultivation and if artificial cultivation conditions exert any influence on their stem cell maintenance. To address this question we first developed human oligonucleotide microarrays with 30.000 elements and then performed large-scale expression profiling of long-term expanded MSC and MSC during differentiation into osteoblasts. Results: The results showed that MSC did not alter their osteogenic differentiation capacity, surface marker profile, and the expression profiles of MSC during expansion. Microarray analysis of MSC during osteogenic differentiation identified three candidate genes for further examination and functional analysis: ID4, CRYAB, and SORT1. Additionally, we were able to reconstruct the three developmental phases during osteoblast differentiation: proliferation, matrix maturation, and mineralization, and illustrate the activation of the SMAD signaling pathways by TGF-beta 2 and BMPs. Conclusion: With a variety of assays we could show that MSC represent a cell population which can be expanded for therapeutic applications.	Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; Graz Univ Technol, Christian Doppler Lab Genom & Bioinformat, A-8010 Graz, Austria; Med Univ Graz, Dept Orthopaed, Graz, Austria; Eccocell Biotechnol Inc, Graz, Austria		Trajanoski, Z (corresponding author), Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria.	birgit.kulterer@gmx.at; gerald.friedl@meduni-graz.at; jandrositz@eccocell.com; f.sanchezcabo@tugraz.at; andreas.prokesch@tugraz.at; christine.paar@tugraz.at; marcel.scheideler@tugraz.at; reinhard.windhager@meduni-graz.at; karl-heinz.preisegger@eccocell.com; zlatko.trajanoski@tugraz.at	Sanchez-Cabo, Fatima/N-5030-2014; Trajanoski, Zlatko/AAT-6703-2021; Scheideler, Marcel/B-3087-2015; Sanchez-Cabo, Fatima/AAC-5563-2020; PROKESCH, ANDREAS/B-6786-2019	Sanchez-Cabo, Fatima/0000-0003-1881-1664; Scheideler, Marcel/0000-0003-4650-7387; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Windhager, Reinhard/0000-0002-6321-1804; PROKESCH, ANDREAS/0000-0002-8487-7103			Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Derham BK, 1999, PROG RETIN EYE RES, V18, P463, DOI 10.1016/S1350-9462(98)00030-5; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Furushima K, 2002, J BONE MINER RES, V17, P128, DOI 10.1359/jbmr.2002.17.1.128; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HARTIGAN JA, 1973, ANNU REV BIOPHYS BIO, V2, P81, DOI 10.1146/annurev.bb.02.060173.000501; HAYFLICK L, 1989, EXP GERONTOL, V24, P355, DOI 10.1016/0531-5565(89)90043-0; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Kon E, 2000, J BIOMED MATER RES, V49, P328; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Maeda S, 2002, J CELL PHYSIOL, V193, P73, DOI 10.1002/jcp.10151; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Maurer M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-101; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Mlecnik B, 2005, NUCLEIC ACIDS RES, V33, pW633, DOI 10.1093/nar/gki391; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Norton JD, 2000, J CELL SCI, V113, P3897; Pagliuca A, 1998, J BIOL CHEM, V273, P7668, DOI 10.1074/jbc.273.13.7668; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pieler R, 2004, BIOINFORMATICS, V20, P1971, DOI 10.1093/bioinformatics/bth174; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu WR, 2004, EXP BIOL MED, V229, P623, DOI 10.1177/153537020422900706; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092; Zwijsen A, 2003, FEBS LETT, V546, P133, DOI 10.1016/S0014-5793(03)00566-0; 2001, REV ENDOCR METAB DIS, V2, P81	57	268	281	1	33	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAR 12	2007	8								70	10.1186/1471-2164-8-70			15	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	153RZ	WOS:000245454100001	17352823	gold, Green Published			2022-01-24	
J	Padiath, QS; Saigoh, K; Schiffmann, R; Asahara, H; Yamada, T; Koeppen, A; Hogan, K; Ptacek, LJ; Fu, YH				Padiath, Quasar S.; Saigoh, Kazumasa; Schiffmann, Raphael; Asahara, Hideaki; Yamada, Takeshi; Koeppen, Anulf; Hogan, Kirk; Ptacek, Louis J.; Fu, Ying-Hui			Lamin B1 duplications cause autosomal dominant leukodystrophy	NATURE GENETICS			English	Article							PROGRESSIVE MULTIPLE-SCLEROSIS; DREIFUSS MUSCULAR-DYSTROPHY; PELIZAEUS-MERZBACHER-DISEASE; NUCLEAR LAMINS; PARTIAL LIPODYSTROPHY; GENE-EXPRESSION; DNA-SEQUENCES; HUMAN TISSUES; DROSOPHILA; PROTEIN	Adult-onset autosomal dominant leukodystrophy (ADLD) is a slowly progressive neurological disorder characterized by symmetrical widespread myelin loss in the central nervous system, with a phenotype similar to chronic progressive multiple sclerosis. In this study, we identify a genomic duplication that causes ADLD. Affected individuals carry an extra copy of the gene for the nuclear laminar protein lamin B1, resulting in increased gene dosage in brain tissue from individuals with ADLD. Increased expression of lamin B1 in Drosophila melanogaster resulted in a degenerative phenotype. In addition, an abnormal nuclear morphology was apparent when cultured cells overexpressed this protein. This is the first human disease attributable to mutations in the gene encoding lamin B1. Antibodies to lamin B are found in individuals with autoimmune diseases, and it is also an antigen recognized by a monoclonal antibody raised against plaques from brains of individuals with multiple sclerosis. This raises the possibility that lamin B may be a link to the autoimmune attack that occurs in multiple sclerosis.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA; Kyushu Univ, Fac Med, Dept Neurol, Fukuoka 812, Japan; Iizuka Hosp, Dept Neurol, Iizuka, Fukuoka, Japan; Albany Med Coll, Vet Adm Med Ctr, Albany, NY 12208 USA; Albany Med Coll, Dept Neurol, Albany, NY 12208 USA; Univ Wisconsin, Dept Anesthesiol, Madison, WI 53792 USA; Howard Hughes Med Inst, San Francisco, CA 94158 USA		Fu, YH (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	yhf@neugenes.org	Saigoh, Kazumasa/AAG-2956-2020	Saigoh, Kazumasa/0000-0002-0905-5935	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS41331] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [Z01NS002984, R01NS041331] Funding Source: NIH RePORTER		Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Asahara H, 1996, Rinsho Shinkeigaku, V36, P968; Ausubel F.M., 1999, CURRENT PROTOCOLS MO; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Coffeen CM, 2000, HUM MOL GENET, V9, P787, DOI 10.1093/hmg/9.5.787; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; ELDRIDGE R, 1984, NEW ENGL J MED, V311, P948, DOI 10.1056/NEJM198410113111504; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Favreau C, 2003, EXP CELL RES, V282, P14, DOI 10.1006/excr.2002.5669; Garcia DM, 2003, BRAIN RES, V976, P9, DOI 10.1016/S0006-8993(03)02597-6; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guillemin K, 2001, NAT CELL BIOL, V3, P848, DOI 10.1038/ncb0901-848; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; Hegele RA, 2006, AM J HUM GENET, V79, P383, DOI 10.1086/505885; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Lin F, 1997, EXP CELL RES, V236, P378, DOI 10.1006/excr.1997.3735; LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Mignot C, 2004, CELL MOL LIFE SCI, V61, P369, DOI 10.1007/s00018-003-3143-3; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; POLLARD KM, 1990, MOL CELL BIOL, V10, P2164, DOI 10.1128/MCB.10.5.2164; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SCHWANKHAUS JD, 1994, ARCH NEUROL-CHICAGO, V51, P757, DOI 10.1001/archneur.1994.00540200033013; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; SEBOUN E, 1997, MOL GENETIC BASIS NE, P631; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Somech R, 2005, PEDIATR RES, V57, p8R, DOI 10.1203/01.PDR.0000159566.54287.6C; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; TAN EM, 1988, ANN INTERN MED, V108, P897, DOI 10.7326/0003-4819-108-6-897; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981	50	268	278	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1114	1123		10.1038/ng1872			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	WOS:000241251100010	16951681				2022-01-24	
J	van Overveld, PGM; Lemmers, RJFL; Sandkuijl, LA; Enthoven, L; Winokur, ST; Bakels, F; Padberg, GW; van Ommen, GJB; Frants, RR; van der Maarel, SM				van Overveld, PGM; Lemmers, RJFL; Sandkuijl, LA; Enthoven, L; Winokur, ST; Bakels, F; Padberg, GW; van Ommen, GJB; Frants, RR; van der Maarel, SM			Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy	NATURE GENETICS			English	Article							DNA REARRANGEMENTS; METHYLATION; MUTATIONS; FSHD	The autosomal dominant myopathy facioscapulohumeral muscular dystrophy (FSHD1, OMIM 158900) is caused by contraction of the D4Z4 repeat array on 4qter. We show that this contraction causes marked hypomethylation of the contracted D4Z4 allele in individuals with FSHD1. Individuals with phenotypic FSHD1, who are clinically identical to FSHD1 but have an unaltered D4Z4, also have hypomethylation of D4Z4. These results strongly suggest that hypomethylation of D4Z4 is a key event in the cascade of epigenetic events causing FSHD1.	Leiden Univ, Med Ctr, Dept Human Genet, Ctr Human & Clin Genet, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, NL-2300 RA Leiden, Netherlands; Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92717 USA; Radboud Univ Nijmegen Med Ctr, Dept Neurol, Nijmegen, Netherlands		van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Ctr Human & Clin Genet, POB 9502, NL-2300 RA Leiden, Netherlands.	maarel@lumc.nl	van der Maarel, Silvere/X-3631-2018; Padberg, G.W.A.M./H-8079-2014	van der Maarel, Silvere/0000-0001-8103-711X; van Overveld, Petra GM/0000-0003-0216-5004			Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lunt P W, 1998, Neuromuscul Disord, V8, P126, DOI 10.1016/S0960-8966(98)00012-1; Padberg GW, 1982, FACIOSCAPULOHUMERAL; Rand E, 2003, J CELL BIOCHEM, V88, P400, DOI 10.1002/jcb.10352; Randolph-Anderson BL, 2002, AM J HUM GENET, V71, P530; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	15	268	278	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2003	35	4					315	317		10.1038/ng1262			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	WOS:000186791000011	14634647				2022-01-24	
J	de los Santos, T; Hunter, N; Lee, C; Larkin, B; Loidl, J; Hollingsworth, NM				de los Santos, T; Hunter, N; Lee, C; Larkin, B; Loidl, J; Hollingsworth, NM			The Mus81/Mms4 endonuclease acts independently of double-holliday junction resolution to promote a distinct subset of crossovers during meiosis in budding yeast	GENETICS			English	Article							MEIOTIC RECIPROCAL RECOMBINATION; DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CROSSING-OVER; CHROMOSOME SYNAPSIS; MUTS HOMOLOG; DNA-REPAIR; PROTEIN; INTERFERENCE	Current models for meiotic recombination require that crossovers derive from the resolution of a double-Holliday junction (dHJ) intermediate. In prokaryotes, enzymes responsible for HJ resolution are well characterized but the identification of a eukaryotic nuclear HJ resolvase has been elusive. Indirect evidence suggests that MUS81 from humans and fission yeast, encodes a HJ resolvase. We provide three lines of evidence that Mus81/Mms4 is not the major meiotic HJ resolvase in S. cerevisiae: (1) MUS81/MMS4 is required to form only a distinct subset of crossovers; (2) rather than accumulating, dHJ intermediates are reduced in an mms4 mutant; and (3) expression of a bacterial HJ resolvase has no suppressive effect on mus81 meiotic phenotypes. Our analysis also reveals the existence of two distinct classes of crossovers in budding yeast. Class I is dependent upon MSH4/MSH5 and exhibits crossover interference, while class 11 is dependent upon MUS81/MMS4 and exhibits no interference. mms4 specifically reduces crossing over on small chromosomes, which are known to Undergo less interference. The correlation between recombination rate and degree of interference to chromosome size may therefore be achieved by modulating tile balance between class I/class II crossovers.	SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Univ Calif Davis, Ctr Genet & Dev, Div Biol Sci, Dept Microbiol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Genet & Dev, Div Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA; Univ Vienna, Inst Bot, Dept Cytol & Genet, A-1030 Vienna, Austria		Hollingsworth, NM (corresponding author), SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, 314 Life Sci Bldg, Stony Brook, NY 11794 USA.	nhollin@notes.cc.sunysb.edu	De+Los+Santos, Teresa/AAU-2840-2021	Lee, Cindy/0000-0002-1893-961X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM050717] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-50717, R01 GM050717] Funding Source: Medline		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Arbel A, 1999, EMBO J, V18, P2648, DOI 10.1093/emboj/18.9.2648; BAHLER J, 1993, J CELL BIOL, V121, P241, DOI 10.1083/jcb.121.2.241; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; BascomSlack CA, 1997, ADV GENET, V35, P253, DOI 10.1016/S0065-2660(08)60452-6; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; Copenhaver GP, 2002, GENETICS, V160, P1631; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; de los Santos T, 2001, GENETICS, V159, P1511; Doe CL, 2000, EMBO J, V19, P2751, DOI 10.1093/emboj/19.11.2751; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; HABRAKEN Y, 1994, NATURE, V371, P531, DOI 10.1038/371531a0; HABRAKEN Y, 1995, J BIOL CHEM, V270, P30194; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; KABACK DB, 1989, P NATL ACAD SCI USA, V86, P3694, DOI 10.1073/pnas.86.10.3694; Kaback DB, 1999, GENETICS, V152, P1475; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kelly KO, 2000, GENETICS, V156, P617; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maniatis T., 1982, MOL CLONING LAB MANU, Vfirst; McKee AHZ, 1997, GENETICS, V146, P797; Mullen JR, 2001, GENETICS, V157, P103; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; MUNZ P, 1994, GENETICS, V137, P701; Novak JE, 2001, GENETICS, V158, P1013; PAPAZIAN HP, 1952, GENETICS, V37, P175; PERKINS DD, 1949, GENETICS, V34, P607; ROCKMILL B, 1990, GENETICS, V126, P563; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; SNOW R, 1979, GENETICS, V92, P231; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; VERSHON AK, 1992, MOL CELL BIOL, V12, P3706, DOI 10.1128/MCB.12.9.3706; Villeneuve AM, 2001, CELL, V106, P647, DOI 10.1016/S0092-8674(01)00500-1; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zalevsky J, 1999, GENETICS, V153, P1271	62	268	276	0	14	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAY	2003	164	1					81	94					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	682YJ	WOS:000183119700008	12750322				2022-01-24	
J	Ramoz, N; Rueda, LA; Bouadjar, B; Montoya, LS; Orth, G; Favre, M				Ramoz, N; Rueda, LA; Bouadjar, B; Montoya, LS; Orth, G; Favre, M			Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis	NATURE GENETICS			English	Article							PAPILLOMAVIRUSES; LESIONS; MODEL	Epidermodysplasia verruciformis (OMIM 226400) is a rare autosomal recessive genodermatosis associated with a high risk of skin carcinoma that results from an abnormal susceptibility to infection by specific human papillomaviruses (HPVs). We recently mapped a susceptibility locus for epidermodysplasia verruciformis (EV1) to chromosome 17q25. Here we report the identification of nonsense mutations in two adjacent novel genes, EVER1 and EVER2, that are associated with the disease. The gene products EVER1 and EVER2 have features of integral membrane proteins and are localized in the endoplasmic reticulum.	Inst Pasteur, Unite Papillomavirus, F-75724 Paris 15, France; Unidad Dermatol LA Rueda, Bogota, Colombia; Ctr Hosp Univ Bab el Oued, Algiers, Algeria; Univ Ind Santander, Bucaramanga, Colombia		Orth, G (corresponding author), Inst Pasteur, Unite Papillomavirus, 25 Rue Dr Roux, F-75724 Paris 15, France.	gorth@pasteur.fr	ORTH, Gerard C/C-2518-2009; ramoz, nicolas/K-3316-2015	ramoz, nicolas/0000-0002-8070-9938			Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boxman ILA, 1997, J INVEST DERMATOL, V108, P712, DOI 10.1111/1523-1747.ep12292090; David K.M., 2001, FIELDS VIROLOGY, P2197; JABLONSKA S, 1972, CANCER RES, V32, P583; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Majewski S, 1997, CLIN DERMATOL, V15, P321, DOI 10.1016/S0738-081X(96)00169-1; ORTH G, 1979, CANCER RES, V39, P1074; ORTH G, 1978, P NATL ACAD SCI USA, V75, P1537, DOI 10.1073/pnas.75.3.1537; ORTH G, 1987, PAPOVAVIRIDAE, V2, P199; Ramoz N, 2000, J INVEST DERMATOL, V114, P1148, DOI 10.1046/j.1523-1747.2000.00996.x; Ramoz N, 1999, J INVEST DERMATOL, V112, P259, DOI 10.1046/j.1523-1747.1999.00536.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	14	268	280	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32	4					579	581		10.1038/ng1044			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	WOS:000179593000008	12426567				2022-01-24	
J	O'Sullivan, JN; Bronner, MP; Brentnall, TA; Finley, JC; Shen, WT; Emerson, S; Emond, MJ; Gollahon, KA; Moskovitz, AH; Crispin, DA; Potter, JD; Rabinovitch, PS				O'Sullivan, JN; Bronner, MP; Brentnall, TA; Finley, JC; Shen, WT; Emerson, S; Emond, MJ; Gollahon, KA; Moskovitz, AH; Crispin, DA; Potter, JD; Rabinovitch, PS			Chromosomal instability in ulcerative colitis is related to telomere shortening	NATURE GENETICS			English	Article							LENGTH DYNAMICS; DYSFUNCTION; CANCER; MICE; EVOLUTION; DYSPLASIA; SEQUENCE; TUMORS; CELLS; P53	Ulcerative colitis, a chronic inflammatory disease of the colon, is associated with a high risk of colorectal carcinoma(1) that is thought to develop through genomic instability(2). We considered that the rapid cell turnover and oxidative injury observed in ulcerative colitis might accelerate telomere shortening(3), thereby increasing the potential of chromosomal ends to fuse(4), resulting in cycles of chromatin bridge breakage and fusion(5,6) and chromosomal instability associated with tumor cell progression(7,8). Here we have used quantitative fluorescence in situ hybridization to compare chromosomal aberrations and telomere shortening in non-dysplastic mucosa taken from individuals affected by ulcerative colitis, either with (UC progressors) or without (UC non-progressors) dysplasia or cancer. Losses, but not gains, of chromosomal arms and centromeres are highly correlated with telomere shortening. Chromosomal losses are greater and telomeres are shorter in biopsy samples from UC progressors than in those from UC non-progressors or control individuals without ulcerative colitis. A mechanistic link between telomere shortening and chromosomal instability is supported by a higher frequency of anaphase bridges-an intermediate in the breakage and fusion of chromatin bridges(9)-in UC progressors than in UC non-progressors or control individuals. Our study shows that telomere length is correlated with chromosomal instability in a precursor of human cancer.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Surg, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA		Rabinovitch, PS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	petersr@u.washington.edu		Potter, John/0000-0001-5439-1500; O'Sullivan, Jacintha/0000-0001-8622-9858			Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Day JP, 1998, CARCINOGENESIS, V19, P259, DOI 10.1093/carcin/19.2.259; DELANGE T, 1995, TELOMERES, P265; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fouladi B, 2000, NEOPLASIA, V2, P540, DOI 10.1038/sj.neo.7900107; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Kilburn AE, 2001, MOL CELL BIOL, V21, P126, DOI 10.1128/MCB.21.1.126-135.2001; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Loeb KR, 1999, AM J PATHOL, V154, P1621, DOI 10.1016/S0002-9440(10)65415-6; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; McClintock B, 1941, GENETICS, V26, P234; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; Oexle K, 1998, J THEOR BIOL, V190, P369, DOI 10.1006/jtbi.1997.0559; Rabinovitch PS, 1999, CANCER RES, V59, P5148; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; RUBIN CE, 1992, GASTROENTEROLOGY, V103, P1611, DOI 10.1016/0016-5085(92)91185-7; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tlsty TD, 1997, CURR TOP MICROBIOL, V221, P37; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Whitehead CM, 1999, J CELL BIOCHEM, P192; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592	29	268	275	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2002	32	2					280	284		10.1038/ng989			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	WOS:000178311100017	12355086				2022-01-24	
J	Gonzalez-Suarez, E; Samper, E; Flores, JM; Blasco, MA				Gonzalez-Suarez, E; Samper, E; Flores, JM; Blasco, MA			Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis	NATURE GENETICS			English	Article							IMMORTAL HUMAN-CELLS; HUMAN TUMOR-CELLS; MOUSE TELOMERASE; CANCER; RAS; CARCINOGENESIS; PAPILLOMAS; INHIBITION; EXPRESSION; SUBUNIT	Inhibition of telomerase is proposed to limit the growth of cancer cells by triggering telomere shortening and cell death(1-9). Telomere maintenance by telomerase is sufficient, in some cell types, to allow immortal growth(1-5). Telomerase has been shown to cooperate with oncogenes in transforming cultured primary human cells into neoplastic cells, suggesting that telomerase activation contributes to malignant transformation(6). Moreover. telomerase inhibition in human tumour cell lines using dominant-negative versions of TERT leads to telomere shortening and cell death(7,8). These findings have led to the proposition that telomerase inhibition may result in cessation of tumour growth(9). The absence of telomerase from most normal cells supports the potential efficacy of anti-telomerase drugs for tumour therapy, as its inhibition is unlikely to have toxic effects. Mice deficient for Terc RNA (encoding telomerase) lack telomerase activity, and constitute a model for evaluating the role of telomerase and telomeres in tumourigenesis(10). Late-generation Terc(-/-) mice show defects in proliferative tissues(10-15) and a moderate increase in the incidence of spontaneous tumours in highly proliferative cell types (lymphomas, teratocarcinomas(12)). The appearance of these tumours is thought to be a consequence of chromosomal instability in these mice(10,12,16,17). These observations have challenged the expected effectiveness of anti-telomerase-based cancer therapies(18). Different cell types may nonetheless vary in their sensitivity to the chromosomal instability produced by telomere lost; or to the activation of telomere-rescue mechanisms. Here we show that late-generation Terc(-/-) mice, which have short telomeres and are telomerase-deficient(10), are resistant to tumour development in multi-stage skin carcinogenesis. Our results predict that an anti-telomerase-based tumour therapy may be effective in epithelial tumours.	Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain; Univ Complutense Madrid, Fac Vet, Dept Anim Pathol 2, Madrid, Spain		Blasco, MA (corresponding author), Natl Biotechnol Ctr, Dept Immunol & Oncol, Madrid, Spain.	mblasco@cnb.uam.es	Blasco, Maria A./M-1694-2014; Gonzalez-Suarez, Eva/L-6298-2014	Blasco, Maria A./0000-0002-4211-233X; Gonzalez-Suarez, Eva/0000-0003-0858-8171			BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BALMAIN A, 1992, PRINCESS TAKAMATSU S, V22, P97; Bednarek AK, 1997, MOL CARCINOGEN, V20, P329, DOI 10.1002/(SICI)1098-2744(199712)20:4<329::AID-MC1>3.0.CO;2-E; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HECKNER E, 1982, CARCINOGENESIS COMPR; HENNINGS H, 1994, KERATINOCYTE METHODS, P21; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423; Zumstein LA, 1999, NAT MED, V5, P1129, DOI 10.1038/13451	30	268	282	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					114	117		10.1038/79089			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000031	10973262				2022-01-24	
J	Escayg, A; De Waard, M; Lee, DD; Bichet, D; Wolf, P; Mayer, T; Johnston, J; Baloh, R; Sander, T; Meisler, MH				Escayg, A; De Waard, M; Lee, DD; Bichet, D; Wolf, P; Mayer, T; Johnston, J; Baloh, R; Sander, T; Meisler, MH			Coding and noncoding variation of the human calcium-channel beta(4)-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CA2+ CHANNEL; BETA-SUBUNIT; FEBRILE SEIZURES; NEUROLOGICAL DISEASE; ALPHA(1C) SUBUNIT; GABA(B) RECEPTOR; N-TYPE; MUTATION; MOUSE; LOCUS	Inactivation of the beta(4) subunit of the calcium channel in the mouse neurological mutant lethargic results in a complex neurological disorder that includes absence epilepsy and ataxia. To determine the role of the calcium-channel beta(4)-subunit gene CACNB4 on chromosome 2q22-23 in related human disorders, we screened for mutations in small pedigrees with familial epilepsy and ataxia. The premature-termination mutation R482X was identified in a patient with juvenile myoclonic epilepsy. The R482X protein lacks the 38 C-terminal amino acids containing part of an interaction domain for the alpha(1) subunit, The missense mutation C104F was identified both in a German family with generalized epilepsy and praxis-induced seizures and in a French Canadian family with episodic ataxia. These coding mutations were not detected in 255 unaffected control individuals (510 chromosomes), and they may be considered candidate disease mutations, The results of functional tests of the truncated protein R482X in Xenopus laevis oocytes demonstrated a small decrease in the fast time constant for inactivation of the cotransfected alpha(1), subunit, Further studies will be required to evaluate the in vivo consequences of these mutations. We also describe eight noncoding single-nucleotide substitutions, two of which are present at polymorphic frequency, and a previously unrecognized first intron of CACNB4 that interrupts exon 1 at codon 21.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Fac Med Nord, Inst Federat Jean Roche, INSERM U464, Marseille, France; Epilepsy Ctr Bethel, Clin Mara, Bielefeld, Germany; Univ Manitoba, Dept Neurol, Winnipeg, MB, Canada; Univ Calif Los Angeles, Sch Med, Reed Neurol Res Ctr, Dept Neurol, Los Angeles, CA USA; Humboldt Univ, Hosp Charite, Dept Neurol, Berlin, Germany		Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, 4708 Med Sci 2, Ann Arbor, MI 48109 USA.	meislerm@umich.edu	De Waard, Michel/G-7406-2014; Lee, David/ABH-1406-2021	De Waard, Michel/0000-0002-2782-9615; Lee, David/0000-0002-2086-0150; Bichet, Delphine/0000-0002-9601-089X	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P01DC02952] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34709] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P01DC002952] Funding Source: NIH RePORTER		[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Burgess DL, 1999, ANN NY ACAD SCI, V868, P199, DOI 10.1111/j.1749-6632.1999.tb11287.x; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Burgess DL, 1999, MOL CELL NEUROSCI, V13, P293, DOI 10.1006/mcne.1999.0748; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066, DOI 10.1152/jn.1999.81.5.2066; Cens T, 1999, FEBS LETT, V450, P17, DOI 10.1016/S0014-5793(99)00463-9; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chien AJ, 1998, J BIOENERG BIOMEMBR, V30, P377, DOI 10.1023/A:1021941706726; Cooper EC, 1999, P NATL ACAD SCI USA, V96, P4759, DOI 10.1073/pnas.96.9.4759; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 1998, GENOMICS, V50, P14, DOI 10.1006/geno.1998.5311; Gerster U, 1999, J PHYSIOL-LONDON, V517, P353, DOI 10.1111/j.1469-7793.1999.0353t.x; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Hartmann HA, 1999, NAT NEUROSCI, V2, P593, DOI 10.1038/10147; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Hosford D A, 1999, Adv Neurol, V79, P239; HOSFORD DA, 1992, SCIENCE, V257, P398, DOI 10.1126/science.1321503; INOUE Y, 1992, J JPN EPILEPSY SOC, V10, P1; Lopes-Cendes I, 2000, AM J HUM GENET, V66, P698, DOI 10.1086/302768; McEnery MW, 1998, J BIOL CHEM, V273, P21435, DOI 10.1074/jbc.273.34.21435; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Meisler MH, 1997, ANN MED, V29, P569, DOI 10.3109/07853899709007484; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Peiffer A, 1999, ANN NEUROL, V46, P671, DOI 10.1002/1531-8249(199910)46:4<671::AID-ANA20>3.0.CO;2-5; PEREZREYES E, 1994, DRUG DEVELOP RES, V33, P295, DOI 10.1002/ddr.430330311; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; RITACCIO AL, 1994, NEUROL CLIN, V12, P57, DOI 10.1016/S0733-8619(18)30111-7; Sander T, 1999, AM J MED GENET, V88, P305, DOI 10.1002/(SICI)1096-8628(19990820)88:4<305::AID-AJMG5>3.0.CO;2-X; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Sprunger LK, 1999, HUM MOL GENET, V8, P471, DOI 10.1093/hmg/8.3.471; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Walker D, 1999, J BIOL CHEM, V274, P12383, DOI 10.1074/jbc.274.18.12383; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; WEI XY, 1994, J BIOL CHEM, V269, P1635; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	44	268	277	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1531	1539		10.1086/302909			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	WOS:000088373700007	10762541	Bronze, Green Published			2022-01-24	
J	di Barletta, MR; Ricci, E; Galluzzi, G; Tonali, P; Mora, M; Morandi, L; Romorini, A; Voit, T; Orstavik, KH; Merlini, L; Trevisan, C; Biancalana, V; Housmanowa-Petrusewicz, I; Bione, S; Ricotti, R; Schwartz, K; Bonne, G; Toniolo, D				di Barletta, MR; Ricci, E; Galluzzi, G; Tonali, P; Mora, M; Morandi, L; Romorini, A; Voit, T; Orstavik, KH; Merlini, L; Trevisan, C; Biancalana, V; Housmanowa-Petrusewicz, I; Bione, S; Ricotti, R; Schwartz, K; Bonne, G; Toniolo, D			Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMATIN BINDING-SITE; NUCLEAR-ENVELOPE; HUMEROPELVIC DISTRIBUTION; ROD DOMAIN; LAMIN-A; DISEASE; EXPRESSION; IDENTIFICATION; CARDIOMYOPATHY; MEMBRANE	Emery-Dreifuss muscular dystrophy (EMD) is a condition characterized by the clinical triad of early-onset contractures, progressive weakness in humeroperoneal muscles, and cardiomyopathy with conduction block. The disease was described for the first time as an X-linked muscular dystrophy, but autosomal dominant and autosomal recessive forms were reported. The genes for X-linked EMD and autosomal dominant EMD (AD-EMD) were identified. We report here that heterozygote mutations in LMNA, the gene for AD-EMD, may cause diverse phenotypes ranging from typical EMD to no phenotypic effect. Our results show that LMNA mutations are also responsible for the recessive form of the disease. Our results give further support to the notion that different genetic forms of EMD have a common pathophysiological background. The distribution of the mutations in AD-EMD patients (in the tail and in the 2A rod domain) suggests that unique interactions between lamin A/C and other nuclear components exist that have an important role in cardiac and skeletal muscle function.	CNR, Inst Genet Biochem & Evolut, I-27100 Pavia, Italy; Catholic Univ, Inst Neurol, Rome, Italy; UILDM, Ctr Neuromuscular Dis, Rome Sect, Rome, Italy; CNR, Inst Cell Biol, I-27100 Pavia, Italy; Ist Neurol Besta, Milan, Italy; Legnano Hosp, Legnano, Italy; Univ Essen, Dept Pediat, Essen, Germany; Ulleval Hosp, Dept Med Genet, Oslo, Norway; Rizzoli Inst, Bologna, Italy; Univ Padua, Dept Clin Neurol, Padua, Italy; Polish Acad Sci, Med Res Ctr, Warsaw, Poland; GH Pitie Salpetriere, Inst Myol, Paris, France; GH Pitie Salpetriere, INSERM, UR153, Paris, France; Strasbourg Univ, Sch Med, Serv Genet, Strasbourg, France		Toniolo, D (corresponding author), CNR, Inst Genet Biochem & Evolut, Via Abbiategrasso 207, I-27100 Pavia, Italy.		Ricci, Enzo/AAC-4448-2020; Bonne, Gisele/G-3121-2013; Merlini, Luciano/N-6478-2019; Toniolo, Daniela/AAE-2969-2019; Biancalana, Valerie/O-2351-2016; Mora, Marina/J-2883-2018	Bonne, Gisele/0000-0002-2516-3258; Merlini, Luciano/0000-0002-1108-1198; Toniolo, Daniela/0000-0001-9545-6032; RICCI, Enzo/0000-0003-3092-3597; Mora, Marina/0000-0002-5765-2320; Bione, Silvia/0000-0002-3924-4606			BIONE S, 1995, HUM MOL GENET, V4, P1859; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BRODSKY GL, 2000, HUM MOL GENET, V101, P473; Cartegni L, 1997, HUM MOL GENET, V6, P2257, DOI 10.1093/hmg/6.13.2257; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; EMERY AEH, 1989, J MED GENET, V26, P637, DOI 10.1136/jmg.26.10.637; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FENICHEL GM, 1982, NEUROLOGY, V32, P1399, DOI 10.1212/WNL.32.12.1399; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Furukawa K, 1997, BIOCHEM BIOPH RES CO, V238, P240, DOI 10.1006/bbrc.1997.7235; GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x; HOGER TH, 1991, EXP CELL RES, V197, P280, DOI 10.1016/0014-4827(91)90434-V; LIN F, 1993, J BIOL CHEM, V268, P16321; Manilal S, 1998, HUM MOL GENET, V7, P855, DOI 10.1093/hmg/7.5.855; MARTIN GJ, 1995, METHODS DETECT ADULT, V1, P1; MILLER RG, 1985, NEUROLOGY, V35, P1230, DOI 10.1212/WNL.35.8.1230; Morris GE, 1999, HUM MOL GENET, V8, P1847, DOI 10.1093/hmg/8.10.1847; Nagano A, 1996, NAT GENET, V12, P254, DOI 10.1038/ng0396-254; OEFNER PJ, 1995, AM J HUM GENET, V57, P266; OEFNER PJ, 1998, CURRENT PROTOCOLS HU; ORSTAVIK KH, 1990, CLIN GENET, V38, P447; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TAKAMOTO K, 1984, ARCH NEUROL-CHICAGO, V41, P1292, DOI 10.1001/archneur.1984.04050230078024; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Taylor J, 1998, NEUROLOGY, V51, P1116, DOI 10.1212/WNL.51.4.1116; Toniolo D, 1999, CURR OPIN GENET DEV, V9, P275, DOI 10.1016/S0959-437X(99)80041-0; TONIOLO D, 1998, NEUROMUSCULAR DISORD, P87; VOIT T, 1988, NEUROPEDIATRICS, V19, P62, DOI 10.1055/s-2008-1052404; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; Yates JRW, 1997, NEUROMUSCULAR DISORD, V7, P67, DOI 10.1016/S0960-8966(96)00403-8	32	268	281	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1407	1412		10.1086/302869			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	WOS:000088373400022	10739764	Green Published, Bronze			2022-01-24	
J	Harrison, KA; Thaler, J; Pfaff, SL; Gu, H; Kehrl, JH				Harrison, KA; Thaler, J; Pfaff, SL; Gu, H; Kehrl, JH			Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice	NATURE GENETICS			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; HOMEOBOX GENE; BETA-CELLS; DIFFERENTIATION; REVEALS; REQUIREMENT; MESENCHYME; INTESTINE; NOTOCHORD; PDX-1	In most mammals the pancreas develops from the foregut endoderm as ventral and dorsal buds. These buds fuse and develop into a complex organ composed of endocrine, exocrine and ductal components(1,2). This developmental process depends upon an integrated network of transcription factors. Gene targeting experiments have revealed critical roles for Pdx1, lsl1, Pax4, Pax6 and Nkx2-2 (refs 3-10). The homeobox gene HLXB9 (encoding HB9) is prominently expressed in adult human pancreas(11), although its role in pancreas development and function is unknown. To facilitate its study, we isolated the mouse HLXB9 orthologue, Hlxb9. During mouse development, the dorsal and ventral pancreatic buds and mature beta-cells in the islets of Langerhans express Hlxb9. In mice homologous for a null mutation of Hlxb9, the dorsal lobe of the pancreas fails to develop. The remnant Hlxb9(-/-) pancreas has small islets of Langerhans with reduced numbers of insulin-producing p-cells. Hlxb9(-/-) beta-cells express low levels of the glucose transporter Glut2 and homeodomain factor Nkx 6-1. Thus, Hlxb9 is key to normal pancreas development and function.	NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA		Kehrl, JH (corresponding author), NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [Z01AI000737, Z01AI000719] Funding Source: NIH RePORTER		Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; BAUBONIS W, 1993, NUCLEIC ACIDS RES, V21, P2025, DOI 10.1093/nar/21.9.2025; Githens Sherwood, 1993, P21; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim SK, 1997, DEVELOPMENT, V124, P4243; Offield MF, 1996, DEVELOPMENT, V122, P983; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; RUDNICK A, 1994, P NATL ACAD SCI USA, V91, P12203, DOI 10.1073/pnas.91.25.12203; Sander M, 1997, J MOL MED, V75, P327, DOI 10.1007/s001090050118; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; THALER J, IN PRESS NEURON; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002	26	268	276	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1999	23	1					71	75		10.1038/12674			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	WOS:000082337300019	10471502				2022-01-24	
J	Pastinen, T; Kurg, A; Metspalu, A; Peltonen, L; Syvanen, AC				Pastinen, T; Kurg, A; Metspalu, A; Peltonen, L; Syvanen, AC			Minisequencing: A specific tool for DNA analysis and diagnostics on oligonucleotide arrays	GENOME RESEARCH			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA; FINNISH PATIENTS; RECEPTOR GENE; HYBRIDIZATION; MUTATION; IDENTIFICATION; DISEASE	We describe a method for multiplex detection of mutations in which the solid-phase minisequencing principle is applied to an oligonucleotide array format. The mutations are detected by extending immobilized primers that anneal to their template sequences immediately adjacent to the mutant nucleotide positions with single labeled dideoxynucleoside triphosphates using a DNA polymerase. The arrays were prepared by coupling one primer per mutation to be detected on a small glass area, Genomic fragments spanning nine disease mutations, which were selected as targets For the assay, were amplified in multiplex PCR reactions and used as templates for the minisequencing reactions on the primer array. The genotypes of homozygous genomic DNA samples were unequivocally defined at each analyzed nucleotide position by the highly specific primer extension reaction. In a comparison to hybridization with immobilized allele-specific probes in the same assay format, the power of discrimination between homozygous and heterozygous genotypes was one order of magnitude higher using the minisequencing method. Therefore, single-nucleotide primer extension is a promising principle for future high-throughput mutation detection and genotyping using high density DNA-chip technology.	NATL PUBL HLTH INST, DEPT HUMAN MOL GENET, SF-00300 HELSINKI, FINLAND; TARTU STATE UNIV, INST MOL & CELL BIOL, EE-2400 TARTU, ESTONIA				Kurg, Ants/J-2616-2015; Kurg, Ants/AAM-1292-2020	Kurg, Ants/0000-0002-0829-1987			AALTOSETALA K, 1989, J CLIN INVEST, V84, P499, DOI 10.1172/JCI114192; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Chamberlain Jeffrey S., 1994, P38; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; Cronin MT, 1996, HUM MUTAT, V7, P244, DOI 10.1002/(SICI)1098-1004(1996)7:3<244::AID-HUMU9>3.0.CO;2-A; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; GUO Z, 1994, NUCLEIC ACIDS RES, V22, P5456, DOI 10.1093/nar/22.24.5456; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; IKONEN E, 1991, EMBO J, V10, P51, DOI 10.1002/j.1460-2075.1991.tb07920.x; Khrapko K R, 1991, DNA Seq, V1, P375, DOI 10.3109/10425179109020793; KOIVISTO UM, 1993, J LIPID RES, V34, P269; KOIVISTO UM, 1992, J CLIN INVEST, V90, P219, DOI 10.1172/JCI115839; KOIVISTO UM, 1995, AM J HUM GENET, V57, P789; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; KURE S, 1992, J CLIN INVEST, V90, P160, DOI 10.1172/JCI115831; LAMTURE JB, 1994, NUCLEIC ACIDS RES, V22, P2121, DOI 10.1093/nar/22.11.2121; McGall G, 1996, P NATL ACAD SCI USA, V93, P13555, DOI 10.1073/pnas.93.24.13555; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; Pastinen T, 1996, CLIN CHEM, V42, P1391; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Shumaker JM, 1996, HUM MUTAT, V7, P346, DOI 10.1002/(SICI)1098-1004(1996)7:4<346::AID-HUMU9>3.3.CO;2-9; SOUTHERN EM, 1992, GENOMICS, V13, P1008, DOI 10.1016/0888-7543(92)90014-J; Southern EM, 1996, TRENDS GENET, V12, P110, DOI 10.1016/0168-9525(96)81422-3; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; Tully G, 1996, GENOMICS, V34, P107, DOI 10.1006/geno.1996.0247; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0	35	268	288	0	5	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUN	1997	7	6					606	614		10.1101/gr.7.6.606			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	XF046	WOS:A1997XF04600006	9199933	Bronze			2022-01-24	
J	ANDERSEN, PM; NILSSON, P; ALAHURULA, V; KERANEN, ML; TARVAINEN, I; HALTIA, T; NILSSON, L; BINZER, M; FORSGREN, L; MARKLUND, SL				ANDERSEN, PM; NILSSON, P; ALAHURULA, V; KERANEN, ML; TARVAINEN, I; HALTIA, T; NILSSON, L; BINZER, M; FORSGREN, L; MARKLUND, SL			AMYOTROPHIC-LATERAL-SCLEROSIS ASSOCIATED WITH HOMOZYGOSITY FOR AN ASP90ALA MUTATION IN CUZN-SUPEROXIDE DISMUTASE	NATURE GENETICS			English	Article							NORTHERN SWEDEN; COPPER; POPULATION; ALS; SOD	Recent reports have shown heterozygosity for some twenty different mutations in the CuZn-superoxide dismutase (CuZn-SOD) gene in familial amyotrophic lateral sclerosis (FALS), and analysed samples from patients have shown decreased enzymic activity. Here we report homozygosity for an exon 4 mutation, Asp90Ala in fourteen patients among four unrelated ALS families and four apparently sporadic ALS patients from Sweden and Finland. The erythrocyte CuZn-SOD activity is essentially normal. Our findings suggest that this CuZn-SOD mutation causes ALS by a gain of function rather than by loss, and that the Asp90Ala mutation is less detrimental than previously reported mutations.	UMEA UNIV HOSP, DEPT CLIN CHEM, S-90185 UMEA, SWEDEN; UMEA UNIV HOSP, DEPT NEUROL, S-90185 UMEA, SWEDEN; CENT LASARETTET KEMI, DEPT NEUROL, SF-94100 KEMI, FINLAND; LAPIN KESKUSSAIRAALA, DEPT NEUROL, SF-96101 ROVANIEMI, FINLAND; MIKKELIN KESKUSSAIRAALA, DEPT NEUROL, SF-50100 MIKKELI, FINLAND; KAUNIALA SJUKHUS KRIGSINVALIDER, SF-02700 KAUNIAINEN, FINLAND								BECKMAN G, 1973, HEREDITAS, V73, P305; BECKMAN G, 1973, HUM HERED, V23, P346, DOI 10.1159/000152595; BECKMAN G, 1975, HEREDITAS, V79, P43; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; CHIO A, 1987, ACTA NEUROL SCAND, V75, P277, DOI 10.1111/j.1600-0404.1987.tb07933.x; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DUMON J, 1971, J MED GENET, V8, P113, DOI 10.1136/jmg.8.1.113; ERIKSSON AW, 1973, ISRAEL J MED SCI, V9, P1156; FORSGREN L, 1983, ACTA NEUROL SCAND, V68, P20, DOI 10.1111/j.1600-0404.1983.tb04810.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; ILSHAFEY A, 1994, HUM MOL GENET, V3, P363; JONES CT, 1994, HUM MOL GENET, V3, P649, DOI 10.1093/hmg/3.4.649; KURLAND LT, 1955, NEUROLOGY, V5, P182, DOI 10.1212/WNL.5.3.182; KURLAND LT, 1955, NEUROLOGY, V5, P249, DOI 10.1212/WNL.5.4.249; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; MARKLUND S, 1976, J BIOL CHEM, V251, P7504; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MARKLUND SL, 1985, CRC HDB METHODS OXYG, P249; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MIETTINEN OS, 1974, AM J EPIDEMIOL, V100, P515; MYLLYLA VV, 1979, ACTA NEUROL SCAND, V60, P170; NAKANO R, 1994, BIOCHEM BIOPH RES CO, V200, P695, DOI 10.1006/bbrc.1994.1506; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; OHMAN M, 1986, CLIN SCI, V70, P365; PRAMATAROVA A, 1995, AM J HUM GENET, V56, P592; RAINERO I, 1994, NEUROLOGY, V44, P347, DOI 10.1212/WNL.44.2.347; ROBBERECHT W, 1994, J NEUROCHEM, V62, P384; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1994, AM J HUM GENET, V55, pA1419; SJALANDER A, IN PRESS HUM MOL GEN; SWASH M, 1992, NEUROMUSCULAR DISORD, V2, P7, DOI 10.1016/0960-8966(92)90020-7; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; TSUDA T, 1994, NEURON, V13, P727, DOI 10.1016/0896-6273(94)90039-6; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; YIM MB, 1993, J BIOL CHEM, V268, P4099	40	268	269	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1995	10	1					61	66		10.1038/ng0595-61			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	WOS:A1995QX57300017	7647793				2022-01-24	
J	ARDINGER, HH; BUETOW, KH; BELL, GI; BARDACH, J; VANDEMARK, DR; MURRAY, JC				ARDINGER, HH; BUETOW, KH; BELL, GI; BARDACH, J; VANDEMARK, DR; MURRAY, JC			ASSOCIATION OF GENETIC-VARIATION OF THE TRANSFORMING GROWTH FACTOR-ALPHA GENE WITH CLEFT-LIP AND PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CHICAGO, DEPT BIOCHEM & MOLEC BIOL, HOWARD HUGHES MED INST, CHICAGO, IL 60637 USA; UNIV IOWA, DEPT OTOLARYNGOL, IOWA CITY, IA 52242 USA; FOX CHASE CANC INST, PHILADELPHIA, PA 19111 USA; UNIV CHICAGO, DEPT MED, HOWARD HUGHES MED INST, CHICAGO, IL 60637 USA		ARDINGER, HH (corresponding author), UNIV IOWA, DEPT PEDIAT, DIV MED GENET, IOWA CITY, IA 52242 USA.				NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [DE08556, DE05506, DE05837] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [P01DE005837, R13DE008556, F32DE005506] Funding Source: NIH RePORTER		CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CASTAGNOLI A, 1987, NUCLEIC ACIDS RES, V15, P866, DOI 10.1093/nar/15.2.866; CHUNG CS, 1986, AM J HUM GENET, V39, P603; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERGUSON MWJ, 1987, IRISH J MED SCI, V156, P309, DOI 10.1007/BF02951261; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; FREZAL J, 1987, CYTOGENET CELL GENET, V46, P1, DOI 10.1159/000132469; HAYWARD NK, 1987, NUCLEIC ACIDS RES, V15, P5503, DOI 10.1093/nar/15.13.5503; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MURRAY JC, 1987, NUCLEIC ACIDS RES, V15, P6765, DOI 10.1093/nar/15.16.6765; MURRAY JC, 1986, NUCLEIC ACIDS RES, V14, P5117, DOI 10.1093/nar/14.12.5117; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; Pratt R., 1980, CURRENT RES TRENDS P, P235; SMITH RF, 1987, NUCLEIC ACIDS RES, V15, P6764, DOI 10.1093/nar/15.16.6764	14	268	287	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					348	353					6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	WOS:A1989AN87900002	2570526				2022-01-24	
J	GILLESPIE, JH				GILLESPIE, JH			NATURAL-SELECTION FOR WITHIN-GENERATION VARIANCE IN OFFSPRING NUMBER	GENETICS			English	Article									UNIV PENN, DEPT BIOL, PHILADELPHIA, PA 19174 USA								CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P153, DOI 10.1016/0040-5809(72)90024-X; GILLESPIE JH, 1973, GENET RES, V21, P115, DOI 10.1017/S001667230001329X; KARLIN S, 1964, P NATL ACAD SCI USA, V51, P598, DOI 10.1073/pnas.51.4.598; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; KIMURA M, 1962, GENETICS, V47, P713; KIMURA M, 1954, GENETICS, V39, P280; WRIGHT S, 1945, P NATL ACAD SCI USA, V31, P382, DOI 10.1073/pnas.31.12.382; [No title captured]	9	268	269	1	37	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1974	76	3					601	606					6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T0769	WOS:A1974T076900017	4833578				2022-01-24	
J	Hu, B; Wang, W; Ou, SJ; Tang, JY; Li, H; Che, RH; Zhang, ZH; Chai, XY; Wang, HR; Wang, YQ; Liang, CZ; Liu, LC; Piao, ZZ; Deng, QY; Deng, K; Xu, C; Liang, Y; Zhang, LH; Li, LG; Chu, CC				Hu, Bin; Wang, Wei; Ou, Shujun; Tang, Jiuyou; Li, Hua; Che, Ronghui; Zhang, Zhihua; Chai, Xuyang; Wang, Hongru; Wang, Yiqin; Liang, Chengzhen; Liu, Linchuan; Piao, Zhongze; Deng, Qiyun; Deng, Kun; Xu, Chi; Liang, Yan; Zhang, Lianhe; Li, Legong; Chu, Chengcai			Variation in NRT1.1B contributes to nitrate-use divergence between rice subspecies	NATURE GENETICS			English	Article							CHLORATE-RESISTANT MUTANTS; ARABIDOPSIS-THALIANA; JAPONICA RICE; TRANSPORTER; AMMONIUM; INDICA; CHL1; SEQUENCE; REVEALS; PLANTS	Asian cultivated rice (Oryza sativa L.) consists of two main subspecies, indica and japonica. Indica has higher nitrate-absorption activity than japonica, but the molecular mechanisms underlying that activity remain elusive. Here we show that variation in a nitrate-transporter gene, NRT1.1B (OsNPF6.5), may contribute to this divergence in nitrate use. Phylogenetic analysis revealed that NRT1.1B diverges between indica and japonica. NRT1.1B-indica variation was associated with enhanced nitrate uptake and root-to-shoot transport and upregulated expression of nitrate-responsive genes. The selection signature of NRT1.1B-indica suggests that nitrate-use divergence occurred during rice domestication. Notably, field tests with near-isogenic and transgenic lines confirmed that the japonica variety carrying the NRT1.1B-indica allele had significantly improved grain yield and nitrogen-use efficiency (NUE) compared to the variety without that allele. Our results show that variation in NRT1.1B largely explains nitrate-use divergence between indica and japonica and that NRT1.1Bindica can potentially improve the NUE of japonica.	[Hu, Bin; Wang, Wei; Ou, Shujun; Tang, Jiuyou; Li, Hua; Che, Ronghui; Zhang, Zhihua; Wang, Hongru; Wang, Yiqin; Liang, Chengzhen; Xu, Chi; Liang, Yan; Chu, Chengcai] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, State Key Lab Plant Gen, Beijing, Peoples R China; [Wang, Wei; Li, Hua; Zhang, Zhihua; Wang, Hongru; Liang, Yan] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Ou, Shujun] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Chai, Xuyang] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Liu, Linchuan] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [Piao, Zhongze] Shanghai Acad Agr Sci, Crop Breeding & Cultivat Res Inst, Shanghai, Peoples R China; [Deng, Qiyun] China Natl Hybrid Rice Res, Changsha, Peoples R China; [Deng, Qiyun] Dev Ctr, Changsha, Peoples R China; [Deng, Kun; Zhang, Lianhe] Henan Univ Sci & Technol, Sch Agr, Luoyang, Peoples R China		Chu, CC (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, State Key Lab Plant Gen, Beijing, Peoples R China.	ccchu@genetics.ac.cn	Wang, Yiqin/AAJ-8144-2020; Zhang, Zhihua/AAJ-4229-2021; Ou, Shujun/N-5263-2019; Chu, Chengcai/AAF-6083-2019	Ou, Shujun/0000-0001-5938-7180; Chu, Chengcai/0000-0001-8097-6115; Liu, Linchuan/0000-0002-8669-7202; Wang, Hongru/0000-0001-8305-5231; Tang, Jiuyou/0000-0002-9059-2139	Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2014AA10A602-5, 2015CB755702]; Chinese Academy of SciencesChinese Academy of Sciences [XDA08010400]	We thank H. Xue (Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China) for providing the nrt1.1b mutant and M. Schlqappi (Marquette University, Milwaukee, Wisconsin, USA) and X. Wang (China Agricultural University, Beijing, China) for language editing. This work was supported by grants from the Ministry of Science and Technology of China (2014AA10A602-5, 2015CB755702) and the Chinese Academy of Sciences (XDA08010400).	Alachiotis N, 2012, BIOINFORMATICS, V28, P2274, DOI 10.1093/bioinformatics/bts419; Almagro A, 2008, PLANT CELL, V20, P3289, DOI 10.1105/tpc.107.056788; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Ho CH, 2010, CURR OPIN PLANT BIOL, V13, P604, DOI 10.1016/j.pbi.2010.08.005; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kirk GJD, 2005, ANN BOT-LONDON, V96, P639, DOI 10.1093/aob/mci216; Koutroubas SD, 2003, FIELD CROP RES, V83, P251, DOI 10.1016/S0378-4290(03)00067-4; Kronzucker HJ, 2000, NEW PHYTOL, V145, P471, DOI 10.1046/j.1469-8137.2000.00606.x; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Mandal A, 2012, BIOCHEM J, V445, P313, DOI 10.1042/BJ20120190; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; MOLL RH, 1987, CROP SCI, V27, P181, DOI 10.2135/cropsci1987.0011183X002700020007x; Monden I, 2001, BIOL CHEM, V382, P1551, DOI 10.1515/BC.2001.189; Oka H.I., 1983, ORIGIN CULTIVATED RI; OOSTINDI.FJ, 1973, MUTAT RES, V19, P175, DOI 10.1016/0027-5107(73)90076-6; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015289; SCHOLTEN HJ, 1986, J PLANT PHYSIOL, V123, P45, DOI 10.1016/S0176-1617(86)80065-7; TA TC, 1981, SOIL SCI PLANT NUTR, V27, P347, DOI 10.1080/00380768.1981.10431289; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/oxfordjournals.molbev.a040023]; Teng S, 2006, EUPHYTICA, V152, P141, DOI 10.1007/s10681-006-9189-1; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; WANG XM, 1986, THEOR APPL GENET, V72, P328, DOI 10.1007/BF00288569; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhao Y, 2014, STRUCTURE, V22, P1152, DOI 10.1016/j.str.2014.06.008	34	267	329	39	378	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					834	+		10.1038/ng.3337			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	WOS:000357090300025	26053497				2022-01-24	
J	Pierron, G; Tirode, F; Lucchesi, C; Reynaud, S; Ballet, S; Cohen-Gogo, S; Perrin, V; Coindre, JM; Delattre, O				Pierron, Gaelle; Tirode, Franck; Lucchesi, Carlo; Reynaud, Stephanie; Ballet, Stelly; Cohen-Gogo, Sarah; Perrin, Virginie; Coindre, Jean-Michel; Delattre, Olivier			A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion	NATURE GENETICS			English	Article							EWING SARCOMA; EXPRESSION; BCOR; TRANSLOCATION; FAMILY; MUTATIONS; CYCLIN; TUMORS	The identification of subtype-specific translocations has revolutionized the diagnostics of sarcoma and has provided new insight into oncogenesis. We used RNA-seq to investigate samples from individuals diagnosed with small round cell tumors of bone, possibly Ewing sarcoma, but which lacked the canonical EWSR1-ETS translocation. A new fusion was observed between BCOR (encoding the BCL6 co-repressor) and CCNB3 (encoding the testis-specific cyclin B3) on the X chromosome. RNA-seq results were confirmed by RT-PCR and through cloning of the tumor-specific genomic translocation breakpoints. In total, 24 BCOR-CCNB3-positive tumors were identified among a series of 594 sarcoma cases. Gene profiling experiments indicated that BCOR-CCNB3-positive cases are biologically distinct from other sarcomas, particularly Ewing sarcoma. Finally, we show that CCNB3 immunohistochemistry is a powerful diagnostic marker for this subgroup of sarcoma and that overexpression of BCOR-CCNB3 or of truncated CCNB3 activates S phase in NIH3T3 cells. Thus, the intrachromosomal X-chromosome fusion described here represents a new subtype of bone sarcoma caused by a newly identified gene fusion mechanism.	[Pierron, Gaelle; Reynaud, Stephanie; Ballet, Stelly; Delattre, Olivier] Ctr Hosp, Inst Curie, Unite Genet Somat, Paris, France; [Tirode, Franck; Lucchesi, Carlo; Cohen-Gogo, Sarah; Perrin, Virginie; Delattre, Olivier] Ctr Rech, Inst Curie, INSERM, U830, Paris, France; [Coindre, Jean-Michel] Inst Bergonie, Bordeaux, France		Delattre, O (corresponding author), Ctr Hosp, Inst Curie, Unite Genet Somat, Paris, France.	olivier.delattre@curie.fr	Cohen-Gogo, Sarah/AAM-4700-2021; Tirode, Franck/B-4586-2009	Cohen-Gogo, Sarah/0000-0002-8852-1104; delattre, olivier/0000-0002-8730-2276; Lucchesi, Carlo/0000-0001-6657-2341; Tirode, Franck/0000-0003-4731-7817	Ligue Nationale Contre le CancerLigue nationale contre le cancer; Region Ile de FranceRegion Ile-de-France; Institut National du Cancer (INCa)Institut National du Cancer (INCA) France [2008-044, 0627, ZP09-027-EPI]; European Union (European Embryonal Tumors pipeline); Courir pour Mathieu; Dans les Pas du Geant; Olivier Chape; Les Bagouzamanon; Les Amis de Claire	We thank S. Chanock for fruitful discussions and critical reading of the manuscript. We are indebted to V. Raynal, P. Legoix-Ne, A. Nicolas, D. Gentien, S. Lair, A. Lermine and E. Barillot for critical technical help. We thank the following individuals for contributing cases and paraffin blocks or for supplying clinical information: J. Champigneulle, A. Croue, P. Dechelotte, J.M. Guinebretiere, C. Jeanne-Pasquier, A. Moreau, J.M. Picquenot, D. Ranchere-Vince, X. Sastre-Garau, P. Terrier, M.C. Vacher-Lavenue, V. Verkaere and L. Guillou. We thank E. Louis, S. Thoraval and T. Scarcez from the Life Science Company for help in applying SOLiD technology. We also thank N. Bretschneider, C. Gugenmus, M. Scherf and M. Seifert from the Genomatix company for the analysis of data. This work was supported by grants from the Ligue Nationale Contre le Cancer (Equipe Labellisee and Carte d'Identite des Tumeurs program), the Region Ile de France, the Institut National du Cancer (INCa; 2008-044, 0627 and ZP09-027-EPI), the European Union (European Embryonal Tumors pipeline) and the following associations: Courir pour Mathieu, Dans les Pas du Geant, Olivier Chape, Les Bagouzamanon and Les Amis de Claire.	Armengol G, 1997, BRIT J CANCER, V75, P1403, DOI 10.1038/bjc.1997.242; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dauphinot L, 2001, ONCOGENE, V20, P3258, DOI 10.1038/sj.onc.1204437; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; GALLANT P, 1994, EMBO J, V13, P595, DOI 10.1002/j.1460-2075.1994.tb06297.x; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh KD, 2000, GENE DEV, V14, P1810; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Ng TL, 2007, J MOL DIAGN, V9, P459, DOI 10.2353/jmoldx.2007.070009; Nguyen TB, 2002, J BIOL CHEM, V277, P41960, DOI 10.1074/jbc.M203951200; Peter M, 2001, LAB INVEST, V81, P905, DOI 10.1038/labinvest.3780299; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szuhai K, 2009, CLIN CANCER RES, V15, P2259, DOI 10.1158/1078-0432.CCR-08-2184; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venables W.N., 2005, R LANGUAGE ENV STAT; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yamamoto Y, 2010, BLOOD, V116, P4274, DOI 10.1182/blood-2010-01-264432	27	267	283	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					461	U151		10.1038/ng.1107			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	WOS:000302130600024	22387997	Green Submitted			2022-01-24	
J	Rogers, MB; Hilley, JD; Dickens, NJ; Wilkes, J; Bates, PA; Depledge, DP; Harris, D; Her, Y; Herzyk, P; Imamura, H; Otto, TD; Sanders, M; Seeger, K; Dujardin, JC; Berriman, M; Smith, DF; Hertz-Fowler, C; Mottram, JC				Rogers, Matthew B.; Hilley, James D.; Dickens, Nicholas J.; Wilkes, Jon; Bates, Paul A.; Depledge, Daniel P.; Harris, David; Her, Yerim; Herzyk, Pawel; Imamura, Hideo; Otto, Thomas D.; Sanders, Mandy; Seeger, Kathy; Dujardin, Jean-Claude; Berriman, Matthew; Smith, Deborah F.; Hertz-Fowler, Christiane; Mottram, Jeremy C.			Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania	GENOME RESEARCH			English	Article							EXPRESSION; ANEUPLOIDY; PROTEIN; GENOME; EVOLUTION; IDENTIFICATION; MODULATION; HOST	Leishmania parasites cause a spectrum of clinical pathology in humans ranging from disfiguring cutaneous lesions to fatal visceral leishmaniasis. We have generated a reference genome for Leishmania mexicana and refined the reference genomes for Leishmania major, Leishmania infantum, and Leishmania braziliensis. This has allowed the identification of a remarkably low number of genes or paralog groups (2, 14, 19, and 67, respectively) unique to one species. These were found to be conserved in additional isolates of the same species. We have predicted allelic variation and find that in these isolates, L. major and L. infantum have a surprisingly low number of predicted heterozygous SNPs compared with L. braziliensis and L. mexicana. We used short read coverage to infer ploidy and gene copy numbers, identifying large copy number variations between species, with 200 tandem gene arrays in L. major and 132 in L. mexicana. Chromosome copy number also varied significantly between species, with nine supernumerary chromosomes in L. infantum, four in L. mexicana, two in L. braziliensis, and one in L. major. A significant bias against gene arrays on supernumerary chromosomes was shown to exist, indicating that duplication events occur more frequently on disomic chromosomes. Taken together, our data demonstrate that there is little variation in unique gene content across Leishmania species, but large-scale genetic heterogeneity can result through gene amplification on disomic chromosomes and variation in chromosome number. Increased gene copy number due to chromosome amplification may contribute to alterations in gene expression in response to environmental conditions in the host, providing a genetic basis for disease tropism.	[Rogers, Matthew B.; Depledge, Daniel P.; Harris, David; Imamura, Hideo; Otto, Thomas D.; Sanders, Mandy; Seeger, Kathy; Berriman, Matthew; Hertz-Fowler, Christiane] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Rogers, Matthew B.; Depledge, Daniel P.; Her, Yerim; Smith, Deborah F.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Hilley, James D.; Dickens, Nicholas J.; Wilkes, Jon; Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; [Bates, Paul A.] Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England; [Herzyk, Pawel] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8TA, Lanark, Scotland; [Imamura, Hideo; Dujardin, Jean-Claude] Inst Trop Med, Dept Parasitol, Unit Mol Parasitol, B-2000 Antwerp, Belgium; [Dujardin, Jean-Claude] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Biomed & Vet Sci, B-2020 Antwerp, Belgium		Hertz-Fowler, C (corresponding author), Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Biosci Bldg, Liverpool L69 7ZB, Merseyside, England.	C.Hertz-Fowler@liverpool.ac.uk; jeremy.mottram@glasgow.ac.uk	Berriman, Matthew/A-7618-2011; Dujardin, Jean-Claude/AAO-1783-2021; Otto, Thomas/ABE-7632-2020; Dickens, Nicholas/G-1445-2013	Berriman, Matthew/0000-0002-9581-0377; Otto, Thomas/0000-0002-1246-7404; Hertz-Fowler, Christiane/0000-0002-0729-6479; Imamura, Hideo/0000-0002-3282-1319; Depledge, Daniel/0000-0002-4292-0599; Bates, Paul/0000-0001-6861-5421; Mottram, Jeremy/0000-0001-5574-3766; Dickens, Nicholas/0000-0003-0492-5855; Wilkes, Jonathan/0000-0002-0920-6967	Wellcome TrustWellcome TrustEuropean Commission [076355, 085822, 085775]	This work was supported by the Wellcome Trust (Grant numbers 076355, 085822, and 085775). We thank our colleagues in the sequencing and informatics groups at the Wellcome Trust Sanger Institute and the Sir Henry Wellcome Functional Genomics Centre at the University of Glasgow. We are grateful to Walide Saad for contributing to the generation of L. infantum SEC14-deficient mutants.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; BRADLEY DJ, 1977, CLIN EXP IMMUNOL, V30, P119; Britto C, 1998, GENE, V222, P107, DOI 10.1016/S0378-1119(98)00472-7; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Depledge DP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000829; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Devault A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-292; Eschenlauer SCP, 2006, FEMS MICROBIOL LETT, V260, P47, DOI 10.1111/j.1574-6968.2006.00303.x; Gelanew T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000889; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Halle M, 2009, J BIOL CHEM, V284, P6893, DOI 10.1074/jbc.M805861200; Hassan P, 2001, MOL BIOCHEM PARASIT, V113, P189, DOI 10.1016/S0166-6851(01)00220-1; Hilley JD, 2000, MOL BIOL CELL, V11, P1183, DOI 10.1091/mbc.11.4.1183; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jackson AP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-261; Jackson AP, 2010, MOL BIOL EVOL, V27, P33, DOI 10.1093/molbev/msp214; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2005, INT J PARASITOL, V35, P419, DOI 10.1016/j.ijpara.2004.12.014; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Noben-Trauth N, 2003, J IMMUNOL, V170, P5152, DOI 10.4049/jimmunol.170.10.5152; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Rougeron V, 2009, P NATL ACAD SCI USA, V106, P10224, DOI 10.1073/pnas.0904420106; Schuster-Bockler B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009474; Smith DF, 2007, INT J PARASITOL, V37, P1173, DOI 10.1016/j.ijpara.2007.05.015; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; Sterkers Y, 2011, CELL MICROBIOL, V13, P274, DOI 10.1111/j.1462-5822.2010.01534.x; Sunkin SM, 2000, MOL BIOCHEM PARASIT, V109, P1, DOI 10.1016/S0166-6851(00)00215-2; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; Wincker P, 1996, NUCLEIC ACIDS RES, V24, P1688, DOI 10.1093/nar/24.9.1688; Yamage M, 2000, J BIOL CHEM, V275, P36369, DOI 10.1074/jbc.M004036200; Zhang WW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000248; Zhang WW, 2010, MOL MICROBIOL, V77, P505, DOI 10.1111/j.1365-2958.2010.07230.x	54	267	273	0	24	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2011	21	12					2129	2142		10.1101/gr.122945.111			14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	860AU	WOS:000297918600013	22038252	Bronze, Green Published			2022-01-24	
J	Wong, LH; McGhie, JD; Sim, M; Anderson, MA; Ahn, S; Hannan, RD; George, AJ; Morgan, KA; Mann, JR; Choo, KHA				Wong, Lee H.; McGhie, James D.; Sim, Marcus; Anderson, Melissa A.; Ahn, Soyeon; Hannan, Ross D.; George, Amee J.; Morgan, Kylie A.; Mann, Jeffrey R.; Choo, K. H. Andy			ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells	GENOME RESEARCH			English	Article							MAMMALIAN-CELLS; PROTEIN ATRX; EPIGENETIC REGULATION; MENTAL-RETARDATION; HP1 PROTEINS; HETEROCHROMATIN; GENE; MUTATIONS; PHOSPHORYLATION; LOCALIZATION	ATRX (alpha thalassemia/mental retardation syndrome X-linked) belongs to the SWI2/SNF2 family of chromatin remodeling proteins. Besides the ATPase/helicase domain at its C terminus, it contains a PHD-like zinc finger at the N terminus. Mutations in the ATRX gene are associated with X-linked mental retardation (XLMR) often accompanied by alpha thalassemia (ATRX syndrome). Although ATRX has been postulated to be a transcriptional regulator, its precise roles remain undefined. We demonstrate ATRX localization at the telomeres in interphase mouse embryonic stem (ES) cells in synchrony with the incorporation of H3.3 during telomere replication at S phase. Moreover, we found that chromobox homolog 5 (CBX5) (also known as heterochromatin protein 1 alpha, or HP1 alpha) is also present at the telomeres in ES cells. We show by coimmunoprecipitation that this localization is dependent on the association of ATRX with histone H3.3, and that mutating the K4 residue of H3.3 significantly diminishes ATRX and H3.3 interaction. RNAi-knockdown of ATRX induces a telomere-dysfunction phenotype and significantly reduces CBX5 enrichment at the telomeres. These findings suggest a novel function of ATRX, working in conjunction with H3.3 and CBX5, as a key regulator of ES-cell telomere chromatin.	[Wong, Lee H.; McGhie, James D.; Sim, Marcus; Anderson, Melissa A.; Ahn, Soyeon; Mann, Jeffrey R.; Choo, K. H. Andy] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Paediat, Parkville, Vic 3052, Australia; [Hannan, Ross D.; George, Amee J.; Morgan, Kylie A.] Peter MacCallum Canc Ctr, Growth Control & Differentiat Program, Melbourne, Vic 3002, Australia; [Hannan, Ross D.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia		Wong, LH (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Paediat, Parkville, Vic 3052, Australia.	lee.wong@mcri.edu.au	Wong, Lee H/H-9757-2012	Wong, Lee H/0000-0002-4005-7330; George, Amee/0000-0002-0265-4476; Mann, Jeff/0000-0003-0028-8692; Hannan, Ross/0000-0002-2166-4493	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	We thank Jim McWhir for EG cell lines. This work was supported by the National Health and Medical Research Council of Australia.	Argentaro A, 2007, P NATL ACAD SCI USA, V104, P11939, DOI 10.1073/pnas.0704057104; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Berube NG, 2002, HUM MOL GENET, V11, P253, DOI 10.1093/hmg/11.3.253; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Cardoso C, 2000, J MED GENET, V37, P746, DOI 10.1136/jmg.37.10.746; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Guerrini R, 2000, ANN NEUROL, V47, P117; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jiang WQ, 2007, ONCOGENE, V26, P4635, DOI 10.1038/sj.onc.1210260; Jiang WQ, 2009, J CELL BIOL, V185, P797, DOI 10.1083/jcb.200810084; Kourmouli N, 2005, BIOCHEM BIOPH RES CO, V337, P901, DOI 10.1016/j.bbrc.2005.09.132; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Lu XJ, 1998, GENOMICS, V54, P241, DOI 10.1006/geno.1998.5578; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Sharma GG, 2003, MOL CELL BIOL, V23, P8363, DOI 10.1128/MCB.23.22.8363-8376.2003; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Wong LH, 2005, J BIOL CHEM, V280, P3954, DOI 10.1074/jbc.M410047200; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100	40	267	268	0	16	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	WOODBURY	500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA	1088-9051			GENOME RES	Genome Res.	MAR	2010	20	3					351	360		10.1101/gr.101477.109			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	563JJ	WOS:000275124600007	20110566	Green Published, Bronze			2022-01-24	
J	Zheng, P; Allen, WB; Roesler, K; Williams, ME; Zhang, S; Li, J; Glassman, K; Ranch, J; Nubel, D; Solawetz, W; Bhattramakki, D; Llaca, V; Deschamps, S; Zhong, GY; Tarczynski, MC; Shen, B				Zheng, Peizhong; Allen, William B.; Roesler, Keith; Williams, Mark E.; Zhang, Shirong; Li, Jiming; Glassman, Kimberly; Ranch, Jerry; Nubel, Douglas; Solawetz, William; Bhattramakki, Dinakar; Llaca, Victor; Deschamps, Stephane; Zhong, Gan-Yuan; Tarczynski, Mitchell C.; Shen, Bo			A phenylalanine in DGAT is a key determinant of oil content and composition in maize	NATURE GENETICS			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; EXPRESSION; SELECTION; PLANT	Plant oil is an important renewable resource for biodiesel production and for dietary consumption by humans and livestock. Through genetic mapping of the oil trait in plants, studies have reported multiple quantitative trait loci (QTLs) with small effects, but the molecular basis of oil QTLs remains largely unknown(1-5). Here we show that a high-oil QTL (qHO6) affecting maize seed oil and oleic-acid contents encodes an acyl-CoA: diacylglycerol acyltransferase (DGAT1-2), which catalyzes the final step of oil synthesis. We further show that a phenylalanine insertion in DGAT1-2 at position 469 (F469) is responsible for the increased oil and oleic-acid contents. The DGAT1-2 allele with F469 is ancestral, whereas the allele without F469 is a more recent mutant selected by domestication or breeding. Ectopic expression of the high-oil DGAT1-2 allele increases oil and oleic-acid contents by up to 41% and 107%, respectively. This work provides insights into the molecular basis of natural variation of oil and oleic-acid contents in plants and highlights DGAT as a promising target for increasing oil and oleic-acid contents in other crops.	[Zheng, Peizhong; Allen, William B.; Roesler, Keith; Zhang, Shirong; Li, Jiming; Glassman, Kimberly; Ranch, Jerry; Nubel, Douglas; Solawetz, William; Bhattramakki, Dinakar; Zhong, Gan-Yuan; Tarczynski, Mitchell C.; Shen, Bo] Pioneer HiBred Int Inc, Dupont Co, Johnston, IA 50131 USA; [Williams, Mark E.; Llaca, Victor; Deschamps, Stephane] Dupont Corp Genet Res, Expt Stn, Wilmington, DE 19880 USA		Shen, B (corresponding author), Pioneer HiBred Int Inc, Dupont Co, 7300 NW 62nd Ave,POB 1004, Johnston, IA 50131 USA.	Bo.Shen@pioneer.com	Deschamps, Stephane/R-3806-2019	Li, Jiming/0000-0003-4344-1896			ALREFAI R, 1995, GENOME, V38, P894, DOI 10.1139/g95-118; AN GH, 1989, PLANT CELL, V1, P115, DOI 10.1105/tpc.1.1.115; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; BERKE TG, 1995, CROP SCI, V35, P1542, DOI 10.2135/cropsci1995.0011183X003500060004x; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Clark D, 2006, CROP SCI, V46, P807, DOI 10.2135/cropsci2005.06-0153; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kinney AJ, 2002, BIOCHEM SOC T, V30, P1099, DOI 10.1042/BST0301099; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lambert R. J., 2004, Plant Breeding Reviews, V24, P153; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Mangolin CA, 2004, EUPHYTICA, V137, P251, DOI 10.1023/B:EUPH.0000041588.95689.47; Milcamps A, 2005, J BIOL CHEM, V280, P5370, DOI 10.1074/jbc.M410276200; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; PONELEIT CG, 1965, SCIENCE, V147, P1585, DOI 10.1126/science.147.3665.1585; Shen B, 2006, PLANT MOL BIOL, V60, P377, DOI 10.1007/s11103-005-4110-1; Song XF, 2004, MAYDICA, V49, P41; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; White P. J., 2003, Corn: chemistry and technology, P355; Zhao Zuo-yu, 2006, Methods Mol Biol, V318, P315	25	267	327	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					367	372		10.1038/ng.85			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	WOS:000253548400031	18278045				2022-01-24	
J	Herring, CD; Raghunathan, A; Honisch, C; Patel, T; Applebee, MK; Joyce, AR; Albert, TJ; Blattner, FR; van den Boom, D; Cantor, CR; Palsson, BO				Herring, Christopher D.; Raghunathan, Anu; Honisch, Christiane; Patel, Trina; Applebee, M. Kenyon; Joyce, Andrew R.; Albert, Thomas J.; Blattner, Frederick R.; van den Boom, Dirk; Cantor, Charles R.; Palsson, Bernhard O.			Comparative genome sequencing of Escherichia coli allows observation of bacterial evolution on a laboratory timescale	NATURE GENETICS			English	Article							ADAPTIVE EVOLUTION; GLYCEROL KINASE; GROWTH PHENOTYPES; ADAPTATION; MUTATIONS; PROTEIN; DISSIMILATION; POPULATION; VIRUS	We applied whole-genome resequencing of Escherichia coli to monitor the acquisition and fixation of mutations that conveyed a selective growth advantage during adaptation to a glycerol-based growth medium. We identified 13 different de novo mutations in five different E. coli strains and monitored their fixation over a 44-d period of adaptation. We obtained proof that the observed spontaneous mutations were responsible for improved fitness by creating single, double and triple site-directed mutants that had growth rates matching those of the evolved strains. The success of this new genome-scale approach indicates that real-time evolution studies will now be practical in a wide variety of contexts.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Nimblegan Syst Inc, Madison, WI 53711 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; CUNY Mt Sinai Sch Med, Div Infect Dis, New York, NY 10029 USA		Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	bpalsson@bioeng.ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785; Herring, Christopher/0000-0003-1621-5906	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM074590, R01GM062791] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM62791, 1F32GM074590-01] Funding Source: Medline		Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Dobrindt U, 2002, CURR TOP MICROBIOL, V264, P157; Dominique SA, 2004, RES MICROBIOL, V155, P319, DOI 10.1016/j.resmic.2003.12.008; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Eppler T, 2002, J BACTERIOL, V184, P3044, DOI 10.1128/JB.184.11.3044-3052.2002; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Holtman CK, 2001, J BACTERIOL, V183, P3336, DOI 10.1128/JB.183.11.3336-3344.2001; Honisch C, 2004, GENOME RES, V14, P2495, DOI 10.1101/gr.2977704; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; JANSON CA, 1974, J BIOL CHEM, V249, P2562; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; LIU WZ, 1994, BIOCHEMISTRY-US, V33, P10120, DOI 10.1021/bi00199a040; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller BG, 2004, BIOCHEMISTRY-US, V43, P6387, DOI 10.1021/bi049424m; Pelosi L, 2006, GENETICS, V173, P1851, DOI 10.1534/genetics.105.049619; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Ross P, 2000, BIOTECHNIQUES, V29, P620, DOI 10.2144/00293rr05; ROTH JR, 1996, ESCHERICHIA COLI SAL, P2256; SAIER MH, 1996, ESCHERICHIA COLI SAL, V1, P1325; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Zeyl C, 2005, GENETICS, V169, P1825, DOI 10.1534/genetics.104.027102; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970	35	267	276	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1406	1412		10.1038/ng1906			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	WOS:000242404200017	17086184	Bronze			2022-01-24	
J	Lopez, LC; Schuelke, M; Quinzii, CM; Kanki, T; Rodenburg, RJT; Naini, A; DiMauro, S; Hirano, M				Lopez, Luis Carlos; Schuelke, Markus; Quinzii, Catarina M.; Kanki, Tomotake; Rodenburg, Richard J. T.; Naini, Ali; DiMauro, Salvatore; Hirano, Michio			Leigh syndrome with nephropathy and CoQ(10) deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME Q(10) DEFICIENCY; CEREBELLAR-ATAXIA; MITOCHONDRIAL ENCEPHALOMYOPATHY; MYOPATHY; PROTEIN	Coenzyme Q(10) (CoQ(10)) is a vital lipophilic molecule that transfers electrons from mitochondrial respiratory chain complexes I and II to complex III. Deficiency of CoQ(10) has been associated with diverse clinical phenotypes, but, in most patients, the molecular cause is unknown. The first defect in a CoQ(10) biosynthetic gene, COQ2, was identified in a child with encephalomyopathy and nephrotic syndrome and in a younger sibling with only nephropathy. Here, we describe an infant with severe Leigh syndrome, nephrotic syndrome, and CoQ(10) deficiency in muscle and fibroblasts and compound heterozygous mutations in the PDSS2 gene, which encodes a subunit of decaprenyl diphosphate synthase, the first enzyme of the CoQ(10) biosynthetic pathway. Biochemical assays with radiolabeled substrates indicated a severe defect in decaprenyl diphosphate synthase in the patient's fibroblasts. This is the first description of pathogenic mutations in PDSS2 and confirms the molecular and clinical heterogeneity of primary CoQ(10) deficiency.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Virchow Univ Hosp Berlin, Charite, Dept Neuropediat, Berlin, Germany; Univ Nijmegen, Radboud Med Ctr, Ctr Mitochondrial Disorders, Nijmegen, Netherlands		Hirano, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St,P&S 4-443, New York, NY 10032 USA.	mh29@columbia.edu	Rodenburg, Richard/N-3579-2014; Lopez, Luis Carlos/AAP-9411-2020; Kanki, Tomotake/H-7250-2012; Lopez, Luis Carlos/L-5129-2014	Rodenburg, Richard/0000-0001-5227-3527; Lopez, Luis Carlos/0000-0003-3355-0298; Kanki, Tomotake/0000-0001-9646-5379; Lopez, Luis Carlos/0000-0003-3355-0298; Schuelke, Markus/0000-0003-2824-3891	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057543, P01HD032062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS011766, P01NS011766] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD032062, R01 HD057543, HD32062] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS11766, P01 NS011766] Funding Source: Medline		Artuch R, 2006, J NEUROL SCI, V246, P153, DOI 10.1016/j.jns.2006.01.021; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c; Kawamukai M, 2002, J BIOSCI BIOENG, V94, P511, DOI 10.1016/S1389-1723(02)80188-8; Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317; Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC; Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849; Naini A, 2003, BIOFACTORS, V18, P145, DOI 10.1002/biof.5520180217; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58; Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Saiki R, 2005, FEBS J, V272, P5606, DOI 10.1111/j.1742-4658.2005.04956.x; Saiki R, 2003, EUR J BIOCHEM, V270, P4113, DOI 10.1046/j.1432-1033.2003.03804.x; Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7; Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371	21	267	279	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1125	1129		10.1086/510023			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	WOS:000242131600015	17186472	Green Published, Bronze			2022-01-24	
J	Jordanova, A; Irobi, J; Thomas, FP; Van Dijck, P; Meerschaert, K; Dewil, M; Dierick, I; Jacobs, A; De Vriendt, E; Guergueltcheva, V; Rao, CV; Tournev, I; Gondim, FAA; D'Hooghe, M; Van Gerwen, V; Callaerts, P; Van den Bosch, L; Timmermans, JPR; Robberecht, W; Gettemans, J; Thevelein, JM; De Jonghe, P; Kremensky, I; Timmerman, V				Jordanova, A; Irobi, J; Thomas, FP; Van Dijck, P; Meerschaert, K; Dewil, M; Dierick, I; Jacobs, A; De Vriendt, E; Guergueltcheva, V; Rao, CV; Tournev, I; Gondim, FAA; D'Hooghe, M; Van Gerwen, V; Callaerts, P; Van den Bosch, L; Timmermans, JPR; Robberecht, W; Gettemans, J; Thevelein, JM; De Jonghe, P; Kremensky, I; Timmerman, V			Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy	NATURE GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; SITE-DIRECTED MUTAGENESIS; AMINO-ACID; ENZYME STRUCTURE; CYTOKINE; DISEASE; LOCALIZATION; TRANSLATION; MUTATIONS; HOMOLOGY	Charcot-Marie-Tooth (CMT) neuropathies are common disorders of the peripheral nervous system caused by demyelination or axonal degeneration, or a combination of both features. We previously assigned the locus for autosomal dominant intermediate CMT neuropathy type C (DI-CMTC) to chromosome 1p34-p35. Here we identify two heterozygous missense mutations (G41R and E196K) and one de novo deletion ( 153 - 156delVKQV) in tyrosyl-tRNA synthetase (YARS) in three unrelated families affected with DI-CMTC. Biochemical experiments and genetic complementation in yeast show partial loss of aminoacylation activity of the mutant proteins, and mutations in YARS, or in its yeast ortholog TYS1, reduce yeast growth. YARS localizes to axonal termini in differentiating primary motor neuron and neuroblastoma cultures. This specific distribution is significantly reduced in cells expressing mutant YARS proteins. YARS is the second aminoacyl-tRNA synthetase found to be involved in CMT, thereby linking protein-synthesizing complexes with neurodegeneration.	Univ Antwerp Flanders Interuniv Inst Biotechnol, Dept Mol Genet, B-2610 Antwerp, Belgium; Med Univ Sofia, Lab Mol Pathol, Sofia 1431, Bulgaria; St Louis Univ, Dept Neurol, St Louis, MO 63110 USA; St Louis Univ, St Louis Vet Affairs Med Ctr, Spinal cord Injury Serv, Inst Mol Virol,Dept Mol Microbiol & Immunol, St Louis, MO 63110 USA; Univ Leuven Flanders Interuniv Inst Biotechnol, Mol Cell Biol Lab, Dept Mol Microbiol, B-3001 Louvain, Belgium; Univ Ghent Flanders Interuniv Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; Univ Leuven, Dept Expt Neurol, Neurobiol Lab, B-3000 Louvain, Belgium; Med Univ Sofia, Dept Neurol, Sofia 1431, Bulgaria; St Jan Hosp, Dept Neurol, B-8000 Brugge, Belgium; Univ Leuven Flanders Interuniv Inst Biotechnol, Dept Human Genet, Lab Dev Genet, B-3000 Louvain, Belgium; Univ Leuven Flanders Interuniv Inst Biotechnol, Dept Biol, Lab Dev Genet, B-3000 Louvain, Belgium; Univ Antwerp, Cell Biol & Histol Lab, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, B-2650 Antwerp, Belgium		Timmerman, V (corresponding author), Univ Antwerp Flanders Interuniv Inst Biotechnol, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Thevelein, Johan M./AAK-4203-2021; Callaerts, Patrick/I-8118-2013; Van Den Bosch, Ludo/B-7258-2012; Timmerman, Vincent/O-7283-2019; Jordanova, Albena/H-8323-2015; Thevelein, Johan M./A-7897-2013; de Assis Gondim, Francisco/J-1463-2014; Thomas, Florian P/AAL-3813-2020	Timmerman, Vincent/0000-0002-2162-0933; Jordanova, Albena/0000-0002-3833-3754; Thevelein, Johan M./0000-0002-2626-0180; de Assis Gondim, Francisco/0000-0002-8957-5796; Callaerts, Patrick/0000-0003-4530-4561; Van Den Bosch, Ludo/0000-0003-0104-4067; Timmermans, Jean-Pierre/0000-0003-2506-6252			Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; BARBARESE E, 1995, J CELL SCI, V108, P2781; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Gaete J, 1998, NEUROSCI LETT, V251, P197, DOI 10.1016/S0304-3940(98)00538-2; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; Kennerson ML, 2001, AM J HUM GENET, V69, P883, DOI 10.1086/323743; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Nair S, 1997, J MOL BIOL, V269, P1, DOI 10.1006/jmbi.1997.1025; Ohno S, 2001, J BIOCHEM-TOKYO, V130, P417, DOI 10.1093/oxfordjournals.jbchem.a003001; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Tanghe A, 2002, APPL ENVIRON MICROB, V68, P5981, DOI 10.1128/AEM.68.12.5981-5989.2002; Van Damme P, 2003, J NEUROSCI, V23, P4942; Verhoeven K, 2001, AM J HUM GENET, V69, P889, DOI 10.1086/323742; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0; Yang XL, 2004, TRENDS BIOCHEM SCI, V29, P250, DOI 10.1016/j.tibs.2004.03.002; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	30	267	277	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2006	38	2					197	202		10.1038/ng1727			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	WOS:000234953200014	16429158	Green Published			2022-01-24	
J	Ekman, D; Light, S; Bjorklund, AK; Elofsson, A				Ekman, Diana; Light, Sara; Bjorklund, Asa K.; Elofsson, Arne			What properties characterize the hub proteins of the protein-protein interaction network of Saccharomyces cerevisiae?	GENOME BIOLOGY			English	Article							INTRINSIC DISORDER; SIMPLE DEPENDENCE; EVOLUTION RATE; COG DATABASE; 3 KINGDOMS; NUMBER; DUPLICATION; MODULARITY; DISCOVERY; TOPOLOGY	Background: Most proteins interact with only a few other proteins while a small number of proteins (hubs) have many interaction partners. Hub proteins and non-hub proteins differ in several respects; however, understanding is not complete about what properties characterize the hubs and set them apart from proteins of low connectivity. Therefore, we have investigated what differentiates hubs from non-hubs and static hubs (party hubs) from dynamic hubs (date hubs) in the protein-protein interaction network of Saccharomyces cerevisiae. Results: The many interactions of hub proteins can only partly be explained by bindings to similar proteins or domains. It is evident that domain repeats, which are associated with binding, are enriched in hubs. Moreover, there is an over representation of multi-domain proteins and long proteins among the hubs. In addition, there are clear differences between party hubs and date hubs. Fewer of the party hubs contain long disordered regions compared to date hubs, indicating that these regions are important for flexible binding but less so for static interactions. Furthermore, party hubs interact to a large extent with each other, supporting the idea of party hubs as the cores of highly clustered functional modules. In addition, hub proteins, and in particular party hubs, are more often ancient. Finally, the more recent paralogs of party hubs are underrepresented. Conclusion: Our results indicate that multiple and repeated domains are enriched in hub proteins and, further, that long disordered regions, which are common in date hubs, are particularly important for flexible binding.	Stockholm Univ, Stockholm Bioinformat Ctr, S-10691 Stockholm, Sweden		Elofsson, A (corresponding author), Stockholm Univ, Stockholm Bioinformat Ctr, S-10691 Stockholm, Sweden.	arne@sbc.su.se	Bjorklund, Asa/J-4587-2013	Bjorklund, Asa/0000-0003-2224-7090; Elofsson, Arne/0000-0002-7115-9751			Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apic G, 2005, FEBS LETT, V579, P1872, DOI 10.1016/j.febslet.2005.02.023; Bjorklund AK, 2005, J MOL BIOL, V353, P911, DOI 10.1016/j.jmb.2005.08.067; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; DOLINSKI K, 2002, METHOD ENZYMOL, V266, P554; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; EDDY SR, HMMER HIDDEN MARKOV; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldovsky Leon, 2005, Appl Bioinformatics, V4, P71, DOI 10.2165/00822942-200504010-00009; Grigoriev A, 2003, NUCLEIC ACIDS RES, V31, P4157, DOI 10.1093/nar/gkg466; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Kunin V, 2004, MOL BIOL EVOL, V21, P1171, DOI 10.1093/molbev/msh085; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Malhotra R, 2001, P NATL ACAD SCI USA, V98, P12342, DOI 10.1073/pnas.231384098; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Pereira-Leal JB, 2005, GENOME RES, V15, P552, DOI 10.1101/gr.3102105; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Qin H, 2003, P NATL ACAD SCI USA, V100, P12820, DOI 10.1073/pnas.2235584100; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Uetz P, 2005, FEBS LETT, V579, P1821, DOI 10.1016/j.febslet.2005.02.001; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; 1998, MOL BIOL EVOL, V9, P3273	52	267	271	1	17	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2006	7	6							R45	10.1186/gb-2006-7-6-r45			13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	094MP	WOS:000241243800010	16780599	Green Published, hybrid			2022-01-24	
J	Cunningham, JM; Kim, CY; Christensen, ER; Tester, DJ; Parc, Y; Burgart, LJ; Halling, KC; McDonnell, SK; Schaid, DJ; Vockley, CW; Kubly, V; Nelson, H; Michels, VV; Thibodeau, SN				Cunningham, JM; Kim, CY; Christensen, ER; Tester, DJ; Parc, Y; Burgart, LJ; Halling, KC; McDonnell, SK; Schaid, DJ; Vockley, CW; Kubly, V; Nelson, H; Michels, VV; Thibodeau, SN			The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPORADIC ENDOMETRIAL CARCINOMA; NONPOLYPOSIS COLON-CANCER; MICROSATELLITE INSTABILITY; MOLECULAR-GENETICS; GERMLINE MUTATIONS; FAMILY HISTORY; GASTRIC-CANCER; HMLH1 PROMOTER; EARLY-ONSET; HNPCC	A comprehensive analysis of somatic and germline mutations related to DNA mismatch-repair (MMR) genes can clarify the prevalence and mechanism of inactivation in colorectal carcinoma (CRC). In the present study, 257 unselected patients referred for CRC resection were examined for evidence of defective DNA MMR. In particular, we sought to determine the frequency of hereditary defects in DNA MMR in this cohort of patients. MMR status was assessed by testing of tumors for the presence or absence of hMLH1, hMSH2, and hMSH6 protein expression and for microsatellite instability (MSI). Of the 257 patients, 51 (20%) had evidence of defective MMR, demonstrating high levels of MSI (MSI-H) and an absence of either hMLH1 (n=48) or hMSH2 (n=3). All three patients lacking hMSH2, as well as one patient lacking hMLH1, also demonstrated an absence of hMSH6. DNA sequence analysis of the 51 patients with defective MMR revealed seven germline mutations-four in hMLH1 (two truncating and two missense) and three in hMSH2 (all truncating). A detailed family history was available for 225 of the 257 patients. Of the seven patients with germline mutations, only three had family histories consistent with hereditary nonpolyposis colorectal cancer. Of the remaining patients who had tumors with defective MMR, eight had somatic mutations in hMLH1. In addition, hypermethylation of the hMLH1 gene promoter was present in 37 (88%) of the 42 hMLH1-negative cases available for study and in all MSI-H tumors that showed loss of hMLH1 expression but no detectable hMLH1 mutations. Our results suggest that, although defective DNA MMR occurs in 20% of unselected patients presenting for CRC resection, hereditary CRC due to mutations in the MMR pathway account for only a small proportion of patients. Of the 257 patients, only 5 (1.9%) appear to have unequivocal evidence of hereditary defects in MMR. The epigenetic (nonhereditary) mechanism of hMLH1 promoter hypermethylation appears to be responsible for the majority of the remaining patients whose tumors are characterized by defective DNA MMR.	Mayo Clin & Mayo Fdn, Genet Lab, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Surg, Rochester, MN 55905 USA		Thibodeau, SN (corresponding author), Mayo Clin & Mayo Fdn, Genet Lab, Dept Lab Med & Pathol, HI 970,200 1st St SW, Rochester, MN 55905 USA.	sthibodeau@mayo.edu		McDonnell, Shannon/0000-0001-6201-369X	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA68535] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA068535] Funding Source: NIH RePORTER		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; AALTONEN LA, 1994, CANCER DETECT PREV, V18, P57; Akiyama Y, 1996, JPN J CANCER RES, V87, P595, DOI 10.1111/j.1349-7006.1996.tb00265.x; ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; Bapat BV, 1999, HUM GENET, V104, P167, DOI 10.1007/s004390050931; Battista P, 1997, INT J ONCOL, V10, P65; Beck NE, 1997, BRIT J SURG, V84, P233, DOI 10.1002/bjs.1800840228; Beck NE, 1997, GUT, V41, P235, DOI 10.1136/gut.41.2.235; Bellacosa A, 1996, AM J MED GENET, V62, P353, DOI 10.1002/(SICI)1096-8628(19960424)62:4<353::AID-AJMG7>3.0.CO;2-S; Boland CR, 1998, CANCER RES, V58, P5248; Brassett C, 1996, J MED GENET, V33, P981, DOI 10.1136/jmg.33.12.981; BURKS RT, 1994, ONCOGENE, V9, P1163; Caduff RF, 1996, AM J PATHOL, V148, P1671; Craanen ME, 1996, SCAND J GASTROENTERO, V31, P92, DOI 10.3109/00365529609094737; Cunningham JM, 1998, CANCER RES, V58, P3455; DUGGAN BD, 1994, J NATL CANCER I, V86, P1216, DOI 10.1093/jnci/86.16.1216; Evans DGR, 1997, BRIT J SURG, V84, P1281; Fante R, 1997, AM J GASTROENTEROL, V92, P1505; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R., 1994, CELL, V77, P167; Fujita S, 1996, JPN J CLIN ONCOL, V26, P351, DOI 10.1093/oxfordjournals.jjco.a023244; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Gurin CC, 1999, CANCER RES, V59, P462; HAN HJ, 1993, CANCER RES, V53, P5087; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Iino H, 2000, GUT, V47, P37, DOI 10.1136/gut.47.1.37; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; KELLER G, 1995, AM J PATHOL, V147, P593; Khine K., 1996, Annals Academy of Medicine Singapore, V25, P64; Lamberti C, 1999, GUT, V44, P839, DOI 10.1136/gut.44.6.839; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; Lipkin SM, 2001, HUM MUTAT, V17, P389, DOI 10.1002/humu.1114; LYNCH HT, 1995, TUMORI, V81, P19; Lynch HT, 1997, CANCER GENET CYTOGEN, V93, P84, DOI 10.1016/S0165-4608(96)00290-7; Lynch HT, 1998, NEW ENGL J MED, V338, P1537, DOI 10.1056/NEJM199805213382109; Moslein G, 1996, HUM MOL GENET, V5, P1245, DOI 10.1093/hmg/5.9.1245; Nakashima H, 1997, ONCOL REP, V4, P387; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; Parc YR, 2000, CANCER RES, V60, P2225; Peel DJ, 2000, J NATL CANCER I, V92, P1517, DOI 10.1093/jnci/92.18.1517; Pistorius SR, 2000, INT J COLORECTAL DIS, V15, P255; Planck M, 2000, GENE CHROMOSOME CANC, V29, P33, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1004>3.0.CO;2-R; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Sankila R, 1996, GASTROENTEROLOGY, V110, P682, DOI 10.1053/gast.1996.v110.pm8608876; Soravia C, 1997, SCHWEIZ MED WSCHR, V127, P682; Thibodeau SN, 1998, CANCER RES, V58, P1713; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612; Yin J, 1997, HUM MUTAT, V10, P474, DOI 10.1002/(SICI)1098-1004(1997)10:6<474::AID-HUMU9>3.3.CO;2-Z	55	267	273	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					780	790		10.1086/323658			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	WOS:000171008200011	11524701	Bronze, Green Published			2022-01-24	
J	Kijas, JMH; Wales, R; Tornsten, A; Chardon, P; Moller, M; Andersson, L				Kijas, JMH; Wales, R; Tornsten, A; Chardon, P; Moller, M; Andersson, L			Melanocortin receptor 1 (MC1R) mutations and coat color in pigs	GENETICS			English	Article							STIMULATING-HORMONE-RECEPTOR; MSH RECEPTOR; GENE; EXTENSION; VARIANT; AGOUTI; MODEL; LOCUS; MAP	The melanocortin receptor 1 (MC1R) plays a central role in regulation of eumelanin (black/brown) and phaeomelanin (red/yellow) synthesis within the mammalian melanocyte and is encoded by the classical Extension (E) coat color locus. Sequence analysis of MC1R from seven porcine breeds revealed a total of four allelic variants corresponding to five different E alleles. The European wild boar possessed a unique MC1R allele that we believe is required for the expression of a wild-type coat color. Two different MCIR alleles were associated with the dominant black color in pigs. MC1R*2 was found in European Large Black and Chinese Meishan pigs and exhibited two missense mutations compared with the wild-type sequence. Comparative data strongly suggest that one of these, L99P, may form a constitutively active receptor. MC1R*3 was associated with the black color in the Hampshire breed and involved a single missense mutation D121N. This same MCIR variant was also associated with E-p, which results in black spots on a white or red background. Two different missense mutations were identified in recessive red (e/e) animals. One of these, A240T, occurs at a highly conserved position, making it a strong candidate for disruption of receptor function.	Swedish Univ Agr Sci, Ctr Biomed, Dept Anim Breeding & Genet, S-75124 Uppsala, Sweden; Pig Improvement Co, Mol Biol Grp, Cambridge CB1 2JN, England; INRA, Commiss Energie Atom Radiolbiol Appl, Lab Mixte, F-78352 Jouy En Josas, France		Andersson, L (corresponding author), Swedish Univ Agr Sci, Ctr Biomed, Dept Anim Breeding & Genet, Box 597, S-75124 Uppsala, Sweden.	leif.andersson@bmc.uu.se	Kijas, James W/A-4656-2011	Kijas, James W/0000-0002-1417-8278; Moller, Maria/0000-0001-9750-6101			BOX NF, 1997, HU MOL GENET, V6, P1892; CHOWDHARY BP, 1995, CYTOGENET CELL GENET, V71, P175, DOI 10.1159/000134101; Green P., 1990, DOCUMENTATION CRIMAP; GUSTAVSSON I, 1988, HEREDITAS, V109, P151, DOI 10.1111/j.1601-5223.1988.tb00351.x; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; JOHANSSON M, 1992, GENOMICS, V14, P965, DOI 10.1016/S0888-7543(05)80118-1; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Koppula SV, 1997, HUM MUTAT, V9, P30, DOI 10.1002/(SICI)1098-1004(1997)9:1<30::AID-HUMU5>3.3.CO;2-5; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Mariani P, 1996, J HERED, V87, P272, DOI 10.1093/oxfordjournals.jhered.a023000; Marklund L, 1996, ANIM GENET, V27, P255, DOI 10.1111/j.1365-2052.1996.tb00487.x; Marklund L, 1996, MAMM GENOME, V7, P895, DOI 10.1007/s003359900264; OLLIVIER L, 1982, ANN GENET SEL ANIM, V14, P481, DOI 10.1186/1297-9686-14-4-481; PAVAN WJ, 1995, GENOME RES, V5, P29, DOI 10.1101/gr.5.1.29; Porter V, 1993, PIGS HDB BREEDS WORL; PRUSIS P, 1995, BIOCHEM BIOPH RES CO, V210, P205, DOI 10.1006/bbrc.1995.1647; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rohrer GA, 1996, GENOME RES, V6, P371, DOI 10.1101/gr.6.5.371; SEARLE AG, 1968, COMP GEN COAT COLOUR; TAKEUCHI S, 1997, BIOCHIM BIOPHYS ACTA, V1308, P164; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Xu XL, 1996, NAT GENET, V14, P384, DOI 10.1038/ng1296-384	24	267	291	0	25	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	NOV	1998	150	3					1177	1185					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	135ND	WOS:000076807800020	9799269				2022-01-24	
J	MARTINI, R; ZIELASEK, J; TOYKA, KV; GIESE, KP; SCHACHNER, M				MARTINI, R; ZIELASEK, J; TOYKA, KV; GIESE, KP; SCHACHNER, M			PROTEIN ZERO (P0)-DEFICIENT MICE SHOW MYELIN DEGENERATION IN PERIPHERAL-NERVES CHARACTERISTIC OF INHERITED HUMAN NEUROPATHIES	NATURE GENETICS			English	Article							PO GENE; SENSORY NEUROPATHY; HEREDITARY MOTOR; EXPRESSION; MUTATION; TYPE-1B; HYPOMYELINATION; TENASCIN	Mutations in the human gene for the myelin recognition molecule protein zero (P0) give rise to severe and progressive forms of dominantly inherited peripheral neuropathies. We have previously reported that mice homozygous for a null mutation in P0 have severely hypomyelinated nerves ten weeks after birth. Here we show hypomyelination already exists at day four with subsequent demyelination and impaired nerve conduction. Furthermore, heterozygous mutants show normal myelination, but develop progressive demyelination after four months of age. Thus, the pathology of homo- and heterozygous P0 mutants resembles that of the severely affected Dejerine-Sottas and the more mildly affected Charcot-Marie-Tooth type 1B patients, respectively.	UNIV WURZBURG,NEUROL KLIN,D-97080 WURZBURG,GERMANY		MARTINI, R (corresponding author), SWISS FED INST TECHNOL,DEPT NEUROBIOL,CH-8093 ZURICH,SWITZERLAND.		Giese, Karl P/A-3112-2011	Giese, Karl P/0000-0003-4503-7344; Martini, Rudolf/0000-0002-5463-5592			ADIKOFER K, 1995, NAT GENET, V11, P274; Dyck PJ, 1993, PERIPHERAL NEUROPATH, P1094; FRUTTIGER M, 1995, J NEUROCYTOL, V24, P1, DOI 10.1007/BF01370156; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; HARTUNG HP, 1988, BRAIN, V111, P1039, DOI 10.1093/brain/111.5.1039; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HAYASAKA K, 1993, BIOCHEM BIOPH RES CO, V194, P1317, DOI 10.1006/bbrc.1993.1968; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; HAYASAKA K, 1993, HUM MOL GENET, V2, P1369, DOI 10.1093/hmg/2.9.1369; HIMORO M, 1993, BIOCHEM MOL BIOL INT, V31, P169; HOOGENDIJK JE, 1995, J NEUROL, V242, P149; HUSMANN K, 1992, J CELL BIOL, V116, P1475, DOI 10.1083/jcb.116.6.1475; KIRSCHNER DA, 1994, J NEUROSCI RES, V39, P63, DOI 10.1002/jnr.490390109; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; Landon D.N, 1976, PERIPHERAL NERVE, P1; MARTINI R, 1990, J NEUROCYTOL, V19, P601, DOI 10.1007/BF01257247; MARTINI R, J NEUROSCI, V15, P4488; MITCHELL LS, 1990, J NEUROSCI RES, V27, P125, DOI 10.1002/jnr.490270202; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; NELIS E, 1994, J MED GENET, V31, P811, DOI 10.1136/jmg.31.10.811; OUVRIER RA, 1987, BRAIN, V110, P121, DOI 10.1093/brain/110.1.121; RAUTENSTRAUSS B, 1994, HUM MOL GENET, V3, P1701, DOI 10.1093/hmg/3.9.1701; REYNOLDS RJ, 1994, J NEUROCYTOL, V23, P555, DOI 10.1007/BF01262056; SHINE HD, 1992, J NEUROCHEM, V58, P342, DOI 10.1111/j.1471-4159.1992.tb09316.x; SU Y, 1993, P NATL ACAD SCI USA, V90, P10856, DOI 10.1073/pnas.90.22.10856; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; TACHI N, 1984, BRAIN DEV-JPN, V6, P560, DOI 10.1016/S0387-7604(84)80101-1; UCHIDA Y, 1985, J NEUROCHEM, V46, P1376	31	267	267	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					281	286		10.1038/ng1195-281			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	WOS:A1995TC63900016	7581451				2022-01-24	
J	FERNANDEZSALGUERO, P; HOFFMAN, SMG; CHOLERTON, S; MOHRENWEISER, H; RAUNIO, H; RAUTIO, A; PELKONEN, O; HUANG, JD; EVANS, WE; IDLE, JR; GONZALEZ, FJ				FERNANDEZSALGUERO, P; HOFFMAN, SMG; CHOLERTON, S; MOHRENWEISER, H; RAUNIO, H; RAUTIO, A; PELKONEN, O; HUANG, JD; EVANS, WE; IDLE, JR; GONZALEZ, FJ			A GENETIC-POLYMORPHISM IN COUMARIN 7-HYDROXYLATION - SEQUENCE OF THE HUMAN CYP2A GENES AND IDENTIFICATION OF VARIANT CYP2A6 ALLELES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-LIVER-MICROSOMES; CYTOCHROME-P450; SUPERFAMILY; METABOLISM; EVOLUTION; SUBFAMILY; MOUSE; RAT	A group of human cytochrome P450 genes encompassing the CYP2A, CYP2B, and CYP2F subfamilies were cloned and assembled into a 350-kb contig localized on the long arm of chromosome 19. Three complete CYP2A genes-CYP2A6, CYP2A7, and CYP2A13-plus two pseudogenes truncated after exon 5, were identified and sequenced, A variant CYP2A6 allele that differed from the corresponding CYP2A6 and CYP2A7 cDNAs previously sequenced was found and was designated CYP2A6v2. Sequence differences in the CYP2A6v2 gene are restricted to regions encompassing exons 3, 6, and 8, which bear sequence relatedness with the corresponding exons of the CYP2A7 gene, located downstream and centromeric of CYP2A6v2, suggesting recent gene-conversion events, The sequencing of all the CYP2A genes allowed the design of a PCR diagnostic test for the normal CYP2A6 allele, the CYP2A6v2 allele, and a variant-designated CYP2A6v1-that encodes an enzyme with a single inactivating amino acid change. These variant alleles were found in individuals who were deficient in their ability to metabolize the CYP2A6 probe drug coumarin, The allelic frequencies of CYP2A6v1 and CYP2A6v2 differed significantly between Caucasian, Asian, and African-American populations, These studies establish the existence of a new cytochrome P450 genetic polymorphism.	NCI, BETHESDA, MD 20892 USA; LAWRENCE LIVERMORE NATL LAB, LIVERMORE, CA USA; UNIV NEWCASTLE UPON TYNE, SCH MED, DEPT PHARMACOL SCI, NEWCASTLE UPON TYNE, TYNE & WEAR, ENGLAND; UNIV OULU, DEPT PHARMACOL & TOXICOL, OULU, FINLAND; NATL CHENG KUNG UNIV, DEPT PHARMACOL, TAINAN 70101, TAIWAN; ST JUDE CHILDRENS RES HOSP, DEPT PHARMACEUT, MEMPHIS, TN 38105 USA				Pelkonen, Olavi R/F-7740-2012; Fernandez-Salguero, Pedro M./J-8437-2014; Evans, William E./C-2069-2012; Hoffman, Susan/K-1995-2019; Idle, Jeff/B-1152-2012	Fernandez-Salguero, Pedro M./0000-0003-2839-5027; Evans, William E./0000-0002-9333-5322; Idle, Jeff/0000-0002-6143-1520			BALE AE, 1991, GENOMICS, V10, P284, DOI 10.1016/0888-7543(91)90514-F; CARRANO AV, 1989, GENOMICS, V4, P129, DOI 10.1016/0888-7543(89)90291-7; CASHMAN JR, 1992, CHEM RES TOXICOL, V5, P639, DOI 10.1021/tx00029a008; CHOLERTON S, 1992, J CHROMATOGR-BIOMED, V575, P325, DOI 10.1016/0378-4347(92)80166-N; DING SH, 1995, BIOCHEM J, V306, P161, DOI 10.1042/bj3060161; EVANS WE, 1993, J CLIN INVEST, V91, P2150, DOI 10.1172/JCI116441; FERNANDEZSALGUE.P, 1995, PHARMACOGENETICS, V5, P123; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; GONZALEZ FJ, 1995, CANCER RES, V55, P710; GONZALEZ FJ, 1992, TRENDS PHARMACOL SCI, V13, P346, DOI 10.1016/0165-6147(92)90107-H; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; HOFFMAN SMG, IN PRESS J MOL EVOL; KAPITULNIK J, 1977, CLIN PHARMACOL THER, V21, P166; KEULS M., 1952, Euphytica, V1, P112, DOI 10.1007/BF01908269; LEVY KJ, 1975, EDUC PSYCHOL MEAS, V35, P599, DOI 10.1177/001316447503500308; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; MATSUNAGA E, 1990, J MOL EVOL, V30, P155, DOI 10.1007/BF02099942; MAURICE M, 1991, EUR J BIOCHEM, V200, P511, DOI 10.1111/j.1432-1033.1991.tb16212.x; McCracken N. W., 1992, Medical Science Research, V20, P877; MILES JS, 1990, BIOCHEM J, V267, P365, DOI 10.1042/bj2670365; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Newman D, 1939, BIOMETRIKA, V31, P20, DOI 10.1093/biomet/31.1-2.20; OHTA T, 1989, GENOME, V31, P304, DOI 10.1139/g89-048; PELKONEN O, 1985, BRIT J CLIN PHARMACO, V19, P59, DOI 10.1111/j.1365-2125.1985.tb02613.x; RAUNIO H, 1988, BIOCHEM PHARMACOL, V37, P3889, DOI 10.1016/0006-2952(88)90070-6; RAUTIO A, 1992, PHARMACOGENETICS, V2, P227, DOI 10.1097/00008571-199210000-00005; TURKEY JW, 1953, PRINCETON U PRINCETO; YAMANO S, 1990, BIOCHEMISTRY-US, V29, P1322, DOI 10.1021/bi00457a031; YUN CH, 1991, MOL PHARMACOL, V40, P679; Zar JH., 1984, BIOSTAT ANAL, P718	30	267	275	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					651	660					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	WOS:A1995RR60500015	7668294				2022-01-24	
J	MATSUO, T; OSUMIYAMASHITA, N; NOJI, S; OHUCHI, H; KOYAMA, E; MYOKAI, F; MATSUO, N; TANIGUCHI, S; DOI, H; ISEKI, S; NINOMIYA, Y; FUJIWARA, M; WATANABE, T; ETO, K				MATSUO, T; OSUMIYAMASHITA, N; NOJI, S; OHUCHI, H; KOYAMA, E; MYOKAI, F; MATSUO, N; TANIGUCHI, S; DOI, H; ISEKI, S; NINOMIYA, Y; FUJIWARA, M; WATANABE, T; ETO, K			A MUTATION IN THE PAX-6 GENE IN RAT SMALL-EYE IS ASSOCIATED WITH IMPAIRED MIGRATION OF MIDBRAIN CREST CELLS	NATURE GENETICS			English	Article							BETA-GLOBIN GENE; POINT MUTATION; SPLICE JUNCTION; NEURAL-TUBE; DEFECT; SITE; THALASSEMIA; DEFICIENCY; DELETION; DISEASE	The rat small eye strain (rSey) lacks eyes and nose in the homozygote, an is similar the mouse Sey strain with mutations in the Pax-6 gene. We isolated Pax-6 cDNA clones from an rSey homozygote library, and found an internal deletion of about 600 basepairs in the serine/threonine-rich domain. At the genomic level, a single base (G) insertion in an exon generates an abnormal 5' donor splice site, thereby producing the truncated mRNA. Anterior midbrain crest cells in the homozygous rSey embryos reached the eye rudiments but did not migrate any further to the nasal rudiments, suggesting that the Pax-6 gene is involved in conducting migration of neural crest cells from the anterior midbrain.	OKAYAMA UNIV,SCH MED,DEPT OPHTHALMOL,OKAYAMA 700,JAPAN; OKAYAMA UNIV,SCH DENT,DEPT BIOCHEM,OKAYAMA 700,JAPAN; TOKYO MED & DENT UNIV,GRAD SCH DENT,DEPT DEV BIOL,DIV LIFE SCI MAXILLOFACIAL SYST,TOKYO 113,JAPAN; UNIV TOKUSHIMA,FAC ENGN,DEPT BIOL SCI & TECHNOL,TOKUSHIMA 770,JAPAN; FUJITSU LABS LTD,IIAS,BIOL INFORMAT SECT,CHIBA 261,JAPAN; YAMANOUCHI PHARMACEUT CO LTD,SAFETY RES LABS,TOKYO 174,JAPAN				Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452; Ninomiya, Youichirou/0000-0003-3572-2532			ATWEH GF, 1987, BLOOD, V70, P147; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DOBKIN C, 1983, P NATL ACAD SCI-BIOL, V80, P1184, DOI 10.1073/pnas.80.5.1184; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FUKIISHI Y, 1992, CELL TISSUE RES, V268, P1, DOI 10.1007/BF00338048; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MOASE CE, 1991, DEVELOPMENT, V113, P1049; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NAKAJIMA H, 1990, J BIOL CHEM, V265, P9392; NAKANO T, 1989, J BIOL CHEM, V264, P5155; NELSON C, 1992, J BIOL CHEM, V267, P3351; NOJI S, 1989, FEBS LETT, V257, P93, DOI 10.1016/0014-5793(89)81794-6; OSUMIYAMASHITA N, 1992, CRANIOFAC GENET DEV, V12, P130; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; REES DJG, 1985, NATURE, V316, P643, DOI 10.1038/316643a0; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; SU TS, 1990, J BIOL CHEM, V265, P19716; TAKEUCHI T, 1990, ENDOCRINOLOGY, V126, P31, DOI 10.1210/endo-126-1-31; TAN SS, 1986, J EMBRYOL EXP MORPH, V98, P21; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TON CCT, 1991, CELL, V67, P1089; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435	34	267	270	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					299	304		10.1038/ng0493-299			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	WOS:A1993KW25700009	7981749				2022-01-24	
J	TUITE, MF; MUNDY, CR; COX, BS				TUITE, MF; MUNDY, CR; COX, BS			AGENTS THAT CAUSE A HIGH-FREQUENCY OF GENETIC CHANGE FROM [PSI+] TO [PSI-] IN SACCHAROMYCES-CEREVISIAE	GENETICS			English	Article									BOT SCH, OXFORD, ENGLAND				Tuite, Mick/ABC-7909-2020	Tuite, Mick/0000-0002-5214-540X			AMES BN, 1973, P NATL ACAD SCI USA, V70, P2281, DOI 10.1073/pnas.70.8.2281; BARCLAY BJ, 1978, MOL GEN GENET, V160, P33, DOI 10.1007/BF00275116; Burdette W.J., 1963, METHODOLOGY BASIC GE, P325; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; COX B. S., 1962, NEW PHYTOL, V61, P342, DOI 10.1111/j.1469-8137.1962.tb06305.x; COX BS, 1971, HEREDITY, V26, P211, DOI 10.1038/hdy.1971.28; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; COX BS, 1980, GENETICS, V95, P589; COX BS, 1977, GENET RES, V30, P187, DOI 10.1017/S0016672300017584; CULBERTSON MR, 1977, GENETICS, V86, P745; EPHRUSSI B, 1951, COLD SPRING HARB SYM, V16, P75, DOI 10.1101/SQB.1951.016.01.007; EVANS WE, 1975, HEREDITY, V35, P347, DOI 10.1038/hdy.1975.105; FINK GR, 1972, P NATL ACAD SCI USA, V69, P2846, DOI 10.1073/pnas.69.10.2846; FRIEND C, 1978, BIOCHEM PHARMACOL, V27, P1309, DOI 10.1016/0006-2952(78)90112-0; HURST DD, 1964, GENETICS, V50, P435; JULIANI MH, 1975, MUTAT RES, V29, P67, DOI 10.1016/0027-5107(75)90021-4; JULIANI MH, 1973, BIOCHEM BIOPH RES CO, V53, P531, DOI 10.1016/0006-291X(73)90694-3; LEVINE L, 1963, BIOCHEMISTRY-US, V2, P168, DOI 10.1021/bi00901a030; LIEBMAN SW, 1975, J MOL BIOL, V94, P595, DOI 10.1016/0022-2836(75)90324-1; MAHLER HR, 1974, P NATL ACAD SCI USA, V71, P2241, DOI 10.1073/pnas.71.6.2241; MCCREADY SJ, 1973, MOL GEN GENET, V124, P305, DOI 10.1007/BF00267660; MITCHELL DJ, 1976, HEREDITY, V37, P129, DOI 10.1038/hdy.1976.71; MOUSTACCHI E, 1963, CR HEBD ACAD SCI, V256, P5646; MUNDY CR, 1979, THESIS OXFORD U OXFO; NAGAI S, 1961, BACTERIOL REV, V25, P404, DOI 10.1128/MMBR.25.4.404-426.1961; NAKANISHI S, 1974, CELL, V3, P39, DOI 10.1016/0092-8674(74)90035-X; NEWLON CS, 1979, MOL GEN GENET, V169, P189, DOI 10.1007/BF00271670; OLIVER SG, 1976, MOL GEN GENET, V146, P253, DOI 10.1007/BF00701248; ONO BI, 1979, J MOL BIOL, V128, P81, DOI 10.1016/0022-2836(79)90309-7; PUTRAMENT A, 1973, MOL GEN GENET, V126, P357, DOI 10.1007/BF00269445; SHERMAN F, 1956, EXP CELL RES, V11, P659, DOI 10.1016/0014-4827(56)90180-X; SHERMAN F, 1959, J CELL COMPAR PHYSL, V54, P37, DOI 10.1002/jcp.1030540106; SINGH A, 1979, P NATL ACAD SCI USA, V76, P1952, DOI 10.1073/pnas.76.4.1952; SINGH DR, 1976, MUTAT RES, V37, P193, DOI 10.1016/0027-5107(76)90033-6; SKOTNICKI ML, 1977, J BACTERIOL, V130, P939, DOI 10.1128/JB.130.2.939-942.1977; SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3; SOMERS JM, 1969, GENET RES, V13, P71, DOI 10.1017/S0016672300002743; THOMAS DY, 1968, BIOCHEM BIOPH RES CO, V30, P368, DOI 10.1016/0006-291X(68)90753-5; TUITE MF, 1980, GENETICS, V95, P611; TUITE MF, 1978, THESIS OXFORD U OXFO; VODKIN M, 1977, J BACTERIOL, V132, P346, DOI 10.1128/JB.132.1.346-348.1977; WICKNER RB, 1974, J BACTERIOL, V117, P1356, DOI 10.1128/JB.117.3.1356-1357.1974; WILLIAMSON DH, 1971, MOL GEN GENET, V111, P209, DOI 10.1007/BF00433106; YEE B, 1972, BIOCHEM BIOPH RES CO, V49, P1336, DOI 10.1016/0006-291X(72)90613-4; YOUNG CSH, 1971, HEREDITY, V26, P413, DOI 10.1038/hdy.1971.52; YOUNG CSH, 1969, THESIS OXFORD U OXFO	46	267	274	0	1	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1981	98	4					691	711					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MX824	WOS:A1981MX82400002	7037537				2022-01-24	
J	Ho, AS; Kannan, K; Roy, DM; Morris, LGT; Ganly, I; Katabi, N; Ramaswami, D; Walsh, LA; Eng, S; Huse, JT; Zhang, JN; Dolgalev, I; Huberman, K; Heguy, A; Viale, A; Drobnjak, M; Leversha, MA; Rice, CE; Singh, B; Iyer, NG; Leemans, CR; Bloemena, E; Ferris, RL; Seethala, RR; Gross, BE; Liang, YP; Sinha, R; Peng, LK; Raphael, BJ; Turcan, S; Gong, YX; Schultz, N; Kim, S; Chiosea, S; Shah, JP; Sander, C; Lee, W; Chan, TA				Ho, Allen S.; Kannan, Kasthuri; Roy, David M.; Morris, Luc G. T.; Ganly, Ian; Katabi, Nora; Ramaswami, Deepa; Walsh, Logan A.; Eng, Stephanie; Huse, Jason T.; Zhang, Jianan; Dolgalev, Igor; Huberman, Kety; Heguy, Adriana; Viale, Agnes; Drobnjak, Marija; Leversha, Margaret A.; Rice, Christine E.; Singh, Bhuvanesh; Iyer, N. Gopalakrishna; Leemans, C. Rene; Bloemena, Elisabeth; Ferris, Robert L.; Seethala, Raja R.; Gross, Benjamin E.; Liang, Yupu; Sinha, Rileen; Peng, Luke; Raphael, Benjamin J.; Turcan, Sevin; Gong, Yongxing; Schultz, Nikolaus; Kim, Seungwon; Chiosea, Simion; Shah, Jatin P.; Sander, Chris; Lee, William; Chan, Timothy A.			The mutational landscape of adenoid cystic carcinoma	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMATIN REMODELING GENES; SOMATIC POINT MUTATIONS; SQUAMOUS-CELL CARCINOMA; DNA-SEQUENCING DATA; BREAST-CANCER; TUMOR-GROWTH; INACTIVATING MUTATIONS; MISSENSE MUTATIONS; PROSTATE-CANCER	Adenoid cystic carcinomas (ACCs) are among the most enigmatic of human malignancies. These aggressive salivary gland cancers frequently recur and metastasize despite definitive treatment, with no known effective chemotherapy regimen. Here we determined the ACC mutational landscape and report the exome or whole-genome sequences of 60 ACC tumor-normal pairs. These analyses identified a low exonic somatic mutation rate (0.31 non-silent events per megabase) and wide mutational diversity. Notably, we found mutations in genes encoding chromatin-state regulators, such as SMARCA2, CREBBP and KDM6A, suggesting that there is aberrant epigenetic regulation in ACC oncogenesis. Mutations in genes central to the DNA damage response and protein kinase A signaling also implicate these processes. We observed MYB-NFIB translocations and somatic mutations in MYB-associated genes, solidifying the role of these aberrations as critical events in ACC. Lastly, we identified recurrent mutations in the FGF-IGF-PI3K pathway (30% of tumors) that might represent new avenues for therapy. Collectively, our observations establish a molecular foundation for understanding and exploring new treatments for ACC.	[Ho, Allen S.; Kannan, Kasthuri; Roy, David M.; Morris, Luc G. T.; Ganly, Ian; Ramaswami, Deepa; Walsh, Logan A.; Eng, Stephanie; Huse, Jason T.; Zhang, Jianan; Dolgalev, Igor; Huberman, Kety; Heguy, Adriana; Peng, Luke; Turcan, Sevin; Gong, Yongxing; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Ho, Allen S.; Morris, Luc G. T.; Ganly, Ian; Singh, Bhuvanesh; Shah, Jatin P.] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA; [Katabi, Nora; Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core, New York, NY 10021 USA; [Drobnjak, Marija] Mem Sloan Kettering Canc Ctr, Pathol Core, New York, NY 10021 USA; [Leversha, Margaret A.; Rice, Christine E.] Mem Sloan Kettering Canc Ctr, Mol Cytogenet Core, New York, NY 10021 USA; [Iyer, N. Gopalakrishna] Natl Canc Ctr Singapore, Dept Surg Oncol, Singapore, Singapore; [Leemans, C. Rene] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands; [Bloemena, Elisabeth] Vrije Univ Amsterdam, Med Ctr, Acad Ctr Dent, Dept Oral & Maxillofacial Surg & Oral Pathol, Amsterdam, Netherlands; [Ferris, Robert L.; Kim, Seungwon] Univ Pittsburgh, Med Ctr, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA; [Seethala, Raja R.; Chiosea, Simion] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; [Gross, Benjamin E.; Liang, Yupu; Sinha, Rileen; Sander, Chris; Lee, William] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Schultz, Nikolaus; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA		Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chant@mskcc.org	Turcan, Sevin/AAF-1095-2019; Chan, Timothy A/ABD-5850-2021; Bloemena, Elisabeth/V-1095-2018; Dolgalev, Igor/AAY-6406-2020; Bloemena, Elisabeth/AAZ-1247-2021; Schultz, Nikolaus/ABE-6347-2020	Turcan, Sevin/0000-0002-0885-5607; Bloemena, Elisabeth/0000-0002-0221-9538; Dolgalev, Igor/0000-0003-4451-126X; Iyer, N. Gopalakrishna/0000-0002-8812-6219; Gong, Yongxing/0000-0003-1071-0375; Ganly, Ian/0000-0001-7636-5426; Lee, William/0000-0001-9582-4413; Shah, Jatin/0000-0002-6444-6592; Ferris, Robert/0000-0001-6605-2071; Walsh, Logan/0000-0001-8771-2577; Chiosea, Simion/0000-0002-5766-8779; Drobnjak, Marija/0000-0003-0676-4709; Kannan, Kasthuri/0000-0002-8479-0657; Sinha, Rileen/0000-0001-5497-5055; Schultz, Nikolaus/0000-0002-0131-4904	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1CA154767, R21DE023229, 5T32CA009685]; Geoffrey Beene Foundation; Starr Cancer Consortium; Louis Gerstner Foundation; American Head and Neck Society/American Academy of Otolaryngology-Head and Neck Surgery Foundation Young Investigator Combined Award; Howard Hughes Medical Institute Medical Research Fellows ProgramHoward Hughes Medical Institute; NIH National Resource for Network Biology [GM103504]; Adenoid Cystic Carcinoma Research Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA008748, T32CA160001, R01CA154767, T32CA009685] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG005690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R21DE023229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P41GM103504, T32GM007739] Funding Source: NIH RePORTER	We thank A. Kayserian and S. Thomas for technical assistance. We are indebted to R.J. Wong (Memorial Sloan-Kettering Cancer Center), P. K. Brindle (St. Jude Children's Research Hospital) and O.J. Baker (State University of New York at Buffalo) for generously providing cell lines and constructs. We are additionally grateful to J.O. Boyle, S. G. Patel, A. R. Shaha, R.J. Wong, A. L. Ho, M. C. Mariano and L. Lopez for facilitating tissue procurement and contributing valuable input. This work was supported by the US National Institutes of Health (NIH) (RO1CA154767 (T. A. C.), R21DE023229 (T. A. C.), 5T32CA009685 (A. S. H.)), the Geoffrey Beene Foundation (T. A. C.), the Starr Cancer Consortium (T. A. C.) and the Louis Gerstner Foundation (T. A. C.). A. S. H. was supported by an American Head and Neck Society/American Academy of Otolaryngology-Head and Neck Surgery Foundation Young Investigator Combined Award. D. M. R. was supported by the Howard Hughes Medical Institute Medical Research Fellows Program. The cBio Portal was supported in part by the NIH National Resource for Network Biology (GM103504). T. A. C. would like to thank Jeff and Marnie Kaufman and the Adenoid Cystic Carcinoma Research Foundation for support of the work and inspiration to see it	Abdul M, 2008, PATHOL ONCOL RES, V14, P157, DOI 10.1007/s12253-008-9045-9; Adelstein DJ, 2012, SEMIN RADIAT ONCOL, V22, P245, DOI 10.1016/j.semradonc.2012.03.009; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Agulnik M, 2007, J CLIN ONCOL, V25, P3978, DOI 10.1200/JCO.2007.11.8612; Allen TD, 2011, CANCER RES, V71, P6010, DOI 10.1158/0008-5472.CAN-11-0595; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Binmadi NO, 2012, AM J PATHOL, V180, P1232, DOI 10.1016/j.ajpath.2011.12.009; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; CHENG J, 1992, CANCER, V69, P2631, DOI 10.1002/1097-0142(19920601)69:11<2631::AID-CNCR2820691103>3.0.CO;2-P; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Egloff AM, 2012, CLIN CANCER RES, V18, P5188, DOI 10.1158/1078-0432.CCR-11-2258; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gopalan A, 2009, CANCER RES, V69, P1400, DOI 10.1158/0008-5472.CAN-08-2467; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Holst VA, 1999, MODERN PATHOL, V12, P956; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kimura S, 2000, VIRCHOWS ARCH, V437, P122, DOI 10.1007/s004280000209; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Laurie SA, 2011, LANCET ONCOL, V12, P815, DOI 10.1016/S1470-2045(10)70245-X; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Munakata R, 1996, J ORAL PATHOL MED, V25, P441, DOI 10.1111/j.1600-0714.1996.tb00294.x; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Persson M, 2012, GENE CHROMOSOME CANC, V51, P805, DOI 10.1002/gcc.21965; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Phuchareon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006040; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Rozen S, 2000, Methods Mol Biol, V132, P365; Sarmento LM, 2011, EXPERT REV ANTICANC, V11, P1403, DOI [10.1586/ERA.11.73, 10.1586/era.11.73]; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; Tien AL, 2011, BIOCHEM J, V435, P175, DOI 10.1042/BJ20100840; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Veekony H, 2007, CLIN CANCER RES, V13, P3133, DOI 10.1158/1078-0432.CCR-06-2555; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wolffe AP, 2001, ONCOGENE, V20, P2988, DOI 10.1038/sj.onc.1204322; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810; 2012, ORAL ONCOL, V48, P95	97	266	276	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2013	45	7					791	+		10.1038/ng.2643			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	WOS:000321005200014	23685749	Green Accepted			2022-01-24	
J	De Keersmaecker, K; Atak, ZK; Li, N; Vicente, C; Patchett, S; Girardi, T; Gianfelici, V; Geerdens, E; Clappier, E; Porcu, M; Lahortiga, I; Luca, R; Yan, JK; Hulselmans, G; Vranckx, H; Vandepoel, R; Sweron, B; Jacobs, K; Mentens, N; Wlodarska, I; Cauwelier, B; Cloos, J; Soulier, J; Uyttebroeck, A; Bagni, C; Hassan, BA; Vandenberghe, P; Johnson, AW; Aerts, S; Cools, J				De Keersmaecker, Kim; Atak, Zeynep Kalender; Li, Ning; Vicente, Carmen; Patchett, Stephanie; Girardi, Tiziana; Gianfelici, Valentina; Geerdens, Ellen; Clappier, Emmanuelle; Porcu, Michael; Lahortiga, Idoya; Luca, Rossella; Yan, Jiekun; Hulselmans, Gert; Vranckx, Hilde; Vandepoel, Roel; Sweron, Bram; Jacobs, Kris; Mentens, Nicole; Wlodarska, Iwona; Cauwelier, Barbara; Cloos, Jacqueline; Soulier, Jean; Uyttebroeck, Anne; Bagni, Claudia; Hassan, Bassem A.; Vandenberghe, Peter; Johnson, Arlen W.; Aerts, Stein; Cools, Jan			Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; SOMATIC MUTATIONS; UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CODING GENOME; PROTEIN; NOTCH; PATHWAY; MLL; INACTIVATION	T-cell acute lymphoblastic leukemia (T-ALL) is caused by the cooperation of multiple oncogenic lesions(1,2). We used exome sequencing on 67 T-ALLs to gain insight into the mutational spectrum in these leukemias. We detected protein-altering mutations in 508 genes, with an average of 8.2 mutations in pediatric and 21.0 mutations in adult T-ALL. Using stringent filtering, we predict seven new oncogenic driver genes in T-ALL. We identify CNOT3 as a tumor suppressor mutated in 7 of 89 (7.9%) adult T-ALLs, and its knockdown causes tumors in a sensitized Drosophila melanogaster model(3). In addition, we identify mutations affecting the ribosomal proteins RPL5 and RPL10 in 12 of 122 (9.8%) pediatric T-ALLs, with recurrent alterations of Arg98 in RPL10. Yeast and lymphoid cells expressing the RPL10 Arg98Ser mutant showed a ribosome biogenesis defect. Our data provide insights into the mutational landscape of pediatric versus adult T-ALL and identify the ribosome as a potential oncogenic factor.	[De Keersmaecker, Kim; Atak, Zeynep Kalender; Vicente, Carmen; Girardi, Tiziana; Gianfelici, Valentina; Geerdens, Ellen; Porcu, Michael; Lahortiga, Idoya; Luca, Rossella; Yan, Jiekun; Hulselmans, Gert; Vranckx, Hilde; Vandepoel, Roel; Sweron, Bram; Jacobs, Kris; Mentens, Nicole; Wlodarska, Iwona; Bagni, Claudia; Hassan, Bassem A.; Vandenberghe, Peter; Aerts, Stein; Cools, Jan] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [De Keersmaecker, Kim; Vicente, Carmen; Girardi, Tiziana; Gianfelici, Valentina; Geerdens, Ellen; Porcu, Michael; Lahortiga, Idoya; Luca, Rossella; Yan, Jiekun; Vandepoel, Roel; Sweron, Bram; Jacobs, Kris; Mentens, Nicole; Bagni, Claudia; Hassan, Bassem A.; Cools, Jan] VIB, Ctr Biol Dis, Louvain, Belgium; [Li, Ning] BGI Europe, Copenhagen, Denmark; [Patchett, Stephanie; Johnson, Arlen W.] Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Clappier, Emmanuelle; Soulier, Jean] Hop St Louis, Paris, France; [Cauwelier, Barbara] Acad Hosp St Jan, Brugge, Belgium; [Cloos, Jacqueline] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Uyttebroeck, Anne] Katholieke Univ Leuven Hosp, Louvain, Belgium		Aerts, S (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	stein.aerts@med.kuleuven.be; jan.cools@cme.vib-kuleuven.be	De Keersmaecker, Kim/W-9702-2018; Gianfelici, Valentina/AAA-8632-2020; Vicente, Carmen/AAA-7098-2021; Atak, Zeynep Kalender/AAW-1560-2020; Hassan, Bassem A/D-5221-2012; Luca, Rossella/J-5921-2018; Clappier, Emmanuelle/V-2921-2017; Aerts, Stein/A-1100-2009	De Keersmaecker, Kim/0000-0002-7420-9531; Vicente, Carmen/0000-0002-3363-3459; Atak, Zeynep Kalender/0000-0003-4761-8169; Hassan, Bassem A/0000-0001-9533-4908; Luca, Rossella/0000-0003-2495-7803; Aerts, Stein/0000-0002-8006-0315; Hulselmans, Gert/0000-0003-2205-1899; Gianfelici, Valentina/0000-0003-3326-091X; Porcu, Michael/0000-0002-9369-5547; Cools, Jan/0000-0001-6626-5843; Bagni, Claudia/0000-0002-4419-210X; Vandenberghe, Peter/0000-0003-4719-1935; Johnson, Arlen/0000-0002-4742-085X; Girardi, Tiziana/0000-0002-1344-8459	KU LeuvenKU Leuven [PF/10/016 SymBioSys]; FWO-VlaanderenFWO [G.0546.11, G.0704.11N]; Foundation against Cancer [SCIE2006-34, 2010-154]; European Research Council (ERC)European Research Council (ERC); Federal Office for Scientific, Technical and Cultural Affairs, Belgium; Ministry of Health, Cancer Plan; French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer); Canceropole d'Ile de FranceRegion Ile-de-France; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM53655]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM053655] Funding Source: NIH RePORTER	This work was supported by grants from KU Leuven (concerted action grant to J. Cools and P.V. and PF/10/016 SymBioSys to J. Cools and S.A.), FWO-Vlaanderen (G.0546.11 to J. Cools, P.V., S.A. and A.U. and G.0704.11N to S.A.), the Foundation against Cancer (SCIE2006-34 to J. Cools and 2010-154 to S.A.), a European Research Council (ERC) starting grant (J. Cools), the Interuniversity Attraction Poles (IAP) granted by the Federal Office for Scientific, Technical and Cultural Affairs, Belgium (J. Cools and P.V.), a grant from the Ministry of Health, Cancer Plan (J. Cools, P.V. and S.A.), a grant from the French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer) and from Canceropole d'Ile de France (J.S.), and a grant from the US National Institutes of Health (NIH; GM53655 to A.W.J. and SE). K.D.K. is a postdoctoral researcher, and P.V. is a senior clinical investigator of FWO-Vlaanderen.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Bossuyt W, 2009, PLOS BIOL, V7, P301, DOI 10.1371/journal.pbio.1000040; Burmeister T, 2009, BLOOD, V113, P4011, DOI 10.1182/blood-2008-10-183483; Chiocchetti A, 2011, AM J MED GENET A, V155A, P1472, DOI 10.1002/ajmg.a.33977; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; De Keersmaecker K, 2005, HAEMATOLOGICA, V90, P1116; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Hofer A, 2007, J BIOL CHEM, V282, P32630, DOI 10.1074/jbc.M705057200; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; King-Underwood L, 1998, BLOOD, V91, P2961, DOI 10.1182/blood.V91.8.2961.2961_2961_2968; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Lower KM, 2004, EUR J HUM GENET, V12, P787, DOI 10.1038/sj.ejhg.5201228; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Ono R, 2002, CANCER RES, V62, P4075; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rao SY, 2012, BLOOD, V120, P3764, DOI 10.1182/blood-2012-03-415349; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	51	266	270	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					186	190		10.1038/ng.2508			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	WOS:000314333000014	23263491	Green Accepted			2022-01-24	
J	Banfai, B; Jia, H; Khatun, J; Wood, E; Risk, B; Gundling, WE; Kundaje, A; Gunawardena, HP; Yu, YB; Xie, L; Krajewski, K; Strahl, BD; Chen, X; Bickel, P; Giddings, MC; Brown, JB; Lipovich, L				Banfai, Balazs; Jia, Hui; Khatun, Jainab; Wood, Emily; Risk, Brian; Gundling, William E., Jr.; Kundaje, Anshul; Gunawardena, Harsha P.; Yu, Yanbao; Xie, Ling; Krajewski, Krzysztof; Strahl, Brian D.; Chen, Xian; Bickel, Peter; Giddings, Morgan C.; Brown, James B.; Lipovich, Leonard			Long noncoding RNAs are rarely translated in two human cell lines	GENOME RESEARCH			English	Article							RELATIVE PROTEIN ABUNDANCE; COMPARING PROTEIN; GENE-EXPRESSION; DISCOVERY; IDENTIFICATION; TRANSCRIPTION; ABSOLUTE; REVEALS; COMPLEX	Data from the Encyclopedia of DNA Elements (ENCODE) project show over 9640 human genome loci classified as long noncoding RNAs (IncRNAs), yet only 100 have been deeply characterized to determine their role in the cell. To measure the protein-coding output from these RNAs, we jointly analyzed two recent data sets produced in the ENCODE project: tandem mass spectrometry (MS/MS) data mapping expressed peptides to their encoding genomic loci, and RNA-seq data generated by ENCODE in long polyA+ and polyA- fractions in the cell lines K562 and GMI2878. We used the machine-learning algorithm RuleFit3 to regress the peptide data against RNA expression data. The most important covariate for predicting translation was, surprisingly, the Cytosol polyA- fraction in both cell lines. LncRNAs are similar to 13-fold less likely to produce detectable peptides than similar mRNAs, indicating that similar to 92% of GENCODE v7 IncRNAs are not translated in these two ENCODE cell lines. Intersecting 9640 IncRNA loci with 79,333 peptides yielded 85 unique peptides matching 69 IncRNAs. Most cases were due to a coding transcript misannotated as IncRNA. Two exceptions were an unprocessed pseudogene and a bona fide IncRNA gene, both with open reading frames (ORFs) compromised by upstream stop codons. All potentially translatable IncRNA ORFs had only a single peptide match, indicating low protein abundance and/or false-positive peptide matches. We conclude that with very few exceptions, ribosomes are able to distinguish coding from noncoding transcripts and, hence, that ectopic translation and cryptic mRNAs are rare in the human IncRNAome.	[Banfai, Balazs; Bickel, Peter; Brown, James B.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Jia, Hui; Wood, Emily; Gundling, William E., Jr.; Lipovich, Leonard] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Khatun, Jainab; Risk, Brian] Boise State Univ, Biomol Res Ctr, Boise, ID 83725 USA; [Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Palo Alto, CA 94305 USA; [Gunawardena, Harsha P.; Yu, Yanbao; Xie, Ling; Krajewski, Krzysztof; Strahl, Brian D.; Chen, Xian] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Giddings, Morgan C.] Boise State Univ, Coll Arts & Sci, Boise, ID 83725 USA		Brown, JB (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	benbrownofberkeley@gmail.com; llipovich@med.wayne.edu	Notredame, Cedric/G-3868-2010; Strahl, Brian/C-7601-2012; Brown, James/H-2971-2015; Jha, Rajneesh/L-5606-2017; Tanzer, Andrea/L-3147-2015; Lipovich, Leonard/B-2355-2019; Kundaje, Anshul/Y-2739-2019; Kundaje, Anshul/Y-2598-2019; Yu, Yanbao/G-3035-2010; Banfai, Balazs/H-3464-2012; Guigo, Roderic/D-1303-2010; Djebali, Sarah/O-9817-2014; Hubbard, Tim J/C-2567-2008	Strahl, Brian/0000-0002-4947-6259; Tanzer, Andrea/0000-0003-2873-4236; Lipovich, Leonard/0000-0002-0531-3570; Kundaje, Anshul/0000-0003-3084-2287; Kundaje, Anshul/0000-0003-3084-2287; Yu, Yanbao/0000-0003-2994-1974; Banfai, Balazs/0000-0003-0422-7977; Guigo, Roderic/0000-0002-5738-4477; Djebali, Sarah/0000-0002-0599-1267; Hubbard, Tim J/0000-0002-1767-9318; Krajewski, Krzysztof/0000-0001-7159-617X	Rosztoczy Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [K99HG006698] Funding Source: NIH RePORTER	B.B. is grateful for the support of the Rosztoczy Foundation. J.B.B. thanks Roger Hoskins, Susan Celniker, Haiyan Huang, and Nathan Boley for useful conversations.	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2011, BIOCHIMIE, V93, P2013, DOI 10.1016/j.biochi.2011.07.018; Djebali S, 2012, NATURE IN PRESS; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Frieman JH, 2008, ANN APPL STAT, V2, P916, DOI 10.1214/07-AOAS148; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gerstein MB, 2012, NATURE IN PRESS; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hube F, 2006, DNA CELL BIOL, V25, P418, DOI 10.1089/dna.2006.25.418; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Karolchik D, 2009, CURR PROTOC BIOINFOR, V28, P141; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Rohrbough James G, 2006, J Biomol Tech, V17, P327; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tay SK, 2009, P NATL ACAD SCI USA, V106, P12019, DOI 10.1073/pnas.0904569106; The ENCODE Project Consortium, 2012, Nature, V489, P57; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Ulveling D, 2011, BIOCHIMIE, V93, P2024, DOI 10.1016/j.biochi.2011.06.019; Vogel C, 2008, NAT PROTOC, V3, P1444, DOI 10.1038/nport.2008.132; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	47	266	280	2	56	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	SEP	2012	22	9			SI		1646	1657		10.1101/gr.134767.111			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	998XD	WOS:000308272800007	22955977	Green Published, Green Submitted, hybrid			2022-01-24	
J	Liebman, SW; Chernoff, YO				Liebman, Susan W.; Chernoff, Yury O.			Prions in Yeast	GENETICS			English	Article							DE-NOVO APPEARANCE; BETA-SHEET STRUCTURES; RNQ1 NONPRION DOMAIN; N-TERMINAL DOMAIN; PSI+ PRION; SACCHAROMYCES-CEREVISIAE; URE3 PRION; HET-S; TRANSLATION TERMINATION; AMYLOID FIBRILS	The concept of a prion as an infectious self-propagating protein isoform was initially proposed to explain certain mammalian diseases. It is now clear that yeast also has heritable elements transmitted via protein. Indeed, the "protein only" model of prion transmission was first proven using a yeast prion. Typically, known prions are ordered cross-beta aggregates (amyloids). Recently, there has been an explosion in the number of recognized prions in yeast. Yeast continues to lead the way in understanding cellular control of prion propagation, prion structure, mechanisms of de novo prion formation, specificity of prion transmission, and the biological roles of prions. This review summarizes what has been learned from yeast prions.	[Liebman, Susan W.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA		Liebman, SW (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, 1664 N Virginia St,Mail Stop 330, Reno, NV 89557 USA.	suel@uic.edu	Chernoff, Yury O/J-2833-2014	Chernoff, Yury/0000-0002-8934-9051	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM 056350]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM 058763]; National Science FoundationNational Science Foundation (NSF) [MCB-1024854]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM056350, R01GM058763] Funding Source: NIH RePORTER	S.W.L. thanks C.V. Vishveshwara for the policemen concept and drawings; F. Arslan, K. Facemyer, and V. Mathur for comments on the manuscript; and K. Facemyer for an introduction to Sketchup. Y.O.C. thanks G. Newnam for technical help with preparation of the manuscript; A. Romanyuk for discussing the model shown in Figure 4; and K. Bruce for help with Figure 12. S. W. L. acknowledges the National Institutes of Health (NIH) (grant R01GM 056350) for financial support. Y.O.C. acknowledges the NIH (grant R01GM 058763) and the National Science Foundation (grant MCB-1024854) for financial support.	Afanasieva EG, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.183889; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Aksenova A Iu, 2006, Mol Biol (Mosk), V40, P844; Al Safadi R, 2011, FEMS YEAST RES, V11, P151, DOI 10.1111/j.1567-1364.2010.00700.x; Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Allen KD, 2007, J BIOL CHEM, V282, P3004, DOI 10.1074/jbc.M609597200; Bagriantsev SN, 2008, MOL BIOL CELL, V19, P2433, DOI 10.1091/mbc.E08-01-0078; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Bailleul PA, 1999, GENETICS, V153, P81; Bailleul-Winslett PA, 2000, GENE EXPRESSION, V9, P145; Bardill JP, 2009, J MOL BIOL, V388, P583, DOI 10.1016/j.jmb.2009.03.036; Bateman DA, 2012, GENETICS, V190, P569, DOI 10.1534/genetics.111.136655; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.E03-01-0007; Baxa U, 2005, J STRUCT BIOL, V150, P170, DOI 10.1016/j.jsb.2005.02.007; Baxa U, 2004, J MOL BIOL, V339, P259, DOI 10.1016/j.jmb.2004.03.033; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Baxa U, 2011, MOL MICROBIOL, V79, P523, DOI 10.1111/j.1365-2958.2010.07466.x; Bockmann A, 2010, PRION, V4, P72, DOI 10.4161/pri.4.2.11963; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Borchsenius AS, 2006, CURR GENET, V49, P21, DOI 10.1007/s00294-005-0035-0; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Bousset L, 2004, BIOCHEMISTRY-US, V43, P5022, DOI 10.1021/bi049828e; Bousset L, 2003, J STRUCT BIOL, V141, P132, DOI 10.1016/S1047-8477(02)00606-8; Bousset L, 2002, CR BIOL, V325, P3, DOI 10.1016/S1631-0691(02)01385-9; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Bousset L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009760; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Brachmann A, 2006, METHODS, V39, P35, DOI 10.1016/j.ymeth.2006.04.008; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Bruce KL, 2011, SEMIN CELL DEV BIOL, V22, P444, DOI 10.1016/j.semcdb.2011.03.005; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Byrne LJ, 2007, P NATL ACAD SCI USA, V104, P11688, DOI 10.1073/pnas.0701392104; Byrne LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004670; Castro CE, 2011, BIOPHYS J, V101, P439, DOI 10.1016/j.bpj.2011.06.016; Chacinska A, 2001, CURR GENET, V39, P62, DOI 10.1007/s002940000180; Chan JCC, 2005, BIOCHEMISTRY-US, V44, P10669, DOI 10.1021/bi050724t; Chang HY, 2008, P NATL ACAD SCI USA, V105, P13345, DOI 10.1073/pnas.0802215105; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chen BX, 2007, P NATL ACAD SCI USA, V104, P2791, DOI 10.1073/pnas.0611158104; Chen BX, 2010, MOL MICROBIOL, V76, P1483, DOI 10.1111/j.1365-2958.2010.07177.x; Chen L, 2011, PROTEIN ENG DES SEL, V24, P69, DOI 10.1093/protein/gzq100; Chernoff Y, 2004, CURR OPIN CHEM BIOL, V8, P665, DOI 10.1016/j.cbpa.2004.09.002; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 2004, PRIONS AND PRION DISEASES: CURRENT PERSPECTIVES, P257; CHERNOFF YO, 1992, YEAST, V8, P489, DOI 10.1002/yea.320080702; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chernoff YO, 2001, MUTAT RES-REV MUTAT, V488, P39, DOI 10.1016/S1383-5742(00)00060-0; Chernoff YO, 2008, P NATL ACAD SCI USA, V105, P13191, DOI 10.1073/pnas.0806234105; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Choe YJ, 2009, EUKARYOT CELL, V8, P968, DOI 10.1128/EC.00353-08; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Cox B, 2003, GENETICS, V165, P23; COX B, 1994, CURR BIOL, V4, P744, DOI 10.1016/S0960-9822(00)00167-6; Cox Brian, 1993, P219; Cox BS, 2007, PRION, V1, P170; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Crist CG, 2003, GENES CELLS, V8, P603, DOI 10.1046/j.1365-2443.2003.00661.x; Crow ET, 2011, MOL CELL BIOL, V31, P3436, DOI 10.1128/MCB.05338-11; DAGKESAMANSKAYA AR, 1991, GENETICS, V128, P513; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1999, CURR GENET, V35, P59, DOI 10.1007/s002940050433; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Derkatch IL, 2007, PRION, V1, P161, DOI 10.4161/pri.1.3.4837; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; DiSalvo S, 2011, NAT STRUCT MOL BIOL, V18, P486, DOI 10.1038/nsmb.2031; DOEL SM, 1994, GENETICS, V137, P659; Dong JJ, 2007, J BIOL CHEM, V282, P34204, DOI 10.1074/jbc.M704952200; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Du ZQ, 2010, MOL CELL BIOL, V30, P4644, DOI 10.1128/MCB.00225-10; Duennwald ML, 2011, PRION, V5, P285, DOI [10.4161/pri.5.4.18071, 10.4161/pri.18071]; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Edskes HK, 2009, GENETICS, V181, P1159, DOI 10.1534/genetics.108.099929; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Engel A, 2011, BIOCHEMISTRY-US, V50, P5971, DOI 10.1021/bi200142x; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; Fayard B, 2006, J MOL BIOL, V356, P843, DOI 10.1016/j.jmb.2005.12.011; Fernandez-Bellot E, 2002, EMBO REP, V3, P76, DOI 10.1093/embo-reports/kvf011; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Foo CK, 2011, J MOL BIOL, V408, P1, DOI 10.1016/j.jmb.2011.02.025; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Garrity SJ, 2010, P NATL ACAD SCI USA, V107, P10596, DOI 10.1073/pnas.0913280107; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Glover JR, 2009, PROTEIN PEPTIDE LETT, V16, P587, DOI 10.2174/092986609788490087; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Goehler H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009642; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Gong H, 2012, PLOS GENET, V8, P223, DOI 10.1371/journal.pgen.1002634; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Griswold CK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000517; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Heinrich SU, 2011, P NATL ACAD SCI USA, V108, P2999, DOI 10.1073/pnas.1019368108; Helsen CW, 2012, J BIOL CHEM, V287, P542, DOI 10.1074/jbc.M111.302869; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Hines JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001309; Hong JY, 2011, YEAST, V28, P555, DOI 10.1002/yea.1857; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Iconomidou VA, 2008, CURR PROTEIN PEPT SC, V9, P291, DOI 10.2174/138920308784534041; Inge-Vechtomov SG, 2007, PRION, V1, P228, DOI 10.4161/pri.1.4.5059; INGEVECHTOMOV SG, 1994, GENETIKA+, V30, P1022; Inou Y, 2004, J BIOL CHEM, V279, P52319, DOI 10.1074/jbc.M408159200; Ito K, 1998, RNA, V4, P958, DOI 10.1017/S1355838298971874; Jensen MA, 2001, GENETICS, V159, P527; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Joseph SB, 2008, J EVOLUTION BIOL, V21, P773, DOI 10.1111/j.1420-9101.2008.01515.x; Jung G, 2000, GENETICS, V156, P559; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kabani M, 2011, MOL MICROBIOL, V81, P640, DOI 10.1111/j.1365-2958.2011.07719.x; Kadnar ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000824; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kawai-Noma S, 2010, J CELL BIOL, V190, P223, DOI 10.1083/jcb.201002149; Kiktev DA, 2011, DOKL BIOCHEM BIOPHYS, V438, P117, DOI 10.1134/S1607672911030021; Kiktev D, 2007, PRION, V1, P136, DOI 10.4161/pri.1.2.4533; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kirkland PA, 2011, GENETICS, V188, P565, DOI 10.1534/genetics.111.129460; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Kochneva-Pervukhova NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029832; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; Kryndushkin DS, 2011, GENETICS, V188, P339, DOI 10.1534/genetics.111.127779; Kryndushkin DS, 2011, J MOL BIOL, V409, P263, DOI 10.1016/j.jmb.2011.03.067; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Krzewska J, 2007, J BIOL CHEM, V282, P1679, DOI 10.1074/jbc.M608110200; Kurahashi H, 2008, MOL CELL BIOL, V28, P3313, DOI 10.1128/MCB.01900-07; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Kurahashi H, 2011, GENES CELLS, V16, P576, DOI 10.1111/j.1365-2443.2011.01511.x; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; LI GC, 1995, INT J HYPERTHER, V11, P459, DOI 10.3109/02656739509022483; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Liebman SW, 2006, METHODS, V39, P23, DOI 10.1016/j.ymeth.2006.04.010; Liebman SW, 2002, P NATL ACAD SCI USA, V99, P9098, DOI 10.1073/pnas.152318899; Lin JY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002297; Liu BD, 2011, CELL, V147, P959, DOI 10.1016/j.cell.2011.11.018; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Liu YX, 2007, BIOCHEM BIOPH RES CO, V353, P139, DOI 10.1016/j.bbrc.2006.11.143; Loquet A, 2009, J MOL BIOL, V394, P108, DOI 10.1016/j.jmb.2009.09.016; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Manogaran AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001386; Manuelidis L, 2003, VIRAL IMMUNOL, V16, P123, DOI 10.1089/088282403322017875; Masel J, 2003, EVOLUTION, V57, P1498; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mason RP, 2011, PRION, V5, P269, DOI [10.4161/pri.5.4.18005, 10.4161/pri.18005]; Mathur V, 2010, MOL BIOL CELL, V21, P1449, DOI 10.1091/mbc.E09-11-0927; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Mizuno N, 2011, P NATL ACAD SCI USA, V108, P3252, DOI 10.1073/pnas.1011342108; Moore RA, 2005, ARCH VIROL, P187; Moosavi B, 2010, YEAST, V27, P167, DOI 10.1002/yea.1742; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Namy O., 2008, NAT CELL BIOL; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Ngo S, 2011, J BIOL CHEM, V286, P29691, DOI 10.1074/jbc.M111.269092; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Park KW, 2006, GENETICS, V173, P35, DOI 10.1534/genetics.105.054221; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Redeker V, 2007, J MOL BIOL, V369, P1113, DOI 10.1016/j.jmb.2007.04.018; Reidy M, 2011, PRION, V5, P245, DOI [10.4161/pri.5.4.17749, 10.4161/pri.17749]; Resende C, 2002, MICROBIOL-SGM, V148, P1049, DOI 10.1099/00221287-148-4-1049; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Rikhvanov EG, 2007, PRION, V1, P217, DOI 10.4161/pri.1.4.5058; Ripaud L, 2004, J BIOL CHEM, V279, P50962, DOI 10.1074/jbc.M408792200; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Roberts BT, 2004, YEAST, V21, P107, DOI 10.1002/yea.1062; Roberts BT, 2003, GENE DEV, V17, P2083, DOI 10.1101/gad.1115803; Romer L, 2008, PRION, V2, P154; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; Saifitdinova AF, 2010, CURR GENET, V56, P467, DOI 10.1007/s00294-010-0314-2; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Saupe S. J., 2011, SEMIN CELL DEV BIOL; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Sen A, 2007, J BIOL CHEM, V282, P5545, DOI 10.1074/jbc.M611464200; Senechal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006939; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Sharma D, 2009, GENETICS, V181, P129, DOI 10.1534/genetics.108.098699; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Shibata S, 2009, PRION, V3, P250, DOI 10.4161/pri.3.4.10388; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2010, MOL BIOSYST, V6, P1115, DOI 10.1039/c004550k; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sideri T. C., 2011, J BIOL CHEM; Sideri TC, 2010, P NATL ACAD SCI USA, V107, P6394, DOI 10.1073/pnas.1000347107; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Speransky VV, 2001, J CELL BIOL, V153, P1327, DOI 10.1083/jcb.153.6.1327; Stein KC, 2011, PRION, V5, P291, DOI [10.4161/pri.5.4.18213, 10.4161/pri.18213]; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Talarek N, 2005, GENETICS, V171, P23, DOI 10.1534/genetics.105.043489; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Toombs JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021953; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; TUITE MF, 1981, J BIOL CHEM, V256, P7298; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Tyedmers J, 2010, P NATL ACAD SCI USA, V107, P8633, DOI 10.1073/pnas.1003895107; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; van der Wel PCA, 2007, J AM CHEM SOC, V129, P5117, DOI 10.1021/ja068633m; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Verges KJ, 2011, NAT STRUCT MOL BIOL, V18, P493, DOI 10.1038/nsmb.2030; Vishveshwara N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-26; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Volkov KV, 2002, GENETICS, V160, P25; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Wang H, 2008, P NATL ACAD SCI USA, V105, P7159, DOI 10.1073/pnas.0801934105; Wang YQ, 2011, J STRUCT BIOL, V174, P505, DOI 10.1016/j.jsb.2011.03.008; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2009, J MOL BIOL, V394, P119, DOI 10.1016/j.jmb.2009.09.015; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wickner R. B., 1997, PRION DIS MAMMALS YE; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2008, BIOESSAYS, V30, P955, DOI 10.1002/bies.20821; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wickner RB, 2011, SEMIN CELL DEV BIOL, V22, P469, DOI 10.1016/j.semcdb.2011.02.021; Wickner RB, 2010, FEMS YEAST RES, V10, P980, DOI 10.1111/j.1567-1364.2010.00666.x; Zadorskii S. P., 2000, Genetika, V36, P1322; ZAKHAROV IA, 1977, MOL CELL BIOCHEM, V14, P15, DOI 10.1007/BF01734159; Zenthon JF, 2006, EUKARYOT CELL, V5, P217, DOI 10.1128/EC.5.2.217-225.2006; Zhang ZR, 2009, J BIOL CHEM, V284, P14058, DOI 10.1074/jbc.M901189200; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	328	266	271	6	37	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	AUG	2012	191	4					1041	1072		10.1534/genetics.111.137760			32	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	009BN	WOS:000309000500004	22879407	Green Published, Bronze			2022-01-24	
J	Svenson, KL; Gatti, DM; Valdar, W; Welsh, CE; Cheng, RY; Chesler, EJ; Palmer, AA; McMillan, L; Churchill, GA				Svenson, Karen L.; Gatti, Daniel M.; Valdar, William; Welsh, Catherine E.; Cheng, Riyan; Chesler, Elissa J.; Palmer, Abraham A.; McMillan, Leonard; Churchill, Gary A.			High-Resolution Genetic Mapping Using the Mouse Diversity Outbred Population	GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; COLLABORATIVE CROSS; LIPID-LEVELS; RESOURCE; RELATEDNESS; INTERCROSS; MRL/MPJ	The JAX Diversity Outbred population is a new mouse resource derived from partially inbred Collaborative Cross strains and maintained by randomized outcrossing. As such, it segregates the same allelic variants as the Collaborative Cross but embeds these in a distinct population architecture in which each animal has a high degree of heterozygosity and carries a unique combination of alleles. Phenotypic diversity is striking and often divergent from phenotypes seen in the founder strains of the Collaborative Cross. Allele frequencies and recombination density in early generations of Diversity Outbred mice are consistent with expectations based on simulations of the mating design. We describe analytical methods for genetic mapping using this resource and demonstrate the power and high mapping resolution achieved with this population by mapping a serum cholesterol trait to a 2-Mb region on chromosome 3 containing only 11 genes. Analysis of the estimated allele effects in conjunction with complete genome sequence data of the founder strains reduced the pool of candidate polymorphisms to seven SNPs, five of which are located in an intergenic region upstream of the Foxo1 gene.	[Svenson, Karen L.; Gatti, Daniel M.; Chesler, Elissa J.; Churchill, Gary A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Valdar, William] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Welsh, Catherine E.; McMillan, Leonard] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Cheng, Riyan] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA		Svenson, KL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	karen.svenson@jax.org	Palmer, Abraham/L-2158-2014; Valdar, William/AAE-4354-2019; Chesler, Elissa/K-4641-2019; Churchill, Gary/AAY-7496-2020	Palmer, Abraham/0000-0003-3634-0747; Chesler, Elissa/0000-0002-5642-5062; Churchill, Gary/0000-0001-9190-9284	Jackson Laboratory; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM076468, GM070683, R01DA021336, R21DA024845, R01MH079103]; Schweppe Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM070683, P50GM076468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH079103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA024845, R01DA021336] Funding Source: NIH RePORTER	We thank Darla Miller for managing the production and transfer of partially inbred CC strains. We are especially grateful to Lisa Somes, Biomedical Technologist, and to the Importation Service at The Jackson Laboratory, for careful and competent management of specific breeding strategies to develop this population in its early phases. We thank Marge Strobel and Adam O'Neill at The Jackson Laboratory for continued dedication to current maintenance of the DO population. We thank Steven Ciciotte for preparing DNA. Finally, we thank our anonymous reviewers for comments that lead to improvements in the content and presentation of the manuscript. This work was supported by The Jackson Laboratory and National Institutes of Health (NIH) grants GM076468 and GM070683 to G.A.C., and by NIH grants R01DA021336, R21DA024845, and R01MH079103 and a Grant from the Schweppe Foundation to A.A.P.	Cheng R, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-66; Cheng RY, 2010, GENETICS, V185, P1033, DOI 10.1534/genetics.110.116863; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Durrant C, 2010, GENETICS, V184, P839, DOI 10.1534/genetics.109.113183; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hartl D. L., 2007, PRINCIPLES POPULATIO; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Lenarcic AB, 2012, GENETICS, V190, P413, DOI 10.1534/genetics.111.132563; Li TG, 2009, BBA-MOL CELL BIOL L, V1791, P991, DOI 10.1016/j.bbalip.2009.05.004; Lynch M, 1997, GENETICS ANAL QUANTI; MARKERT CL, 1956, GENETICS, V41, P429; Naggert J. K., 2003, DIET EFFECTS BONE MI; Paigen B., 2002, DIET EFFECTS PLASMA; Peters LL, 2001, HEMATOLOGY CLOTTING; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; RUSSELL LB, 1948, GENETICS, V33, P237; SILVERS WK, 1979, COAT COLORS MICE; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Srivastava AK, 2006, J LIPID RES, V47, P123, DOI 10.1194/jlr.M500295-JLR200; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; Wergedal JE, 2007, J LIPID RES, V48, P1724, DOI 10.1194/jlr.M700015-JLR200; Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Zagryagskaya AN, 2008, J IMMUNOTOXICOL, V5, P347, DOI 10.1080/15476910802482888	31	266	267	0	24	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	FEB	2012	190	2					437	U234		10.1534/genetics.111.132597			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	897CW	WOS:000300621200011	22345611	Green Published, Bronze			2022-01-24	
J	Tan, LB; Li, XR; Liu, FX; Sun, XY; Li, CG; Zhu, ZF; Fu, YC; Cai, HW; Wang, XK; Xie, DX; Sun, CQ				Tan, Lubin; Li, Xianran; Liu, Fengxia; Sun, Xianyou; Li, Chenggang; Zhu, Zuofeng; Fu, Yongcai; Cai, Hongwei; Wang, Xiangkun; Xie, Daoxin; Sun, Chuanqing			Control of a key transition from prostrate to erect growth in rice domestication	NATURE GENETICS			English	Article							ORYZA-RUFIPOGON; PLANT; GENE; GRAVITROPISM; EVOLUTION; PROTEIN; ORIGIN; MAIZE; LAZY1	The transition from the prostrate growth of ancestral wild rice (O. rufipogon Griff.) to the erect growth of Oryza sativa cultivars was one of the most critical events in rice domestication. This evolutionary step importantly improved plant architecture and increased grain yield. Here we find that prostrate growth of wild rice from Yuanjiang County in China is controlled by a semi-dominant gene, PROG1 (PROSTRATE GROWTH 1), on chromosome 7 that encodes a single Cys(2)-His(2) zinc-finger protein. prog1 variants identified in O. sativa disrupt the prog1 function and inactivate prog1 expression, leading to erect growth, greater grain number and higher grain yield in cultivated rice. Sequence comparison shows that 182 varieties of cultivated rice, including 87 indica and 95 japonica cultivars from 17 countries, carry identical mutations in the prog1 coding region that may have become fixed during rice domestication.	[Tan, Lubin; Li, Xianran; Liu, Fengxia; Sun, Xianyou; Li, Chenggang; Zhu, Zuofeng; Fu, Yongcai; Cai, Hongwei; Wang, Xiangkun; Sun, Chuanqing] China Agr Univ, Dept Genet & Plant Breeding, Natl Ctr Evaluat Agr Wild Plants Rice, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Xie, Daoxin] Tsinghua Univ, Dept Biol Sci & Biotechnol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China		Sun, CQ (corresponding author), China Agr Univ, Dept Genet & Plant Breeding, Natl Ctr Evaluat Agr Wild Plants Rice, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	daoxin@tsinghua.edu.cn; suncq@cau.edu.cn	Li, Xianran/AAH-1070-2019; xie, daoxin d/C-8646-2017; Tan, Lubin/H-9270-2017; Li, Xianran/I-5651-2012	Tan, Lubin/0000-0003-3775-7720; Li, Xianran/0000-0002-4252-6911	National Natural Science FoundationNational Natural Science Foundation of China (NSFC); Ministry of AgricultureGida Tarim Ve Hayvancilik Bakanligi; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China	We thank N. Harberd for comments on the manuscript, Y. Wang for assisting in cross sections, and the International Rice Research Institute, Chinese Rice Research Institute, Institute of Crop Sciences of Chinese Academy of Agricultural Sciences, Guangxi Academy of Agricultural Sciences and Guangdong Academy of Agricultural Sciences for providing the wild rice and cultivated rice samples. This research was supported by the National Natural Science Foundation, the Ministry of Agriculture and the Ministry of Science and Technology of China.	Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li XR, 2008, BIOTECHNOL LETT, V30, P555, DOI 10.1007/s10529-007-9558-4; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tan LB, 2007, J INTEGR PLANT BIOL, V49, P871, DOI 10.1111/j.1744-7909.2007.00497.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WAISEL Y, 1987, OECOLOGIA, V73, P630, DOI 10.1007/BF00379428; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Yuan QP, 2003, NUCLEIC ACIDS RES, V31, P229, DOI 10.1093/nar/gkg059	21	266	324	21	203	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1360	1364		10.1038/ng.197			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	WOS:000260501500031	18820699				2022-01-24	
J	Di Bernardo, MC; Crowther-Swanepoel, D; Broderick, P; Webb, E; Sellick, G; Wild, R; Sullivan, K; Vijayakrishnan, J; Wang, YF; Pittman, AM; Sunter, NJ; Hall, AG; Dyer, MJS; Matutes, E; Dearden, C; Mainou-Fowler, T; Jackson, GH; Summerfield, G; Harris, RJ; Pettitt, AR; Hillmen, P; Allsup, DJ; Bailey, JR; Pratt, G; Pepper, C; Fegan, C; Allan, JM; Catovsky, D; Houlston, RS				Di Bernardo, Maria Chiara; Crowther-Swanepoel, Dalemari; Broderick, Peter; Webb, Emily; Sellick, Gabrielle; Wild, Ruth; Sullivan, Kate; Vijayakrishnan, Jayaram; Wang, Yufei; Pittman, Alan M.; Sunter, Nicola J.; Hall, Andrew G.; Dyer, Martin J. S.; Matutes, Estella; Dearden, Claire; Mainou-Fowler, Tryfonia; Jackson, Graham H.; Summerfield, Geoffrey; Harris, Robert J.; Pettitt, Andrew R.; Hillmen, Peter; Allsup, David J.; Bailey, James R.; Pratt, Guy; Pepper, Chris; Fegan, Chris; Allan, James M.; Catovsky, Daniel; Houlston, Richard S.			A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia	NATURE GENETICS			English	Article							CELL DEVELOPMENT; NUCLEAR-BODY; EXPRESSION; FAMILIES; RISK	We conducted a genome-wide association study of 299,983 tagging SNPs for chronic lymphocytic leukemia (CLL) and performed validation in two additional series totaling 1,529 cases and 3,115 controls. We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). These data provide the first evidence for the existence of common, low-penetrance susceptibility to a hematological malignancy and new insights into disease causation in CLL.	[Di Bernardo, Maria Chiara; Crowther-Swanepoel, Dalemari; Broderick, Peter; Webb, Emily; Sellick, Gabrielle; Wild, Ruth; Sullivan, Kate; Vijayakrishnan, Jayaram; Wang, Yufei; Pittman, Alan M.; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Sunter, Nicola J.; Hall, Andrew G.; Allan, James M.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Dyer, Martin J. S.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Matutes, Estella; Dearden, Claire; Catovsky, Daniel] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England; [Mainou-Fowler, Tryfonia] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Jackson, Graham H.] Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Summerfield, Geoffrey] Queen Elizabeth Hosp, Dept Haematol, Newcastle Upon Tyne NE9 6SX, Tyne & Wear, England; [Harris, Robert J.; Pettitt, Andrew R.] Univ Liverpool, Sch Canc Studies, Div Haematol, Liverpool L69 3BX, Merseyside, England; [Hillmen, Peter] Gen Infirm, Dept Haematol, Leeds LS1 3EX, W Yorkshire, England; [Allsup, David J.] Hull Royal Infirm, Dept Haematol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bailey, James R.] Hull York Med Sch, Kingston Upon Hull HU16 5JQ, N Humberside, England; [Bailey, James R.] Univ Hull, Kingston Upon Hull HU16 5JQ, N Humberside, England; [Pratt, Guy] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9, W Midlands, England; [Pepper, Chris] Cardiff Univ, Sch Med, Dept Haematol, Cardiff, S Glam, Wales; [Fegan, Chris] Cardiff & Vale NHS Trust, Cardiff CF14 4XW, S Glam, Wales		Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	richard.houlston@icr.ac.uk	Hall, Andy/AAD-8622-2020; Pittman, Alan/AAP-2534-2020; Hall, Andrew G/B-3485-2009; Allan, James/B-4448-2009; Pittman, Alan M/D-6231-2012; Pepper, Chris/B-4357-2009; Allsup, David/H-2195-2017; Dyer, Martin/F-2691-2014	Pittman, Alan/0000-0002-8112-2987; Pittman, Alan M/0000-0002-8112-2987; Allsup, David/0000-0001-6159-6109; Dyer, Martin/0000-0002-5033-2236; Pepper, Chris/0000-0003-3603-8839; Broderick, Peter/0000-0002-8348-5829; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Webb, Emily/0000-0002-4019-7456; Houlston, Richard/0000-0002-5268-0242; Allan, James/0000-0002-7580-5087	Leukaemia Research Fund (LRF) [LRF05001 and 06002]; CLL Global Research Foundation, Cancer Research UKCancer Research UK; Bobby Moore Fund [C1298/A8362]; European UnionEuropean Commission [CPRB LSHC-CT-2004-503465]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934, MC_U132670597] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U132670597, G0000934] Funding Source: researchfish	Leukaemia Research Fund (LRF) provided principal funding for the study (LRF05001 and 06002). Additional funding was provided by CLL Global Research Foundation, Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund), the Arbib fund and the European Union (CPRB LSHC-CT-2004-503465). D. C.-S. was in receipt of a PhD studentship from the Institute of Cancer Research. We are grateful to M. Yuille for input into our early work on familial CLL. This study made use of genotyping data on the 1958 Birth Cohort. Genotyping data on controls was generated and generously supplied to us by P. Deloukas of the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the data are available from http:// www. wtccc. org. uk. We are grateful to all investigators who contributed to the study of acute leukemia, from which phase 3 controls were drawn, to members of the ICLLLC (Supplementary Note online) and to investigators who contributed to NSCCG and GELCAPS, from which phase 1 and 2 controls were drawn. Finally, we are grateful to all the study subjects for their participation.	Allan JM, 2001, P NATL ACAD SCI USA, V98, P11592, DOI 10.1073/pnas.191211198; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kovalevska L. M., 2006, Experimental Oncology, V28, P225; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Madani N, 2002, J VIROL, V76, P11133, DOI 10.1128/JVI.76.21.11133-11138.2002; Oliver PM, 2004, J EXP MED, V200, P1179, DOI 10.1084/jem.20041129; Petitti DB, 1994, METAANALYSIS DECISIO; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Sayala HA, 2006, BLOOD, V108, p14A, DOI 10.1182/blood.V108.11.34.34; Sellick GS, 2007, BLOOD, V110, P3326, DOI 10.1182/blood-2007-05-091561; Sellick GS, 2006, SEMIN ONCOL, V33, P195, DOI 10.1053/j.seminoncol.2006.01.013; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Weiss N S, 1979, Natl Cancer Inst Monogr, P139	28	266	272	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1204	1210		10.1038/ng.219			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	WOS:000259651000020	18758461				2022-01-24	
J	Benetti, R; Garcia-Cao, M; Blasco, MA				Benetti, Roberta; Garcia-Cao, Marta; Blasco, Maria A.			Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres	NATURE GENETICS			English	Article							CONSTITUTIVE HETEROCHROMATIN; HISTONE METHYLTRANSFERASES; CHROMOSOMAL INSTABILITY; DNA-DAMAGE; CELLS; MICE; STABILITY/; PROTEINS; COMPLEX; FAMILY	Mammalian telomeres have epigenetic marks of constitutive heterochromatin. Here, we study the impact of telomere length on the maintenance of heterochromatin domains at telomeres. Telomerase-deficient Terc(-/-) mice with short telomeres show decreased trimethylation of histone 3 at Lys9 ( H3K9) and histone 4 at Lys20 ( H4K20) in telomeric and subtelomeric chromatin as well as decreased CBX3 binding accompanied by increased H3 and H4 acetylation at these regions. Subtelomeric DNA methylation is also decreased in conjunction with telomere shortening in Terc(-/-) mice. In contrast, telomere repeat factors 1 and 2 show normal binding to telomeres independent of telomere length. These results indicate that loss of telomeric repeats leads to a change in the architecture of telomeric and subtelomeric chromatin consisting of loss of heterochromatic features leading to a more 'open' chromatin state. These observations highlight the importance of telomere repeats in the establishment of constitutive heterochromatin at mammalian telomeres and subtelomeres and point to histone modifications as important in counting telomere repeats.	Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain		Blasco, MA (corresponding author), Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; BENETTI, Roberta/0000-0001-8863-0821			Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Steinert S, 2004, MOL CELL BIOL, V24, P4571, DOI 10.1128/MCB.24.10.4571-4580.2004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4	29	266	280	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					243	250		10.1038/ng1952			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	WOS:000244063900024	17237781				2022-01-24	
J	Clark, RM; Wagler, TN; Quijada, P; Doebley, J				Clark, RM; Wagler, TN; Quijada, P; Doebley, J			A distant upstream enhancer at the maize domestication gene tb1 has pleiotropic effects on plant and inflorescent architecture	NATURE GENETICS			English	Article							MORPHOLOGICAL DIFFERENCES; QUANTITATIVE TRAITS; GENOME EVOLUTION; FLOWERING PLANTS; FRUIT SIZE; TEOSINTE; ORIGIN; MECHANISMS; EXPRESSION; DOMINANCE	Although quantitative trait locus (QTL) mapping has been successful in describing the genetic architecture of complex traits(1-4), the molecular basis of quantitative variation is less well understood, especially in plants such as maize that have large genome sizes. Regulatory changes at the teosinte branched1 (tb1) gene have been proposed to underlie QTLs of large effect for morphological differences that distinguish maize (Zea mays ssp. mays) from its wild ancestors, the teosintes (Z. mays ssp. parviglumis and mexicana)(1,5-7). We used a fine mapping approach to show that intergenic sequences similar to 58-69 kb 5' to the tb1 cDNA confer pleiotropic effects on Z. mays morphology. Moreover, using an allele-specific expression assay, we found that sequences > 41 kb upstream of tb1 act in cis to alter tb1 transcription. Our findings show that the large stretches of noncoding DNA that comprise the majority of many plant genomes can be a source of variation affecting gene expression and quantitative phenotypes.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA		Doebley, J (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	jdoebley@wisc.edu			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-58816, F32 GM-65008] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM058816, F32GM065008] Funding Source: NIH RePORTER		Alonso-Blanco C, 2005, INT J DEV BIOL, V49, P717, DOI 10.1387/ijdb.051994ca; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; DOEBLEY J, 1990, P NATL ACAD SCI USA, V87, P9888, DOI 10.1073/pnas.87.24.9888; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1993, GENETICS, V134, P559; DOEBLEY J, 1991, GENETICS, V129, P285; DOEBLEY J, 1995, GENETICS, V141, P333; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Gentleman, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lukens LN, 1999, GENET RES, V74, P291, DOI 10.1017/S0016672399004073; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Meagher TR, 2005, NEW PHYTOL, V168, P71, DOI 10.1111/j.1469-8137.2005.01527.x; Rostoks N, 2002, FUNCT INTEGR GENOMIC, V2, P51, DOI 10.1007/s10142-002-0055-5; Salvi S, 2005, TRENDS PLANT SCI, V10, P297, DOI 10.1016/j.tplants.2005.04.008; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Stam M, 2002, GENETICS, V162, P917; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wendel JF, 2002, GENETICA, V115, P37, DOI 10.1023/A:1016020030189; Wicker T, 2005, PLANT J, V41, P184, DOI 10.1111/j.1365-313X.2004.02285.x; Wicker T, 2001, PLANT J, V26, P307, DOI 10.1046/j.1365-313X.2001.01028.x	29	266	289	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					594	597		10.1038/ng1784			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	WOS:000237147500024	16642024				2022-01-24	
J	Camon, E; Magrane, M; Barrell, D; Binns, D; Fleischmann, W; Kersey, P; Mulder, N; Oinn, T; Maslen, J; Cox, A; Apweiler, R				Camon, E; Magrane, M; Barrell, D; Binns, D; Fleischmann, W; Kersey, P; Mulder, N; Oinn, T; Maslen, J; Cox, A; Apweiler, R			The gene ontology annotation (GOA) project: Implementation of GO in SWISS-PROT, TrEMBL, and InterPro	GENOME RESEARCH			English	Article							DATABASE; FAMILIES; RESOURCE; CLUSTR; PRODOM; MOUSE	Gene Ontology Annotation (GOA) is a project run by the European Bioinformatics Institute (EBI) that aims to provide assignments of terms from the Gene Ontology (GO) resource to gene products in a number of its databases (http:/ /www.ebi.ac.uk/GOA). In the first stage of this project, GO assignments have been applied to a data set representing the complete human proteome by a combination of electronic mappings and manual curation. This vocabulary has also been applied to the nonredundant proteome sets for all other completely sequenced organisms as well as to proteins from a wide range of organisms where the proteome is not yet complete.	European Bioinformat Inst, EMBL Outstn, Cambridge CB10 1SD, England; Sanger Inst, Cambridge CB10 1SA, England		Camon, E (corresponding author), European Bioinformat Inst, EMBL Outstn, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	camon@ebi.ac.uk		Kersey, Paul/0000-0002-7054-800X; Magrane, Michele/0000-0003-3544-996X; Mulder, Nicola J/0000-0003-4905-0941; Apweiler, Rolf/0000-0001-7078-200X	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002273] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [1R01HGO2273-01] Funding Source: Medline		Apweiler R, 2001, Brief Bioinform, V2, P9, DOI 10.1093/bib/2.1.9; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P44, DOI 10.1093/nar/29.1.44; Ashburner M, 2001, GENOME RES, V11, P1425; Attwood TK, 2002, NUCLEIC ACIDS RES, V30, P239, DOI 10.1093/nar/30.1.239; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Blake JA, 2002, NUCLEIC ACIDS RES, V30, P113, DOI 10.1093/nar/30.1.113; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Dodge C, 1998, NUCLEIC ACIDS RES, V26, P313, DOI 10.1093/nar/26.1.313; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fleischmann W, 1999, BIOINFORMATICS, V15, P228, DOI 10.1093/bioinformatics/15.3.228; Gelbart WM, 2002, NUCLEIC ACIDS RES, V30, P106; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hermjakob H, 2002, COMPAR FUNCT GENOM, V3, P47, DOI 10.1002/cfg.133; Hill DP, 2001, GENOMICS, V74, P121, DOI 10.1006/geno.2001.6513; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kriventseva EV, 2001, NUCLEIC ACIDS RES, V29, P33, DOI 10.1093/nar/29.1.33; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Schug J, 2002, GENOME RES, V12, P648, DOI 10.1101/gr.222902; SHIELDS DC, 1995, CYTOKINE, V7, P679, DOI 10.1006/cyto.1995.0080; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Stoesser G, 2003, NUCLEIC ACIDS RES, V31, P17, DOI 10.1093/nar/gkg021; Westbrook J, 2002, NUCLEIC ACIDS RES, V30, P245, DOI 10.1093/nar/30.1.245; Zdobnov EM, 2002, BIOINFORMATICS, V18, P368, DOI 10.1093/bioinformatics/18.2.368	29	266	276	0	19	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2003	13	4					662	672		10.1101/gr.461403			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	664DK	WOS:000182046300013	12654719	Bronze, Green Published			2022-01-24	
J	Baxter, RV; Ben Othmane, K; Rochelle, JM; Stajich, JE; Hulette, C; Dew-Knight, S; Hentati, F; Ben Hamida, M; Bel, S; Stenger, JE; Gilbert, JR; Pericak-Vance, MA; Vance, JM				Baxter, RV; Ben Othmane, K; Rochelle, JM; Stajich, JE; Hulette, C; Dew-Knight, S; Hentati, F; Ben Hamida, M; Bel, S; Stenger, JE; Gilbert, JR; Pericak-Vance, MA; Vance, JM			Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21	NATURE GENETICS			English	Article								We previously localized and fine-mapped Charcot Marie Tooth 4A (CMT4A), the autosoma[ recessive, demyelinating peripheral neuropathy, to chromosome 8. Through additional positional cloning, we have identified a good candidate gene, encoding ganglioside-induced differentiation-associated protein-1 (GDAP1). We found three different mutations in four different Tunisian families-two nonsense and one missense mutation. How mutations in GDAP1 lead to CMT4A remains to be understood.	Duke Univ, Med Ctr, Inst Genom Sci & Policy, Ctr Human Genet, Durham, NC 27710 USA; Inst Natl Neurol, Tunis 1007, Tunisia		Vance, JM (corresponding author), Duke Univ, Med Ctr, Inst Genom Sci & Policy, Ctr Human Genet, Res Pk Bldg 11 Room 105,Box 2903, Durham, NC 27710 USA.	jeff@chg.mc.duke.edu	Stajich, Jason Eric/C-7297-2008	Stajich, Jason Eric/0000-0002-7591-0020; Vance, Jeffery/0000-0003-3815-8199			Barhoumi C, 2001, NEUROMUSCULAR DISORD, V11, P27, DOI 10.1016/S0960-8966(00)00162-0; Ben Othmane K, 1998, NEUROGENETICS, V2, P18, DOI 10.1007/s100480050047; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; De Jonghe P, 1997, J Peripher Nerv Syst, V2, P370; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; Martinotti Alessia, 1992, Human Molecular Genetics, V1, P331, DOI 10.1093/hmg/1.5.331; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Vance JM, 2000, ARCH NEUROL-CHICAGO, V57, P638, DOI 10.1001/archneur.57.5.638	9	266	275	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					21	22		10.1038/ng796			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	WOS:000173105600006	11743579				2022-01-24	
J	Howard, TD; Koppelman, GH; Xu, JF; Zheng, SQL; Postma, DS; Meyers, DA; Bleecker, ER				Howard, TD; Koppelman, GH; Xu, JF; Zheng, SQL; Postma, DS; Meyers, DA; Bleecker, ER			Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKIN-TEST REACTIVITY; SERUM IGE LEVELS; INTERLEUKIN-4 RECEPTOR; AIRWAY INFLAMMATION; BRONCHIAL RESPONSIVENESS; IL4-RECEPTOR GENE; ATOPIC ASTHMA; ALPHA-GENE; ASSOCIATION; IL-4	Asthma is a common respiratory disease that is characterized by variable airways obstruction caused by acute and chronic bronchial inflammation; associated phenotypes include bronchial hyperresponsiveness (BHR), elevated total serum immunoglobulin E (IgE) levels, and skin tests positive to common allergens. Binding of interleukin-13 (IL13) or interleukin-4 (IL4) to the IL4 receptor (IL4R) induces the initial response for Th2 lymphocyte polarization. Both IL13 and IL4 are produced by Th2 cells and are capable of inducing isotype class-switching of B-cells to produce IgE after allergen exposure. These cytokines also share a common receptor component, IL4R. We have investigated five IL4RA single-nucleotide polymorphisms in a population of Dutch families ascertained through a proband with asthma. By considering the probands and their spouses as an unrelated sample, we observed significant associations of atopy and asthma-related phenotypes with several IL4RA polymorphisms, including S478P and total serum IgE levels (P=.0007). A significant gene-gene interaction between S478P in IL4RA and the - 1111 promoter variation in IL13, previously shown to be associated with BHR (P = .003), was detected. Individuals with the risk genotype for both genes were at almost five times greater risk for the development of asthma compared to individuals with both nonrisk genotypes (P = .0004). These data suggest that variations in IL4RA contribute to elevated total serum IgE levels, and interaction between IL4RA and IL13 markedly increases an individual's susceptibility to asthma.	Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genome, Winston Salem, NC 27157 USA; Univ Groningen Hosp, Dept Pulmonol, Groningen, Netherlands; Beatrixoord, Dept Pulm Rehabil, Haren, Netherlands		Bleecker, ER (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genome, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL066393, R01HL048341] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL048341, R01HL/48341, R01 HL066393, R01HL/66393] Funding Source: Medline		Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; BRUSSELLE G, 1995, AM J RESP CELL MOL, V12, P254, DOI 10.1165/ajrcmb.12.3.7873190; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; BURROWS B, 1995, J ALLERGY CLIN IMMUN, V95, P548, DOI 10.1016/S0091-6749(95)70317-9; Deichmann K, 1997, BIOCHEM BIOPH RES CO, V231, P696, DOI 10.1006/bbrc.1997.6115; Deichmann KA, 1998, CLIN EXP ALLERGY, V28, P151; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Gauchat JF, 1997, EUR J IMMUNOL, V27, P971, DOI 10.1002/eji.1830270425; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hackstein H, 2001, IMMUNOGENETICS, V53, P264, DOI 10.1007/s002510100324; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Henderson WR, 2000, J IMMUNOL, V164, P1086, DOI 10.4049/jimmunol.164.2.1086; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Howard TD, 2001, AM J RESP CELL MOL, V25, P377, DOI 10.1165/ajrcmb.25.3.4483; Howard TD, 1999, BIOTECHNIQUES, V26, P380, DOI 10.2144/99263bm01; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Kruse S, 1999, IMMUNOLOGY, V96, P365; Kruse S, 1999, INT IMMUNOL, V11, P1965, DOI 10.1093/intimm/11.12.1965; Liu X, 2000, J ALLERGY CLIN IMMUN, V106, P167, DOI 10.1067/mai.2000.107935; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Panhuysen CIM, 1998, AM J RESP CRIT CARE, V157, P1734, DOI 10.1164/ajrccm.157.6.9606088; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162	29	266	289	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					230	236		10.1086/338242			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	WOS:000172571900020	11709756	Bronze, Green Published			2022-01-24	
J	Marini, AM; Matassi, G; Raynal, V; Andre, B; Cartron, JP; Cherif-Zahar, B				Marini, AM; Matassi, G; Raynal, V; Andre, B; Cartron, JP; Cherif-Zahar, B			The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENE FAMILY; PERMEASE; EXPRESSION; EVOLUTION; CLONING; RH50	The Rhesus blood-group antigens are defined by a complex association of membrane polypeptides that includes the nonglycosylated Rh proteins (RhD and RhCE) and the RHag glycoprotein, which is strictly required for cell surface expression of these antigens', RhAG and the Rh polypeptides are erythroid-specific transmembrane proteins belonging to the same family (36% identity)(2,3). Despite their importance in transfusion medicine, the function of RhAG and Rh proteins remains unknown, except that their absence in Rh-null individuals leads to morphological and functional abnormalities of erythrocytes, known as the Rh-deficiency syndrome. We recently found significant sequence similarity between the Rh family proteins, especially RhAG, and Mep/Amt ammonium transporters(4,5). We show here that RhAG and also RhGK, a new human homologue expressed in kidney cells only, function as ammonium transport proteins when expressed in yeast. Both specifically complement the growth defect of a yeast mutant deficient in ammonium uptake. Moreover, ammonium efflux assays and growth tests in the presence of toxic concentrations of the analogue methylammonium indicate that RhAG and RhGK also promote ammonium export. Our results provide the first experimental evidence for a direct role of RhAG and RhGK in ammonium transport. These findings are of high interest, because no specific ammonium transport system has been characterized so far in human.	Free Univ Brussels, Lab Physiol Cellularie, Inst Biol & Med Mol, Gosselies, Belgium; Inst Natl Transfus Sanguine, Unite INSERM U76, F-75015 Paris, France; Stn Zool Anton Dohrn, Lab Evoluz Mol, Naples, Italy		Andre, B (corresponding author), Free Univ Brussels, Lab Physiol Cellularie, Inst Biol & Med Mol, Gosselies, Belgium.		Matassi, Giorgio/G-6301-2014; Andre, Bruno/D-1725-2010	Matassi, Giorgio/0000-0003-4923-226X; Cherif-Zahar, Baya/0000-0002-4965-7252			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; CherifZahar B, 1996, NAT GENET, V12, P168, DOI 10.1038/ng0296-168; DEJONG CH, 1996, J GASTROENTEROL S, V218, P61; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GOOD DW, 1985, AM J PHYSIOL, V248, pF459, DOI 10.1152/ajprenal.1985.248.4.F459; HUIZENGA JR, 1994, ANN CLIN BIOCHEM, V31, P529, DOI 10.1177/000456329403100602; Iraqui I, 1999, MOL CELL BIOL, V19, P989; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Kitano T, 1998, BIOCHEM BIOPH RES CO, V249, P78, DOI 10.1006/bbrc.1998.9074; KNEPPER MA, 1989, PHYSIOL REV, V69, P179, DOI 10.1152/physrev.1989.69.1.179; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Matassi G, 1999, J MOL EVOL, V48, P151, DOI 10.1007/PL00006453; Matassi G, 1998, GENOMICS, V47, P286, DOI 10.1006/geno.1997.5112; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakamura RL, 1997, J BIOL CHEM, V272, P1011, DOI 10.1074/jbc.272.2.1011; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Seack J, 1997, IMMUNOGENETICS, V46, P493, DOI 10.1007/s002510050310	26	266	271	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					341	344		10.1038/81656			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	WOS:000165176500025	11062476				2022-01-24	
J	Bargal, R; Avidan, N; Ben-Asher, E; Olender, Z; Zeigler, M; Frumkin, A; Raas-Rothschild, A; Glusman, G; Lancet, D; Bach, G				Bargal, R; Avidan, N; Ben-Asher, E; Olender, Z; Zeigler, M; Frumkin, A; Raas-Rothschild, A; Glusman, G; Lancet, D; Bach, G			Identification of the gene causing mucolipidosis type IV	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; NATURAL-HISTORY; PROTEIN; PREDICTION; DATABASE; DNA	Mucolipidosis type IV (MLIV) is an autosomal recessive, neurodegenerative, lysosomal storage disorder(1) characterized by psychomotor retardation and ophthalmological abnormalities including corneal opacities, retinal degeneration and strabismus. Most patients reach a maximal developmental level of 12-15 months(2). The disease was classified as a mucolipidosis following observations by electron microscopy indicating the lysosomal storage of lipids together with water-soluble, granulated substances(1,3-6). Over 80% of the MLIV patients diagnosed are Ashkenazi Jews, including severely affected and mildly affected patients(3,4). The gene causing MLIV was previously mapped to human chromosome 19p13.2-13.3 in a region of approximately 1 cM (ref. 7). Haplotype analysis in the MLIV gene region of over 70 MLIV Ashkenazi chromosomes indicated the existence of two founder chromosomes among 95% of the Ashkenazi MLIV families: a major haplotype in 72% and a minor haplotype in 23% of the MLIV chromosomes (ref. 7, and G.B., unpublished data). The remaining 5% are distinct haplotypes found only in single patients. The basic metabolic defect causing the lysosomal storage in MLIV has not yet been identified. Thus. positional cloning was an alternative to identify the MLIV gene. We report here the identification of a new gene in this human chromosomal region in which MLIV-specific mutations were identified.	Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel; Weizmann Inst Sci, Dept Mol Genet, Crown Human Genome Ctr, IL-76100 Rehovot, Israel		Bach, G (corresponding author), Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel.						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMIR N, 1987, PEDIATRICS, V79, P953; BACH G, 1992, GENETIC DIVERSITY AMONG JEWS, P301; BERMAN ER, 1974, J PEDIATR-US, V84, P519, DOI 10.1016/S0022-3476(74)80671-2; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHITAYAT D, 1991, AM J MED GENET, V41, P313, DOI 10.1002/ajmg.1320410310; Glusman G, 2000, BIOINFORMATICS, V16, P482, DOI 10.1093/bioinformatics/16.5.482; GOEBEL HH, 1982, CLIN NEUROPATHOL, V1, P73; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Harris PC, 1999, HUM MOL GENET, V8, P1861, DOI 10.1093/hmg/8.10.1861; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MERIN S, 1975, INVEST OPHTH VISUAL, V14, P437; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REIS S, 1993, AM J MED GENET, V47, P392; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Sessa A, 1997, J NEPHROL, V10, P295; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; SOLOVYEV V, 1997, ISMB, V5, P294	21	266	273	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					118	121		10.1038/79095			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000032	10973263				2022-01-24	
J	Pastinen, T; Raitio, M; Lindroos, K; Tainola, P; Peltonen, L; Syvanen, AC				Pastinen, T; Raitio, M; Lindroos, K; Tainola, P; Peltonen, L; Syvanen, AC			A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays	GENOME RESEARCH			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DENSITY OLIGONUCLEOTIDE ARRAYS; NEURONAL CEROID-LIPOFUSCINOSIS; LOW-INCIDENCE POPULATION; GENETIC BIT ANALYSIS; MUTATION DETECTION; SEQUENCE-ANALYSIS; CYSTIC-FIBROSIS; FINNISH POPULATION; COMMON MUTATION	This study describes a practical system that allows high-throughput genotyping of single nucleotide polymorphisms (SNPs) and detection of mutations by allele-specific extension on primer arrays. The method relies on the sequence-specific extension of two immobilized allele-specific primers that differ at their 3'-nucleotide defining the alleles, by a reverse transcriptase (RT) enzyme at optimized reaction conditions. We show the potential of this simple one-step procedure performed on spotted primer arrays of low redundancy by generating over 8000 genotypes for 40 mutations or SNPs. The genotypes formed three easily identifiable clusters and all known genotypes were assigned correctly. Higher degrees of multiplexing will be possible with this system as the power of discrimination between genotypes remained unaltered in the presence of over 100 amplicons in a single reaction. The enzyme-assisted reaction provides highly specific allele distinction, evidenced by its ability to detect minority sequence variants present in 5% of a sample at multiple sites. The assay format based on miniaturized reaction chambers at standard 384-well spacing on microscope slides carrying arrays with two primers per SNP for 80 samples results in low consumption of reagents and makes parallel analysis of a large number of samples convenient. In the assay one or two fluorescent nucleotide analogs are used as labels, and thus the genotyping results can be interpreted with presently available array scanners and software. The general accessibility, simple set-up, and the robust procedure of the array-based genotyping system described here will offer an easy way to increase the throughput of SNP typing in any molecular biology laboratory.	Natl Publ Hlth Inst, Dept Human Mol Genet, FIN-00300 Helsinki, Finland; Gonda Neurosci & Genet Res Ctr, Dept Human Genet, Los Angeles, CA 90095 USA; Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden		Pastinen, T (corresponding author), McGill Univ, Ctr Hlth, Montreal Genome Ctr, Room C10-133,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	tomi@orion.ri.mgh.mcgill.ca					AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Beutler E, 1997, MOL MED, V3, P397, DOI 10.1007/BF03401686; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; BUNGE S, 1994, HUM MOL GENET, V3, P861, DOI 10.1093/hmg/3.6.861; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; Cox D.W, 1989, METABOLIC BASIS INHE, P2409; Cronin MT, 1996, HUM MUTAT, V7, P244, DOI 10.1002/(SICI)1098-1004(1996)7:3<244::AID-HUMU9>3.0.CO;2-A; CROSS NCP, 1990, LANCET, V335, P306, DOI 10.1016/0140-6736(90)90603-3; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Drobyshev A, 1997, GENE, V188, P45, DOI 10.1016/S0378-1119(96)00775-5; Dubiley S, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e19; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; *FINN GERM APECED, 1997, NAT GENET, V17, P339; Gerry NP, 1999, J MOL BIOL, V292, P251, DOI 10.1006/jmbi.1999.3063; Gilles PN, 1999, NAT BIOTECHNOL, V17, P365, DOI 10.1038/7921; GULDBERG P, 1995, J MED GENET, V32, P976, DOI 10.1136/jmg.32.12.976; Gunderson KL, 1998, GENOME RES, V8, P1142, DOI 10.1101/gr.8.11.1142; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; GUO Z, 1994, NUCLEIC ACIDS RES, V22, P5456, DOI 10.1093/nar/22.24.5456; Hacia JC, 1998, GENOME RES, V8, P1245, DOI 10.1101/gr.8.12.1245; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Hacia JG, 1998, NUCLEIC ACIDS RES, V26, P4975, DOI 10.1093/nar/26.21.4975; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Head SR, 1997, NUCLEIC ACIDS RES, V25, P5065, DOI 10.1093/nar/25.24.5065; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Huopaniemi L, 1999, EUR J HUM GENET, V7, P368, DOI 10.1038/sj.ejhg.5200300; Ijlst L, 1996, J CLIN INVEST, V98, P1028, DOI 10.1172/JCI118863; IKONEN E, 1991, EMBO J, V10, P51, DOI 10.1002/j.1460-2075.1991.tb07920.x; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jeffrey GP, 1999, NAT GENET, V22, P325, DOI 10.1038/11892; KERE J, 1994, HUM GENET, V93, P162, DOI 10.1007/BF00210603; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; KURE S, 1992, J CLIN INVEST, V90, P160, DOI 10.1172/JCI115831; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; MATSUBARA Y, 1990, BIOCHEM BIOPH RES CO, V171, P498, DOI 10.1016/0006-291X(90)91421-N; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; Mizuno Y, 1999, NUCLEIC ACIDS RES, V27, P1345, DOI 10.1093/nar/27.5.1345; Nguyen HK, 1999, NUCLEIC ACIDS RES, V27, P1492, DOI 10.1093/nar/27.6.1492; NIKIFOROV TT, 1994, NUCLEIC ACIDS RES, V22, P4167, DOI 10.1093/nar/22.20.4167; Pastinen T, 1998, HUM MOL GENET, V7, P1453, DOI 10.1093/hmg/7.9.1453; Pastinen T, 1998, AIDS RES HUM RETROV, V14, P695, DOI 10.1089/aid.1998.14.695; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; Sapolsky RJ, 1999, GENET ANAL-BIOMOL E, V14, P187, DOI 10.1016/S1050-3862(98)00026-6; Savukoski M, 1998, NAT GENET, V19, P286, DOI 10.1038/975; Schafer AJ, 1998, NAT BIOTECHNOL, V16, P33, DOI 10.1038/nbt0198-33; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Shumaker JM, 1996, HUM MUTAT, V7, P346, DOI 10.1002/(SICI)1098-1004(1996)7:4<346::AID-HUMU9>3.3.CO;2-9; SOUTHERN EM, 1992, GENOMICS, V13, P1008, DOI 10.1016/0888-7543(92)90014-J; Southern EM, 1996, TRENDS GENET, V12, P110, DOI 10.1016/0168-9525(96)81422-3; STLOUIS M, 1994, HUM MOL GENET, V3, P69, DOI 10.1093/hmg/3.1.69; SYVANEN AC, 1992, GENOMICS, V12, P590, DOI 10.1016/0888-7543(92)90452-X; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	70	266	290	0	14	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2000	10	7					1031	1042		10.1101/gr.10.7.1031			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	335VE	WOS:000088264800016	10899152	Green Published, Bronze			2022-01-24	
J	Siegfried, Z; Eden, S; Mendelsohn, M; Feng, X; Tsuberi, BZ; Cedar, H				Siegfried, Z; Eden, S; Mendelsohn, M; Feng, X; Tsuberi, BZ; Cedar, H			DNA methylation represses transcription in vivo	NATURE GENETICS			English	Article							CELL-SPECIFIC DEMETHYLATION; GLOBIN GENE-EXPRESSION; CYTOSINE METHYLATION; CPG ISLAND; ACTIVATION; BINDING; SITES	DNA in somatic tissue is characterized by a bimodal pattern of methylation, which is established in the animal through a series of developmental events'. In the mouse blastula, most DNA is unmethylated, but after implantation a wave of de novo methylation modifies most of the genome, excluding the majority of Cpt islands, which are mainly associated with housekeeping genes. This genomic methylation pattern is broadly maintained during the life of the organism by maintenance methylation, and generally correlates with gene expression. Experiments both in vitro(3-5) and in vivo(6-9) indicate that methylation inhibits transcription, It has not yet been possible, however, to determine the role of DNA methylation on specific. sequences during normal development Cis-acting regulatory elements and trans-acting factors appear to be involved in both stage- and tissue-specific demethylation processes(10,11). Spl-like elements have a key role in protecting the CpG island of Aprt (encoding adenine phosphoribosyl transferase) from de novo methylation, and when these elements are specifically mutated, the Aprf CpG island becomes methylated genome, in transgenic mice(12,13) . We have now characterized an embryo-specific element,ment from the CpG island sequence upstream of Aprt that can protect itself from de novo methylation in transgenic mice as well as reduce methylation of flanking sequences. We placed this element on a removable cassette adjacent to a human HBB (encoding P-globin) reporter and generated a transgene whose methylation pattern can be switched in vivo. Analysis of globin transcription in this system showed that methylation in cis inhibits gt,ne expression in a variety of tissues, indicating that DNA modification may serve as a global genomic repressor.	Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem, IL-91120 Jerusalem, Israel; Columbia Univ, Sch Med, Ctr Neurobiol & Behav, New York, NY 10032 USA		Cedar, H (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem, IL-91120 Jerusalem, Israel.	cedar@md2.huji.ac.il					BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HOGAN B, 1986, MANIPULATING MOUSE E, P92; HORNSTRA IK, 1994, MOL CELL BIOL, V14, P1419, DOI 10.1128/MCB.14.2.1419; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; KLAGES S, 1992, NUCLEIC ACIDS RES, V20, P1925, DOI 10.1093/nar/20.8.1925; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nickel J, 1995, NUCLEIC ACIDS RES, V23, P4785, DOI 10.1093/nar/23.23.4785; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; YISRAELI J, 1986, CELL, V46, P409, DOI 10.1016/0092-8674(86)90661-6; YISRAELI J, 1988, P NATL ACAD SCI USA, V85, P4638, DOI 10.1073/pnas.85.13.4638; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	28	266	272	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1999	22	2					203	206		10.1038/9727			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	WOS:000080680900031	10369268				2022-01-24	
J	D'Adamo, P; Menegon, A; Lo Nigro, C; Grasso, M; Gulisano, M; Tamanini, F; Bienvenu, T; Gedeon, AK; Oostra, B; Wu, SK; Tandon, A; Valtorta, F; Balch, WE; Chelly, J; Toniolo, D				D'Adamo, P; Menegon, A; Lo Nigro, C; Grasso, M; Gulisano, M; Tamanini, F; Bienvenu, T; Gedeon, AK; Oostra, B; Wu, SK; Tandon, A; Valtorta, F; Balch, WE; Chelly, J; Toniolo, D			Mutations in GDI1 are responsible for X-linked non-specific mental retardation	NATURE GENETICS			English	Article							GDP-DISSOCIATION INHIBITOR; GTP-BINDING PROTEIN; HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; RAB PROTEINS; GENE; EXOCYTOSIS; XQ28; IDENTIFICATION; EXPRESSION	Rab GDP-dissociation inhibitors (GDI) are evolutionarily conserved proteins that play an essential role in the recycling of Rab GTPases required for vesicular transport through the secretory pathway We have found mutations in the GDI1 gene (which encodes alpha GDI) in two families affected with X-linked non-specific mental retardation. One of the mutations caused a non-conservative substitution (L92P) which reduced binding and recycling of RAB3A, the second was a null mutation. Our results show that both functional and developmental alterations in the neuron may account for the severe impairment of learning abilities as a consequence of mutations in GDI1, emphasizing its critical role in development of human intellectual and learning abilities.	CNR, Inst Genet Biochem & Evolut, I-27100 Pavia, Italy; Galliera Hosp, Lab Human Genet, Genoa, Italy; HSR, DIBIT, Milan, Italy; Inst Cochin Genet Mol, F-75014 Paris, France; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA, Australia; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Scripps Res Inst, Dept Mol & Cell Biol, La Jolla, CA USA; Univ Milan, Dept Med Pharmacol, Milan, Italy		Toniolo, D (corresponding author), CNR, Inst Genet Biochem & Evolut, I-27100 Pavia, Italy.	Toniola@igbe.pv.cnr.it	Toniolo, Daniela/AAE-2969-2019; menegon, andrea/AAN-3736-2020; Gedeon, Agi/G-7890-2011; D'Adamo, Patrizia/AAN-3919-2020; Chelly, Jamel/J-7528-2015; Flavia, Valtorta/F-3450-2012; Grasso, Marina/AAC-8722-2019	Toniolo, Daniela/0000-0001-9545-6032; menegon, andrea/0000-0002-2396-756X; D'Adamo, Patrizia/0000-0002-0312-5541; Chelly, Jamel/0000-0002-0939-8719; Flavia, Valtorta/0000-0001-9556-4746; s, hema/0000-0002-3440-9475; Grasso, Marina/0000-0001-5682-1789; GULISANO, Massimo/0000-0001-8654-1745	NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY011606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM033301] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY11606] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM33301] Funding Source: Medline; TelethonFondazione Telethon [E.0297] Funding Source: Medline		BACHNER D, 1995, HUM MOL GENET, V4, P701, DOI 10.1093/hmg/4.4.701; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BEAN JA, 1997, NEURON, V19, P751; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; BURGAYA F, 1995, EUR J NEUROSCI, V7, P1810, DOI 10.1111/j.1460-9568.1995.tb00700.x; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; Claes S, 1997, CLIN GENET, V52, P155; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DEKKER LV, 1991, J NEUROCHEM, V56, P1146, DOI 10.1111/j.1471-4159.1991.tb11404.x; desPortes V, 1997, AM J HUM GENET, V60, P903; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gedeon AK, 1996, AM J MED GENET, V64, P158, DOI 10.1002/(SICI)1096-8628(19960712)64:1<158::AID-AJMG26>3.0.CO;2-L; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; Hamel BCJ, 1996, AM J MED GENET, V64, P131, DOI 10.1002/(SICI)1096-8628(19960712)64:1<131::AID-AJMG22>3.3.CO;2-T; Lubs HA, 1996, AM J MED GENET, V64, P147, DOI 10.1002/(SICI)1096-8628(19960712)64:1<147::AID-AJMG25>3.0.CO;2-M; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NUOFFER C, 1995, METHOD ENZYMOL, V257, P3; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEDLACEK Z, 1994, MAMM GENOME, V5, P633, DOI 10.1007/BF00411459; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; SUEDHOF TC, 1997, NEURON, V18, P519; Takai Y, 1996, GENES CELLS, V1, P615, DOI 10.1046/j.1365-2443.1996.00257.x; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1	42	266	274	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					134	139		10.1038/487			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	WOS:000073865100019	9620768				2022-01-24	
J	LAMB, BT; SISODIA, SS; LAWLER, AM; SLUNT, HH; KITT, CA; KEARNS, WG; PEARSON, PL; PRICE, DL; GEARHART, JD				LAMB, BT; SISODIA, SS; LAWLER, AM; SLUNT, HH; KITT, CA; KEARNS, WG; PEARSON, PL; PRICE, DL; GEARHART, JD			INTRODUCTION AND EXPRESSION OF THE 400 KILOBASE PRECURSOR AMYLOID PROTEIN GENE IN TRANSGENIC MICE	NATURE GENETICS			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; FAMILIAL ALZHEIMERS-DISEASE; AGE-ASSOCIATED INCLUSIONS; BETA-PROTEIN; NEUROFIBRILLARY TANGLES; GEL-ELECTROPHORESIS; TERMINAL FRAGMENT; DOWNS-SYNDROME; CLEAVAGE SITE; MOUSE-BRAIN	Overexpression of the gene encoding the beta-amyloid precursor protein (APP) may have a key role in the pathogenesis of both Alzheimer's disease (AD) and Down Syndrome (DS). We have therefore introduced a 650 kilobase (kb) yeast artificial chromosome (YAC) that contains the entire, unrearranged 400 kb human APP gene into mouse embryonic stem (ES) cells by lipid-mediated transfection. ES lines were generated that contain a stably integrated, unrearranged human APP gene. Moreover, we demonstrate germ line transmission of the APP YAC in transgenic mice and expression of human APP mRNA and protein at levels comparable to endogenous APP. This transgenic strategy may prove invaluable for the development of mouse models for AD and DS.	JOHNS HOPKINS UNIV, SCH MED,DEPT GYNECOL & OBSTET,DEV GENET LAB, 205 PHYSIOL BLDG,725 N WOLFE ST, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, DEPT MED, BALTIMORE, MD 21205 USA				Kearns, William/AAE-7699-2020				ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CHOI TK, 1993, NAT GENET, V4, P117, DOI 10.1038/ng0693-117; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CONNELLY C, 1991, GENOMICS, V10, P10, DOI 10.1016/0888-7543(91)90477-V; Davis R W, 1980, Methods Enzymol, V65, P404; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HIETER P, 1990, GENOME ANAL, V1, P83; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; JUCKER M, 1992, SCIENCE, V255, P1443, DOI 10.1126/science.1542796; KAMMESHEIDT A, 1992, P NATL ACAD SCI USA, V89, P10857, DOI 10.1073/pnas.89.22.10857; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0; KAWABATA S, 1992, NATURE, V356, P23, DOI 10.1038/356023b0; Kemper T.N., 1984, CLIN NEUROLOGY AGING, P9; Lamb Bruce T., 1991, Gene Expression, V1, P185; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LINNEY E, 1983, CELL, V35, P693, DOI 10.1016/0092-8674(83)90102-2; MANN DMA, 1989, J NEUROL SCI, V89, P169, DOI 10.1016/0022-510X(89)90019-1; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; PRICE DL, 1992, AM J PATHOL, V141, P767; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Robertson E.J., 1987, TERATOCARCINOMAS EMB, P71; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sisodia S S, 1992, Curr Opin Neurobiol, V2, P648, DOI 10.1016/0959-4388(92)90033-H; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STRAUSS WM, 1993, SCIENCE, V259, P1904, DOI 10.1126/science.8096090; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TASSONE F, 1992, AM J HUM GENET, V51, P1251; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; WANG R, 1991, J BIOL CHEM, V266, P16960; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WIRAK D, 1992, SCIENCE, V255, P1445, DOI 10.1126/science.255.5050.1445; WIRAK DO, 1991, EMBO J, V10, P289, DOI 10.1002/j.1460-2075.1991.tb07949.x; WIRAK DO, 1991, SCIENCE, V253, P323, DOI 10.1126/science.1857970; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N; YOSHIKAI S, 1991, GENE, V102, P291, DOI 10.1016/0378-1119(91)90093-Q	67	266	269	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1993	5	1					22	29		10.1038/ng0993-22			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	WOS:A1993LV56500010	8220418				2022-01-24	
J	KANDT, RS; HAINES, JL; SMITH, M; NORTHRUP, H; GARDNER, RJM; SHORT, MP; DUMARS, K; ROACH, ES; STEINGOLD, S; WALL, S; BLANTON, SH; FLODMAN, P; KWIATKOWSKI, DJ; JEWELL, A; WEBER, JL; ROSES, AD; PERICAKVANCE, MA				KANDT, RS; HAINES, JL; SMITH, M; NORTHRUP, H; GARDNER, RJM; SHORT, MP; DUMARS, K; ROACH, ES; STEINGOLD, S; WALL, S; BLANTON, SH; FLODMAN, P; KWIATKOWSKI, DJ; JEWELL, A; WEBER, JL; ROSES, AD; PERICAKVANCE, MA			LINKAGE OF AN IMPORTANT GENE LOCUS FOR TUBEROUS SCLEROSIS TO A CHROMOSOME 16 MARKER FOR POLYCYSTIC KIDNEY-DISEASE	NATURE GENETICS			English	Article							HYDROXYLASE PAH LOCUS; ABO BLOOD-GROUP; PCR DETECTION; V-ABL; HETEROGENEITY; RECOMBINATION; POLYMORPHISM; RFLP	Tuberous sclerosis complex (TSC) is an autosomal dominant disorder of unknown aetiology that affects numerous body systems including skin, brain and kidneys. Some TSC has been linked to chromosome 9, additional TSC genes on chromosomes 11 and 12 have been proposed, but the majority of TSC families remain unlinked. Using TSC families in which data had excluded linkage to chromosome 9, we failed to detect linkage with loci on chromosomes 11, 12 and others. One marker examined was D16S283, the closest locus on the proximal side of the polycystic kidney disease type 1 (PKD1) gene. Linkage between TSC and D16S283 demonstrated a lod score of 9.50 at THETA = 0.02 with one family independently presenting a lod score of 4.44 at THETA = 0.05. These data reveal an important TSC locus near the region of PKD1 on chromosome 16p13.	MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET LAB,CHARLESTON,MA 02129; UNIV CALIF IRVINE,DEPT PEDIAT,IRVINE,CA 92717; UNIV TEXAS,SCH MED,DEPT PEDIAT,DIV MED GENET,HOUSTON,TX 77030; UNIV OTAGO,DEPT PEDIAT & CHILD HLTH,DUNEDIN,NEW ZEALAND; UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DIV PEDIAT NEUROL,DALLAS,TX 75235; UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA 22908; BRIGHAM & WOMENS HOSP,DIV EXPTL MED & HEMATOL ONCOL,BOSTON,MA 02115; MARSHFIELD MED RES FDN,MARSHFIELD,WI 54449		KANDT, RS (corresponding author), UNIV N CAROLINA,MED CTR,DEPT PEDIAT,DIV NEUROL,DURHAM,NC 27710, USA.		Blanton, Susan Halloran/ABF-1323-2021; Haines, Jonathan/C-3374-2012; Roach, Ewell/E-3958-2011	Haines, Jonathan/0000-0002-4351-4728; 			ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BERNSTEIN J, 1974, Birth Defects Original Article Series, V10, P35; BURLEY MW, IN PRESS ANN HUM GEN; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CONNOR JM, 1987, J MED GENET, V24, P544, DOI 10.1136/jmg.24.9.544; DWORNICZAK B, 1991, NUCLEIC ACIDS RES, V19, P1958; FAHSOLD R, 1991, HUM GENET, V88, P85, DOI 10.1007/BF00204934; FRYER AE, 1987, LANCET, V1, P659; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; GLEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103; HAINES JL, 1991, ANN NY ACAD SCI, V615, P256; HAINES JL, 1991, CYTOGENET CELL GENET, V58, P1939; HAINES JL, 1991, AM J HUM GENET, V49, P764; HAINES JL, IN PRESS ANN HUM GEN; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; JANSSEN LAJ, 1990, GENOMICS, V8, P237, DOI 10.1016/0888-7543(90)90277-2; JANSSEN LAJ, 1991, ANN NY ACAD SCI, V615, P306; KANDT RS, 1989, EXP NEUROL, V104, P223, DOI 10.1016/0014-4886(89)90033-2; KANDT RS, 1991, ANN NY ACAD SCI, V615, P284; KANDT RS, IN PRESS ANN HUM GEN; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LITT M, 1990, NUCLEIC ACIDS RES, V18, P5921, DOI 10.1093/nar/18.19.5921-a; NORTHRUP H, 1987, LANCET, V2, P804; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; POVEY S, 1988, LANCET, V2, P279; POVEY S, 1991, ANN NY ACAD SCI, V615, P298; POVEY S, 1992, IN PRESS ANN HUM GEN; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; SAMPSON JR, 1989, J MED GENET, V26, P511, DOI 10.1136/jmg.26.8.511; SANTOS C C, 1990, Current Opinion in Pediatrics, V2, P1075, DOI 10.1097/00008480-199012000-00006; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; STAPLETON FB, 1980, J PEDIATR-US, V97, P574, DOI 10.1016/S0022-3476(80)80011-4; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEDEMEYER N, 1991, NUCLEIC ACIDS RES, V19, P1959, DOI 10.1093/nar/19.8.1959; WIEDERHOLT WC, 1985, NEUROLOGY, V35, P600, DOI 10.1212/WNL.35.4.600; [No title captured]	43	266	273	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					37	41		10.1038/ng0992-37			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	WOS:A1992JM64600013	1303246	Green Published			2022-01-24	
J	NAGYLAKI, T				NAGYLAKI, T			CONDITIONS FOR EXISTENCE OF CLINES	GENETICS			English	Article									UNIV WISCONSIN, DEPT MED GENET, MADISON, WI 53706 USA; UNIV WISCONSIN, MATH RES CTR, MADISON, WI 53706 USA								BHARUCHAREID AT, 1960, ELEMENTS THEORY MARK; CONLEY CC, 1974, 1444 U WISC MATH RES; Ewens W, 1969, POPULATION GENETICS; EYLAND EA, 1971, GENETICS, V69, P399; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; FISHER RA, 1950, BIOMETRICS, V6, P353, DOI 10.2307/3001780; FLEMING WH, 1974, NONLINEAR PARABOLIC; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; HANSON WD, 1966, BIOMETRICS, V22, P453, DOI 10.2307/2528182; KARLIN S, 1972, THEOR POPUL BIOL, V3, P186, DOI 10.1016/0040-5809(72)90026-3; KIMURA M, 1969, GENET RES, V13, P127, DOI 10.1017/S0016672300002846; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; KIMURA M, 1964, ANN REPT NAT I GENET, V15, P95; MAY RM, IN PRESS; MAYNARD SMITH J., 1966, AMER NATUR, V100, P637; Mayr E, 1963, ANIMAL SPECIES EVOLU; MORAN PAP, 1962, STATISTICAL PROCESSE; NAGYLAKI T, 1974, THEOR POPUL BIOL, V5, P257, DOI 10.1016/0040-5809(74)90045-8; NAGYLAKI T, 1974, P NATL ACAD SCI USA, V71, P2932, DOI 10.1073/pnas.71.8.2932; NAGYLAKI T, IN PRESS; OLIVER FWJ, 1964, HDB MATHEMATICAL FUN; PIMENTEL D, 1967, AM NAT, V101, P493, DOI 10.1086/282513; SLATKIN M, 1973, GENETICS, V75, P733; STEBBINS G. L., 1950, VARIATION EVOLUTION	24	266	269	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics		1975	80	3					595	615					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AL483	WOS:A1975AL48300014	1232026				2022-01-24	
J	Andersson, AK; Ma, J; Wang, JM; Chen, X; Gedman, AL; Dang, JJ; Nakitandwe, J; Holmfeldt, L; Parker, M; Easton, J; Huether, R; Kriwacki, R; Rusch, M; Wu, G; Li, YJ; Mulder, H; Raimondi, S; Pounds, S; Kang, GL; Shi, L; Becksfort, J; Gupta, P; Payne-Turner, D; Vadodaria, B; Boggs, K; Yergeau, D; Manne, J; Song, GC; Edmonson, M; Nagahawatte, P; Wei, L; Cheng, C; Pei, DQ; Sutton, R; Venn, NC; Chetcuti, A; Rush, A; Catchpoole, D; Heldrup, J; Fioretos, T; Lu, C; Ding, L; Pui, CH; Shurtleff, S; Mullighan, CG; Mardis, ER; Wilson, RK; Gruber, TA; Zhang, JH; Downing, JR				Andersson, Anna K.; Ma, Jing; Wang, Jianmin; Chen, Xiang; Gedman, Amanda Larson; Dang, Jinjun; Nakitandwe, Joy; Holmfeldt, Linda; Parker, Matthew; Easton, John; Huether, Robert; Kriwacki, Richard; Rusch, Michael; Wu, Gang; Li, Yongjin; Mulder, Heather; Raimondi, Susana; Pounds, Stanley; Kang, Guolian; Shi, Lei; Becksfort, Jared; Gupta, Pankaj; Payne-Turner, Debbie; Vadodaria, Bhavin; Boggs, Kristy; Yergeau, Donald; Manne, Jayanthi; Song, Guangchun; Edmonson, Michael; Nagahawatte, Panduka; Wei, Lei; Cheng, Cheng; Pei, Deqing; Sutton, Rosemary; Venn, Nicola C.; Chetcuti, Albert; Rush, Amanda; Catchpoole, Daniel; Heldrup, Jesper; Fioretos, Thoas; Lu, Charles; Ding, Li; Pui, Ching-Hon; Shurtleff, Sheila; Mullighan, Charles G.; Mardis, Elaine R.; Wilson, Richard K.; Gruber, Tanja A.; Zhang, Jinghui; Downing, James R.		St Jude Children's Res Hosp-Washin	The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; K-RAS MUTATIONS; CHROMOSOMAL TRANSLOCATIONS; GENETIC ALTERATIONS; CANCER; IDENTIFICATION; RESISTANCE; T(4/11); FLT3; BREAKPOINT	Infant acute lymphoblastic leukemia (ALL) with MLL rearrangements (MLL-R) represents a distinct leukemia with a poor prognosis. To define its mutational landscape, we performed whole-genome, exome, RNA and targeted DNA sequencing on 65 infants (47 MLL-R and 18 non-MLL-R cases) and 20 older children (MLL-R cases) with leukemia. Our data show that infant MLL-R ALL has one of the lowest frequencies of somatic mutations of any sequenced cancer, with the predominant leukemic clone carrying a mean of 1.3 non-silent mutations. Despite this paucity of mutations, we detected activating mutations in kinase-PI3K-RAS signaling pathway components in 47% of cases. Surprisingly, these mutations were often subclonal and were frequently lost at relapse. In contrast to infant cases, MLL-R leukemia in older children had more somatic mutations (mean of 6.5 mutations/case versus 1.3 mutations/case, P = 7.15 x 10(-5)) and had frequent mutations (45%) in epigenetic regulators, a category of genes that, with the exception of MLL, was rarely mutated in infant MLL-R ALL.	[Andersson, Anna K.; Ma, Jing; Gedman, Amanda Larson; Dang, Jinjun; Nakitandwe, Joy; Holmfeldt, Linda; Raimondi, Susana; Payne-Turner, Debbie; Song, Guangchun; Pui, Ching-Hon; Shurtleff, Sheila; Mullighan, Charles G.; Gruber, Tanja A.; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Andersson, Anna K.; Fioretos, Thoas] Lund Univ, Dept Clin Genet, Lund, Sweden; [Wang, Jianmin; Chen, Xiang; Parker, Matthew; Huether, Robert; Rusch, Michael; Wu, Gang; Li, Yongjin; Becksfort, Jared; Gupta, Pankaj; Edmonson, Michael; Nagahawatte, Panduka; Wei, Lei; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Easton, John; Mulder, Heather; Vadodaria, Bhavin; Boggs, Kristy; Yergeau, Donald; Manne, Jayanthi] St Jude Childrens Res Hosp, Pediat Canc Genome Project Lab, Memphis, TN 38105 USA; [Kriwacki, Richard] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Pounds, Stanley; Kang, Guolian; Shi, Lei; Cheng, Cheng; Pei, Deqing] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Sutton, Rosemary; Venn, Nicola C.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Sydney, NSW, Australia; [Chetcuti, Albert; Rush, Amanda; Catchpoole, Daniel] Childrens Hosp Westmead, Tumor Bank, Childrens Canc Res Unit, Sydney, NSW, Australia; [Heldrup, Jesper] Skane Univ Hosp, Dept Pediat, Lund, Sweden; [Lu, Charles; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Genet, St Louis, MO USA; [Lu, Charles; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Genome Inst, St Louis, MO USA; [Pui, Ching-Hon; Gruber, Tanja A.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA		Andersson, AK (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	anna.andersson@med.lu.se; tanja.gruber@stjude.org; james.downing@stjude.org	Mullighan, Charles/H-3253-2011; Rush, Amanda/ABD-3077-2020; Raimondi, Susana C/N-8166-2018; Kriwacki, Richard/N-8154-2018; Cheng, Cheng/N-8075-2018; Gruber, Tanja/AAH-1248-2021; Rush, Amanda/AAZ-5391-2020; Heldrup, Jesper/AAW-6836-2020; Pounds, Stanley B/N-2480-2018; Wilson, Richard K./AAF-4139-2019; Rusch, Michael/AAG-1998-2019; LI, YONGJIN/E-1688-2011; Chen, Xiang/N-2524-2018; Mardis, Elaine/W-2202-2019; Wu, Gang/M-8012-2014; Pui, Ching-Hon/N-8076-2018; Downing, James R./N-8102-2018; Sutton, Rosemary/J-3784-2014; Huether, Robert/E-9638-2012	Mullighan, Charles/0000-0002-1871-1850; Kriwacki, Richard/0000-0002-9798-6018; Pounds, Stanley B/0000-0002-9167-2114; Wilson, Richard K./0000-0002-1992-1358; Rusch, Michael/0000-0002-5363-1848; Chen, Xiang/0000-0002-2499-8261; Wu, Gang/0000-0002-1678-5864; Pui, Ching-Hon/0000-0003-0303-5658; Sutton, Rosemary/0000-0002-0188-6005; Easton, John/0000-0003-4503-6608; Parker, Matthew/0000-0003-2999-3870; Huether, Robert/0000-0001-7077-7470; Hagstrom-Andersson, Anna/0000-0002-2904-1311; Heldrup, Jesper/0000-0002-6211-1967; Fioretos, Thoas/0000-0002-3235-6154; Holmfeldt, Linda/0000-0003-4140-3423	St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project; American Lebanese and Syrian Associated Charities of St. Jude Children's Research HospitalAmerican Lebanese Syrian Associated Charities (ALSAC); US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA021765]; Swedish Childhood Cancer Society; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Cancer SocietySwedish Cancer Society; BioCARE; Gunnar Nilsson Cancer Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016056, P30CA021765] Funding Source: NIH RePORTER	We thank all the patients and their parents from the St. Jude Children's Research Hospital (USA), the Department of Pediatrics at Lund University Hospital (Sweden) and the children's hospitals associated with the Australian and New Zealand Children's Haematology and Oncology Group. We thank B. Pappas and S. Malone for IT infrastructure. We thank the Tissue Resources Laboratory, the Flow Cytometry and Cell Sorting Core and the Clinical Applications of Core Technology Laboratories of the Hartwell Center for Bioinformatics and Biotechnology of St. Jude Children's Research Hospital. We thank E. Parganas and J. Ihle (St. Jude Children's Research Hospital) for the mouse BaF3 cells. This work was funded by the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project and the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital and was supported by a grant from the US National Institutes of Health (P30 CA021765). A.K.A. was supported by the Swedish Childhood Cancer Society, the Swedish Research Council, the Swedish Cancer Society, BioCARE and the Gunnar Nilsson Cancer Foundation. C.G.M. is a Pew Scholar in Biomedical Sciences and a St. Baldrick's Scholar.	Bardini M, 2015, LEUKEMIA, V29, P38, DOI 10.1038/leu.2014.154; Bardini M, 2011, LEUKEMIA, V25, P175, DOI 10.1038/leu.2010.232; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkn723, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkx1094, 10.1093/nar/gkr1202]; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Chang VY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-55; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; De Lorenzo P, 2014, LEUKEMIA, V28, P428, DOI 10.1038/leu.2013.280; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dobbins SE, 2013, GENE CHROMOSOME CANC, V52, P954, DOI 10.1002/gcc.22090; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; DOWNING JR, 1994, BLOOD, V83, P330, DOI 10.1182/blood.V83.2.330.bloodjournal832330; Driessen EMC, 2013, HAEMATOLOGICA, V98, P937, DOI 10.3324/haematol.2012.067983; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Heerema NA, 2002, CANCER-AM CANCER SOC, V94, P1102, DOI 10.1002/cncr.10325; HEEREMA NA, 1994, BLOOD, V83, P2274, DOI 10.1182/blood.V83.8.2274.bloodjournal8382274; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Kalbfleisch JohnD., 1980, STAT ANAL FAILURE TI; Kim WI, 2009, BLOOD, V113, P1086, DOI 10.1182/blood-2008-01-132316; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liang DC, 2006, CANCER, V106, P950, DOI 10.1002/cncr.21687; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Mullighan CG, 2008, GENE DEV, V22, P1411, DOI 10.1101/gad.1673908; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ono R, 2009, LEUKEMIA, V23, P2197, DOI 10.1038/leu.2009.177; Opatz S, 2013, BLOOD, V122, P1761, DOI 10.1182/blood-2013-01-476473; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pounds S, 2013, BIOINFORMATICS, V29, P2088, DOI 10.1093/bioinformatics/btt372; Prelle C, 2013, LEUKEMIA, V27, P1425, DOI 10.1038/leu.2012.365; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Reichel M, 1998, ONCOGENE, V17, P3035, DOI 10.1038/sj.onc.1202229; Rozen S, 2000, Methods Mol Biol, V132, P365; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Smith CC, 2013, BLOOD, V121, P3165, DOI 10.1182/blood-2012-07-442871; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; Szczepanski T, 2010, LANCET ONCOL, V11, P880, DOI 10.1016/S1470-2045(09)70369-9; Tamai H, 2011, LEUKEMIA, V25, P888, DOI 10.1038/leu.2011.15; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; von Bubnoff N, 2009, CANCER RES, V69, P3032, DOI 10.1158/0008-5472.CAN-08-2923; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	67	265	273	0	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					330	U192		10.1038/ng.3230			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	WOS:000351922900007	25730765	Green Accepted			2022-01-24	
J	Qi, JJ; Liu, X; Shen, D; Miao, H; Xie, BY; Li, XX; Zeng, P; Wang, SH; Shang, Y; Gu, XF; Du, YC; Li, Y; Lin, T; Yuan, JH; Yang, XY; Chen, JF; Chen, HM; Xiong, XY; Huang, K; Fei, ZJ; Mao, LY; Tian, L; Stadler, T; Renner, SS; Kamoun, S; Lucas, WJ; Zhang, ZH; Huang, SW				Qi, Jianjian; Liu, Xin; Shen, Di; Miao, Han; Xie, Bingyan; Li, Xixiang; Zeng, Peng; Wang, Shenhao; Shang, Yi; Gu, Xingfang; Du, Yongchen; Li, Ying; Lin, Tao; Yuan, Jinhong; Yang, Xueyong; Chen, Jinfeng; Chen, Huiming; Xiong, Xingyao; Huang, Ke; Fei, Zhangjun; Mao, Linyong; Tian, Li; Staedler, Thomas; Renner, Susanne S.; Kamoun, Sophien; Lucas, William J.; Zhang, Zhonghua; Huang, Sanwen			A genomic variation map provides insights into the genetic basis of cucumber domestication and diversity	NATURE GENETICS			English	Article							WIDE PATTERNS; DRAFT GENOME; ARABIDOPSIS; SATIVUS; RICE; REVEALS; ORIGIN; WILD; LD	Most fruits in our daily diet are the products of domestication and breeding. Here we report a map of genome variation for a major fruit that encompasses similar to 3.6 million variants, generated by deep resequencing of 115 cucumber lines sampled from 3,342 accessions worldwide. Comparative analysis suggests that fruit crops underwent narrower bottlenecks during domestication than grain crops. We identified 112 putative domestication sweeps; 1 of these regions contains a gene involved in the loss of bitterness in fruits, an essential domestication trait of cucumber. We also investigated the genomic basis of divergence among the cultivated populations and discovered a natural genetic variant in a beta-carotene hydroxylase gene that could be used to breed cucumbers with enhanced nutritional value. The genomic history of cucumber evolution uncovered here provides the basis for future genomics-enabled breeding.	[Qi, Jianjian; Shen, Di; Miao, Han; Xie, Bingyan; Li, Xixiang; Wang, Shenhao; Shang, Yi; Gu, Xingfang; Du, Yongchen; Li, Ying; Lin, Tao; Yuan, Jinhong; Yang, Xueyong; Xiong, Xingyao; Zhang, Zhonghua; Huang, Sanwen] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Minist Agr,Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Liu, Xin; Zeng, Peng] BGI Shenzhen, Shenzhen, Peoples R China; [Chen, Jinfeng] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Chen, Huiming] Hunan Acad Agr Sci, Hunan Vegetable Res Inst, Changsha, Hunan, Peoples R China; [Xiong, Xingyao; Huang, Ke] Hunan Agr Univ, Hort & Landscape Coll, Hunan Prov Key Lab Germplasm Innovat & Utilizat C, Changsha, Hunan, Peoples R China; [Fei, Zhangjun; Mao, Linyong] Robert W Holley Ctr Agr & Hlth, Boyce Thompson Inst Plant Res, USDA, Ithaca, NY USA; [Tian, Li] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Staedler, Thomas] ETH, Inst Integrat Biol, Zurich, Switzerland; [Renner, Susanne S.] Univ Munich, Dept Biol, Munich, Germany; [Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England; [Lucas, William J.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA		Huang, SW (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Minist Agr,Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	zhangzhonghua@caas.cn; huangsanwen@caas.cn	Stadler, Thomas/B-7286-2009; Kamoun, Sophien/B-3529-2009; Yuan, Jinhong/AAF-7715-2019; Huang, Sanwen/ABE-9053-2020; Fei, Zhangjun/H-5152-2012	Stadler, Thomas/0000-0003-4513-8583; Kamoun, Sophien/0000-0002-0290-0315; Liu, Xin/0000-0003-3256-2940; Fei, Zhangjun/0000-0001-9684-1450; Huang, Sanwen/0000-0002-8547-5309; Yang, Xueyong/0000-0003-0453-2023	National Program on Key Basic Research Projects in China (the 973 Program)National Basic Research Program of China [2012CB113900]; National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [31225025]; National High-Tech Research Development Program in China (the 863 Program)National High Technology Research and Development Program of China [2010AA10A108, 2012AA100101]; NSFCNational Natural Science Foundation of China (NSFC) [31030057, 30972011, 31101550, 31071797, 31171961, 31272161, 31322047]; Chinese Ministry of AgricultureMinistry of Agriculture, China [2008-Z42]; Chinese Ministry of Finance [1251610601001]; CAAS	We thank J. Ross-Ibarra (University of California, Davis) and J.-Y. Li (Chinese Academy of Agricultural Sciences (CAAS)) for critical comments, D. DellaPenna (Michigan State University) for assistance in beta-carotene pathway analysis and the three anonymous referees for their constructive comments. We thank F. Cunningham (University of Maryland) for providing the pAC-BETA plasmid. This work was supported by funding from the National Program on Key Basic Research Projects in China (the 973 Program; 2012CB113900), the National Natural Science Foundation of China (NSFC; 31225025) the National High-Tech Research Development Program in China (the 863 Program; 2010AA10A108 and 2012AA100101), and other NSFC grants (31030057, 30972011, 31101550, 31071797, 31171961, 31272161 and 31322047), the Chinese Ministry of Agriculture (the 948 program; 2008-Z42), the Chinese Ministry of Finance (1251610601001) and CAAS (seed grant to S.H.).	Anderson M. J., 2003, PCO FORTRAN COMPUTER; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Balkema-Boomstra AG, 2003, J CHEM ECOL, V29, P225, DOI 10.1023/A:1021945101308; BARHAM WS, 1953, P AM SOC HORTIC SCI, V62, P441; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bo KL, 2012, MOL BREEDING, V30, P335, DOI 10.1007/s11032-011-9624-4; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; de Meeus T, 2007, INFECT GENET EVOL, V7, P731, DOI 10.1016/j.meegid.2007.07.005; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Horiguchi G, 2009, PLANT J, V60, P122, DOI 10.1111/j.1365-313X.2009.03940.x; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kang HX, 2011, THEOR APPL GENET, V122, P795, DOI 10.1007/s00122-010-1487-2; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li XueFeng, 2011, Acta Horticulturae Sinica, V38, P886; Li Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-540; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Qi C. Z., 1983, Acta Horticulturae Sinica, V10, P259; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; TAJIMA F, 1983, GENETICS, V105, P437; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Tian L, 2001, PLANT MOL BIOL, V47, P379, DOI 10.1023/A:1011623907959; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu ZL, 2007, BIOINFORMATICS, V23, P3254, DOI 10.1093/bioinformatics/btm426; Yang LM, 2012, PLANT J, V71, P895, DOI 10.1111/j.1365-313X.2012.05017.x	52	265	311	18	249	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1510	U149		10.1038/ng.2801			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	WOS:000327715800021	24141363				2022-01-24	
J	Lindsay, ME; Schepers, D; Bolar, NA; Doyle, JJ; Gallo, E; Fert-Bober, J; Kempers, MJE; Fishman, EK; Chen, YC; Myers, L; Bjeda, D; Oswald, G; Elias, AF; Levy, HP; Anderlid, BM; Yang, MH; Bongers, EMHF; Timmermans, J; Braverman, AC; Canham, N; Mortier, GR; Brunner, HG; Byers, PH; Van Eyk, J; Van Laer, L; Dietz, HC; Loeys, BL				Lindsay, Mark E.; Schepers, Dorien; Bolar, Nikhita Ajit; Doyle, Jefferson J.; Gallo, Elena; Fert-Bober, Justyna; Kempers, Marlies J. E.; Fishman, Elliot K.; Chen, Yichun; Myers, Loretha; Bjeda, Djahita; Oswald, Gretchen; Elias, Abdallah F.; Levy, Howard P.; Anderlid, Britt-Marie; Yang, Margaret H.; Bongers, Ernie M. H. F.; Timmermans, Janneke; Braverman, Alan C.; Canham, Natalie; Mortier, Geert R.; Brunner, Han G.; Byers, Peter H.; Van Eyk, Jennifer; Van Laer, Lut; Dietz, Harry C.; Loeys, Bart L.			Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; MARFAN-SYNDROME; MOUSE MODEL; PATHOGENESIS; RECEPTOR; MICE; CONTRIBUTES; ACTIVATION; FIBRILLIN	Loeys-Dietz syndrome (LDS) associates with a tissue signature for high transforming growth factor (TGF)-beta signaling but is often caused by heterozygous mutations in genes encoding positive effectors of TGF-beta signaling, including either subunit of the TGF-beta receptor or SMAD3, thereby engendering controversy regarding the mechanism of disease. Here, we report heterozygous mutations or deletions in the gene encoding the TGF-beta 2 ligand for a phenotype within the LDS spectrum and show upregulation of TGF-beta signaling in aortic tissue from affected individuals. Furthermore, haploinsufficient Tgfb2(+/-) mice have aortic root aneurysm and biochemical evidence of increased canonical and noncanonical TGF-beta signaling. Mice that harbor both a mutant Marfan syndrome (MFS) allele (Fbn1(C1039G/+)) and Tgfb2 haploinsufficiency show increased TGF-beta signaling and phenotypic worsening in association with normalization of TGF-beta 2 expression and high expression of TGF-beta 1. Taken together, these data support the hypothesis that compensatory autocrine and/or paracrine events contribute to the pathogenesis of TGF-beta-mediated vasculopathies.	[Schepers, Dorien; Bolar, Nikhita Ajit; Mortier, Geert R.; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2020 Antwerp, Belgium; [Lindsay, Mark E.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Helen B Taussig Childrens Heart Ctr, Baltimore, MD 21205 USA; [Lindsay, Mark E.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Lindsay, Mark E.; Doyle, Jefferson J.; Gallo, Elena; Chen, Yichun; Myers, Loretha; Bjeda, Djahita; Oswald, Gretchen; Elias, Abdallah F.; Levy, Howard P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Schepers, Dorien; Bolar, Nikhita Ajit; Mortier, Geert R.; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp Hosp, Antwerp, Belgium; [Fert-Bober, Justyna; Van Eyk, Jennifer] Johns Hopkins Univ, Dept Med, Div Cardiol, Bayview Prote Ctr, Baltimore, MD USA; [Kempers, Marlies J. E.; Bongers, Ernie M. H. F.; Brunner, Han G.; Loeys, Bart L.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kempers, Marlies J. E.; Bongers, Ernie M. H. F.; Brunner, Han G.; Loeys, Bart L.] Radboud Univ Nijmegen, Inst Genet & Metab Disorders, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Fishman, Elliot K.] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Anderlid, Britt-Marie] Karolinska Inst, Dept Clin Genet, Karolinska Univ Hosp, Stockholm, Sweden; [Yang, Margaret H.; Byers, Peter H.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Yang, Margaret H.; Byers, Peter H.] Univ Washington, Sch Med, Dept Genet, Seattle, WA USA; [Timmermans, Janneke] Radboud Univ Nijmegen, Dept Cardiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Braverman, Alan C.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Canham, Natalie] Northwick Pk Hosp & Clin Res Ctr, Dept Clin Genet, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Loeys, Bart L.] Univ Ghent, Dept Pediat & Genet, B-9000 Ghent, Belgium		Loeys, BL (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2020 Antwerp, Belgium.	Bart.Loeys@ua.ac.be	Loeys, Bart/B-3236-2017; Chen, Yi-Chun/H-4468-2013; Bongers, M.H.F./L-4214-2015; Loeys, B.L./L-4493-2015; Timmermans, J./L-4693-2015; Doyle, Jefferson/C-3156-2013; Elias, Abdallah F./R-7187-2019; Mortier, Geert/D-2542-2012; Elias, Abdallah Frederic/ABH-8521-2020; Brunner, Han/C-9928-2013	Loeys, Bart/0000-0003-3703-9518; Mortier, Geert/0000-0001-9871-4578; fishman, elliot/0000-0002-2567-1658; Byers, Peter H./0000-0001-7786-7030; Schepers, Dorien/0000-0003-4225-6621	Fund for Scientific Research, Flanders (FWO; Belgium)FWO [G.0458.09, G.0221.12]; European Grant Fighting Aneurysmal Disease [EC-FP7]; Special Research Fund of Ghent UniversityGhent University [BOF10/GOA/005]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1-AR41135, PO1-AR049698, 5RC1HL100021-02]; Institutional Clinical and Translational Science Award [1U54RR023561-01A1]; National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical InstituteHoward Hughes Medical Institute; Freudmann Fund for Research in Ehlers Danlos Syndrome and Related Disorders; Baylor-Hopkins Center for Mendelian Genetics [1U54HG006542]; Scientific Research, Flanders (Belgium)FWO; Aneurysmal Pathology Foundation; Agency for Innovation by Science and Technology (IWT)Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); Helen Hay Whitney Foundation; McKusick Fellowship of the National Marfan Foundation; NHLBI K08 Award [HL107738-01]; Fellow-to-Faculty Award from the National Marfan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K08HL107738, RC1HL100021] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR041135, P01AR049698] Funding Source: NIH RePORTER	This study was supported in part by funding from the Fund for Scientific Research, Flanders (FWO; Belgium) (G.0458.09 and G.0221.12); a European Grant Fighting Aneurysmal Disease (EC-FP7); the Special Research Fund of Ghent University (BOF10/GOA/005); the US National Institutes of Health (RO1-AR41135 and PO1-AR049698 to H.C.D., 5RC1HL100021-02 to J.V.E. and H.C.D. and an Institutional Clinical and Translational Science Award 1U54RR023561-01A1 to J.V.E.); the National Marfan Foundation; the Smilow Center for Marfan Syndrome Research; the Howard Hughes Medical Institute; the Freudmann Fund for Research in Ehlers Danlos Syndrome and Related Disorders; and the Baylor-Hopkins Center for Mendelian Genetics (1U54HG006542). B.L.L. is senior clinical investigator of the Fund for Scientific Research, Flanders (Belgium); N.A.B. is supported by the Aneurysmal Pathology Foundation; D.S. is supported by a PhD grant from the Agency for Innovation by Science and Technology (IWT); E.G. is supported by a fellowship from the Helen Hay Whitney Foundation; J.J.D. is supported by the McKusick Fellowship of the National Marfan Foundation; and M.E.L. is supported by an NHLBI K08 Award (HL107738-01) and by a Fellow-to-Faculty Award from the National Marfan Foundation.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Bartram U, 2001, CIRCULATION, V103, P2745; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Choudhary B, 2009, GENESIS, V47, P115, DOI 10.1002/dvg.20466; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Langlois D, 2010, TRANSGENIC RES, V19, P1069, DOI 10.1007/s11248-010-9379-4; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Maleszewski JJ, 2009, AM J SURG PATHOL, V33, P194, DOI 10.1097/PAS.0b013e31817f3661; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; MCKUSICK VA, 1955, CIRCULATION, V11, P321, DOI 10.1161/01.CIR.11.3.321; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744	31	265	277	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					922	+		10.1038/ng.2349			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	WOS:000306854700019	22772368	Green Accepted			2022-01-24	
J	Numata, S; Ye, TZ; Hyde, TM; Guitart-Navarro, X; Tao, R; Wininger, M; Colantuoni, C; Weinberger, DR; Kleinman, JE; Lipska, BK				Numata, Shusuke; Ye, Tianzhang; Hyde, Thomas M.; Guitart-Navarro, Xavier; Tao, Ran; Wininger, Michael; Colantuoni, Carlo; Weinberger, Daniel R.; Kleinman, Joel E.; Lipska, Barbara K.			DNA Methylation Signatures in Development and Aging of the Human Prefrontal Cortex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN BRAIN; MONOZYGOTIC TWINS; CPG ISLAND; EPIGENETIC DIFFERENCES; BIPOLAR DISORDER; GENE-EXPRESSION; SCHIZOPHRENIA; GENOME; HYPERMETHYLATION; AGE	The human prefrontal cortex (PFC), a mastermind of the brain, is one of the last brain regions to mature. To investigate the role of epigenetics in the development of PFC, we examined DNA methylation in similar to 14,500 genes at similar to 27,000 CpG loci focused on 5' promoter regions in 108 subjects range in age from fetal to elderly. DNA methylation in the PFC shows unique temporal patterns across life. The fastest changes occur during the prenatal period, slow down markedly after birth and continue to slow further with aging. At the genome level, the transition from fetal to postnatal life is typified by a reversal of direction, from demethylation prenatally to increased methylation postnatally. DNA methylation is strongly associated with genotypic variants and correlates with expression of a subset of genes, including genes involved in brain development and in de novo DNA methylation. Our results indicate that promoter DNA methylation in the human PFC is a highly dynamic process modified by genetic variance and regulating gene transcription. Additional discovery is made possible with a stand-alone application, BrainCloudMethyl.	[Numata, Shusuke; Ye, Tianzhang; Hyde, Thomas M.; Tao, Ran; Wininger, Michael; Colantuoni, Carlo; Weinberger, Daniel R.; Kleinman, Joel E.; Lipska, Barbara K.] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Ye, Tianzhang; Hyde, Thomas M.; Colantuoni, Carlo; Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Guitart-Navarro, Xavier] NIDA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Colantuoni, Carlo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA		Lipska, BK (corresponding author), NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA.	lipskab@mail.nih.gov	Lipska, Barbara K/E-4569-2017; Tao, Ran/L-3460-2014; Tao, Ran/C-2662-2013; Wininger, Michael/K-8985-2012	Colantuoni, Carlo/0000-0001-6818-6380; Wininger, Michael/0000-0002-7871-3292	National Institute of Mental Health at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZICMH002903, ZIAMH002399] Funding Source: NIH RePORTER	We thank Liqin Wang and Vesna Imamovic for their technical expertise; Mary Herman for her contribution to the Clinical Brain Disorders Branch/National Institute of Mental Health brain collection; Abdel Elkahloun at National Human Genome Research Institute Microarray Core Facility for scanning data; and Ronald Zielke, Robert Johnson, and Robert Vigorito at the NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland School of Medicine, for their collection of brains. We also thank the families of the deceased for the donations of brain tissue and their time and effort devoted to the consent process and interviews. This research was supported by the Intramural Research Program of the National Institute of Mental Health at the National Institutes of Health.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Connor CM, 2008, EPIGENETICS-US, V3, P55, DOI 10.4161/epi.3.2.5938; Cotton AM, 2009, HUM MOL GENET, V18, P3544, DOI 10.1093/hmg/ddp299; Cox T.E., 1994, MULTIDIMENSIONAL SCA, V213; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kleinman JE, 2011, BIOL PSYCHIAT, V69, P140, DOI 10.1016/j.biopsych.2010.10.032; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028; Mastroeni D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006617; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Need AC, 2009, EUR J HUM GENET, V17, P946, DOI 10.1038/ejhg.2008.264; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Revill K, 2009, ENDOCR-RELAT CANCER, V16, P537, DOI 10.1677/ERC-09-0008; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Veldic M, 2005, P NATL ACAD SCI USA, V102, P2152, DOI 10.1073/pnas.0409665102; Weinberger D. R., 2010, SCHIZOPHRENIA; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xin YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011357; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	52	265	268	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					260	272		10.1016/j.ajhg.2011.12.020			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	WOS:000300742200006	22305529	Green Published, Bronze			2022-01-24	
J	Amores, A; Catchen, J; Ferrara, A; Fontenot, Q; Postlethwait, JH				Amores, Angel; Catchen, Julian; Ferrara, Allyse; Fontenot, Quenton; Postlethwait, John H.			Genome Evolution and Meiotic Maps by Massively Parallel DNA Sequencing: Spotted Gar, an Outgroup for the Teleost Genome Duplication	GENETICS			English	Article							GENETIC-LINKAGE MAPS; ANCIENT FISH; RAD MARKERS; MUTATIONS; REVEALS; MODEL; IDENTIFICATION; REARRANGEMENT; PHYLOGENY; STRATEGY	Genomic resources for hundreds of species of evolutionary, agricultural, economic, and medical importance are unavailable due to the expense of well-assembled genome sequences and difficulties with multigenerational studies. Teleost fish provide many models for human disease but possess anciently duplicated genomes that sometimes obfuscate connectivity. Genomic information representing a fish lineage that diverged before the teleost genome duplication (TGD) would provide an outgroup for exploring the mechanisms of evolution after whole-genome duplication. We exploited massively parallel DNA sequencing to develop meiotic maps with thrift and speed by genotyping F-1 offspring of a single female and a single male spotted gar (Lepisosteus oculatus) collected directly from nature utilizing only polymorphisms existing in these two wild individuals. Using Stacks, software that automates the calling of genotypes from polymorphisms assayed by Illumina sequencing, we constructed a map containing 8406 markers. RNA-seq on two map-cross larvae provided a reference transcriptome that identified nearly 1000 mapped protein-coding markers and allowed genome-wide analysis of conserved synteny. Results showed that the gar lineage diverged from teleosts before the TGD and its genome is organized more similarly to that of humans than teleosts. Thus, spotted gar provides a critical link between medical models in teleost fish, to which gar is biologically similar, and humans, to which gar is genomically similar. Application of our F1 dense mapping strategy to species with no prior genome information promises to facilitate comparative genomics and provide a scaffold for ordering the numerous contigs arising from next generation genome sequencing.	[Amores, Angel; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Catchen, Julian] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; [Ferrara, Allyse; Fontenot, Quenton] Nicholls State Univ, Dept Biol Sci, Thibodaux, LA 70310 USA		Postlethwait, JH (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	jpostle@uoregon.edu	Catchen, Julian/D-9795-2016	Amores, Angel/0000-0002-9307-3609	National Institutes of Health (NIH)/National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR020833]; Golden Ranch Plantation grant; NIH National Research ServiceUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1F32GM095213-01]; National Science FoundationNational Science Foundation (NSF) [DEB-1025212]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR020833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM095213] Funding Source: NIH RePORTER	We thank W. Cresko, E. Johnson, I. Braasch, J. Smith, S. Bassham, and T. Titus for helpful conversations. This work was supported by National Institutes of Health (NIH)/National Center for Research Resources grant R01RR020833 to J. H. P, a Golden Ranch Plantation grant to A. F. and Q. F, an NIH National Research Service Award Ruth L. Kirschstein post-doctoral fellowship 1F32GM095213-01 to J. C., and National Science Foundation grant DEB-1025212 to W. Cresko.	Albertson RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-4; Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Birstein VJ, 1998, MOL PHYLOGENET EVOL, V9, P141, DOI 10.1006/mpev.1997.0443; BLACKLIDGE KH, 1993, J HERED, V84, P427, DOI 10.1093/oxfordjournals.jhered.a111367; Braasch I, 2011, P NATL ACAD SCI USA, V108, pE47, DOI 10.1073/pnas.1101594108; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chintamanani S, 2010, GENETICS, V184, P813, DOI 10.1534/genetics.109.111880; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; EASTMAN JT, 1981, J MORPHOL, V167, P91, DOI 10.1002/jmor.1051670108; EDWARDS JH, 1991, ANN HUM GENET, V55, P17, DOI 10.1111/j.1469-1809.1991.tb00394.x; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Force A, 1999, GENETICS, V151, P1531; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hardie DC, 2004, CAN J FISH AQUAT SCI, V61, P1636, DOI 10.1139/F04-106; Hobert O, 2010, GENETICS, V184, P317, DOI 10.1534/genetics.109.112938; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hufton AL, 2008, GENOME RES, V18, P1582, DOI 10.1101/gr.080119.108; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeffery WR, 2009, CURR TOP DEV BIOL, V86, P191, DOI 10.1016/S0070-2153(09)01008-4; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Katsu Y, 2008, ENDOCRINOLOGY, V149, P6300, DOI 10.1210/en.2008-0670; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Lampert KP, 2010, CURR BIOL, V20, P1729, DOI 10.1016/j.cub.2010.08.029; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; Li WT, 2010, GENETICS, V185, P1069, DOI 10.1534/genetics.110.116343; Long W L, 2001, BMC Dev Biol, V1, P6, DOI 10.1186/1471-213X-1-6; Meierjohann S, 2006, TRENDS GENET, V22, P654, DOI 10.1016/j.tig.2006.09.013; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Moore JL, 2006, GENETICS, V174, P585, DOI 10.1534/genetics.106.059386; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Near TJ, 2006, MOL BIOL EVOL, V23, P2008, DOI 10.1093/molbev/msl071; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Rab P, 1999, CHROMOSOME RES, V7, P475, DOI 10.1023/A:1009202030456; Salaneck E, 2008, GENE, V409, P61, DOI 10.1016/j.gene.2007.11.011; Sanetra M, 2009, GENETICS, V182, P387, DOI 10.1534/genetics.108.089367; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Semon M, 2007, MOL BIOL EVOL, V24, P860, DOI 10.1093/molbev/msm003; Smith O. A., 2006, MARINE ENV BIOL, P116; Streelman JT, 2003, EVOL DEV, V5, P600, DOI 10.1046/j.1525-142X.2003.03065.x; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Valenzano DR, 2009, GENETICS, V183, P1385, DOI 10.1534/genetics.109.108670; Van Ooijen J W, 2006, JOINMAP R 4 SOFTWARE; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang C, 2010, P NATL ACAD SCI USA, V107, P20164, DOI 10.1073/pnas.1014941107; Zhang GJ, 2010, P NATL ACAD SCI USA, V107, P16940, DOI 10.1073/pnas.1011548107; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	60	265	269	5	113	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731			GENETICS	Genetics	AUG	2011	188	4					799	U79		10.1534/genetics.111.127324			34	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	805BB	WOS:000293700000005	21828280	Bronze, Green Published			2022-01-24	
J	Zheng, P; Xia, YL; Xiao, GH; Xiong, CH; Hu, X; Zhang, SW; Zheng, HJ; Huang, Y; Zhou, Y; Wang, SY; Zhao, GP; Liu, XZ; St Leger, RJ; Wang, CS				Zheng, Peng; Xia, Yongliang; Xiao, Guohua; Xiong, Chenghui; Hu, Xiao; Zhang, Siwei; Zheng, Huajun; Huang, Yin; Zhou, Yan; Wang, Shengyue; Zhao, Guo-Ping; Liu, Xingzhong; St Leger, Raymond J.; Wang, Chengshu			Genome sequence of the insect pathogenic fungus Cordyceps militaris, a valued traditional chinese medicine	GENOME BIOLOGY			English	Article							INDUCED POINT MUTATION; OPEN READING FRAME; METARHIZIUM-ANISOPLIAE; POLYKETIDE SYNTHASE; SUBSTRATE-SPECIFICITY; SCHIZOPHYLLUM-COMMUNE; ASPERGILLUS-NIDULANS; FUSARIUM-GRAMINEARUM; EXPRESSION ANALYSIS; NEUROSPORA-CRASSA	Background: Species in the ascomycete fungal genus Cordyceps have been proposed to be the teleomorphs of Metarhizium species. The latter have been widely used as insect biocontrol agents. Cordyceps species are highly prized for use in traditional Chinese medicines, but the genes responsible for biosynthesis of bioactive components, insect pathogenicity and the control of sexuality and fruiting have not been determined. Results: Here, we report the genome sequence of the type species Cordyceps militaris. Phylogenomic analysis suggests that different species in the Cordyceps/Metarhizium genera have evolved into insect pathogens independently of each other, and that their similar large secretomes and gene family expansions are due to convergent evolution. However, relative to other fungi, including Metarhizium spp., many protein families are reduced in C. militaris, which suggests a more restricted ecology. Consistent with its long track record of safe usage as a medicine, the Cordyceps genome does not contain genes for known human mycotoxins. We establish that C. militaris is sexually heterothallic but, very unusually, fruiting can occur without an opposite mating-type partner. Transcriptional profiling indicates that fruiting involves induction of the Zn2Cys6-type transcription factors and MAPK pathway; unlike other fungi, however, the PKA pathway is not activated. Conclusions: The data offer a better understanding of Cordyceps biology and will facilitate the exploitation of medicinal compounds produced by the fungus.	[Zheng, Peng; Xia, Yongliang; Xiao, Guohua; Xiong, Chenghui; Hu, Xiao; Zhang, Siwei; Zhao, Guo-Ping; Wang, Chengshu] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Zheng, Huajun; Huang, Yin; Zhou, Yan; Wang, Shengyue; Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; [Liu, Xingzhong] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China; [St Leger, Raymond J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA		Wang, CS (corresponding author), Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	cswang@sibs.ac.cn	Wang, Chengshu/A-1656-2011; St. Leger, Raymond/N-3219-2013; hu, xiao/H-8278-2019; Xiao, Guohua/G-3083-2013	Wang, Chengshu/0000-0003-1477-1466; hu, xiao/0000-0002-3309-9575; Xiao, Guohua/0000-0003-3407-2734	Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2009CB118904]; Ministry of Agriculture of ChinaMinistry of Agriculture, China [2009ZX08009-035B]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [08DZ1970200]; Chinese Academy of SciencesChinese Academy of Sciences [KSCX2-EW-N-06, KSCX2-EW-G-16]	CSW was supported by the Ministry of Science and Technology of China (grant number 2009CB118904), the Ministry of Agriculture of China (grant number 2009ZX08009-035B), the Science and Technology Commission of Shanghai Municipality (grant number 08DZ1970200) and the Chinese Academy of Sciences (KSCX2-EW-N-06 and KSCX2-EW-G-16).	Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; [Anonymous], SIGNALP 3 0 SERVER; [Anonymous], REPEASTMASKER SERV; [Anonymous], INTERPRO PROTEIN SEQ; [Anonymous], GPCR DAT; [Anonymous], CYTOCHROME P450 SERV; Artigot MP, 2009, MICROBIOL-SGM, V155, P1738, DOI 10.1099/mic.0.024836-0; Benjamini Y, 2001, ANN STAT, V29, P1165; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Brown DW, 2001, FUNGAL GENET BIOL, V32, P121, DOI 10.1006/fgbi.2001.1256; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Chong SL, 2011, APPL MICROBIOL BIOT, V90, P1323, DOI 10.1007/s00253-011-3157-y; Clarkson JP, 2003, MYCOL RES, V107, P213, DOI 10.1017/S0953756203007159; Coetzer THT, 2008, BIOCHIMIE, V90, P336, DOI 10.1016/j.biochi.2007.10.011; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dao HP, 2005, INT J FOOD MICROBIOL, V104, P61, DOI 10.1016/j.ijfoodmicro.2005.02.004; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Duan ZB, 2009, ENVIRON MICROBIOL, V11, P2351, DOI 10.1111/j.1462-2920.2009.01961.x; Ehrlich KC, 2004, APPL ENVIRON MICROB, V70, P6518, DOI 10.1128/AEM.70.11.6518-6524.2004; Ekman D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/j.jmb.2009.11.053; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; HAESE A, 1993, MOL MICROBIOL, V7, P905, DOI 10.1111/j.1365-2958.1993.tb01181.x; Heitman J, 2010, CELL HOST MICROBE, V8, P86, DOI 10.1016/j.chom.2010.06.011; HEJTMANEK M, 1989, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V123, P11; Jarrold SL, 2007, MYCOL RES, V111, P240, DOI 10.1016/j.mycres.2006.10.007; Kamata N, 1997, J APPL ENTOMOL, V121, P17, DOI 10.1111/j.1439-0418.1997.tb01364.x; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; LENNON MB, 1976, BIOCHIM BIOPHYS ACTA, V425, P532, DOI 10.1016/0005-2787(76)90017-4; Liu M, 2009, EVOL BIOINFORM, V5, P15; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Luz C, 2007, MYCOPATHOLOGIA, V164, P39, DOI 10.1007/s11046-007-9020-0; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; Montiel MD, 2006, FUNGAL GENET BIOL, V43, P439, DOI 10.1016/j.fgb.2006.01.011; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Ohta Y, 2007, J AGR FOOD CHEM, V55, P10194, DOI 10.1021/jf0721287; Paterson RRM, 2008, PHYTOCHEMISTRY, V69, P1469, DOI 10.1016/j.phytochem.2008.01.027; *PFAM, PFAM DAT; PHI-base: Pathogen-Host Interactions, PHI BASE PATHOGEN HO; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Proctor RH, 1999, FUNGAL GENET BIOL, V27, P100, DOI 10.1006/fgbi.1999.1141; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI [10.1128/JB.186.15.5040-5051.2004, 10.1128/jb.186.15.5040-5051.2004]; Reichard P, 2010, BIOCHEM BIOPH RES CO, V396, P19, DOI 10.1016/j.bbrc.2010.02.108; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schomburg D, 2010, METHODS MOL BIOL, V609, P113, DOI 10.1007/978-1-60327-241-4_7; SCOTTCRAIG JS, 1992, J BIOL CHEM, V267, P26044; Screen SE, 2000, J BIOL CHEM, V275, P6689, DOI 10.1074/jbc.275.9.6689; Shimizu T, 2005, APPL ENVIRON MICROB, V71, P3453, DOI 10.1128/AEM.71.7.3453-3457.2005; SMURF, SMURF; St Leger RJ, 2010, APPL MICROBIOL BIOT, V85, P901, DOI 10.1007/s00253-009-2306-z; Stone R, 2008, SCIENCE, V322, P1182, DOI 10.1126/science.322.5905.1182; Sung GH, 2008, MOL PHYLOGENET EVOL, V49, P495, DOI 10.1016/j.ympev.2008.08.028; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Wang C, 2006, P NATL ACAD SCI USA, V103, P6647, DOI 10.1073/pnas.0601951103; Wang CS, 2008, EUKARYOT CELL, V7, P302, DOI 10.1128/EC.00310-07; Wang CS, 2007, J BIOL CHEM, V282, P21110, DOI 10.1074/jbc.M609592200; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; WEBER G, 1994, CURR GENET, V26, P120, DOI 10.1007/BF00313798; Xiao Jian-Hui, 2007, Recent Pat Biotechnol, V1, P123, DOI 10.2174/187220807780809454; Xiong ChengHui, 2010, Mycology - An International Journal on Fungal Biology, V1, P25; Yan WJ, 2010, FOOD CHEM TOXICOL, V48, P3080, DOI 10.1016/j.fct.2010.08.001; YU JH, 1995, J BACTERIOL, V177, P4792, DOI 10.1128/jb.177.16.4792-4800.1995; Zhang ZL, 2006, BIOINFORMATICS, V22, P1437, DOI 10.1093/bioinformatics/btl116; Zhou XW, 2009, J PHARM PHARMACOL, V61, P279, DOI [10.1211/jpp/61.03.0002, 10.1211/jpp.61.03.0002]	88	265	316	6	126	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-6906	1474-760X		GENOME BIOL	Genome Biol.		2011	12	11							R116	10.1186/gb-2011-12-11-r116			21	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	904FB	WOS:000301178400007	22112802	Green Published, hybrid			2022-01-24	
J	Goldstone, JV; McArthur, AG; Kubota, A; Zanette, J; Parente, T; Jonsson, ME; Nelson, DR; Stegeman, JJ				Goldstone, Jared V.; McArthur, Andrew G.; Kubota, Akira; Zanette, Juliano; Parente, Thiago; Jonsson, Maria E.; Nelson, David R.; Stegeman, John J.			Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish	BMC GENOMICS			English	Article							RETINOIC ACID ACTIVITY; TISSUE DISTRIBUTION; DANIO-RERIO; FUNCTIONAL-CHARACTERIZATION; PROMOTER CHARACTERISTICS; MOLECULAR-CLONING; CDNA CLONING; CYP19 GENES; SUBFAMILY; P450	Background: Increasing use of zebrafish in drug discovery and mechanistic toxicology demands knowledge of cytochrome P450 (CYP) gene regulation and function. CYP enzymes catalyze oxidative transformation leading to activation or inactivation of many endogenous and exogenous chemicals, with consequences for normal physiology and disease processes. Many CYPs potentially have roles in developmental specification, and many chemicals that cause developmental abnormalities are substrates for CYPs. Here we identify and annotate the full suite of CYP genes in zebrafish, compare these to the human CYP gene complement, and determine the expression of CYP genes during normal development. Results: Zebrafish have a total of 94 CYP genes, distributed among 18 gene families found also in mammals. There are 32 genes in CYP families 5 to 51, most of which are direct orthologs of human CYPs that are involved in endogenous functions including synthesis or inactivation of regulatory molecules. The high degree of sequence similarity suggests conservation of enzyme activities for these CYPs, confirmed in reports for some steroidogenic enzymes (e.g. CYP19, aromatase; CYP11A, P450scc; CYP17, steroid 17a-hydroxylase), and the CYP26 retinoic acid hydroxylases. Complexity is much greater in gene families 1, 2, and 3, which include CYPs prominent in metabolism of drugs and pollutants, as well as of endogenous substrates. There are orthologous relationships for some CYP1 s and some CYP3 s between zebrafish and human. In contrast, zebrafish have 47 CYP2 genes, compared to 16 in human, with only two (CYP2R1 and CYP2U1) recognized as orthologous based on sequence. Analysis of shared synteny identified CYP2 gene clusters evolutionarily related to mammalian CYP2 s, as well as unique clusters. Conclusions: Transcript profiling by microarray and quantitative PCR revealed that the majority of zebrafish CYP genes are expressed in embryos, with waves of expression of different sets of genes over the course of development. Transcripts of some CYP occur also in oocytes. The results provide a foundation for the use of zebrafish as a model in toxicological, pharmacological and chemical disease research.	[Goldstone, Jared V.; Kubota, Akira; Zanette, Juliano; Parente, Thiago; Jonsson, Maria E.; Stegeman, John J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [McArthur, Andrew G.] Andrew McArthur Consulting, Hamilton, ON, Canada; [Zanette, Juliano] Univ Fed Rio Grande, Inst Ciencias Biol, BR-96201900 Rio Grande, RS, Brazil; [Parente, Thiago] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Jonsson, Maria E.] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Nelson, David R.] Univ Tennessee, Dept Mol Sci, Memphis, TN USA		Stegeman, JJ (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	jstegeman@whoi.edu	Parente, Thiago/C-3910-2014; Zanette, Juliano/E-6773-2013	Parente, Thiago/0000-0001-7501-726X; Zanette, Juliano/0000-0001-8107-2468; Nelson, David/0000-0003-0583-5421; McArthur, Andrew/0000-0002-1142-3063; Goldstone, Jared/0000-0002-9618-4961; Stegeman, John/0000-0001-8204-5357	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01ES015912, P42ES007381]; Swedish research council FormasSwedish Research CouncilSwedish Research Council Formas; Carl Trygger's foundation; Japanese Society for Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CNPq, BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES015912, P42ES007381] Funding Source: NIH RePORTER	This work was supported by NIH grants R01ES015912 and P42ES007381 (Superfund Basic Research Program at Boston University) (to JJS). MEJ was a Guest Investigator at the Woods Hole Oceanographic Institution (WHOI) and was supported by grants from the Swedish research council Formas and Carl Trygger's foundation. AK was a Post-doctoral Fellow at WHOI, and was supported by a fellowship from the Japanese Society for Promotion of Science (JSPS). JZ and TP were Guest Students at the WHOI and were supported by a CAPES Ph.D. Fellowship and CNPq Ph.D. Sandwich Fellowship (JZ), and by a CNPq Ph.D. Fellowship (TP), from Brazil. The sponsors had no involvement in performing or in the decision to publish this study. The U.S. Government is authorized to produce and distribute reprints for governmental purposes notwithstanding any copyright notation that may appear hereon.	Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; Alsop D, 2009, COMP BIOCHEM PHYS A, V153, P49, DOI 10.1016/j.cbpa.2008.12.008; Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Bair SR, 2004, MOL CELL BIOL, V24, P5383, DOI 10.1128/MCB.24.12.5383-5390.2004; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bresolin T, 2005, COMP BIOCHEM PHYS C, V140, P403, DOI 10.1016/j.cca.2005.04.003; Callard GV, 2001, J STEROID BIOCHEM, V79, P305, DOI 10.1016/S0960-0760(01)00147-9; Celander M, 1996, FISH PHYSIOL BIOCHEM, V15, P323, DOI 10.1007/BF02112359; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Cheshenko K, 2007, TOXICOL SCI, V96, P255, DOI 10.1093/toxsci/kfm003; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Corley-Smith GE, 2006, BIOCHEM BIOPH RES CO, V340, P1039, DOI 10.1016/j.bbrc.2005.12.110; Craig TA, 2008, J BONE MINER RES, V23, P1486, DOI 10.1359/jbmr.080403; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edler D, 2009, EUR J CANCER, V45, P705, DOI 10.1016/j.ejca.2008.11.031; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Godard CAJ, 2005, BIOCHEM BIOPH RES CO, V331, P1016, DOI 10.1016/j.bbrc.2005.03.231; Goldstone HMH, 2006, J MOL EVOL, V62, P708, DOI 10.1007/s00239-005-0134-z; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Goldstone JV, 2009, ARCH BIOCHEM BIOPHYS, V482, P7, DOI 10.1016/j.abb.2008.12.002; Goldstone JV, 2007, MOL BIOL EVOL, V24, P2619, DOI 10.1093/molbev/msm200; Goto-Kazeto R, 2004, GEN COMP ENDOCR, V139, P72, DOI 10.1016/j.ygcen.2004.07.003; Gu XX, 2006, MOL ENDOCRINOL, V20, P1661, DOI 10.1210/me.2005-0362; Gu XX, 2005, GENE EXPR PATTERNS, V5, P733, DOI 10.1016/j.modgep.2005.04.005; Guengerich F. P., 2005, CYTOCHROME P450 STRU, V3rd, P377; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Hines RN, 2007, J BIOCHEM MOL TOXIC, V21, P169, DOI 10.1002/jbt.20179; Hoffmann JL, 2006, AQUAT TOXICOL, V78, P332, DOI 10.1016/j.aquatox.2006.04.007; Hsu HJ, 2006, NATURE, V439, P480, DOI 10.1038/nature04436; Hsu Hwei-Jan, 2002, Gene Expression Patterns, V2, P219, DOI 10.1016/S1567-133X(02)00059-5; Hu MC, 2004, MOL CELL ENDOCRINOL, V215, P95, DOI 10.1016/j.mce.2003.11.024; ITO Y, COMP BIOCH PHYSL C, V152, P189; James MO, 2005, AQUAT TOXICOL, V72, P361, DOI 10.1016/j.aquatox.2005.03.001; Jonsson ME, 2007, TOXICOL SCI, V100, P180, DOI 10.1093/toxsci/kfm207; Jonsson ME, 2007, TOXICOL APPL PHARM, V221, P29, DOI 10.1016/j.taap.2007.02.017; Kalsotra A, 2006, PHARMACOL THERAPEUT, V112, P589, DOI 10.1016/j.pharmthera.2006.03.008; Karlgren M, 2006, BIOCHEM BIOPH RES CO, V341, P451, DOI 10.1016/j.bbrc.2005.12.200; Karlgren M, 2004, BIOCHEM BIOPH RES CO, V315, P679, DOI 10.1016/j.bbrc.2004.01.110; Kawai YK, 2010, MAMM GENOME, V21, P320, DOI 10.1007/s00335-010-9263-9; Kinkel MD, 2009, P NATL ACAD SCI USA, V106, P7864, DOI 10.1073/pnas.0813108106; Kishida M, 2001, COMP BIOCHEM PHYS B, V129, P261, DOI 10.1016/S1096-4959(01)00319-0; Kishida M, 2001, ENDOCRINOLOGY, V142, P740, DOI 10.1210/en.142.2.740; Lai WWK, 1998, ENDOCR RES, V24, P927, DOI 10.3109/07435809809032708; Lamb DC, 1998, FEBS LETT, V425, P263, DOI 10.1016/S0014-5793(98)00247-6; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YC, 2008, J BIOL CHEM, V283, P2917, DOI 10.1074/jbc.M707470200; Liu CS, 2009, AQUAT TOXICOL, V93, P131, DOI 10.1016/j.aquatox.2009.04.005; Liu Y, 2009, COMP BIOCHEM PHYS C, V150, P57, DOI 10.1016/j.cbpc.2009.02.008; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; McArthur AG, 2003, J MOL EVOL, V57, P200, DOI 10.1007/s00239-003-2466-x; MORRISON AM, 2003, CLONING CHARACTERIZA; Mosadeghi S, 2007, BBA-GEN SUBJECTS, V1770, P1045, DOI 10.1016/j.bbagen.2007.03.008; Nakano M, 2009, DRUG METAB DISPOS, V37, P2119, DOI 10.1124/dmd.109.028530; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V371, P345, DOI 10.1006/abbi.1999.1438; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Oleksiak MF, 2003, ARCH BIOCHEM BIOPHYS, V411, P223, DOI 10.1016/S0003-9861(02)00734-8; Oleksiak MF, 2000, J BIOL CHEM, V275, P2312, DOI 10.1074/jbc.275.4.2312; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Prasad JC, 2007, BIOCHEMISTRY-US, V46, P2640, DOI 10.1021/bi062320m; Qiu H, 2008, PHARMACOGENET GENOM, V18, P53, DOI 10.1097/FPC.0b013e3282f313f8; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Reijntjes S, 2007, INT J DEV BIOL, V51, P351, DOI 10.1387/ijdb.062258sr; Reschly EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-222; Rozman D, 1996, GENOMICS, V38, P371, DOI 10.1006/geno.1996.0640; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Sabourault C, 1998, BIOCHEM BIOPH RES CO, V251, P213, DOI 10.1006/bbrc.1998.9429; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sato-Kuwabara Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-6; Sawyer SJ, 2006, GEN COMP ENDOCR, V147, P108, DOI 10.1016/j.ygcen.2005.12.010; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Schadt EE, 2000, J CELL BIOCHEM, V80, P192; Schlenk D, 2002, MAR ENVIRON RES, V54, P391, DOI 10.1016/S0141-1136(02)00202-7; Schlezinger JJ, 2000, COMP BIOCHEM PHYS C, V125, P273, DOI 10.1016/S0742-8413(99)00112-7; Scornaienchi ML, 2010, ARCH BIOCHEM BIOPHYS, V502, P17, DOI 10.1016/j.abb.2010.06.018; SCORNAIENCHI ML, 2010, J ENDOCRINOL; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stark K, 2008, DRUG METAB DISPOS, V36, P1930, DOI 10.1124/dmd.108.022020; Stark K, 2007, DRUG METAB REV, V39, P627, DOI 10.1080/03602530701467708; STEGEMAN JJ, 1981, POLYCYCLIC HYDROCARB, V3, P1; Stoilov I, 2001, TRENDS GENET, V17, P629, DOI 10.1016/S0168-9525(01)02444-1; Stoilov I, 2001, DRUG METAB DRUG INTE, V18, P33, DOI DOI 10.1515/DMDI.2001.18.1.33); Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Tchoudakova A, 2001, J STEROID BIOCHEM, V78, P427, DOI 10.1016/S0960-0760(01)00120-0; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Trant JM, 2001, J EXP ZOOL, V290, P475, DOI 10.1002/jez.1090; Tseng HP, 2005, TOXICOL APPL PHARM, V205, P247, DOI 10.1016/j.taap.2004.10.019; Uehara M, 2007, DEV BIOL, V302, P399, DOI 10.1016/j.ydbio.2006.09.045; Wang L, 2007, BIOCHEM BIOPH RES CO, V352, P850, DOI 10.1016/j.bbrc.2006.11.129; Wang YJ, 2004, GEN COMP ENDOCR, V135, P241, DOI 10.1016/j.ygcen.2003.09.015; Wang-Buhler JL, 2005, COMP BIOCHEM PHYS C, V140, P207, DOI 10.1016/j.cca.2005.02.002; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Wu KK, 2005, BIOCHEM BIOPH RES CO, V338, P45, DOI 10.1016/j.bbrc.2005.08.021; Yamazaki K, 2002, J VET MED SCI, V64, P829, DOI 10.1292/jvms.64.829; Yoshioka H, 2006, BIOCHEM BIOPH RES CO, V345, P169, DOI 10.1016/j.bbrc.2006.04.080; Zhao QS, 2005, GENE EXPR PATTERNS, V5, P363, DOI 10.1016/j.modgep.2004.09.011; Zhou LY, 2007, BIOCHEM BIOPH RES CO, V362, P619, DOI 10.1016/j.bbrc.2007.08.044; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487; ENSEMBL ZEBRAFISH	119	265	280	0	77	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	NOV 18	2010	11								643	10.1186/1471-2164-11-643			21	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	691TX	WOS:000285104800001	21087487	Green Published, gold			2022-01-24	
J	Huffmeier, U; Uebe, S; Ekici, AB; Bowes, J; Giardina, E; Korendowych, E; Juneblad, K; Apel, M; McManus, R; Ho, P; Bruce, IN; Ryan, AW; Behrens, F; Lascorz, J; Bohm, B; Traupe, H; Lohmann, J; Gieger, C; Wichmann, HE; Herold, C; Steffens, M; Klareskog, L; Wienker, TF; FitzGerald, O; Alenius, GM; McHugh, NJ; Novelli, G; Burkhardt, H; Barton, A; Reis, A				Hueffmeier, Ulrike; Uebe, Steffen; Ekici, Arif B.; Bowes, John; Giardina, Emiliano; Korendowych, Eleanor; Juneblad, Kristina; Apel, Maria; McManus, Ross; Ho, Pauline; Bruce, Ian N.; Ryan, Anthony W.; Behrens, Frank; Lascorz, Jesus; Boehm, Beate; Traupe, Heiko; Lohmann, Joerg; Gieger, Christian; Wichmann, Heinz-Erich; Herold, Christine; Steffens, Michael; Klareskog, Lars; Wienker, Thomas F.; FitzGerald, Oliver; Alenius, Gerd-Marie; McHugh, Neil J.; Novelli, Giuseppe; Burkhardt, Harald; Barton, Anne; Reis, Andre			Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis	NATURE GENETICS			English	Article							GENES; IL23R; IL12B; ACT1	Psoriatic arthritis (PsA) is an inflammatory joint disease that is distinct from other chronic arthritides and which is frequently accompanied by psoriasis vulgaris (PsV) and seronegativity for rheumatoid factor. We conducted a genome-wide association study in 609 German individuals with PsA (cases) and 990 controls with replication in 6 European cohorts including a total of 5,488 individuals. We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 x 10(-17)). TRAF3IP2 was also associated with PsV in a German cohort including 2,040 individuals (rs13190932, P = 1.95 x 10(-3)). Sequencing of the exons of TRAF3IP2 identified a coding variant (p.Asp10Asn, rs33980500) as the most significantly associated SNP (P = 1.13 x 10(-20), odds ratio = 1.95). Functional assays showed reduced binding of this TRAF3IP2 variant to TRAF6, suggesting altered modulation of immunoregulatory signals through altered TRAF interactions as a new and shared pathway for PsA and PsV.	[Hueffmeier, Ulrike; Uebe, Steffen; Ekici, Arif B.; Lascorz, Jesus; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Bowes, John; Ho, Pauline; Bruce, Ian N.; Barton, Anne] Univ Manchester, Arthritis Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Giardina, Emiliano; Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biopathol, Ctr Excellence Genom Risk Assessment Multifactori, Sch Med, Rome, Italy; [Giardina, Emiliano; Novelli, Giuseppe] Fdn PTV Policlin Tor Vergata, Rome, Italy; [Korendowych, Eleanor; McHugh, Neil J.] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England; [Juneblad, Kristina; Alenius, Gerd-Marie] Univ Hosp, Dept Publ Hlth & Clin Med, Umea, Sweden; [McManus, Ross; Ryan, Anthony W.] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Behrens, Frank; Boehm, Beate; Burkhardt, Harald] Goethe Univ Frankfurt, Div Rheumatol, Dept Internal Med 2, Frankfurt, Germany; [Traupe, Heiko] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Lohmann, Joerg] Psoriasis Rehabil Hosp, Bad Bentheim, Germany; [Gieger, Christian; Wichmann, Heinz-Erich] Helmholtz Ctr Munich, Inst Epidemiol, Munich, Germany; [Wichmann, Heinz-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Wichmann, Heinz-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Herold, Christine; Steffens, Michael; Wienker, Thomas F.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Klareskog, Lars] Karolinska Inst, Stockholm, Sweden; [FitzGerald, Oliver] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [FitzGerald, Oliver] Univ Coll Dublin, Sch Med & Med Sci, St Vincents Univ Hosp, Dept Rheumatol, Dublin 2, Ireland; [McHugh, Neil J.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England		Reis, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany.	andre.reis@uk-erlangen.de	Huffmeier, Ulrike/D-2806-2013; Behrens, Frank/AAI-8910-2021; Wichmann, Heinz Erich/AAA-5695-2022; Novelli, Giuseppe/T-8822-2019; Barton, Anne/N-2053-2014; Novelli, Giuseppe/A-5195-2013; Ekici, Arif B/C-3971-2013; McManus, Ross/AAE-9236-2020; Ryan, Anthony W/A-1336-2010; Giardina, Emiliano/J-1965-2012; Bowes, John/B-3472-2015; Reis, Andre/D-2309-2009	Huffmeier, Ulrike/0000-0001-6448-4671; Behrens, Frank/0000-0001-8750-7186; Novelli, Giuseppe/0000-0002-7781-602X; Barton, Anne/0000-0003-3316-2527; Novelli, Giuseppe/0000-0002-7781-602X; Ekici, Arif B/0000-0001-6099-7066; Bowes, John/0000-0003-4659-031X; Reis, Andre/0000-0002-6301-6363; Ryan, Anthony/0000-0001-5005-3344; Klareskog, Lars/0000-0001-9601-6186; Bruce, Ian/0000-0003-3047-500X; Steffens, Michael/0000-0002-6445-8593; Gieger, Christian/0000-0001-6986-9554; McManus, Ross/0000-0002-0529-9617; FitzGerald, Oliver/0000-0002-6607-6070; giardina, emiliano/0000-0002-2741-5009	Interdisciplinary Centre for Clinical Research of the University of Erlangen-Nuremberg [IZKF B32/A8]; Helmholtz Center MunichHelmholtz Association; German Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF); German National Genome Research Network [NGFN-2, NGFNPlus: 01GS0823]; Munich Center of Health Sciences (MC Health); National Institute for Health ResearchNational Institute for Health Research (NIHR); Manchester Biomedical Research CentreNational Institute for Health Research (NIHR); Science Foundation IrelandScience Foundation IrelandEuropean Commission; Arthritis ResearchVersus Arthritis; Wyeth Pharma GmbH, Germany; ADIPSO (Association for the Defense of Psoriasis Patients); Wellcome TrustWellcome TrustEuropean Commission [076113]	We are grateful to all subjects and control probands for participation in this study. We thank P. Rothe, M. Kirsch, P. Badorf, P. Gilbert and K. Krause for excellent technical assistance. We thank D. Fried for helping with the cloning of constructs. The work was supported in part by a grant from the Interdisciplinary Centre for Clinical Research (IZKF B32/A8) of the University of Erlangen-Nuremberg and a grant from the ELAN fund (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung) of the University of Erlangen-Nuremberg. The KORA (Cooperative Health Research in the Region of Augsburg) research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823). Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. We acknowledge the National Institute for Health Research, Manchester Biomedical Research Centre and Science Foundation Ireland for support. A. B., I.N. B. and J.B. are funded by Arthritis Research. H. B. and F. B. were supported by a research grant of Wyeth Pharma GmbH, Germany (Forschungsforderungspreis Rheumatologie 2008). E.G. and G.N. are funded by the ADIPSO (Association for the Defense of Psoriasis Patients).; The Irish control DNA was provided by the Irish Blood Transfusion Service and Trinity College Dublin population DNA Biobank. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. U.H., E.G., E.K., M.A., P.H., I.N.B., F.B., O.F., G.-M.A., N.J.M., G.N., H.B., A.B. and A.R. are members of the Psoriatic Arthritis Genetics in Europe (PAGE) Consortium.	Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Filer C, 2008, ARTHRITIS RHEUM-US, V58, P3705, DOI 10.1002/art.24128; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huffmeier U, 2009, J MED GENET, V46, P736, DOI 10.1136/jmg.2008.065029; Huffmeier U, 2010, ANN RHEUM DIS, V69, P876, DOI 10.1136/ard.2009.108951; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Hunter CA, 2007, NAT IMMUNOL, V8, P232, DOI 10.1038/ni0307-232; Ibrahim G, 2009, ARTHRIT CARE RES, V61, P1373, DOI 10.1002/art.24608; Kanamori M, 2002, FEBS LETT, V532, P241, DOI 10.1016/S0014-5793(02)03688-8; Karason A, 2009, RHEUMATOLOGY, V48, P1424, DOI 10.1093/rheumatology/kep243; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Uebe S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-472	29	265	279	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					996	U118		10.1038/ng.688			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	WOS:000283540500018	20953186	Green Accepted			2022-01-24	
J	Surget-Groba, Y; Montoya-Burgos, JI				Surget-Groba, Yann; Montoya-Burgos, Juan I.			Optimization of de novo transcriptome assembly from next-generation sequencing data	GENOME RESEARCH			English	Article							RNA-SEQ; MODEL ORGANISMS; GENE DISCOVERY; LARGE SETS; GENOME; RESOLUTION; ALLPATHS; PROGRAM; PROTEIN; FISHES	Transcriptome analysis has important applications in many biological fields. However, assembling a transcriptome without a known reference remains a challenging task requiring algorithmic improvements. We present two methods for substantially improving transcriptome de novo assembly. The first method relies on the observation that the use of a single k-mer length by current de novo assemblers is suboptimal to assemble transcriptomes where the sequence coverage of transcripts is highly heterogeneous. We present the Multiple-k method in which various k-mer lengths are used for de novo transcriptome assembly. We demonstrate its good performance by assembling de novo a published next-generation transcriptome sequence data set of Aedes aegypti, using the existing genome to check the accuracy of our method. The second method relies on the use of a reference proteome to improve the de novo assembly. We developed the Scaffolding using Translation Mapping (STM) method that uses mapping against the closest available reference proteome for scaffolding contigs that map onto the same protein. In a controlled experiment using simulated data, we show that the STM method considerably improves the assembly, with few errors. We applied these two methods to assemble the transcriptome of the non-model catfish Loricaria gr. cataphracta. Using the Multiple-k and STM methods, the assembly increases in contiguity and in gene identification, showing that our methods clearly improve quality and can be widely used. The new methods were used to assemble successfully the transcripts of the core set of genes regulating tooth development in vertebrates, while classic de novo assembly failed.	[Surget-Groba, Yann; Montoya-Burgos, Juan I.] Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland		Montoya-Burgos, JI (corresponding author), Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland.	Juan.Montoya@unige.ch	; Surget-Groba, Yann/K-4917-2012	Montoya-Burgos, Juan/0000-0001-9080-9820; Surget-Groba, Yann/0000-0001-7612-4892	funds from the Canton de Geneve; Swiss National Research FundSwiss National Science Foundation (SNSF) [3100A0-122303/1]; G & A Claraz Foundation	We thank Antonis Rokas for sharing with us his Ae. aegypti next-generation short-read data set. We thank Ilham Bahechar for her help with laboratory work, and Marta Burgos and Alison R. Davis for revising the manuscript. We thank Patrick Descombes, Laurent Farinelli, and three anonymous reviewers for their useful discussions and comments. This work was supported by funds fromthe Canton de Geneve, the Swiss National Research Fund (Number 3100A0-122303/1), and the G & A Claraz Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arslan AN, 2001, BIOINFORMATICS, V17, P327, DOI 10.1093/bioinformatics/17.4.327; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Carninci P, 2008, NAT METHODS, V5, P587, DOI 10.1038/nmeth0708-587; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Disset A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007779; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Elling AA, 2009, PLANT SIGNAL BEHAV, V4, P760, DOI 10.1105/tpc.109.065714; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; HUANG XQ, 1992, GENOMICS, V14, P18, DOI 10.1016/S0888-7543(05)80277-0; Hughes J, 2006, MOL BIOL EVOL, V23, P268, DOI 10.1093/molbev/msj041; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Main BJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-422; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Montoya-Burgos JI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-126; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Salzberg SL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000186; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sire JY, 2001, EVOL DEV, V3, P104, DOI 10.1046/j.1525-142x.2001.003002104.x; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/nmeth.1315, 10.1038/NMETH.1315]; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	265	272	1	87	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2010	20	10					1432	1440		10.1101/gr.103846.109			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	656XS	WOS:000282375000013	20693479	Bronze, Green Published			2022-01-24	
J	Kohler, S; Schulz, MH; Krawitz, P; Bauer, S; Dolken, S; Ott, CE; Mundlos, C; Horn, D; Mundlos, S; Robinson, PN				Koehler, Sebastian; Schulz, Marcel H.; Krawitz, Peter; Bauer, Sebastian; Doelken, Sandra; Ott, Claus E.; Mundlos, Christine; Horn, Denise; Mundlos, Stefan; Robinson, Peter N.			Clinical Diagnostics in Human Genetics with Semantic Similarity Searches in Ontologies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; DEVELOPMENTAL DELAY; DECISION-SUPPORT; YIELD; SYSTEM; TOOL	The differential diagnostic process attempts to identify candidate diseases that best explain a set of clinical features. This process can be complicated by the fact that the features can have varying degrees of specificity as well as by the presence of features unrelated to the disease itself. Depending on the experience of the physician and the availability of laboratory tests, clinical abnormalities may be described in greater or lesser detail. We have adapted semantic similarity metrics to measure phenotypic similarity between queries and hereditary diseases annotated with the use of the Human Phenotype Ontology (HPO) and have developed a statistical model to assign 1) values to the resulting similarity scores, which can be used to rank the candidate diseases. We show that our approach outperforms simpler term-matching approaches that do not take the semantic interrelationships between terms into account. The advantage of our approach was greater for queries containing phenotypic noise or imprecise clinical descriptions. The semantic network defined by the HPO can be used to refine the differential diagnosis by suggesting clinical features that, if present, best differentiate among the candidate diagnoses. Thus, semantic similarity searches in ontologies represent a useful way of harnessing the semantic structure of human phenotypic abnormalities to help with the differential diagnosis. We have implemented Our methods in a freely available web application for the field of human Mendelian disorders.	[Koehler, Sebastian; Krawitz, Peter; Bauer, Sebastian; Doelken, Sandra; Ott, Claus E.; Horn, Denise; Mundlos, Stefan; Robinson, Peter N.] Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany; [Koehler, Sebastian; Krawitz, Peter; Mundlos, Stefan; Robinson, Peter N.] Charite Univ Med Berlin, BCRT, D-13353 Berlin, Germany; [Schulz, Marcel H.; Mundlos, Stefan; Robinson, Peter N.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Schulz, Marcel H.] Int Max Planck Res Sch Computat Biol & Sci Comp, D-14195 Berlin, Germany; [Mundlos, Christine] ACHSE, D-14050 Berlin, Germany		Robinson, PN (corresponding author), Charite Univ Med Berlin, Inst Med Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	peter.robinson@charite.de	Krawitz, Peter M/F-3142-2012; Kohler, Sebastian/A-2029-2012; Mundlos, Stefan/ABH-9585-2020; Ott, Claus/U-8226-2019; Ott, Claus E/G-1936-2011; Kohler, Sebastian/H-3301-2019	Krawitz, Peter M/0000-0002-3194-8625; Kohler, Sebastian/0000-0002-5316-1399; Ott, Claus/0000-0003-3627-3791; Ott, Claus E/0000-0003-3627-3791; Kohler, Sebastian/0000-0002-5316-1399; Robinson, Peter/0000-0002-0736-9199; Schulz, Marcel H./0000-0002-1252-3656	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG RO 2005/4-1, SFB 760]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [0313911]	The authors would like to acknowledge the monumental work of the late Professor Victor McKusick and colleagues at OMIM, without which our own work on the HPO would have been impossible. This work was supported by the Deutsche Forschungsgemeinschaft (DFG RO 2005/4-1, SFB 760) and the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) (Bundesministerium fur Bildung und Forschung, project no. 0313911).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayme Segolene, 2003, Soins, P46; BANKIER A, 1989, OPHTHALMIC PAED GEN, V10, P51, DOI 10.3109/13816818909083773; BARNETT GO, 1987, JAMA-J AM MED ASSOC, V258, P67, DOI 10.1001/jama.258.1.67; Battaglia A, 1999, AM J MED GENET, V82, P60, DOI 10.1002/(SICI)1096-8628(19990101)82:1<60::AID-AJMG12>3.0.CO;2-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Couto FM, 2007, DATA KNOWL ENG, V61, P137, DOI 10.1016/j.datak.2006.05.003; Cover T. M., 2006, ELEMENTS INFORM THEO, V2nd; Curry CJ, 1997, AM J MED GENET, V72, P468, DOI 10.1002/(SICI)1096-8628(19971112)72:4<468::AID-AJMG18>3.0.CO;2-P; Fryns JP, 2002, HUM GENET, V111, P113, DOI 10.1007/s00439-002-0759-6; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Jones K., 2005, SMITHS RECOGNIZABLE; Lin D., 1998, INFORM THEORETIC DEF, P296; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; MILLER R, 1986, M D COMPUT, V3, P34; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Neveol Aurelie, 2006, AMIA Annu Symp Proc, P589; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; RESNIK P, 1995, P 14 INT JOINT C ART, P448; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Schurink CAM, 2005, LANCET INFECT DIS, V5, P305, DOI 10.1016/S1473-3099(05)70115-8; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Srour M, 2006, PEDIATRICS, V118, P139, DOI 10.1542/peds.2005-2702; TRACE D, 1990, S COMP APPL MED CAR, P635; van Karnebeek CDM, 2005, EUR J HUM GENET, V13, P6, DOI 10.1038/sj.ejhg.5201279; WARNER HR, 1989, METHOD INFORM MED, V28, P370; Yu HY, 2007, BIOINFORMATICS, V23, P2163, DOI 10.1093/bioinformatics/btm291; [No title captured]	29	265	272	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					457	464		10.1016/j.ajhg.2009.09.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	WOS:000270836000003	19800049	Green Published, Bronze			2022-01-24	
J	Saal, LH; Gruvberger-Saal, SK; Persson, C; Loevgren, K; Jumppanen, M; Staaf, J; Jonsson, G; Pires, MM; Maurer, M; Holm, K; Koujak, S; Subramaniyam, S; Vallon-Christersson, J; Olsson, H; Su, T; Memeo, L; Ludwig, T; Ethier, SP; Krogh, M; Szabolcs, M; Murty, VV; Isola, J; Hibshoosh, H; Parsons, R; Borg, A				Saal, Lao H.; Gruvberger-Saal, Sofia K.; Persson, Camilla; Loevgren, Kristina; Jumppanen, Mervi; Staaf, Johan; Jonsson, Goeran; Pires, Maira M.; Maurer, Matthew; Holm, Karolina; Koujak, Susan; Subramaniyam, Shivakumar; Vallon-Christersson, Johan; Olsson, Hakan; Su, Tao; Memeo, Lorenzo; Ludwig, Thomas; Ethier, Stephen P.; Krogh, Morten; Szabolcs, Matthias; Murty, Vundavalli V. V. S.; Isola, Jorma; Hibshoosh, Hanina; Parsons, Ramon; Borg, Ake			Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair	NATURE GENETICS			English	Article							CELL-LINES; PROSTATE-CANCER; BRCA1; INSTABILITY; PHENOTYPE; CARCINOMA; PATTERNS; SUBTYPES; MICE	Basal-like breast cancer (BBC) is a subtype of breast cancer with poor prognosis(1 - 3). Inherited mutations of BRCA1, a cancer susceptibility gene involved in double-strand DNA break (DSB) repair, lead to breast cancers that are nearly always of the BBC subtype(3 - 5); however, the precise molecular lesions and oncogenic consequences of BRCA1 dysfunction are poorly understood. Here we show that heterozygous inactivation of the tumor suppressor gene Pten leads to the formation of basal-like mammary tumors in mice, and that loss of PTEN expression is significantly associated with the BBC subtype in human sporadic and BRCA1-associated hereditary breast cancers. In addition, we identify frequent gross PTEN mutations, involving intragenic chromosome breaks, inversions, deletions and micro copy number aberrations, specifically in BRCA1-deficient tumors. These data provide an example of a specific and recurrent oncogenic consequence of BRCA1-dependent dysfunction in DNA repair and provide insight into the pathogenesis of BBC with therapeutic implications. These findings also argue that obtaining an accurate census of genes mutated in cancer will require a systematic examination for gross gene rearrangements, particularly in tumors with deficient DSB repair.	[Saal, Lao H.] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Persson, Camilla; Loevgren, Kristina; Staaf, Johan; Jonsson, Goeran; Holm, Karolina; Vallon-Christersson, Johan; Olsson, Hakan; Borg, Ake] Lund Univ, Dept Clin Sci, Div Oncol, S-22185 Lund, Sweden; [Jumppanen, Mervi] Seinajoki Cent Hosp, Dept Pathol, Seinajoki 60220, Finland; [Jumppanen, Mervi; Isola, Jorma] Tampere Univ, Inst Med Technol, Tampere 33014, Finland; [Pires, Maira M.] Columbia Univ, Dept Biochem, New York, NY 10032 USA; [Maurer, Matthew; Parsons, Ramon] Columbia Univ, Dept Med, New York, NY 10032 USA; [Subramaniyam, Shivakumar; Ludwig, Thomas; Szabolcs, Matthias; Murty, Vundavalli V. V. S.; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Memeo, Lorenzo] Mediterranean Inst Oncol, Pathol Unit, I-95029 Catania, Italy; [Ethier, Stephen P.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Krogh, Morten] Lund Univ, Dept Theoret, S-22362 Lund, Sweden; [Borg, Ake] Lund Univ, Lund Strateg Ctr Stem Cell Biol & Cell Therapy, S-22185 Lund, Sweden; [Saal, Lao H.; Gruvberger-Saal, Sofia K.; Maurer, Matthew; Koujak, Susan; Murty, Vundavalli V. V. S.; Parsons, Ramon] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA		Parsons, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	rep15@columbia.edu	Saal, Lao H/A-2919-2011; Ludwig, Thomas/Q-6484-2016; Califano, Andrea/F-7239-2012; Jonsson, Goran/D-1212-2014	Saal, Lao H/0000-0002-0815-1896; Ludwig, Thomas/0000-0003-3461-2585; Memeo, Lorenzo/0000-0003-4251-7203; Parsons, Ramon/0000-0002-6656-3514; Olsson, Hakan/0000-0002-8794-9635; Vallon-Christersson, Johan/0000-0002-2195-0385	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA097403, R01CA082783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007367] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA097403, CA082783, R01 CA082783-08, R01 CA082783-06, R01 CA082783-07, P01 CA097403, R01 CA082783] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5T32 GM07367-29, T32 GM007367] Funding Source: Medline		Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; GIOVANELLA BC, 1974, JNCI-J NATL CANCER I, V52, P921, DOI 10.1093/jnci/52.3.921; Greenblatt MS, 2001, CANCER RES, V61, P4092; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Janzen V, 2006, NATURE, V441, P418, DOI 10.1038/441418b; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Laakso M, 2005, MODERN PATHOL, V18, P1321, DOI 10.1038/modpathol.3800456; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Saal LH, 2002, GENOME BIOL, V3; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; SILVA LD, 2007, J CLIN PATHOL   0511; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STAAF J, IN PRESS HUM MUTAT; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlinson GE, 1998, CANCER RES, V58, P3237; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	30	265	273	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					102	107		10.1038/ng.2007.39			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	WOS:000252118600025	18066063	Green Published, Green Accepted			2022-01-24	
J	Richards, A; van den Maagdenberg, AMJM; Jen, JC; Kavanagh, D; Bertram, P; Spitzer, D; Liszewski, MK; Barilla-LaBarca, ML; Terwindt, GM; Kasai, Y; McLellan, M; Grand, MG; Vanmolkot, KRJ; de Vries, B; Wan, J; Kane, MJ; Mamsa, H; Schafer, R; Stam, AH; Haan, J; Paulus, TVMDJ; Storimans, CW; van Schooneveld, MJ; Oosterhuis, JA; Gschwendter, A; Dichgans, M; Kotschet, KE; Hodgkinson, S; Hardy, TA; Delatycki, MB; Hajj-Ali, RA; Kothari, PH; Nelson, SF; Frants, RR; Baloh, RW; Ferrari, MD; Atkinson, JP				Richards, Anna; van den Maagdenberg, Arn M. J. M.; Jen, Joanna C.; Kavanagh, David; Bertram, Paula; Spitzer, Dirk; Liszewski, M. Kathryn; Barilla-LaBarca, Maria-Louise; Terwindt, Gisela M.; Kasai, Yumi; McLellan, Mike; Grand, Mark Gilbert; Vanmolkot, Kaate R. J.; de Vries, Boukje; Wan, Jijun; Kane, Michael J.; Mamsa, Hafsa; Schaefer, Ruth; Stam, Anine H.; Haan, Joost; Paulus, T. V. M. de Jong; Storimans, Caroline W.; van Schooneveld, Mary J.; Oosterhuis, Jendo A.; Gschwendter, Andreas; Dichgans, Martin; Kotschet, Katya E.; Hodgkinson, Suzanne; Hardy, Todd A.; Delatycki, Martin B.; Hajj-Ali, Rula A.; Kothari, Parul H.; Nelson, Stanley F.; Frants, Rune R.; Baloh, Robert W.; Ferrari, Michel D.; Atkinson, John P.			C-terminal truncations in human 3 '-5 ' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy	NATURE GENETICS			English	Article							CEREBRORETINAL VASCULOPATHY; HEREDITARY ENDOTHELIOPATHY; VASCULAR RETINOPATHY; NEPHROPATHY	Autosomal dominant retinal vasculopathy with cerebral leukodystrophy is a microvascular endotheliopathy with middle- age onset. In nine families, we identified heterozygous C- terminal frameshift mutations in TREX1, which encodes a 3'-5' exonuclease. These truncated proteins retain exonuclease activity but lose normal perinuclear localization. These data have implications for the maintenance of vascular integrity in the degenerative cerebral microangiopathies leading to stroke and dementias.	Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; N Shore Long Isl Jewish Hlth Syst, Dept Med, Div Rheumatol, Manhasset, NY 11030 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol, St Louis, MO 63110 USA; Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Ophthalmogenet, NL-1000 GC Amsterdam, Netherlands; Acad Med Ctr, Dept Ophthalmol, NL-1100 DD Amsterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; Meander Med Ctr, NL-3800 BM Amersfoort, Netherlands; Univ Med Ctr, Dept Ophthalmol, NL-3508 GA Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Ophthalmol, NL-2300 RC Leiden, Netherlands; Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany; Monash Med Ctr, Dept Neurol, Clayton, Vic 3168, Australia; Liverpool Hosp, Dept Neurol, Liverpool, NSW 2170, Australia; Concord Repatriat Gen Hosp, Dept Neurol, Concord, NSW 2139, Australia; Bruce Lefroy Ctr Genet Hlth Res, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; Cleveland Clin Fdn, Dept Rheumat & Immunol Dis, Cleveland, OH 44195 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA		Atkinson, JP (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.	jatkinso@im.wustl.edu	Ferrari, Michel D./ABE-3758-2021; Kavanagh, David/E-8498-2011; Richards, Anna/E-8337-2013; Nelson, Stanley F/D-4771-2009; Delatycki, Martin B/A-5409-2013; Barillla-LaBarca, Maria Louise/AAR-9207-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019	Ferrari, Michel D./0000-0001-9691-9449; Kavanagh, David/0000-0003-4718-0072; Nelson, Stanley F/0000-0002-2082-3114; MCLELLAN, MICHAEL/0000-0002-2703-8784; Hodgkinson, Suzanne/0000-0002-9029-6663; Schafer, Ruth Christine/0000-0002-4324-1854	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01 EY15311] Funding Source: Medline; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P50 DC02952] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY015311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P01DC002952] Funding Source: NIH RePORTER		Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cohn AC, 2005, CLIN EXP OPHTHALMOL, V33, P181, DOI 10.1111/j.1442-9071.2005.00976.x; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Goutieres F, 2005, BRAIN DEV-JPN, V27, P201, DOI 10.1016/j.braindev.2003.12.011; GRAND MG, 1988, OPHTHALMOLOGY, V95, P649, DOI 10.1016/s0161-6420(88)33131-3; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Jen J, 1997, NEUROLOGY, V49, P1322, DOI 10.1212/WNL.49.5.1322; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Ophoff RA, 2001, AM J HUM GENET, V69, P447, DOI 10.1086/321975; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Storimans C W, 1991, Eur J Ophthalmol, V1, P73; Terwindt GM, 1998, BRAIN, V121, P303, DOI 10.1093/brain/121.2.303; Weil S, 1999, NEUROLOGY, V53, P629, DOI 10.1212/WNL.53.3.629	15	265	276	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1068	1070		10.1038/ng2082			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	WOS:000249122400014	17660820				2022-01-24	
J	Holst, F; Stahl, PR; Ruiz, C; Hellwinkel, O; Jehan, Z; Wendland, M; Lebeau, A; Terracciano, L; Al-Kuraya, K; Janicke, F; Sauter, G; Simon, R				Holst, Frederik; Stahl, Phillip R.; Ruiz, Christian; Hellwinkel, Olaf; Jehan, Zeenath; Wendland, Marc; Lebeau, Annette; Terracciano, Luigi; Al-Kuraya, Khawla; Jaenicke, Fritz; Sauter, Guido; Simon, Ronald			Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer	NATURE GENETICS			English	Article							URINARY-BLADDER CANCER; IN-SITU HYBRIDIZATION; CLINICAL-TRIALS; TISSUE; OVEREXPRESSION; PROLIFERATION; HETEROGENEITY; EXPRESSION; TAMOXIFEN; THERAPY	Using an Affymetrix 10K SNP array to screen for gene copy number changes in breast cancer, we detected a single-gene amplification of the ESR1 gene, which encodes estrogen receptor alpha, at 6q25. A subsequent tissue microarray analysis of more than 2,000 clinical breast cancer samples showed ESR1 amplification in 20.6% of breast cancers. Ninety-nine percent of tumors with ESR1 amplification showed estrogen receptor protein overexpression, compared with 66.6% cancers without ESR1 amplification ( P < 0.0001). In 175 women who had received adjuvant tamoxifen monotherapy, survival was significantly longer for women with cancer with ESR1 amplification than for women with estrogen receptor - expressing cancers without ESR1 amplification ( P = 0.023). Notably, we also found ESR1 amplification in benign and precancerous breast diseases, suggesting that ESR1 amplification may be a common mechanism in proliferative breast disease and a very early genetic alteration in a large subset of breast cancers.	Univ Med Ctr Hamburg Eppendorf, Dept Pathol, D-20246 Hamburg, Germany; Univ Basel Hosp, Dept Pathol, CH-4031 Basel, Switzerland; Univ Med Ctr Hamburg Eppendorf, Dept Urol, D-20246 Hamburg, Germany; Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, D-20246 Hamburg, Germany; King Faisal Specialist Hosp & Res Ctr, Riyadh 21211, Saudi Arabia		Simon, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pathol, D-20246 Hamburg, Germany.	r.simon@uke.uni-hamburg.de	Terracciano, Luigi M./AAB-5335-2022; Holst, Frederik/H-3149-2019	Terracciano, Luigi M./0000-0002-9393-9660; Holst, Frederik/0000-0002-5928-2175; Simon, Ronald/0000-0003-0158-4258			Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; ANDERSEN J, 1989, CANCER, V64, P1901, DOI 10.1002/1097-0142(19891101)64:9<1901::AID-CNCR2820640924>3.0.CO;2-W; Courjal F, 1996, INT J CANCER, V69, P247; Dybdal N, 2005, BREAST CANCER RES TR, V93, P3, DOI 10.1007/s10549-004-6275-8; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; IP M, 1979, SCIENCE, V203, P361, DOI 10.1126/science.760195; KATZENELLENBOGEN BS, 1987, CANCER RES, V47, P4355; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Koivisto P, 1997, CANCER RES, V57, P314; Nessling M, 2005, CANCER RES, V65, P439; Pauletti G, 1996, ONCOGENE, V13, P63; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Press MF, 2005, CLIN CANCER RES, V11, P6598, DOI 10.1158/1078-0432.CCR-05-0636; Rose C, 1980, Recent Results Cancer Res, V71, P134; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; SAUTER G, 1993, CANCER RES, V53, P2199; SAUTER G, 1995, CYTOMETRY, V21, P40, DOI 10.1002/cyto.990210109; Shoker BS, 1999, J PATHOL, V188, P237; Simon R, 2002, ONCOGENE, V21, P2476, DOI 10.1038/sj.onc.1205304; Simon R, 2001, J NATL CANCER I, V93, P1141, DOI 10.1093/jnci/93.15.1141; STIERER M, 1993, ANN SURG, V218, P13, DOI 10.1097/00000658-199307000-00004; SUNDERLAND MC, 1991, J CLIN ONCOL, V9, P1283, DOI 10.1200/JCO.1991.9.7.1283; Wagner U, 1997, AM J PATHOL, V151, P753; Wolmark N, 2001, ANN NY ACAD SCI, V949, P99	25	265	270	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2007	39	5					655	660		10.1038/ng2006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	WOS:000245971300022	17417639				2022-01-24	
J	O'Sullivan, JM; Tan-Wong, SM; Morillon, A; Lee, B; Coles, J; Mellor, J; Proudfoot, NJ				O'Sullivan, JM; Tan-Wong, SM; Morillon, A; Lee, B; Coles, J; Mellor, J; Proudfoot, NJ			Gene loops juxtapose promoters and terminators in yeast	NATURE GENETICS			English	Article							RNA-POLYMERASE-II; 3 END; TRANSCRIPTION; SSU72; POLYADENYLATION; ARCHITECTURE; ELONGATION; COMPLEXES	Mechanistic analysis of transcriptional initiation and termination by RNA polymerase II (PolII) indicates that some factors are common to both processes(1,2). Here we show that two long genes of Saccharomyces cerevisiae, FMP27 and SEN1, exist in a looped conformation, effectively bringing together their promoter and terminator regions. We also show that PolII is located at both ends of FMP27 when this gene is transcribed from a GAL1 promoter under induced and noninduced conditions. Under these conditions, the C-terminal domain of the large subunit of PolII is phosphorylated at Ser5. Notably, inactivation of Kin28p causes a loss of both Ser5 phosphorylation and the loop conformation. These data suggest that gene loops are involved in the early stages of transcriptional activation. They also predict a previously unknown structural dimension to gene regulation, in which both ends of the transcription unit are defined before and during the transcription cycle.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, Dept Biochem, Oxford OX1 3RE, England		Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk	Morillon, Antonin/M-4751-2017	Morillon, Antonin/0000-0002-0575-5264; Proudfoot, Nicholas/0000-0001-8646-3222; O'Sullivan, Justin/0000-0003-2927-450X			Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1	27	265	270	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					1014	1018		10.1038/ng1411			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	WOS:000223658100031	15314641	Bronze			2022-01-24	
J	Bignell, GR; Huang, J; Greshock, J; Watt, S; Butler, A; West, S; Grigorova, M; Jones, KW; Wei, W; Stratton, MR; Futreal, PA; Weber, B; Shapero, MH; Wooster, R				Bignell, GR; Huang, J; Greshock, J; Watt, S; Butler, A; West, S; Grigorova, M; Jones, KW; Wei, W; Stratton, MR; Futreal, PA; Weber, B; Shapero, MH; Wooster, R			High-resolution analysis of DNA copy number using oligonucleotide microarrays	GENOME RESEARCH			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CGH; EXPRESSION; TUMORS	Genomic copy number alterations are a feature of many human diseases including cancer. We have evaluated the effectiveness of an oligonucleotide array, originally designed to detect single-nucleotide polymorphisms, to assess DNA copy number. We first showed that fluorescent signal from the oligonucleotide array varies in proportion to both decreases and increases in copy number. Subsequently we applied the system to a series of 20 cancer cell lines. All of the putative homozygous deletions (10) and high-level amplifications (12; putative copy number >4) tested were confirmed by PCR (either qPCR or normal PCR) analysis. Low-level copy number changes for two of the lines under analysis were compared with BAC array CGH; 77% (n = 44) of the autosomal chromosomes used in the comparison showed consistent patterns of LOH (loss of heterozygosity) and low-level amplification. Of the remaining 10 comparisons that were discordant, eight were caused by low SNP densities and failed in both lines. The studies demonstrate that combining the genotype and copy number analyses gives greater insight into the underlying genetic alterations in cancer cells with identification of complex events including loss and reduplication of loci.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Affymetrix Inc, Santa Clara, CA 95051 USA; Univ Penn, Ctr Canc, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England		Futreal, PA (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	paf@sanger.ac.uk					Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; DUMUR DI, 2003, GENOME, V81, P260; Ghaffari SR, 1998, J MED GENET, V35, P225, DOI 10.1136/jmg.35.3.225; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Lucito R, 1998, P NATL ACAD SCI USA, V95, P4487, DOI 10.1073/pnas.95.8.4487; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Schubert EL, 2002, AM J PATHOL, V160, P73, DOI 10.1016/S0002-9440(10)64351-9; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Yang L, 2001, GENOME RES, V11, P1888, DOI 10.1101/gr.190901	16	265	280	0	20	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2004	14	2					287	295		10.1101/gr.2012304			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	771XR	WOS:000188811800010	14762065	Green Published, Bronze			2022-01-24	
J	Nuwaysir, EF; Huang, W; Albert, TJ; Singh, J; Nuwaysir, K; Pitas, A; Richmond, T; Gorski, T; Berg, JP; Ballin, J; McCormick, M; Norton, J; Pollock, T; Sumwalt, T; Butcher, L; Porter, D; Molla, M; Hall, C; Blattner, F; Sussman, MR; Wallace, RL; Cerrina, F; Green, RD				Nuwaysir, EF; Huang, W; Albert, TJ; Singh, J; Nuwaysir, K; Pitas, A; Richmond, T; Gorski, T; Berg, JP; Ballin, J; McCormick, M; Norton, J; Pollock, T; Sumwalt, T; Butcher, L; Porter, D; Molla, M; Hall, C; Blattner, F; Sussman, MR; Wallace, RL; Cerrina, F; Green, RD			Gene expression analysis using oligonucleotide arrays produced by maskless photolithography	GENOME RESEARCH			English	Article							HYBRIDIZATION	Microarrays containing 195,000 in situ synthesized oligonucleotide features have been created using a benchtop, maskless photolithographic instrument. This instrument, the Maskless Array Synthesizer (MAS), uses a digital light processor (DLP) developed by Texas Instruments. The DLP creates the patterns of UV light used in the light-directed synthesis of oligonucleotides. This digital mask eliminates the need for expensive and time-consuming chromium masks. In this report, we describe experiments in which we tested this maskless technology for DNA synthesis on glass surfaces. Parameters examined included deprotection rates, repetitive yields, and oligonucleotide length. Custom gene expression arrays were manufactured and hybridized to Drosophila melanogaster and mouse samples. Quantitative PCR was used to validate the gene expression data from the mouse arrays.	NimbleGen Syst Inc, Madison, WI 53711 USA; Univ Wisconsin, Ctr Nanotechnol, Dept Elect Engn & Comp Engn, Madison, WI 53706 USA; Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA		Green, RD (corresponding author), NimbleGen Syst Inc, Madison, WI 53711 USA.	rgreen@nimblegen.com	Ballin, Jeff/D-3752-2011; Ballin, Jeff D/AAC-3869-2022	Ballin, Jeff/0000-0002-2712-130X; Ballin, Jeff D/0000-0002-2712-130X			Dill K, 1999, J BIOCHEM BIOPH METH, V41, P61, DOI 10.1016/S0165-022X(99)00027-5; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hasan A, 1997, TETRAHEDRON, V53, P4247, DOI 10.1016/S0040-4020(97)00154-3; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; McGall GH, 1997, J AM CHEM SOC, V119, P5081, DOI 10.1021/ja964427a; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M., 1999, DNA MICROARRAYS PRAC; Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P1155, DOI 10.1093/nar/25.6.1155; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; SOUTHERN EM, 1992, GENOMICS, V13, P1008, DOI 10.1016/0888-7543(92)90014-J; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001	12	265	276	0	31	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2002	12	11					1749	1755		10.1101/gr.362402			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	612DB	WOS:000179058300014	12421762	Bronze, Green Published			2022-01-24	
J	Date, H; Onodera, O; Tanaka, H; Iwabuchi, K; Uekawa, K; Igarashi, S; Koike, R; Hiroi, T; Yuasa, T; Awaya, Y; Sakai, T; Takahashi, T; Nagatomo, H; Sekijima, Y; Kawachi, I; Takiyama, Y; Nishizawa, M; Fukuhara, N; Saito, K; Sugano, S; Tsuji, S				Date, H; Onodera, O; Tanaka, H; Iwabuchi, K; Uekawa, K; Igarashi, S; Koike, R; Hiroi, T; Yuasa, T; Awaya, Y; Sakai, T; Takahashi, T; Nagatomo, H; Sekijima, Y; Kawachi, I; Takiyama, Y; Nishizawa, M; Fukuhara, N; Saito, K; Sugano, S; Tsuji, S			Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene	NATURE GENETICS			English	Article							CEREBELLAR ATROPHY HMSNCA; HEREDITARY MOTOR; LINKAGE ANALYSIS; PROTEINS; FEATURES; FAMILY	Friedreich ataxia (FRDA), the most common autosomal recessive neurodegenerative disease among Europeans and people of European descent, is characterized by an early onset (usually before the age of 25), progressive ataxia, sensory loss, absence of tendon reflexes and pyramidal weakness of the legs(1-4). We have recently identified a unique group of patients whose clinical presentations are characterized by autosomal recessive inheritance, early age of onset, FRDA-like clinical presentations and hypoalbuminemia. Linkage to the FRDA locus, however, was excluded. Given the similarities of the clinical presentations to those of the recently described ataxia with oculomotor apraxia (AOA) linked to chromosome 9p13, we confirmed that the disorder of our patients is also linked to the same locus(5). We narrowed the candidate region and have identified a new gene encoding a member of the histidine triad (HIT) superfamily as the 'causative' gene. We have called its product aprataxin; the gene symbol is APTX. Although many HIT proteins have been identified, aprataxin is the first to be linked to a distinct phenotype.	Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Kanagawa Rehabil Ctr, Dept Neurol & Psychiat, Kanagawa, Japan; Natl Kumamoto Minami Hosp, Dept Neurol, Kumamoto, Japan; Hosoki Hosp, Kouchi, Japan; Kohnodai Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan; Seibo Hosp, Dept Pediat, Tokyo, Japan; Natl Chikugo Hosp, Fukuoka, Japan; Yokohama City Univ, Med Ctr, Dept Psychiat, Kanagawa, Japan; Shinshu Univ, Sch Med, Dept Med 3, Nagano, Japan; Jichi Med Sch, Dept Neurol, Minami Kawachi, Tochigi 32904, Japan; Natl Saigata Hosp, Dept Neurol, Niigata, Japan; Tokyo Womens Med Univ, Sch Med, Dept Pediat, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Virol, Tokyo, Japan		Tsuji, S (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, 1 Asahimachi, Niigata 951, Japan.		Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472			AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; ARAIE M, 1977, JPN J OPHTHALMOL, V21, P355; Barbot C, 2001, ARCH NEUROL-CHICAGO, V58, P201, DOI 10.1001/archneur.58.2.201; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; COGAN DG, 1953, AM J OPHTHALMOL, V36, P433, DOI 10.1016/0002-9394(53)90553-4; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Friedreich N, 1876, VIRCHOWS ARCH PATHOL, V68, P145; Friedreich N., 1877, VIRCHOWS ARCH PATHOL, V70, P140, DOI [10.1007/BF01936635, DOI 10.1007/BF01936635]; FUKUHARA N, 1995, J NEUROL SCI, V133, P140, DOI 10.1016/0022-510X(95)00176-3; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; INOUE N, 1971, CLIN NEUROL TOKYO, V11, P855; KAWASAKI S, 1982, CLIN NEUROL, V22, P15; KOIKE R, 1998, NEUROL MED, V48, P237; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kubota Hiroshi, 1995, Brain and Nerve (Tokyo), V47, P289; KURITATAKAHASHI S, NEUROOPHTHALMOL, V12, P41; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Moreira MD, 2001, AM J HUM GENET, V68, P501, DOI 10.1086/318191; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMBROOK J, 2001, MOL CLONING LAB MANU, V1; Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8; Seraphin B., 1992, DNA Sequence, V3, P177, DOI 10.3109/10425179209034013; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UEKAWA K, 1992, CLIN NEUROL, V32, P1067	28	265	274	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					184	188		10.1038/ng1001-184			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	WOS:000171374100025	11586299				2022-01-24	
J	Orr, HA; Betancourt, AJ				Orr, HA; Betancourt, AJ			Haldane's sieve and adaptation from the standing genetic variation	GENETICS			English	Article							POPULATION-GENETICS; INSECTICIDE; SELECTION; EVOLUTION; HELICONIUS; RATES	We consider populations that adapt to a sudden environmental change by fixing alleles found at mutation-selection balance. In particular, we calculate probabilities of fixation for previously deleterious alleles, ignoring the input of new mutations. We find that "Haldane's siere"-the bias against the establishment of recessive beneficial mutations-does not hold under these conditions. Instead probabilities of fixation are generally independent of dominance. We show that this result is robust to patterns of sex expression for both X-Linked and autosomal loci. We further show that adaptive evolution is invariably slower at X-linked than autosomal loci when evolution begins from mutation-selection balance. This result differs from that obtained when adaptation uses new mutations, a finding that may have some bearing on recent attempts to distinguish between hitchhiking and background selection by contrasting the molecular population genetics of X-linked vs. autosomal loci. Last, we suggest a test to determine whether adaptation used new mutations or previously deleterious alleles from the standing genetic variation.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA		Orr, HA (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	aorr@mail.rochester.edu	Betancourt, Andrea/E-9667-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM051932, R29GM051932] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM51932] Funding Source: Medline		Andreev D, 1999, J MOL EVOL, V48, P615, DOI 10.1007/PL00006504; Aquadro Charles F., 1994, P46; AVERY PJ, 1984, GENET RES, V44, P321, DOI 10.1017/S0016672300026550; Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; Bourguet D, 1998, J EVOLUTION BIOL, V11, P103, DOI 10.1046/j.1420-9101.1998.11010103.x; Bradshaw HD, 1998, GENETICS, V149, P367; CHARLESWORTH B, 1992, AM NAT, V140, P126, DOI 10.1086/285406; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Coyne J.A., 1989, P180; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; FFRENCHCONSTANT RH, 1994, INSECT BIOCHEM MOLEC, V24, P335, DOI 10.1016/0965-1748(94)90026-4; GALE JS, 1990, THEORETICAL POPULATI; Haldane J. B. S., 1924, Trans Phil Soc Cambridge U K, V23, P19; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; JAMES JW, 1965, HEREDITY, V20, P142, DOI 10.1038/hdy.1965.16; Kettlewell H., 1973, EVOLUTION MELANISM S; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; LANDE R, 1983, HEREDITY, V50, P47, DOI 10.1038/hdy.1983.6; Maynard Smith John, 1975, THEORY EVOLUTION, V3rd; MERRELL D J, 1969, Genetics Lectures, P167; Moran P.A.P., 1962, STAT PROCESSES EVOLU; NAGYLAKI T, 1979, ANN HUM GENET, V43, P143, DOI 10.1111/j.1469-1809.1979.tb02007.x; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Prowell DP, 1998, ENDLESS FORMS, P309; ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.en.32.010187.002045; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Smith J.M, 1993, THEORY EVOLUTION; Turner J.R.G., 1976, P185; Turner J. R. G., 1977, Evolutionary Biol, V10, P163; TURNER JRG, 1981, ANNU REV ECOL SYST, V12, P99, DOI 10.1146/annurev.es.12.110181.000531; Wood R.J., 1981, GENETIC CONSEQUENCES, P97; Wright S, 1939, STAT GENETICS RELATI	32	265	267	0	53	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	FEB	2001	157	2					875	884					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399KL	WOS:000166810200038	11157004				2022-01-24	
J	Sosa-Pineda, B; Wigle, JT; Oliver, G				Sosa-Pineda, B; Wigle, JT; Oliver, G			Hepatocyte migration during liver development requires Prox1	NATURE GENETICS			English	Article							MOUSE DEVELOPMENT; ENDODERM; GENE; GUT		St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA		Oliver, G (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.		Wigle, J.t./G-2005-2014	Wigle, J.t./0000-0002-4985-7684	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY12162] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM58462] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM058462] Funding Source: NIH RePORTER		BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hentsch B, 1996, GENE DEV, V10, P70, DOI 10.1101/gad.10.1.70; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; LEDOUARIN NM, 1975, MED BIOL, V53, P427; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Zaret KS, 1996, ANNU REV PHYSIOL, V58, P231, DOI 10.1146/annurev.ph.58.030196.001311; ZARET KS, 1988, CURR OPIN GENE DEV, V8, P526	12	265	271	2	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					254	255		10.1038/76996			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	WOS:000087920900007	10888866				2022-01-24	
J	Vieira, C; Pasyukova, EG; Zeng, ZB; Hackett, JB; Lyman, RF; Mackay, TFC				Vieira, C; Pasyukova, EG; Zeng, ZB; Hackett, JB; Lyman, RF; Mackay, TFC			Genotype-environment interaction for quantitative trait loci affecting life span in Drosophila melanogaster	GENETICS			English	Article							AGE-SPECIFIC PATTERNS; BRISTLE NUMBER; CAENORHABDITIS-ELEGANS; POSTPONED SENESCENCE; LABORATORY EVOLUTION; PHENOTYPIC VARIATION; STRESS RESISTANCE; GENETIC VARIANCE; FAMILY MEMBER; SELECTION	The nature of genetic variation for Drosophila longevity in a population of recombinant inbred lines was investigated by estimating quantitative genetic parameters and mapping quantitative trait loci (QTL) for adult life span in five environments: standard culture conditions, high and low temperature, and heat-shock and starvation stress. There was highly significant genetic variation for life span within each sex and environment. In the analysis of variance of life span pooled over sexes and environments, however, the significant genetic variation appeared in the genotype X sex and genotype X environment interaction re rms. The genetic correlation of longevity across the sexes and environments was not significantly different from zero in these lines. We estimated map positions and effects of QTL affecting life span by linkage to highly polymorphic roo transposable element markers, using a multiple-trait composite interval mapping procedure. X minimum of 17 QTL were detected; all were sex and/or environment-specific. Ten of the QTL had sexually antagonistic or antagonistic pleiotropic effects in different environments. These data provide support for the pleiotropy theory of senescence and the hypothesis that variation for longevity might be maintained by opposing selection pressures in males and females and variable environments. Further work is necessary to assess the generality of these results, using different strains, to determine heterozygous effects and to map the life span QTL to the level of generic loci.	N Carolina State Univ, Dept Genet, Coll Agr & Life Sci, Raleigh, NC 27695 USA; Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA		Mackay, TFC (corresponding author), N Carolina State Univ, Dept Genet, Coll Agr & Life Sci, Box 7614, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu	Pasyukova, Elena G/I-8377-2017; Vieira, Cristina/Q-3137-2017	Vieira, Cristina/0000-0003-3414-3993	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM045146, P01GM045344] Funding Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [TW00997] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 45344, GM 45146] Funding Source: Medline		ARKING R, 1987, EXP GERONTOL, V22, P199, DOI 10.1016/0531-5565(87)90040-4; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BUCK S, 1993, HEREDITY, V71, P23, DOI 10.1038/hdy.1993.103; Bulmer MG, 1985, MATH THEORY QUANTITA; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; Charlesworth B, 1980, EVOLUTION AGE STRUCT; DeckertCruz DJ, 1997, EVOLUTION, V51, P865, DOI [10.2307/2411161, 10.1111/j.1558-5646.1997.tb03668.x]; ENGSTROM G, 1989, THEOR APPL GENET, V77, P119, DOI 10.1007/BF00292325; ENGSTROM G, 1992, THEOR APPL GENET, V85, P26, DOI 10.1007/BF00223841; Falconer D, 1996, INTRO QUANTITATIVE G INTRO QUANTITATIVE G; FALCONER DS, 1952, AM NAT, V86, P293, DOI 10.1086/281736; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; FINCH CE, 1990, LONEVITY SENESCENCE; Force AG, 1995, DEV GENET, V17, P340, DOI 10.1002/dvg.1020170407; GILLESPIE JH, 1989, GENETICS, V121, P129; GRAVES JL, 1992, PHYSIOL ZOOL, V65, P268, DOI 10.1086/physzool.65.2.30158253; Gurganus MC, 1998, GENETICS, V149, P1883; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; HARRISON DE, 1990, GENETIC EFFECTS AGIN, V2; Hekimi S, 1998, TRENDS GENET, V14, P14, DOI 10.1016/S0168-9525(97)01299-7; Houle D, 1996, GENETICS, V143, P1467; HOULE D, 1992, GENETICS, V130, P195; HUGHES KA, 1995, EVOLUTION, V49, P521, DOI 10.1111/j.1558-5646.1995.tb02284.x; HUGHES KA, 1994, NATURE, V367, P64, DOI 10.1038/367064a0; JIANG CJ, 1995, GENETICS, V140, P1111; Khazaeli AA, 1997, J GERONTOL A-BIOL, V52, pB48, DOI 10.1093/gerona/52A.1.B48; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; LAI CG, 1994, SCIENCE, V266, P1697, DOI 10.1126/science.7992053; LEROI AM, 1994, EVOLUTION, V48, P1244, DOI 10.1111/j.1558-5646.1994.tb05309.x; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; LINDSLEY DL, 1992, GENOME DROSOPHILA CA; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Long AD, 1998, GENETICS, V149, P999; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; Lyman RF, 1996, GENETICS, V143, P277; Lyman RF, 1998, GENETICS, V149, P983; MACKAY TFC, 1990, NATURE, V348, P64, DOI 10.1038/348064a0; MARTIN L, 1994, DEMOGRAPHY AGING; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Medawar P.B., 1952, UNSOLVED PROBLEM BIO; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; NIEDZWIECKI A, 1991, J BIOL CHEM, V266, P9332; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; PARTRIDGE L, 1992, EVOLUTION, V46, P76, DOI [10.2307/2409806, 10.1111/j.1558-5646.1992.tb01986.x]; PASYUKOVA EG, 1993, MOL GEN GENET, V240, P302, DOI 10.1007/BF00277071; Promislow DEL, 1996, GENETICS, V143, P839; ROBERTSON A, 1959, BIOMETRICS, V15, P469, DOI 10.2307/2527750; ROPER C, 1993, EVOLUTION, V47, P445, DOI 10.1111/j.1558-5646.1993.tb02105.x; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; ROSE MR, 1981, GENETICS, V97, P172; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; ROSE MR, 1981, GENETICS, V97, P187; Rowe JW, 1997, SCIENCE, V278, P367, DOI 10.1126/science.278.5337.367; SAS Institute, 1988, SAS STAT US GUID SAS STAT US GUID, V6th; SERVICE PM, 1993, EVOLUTION, V47, P387, DOI 10.1111/j.1558-5646.1993.tb02101.x; SERVICE PM, 1988, EVOLUTION, V42, P708, DOI 10.1111/j.1558-5646.1988.tb02489.x; SERVICE PM, 1987, PHYSIOL ZOOL, V60, P321, DOI 10.1086/physzool.60.3.30162285; Sokal R.R., 1981, BIOMETRY; SOLLER M, 1990, THEOR APPL GENET, V80, P205, DOI 10.1007/BF00224388; STEARNS SC, 1993, GENETICA, V91, P167, DOI 10.1007/BF01435996; Tatar M, 1996, GENETICS, V143, P849; TOWLER J, 1996, BIOESSAYS, V18, P799; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WOODHEAD AD, 1985, MOL BIOL AGING; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; ZENG ZB, 1994, GENETICS, V136, P1457; ZWAAN B, 1995, EVOLUTION, V49, P649, DOI [10.2307/2410318, 10.1111/j.1558-5646.1995.tb02301.x]; [No title captured]	73	265	272	0	25	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JAN	2000	154	1					213	227					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	272LK	WOS:000084651500023	10628982				2022-01-24	
J	Nagano, A; Koga, R; Ogawa, M; Kurano, Y; Kawada, J; Okada, R; Hayashi, YK; Tsukahara, T; Arahata, K				Nagano, A; Koga, R; Ogawa, M; Kurano, Y; Kawada, J; Okada, R; Hayashi, YK; Tsukahara, T; Arahata, K			Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy	NATURE GENETICS			English	Article							X-CHROMOSOME; FACTOR-VIII; LINKAGE; GENE; LOCALIZATION; SKELETAL; PROTEIN; MUSCLE	Mutations in the STA gene at the Xq28 locus have been found in patients with X-linked Emery-Dreifuss muscular dystrophy (EDMD). This gene encodes a hitherto unknown protein named 'emerin'. To elucidate the subcellular localization of emerin, we raised two antisera against synthetic peptide fragments predicted from emerin cDNA. Using both antisera, we found positive nuclear membrane staining in skeletal, cardiac and smooth muscles in the normal controls and in patients with neuromuscular diseases other than EDMD. In contrast, a deficiency in immunofluorescent staining of skeletal and cardiac muscle from EDMD patients was observed. A 34 kD protein is immunoreactive with the antisera - the protein is equivalent to that predicted for emerin. Together, our findings suggest the specific deficiency of emerin in the nuclear membrane of muscle cells in patients with EDMD.	NCNP,DEPT NEUROMUSCULAR RES,NATL INST NEUROSCI,KODAIRA,TOKYO 187,JAPAN; TOKYO MED COLL,DEPT INTERNAL MED 3,SHINJUKU KU,TOKYO 160,JAPAN; FUJIREBIO CENT RES INST,HACHIOJI,TOKYO 192,JAPAN; KANAZAWA MED UNIV,DEPT NEUROL,UCHINADA,ISHIKAWA 92002,JAPAN; JUNTENDO UNIV,SCH MED,RES LAB CARDIOVASC PATHOL,BUNKYO KU,TOKYO 113,JAPAN								ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; ARIKAWAHIRASAWA E, 1995, NEUROMUSCULAR DISORD, V5, P429, DOI 10.1016/0960-8966(94)00087-P; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1995, HUM MOL GENET, V4, P1859; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; COLE CG, 1992, NEUROMUSCULAR DISORD, V2, P51, DOI 10.1016/0960-8966(92)90027-4; DEDUVE C, 1981, J CELL BIOL, V91, pS293, DOI 10.1083/jcb.91.3.293s; DUBOWITZ V, 1989, COLOR ATLAS MUSCLE D; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; EMERY AEH, 1989, BRIT MED BULL, V45, P772, DOI 10.1093/oxfordjournals.bmb.a072357; HODGSON S, 1986, HUM GENET, V74, P409, DOI 10.1007/BF00280495; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KLAUCK SM, 1995, HUM MOL GENET, V4, P1853, DOI 10.1093/hmg/4.10.1853; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOGA R, 1994, BIOCHEM BIOPH RES CO, V202, P577, DOI 10.1006/bbrc.1994.1967; KRESS W, 1992, NEUROMUSCULAR DISORD, V2, P111, DOI 10.1016/0960-8966(92)90042-5; NIGRO V, 1995, HUM MOL GENET, V4, P2003, DOI 10.1093/hmg/4.10.2003; ROMEO G, 1988, HUM GENET, V80, P59, DOI 10.1007/BF00451457; THOMAS NST, 1986, J MED GENET, V23, P596, DOI 10.1136/jmg.23.6.596; YATES JRW, 1986, J MED GENET, V23, P587, DOI 10.1136/jmg.23.6.587	22	265	266	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					254	259		10.1038/ng0396-254			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	WOS:A1996TY18300013	8589715				2022-01-24	
J	NEALE, MC; KENDLER, KS				NEALE, MC; KENDLER, KS			MODELS OF COMORBIDITY FOR MULTIFACTORIAL DISORDERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENERALIZED ANXIETY DISORDER; DEPRESSION; TWIN; AGE	We develop several formal models for comorbidity between multifactorial disorders. Based on the work of D. N. Klein and L. P. Rise, the models include (i) alternate forms, where the two disorders have the same underlying continuum of liability; (ii) random multiformity, in which affection status on one disorder abruptly increases risk for the second; (iii) extreme multiformity, where only extreme cases have an abruptly increased risk for the second disorder; (iv) three independent disorders, in which excess comorbid cases are due to a separate, third disorder; (v) correlated liabilities, where the risk factors for the two disorders correlate; and (vi) direct causal models, where the liability for one disorder is a cause of the other disorder. These models are used to make quantitative predictions about the relative proportions of pairs of relatives who are classified according to whether each relative has neither disorder, disorder A but not B, disorder B but not A, or both A and B. For illustration, we analyze data on major depression (MD) and generalized anxiety disorder (GAD) assessed in adult female MZ and DZ twins, which enable estimation of the relative impact of genetic and environmental factors. Several models are rejected-that comorbid cases are due to chance; multiformity of GAD; a third independent disorder; and GAD being a cause of MD, Of the models that fit the data, correlated liabilities, MD causes GAD, and reciprocal causation seem best. MD appears to be a source of liability for GAD. Possible extensions to the models are discussed.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298		NEALE, MC (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHIAT,BOX 980710,RICHMOND,VA 23298, USA.		Neale, Michael/AAD-5056-2020; Neale, Michael C/B-1418-2008; Kendler, Kenneth/AAF-2876-2019		NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR-08123] Funding Source: Medline; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA-09095] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH/AA-49492] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH049492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA009095] Funding Source: NIH RePORTER		Agresti A., 1990, CATEGORICAL DATA ANA; Bagozzi RP, 1994, STRUCT EQU MODELING, V1, P35, DOI 10.1080/10705519409539961; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V48, P633; Bollen K.A., 1989, STRUCTURAL EQUATIONS, VXIV; BOYD JH, 1984, ARCH GEN PSYCHIAT, V41, P983; BRADY EU, 1992, PSYCHOL BULL, V111, P244, DOI 10.1037/0033-2909.111.2.244; BRESLAU N, 1985, PSYCHIAT RES, V1, P231; BROWNE MW, 1984, BRIT J MATH STAT PSY, V37, P62, DOI 10.1111/j.2044-8317.1984.tb00789.x; CARMELLI D, 1994, AM J HUM GENET, V55, P566; CARON C, 1991, J CHILD PSYCHOL PSYC, V32, P1063, DOI 10.1111/j.1469-7610.1991.tb00350.x; Docherty J, 1986, AM PSYCHIATRIC ASS A, V5, P315; DUFFY DL, 1994, GENET EPIDEMIOL, V11, P483, DOI 10.1002/gepi.1370110606; EAVES L, 1993, NATURE NURTURE PSYCH; EAVES LJ, 1987, BEHAV GENET, V17, P331, DOI 10.1007/BF01068135; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580; GUNDERSON JG, 1991, AM J PSYCHIAT, V148, P967; HEATH AC, 1993, BEHAV GENET, V23, P29, DOI 10.1007/BF01067552; HEATH AC, 1989, BEHAV GENET, V19, P9, DOI 10.1007/BF01065881; JARDINE R, 1984, Genetic Epidemiology, V1, P89, DOI 10.1002/gepi.1370010202; Joreskog K., 1989, LISREL 7 GUIDE PROGR, V2nd ed.; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P267; KENDLER KS, 1995, BEHAV GENET, V25, P217, DOI 10.1007/BF02197180; KENDLER KS, 1986, ANN HUM GENET, V50, P83, DOI 10.1111/j.1469-1809.1986.tb01941.x; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; KENDLER KS, 1995, ARCH GEN PSYCHIAT, V52, P374; KENDLER KS, IN PRESS BR J PSYCHI; KLEIN DN, 1994, BASIC ISSUES PSYCHOP, P19; MARTIN NG, 1982, BEHAV GENET, V12, P467, DOI 10.1007/BF01065638; Maser JD, 1990, COMORBIDITY MOOD ANX; NEALE MC, 1994, MULTIVAR BEHAV RES, V29, P33, DOI 10.1207/s15327906mbr2901_2; NEALE MC, 1989, BEHAV GENET, V19, P63, DOI 10.1007/BF01065884; NEALE MC, 1989, AM J HUM GENET, V45, P226; NEALE MC, 1994, GENET EPIDEMIOL, V11, P503, DOI 10.1002/gepi.1370110607; NEALE MC, 1994, BEHAV GENET, V24, P239, DOI 10.1007/BF01067191; NEALE MC, 1994, MX STATISTICAL MODEL; Neale MMC, 1992, METHODOLOGY GENETIC; Pearson K., 1903, BIOMETRIKA, V2, P357; ROY M, IN PRESS PSYCHOL MED; Spitzer RL, 1987, STRUCTURED CLIN INTE; Williams LJ, 1994, STRUCT EQU MODELING, V1, P161, DOI 10.1080/10705519409539970; [No title captured]; [No title captured]; [No title captured]	47	265	266	1	12	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					935	953					19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RV793	WOS:A1995RV79300025	7573055				2022-01-24	
J	LIFTON, RP; DLUHY, RG; POWERS, M; RICH, GM; GUTKIN, M; FALLO, F; GILL, JR; FELD, L; GANGULY, A; LAIDLAW, JC; MURNAGHAN, DJ; KAUFMAN, C; STOCKIGT, JR; ULICK, S; LALOUEL, JM				LIFTON, RP; DLUHY, RG; POWERS, M; RICH, GM; GUTKIN, M; FALLO, F; GILL, JR; FELD, L; GANGULY, A; LAIDLAW, JC; MURNAGHAN, DJ; KAUFMAN, C; STOCKIGT, JR; ULICK, S; LALOUEL, JM			HEREDITARY HYPERTENSION CAUSED BY CHIMERIC GENE DUPLICATIONS AND ECTOPIC EXPRESSION OF ALDOSTERONE SYNTHASE	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; GLUCOCORTICOID-SUPPRESSIBLE ALDOSTERONISM; HYPER-ALDOSTERONISM; DNA; CLONING; IDENTIFICATION; 18-OXOCORTISOL; POLYMORPHISMS; LOCALIZATION; FRAGMENTS	Patients with glucocorticoid-remediable aldosteronism (GRA) from 12 kindreds possess chimaeric gene duplications arising from unequal crossing-over, fusing regulatory sequences of steroid 11-beta-hydroxylase to coding sequences of aldosterone synthase. These chimaeric genes are specific for GRA and explain the biochemistry, physiology and genetics of this form of hypertension. Sites of crossing over range from intron 2 to intron 4. Most mutations have arisen independently from either sister or non-sister chromatid exchange between these genes, which are only 45 kilobases apart. The possibility of a susceptibility allele for GRA of Irish origin is suggested. These findings indicate the utility of a direct genetic test for this disorder.	UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; BRIGHAM & WOMENS HOSP,DIV ENDOCRINE HYPERTENS,BOSTON,MA 02115; HYPERTENS RENAL GRP,LIVINGSTON,NJ 07039; UNIV PADUA,INST SEMEIOT MED,I-35100 PADUA,ITALY; NHLBI,BETHESDA,MD 20892; CHILDRENS HOSP,DIV NEPHROL,BUFFALO,NY 14222; UNIV S FLORIDA,COLL MED,DEPT MED,TAMPA,FL 33620; CANADIAN CANC SOC,TORONTO M4V 3B1,ONTARIO,CANADA; REG HOSP CORK,DEPT MED,CORK,IRELAND; UNIV OKLAHOMA,HLTH SCI CTR,NEPHROL SECT,OKLAHOMA CITY,OK 73112; ALFRED HOSP,EWEN DOWNIE METAB UNIT,MELBOURNE,VIC 3181,AUSTRALIA; VET AFFAIRS HOSP,BRONX,NY 10468		LIFTON, RP (corresponding author), UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112, USA.			FALLO, FRANCESCO/0000-0002-7511-0226			BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CHU MD, 1982, J BIOL CHEM, V257, P2218; CHUA SC, 1987, P NATL ACAD SCI USA, V84, P7193, DOI 10.1073/pnas.84.20.7193; FALLO F, CLIN ENDOCRINOL, V22, P777; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; GIEBINK GS, 1973, J CLIN ENDOCR METAB, V36, P715, DOI 10.1210/jcem-36-4-715; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; GOMEZSANCHEZ CE, 1984, J CLIN ENDOCR METAB, V59, P1022, DOI 10.1210/jcem-59-5-1022; GRIM CE, 1980, PEDIATRICS, V65, P597; HAHN RA, 1990, JAMA-J AM MED ASSOC, V264, P2654, DOI 10.1001/jama.264.20.2654; KAWAMOTO T, 1990, BIOCHEM BIOPH RES CO, V173, P309, DOI 10.1016/S0006-291X(05)81058-7; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; LIFTON RP, 1990, GENOMICS, V7, P131, DOI 10.1016/0888-7543(90)90530-8; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; MORNET E, 1989, J BIOL CHEM, V264, P20961; NATHANS J, 1987, ANNU REV NEUROSCI, V10, P163; NEW MI, 1967, J CLIN ENDOCR METAB, V27, P300, DOI 10.1210/jcem-27-2-300; OGISHIMA T, 1991, J BIOL CHEM, V266, P10731; OMAHONY S, 1989, J HUM HYPERTENS, V3, P255; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RICH GM, 1992, ANN INTERN MED, V116, P813, DOI 10.7326/0003-4819-116-10-813; SCHOWALTER DB, 1989, ANAL BIOCHEM, V177, P90, DOI 10.1016/0003-2697(89)90019-5; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; STOCKIGT JR, 1987, J CLIN ENDOCR METAB, V64, P22, DOI 10.1210/jcem-64-1-22; SUTHERLAND DJ, 1966, CAN MED ASSOC J, V95, P1109; ULICK S, 1990, J CLIN ENDOCR METAB, V71, P1151, DOI 10.1210/jcem-71-5-1151; ULICK S, 1983, J BIOL CHEM, V258, P5498; WARD R, 1990, DIAGNOSIS MANAGEMENT, P81; WEIR BS, 1990, GENETIC DATA ANAL, P102; WHITE PC, 1991, J CLIN INVEST, V87, P1664, DOI 10.1172/JCI115182; YABU M, 1991, HISTOCHEMISTRY, V96, P391, DOI 10.1007/BF00315995	32	265	274	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					66	74		10.1038/ng0992-66			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	WOS:A1992JM64600019	1303253				2022-01-24	
J	EISSENBERG, JC; MORRIS, GD; REUTER, G; HARTNETT, T				EISSENBERG, JC; MORRIS, GD; REUTER, G; HARTNETT, T			THE HETEROCHROMATIN-ASSOCIATED PROTEIN HP-1 IS AN ESSENTIAL PROTEIN IN DROSOPHILA WITH DOSAGE-DEPENDENT EFFECTS ON POSITION-EFFECT VARIEGATION	GENETICS			English	Article							NONHISTONE CHROMOSOMAL PROTEIN; MELANOGASTER; GENE; CHROMATIN; DNA; HYBRIDIZATION; EXPRESSION; MUTATIONS; VECTORS; PUFF	Chromosome rearrangements which place euchromatic genes adjacent to a heterochromatic break-point frequently result in gene repression (position-effect variegation). This repression is thought to reflect the spreading of a heterochromatic structure into neighboring euchromatin. Two allelic dominant suppressors of position-effect variegation were found to contain mutations within the gene encoding the heterochromatin-specific chromosomal protein HP-1. The site of mutation for each allele is given: one converts Lys169 into a nonsense (ochre) codon, while the other is a frameshift after Ser10. In flies heterozygous for one of the mutant alleles (Su(var)2-5(04)), a truncated HP-1 protein was detectable by Western blot analysis. An HP-1 minigene, consisting of HP-1 cDNA under the control of an Hsp70 heat-inducible promoter, was transduced into flies by P element-mediated germ line transformation. Heat-shock driven expression of this minigene results in elevated HP-1 protein level and enhancement of position-effect variegation. Levels of variegating gene expression thus appear to depend upon the level of expression of a heterochromatin-specific protein. The implications of these observations for mechanism of heterochromatic position effects and heterochromatin function are discussed.	ST LOUIS UNIV,SCH MED,CELL & MOLEC BIOL PROGRAM,ST LOUIS,MO 63104; MARTIN LUTHER UNIV,INST GENET,O-4020 HALLE,GERMANY		EISSENBERG, JC (corresponding author), ST LOUIS UNIV,SCH MED,EDWARD A DOISY DEPT BIOCHEM & MOLEC BIOL,ST LOUIS,MO 63104, USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM40732] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM040732] Funding Source: NIH RePORTER		ASHBURNER M, 1989, DROSOPHILA LABORATOR; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Duncan I., 1982, DEV ORDER ITS ORIGIN, P533; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; EISSENBERG JC, 1989, BIOESSAYS, V11, P14, DOI 10.1002/bies.950110105; Ephrussi B, 1944, GENETICS, V29, P148; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HARLOW E, 1988, ANTIBODIES LABORATOR; HENIKOFF S, 1981, CHROMOSOMA, V83, P381, DOI 10.1007/BF00327360; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jowett T., 1986, DROSOPHILA PRACTICAL, P275; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KORNHER JS, 1986, CHROMOSOMA, V94, P205, DOI 10.1007/BF00288495; KRAUS KW, 1988, MOL CELL BIOL, V8, P4756, DOI 10.1128/MCB.8.11.4756; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V627; LOCKE J, 1988, GENETICS, V120, P181; Maniatis T, 1982, MOLECULAR; MCCLELLAND M, 1988, NUCLEIC ACIDS RES, V16, P364, DOI 10.1093/nar/16.1.364; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MEYEROWITZ EM, 1982, CELL, V28, P165, DOI 10.1016/0092-8674(82)90386-5; PARDUE ML, 1990, CHROMOSOMA, V100, P3, DOI 10.1007/BF00337597; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; PARO R, 1990, TRENDS GENET, V6, P416, DOI 10.1016/0168-9525(90)90303-N; PHILLIPS MD, 1990, GENETICS, V125, P91; PIMPINELLI S, 1985, GENETICS, V109, P701; REUTER G, 1981, MOL GEN GENET, V182, P516, DOI 10.1007/BF00293947; REUTER G, 1990, NATURE, V344, P219, DOI 10.1038/344219a0; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANDLER L, 1977, GENETICS, V86, P567; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SINCLAIR DAR, 1983, MOL GEN GENET, V191, P326, DOI 10.1007/BF00334834; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; TARTOF KD, 1980, DEVELOPMENT S, P35; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WONG YC, 1981, NUCLEIC ACIDS RES, V9, P6749, DOI 10.1093/nar/9.24.6749; WUSTMANN G, 1989, MOL GEN GENET, V217, P520, DOI 10.1007/BF02464926; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZHIMULEV IF, 1986, CHROMOSOMA, V94, P492, DOI 10.1007/BF00292759; ZINK B, 1989, NATURE, V337, P468, DOI 10.1038/337468a0; ZUCKERKANDL E, 1974, BIOCHIMIE, V56, P937, DOI 10.1016/S0300-9084(74)80516-X	46	265	266	0	6	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JUN	1992	131	2					345	352					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW759	WOS:A1992HW75900010	1644277				2022-01-24	
J	HALL, BG				HALL, BG			SPONTANEOUS POINT MUTATIONS THAT OCCUR MORE OFTEN WHEN ADVANTAGEOUS THAN WHEN NEUTRAL	GENETICS			English	Article											HALL, BG (corresponding author), UNIV ROCHESTER,DEPT BIOL,ROCHESTER,NY 14627, USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 37110] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM037110] Funding Source: NIH RePORTER		BENSON SA, 1988, NATURE, V336, P21, DOI 10.1038/336021c0; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; CHARLESWORTH D, 1988, NATURE, V336, P525, DOI 10.1038/336525a0; DAVIS BD, 1989, P NATL ACAD SCI USA, V86, P5005, DOI 10.1073/pnas.86.13.5005; DRAKE JW, 1969, NATURE, V221, P1132, DOI 10.1038/2211132a0; HALL BG, 1977, GENETICS, V85, P193; HALL BG, 1988, GENETICS, V120, P887; HALL BG, 1989, GENETICS, V123, P635; HALL BG, 1989, GENOME, V31, P265, DOI 10.1139/g89-044; HALL BG, 1982, J BACTERIOL, V151, P269, DOI 10.1128/JB.151.1.269-273.1982; HALL BG, 1982, EVOL BIOL, V15, P85; KRICKER M, 1984, MOL BIOL EVOL, V1, P171; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LENSKI RE, 1989, TRENDS ECOL EVOL, V4, P148, DOI 10.1016/0169-5347(89)90218-8; LENSKI RE, 1989, P NATL ACAD SCI USA, V86, P2775, DOI 10.1073/pnas.86.8.2775; Luria SE, 1943, GENETICS, V28, P491; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; MILLE RJH, 1972, EXPT MOL GENETICS; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; SHAPIRO JA, 1984, MOL GEN GENET, V194, P79, DOI 10.1007/BF00383501; SLATER JH, 1985, MOL BIOL EVOL, V2, P557; STAHL FW, 1988, NATURE, V335, P112, DOI 10.1038/335112a0; SYMONDS N, 1989, NATURE, V337, P119, DOI 10.1038/337119a0; VINOPAL RT, 1987, ESCHERICHIA COLI SAL, P990; YANOFSKY C, 1987, ESCHERICHIA COLI SAL, P1453	26	265	267	0	4	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	SEP	1990	126	1					5	16					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX919	WOS:A1990DX91900002	2227388				2022-01-24	
J	LEDERBERG, J; CAVALLI, LL; LEDERBERG, EM				LEDERBERG, J; CAVALLI, LL; LEDERBERG, EM			SEX COMPATIBILITY IN ESCHERICHIA-COLI	GENETICS			English	Article																	CAVALLI L. L., 1948, RICERCA SCI E RICOSTRUZIONE, V18, P1569; CAVALLI-SFORZA L L, 1950, Boll Ist Sieroter Milan, V29, P281; DAVIS BD, 1950, J BACTERIOL, V60, P507, DOI 10.1128/JB.60.4.507-508.1950; DAVIS BD, 1950, EXPERIENTIA, V6, P41, DOI 10.1007/BF02174810; HARTMANN M, 1929, HDB VERERBUNGSWISS; HAYES W, 1952, NATURE, V169, P118, DOI 10.1038/169118b0; LEDERBERG EM, 1951, GENETICS, V36, P560; LEDERBERG J, 1951, COLD SPRING HARB SYM, V16, P413, DOI 10.1101/SQB.1951.016.01.030; LEDERBERG J, 1949, P NATL ACAD SCI USA, V35, P178, DOI 10.1073/pnas.35.4.178; LEDERBERG J, 1947, GENETICS, V32, P505; LEDERBERG J, 1951, GENETICS 20TH CENTUR; LEDERBERG J, 1952, IN PRESS PHYSL REV; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; Metz CW, 1938, AM NAT, V72, P485, DOI 10.1086/280803; NELSON TC, 1951, GENETICS, V36, P162; NEWCOMBE HB, 1950, AM NAT, V84, P457, DOI 10.1086/281642; ROTHFELS KH, 1952, GENETICS, V37, P297; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; TATUM EL, 1945, P NATL ACAD SCI USA, V31, P215, DOI 10.1073/pnas.31.8.215; WHITEHOUSE HLK, 1949, BIOL REV, V24, P411, DOI 10.1111/j.1469-185X.1949.tb00582.x; ZINDER ND, 1952, IN PRESS J BACT	21	265	267	0	12	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1952	37	6					720	730					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW855	WOS:A1952XW85500007	17247418				2022-01-24	
J	Xie, F; Ye, L; Chang, JC; Beyer, AI; Wang, JM; Muench, MO; Kan, YW				Xie, Fei; Ye, Lin; Chang, Judy C.; Beyer, Ashley I.; Wang, Jiaming; Muench, Marcus O.; Kan, Yuet Wai			Seamless gene correction of beta-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac	GENOME RESEARCH			English	Article							PLURIPOTENT STEM-CELLS; RNA-GUIDED ENDONUCLEASE; HEMATOPOIETIC PROGENITORS; HOMOLOGOUS RECOMBINATION; DNA-SEQUENCES; CAS9; NUCLEASES; GLOBIN; MUTAGENESIS; GENERATION	beta-thalassemia, one of the most common genetic diseases worldwide, is caused by mutations in the human hemoglobin beta (HBB) gene. Creation of human induced pluripotent stem cells (iPSCs) from beta-thalassemia patients could offer an approach to cure this disease. Correction of the disease-causing mutations in iPSCs could restore normal function and provide a rich source of cells for transplantation. In this study, we used the latest gene-editing tool, CRISPR / Cas9 technology, combined with the piggyBac transposon to efficiently correct the HBB mutations in patient-derived iPSCs without leaving any residual footprint. No off-target effects were detected in the corrected iPSCs, and the cells retain full pluripotency and exhibit normal karyotypes. When differentiated into erythroblasts using a monolayer culture, gene-corrected iPSCs restored expression of HBB compared to the parental iPSCs line. Our study provides an effective approach to correct HBB mutations without leaving any genetic footprint in patient-derived iPSCs, thereby demonstrating a critical step toward the future application of stem cell-based gene therapy to monogenic diseases.	[Xie, Fei; Ye, Lin; Chang, Judy C.; Wang, Jiaming; Kan, Yuet Wai] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Beyer, Ashley I.; Muench, Marcus O.] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Wang, Jiaming; Muench, Marcus O.; Kan, Yuet Wai] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Kan, Yuet Wai] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA		Kan, YW (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	yw.kan@ucsf.edu	Muench, Marcus O./C-5025-2009; Wilson, Matthew H/K-3193-2013	Muench, Marcus O./0000-0001-8946-6605; 	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01-DK088760]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK026743, P01DK088760] Funding Source: NIH RePORTER	We thank Zhongxia Qi and Jingwei Yu for the karyotype analyses. This work was supported by NIH Grant P01-DK088760.	Cao A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011775; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Chang KH, 2010, BLOOD, V115, P2553, DOI 10.1182/blood-2009-11-252650; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kan YW, 2010, PRENATAL DIAG, V30, P608, DOI 10.1002/pd.2479; Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Sun N, 2014, BIOTECHNOL BIOENG, V111, P1048, DOI 10.1002/bit.25018; THOMAS KR, 1986, NATURE, V324, P34, DOI 10.1038/324034a0; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang CY, 2012, CELL RES, V22, P194, DOI 10.1038/cr.2011.138; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Ye L, 2013, STEM CELL TRANSL MED, V2, P558, DOI 10.5966/sctm.2013-0006; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	41	264	304	6	111	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	SEP	2014	24	9					1526	1533		10.1101/gr.173427.114			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	AO4BM	WOS:000341281200011	25096406	Green Published, hybrid			2022-01-24	
J	Calvo, SE; Tucker, EJ; Compton, AG; Kirby, DM; Crawford, G; Burtt, NP; Rivas, M; Guiducci, C; Bruno, DL; Goldberger, OA; Redman, MC; Wiltshire, E; Wilson, CJ; Altshuler, D; Gabriel, SB; Daly, MJ; Thorburn, DR; Mootha, VK				Calvo, Sarah E.; Tucker, Elena J.; Compton, Alison G.; Kirby, Denise M.; Crawford, Gabriel; Burtt, Noel P.; Rivas, Manuel; Guiducci, Candace; Bruno, Damien L.; Goldberger, Olga A.; Redman, Michelle C.; Wiltshire, Esko; Wilson, Callum J.; Altshuler, David; Gabriel, Stacey B.; Daly, Mark J.; Thorburn, David R.; Mootha, Vamsi K.			High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency	NATURE GENETICS			English	Article							RESPIRATORY-CHAIN DISORDERS; NONSENSE MUTATION; MITOCHONDRIAL-DNA; NDUFS4 GENE; DATABASE; CRITERIA; CAPTURE; PATIENT	Discovering the molecular basis of mitochondrial respiratory chain disease is challenging given the large number of both mitochondrial and nuclear genes that are involved. We report a strategy of focused candidate gene prediction, high-throughput sequencing and experimental validation to uncover the molecular basis of mitochondrial complex I disorders. We created seven pools of DNA from a cohort of 103 cases and 42 healthy controls and then performed deep sequencing of 103 candidate genes to identify 151 rare variants that were predicted to affect protein function. We established genetic diagnoses in 13 of 60 previously unsolved cases using confirmatory experiments, including cDNA complementation to show that mutations in NUBPL and FOXRED1 can cause complex I deficiency. Our study illustrates how large-scale sequencing, coupled with functional prediction and experimental validation, can be used to identify causal mutations in individual cases.	[Calvo, Sarah E.; Rivas, Manuel; Goldberger, Olga A.; Altshuler, David; Daly, Mark J.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Calvo, Sarah E.; Goldberger, Olga A.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Calvo, Sarah E.; Crawford, Gabriel; Burtt, Noel P.; Rivas, Manuel; Guiducci, Candace; Redman, Michelle C.; Altshuler, David; Gabriel, Stacey B.; Daly, Mark J.; Mootha, Vamsi K.] Harvard & MIT, Broad Inst, Cambridge, MA USA; [Tucker, Elena J.; Compton, Alison G.; Kirby, Denise M.; Bruno, Damien L.; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Tucker, Elena J.; Compton, Alison G.; Kirby, Denise M.; Bruno, Damien L.; Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia; [Tucker, Elena J.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Wiltshire, Esko] Univ Otago Wellington, Dept Paediat & Child Hlth, Wellington, New Zealand; [Wiltshire, Esko] Capital & Coast Dist Hlth Board, Cent Reg Genet Serv, Wellington, New Zealand; [Wilson, Callum J.] Starship Childrens Hosp, Natl Metab Serv, Auckland, New Zealand; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA		Mootha, VK (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	david.thorburn@mcri.edu.au; vamsi@hms.harvard.edu	Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Rivas, Manuel/ABE-8173-2020; Tucker, Elena J/B-3487-2012; Bruno, Damien L/C-3665-2013; Thorburn, David R/G-6266-2013	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Rivas, Manuel/0000-0003-1457-9925; Wiltshire, Esko/0000-0002-8962-2708; thorburn, david/0000-0002-7725-9470; Compton, Alison/0000-0002-2725-7055; Tucker, Elena/0000-0002-6380-5100	Australian National Health & Medical Research CouncilNational Health and Medical Research Council of Australia [436901]; Australian Postgraduate AwardAustralian Government; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM077465]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM077465] Funding Source: NIH RePORTER	We thank S. Tregoning, A. Laskowski and S. Smith for assistance with enzyme assays and DNA preparation, M. McKenzie and M. Ryan for the NDUFAF2 antibody, J. Boehm for the lentiviral expression vector, S. Flynn for assistance with human subjects protocols, R. Onofrio for designing PCR primers, K. Ardlie and S. Mahan for assistance in DNA sample preparation, J. Wilkinson and L. Ambrogio for Illumina sequence project management, T. Fennel for sequence alignment, L. Ziaugra for genotyping assistance, M. Cabili for tool evaluation, J. Flannick for assistance with pooled sequence analysis, I. Adzhubei and S. Sunyaev for PolyPhen-2.0 predictions, M. DePristo, E. Banks and A. Sivachenko for advice on sequence data analysis, M. Garber for assistance with evolutionary conservation analyses, J. Pirruccello, R. Do and S. Kathiresan for data and analysis of control data, and the many physicians who referred subjects and assisted with these studies. This work was supported by a grant (436901) and Principal Research Fellowship from the Australian National Health & Medical Research Council awarded to D. R. T., an Australian Postgraduate Award to E. J. T. and a grant from the US National Institutes of Health (GM077465) to V. K. M. The authors wish to dedicate this article to the memory of our co-author Denise Kirby, an outstanding scientist and dear colleague who died during the preparation of this manuscript.	ANDERSON SL, 2009, J INHERIT METAB DIS, V32, P121; Benit P, 2003, HUM GENET, V112, P563, DOI 10.1007/s00439-002-0884-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Dimmic Matthew W, 2005, Pac Symp Biocomput, P382; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683; Lamande SR, 1998, HUM MOL GENET, V7, P981, DOI 10.1093/hmg/7.6.981; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896; Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716	51	264	281	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					851	+		10.1038/ng.659			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	WOS:000282276600014	20818383	Green Accepted			2022-01-24	
J	Goode, LL; Chenevix-Trench, G; Song, H; Ramus, SJ; Notaridou, M; Lawrenson, K; Widschwendter, M; Vierkant, RA; Larson, MC; Kjaer, SK; Birrer, MJ; Berchuck, A; Schildkraut, J; Tomlinson, I; Kiemeney, LA; Cook, LS; Gronwald, J; Garcia-Closas, M; Gore, ME; Campbell, I; Whittemore, AS; Sutphen, R; Phelan, C; Anton-Culver, H; Pearce, CL; Lambrechts, D; Rossing, MA; Chang-Claude, J; Moysich, KB; Goodman, MT; Dork, T; Nevanlinna, H; Ness, RB; Rafnar, T; Hogdall, C; Hogdall, E; Fridley, BL; Cunningham, JM; Sieh, W; McGuire, V; Godwin, AK; Cramer, DW; Hernandez, D; Levine, D; Lu, K; Iversen, ES; Palmieri, RT; Houlston, R; van Altena, AM; Aben, KKH; Massuger, LFAG; Brooks-Wilson, A; Kelemen, LE; Le, ND; Jakubowska, A; Lubinski, J; Medrek, K; Stafford, A; Easton, DF; Tyrer, J; Bolton, KL; Harrington, P; Eccles, D; Chen, A; Molina, AN; Davila, BN; Arango, H; Tsai, Y; Chen, ZH; Risch, HA; McLaughlin, J; Narod, SA; Ziogas, A; Brewster, W; Gentry-Maharaj, A; Menon, U; Wu, AH; Stram, DO; Pike, MC; Beesley, J; Webb, PM; Chen, XQ; Ekici, AB; Thiel, FC; Beckmann, MW; Yang, H; Wentzensen, N; Lissowska, J; Fasching, PA; Despierre, E; Amant, F; Vergote, I; Doherty, J; Hein, R; Wang-Gohrke, S; Lurie, G; Carney, ME; Thompson, PJ; Runnebaum, I; Hillemanns, P; Durst, M; Antonenkova, N; Bogdanova, N; Leminen, A; Butzow, R; Heikkinen, T; Stefansson, K; Sulem, P; Besenbacher, S; Sellers, TA; Gayther, SA; Pharoah, PDP				Goode, Llen L.; Chenevix-Trench, Georgia; Song, Honglin; Ramus, Susan J.; Notaridou, Maria; Lawrenson, Kate; Widschwendter, Martin; Vierkant, Robert A.; Larson, Melissa C.; Kjaer, Susanne K.; Birrer, Michael J.; Berchuck, Andrew; Schildkraut, Joellen; Tomlinson, Ian; Kiemeney, Lambertus A.; Cook, Linda S.; Gronwald, Jacek; Garcia-Closas, Montserrat; Gore, Martin E.; Campbell, Ian; Whittemore, Alice S.; Sutphen, Rebecca; Phelan, Catherine; Anton-Culver, Hoda; Pearce, Celeste Leigh; Lambrechts, Diether; Rossing, Mary Anne; Chang-Claude, Jenny; Moysich, Kirsten B.; Goodman, Marc T.; Doerk, Thilo; Nevanlinna, Heli; Ness, Roberta B.; Rafnar, Thorunn; Hogdall, Claus; Hogdall, Estrid; Fridley, Brooke L.; Cunningham, Julie M.; Sieh, Weiva; McGuire, Valerie; Godwin, Andrew K.; Cramer, Daniel W.; Hernandez, Dena; Levine, Douglas; Lu, Karen; Iversen, Edwin S.; Palmieri, Rachel T.; Houlston, Richard; van Altena, Anne M.; Aben, Katja K. H.; Massuger, Leon F. A. G.; Brooks-Wilson, Angela; Kelemen, Linda E.; Le, Nhu D.; Jakubowska, Anna; Lubinski, Jan; Medrek, Krzysztof; Stafford, Anne; Easton, Douglas F.; Tyrer, Jonathan; Bolton, Kelly L.; Harrington, Patricia; Eccles, Diana; Chen, Ann; Molina, Ashley N.; Davila, Barbara N.; Arango, Hector; Tsai, Yu; Chen, Zhihua; Risch, Harvey A.; McLaughlin, John; Narod, Steven A.; Ziogas, Argyrios; Brewster, Wendy; Gentry-Maharaj, Aleksandra; Menon, Usha; Wu, Anna H.; Stram, Daniel O.; Pike, Malcolm C.; Beesley, Jonathan; Webb, Penelope M.; Chen, Xiaoqing; Ekici, Arif B.; Thiel, Falk C.; Beckmann, Matthias W.; Yang, Hannah; Wentzensen, Nicolas; Lissowska, Jolanta; Fasching, Peter A.; Despierre, Evelyn; Amant, Frederic; Vergote, Ignace; Doherty, Jennifer; Hein, Rebecca; Wang-Gohrke, Shan; Lurie, Galina; Carney, Michael E.; Thompson, Pamela J.; Runnebaum, Ingo; Hillemanns, Peter; Duerst, Matthias; Antonenkova, Natalia; Bogdanova, Natalia; Leminen, Arto; Butzow, Ralf; Heikkinen, Tuomas; Stefansson, Kari; Sulem, Patrick; Besenbacher, Soeren; Sellers, Thomas A.; Gayther, Simon A.; Pharoah, Paul D. P.		Wellcome Trust Case-Control Conso; Australian Canc Study Ovarian Canc; Australian Ovarian Canc Study Grp; OCAC	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24	NATURE GENETICS			English	Article							POLY(ADP-RIBOSE) POLYMERASE; MULTIPLE LOCI; CELLS; GENE; VARIANTS	Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify common low-penetrance ovarian cancer susceptibility genes, we conducted a genome-wide association study of 507,094 SNPs in 1,768 individuals with ovarian cancer (cases) and 2,354 controls, with follow up of 21,955 SNPs in 4,162 cases and 4,810 controls, leading to the identification of a confirmed susceptibility locus at 9p22 (in BNC2)(1). Here, we report on nine additional candidate loci (defined as having P <= 10(-4)) identified after stratifying cases by histology, which we genotyped in an additional 4,353 cases and 6,021 controls. We confirmed two new susceptibility loci with P <= 5 x 10(-8) (8q24, P = 8.0 x 10(-15) and 2q31, P = 3.8 x 10(-14)) and identified two additional loci that approached genome-wide significance (3q25, P = 7.1 x 10(-8) and 17q21, P = 1.4 x 10(-7)). The associations of these loci with serous ovarian cancer were generally stronger than with other cancer subtypes. Analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.	[Goode, Llen L.; Vierkant, Robert A.; Larson, Melissa C.; Fridley, Brooke L.] Mayo Clin Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Chenevix-Trench, Georgia; Beesley, Jonathan; Webb, Penelope M.; Chen, Xiaoqing; Australian Canc Study Ovarian Canc] Post Off Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld, Australia; [Song, Honglin; Stafford, Anne; Tyrer, Jonathan; Harrington, Patricia] Univ Cambridge, Strangeways Res Lab, Dept Oncol, Cancer Res United Kingdom, Cambridge, England; [Notaridou, Maria; Lawrenson, Kate; Widschwendter, Martin; Menon, Usha; Gayther, Simon A.] UCL, Dept Gynecol Oncol, Elizabeth Garrett Anderson EGA Inst Womens Hlt, London, England; [Kjaer, Susanne K.; Runnebaum, Ingo] Juliane Marie Ctr, Dept Gynecol & Obstet, Copenhagen, Denmark; [Kjaer, Susanne K.; Runnebaum, Ingo] Inst Canc Epidemiol, Dept Virus, Hormones & Canc, Danish Canc Soc, Copenhagen, Denmark; [Birrer, Michael J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Berchuck, Andrew; Schildkraut, Joellen] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC USA; [Tomlinson, Ian] London Sch Med & Dent, Inst Canc, Ctr Mol Oncol & Imaging, London, England; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol, Biostatist & Hlth Technol Assessment HTA, NL-6525 ED Nijmegen, Netherlands; [Lubinski, Jan] Univ New Mexico, Div Epidemiol & Biostatist, Albuquerque, NM 87131 USA; [Cook, Linda S.] Alberta Hlth Services Canc Care, Calgary, AB, Canada; [Gronwald, Jacek; Medrek, Krzysztof] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Garcia-Closas, Montserrat; Wentzensen, Nicolas] Natl Canc Inst, Natl Inst Hlth, Div Canc Epidemiol & Genet, Rockville, MD USA; [Gore, Martin E.] Royal Marsden Hosp, Gynecol Oncol Unit, London, England; [Campbell, Ian] Peter MacCallum Canc Inst, Ctr Canc Genom & Predict Med, Melbourne, Australia; [Campbell, Ian] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Whittemore, Alice S.; Molina, Ashley N.; Davila, Barbara N.] Stanford Univ, Sch Med, Div Epidemiol & Biostatist, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Sutphen, Rebecca; Sieh, Weiva; McGuire, Valerie] Univ S Florida, Coll Med, Pediat Epidemiol Ctr, Tampa, FL USA; [Phelan, Catherine] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Anton-Culver, Hoda] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Pearce, Celeste Leigh; Wu, Anna H.; Stram, Daniel O.; Pike, Malcolm C.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Brussels, Belgium; [Lambrechts, Diether] LU Leuven, Louvain, Belgium; [Rossing, Mary Anne] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA; [Chang-Claude, Jenny; Hein, Rebecca] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Moysich, Kirsten B.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Goodman, Marc T.; Carney, Michael E.; Thompson, Pamela J.] Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; [Doerk, Thilo] Hannover Med Sch, Clin Obstet & Gynaecol, Hannover, Germany; [Nevanlinna, Heli; Leminen, Arto; Heikkinen, Tuomas] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Rafnar, Thorunn; Stefansson, Kari; Sulem, Patrick; Besenbacher, Soeren] DeCODE Genet, Reykjavik, Iceland; [Hogdall, Claus] Juliane Marie Ctr, Dept Gynecol & Obstet, Copenhagen, Denmark; [Hogdall, Estrid] Hormones & Canc Inst Canc Epidemiol, Danish Canc Soc, Dept Virus, Copenhagen, Denmark; [Cunningham, Julie M.] Mayo Clin Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Godwin, Andrew K.] Fox Chase Canc Ctr, Dept Med Oncol, Womens Canc Program, Philadelphia, PA 19111 USA; [Cramer, Daniel W.] Brigham & Womens Hosp, Obstetr & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Hernandez, Dena] Natl Inst Hlth, NIA, Bethesda, MD USA; [Levine, Douglas] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lu, Karen] MD Anderson Canc Ctr, Houston, TX USA; [Iversen, Edwin S.] Duke Univ, Dept Stat, Durham, NC USA; [Palmieri, Rachel T.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Houlston, Richard] Inst Canc Res, Royal Canc Hosp, Mol & Populat Genet Team, London, England; [van Altena, Anne M.; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Brooks-Wilson, Angela] Genome Sci Ctr, British Columbia Canc Agcy, Vancouver, BC, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Kelemen, Linda E.] Alberta Hlth Serv Canc Care, Calgary, AB, Canada; [Le, Nhu D.] British Columbia Canc Agcy, Cancer Control Res, Vancouver, BC V5Z 4E6, Canada; [Easton, Douglas F.] Univ Cambridge, Strangeways Res Lab, Canc Res United Kingdom Genet Epidemiol Unit, Cambridge, England; [Bolton, Kelly L.] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge, England; [Eccles, Diana] Univ Southampton, Sch Med, Wessex Clin Genet Serv Princess Anne Hosp, Southampton, Hants, England; [Arango, Hector] W Coast Gynecol Oncol, Clearwater, FL USA; [Risch, Harvey A.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT USA; [McLaughlin, John] Canc Care Ontario, Toronto, ON, Canada; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Brewster, Wendy] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Australian Ovarian Canc Study Grp] Peter MacCallum Canc Inst, Melbourne, Australia; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Thiel, Falk C.] Univ Breast Ctr Franconia, Univ Hosp Erlangen, Dept Gynecol & Obstet, Erlangen, Germany; [Beckmann, Matthias W.; Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Beckmann, Matthias W.; Lissowska, Jolanta] M Sklodowska Curie Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Fasching, Peter A.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Despierre, Evelyn; Amant, Frederic; Vergote, Ignace] Univ Hosp Leuven, Dept Gynecol Oncol, Leuven, Belgium; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynaecol, Ulm, Germany; [Duerst, Matthias] Friedrich Schiller Univ, Clin Obstet & Gynaecol, Jena, Germany; [Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandro N, Minsk, BELARUS; [Bogdanova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandro N, Minsk, BELARUS; [Bogdanova, Natalia] Hannover Med Sch, Clin Obstet & Gynaecol, D-3000 Hannover, Germany; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Pharoah, Paul D. P.] Univ Cambridge, Strangeways Res Lab, Canc Res United Kingdom Dept Oncol, Cambridge, England; [Pharoah, Paul D. P.] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge, England		Gayther, SA (corresponding author), Mayo Clin Coll Med, Dept Hlth Sci Res, Rochester, MN USA.	gayther@usc.edu	van Altena, Anne M/B-9824-2016; Bowtell, David/H-1007-2016; Lissowska, Jolanta/AAH-3252-2020; Vierkant, Robert/AAP-4927-2020; Narod, Steven A/AAA-6112-2022; Webb, Penelope/D-5736-2013; Ekici, Arif B/C-3971-2013; Dork, Thilo/J-8620-2012; Massuger, Leon F.A.G./H-8072-2014; McLaughlin, John R/E-4577-2013; Eccles, Diana/K-6327-2019; campbell, Ian G/F-6006-2011; Stefansson, Kari/AAE-7187-2019; Chenevix-Trench, Georgia/AAV-2014-2020; Brooks-Wilson, Angela/E-9399-2012; Bogdanova, Natalia V./Y-2205-2019; Verdrengh, Evelien/H-4571-2012; Menon, Usha/C-4716-2008; Amant, Frederic/W-7436-2019; Kiemeney, Lambertus A./D-3357-2009; Garcia-Closas, Montserrat/AAZ-6930-2021; Pharoah, Paul/V-6658-2019; Garcia-Closas, Montserrat/F-3871-2015; Fasching, Peter/ABH-9912-2020; Jakubowska, Anna/O-8050-2014; Ramus, Susan/AAG-8352-2019; Lambrechts, Diether/AAJ-3167-2020; Fridley, Brooke L/D-8315-2015; Aben, Katja KH/G-9686-2016; Gronwald, Jacek/A-4576-2017; Wentzensen, Nicolas/AAG-8522-2019	Bowtell, David/0000-0001-9089-7525; Lissowska, Jolanta/0000-0003-2695-5799; Vierkant, Robert/0000-0001-6242-5221; Webb, Penelope/0000-0003-0733-5930; Ekici, Arif B/0000-0001-6099-7066; Dork, Thilo/0000-0002-9458-0282; Eccles, Diana/0000-0002-9935-3169; Chenevix-Trench, Georgia/0000-0002-1878-2587; Brooks-Wilson, Angela/0000-0003-1009-6408; Menon, Usha/0000-0003-3708-1732; Amant, Frederic/0000-0002-5452-4905; Kiemeney, Lambertus A./0000-0002-2368-1326; Garcia-Closas, Montserrat/0000-0003-1033-2650; Pharoah, Paul/0000-0001-8494-732X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Jakubowska, Anna/0000-0002-5650-0501; Ramus, Susan/0000-0003-0005-7798; Fridley, Brooke L/0000-0001-7739-7956; Aben, Katja KH/0000-0002-0214-2147; Gronwald, Jacek/0000-0002-3643-2871; Hogdall, Estrid/0000-0003-4689-5658; Weber, Rachel/0000-0001-7119-7734; Lubinski, Jan/0000-0003-2931-3003; Widschwendter, Martin/0000-0002-7778-8380; Hogdall, Claus/0000-0002-5959-8874; Levine, Douglas/0000-0003-1038-8232; Kjaer, Susanne/0000-0002-8347-1398; Lambrechts, Diether/0000-0002-3429-302X; Campbell, Ian/0000-0002-7773-4155; Beesley, Jonathan/0000-0003-1942-325X; Heikkinen, Tuomas/0000-0003-1154-6204; Bolton, Kelly/0000-0001-6584-3357; Houlston, Richard/0000-0002-5268-0242; Roth, Rebecca/0000-0002-2841-4921; Nevanlinna, Heli/0000-0002-0916-2976; Besenbacher, Soren/0000-0003-1455-1738	Ovarian Cancer Research Fund; Mermaid 1; Danish Cancer SocietyDanish Cancer Society; National Cancer Institute, Bethesda, Maryland, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01-CA61107]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA- 122443, CA-58860, CA-92044, R01-CA58598, N01-CN-55424, N01-PC-67001, N01-PC-35137]; Mayo Foundation; US National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); Department of Health and Human Services; Ovarian Cancer Specialized Program of Research Excellence (SPORE) [P50 CA083638]; Cancer Research UKCancer Research UK; Eastern Cancer Registration and Information Centre for subject recruitment; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-CA106414, R01-CA-63682, R01CA- 63678, R01-CA112523, R01-CA-87538]; American Cancer SocietyAmerican Cancer Society [CRTG-00-196-01-CCE]; Advanced Cancer Detection Center; Department of DefenseUnited States Department of Defense [DAMD17-98-1-8659]; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Cancer SocietyCanadian Cancer Society (CCS); University of California, IrvineUniversity of California System [R01-CA-114343]; Lon V Smith Foundation [LVS-39420]; OAK Foundation; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [199600]; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD17-01-1-0729, W81XWH-06-1-0220]; Cancer Council TasmaniaCancer Council Tasmania; Cancer Foundation of Western AustraliaCancer Council Western Australia; ELAN Foundation; Erlangen University Hospital; German Federal Ministry of Education and Research of Germany; Programme of Clinical Biomedical Research [01 GB 9401]; University of Ulm; German Cancer Research Center; California Cancer Research Program [00-01389V-20170, 2110200]; Helsinki University Central Hospital; Academy of FinlandAcademy of FinlandEuropean Commission; Finnish Cancer Society; Cancer Research UKCancer Research UK [10118, 11022] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801875] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0801875] Funding Source: UKRI; DIVISION OF CANCER CONTROL &POPULATION SCIENCEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences [N01PC067010] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA106414, K07CA143047, P30CA014089, R01CA063464, R03CA113148, P50CA083638, P50CA136393, R01CA063678, U01CA058860, R01CA087538, R01CA063682, U01CA063464, P01CA017054, R01CA061132, R01CA076016, R01CA112523, R01CA114343, K07CA092044, R01CA140323, R01CA122443, R01CA058860, R01CA058598] Funding Source: NIH RePORTER	This study made use of data generated by the Wellcome Trust Case Control consortium. A full list of the investigators who contributed to the generation of the data is available from http://www. wtccc. org. uk/.Funding for the project was provided by the Wellcome Trust under award 076113. The Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith.; The MAL study is supported by grants from Mermaid 1, the Danish Cancer Society and the National Cancer Institute, Bethesda, Maryland, USA (R01-CA61107). The MAY study and the phase 3 and combined analyses were supported by the US National Institutes of Health, National Cancer Institute grants R01CA- 122443 and funding from the Mayo Foundation. The PBCS was funded by Intramural Research Funds of the US National Cancer Institute, Department of Health and Human Services. The Fox Chase Cancer Center ovarian cancer study, part of the National Cancer Institute collaboration, is supported by an Ovarian Cancer Specialized Program of Research Excellence (SPORE) (P50 CA083638). The NCO study is supported by the US National Institutes of Health, National Cancer Institute grant R01-CA-76016. The SEA study is funded by a programme grant from Cancer Research UK. We thank the SEARCH team and the Eastern Cancer Registration and Information Centre for subject recruitment. The TBO study was supported by the US National Institutes of Health (R01-CA106414); the American Cancer Society (CRTG-00-196-01-CCE); and the Advanced Cancer Detection Center Grant, Department of Defense (DAMD17-98-1-8659). The TOR study was supported by grants from the Canadian Institutes for Health Research, the National Cancer Institute of Canada with funds provided by the Canadian Cancer Society and the US National Institutes of Health (R01-CA-63682 and R01CA- 63678). Additional support for the TOR, NCO, MAY, TBO and NCI studies was provided by the University of California, Irvine grant R01-CA-114343. The UCI study is supported by the US National Institutes of Health, National Cancer Institute grants CA-58860, CA-92044 and the Lon V Smith Foundation grant LVS-39420. The UKO study is supported by funding from Cancer Research UK, the Eve Appeal and the OAK Foundation. Some of this work was undertaken at University College London Hospital/University College London, who received a proportion of funding from the Department of Health's National Institutes for Health Research Biomedical Research Centre funding scheme. We particularly thank I. Jacobs, E. Wozniak, A. Ryan, J. Ford and N. Balogun for their contribution to the study. The AUS study is supported by the National Health and Medical Research Council of Australia (199600), US Army Medical Research and Materiel Command under DAMD17-01-1-0729 (award no. W81XWH-06-1-0220) and the Cancer Council Tasmania and Cancer Foundation of Western Australia. G. C.-M. T. and P. M. W. are Research Fellows of the National Health and Medical Research Council. The Australian Ovarian Cancer Study (AOCS) Management Group (D. Bowtell, A. deFazio, G. C.-T., D. G., A. K. G. and P. M. W.) gratefully acknowledges the contribution of all the clinical and scientific collaborators (see http://www. aocstudy. org/). The Australian Cancer Study (ACS) Management Group comprises P. D. P. P., P. M. W., A. Green, N. Hayward and D. Whiteman. The BAV study is supported by the ELAN Foundation and Erlangen University Hospital. The BEL study is supported by the National Cancer Plan-Action 29 for the support of Translational Research. The DOV study (Seattle Diseases of the Ovary) was supported by the US National Institutes of Health grants R01-CA112523 and R01-CA-87538. The GER study was supported by the German Federal Ministry of Education and Research of Germany, the Programme of Clinical Biomedical Research (01 GB 9401), and the genotyping was supported in part by the state of Baden-Wrttemberg through the Medical Faculty, University of Ulm (P. 685).; Data management wassupported by the German Cancer Research Center. The HAW study was supported by the US Public Health Service grant R01-CA58598 and contracts N01-CN-55424, N01-PC-67001 and N01-PC-35137 from the National Cancer Institute, US National Institutes of Health, Department of Health and Human Services. Funding for the USC study was received from the California Cancer Research Program grants 00-01389V-20170 and 2110200, US Public Health Service grants CA14089, CA17054, CA61132, CA63464, N01-PC-67010 and R03CA113148 and the California Department of Health Services sub-contract 050E8709 as part of its statewide cancer reporting program (University of Southern California). The HJO study gratefully acknowledges the contribution of F. Kramer and W. Zheng to the recruitment of subjects at Hannover Medical School. The HMO study gratefully acknowledges the help of L. Gacucova in sample preparation. The HOC study was financially supported by the Helsinki University Central Hospital Research Fund, Academy of Finland and the Finnish Cancer Society.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Buzzai M, 2008, CURR OPIN HEMATOL, V15, P82, DOI 10.1097/MOH.0b013e3282f3ded0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Katoh M, 2003, INT J ONCOL, V23, P541; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kosco KA, 2008, MOL IMMUNOL, V45, P510, DOI 10.1016/j.molimm.2007.05.024; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Lawrenson K, 2009, CELL PROLIFERAT, V42, P385, DOI 10.1111/j.1365-2184.2009.00604.x; Lawrenson K, 2010, NEOPLASIA, V12, P317, DOI 10.1593/neo.91948; Li NFF, 2004, LAB INVEST, V84, P923, DOI 10.1038/labinvest.3700093; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; Okubo Y, 2002, CLIN EXP METASTAS, V19, P503, DOI 10.1023/A:1020346211686; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Shiraishi M, 2002, ONCOGENE, V21, P3659, DOI 10.1038/sj.onc.1205453; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444	30	264	269	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					874	+		10.1038/ng.668			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	WOS:000282276600018	20852632	Green Accepted, Green Submitted			2022-01-24	
J	Eckert, AJ; van Heerwaarden, J; Wegrzyn, JL; Nelson, CD; Ross-Ibarra, J; Gonzalez-Martinez, SC; Neale, DB				Eckert, Andrew J.; van Heerwaarden, Joost; Wegrzyn, Jill L.; Nelson, C. Dana; Ross-Ibarra, Jeffrey; Gonzalez-Martinez, Santiago C.; Neale, David. B.			Patterns of Population Structure and Environmental Associations to Aridity Across the Range of Loblolly Pine (Pinus taeda L., Pinaceae)	GENETICS			English	Article							CARBON-ISOTOPE DISCRIMINATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; PLANT PHYSIOLOGICAL TRAITS; DROUGHT-STRESS-RESPONSE; CANDIDATE GENES; ARABIDOPSIS-THALIANA; GEOGRAPHIC-VARIATION; DIFFERING SELECTION; SIGNAL-TRANSDUCTION; WATER AVAILABILITY	Natural populations of forest trees exhibit striking phenotypic adaptations to diverse environmental gradients, thereby making them appealing subjects for the study of genes underlying ecologically relevant phenotypes. Here, we use a genome-wide data set of single nucleotide polymorphisms genotyped across 3059 functional genes to study patterns of population structure and identify loci associated with aridity across the natural range of loblolly pine (Pinus taeda L.). Overall patterns of population structure, as inferred using principal components and Bayesian cluster analyses, were consistent with three genetic clusters likely resulting from expansions out of Pleistocene refugia located in Mexico and Florida. A novel application of association analysis, which removes the confounding effects of shared ancestry on correlations between genetic and environmental variation, identified five loci correlated with aridity. These loci were primarily involved with abiotic stress response to temperature and drought. A unique set of 24 loci was identified as FST outliers on the basis of the genetic clusters identified previously and after accounting for expansions out of Pleistocene refugia. These loci were involved with a diversity of physiological processes. Identification of nonoverlapping sets of loci highlights the fundamental differences implicit in the use of either method and suggests a pluralistic, yet complementary, approach to the identification of genes underlying ecologically relevant phenotypes.	[van Heerwaarden, Joost; Wegrzyn, Jill L.; Ross-Ibarra, Jeffrey; Neale, David. B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Eckert, Andrew J.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Eckert, Andrew J.; Neale, David. B.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Nelson, C. Dana] US Dept Agr Forest Serv, So Inst Forest Genet, Saucier, MS 39574 USA; [Gonzalez-Martinez, Santiago C.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Forest Res, Forest Res Inst, Dept Forest Syst & Resources, Madrid 28040, Spain; [Neale, David. B.] USDA, Inst Forest Genet, Pacific SW Res Stn, Davis, CA 95616 USA		Neale, DB (corresponding author), Univ Calif Davis, Dept Plant Sci, 1 Shields Ave, Davis, CA 95616 USA.	dbneale@ucdavis.edu	Gonzalez-Martinez, Santiago C/H-2014-2012; Eckert, Andrew/E-4788-2011; Ross-Ibarra, Jeffrey/D-7782-2011; van Heerwaarden, Joost/A-1424-2014; Wegrzyn, Jill/H-3745-2019	Gonzalez-Martinez, Santiago C/0000-0002-4534-3766; Eckert, Andrew/0000-0002-6522-2646; Ross-Ibarra, Jeffrey/0000-0003-1656-4954; van Heerwaarden, Joost/0000-0002-4959-3914; Wegrzyn, Jill/0000-0001-5923-0888	National Science FoundationNational Science Foundation (NSF) [DBI-0501763]	We thank Sedley Josserand, Dennis Deemer, Craig Echt, Valerie Hipkins, Vanessa K. Rashbrook, Charles M. Nicolet, John D. Liechty, Benjamin N. Figueroa, and Gabriel G. Rosa for laboratory and bioinformatics support. We also thank Andrew Bower for advice on GIS-derived climate data, W. Patrick Cumbie and Barry Goldfarb for providing geographic information for sampled trees, and Aslam Mohamed for creating the linkage map. The manuscript was also much improved by critical and insightful comments made by two anonymous reviewers. This work was supported by a National Science Foundation (grant no. DBI-0501763).	Aitken S. N., 1995, Forest Genetics, V2, P199; Al-Rabab'ah MA, 2002, FOREST ECOL MANAG, V163, P263, DOI 10.1016/S0378-1127(01)00584-9; Al-Rabah'ah MA, 2004, MOL ECOL, V13, P1075, DOI 10.1111/j.1365-294X.2004.02142.x; ALLARD RW, 1972, P NATL ACAD SCI USA, V69, P3043, DOI 10.1073/pnas.69.10.3043; ANTONOVICS J, 1971, AM SCI, V59, P593; ANTONOVICS J, 1970, HEREDITY, V25, P349, DOI 10.1038/hdy.1970.36; AUKLAND L, 2002, CONIFER MICROSATELLI; Baltunis BS, 2008, TREE GENET GENOMES, V4, P797, DOI 10.1007/s11295-008-0152-2; Barton NH, 1999, GENET RES, V74, P223, DOI 10.1017/S001667239900422X; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beck EH, 2007, J BIOSCIENCES, V32, P501, DOI 10.1007/s12038-007-0049-5; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Brendel O, 2002, PLANT CELL ENVIRON, V25, P945, DOI 10.1046/j.1365-3040.2002.00872.x; Chen JW, 2004, CAN J FOREST RES, V34, P2508, DOI [10.1139/x04-134, 10.1139/X04-134]; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Costaglioli P, 2005, BBA-MOL CELL BIOL L, V1734, P247, DOI 10.1016/j.bbalip.2005.04.002; Dubos C, 2003, PLANT MOL BIOL, V51, P249, DOI 10.1023/A:1021168811590; Dudley SA, 1996, EVOLUTION, V50, P92, DOI [10.1111/j.1558-5646.1996.tb04475.x, 10.2307/2410783]; Dudley SA, 1996, EVOLUTION, V50, P103, DOI 10.1111/j.1558-5646.1996.tb04476.x; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Fabro G, 2008, PLANT PHYSIOL, V146, P1421, DOI 10.1104/pp.107.111286; Falush D, 2003, GENETICS, V164, P1567; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Gonzalez-Martinez SC, 2008, HEREDITY, V101, P19, DOI 10.1038/hdy.2008.21; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; Gram WK, 2001, ECOLOGY, V82, P2012, DOI 10.1890/0012-9658(2001)082[2012:ABEAGH]2.0.CO;2; Guillot G, 2009, BIOINFORMATICS, V25, P1796, DOI 10.1093/bioinformatics/btp267; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HAMRICK JL, 1972, P NATL ACAD SCI USA, V69, P2100, DOI 10.1073/pnas.69.8.2100; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; Johnsen KH, 1999, CAN J FOREST RES, V29, P1727, DOI 10.1139/cjfr-29-11-1727; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; LANGLET O, 1971, Taxon, V20, P653, DOI 10.2307/1218596; Latta RG, 1998, AM NAT, V151, P283, DOI 10.1086/286119; LE CORRE V, 2003, GENETICS, V164, P1205; Ledig F. Thomas, 1998, P251; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Lohmueller KE, 2006, AM J HUM GENET, V78, P130, DOI 10.1086/499287; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Mitton JB, 1998, AM J BOT, V85, P1262, DOI 10.2307/2446636; Mitton JB, 1997, SELECTION NATURAL PO; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Morgenstern E.K., 1996, GEOGRAPHIC VARIATION; NAMKOONG G, 1979, USDA FOREST SERVICE, V1588; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; NEWTON RJ, 1991, FOREST ECOL MANAG, V43, P225, DOI 10.1016/0378-1127(91)90129-J; Nicaise V, 2007, FEBS LETT, V581, P1041, DOI 10.1016/j.febslet.2007.02.007; Olivas-Garcia JM, 2000, CAN J FOREST RES, V30, P1581, DOI 10.1139/cjfr-30-10-1581; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2007, R LANG ENV STAT COMP; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schmidtling RC, 1999, SILVAE GENET, V48, P35; SCHMIDTLING RC, 2003, ISHS ACTA HORTICULTU, V615, P203; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; SQUILLACE AE, 1981, SILVAE GENET, V30, P127; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; Tan QKG, 2006, PLANT PHYSIOL, V140, P1095, DOI 10.1104/pp.105.070565; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Turner TL, 2008, GENETICS, V179, P455, DOI 10.1534/genetics.107.083659; VAN HEERWAARDEN J, 2010, MOL ECOL, V19, P1162; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; Vergnolle C, 2005, PLANT PHYSIOL, V139, P1217, DOI 10.1104/pp.105.068171; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Warren CR, 2001, OECOLOGIA, V127, P476, DOI 10.1007/s004420000609; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Watkinson JI, 2003, PLANT PHYSIOL, V133, P1702, DOI 10.1104/pp.103.026914; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WELLS OO, 1991, SILVAE GENET, V40, P105; WELLS OSBORN O., 1966, FOREST SCI MONOGR, V11, P1; Westfall R. D., 1992, New Forests, V6, P279, DOI 10.1007/BF00120649; Westfall RD, 2004, FOREST ECOL MANAG, V197, P159, DOI 10.1016/j.foreco.2004.05.011; Wong CE, 2006, PLANT PHYSIOL, V140, P1437, DOI 10.1104/pp.105.070508; Xu SQ, 2008, TREE GENET GENOMES, V4, P859, DOI 10.1007/s11295-008-0158-9; Yang SH, 2005, TREE PHYSIOL, V25, P1063, DOI 10.1093/treephys/25.8.1063; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZHANG J, 1994, CAN J FOREST RES, V24, P92, DOI 10.1139/x94-014	104	264	269	0	102	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	2010	185	3					969	982		10.1534/genetics.110.115543			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651EE	WOS:000281906800021	20439779	Green Published, Bronze			2022-01-24	
J	Morin, RD; Aksay, G; Dolgosheina, E; Ebhardt, HA; Magrini, V; Mardis, ER; Sahinalp, SC; Unrau, PJ				Morin, Ryan D.; Aksay, Gozde; Dolgosheina, Elena; Ebhardt, H. Alexander; Magrini, Vincent; Mardis, Elaine R.; Sahinalp, S. Cenk; Unrau, Peter J.			Comparative analysis of the small RNA transcriptomes of Pinus contorta and Oryza sativa	GENOME RESEARCH			English	Article							PLANT MICRORNAS; ARABIDOPSIS; SEQUENCE; DATABASE; IDENTIFICATION; BROWSER; TARGETS; SIRNAS; SYSTEM	The diversity of microRNAs and small-interfering RNAs has been extensively explored within angiosperms by focusing on a few key organisms such as Oryza sativa and Arabidopsis thaliana. A deeper division of the plants is defined by the radiation of the angiosperms and gymnosperms, with the latter comprising the commercially important conifers. The conifers are expected to provide important information regarding the evolution of highly conserved small regulatory RNAs. Deep sequencing provides the means to characterize and quantitatively profile small RNAs in understudied organisms such as these. Pyrosequencing of small RNAs from O. sativa revealed, as expected, similar to 21- and similar to 24-nt RNAs. The former contained known microRNAs, and the latter largely comprised intergenic-derived sequences likely representing heterochromatin siRNAs. In contrast, sequences from Pinus contorta were dominated by 21-nt small RNAs. Using a novel sequence-based clustering algorithm, we identified sequences belonging to 18 highly conserved microRNA families in P. contorta as well as numerous clusters of conserved small RNAs of unknown function. Using multiple methods, including expressed sequence folding and machine learning algorithms, we found a further 53 candidate novel microRNA families, 51 appearing specific to the P. contorta library. In addition, alignment of small RNA sequences to the O. sativa genome revealed six perfectly conserved classes of small RNA that included chloroplast transcripts and specific types of genomic repeats. The conservation of microRNAs and other small RNAs between the conifers and the angiosperms indicates that important RNA silencing processes were highly developed in the earliest spermatophytes. Genomic mapping of all sequences to the O. sativa genome can be viewed at http://microrna.bcgsc.ca/cgi-bin/gbrowse/rice_build_3/.	[Dolgosheina, Elena; Unrau, Peter J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Morin, Ryan D.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Aksay, Gozde] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Ebhardt, H. Alexander] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Magrini, Vincent; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Sahinalp, S. Cenk] Simon Fraser Univ, Dept Comp Sci, Burnaby, BC V5A 1S6, Canada		Unrau, PJ (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	punrau@sfu.ca	Morin, Ryan/AAE-7824-2019; Magrini, Vincent/AAT-5830-2020; Mardis, Elaine/W-2202-2019; Sahinalp, Suleyman Cenk/X-7843-2018	Morin, Ryan/0000-0003-2932-7800; Magrini, Vincent/0000-0002-2019-4872; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Ebhardt, Holger Alexander/0000-0001-9019-8388			Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett MD, 2005, ANN BOT-LONDON, V95, P45, DOI 10.1093/aob/mci003; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen ZY, 2006, GENETICA, V128, P21, DOI 10.1007/s10709-005-2486-0; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; GOWER JC, 1969, APPL STAT, V18, P54, DOI DOI 10.2307/2346439; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Herr AJ, 2005, FEBS LETT, V579, P5879, DOI 10.1016/j.febslet.2005.08.040; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Johnson C, 2007, NUCLEIC ACIDS RES, V35, pD829, DOI 10.1093/nar/gkl991; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; LAU LC, 2001, SCIENCE, V5543, P858; Lindow M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-119; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCarthy EM, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0053; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pavy N, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-144; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; PONTIUS JU, 2002, NCBI HDB; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seliverstov Alexander, 2006, Journal of Bioinformatics and Computational Biology, V4, P783, DOI 10.1142/S0219720006002235; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Talmor-Neiman M, 2006, PLANT J, V48, P511, DOI 10.1111/j.1365-313X.2006.02895.x; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Wang MB, 2005, CURR OPIN PLANT BIOL, V8, P216, DOI 10.1016/j.pbi.2005.01.006; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Witten I. H., 2005, DATA MINING PRACTICA; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	45	264	282	1	29	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2008	18	4					571	584		10.1101/gr.6897308			14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	282IZ	WOS:000254562400007	18323537	Green Published, Bronze			2022-01-24	
J	Matsushima, N; Tanaka, T; Enkhbayar, P; Mikami, T; Taga, M; Yamada, K; Kuroki, Y				Matsushima, Norio; Tanaka, Takanori; Enkhbayar, Purevjav; Mikami, Tomoko; Taga, Masae; Yamada, Keiko; Kuroki, Yoshio			Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors	BMC GENOMICS			English	Article							GLYCOPROTEIN-IB-ALPHA; SECONDARY STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; LISTERIA-MONOCYTOGENES; STRUCTURAL BASIS; RIBONUCLEASE INHIBITOR; INVASION PROTEIN; BINDING-SITE; COMPLEX; DOMAIN	Background: Toll-like receptors (TLRs) play a central role in innate immunity. TLRs are membrane glycoproteins and contain leucine rich repeat (LRR) motif in the ectodomain. TLRs recognize and respond to molecules such as lipopolysaccharide, peptidoglycan, flagellin, and RNA from bacteria or viruses. The LRR domains in TLRs have been inferred to be responsible for molecular recognition. All LRRs include the highly conserved segment, LxxLxLxxNxL, in which "L" is Leu, Ile, Val, or Phe and "N" is Asn, Thr, Ser, or Cys and "x" is any amino acid. There are seven classes of LRRs including "typical" ("T") and " bacterial" ("S"). All known domain structures adopt an arc or horseshoe shape. Vertebrate TLRs form six major families. The repeat numbers of LRRs and their "phasing" in TLRs differ with isoforms and species; they are aligned differently in various databases. We identified and aligned LRRs in TLRs by a new method described here. Results: The new method utilizes known LRR structures to recognize and align new LRR motifs in TLRs and incorporates multiple sequence alignments and secondary structure predictions. TLRs from thirty-four vertebrate were analyzed. The repeat numbers of the LRRs ranges from 16 to 28. The LRRs found in TLRs frequently consists of LxxLxLxxNxLxxLxxxxF/LxxLxx ("T") and sometimes short motifs including LxxLxLxxNxLxxLPx(x) LPxx ("S"). The TLR7 family (TLR7, TLR8, and TLR9) contain 27 LRRs. The LRRs at the N-terminal part have a super-motif of STT with about 80 residues. The super-repeat is represented by STTSTTSTT or _TTSTTSTT. The LRRs in TLRs form one or two horseshoe domains and are mostly flanked by two cysteine clusters including two or four cysteine residue. Conclusion: Each of the six major TLR families is characterized by their constituent LRR motifs, their repeat numbers, and their patterns of cysteine clusters. The central parts of the TLR1 and TLR7 families and of TLR4 have more irregular or longer LRR motifs. These central parts are inferred to play a key role in the structure and/or function of their TLRs. Furthermore, the super-repeat in the TLR7 family suggests strongly that " bacterial" and "typical" LRRs evolved from a common precursor.	Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido 0608556, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Natl Univ Mongolia, Fac Biol, Ulaanbaatar 210646 377, Mongolia; Sapporo City Univ, Dept Nursing, Sapporo, Hokkaido 0600011, Japan; Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 0608556, Japan		Matsushima, N (corresponding author), Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido 0608556, Japan.	matusima@sapmed.ac.jp; gouhan@gsc.riken.jp; enkhbayar@biology.num.edu.mn; t.mikami@scu.ac.jp; m.taga@scu.ac.jp; oyama@sapmed.ac.jp; kurokiy@sapmed.ac.jp					Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Asahina Y, 2003, VET IMMUNOL IMMUNOP, V96, P159, DOI 10.1016/S0165-2427(03)00159-4; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Cheng HL, 2005, COUNS PSYCHOL, V33, P72, DOI 10.1177/0011000004270343; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Faber J, 2006, PEDIATR INFECT DIS J, V25, P80, DOI 10.1097/01.inf.0000195595.22547.fe; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Galiana-Arnoux D, 2006, TISSUE ANTIGENS, V67, P267, DOI 10.1111/j.1399-0039.2006.00583.x; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Hillig RC, 1999, MOL CELL, V3, P781, DOI 10.1016/S1097-2765(01)80010-1; Hirono I, 2004, IMMUNOGENETICS, V56, P38, DOI 10.1007/s00251-004-0657-2; Ho DN, 2002, P NATL ACAD SCI USA, V99, P1888, DOI 10.1073/pnas.042698599; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kang SSW, 2006, J AM ACAD DERMATOL, V54, P951, DOI 10.1016/j.jaad.2005.05.004; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; Kumar A, 2006, CURR MOL MED, V6, P327, DOI 10.2174/156652406776894572; Kumpf O, 2006, SHOCK, V25, P123, DOI 10.1097/01.shk.0000190823.44030.e6; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Lu SY, 2004, PROTEINS, V56, P384, DOI 10.1002/prot.10597; Marino M, 2004, BIOCHEM BIOPH RES CO, V316, P379, DOI 10.1016/j.bbrc.2004.02.064; Marino M, 2002, EMBO J, V21, P5623, DOI 10.1093/emboj/cdf558; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Matsushima N, 2000, PROTEINS, V38, P210, DOI 10.1002/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1; MATUSHIMA N, 2005, DRUG DESIGN REV, V2, P305; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; MOCHIDA Y, 2006, IN PRESS J BIOL CHEM; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Montes AH, 2006, CLIN EXP IMMUNOL, V143, P404, DOI 10.1111/j.1365-2249.2005.03002.x; Montgomerie S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-301; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Nishitani C, 2006, J BIOL CHEM, V281, P38322, DOI 10.1074/jbc.M606904200; Ohara T, 2006, INT J MOL MED, V18, P59; Ohyanagi T, 1997, FASEB J, V11, pA949; Pandey S, 2006, IMMUNOL CELL BIOL, V84, P333, DOI 10.1111/j.1440-1711.2006.01444.x; Papageorgiou AC, 1997, EMBO J, V16, P5162, DOI 10.1093/emboj/16.17.5162; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Schubert WD, 2001, J MOL BIOL, V312, P783, DOI 10.1006/jmbi.2001.4989; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Varughese KI, 2004, ACTA CRYSTALLOGR D, V60, P405, DOI 10.1107/S0907444903026805; Vogel SN, 2005, J ENDOTOXIN RES, V11, P333, DOI 10.1179/096805105X58724; Wu HW, 2000, NAT STRUCT BIOL, V7, P575; Wu HW, 2003, BIOCHEMISTRY-US, V42, P57, DOI 10.1021/bi026762j; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7	78	264	284	1	33	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAY 21	2007	8								124	10.1186/1471-2164-8-124			20	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	183JD	WOS:000247568200001	17517123	Green Published, gold			2022-01-24	
J	Normand, P; Lapierre, P; Tisa, LS; Gogarten, JP; Alloisio, N; Bagnarol, E; Bassi, CA; Berry, AM; Bickhart, DM; Choisne, N; Couloux, A; Cournoyer, B; Cruveiller, S; Daubin, V; Demange, N; Francino, MP; Goltsman, E; Huang, Y; Kopp, OR; Labarre, L; Lapidus, A; Lavire, C; Marechal, J; Martinez, M; Mastronunzio, JE; Mullin, BC; Niemann, J; Pujic, P; Rawnsley, T; Rouy, Z; Schenowitz, C; Sellstedt, A; Tavares, F; Tomkins, JP; Vallenet, D; Valverde, C; Wall, LG; Wang, Y; Medigue, C; Benson, DR				Normand, Philippe; Lapierre, Pascal; Tisa, Louis S.; Gogarten, Johann Peter; Alloisio, Nicole; Bagnarol, Emilie; Bassi, Carla A.; Berry, Alison M.; Bickhart, Derek M.; Choisne, Nathalie; Couloux, Arnaud; Cournoyer, Benoit; Cruveiller, Stephane; Daubin, Vincent; Demange, Nadia; Francino, Maria Pilar; Goltsman, Eugene; Huang, Ying; Kopp, Olga R.; Labarre, Laurent; Lapidus, Alla; Lavire, Celine; Marechal, Joelle; Martinez, Michele; Mastronunzio, Juliana E.; Mullin, Beth C.; Niemann, James; Pujic, Pierre; Rawnsley, Tania; Rouy, Zoe; Schenowitz, Chantal; Sellstedt, Anita; Tavares, Fernando; Tomkins, Jeffrey P.; Vallenet, David; Valverde, Claudio; Wall, Luis G.; Wang, Ying; Medigue, Claudine; Benson, David R.			Genome characteristics of facultatively symbiotic Frankia sp strains reflect host range and host plant biogeography	GENOME RESEARCH			English	Article							ROOT-NODULES; EVOLUTION; SEQUENCE; NODULATION; PHYLOGENY; FAMILY; ANNOTATION; STRATEGIES; DIVERSITY; ORIGIN	Soil bacteria that also form mutualistic symbioses in plants encounter two major levels of selection. One occurs during adaptation to and survival in soil, and the other occurs in concert with host plant speciation and adaptation. Actinobacteria from the genus Frankia are facultative symbionts that form N-2-fixing root nodules on diverse and globally distributed angiosperms in the "actinorhizal" symbioses. Three closely related clades of Frankia sp. strains are recognized; members of each clade infect a subset of plants from among eight angiosperm families. We sequenced the genomes from three strains; their sizes varied from 5.43 Mbp for a narrow host range strain (Frankia sp. strain HFPCcl3) to 7.50 Mbp for a medium host range strain (Frankia alni strain ACNl4a) to 9.04 Mbp for a broad host range strain (Frankia sp. strain EANlpec.) This size divergence is the largest yet reported for such closely related soil bacteria (97.8% - 98.9% identity of 16S rRNA genes). The extent of gene deletion, duplication, and acquisition is in concert with the biogeographic history of the symbioses and host plant speciation. Host plant isolation favored genome contraction, whereas host plant diversification favored genome expansion. The results support the idea that major genome expansions as well as reductions can occur in facultative symbiotic soil bacteria as they respond to new environments in the context of their symbioses.	Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06279 USA; Univ Lyon 1, IFR Bio Environm Sante 41, CNRS, UMR, F-69622 Villeurbanne, France; Univ New Hampshire, Dept Microbiol, Durham, NH 03824 USA; Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; Unite Rech Genomique Vegetale, Inst Natl Rech Agronom, F-91057 Evry, France; Geonoscope, Ctr Natl Sequencage, F-91057 Evry, France; Genoscope, UMR 8030, CNRS, Atelier Genomique Comparat, F-91006 Evry, France; Univ Lyon 1, CNRS, UMR 5558, Bioinformat & Evolutionary Genomics Lab, F-69622 Villeurbanne, France; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN 37996 USA; Umea Univ, Dept Plant Physiol, S-90187 Umea, Sweden; Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; Clemson Univ, Genomics Inst, Clemson, SC 29634 USA; Univ Nacl Quilmes, Dept Ciencia & Tecnol, Programa Interacciones Biol, RA-1876 Bernal, Argentina		Benson, DR (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06279 USA.	david.benson@uconn.edu	Normand, Philippe/ABD-2235-2020; Francino, M.Pilar/H-9090-2015; LAVIRE, Celine/AAC-4222-2019; Lapidus, Alla L/I-4348-2013; Normand, Philippe/A-1142-2012; Valverde, Claudio F/I-3375-2019; LAVIRE, Celine/D-3126-2019; Tavares, Fernando/C-3375-2013	Normand, Philippe/0000-0002-2139-2141; Francino, M.Pilar/0000-0002-4510-5653; LAVIRE, Celine/0000-0002-0698-4683; Lapidus, Alla L/0000-0003-0427-8731; LAVIRE, Celine/0000-0002-0698-4683; Tavares, Fernando/0000-0001-9913-1155; Couloux, Arnaud/0000-0003-2356-0062; CHOISNE, Nathalie/0000-0001-6024-1664; Valverde, Claudio/0000-0001-8296-1291; Daubin, Vincent/0000-0001-8269-9430; Sellstedt, Anita/0000-0002-0536-903X; Bickhart, Derek/0000-0003-2223-9285; Tisa, Louis/0000-0001-5597-8477; Gogarten, Johann Peter/0000-0001-6459-6518; Pujic, Petar/0000-0003-1957-8534			BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Benson DR, 2004, PLANT MICROBIOLOGY, P97; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BERG RH, 1988, CAN J BOT, V66, P2038, DOI 10.1139/b88-279; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Bremer K, 1998, ANN MO BOT GARD, V85, P531, DOI 10.2307/2992015; CAMPBELL JD, 1984, NEW ZEAL J BOT, V22, P159, DOI 10.1080/0028825X.1984.10425242; Chain Patrick, 2003, Briefings in Bioinformatics, V4, P105, DOI 10.1093/bib/4.2.105; CHEN LM, 1992, MOL GEN GENET, V233, P311, DOI 10.1007/BF00587593; Chen WM, 2001, INT J SYST EVOL MICR, V51, P1729, DOI 10.1099/00207713-51-5-1729; Clawson ML, 2004, MOL PHYLOGENET EVOL, V31, P131, DOI 10.1016/j.ympev.2003.08.001; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Heuvel BDV, 2004, CAN J MICROBIOL, V50, P989, DOI [10.1139/w04-079, 10.1139/W04-079]; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Lalonde M., 1981, Current perspectives in nitrogen fixation., P296; Luo MZ, 2003, METH MOL B, V236, P3; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moulin L, 2004, MOL PHYLOGENET EVOL, V30, P720, DOI 10.1016/S1055-7903(03)00255-0; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; NORMAND P, 1982, CAN J MICROBIOL, V28, P1133, DOI 10.1139/m82-168; Normand P, 1996, INT J SYST BACTERIOL, V46, P1, DOI 10.1099/00207713-46-1-1; NORMAND P, 2007, IN PRESS ACTINORHIZA; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SELLSTEDT A, 1995, FEMS MICROBIOL LETT, V125, P231, DOI 10.1111/j.1574-6968.1995.tb07363.x; Silvester W. B., 1976, Proceedings of the 1st International Symposium on Nitrogen Fixation [Newton, W.E.; Nyman, C.J. Editors]., P489; Silvester W. B., 1977, A treatise on dinitrogen fixation. Section 4. Agronomy and ecology. [Hardy, R.W.F.; Gibson, A.H.]., P141; Simonet P, 1999, ENVIRON MICROBIOL, V1, P525, DOI 10.1046/j.1462-2920.1999.00068.x; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Swensen SM, 1996, AM J BOT, V83, P1503, DOI 10.2307/2446104; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Young JPW, 1996, NEW PHYTOL, V133, P87, DOI 10.1111/j.1469-8137.1996.tb04344.x; ZHANG Z, 1984, PLANT SOIL, V78, P79, DOI 10.1007/BF02277841; Zimpfer JF, 1997, PHYSIOL PLANTARUM, V99, P664, DOI 10.1034/j.1399-3054.1997.990419.x; [No title captured]	50	264	917	2	76	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JAN	2007	17	1					7	15		10.1101/gr.5798407			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	121XX	WOS:000243191400002	17151343	Green Published, Bronze			2022-01-24	
J	Wenzl, P; Li, HB; Carling, J; Zhou, MX; Raman, H; Paul, E; Hearnden, P; Maier, C; Xia, L; Caig, V; Ovesna, J; Cakir, M; Poulsen, D; Wang, JP; Raman, R; Smith, KP; Muehlbauer, GJ; Chalmers, KJ; Kleinhofs, A; Huttner, E; Kilian, A				Wenzl, Peter; Li, Haobing; Carling, Jason; Zhou, Meixue; Raman, Harsh; Paul, Edie; Hearnden, Phillippa; Maier, Christina; Xia, Ling; Caig, Vanessa; Ovesna, Jaroslava; Cakir, Mehmet; Poulsen, David; Wang, Junping; Raman, Rosy; Smith, Kevin P.; Muehlbauer, Gary J.; Chalmers, Ken J.; Kleinhofs, Andris; Huttner, Eric; Kilian, Andrzej			A high-density consensus map of barley linking DArT markers to SSR, RFLP and STS loci and agricultural traits	BMC GENOMICS			English	Article							LINKAGE MAPS; DIVERSITY ARRAYS; TECHNOLOGY DART; GENOME; GENE; RECOMBINATION; TOMATO	Background: Molecular marker technologies are undergoing a transition from largely serial assays measuring DNA fragment sizes to hybridization-based technologies with high multiplexing levels. Diversity Arrays Technology (DArT) is a hybridization-based technology that is increasingly being adopted by barley researchers. There is a need to integrate the information generated by DArT with previous data produced with gel-based marker technologies. The goal of this study was to build a high-density consensus linkage map from the combined datasets of ten populations, most of which were simultaneously typed with DArT and Simple Sequence Repeat (SSR), Restriction Enzyme Fragment Polymorphism (RFLP) and/ or Sequence Tagged Site (STS) markers. Results: The consensus map, built using a combination of JoinMap 3.0 software and several purpose-built perl scripts, comprised 2,935 loci (2,085 DArT, 850 other loci) and spanned 1,161 cM. It contained a total of 1,629 'bins' (unique loci), with an average inter- bin distance of 0.7 +/- 1.0 cM (median = 0.3 cM). More than 98% of the map could be covered with a single DArT assay. The arrangement of loci was very similar to, and almost as optimal as, the arrangement of loci in component maps built for individual populations. The locus order of a synthetic map derived from merging the component maps without considering the segregation data was only slightly inferior. The distribution of loci along chromosomes indicated centromeric suppression of recombination in all chromosomes except 5H. DArT markers appeared to have a moderate tendency toward hypomethylated, gene-rich regions in distal chromosome areas. On the average, 14 +/- 9 DArT loci were identified within 5 cM on either side of SSR, RFLP or STS loci previously identified as linked to agricultural traits. Conclusion: Our barley consensus map provides a framework for transferring genetic information between different marker systems and for deploying DArT markers in molecular breeding schemes. The study also highlights the need for improved software for building consensus maps from high-density segregation data of multiple populations.	Triticarte PL, Canberra, ACT 2600, Australia; DAIT PL, Canberra, ACT 2600, Australia; Univ Tasmania, Sch Agr Sci, Hobart, Tas 7001, Australia; Tasmania Inst Agr Res, Kings Meadows, Tas 7249, Australia; Wagga Wagga Agr Inst, NSW Agr Genom Ctr, Wagga Wagga, NSW 2650, Australia; Wagga Wagga Agr Inst, NSW Dept Primary Ind, Wagga Wagga, NSW 2650, Australia; GeneFlow Inc, Centreville, VA 20120 USA; Univ Adelaide, Sch Agr Food & Wine, Plant Genom Ctr, Glen Osmond, SA 5064, Australia; Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Res Inst Crop Prod, Prague 16106 6, Czech Republic; Murdoch Univ, WA State Agr Biotechnol Ctr, Mol Plant Breeding CRC, Murdoch, WA 6150, Australia; Dept Primary Ind & Fisheries, Warwick, Qld 4370, Australia; Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA		Kilian, A (corresponding author), Triticarte PL, POB 7141 Yarralumla, Canberra, ACT 2600, Australia.	peter@DiversityArrays.com; haobingl@postoffice.newnham.utas.edu.au; jason@DiversityArrays.com; meixue.zhou@dpiwe.tas.gov.au; harsh.raman@agric.nsw.gov.au; epaul@geneflowinc.com; phillippa.hearnden@adelaide.edu.au; cmaier@wsu.edu; ling@DiversityArrays.com; vanessa@DiversityArrays.com; ovesna@vurv.cz; m.cakir@murdoch.edu.au; david.poulsen@dpi.qld.gov.au; junping.wang@dpi.nsw.gov.au; rosy.raman@dpi.nsw.gov.au; smith376@umn.edu; muehl003@umn.edu; ken.chalmers@adelaide.edu.au; andyk@wsu.edu; eric@DiversityArrays.com; a.kilian@diversityarrays.com	Chalmers, Ken J/G-2713-2014; RAMAN, HARSH/N-8891-2016; , Meixue/C-2387-2014	RAMAN, HARSH/0000-0001-9761-1518; , Meixue/0000-0003-3009-7854; Smith, Kevin/0000-0001-8253-3326; Huttner, Eric/0000-0002-3240-9885; Kilian, Andrzej/0000-0002-2730-7462			AKBARI M, IN PRESS THEOR APPL; CALDWELL KS, 2006, HORDEUM VULGARE, V172, P557; Cooper M, 2005, AUST J AGR RES, V56, P895, DOI 10.1071/AR05154; Devaux P, 1995, MOL GEN GENET, V249, P600, DOI 10.1007/BF00418029; DIAB A, AFR J BIOTECH, V5, P235; Frary A, 1996, MOL GEN GENET, V250, P295, DOI 10.1007/BF02174387; Haldane JBS, 1931, GENETICS, V16, P0357; Haubold B, 2002, GENETICS, V161, P1269; HAYES PM, SUMMARY PUBLISHED BA; Horsley RD, 2006, CROP SCI, V46, P145, DOI 10.2135/cropsci2005.0247; Hospital Frederic, 2002, P135, DOI 10.1079/9780851996011.0135; Isidore E, 2003, GENETICS, V165, P2107; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Karakousis A, 2003, AUST J AGR RES, V54, P1173, DOI 10.1071/AR02177; Karakousis A, 2003, AUST J AGR RES, V54, P1137, DOI 10.1071/AR02180; Kilian A., 2005, P INT C WAK DOUBL HE, P443; KLEINHOFS A, 1993, THEOR APPL GENET, V86, P705, DOI 10.1007/BF00222660; Koebner R. M. D., 2001, Plant Breeding Reviews, V21, P181; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; LALOUEL JM, 1977, HEREDITY, V38, P61, DOI 10.1038/hdy.1977.8; Langridge P, 2003, AUST J AGR RES, V54, pI, DOI 10.1071/ARv54n12_PR; LANGRIDGE P, 1995, MOL BREEDING, V1, P389, DOI 10.1007/BF01248416; Lezar S, 2004, THEOR APPL GENET, V109, P1329, DOI 10.1007/s00122-004-1759-9; LI H, 2005, P 12 AUSTR BARL TECH; LI H, P 13 AUSTR PLANT BRE; LIANG N, 2002, GENETICS, V161, P1293; LIU BH, 1990, J HERED, V81, P407; Mather Diane E., 2002, P101, DOI 10.1079/9780851996011.0101; Mesfin A, 2003, CROP SCI, V43, P307, DOI 10.2135/cropsci2003.0307; MESTER D, 2006, PLANT AN GEN 13 C 15; Moore G, 2000, ANNU REV PLANT PHYS, V51, P195, DOI 10.1146/annurev.arplant.51.1.195; Peleman JD, 2003, TRENDS PLANT SCI, V8, P330, DOI 10.1016/S1360-1385(03)00134-1; Qi XQ, 1996, GENOME, V39, P379, DOI 10.1139/g96-049; Raman Rosy, 2005, Functional & Integrative Genomics, V5, P185, DOI 10.1007/s10142-005-0144-3; Ramsay L, 2000, GENETICS, V156, P1997; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; SALL T, 1994, THEOR APPL GENET, V89, P211, DOI 10.1007/BF00225144; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; SVENSSON JT, 2006, PLANT AN GEN 14 C 14; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; TANKSLEY SD, 1995, TRENDS GENET, V11, P63, DOI 10.1016/S0168-9525(00)88999-4; TANKSLEY SD, 1992, GENETICS, V132, P1141; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; VARSHNEY RK, 2006, PLANT AN GEN 14 C 14; VIVAR HE, 2003, P INT S 13 14 MARCH; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Voorrips RE, 2001, PLANT RES INT WAGENI; Vuylsteke M, 1999, THEOR APPL GENET, V99, P921, DOI 10.1007/s001220051399; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wittenberg AHJ, 2005, MOL GENET GENOMICS, V274, P30, DOI 10.1007/s00438-005-1145-6; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; YANG S, IN PRESS THEOR APPL; Zohary D., 1988, DOMESTICATION PLANTS	54	264	274	0	51	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	AUG 12	2006	7								206	10.1186/1471-2164-7-206			22	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	087GW	WOS:000240731900001	16904008	Green Published, Green Accepted, gold			2022-01-24	
J	Sato, TK; Yamada, RG; Ukai, H; Baggs, JE; Miraglia, LJ; Kobayashi, TJ; Welsh, DK; Kay, SA; Ueda, HR; Hogenesch, JB				Sato, TK; Yamada, RG; Ukai, H; Baggs, JE; Miraglia, LJ; Kobayashi, TJ; Welsh, DK; Kay, SA; Ueda, HR; Hogenesch, JB			Feedback repression is required for mammalian circadian clock function	NATURE GENETICS			English	Article							KAIC PHOSPHORYLATION; GENE-EXPRESSION; TRANSCRIPTION; MPER1; LOOP; CRYPTOCHROMES; MECHANISM; RHYTHMS; PROTEIN; PERIOD	Direct evidence for the requirement of transcriptional feedback repression in circadian clock function has been elusive. Here, we developed a molecular genetic screen in mammalian cells to identify mutants of the circadian transcriptional activators CLOCK and BMAL1, which were uncoupled from CRYPTOCHROME (CRY)- mediated transcriptional repression. Notably, mutations in the PER-ARNT-SIM domain of CLOCK and the C terminus of BMAL1 resulted in synergistic insensitivity through reduced physical interactions with CRY. Coexpression of these mutant proteins in cultured fibroblasts caused arrhythmic phenotypes in population and single-cell assays. These data demonstrate that CRY-mediated repression of the CLOCK/BMAL1 complex activity is required for maintenance of circadian rhythmicity and provide formal proof that transcriptional feedback is required for mammalian clock function.	Genom Inst, San Diego, CA 92121 USA; Novartis Res Fdn, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Genome Technol, Jupiter, FL 33458 USA; RIKEN, Ctr Dev Biol, Lab Syst Biol, Kobe, Hyogo 6500047, Japan; Scripps Res Inst, Dept Biochem, Jupiter, FL 33458 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; Vet Adm San Diego Healthcare Syst, La Jolla, CA 92161 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA		Ueda, HR (corresponding author), Genom Inst, 10675 John J Hopkins Dr, San Diego, CA 92121 USA.	uedah-tky@umin.ac.jp; hogenesch@scripps.edu	Kay, Steve A/F-6025-2011; Welsh, David K/G-2277-2011; Ueda, Hiroki R/C-5037-2014	Kay, Steve A/0000-0002-0402-2878; Ueda, Hiroki R/0000-0001-8342-9176	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50 MH074924, P50 MH074924-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50MH074924] Funding Source: NIH RePORTER		Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	33	264	268	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					312	319		10.1038/ng1745			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	WOS:000235589600012	16474406	Green Accepted			2022-01-24	
J	Liao, DQ				Liao, DQ			Concerted evolution: Molecular mechanism and biological implications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMALL NUCLEAR-RNA; GENE CONVERSION; RIBOSOMAL DNA; RNU2 LOCUS; MULTIGENE FAMILIES; REPETITIVE DNA; U2 SNRNA; SEQUENCE; GENOME; HOMOGENIZATION		Univ Sherbrooke, Dept Microbiol & Infect Dis, Fac Med, Sherbrooke, PQ J1H 5N4, Canada		Liao, DQ (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Fac Med, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	dliao@courrier.usherb.ca	Liao, Daiqing/A-8941-2008				Abdulkarim F, 1996, J MOL BIOL, V260, P506, DOI 10.1006/jmbi.1996.0418; AMSTUTZ H, 1985, CELL, V40, P879, DOI 10.1016/0092-8674(85)90347-2; ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; Benedict MQ, 1996, INSECT MOL BIOL, V5, P73, DOI 10.1111/j.1365-2583.1996.tb00042.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRUNNER AM, 1986, BIOCHEMISTRY-US, V25, P5028, DOI 10.1021/bi00366a009; Carranza S, 1996, MOL BIOL EVOL, V13, P824, DOI 10.1093/oxfordjournals.molbev.a025643; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X; Copenhaver GP, 1996, PLANT J, V9, P273, DOI 10.1046/j.1365-313X.1996.09020273.x; DOVER GA, 1993, CURR OPIN GENET DEV, V3, P902, DOI 10.1016/0959-437X(93)90012-E; DOVER GA, 1993, METHOD ENZYMOL, V224, P525, DOI 10.1016/0076-6879(93)24039-W; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; HEIX J, 1995, CURR OPIN GENET DEV, V5, P652, DOI 10.1016/0959-437X(95)80035-2; HIBNER BL, 1991, GENETICS, V128, P595; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; JINKSROBERTSON S, 1993, METHOD ENZYMOL, V224, P631; KOOP BF, 1986, J MOL EVOL, V24, P94, DOI 10.1007/BF02099956; Lan RT, 1998, MICROBIOL-UK, V144, P1213, DOI 10.1099/00221287-144-5-1213; Liao DQ, 1998, J MOL EVOL, V46, P649, DOI 10.1007/PL00006345; Liao DQ, 1995, GENOMICS, V30, P583, DOI 10.1006/geno.1995.1280; Liao DQ, 1997, EMBO J, V16, P588, DOI 10.1093/emboj/16.3.588; MATERA AG, 1990, MOL CELL BIOL, V10, P5876, DOI 10.1128/MCB.10.11.5876; MURTI JR, 1994, GENETICS, V137, P837; MURTI JR, 1992, MOL CELL BIOL, V12, P2545, DOI 10.1128/MCB.12.6.2545; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nenoi M, 1998, GENETICS, V148, P867; OHTA T, 1983, P NATL ACAD SCI-BIOL, V80, P4079, DOI 10.1073/pnas.80.13.4079; PAVELITZ T, 1995, EMBO J, V14, P169, DOI 10.1002/j.1460-2075.1995.tb06987.x; Polanco C, 1998, GENETICS, V149, P243; Schimenti JC, 1999, AM J HUM GENET, V64, P40, DOI 10.1086/302220; SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5; Swanson WJ, 1998, SCIENCE, V281, P710, DOI 10.1126/science.281.5377.710	35	264	277	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					24	30		10.1086/302221			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	WOS:000078477400005	9915939	Green Published, Bronze			2022-01-24	
J	Brinkman, RR; Mezei, MM; Theilmann, J; Almqvist, E; Hayden, MR				Brinkman, RR; Mezei, MM; Theilmann, J; Almqvist, E; Hayden, MR			The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRINUCLEOTIDE REPEAT EXPANSION; MACHADO-JOSEPH DISEASE; DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; OF-ONSET; PHENOTYPIC VARIATION; MOLECULAR ANALYSIS; CLINICAL-FEATURES; INTERMEDIATE ALLELES; (CAG)(N) REPEATS; (GAG)(N) REPEAT	Prior studies describing the relationship between CAG size and the age at onset of Huntington disease (HD) have focused on affected persons. To further define the relationship between CAG repeat size and age at onset of HD, we now have analyzed a large cohort of affected and asymptomatic at-risk persons with CAG expansion. This cohort numbered 1,049 persons, including 321 at-risk and 728 affected individuals with a CAG size of 29-121 repeats. Kaplan-Meier analysis has provided curves for determining the likelihood of onset at a given age, for each CAG repeat length in the 39-50 range. The curves were significantly different (P < .0005), with relatively narrow 95% confidence intervals (95% CI) (+/-10%). Penetrance of the mutation for HD also was examined. Although complete penetrance of HD was observed for CAG sizes of greater than or equal to 42, only a proportion of those with a CAG repeat length of 36-41 showed signs or symptoms of HD within a normal life span. These data provide information concerning the likelihood of being affected, by a specific age, with a particular CAG size, and they may be useful in predictive-testing programs and for the design of clinical trials for persons at increased risk for HD.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC V6T 1Z4,CANADA; UNIV BRITISH COLUMBIA,DEPT MED,DIV NEUROL,VANCOUVER,BC V6T 1Z4,CANADA; KAROLINSKA INST,DEPT MOL MED,STOCKHOLM,SWEDEN; KAROLINSKA INST,DEPT CLIN NEUROSCI,DIV GERIATR MED,STOCKHOLM,SWEDEN				Brinkman, Ryan/B-1108-2008; Hayden, Michael R/D-8581-2011	Brinkman, Ryan/0000-0002-9765-2990; Hayden, Michael R/0000-0001-5159-1419			ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ASHIZAWA T, 1994, NEUROLOGY, V44, P1137, DOI 10.1212/WNL.44.6.1137; BARRON LH, 1993, J MED GENET, V30, P1003, DOI 10.1136/jmg.30.12.1003; BENITEZ J, 1994, HUM GENET, V94, P563; Brandt J, 1996, NEUROLOGY, V46, P527, DOI 10.1212/WNL.46.2.527; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; CLAES S, 1995, ARCH NEUROL-CHICAGO, V52, P749, DOI 10.1001/archneur.1995.00540320021009; CRAUFURD D, 1993, J MED GENET, V30, P1008, DOI 10.1136/jmg.30.12.1008; DEROOIJ KE, 1993, J MED GENET, V30, P996, DOI 10.1136/jmg.30.12.996; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; Harper PS, 1991, HUNTINGTONS DIS; Hayden MR, 1981, HUNTINGTONS CHOREA; *HUNT DIS COLL RES, 1993, CELL, V72, P971; *HUNT STUD GROUP, 1995, HUNT STUD GROUP HSG; Huntington George, 1872, MED SURG REPORTER, V26, P317; JODICE C, 1994, AM J HUM GENET, V54, P959; KIEBURTZ K, 1994, J MED GENET, V31, P872, DOI 10.1136/jmg.31.11.872; KING RA, 1992, OXF MONOGR MED GENET, V20, P3; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOMURE O, 1995, NEUROLOGY, V45, P143, DOI 10.1212/WNL.45.1.143; KREMER B, 1995, AM J HUM GENET, V57, P343; KREMER HPH, 1994, NEW ENGL J MED, V330, P1401; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; Legius Eric, 1994, European Journal of Human Genetics, V2, P44; LUCOTTE G, 1995, HUM GENET, V95, P231; MACIEL P, 1995, AM J HUM GENET, V57, P54; MACMILLAN JC, 1993, LANCET, V342, P954, DOI 10.1016/0140-6736(93)92002-B; MARSHALL FJ, 1996, NEUROLOGY, V46, P258; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MASUDA N, 1995, J MED GENET, V32, P701, DOI 10.1136/jmg.32.9.701; MYERS RH, 1985, J NEUROL NEUROSUR PS, V48, P530, DOI 10.1136/jnnp.48.6.530; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Nance MA, 1996, AM J HUM GENET, V59, P1; NORREMOLLE A, 1993, HUM MOL GENET, V2, P1475, DOI 10.1093/hmg/2.9.1475; NOVELLETTO A, 1994, HUM MOL GENET, V3, P93, DOI 10.1093/hmg/3.1.93; RANEN NG, 1995, AM J HUM GENET, V57, P593; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; RUBINSZTEIN DC, 1993, HUM MOL GENET, V2, P1713, DOI 10.1093/hmg/2.10.1713; SIMPSON SA, 1993, J MED GENET, V30, P1014, DOI 10.1136/jmg.30.12.1014; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; SOONG BW, 1995, J MED GENET, V32, P404, DOI 10.1136/jmg.32.5.404; *STAT CAN, 1995, 84537 STAT CAN; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; VALDES JM, 1993, HUM MOL GENET, V2, P633, DOI 10.1093/hmg/2.6.633; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; YAPIJAKIS C, 1995, EUR J HUM GENET, V3, P228; ZUHLKE C, 1993, HUM MOL GENET, V2, P1467	57	264	269	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1202	1210					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	WOS:A1997WX76000021	9150168				2022-01-24	
J	RISINGER, JI; BERCHUCK, A; KOHLER, MF; BOYD, J				RISINGER, JI; BERCHUCK, A; KOHLER, MF; BOYD, J			MUTATIONS OF THE E-CADHERIN GENE IN HUMAN GYNECOLOGIC CANCERS	NATURE GENETICS			English	Article							CELL-ADHESION MOLECULE; TUMOR SUPPRESSOR GENE; PROSTATE-CANCER; EXPRESSION; CARCINOMA; CHROMOSOME-16; UVOMORULIN; ADENOCARCINOMA; PROGRESSION; ALLELOTYPE	Expression of the E-cadherin cell adhesion molecule is reduced in several types of human carcinomas, and the protein serves as an invasion suppressor in vitro. To determine if mutations of the E-cadherin gene (on chromosome 16q22) contribute to epithelial tumorigenesis, 135 carcinomas of the endometrium and ovary were examined for alterations in the E-cadherin coding region. Four mutations were identified: one somatic nonsense and one somatic missense mutation, both with retention of the wildtype alleles, and two missense mutations with somatic loss of heterozygosity in the tumour tissue. These data support the classification of E-cadherin as a human tumour suppressor gene.	NIEHS,GYNECOL PATHOBIOL GRP,MOLEC CARCINOGENESIS LAB,RES TRIANGLE PK,NC 27709; DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DURHAM,NC 27710								BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; BERGERHEIM USR, 1991, GENE CHROMOSOME CANC, V3, P215, DOI 10.1002/gcc.2870030308; BRABANT G, 1993, CANCER RES, V53, P4987; BRINGUIER PP, 1993, CANCER RES, V53, P3241; BUSSEMAKERS MJG, 1993, MOL BIOL REP, V17, P123, DOI 10.1007/BF00996219; BUSSEMAKERS MJG, 1992, CANCER RES, V52, P2916; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEVILEE P, 1991, ONCOGENE, V6, P1705; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; EDELMAN GM, 1988, BIOCHEMISTRY-US, V27, P3533, DOI 10.1021/bi00410a001; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; GAO X, 1993, CANCER RES, V53, P2723; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; HOHNE MW, 1992, CANCER RES, V52, P2616; INOUE M, 1992, AM J CLIN PATHOL, V98, P76, DOI 10.1093/ajcp/98.1.76; KUNIMI K, 1991, GENOMICS, V11, P530, DOI 10.1016/0888-7543(91)90059-N; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; MANSOURI A, 1988, DIFFERENTIATION, V38, P67, DOI 10.1111/j.1432-0436.1988.tb00593.x; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NATT E, 1989, CYTOGENET CELL GENET, V50, P145, DOI 10.1159/000132745; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; SASAKI H, 1993, CANCER RES, V53, P1906; SATO T, 1991, CANCER RES, V51, P5118; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; SHIMOYAMA Y, 1991, CANCER RES, V51, P2185; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.bi.59.070190.001321; TSUDA H, 1990, P NATL ACAD SCI USA, V87, P6791, DOI 10.1073/pnas.87.17.6791; UMBAS R, 1992, CANCER RES, V52, P5104; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M	31	264	270	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					98	102		10.1038/ng0594-98			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	WOS:A1994NJ84200021	8075649				2022-01-24	
J	GEORGE, AL; CRACKOWER, MA; ABDALLA, JA; HUDSON, AJ; EBERS, GC				GEORGE, AL; CRACKOWER, MA; ABDALLA, JA; HUDSON, AJ; EBERS, GC			MOLECULAR-BASIS OF THOMSEN DISEASE (AUTOSOMAL DOMINANT MYOTONIA-CONGENITA)	NATURE GENETICS			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; RECESSIVE GENERALIZED MYOTONIA; AROMATIC CARBOXYLIC-ACIDS; MUSCLE CHLORIDE CHANNEL; CONDUCTANCE; MUTATION; EXPRESSION; FIBERS; DNA	Thomsen's disease (autosomal dominant myotonia congenita) has recently been linked to chromosome 7q35 in the region of the human skeletal muscle chloride channel gene (HUMCLC). Single strand conformation polymorphism analysis (SSCP) was used to screen DNA from members of four unrelated pedigrees with this disorder for mutations in HUMCLC. Abnormal bands were detected in all affected, but no unaffected individuals in three of the families. Direct sequencing revealed a G to A transition that results in the substitution of a glutamic acid for a glycine residue located between the third and fourth predicted membrane spanning segments. This glycine residue is conserved in all known members of this class of chloride channel proteins. These findings establish HUMCLC as the Thomsen's disease gene.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232; UNIV WESTERN ONTARIO,UNIV HOSP,RICHARD IVEY CTR MOLEC BIOL,LONDON N6A 5A5,ONTARIO,CANADA; UNIV WESTERN ONTARIO,UNIV HOSP,DEPT CLIN NEUROL SCI,LONDON N6A 5A5,ONTARIO,CANADA		GEORGE, AL (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,NASHVILLE,TN 37232, USA.			Ebers, George/0000-0003-4771-4177			ABADALLA JA, 1992, AM J HUM GENET, V51, P579; ADRIAN RH, 1974, J PHYSIOL-LONDON, V240, P505, DOI 10.1113/jphysiol.1974.sp010620; BARCHI RL, 1975, ARCH NEUROL-CHICAGO, V32, P175, DOI 10.1001/archneur.1975.00490450055007; BARCHI RL, 1982, MUSCLE NERVE, V5, P360; BECKER PE, 1979, HUM GENET, V46, P325, DOI 10.1007/BF00273316; BECKER PE, 1977, PATHOGENESIS HUMAN M, P699; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BRETAG AH, 1973, NEW DEV ELECTROMYOGR, P464; Bryant S H, 1979, Ann N Y Acad Sci, V317, P314, DOI 10.1111/j.1749-6632.1979.tb56540.x; BRYANT SH, 1977, PATHOGENESIS HUMAN M, P715; BRYANT SH, 1971, J PHYSIOL-LONDON, V219, P361; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; FRANKE C, 1991, MUSCLE NERVE, V14, P762, DOI 10.1002/mus.880140811; FURMAN RE, 1978, ANN NEUROL, V4, P357, DOI 10.1002/ana.410040411; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Iaizzo P A, 1991, Neuromuscul Disord, V1, P47, DOI 10.1016/0960-8966(91)90042-Q; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Lipicky R.J., 1973, NEW DEV ELECTROMYOGR, P451; LIPICKY RJ, 1979, HDB CLIN NEUROLOGY, P533; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; MEHRKE G, 1988, MUSCLE NERVE, V11, P440, DOI 10.1002/mus.880110505; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTT J, 1985, ANAL HUMAN GENETIC L; PALADE PT, 1977, J GEN PHYSIOL, V69, P325, DOI 10.1085/jgp.69.3.325; PALADE PT, 1977, J GEN PHYSIOL, V69, P879, DOI 10.1085/jgp.69.6.879; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; RUDEL R, 1985, PHYSIOL REV, V65, P310, DOI 10.1152/physrev.1985.65.2.310; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; STREIB EW, 1987, MUSCLE NERVE, V10, P603, DOI 10.1002/mus.880100704; Thomsen J., 1876, ARCH PSYCHIAT NERVEN, V6, P702, DOI DOI 10.1007/BF02164912; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615	38	264	269	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					305	310		10.1038/ng0493-305			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	WOS:A1993KW25700010	7981750				2022-01-24	
J	THOMPSON, EA; DEEB, S; WALKER, D; MOTULSKY, AG				THOMPSON, EA; DEEB, S; WALKER, D; MOTULSKY, AG			THE DETECTION OF LINKAGE DISEQUILIBRIUM BETWEEN CLOSELY LINKED MARKERS - RFLPS AT THE AI-CIII APOLIPOPROTEIN GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON, SCH MED, DEPT MED, RG-25, SEATTLE, WA 98195 USA; UNIV WASHINGTON, CTR INHERITED DIS, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT STAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT GENET, SEATTLE, WA 98195 USA						NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL030086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007454, P50GM015253] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL 30086] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 07454, GM 15253] Funding Source: Medline		AVOGARO P, 1980, ATHEROSCLEROSIS, V37, P69, DOI 10.1016/0021-9150(80)90094-5; BARKER D, 1984, AM J HUM GENET, V36, P1159; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BODMER WF, 1978, BRIT MED BULL, V34, P309, DOI 10.1093/oxfordjournals.bmb.a071518; BRESLOW JL, 1982, P NATL ACAD SCI-BIOL, V79, P6861, DOI 10.1073/pnas.79.22.6861; BROWN AHD, 1975, THEOR POPUL BIOL, V8, P184, DOI 10.1016/0040-5809(75)90031-3; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; CHAKRABORTY R, 1984, GENETICS, V108, P719; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHEUNG P, 1984, P NATL ACAD SCI-BIOL, V81, P508, DOI 10.1073/pnas.81.2.508; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; DEEB S, 1986, COLD SPRING HARB SYM, V51, P403, DOI 10.1101/SQB.1986.051.01.048; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; GOLDING GB, 1984, GENETICS, V108, P257; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; HUDSON RR, 1985, GENETICS, V109, P611; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; KARATHANASIS SK, 1983, NATURE, V304, P371, DOI 10.1038/304371a0; KESSLING AM, 1985, CLIN GENET, V28, P296; LAW SW, 1984, BIOCHEM BIOPH RES CO, V118, P934, DOI 10.1016/0006-291X(84)91485-2; LITT M, 1986, AM J HUM GENET, V39, P166; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MANIATIS T., 1982, MOL CLONING LABORATO, P382; MILLER GJ, 1975, LANCET, V1, P16; MORRIS SW, 1985, LANCET, V2, P1127; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; OHTA T, 1969, GENETICS, V63, P229; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; REES A, 1986, HUM GENET, V72, P168; REES A, 1983, LANCET, V1, P444; SEILHAMER JJ, 1984, DNA-J MOLEC CELL BIO, V3, P309, DOI 10.1089/dna.1.1984.3.309; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WEIR BS, 1978, GENETICS, V88, P633; WEIR BS, 1986, AM J HUM GENET, V38, P776; WEIR BS, 1980, GENETICS, V95, P477	40	264	271	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					113	124					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	WOS:A1988L869700016	2892394				2022-01-24	
J	Buch, S; Stickel, F; Trepo, E; Way, M; Herrmann, A; Nischalke, HD; Brosch, M; Rosendahl, J; Berg, T; Ridinger, M; Rietschel, M; McQuillin, A; Frank, J; Kiefer, F; Schreiber, S; Lieb, W; Soyka, M; Semmo, N; Aigner, E; Datz, C; Schmelz, R; Bruckner, S; Zeissig, S; Stephan, AM; Wodarz, N; Deviere, J; Clumeck, N; Sarrazin, C; Lammert, F; Gustot, T; Deltenre, P; Volzke, H; Lerch, MM; Mayerle, J; Eyer, F; Schafmayer, C; Cichon, S; Nothen, MM; Nothnagel, M; Ellinghaus, D; Huse, K; Franke, A; Zopf, S; Hellerbrand, C; Moreno, C; Franchimont, D; Morgan, MY; Hampe, J				Buch, Stephan; Stickel, Felix; Trepo, Eric; Way, Michael; Herrmann, Alexander; Nischalke, Hans Dieter; Brosch, Mario; Rosendahl, Jonas; Berg, Thomas; Ridinger, Monika; Rietschel, Marcella; McQuillin, Andrew; Frank, Josef; Kiefer, Falk; Schreiber, Stefan; Lieb, Wolfgang; Soyka, Michael; Semmo, Nasser; Aigner, Elmar; Datz, Christian; Schmelz, Renate; Brueckner, Stefan; Zeissig, Sebastian; Stephan, Anna-Magdalena; Wodarz, Norbert; Deviere, Jacques; Clumeck, Nicolas; Sarrazin, Christoph; Lammert, Frank; Gustot, Thierry; Deltenre, Pierre; Voelzke, Henry; Lerch, Markus M.; Mayerle, Julia; Eyer, Florian; Schafmayer, Clemens; Cichon, Sven; Noethen, Markus M.; Nothnagel, Michael; Ellinghaus, David; Huse, Klaus; Franke, Andre; Zopf, Steffen; Hellerbrand, Claus; Moreno, Christophe; Franchimont, Denis; Morgan, Marsha Y.; Hampe, Jochen			A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis	NATURE GENETICS			English	Article							FATTY LIVER-DISEASE; GENETIC PREDISPOSITION; CONFERS SUSCEPTIBILITY; END-POINTS; DEPENDENCE; FIBROSIS; PROGRESSION; VARIANT; TRANSPLANTATION; POLYMORPHISM	Alcohol misuse is the leading cause of cirrhosis and the second most common indication for liver transplantation in the Western world(1-3). We performed a genome-wide association study for alcohol-related cirrhosis in individuals of European descent (712 cases and 1,426 controls) with subsequent validation in two independent European cohorts (1,148 cases and 922 controls). We identified variants in the MBOAT7 (P = 1.03 x 10(-9)) and TM6SF2 (P = 7.89 x 10(-10)) genes as new risk loci and confirmed rs738409 in PNPLA3 as an important risk locus for alcohol-related cirrhosis (P = 1.54 x 10(-48)) at a genome-wide level of significance. These three loci have a role in lipid processing, suggesting that lipid turnover is important in the pathogenesis of alcohol-related cirrhosis.	[Buch, Stephan; Herrmann, Alexander; Brosch, Mario; Schmelz, Renate; Brueckner, Stefan; Zeissig, Sebastian; Stephan, Anna-Magdalena; Hampe, Jochen] Tech Univ Dresden, Univ Hosp Dresden, Dept Med 1, Dresden, Germany; [Stickel, Felix] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Trepo, Eric; Deviere, Jacques; Gustot, Thierry; Deltenre, Pierre; Moreno, Christophe; Franchimont, Denis] Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium; [Trepo, Eric; Deviere, Jacques; Gustot, Thierry; Moreno, Christophe; Franchimont, Denis] Univ Libre Bruxelles, Lab Expt Gastroenterol, Brussels, Belgium; [Way, Michael; Morgan, Marsha Y.] UCL, UCL Inst Liver & Digest Hlth, Div Med, London, England; [Way, Michael; McQuillin, Andrew] UCL, Div Psychiat, Mol Psychiat Lab, London, England; [Nischalke, Hans Dieter] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Rosendahl, Jonas; Berg, Thomas] Univ Hosp Leipzig, Sect Hepatol, Leipzig, Germany; [Ridinger, Monika; Wodarz, Norbert] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Ridinger, Monika] Psychiat Dienste Aargau, Psychiat Hlth Care Aargau, Windisch, Switzerland; [Rietschel, Marcella; Frank, Josef; Kiefer, Falk] Heidelberg Univ, Fac Med Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Biobank PopGen, Kiel, Germany; [Soyka, Michael] Univ Munich, Hosp Psychiat, D-80539 Munich, Germany; [Semmo, Nasser] Inselspital Bern, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland; [Aigner, Elmar; Datz, Christian] Salzburg Univ, Teaching Hosp Paracelsus Private, Hosp Oberndorf, Dept Internal Med, A-5020 Salzburg, Austria; [Clumeck, Nicolas] Univ Libre Bruxelles, Ctr Hosp Le Domaine, Braine Lalleud, Belgium; [Sarrazin, Christoph] Univ Hosp Frankfurt, Dept Gastroenterol, Frankfurt, Germany; [Lammert, Frank] Saarland Univ Hosp, Dept Med 2, Homburg, Germany; [Deltenre, Pierre] Hop Jolimont, Serv Hepatogastroenterol, Haine St Paul, Belgium; [Deltenre, Pierre] Univ Lausanne, CHU Vaudois, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Lerch, Markus M.; Mayerle, Julia] Univ Med Greifswald, Dept Internal Med A, Greifswald, Germany; [Eyer, Florian] Tech Univ Munich, Klinikum Rechts Isar, Dept Clin Toxicol, D-80290 Munich, Germany; [Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, Kiel, Germany; [Cichon, Sven] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Ellinghaus, David; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Huse, Klaus] Fritz Lipmann Inst Age Res FLI, Jena, Germany; [Zopf, Steffen] Univ Hosp Erlangen, Dept Internal Med 1, Erlangen, Germany; [Hellerbrand, Claus] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany		Stickel, F (corresponding author), Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	felix.stickel@ikp.unibe.ch	Nothnagel, Michael/L-7187-2019; Lerch, Markus M./E-2206-2016; Eyer, Florian/S-5801-2019; Ellinghaus, David/ABC-3610-2020; Buch, Stephan/AAV-5028-2021; McQuillin, Andrew/C-1623-2008; Ellinghaus, David/G-4467-2012; Trepo, Eric/ABD-9339-2021; Zeissig, Sebastian/B-6297-2012; Hampe, Jochen/A-2555-2010; Mayerle, Julia/W-7907-2019; Franke, Andre/B-2151-2010; Nothnagel, Michael/G-6545-2014; Lieb, Wolfgang/C-1990-2012	Nothnagel, Michael/0000-0001-8305-7114; Lerch, Markus M./0000-0002-9643-8263; Eyer, Florian/0000-0002-4753-2747; Ellinghaus, David/0000-0002-4332-6110; McQuillin, Andrew/0000-0003-1567-2240; Zeissig, Sebastian/0000-0001-5124-0897; Hampe, Jochen/0000-0002-2421-6127; Franke, Andre/0000-0003-1530-5811; Trepo, Eric/0000-0003-0475-3934; Way, Michael/0000-0001-7750-5857; Gustot, Thierry/0000-0002-5537-9607; Mayerle, Julia/0000-0002-3666-6459; Nothen, Markus/0000-0002-8770-2464; Brosch, Mario/0000-0001-8983-6557; Huse, Klaus/0000-0003-3854-1884; Nischalke, Hans Dieter/0000-0002-3457-0023	German Ministry of Education and Research through the Virtual Liver Network; PopGen 2.0 network biobank [01EY1103]; medical faculties of TU Dresden and Christian Albrechts University Kiel; Swiss National FundsSwiss National Science Foundation (SNSF) [310030_138747]; Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF GANI-MED 03152061A, BMBF 0314107]; European UnionEuropean Commission; EFRE-State Ministry of Economics [V-630-S-150-2012/132/133]; German Federal Ministry of Education and Research (BMBF) through the Integrated Networks IntegraMent and Sysmed AlcoholFederal Ministry of Education & Research (BMBF) [01ZX1314A, 01ZX1311A]; DFG (Deutsche Forschungsgemeinschaft)-funded Excellence Cluster ImmunoSensationGerman Research Foundation (DFG); Deutsche KrebshilfeDeutsche Krebshilfe [107865]; German Federal Ministry of Education and Research (BMBF) within the framework of the e: Med research and funding conceptFederal Ministry of Education & Research (BMBF) [01ZX1306A]; DFG Excellence Cluster, 'Inflammation at Interfaces'German Research Foundation (DFG) [306]; Foundation for Experimental Medicine (Zurich, Switzerland); University College LondonGeneral Electric; Avon and Wiltshire Mental Health Partnership; Lincolnshire Partnership; Belgian Medical Genomics Initiative (BeMGI) - phase VII Interuniversity Attraction Poles (IAP) program of the Belgian Federal Science Policy Office (BELSPO); Fund for Scientific Research-FNRS (F.R.S.-FNRS)Fonds de la Recherche Scientifique - FNRS	This study was supported by the German Ministry of Education and Research through the Virtual Liver Network (to J.H.), the PopGen 2.0 network biobank (grant 01EY1103) and institutional funds from the medical faculties of TU Dresden and Christian Albrechts University Kiel and by Swiss National Funds (grant 310030_138747 to F.S.). The Community Medicine Research network of the University of Greifswald, Germany, is funded by the Federal Ministry of Education and Research, the Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. M.M.L. and J.M. were supported by the Federal Ministry of Education and Research (BMBF GANI-MED 03152061A and BMBF 0314107), the European Union (EU-FP-7: EPC-TM and EU-FP-7-REGPOT-2010-1) and the EFRE-State Ministry of Economics (V-630-S-150-2012/132/133). S.C., M.M.N. and M. Rietschel were supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Networks IntegraMent and Sysmed Alcohol under the auspices of the e: Med Programme (grant 01ZX1314A to M.M.N. and S.C. and grant 01ZX1311A to M.M.N. and M. Rietschel). M.M.N. is a member of the DFG (Deutsche Forschungsgemeinschaft)-funded Excellence Cluster ImmunoSensation. Research by H.D.N. related to this project was funded by the Deutsche Krebshilfe (107865). The work of A.F. and D.E. was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e: Med research and funding concept (SysInflame grant 01ZX1306A). This project received infrastructure support from DFG Excellence Cluster 306, 'Inflammation at Interfaces'. A.F. receives an endowment professorship from the Foundation for Experimental Medicine (Zurich, Switzerland). The UK research effort was funded by a PhD studentship award jointly funded by University College London and an anonymous donor. We thank colleagues from the following centers for obtaining samples from alcohol-dependent cases for genotyping: the Bexley Substance Misuse Service, South London and Maudsley National Health Service (NHS) Trust; the East Hertfordshire Community Drug Action Team; the Max Glatt Unit, Southall; Renfrew and Inverclyde Alcohol Services, Strathclyde; the Newcastle North Tyneside Drug and Alcohol Service, Tyne and Wear; and the Acute Admissions Unit and the Centre for Hepatology at the Royal Free Hospital, London. We also thank colleagues associated with the National Institute for Health Research (NIHR) Mental Health Research Network for their assistance in identifying cases, obtaining consent and collecting samples at the following NHS trusts: Sandwell Mental Health and Social Care; Northamptonshire Healthcare; Avon and Wiltshire Mental Health Partnership, Sheffield Health and Social Care; Tees Esk and Wear Valleys; Lincolnshire Partnership; Nottinghamshire Healthcare; Central and North West London; South Staffordshire and Shropshire Healthcare; Coventry and Warwickshire; and Dudley and Walsall Mental Health Partnership. We are grateful to J. Saini, K. Ruparelia, S. Montagnese, R. Kandaswamy, A. Jarram, G. Quadri and N. O'Brien for assisting with the collection and processing of samples and DNA extraction.; The Belgian research effort was supported by the Belgian Medical Genomics Initiative (BeMGI) funded by the phase VII Interuniversity Attraction Poles (IAP) program of the Belgian Federal Science Policy Office (BELSPO) and the Fund for Scientific Research-FNRS (F.R.S.-FNRS). E.T. is a Postdoctoral Researcher of the F.R.S.-FNRS, and D.F. is a Research Director of the F.R.S.-FNRS. We are grateful to O. Lemoine, D. Degre, A. Lemmers and M. Amrani for identifying cases and controls, obtaining consent and collecting samples at CUB Hopital Erasme, Universite Libre de Bruxelles. We also thank E. Quertinmont at the Laboratory of Experimental Gastroenterology, Universite Libre de Bruxelles, for his help with the collection and processing of samples and DNA extraction.	Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; Burra P, 2010, AM J TRANSPLANT, V10, P138, DOI 10.1111/j.1600-6143.2009.02869.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chamorro AJ, 2014, ALIMENT PHARM THER, V40, P571, DOI 10.1111/apt.12890; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Dongiovanni P, 2015, HEPATOLOGY, V61, P506, DOI 10.1002/hep.27490; Edenberg HJ, 2013, NAT REV GASTRO HEPAT, V10, P487, DOI 10.1038/nrgastro.2013.86; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Han SZ, 2013, AM J HUM GENET, V93, P1027, DOI 10.1016/j.ajhg.2013.10.021; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; HRUBEC Z, 1981, ALCOHOL CLIN EXP RES, V5, P207, DOI 10.1111/j.1530-0277.1981.tb04890.x; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; ISHAK KG, 1991, ALCOHOL CLIN EXP RES, V15, P45, DOI 10.1111/j.1530-0277.1991.tb00518.x; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Liu YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5309; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; Nischalke HD, 2014, J HEPATOL, V61, P1073, DOI 10.1016/j.jhep.2014.06.006; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Patsenker E, 2011, MOL MED, V17, P1285, DOI 10.2119/molmed.2011.00149; Pirazzi C, 2014, HUM MOL GENET, V23, P4077, DOI 10.1093/hmg/ddu121; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Reed T, 1996, ALCOHOL CLIN EXP RES, V20, P1528, DOI 10.1111/j.1530-0277.1996.tb01695.x; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Roshyara NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097589; Salameh H, 2015, AM J GASTROENTEROL, V110, P846, DOI 10.1038/ajg.2015.137; Sinnott JA, 2012, HUM GENET, V131, P111, DOI 10.1007/s00439-011-1054-1; Smagris E, 2015, HEPATOLOGY, V61, P108, DOI 10.1002/hep.27242; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Tamura S, 2012, NEW ENGL J MED, V366, P477, DOI 10.1056/NEJMc1114241; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2013, J HEPATOL, V59, P344, DOI 10.1016/j.jhep.2013.03.024; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Vanlemmens C, 2009, ANN INTERN MED, V150, P153, DOI 10.7326/0003-4819-150-3-200902030-00004; Way M, 2015, ADDICT BIOL, V20, P594, DOI 10.1111/adb.12141; Yamashita A, 2003, J BIOL CHEM, V278, P30382, DOI 10.1074/jbc.M303391200; Zintzaras E, 2006, HEPATOLOGY, V43, P352, DOI 10.1002/hep.21023	49	263	272	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1443	+		10.1038/ng.3417			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	WOS:000365813200016	26482880	Green Accepted			2022-01-24	
J	Witkowski, L; Carrot-Zhang, J; Albrecht, S; Fahiminiya, S; Hamel, N; Tomiak, E; Grynspan, D; Saloustros, E; Nadaf', J; Rivera, B; Gilpin, C; Castellsague, E; Silva-Smith, R; Plourde, F; Wu, M; Saskin, A; Arseneault, M; Karabakhtsian, RG; Reilly, EA; Ueland, FR; Margiolaki, A; Pavlakis, K; Castellino, SM; Lamovec, J; Mackay, HJ; Roth, LM; Ulbright, TM; Bender, TA; Georgoulias, V; Longy, M; Berchuck, A; Tischkowitz, M; Nage, I; Siebert, R; Stewart, CJR; Arseneau, J; McCluggage, WG; Clarke, BA; Riazalhosseini', Y; Hasselblatt, M; Majewski, J; Foulkes, WD				Witkowski, Leora; Carrot-Zhang, Jian; Albrecht, Steffen; Fahiminiya, Somayyeh; Hamel, Nancy; Tomiak, Eva; Grynspan, David; Saloustros, Emmanouil; Nadaf', Javad; Rivera, Barbara; Gilpin, Catherine; Castellsague, Ester; Silva-Smith, Rachel; Plourde, Francois; Wu, Mona; Saskin, Avi; Arseneault, Madeleine; Karabakhtsian, Rouzan G.; Reilly, Elizabeth A.; Ueland, Frederick R.; Margiolaki, Anna; Pavlakis, Kitty; Castellino, Sharon M.; Lamovec, Janez; Mackay, Helen J.; Roth, Lawrence M.; Ulbright, Thomas M.; Bender, Tracey A.; Georgoulias, Vassilis; Longy, Michel; Berchuck, Andrew; Tischkowitz, Marc; Nage, Inga; Siebert, Reiner; Stewart, Colin J. R.; Arseneau, Jocelyne; McCluggage, W. Glenn; Clarke, Blaise A.; Riazalhosseini, Yasser; Hasselblatt, Martin; Majewski, Jacek; Foulkes, William D.			Germ line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type	NATURE GENETICS			English	Article							BRG1; EXPRESSION; CANCERS; COMPLEXES; NEOPLASMS; GENOME; TUMORS; EXOME; GENE	Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is the most common undifferentiated ovarian malignancy in women under 40 years of age(1). We sequenced the exomes of six individuals from three families with SCCOHT. After discovering segregating deleterious germline mutations in SMARCA4 in all three families, we tested DNA from a fourth affected family, which also carried a segregating SMARCA4 germline mutation. All the familial tumors sequenced harbored either a somatic mutation or loss of the wild-type allele. Immunohistochemical analysis of these cases and additional familial and non-familial cases showed loss of SMARCA4 (BRG1) protein in 38 of 40 tumors overall. Sequencing of cases with available DNA identified at least one germline or somatic deleterious SMARCA4 mutation in 30 01 32 cases. Additionally, the SCCOHT cell line BIN-67 had biallelic deleterious mutations in SMARCA4. Our findings identify alterations in SMARCA4 as the major cause of SCCOHT, which could lead to improvements in genetic counseling and new treatment approaches.	[Witkowski, Leora; Hamel, Nancy; Gilpin, Catherine; Castellsague, Ester; Silva-Smith, Rachel; Plourde, Francois; Wu, Mona; Foulkes, William D.] McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Witkowski, Leora; Silva-Smith, Rachel; Plourde, Francois; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Dept Med Genet, Montreal, PQ, Canada; [Witkowski, Leora; Silva-Smith, Rachel; Plourde, Francois; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada; [Witkowski, Leora; Carrot-Zhang, Jian; Fahiminiya, Somayyeh; Rivera, Barbara; Castellsague, Ester; Wu, Mona; Saskin, Avi; Arseneault, Madeleine; Majewski, Jacek; Foulkes, William D.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Carrot-Zhang, Jian; Fahiminiya, Somayyeh; Nadaf', Javad; Arseneault, Madeleine; Riazalhosseini, Yasser; Majewski, Jacek] McGill Univ, Montreal, PQ, Canada; [Carrot-Zhang, Jian; Fahiminiya, Somayyeh; Nadaf', Javad; Arseneault, Madeleine; Riazalhosseini, Yasser; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Albrecht, Steffen] McGill Univ, Montreal Childrens Hosp, McGill Univ Hlth Ctr, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Dept Med Genet, Montreal, PQ H3H 1P3, Canada; [Tomiak, Eva; Gilpin, Catherine] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON, Canada; [Grynspan, David] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Saloustros, Emmanouil; Margiolaki, Anna; Georgoulias, Vassilis] Univ Hosp Heraklion, Dept Med Oncol, Hereditary Canc Clin, Iraklion, Greece; [Karabakhtsian, Rouzan G.; Reilly, Elizabeth A.; Ueland, Frederick R.] Univ Kentucky, Markey Canc Ctr, Dept Pathol & Lab Med, Lexington, KY USA; [Pavlakis, Kitty] Univ Athens, Dept Pathol, Athens 11528, Greece; [Castellino, Sharon M.] Wake Forest Sch Med, Dept Pediat Hematol Oncol, Winston Salem, NC USA; [Lamovec, Janez] Inst Oncol, Dept Pathol, Ljubljana, Slovenia; [Mackay, Helen J.] Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada; [Roth, Lawrence M.; Ulbright, Thomas M.; Bender, Tracey A.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Longy, Michel] Inst Bergonie, Unite Oncogenet, Bordeaux, France; [Berchuck, Andrew] Duke Univ, Med Ctr, Div Gynecol Oncol, Durham, NC USA; [Tischkowitz, Marc] Univ Cambridge, Dept Med Genet, Cambridge, England; [Nage, Inga; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Nage, Inga; Siebert, Reiner] Univ Hosp Schleswig Holstein, Kiel, Germany; [Stewart, Colin J. R.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Arseneau, Jocelyne] McGill Univ, Royal Victoria Hosp, McGill Univ Hlth Ctr, Dept Pathol, Montreal, PQ H3A 1A1, Canada; [McCluggage, W. Glenn] Royal Grp Hosp Trust, Dept Pathol, Belfast, Antrim, North Ireland; [Clarke, Blaise A.] Univ Hlth Network, Dept Pathol Lab Med Program, Toronto, ON, Canada; [Hasselblatt, Martin] Univ Hosp Munster, Inst Neuropathol, Munster, Germany		Foulkes, WD (corresponding author), McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada.	william.foulkes@mcgill.ca	Castellsague, Ester/R-1676-2016; Hamel, Nancy/L-5122-2016; Rivera, Barbara/AAI-8047-2020; Siebert, Reiner/A-8049-2010; Tischkowitz, Marc/O-4452-2018; Foulkes, William D./AAR-9586-2021; Saloustros, Emmanouil/AAC-8235-2020; Carrot-Zhang, Jian/K-8618-2019	Castellsague, Ester/0000-0003-1298-9971; Hamel, Nancy/0000-0001-8971-0428; Rivera, Barbara/0000-0001-9434-6288; Tischkowitz, Marc/0000-0002-7880-0628; Foulkes, William D./0000-0001-7427-4651; Saloustros, Emmanouil/0000-0002-0485-0120; Clarke, Blaise/0000-0002-2585-8391; Hasselblatt, Martin/0000-0003-2707-8484	Jewish General Hospital Foundation; Jodi Taiger Lazarus Fund; Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec; KinderKrebsInitiative Buchholz/Holm-Seppensen; Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Munster [Ha3/016/11]	This work is dedicated to the memory of Georgia Enter and Latosha Durham. We thank K. Hill and the Small Cell Ovarian Cancer Foundation for help in recruitment to this study, B. Vanderhyden (University of Ottawa) for providing the BIN-67 cells, S. Croce and CS. Choong for aiding in the collection of pathological samples, P.-O. Fiset for help with immunohistochemistry and N. Benlimame, R. Zuhlke-Jenisch, C. Kemming, M. LeiBe, S. Peetz-Dienhart, L. Raestrup, K. Schmidt and C. Theile for technical assistance. N. Jabado, I. Bah and members of the Foulkes laboratory provided helpful discussions. We also thank the McGill University and Genome Quebec Innovation Centre for their cooperation, H. Pierce for her help with contacting family 1 and D. Samelak for her help with family 3. Equipment for immunohistochemistry analysis was made available through Sonderforschungsbereich Transregio (SFB TR) 128 (grant to T. Kuhlmann (Z1)). We received funding from the Jewish General Hospital Foundation and the Jodi Taiger Lazarus Fund (W.D.F.), the Fonds de Recherche du Quebec-Sante (LW), KinderKrebsInitiative Buchholz/Holm-Seppensen (R.S.) and Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Munster (Ha3/016/11) (M.H.).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brennan B, 2013, LANCET ONCOL, V14, pE329, DOI 10.1016/S1470-2045(13)70088-3; Clement PB, 2005, MODERN PATHOL, V18, pS113, DOI 10.1038/modpathol.3800313; Distelmaier F, 2006, CANCER, V107, P2298, DOI 10.1002/cncr.22213; EICHHORN JH, 1992, AM J SURG PATHOL, V16, P926, DOI 10.1097/00000478-199210000-00002; Estel R, 2011, ARCH GYNECOL OBSTET, V284, P1277, DOI 10.1007/s00404-011-1846-5; Gunduz E, 2005, INT J ONCOL, V26, P201; Hasselblatt M, 2011, AM J SURG PATHOL, V35, P933, DOI 10.1097/PAS.0b013e3182196a39; Holley T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050586; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kosho T, 2013, AM J MED GENET A, V161A, P1221, DOI 10.1002/ajmg.a.35933; Kupryjanczyk J, 2013, POL J PATHOL, V64, P238, DOI 10.5114/PJP.2013.39331; LAMOVEC J, 1995, ARCH PATHOL LAB MED, V119, P523; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Longy M, 1996, J MED GENET, V33, P333, DOI 10.1136/jmg.33.4.333; Martinez-Borges AR, 2009, PEDIATR BLOOD CANCER, V53, P1334, DOI 10.1002/pbc.22184; Matsubara D, 2013, CANCER SCI, V104, P266, DOI 10.1111/cas.12065; McCluggage WG, 2004, ADV ANAT PATHOL, V11, P288, DOI 10.1097/01.pap.0000138146.357376.1e; McCluggage WG, 2004, INT J GYNECOL PATHOL, V23, P330, DOI 10.1097/01.pgp.0000139644.38835.9d; McDonald JM, 2012, J PEDIATR SURG, V47, P588, DOI 10.1016/j.jpedsurg.2011.12.004; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; PECCATORI F, 1993, GYNECOL ONCOL, V49, P95, DOI 10.1006/gyno.1993.1093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; SCULLY RE, 1987, ENVIRON HEALTH PERSP, V73, P15, DOI 10.2307/3430594; Scully RE, 1979, ATLAS TUMOR PATHOLOG; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Smith MJ, 2013, NAT GENET, V45, P295, DOI 10.1038/ng.2552; Smith MJ, 2012, NEUROGENETICS, V13, P141, DOI 10.1007/s10048-012-0319-8; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; ULBRIGHT TM, 1987, HUM PATHOL, V18, P175, DOI 10.1016/S0046-8177(87)80336-2; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Witkowski L, 2013, J PATHOL, V231, P35, DOI 10.1002/path.4225; Wong AKC, 2000, CANCER RES, V60, P6171; YOUNG RH, 1994, AM J SURG PATHOL, V18, P1102, DOI 10.1097/00000478-199411000-00004	38	263	272	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					438	443		10.1038/ng.2931			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	WOS:000335422900008	24658002				2022-01-24	
J	Li, MX; Gui, HS; Kwan, JSH; Sham, PC				Li, Miao-Xin; Gui, Hong-Sheng; Kwan, Johnny S. H.; Sham, Pak C.			GATES: A Rapid and Powerful Gene-Based Association Test Using Extended Simes Procedure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; COMPLEX TRAITS; SUSCEPTIBILITY; METAANALYSIS; INTERACTOME; HAPLOTYPE; VARIANTS; NETWORK; LOCI	The gene has been proposed as an attractive unit of analysis for association studies, but a simple yet valid, powerful, and sufficiently fast method of evaluating the statistical significance of all genes in large, genome-wide datasets has been lacking. Here we propose the use of an extended Simes test that integrates functional information and association evidence to combine the p values of the single nucleotide polymorphisms within a gene to obtain an overall p value for the association of the entire gene. Our computer simulations demonstrate that this test is more powerful than the SNP-based test, offers effective control of the type 1 error rate regardless of gene size and linkage-disequilibrium pattern among markers, and does not need permutation or simulation to evaluate empirical significance. Its statistical power in simulated data is at least comparable, and often superior, to that of several alternative gene-based tests. When applied to real genome-wide association study (GWAS) datasets on Crohn disease, the test detected more significant genes than SNP-based tests and alternative gene-based tests. The proposed test, implemented in an open-source package, has the potential to identify additional novel disease-susceptibility genes for complex diseases from large GWAS datasets.	[Li, Miao-Xin; Gui, Hong-Sheng; Kwan, Johnny S. H.; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [Li, Miao-Xin; Gui, Hong-Sheng; Kwan, Johnny S. H.; Sham, Pak C.] Univ Hong Kong, State Key Lab Cognit & Brain Sci, Pokfulam, Hong Kong, Peoples R China; [Li, Miao-Xin; Sham, Pak C.] Univ Hong Kong, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; [Li, Miao-Xin; Sham, Pak C.] Univ Hong Kong, Genome Res Ctr, Pokfulam, Hong Kong, Peoples R China		Sham, PC (corresponding author), Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China.	pcsham@hkucc.hku.hk	Gui, Hongsheng/D-1063-2013; Li, Miaoxin/B-7079-2013	Gui, Hongsheng/0000-0002-0460-7446; 	Hong Kong Research Grants CouncilHong Kong Research Grants Council [GRF HKU 774707]; European CommunityEuropean Commission [HEALTH-F2-2009-241909]; University of Hong Kong Strategic Research Theme on Genomics;  [HKU 201007176166]	We are grateful to Mark J. Daly for sharing data on CD.<SUP>30</SUP> This work was funded by Hong Kong Research Grants Council GRF HKU 774707, the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI), the Small Project Funding HKU 201007176166, and The University of Hong Kong Strategic Research Theme on Genomics. We also thank two anonymous reviewers for their useful comments, which improved this paper significantly.	Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; CURTIS D, 2008, ADV APPL BIOINFORMAT, P1; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Fisher R.A., 1954, STAT METHODS RES WOR, V20th ed; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Galwey NW, 2009, GENET EPIDEMIOL, V33, P559, DOI 10.1002/gepi.20408; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HOLM S, 1979, SCAND J STAT, V6, P65; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Kakuta Y, 2009, HUM MOL GENET, V18, P1089, DOI 10.1093/hmg/ddp005; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Latiano A, 2010, INFLAMM BOWEL DIS, V16, P1108, DOI 10.1002/ibd.21176; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marquez A, 2009, GENES IMMUN, V10, P631, DOI 10.1038/gene.2009.56; McCabe ERB, 2002, LANCET, V359, P1169, DOI 10.1016/S0140-6736(02)08249-1; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Michelsen KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004719; Montana G, 2005, BIOINFORMATICS, V21, P4309, DOI 10.1093/bioinformatics/bti689; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Nakagome S, 2010, ANN HUM GENET, V74, P126, DOI 10.1111/j.1469-1809.2010.00567.x; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RISCH N, 1990, AM J HUM GENET, V46, P222; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang H., 2009, BMC P, V3, pS135; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zintzaras E, 2008, J HUM GENET, V53, P1, DOI 10.1007/s10038-007-0223-5	52	263	266	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					283	293		10.1016/j.ajhg.2011.01.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	WOS:000288589000006	21397060	Green Published, Bronze			2022-01-24	
J	Li, M; Atmaca-Sonmez, P; Othman, M; Branham, KEH; Khanna, R; Wade, MS; Li, Y; Liang, LM; Zareparsi, S; Swaroop, A; Abecasis, GR				Li, Mingyao; Atmaca-Sonmez, Pelin; Othman, Mohammad; Branham, Kari E. H.; Khanna, Ritu; Wade, Michael S.; Li, Yun; Liang, Liming; Zareparsi, Sepideh; Swaroop, Anand; Abecasis, Goncalo R.			CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; LINKAGE DISEQUILIBRIUM; RISK-FACTORS; GENOME SCAN; MACULOPATHY; POLYMORPHISM; DISEASE; LOC387715; SMOKING; TRAITS	In developed countries, age-related macular degeneration is a common cause of blindness in the elderly. A common polymorphism, encoding the sequence variation Y402H in complement factor H (CFH), has been strongly associated with disease susceptibility. Here, we examined 84 polymorphisms in and around CFH in 726 affected individuals (including 544 unrelated individuals) and 268 unrelated controls. In this sample, 20 of these polymorphisms showed stronger association with disease susceptibility than the Y402H variant. Further, no single polymorphism could account for the contribution of the CFH locus to disease susceptibility. Instead, multiple polymorphisms defined a set of four common haplotypes (of which two were associated with disease susceptibility and two seemed to be protective) and multiple rare haplotypes (associated with increased susceptibility in aggregate). Our results suggest that there are multiple disease susceptibility alleles in the region and that noncoding CFH variants play a role in disease susceptibility.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA		Abecasis, GR (corresponding author), Univ Michigan, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	swaroop@umich.edu; goncalo@umich.edu	Abecasis, Goncalo R/B-7840-2010; Branham, Kari/AAA-8336-2022	Branham, Kari/0000-0002-2492-254X; Swaroop, Anand/0000-0002-1975-1141; Abecasis, Goncalo/0000-0003-1509-1825	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01 EY016862-01A1] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY016862] Funding Source: NIH RePORTER		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Abecasis GR, 2001, AM J HUM GENET, V69, P198; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hirvela H, 1996, OPHTHALMOLOGY, V103, P871, DOI 10.1016/S0161-6420(96)30593-9; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein R, 2002, AM J EPIDEMIOL, V156, P589, DOI 10.1093/aje/kwf092; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Li N, 2003, GENETICS, V165, P2213; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; RISCH N, 1990, AM J HUM GENET, V46, P222; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Valdes AM, 1997, AM J HUM GENET, V60, P703; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	30	263	268	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1049	1054		10.1038/ng1871			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	WOS:000240112100023	16936733	Green Accepted, Green Submitted			2022-01-24	
J	Oh, SW; Mukhopadhyay, A; Dixit, BL; Raha, T; Green, MR; Tissenbaum, HA				Oh, SW; Mukhopadhyay, A; Dixit, BL; Raha, T; Green, MR; Tissenbaum, HA			Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation	NATURE GENETICS			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; REGULATES LIFE-SPAN; C-ELEGANS; SIGNALING PATHWAY; OXIDATIVE STRESS; PROTEIN DAF-16; GENES; MUTANTS; SCREEN; FAMILY	DAF-16, a forkhead transcription factor, is a key regulator of longevity, metabolism and dauer diapause in Caenorhabditis elegans. The precise mechanism by which DAF-16 regulates multiple functions, however, is poorly understood. Here, we used chromatin immunoprecipitation (ChIP) to identify direct targets of DAF-16. We cloned 103 target sequences containing consensus DAF-16 binding sites and selected 33 targets for further analysis. Expression of most of these genes is regulated in a DAF-16-dependent manner, and inactivation of more than half of these genes significantly altered DAF-16-dependent functions, including life span, fat storage and dauer formation. Our results show that the ChIP-based cloning strategy leads to greater enrichment for DAF-16 target genes than previous screening strategies. We also demonstrate that DAF-16 is recruited to multiple promoters to coordinate regulation of its downstream targets. The large number of target genes discovered provides insight into how DAF-16 controls diverse biological functions.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA		Tissenbaum, HA (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	heidi.tissenbaum@umassmed.edu	Mukhopadhyay, Arnab/N-6005-2016	Mukhopadhyay, Arnab/0000-0002-5266-7849			Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; CONTE D, 2003, CURRENT PROTOCOLS MO; de Belle I, 2003, J BIOL CHEM, V278, P14306, DOI 10.1074/jbc.M210502200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GOTTLIEB S, 1994, GENETICS, V137, P107; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOSONO R, 1982, EXP GERONTOL, V17, P163, DOI 10.1016/0531-5565(82)90052-3; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MALONE EA, 1994, GENETICS, V136, P879; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Oka T, 1998, J BIOL CHEM, V273, P22570, DOI 10.1074/jbc.273.35.22570; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Weinmann AS, 2004, NAT REV IMMUNOL, V4, P381, DOI 10.1038/nri1353; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3	30	263	296	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2006	38	2					251	257		10.1038/ng1723			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	WOS:000234953200024	16380712				2022-01-24	
J	Ono, R; Nakamura, K; Inoue, K; Naruse, M; Usami, T; Wakisaka-Saito, N; Hino, T; Suzuki-Migishima, R; Ogonuki, N; Miki, H; Kohda, T; Ogura, A; Yokoyama, M; Kaneko-Ishino, T; Ishino, F				Ono, R; Nakamura, K; Inoue, K; Naruse, M; Usami, T; Wakisaka-Saito, N; Hino, T; Suzuki-Migishima, R; Ogonuki, N; Miki, H; Kohda, T; Ogura, A; Yokoyama, M; Kaneko-Ishino, T; Ishino, F			Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENTS; MAMMALIAN GENOMES; RETROVIRAL GAG; IDENTIFICATION; EVOLUTION; ORIGIN; SYNCYTIN; FAMILY; GROWTH; MICE	By comparing mammalian genomes, we and others have identified actively transcribed Ty3/gypsy retrotransposon-derived genes with highly conserved DNA sequences and insertion sites(1-6). To elucidate the functions of evolutionarily conserved retrotransposon-derived genes in mammalian development, we produced mice that lack one of these genes, Peg10 ( paternally expressed 10)(1-3,7), which is a paternally expressed imprinted gene on mouse proximal chromosome 6. The Peg10 knockout mice showed early embryonic lethality owing to defects in the placenta. This indicates that Peg10 is critical for mouse parthenogenetic development and provides the first direct evidence of an essential role of an evolutionarily conserved retrotransposon-derived gene in mammalian development.	Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320011, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Chiyoda Ku, Tokyo 1010062, Japan; Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; RIKEN, BioResouce Ctr, Tsukuba, Ibaraki 3050074, Japan; Tokyo Med & Dent Univ, Med Res Inst, Fac Recombinant Mice, Chiyoda Ku, Tokyo 1010062, Japan; Tokyo Inst Technol, Ctr Biol Resources & Informat, Div Gene Res, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Tokai Univ, Sch Hlth Sci, Kanagawa 2591193, Japan		Kaneko-Ishino, T (corresponding author), Japan Sci & Technol Agcy, CREST, 4-1-8 Hon Machi, Kawaguchi, Saitama 3320011, Japan.	tkanekoi@is.icc.u-tokai.ac.jp; fishino.epgn@mri.tmd.ac.jp	Ogura, Atsuo/J-3916-2014; Kohda, Takashi/C-2879-2014	Ogura, Atsuo/0000-0003-0447-1988; Kohda, Takashi/0000-0002-6856-5601			Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; BEECHEY C, 2003, MOUSE IMPRINTING DAT; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; Butler M, 2001, J MOL EVOL, V52, P260, DOI 10.1007/s002390010154; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Nagasaki K, 1999, CANCER LETT, V140, P227, DOI 10.1016/S0304-3835(99)00087-7; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Okabe H, 2003, CANCER RES, V63, P3043; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Poulter R, 1998, GENE, V215, P241, DOI 10.1016/S0378-1119(98)00296-0; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; STURM KS, 1994, DEV DYNAM, V201, P11, DOI 10.1002/aja.1002010103; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TOH H, 1985, NATURE, V318, P388, DOI 10.1038/318388a0; Tsou AP, 2003, J BIOMED SCI, V10, P625, DOI 10.1159/000073528; Volff JN, 2001, MOL BIOL EVOL, V18, P266, DOI 10.1093/oxfordjournals.molbev.a003801	30	263	281	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					101	106		10.1038/ng1699			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	WOS:000234227200024	16341224				2022-01-24	
J	Dumitrescu, AM; Liao, XH; Abdullah, MSY; Lado-Abeal, J; Majed, FA; Moeller, LC; Boran, G; Schomburg, L; Weiss, RE; Refetoff, S				Dumitrescu, AM; Liao, XH; Abdullah, MSY; Lado-Abeal, J; Majed, FA; Moeller, LC; Boran, G; Schomburg, L; Weiss, RE; Refetoff, S			Mutations in SECISBP2 result in abnormal thyroid hormone metabolism	NATURE GENETICS			English	Article							SELENOCYSTEINE TRANSFER-RNA; 5'-DEIODINASE ACTIVITY; TARGETED DISRUPTION; SELENOPROTEIN-P; GENE TRSP; SELENIUM; EXPRESSION; MICE; TRANSPORTER; THYROXINE	Incorporation of selenocysteine (Sec), through recoding of the UGA stop codon, creates a unique class of proteins. Mice lacking tRNA(Sec) die in utero(1), but the in vivo role of other components involved in selenoprotein synthesis is unknown, and Sec incorporation defects have not been described in humans. Deiodinases (DIOs) are selenoproteins involved in thyroid hormone metabolism. We identified three of seven siblings with clinical evidence of abnormal thyroid hormone metabolism. Their fibroblasts showed decreased DIO2 enzymatic activity not linked to the DIO2 locus. Systematic linkage analysis of genes involved in DIO2 synthesis and degradation led to the identification of an inherited Sec incorporation defect, caused by a homozygous missense mutation in SECISBP2 (also called SBP2). An unrelated child with a similar phenotype was compound heterozygous with respect to mutations in SECISBP2. Because SBP2 is epistatic to selenoprotein synthesis, these defects had a generalized effect on selenoproteins. Incomplete loss of SBP2 function probably causes the mild phenotype.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Secur Forces Hosp, Dept Pediat Endocrinol, Riyadh, Saudi Arabia; Prince Abdullah Hosp, Bisha, Saudi Arabia; Adelaide & Meath Hosp, Dept Pathol, Dublin, Ireland; Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA		Refetoff, S (corresponding author), Univ Chicago, Dept Med, MC 3090,5841 S Maryland Ave, Chicago, IL 60637 USA.	refetoff@uchicago.edu	Refetoff, Samuel/ABB-1263-2021; Schomburg, Lutz/D-8096-2013	Refetoff, Samuel/0000-0003-0164-8231; lado-abeal, joaquin/0000-0002-3970-9696; Moeller, Lars/0000-0002-9330-9036; Schomburg, Lutz/0000-0001-9445-1555			BALZANO S, 1990, ENDOCRINOLOGY, V127, P882, DOI 10.1210/endo-127-2-882; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Botero D, 2002, MOL ENDOCRINOL, V16, P1999, DOI 10.1210/me.2002-0135; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Copeland PR, 2003, GENE, V312, P17, DOI 10.1016/S0378-1119(03)00588-2; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Dumitrescu A, 2004, THYROID, V14, P761; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; LEONARD JL, 1988, BIOCHEM BIOPH RES CO, V151, P1164, DOI 10.1016/S0006-291X(88)80488-1; Lescure A, 2002, GENE, V291, P279, DOI 10.1016/S0378-1119(02)00629-7; Moustafa ME, 2003, J NUTR, V133, p2494S, DOI 10.1093/jn/133.7.2494S; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Sachdev SW, 2001, BIOCHEM J, V357, P851; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Schussler GC, 2000, THYROID, V10, P141, DOI 10.1089/thy.2000.10.141; SCHUSSLER GC, 1967, J CLIN ENDOCR METAB, V27, P242, DOI 10.1210/jcem-27-2-242; Schweizer U, 2004, J NUTR, V134, P707, DOI 10.1093/jn/134.4.707	27	263	276	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1247	1252		10.1038/ng1654			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	WOS:000233045200025	16228000				2022-01-24	
J	Jensen, LR; Amende, M; Gurok, U; Moser, B; Gimmel, V; Tzschach, A; Janecke, AR; Tariverdian, G; Chelly, J; Fryns, JP; Van Esch, H; Kleefstra, T; Hamel, B; Moraine, C; Gecz, J; Turner, G; Reinhardt, R; Kalscheuer, VM; Ropers, HH; Lenzner, S				Jensen, LR; Amende, M; Gurok, U; Moser, B; Gimmel, V; Tzschach, A; Janecke, AR; Tariverdian, G; Chelly, J; Fryns, JP; Van Esch, H; Kleefstra, T; Hamel, B; Moraine, C; Gecz, J; Turner, G; Reinhardt, R; Kalscheuer, VM; Ropers, HH; Lenzner, S			Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARID PROTEINS; MOUSE; DECAY; PREVALENCE; CHROMOSOME; EXPRESSION; FREQUENCY; INTERACTS; HOMOLOG; FAMILY	In families with nonsyndromic X-linked mental retardation (NS-XLMR), >30% of mutations seem to cluster on proximal Xp and in the pericentric region. In a systematic screen of brain-expressed genes from this region in 210 families with XLMR, we identified seven different mutations in JARID1C, including one frameshift mutation and two nonsense mutations that introduce premature stop codons, as well as four missense mutations that alter evolutionarily conserved amino acids. In two of these families, expression studies revealed the almost complete absence of the mutated JARID1C transcript, suggesting that the phenotype in these families results from functional loss of the JARID1C protein. JARID1C (Jumonji AT-rich interactive domain 1C), formerly known as "SMCX," is highly similar to the Y-chromosomal gene JARID1D/SMCY, which encodes the H-Y antigen. The JARID1C protein belongs to the highly conserved ARID protein family. It contains several DNA-binding motifs that link it to transcriptional regulation and chromatin remodeling, processes that are defective in various other forms of mental retardation. Our results suggest that JARID1C mutations are a relatively common cause of XLMR and that this gene might play an important role in human brain function.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Innsbruck Med Univ, Dept Med Biol & Human Genet, Innsbruck, Austria; Heidelberg Univ, Inst Human Genet, D-6900 Heidelberg, Germany; CHU Cochin, Inst Cochin Genet Mol, CNRS, INSERM, Paris, France; Catholic Univ Louvain, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; CHU Bretonneau, Serv Genet, INSERM, U316, F-37044 Tours, France; Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Adelaide, Adelaide, SA, Australia; Univ Newcastle, Hunter Genet, Genet Learning Disabil Serv, Newcastle, NSW 2308, Australia		Lenzner, S (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	Lenzner@molgen.mpg.de	Van+Esch, Hilde/AAU-5688-2020; Kleefstra, Tjitske/G-2619-2012; Chelly, Jamel/J-7528-2015; Tzschach, Andreas/I-2648-2019; Gecz, Jozef/X-3469-2019; Janecke, Andreas/AAA-5227-2019	Chelly, Jamel/0000-0002-0939-8719; Tzschach, Andreas/0000-0002-6840-965X; Gecz, Jozef/0000-0002-7884-6861; Janecke, Andreas/0000-0001-7155-0315; Kalscheuer, Vera/0000-0001-6898-3259; Reinhardt, Richard/0000-0001-9376-2132			AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Asselta R, 2001, BLOOD, V98, P3685, DOI 10.1182/blood.V98.13.3685; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Chelly J, 2003, CONTEMPORARY CLIN NE, P263; Claes S, 2000, AM J MED GENET, V94, P1, DOI 10.1002/1096-8628(20000904)94:1<1::AID-AJMG1>3.0.CO;2-V; Delbridge ML, 2004, CHROMOSOME RES, V12, P345, DOI 10.1023/B:CHRO.0000034134.91243.1c; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FATTAEY AR, 1993, ONCOGENE, V8, P3149; FISHBURN J, 1983, AM J MED GENET, V14, P713, DOI 10.1002/ajmg.1320140413; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; Rosenberg EH, 2004, AM J HUM GENET, V75, P97, DOI 10.1086/422102; Sheardown S, 1996, HUM MOL GENET, V5, P1355, DOI 10.1093/hmg/5.9.1355; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	30	263	271	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					227	236		10.1086/427563			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	WOS:000226215100008	15586325	Green Published, Bronze			2022-01-24	
J	Adai, A; Johnson, C; Mlotshwa, S; Archer-Evans, S; Manocha, V; Vance, V; Sundaresan, V				Adai, A; Johnson, C; Mlotshwa, S; Archer-Evans, S; Manocha, V; Vance, V; Sundaresan, V			Computational prediction of miRNAs in Arabidopsis thaliana	GENOME RESEARCH			English	Article							INFORMATION RESOURCE TAIR; MESSENGER-RNA TARGETS; VIRAL SUPPRESSOR; PLANT MICRORNAS; GRASS GENOMICS; AUXIN RESPONSE; GENES; IDENTIFICATION; EXPRESSION; DROSOPHILA	MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression in animals and plants. Comparative genomic computational methods have been developed to predict new miRNAs in worms, flies, and humans. Here, we present a novel single genome approach for the detection of miRNAs in Arabidopsis thaliana. This was initiated by producing a candidate miRNA-target data set using an algorithm called findMiRNA, which predicts potential miRNAs within candidate precursor sequences that have corresponding target sites within transcripts. From this data set, we used a characteristic divergence pattern of miRNA precursor families to select 13 potential new miRNAs for experimental verification, and found that corresponding small RNAs could be detected for at least eight of the candidate miRNAs. Expression of some of these miRNAs appears to be under developmental control. Our results are consistent with the idea that targets of miRNAs encompass a wide range of transcripts, including those for F-box factors, ubiquitin conjugases, Leucine-rich repeat proteins, and metabolic enzymes, and that regulation by miRNAs might be widespread in the genome. The entire set of annotated transcripts in the Arabidopsis genome has been run through findMiRNA to yield a data set that will enable identification of potential miRNAs directed against any target gene.	Univ Calif Davis, Plant Biol Sect, Div Biol Sci, Davis, CA 95616 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA		Sundaresan, V (corresponding author), Univ Calif Davis, Plant Biol Sect, Div Biol Sci, Davis, CA 95616 USA.	sundar@ucdavis.edu					Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergmann A, 2003, TRENDS BIOCHEM SCI, V28, P461, DOI 10.1016/S0968-0004(03)00175-0; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dharmasiri S, 2002, PLANT MOL BIOL, V49, P401, DOI 10.1023/A:1015203013208; DURBIN R, 1998, BIOL SEQUENCE PROBAB; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hipfner DR, 2002, GENETICS, V161, P1527; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Jaiswal P, 2002, COMPAR FUNCT GENOM, V3, P132, DOI 10.1002/cfg.156; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2004, CURR OPIN PLANT BIOL, V7, P120, DOI 10.1016/j.pbi.2004.01.006; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Nicolas FE, 2003, EMBO J, V22, P3983, DOI 10.1093/emboj/cdg384; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rotte C, 2000, PLANT PHYSIOL, V124, P715, DOI 10.1104/pp.124.2.715; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Ware D, 2002, NUCLEIC ACIDS RES, V30, P103, DOI 10.1093/nar/30.1.103; Ware DH, 2002, PLANT PHYSIOL, V130, P1606, DOI 10.1104/pp.015248; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	263	306	1	18	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JAN	2005	15	1					78	91		10.1101/gr.2908205			14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	885QB	WOS:000226170900008	15632092	Bronze, Green Published			2022-01-24	
J	Kim, Y; Nielsen, R				Kim, Y; Nielsen, R			Linkage disequilibrium as a signature of selective sweeps	GENETICS			English	Article							POSITIVE SELECTION; HITCHHIKING; POLYMORPHISM; RECOMBINATION; MUTATIONS; EVOLUTION; FIXATION; REGION	The hitchhiking effect of a beneficial mutation, or a selective sweep, generates a unique distribution of allele frequencies and spatial distribution of polymorphic sites. A composite-likelihood test was previously designed to detect these signatures of a selective sweep, solely on the basis of the spatial distribution and marginal allele frequencies of polymorphisms. As an excess of linkage disequilibrium (LD) is also known to be a strong signature of a selective sweep, we investigate how much statistical power is increased by the inclusion of information regarding LD. The expected pattern of LD is predicted by a genealogical approach. Both theory and simulation suggest that strong LD is generated in narrow regions at both sides of the location of beneficial mutation. However, a lack of LD is expected across the two sides. We explore various ways to detect this signature of selective sweeps by statistical tests. A new composite-likelihood method is proposed to incorporate information regarding LD. This method enables us to detect selective sweeps and estimate the parameters of the selection model better than the previous composite-likelihood method that does not take LD into account. However, the improvement made by including LD is rather small, suggesting that most of the relevant information regarding selective sweeps is captured by the spatial distribution and marginal allele frequencies of polymorphisms.	Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA		Kim, Y (corresponding author), Univ Rochester, Dept Biol, Hutchison Hall, Rochester, NY 14627 USA.	ykim@mail.rochester.edu	Nielsen, Rasmus/D-4405-2009	Nielsen, Rasmus/0000-0003-0513-6591			AGUADE M, 1992, GENETICS, V132, P755; Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Fay JC, 2001, GENETICS, V158, P1227; Fay JC, 2000, GENETICS, V155, P1405; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Hill W. G., 1968, THEOR APPL GENET, V38, P473; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1987, GENETICS, V116, P153; KAPLAN NL, 1989, GENETICS, V123, P887; Kelly JK, 1997, GENETICS, V146, P1197; Kim Y, 2002, GENETICS, V160, P765; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; McVean GAT, 2002, GENETICS, V162, P987; Nielsen R, 2003, MOL BIOL EVOL, V20, P1231, DOI 10.1093/molbev/msg147; Nielsen R, 2000, GENETICS, V154, P931; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Parsch J, 2001, GENETICS, V159, P647; Piganeau G, 2003, P NATL ACAD SCI USA, V100, P10335, DOI 10.1073/pnas.1833064100; Przeworski M, 2003, GENETICS, V164, P1667; Przeworski M, 2002, GENETICS, V160, P1179; Quesada H, 2003, GENETICS, V165, P895; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; STEPHAN W, 1995, MOL BIOL EVOL, V12, P959; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	34	263	269	1	35	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	2004	167	3					1513	1524		10.1534/genetics.103.025387			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	843TL	WOS:000223109300039	15280259	Green Published, Bronze			2022-01-24	
J	Windpassinger, C; Auer-Grumbach, M; Irobi, J; Patel, H; Petek, E; Horl, G; Malli, R; Reed, JA; Dierick, I; Verpoorten, N; Warner, TT; Proukakis, C; Van den Bergh, P; Verellen, C; Van Maldergem, L; Merlini, L; De Jonghe, P; Timmerman, V; Crosby, AH; Wagner, K				Windpassinger, C; Auer-Grumbach, M; Irobi, J; Patel, H; Petek, E; Horl, G; Malli, R; Reed, JA; Dierick, I; Verpoorten, N; Warner, TT; Proukakis, C; Van den Bergh, P; Verellen, C; Van Maldergem, L; Merlini, L; De Jonghe, P; Timmerman, V; Crosby, AH; Wagner, K			Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; CHROMOSOME 11Q12-Q14; AGGRESOME FORMATION; SPASTIC PARAPLEGIA; HETEROGENEITY	Distal hereditary motor neuropathy (dHMN) or distal spinal muscular atrophy (OMIM #182960) is a heterogeneous group of disorders characterized by an almost exclusive degeneration of motor nerve fibers, predominantly in the distal part of the limbs(1). Silver syndrome (OMIM #270685) is a rare form of hereditary spastic paraparesis mapped to chromosome 11q12q14 (SPG17) in which spasticity of the legs is accompanied by amyotrophy of the hands and occasionally also the lower limbs(2,3). Silver syndrome and most forms of dHMN are autosomal dominantly inherited with incomplete penetrance and a broad variability in clinical expression. A genome-wide scan in an Austrian family with dHMN-V (ref. 4) showed linkage to the locus SPG17, which was confirmed in 16 additional families with a phenotype characteristic of dHMN or Silver syndrome. After refining the critical region to 1 Mb, we sequenced the gene Berardinelli-Seip congenital lipodystrophy (BSCL2) and identified two heterozygous missense mutations resulting in the amino acid substitutions N88S and S90L. Null mutations in BSCL2, which encodes the protein seipin, were previously shown to be associated with autosomal recessive Berardinelli-Seip congenital lipodystrophy 5 (OMIM #269700). We show that seipin is an integral membrane protein of the endoplasmic reticulum (ER). The amino acid substitutions N88S and S90L affect glycosylation of seipin and result in aggregate formation leading to neurodegeneration.	Med Univ Graz, Inst Med Biol & Human Genet, A-8010 Graz, Austria; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ London St Georges Hosp, Sch Med, Div Med Genet, London SW17 0RE, England; Med Univ Graz, Dept Med Biochem & Med Mol Biol, A-8010 Graz, Austria; UCL Royal Free & Univ Coll Med Sch, Dept Clin Neurosci, London NW3 2PF, England; Univ Louvain, St Luc Univ Hosp, Dept Neurol, Brussels, Belgium; Univ Louvain, St Luc Univ Hosp, Med Genet Unit, Brussels, Belgium; Ctr Human Genet, Inst Pathol & Genet, Loverval, Belgium; Ist Ortoped Rizzoli, Neuromuscular Lab, Bologna, Italy		Wagner, K (corresponding author), Med Univ Graz, Inst Med Biol & Human Genet, Harrachgasse 21-8, A-8010 Graz, Austria.	klaus.wagner@meduni-graz.at	Malli, Roland/B-7369-2008; Crosby, Andrew H/E-2218-2015; Van Maldergem, Lionel/G-9849-2017; Merlini, Luciano/N-6478-2019; Proukakis, Christos/G-4548-2013; Van Maldergem, Lionel/O-3242-2019; proukakis, christos/ABE-3447-2020; Timmerman, Vincent/O-7283-2019; Warner, Thomas T/A-1454-2013	Crosby, Andrew H/0000-0003-3667-9054; Van Maldergem, Lionel/0000-0001-8880-5214; Merlini, Luciano/0000-0002-1108-1198; Van Maldergem, Lionel/0000-0001-8880-5214; proukakis, christos/0000-0001-6423-6539; Timmerman, Vincent/0000-0002-2162-0933; Warner, Thomas T/0000-0001-6195-6995; Malli, Roland/0000-0001-6327-8729; Hoerl, Gerd/0000-0002-0884-0851			Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Auer-Grumbach M, 2000, BRAIN, V123, P1612, DOI 10.1093/brain/123.8.1612; CHRISTODOULOU K, 1995, HUM MOL GENET, V4, P1629, DOI 10.1093/hmg/4.9.1629; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee MJ, 2003, HUM MOL GENET, V12, P1917, DOI 10.1093/hmg/ddg198; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Patel H, 2001, AM J HUM GENET, V69, P209, DOI 10.1086/321267; Ryan MC, 2002, NEUROBIOL DIS, V10, P109, DOI 10.1006/nbdi.2002.0500; Saliba RS, 2002, J CELL SCI, V115, P2907; SILVER JR, 1966, J NEUROL NEUROSUR PS, V29, P135, DOI 10.1136/jnnp.29.2.135; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Windpassinger C, 2003, HUM GENET, V114, P99, DOI 10.1007/s00439-003-1021-6	17	263	284	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					271	276		10.1038/ng1313			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	WOS:000189250400016	14981520	Bronze			2022-01-24	
J	Abecasis, GR; Noguchi, E; Heinzmann, A; Traherne, JA; Bhattacharyya, S; Leaves, NI; Anderson, GG; Zhang, YM; Lench, NJ; Carey, A; Cardon, LR; Moffatt, MF; Cookson, WOC				Abecasis, GR; Noguchi, E; Heinzmann, A; Traherne, JA; Bhattacharyya, S; Leaves, NI; Anderson, GG; Zhang, YM; Lench, NJ; Carey, A; Cardon, LR; Moffatt, MF; Cookson, WOC			Extent and distribution of linkage disequilibrium in three genomic regions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIATION; POPULATION; DISEASES; MAP	The positional cloning of genes underlying common complex diseases relies on the identification of linkage disequilibrium (LD) between genetic markers and disease. We have examined 127 polymorphisms in three genomic regions in a sample of 575 chromosomes from unrelated individuals of British ancestry. To establish phase, 800 individuals were genotyped in 160 families. The fine structure of LD was found to be highly irregular. Forty-five percent of the variation in disequilibrium measures could be explained by physical distance. Additional factors, such as allele frequency, type of polymorphism, and genomic location, explained <5 % of the variation. Nevertheless, disequilibrium was occasionally detectable at 500 kb and was present for over one-half of marker pairs separated by <50 kb. Although these findings are encouraging for the prospects of a genomewide LD map, they suggest caution in interpreting localization due to allelic association.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Oxagen Ltd, Abingdon, Oxon, England		Cookson, WOC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	william.cookson@ndm.ox.ac.uk	Lench, Nicholas/AAB-1791-2021; Abecasis, Goncalo R/B-7840-2010	Abecasis, Goncalo/0000-0003-1509-1825; Lench, Nicholas/0000-0002-6108-0759			Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; BHATTACHARYYA S, 1998, DISSECTING GENETICS; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Eaves IA, 2000, NAT GENET, V25, P320; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Farrall M, 1999, NAT GENET, V23, P270, DOI 10.1038/15449; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; HARD D, 1997, PRINCIPLES POPULATIO; HEDRICK PW, 1987, GENETICS, V117, P331; Huttley GA, 1999, GENETICS, V152, P1711; JORDE LB, 1994, AM J HUM GENET, V54, P884; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; KIMURA M, 1973, GENETICS, V75, P199; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; MOFFATT F, 1994, LANCET, V343, P1597, DOI 10.1016/S0140-6736(94)93057-0; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; MullerMyhsok B, 1997, SCIENCE, V275, P1328; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sobel E, 1996, AM J HUM GENET, V58, P1323; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Thompson EA, 1997, AM J HUM GENET, V60, P197; Tu IP, 1999, AM J HUM GENET, V64, P641, DOI 10.1086/302253; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	33	263	272	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					191	197		10.1086/316944			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	WOS:000166399900017	11083947	Green Published, Bronze			2022-01-24	
J	Dubchak, I; Brudno, M; Loots, GG; Pachter, L; Mayor, C; Rubin, EM; Frazer, KA				Dubchak, I; Brudno, M; Loots, GG; Pachter, L; Mayor, C; Rubin, EM; Frazer, KA			Active conservation of noncoding sequences revealed by three-way species comparisons	GENOME RESEARCH			English	Article								Human and mouse genomic sequence comparisons are being increasingly used to search for evolutionarily conserved gene regulatory elements. Large-scale human-mouse DNA comparison studies have discovered numerous conserved noncoding sequences of which only a fraction has been functionally investigated A question therefore remains as to whether most of these noncoding sequences are conserved because of functional constraints or are the result of a lack of divergence time.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genome Sci Dept, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Ctr Bioinformat & Computat Genom, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA		Frazer, KA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genome Sci Dept, Berkeley, CA 94720 USA.			Pachter, Lior/0000-0002-9164-6231; Frazer, Kelly/0000-0002-6060-8902; Loots, Gabriela/0000-0001-9546-5561	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-5748202] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM057482] Funding Source: NIH RePORTER		Ansari-Lari MA, 1998, GENOME RES, V8, P29; BTZOGLOU S, 2000, IN PRESS GENOME RES; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; HENKEL G, 1992, J IMMUNOL, V149, P3239; KOOP BF, 1994, NAT GENET, V7, P48, DOI 10.1038/ng0594-48; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Oeltjen JC, 1997, GENOME RES, V7, P315, DOI 10.1101/gr.7.4.315	8	263	267	0	2	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	SEP	2000	10	9					1304	1306		10.1101/gr.142200			3	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	353BY	WOS:000089254900005	10984448	Green Published, Bronze, Green Accepted			2022-01-24	
J	Ewing, B; Green, P				Ewing, B; Green, P			Analysis of expressed sequence tags indicates 35,000 human genes	NATURE GENETICS			English	Article							HUMAN GENOME; CPG ISLANDS	The number of protein-coding genes in an organism provides a useful first measure of its molecular complexity. Single-celled prokaryotes and eukaryotes typically have a few thousand genes; for example. Escherichia coli(1) has 4,300 and Saccharomyces cerevisiae(2) has 6.000. Evolution of multicellularity appears to have been accompanied by a several-fold increase in gene number, the invertebrates Caenorhabditis elegans(3) and Drosophila melanogaster(4) having 19,000 and 13,600 genes, respectively. Here we estimate the number of human genes by comparing a set of human expressed sequence tag (EST) contigs with human chromosome 22 and with a non-redundant set of mRNA sequences. The two comparisons give mutually consistent estimates of approximately 35,000 genes, substantially lower than most previous estimates. Evolution of the increased physiological complexity of vertebrates may therefore have depended more on the combinatorial diversification of regulatory networks or alternative splicing than on a substantial increase in gene number.	Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA		Green, P (corresponding author), Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA.	phg@u.washington.edu					Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dickson D, 1999, NATURE, V401, P311, DOI 10.1038/43722; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; Goffeau A., 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; GREEN P, 1993, SCIENCE, V259, P1711, DOI 10.1126/science.8456298; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LEWIN B, 1990, GENES, V4, P466; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; Wolfsberg TG, 1997, NUCLEIC ACIDS RES, V25, P1626, DOI 10.1093/nar/25.8.1626	19	263	278	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2000	25	2					232	234		10.1038/76115			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	WOS:000087459200028	10835644				2022-01-24	
J	Perry, WL; Hustad, CM; Swing, DA; O'Sullivan, TN; Jenkins, NA; Copeland, NG				Perry, WL; Hustad, CM; Swing, DA; O'Sullivan, TN; Jenkins, NA; Copeland, NG			The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a(18H) mice	NATURE GENETICS			English	Article							MOTH-EATEN; RECEPTOR; MOUSE; GENE; POLYUBIQUITINATION; DEGRADATION; PATHOLOGY; MUTATIONS; PATHWAY; DOMAIN	Non-agouti-lethal 18H (a(18H)) mice are dark agouti with black pinna hairs. What makes these mice unique is that they develop a spectrum of immunological diseases not seen in other agouti mutant mice(1). On the JU/Ct background, a(18H) mice develop an inflammatory disease of the large intestine, On the C57BL/6J background, they develop a fatal disease characterized by pulmonary chronic interstitial inflammation and alveolar proteinosis, inflammation of the glandular stomach and skin resulting in scarring due to constant itching, and hyperplasia of lymphoid cells, haematopoietic cells and the forestomach epithelium. Previous studies suggested that the a(18H) mutation results from a paracentric inversion that affects two loci: agouti and another, as yet unidentified locus designated itchy (the provisional gene symbol is Itch), that is responsible for the immunological phenotype of a(18H) mice(1). Here we confirm that a(18H) results from an inversion and show that Itch encodes a novel E3 ubiquitin protein ligase, a protein involved in ubiquitin-mediated protein degradation. Our results indicate that ubiquitin-dependent proteolysis is an important mediator of the immune response in vivo and provide evidence for itch's role in inflammation and the regulation of epithelial and haematopoietic cell growth.	NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Mammalian Genet Lab, Frederick, MD 21702 USA		Copeland, NG (corresponding author), NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Mammalian Genet Lab, Frederick, MD 21702 USA.	copeland@ncifcrf.gov					CATTANACH BM, 1987, MOUSE NEWS LETT, V77, P123; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DAVID M, 1995, MOL CELL BIOL, V15, P7050; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; FERRY WL, 1995, GENETICS, V140, P267; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; HUSTAD CM, 1995, GENETICS, V140, P255; Jiao HY, 1997, EXP HEMATOL, V25, P592; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; MIYAZAWA K, 1994, BLOOD, V83, P137; MORI S, 1995, BIOCHEM BIOPH RES CO, V213, P32, DOI 10.1006/bbrc.1995.2094; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; MORI S, 1993, J BIOL CHEM, V268, P577; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SIDMAN CL, 1978, J IMMUNOL, V121, P2392; Sudol M, 1996, TRENDS BIOCHEM SCI, V21, P161, DOI 10.1016/0968-0004(96)30018-2; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; VRIELING HD, 1994, P NATL ACAD SCI USA, V91, P170; WARD JM, 1978, VET PATHOL, V15, P170, DOI 10.1177/030098587801500203	25	263	269	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1998	18	2					143	146		10.1038/ng0298-143			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	WOS:000071779500021	9462742				2022-01-24	
J	Samadashwily, GM; Raca, G; Mirkin, SM				Samadashwily, GM; Raca, G; Mirkin, SM			Trinucleotide repeats affect DNA replication in vivo	NATURE GENETICS			English	Article							FRAGILE-X-SYNDROME; AGAROSE-GEL ELECTROPHORESIS; HUMAN HEREDITARY-DISEASES; CGG TRIPLET REPEATS; SYNTHESIS IN-VITRO; ESCHERICHIA-COLI; DELAYED REPLICATION; MISMATCH REPAIR; SWITCH REGION; CTG	(CCG)(n).(CCG)(n) and (CTG)(n).(CAG)(n) repeats of varying length were cloned into a bacterial plasmid, and the progression of the replication fork through these repeats was followed using electrophoretic analysis of replication intermediates. We observed stalling of the replication fork within repeated DNAs and found that this effect depends on repeat length, repeat orientation relative to the replication origin and the status of protein synthesis in a cell. Interruptions within repeated DNAs, similar to those observed in human genes, abolished the replication blockage. Our results suggest that the formation of unusual DNA structures by trinucleotide repeats in the lagging-strand template may account for the observed replication blockage and have relevance to repeat expansion in humans.	UNIV ILLINOIS, DEPT MOL GENET, CHICAGO, IL 60607 USA				Mirkin, Sergei/AAR-7226-2020; Mirkin, Sergei/A-7310-2010	Mirkin, Sergei/0000-0003-4576-7582; 			AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Bacolla A, 1997, J BIOL CHEM, V272, P16783, DOI 10.1074/jbc.272.27.16783; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; Bowater RP, 1996, J MOL BIOL, V264, P82, DOI 10.1006/jmbi.1996.0625; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; CLEWELL DB, 1972, J BACTERIOL, V110, P667, DOI 10.1128/JB.110.2.667-676.1972; Cox R, 1997, P NATL ACAD SCI USA, V94, P5237, DOI 10.1073/pnas.94.10.5237; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; GACY AM, 1995, CELL, V81, P533; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; JAWORSKI A, 1995, P NATL ACAD SCI USA, V92, P11019, DOI 10.1073/pnas.92.24.11019; JODICE C, 1994, AM J HUM GENET, V54, P959; Kang S, 1996, J MOL BIOL, V258, P543, DOI 10.1006/jmbi.1996.0266; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; KOHWI Y, 1993, NUCLEIC ACIDS RES, V21, P5651; Kornberg A., 1992, DNA REPLICATION, V2nd ed.; Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; KURYAVYI VV, 1995, NAT GENET, V9, P339, DOI 10.1038/ng0495-339; MARTINPARRAS L, 1991, J MOL BIOL, V220, P843, DOI 10.1016/0022-2836(91)90357-C; MCMURRAY CT, 1995, CHROMOSOMA, V104, P2; MITCHELL JE, 1995, NUCLEIC ACIDS RES, V23, P1876, DOI 10.1093/nar/23.11.1876; Ohshima K, 1996, J BIOL CHEM, V271, P1853, DOI 10.1074/jbc.271.4.1853; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; REABAN ME, 1994, J BIOL CHEM, V269, P21850; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; REISS AL, 1994, HUM MOL GENET, V3, P393, DOI 10.1093/hmg/3.3.393; SAMADASHWILY GM, 1993, EMBO J, V12, P4975, DOI 10.1002/j.1460-2075.1993.tb06191.x; Shimizu M, 1996, J MOL BIOL, V258, P614, DOI 10.1006/jmbi.1996.0273; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Subramanian PS, 1996, AM J HUM GENET, V59, P407; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; WEBB T, 1992, AM J MED GENET, V43, P1057, DOI 10.1002/ajmg.1320430633; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Yu A, 1997, BIOCHEMISTRY-US, V36, P3687, DOI 10.1021/bi9625410; YU AD, 1995, NUCLEIC ACIDS RES, V23, P2706, DOI 10.1093/nar/23.14.2706; Zheng MX, 1996, J MOL BIOL, V264, P323, DOI 10.1006/jmbi.1996.0643	50	263	265	1	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					298	304		10.1038/ng1197-298			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	WOS:A1997YD66700023	9354793				2022-01-24	
J	Glazebrook, J; Zook, M; Mert, F; Kagan, I; Rogers, EE; Crute, IR; Holub, EB; Hammerschmidt, R; Ausubel, FM				Glazebrook, J; Zook, M; Mert, F; Kagan, I; Rogers, EE; Crute, IR; Holub, EB; Hammerschmidt, R; Ausubel, FM			Phytoalexin-deficient mutants of Arabidopsis reveal that PAD4 encodes a regulatory factor and that four PAD genes contribute to downy mildew resistance	GENETICS			English	Article							CAMPESTRIS PV CAMPESTRIS; DISEASE RESISTANCE; PERONOSPORA-PARASITICA; ANTIFUNGAL PROTEINS; TRANSGENIC TOBACCO; THALIANA; PLANT; PATHOGENS; SYRINGAE; LEAVES	We are working to determine the role of the Arabidopsis phytoalexin, camalexin, in protecting the plant from pathogen attack by isolating phytoalexin-deficient (pad) mutants in the accession Columbia (Col-0) and examining their response to pathogens. Mutations in PAD1, PAD2, and PAD4 caused enhanced susceptibility to the bacterial pathogen Pseudomonas syringae pv. maculicola strain ES4326 (PsmES4326), while mutations in PAD3 or PAD5 did not. Camalexin was not detected in any of the double mutants pad1-1 pad2-1, pad1-1 pad3-1 or pad2-1 pad3-1. Growth of PsmES4326 in pad1-1 pad2-1 was greater than that in pad1-1 or pad2-1 plants, while growth in pad1-1 pad3-1 and pad2-1 pad3-1 plants was similar to that in pad1-1 and pad2-1 plants, respectively. The pad4-1 mutation caused reduced camalexin synthesis in response to PsmES4326 infection, but not in response to Cochliobolus carbonum infection, indicating that PAD4 has a regulatory function. PAD1, PAD2, PAD3 and PAD4 are all required for resistance to the eukaryotic biotroph Peronospora parasitica. The pad4-1 mutation caused the most dramatic change, exhibiting full susceptibility to four of six Col-incompatible parasite isolates. Interestingly, each combination of double mutants between pad1-1, pad2-1 and pad3-1 exhibited additive shifts to moderate or full susceptibility to most of the isolates.	MASSACHUSETTS GEN HOSP,DEPT MOL BIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA; MICHIGAN STATE UNIV,DEPT BOT & PLANT PATHOL,E LANSING,MI 48824; HORT RES INT,DEPT PLANT PATHOL WEED SCI,WELLESBOURNE CV35 9EF,WARWICK,ENGLAND		Glazebrook, J (corresponding author), UNIV MARYLAND,CTR AGR BIOTECHNOL,INST BIOTECHNOL,5128 PLANT SCI BLDG,COLLEGE PK,MD 20742, USA.		Rogers, Elizabeth/AAB-3643-2021	Rogers, Elizabeth/0000-0002-0545-4744; Glazebrook, Jane/0000-0001-5167-736X			ALEXANDER D, 1993, P NATL ACAD SCI USA, V90, P7327, DOI 10.1073/pnas.90.15.7327; Ausubel FM, 1995, CURRENT PROTOCOLS MO; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; BRINDLE PA, 1988, PHYTOCHEMISTRY, V27, P133, DOI 10.1016/0031-9422(88)80603-4; BROGLIE K, 1991, SCIENCE, V254, P1194, DOI 10.1126/science.254.5035.1194; BROWNE LM, 1991, TETRAHEDRON, V47, P3909, DOI 10.1016/S0040-4020(01)86431-0; Channon A. G., 1981, DOWNY MILDEWS, P321; CHAPPLE CCS, 1994, ARABIDOPSIS, P989; CONN KL, 1988, PLANT SCI, V56, P21, DOI 10.1016/0168-9452(88)90180-X; Dangl J. L., 1992, Methods in Arabidopsis research., P393; DARVILL AG, 1984, ANNU REV PLANT PHYS, V35, P243, DOI 10.1146/annurev.pp.35.060184.001331; DENNY TP, 1981, PHYSIOL PLANT PATHOL, V19, P419; DIXON RA, 1990, ANNU REV PLANT PHYS, V41, P339, DOI 10.1146/annurev.pp.41.060190.002011; DONG XN, 1991, PLANT CELL, V3, P61, DOI 10.1105/tpc.3.1.61; ESSENBERG M, 1992, PHYSIOL MOL PLANT P, V41, P85, DOI 10.1016/0885-5765(92)90002-D; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Glazebrook J, 1996, GENETICS, V143, P973; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; HOLUB EB, 1996, ADV BOT RES, V24, P227; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; LAMB CJ, 1989, CELL, V56, P215, DOI 10.1016/0092-8674(89)90894-5; LIU D, 1994, P NATL ACAD SCI USA, V91, P1888, DOI 10.1073/pnas.91.5.1888; LONG M, 1985, PHYTOPATHOLOGY, V75, P235, DOI 10.1094/Phyto-75-235; LUCY MC, 1988, PHYSIOL MOL PLANT P, V33, P187, DOI 10.1016/0885-5765(88)90019-7; MINDRINOS M, 1994, CELL, V78, P1856; MITTLER R, 1995, PLANT CELL, V7, P1951, DOI 10.1105/tpc.7.11.1951; MOSS NA, 1994, PLANT PATHOL, V43, P713, DOI 10.1111/j.1365-3059.1994.tb01611.x; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; PEDRAS MSC, 1992, CAN J PLANT PATHOL, V14, P67, DOI 10.1080/07060669209500907; PONSTEIN AS, 1994, PLANT PHYSIOL, V104, P109, DOI 10.1104/pp.104.1.109; PUEPPKE SG, 1976, PHYTOPATHOLOGY, V66, P1174, DOI 10.1094/Phyto-66-1174; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; ROUXEL T, 1991, PLANTA, V184, P271, DOI 10.1007/BF00197957; Ryerson DE, 1996, PLANT CELL, V8, P393, DOI 10.1105/tpc.8.3.393; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; SELABUURLAGE MB, 1993, PLANT PHYSIOL, V101, P857, DOI 10.1104/pp.101.3.857; Smith D. A., 1982, Phytoalexins., P218; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; TSUJI J, 1991, PHYSIOL MOL PLANT P, V38, P57, DOI 10.1016/S0885-5765(05)80142-0; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; Wang H, 1996, PLANT CELL, V8, P375, DOI 10.1105/tpc.8.3.375; WEISS BD, 1994, J BACTERIOL, V176, P3354, DOI 10.1128/jb.176.11.3354-3359.1994; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; WOLOSHUK CP, 1991, PLANT CELL, V3, P619, DOI 10.1105/tpc.3.6.619; WU GS, 1995, PLANT CELL, V7, P1357, DOI 10.1105/tpc.7.9.1357; ZHU Q, 1994, BIO-TECHNOL, V12, P807, DOI 10.1038/nbt0894-807	52	263	274	2	13	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	MAY	1997	146	1					381	392					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WW880	WOS:A1997WW88000031	9136026				2022-01-24	
J	Zeng, YX; Somasundaram, K; ElDeiry, WS				Zeng, YX; Somasundaram, K; ElDeiry, WS			AP2 inhibits cancer cell growth and activates p21(WAF1)/(CIP1) expression	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR AP-2; INDUCIBLE ENHANCER; LEUKEMIA-CELLS; GENE; DIFFERENTIATION; INDUCTION; CARCINOMA; CHROMOSOME-6; PATHWAY; KINASES	The 52-kD Activator Protein (AP2) is a DNA-binding transcription factor(1-3) implicated in signalling terminal differentiation(2-4). Profound developmental abnormalities have been recently observed in AP2-null mice(5-6). The molecular events by which AP2 promotes differentiation or development are, however, unknown. Increased expression of the universal cell cycle inhibitor p21(WAF1/CIP1) occurs in growth-arrested terminally differentiating cells(7-12). In a search for cellular factors that could activate p21 during phorbol ester (TPA)-induced differentiation, we identified AP2 as a regulator of p21 expression. Mutagenesis of an AP2 DNA-binding site within a p21 promoter-luciferase reporter inhibited its activation by either AP2 transfection or TPA stimulation. Endogenous p21 protein levels were elevated and DNA synthesis was inhibited in AP2 versus control vector-transfected cells. Overexpression of AP2 in HepG2 human hepatoblastoma and SW480 human colon adenocarcinoma cells inhibited cell division and stable colony formation. These results link the differentiation-associated factor AP2 to negative cell cycle and growth control, possibly through p21 activation.	UNIV PENN,SCH MED,HOWARD HUGHES MED INST,DEPT MED & GENET,LAB MOL ONCOL & CELL CYCLE REGULAT,PHILADELPHIA,PA 19104								BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; BUETTNER R, 1993, MOL CELL BIOL, V13, P4174, DOI 10.1128/MCB.13.7.4174; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; DUAN CM, 1995, J BIOL CHEM, V270, P24844, DOI 10.1074/jbc.270.42.24844; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; FOULKES WD, 1993, BRIT J CANCER, V67, P551, DOI 10.1038/bjc.1993.101; GAYNOR RB, 1991, GENOMICS, V10, P1100, DOI 10.1016/0888-7543(91)90209-W; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HYMAN SE, 1989, MOL CELL BIOL, V9, P321, DOI 10.1128/MCB.9.1.321; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KANNAN F, 1994, GENE DEV, V8, P1258, DOI 10.1101/gad.8.11.1258; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHARBANDA S, 1994, J BIOL CHEM, V269, P872; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; MICHIELI P, 1994, CANCER RES, V54, P3391; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; NAWROZ H, 1994, CANCER RES, V54, P1152; Robertson GP, 1996, CANCER RES, V56, P1635; SATO EF, 1995, BBA-MOL CELL RES, V1266, P23, DOI 10.1016/0167-4889(94)00238-A; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Somasundaram K, 1996, P NATL ACAD SCI USA, V93, P3088, DOI 10.1073/pnas.93.7.3088; STEINMAN RA, 1994, ONCOGENE, V9, P389; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; WILL, 1991, WILLIAMS T, V5, P671; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	32	263	267	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					78	82		10.1038/ng0197-78			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	WOS:A1997WA37300025	8988173				2022-01-24	
J	GOTTLIEB, S; RUVKUN, G				GOTTLIEB, S; RUVKUN, G			DAF-2, DAF-16 AND DAF-23 - GENETICALLY INTERACTING GENES-CONTROLLING DAUER FORMATION IN CAENORHABDITIS-ELEGANS	GENETICS			English	Article							LARVAL DEVELOPMENT; PHEROMONE; TEMPERATURE; MUTANTS	Under conditions of high population density and low food, Caenorhabditis elegans forms an alternative third larval stage, called the dauer stage, which is resistant to desiccation and harsh environments. Genetic analysis of some dauer constitutive (Daf-c) and dauer defective (Daf-d) mutants has revealed a complex pathway that is likely to function in particular neurons and/or responding tissues. Here we analyze the genetic interactions between three genes which comprise a branch of the dauer formation pathway that acts in parallel to or downstream of the other branches of the pathway, the Daf-c genes daf-2 and daf-23 and the Daf-d gene daf-16. Unlike mutations in other Daf-c genes, mutations in both daf-2 and daf-23 cause non-conditional arrest at the dauer stage. Our epistasis analysis suggests that daf-2 and daf-23 are functioning at a similar point in the dauer pathway. First, mutations in daf-2 and daf-23 are epistatic to mutations in the same set of Daf-d genes. Second, daf-2 and daf-23 mutants are suppressed by mutations in daf-16. Mutations in daf-16 do not suppress any of the other Daf-c mutants as efficiently as they suppress daf-2 and daf-23 mutants. Third, double mutants between either daf-2 or daf-23 and several other daf-d mutants exhibit an unusual interaction. Based on these results, we present a model for the function of daf-2, daf-23 and daf-16 in dauer formation.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02114		GOTTLIEB, S (corresponding author), MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114, USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM44619] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM044619] Funding Source: NIH RePORTER		ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HERMAN RK, 1978, GENETICS, V88, P49; HERMAN RK, 1984, GENETICS, V108, P165; HERMAN RK, 1990, NATURE, V348, P169, DOI 10.1038/348169a0; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; MALONE EA, 1994, IN PRESS GENETICS; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; RIDDLE D.L., 1988, NEMATODE CAENORHABDI, P393; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; ROSENBLUTH RE, 1985, GENETICS, V109, P493; SIGURDSON DC, 1984, GENETICS, V108, P331; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; THOMAS JH, 1993, GENETICS, V134, P1105; VOWELS JJ, 1992, GENETICS, V130, P105	21	263	286	1	22	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	MAY	1994	137	1					107	120					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NG992	WOS:A1994NG99200011	8056303				2022-01-24	
J	Moore, JW; Herrera-Foessel, S; Lan, CX; Schnippenkoetter, W; Ayliffe, M; Huerta-Espino, J; Lillemo, M; Viccars, L; Milne, R; Periyannan, S; Kong, XY; Spielmeyer, W; Talbot, M; Bariana, H; Patrick, JW; Dodds, P; Singh, R; Lagudah, E				Moore, John W.; Herrera-Foessel, Sybil; Lan, Caixia; Schnippenkoetter, Wendelin; Ayliffe, Michael; Huerta-Espino, Julio; Lillemo, Morten; Viccars, Libby; Milne, Ricky; Periyannan, Sambasivam; Kong, Xiuying; Spielmeyer, Wolfgang; Talbot, Mark; Bariana, Harbans; Patrick, John W.; Dodds, Peter; Singh, Ravi; Lagudah, Evans			A recently evolved hexose transporter variant confers resistance to multiple pathogens in wheat	NATURE GENETICS			English	Article							ADULT-PLANT RESISTANCE; LEAF RUST RESISTANCE; STRIPE RUST; POWDERY MILDEW; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; DURABLE RESISTANCE; FUNGAL PATHOGENS; AESTIVUM L.; STEM RUST	As there are numerous pathogen species that cause disease and limit yields of crops, such as wheat (Triticum aestivum), single genes that provide resistance to multiple pathogens are valuable in crop improvement(1,2). The mechanistic basis of multi-pathogen resistance is largely unknown. Here we use comparative genomics, mutagenesis and transformation to isolate the wheat Lr67 gene, which confers partial resistance to all three wheat rust pathogen species and powdery mildew. The Lr67 resistance gene encodes a predicted hexose transporter (LR67res) that differs from the susceptible form of the same protein (LR67sus) by two amino acids that are conserved in orthologous hexose transporters. Sugar uptake assays show that LR67sus, and related proteins encoded by homeoalleles, function as high-affinity glucose transporters. LR67res exerts a dominant-negative effect through heterodimerization with these functional transporters to reduce glucose uptake. Alterations in hexose transport in infected leaves may explain its ability to reduce the growth of multiple biotrophic pathogen species.	[Moore, John W.; Schnippenkoetter, Wendelin; Ayliffe, Michael; Viccars, Libby; Milne, Ricky; Periyannan, Sambasivam; Spielmeyer, Wolfgang; Talbot, Mark; Dodds, Peter; Lagudah, Evans] Commonwealth Sci & Ind Res Org CSIRO Agr, Canberra, ACT, Australia; [Herrera-Foessel, Sybil; Lan, Caixia; Singh, Ravi] Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico; [Huerta-Espino, Julio] Campo Expt Valle Mexico INIFAP, Chapingo, Edo De Mexico, Mexico; [Lillemo, Morten] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Kong, Xiuying] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Bariana, Harbans] Univ Sydney, Plant Breeding Inst Cobbitty, Narellan, Australia; [Patrick, John W.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia		Lagudah, E (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Agr, Canberra, ACT, Australia.	evans.lagudah@csiro.au	Huerta-Espino, Julio/E-7345-2010; Dodds, Peter N/D-1181-2009; Periyannan, Sambasivam/C-1722-2014; Lillemo, Morten/H-9406-2019; Huerta-Espino, Julio JH/N-9840-2018; Lagudah, Evans/A-2007-2010; Milne, Ricky J/C-3386-2016; Spielmeyer, Wolfgang/M-3254-2018; Ayliffe, Michael A/A-2089-2010; Singh, Ravi Prakash/I-5575-2019	Huerta-Espino, Julio/0000-0001-8334-9862; Dodds, Peter N/0000-0003-0620-5923; Periyannan, Sambasivam/0000-0002-5421-2872; Lillemo, Morten/0000-0002-8594-8794; Huerta-Espino, Julio JH/0000-0001-8334-9862; Lagudah, Evans/0000-0002-6234-1789; Milne, Ricky J/0000-0002-9792-4175; Spielmeyer, Wolfgang/0000-0002-5115-7820; Schnippenkoetter, Wendelin/0000-0003-4120-4379; Patrick, John/0000-0003-0964-9327	Grains Research and Development Corporation, AustraliaGrains R&D Corp [CSP00161, CSP00164]; Office of the Chief Executive (OCE) Post Doctoral Fellowship of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia	This work was supported by funds provided through Grains Research and Development Corporation (CSP00161, CSP00164), Australia, and the Office of the Chief Executive (OCE) Post Doctoral Fellowship of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia. We are grateful to S. Chandramohan, V. Calvo-Salazar, T. Richardson, H. Miah and X. Xia for technical assistance. We thank A. Ashton, I. Dry, P. Ryan and A. Rae for helpful discussions.	Ayliffe M, 2013, MOL PLANT MICROBE IN, V26, P658, DOI 10.1094/MPMI-12-12-0291-R; Buttner M, 2010, PLANT BIOLOGY, V12, P35, DOI 10.1111/j.1438-8677.2010.00383.x; CGIAR Research Program on Wheat, 2014, WHEAT CRP ANN REP 20; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; DYCK PL, 1979, CAN J PLANT SCI, V59, P329, DOI 10.4141/cjps79-053; DYCK PL, 1994, GENOME, V37, P556, DOI 10.1139/g94-079; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gou JY, 2015, PLANT CELL, V27, P1755, DOI 10.1105/tpc.114.134296; Hayes MA, 2007, J EXP BOT, V58, P1985, DOI 10.1093/jxb/erm061; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; Herrera-Foessel SA, 2014, THEOR APPL GENET, V127, P781, DOI 10.1007/s00122-013-2256-9; Herrera-Foessel SA, 2011, THEOR APPL GENET, V122, P239, DOI 10.1007/s00122-010-1439-x; Hiebert CW, 2010, THEOR APPL GENET, V121, P1083, DOI 10.1007/s00122-010-1373-y; Hulbert S, 2014, MOL PLANT MICROBE IN, V27, P207, DOI 10.1094/MPMI-09-13-0295-FI; Ishida Y, 2015, METHODS MOL BIOL, V1223, P189, DOI 10.1007/978-1-4939-1695-5_15; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kolmer JA, 2008, CROP SCI, V48, P1841, DOI 10.2135/cropsci2007.08.0474; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; LEMOINE R, 1987, PHYSIOL PLANTARUM, V69, P639, DOI 10.1111/j.1399-3054.1987.tb01978.x; Lemonnier P, 2014, PLANT MOL BIOL, V85, P473, DOI 10.1007/s11103-014-0198-5; Liesche J, 2011, J PLANT PHYSIOL, V168, P1426, DOI 10.1016/j.jplph.2011.02.005; McCurdy DW, 2010, MOL PLANT, V3, P1049, DOI 10.1093/mp/ssq050; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Norholm MHH, 2006, FEBS LETT, V580, P2381, DOI 10.1016/j.febslet.2006.03.064; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Proels RK, 2014, MOL PLANT PATHOL, V15, P858, DOI 10.1111/mpp.12139; Richardson T, 2014, PLANT CELL TISS ORG, V119, P647, DOI 10.1007/s11240-014-0564-7; Risk JM, 2012, PLANT BIOTECHNOL J, V10, P477, DOI 10.1111/j.1467-7652.2012.00683.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sonnewald S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051763; Spielmeyer W, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-96; Stodart BJ, 2007, GENET RESOUR CROP EV, V54, P759, DOI 10.1007/s10722-006-9150-0; Tingay S, 1997, PLANT J, V11, P1369, DOI 10.1046/j.1365-313X.1997.11061369.x; Wang MB, 1998, ACTA HORTIC, P401, DOI 10.17660/ActaHortic.1998.461.46; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110	45	262	276	6	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1494	1498		10.1038/ng.3439			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	WOS:000365813200024	26551671				2022-01-24	
J	Li, L; Eichten, SR; Shimizu, R; Petsch, K; Yeh, CT; Wu, W; Chettoor, AM; Givan, SA; Cole, RA; Fowler, JE; Evans, MMS; Scanlon, MJ; Yu, JM; Schnable, PS; Timmermans, MCP; Springer, NM; Muehlbauer, GJ				Li, Lin; Eichten, Steven R.; Shimizu, Rena; Petsch, Katherine; Yeh, Cheng-Ting; Wu, Wei; Chettoor, Antony M.; Givan, Scott A.; Cole, Rex A.; Fowler, John E.; Evans, Matthew M. S.; Scanlon, Michael J.; Yu, Jianming; Schnable, Patrick S.; Timmermans, Marja C. P.; Springer, Nathan M.; Muehlbauer, Gary J.			Genome-wide discovery and characterization of maize long non-coding RNAs	GENOME BIOLOGY			English	Article							MESSENGER-RNA; DNA METHYLATION; GENE-EXPRESSION; ARABIDOPSIS; IDENTIFICATION; TRANSCRIPTS; REVEALS; PROTEIN; PARAMUTATION; FEATURES	Background: Long non-coding RNAs (IncRNAs) are transcripts that are 200 bp or longer, do not encode proteins, and potentially play important roles in eukaryotic gene regulation. However, the number, characteristics and expression inheritance pattern of lncRNAs in maize are still largely unknown. Results: By exploiting available public EST databases, maize whole genome sequence annotation and RNA seq datasets from 30 different experiments, we identified 20,163 putative lncRNAs. Of these lncRNAs, more than 90% are predicted to be the precursors of small RNAs, while 1,704 are considered to be high-confidence lncRNAs. High confidence lncRNAs have an average transcript length of 463 bp and genes encoding them contain fewer exons than annotated genes. By analyzing the expression pattern of these lncRNAs in 13 distinct tissues and 105 maize recombinant inbred lines, we show that more than 50% of the high confidence lncRNAs are expressed in a tissue-specific manner, a result that is supported by epigenetic marks. Intriguingly, the inheritance of IncRNA expression patterns in 105 recombinant inbred lines reveals apparent transgressive segregation, and maize lncRNAs are less affected by cis-than by trans-genetic factors. Conclusions: We integrate all available transcriptomic datasets to identify a comprehensive set of maize lncRNAs, provide a unique annotation resource of the maize genome and a genome-wide characterization of maize lncRNAs, and explore the genetic control of their expression using expression quantitative trait locus mapping.	[Li, Lin; Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Eichten, Steven R.; Springer, Nathan M.; Muehlbauer, Gary J.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Shimizu, Rena; Scanlon, Michael J.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; [Petsch, Katherine; Timmermans, Marja C. P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Yeh, Cheng-Ting; Wu, Wei; Yu, Jianming; Schnable, Patrick S.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Yeh, Cheng-Ting; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA 50011 USA; [Chettoor, Antony M.; Evans, Matthew M. S.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Givan, Scott A.] Univ Missouri, Informat Res Core Facil, Columbia, MO 65211 USA; [Cole, Rex A.; Fowler, John E.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA		Muehlbauer, GJ (corresponding author), Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA.	Muehl003@umn.edu	Fowler, John E/U-4529-2017; Yu, Jianming/Q-6722-2019	Fowler, John E/0000-0002-9254-5934; Yu, Jianming/0000-0001-5326-3099; Eichten, Steven/0000-0003-2268-395X; Yeh, Cheng-Ting/0000-0002-1392-2018; Givan, Scott/0000-0002-0630-8589; Schnable, Patrick/0000-0001-9169-5204	Minnesota Supercomputing Institute; National Science FoundationNational Science Foundation (NSF) [0820610, 1027527, 0701731]	We acknowledge the support of the Minnesota Supercomputing Institute. We thank Dr Ying Zhang from Minnesota Supercomputing Institute for the set-up of the computation environment. We are grateful to the editor and the anonymous reviewers for their helpful comments and suggestions. This work was supported by the National Science Foundation (Genomic Analyses of shoot meristem function in maize-NSF #0820610; Functional Structural Diversity among Maize Haplotypes-NSF #1027527; and Functional Genomics of Maize Gametophytes NSF #0701731). Funding for open access charge: National Science Foundation.	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Bolduc N, 2012, GENE DEV, V26, P1685, DOI 10.1101/gad.193433.112; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Carles CC, 2003, TRENDS PLANT SCI, V8, P394, DOI 10.1016/S1360-1385(03)00164-X; Chang YM, 2012, PLANT PHYSIOL, V160, P165, DOI 10.1104/pp.112.203810; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Davidson RM, 2011, PLANT GENOME-US, V4, P191, DOI 10.3835/plantgenome2011.05.0015; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; DOEBLEY J, 1995, GENETICS, V141, P333; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Eichten SR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003127; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gultyaev AP, 2007, NUCLEIC ACIDS RES, V35, P3144, DOI 10.1093/nar/gkm173; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Kanduri C, 2011, SEMIN CELL DEV BIOL, V22, P343, DOI 10.1016/j.semcdb.2011.02.020; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Li L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003202; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; MacIntosh GC, 2001, PLANT PHYSIOL, V127, P765, DOI 10.1104/pp.010501; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Makarevitch I, 2013, PLANT CELL, V25, P780, DOI 10.1105/tpc.112.106427; Marker C, 2002, CURR BIOL, V12, P2002, DOI 10.1016/S0960-9822(02)01304-0; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nobuta K, 2008, P NATL ACAD SCI USA, V105, P14958, DOI 10.1073/pnas.0808066105; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Paschold A, 2012, GENOME RES, V22, P2445, DOI 10.1101/gr.138461.112; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Sidorenko L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000725; Song DD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S36; Stam M, 2002, GENETICS, V162, P917; Studer AJ, 2011, GENETICS, V188, P673, DOI 10.1534/genetics.111.126508; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Takacs EM, 2012, PLANT CELL, V24, P3219, DOI 10.1105/tpc.112.099614; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Waters AJ, 2011, PLANT CELL, V23, P4221, DOI 10.1105/tpc.111.092668; Wen Jiayu, 2007, In Silico Biology, V7, P485; Zhang Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-61; Zhu QH, 2012, GENES-BASEL, V3, P176, DOI 10.3390/genes3010176; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	69	262	277	6	96	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2014	15	2							R40	10.1186/gb-2014-15-2-r40			15	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	AH6QU	WOS:000336256600023	24576388	Green Published, Green Accepted, hybrid			2022-01-24	
J	Browning, BL; Browning, SR				Browning, Brian L.; Browning, Sharon R.			Improving the Accuracy and Efficiency of Identity-by-Descent Detection in Population Data	GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; GENOTYPE DATA; LINKAGE DISEQUILIBRIUM; POSITIVE SELECTION; BIRTH COHORT; VARIANTS; HERITABILITY; INDIVIDUALS; HAPLOTYPES; IMPUTATION	Segments of indentity-by-descent (IBD) detected from high-density genetic data are useful for many applications, including long-range phase determination, phasing family data, imputation, IBD mapping, and heritability analysis in founder populations. We present Refined IBD, a new method for IBD segment detection. Refined IBD achieves both computational efficiency and highly accurate IBD segment reporting by searching for IBD in two steps. The first step (identification) uses the GERMLINE algorithm to find shared haplotypes exceeding a length threshold. The second step (refinement) evaluates candidate segments with a probabilistic approach to assess the evidence for IBD. Like GERMLINE, Refined IBD allows for IBD reporting on a haplotype level, which facilitates determination of multi-individual IBD and allows for haplotype-based downstream analyses. To investigate the properties of Refined IBD, we simulate SNP data from a model with recent superexponential population growth that is designed to match United Kingdom data. The simulation results show that Refined IBD achieves a better power/accuracy profile than fastIBD or GERMLINE. We find that a single run of Refined IBD achieves greater power than 10 runs of fastIBD. We also apply Refined IBD to SNP data for samples from the United Kingdom and from Northern Finland and describe the IBD sharing in these data sets. Refined IBD is powerful, highly accurate, and easy to use and is implemented in Beagle version 4.	[Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA		Browning, BL (corresponding author), Univ Washington, Dept Med, Div Med Genet, Hlth Sci Bldg,K-253,Box 357720, Seattle, WA 98195 USA.	browning@uw.edu	Browning, Brian L/A-1178-2010; Browning, Sharon/B-1530-2008	Browning, Brian L/0000-0001-6454-6633; Browning, Sharon/0000-0001-7251-9715	National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); Wellcome TrustWellcome TrustEuropean Commission [076113, 085475]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HG004960, HG005701, GM099568, GM075091]; Broad Institute; University of California at Los Angeles (UCLA); University of Oulu; National Institute for Health and Welfare in Finland; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG005701, R01HG004960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM075091, P01GM099568] Funding Source: NIH RePORTER	The Northern Finland Birth Cohort (NFBC1966) Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the Broad Institute, University of California at Los Angeles (UCLA), University of Oulu, and the National Institute for Health and Welfare in Finland. This article does not necessarily reflect the opinions or views of the NFBC1966 Study Investigators, Broad Institute, UCLA, University of Oulu, the National Institute for Health and Welfare in Finland, and the NHLBI. This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under awards 076113 and 085475. This study was supported by research grants HG004960, HG005701, GM099568, and GM075091 from the National Institutes of Health.	Albrechtsen A, 2009, GENET EPIDEMIOL, V33, P266, DOI 10.1002/gepi.20378; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Baum LE, 1972, INEQUALITIES, P1; Brown MD, 2012, GENETICS, V190, P1447, DOI 10.1534/genetics.111.137570; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2013, HUM GENET, V132, P129, DOI 10.1007/s00439-012-1230-y; Browning SR, 2012, ANNU REV GENET, V46, P617, DOI 10.1146/annurev-genet-110711-155534; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Cai Z, 2011, EUR J HUM GENET, V19, P667, DOI 10.1038/ejhg.2010.257; Campbell CL, 2012, P NATL ACAD SCI USA, V109, P13865, DOI 10.1073/pnas.1204840109; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gusev A, 2012, MOL BIOL EVOL, V29, P473, DOI 10.1093/molbev/msr133; Gusev A, 2011, AM J HUM GENET, V88, P706, DOI 10.1016/j.ajhg.2011.04.023; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Han LD, 2013, EUR J HUM GENET, V21, P205, DOI 10.1038/ejhg.2012.148; Han L, 2011, GENET EPIDEMIOL, V35, P557, DOI 10.1002/gepi.20606; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Livi Bacci M., 2000, POPULATION EUROPE; Moltke I, 2011, GENOME RES, V21, P1168, DOI 10.1101/gr.115360.110; Nachman MW, 2000, GENETICS, V156, P297; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ralph P., 2012, ARXIV12073815QBIOPE; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	44	262	264	2	40	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	1943-2631			GENETICS	Genetics	JUN	2013	194	2					459	+		10.1534/genetics.113.150029			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	156IG	WOS:000319814700014	23535385	Green Published, Bronze			2022-01-24	
J	Andreassen, OA; Djurovic, S; Thompson, WK; Schork, AJ; Kendler, KS; O'Donovan, MC; Rujescu, D; Werge, T; van de Bunt, M; Morris, AP; McCarthy, MI; Roddey, JC; McEvoy, LK; Desikan, RS; Dale, AM				Andreassen, Ole A.; Djurovic, Srdjan; Thompson, Wesley K.; Schork, Andrew J.; Kendler, Kenneth S.; O'Donovan, Michael C.; Rujescu, Dan; Werge, Thomas; van de Bunt, Martijn; Morris, Andrew P.; McCarthy, Mark I.; Roddey, J. Cooper; McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.		Int Consortium Blood Pressure GWAS; Diabet Genetics Replication; Psychiatric Genomics Consortium	Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; LOCI; HERITABILITY; HYPOTHESIS; MORTALITY; INFERENCE	Several lines of evidence suggest that genome-wide association studies (GWASs) have the potential to explain more of the "missing heritability" of common complex phenotypes. However, reliable methods for identifying a larger proportion of SNPs are currently lacking. Here, we present a genetic-pleiotropy-informed method for improving gene discovery with the use of GWAS summary-statistics data. We applied this methodology to identify additional loci associated with schizophrenia (SCZ), a highly heritable disorder with significant missing heritability. Epidemiological and clinical studies suggest comorbidity between SCZ and cardiovascular-disease (CVD) risk factors, including systolic blood pressure, triglycerides, low- and high-density lipoprotein, body mass index, waist-to-hip ratio, and type 2 diabetes. Using stratified quantile-quantile plots, we show enrichment of SNPs associated with SCZ as a function of the association with several CVD risk factors and a corresponding reduction in false discovery rate (FDR). We validate this "pleiotropic enrichment" by demonstrating increased replication rate across independent SCZ substudies. Applying the stratified FDR method, we identified 25 loci associated with SCZ at a conditional FDR level of 0.01. Of these, ten loci are associated with both SCZ and CVD risk factors, mainly triglycerides and low- and high-density lipoproteins but also waist-to-hip ratio, systolic blood pressure, and body mass index. Together, these findings suggest the feasibility of using genetic-pleiotropy-informed methods for improving gene discovery in SCZ and identifying potential mechanistic relationships with various CVD risk factors.	[Andreassen, Ole A.; Djurovic, Srdjan] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, N-0407 Oslo, Norway; [Andreassen, Ole A.; Djurovic, Srdjan] Oslo Univ Hosp, Div Mental Hlth & Addict, N-0407 Oslo, Norway; [Andreassen, Ole A.; Thompson, Wesley K.; Dale, Anders M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; [Schork, Andrew J.; Roddey, J. Cooper; McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92037 USA; [Schork, Andrew J.] Univ Calif San Diego, Cognit Sci Grad Program, La Jolla, CA 92037 USA; [Schork, Andrew J.] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92037 USA; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [O'Donovan, Michael C.] Cardiff Univ, Sch Med, Med Res Council Ctr Neuropsychiat Genet & Genom, Cardiff CF14 4XN, S Glam, Wales; [Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, D-06112 Halle, Germany; [Werge, Thomas] Univ Copenhagen, Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, iPSYCH, DK-4000 Roskilde, Denmark; [van de Bunt, Martijn; Morris, Andrew P.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7LJ, England; [McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92037 USA; [Roddey, J. Cooper; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA		Andreassen, OA (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, N-0407 Oslo, Norway.	o.a.andreassen@medisin.uio.no; amdale@ucsd.edu	O'Donovan, Michael C/P-7005-2018; Andreassen, Ole A./AAY-7531-2020; Myin-Germeys, Inez/L-5106-2014; Melle, Ingrid S/B-4858-2011; van Os, Jim/C-2113-2014; Cichon, Sven/B-9618-2014; Mattheisen, Manuel/S-3725-2019; Konte, Bettina/AAT-1142-2021; Fanous, Ayman H/O-1263-2017; Hartmann, Annette/AAS-6331-2021; Mattheisen, Manuel/B-4949-2012; McQuillin, Andrew/C-1623-2008; Kendler, Kenneth/AAF-2876-2019; Ruderfer, Douglas M/M-5795-2016; Kahler, Anna K/J-2874-2012; Cichon, Sven/H-8803-2013; Mattingsdal, Morten/Q-9367-2016; Hansen, Thomas Folkmann/O-5965-2014; McCarthy, Mark/M-3763-2015	O'Donovan, Michael C/0000-0001-7073-2379; Melle, Ingrid S/0000-0002-9783-548X; Cichon, Sven/0000-0002-9475-086X; Mattheisen, Manuel/0000-0002-8442-493X; Konte, Bettina/0000-0001-5287-308X; Mattheisen, Manuel/0000-0002-8442-493X; McQuillin, Andrew/0000-0003-1567-2240; Ruderfer, Douglas M/0000-0002-2365-386X; Cichon, Sven/0000-0002-9475-086X; Mattingsdal, Morten/0000-0003-4440-0324; Hansen, Thomas Folkmann/0000-0001-6703-7762; Myin-Germeys, Inez/0000-0002-3731-4930; KELLER, MATTHEW/0000-0002-6075-9882; Agartz, Ingrid/0000-0002-9839-5391; Djurovic, Srdjan/0000-0002-8140-8061; McCarthy, Mark/0000-0002-4393-0510; Bruggeman, Richard/0000-0002-3238-8471; Nothen, Markus/0000-0002-8770-2464; van de Bunt, Martijn/0000-0002-6744-6125; Posthuma, Danielle/0000-0001-7582-2365; Zammit, Stanley/0000-0002-2647-9211; Andreassen, Ole A./0000-0002-4461-3568	Kristian Gerhard Jebsen Foundation; Research Council of NorwayResearch Council of Norway; South East Norway Health Authority; Unger-Vetlesen Medical Fund; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 EB005970, R01AG031224, R01EB000790, RC2DA29475, RC2DA029475, R01HD061414]; Robert J. Glushko and Pamela Samuelson Graduate Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB005970, R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG031224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [RC2DA029475] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801418B, G0800509] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800509] Funding Source: UKRI	The authors would like to thank Terry Jernigan for helpful input on this manuscript. O.A.A. was supported by the Kristian Gerhard Jebsen Foundation, the Research Council of Norway, the South East Norway Health Authority, and the Unger-Vetlesen Medical Fund. R.S.D. was supported by National Institutes of Health (NIH) grant T32 EB005970. A.M.D. was supported by NIH grants R01AG031224, R01EB000790, and RC2DA29475. A.J.S. was supported by NIH grants RC2DA029475 and R01HD061414 and the Robert J. Glushko and Pamela Samuelson Graduate Fellowship.	Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Craiu RV, 2008, STAT SINICA, V18, P861; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; De Hert MA, 2006, SCHIZOPHR RES, V83, P87, DOI 10.1016/j.schres.2005.12.855; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Efron B., 2010, LARGE SCALE INFERENC; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hansen T, 2011, BIOL PSYCHIAT, V70, P59, DOI 10.1016/j.biopsych.2011.01.031; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Karoutzou G, 2008, MOL PSYCHIATR, V13, P245, DOI 10.1038/sj.mp.4002096; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lopez AD, 1996, GLOBAL BURDEN DIS CO; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138; Mitchell AJ, 2011, SCHIZOPHR B; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raphael T, 1921, ARCH NEURO PSYCHIATR, V5, P687, DOI 10.1001/archneurpsyc.1921.02180300052005; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2012, NAT MED, V18, P210, DOI 10.1038/nm.2670; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yoo Yun Joo, 2009, BMC Proc, V3 Suppl 7, pS103	48	262	262	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					197	209		10.1016/j.ajhg.2013.01.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	WOS:000315179600004	23375658	Green Published, Bronze			2022-01-24	
J	Karmodiya, K; Krebs, AR; Oulad-Abdelghani, M; Kimura, H; Tora, L				Karmodiya, Krishanpal; Krebs, Arnaud R.; Oulad-Abdelghani, Mustapha; Kimura, Hiroshi; Tora, Laszlo			H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells	BMC GENOMICS			English	Article						ChIP-seq; Histone acetylation; CpG islands; Embryonic stem cells; Gene regulation; Genome-wide mapping; Bivalent promoters; Epigenetics	GENOME-WIDE; HISTONE H3; CPG ISLANDS; CHROMATIN-STRUCTURE; TRANSCRIPTION; METHYLATION; ENHANCERS; COMPLEXES; PLURIPOTENT; LYSINE-4	Background: Transcription regulation in pluripotent embryonic stem (ES) cells is a complex process that involves multitude of regulatory layers, one of which is post-translational modification of histones. Acetylation of specific lysine residues of histones plays a key role in regulating gene expression. Results: Here we have investigated the genome-wide occurrence of two histone marks, acetylation of histone H3K9 and K14 (H3K9ac and H3K14ac), in mouse embryonic stem (mES) cells. Genome-wide H3K9ac and H3K14ac show very high correlation between each other as well as with other histone marks (such as H3K4me3) suggesting a coordinated regulation of active histone marks. Moreover, the levels of H3K9ac and H3K14ac directly correlate with the CpG content of the promoters attesting the importance of sequences underlying the specifically modified nucleosomes. Our data provide evidence that H3K9ac and H3K14ac are also present over the previously described bivalent promoters, along with H3K4me3 and H3K27me3. Furthermore, like H3K27ac, H3K9ac and H3K14ac can also differentiate active enhancers from inactive ones. Although, H3K9ac and H3K14ac, a hallmark of gene activation exhibit remarkable correlation over active and bivalent promoters as well as distal regulatory elements, a subset of inactive promoters is selectively enriched for H3K14ac. Conclusions: Our study suggests that chromatin modifications, such as H3K9ac and H3K14ac, are part of the active promoter state, are present over bivalent promoters and active enhancers and that the extent of H3K9 and H3K14 acetylation could be driven by cis regulatory elements such as CpG content at promoters. Our study also suggests that a subset of inactive promoters is selectively and specifically enriched for H3K14ac. This observation suggests that histone acetyl transferases (HATs) prime inactive genes by H3K14ac for stimuli dependent activation. In conclusion our study demonstrates a wider role for H3K9ac and H3K14ac in gene regulation than originally thought.	[Karmodiya, Krishanpal; Krebs, Arnaud R.; Oulad-Abdelghani, Mustapha; Tora, Laszlo] Univ Strasbourg, INSERM, U964, IGBMC,CNRS UMR 7104,CU Strasbourg, F-67404 Illkirch Graffenstaden, France; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan		Tora, L (corresponding author), Univ Strasbourg, INSERM, U964, IGBMC,CNRS UMR 7104,CU Strasbourg, BP 10142, F-67404 Illkirch Graffenstaden, France.	laszlo@igbmc.fr	Tora, Laszlo/E-9999-2018; Kimura, Hiroshi/B-9524-2015; abdelghani, mustapha oulad/A-5986-2017	Tora, Laszlo/0000-0001-7398-2250; Kimura, Hiroshi/0000-0003-0854-083X; abdelghani, mustapha oulad/0000-0002-8381-4397; Karmodiya, Krishanpal/0000-0002-5714-0587; Krebs, Arnaud/0000-0001-7999-6127	INSERM-Region AlsaceInstitut National de la Sante et de la Recherche Medicale (Inserm)Region Grand-Est; Association pour la Recherche sur le CancerFondation ARC pour la Recherche sur le CancerAustralian Research CouncilEuropean Commission; ANR (GenomATAC)French National Research Agency (ANR) [ANR-09-BLAN-0266]; EU (EUTRACC)European Commission; EU (EPIDIACAN); CNRS (LEA-SkinChroma)	The authors are very grateful to the labs of B. E. Bernstein, R. Jaenisch and D. Schubeler from which released data were used in the analyses and to D. Schubeler lab for providing unpublished RNA-seq data. The authors are grateful to T. Ye, and S. Le Gras for bioinformatics support; the IGBMC NGS platform for data generation; P. Eberling for generation of peptides and the IGBMC cell culture service. We thank D. Devys for critical reading of the manuscript. ARK was a recipient of a fellowship from INSERM-Region Alsace and the Association pour la Recherche sur le Cancer. This work was funded by grants from ANR (GenomATAC; ANR-09-BLAN-0266), the EU (EUTRACC and EPIDIACAN) and CNRS (LEA-SkinChroma). None of the authors have a financial interest related to this work.	Anamika K, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-18; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herz HM, 2009, DEV CELL, V17, P301, DOI 10.1016/j.devcel.2009.08.014; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; Hezroni H, 2011, J BIOL CHEM, V286, P35977, DOI 10.1074/jbc.M111.266254; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li XG, 2011, BLOOD, V118, P1386, DOI 10.1182/blood-2010-11-319111; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; Zhang Y, 2006, NAT STRUCT MOL BIOL, V13, P572, DOI 10.1038/nsmb0706-572; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	262	265	2	29	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	AUG 24	2012	13								424	10.1186/1471-2164-13-424			18	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	022AW	WOS:000309928400001	22920947	Green Published, gold			2022-01-24	
J	Soler Artigas, M; Loth, DW; Wain, LV; Gharib, SA; Obeidat, M; Tang, WB; Zhai, GJ; Zhao, JH; Smith, AV; Huffman, JE; Albrecht, E; Jackson, CM; Evans, DM; Cadby, G; Fornage, M; Manichaikul, A; Lopez, LM; Johnson, T; Aldrich, MC; Aspelund, T; Barroso, I; Campbell, H; Cassano, PA; Couper, DJ; Eiriksdottir, G; Franceschini, N; Garcia, M; Gieger, C; Gislason, GK; Grkovic, I; Hammond, CJ; Hancock, DB; Harris, TB; Ramasamy, A; Heckbert, SR; Heliovaara, M; Homuth, G; Hysi, PG; Alan, L; Jankovic, S; Joubert, BR; Karrasch, S; Klopp, N; Koch, B; Kritchevsky, SB; Launer, LJ; Liu, YM; Loehr, LR; Lohman, K; Loos, RJF; Lumley, T; Al Balushi, KA; Ang, WQ; Barr, RG; Beilby, J; Blakey, JD; Boban, M; Boraska, V; Brisman, J; Britton, JR; Brusselle, GG; Cooper, C; Curjuric, I; Dahgam, S; Deary, IJ; Ebrahim, S; Eijgelsheim, M; Francks, C; Gaysina, D; Granell, R; Gu, XJ; Hankinson, JL; Hardy, R; Harris, SE; Henderson, J; Henry, A; Hingorani, AD; Hofman, A; Holt, PG; Hui, JN; Hunter, ML; Imboden, M; Jameson, KA; Kerr, SM; Kolcic, I; Kronenberg, F; Liu, JZ; Marchini, J; McKeever, T; Morris, AD; Olin, AC; Porteous, DJ; Postma, DS; Rich, SS; Ring, SM; Rivadeneira, F; Rochat, T; Sayer, AA; Sayers, I; Sly, PD; Smith, GD; Sood, A; Starr, JM; Uitterlinden, AG; Vonk, JM; Wannamethee, SG; Whincup, PH; Wijmenga, C; Williams, OD; Wong, A; Mangino, M; Marciante, KD; McArdle, WL; Meibohm, B; Morrison, AC; North, KE; Omenaas, E; Palmer, LJ; Pietilainen, KH; Pin, I; Polasek, O; Pouta, A; Psaty, BM; Hartikainen, AL; Rantanen, T; Ripatti, S; Rotter, JI; Rudan, I; Rudnicka, AR; Schulz, H; Shin, SY; Spector, TD; Surakka, I; Vitart, V; Volzke, H; Wareham, NJ; Warrington, NM; Wichmann, HE; Wild, SH; Wilk, JB; Wjst, M; Wright, AF; Zgaga, L; Zemunik, T; Pennell, CE; Nyberg, F; Kuh, D; Holloway, JW; Boezen, HM; Lawlor, DA; Morris, RW; Probst-Hensch, N; Kaprio, J; Wilson, JF; Hayward, C; Kahonen, M; Heinrich, J; Musk, AW; Jarvis, DL; Glaser, S; Jarvelin, MR; Stricker, BHC; Elliott, P; O'Connor, GT; Strachan, DP; London, SJ; Hall, IP; Gudnason, V; Tobin, MD				Soler Artigas, Maria; Loth, Daan W.; Wain, Louise V.; Gharib, Sina A.; Obeidat, Ma'en; Tang, Wenbo; Zhai, Guangju; Zhao, Jing Hua; Smith, Albert Vernon; Huffman, Jennifer E.; Albrecht, Eva; Jackson, Catherine M.; Evans, David M.; Cadby, Gemma; Fornage, Myriam; Manichaikul, Ani; Lopez, Lorna M.; Johnson, Toby; Aldrich, Melinda C.; Aspelund, Thor; Barroso, Ines; Campbell, Harry; Cassano, Patricia A.; Couper, David J.; Eiriksdottir, Gudny; Franceschini, Nora; Garcia, Melissa; Gieger, Christian; Gislason, Gauti Kjartan; Grkovic, Ivica; Hammond, Christopher J.; Hancock, Dana B.; Harris, Tamara B.; Ramasamy, Adaikalavan; Heckbert, Susan R.; Heliovaara, Markku; Homuth, Georg; Hysi, Pirro G.; James, Alan L.; Jankovic, Stipan; Joubert, Bonnie R.; Karrasch, Stefan; Klopp, Norman; Koch, Beate; Kritchevsky, Stephen B.; Launer, Lenore J.; Liu, Yongmei; Loehr, Laura R.; Lohman, Kurt; Loos, Ruth J. F.; Lumley, Thomas; Al Balushi, Khalid A.; Ang, Wei Q.; Barr, R. Graham; Beilby, John; Blakey, John D.; Boban, Mladen; Boraska, Vesna; Brisman, Jonas; Britton, John R.; Brusselle, Guy G.; Cooper, Cyrus; Curjuric, Ivan; Dahgam, Santosh; Deary, Ian J.; Ebrahim, Shah; Eijgelsheim, Mark; Francks, Clyde; Gaysina, Darya; Granell, Raquel; Gu, Xiangjun; Hankinson, John L.; Hardy, Rebecca; Harris, Sarah E.; Henderson, John; Henry, Amanda; Hingorani, Aroon D.; Hofman, Albert; Holt, Patrick G.; Hui, Jennie; Hunter, Michael L.; Imboden, Medea; Jameson, Karen A.; Kerr, Shona M.; Kolcic, Ivana; Kronenberg, Florian; Liu, Jason Z.; Marchini, Jonathan; McKeever, Tricia; Morris, Andrew D.; Olin, Anna-Carin; Porteous, David J.; Postma, Dirkje S.; Rich, Stephen S.; Ring, Susan M.; Rivadeneira, Fernando; Rochat, Thierry; Sayer, Avan Aihie; Sayers, Ian; Sly, Peter D.; Smith, George Davey; Sood, Akshay; Starr, John M.; Uitterlinden, Andre G.; Vonk, Judith M.; Wannamethee, S. Goya; Whincup, Peter H.; Wijmenga, Cisca; Williams, O. Dale; Wong, Andrew; Mangino, Massimo; Marciante, Kristin D.; McArdle, Wendy L.; Meibohm, Bernd; Morrison, Alanna C.; North, Kari E.; Omenaas, Ernst; Palmer, Lyle J.; Pietilainen, Kirsi H.; Pin, Isabelle; Polasek, Ozren; Pouta, Anneli; Psaty, Bruce M.; Hartikainen, Anna-Liisa; Rantanen, Taina; Ripatti, Samuli; Rotter, Jerome I.; Rudan, Igor; Rudnicka, Alicja R.; Schulz, Holger; Shin, So-Youn; Spector, Tim D.; Surakka, Ida; Vitart, Veronique; Voelzke, Henry; Wareham, Nicholas J.; Warrington, Nicole M.; Wichmann, H-Erich; Wild, Sarah H.; Wilk, Jemma B.; Wjst, Matthias; Wright, Alan F.; Zgaga, Lina; Zemunik, Tatijana; Pennell, Craig E.; Nyberg, Fredrik; Kuh, Diana; Holloway, John W.; Boezen, H. Marike; Lawlor, Debbie A.; Morris, Richard W.; Probst-Hensch, Nicole; Kaprio, Jaakko; Wilson, James F.; Hayward, Caroline; Kahonen, Mika; Heinrich, Joachim; Musk, Arthur W.; Jarvis, Deborah L.; Glaeser, Sven; Jarvelin, Marjo-Riitta; Stricker, Bruno H. Ch; Elliott, Paul; O'Connor, George T.; Strachan, David P.; London, Stephanie J.; Hall, Ian P.; Gudnason, Vilmundur; Tobin, Martin D.		Int Lung Canc Consortium; GIANT Consortium	Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function	NATURE GENETICS			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENETIC-VARIATION; METAANALYSIS; VARIANTS; RISK; PROTEIN; POLYMORPHISMS; IMPUTATION; MORTALITY; WOMEN	Pulmonary function measures reflect respiratory health and are used in the diagnosis of chronic obstructive pulmonary disease. We tested genome-wide association with forced expiratory volume in 1 second and the ratio of forced expiratory volume in 1 second to forced vital capacity in 48,201 individuals of European ancestry with follow up of the top associations in up to an additional 46,411 individuals. We identified new regions showing association (combined P < 5 x 10(-8)) with pulmonary function in or near MFAP2, TGFB2, HDAC4, RARB, MECOM (also known as EVI1), SPATA9, ARMC2, NCR3, ZKSCAN3, CDC123, C10orf11, LRP1, CCDC38, MMP15, CFDP1 and KCNE2. Identification of these 16 new loci may provide insight into the molecular mechanisms regulating pulmonary function and into molecular targets for future therapy to alleviate reduced lung function.	[Soler Artigas, Maria; Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Soler Artigas, Maria; Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Loth, Daan W.; Eijgelsheim, Mark; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Loth, Daan W.; Stricker, Bruno H. Ch] Inspectorate Healthcare, The Hague, Netherlands; [Gharib, Sina A.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Gharib, Sina A.; Marciante, Kristin D.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Obeidat, Ma'en; Launer, Lenore J.; Al Balushi, Khalid A.; Blakey, John D.; Henry, Amanda; Sayers, Ian; Hall, Ian P.] Univ Nottingham Hosp, Nottingham Resp Biomed Res Unit, Div Therapeut & Mol Med, London, England; [Tang, Wenbo; Cassano, Patricia A.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Zhai, Guangju; Hammond, Christopher J.; Hysi, Pirro G.; Mangino, Massimo; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Zhai, Guangju] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, Epidemiol Unit, MRC, Cambridge, England; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gislason, Gauti Kjartan; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Huffman, Jennifer E.; Vitart, Veronique; Wright, Alan F.; Hayward, Caroline] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Albrecht, Eva; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Jackson, Catherine M.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Evans, David M.; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Cadby, Gemma; Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Cadby, Gemma; Palmer, Lyle J.; Warrington, Nicole M.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Fornage, Myriam; Gu, Xiangjun] Univ Texas Houston, Brown Fdn Inst Mol Med, Houston, TX USA; [Fornage, Myriam; Morrison, Alanna C.] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Manichaikul, Ani] Univ Virginia, Div Biostat & Epidemiol, Dept Publ Hlth Sci, Charlottesville, VA USA; [Lopez, Lorna M.; Deary, Ian J.; Harris, Sarah E.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Johnson, Toby] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Genome Ctr, London, England; [Aldrich, Melinda C.] Vanderbilt Univ, Dept Thorac Surg, Nashville, TN USA; [Aldrich, Melinda C.] Vanderbilt Univ, Div Epidemiol, Nashville, TN USA; [Barroso, Ines; Shin, So-Youn] Wellcome Trust Sanger Inst, Cambridge, England; [Barroso, Ines] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Campbell, Harry; Rudan, Igor; Wild, Sarah H.; Zgaga, Lina; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Couper, David J.] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Franceschini, Nora; Loehr, Laura R.; North, Kari E.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Garcia, Melissa; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Grkovic, Ivica; Jankovic, Stipan; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Hancock, Dana B.; Joubert, Bonnie R.; London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Hancock, Dana B.] Res Triangle Inst Int, Behav Hlth Epidemiol Program, Res Triangle Pk, NC USA; [Ramasamy, Adaikalavan; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Ramasamy, Adaikalavan] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Heckbert, Susan R.; Marciante, Kristin D.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Heckbert, Susan R.; Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Heliovaara, Markku; Kaprio, Jaakko] Natl Inst Hlth & Welf, Helsinki, Finland; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, W Australian Sleep Disorders Res Inst, Nedlands, WA 6009, Australia; [James, Alan L.; Musk, Arthur W.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [James, Alan L.; Hui, Jennie; Hunter, Michael L.; Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Busselton Populat Med Res Fdn, Nedlands, WA 6009, Australia; [Karrasch, Stefan] Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Klopp, Norman] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Unit Mol Epidemiol, Neuherberg, Germany; [Koch, Beate] Univ Hosp Greifswald, Dept Internal Med B, Greifswald, Germany; [Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Aging, Winston Salem, NC USA; [Lohman, Kurt] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA; [Liu, Yongmei; Ang, Wei Q.; Warrington, Nicole M.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Barr, R. Graham] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Beilby, John] Univ Western Australia, Dept Surg & Pathol, Nedlands, WA 6009, Australia; [Beilby, John; Hui, Jennie] Queen Elizabeth II Med Ctr, PathW Lab Med Western Australia, Nedlands, WA, Australia; [Boban, Mladen; Boraska, Vesna; Kolcic, Ivana; Polasek, Ozren; Zemunik, Tatijana] Univ Split, Fac Med, Split, Croatia; [Brisman, Jonas; Dahgam, Santosh; Olin, Anna-Carin; Nyberg, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Britton, John R.; McKeever, Tricia] Univ Nottingham, Sch Community Hlth Sci, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Britton, John R.; McKeever, Tricia] Univ Nottingham, Nottingham Resp Biomed Res Unit, Nottingham NG7 2RD, England; [Cooper, Cyrus; Jameson, Karen A.; Sayer, Avan Aihie] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Curjuric, Ivan; Imboden, Medea; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth TPH Inst, Basel, Switzerland; [Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium; [Curjuric, Ivan; Imboden, Medea; Probst-Hensch, Nicole] Univ Basel, CH-4003 Basel, Switzerland; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Noncommun Dis Epidemiol Unit, London WC1, England; [Ebrahim, Shah] S Asia Ctr Chron Dis, New Delhi, India; [Francks, Clyde] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Gaysina, Darya; Hardy, Rebecca; Wong, Andrew; Kuh, Diana] MRC Unit Lifelong Hlth & Ageing, London, England; [Granell, Raquel; Henderson, John; Ring, Susan M.; McArdle, Wendy L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hankinson, John L.] Hankinson Consulting Inc, Athens, GA USA; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Edinburgh, Midlothian, Scotland; [Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Holt, Patrick G.; Sly, Peter D.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Holt, Patrick G.; Sly, Peter D.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Hui, Jennie] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Hui, Jennie; Hunter, Michael L.; Musk, Arthur W.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Kerr, Shona M.; Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Mol Med Ctr, Edinburgh, Midlothian, Scotland; [Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Liu, Jason Z.; Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Morris, Andrew D.] Univ Dundee, Inst Med Res, Dundee, Scotland; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Rochat, Thierry] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Sood, Akshay] Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA; [Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wannamethee, S. Goya; Morris, Richard W.] UCL, Dept Primary Care & Populat Hlth, London, England; [Whincup, Peter H.; Rudnicka, Alicja R.; Strachan, David P.] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Williams, O. Dale] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA; [Omenaas, Ernst] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Pietilainen, Kirsi H.] Univ Helsinki, Cent Hosp, Obes Res Unit, Dept Med,Div Internal Med, Helsinki, Finland; [Pietilainen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Pietilainen, Kirsi H.; Ripatti, Samuli; Surakka, Ida; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Pin, Isabelle] CHU Grenoble, F-38043 Grenoble, France; [Pin, Isabelle] Ctr Rech Albert Bonniot, INSERM, U823, Grenoble, France; [Pin, Isabelle] Univ Grenoble 1, Grenoble, France; [Polasek, Ozren; Rudan, Igor] Gen Info Ltd, Zagreb, Croatia; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Oulu, Finland; [Rantanen, Taina] Univ Jyvaskyla, Dept Hlth Sci, Ctr Gerontol Res, Jyvaskyla, Finland; [Ripatti, Samuli; Surakka, Ida] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Unit, Helsinki, Finland; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Schulz, Holger; Wichmann, H-Erich; Heinrich, Joachim] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Study Hlth Pomerania SHIP Clin Epidemiol Res, Greifswald, Germany; [Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Wilk, Jemma B.] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA; [Wilk, Jemma B.] Harvard Univ, Sch Med, Boston, MA USA; [Wjst, Matthias] Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr, Inst Lung Biol & Dis, Neuherberg, Germany; [Wjst, Matthias] Tech Univ Munich, IMSE, Munich, Germany; [Zgaga, Lina] Univ Zagreb, Fac Med, Andrija Stampar Sch Publ Hlth, Zagreb 41000, Croatia; [Nyberg, Fredrik] AstraZeneca Res & Dev, Molndal, Sweden; [Holloway, John W.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Jarvis, Deborah L.; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy HPA Ctr Environm & Hlth, London, England; [Glaeser, Sven] Univ Hosp Greifswald, Dept Internal Med B, Greifswald, Germany; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Stricker, Bruno H. Ch] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [O'Connor, George T.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA		Tobin, MD (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	london2@niehs.nih.gov; mt47@leicester.ac.uk	Aldrich, Melinda/C-7783-2013; Gudnason, Vilmundur/AAE-7126-2019; Holloway, John W/B-5424-2009; Artigas, Maria Soler/L-6529-2013; Heinrich, Joachim/N-1720-2013; Evans, David M/H-6325-2013; Loos, Ruth J F/Q-2862-2016; Rantanen, Taina/O-6579-2016; Hancock, Dana/D-8577-2012; Gaysina, Darya/J-5720-2013; Palmer, Lyle John/K-3196-2014; Kuh, Diana/L-6019-2014; Porteous, David/AAA-3446-2021; Aspelund, Thor/C-5983-2008; Palmer, Lyle John/N-1948-2019; Hunter, Michael L/B-3213-2013; Perica, Vesna Boraska/D-8230-2017; Gudnason, Vilmundur/K-6885-2015; Rivadeneira, Fernando/O-5385-2015; Wijmenga, Cisca/AAE-7719-2019; Wichmann, Heinz Erich/AAA-5695-2022; London, Stephanie/C-3734-2019; Sly, Peter D/F-1486-2010; mangino, massimo/F-5134-2011; Wijmenga, Cisca/D-2173-2009; Francks, Clyde/E-1384-2012; Jankovic, Stipan/E-3315-2017; Hui, Jennie/A-9543-2013; Lopez, Lorna M/F-7265-2010; Wong, Andrew/M-8899-2016; Zemunik, Tatijana/D-8584-2017; Warrington, Nicole/P-4868-2014; Vonk, Judith M/ABA-3009-2020; Aspelund, Thor/K-7022-2019; Deary, Ian J/C-6297-2009; Wilson, James F/A-5704-2009; Hayward, Caroline/M-8818-2016; Granell, Raquel/AAY-4846-2020; Study, Raine/K-4517-2013; Rotter, Jerome/AAY-6598-2021; Olin, Anna-Carin/ABH-2627-2021; Davey Smith, George/A-7407-2013; Kronenberg, Florian/B-1736-2008; Boban, Mladen/E-2777-2017; Lopez, Lorna/AAR-4912-2020; Grkovic, Ivica/D-8728-2017; Porteous, David J/C-7289-2013; Zgaga, Lina/Q-9415-2018; Smith, Albert Vernon/K-5150-2015; Granell, Raquel/AAB-5256-2022; Vonk, Judith/K-8477-2019; Pennell, Craig/ABD-6902-2020; Sayer, Avan Aihie/A-4359-2012; jackson, cathy/H-4869-2013; Kolcic, Ivana/E-2713-2017; Schulz, Holger/J-5643-2015; Ramasamy, Adaikalavan/G-2632-2010; Marchini, Jonathan/ABE-9024-2020; Rudan, Igor/I-1467-2012; Polasek, Ozren/B-6002-2011; Campbell, Harry/E-2959-2010; Wong, Andrew/AAE-6995-2019; Ripatti, Samuli/H-9446-2014; Kaprio, Jaakko/A-1820-2008; PIN, Isabelle/N-3020-2013; Holt, Patrick/H-1548-2011	Gudnason, Vilmundur/0000-0001-5696-0084; Holloway, John W/0000-0001-9998-0464; Artigas, Maria Soler/0000-0002-3213-1107; Heinrich, Joachim/0000-0002-9620-1629; Evans, David M/0000-0003-0663-4621; Loos, Ruth J F/0000-0002-8532-5087; Rantanen, Taina/0000-0002-1604-1945; Palmer, Lyle John/0000-0002-1628-3055; Kuh, Diana/0000-0001-7386-2857; Porteous, David/0000-0003-1249-6106; Aspelund, Thor/0000-0002-7998-5433; Palmer, Lyle John/0000-0002-1628-3055; Hunter, Michael L/0000-0001-6704-4815; Perica, Vesna Boraska/0000-0003-3999-1529; Gudnason, Vilmundur/0000-0001-5696-0084; Rivadeneira, Fernando/0000-0001-9435-9441; Wijmenga, Cisca/0000-0002-5635-1614; London, Stephanie/0000-0003-4911-5290; Sly, Peter D/0000-0001-6305-2201; mangino, massimo/0000-0002-2167-7470; Hui, Jennie/0000-0002-1653-2496; Wong, Andrew/0000-0003-2079-4779; Warrington, Nicole/0000-0003-4195-775X; Vonk, Judith M/0000-0001-7531-4547; Aspelund, Thor/0000-0002-7998-5433; Deary, Ian J/0000-0002-1733-263X; Wilson, James F/0000-0001-5751-9178; Hayward, Caroline/0000-0002-9405-9550; Granell, Raquel/0000-0002-4890-4012; Davey Smith, George/0000-0002-1407-8314; Kronenberg, Florian/0000-0003-2229-1120; Boban, Mladen/0000-0003-1570-9621; Lopez, Lorna/0000-0002-0241-9783; Grkovic, Ivica/0000-0001-9010-2091; Porteous, David J/0000-0003-1249-6106; Zgaga, Lina/0000-0003-4089-9703; Smith, Albert Vernon/0000-0003-1942-5845; Vonk, Judith/0000-0001-7531-4547; Pennell, Craig/0000-0002-0937-6165; Kolcic, Ivana/0000-0001-7918-6052; Schulz, Holger/0000-0002-1157-200X; Ramasamy, Adaikalavan/0000-0002-7598-2892; Marchini, Jonathan/0000-0003-0610-8322; Rudan, Igor/0000-0001-6993-6884; Polasek, Ozren/0000-0002-5765-1862; Campbell, Harry/0000-0002-6169-6262; Wong, Andrew/0000-0003-2079-4779; Ripatti, Samuli/0000-0002-0504-1202; Kaprio, Jaakko/0000-0002-3716-2455; Aihie Sayer, Avan/0000-0003-1283-6457; Meibohm, Bernd/0000-0003-3923-3648; s, hema/0000-0002-3440-9475; Morrison, Alanna/0000-0001-6381-4296; Nyberg, Fredrik/0000-0003-0892-5668; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Hysi, Pirro/0000-0001-5752-2510; GHARIB, SINA A./0000-0002-2480-4367; Hardy, Rebecca/0000-0001-9949-0799; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Zemunik, Tatijana/0000-0001-8120-2891; Pietilainen, Kirsi/0000-0002-8522-1288; McKeever, Tricia/0000-0003-0914-0416; Johnson, Toby/0000-0002-5998-3270; Sayers, Ian/0000-0001-5601-5410; Hingorani, Aroon/0000-0001-8365-0081; Al Balushi, Khalid/0000-0003-4638-8787; Tobin, Martin/0000-0002-3596-7874; Kritchevsky, Stephen/0000-0003-3336-6781; Cooper, Cyrus/0000-0003-3510-0709; Kahonen, Mika/0000-0002-4510-7341; Wain, Louise/0000-0003-4951-1867; Loehr, Laura/0000-0002-9054-1825; Holt, Patrick/0000-0003-1193-0935; Jarvis, Deborah/0000-0002-1753-3896; Elliott, Paul/0000-0002-7511-5684; Couper, David/0000-0002-4313-9235; Hancock, Dana/0000-0003-2240-3604; Morris, Richard/0000-0001-7240-4563; Gaysina, Darya/0000-0002-9283-5667; Joubert, Bonnie/0000-0001-7952-1180; Barroso, Ines/0000-0001-5800-4520; Rudnicka, Alicja/0000-0003-0369-8574; Hall, Ian/0000-0001-9933-3216; Francks, Clyde/0000-0002-9098-890X; Wannamethee, Sasiwarang/0000-0001-9484-9977; Gieger, Christian/0000-0001-6986-9554; Lawlor, Debbie A/0000-0002-6793-2262; Beilby, John/0000-0002-4915-2254; Kerr, Shona/0000-0002-4137-1495; Whincup, Peter/0000-0002-5589-4107; O'Connor, George/0000-0002-6476-3926; Cassano, Patricia A./0000-0003-4827-5073; Hammond, Christopher/0000-0002-3227-2620; Loth, Daan/0000-0003-1260-9326; Brisman, Jonas/0000-0003-2333-3273; Henry, Amanda/0000-0001-6299-7676; Brusselle, Guy/0000-0001-7021-8505	Academy of FinlandAcademy of FinlandEuropean Commission [104781, 120315, 129269, 1114194]; Center of Excellence in Complex Disease GeneticsAcademy of Finland [213506, 129680]; SALVE; Althingi (Icelandic Parliament); Arthritis Research CampaignVersus Arthritis; Asthma UK; AstraZenecaAstraZeneca; AXA; Biotechnology and Biological Sciences Research Council (BBSRC)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1, G20234]; British Heart FoundationBritish Heart Foundation [PG/97012, PG/06/154/22043, FS05/125]; British Lung Foundation; Research United Kingdom; Chief Scientist Office, Scottish Government Health Directorate [CZD/16/6]; Croatian Institute for Public Health; UK Department of Health; Dutch Kidney Foundation; Erasmus Medical Center and Erasmus University, Rotterdam; Estonian Genome Center, University of Tartu, Estonia [SF0180142s08]; EUEuropean Commission [018996, QLK4-CT-1999-01237]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [QLG1-CT-2000-01643, LSHB-CT-2006-018996, LSHG-CT2006- 01894, QLG2-CT-2002-01254, HEALTH-F2-2008-201865, HEALTH-F2-2008-35627, HEALTH-F4-2007-201413]; Finnish Foundation for Cardiovascular Research; Flight Attendant Medical Research Institute (FAMRI); German Asthma and COPD Network (COSYCONET: BMBF)Federal Ministry of Education & Research (BMBF) [01GI0883]; German Bundesministerium fuer Forschung und Technology [01 AK 803 A-H, 01 IG 07015 G]; German Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF); German National Genome Research Network; German Ministry of Cultural Affairs; GlaxoSmithKline; Gyllenberg FoundationsGlaxoSmithKline; Healthway, Western Australia; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, GermanyHelmholtz Association; East Midlands Development Agency; European Regional Development FundEuropean Commission; Higher Education Funding Council for England (HEFCE)UK Research & Innovation (UKRI)Higher Education Funding Council for England; Hjartavernd (Icelandic Heart Association); Innsbruck Medical University; Institute for Anthropological Research in Zagreb; International Osteoporosis Foundation; NIH, National Institute on Aging and National Institute of Environmental Health SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Jalmari and Rauha Ahokas Foundation; Juvenile Diabetes Research Foundation International (JDRF)Juvenile Diabetes Research Foundation; Lifelong Health and Wellbeing Initiative [G0700704/84698]; Medical Research Council UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1000861, G0501942, G0902313, G0000934, G0800582, G0500539, G0600705, G9901462]; Tampere University Hospital; Ministry of Science, Education and Sport of the Republic of CroatiaMinistry of Science, Education and Sports, Republic of Croatia [108-1080315-0302]; Medical Research Council Human Genetics UnitUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Medisearch-The Leicester Medical Research Foundation; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [ID 403981, ID 003209]; National Human Genome Research Institute (NHGRI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01-HG-004729, U01-HG-004402]; National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centres (Guy's & St. Thomas' NHS Foundation TrustNational Institute for Health Research (NIHR); King's College London and Cambridge University Hospitals NHS Foundation Trust; University of CambridgeUniversity of Cambridge; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO)Netherlands Government [050-060-810]; Netherlands Organization for the Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development; Netherlands Organization of Scientific Research NOWNetherlands Organization for Scientific Research (NWO) [1750102007006, 175.010.2005.011, 911-03-012]; Northern Netherlands Collaboration of Provinces (SNN); Norwegian University of Science and Technology; Novo NordiskNovo Nordisk; Ontario Institute of Cancer Research and Canadian Cancer Society Research Institute [CCSRI 020214]; Republic of Croatia Ministry of Science, Education and SportsMinistry of Science, Education and Sports, Republic of Croatia [108-1080315-0302]; Research Institute for Diseases in the Elderly (RIDE) [014-93-015]; Research Into Ageing [251]; Siemens Healthcare, Erlangen, GermanySiemens AG; Federal State of Mecklenburg-West Pomerania; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Structure Enhancing Fund (FES) of the Dutch government; Swedish Heart and Lung FoundationSwedish Heart-Lung Foundation [20050561]; Swedish Research Council for Worklife and Social research (FAS) [2001-0263, 2003-0139]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [4026-28099, 3347CO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 32-65896.01, 32-59302.99, 32-52720.97, 32-4253.94]; Asthma, Allergy and Inflammation Research Trust; Great Wine Estates of the Margaret River region of Western Australia; Netherlands' Ministry of Economic Affairs, Ministry of Education, Culture and Science and Ministry for Health, Welfare and Sports; Royal SocietyRoyal Society of LondonEuropean Commission; University of Split and Zagreb Medical Schools; Tromso University [U01 DK062418]; UBS Wealth Foundation [BA29s8Q7-DZZ]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; University Medical Center Groningen; University of Bristol; University of Leicester; University of Nottingham; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1P50 CA70907, RO1 CA121197, U19 CA148127, CA55769, CA127219, R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071252, R01HL071258, R01HL071259, UL1RR025005, HHSN268200625226C, HHSN268200782096C, R01-HL084099]; US NIH National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [RO1CA111703]; US NIH National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01-RR00425, 5M01 RR00997]; US NIH National Eye Institute (NEI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI); US NIH National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222]; US NIH National Institute of Allergy and Infectious Diseases (NIAID)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); US NIH National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); US NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK063491]; US NIH National Institute of Environmental Health Sciences (NIEHS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ZO1 ES49019, ES015794]; US NIH National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [5R01MH63706: 02]; US NIH National Institute of Neurological Disorders and Stroke (NINDD); US NIH National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG032098, RC1 AG035835, N01AG12100, N01AG62101, N01AG62103, N01AG62106, 1R01AG032098-01A1, AG-023269, AG-15928, AG-20098, AG-027058]; Wellcome TrustWellcome TrustEuropean Commission [077016/Z/05/Z, GR069224, 068545/Z/02, 076113/B/04/Z, 079895]; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U106188470, G1000861, G0801056, G0701863, G0800582, G0902125, MC_U123092721, G0902313, MC_UP_A620_1015, MC_U123092720, G0401540, G0501942, MC_U127561128, MC_PC_U127561128, G0600705, G0000934] Funding Source: UKRI; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1] Funding Source: researchfish; British Heart FoundationBritish Heart Foundation [RG/08/013/25942] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_PC_U127561128, G0801056, G0902313, MC_U106188470, G0700704B, G1000861, G0000934, G0501942, G9815508, MC_U127561128, U1475000001, G0401540, G0701863, MC_UP_A620_1014, G0801056B, G0902125, MC_UP_A620_1015, G0600705, G0800582, MC_U123092721, U1475000002, MC_U123092720] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/2, CZB/4/710] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [N01HC095165, N01HC048049, N01HC095169, N01HC005187, N01HC075150, N01HC095168, N01HC095160, N01HC085086, N01HC095166, N01HC095164, N01HC085083, N01HC095095, N01HC055222, N01HC095167, N01HC095159, N01HC085082, N01HC095161, N01HC048048, N01HC095163, N01HC085080, N01HC085079, N01HC045133, N01HC025195, N01HC035129, N01HC085081, N01HC085084, N01HC048050, N01HC048047, N01HC085085, N01HC095162, N01HC015103, N01HC045134] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA121197, R01CA055769, U19CA148127, R01CA127219, R01CA111703, P50CA070907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000997, UL1RR024156, UL1RR025005, M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R44HL095169, R01HL071205, RC1HL100543, R01HL088133, R01HL048050, R01HL074104, R43HL095169, R01HL059367, R01HL105756, U01HL080295, K23HL094531, R01HL064278, R01HL071022, R01HL080295, R01HL087679, R01HL087652, R01HL071252, R01HL086694, R01HL048048, R01HL087641, R01HL077612, R01HL071259, R01HL075476, R01HL071051, R01HL048049, R01HL071258, R29HL048048, R01HL084099, R01HL071250, R01HL071251] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004402, U01HG004729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [U01DK062418, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES015794, Z01ES049019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG027058, ZIAAG007380, R01AG032098, RC1AG035835, N01AG012100, N01AG062106, R56AG020098, R01AG015928, R01AG020098, N01AG062101, N01AG062103] Funding Source: NIH RePORTER	We thank the many colleagues who contributed to collection and phenotypic characterization of the clinical sampling, genotyping and analysis of the data. We especially thank those who kindly agreed to participate in the studies. Major funding for this work is from the following sources (alphabetical): Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics (213506 and 129680) and SALVE); Althingi (Icelandic Parliament); Arthritis Research Campaign; Asthma UK; AstraZeneca; AXA Research Fund; Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F019394/1, G20234); British Heart Foundation (PG/97012, PG/06/154/22043, FS05/125); British Lung Foundation; Canadian Institutes of Health Research (Grant ID MOP-82893); Cancer Research United Kingdom; Chief Scientist Office, Scottish Government Health Directorate (CZD/16/6); Croatian Institute for Public Health; UK Department of Health; Dutch Kidney Foundation; Erasmus Medical Center and Erasmus University, Rotterdam; Estonian Genome Center, University of Tartu, Estonia (SF0180142s08); EU funding (GABRIEL GRANT Number: 018996, ECRHS II Coordination Number: QLK4-CT-1999-01237); European Commission (DG XII, EURO-BLCS, FP-5 QLG1-CT-2000-01643, FP-6 LSHB-CT-2006-018996 (GABRIEL), FP-6 LSHG-CT2006- 018947 (EUROSPAN), FP-6 GenomEUtwin project QLG2-CT-2002-01254, FP7/2007-2013: HEALTH-F2-2008-201865, GEFOS, HEALTH-F2-2008-35627, TREAT-OA, HEALTH-F4-2007-201413 (ENGAGE)); Finnish Foundation for Cardiovascular Research; Flight Attendant Medical Research Institute (FAMRI); German Asthma and COPD Network (COSYCONET: BMBF grant 01GI0883); German Bundesministerium fuer Forschung und Technology (01 AK 803 A-H, 01 IG 07015 G); German Federal Ministry of Education and Research (BMBF) (03ZIK012, 01ZZ9603, 01ZZ0103 and 01ZZ0403): German National Genome Research Network (NGFN-2 and NGFN-plus); German Ministry of Cultural Affairs; GlaxoSmithKline; Gyllenberg Foundations; Healthway, Western Australia; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany; Healthcare and Bioscience iNet (funded by the East Midlands Development Agency, partially financed by the European Regional Development Fund, delivered by Medilink East Midlands); Higher Education Funding Council for England (HEFCE); Hjartavernd (Icelandic Heart Association); Innsbruck Medical University; Institute for Anthropological Research in Zagreb; International Osteoporosis Foundation; Intramural Research Program of the NIH, National Institute on Aging and National Institute of Environmental Health Sciences; Jalmari and Rauha Ahokas Foundation; Juvenile Diabetes Research Foundation International (JDRF); Lifelong Health and Wellbeing Initiative (G0700704/84698); Medical Research Council UK (G1000861, G0501942, G0902313, G0000934, G0800582, G0500539, G0600705, PrevMetSyn/SALVE, G9901462); Medical Research Fund of the Tampere University Hospital; Ministry of Science, Education and Sport of the Republic of Croatia (108-1080315-0302); Medical Research Council Human Genetics Unit; Medisearch-The Leicester Medical Research Foundation; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; National Health and Medical Research Council of Australia (Grant ID 403981 and ID 003209); National Human Genome Research Institute (NHGRI) (U01-HG-004729, U01-HG-004402); National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centres (Guy's & St.; Thomas' NHS Foundation Trust in partnership with King's College London and Cambrdge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge); Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) (050-060-810); Netherlands Organization for the Health Research and Development (ZonMw); Netherlands Organization of Scientific Research NOW (1750102007006, 175.010.2005.011, 911-03-012); Northern Netherlands Collaboration of Provinces (SNN); Norwegian University of Science and Technology; Novo Nordisk; Ontario Institute of Cancer Research and Canadian Cancer Society Research Institute (CCSRI 020214); Republic of Croatia Ministry of Science, Education and Sports research grants (108-1080315-0302); Research Institute for Diseases in the Elderly (RIDE) (014-93-015: RIDE2); Research Into Ageing (251); Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Structure Enhancing Fund (FES) of the Dutch government; Swedish Heart and Lung Foundation grant 20050561; Swedish Research Council for Worklife and Social research (FAS), grants 2001-0263, 2003-0139; Swiss National Science Foundation (grants no. 4026-28099,3347CO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 32-65896.01,32-59302.99, 32-52720.97, 32-4253.; 94); The Asthma, Allergy and Inflammation Research Trust; The Great Wine Estates of the Margaret River region of Western Australia; The Netherlands' Ministry of Economic Affairs, Ministry of Education, Culture and Science and Ministry for Health, Welfare and Sports; The Royal Society; The University of Split and Zagreb Medical Schools; Tromso University; U01 DK062418; UBS Wealth Foundation Grant BA29s8Q7-DZZ; UK Department of Health Policy Research Programme; University Hospital Oulu, Biocenter, University of Oulu, Finland (75617); University Medical Center Groningen; University of Bristol; University of Leicester HEFCE CIF award; University of Nottingham; US National Institutes of Health (NIH) (1P50 CA70907, RO1 CA121197, U19 CA148127, CA55769, CA127219, R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071252, R01HL071258, R01HL071259, UL1RR025005, contracts HHSN268200625226C, HHSN268200782096C, R01-HL084099); US NIH National Cancer Institute (RO1CA111703); US NIH National Center for Research Resources (grants M01-RR00425 and 5M01 RR00997); US NIH National Eye Institute (NEI); US NIH National Heart, Lung and Blood Institute (contracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, N01-HC-45204, N01 HC-25195, N01-HC-95159 through N01-HC-95169, RR-024156, N02-HL-6-4278, R01 HL-071022, R01 HL-077612, R01 HL-074104, RC1 HL100543, HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C and HHSN268201100012C, grants HL080295, HL087652, HL105756, R01-HL-084099, R01HL087641, R01HL59367, R01HL086694, HL088133, HL075336 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), 1K23HL094531-01); US NIH National Institute of Allergy and Infectious Diseases (NIAID); US NIH National Institute of Child Health and Human Development (NICHD); US NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK063491); US NIH National Institute of Environmental Health Sciences (NIEHS) (ZO1 ES49019, ES015794); US IH National Institute of Mental Health (NIMH) (5R01MH63706: 02); US NIH National Institute of Neurological Disorders and Stroke (NINDD); US NIH National Institute on Aging (NIA) (R01 AG032098, RC1 AG035835, N01AG12100, N01AG62101, N01AG62103, N01AG62106, 1R01AG032098-01A1, AG-023269, AG-15928, AG-20098, AG-027058); Wellcome Trust (077016/Z/05/Z, GR069224, 068545/Z/02, 076113/B/04/Z, 079895).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Clancy RM, 2010, ARTHRITIS RHEUM-US, V62, P3415, DOI 10.1002/art.27658; Cowley EA, 2002, J PHYSIOL-LONDON, V538, P747, DOI 10.1113/jphysiol.2001.013300; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hole DJ, 1996, BRIT MED J, V313, P711; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Maran C, 2009, CURR GENOMICS, V10, P361, DOI 10.2174/138920209788920976; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Massaro GD, 2000, PHYSIOL GENOMICS, V4, P51, DOI 10.1152/physiolgenomics.2000.4.1.51; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Ruse CE, 2007, RESP MED, V101, P340, DOI 10.1016/j.rmed.2006.05.017; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; STRACHAN DP, 1992, J EPIDEMIOL COMMUN H, V46, P66, DOI 10.1136/jech.46.1.66; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Thompson HGR, 2006, AM J PHYSIOL-LUNG C, V291, pL1277, DOI 10.1152/ajplung.00057.2006; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Wu H, 2007, ENVIRON HEALTH PERSP, V115, P616, DOI 10.1289/ehp.9740; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	54	262	263	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1082	1090		10.1038/ng.941			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	WOS:000296584000011	21946350	Green Accepted, Green Published, Green Submitted			2022-01-24	
J	Fisher, S; Barry, A; Abreu, J; Minie, B; Nolan, J; Delorey, TM; Young, G; Fennell, TJ; Allen, A; Ambrogio, L; Berlin, AM; Blumenstiel, B; Cibulskis, K; Friedrich, D; Johnson, R; Juhn, F; Reilly, B; Shammas, R; Stalker, J; Sykes, SM; Thompson, J; Walsh, J; Zimmer, A; Zwirko, Z; Gabriel, S; Nicol, R; Nusbaum, C				Fisher, Sheila; Barry, Andrew; Abreu, Justin; Minie, Brian; Nolan, Jillian; Delorey, Toni M.; Young, Geneva; Fennell, Timothy J.; Allen, Alexander; Ambrogio, Lauren; Berlin, Aaron M.; Blumenstiel, Brendan; Cibulskis, Kristian; Friedrich, Dennis; Johnson, Ryan; Juhn, Frank; Reilly, Brian; Shammas, Ramy; Stalker, John; Sykes, Sean M.; Thompson, Jon; Walsh, John; Zimmer, Andrew; Zwirko, Zac; Gabriel, Stacey; Nicol, Robert; Nusbaum, Chad			A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries	GENOME BIOLOGY			English	Article							HUMAN GENOME; DNA; MUTATIONS; DISCOVERY	Genome targeting methods enable cost-effective capture of specific subsets of the genome for sequencing. We present here an automated, highly scalable method for carrying out the Solution Hybrid Selection capture approach that provides a dramatic increase in scale and throughput of sequence-ready libraries produced. Significant process improvements and a series of in-process quality control checkpoints are also added. These process improvements can also be used in a manual version of the protocol.	[Berlin, Aaron M.; Sykes, Sean M.; Gabriel, Stacey; Nusbaum, Chad] MIT, Genome Sequencing & Anal Program, Broad Inst, Cambridge, MA 02141 USA; [Fisher, Sheila; Barry, Andrew; Abreu, Justin; Minie, Brian; Nolan, Jillian; Delorey, Toni M.; Young, Geneva; Fennell, Timothy J.; Allen, Alexander; Ambrogio, Lauren; Berlin, Aaron M.; Blumenstiel, Brendan; Cibulskis, Kristian; Friedrich, Dennis; Johnson, Ryan; Reilly, Brian; Shammas, Ramy; Stalker, John; Sykes, Sean M.; Thompson, Jon; Walsh, John; Zimmer, Andrew; Zwirko, Zac; Gabriel, Stacey; Nicol, Robert; Nusbaum, Chad] Harvard Univ, Cambridge, MA 02141 USA; [Juhn, Frank; Zwirko, Zac] Fdn Med, Cambridge, MA 02139 USA		Nusbaum, C (corresponding author), MIT, Genome Sequencing & Anal Program, Broad Inst, 320 Charles St, Cambridge, MA 02141 USA.	chad@broadinstitute.org	Cibulskis, Kristian/AAC-7380-2019	Delorey, Toni/0000-0001-6614-3803	National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG03067-05]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003067] Funding Source: NIH RePORTER	We thank the Broad Institute Sequencing Platform for data generation, Peter Kisner and Erin Dooley for in-house library kits, Carrie Sougnez for sample acquisition, Jim Meldrim and Maura Costello for troubleshooting expertise and comments on the manuscript, Mark Depristo and Kiran Garimella for help with 1000 Genomes data, Jennifer Wineski for help with editing, Leslie Gaffney for help with figures and tables, Andreas Gnirke and Alexander Melnikov for advice on reaction optimization, Niall Lennon and Andreas Gnirke for comments on the manuscript and Emily LeProust (Agilent Technologies) for technical advice and collaboration. We acknowledge the 1000 Genomes Consortium SNP calls from NA12878. Work was funded by a grant from the National Human Genome Research Institute HG03067-05 (CN).	Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BLEEKER LG, 2010, NAT GENET, V42, P13; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Daiger SP, 2010, ADV EXP MED BIOL, V664, P325, DOI 10.1007/978-1-4419-1399-9_37; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Kaiser J, 2008, SCIENCE, V319, P395, DOI 10.1126/science.319.5862.395; LANDER E S, 1988, Genomics, V2, P231; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; *NCBI, NCBI TRUTH CALLS; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; *PIC, PIC AN PIP SOURC COD; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Summerer D, 2010, GENOMICS, V95, P241, DOI 10.1016/j.ygeno.2010.01.006; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	31	262	264	0	25	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2011	12	1							R1	10.1186/gb-2011-12-1-r1			15	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	749BL	WOS:000289437000004	21205303	Green Published, hybrid			2022-01-24	
J	Jallow, M; Teo, YY; Small, KS; Rockett, KA; Deloukas, P; Clark, TG; Kivinen, K; Bojang, KA; Conway, DJ; Pinder, M; Sirugo, G; Sisay-Joof, F; Usen, S; Auburn, S; Bumpstead, SJ; Campino, S; Coffey, A; Dunham, A; Fry, AE; Green, A; Gwilliam, R; Hunt, SE; Inouye, M; Jeffreys, AE; Mendy, A; Palotie, A; Potter, S; Ragoussis, J; Rogers, J; Rowlands, K; Somaskantharajah, E; Whittaker, P; Widden, C; Donnelly, P; Howie, B; Marchini, J; Morris, A; SanJoaquin, M; Achidi, EA; Agbenyega, T; Allen, A; Amodu, O; Corran, P; Djimde, A; Dolo, A; Doumbo, OK; Drakeley, C; Dunstan, S; Evans, J; Farrar, J; Fernando, D; Hien, TT; Horstmann, RD; Ibrahim, M; Karunaweera, N; Kokwaro, G; Koram, KA; Lemnge, M; Makani, J; Marsh, K; Michon, P; Modiano, D; Molyneux, ME; Mueller, I; Parker, M; Peshu, N; Plowe, CV; Puijalon, O; Reeder, J; Reyburn, H; Riley, EM; Sakuntabhai, A; Singhasivanon, P; Sirima, S; Tall, A; Taylor, TE; Thera, M; Troye-Blomberg, M; Williams, TN; Wilson, M; Kwiatkowski, DP				Jallow, Muminatou; Teo, Yik Ying; Small, Kerrin S.; Rockett, Kirk A.; Deloukas, Panos; Clark, Taane G.; Kivinen, Katja; Bojang, Kalifa A.; Conway, David J.; Pinder, Margaret; Sirugo, Giorgio; Sisay-Joof, Fatou; Usen, Stanley; Auburn, Sarah; Bumpstead, Suzannah J.; Campino, Susana; Coffey, Alison; Dunham, Andrew; Fry, Andrew E.; Green, Angela; Gwilliam, Rhian; Hunt, Sarah E.; Inouye, Michael; Jeffreys, Anna E.; Mendy, Alieu; Palotie, Aarno; Potter, Simon; Ragoussis, Jiannis; Rogers, Jane; Rowlands, Kate; Somaskantharajah, Elilan; Whittaker, Pamela; Widden, Claire; Donnelly, Peter; Howie, Bryan; Marchini, Jonathan; Morris, Andrew; SanJoaquin, Miguel; Achidi, Eric Akum; Agbenyega, Tsiri; Allen, Angela; Amodu, Olukemi; Corran, Patrick; Djimde, Abdoulaye; Dolo, Amagana; Doumbo, Ogobara K.; Drakeley, Chris; Dunstan, Sarah; Evans, Jennifer; Farrar, Jeremy; Fernando, Deepika; Hien, Tran Tinh; Horstmann, Rolf D.; Ibrahim, Muntaser; Karunaweera, Nadira; Kokwaro, Gilbert; Koram, Kwadwo A.; Lemnge, Martha; Makani, Julie; Marsh, Kevin; Michon, Pascal; Modiano, David; Molyneux, Malcolm E.; Mueller, Ivo; Parker, Michael; Peshu, Norbert; Plowe, Christopher V.; Puijalon, Odile; Reeder, John; Reyburn, Hugh; Riley, Eleanor M.; Sakuntabhai, Anavaj; Singhasivanon, Pratap; Sirima, Sodiomon; Tall, Adama; Taylor, Terrie E.; Thera, Mahamadou; Troye-Blomberg, Marita; Williams, Thomas N.; Wilson, Michael; Kwiatkowski, Dominic P.		Wellcome Trust Case Control Consor; Malaria Genomic Epidemiology Netwo	Genome-wide and fine-resolution association analysis of malaria in West Africa	NATURE GENETICS			English	Article							BETA-GLOBIN GENE; LINKAGE DISEQUILIBRIUM; NATURAL-SELECTION; HEMOGLOBIN-C; POPULATION; CHILDREN; POWER; INDICATORS; COVERAGE; ORIGIN	We report a genome-wide association (GWA) study of severe malaria in The Gambia. The initial GWA scan included 2,500 children genotyped on the Affymetrix 500K GeneChip, and a replication study included 3,400 children. We used this to examine the performance of GWA methods in Africa. We found considerable population stratification, and also that signals of association at known malaria resistance loci were greatly attenuated owing to weak linkage disequilibrium (LD). To investigate possible solutions to the problem of low LD, we focused on the HbS locus, sequencing this region of the genome in 62 Gambian individuals and then using these data to conduct multipoint imputation in the GWA samples. This increased the signal of association, from P = 4 x 10(-7) to P = 4 x 10(-14), with the peak of the signal located precisely at the HbS causal variant. Our findings provide proof of principle that fine-resolution multipoint imputation, based on population-specific sequencing data, can substantially boost authentic GWA signals and enable fine mapping of causal variants in African populations.	[Teo, Yik Ying; Small, Kerrin S.; Rockett, Kirk A.; Clark, Taane G.; Auburn, Sarah; Campino, Susana; Fry, Andrew E.; Green, Angela; Jeffreys, Anna E.; Mendy, Alieu; Ragoussis, Jiannis; Rogers, Jane; Rowlands, Kate; Donnelly, Peter; Marchini, Jonathan; Morris, Andrew; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Jallow, Muminatou; Bojang, Kalifa A.; Conway, David J.; Pinder, Margaret; Sirugo, Giorgio; Sisay-Joof, Fatou; Usen, Stanley] MRC Labs, Banjul, Gambia; [Rockett, Kirk A.; Deloukas, Panos; Clark, Taane G.; Kivinen, Katja; Auburn, Sarah; Bumpstead, Suzannah J.; Campino, Susana; Coffey, Alison; Dunham, Andrew; Gwilliam, Rhian; Hunt, Sarah E.; Inouye, Michael; Palotie, Aarno; Potter, Simon; Somaskantharajah, Elilan; Whittaker, Pamela; Widden, Claire; SanJoaquin, Miguel; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Donnelly, Peter; Howie, Bryan; Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [SanJoaquin, Miguel; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Achidi, Eric Akum] Univ Buea, Buea, South West Prov, Cameroon; [Agbenyega, Tsiri; Evans, Jennifer] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Allen, Angela; Michon, Pascal; Mueller, Ivo; Reeder, John] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Allen, Angela] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Amodu, Olukemi] Univ Ibadan, Coll Med, Inst Child Hlth, Ibadan, Nigeria; [Corran, Patrick] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Djimde, Abdoulaye; Dolo, Amagana; Doumbo, Ogobara K.; Thera, Mahamadou] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Drakeley, Chris; Reyburn, Hugh; Riley, Eleanor M.] London Sch Hyg & Trop Med, London WC1, England; [Drakeley, Chris; Reyburn, Hugh; Riley, Eleanor M.] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Dunstan, Sarah; Farrar, Jeremy; Hien, Tran Tinh] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Evans, Jennifer; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany; [Fernando, Deepika; Karunaweera, Nadira] Univ Colombo, Fac Med, Colombo, Sri Lanka; [Ibrahim, Muntaser] Univ Khartoum, Inst Endem Dis, Khartoum, Sudan; [Kokwaro, Gilbert; Marsh, Kevin; Peshu, Norbert; Williams, Thomas N.] Kenyan Med Res Inst KEMRI, Wellcome Trust Programme, Kilifi, Kenya; [Koram, Kwadwo A.; Wilson, Michael] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Lemnge, Martha] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Makani, Julie] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Modiano, David] Univ Roma La Sapienza, Rome, Italy; [Parker, Michael] Univ Oxford, Dept Publ Hlth & Primary Hlth Care, Ethox Ctr, Oxford, England; [Plowe, Christopher V.; Taylor, Terrie E.] Blantyre Malaria Project, Blantyre 3, Malawi; [Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Puijalon, Odile; Sakuntabhai, Anavaj] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Sirima, Sodiomon] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Tall, Adama] Inst Pasteur, Dakar, Senegal; [Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; [Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden		Kwiatkowski, DP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	dominic@sanger.ac.uk	Sirugo, Giorgio/N-9056-2019; Mead, Daniel/AAE-6629-2019; Troye-Blomberg, Marita/B-9210-2016; eyre, stephen/K-3776-2017; Riley, Eleanor/AAL-1382-2020; Fry, Andrew/AAN-2730-2020; Dunstan, Sarah/AAO-9597-2020; Sirugo, Giorgio/L-1628-2016; Makani, Julie/N-9370-2013; Deloukas, Panos/B-2922-2013; Breen, Gerome/Y-2706-2019; Riley, Eleanor M/C-8960-2013; Mueller, Ivo/C-7251-2013; Dominiczak, Anna F/P-9390-2017; Campino, Susana/AAM-2577-2020; Breen, Gerome D/A-5540-2010; Clark, Taane G./AAM-2570-2020; mangano, valentina/I-2456-2012; Makani, Julie/E-8525-2017; Marchini, Jonathan/ABE-9024-2020; Auburn, Sarah/N-2266-2013	Mead, Daniel/0000-0001-7717-4330; Troye-Blomberg, Marita/0000-0002-2804-0325; eyre, stephen/0000-0002-1251-6974; Riley, Eleanor/0000-0003-3447-3570; Fry, Andrew/0000-0001-9778-6924; Makani, Julie/0000-0002-4801-6250; Deloukas, Panos/0000-0001-9251-070X; Breen, Gerome/0000-0003-2053-1792; Riley, Eleanor M/0000-0003-3447-3570; Mueller, Ivo/0000-0001-6554-6889; Dominiczak, Anna F/0000-0003-4913-3608; Campino, Susana/0000-0003-1403-6138; Breen, Gerome D/0000-0003-2053-1792; Clark, Taane G./0000-0001-8985-9265; Makani, Julie/0000-0002-4801-6250; Marchini, Jonathan/0000-0003-0610-8322; Small, Kerrin/0000-0003-4566-0005; Dunstan, Sarah/0000-0001-7873-933X; Dunger, Professor David/0000-0002-2566-9304; Lango Allen, Hana/0000-0002-7803-8688; Lees, Charlie/0000-0002-0732-8215; Hattersley, Andrew/0000-0001-5620-473X; Moyes, Catherine/0000-0002-8028-4079; Reeder, John/0000-0003-1395-1289; Weedon, Michael/0000-0002-6174-6135; Mangano, Valentina D/0000-0002-2021-6162; Inouye, Michael/0000-0001-9413-6520; Amodu, Olukemi/0000-0003-1477-4229; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Newport, Melanie/0000-0002-8946-7525; Oluoch, Tom/0000-0001-9621-5900; Manske, Magnus/0000-0001-5916-0947; Conway, David/0000-0002-8711-3037; Zeggini, Eleftheria/0000-0003-4238-659X; Karunaweera, Nadira/0000-0003-3985-1817; Hart, Lee/0000-0002-6473-0964; Hunt, Sarah/0000-0002-8350-1235; Donnelly, Peter/0000-0001-9495-3408; Kivinen, Katja/0000-0002-1135-7625; Munroe, Patricia/0000-0002-4176-2947; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Kwiatkowski, Dominic/0000-0002-5023-0176; Singhasivanon, Pratap/0000-0002-9759-1702; Farrar, Jeremy/0000-0002-2700-623X; Maslen, Gareth/0000-0001-7318-3678; Walton, Robert/0000-0001-7700-1907; Thera, Mahamadou A/0000-0002-2679-035X; Ishengoma, Deus/0000-0003-2040-3416; Auburn, Sarah/0000-0002-4638-536X; Palotie, Aarno/0000-0002-2527-5874; Bojang, Kalifa/0000-0001-7506-0938	Wellcome TrustWellcome TrustEuropean Commission [077383/Z/05/Z]; Bill & Melinda Gates FoundationBill & Melinda Gates FoundationCGIAR; Foundation for the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [566]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600230]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800675, G9828345, G0600329, MC_U190081977, G0800759, G19/9, MC_U190081993, G0600230, G0600718] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI065683] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600329, MC_U190081993, MC_U190081977, G0600718, G19/9, G9828345, G0800675, G0800759] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish	We thank the Gambian children and their parents and guardians who made this study possible; and the doctors, nurses and fieldworkers at the Royal Victoria Hospital, Banjul and other health clinics who assisted with this work. MalariaGEN's primary funding is from the Wellcome Trust (grant number 077383/Z/05/Z) and from the Bill & Melinda Gates Foundation, through the Foundation for the National Institutes of Health (grant number 566) as part of the Grand Challenges in Global Health initiative. The Wellcome Trust (Sanger Institute core funding) and the Medical Research Council (grant number G0600230) provide additional support for genotyping, bioinformatics and analysis. The MalariaGEN Resource Centre is part of the European Union Network of Excellence on the Biology and Pathology of Malaria Parasites.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Hanchard N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-52; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Modiano D, 2008, HUM MOL GENET, V17, P789, DOI 10.1093/hmg/ddm350; MOLYNEUX ME, 1989, Q J MED, V71, P441; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Romans P, 1999, AM J TROP MED HYG, V60, P22, DOI 10.4269/ajtmh.1999.60.22; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313	38	262	264	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					657	665		10.1038/ng.388			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	WOS:000266411700014	19465909	Green Accepted, Green Published			2022-01-24	
J	Styrkarsdottir, U; Halldorsson, BV; Gretarsdottir, S; Gudbjartsson, DF; Walters, GB; Ingvarsson, T; Jonsdottir, T; Saemundsdottir, J; Snorradottir, S; Center, JR; Nguyen, TV; Alexandersen, P; Gulcher, JR; Eisman, JA; Christiansen, C; Sigurdsson, G; Kong, A; Thorsteinsdottir, U; Stefansson, K				Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gretarsdottir, Solveig; Gudbjartsson, Daniel F.; Walters, G. Bragi; Ingvarsson, Thorvaldur; Jonsdottir, Thorbjorg; Saemundsdottir, Jona; Snorradottir, Steinunn; Center, Jacqueline R.; Nguyen, Tuan V.; Alexandersen, Peter; Gulcher, Jeffrey R.; Eisman, John A.; Christiansen, Claus; Sigurdsson, Gunnar; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			New sequence variants associated with bone mineral density	NATURE GENETICS			English	Article							OSTEOPOROTIC FRACTURES; BUCHEM-DISEASE; SOST GENE; BMD; SCLEROSTEOSIS; PROTEIN; LRP5; HIP	In an extended genome-wide association study of bone mineral density among 6,865 Icelanders and a follow-up in 8,510 subjects of European descent, we identified four new genome-wide significant loci. These are near the SOST gene at 17q21, the MARK3 gene at 14q32, the SP7 gene at 12q13 and the TNFRSF11A (RANK) gene at 18q21. Furthermore, nonsynonymous SNPs in the C17orf53, LRP4, ADAM19 and IBSP genes were suggestively associated with bone density.	[Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gretarsdottir, Solveig; Gudbjartsson, Daniel F.; Walters, G. Bragi; Jonsdottir, Thorbjorg; Saemundsdottir, Jona; Snorradottir, Steinunn; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Styrkarsdottir, Unnur] Reykjavik Univ, IS-103 Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Inst Hlth Sci, FSA Univ Hosp, IS-600 Akureyri, Iceland; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] Univ New S Wales, Sydney, NSW 2010, Australia; [Alexandersen, Peter] Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark; [Christiansen, Claus] Nordic Biosci AS, DK-2730 Herlev, Denmark; [Sigurdsson, Gunnar] Univ Iceland, Landspitali Univ Hosp, Div Endocrinol & Metab, IS-108 Reykjavik, Iceland		Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.styrkarsdottir@decode.is; kari.stefansson@decode.is	Nguyen, Tuan V/B-6147-2008; Walters, G. Bragi/L-4215-2013; Stefansson, Kari/AAE-7187-2019; Nguyen, Tuan V./AAD-9503-2020; Eisman, John A/C-2886-2014; Center, Jacqueline/AAY-8712-2021	Nguyen, Tuan V/0000-0002-3246-6281; Walters, G. Bragi/0000-0002-5415-6487; Nguyen, Tuan V./0000-0002-3246-6281; Center, Jacqueline/0000-0002-5278-4527; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Styrkarsdottir, Unnur/0000-0001-8146-8278; Halldorsson, Bjarni/0000-0003-0756-0767			Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Mizuguchi T, 2004, J HUM GENET, V49, P80, DOI 10.1007/s10038-003-0111-6; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Sigurdsson G, 2008, J BONE MINER RES, V23, P1584, DOI [10.1359/jbmr.080507, 10.1359/JBMR.080507]; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277	15	262	281	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					15	17		10.1038/ng.284			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	WOS:000262085300011	19079262				2022-01-24	
J	Segal, E; Friedman, N; Kaminski, N; Regev, A; Koller, D				Segal, E; Friedman, N; Kaminski, N; Regev, A; Koller, D			From signatures to models: understanding cancer using microarrays	NATURE GENETICS			English	Article							HUMAN BREAST-CANCER; GENE-EXPRESSION; CELL-CYCLE; REGULATORY NETWORKS; TRANSCRIPTION FACTORS; LUNG ADENOCARCINOMA; BINDING-SITES; C-MYC; GENOME; PATTERNS	Genomics has the potential to revolutionize the diagnosis and management of cancer by offering an unprecedented comprehensive view of the molecular underpinnings of pathology. Computational analysis is essential to transform the masses of generated data into a mechanistic understanding of disease. Here we review current research aimed at uncovering the modular organization and function of transcriptional networks and responses in cancer. We first describe how methods that analyze biological processes in terms of higher-level modules can identify robust signatures of disease mechanisms. We then discuss methods that aim to identify the regulatory mechanisms underlying these modules and processes. Finally, we show how comparative analysis, combining human data with model organisms, can lead to more robust findings. We conclude by discussing the challenges of generalizing these methods from cells to tissues and the opportunities they offer to improve cancer diagnosis and management.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA; Hebrew Univ Jerusalem, Sch Engn & Comp Sci, Jerusalem, Israel		Segal, E (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	koller@cs.stanford.edu	Segal, Eran/AAF-4855-2019; Friedman, Nir/H-9692-2012	Segal, Eran/0000-0002-6859-1164; Kaminski, Naftali/0000-0001-5917-4601; Friedman, Nir/0000-0002-9678-3550			Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Chang CF, 2004, NUCLEIC ACIDS RES, V32, P1798, DOI 10.1093/nar/gkh507; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fuller AP, 2003, J MAMMARY GLAND BIOL, V8, P335, DOI 10.1023/B:JOMG.0000010033.49464.0c; Garber K, 2004, SCIENCE, V303, P1754, DOI 10.1126/science.303.5665.1754; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Hulboy DL, 2001, MOL CELL BIOL, V21, P5478, DOI 10.1128/MCB.21.16.5478-5487.2001; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Khan J, 1999, ELECTROPHORESIS, V20, P223, DOI 10.1002/(SICI)1522-2683(19990201)20:2<223::AID-ELPS223>3.0.CO;2-A; Kobayashi K, 2004, ONCOGENE, V23, P3089, DOI 10.1038/sj.onc.1207433; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lossos IS, 2002, P NATL ACAD SCI USA, V99, P8886, DOI 10.1073/pnas.132253599; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Mecham BH, 2004, PHYSIOL GENOMICS, V18, P308, DOI 10.1152/physiolgenomics.00066.2004; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pe'er Dana, 2002, Bioinformatics, V18 Suppl 1, pS258; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pritsker M, 2004, GENOME RES, V14, P99; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Rostomily RC, 1997, CANCER RES, V57, P3526; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; SEGAL E, 2004, RECOMB 2004 P 8 ANN, P141; SEGAL E, 2002, P 6 INT C RES COMP M, P263; SEGAL E, 2004, THESIS STANFORD U; Sharan R, 2004, NUCLEIC ACIDS RES, V32, pW253, DOI 10.1093/nar/gkh385; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431	69	262	282	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S38	S45		10.1038/ng1561			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	WOS:000229590000008	15920529	Bronze			2022-01-24	
J	Dallas, PB; Gottardo, NG; Firth, MJ; Beesley, AH; Hoffmann, K; Terry, PA; Freitas, JR; Boag, JM; Cummings, AJ; Kees, UR				Dallas, PB; Gottardo, NG; Firth, MJ; Beesley, AH; Hoffmann, K; Terry, PA; Freitas, JR; Boag, JM; Cummings, AJ; Kees, UR			Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate?	BMC GENOMICS			English	Article							TECHNOLOGY	Background: The use of microarray technology to assess gene expression levels is now widespread in biology. The validation of microarray results using independent mRNA quantitation techniques remains a desirable element of any microarray experiment. To facilitate the comparison of microarray expression data between laboratories it is essential that validation methodologies be critically examined. We have assessed the correlation between expression scores obtained for 48 human genes using oligonucleotide microarrays and the expression levels for the same genes measured by quantitative real-time RT-PCR (qRT-PCR). Results: Correlations with qRT-PCR data were obtained using microarray data that were processed using robust multi-array analysis (RMA) and the MAS 5.0 algorithm. Our results indicate that when identical transcripts are targeted by the two methods, correlations between qRT-PCR and microarray data are generally strong (r = 0.89). However, we observed poor correlations between qRT-PCR and RMA or MAS 5.0 normalized microarray data for 13% or 16% of genes, respectively. Conclusion: These results highlight the complementarity of oligonucleotide microarray and qRT-PCR technologies for validation of gene expression measurements, while emphasizing the continuing requirement for caution in interpreting gene expression data.	Univ Western Australia, Telethon Inst Child Hlth Res, Div Childrens Leukaemia & Canc Res, Perth, WA 6009, Australia; Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; Univ Western Australia, Telethon Inst Child Hlth Res, Div Biostat & Genet Epidemiol, Perth, WA 6009, Australia		Dallas, PB (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Div Childrens Leukaemia & Canc Res, Perth, WA 6009, Australia.	peterd@ichr.uwa.edu.au; nickg@ichr.uwa.edu.au; martyf@ichr.uwa.edu.au; alex@ichr.uwa.edu.au; katrinh@ichr.uwa.edu.au; philippa@ichr.uwa.edu.au; josephf@ichr.uwa.edu.au; joanneb@ichr.uwa.edu.au; aaroncummings1@optusnet.com.au; ursula@ichr.uwa.edu.au	Dallas, Peter B/C-4695-2013; Beesley, Alex H/K-5805-2013	Dallas, Peter B/0000-0003-0861-9054; Beesley, Alex H/0000-0002-5742-7270; Firth, Martin/0000-0002-7471-0860; Freitas, Joseph/0000-0003-3104-6282; Gottardo, Nicholas/0000-0002-1082-6776	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [95475] Funding Source: Medline		Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; ETIENNE W, 2004, BIOTECHNIQUES, V622, P624; Gilbertson RJ, 2003, NAT GENET, V35, P197, DOI 10.1038/ng1103-197; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hoffmann K, 2005, MOL BIOTECHNOL, V29, P31, DOI 10.1385/MB:29:1:31; Howbrook DN, 2003, DRUG DISCOV TODAY, V8, P642, DOI 10.1016/S1359-6446(03)02773-9; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jordan B, 2002, ANN NY ACAD SCI, V975, P24, DOI 10.1111/j.1749-6632.2002.tb05938.x; Kees UR, 2004, IMMUNOL CELL BIOL, V82, P154, DOI 10.1046/j.0818-9641.2004.01236.x; Kees UR, 2001, BLOOD, V97, P4003; Kees UR, 2003, LEUKEMIA, V17, P887, DOI 10.1038/sj.leu.2402892; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Mocellin S, 2003, TRENDS MOL MED, V9, P189, DOI 10.1016/S1471-4914(03)00047-9; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Mutch DM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-17; Petricoin EF, 2002, NAT GENET, V32, P474, DOI 10.1038/ng1029; Rockett JC, 2004, GENOMICS, V83, P541, DOI 10.1016/j.ygeno.2003.09.017; Russo G, 2003, ONCOGENE, V22, P6497, DOI 10.1038/sj.onc.1206865; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	24	262	274	0	24	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	APR 27	2005	6								59	10.1186/1471-2164-6-59			10	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	932HO	WOS:000229545000001	15854232	Green Published, gold			2022-01-24	
J	Chardon, F; Virlon, B; Moreau, L; Falque, M; Joets, J; Decousset, L; Murigneux, A; Charcosset, A				Chardon, F; Virlon, B; Moreau, L; Falque, M; Joets, J; Decousset, L; Murigneux, A; Charcosset, A			Genetic architecture of flowering time in maize as inferred from quantitative trait loci meta-analysis and synteny conservation with the rice genome	GENETICS			English	Article							MARKER-ASSISTED INTROGRESSION; PLANT HEIGHT; TROPICAL MAIZE; PHOTOPERIOD SENSITIVITY; MERISTEM IDENTITY; DRAFT SEQUENCE; INBRED LINES; QTL; IDENTIFICATION; TRANSITION	Genetic architecture of flowering time in maize was addressed by synthesizing a total of 313 quantitative trait loci (QTL) available for this trait. These were analyzed first with an overview Statistic that highlighted regions of key importance and then with a meta-analysis method that yielded a synthetic genetic model with 62 consensus QTL. Six of these displayed a major effect. Meta-analysis led in this case to a twofold increase in die precision in QTL position estimation, Mien compared to the most precise initial QTL position within the corresponding region. The 62 consensus QTL were compared first to the positions of the few flowering-time candidate genes that have been mapped in maize. We then projected rice candidate genes onto the maize genome using a synteny conservation approach based on comparative mapping between the maize genetic map and japonica rice physical map. This yielded 19 associations between maize QTL and genes involved in flowering time in rice and in Arabidopsis. Results suggest that the combination of meta-analysis within a species of interest and synteny-based projections front a related model plant can be an efficient strategy for identifying new candidate genes for trait variation.	CNRS, INRA, INA PG, UPS,Stn Genet Vegetale, F-91190 Gif Sur Yvette, France; Biogemma, F-63170 Clermont Ferrand, France		Chardon, F (corresponding author), CNRS, INRA, INA PG, UPS,Stn Genet Vegetale, F-91190 Gif Sur Yvette, France.	charcos@moulon.inra.fr	Chardon, Fabien/G-4826-2013; Joets, Johann/G-3710-2010; Chardon, Fabien/J-1963-2019	Chardon, Fabien/0000-0001-7909-3884; Chardon, Fabien/0000-0001-7909-3884; Falque, Matthieu/0000-0002-6444-858X; Charcosset, Alain/0000-0001-6125-503X; Joets, Johann/0000-0002-5353-5100			ABLER BSB, 1991, CROP SCI, V31, P267, DOI 10.2135/cropsci1991.0011183X003100020006x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Austin DF, 1996, GENOME, V39, P957, DOI 10.1139/g96-120; Basu D, 2000, PLANT MOL BIOL, V44, P27, DOI 10.1023/A:1006488119301; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETZEN JL, 1993, TRENDS GENET, V9, P259, DOI 10.1016/0168-9525(93)90001-X; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; BLANC G, 2003, 12 M EUCARPIA SECT B, P55; Blazquez MA, 2000, J CELL SCI, V113, P3547; Bohn M, 2000, THEOR APPL GENET, V101, P907, DOI 10.1007/s001220051561; Bohn M, 1996, CROP SCI, V36, P1352, DOI 10.2135/cropsci1996.0011183X003600050045x; Bomblies K, 2003, DEVELOPMENT, V130, P2385, DOI 10.1242/dev.00457; Bouchez A, 2002, GENETICS, V162, P1945; Cardinal AJ, 2001, CROP SCI, V41, P835, DOI 10.2135/cropsci2001.413835x; Chandler VL, 2002, PLANT PHYSIOL, V130, P1594, DOI 10.1104/pp.015594; CHRISTENSEN AH, 1989, GENE, V85, P381, DOI 10.1016/0378-1119(89)90431-9; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; DABNEY A, 2003, QVALUE; DANILEVSKAYA O, 2003, PLANT BIOL 2003; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; DEHESH K, 1991, MOL GEN GENET, V225, P305, DOI 10.1007/BF00269863; DELVIN B, 2003, HEREDITY, V91, P537; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; Dunford RP, 2002, GENETICS, V161, P825; ELASSAL SED, 2003, PLANT PHYSIOL, V133, P1; FALQUE M, 2003, 45 ANN MAIZ GEN C U; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Goffinet B, 2000, GENETICS, V155, P463; Groh S, 1998, PLANT BREEDING, V117, P193, DOI 10.1111/j.1439-0523.1998.tb01926.x; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; IRISH EE, 1991, DEVELOPMENT, V112, P891; Izawa T, 2000, PLANT J, V22, P391, DOI 10.1046/j.1365-313X.2000.00753.x; Izawa T, 2003, CURR OPIN PLANT BIOL, V6, P113, DOI 10.1016/S1369-5266(03)00014-1; Kearsey MJ, 1998, HEREDITY, V80, P137, DOI 10.1046/j.1365-2540.1998.00500.x; KOESTER RP, 1993, CROP SCI, V33, P1209, DOI 10.2135/cropsci1993.0011183X003300060020x; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Laurie DA, 1997, PLANT MOL BIOL, V35, P167, DOI 10.1023/A:1005726329248; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; LIN YR, 1995, GENETICS, V141, P391; Lubberstedt T, 1997, CROP SCI, V37, P921, DOI 10.2135/cropsci1997.0011183X003700030037x; Lynch M., 1998, GENETICS ANAL QUANTI; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; Mechin V, 2001, CROP SCI, V41, P690, DOI 10.2135/cropsci2001.413690x; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Millar AJ, 2004, J EXP BOT, V55, P277, DOI 10.1093/jxb/erh034; MOREAU L, 1998, THESIS I NATL AGRONO; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Ogas J, 1998, CURR BIOL, V8, pR165, DOI 10.1016/S0960-9822(98)70101-0; Paterson AH, 2003, CURR OPIN GENET DEV, V13, P644, DOI 10.1016/j.gde.2003.10.002; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; RAGOT M, 1995, CROP SCI, V35, P1306, DOI 10.2135/cropsci1995.0011183X003500050009x; Rebai A, 1997, THEOR APPL GENET, V95, P451, DOI 10.1007/s001220050582; Reymond M, 2003, PLANT PHYSIOL, V131, P664, DOI 10.1104/pp.013839; Ribaut JM, 1996, THEOR APPL GENET, V92, P905, DOI 10.1007/BF00221905; Salvi S, 2002, PLANT MOL BIOL, V48, P601, DOI 10.1023/A:1014838024509; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STUBER CW, 1992, GENETICS, V132, P823; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takano M, 2001, PLANT CELL, V13, P521, DOI 10.1105/tpc.13.3.521; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; van Nocker S, 2000, PLANT MOL BIOL, V44, P107, DOI 10.1023/A:1006472929800; Vandepoele K, 2003, PLANT CELL, V15, P2192, DOI 10.1105/tpc.014019; Vega SH, 2002, PLANT CELL, V14, P133, DOI 10.1105/tpc.010406; Veldboom LR, 1996, CROP SCI, V36, P1320, DOI 10.2135/cropsci1996.0011183X003600050041x; Visscher PM, 1996, GENETICS, V144, P1923; Vladutu C, 1999, GENETICS, V153, P993; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wilson WA, 1999, GENETICS, V153, P453; Yano M, 1997, PLANT MOL BIOL, V35, P145, DOI 10.1023/A:1005764209331; Yano M, 2001, PLANT PHYSIOL, V127, P1425, DOI 10.1104/pp.010710; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	79	262	328	6	72	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	DEC	2004	168	4					2169	2185		10.1534/genetics.104.032375			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	890AE	WOS:000226483300035	15611184	Bronze, Green Published			2022-01-24	
J	Tishkoff, SA; Kidd, KK				Tishkoff, SA; Kidd, KK			Implications of biogeography of human populations for 'race' and medicine	NATURE GENETICS			English	Article							RECENT POSITIVE SELECTION; LOW NUCLEOTIDE DIVERSITY; HUMAN GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; SEQUENCE VARIATION; HUMAN GENOME; EVOLUTIONARY HISTORY; BALANCING SELECTION; HAPLOTYPE VARIATION; NATURAL-SELECTION	In this review, we focus on the biogeographical distribution of genetic variation and address whether or not populations cluster according to the popular concept of 'race'. We show that racial classifications are inadequate descriptors of the distribution of genetic variation in our species. Although populations do cluster by broad geographic regions, which generally correspond to socially recognized races, the distribution of genetic variation is quasicontinuous in clinal patterns related to geography. The broad global pattern reflects the accumulation of genetic drift associated with a recent African origin of modern humans, followed by expansion out of Africa and across the rest of the globe. Because disease genes may be geographically restricted due to mutation, genetic drift, migration and natural selection, knowledge of individual ancestry will be important for biomedical studies. Identifiers based on race will often be insufficient.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA		Kidd, KK (corresponding author), Univ Maryland, Dept Biol, Bldg 144, College Pk, MD 20742 USA.	tishkoff@umd.edu; kenneth.kidd@yale.edu					Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gould Stephen Jay, 1981, MISMEASURE MAN; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; KIDD K, 2001, NEW DIMENSIONS BIOET, P11; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kidd KK, 2004, J HERED, V95, P406, DOI 10.1093/jhered/esh060; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; LI WH, 1991, GENETICS, V129, P513; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; Marks Jonathan M, 1995, HUMAN BIODIVERSITY G; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Oota H, 2004, ANN HUM GENET, V68, P93, DOI 10.1046/j.1529-8817.2003.00060.x; Osier MV, 2002, AM J PHYS ANTHROPOL, V119, P77, DOI 10.1002/ajpa.10094; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 2003, AM J HUM GENET, V72, P812, DOI 10.1086/373882; RISCH N, 2002, GENOME BIOL, V12, P602; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saunders MA, 2002, GENETICS, V162, P1849; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 2003, CURR OPIN GENET DEV, V13, P569, DOI 10.1016/j.gde.2003.10.010; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Verrelli BC, 2004, AM J HUM GENET, V75, P363, DOI 10.1086/423287; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wolpoff MH, 1996, SCIENCE, V274, P704; Wooding SP, 2002, AM J HUM GENET, V71, P528, DOI 10.1086/342260; Wright S., 1969, EVOLUTION GENETICS P, VII; Yu N, 2003, GENETICS, V164, P1511; Zhao H, 1999, ANN HUM GENET, V63, P167, DOI 10.1046/j.1469-1809.1999.6320167.x	70	262	274	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S21	S27		10.1038/ng1438			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	WOS:000224854000007	15507999	Bronze			2022-01-24	
J	Reilly, KM; Loisel, DA; Bronson, RT; McLaughlin, ME; Jacks, T				Reilly, KM; Loisel, DA; Bronson, RT; McLaughlin, ME; Jacks, T			Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects	NATURE GENETICS			English	Article							NF1 TUMOR-SUPPRESSOR; NEUROFIBROMATOSIS TYPE-1; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; MOLECULAR ANALYSIS; TRANSGENIC MICE; P53 MUTATIONS; BRAIN-TUMORS; PROGRESSION; PATHWAYS; CELLS	Astrocytomas are the leading cause of brain cancer in humans. Because these tumours are highly infiltrative, current treatments that rely on targeting the tumour mass are often ineffective. A mouse model for astrocytoma would be a powerful tool for dissecting tumour progression and testing therapeutics. Mouse models of astrocytoma have been designed to express oncogenic proteins in astrocytes, but have had limited success due to low tumour penetrance or limited tumour progression(1-3). We present here a mouse model of astrocytomas involving mutation of two tumour-suppressor genes, Nf1 and Trp53. Humans with mutations in NF1 develop neurofibromatosis type I (NF1) and have increased risk of optic gliomas, astrocytomas and glioblastomas(4,5). The TP53 tumour suppressor is often mutated in a subset of astrocytomas that develop at a young age and progress slowly to glioblastoma (termed secondary glioblastomas, in contrast to primary glioblastomas that develop rapidly de novo(6-10)). This mouse model shows a range of astrocytoma stages, from low-grade astrocytoma to glioblastoma multiforme, and may accurately model human secondary glioblastoma involving TP53 loss. This is the first reported mouse model of astrocytoma initiated by loss of tumour suppressors, rather than overexpression of transgenic oncogenes.	MIT, Dept Biol, Cambridge, England; MIT, Ctr Canc Res, Cambridge, England; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Vet Med, Dept Pathol, Boston, MA 02111 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; MIT, Howard Hughes Med Inst, Cambridge, MA USA		Jacks, T (corresponding author), MIT, Dept Biol, Cambridge, England.		Reilly, Karlyne/V-4475-2019; Loisel, Dagan/A-6671-2010	Reilly, Karlyne/0000-0001-9109-4409; 			Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; DANKS RA, 1995, CANCER RES, V55, P4302; EASTGATE AR, 1993, J ANAL ATOM SPECTROM, V8, P305, DOI 10.1039/ja9930800305; GOULD VE, 1986, HUM PATHOL, V17, P979, DOI 10.1016/S0046-8177(86)80080-6; Gutmann DH, 1999, ONCOGENE, V18, P4450, DOI 10.1038/sj.onc.1202829; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Huson S, 1994, NEUROFIBROMATOSES PA; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kleihues P., 1997, PATHOLOGY GENETICS T; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; MARSDEN HB, 1983, INT J CANCER, V31, P439, DOI 10.1002/ijc.2910310408; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; RASHEED BKA, 1994, CANCER RES, V54, P1324; Rizvi TA, 1999, BRAIN RES, V816, P111, DOI 10.1016/S0006-8993(98)01133-0; Scherer HJ, 1940, BRAIN, V63, P1, DOI 10.1093/brain/63.1.1; SORENSEN SA, 1986, NEW ENGL J MED, V314, P1010, DOI 10.1056/NEJM198604173141603; TISCHLER AS, 1995, ENDOCR PATHOL, V6, P323, DOI 10.1007/BF02738732; VANMEYEL DJ, 1994, JNCI-J NATL CANCER I, V86, P1011, DOI 10.1093/jnci/86.13.1011; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Watanabe K, 1997, CLIN CANCER RES, V3, P523; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Weissenberger J, 1997, ONCOGENE, V14, P2005, DOI 10.1038/sj.onc.1201168	27	262	271	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					109	113		10.1038/79075			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000030	10973261				2022-01-24	
J	Farnir, F; Coppieters, W; Arranz, JJ; Berzi, P; Cambisano, N; Grisart, B; Karim, L; Marcq, F; Moreau, L; Mni, M; Nezer, C; Simon, P; Vanmanshoven, P; Wagenaar, D; Georges, M				Farnir, F; Coppieters, W; Arranz, JJ; Berzi, P; Cambisano, N; Grisart, B; Karim, L; Marcq, F; Moreau, L; Mni, M; Nezer, C; Simon, P; Vanmanshoven, P; Wagenaar, D; Georges, M			Extensive genome-wide linkage disequilibrium in cattle	GENOME RESEARCH			English	Article							DAIRY-CATTLE; HUMAN-POPULATIONS; REGION; GENE; MAP	A genome-wide linkage disequilibrium (LD) map was generated using microsatellite genotypes (284 autosomal microsatellite loci) of 581 gametes sampled From the dutch black-and-white dairy cattle population. LD was measured between all marker pairs, both syntenic and nonsyntenic. Analysis of syntenic pairs revealed surprisingly high levels of LD that, although more pronounced for closely linked marker pairs, extended over several tens of centimorgan. In addition, significant gametic associations were also shown to be very common between nonsyntenic loci. Simulations using the known genealogies of the studied sample indicate that random drift alone is likely to account for most of the observed disequilibrium. No clear evidence was obtained for a direct effect of selection ("Bulmer effect"). The observation of long range disequilibrium between syntenic loci using low-density marker maps indicates that LD mapping has the potential to be very effective in livestock populations. The frequent occurrence of gametic associations between nonsyntenic loci, however, encourages the combined use of linkage and linkage disequilibrium methods to avoid false positive results when mapping genes in livestock.	Univ Liege B43, Fac Med Vet, Dept Genet, B-4000 Liege, Belgium		Georges, M (corresponding author), Univ Liege B43, Fac Med Vet, Dept Genet, B-4000 Liege, Belgium.		Arranz, Juan-Jose/H-1225-2015; Coppieters, Wouter/AAF-5030-2021	Arranz, Juan-Jose/0000-0001-9058-131X; Coppieters, Wouter/0000-0001-8109-7825; Georges, Michel/0000-0003-4124-2375			Boichard D, 1996, PROD ANIM, V9, P323; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Charlier C, 1996, GENOME RES, V6, P580, DOI 10.1101/gr.6.7.580; Coppieters W, 1998, MAMM GENOME, V9, P540, DOI 10.1007/s003359900815; CrouauRoy B, 1996, HUM MOL GENET, V5, P1131, DOI 10.1093/hmg/5.8.1131; GEORGES M, 1995, GENETICS, V139, P907; GODDARD ME, 1992, J DAIRY SCI, V75, P2902, DOI 10.3168/jds.S0022-0302(92)78052-7; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEDRICK PW, 1987, GENETICS, V117, P331; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Kappes SM, 1997, GENOME RES, V7, P235, DOI 10.1101/gr.7.3.235; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; LEWONTIN RC, 1964, GENETICS, V49, P49; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; OHTA T, 1969, GENETICS, V63, P229; Riquet J, 1999, P NATL ACAD SCI USA, V96, P9252, DOI 10.1073/pnas.96.16.9252; Searle M, 1971, LINEAR MODELS; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; WALSH B, 1999, EVOLUTION SELECTION; WEIR BS, 1996, GENETIC DATA ANAL, V2, P117	24	262	280	0	15	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	FEB	2000	10	2					220	227		10.1101/gr.10.2.220			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	285ZH	WOS:000085417900008	10673279	Bronze			2022-01-24	
J	Stickens, D; Clines, G; Burbee, D; Ramos, P; Thomas, S; Hogue, D; Hecht, JT; Lovett, M; Evans, GA				Stickens, D; Clines, G; Burbee, D; Ramos, P; Thomas, S; Hogue, D; Hecht, JT; Lovett, M; Evans, GA			The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes	NATURE GENETICS			English	Article							DIRECT SELECTION; COMPLEX GENOMES; CHROMOSOME-11; MAP; MARKERS; LOCUS; HUMAN-CHROMOSOME-11; HETEROZYGOSITY; LOCALIZATION	Hereditary multiple exostoses (EXT) is an autosomal dominant condition characterized by short stature and the development of bony protuberances at the ends of all the long bones. Three genetic loci have been identified by genetic linkage analysis at chromosomes 8q24.1, 11p11-13 and 19p. The EXT1 gene on chromosome 8 was recently identified and characterized. Here, we report the isolation and characterization of the EXT2 gene. This gene shows striking sequence similarity to the EXT1 gene, and we have identified a four base deletion segregating with the phenotype. Both EXT1 and EXT2 show significant homology with one additional expressed sequence tag, defining a new multigene family of proteins with potential tumour suppressor activity.	UNIV TEXAS, SW MED CTR, MCDERMOTT CTR HUMAN GROWTH & DEV, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA; UNIV TEXAS, SCH MED, DEPT PEDIAT, HOUSTON, TX 77225 USA						NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG000368] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00368, HG00202] Funding Source: Medline		AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COOK A, 1993, AM J HUM GENET, V53, P71; DELMASTRO RG, 1995, GENOME RES, V5, P185, DOI 10.1101/gr.5.2.185; EVANS GA, 1989, P NATL ACAD SCI USA, V86, P5030, DOI 10.1073/pnas.86.13.5030; EVANS GA, IN PRESS GENOME ANAL; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; HECHT JT, 1995, AM J HUM GENET, V56, P1125; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; KOOTH R, 1961, AM J HUM GENET, V13, P340; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; LENNON G, IN PRESS GENOMICS; LEONE NC, 1987, J HERED, V78, P171, DOI 10.1093/oxfordjournals.jhered.a110351; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LONGMIRE J, 1993, GENET ANAL TECH APPL, V10, P49; LOVETT M, 1994, TRENDS GENET, V10, P352, DOI 10.1016/0168-9525(94)90131-7; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; QIN S, 1993, GENOMICS, V16, P580, DOI 10.1006/geno.1993.1233; QUACKENBUSH J, 1995, GENOMICS, V29, P512, DOI 10.1006/geno.1995.9974; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SMITH MW, 1994, NAT GENET, V7, P40, DOI 10.1038/ng0594-40; SMITH MW, 1993, GENOMICS, V17, P699, DOI 10.1006/geno.1993.1392; SOLOMON L, 1961, J BONE JOINT SURG BR, V43, P700, DOI 10.1302/0301-620X.43B4.700; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; WUYTS W, 1995, AM J HUM GENET, V57, P382; [No title captured]	33	262	273	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1996	14	1					25	32		10.1038/ng0996-25			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VF611	WOS:A1996VF61100017	8782816				2022-01-24	
J	STIFANI, S; BLAUMUELLER, CM; REDHEAD, NJ; HILL, RE; ARTAVANISTSAKONAS, S				STIFANI, S; BLAUMUELLER, CM; REDHEAD, NJ; HILL, RE; ARTAVANISTSAKONAS, S			HUMAN HOMOLOGS OF A DROSOPHILA ENHANCER OF SPLIT GENE-PRODUCT DEFINE A NOVEL FAMILY OF NUCLEAR PROTEINS	NATURE GENETICS			English	Article							CASEIN KINASE-II; SV40 T-ANTIGEN; NEUROGENIC LOCUS; SACCHAROMYCES-CEREVISIAE; NOTCH LOCUS; TRANSMEMBRANE PROTEIN; GLUCOSE REPRESSION; SERRATE ENCODES; BINDING-PROTEIN; SHOWS HOMOLOGY	Notch and the m9/10 gene (groucho) of the Enhancer of split (E(spl)) complex are members of the "Notch group" of genes, which is required for a variety of cell fate choices in Drosophila. We have characterized human cDNA clones encoding a family of proteins, designated TLE, that are homologous to the E(spl) m9/10 gene product, as well as a novel Notch-related protein. The TLE genes are differentially expressed and encode nuclear proteins, consistent with the presence of sequence motifs associated with nuclear functions. The structural redundancy implied by the existence of more than one TLE and Notch-homologous gene may be a feature of the human counterparts of the developmentally important Drosophila Notch group genes.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,BOYER CTR MOLEC MED,DEPT CELL BIOL,NEW HAVEN,CT 06536; YALE UNIV,SCH MED,DEPT BIOL,NEW HAVEN,CT 06536; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND					Stifani, Stefano/0000-0002-2376-7701			ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; DALRYMPLE MA, 1989, CELL, V58, P811, DOI 10.1016/0092-8674(89)90930-6; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DELIDAKIS C, 1991, GENETICS, V129, P803; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; GUILLEMOT F, 1989, P NATL ACAD SCI USA, V86, P4594, DOI 10.1073/pnas.86.12.4594; HARTLEY DA, 1988, CELL, V55, P785, DOI 10.1016/0092-8674(88)90134-1; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KALDERON D, 1984, NATURE, V311, P499; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1987, EMBO J, V6, P4113, DOI 10.1002/j.1460-2075.1987.tb02757.x; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Meisner H, 1991, CURR OPIN CELL BIOL, V3, P474, DOI 10.1016/0955-0674(91)90076-B; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; PREISS A, 1988, EMBO J, V7, P3917, DOI 10.1002/j.1460-2075.1988.tb03278.x; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; RUGGIERI R, 1989, P NATL ACAD SCI USA, V86, P8778, DOI 10.1073/pnas.86.22.8778; SAMBROOK J, 1989, MOL CLINING LABORATO; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STIFANI S, 1988, BIOCHEM J, V250, P467, DOI 10.1042/bj2500467; THOMAS U, 1991, DEVELOPMENT, V111, P749; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; VAESSIN H, 1985, J NEUROGENET, V2, P291; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WILLIAMS FE, 1990, MOL CELL BIOL, V10, P6500, DOI 10.1128/MCB.10.12.6500; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; XU T, 1991, GENETICS, V126, P665; YOCHEM J, 1987, J MOL BIOL, V195, P233, DOI 10.1016/0022-2836(87)90646-2	55	262	269	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					119	127		10.1038/ng1092-119			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	WOS:A1992JR08400010	1303260				2022-01-24	
J	AVISE, JC; LANSMAN, RA; SHADE, RO				AVISE, JC; LANSMAN, RA; SHADE, RO			USE OF RESTRICTION ENDONUCLEASES TO MEASURE MITOCHONDRIAL-DNA SEQUENCE RELATEDNESS IN NATURAL-POPULATIONS .1. POPULATION-STRUCTURE AND EVOLUTION IN THE GENUS PEROMYSCUS	GENETICS			English	Article									UNIV GEORGIA, DEPT MICROBIOL, ATHENS, GA 30602 USA		AVISE, JC (corresponding author), UNIV GEORGIA, DEPT ZOOL, ATHENS, GA 30602 USA.						AVISE JC, 1979, J MAMMAL, V60, P177, DOI 10.2307/1379769; BATTEY J, 1978, CELL, V14, P143, DOI 10.1016/0092-8674(78)90309-4; BLAIR WF, 1950, EVOLUTION, V4, P253, DOI 10.2307/2405335; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; BORST P, 1972, ANNU REV BIOCHEM, V41, P333, DOI 10.1146/annurev.bi.41.070172.002001; BOYER HW, 1971, ANNU REV MICROBIOL, V25, P153, DOI 10.1146/annurev.mi.25.100171.001101; BOYER HW, 1974, FED PROC, V33, P1125; BROWN WM, 1974, P NATL ACAD SCI USA, V71, P4617, DOI 10.1073/pnas.71.11.4617; CHANG ACY, 1975, CELL, V6, P231, DOI 10.1016/0092-8674(75)90014-8; DAWID IB, 1972, DEV BIOL, V29, P152, DOI 10.1016/0012-1606(72)90052-8; Dice L. R., 1968, P75; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; GREENE PJ, 1978, NUCLEIC ACIDS RES, V5, P2373, DOI 10.1093/nar/5.7.2373; Gresson RAR, 1940, NATURE, V145, P425, DOI 10.1038/145425b0; HAYASHI JI, 1978, BIOCHEM BIOPH RES CO, V83, P1032, DOI 10.1016/0006-291X(78)91499-7; HELLING RB, 1974, J VIROL, V14, P1235, DOI 10.1128/JVI.14.5.1235-1244.1974; JAKOVCIC S, 1975, BIOCHEMISTRY-US, V14, P2043, DOI 10.1021/bi00681a002; KIMURA M, 1973, GENETICS, V75, P199; KOHNE DE, 1972, EVOLUTION MAMMALIAN, V5, P193; MANIATIS T, 1975, BIOCHEMISTRY-US, V14, P3787, DOI 10.1021/bi00688a010; MICHAELI.P, 1967, NUCLEUS, V10, P1; MURRAY K, 1975, J MOL BIOL, V98, P551, DOI 10.1016/S0022-2836(75)80086-6; NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215; OHTA T, 1974, NATURE, V252, P351, DOI 10.1038/252351a0; OJALA D, 1977, PLASMID, V1, P78, DOI 10.1016/0147-619X(77)90010-5; POTTER SS, 1975, P NATL ACAD SCI USA, V72, P4496, DOI 10.1073/pnas.72.11.4496; PRAGER EM, 1978, J MOL EVOL, V11, P129, DOI 10.1007/BF01733889; SACCONE C, 1976, GENETIC FUNCTION MIT; Sneath P. H. A., 1973, NUMERICAL TAXONOMY; UPHOLT WB, 1977, NUCLEIC ACIDS RES, V4, P1257, DOI 10.1093/nar/4.5.1257; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; [No title captured]	33	262	270	0	13	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics		1979	92	1					279	295					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HG444	WOS:A1979HG44400021	499767				2022-01-24	
J	Jones, DF				Jones, DF			Dominance of linked factors as a means of accounting for heterosis	GENETICS			English	Article									Connecticut Agr Expt Stn, New Haven, CT USA								BAUR E, 1911, EINFUHRUNG EXPT VERE; Darwin C., 1877, EFFECTS CROSS SELF F; East EM, 1909, AM NAT, V43, P173, DOI 10.1086/279042; East EM, 1910, AM NAT, V44, P65, DOI 10.1086/279117; East EM, 1915, AM NAT, V49, P457, DOI 10.1086/279494; EAST EM, 1912, USDA BUR PLANT IND B, V243, P58; EAST EM, 1908, CONNECTICUT AGR EXP, P419; EMERSON RA, 1913, NEBRASKA AGR EXP STA, V2, P120; FOCKE WO, 1881, PFLANZENMISCHLINGE B, P569; GARTNER CF, 1849, VERSUCHE BEOBACHTUNG; HAYES HK, 1912, CONN AGR EXP STA B, V171, P45; JONES DF, 1916, SCIENCE, V63, P290; Keeble F, 1910, J GENET, V1, P47, DOI 10.1007/BF02981568; KOLREUTER JG, 1766, DRITTE FORTSETZUNG V; Morgan TH, 1915, MECH MENDELIAN HERED; Nilsson-Ehle H, 1909, KREUZUNGSUNTERSUCHUN, V5; NILSSONEHLE H, 1908, BOT NOTISER, P257; Shull G.H, 1909, AM BREEDERS ASS REP, V4, P296, DOI 10.1093/jhered/os-5.1.51; Shull G.H., 1914, MOL GEN GENET, V12, P97, DOI [10.1007/BF01837282, DOI 10.1007/BF01837282]; Shull GH, 1911, AM NAT, V45, P234, DOI 10.1086/279207; Shull GH., 1908, AM BREEDERSASSOC REP, Vos-4, P296, DOI 10.1093/jhered/os-4.1.296; SHULL GH, 1910, AM BREEDERS MAG, V1, P98	22	262	279	1	9	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	SEP	1917	2	5					466	479					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V23KU	WOS:000201582800004	17245892				2022-01-24	
J	Cooper, CS; Eeles, R; Wedge, DC; Van Loo, P; Gundem, G; Alexandrov, LB; Kremeyer, B; Butler, A; Lynch, AG; Camacho, N; Massie, CE; Kay, J; Luxton, HJ; Edwards, S; Kote-Jarai, Z; Dennis, N; Merson, S; Leongamornlert, D; Zamora, J; Corbishley, C; Thomas, S; Nik-Zainal, S; O'Meara, S; Matthews, L; Clark, J; Hurst, R; Mithen, R; Bristow, RG; Boutros, PC; Fraser, M; Cooke, S; Raine, K; Jones, D; Menzies, A; Stebbings, L; Hinton, J; Teague, J; McLaren, S; Mudie, L; Hardy, C; Anderson, E; Joseph, O; Goody, V; Robinson, B; Maddison, M; Gamble, S; Greenman, C; Berney, D; Hazell, S; Livni, N; Fisher, C; Ogden, C; Kumar, P; Thompson, A; Woodhouse, C; Nicol, D; Mayer, E; Dudderidge, T; Shah, NC; Gnanapragasam, V; Voet, T; Campbell, P; Futreal, A; Easton, D; Warren, AY; Foster, CS; Stratton, MR; Whitaker, HC; McDermott, U; Brewer, DS; Neal, DE				Cooper, Colin S.; Eeles, Rosalind; Wedge, David C.; Van Loo, Peter; Gundem, Gunes; Alexandrov, Ludmil B.; Kremeyer, Barbara; Butler, Adam; Lynch, Andrew G.; Camacho, Niedzica; Massie, Charlie E.; Kay, Jonathan; Luxton, Hayley J.; Edwards, Sandra; Kote-Jarai, Zsofia; Dennis, Nening; Merson, Sue; Leongamornlert, Daniel; Zamora, Jorge; Corbishley, Cathy; Thomas, Sarah; Nik-Zainal, Serena; O'Meara, Sarah; Matthews, Lucy; Clark, Jeremy; Hurst, Rachel; Mithen, Richard; Bristow, Robert G.; Boutros, Paul C.; Fraser, Michael; Cooke, Susanna; Raine, Keiran; Jones, David; Menzies, Andrew; Stebbings, Lucy; Hinton, Jon; Teague, Jon; McLaren, Stuart; Mudie, Laura; Hardy, Claire; Anderson, Elizabeth; Joseph, Olivia; Goody, Victoria; Robinson, Ben; Maddison, Mark; Gamble, Stephen; Greenman, Christopher; Berney, Dan; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Woodhouse, Christopher; Nicol, David; Mayer, Erik; Dudderidge, Tim; Shah, Nimish C.; Gnanapragasam, Vincent; Voet, Thierry; Campbell, Peter; Futreal, Andrew; Easton, Douglas; Warren, Anne Y.; Foster, Christopher S.; Stratton, Michael R.; Whitaker, Hayley C.; McDermott, Ultan; Brewer, Daniel S.; Neal, David E.		ICGC Prostate Grp	Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue	NATURE GENETICS			English	Article							COPY-NUMBER ANALYSIS; 21 BREAST CANCERS; MUTATIONAL PROCESSES; RADICAL PROSTATECTOMY; LANDSCAPE; GENOMES; HETEROGENEITY; ALGORITHMS; SIGNATURES; EVOLUTION	Genome-wide DNA sequencing was used to decrypt the phylogeny of multiple samples from distinct areas of cancer and morphologically normal tissue taken from the prostates of three men. Mutations were present at high levels in morphologically normal tissue distant from the cancer, reflecting clonal expansions, and the underlying mutational processes at work in morphologically normal tissue were also at work in cancer. Our observations demonstrate the existence of ongoing abnormal mutational processes, consistent with field effects, underlying carcinogenesis. This mechanism gives rise to extensive branching evolution and cancer clone mixing, as exemplified by the coexistence of multiple cancer lineages harboring distinct ERG fusions within a single cancer nodule. Subsets of mutations were shared either by morphologically normal and malignant tissues or between different ERG lineages, indicating earlier or separate clonal cell expansions. Our observations inform on the origin of multifocal disease and have implications for prostate cancer therapy in individual cases.	[Cooper, Colin S.; Eeles, Rosalind; Camacho, Niedzica; Edwards, Sandra; Kote-Jarai, Zsofia; Merson, Sue; Leongamornlert, Daniel; Matthews, Lucy; Brewer, Daniel S.] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Cooper, Colin S.] Univ E Anglia, Dept Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Cooper, Colin S.; Clark, Jeremy; Hurst, Rachel; Brewer, Daniel S.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Eeles, Rosalind; Dennis, Nening; Thomas, Sarah; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Woodhouse, Christopher; Nicol, David; Mayer, Erik; Dudderidge, Tim] Royal Marsden NHS Fdn Trust, London, England; [Eeles, Rosalind; Dennis, Nening; Thomas, Sarah; Hazell, Steven; Livni, Naomi; Fisher, Cyril; Ogden, Christopher; Kumar, Pardeep; Thompson, Alan; Woodhouse, Christopher; Nicol, David; Mayer, Erik; Dudderidge, Tim] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England; [Wedge, David C.; Van Loo, Peter; Gundem, Gunes; Alexandrov, Ludmil B.; Kremeyer, Barbara; Butler, Adam; Zamora, Jorge; Nik-Zainal, Serena; O'Meara, Sarah; Cooke, Susanna; Raine, Keiran; Jones, David; Menzies, Andrew; Stebbings, Lucy; Hinton, Jon; Teague, Jon; McLaren, Stuart; Mudie, Laura; Hardy, Claire; Anderson, Elizabeth; Joseph, Olivia; Goody, Victoria; Robinson, Ben; Maddison, Mark; Gamble, Stephen; Campbell, Peter; Futreal, Andrew; Stratton, Michael R.; McDermott, Ultan] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Leuven, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Leuven, Belgium; [Van Loo, Peter] Canc Res UK London Res Inst, London WC2A 3PX, England; [Lynch, Andrew G.] Canc Res UK Cambridge Res Inst, Stat & Computat Biol Lab, Cambridge, England; [Massie, Charlie E.; Kay, Jonathan; Luxton, Hayley J.; Shah, Nimish C.; Gnanapragasam, Vincent; Whitaker, Hayley C.; Neal, David E.] Canc Res UK Cambridge Res Inst, Urol Res Lab, Cambridge, England; [Corbishley, Cathy] St George Hosp, Dept Histopathol, London, England; [Mithen, Richard] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Bristow, Robert G.; Fraser, Michael] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Bristow, Robert G.; Fraser, Michael] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Bristow, Robert G.; Fraser, Michael] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Greenman, Christopher] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Berney, Dan] Barts & London Queen Marys Sch Med & Dent, Barts Canc Ctr, Dept Mol Oncol, London, England; [Voet, Thierry] Katholieke Univ Leuven, Dept Human Genet, Lab Reprod Genom, Leuven, Belgium; [Easton, Douglas] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Warren, Anne Y.] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Foster, Christopher S.] Univ Liverpool, Dept Histopathol, Liverpool L69 3BX, Merseyside, England; [Foster, Christopher S.] HCA Pathol Labs, London, England; [Brewer, Daniel S.] Genome Anal Ctr, Norwich, Norfolk, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg Oncol, Cambridge CB2 2QQ, England		Cooper, CS (corresponding author), Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England.	colin.cooper@icr.ac.uk; ros.eeles@icr.ac.uk; den22@medschl.cam.ac.uk	Alexandrov, Ludmil/AAS-1454-2021; Luxton, Hayley/AAT-2450-2020; Voet, Thierry/E-8877-2017; Dudderidge, Tim/AAO-1430-2020; Nicol, David L/M-6809-2016; Wedge, David/AAC-4977-2021; Nik-Zainal, Serena/ABD-4437-2020; Mayer, Erik K/A-6207-2013; Brewer, Daniel S/D-6201-2018; Gamble, Stephen/D-1417-2011	Alexandrov, Ludmil/0000-0003-3596-4515; Luxton, Hayley/0000-0003-1431-3844; Voet, Thierry/0000-0003-1204-9963; Nicol, David L/0000-0002-5623-7467; Mayer, Erik K/0000-0002-5509-4580; Brewer, Daniel S/0000-0003-4753-9794; Massie, Charlie/0000-0003-2314-4843; Wedge, David/0000-0002-7572-3196; Berney, Daniel/0000-0001-5474-8696; Leongamornlert, Daniel/0000-0002-3486-3168; Hurst, Rachel/0000-0001-8066-324X; Raine, Keiran/0000-0002-5634-1539; Van Loo, Peter/0000-0003-0292-1949; Gamble, Stephen/0000-0002-0867-3723; Lynch, Andy/0000-0002-7876-7338; Eeles, Rosalind/0000-0002-3698-6241; Bristow, Robert/0000-0002-8553-9544; Mithen, Richard/0000-0001-7307-4324; Nik-Zainal, Serena/0000-0001-5054-1727; Dudderidge, Tim/0000-0001-6373-3613; Bova, George/0000-0003-1639-3104; Nicol, David/0000-0003-0107-6990; McDermott, Ultan/0000-0001-9032-4700; Boutros, Paul/0000-0003-0553-7520	Cancer Research UKCancer Research UK [C5047/A14835]; Dallaglio Foundation; Wellcome TrustWellcome TrustEuropean Commission; Bob Champion Cancer Trust; Orchid Cancer Appeal; RoseTrees TrustRosetrees Trust; North West Cancer Research Fund; Big C; King family; Grand Charity of Freemasons; Research Foundation Flanders (FWO)FWO; Biomedical Research Centre at the Institute of Cancer Research - National Institute for Health Research; Royal Marsden NHS Foundation Trust - National Institute for Health Research; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) [G0500966/75466]; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/F/00042686, BBS/E/T/000PR5885, BBS/E/T/000PR6193, BBS/E/F/00044431] Funding Source: UKRI; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/F/00042686, BBS/E/T/000PR6193, BBS/E/F/00044431, BBS/E/T/000PR5885] Funding Source: researchfish; Cancer Research UKCancer Research UK [14835, 15007, 17528] Funding Source: researchfish; Versus ArthritisVersus Arthritis [20406] Funding Source: researchfish; The Francis Crick Institute [10202] Funding Source: researchfish	This work was funded by Cancer Research UK (grant C5047/A14835), the Dallaglio Foundation and the Wellcome Trust. We also acknowledge support from the Bob Champion Cancer Trust, the Orchid Cancer Appeal, the RoseTrees Trust, the North West Cancer Research Fund, Big C, the King family, the Grand Charity of Freemasons, and the Research Foundation Flanders (FWO). We thank D. Holland from the Infrastructure Management Team and P. Clapham from the Informatics Systems Group at the Wellcome Trust Sanger Institute. We acknowledge the Biomedical Research Centre at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, supported by the National Institute for Health Research. We acknowledge support from the National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) collaborative (grant G0500966/75466). We thank the National Institute for Health Research, Hutchison Whampoa Limited and the Human Research Tissue Bank (Addenbrooke's Hospital), the Cancer Research UK Cambridge Research Institute Histopathology, the In-situ Hybridisation Core Facility, the Genomics Core Facility Cambridge and the Cambridge University Hospitals Media Studio.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Boyd LK, 2012, GENE CHROMOSOME CANC, V51, P579, DOI 10.1002/gcc.21944; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Cheng L, 1998, J NATL CANCER I, V90, P233, DOI 10.1093/jnci/90.3.233; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Gaisa NT, 2011, J PATHOL, V225, P172, DOI 10.1002/path.2959; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Karavitakis M, 2011, NAT REV CLIN ONCOL, V8, P48, DOI 10.1038/nrclinonc.2010.190; Kobayashi M, 2008, PROSTATE, V68, P1715, DOI 10.1002/pros.20832; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Mucci NR, 2000, J NATL CANCER I, V92, P1941, DOI 10.1093/jnci/92.23.1941; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Svensson MA, 2011, LAB INVEST, V91, P404, DOI 10.1038/labinvest.2010.179; Tareen Basir, 2009, Rev Urol, V11, P203; Tsai MF, 2007, NUCLEIC ACIDS RES, V35, pW63, DOI 10.1093/nar/gkm383; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Warren AY, 2013, PROSTATE, V73, P194, DOI 10.1002/pros.22556; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	38	261	261	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					367	U118		10.1038/ng.3221			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	WOS:000351922900012	25730763	Green Accepted, Green Submitted			2022-01-24	
J	Giannakis, M; Hodis, E; Mu, XJ; Yamauchi, M; Rosenbluh, J; Cibulskis, K; Saksena, G; Lawrence, MS; Qian, ZR; Nishihara, R; Van Allen, EM; Hahn, WC; Gabriel, SB; Lander, ES; Getz, G; Ogino, S; Fuchs, CS; Garraway, LA				Giannakis, Marios; Hodis, Eran; Mu, Xinmeng Jasmine; Yamauchi, Mai; Rosenbluh, Joseph; Cibulskis, Kristian; Saksena, Gordon; Lawrence, Michael S.; Qian, Zhi Rong; Nishihara, Reiko; Van Allen, Eliezer M.; Hahn, William C.; Gabriel, Stacey B.; Lander, Eric S.; Getz, Gad; Ogino, Shuji; Fuchs, Charles S.; Garraway, Levi A.			RNF43 is frequently mutated in colorectal and endometrial cancers	NATURE GENETICS			English	Article							COMPREHENSIVE MOLECULAR CHARACTERIZATION; GASTRIC ADENOCARCINOMA; DRIVER MUTATIONS; CARCINOMA; LANDSCAPE; COLON	We report somatic mutations of RNF43 in over 18% of colorectal adenocarcinomas and endometrial carcinomas. RNF43 encodes an E3 ubiquitin ligase that negatively regulates Wnt signaling. Truncating mutations of RNF43 are more prevalent in microsatellite-unstable tumors and show mutual exclusivity with inactivating APC mutations in colorectal adenocarcinomas. These results indicate that RNF43 is one of the most commonly mutated genes in colorectal and endometrial cancers.	[Giannakis, Marios; Hodis, Eran; Mu, Xinmeng Jasmine; Yamauchi, Mai; Rosenbluh, Joseph; Qian, Zhi Rong; Nishihara, Reiko; Van Allen, Eliezer M.; Hahn, William C.; Ogino, Shuji; Fuchs, Charles S.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Van Allen, Eliezer M.; Hahn, William C.; Garraway, Levi A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Giannakis, Marios; Hodis, Eran; Mu, Xinmeng Jasmine; Rosenbluh, Joseph; Cibulskis, Kristian; Saksena, Gordon; Lawrence, Michael S.; Van Allen, Eliezer M.; Hahn, William C.; Gabriel, Stacey B.; Lander, Eric S.; Getz, Gad; Ogino, Shuji; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hodis, Eran] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Hodis, Eran] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Nishihara, Reiko; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Nishihara, Reiko] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Nishihara, Reiko] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Getz, Gad] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Ogino, Shuji] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Fuchs, Charles S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Charming Div Network Med,Dept Med, Boston, MA 02115 USA		Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	levi_garraway@dfci.harvard.edu	Giannakis, Marios/Z-4908-2019; Mu, Xinmeng/P-2562-2016; Lawrence, Michael/AAC-8202-2020; Cibulskis, Kristian/AAC-7380-2019	Mu, Xinmeng/0000-0002-8079-0828; Ogino, Shuji/0000-0002-3909-2323; Rosenbluh, Joseph/0000-0001-9815-8049	Dana-Farber Cancer Institute Leadership Council; Colon Cancer Alliance-American Association for Cancer Research Fellowship for Biomarker Research [14-40-40-GIAN]; Perry S. Levy Endowed Fellowship; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007753]; Herchel Smith Fellowship; Agrusa Fund for Colorectal Cancer Research; National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003067]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [K07CA190673, P01CA87969, UM1CA167552, R01CA151993, R01CA118553, R01CA168141, P50CA127003]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA127003, U01CA176058, R01CA151993, UM1CA167552, R01CA118553, K07CA190673, P01CA087969] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007753] Funding Source: NIH RePORTER	We thank S. Bahl, E. Nickerson and S. Chauvin for project management and A. Regev for help with computing resources, as well as A. Sivachenko, F. Huang and P. Tamayo for helpful discussions. This work was supported by the Dana-Farber Cancer Institute Leadership Council, the 2014 Colon Cancer Alliance-American Association for Cancer Research Fellowship for Biomarker Research, grant 14-40-40-GIAN, the Perry S. Levy Endowed Fellowship (M.G.), award T32GM007753 from the National Institute of General Medical Sciences, the Herchel Smith Fellowship (E.H.) and the Agrusa Fund for Colorectal Cancer Research (C.S.F.), as well as National Human Genome Research Institute grant U54HG003067 (E.S.L. and S.B.G.) and National Cancer Institute grants, K07CA190673 (R.N.), P01CA87969, UM1CA167552 and R01CA151993 (S.O.), R01CA118553 and R01CA168141 (C.S.F.) and P50CA127003 (M.G., W.C.H., L.A.G. and C.S.F.).	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Jiao YC, 2014, J PATHOL, V232, P428, DOI 10.1002/path.4310; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	16	261	265	3	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1264	1266		10.1038/ng.3127			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	WOS:000345547300006	25344691	Green Accepted, Green Published			2022-01-24	
J	Naccache, SN; Federman, S; Veeraraghavan, N; Zaharia, M; Lee, D; Samayoa, E; Bouquet, J; Greninger, AL; Luk, KC; Enge, B; Wadford, DA; Messenger, SL; Genrich, GL; Pellegrino, K; Grard, G; Leroy, E; Schneider, BS; Fair, JN; Martinez, MA; Isa, P; Crump, JA; DeRisi, JL; Sittler, T; Hackett, J; Miller, S; Chiu, CY				Naccache, Samia N.; Federman, Scot; Veeraraghavan, Narayanan; Zaharia, Matei; Lee, Deanna; Samayoa, Erik; Bouquet, Jerome; Greninger, Alexander L.; Luk, Ka-Cheung; Enge, Barryett; Wadford, Debra A.; Messenger, Sharon L.; Genrich, Gillian L.; Pellegrino, Kristen; Grard, Gilda; Leroy, Eric; Schneider, Bradley S.; Fair, Joseph N.; Martinez, Miguel A.; Isa, Pavel; Crump, John A.; DeRisi, Joseph L.; Sittler, Taylor; Hackett, John, Jr.; Miller, Steve; Chiu, Charles Y.			A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples	GENOME RESEARCH			English	Article							READ ALIGNMENT; INFECTION; ETIOLOGY; MALARIA; PNEUMONIA; AUSTRALIA; SOFTWARE; PROGRAM; GENOMES; QUALITY	Unbiased next-generation sequencing (NGS) approaches enable comprehensive pathogen detection in the clinical microbiology laboratory and have numerous applications for public health surveillance, outbreak investigation, and the diagnosis of infectious diseases. However, practical deployment of the technology is hindered by the bioinformatics challenge of analyzing results accurately and in a clinically relevant timeframe. Here we describe SURPI (``sequence-based ultrarapid pathogen identification''), a computational pipeline for pathogen identification from complex metagenomic NGS data generated from clinical samples, and demonstrate use of the pipeline in the analysis of 237 clinical samples comprising more than 1.1 billion sequences. Deployable on both cloud-based and standalone servers, SURPI leverages two state-of-the-art aligners for accelerated analyses, SNAP and RAPSearch, which are as accurate as existing bioinformatics tools but orders of magnitude faster in performance. In fast mode, SURPI detects viruses and bacteria by scanning data sets of 7-500 million reads in 11 min to 5 h, while in comprehensive mode, all known microorganisms are identified, followed by de novo assembly and protein homology searches for divergent viruses in 50 min to 16 h. SURPI has also directly contributed to real-time microbial diagnosis in acutely ill patients, underscoring its potential key role in the development of unbiased NGS-based clinical assays in infectious diseases that demand rapid turnaround times.	[Naccache, Samia N.; Federman, Scot; Veeraraghavan, Narayanan; Lee, Deanna; Samayoa, Erik; Bouquet, Jerome; Genrich, Gillian L.; Sittler, Taylor; Miller, Steve; Chiu, Charles Y.] UCSF, Dept Lab Med, San Francisco, CA 94107 USA; [Naccache, Samia N.; Federman, Scot; Veeraraghavan, Narayanan; Lee, Deanna; Samayoa, Erik; Bouquet, Jerome; Miller, Steve; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94107 USA; [Zaharia, Matei] Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA; [Greninger, Alexander L.; DeRisi, Joseph L.] UCSF, Dept Biochem, San Francisco, CA 94107 USA; [Luk, Ka-Cheung; Hackett, John, Jr.] Abbott Diagnost, Abbott Pk, IL 60064 USA; [Enge, Barryett; Wadford, Debra A.; Messenger, Sharon L.] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA 94804 USA; [Pellegrino, Kristen] UCSF, Dept Family & Community Med, San Francisco, CA 94143 USA; [Grard, Gilda; Leroy, Eric] Ctr Int Rech Med Franceville, Viral Emergent Dis Unit, Franceville, Gabon; [Schneider, Bradley S.; Fair, Joseph N.] Metabiota Inc, San Francisco, CA 94104 USA; [Martinez, Miguel A.; Isa, Pavel] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62260, Morelos, Mexico; [Crump, John A.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC 27708 USA; [Crump, John A.] Duke Univ, Med Ctr, Duke Global Hlth Inst, Durham, NC 27708 USA; [Crump, John A.] Kilimanjaro Christian Med Ctr, Moshi 7393, Kilimanjaro, Tanzania; [Crump, John A.] Univ Otago, Ctr Int Hlth, Dunedin 9054, New Zealand; [Chiu, Charles Y.] UCSF, Div Infect Dis, Dept Med, San Francisco, CA 94143 USA		Chiu, CY (corresponding author), UCSF, Dept Lab Med, San Francisco, CA 94107 USA.	charles.chiu@ucsf.edu	LEROY, Eric M/I-4347-2016; Crump, John A./AAZ-6412-2020; Crump, John A./AAZ-6289-2020	LEROY, Eric M/0000-0003-0022-0890; Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X; Schneider, Bradley S/0000-0001-7642-0018; Sittler, Taylor/0000-0001-7495-4147; Martinez, Miguel/0000-0003-2429-8772; Greninger, Alexander/0000-0002-7443-0527; Bouquet, Jerome/0000-0001-8077-6025; Chiu, Charles/0000-0003-2915-2094	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HL105704]; University of California Discovery GrantUniversity of California System; Defense Threat Reduction Agency Cooperative Biological Engagement Program (DTRA-CBEP)United States Department of DefenseDefense Threat Reduction Agency; United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT ProgramUnited States Agency for International Development (USAID); AWS in Education Research Grants Program; Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007618] Funding Source: NIH RePORTER	We thank Guixia Yu, Eunice Chen, and Stephanie Yen for processing NGS libraries; William J. Bolosky and Kristal Curtis for their work on SNAP; Andrew Sanderson, Shimona Carvalho, and Geoffrey Hulette for their helpful input on pipeline design; and Eric Delwart for constructive feedback. This work is supported by National Institutes of Health (NIH) grant R01-HL105704 (C.Y.C.), a University of California Discovery Grant (C.Y.C.), the Defense Threat Reduction Agency Cooperative Biological Engagement Program (DTRA-CBEP) (B. S. S., J.N.F., E. L., and C.Y.C.), the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT Program (B. S. S., J.N.F., E. L., and C.Y.C.), the AWS in Education Research Grants Program (S. F., N.V., and C.Y.C.), and an Abbott Viral Discovery Award (C.Y.C.). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barnes GL, 1998, J CLIN MICROBIOL, V36, P133, DOI 10.1128/JCM.36.1.133-138.1998; Bhaduri A, 2012, BIOINFORMATICS, V28, P1174, DOI 10.1093/bioinformatics/bts100; Bloch Karen C, 2007, Curr Infect Dis Rep, V9, P315, DOI 10.1007/s11908-007-0049-5; Borozan I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-206; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Denno DM, 2012, CLIN INFECT DIS, V55, P897, DOI 10.1093/cid/cis553; Dimon MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064546; Dunne WM, 2012, EUR J CLIN MICROBIOL, V31, P1719, DOI 10.1007/s10096-012-1641-7; Firth C, 2013, ANNU REV GENOM HUM G, V14, P281, DOI 10.1146/annurev-genom-091212-153446; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Knope K, 2013, COMMUN DIS INTELL, V37, pE1; Kollef KE, 2008, CHEST, V134, P281, DOI 10.1378/chest.08-1116; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; MacConaill L, 2008, NAT GENET, V40, P380, DOI 10.1038/ng0408-380; Martin M., 2013, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Naeem R, 2013, BIOINFORMATICS, V29, P391, DOI 10.1093/bioinformatics/bts684; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Nunez JJ, 2014, EMERG INFECT DIS, V20, P386, DOI 10.3201/eid2003.131581; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Swei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062083; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Treangen T.J., 2011, CURR PROTOC BIOINFOR, V33, P1181; van Gageldonk-Lafeber AB, 2005, CLIN INFECT DIS, V41, P490, DOI 10.1086/431982; Wang QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064465; Ward KN, 2002, J MED VIROL, V67, P538, DOI 10.1002/jmv.10135; Wilson MR, 2014, NEW ENGL J MED, DOI [10.1056/NEJMoa.1401268, DOI 10.1056/NEJMOA.1401268]; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449; Zaharia M., 2011, ARXIV11115572; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078470; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595; ZWEIG MH, 1993, CLIN CHEM, V39, P561	56	261	269	1	54	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2014	24	7					1180	1192		10.1101/gr.171934.113			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	AK1OS	WOS:000338185000012	24899342	Green Published, Green Submitted, hybrid			2022-01-24	
J	Raychaudhuri, S; Thomson, BP; Remmers, EF; Eyre, S; Hinks, A; Guiducci, C; Catanese, JJ; Xie, G; Stahl, EA; Chen, R; Alfredsson, L; Amos, CI; Ardlie, KG; Barton, A; Bowes, J; Burtt, NP; Chang, M; Coblyn, J; Costenbader, KH; Criswell, LA; Crusius, JBA; Cui, J; De Jager, PL; Ding, B; Emery, P; Flynn, E; Harrison, P; Hocking, LJ; Huizinga, TWJ; Kastner, DL; Ke, XY; Kurreeman, FAS; Lee, AT; Liu, XD; Li, YH; Martin, P; Morgan, AW; Padyukov, L; Reid, DM; Seielstad, M; Seldin, MF; Shadick, NA; Steer, S; Tak, PP; Thomson, W; van der Helm-van Mil, AHM; van der Horst-Bruinsma, IE; Weinblatt, ME; Wilson, AG; Wolbink, GJ; Wordsworth, P; Altshuler, D; Karlson, EW; Toes, REM; de Vries, N; Begovich, AB; Siminovitch, KA; Worthington, J; Klareskog, L; Gregersen, PK; Daly, MJ; Plenge, RM				Raychaudhuri, Soumya; Thomson, Brian P.; Remmers, Elaine F.; Eyre, Stephen; Hinks, Anne; Guiducci, Candace; Catanese, Joseph J.; Xie, Gang; Stahl, Eli A.; Chen, Robert; Alfredsson, Lars; Amos, Christopher I.; Ardlie, Kristin G.; Barton, Anne; Bowes, John; Burtt, Noel P.; Chang, Monica; Coblyn, Jonathan; Costenbader, Karen H.; Criswell, Lindsey A.; Crusius, J. Bart A.; Cui, Jing; De Jager, Phillip L.; Ding, Bo; Emery, Paul; Flynn, Edward; Harrison, Pille; Hocking, Lynne J.; Huizinga, Tom W. J.; Kastner, Daniel L.; Ke, Xiayi; Kurreeman, Fina A. S.; Lee, Annette T.; Liu, Xiangdong; Li, Yonghong; Martin, Paul; Morgan, Ann W.; Padyukov, Leonid; Reid, David M.; Seielstad, Mark; Seldin, Michael F.; Shadick, Nancy A.; Steer, Sophia; Tak, Paul P.; Thomson, Wendy; van der Helm-van Mil, Annette H. M.; van der Horst-Bruinsma, Irene E.; Weinblatt, Michael E.; Wilson, Anthony G.; Wolbink, Gert Jan; Wordsworth, Paul; Altshuler, David; Karlson, Elizabeth W.; Toes, Rene E. M.; de Vries, Niek; Begovich, Ann B.; Siminovitch, Katherine A.; Worthington, Jane; Klareskog, Lars; Gregersen, Peter K.; Daly, Mark J.; Plenge, Robert M.		BIRAC Consortium; Consortium, Y	Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISM; MULTIPLE-SCLEROSIS; SUSCEPTIBILITY LOCI; CELIAC-DISEASE; PTPN22; REPLICATION; PTPRC; CD45; MUTATION	To discover new rheumatoid arthritis (RA) risk loci, we systematically examined 370 SNPs from 179 independent loci with P < 0.001 in a published meta-analysis of RA genome-wide association studies (GWAS) of 3,393 cases and 12,462 controls(1). We used Gene Relationships Across Implicated Loci (GRAIL)(2), a computational method that applies statistical text mining to PubMed abstracts, to score these 179 loci for functional relationships to genes in 16 established RA disease loci(1,3-11). We identified 22 loci with a significant degree of functional connectivity. We genotyped 22 representative SNPs in an independent set of 7,957 cases and 11,958 matched controls. Three were convincingly validated: CD2-CD58 (rs11586238, P = 1 x 10(-6) replication, P = 1 x 10(-9) overall), CD28 (rs1980422, P = 5 x 10(-6) replication, P = 1 x 10(-9) overall) and PRDM1 (rs548234, P = 1 x 10(-5) replication, P = 2 x 10(-8) overall). An additional four were replicated (P < 0.0023): TAGAP (rs394581, P = 0.0002 replication, P = 4 x 10(-7) overall), PTPRC (rs10919563, P = 0.0003 replication, P = 7 x 10(-7) overall), TRAF6-RAG1 (rs540386, P = 0.0008 replication, P = 4 x 10(-6) overall) and FCGR2A (rs12746613, P = 0.0022 replication, P = 2 x 10(-5) overall). Many of these loci are also associated to other immunologic diseases.	[Raychaudhuri, Soumya; Stahl, Eli A.; Chen, Robert; Coblyn, Jonathan; Costenbader, Karen H.; Cui, Jing; Kurreeman, Fina A. S.; Shadick, Nancy A.; Weinblatt, Michael E.; Karlson, Elizabeth W.; Plenge, Robert M.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Thomson, Brian P.; Guiducci, Candace; Ardlie, Kristin G.; Burtt, Noel P.; De Jager, Phillip L.; Altshuler, David; Daly, Mark J.; Plenge, Robert M.] Broad Inst, Cambridge, MA USA; [Raychaudhuri, Soumya; Altshuler, David; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Remmers, Elaine F.; Kastner, Daniel L.] NIAMSD, Genet & Genom Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Eyre, Stephen; Hinks, Anne; Barton, Anne; Bowes, John; Flynn, Edward; Ke, Xiayi; Martin, Paul; Thomson, Wendy; Worthington, Jane] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester, Lancs, England; [Catanese, Joseph J.; Chang, Monica; Li, Yonghong; Begovich, Ann B.] Celera, Alameda, CA USA; [Xie, Gang; Liu, Xiangdong; Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Xie, Gang; Liu, Xiangdong; Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON, Canada; [Alfredsson, Lars; Ding, Bo] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA USA; [Crusius, J. Bart A.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Immunogenet Lab, Amsterdam, Netherlands; [De Jager, Phillip L.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Emery, Paul; Morgan, Ann W.] Univ Leeds, Leeds Inst Mol Med, Natl Inst Hlth Res, Leeds Musculoskeletal Biomed Res Unit, Leeds LS2 9JT, W Yorkshire, England; [Harrison, Pille; Wordsworth, Paul] Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Oxford, England; [Hocking, Lynne J.; Reid, David M.] Univ Aberdeen, Div Appl Med, Musculoskeletal & Genet Sect, Aberdeen AB9 1FX, Scotland; [Huizinga, Tom W. J.; Kurreeman, Fina A. S.; van der Helm-van Mil, Annette H. M.; Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Lee, Annette T.; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Padyukov, Leonid; Klareskog, Lars] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Seielstad, Mark] Genome Inst Singapore, Singapore, Singapore; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Steer, Sophia] Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, London, England; [Tak, Paul P.; de Vries, Niek] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van der Horst-Bruinsma, Irene E.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Wilson, Anthony G.] Univ Sheffield, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Wolbink, Gert Jan] Jan van Breemen Inst, Amsterdam, Netherlands; [Wolbink, Gert Jan] Univ Amsterdam, Acad Med Ctr, Sanquin Res Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Begovich, Ann B.] Roche Diagnost, Pleasanton, CA USA		Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.	soumya@broad.mit.edu; rplenge@partners.org	Daly, Mark J/B-2453-2017; Bowes, John/B-3472-2015; Altshuler, David M/A-4476-2009; Worthington, Jane/M-9770-2014; Barton, Anne/N-2053-2014; eyre, stephen/K-3776-2017; Crusius, Jakob Bart/AAE-9051-2019; Alfredsson, Lars/AAC-9007-2019; Ke, Xiayi/C-7674-2009; Siminovitch, Katherine/K-1475-2013; Seielstad, Mark/T-7841-2019; Hinks, Anne/E-1853-2015; de Vries, Niek/J-9348-2013; Padyukov, Leonid/A-4890-2009; Ng, Wan-Fai/R-8083-2016	Daly, Mark J/0000-0002-0949-8752; Bowes, John/0000-0003-4659-031X; Altshuler, David M/0000-0002-7250-4107; Worthington, Jane/0000-0003-0544-042X; Barton, Anne/0000-0003-3316-2527; eyre, stephen/0000-0002-1251-6974; Crusius, Jakob Bart/0000-0001-9046-0155; Alfredsson, Lars/0000-0003-1688-6697; Hinks, Anne/0000-0001-8843-3967; de Vries, Niek/0000-0002-6257-8604; Padyukov, Leonid/0000-0003-2950-5670; Hocking / Mennie, Lynne J/0000-0002-2414-2826; Li, Yonghong/0000-0001-7326-0717; Seielstad, Mark/0000-0001-5783-1401; Hensor, Elizabeth/0000-0002-5245-4755; Thomson, Wendy/0000-0002-9022-5179; Harrison, Pille/0000-0003-4117-6910; van der Helm - van Mil, Annette/0000-0001-8572-1437; Morgan, Ann/0000-0003-1109-624X; Wilson, Anthony Gerard/0000-0003-4855-3926; Klareskog, Lars/0000-0001-9601-6186; Wolbink, Gerrit Jan/0000-0003-1924-7460; Packham, Jon/0000-0001-5531-1680; Martin, Paul/0000-0002-1016-6851; Toes, Rene/0000-0002-9618-6414; Young-Min, Steven/0000-0001-8270-6207; Raychaudhuri, Soumya/0000-0002-1901-8265; Ng, Wan-Fai/0000-0002-5539-388X; Conaghan, Philip/0000-0002-3478-5665; Remmers, Elaine F/0000-0002-9522-1249; McInnes, Iain/0000-0002-6462-4280	US National Institutes of Health (NIH) Career Development AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K08AR055688-01A1]; American College of Rheumatology Bridge Grant; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AI55314-3, U01 HG004171, DK62432, R01 DK083756-1, DK64869, NO1-AR-2-2263, RO1 AR44422]; Fox Trot Fund; William Randolph Hearst Fund of Harvard University; Burroughs Wellcome FundBurroughs Wellcome Fund; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54 RR020278]; Millennium PharmaceuticalsTakeda Pharmaceutical Company Ltd; Intramural Research Program of the National Institute of Arthritis; Musculoskeletal and Skin Diseases of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [MOP79321, IIN-84042]; Ontario Research Fund [RE01061]; Canada Research ChairNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs; Biogen-IdecBiogen; National Heart, Lung, and Blood Institute's (STAMPEED);  [R01HL087676]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10299] Funding Source: researchfish; Versus ArthritisVersus Arthritis [18475] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL087676] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [K08AI055314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR044422, K08AR055688, N01AR022263, R01AR056768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK083756, R01DK064869, U01DK062432] Funding Source: NIH RePORTER	S. R. is supported by a US National Institutes of Health (NIH) Career Development Award (1K08AR055688-01A1) and an American College of Rheumatology Bridge Grant. R. M. P. is supported by a K08 grant from the NIH (AI55314-3), a private donation from the Fox Trot Fund, the William Randolph Hearst Fund of Harvard University, the American College of Rheumatology 'Within Our Reach' campaign and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. M. J. D. is supported by NIH grants through the U01 (HG004171, DK62432) and R01 (DK083756-1, DK64869) mechanisms. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. The Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study (BRASS) Registry is supported by a grant from Millennium Pharmaceuticals and Biogen-Idec. The North American Rheumatoid Arthritis Consortium (NARAC) is supported by the NIH (NO1-AR-2-2263 and RO1 AR44422). This research was also supported in part by the Intramural Research Program of the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the NIH. This research was also supported in part by grants to KAS from the Canadian Institutes for Health Research (MOP79321 and IIN-84042) and the Ontario Research Fund (RE01061) and by a Canada Research Chair. We acknowledge the help of C. E. van der Schoot for healthy control samples for the Genetics Network Rheumatology Amsterdam (GENRA) and the help of B. A. C. Dijkmans, D. van Schaardenburg, A. S. Pe a, P. L. Klarenbeek, Z. Zhang, M. T. Nurmohammed, W. F. Lems, R. R. J. van de Stadt, W. H. Bos, J. Ursum, M. G. M. Bartelds, D. M. Gerlag, M. G. H. van der Sande, C. A. Wijbrandts and M. M. J. Herenius in gathering GENRA patient samples and data. We thank the Myocardial Infarction Genetics Consortium (MIGen) study for the use of genotype data from their healthy controls in our study. The MIGen study was funded by the US NIH and National Heart, Lung, and Blood Institute's SNP Typing for Association with Multiple Phenotypes from Existing Epidemiologic Data (STAMPEED) genomics research program R01HL087676 and a grant from the National Center for Research Resources. We thank the Johanna Seddon Progression of AMD Study, AMD Registry Study, Family Study of AMD, The US Twin Study of AMD and the Age-Related Eye Disease Study (AREDS) for use of genotype data from their healthy controls in our study. We thank D. Hafler and the Multiple Sclerosis collaborative for use of genotype data from their healthy controls recruited at Brigham and Women's Hospital.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barcellos LF, 2001, NAT GENET, V29, P23, DOI 10.1038/ng722; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Costenbader KH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2421; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; De Jager PL, 2009, P NATL ACAD SCI USA, V106, P5264, DOI 10.1073/pnas.0813310106; Duits AJ, 1995, ARTHRITIS RHEUM, V38, P1832, DOI 10.1002/art.1780381217; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Isenberg DA, 2004, OXFORD TXB RHEUMATOL; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Nielen MMJ, 2005, ANN RHEUM DIS, V64, P1199, DOI 10.1136/ard.2004.029389; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raychaudhuri S., 2006, COMPUTATIONAL TEXT A; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Sato M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1921; SCHRAVEN B, 1990, NATURE, V345, P71, DOI 10.1038/345071a0; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Tchilian EZ, 2001, J IMMUNOL, V166, P6144, DOI 10.4049/jimmunol.166.10.6144; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Vorechovsky I, 2001, NAT GENET, V29, P22, DOI 10.1038/ng723; Wesoly J, 2005, ARTHRITIS RHEUM-US, V52, P2948, DOI 10.1002/art.21294; WIJBRANDTS CA, 2007, ANN RHEUM DIS; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	43	261	265	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2009	41	12					1313	U76		10.1038/ng.479			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	WOS:000272144900013	19898481	Green Accepted			2022-01-24	
J	Gregersen, PK; Amos, CI; Lee, AT; Lu, Y; Remmers, EF; Kastner, DL; Seldin, MF; Criswell, LA; Plenge, RM; Holers, VM; Mikuls, TR; Sokka, T; Moreland, LW; Bridges, SL; Xie, G; Begovich, AB; Siminovitch, KA				Gregersen, Peter K.; Amos, Chistopher I.; Lee, Annette T.; Lu, Yue; Remmers, Elaine F.; Kastner, Daniel L.; Seldin, Michael F.; Criswell, Lindsey A.; Plenge, Robert M.; Holers, V. Michael; Mikuls, Ted R.; Sokka, Tuulikki; Moreland, Larry W.; Bridges, S. Louis, Jr.; Xie, Gang; Begovich, Ann B.; Siminovitch, Katherine A.			REL, encoding a member of the NF-kappa B family of transcription factors, is a newly defined risk locus for rheumatoid arthritis	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-REL; INCEPTION COHORT; CELLS; ASSOCIATION; EXPRESSION; VARIANTS; ITGAM	We conducted a genome-wide association study of rheumatoid arthritis in 2,418 cases and 4,504 controls from North America and identified an association at the REL locus, encoding c-Rel, on chromosome 2p13 (rs13031237, P = 6.01 x 10(-10)). Replication in independent case-control datasets comprising 2,604 cases and 2,882 controls confirmed this association, yielding an allelic OR 1.25 (P = 3.08 x 10(-14)) for marker rs13031237 and an allelic OR 1.21 (P = 2.60 x 10(-11)) for marker rs13017599 in the combined dataset. The combined dataset also provides definitive support for associations at both CTLA4 (rs231735; OR = 0.85; P = 6.25 x 10(-9)) and BLK (rs2736340; OR = 1.19; P = 5.69 x 10(-9)). c-Rel is an NF-kappa B family member with distinct functional properties in hematopoietic cells, and its association with rheumatoid arthritis suggests disease pathways that involve other recently identified rheumatoid arthritis susceptibility genes including CD40, TRAF1, TNFAIP3 and PRKCQ(1,2).	[Gregersen, Peter K.; Lee, Annette T.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Amos, Chistopher I.; Lu, Yue] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Remmers, Elaine F.; Kastner, Daniel L.] NIAMSD, Genet & Genom Branch, NIH, Bethesda, MD 20892 USA; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Holers, V. Michael] Univ Colorado, Denver Sch Med, Denver, CO 80202 USA; [Sokka, Tuulikki] Univ Nebraska, Med Ctr, Omaha, NE USA; [Sokka, Tuulikki] Jyvaskyla Cent Hosp, Jyvaskyla, Finland; [Moreland, Larry W.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Bridges, S. Louis, Jr.] Univ Alabama Birmingham, Birmingham, AL USA; [Xie, Gang; Siminovitch, Katherine A.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Xie, Gang; Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON M5G 1X5, Canada; [Begovich, Ann B.] Celera, Alameda, CA USA		Gregersen, PK (corresponding author), N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA.	peterg@nshs.edu; ksimin@mshri.on.ca	Siminovitch, Katherine/K-1475-2013	Remmers, Elaine F/0000-0002-9522-1249; Moreland, Larry/0000-0003-4483-0359	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NO1-AR-2-2263, RO1 AR44422]; Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the Muriel Fusfeld Foundation; Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [MOP79321]; Ontario Research Fund [RE01061]; Canada Research ChairNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [ZIAAR041139, R01AR044422, N01AR022263] Funding Source: NIH RePORTER	This work was supported by grants from the US National Institutes of Health NO1-AR-2-2263 (P. K. G.), RO1 AR44422 (P. K. G.) and by the Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the Muriel Fusfeld Foundation. The work was also supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and by grants from the Canadian Institutes for Health Research (MOP79321) and Ontario Research Fund (RE01061) and a Canada Research Chair to K. A. S.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Coenen MJH, 2009, GENES IMMUN, V10, P101, DOI 10.1038/gene.2008.77; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Fries JF, 2002, ARTHRITIS RHEUM, V46, P2320, DOI 10.1002/art.10485; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Lee HS, 2009, ARTHRITIS RHEUM-US, V60, P364, DOI 10.1002/art.24245; Lu KT, 2006, BLOOD, V108, P3769, DOI 10.1182/blood-2006-03-008839; Mason NJ, 2004, J IMMUNOL, V172, P3704, DOI 10.4049/jimmunol.172.6.3704; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Owyang AM, 2001, J IMMUNOL, V167, P4948, DOI 10.4049/jimmunol.167.9.4948; Pennisi E, 2008, SCIENCE, V322, P842, DOI 10.1126/science.322.5903.842; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Sokka T, 2005, CLIN EXP RHEUMATOL, V23, pS178; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; TRYNKA G, 2009, GUT             0224, DOI DOI 10.1136/GUT.2008.169052; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Weisman MH, 2003, ARTHRITIS RHEUM, V48, pS119; Wolfe F, 2003, ARTHRITIS RHEUM, V48, P1530, DOI 10.1002/art.11024; Zhou HJ, 2007, BLOOD, V110, P2121, DOI 10.1182/blood-2007-02-073080	30	261	266	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					820	U77		10.1038/ng.395			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	WOS:000267786200013	19503088	Green Accepted			2022-01-24	
J	Sandhu, MS; Weedon, MN; Fawcett, KA; Wasson, J; Debenham, SL; Daly, A; Lango, H; Frayling, TM; Neumann, RJ; Sherva, R; Blech, I; Pharoah, PD; Palmer, CNA; Kimber, C; Tavendale, R; Morris, AD; McCarthy, MI; Walker, M; Hitman, G; Glaser, B; Permutt, MA; Hattersley, AT; Wareham, NJ; Barroso, I				Sandhu, Manjinder S.; Weedon, Michael N.; Fawcett, Katherine A.; Wasson, Jon; Debenham, Sally L.; Daly, Allan; Lango, Hana; Frayling, Timothy M.; Neumann, Rosalind J.; Sherva, Richard; Blech, Ilana; Pharoah, Paul D.; Palmer, Colin N. A.; Kimber, Charlotte; Tavendale, Roger; Morris, Andrew D.; McCarthy, Mark I.; Walker, Mark; Hitman, Graham; Glaser, Benjamin; Permutt, M. Alan; Hattersley, Andrew T.; Wareham, Nicholas J.; Barroso, Ines			Common variants in WFS1 confer risk of type 2 diabetes	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; NUCLEAR FACTOR-4-ALPHA GENE; BETA-CELL LOSS; TRANSMEMBRANE PROTEIN; OPTIC ATROPHY; E23K VARIANT; POLYMORPHISM; ASSOCIATION; MELLITUS	We studied genes involved in pancreatic beta cell function and survival, identifying associations between SNPs in WFS1 and diabetes risk in UK populations that we replicated in an Ashkenazi population and in additional UK studies. In a pooled analysis comprising 9,533 cases and 11,389 controls, SNPs in WFS1 were strongly associated with diabetes risk. Rare mutations in WFS1 cause Wolfram syndrome; using a gene-centric approach, we show that variation in WFS1 also predisposes to common type 2 diabetes.	UK Med Res Council, Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England; Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Wellcome Trust Sanger Inst, Metab Dis Grp, Cambridge CB10 1SA, England; Washington Univ, Sch Med, St Louis, MO 63110 USA; Hadassah Hebrew Univ, Med Ctr, Endocrine & Metab Serv, IL-91120 Jerusalem, Israel; Univ Cambridge, Strangeways Res Lab, Dept Oncol, Canc Res UK, Cambridge CB1 8RN, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Newcastle, Sch Clin Med Sci, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ London, Queen Marys Sch Med & Dent, Ctr Diabet & Metab Med, London E1 1BB, England		Sandhu, MS (corresponding author), UK Med Res Council, Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England.	manj.sandhu@srl.cam.ac.uk; ib1@sanger.ac.uk	Allen, Hana Lango/G-9026-2012; Palmer, Colin NA/C-7053-2008; Pharoah, Paul/V-6658-2019; Morris, Andrew D/C-2837-2009; Glaser, Benjamin/F-8411-2017; Study, GoDARTS/K-9448-2016; McCarthy, Mark/M-3763-2015	Allen, Hana Lango/0000-0002-7803-8688; Palmer, Colin NA/0000-0002-6415-6560; Pharoah, Paul/0000-0001-8494-732X; Glaser, Benjamin/0000-0003-4711-5000; Weedon, Michael/0000-0002-6174-6135; Hattersley, Andrew/0000-0001-5620-473X; Sherva, Richard/0000-0003-2133-1493; McCarthy, Mark/0000-0002-4393-0510; Barroso, Ines/0000-0001-5800-4520; Ricketts, Sally/0000-0002-5644-7958; Fawcett, Katherine/0000-0002-6675-2112	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0500070, MC_U106179471] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [068545/z/02, 077016] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0500070] Funding Source: UKRI		Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; KARASIK A, 1989, DIABETES CARE, V12, P135, DOI 10.2337/diacare.12.2.135; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Minton JAL, 2002, DIABETES, V51, P1287, DOI 10.2337/diabetes.51.4.1287; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081	14	261	269	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					951	953		10.1038/ng2067			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	WOS:000248446900007	17603484	Green Accepted, Green Published			2022-01-24	
J	West, MAL; Kim, K; Kliebenstein, DJ; van Leeuwen, H; Michelmore, RW; Doerge, RW; Clair, DAS				West, Marilyn A. L.; Kim, Kyunga; Kliebenstein, Daniel J.; van Leeuwen, Hans; Michelmore, Richard W.; Doerge, R. W.; Clair, Dina A. St.			Global eQTL mapping reveals the complex genetic architecture of transcript-level variation in Arabidopsis	GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; FLOWERING-TIME; INSECT RESISTANCE; PROTEIN NETWORKS; EXPRESSION; GENOMICS; EVOLUTION; IDENTIFICATION; POPULATION; HYDROLYSIS	The genetic architecture of transcript-level variation is largely unknown. The genetic determinants of transcript-level variation were characterized in a recombinant inbred line (RIL) population (n = 211) of Arabidopsis thaliana using whole-genome microarray analysis and expression quantitative trait loci (eQTL) mapping of transcript levels as expression traits (e-traits). Genetic control of transcription was highly complex: one-third of the quantitatively controlled transcripts/e-traits were regulated by cis-eQTL, and many trans-eQTL mapped to hotspots that regulated hundreds to thousands of e-traits. Several thousand eQTL of large phenotypic effect were detected, but almost all (93%) of the 36,871 eQTL were associated with small phenotypic effects (R-2 < 0.3). Many transcripts/e-traits were controlled by multiple eQTL with opposite allelic effects and exhibited higher heritability in the RILs than their parents, suggesting nonadditive genetic variation. To our knowledge, this is the first large-scale global eQTL study in a relatively large plant mapping population. It reveals that the genetic control of transcript level is highly variable and multifaceted and that this complexity may be a general characteristic of eukaryotes.	Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA		Clair, DAS (corresponding author), Univ Calif Davis, Dept Plant Sci, Mail Stop 3,1 Shields Ave, Davis, CA 95616 USA.	dastclair@ucdavis.edu		Kliebenstein, Daniel/0000-0001-5759-3175			Basten CJ, 1999, QTL CARTOGRAPHER VER; Beavis William D., 1998, P145; Berardini T.Z., 2004, PLANT PHYSIOL, V135, P1; Bogdan M, 2005, HEREDITY, V95, P476, DOI 10.1038/sj.hdy.6800747; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Chen WQJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r32; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; CHURCHILL GA, 1994, GENETICS, V138, P963; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; DeCook R, 2006, GENETICS, V172, P1155, DOI 10.1534/genetics.105.042275; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Falconer D, 1996, INTRO QUANTITATIVE G INTRO QUANTITATIVE G; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hughes KA, 2006, GENETICS, V173, P1347, DOI 10.1534/genetics.105.051474; Jansen RC, 2002, NAT BIOTECHNOL, V20, P19, DOI 10.1038/nbt0102-19b; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kim K, 2005, STADLER GEN, P89; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Kliebenstein DJ, 2006, GENETICS, V172, P1179, DOI 10.1534/genetics.105.049353; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; Liu YF, 2000, GENET RES, V75, P345, DOI 10.1017/S0016672300004493; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; TURELLI M, 1988, EVOLUTION, V42, P1342, DOI 10.1111/j.1558-5646.1988.tb04193.x; Wagner A, 2000, GENETICS, V154, P1389; Wayne ML, 2004, GENETICS, V168, P1413, DOI 10.1534/genetics.104.030973; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Wright S, 1977, EVOLUTION GENETICS P; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	50	261	268	4	50	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAR	2007	175	3					1441	1450		10.1534/genetics.106.064972			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155PO	WOS:000245590600039	17179097	Green Published, Bronze			2022-01-24	
J	Yue, B; Xue, WY; Xiong, LZ; Yu, XQ; Luo, LJ; Cui, KH; Jin, DM; Xing, YZ; Zhang, QF				Yue, B; Xue, WY; Xiong, LZ; Yu, XQ; Luo, LJ; Cui, KH; Jin, DM; Xing, YZ; Zhang, QF			Genetic basis of drought resistance at reproductive stage in rice: Separation of drought tolerance from drought avoidance	GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; ORYZA-SATIVA L.; CONTRASTING MOISTURE REGIMES; ROOT-PENETRATION ABILITY; MAPPING QTLS; OSMOTIC ADJUSTMENT; UPLAND RICE; MORPHOLOGICAL TRAITS; INBRED POPULATION; MOLECULAR MARKERS	Drought tolerance (DT) and drought avoidance (DA) are two major mechanisms in drought resistance of higher plants. In this study, the genetic bases of DT and Mat reproductive stage in rice were analyzed using a recombinant inbred line population from a cross between an indica lowland and a tropical japonica upland cultivar. The plants were grown individually in PVC pipes and two cycles of drought stress were applied to individual plants with unstressed plants as the control. A total of 21 traits measuring fitness, yield, and the root system were investigated. Little correlation of relative yield traits with potential yield, plant size, and root traits was detected, suggesting that DT and DA were well separated in the experiment. Agenetic linkage map consisting of 245 SSR markers was constructed for mapping QTL for these traits. A total of 27 QTL were resolved for 7 traits of relative performance of fitness and yield, 36 QTL for 5 root traits under control, and 38 for 7 root traits under drought stress conditions, suggesting the complexity of the genetic bases of both DT and DA. Only a small portion of QTL for fitness- and yield-related traits overlapped with QTL for root traits, indicating that DT and DA had distinct genetic bases.	Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Peoples R China; Shanghai Agrobiol Gene Ctr, Shanghai 201106, Peoples R China		Zhang, QF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.	qifazh@mail.hzau.edu.cn	xue, weiya/L-5834-2015; Xiong, Lizhong/AAE-6984-2019	yue, bing/0000-0002-2552-1668; xiong, lizhong/0000-0003-0490-1474; Xing, Yongzhong/0000-0003-1376-1514			Ali ML, 2000, THEOR APPL GENET, V101, P756, DOI 10.1007/s001220051541; Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Blum A., 1988, DROUGHT RESISTANCE P; Bolanos J, 1996, FIELD CROP RES, V48, P65, DOI 10.1016/0378-4290(96)00036-6; Boonjung H, 2000, FIELD CROPS RES, V43, P47; CHAMPOUX MC, 1995, THEOR APPL GENET, V90, P756; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Courtois B, 2000, MOL BREEDING, V6, P55, DOI 10.1023/A:1009652326121; CRUZ RT, 1984, AGRON J, V76, P178, DOI 10.2134/agronj1984.00021962007600020003x; FUKAI S, 1995, FIELD CROP RES, V40, P67, DOI 10.1016/0378-4290(94)00096-U; Fukai S, 1999, FIELD CROP RES, V64, P61, DOI 10.1016/S0378-4290(99)00051-9; GARRITY DP, 1994, FIELD CROP RES, V39, P99, DOI 10.1016/0378-4290(94)90012-4; Kamoshita A, 2002, THEOR APPL GENET, V104, P880, DOI 10.1007/s00122-001-0837-5; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Lander E. S., 1992, CONSTRUCTING GENETIC; Lilley JM, 1996, J EXP BOT, V47, P1427, DOI 10.1093/jxb/47.9.1427; Luo LiJun, 2001, Chinese Journal of Rice Science, V15, P209; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Pantuwan G, 2002, FIELD CROP RES, V73, P181, DOI 10.1016/S0378-4290(01)00194-0; Price A, 1999, PLANT GROWTH REGUL, V29, P123, DOI 10.1023/A:1006255832479; Price AH, 2002, FIELD CROP RES, V76, P25, DOI 10.1016/S0378-4290(02)00010-2; Price AH, 1997, NEW PHYTOL, V137, P83, DOI 10.1046/j.1469-8137.1997.00818.x; Price AH, 1997, THEOR APPL GENET, V95, P143, DOI 10.1007/s001220050542; Quarrie SA, 1997, PLANT MOL BIOL, V35, P155, DOI 10.1023/A:1005864202924; QUARRIE SA, 1994, THEOR APPL GENET, V89, P794, DOI 10.1007/BF00223721; Ray JD, 1996, THEOR APPL GENET, V92, P627, DOI 10.1007/BF00226082; Robin S, 2003, THEOR APPL GENET, V107, P1288, DOI 10.1007/s00122-003-1360-7; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Toorchi M, 2003, CROP SCI, V43, P1448, DOI 10.2135/cropsci2003.1448; Tripathy JN, 2000, THEOR APPL GENET, V100, P1197, DOI 10.1007/s001220051424; Venuprasad R, 2002, EUPHYTICA, V128, P293, DOI 10.1023/A:1021281428957; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2001, THEOR APPL GENET, V103, P19, DOI 10.1007/s001220000534; Zhang JX, 1999, J EXP BOT, V50, P291, DOI 10.1093/jexbot/50.332.291; Zheng BS, 2003, THEOR APPL GENET, V107, P1505, DOI 10.1007/s00122-003-1390-1; Zheng HG, 2000, GENOME, V43, P53, DOI 10.1139/gen-43-1-53	38	261	294	5	59	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	FEB	2006	172	2					1213	1228		10.1534/genetics.105.045062			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	024ER	WOS:000236178800044	16272419	Bronze, Green Published			2022-01-24	
J	Wang, JL; Tian, L; Madlung, A; Lee, HS; Chen, M; Lee, JJ; Watson, B; Kagochi, T; Comai, L; Chen, ZJ				Wang, JL; Tian, L; Madlung, A; Lee, HS; Chen, M; Lee, JJ; Watson, B; Kagochi, T; Comai, L; Chen, ZJ			Stochastic and epigenetic changes of gene expression in arabidopsis polyploids	GENETICS			English	Article							NUCLEOLAR DOMINANCE; DNA METHYLATION; FLOWERING PLANTS; GENOME EVOLUTION; YEAST GENOME; RNA; DUPLICATION; INSTABILITY; ACTIVATION; MECHANISMS	Polyploidization is an abrupt speciation mechanism for eukaryotes and is especially common in plants. However, little is known about patterns and mechanisms of gene regulation during early stages of polyploid formation. Here we analyzed differential expression patterns of the progenitors' genes among successive selfing generations and independent lineages. The synthetic Arabidopsis allotetraploid lines were produced by a genetic cross between A. thaliana and A. arenosa autotetraploids. We found that some progenitors' genes are differentially expressed in early generations, whereas other genes are silenced in late generations or among different siblings within a selfing generation, suggesting that the silencing of progenitors' genes is rapidly and/or stochastically established. Moreover, a subset of genes is affected in autotetraploid and multiple independent allotetraploid lines and in A. suecica, a natural allotetraploid derived from A. thaliana and A. arenosa, indicating locus-specific susceptibility to ploidy-dependent gene regulation. The role of DNA methylation in silencing progenitors' genes is tested in DNA-hyomethylation transgenic lines of A. suecica using RNA interference (RNAi). Two silenced genes are reactivated in both ddm1- and met1-RNAi lines, consistent with the demethylation of centromeric repeats and gene-specific regions in the genome. A rapid and stochastic process of differential gene expression is reinforced by epigenetic regulation during polyploid formation and evolution.	Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; Texas A&M Univ, Genet Program, College Stn, TX 77843 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Puget Sound, Dept Biol, Tacoma, WA 98416 USA		Chen, ZJ (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, MS 2474, College Stn, TX 77843 USA.	zjchen@tamu.edu	Comai, Luca/F-4279-2010	Comai, Luca/0000-0003-2642-6619	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM67015, R01 GM067015] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM067015] Funding Source: NIH RePORTER		Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; An YQ, 1996, PLANT J, V10, P107, DOI 10.1046/j.1365-313X.1996.10010107.x; BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; Beasley JO, 1940, AM NAT, V74, P285, DOI 10.1086/280895; Becak ML, 1998, CYTOGENET CELL GENET, V80, P28, DOI 10.1159/000014952; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; BOGART JP, 1980, POLYPLOIDY BIOL RELE, P341, DOI DOI 10.1007/978-1-4613-3069-1_; Bushell C, 2003, PLANT CELL, V15, P1430, DOI 10.1105/tpc.010496; CHANDLER VL, 1989, PLANT CELL, V1, P1175, DOI 10.1105/tpc.1.12.1175; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Chen ZJ, 2004, BIOL J LINN SOC, V82, P689, DOI 10.1111/j.1095-8312.2004.00351.x; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; CLARKE CA, 1984, J ROY SOC MED, V77, P821, DOI 10.1177/014107688407701004; COLE GM, 1989, MOL CELL BIOL, V9, P3101, DOI 10.1128/MCB.9.7.3101; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Comai L, 2003, CHROMOSOME RES, V11, P217, DOI 10.1023/A:1022883709060; Comai L, 2003, PHILOS T R SOC B, V358, P1149, DOI 10.1098/rstb.2003.1305; Cook LM, 1999, HEREDITY, V82, P237, DOI 10.1038/sj.hdy.6884620; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; FERRIS SD, 1977, NATURE, V265, P258, DOI 10.1038/265258a0; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gaut BS, 2001, GENOME RES, V11, P55, DOI 10.1101/gr.160601; GRANT V., 1981, PLANT SPECIATION; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; He P, 2003, PLANT MOL BIOL, V52, P401, DOI 10.1023/A:1023965400532; Heyne E.G., 1987, WHEAT WHEAT IMPROVEM; Hilu K. W, 1993, AM J BOT, V80, P2521; Kashkush K, 2002, GENETICS, V160, P1651; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lawrence RJ, 2003, PLANT J, V36, P114, DOI 10.1046/j.1365-313X.2003.01857.x; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Lewis W.H, 1980, POLYPLOIDY BIOL RELE; LEWIS WH, 1980, POLYPLOIDY NOVELITY; Liu Bao, 2002, Current Genomics, V3, P489, DOI 10.2174/1389202023350255; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; MARTIENSSEN RA, 1995, CURR OPIN GENET DEV, V5, P234, DOI 10.1016/0959-437X(95)80014-X; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; MENA M, 1984, SCIENCE, V274, P792; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Miyagawa K, 2002, EMBO J, V21, P175, DOI 10.1093/emboj/21.1.175; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Ohno S., 1970, EVOLUTION GENE DUPLI; OKane SL, 1996, SYST BOT, V21, P559, DOI 10.2307/2419615; ORR HA, 1990, AM NAT, V136, P759, DOI 10.1086/285130; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pikaard CS, 1999, TRENDS PLANT SCI, V4, P478, DOI 10.1016/S1360-1385(99)01501-0; PONTES O, 2003, P NATL ACAD SCI USA, V22, P22; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; RAYBOULD AF, 1991, BIOL J LINN SOC, V43, P111, DOI 10.1111/j.1095-8312.1991.tb00588.x; REEDER RH, 1984, CELL, V38, P39, DOI 10.1016/0092-8674(84)90524-5; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Scheid OM, 1996, P NATL ACAD SCI USA, V93, P7114, DOI 10.1073/pnas.93.14.7114; SCHULTZ RJ, 1980, POLYPLOIDY BIOL RELE, P313; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P8089, DOI 10.1073/pnas.92.18.8089; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stokes TL, 2002, P NATL ACAD SCI USA, V99, P7792, DOI 10.1073/pnas.112040999; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; THOMPSON JD, 1992, TRENDS ECOL EVOL, V7, P302, DOI 10.1016/0169-5347(92)90228-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Vrana PB, 2000, NAT GENET, V25, P120, DOI 10.1038/75518; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wolfe KH, 2003, NAT GENET, V33, P255, DOI 10.1038/ng1088; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009	88	261	292	0	44	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	AUG	2004	167	4					1961	1973		10.1534/genetics.104.027896			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851XR	WOS:000223720300039	15342533	Bronze, Green Published			2022-01-24	
J	Person, RE; Li, FQ; Duan, ZJ; Benson, KF; Wechsler, J; Papadaki, HA; Eliopoulos, G; Kaufman, C; Bertolone, SJ; Nakamoto, B; Papayannopoulou, T; Grimes, HL; Horwitz, M				Person, RE; Li, FQ; Duan, ZJ; Benson, KF; Wechsler, J; Papadaki, HA; Eliopoulos, G; Kaufman, C; Bertolone, SJ; Nakamoto, B; Papayannopoulou, T; Grimes, HL; Horwitz, M			Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2	NATURE GENETICS			English	Article							SEVERE CONGENITAL NEUTROPENIA; HERMANSKY-PUDLAK-SYNDROME; ELASTASE; GENE; DIFFERENTIATION	Mice lacking the transcriptional repressor oncoprotein Gfi1 are unexpectedly neutropenic(1,2). We therefore screened GFI1 as a candidate for association with neutropenia in affected individuals without mutations in ELA2 (encoding neutrophil elastase), the most common cause of severe congenital neutropenia (SCN; ref. 3). We found dominant negative zinc finger mutations that disable transcriptional repressor activity. The phenotype also includes immunodeficient lymphocytes and production of a circulating population of myeloid cells that appear immature. We show by chromatin immunoprecipitation, gel shift, reporter assays and elevated expression of ELA2 in vivo in neutropenic individuals that GFI1 represses ELA2, linking these two genes in a common pathway involved in myeloid differentiation.	Univ Washington, Div Med Genet, Dept Med, Sch Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; Univ Crete, Dept Hematol, Sch Med, Univ Hosp Heraklion, Iraklion, Greece; Univ Louisville, Inst Cellular Therapeut, Sch Med, Louisville, KY 40202 USA; Univ Louisville, Dept Surg, Sch Med, Louisville, KY 40202 USA; Univ Louisville, Div Hematol Oncol, Sch Med, Dept Pediat, Louisville, KY 40202 USA; Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA		Horwitz, M (corresponding author), Univ Washington, Div Med Genet, Dept Med, Sch Med, Box 357720, Seattle, WA 98195 USA.			Grimes, H. Leighton/0000-0001-8162-6758; Horwitz, Marshall/0000-0002-1683-1680	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA105152, R01 CA105152-02] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA105152] Funding Source: NIH RePORTER		Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.3.CO;2-0; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz M, 2003, CURR OPIN HEMATOL, V10, P49, DOI 10.1097/00062752-200301000-00008; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Li FQ, 2001, J BIOL CHEM, V276, P14230, DOI 10.1074/jbc.M010279200; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Papadaki HA, 2002, ANN HEMATOL, V81, P50, DOI 10.1007/s00277-001-0401-z; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; ZWEIDLERMCKAY PA, 1996, MOL CELL BIOL, V16, P40242	19	261	272	1	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					308	312		10.1038/ng1170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	WOS:000183815300019	12778173	Green Accepted			2022-01-24	
J	Shao, YJ; Cuccaro, ML; Hauser, ER; Raiford, KL; Menold, MM; Wolpert, CM; Ravan, SA; Elston, L; Decena, K; Donnelly, SL; Abramson, RK; Wright, HH; Delong, GR; Gilbert, JR; Pericak-Vance, MA				Shao, YJ; Cuccaro, ML; Hauser, ER; Raiford, KL; Menold, MM; Wolpert, CM; Ravan, SA; Elston, L; Decena, K; Donnelly, SL; Abramson, RK; Wright, HH; Delong, GR; Gilbert, JR; Pericak-Vance, MA			Fine mapping of Autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; BLOOD-PRESSURE; GENOME SCAN; LINKAGE-DISEQUILIBRIUM; ISODICENTRIC CHROMOSOME-15; DIAGNOSTIC INTERVIEW; MULTIPLE-SCLEROSIS; ANGELMAN SYNDROME; GENETICS FUSION; COMPLEX TRAITS	Autistic disorder (AutD) is a complex genetic disease. Available evidence suggests that several genes contribute to the underlying genetic risk for the development of AutD. However, both etiologic heterogeneity and genetic heterogeneity confound the discovery of AutD-susceptibility genes. Chromosome 15q11-q13 has been identified as a strong candidate region on the basis of both the frequent occurrence of chromosomal abnormalities in that region and numerous suggestive linkage and association findings. Ordered-subset analysis (OSA) is a novel statistical method to identify a homogeneous subset of families that contribute to overall linkage at a given chromosomal location and thus to potentially help in the fine mapping and localization of the susceptibility gene within a chromosomal area. For the present analysis, a factor that represents insistence on sameness (IS)-derived from a principal-component factor analysis using data on 221 patients with AutD from the repetitive behaviors/stereotyped patterns domain in the Autism Diagnostic Interview-Revised-was used as a covariate in OSA. Analysis of families sharing high scores on the IS factor increased linkage evidence for the 15q11-q13 region, at the GABRB3 locus, from a LOD score of 1.45 to a LOD score of 4.71. These results narrow our region of interest on chromosome 15 to an area surrounding the gamma-aminobutyric acid-receptor subunit genes, in AutD, and support the hypothesis that the analysis of phenotypic homogeneous subtypes may be a powerful tool for the mapping of disease-susceptibility genes in complex traits.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Univ S Carolina, WS Hall Psychiat Inst, Columbia, SC 29208 USA		Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Box 3445, Durham, NC 27710 USA.	mpv@chg.duhs.duke.edu		Hauser, Elizabeth/0000-0003-0367-9189	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD36701] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26630, R01 NS036768, R01 NS36768, P01 NS026630] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD036701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS026630, R01NS036768] Funding Source: NIH RePORTER		Allayee H, 2001, HYPERTENSION, V38, P773, DOI 10.1161/hy1001.092617; Arrieta I., 1994, Psychiatric Genetics, V4, P63, DOI 10.1097/00041444-199421000-00009; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; Bass MP, 2000, NEUROGENETICS, V2, P219, DOI 10.1007/s100480050067; Boyar FZ, 2001, CLIN GENET, V60, P421, DOI 10.1034/j.1399-0004.2001.600604.x; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Collaborative Linkage Study of Autism, 2001, Am J Med Genet, V105, P609; Cook EH, 1997, AM J HUM GENET, V60, P928; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; CUCCARO ML, IN PRESS J AUTISM DE; DEMB HB, 1995, J AM ACAD CHILD PSY, V34, P539, DOI 10.1097/00004583-199505000-00006; DILAVORE PC, 1995, J AUTISM DEV DISORD, V25, P355, DOI 10.1007/BF02179373; Dykens EM, 1997, AM J MENT RETARD, V102, P228, DOI 10.1352/0895-8017(1997)102<0228:MBICWP>2.0.CO;2; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FOLSTEIN SE, 1991, PEDIATRICS, V87, P767; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Fombonne E, 2002, MOL PSYCHIATR, V7, pS4, DOI 10.1038/sj.mp.4001162; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hauser ER, 1998, BIOMETRICS, V54, P1238, DOI 10.2307/2533653; Hauser ER, 2001, AM J HUM GENET, V69, P529; HINDS D, 1998, ASPEX PACKAGE AFFECT; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Kanner L, 1943, NERV CHILD, V2, P217; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KNOLL JHM, 1993, AM J MED GENET, V46, P2, DOI 10.1002/ajmg.1320460103; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 1997, J AUTISM DEV DISORD, V27, P501, DOI 10.1023/A:1025873925661; LOTSPEICH LJ, 1993, INT REV NEUROBIOL, V35, P87, DOI 10.1016/S0074-7742(08)60569-3; Maddox LO, 1999, GENOMICS, V62, P325, DOI 10.1006/geno.1999.6017; Maestrini E, 1998, J AUTISM DEV DISORD, V28, P427, DOI 10.1023/A:1026056522602; Martin ER, 2000, AM J MED GENET, V96, P43, DOI 10.1002/(SICI)1096-8628(20000207)96:1<43::AID-AJMG9>3.0.CO;2-3; Menold MM, 2001, J NEUROGENET, V15, P245, DOI 10.3109/01677060109167380; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; Rimmler JB, 1999, AM J HUM GENET, V65, pA442; Rineer S, 1998, AM J MED GENET, V81, P428, DOI 10.1002/(SICI)1096-8628(19980907)81:5<428::AID-AJMG12>3.0.CO;2-E; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; Rubattu S, 1996, NAT GENET, V13, P429, DOI 10.1038/ng0896-429; Salmon B, 1999, AM J MED GENET, V88, P551, DOI 10.1002/(SICI)1096-8628(19991015)88:5<551::AID-AJMG21>3.3.CO;2-R; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Silverman JM, 2002, AM J MED GENET, V114, P64, DOI 10.1002/ajmg.10048; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; Smith M, 2000, AM J MED GENET, V96, P765, DOI 10.1002/1096-8628(20001204)96:6<765::AID-AJMG13>3.0.CO;2-L; Sparrow S., 1984, VINELAND ADAPTIVE BE; Steffenburg S, 1996, PEDIATR NEUROL, V14, P131, DOI 10.1016/0887-8994(96)00011-2; SUMMERS JA, 1995, J INTELL DISABIL RES, V39, P97, DOI 10.1111/j.1365-2788.1995.tb00477.x; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Vance Jeffery M., 1998, P201; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Wolpert CM, 2000, AM J MED GENET, V96, P365, DOI 10.1002/1096-8628(20000612)96:3<365::AID-AJMG25>3.0.CO;2-X; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405	75	261	268	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					539	548		10.1086/367846			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	WOS:000181152600004	12567325	Green Published, Bronze			2022-01-24	
J	Aksentijevich, I; Galon, J; Soares, M; Mansfield, E; Hull, K; Oh, HH; Goldbach-Mansky, R; Dean, J; Athreya, B; Reginato, AJ; Henrickson, M; Pons-Estel, B; O'Shea, JJ; Kastner, DL				Aksentijevich, I; Galon, J; Soares, M; Mansfield, E; Hull, K; Oh, HH; Goldbach-Mansky, R; Dean, J; Athreya, B; Reginato, AJ; Henrickson, M; Pons-Estel, B; O'Shea, JJ; Kastner, DL			The tumor-necrosis-factor receptor-associated periodic syndrome: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL MEDITERRANEAN FEVER; ENCODING MEVALONATE KINASE; TNF RECEPTOR; HIBERNIAN FEVER; AA AMYLOIDOSIS; COMPLEX; IDENTIFICATION; LOCALIZATION; LINKAGE; DOMAIN	Mutations in the extracellular domain of the 55-kD tumor-necrosis factor (TNF) receptor (TNFRSF1A), a key regulator of inflammation, define a periodic-fever syndrome, TRAPS (TNF receptor-associated periodic syndrome [MIM 142680]), which is characterized by attacks of fever, sterile peritonitis, arthralgia, myalgia, skin rash, and/or conjunctivitis; some patients also develop systemic amyloidosis. Elsewhere we have described six disease-associated TNFRSF1A mutations, five of which disrupt extracellular cysteines involved in disulfide bonds; four other mutations have subsequently been reported. Among 150 additional patients with unexplained periodic fevers, we have identified four novel TNFRSF1A mutations (H22Y, C33G, S86P, and c. 193-14 G-->A), one mutation (C30S) described by another group, and two substitutions (P46L and R92Q) present in similar to1% of control chromosomes. The increased frequency of P46L and R92Q among patients with periodic fever, as well as functional studies of TNFRSF1A, argue that these are low- penetrance mutations rather than benign polymorphisms. The c. 193-14 G-->A mutation creates a splice-acceptor site upstream of exon 3, resulting in a transcript encoding four additional extracellular amino acids. T50M and c. 193-14 G-->A occur at CpG hotspots, and haplotype analysis is consistent with recurrent mutations at these sites. In contrast, although R92Q also arises at a CpG motif, we identified a common founder chromosome in unrelated individuals with this substitution. Genotype-phenotype studies identified, as carriers of cysteine mutations, 13 of 14 patients with TRAPS and amyloidosis and indicated a lower penetrance of TRAPS symptoms in individuals with noncysteine mutations. In two families with dominantly inherited disease and in 90 sporadic cases that presented with a compatible clinical history, we have not identified any TNFRSF1A mutation, despite comprehensive genomic sequencing of all of the exons, therefore suggesting further genetic heterogeneity of the periodic-fever syndromes.	NIAMSD, Genet Sect, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; NIAMSD, Sect Lymphocyte Cell Biol, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; NIAMSD, Off Clin Director, NIH, Bethesda, MD 20892 USA; Inst Curie, Lab Immunol Cellulaire & Clin, INSERM, U255, Paris, France; duPont Hosp Children, Div Rheumatol, Wilmington, DE USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cooper Univ Med Ctr, Dept Med,Rheumatol Sect, Camden, NJ 08103 USA; Valley Childrens Hosp, Pediat Arthrit Ctr, Madera, CA USA; Sanatorio Parque, Rosario, Santa Fe, Argentina		Aksentijevich, I (corresponding author), NIAMSD, Genet Sect, Arthrit & Rheumatism Branch, NIH, Bldg 10,Room 9N214, Bethesda, MD 20892 USA.	aksentii@exchange.nih.gov	Aksentijevich, Ivona/AAF-1335-2019; Soares, Miguel Luz/M-1968-2019; Goldbach-Mansky, Raphaela/N-5917-2017; Galon, Jerome/G-9838-2019	Soares, Miguel Luz/0000-0002-1812-6117; Galon, Jerome/0000-0001-9635-1339; Pons-Estel, Bernardo/0000-0003-2518-0266	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [Z01AR041123, ZIAAR041123, ZIAAR041106, Z01AR041106] Funding Source: NIH RePORTER		Aganna E, 2001, EUR J HUM GENET, V9, P63, DOI 10.1038/sj.ejhg.5200573; Aksentijevich I, 1997, CELL, V90, P797; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bazzoni F, 2000, IMMUNOGENETICS, V51, P159, DOI 10.1007/s002510050025; Beckmann JS, 1996, AM J HUM GENET, V59, P1400; Bernot A, 1997, NAT GENET, V17, P25; Centola M, 1998, HUM MOL GENET, V7, P1581, DOI 10.1093/hmg/7.10.1581; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Cuisset L, 1999, AM J HUM GENET, V65, P1054, DOI 10.1086/302589; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dode C, 2000, ARTHRITIS RHEUM-US, V43, P1535, DOI 10.1002/1529-0131(200007)43:7<1535::AID-ANR18>3.0.CO;2-C; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Drenth JPH, 2000, BRIT MED J, V320, P1091, DOI 10.1136/bmj.320.7242.1091; Eskdale J, 2000, GENES IMMUN, V1, P228, DOI 10.1038/sj.gene.6363663; FUCHS P, 1992, GENOMICS, V13, P219, DOI 10.1016/0888-7543(92)90226-I; GERTZ MA, 1987, MAYO CLIN PROC, V62, P1095, DOI 10.1016/S0025-6196(12)62502-6; Hoffman HM, 2000, AM J HUM GENET, V66, P1693, DOI 10.1086/302874; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Jadoul M, 2001, KIDNEY INT, V59, P1677, DOI 10.1046/j.1523-1755.2001.0590051677.x; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; McDermott EM, 1997, MAYO CLIN PROC, V72, P806, DOI 10.4065/72.9.806; McDermott MF, 1998, AM J HUM GENET, V62, P1446, DOI 10.1086/301886; McDermott MF, 2000, ARTHRITIS RHEUM-US, V43, P2034, DOI 10.1002/1529-0131(200009)43:9<2034::AID-ANR14>3.0.CO;2-J; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Mulley J, 1998, AM J HUM GENET, V62, P884, DOI 10.1086/301793; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Simon A, 2001, AM J MED, V110, P313, DOI 10.1016/S0002-9343(00)00716-6; WILLIAMSON LM, 1982, Q J MED, V51, P469; ZAKS N, 1997, FAMILIAL MEDITERRANE, P211	33	261	271	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					301	314		10.1086/321976			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	WOS:000170108200006	11443543	Green Published, Bronze			2022-01-24	
J	Wong, KK; Chang, S; Weiler, SR; Ganesan, S; Chaudhuri, J; Zhu, CM; Artandi, SE; Rudolph, KL; Gottlieb, GJ; Chin, L; Alt, FW; DePinho, RA				Wong, KK; Chang, S; Weiler, SR; Ganesan, S; Chaudhuri, J; Zhu, CM; Artandi, SE; Rudolph, KL; Gottlieb, GJ; Chin, L; Alt, FW; DePinho, RA			Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation	NATURE GENETICS			English	Article							STRAND BREAK REPAIR; V(D)J RECOMBINATION; MAMMALIAN-CELLS; LIGASE-IV; CHROMOSOME BREAKAGE; STEM-CELLS; MICE; KU; IDENTIFICATION; PROTEINS	Telomeres are specialized nucleoprotein complexes that serve as protective caps of linear eukaryotic chromosomes. Loss of telomere function is associated with rampant genetic instability and loss of cellular viability and renewal potential. The telomere also participates in processes of chromosomal repair, as evidenced by the 'capture' or de novo synthesis of telomere repeats at double-stranded breaks(1-4) and by the capacity of yeast telomeres to serve as repositories of essential components of the DNA repair machinery, particularly those involved in non-homologous end-joining(5-7) (NHEJ). Here we used the telomerase-deficient mouse. null for the essential telomerase RNA gene (Terc). to assess the role of telomerase and telomere function on the cellular and organismal response to ionizing radiation. Although the loss of telomerase activity per se had no discernable impact on the response to ionizing radiation, the emergence of telomere dysfunction in late-generation Terc(-/-) mice imparted a radiosensitivity syndrome associated with accelerated mortality. On the cellular level, the gastrointestinal crypt stem cells and primary thymocytes showed increased rates of apoptosis, and mouse embryonic fibroblasts (MEFs) showed diminished dose-dependent clonogenic survival. The radiosensitivity of telomere dysfunctional cells correlated with delayed DNA break repair kinetics, persistent chromosomal breaks and cytogenetic profiles characterized by complex chromosomal aberrations and massive fragmentation. Our findings establish a intimate relationship between functionally intact telomeres and the genomic. cellular and organismal response to ionizing radiation.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; Quest Diagnost Inc, Anat Pathol, Teterboro, NJ USA; Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA		DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.			Rudolph, Karl Lenhard/0000-0002-4839-2862; DePinho, Ronald/0000-0002-5625-577X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD028317, R01HD034880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K08AR002104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K08AG001019] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K08AR02104-01] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K08 AG001019] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD28317, R01HD 34880] Funding Source: Medline		Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Haber JE, 1999, CELL, V97, P829, DOI 10.1016/S0092-8674(00)80795-3; Hall EJ., 1988, RADIOBIOLOGY RADIOLO; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Jeggo PA, 1998, RADIAT RES, V150, pS80, DOI 10.2307/3579810; Kiltie AE, 1997, NUCLEIC ACIDS RES, V25, P2945, DOI 10.1093/nar/25.14.2945; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; MELTZER PS, 1993, NAT GENET, V4, P252, DOI 10.1038/ng0793-252; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; MURNANE JP, 1993, MOL CELL BIOL, V13, P977, DOI 10.1128/MCB.13.2.977; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SAVAGE JRK, 1975, J MED GENET, V12, P103; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Slijepcevic P, 1998, MUTAGENESIS, V13, P45; Sprung CN, 1999, P NATL ACAD SCI USA, V96, P6781, DOI 10.1073/pnas.96.12.6781; Sturzbecher HW, 1996, EMBO J, V15, P1992, DOI 10.1002/j.1460-2075.1996.tb00550.x; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Weaver DT, 1996, CRIT REV EUKAR GENE, V6, P345, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.20	30	261	279	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					85	88		10.1038/79232			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000024	10973255				2022-01-24	
J	Lim, KC; Lakshmanan, G; Crawford, SE; Gu, Y; Grosveld, F; Engel, JD				Lim, KC; Lakshmanan, G; Crawford, SE; Gu, Y; Grosveld, F; Engel, JD			Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system	NATURE GENETICS			English	Article							TYROSINE-HYDROXYLASE GENE; MOUSE FETAL DEVELOPMENT; REGULATORY ELEMENTS; TARGETED DISRUPTION; EXPRESSION; TRANSCRIPTION; MICE; DIFFERENTIATION; LOCUS; PROMOTER	Mouse embryos deficient in Gata3 die by 11 days post coitum (d.p.c) from pathology of undetermined origin(1). We recently showed that Gata3-directed lacZ expression of a 625-kb Gata3 YAC transgene in mice mimics endogenous Gata3 expression, except in thymus and the sympathoadrenal system(2). As this transgene failed to overcome embryonic lethality (unpublished data and ref. 3) in Gata3(-/-) mice, we hypothesized that a neuroendocrine deficiency in the sympathetic nervous system (SNS) might cause embryonic lethality in these mutants. We find here that null mutation of Gata3 leads to reduced accumulation of Th (encoding tyrosine hydroxylase, Th) and Dbh (dopamine beta-hydroxylase. Dbh) mRNA. whereas several other SNS genes are unaffected. We show that Th and Dbh deficiencies lead to reduced noradrenaline in the SNS, and that noradrenaline deficiency is a proximal cause of death in mutants by feeding catechol intermediates to pregnant dams, thereby partially averting Gata3 mutation-induced lethality. These older, pharmacologically rescued mutants revealed abnormalities that previously could not be detected in untreated mutants. These late embryonic defects include renal hypoplasia and developmental defects in structures derived from cephalic neural crest cells. Thus we have shown that Gata3 has a role in the differentiation of multiple cell lineages during embryogenesis.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Sch Med, Childrens Mem Inst Educ & Res, Dept Pathol, Evanston, IL 60208 USA; Erasmus Univ, Dept Cell Biol & Genet, Rotterdam, Netherlands		Engel, JD (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.			Govindan, Lakshmanan/0000-0002-7503-354X	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA60553] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM28896] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM028896] Funding Source: NIH RePORTER		Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Esler M, 1997, AM J CARDIOL, V80, pL7, DOI 10.1016/S0002-9149(97)00844-8; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; GROVES AK, 1995, DEVELOPMENT, V121, P887; Hirsch MR, 1998, DEVELOPMENT, V125, P599; HOYLE GW, 1994, J NEUROSCI, V14, P2455; Joh T H, 1998, Adv Pharmacol, V42, P33; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Lakshmanan G, 1998, DEV BIOL, V204, P451, DOI 10.1006/dbio.1998.8991; Lakshmanan G, 1999, MOL CELL BIOL, V19, P1558; LEONARD MW, 1993, DEVELOPMENT, V119, P519; Lieuw KH, 1997, DEV BIOL, V188, P1, DOI 10.1006/dbio.1997.8575; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Onodera K, 2000, EMBO J, V19, P1335, DOI 10.1093/emboj/19.6.1335; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; RAHMAN MK, 1981, BIOCHEM PHARMACOL, V30, P645, DOI 10.1016/0006-2952(81)90139-8; ten Berge D, 1998, DEVELOPMENT, V125, P3831; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Vainio S, 1997, CELL, V90, P975, DOI 10.1016/S0092-8674(00)80363-3; Yang CY, 1998, J NEUROCHEM, V71, P1358; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	27	261	264	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					209	212		10.1038/76080			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	WOS:000087459200023	10835639				2022-01-24	
J	Wu, GQ; Markowitz, GS; Li, L; D'Agati, VD; Factor, SM; Geng, L; Tibara, S; Tuchman, J; Cai, YQ; Park, JH; van Adelsberg, J; Hou, H; Kucherlapati, R; Edelmann, W; Somlo, S				Wu, GQ; Markowitz, GS; Li, L; D'Agati, VD; Factor, SM; Geng, L; Tibara, S; Tuchman, J; Cai, YQ; Park, JH; van Adelsberg, J; Hou, H; Kucherlapati, R; Edelmann, W; Somlo, S			Cardiac defects and renal failure in mice with targeted mutations in Pkd2	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; HEART; GENE; ENCODES; PROTEIN; MOUSE	PKD2, mutations in which cause autosomal dominant polycystic kidney disease(1) (ADPKD), encodes an integral membrane glycoprotein(2) with similarity to calcium channel subunits(1,3). We induced two mutations in the mouse homologue Pkd2 (ref. 4): an unstable allele (WS25; hereafter denoted pkd2(WS25)) that can undergo homologous-recombination-based somatic rearrangement to form a null allele; and a true null mutation (WS183; hereafter denoted Pkd2(-)). We examined these mutations to understand the function of polycystin-2, the protein product of Pkd2, and to provide evidence that kidney and liver cyst formation associated with Pkd2 deficiency occurs by a two-hit mechanism(4-9). Pkd2(-/-) mice die in utero between embryonic day (E) 13.5 and parturition. They have structural defects in cardiac septation and cyst formation in maturing nephrons and pancreatic ducts. Pancreatic ductal cysts also occur in adult pkd2(WS25/-) mice, suggesting that this clinical manifestation of ADPKD also occurs by a two-hit mechanism. As in human ADPKD, formation of kidney cysts in adult pkd2(WS25/-) mice is associated with renal failure and early death (median survival, 65 weeks versus 94 weeks for controls). Adult Pkd2(+/-) mice have intermediate survival in the absence of cystic disease or renal failure, providing the first indication of a deleterious effect of haploinsufficiency at Pkd2 on long-term survival. Our studies advance our understanding of the function of polycystin-2 in development and our mouse models recapitulate the complex human ADPKD phenotype.	Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT USA		Somlo, S (corresponding author), Yale Univ, Sch Med, Nephrol Sect, Boyer Ctr Mol Med, 333 Cedar St, New Haven, CT 06510 USA.	stefan.somlo@yale.edu	Kucherlapati, Raju/ABC-8807-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK051041, R01DK054053] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1RO1 DK54053, R01 DK051041] Funding Source: Medline		Bardaji A, 1998, AM J KIDNEY DIS, V32, P970, DOI 10.1016/S0272-6386(98)70071-X; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43910; Clark TG, 1999, DEVELOPMENT, V126, P2631; Conway SJ, 1997, CARDIOVASC RES, V36, P163, DOI 10.1016/S0008-6363(97)00172-7; Emmons SW, 1999, NATURE, V401, P339, DOI 10.1038/43810; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Gittes GK, 1996, DEVELOPMENT, V122, P439; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; HUSTON J, 1993, J AM SOC NEPHROL, V3, P1871; Koptides M, 1999, HUM MOL GENET, V8, P509, DOI 10.1093/hmg/8.3.509; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Markowitz GS, 1999, AM J PHYSIOL-RENAL, V277, pF17, DOI 10.1152/ajprenal.1999.277.1.F17; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rossant J, 1996, CIRC RES, V78, P349, DOI 10.1161/01.RES.78.3.349; Stockelman MG, 1998, AM J PHYSIOL-RENAL, V275, pF154, DOI 10.1152/ajprenal.1998.275.1.F154; Torra R, 1999, AM J HUM GENET, V65, P345, DOI 10.1086/302501; Torra R, 1997, CLIN NEPHROL, V47, P19; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	28	261	267	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2000	24	1					75	78		10.1038/71724			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	271TH	WOS:000084609200020	10615132				2022-01-24	
J	Tissenbaum, HA; Ruvkun, G				Tissenbaum, HA; Ruvkun, G			An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans	GENETICS			English	Article							CONTROLLING DAUER FORMATION; RECEPTOR GENE; C-ELEGANS; DROSOPHILA-MELANOGASTER; LIFE-SPAN; DEVELOPMENTAL VARIANT; INTERACTING GENES; OXIDATIVE STRESS; AGE-1; MUTATION	Mutations in daf-2 and age-1 cause a dramatic increase in longevity as well as developmental arrest at the dauer diapause stage in Caenorhabditis elegans. daf-2 and age-1 encode components of an insulin-like signaling pathway. Both daf-2 and age-1 act at a similar point in the genetic epistasis pathway for dauer arrest and longevity and regulate the activity of the daf-16 gene. Mutations in daf-16 cause a dauer-defective phenotype and are epistatic to the diapause arrest and life span extension phenotypes of daf-2 and age-1 mutants. Here we show that mutations in this pathway also affect fertility and embryonic development. Weak daf-2 alleles, and maternally rescued age-1 alleles that cause life span extension but do not arrest at the dauer stage, also reduce fertility and viability. We find that age-1(hx546) has reduced both maternal and zygotic age-1 activity. daf-16 mutations suppress all of the daf-2 and age-1 phenotypes, including dauer arrest, life span extension, reduced fertility, and viability defects. These data show that insulin signaling, mediated by DAF-2 through the AGE-1 phosphatidylinositol-3-OH kinase, regulates reproduction and embryonic development, as well as dauer diapause and life span, and that DAF-16 transduces these signals. The regulation of fertility, life span, and metabolism by an insulin-like signaling pathway is similar to the endocrine regulation of metabolism and fertility by mammalian insulin signaling.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA		Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Wellman Bldg,8th Floor,50 Blossom St, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu			NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG014161, R37AG014161] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-14161] Funding Source: Medline		Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; ANDERSON GL, 1982, CAN J ZOOL, V60, P288, DOI 10.1139/z82-038; BONFINI L, 1996, TIBS, V247, P257; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHAPMAN T, 1992, J INSECT PHYSIOL, V38, P223, DOI 10.1016/0022-1910(92)90070-T; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; DORMAN JB, 1995, GENETICS, V141, P1399; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Finch C.E., 1990, LONGEVITY SENESCENCE; FRIEDMAN DB, 1988, GENETICS, V118, P75; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOTTLIEB S, 1994, GENETICS, V137, P107; Guarente L, 1996, CELL, V86, P9, DOI 10.1016/S0092-8674(00)80072-0; Harman S.M., 1985, HDB BIOL AGING HDB BIOL AGING, P457; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; HODGKIN J, 1992, P R SOC LOND B, V246, P19; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Kahn CR, 1994, JOSLINS DIABETES MEL; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon C, 1996, CELL, V84, P501, DOI 10.1016/S0092-8674(00)81024-7; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; KROOK A, 1993, LANCET, V342, P277, DOI 10.1016/0140-6736(93)91820-C; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; MALONE EA, 1994, GENETICS, V136, P879; Malone EA, 1996, GENETICS, V143, P1193; MASORO EJ, 1991, ANN NY ACAD SCI, V621, P337; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; PARTRIDGE L, 1987, J INSECT PHYSIOL, V33, P745, DOI 10.1016/0022-1910(87)90060-6; PARTRIDGE L, 1981, NATURE, V294, P580, DOI 10.1038/294580a0; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Priess J.R., 1997, C ELEGANS 2 1997, P739; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; RIDDLE D.L., 1988, NEMATODE CAENORHABDI, P393; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SCHNEIDER EL, 1990, HDB BIOL AGING; SMITH JM, 1958, J EXP BIOL, V35, P832; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; THOMAS JH, 1993, BIOESSAYS, V15, P791, DOI 10.1002/bies.950151204; THOMAS JH, 1993, GENETICS, V134, P1105; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; VOWELS JJ, 1992, GENETICS, V130, P105; WERTHEIMER E, 1993, NAT GENET, V5, P71, DOI 10.1038/ng0993-71	60	261	276	1	46	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	FEB	1998	148	2					703	717					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY808	WOS:000072187500015	9504918				2022-01-24	
J	Bull, JJ; Badgett, MR; Wichman, HA; Huelsenbeck, JP; Hillis, DM; Gulati, A; Ho, C; Molineux, IJ				Bull, JJ; Badgett, MR; Wichman, HA; Huelsenbeck, JP; Hillis, DM; Gulati, A; Ho, C; Molineux, IJ			Exceptional convergent evolution in a virus	GENETICS			English	Article							COLI DNA GYRASE; MOLECULAR EVOLUTION; RESISTANCE; PHYLOGENY; SELECTION; MUTATIONS; BACTERIOPHAGE-T7; SEQUENCES; PROTEIN; MUTANTS	Replicate lineages of the bacteriophage phi X 174 adapted to growth at high temperature on either of two hosts exhibited high rates of identical, independent substitutions. Typically, a dozen or more substitutions accumulated in the 5.4-kilobase genome during propagation. Across the entire data set of nine lineages, 119 independent substitutions occurred at 68 nucleotide sites. Over half of these substitutions, accounting far one third of the sites, were identical with substitutions in other lineages. Some convergent substitutions were specific to the host used for phage propagation, but others occurred across both hosts. Continued adaptation of an evolved phage at high temperature, but on the other host, led to additional changes that included reversions of previous substitutions. Phylogenetic reconstruction using the complete genome sequence not only failed to recover the correct evolutionary history because of these convergent changes, but the true history was rejected as being a significantly inferior fit to the data. Replicate lineages subjected to similar environmental challenges showed similar rates of substitution and similar rates of fitness improvement across corresponding times of adaptation. Substitution rates and fitness improvements were higher during the initial period of adaptation than during a later period, except when the host was changed.	UNIV TEXAS, DEPT MICROBIOL, AUSTIN, TX 78712 USA; UNIV TEXAS, INST CELLULAR & MOL BIOL, AUSTIN, TX 78712 USA; UNIV IDAHO, DEPT SCI BIOL, MOSCOW, ID 83844 USA; UNIV CALIF BERKELEY, DEPT INTEGRAT BIOL, BERKELEY, CA 94702 USA		Bull, JJ (corresponding author), UNIV TEXAS, DEPT ZOOL, AUSTIN, TX 78712 USA.		Huelsenbeck, John P/C-6398-2013; Hillis, David/L-5421-2019; Hillis, David M/B-4278-2008		NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [MCB 95-06954] Funding Source: Medline		BEINTEMA JJ, 1977, J MOL EVOL, V10, P49, DOI 10.1007/BF01796134; Borman AM, 1996, J GEN VIROL, V77, P419, DOI 10.1099/0022-1317-77-3-419; BULL JJ, 1993, EVOLUTION, V47, P993, DOI 10.1111/j.1558-5646.1993.tb02130.x; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cunningham CW, 1997, MOL BIOL EVOL, V14, P113, DOI 10.1093/oxfordjournals.molbev.a025697; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; DOWELL CE, 1980, J GEN VIROL, V49, P41, DOI 10.1099/0022-1317-49-1-41; DYKHUIZEN DE, 1993, METHOD ENZYMOL, V224, P613, DOI 10.1016/0076-6879(93)24046-W; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FUNATSU G, 1972, J MOL BIOL, V68, P547, DOI 10.1016/0022-2836(72)90108-8; GODSON GN, 1978, SINGLE STRANDED DNA, P103; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hedges SB, 1996, MOL PHYLOGENET EVOL, V6, P312, DOI 10.1006/mpev.1996.0079; Heisig P, 1996, ANTIMICROB AGENTS CH, V40, P879, DOI 10.1128/AAC.40.4.879; HILLIS DM, 1992, SCIENCE, V255, P589, DOI 10.1126/science.1736360; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; INCARDONA NL, 1985, J MOL BIOL, V181, P479, DOI 10.1016/0022-2836(85)90421-8; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; LANDE R, 1983, HEREDITY, V50, P47, DOI 10.1038/hdy.1983.6; Li W.H., 1997, MOL EVOLUTION; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; MULLER UR, 1980, J MOL BIOL, V141, P25, DOI 10.1016/S0022-2836(80)80027-1; PEACOCK D, 1975, J MOL BIOL, V95, P513, DOI 10.1016/0022-2836(75)90314-9; ROMEROHERRERA AE, 1979, BIOCHIMIE, V61, P767, DOI 10.1016/S0300-9084(79)80271-0; Sanderson Michael J., 1996, P67, DOI 10.1016/B978-012618030-5/50005-8; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0; SWOFFORD DL, 1997, PAUP STAR PHYLOGENET; VIZAN JL, 1991, EMBO J, V10, P467, DOI 10.1002/j.1460-2075.1991.tb07969.x; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Wells RS, 1996, P ROY SOC B-BIOL SCI, V263, P393, DOI 10.1098/rspb.1996.0060; Yang Z., 1996, PHYLOGENETIC ANAL MA; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; YIN J, 1993, J BACTERIOL, V175, P1272, DOI 10.1128/JB.175.5.1272-1277.1993; YOSHIDA H, 1993, ANTIMICROB AGENTS CH, V37, P839, DOI 10.1128/AAC.37.4.839	38	261	261	3	22	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	DEC	1997	147	4					1497	1507					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YK654	WOS:A1997YK65400002	9409816				2022-01-24	
J	Reiter, LT; Murakami, T; Koeuth, T; Pentao, L; Muzny, DM; Gibbs, RA; Lupski, JR				Reiter, LT; Murakami, T; Koeuth, T; Pentao, L; Muzny, DM; Gibbs, RA; Lupski, JR			A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element	NATURE GENETICS			English	Article							TOOTH DISEASE TYPE-1A; HUMAN X-CHROMOSOME; DISTAL SHORT ARM; DROSOPHILA-MELANOGASTER; REPETITIVE ELEMENTS; FREQUENT DELETIONS; DNA DUPLICATION; GENE; MUTATION; FAMILIES	The Charcot-Marie Tooth disease type 1A (CMT1A) duplication and hereditary neuropathy with liability to pressure palsies (HNPP) deletion are reciprocal products of an unequal crossing-over event between misaligned flanking CMT1A-REP repeats. The molecular aetiology of this apparently homologous recombination event was examined by sequencing the crossover region. Through the detection of novel junction fragments from the recombinant CMT1A-REPs in both CMT1A and HNPP patients, a 1.7-kb recombination hotspot within the similar to 30-kb CMT1A-REPs was identified. This hotspot is 98% identical between CMT1A-REPs indicating that sequence identity is not likely the sole factor involved in promoting crossover events. Sequence analysis revealed a mariner transposon-like element (MITE) near the hotspot which we hypothesize could mediate strand exchange events via cleavage by a transposase at or near the 3' end of the element.	BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CELL & MOLEC BIOL PROGRAM,HOUSTON,TX 77030; BAYLOR COLL MED,DEV BIOL PROGRAM,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030				Reiter, Lawrence T./H-4161-2019	Reiter, Lawrence T./0000-0002-4100-2630; Murakami, Tatsufumi/0000-0001-7851-6822	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00210] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27042] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027042] Funding Source: NIH RePORTER		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSSON B, 1994, ANAL BIOCHEM, V218, P300, DOI 10.1006/abio.1994.1182; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; CAPY P, 1992, GENETICA, V86, P37, DOI 10.1007/BF00133709; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; DAVIES DM, 1954, LANCET, V2, P266; De Jong J, 1947, PSYCHIAT NEUROL BL A, V50, P60; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GARZA D, 1991, GENETICS, V128, P303; HERTZ JM, 1994, CLIN GENET, V46, P291; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; IONASESCU VV, 1993, MUSCLE NERVE, V16, P1232, DOI 10.1002/mus.880161114; JACOBSON JW, 1986, P NATL ACAD SCI USA, V83, P8684, DOI 10.1073/pnas.83.22.8684; JURKA J, 1990, NUCLEIC ACIDS RES, V18, P137, DOI 10.1093/nar/18.1.137; JURKA J, IN PRESS COMP CHEM; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KALLIONIEMI OP, 1994, GENOMICS, V20, P125, DOI 10.1006/geno.1994.1138; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LEGUERN E, 1995, HUM MOL GENET, V4, P1673, DOI 10.1093/hmg/4.9.1673; LI XM, 1992, NUCLEIC ACIDS RES, V20, P1117, DOI 10.1093/nar/20.5.1117; LIDHOLM DA, 1993, GENETICS, V134, P859; LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191; LOHE AR, 1995, GENETICS, V140, P183; LORENZETTI D, 1995, AM J HUM GENET, V56, P91; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; Lupski JR, 1996, AM J HUM GENET, V58, P21; LUPSKI JR, 1993, AM J MED GENET, V45, P92, DOI 10.1002/ajmg.1320450122; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MARUYAMA K, 1991, J MOL EVOL, V33, P514, DOI 10.1007/BF02102804; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MAZNY DM, 1994, AUTOMATED DNA SEQUEN, P182; MCCARRON M, 1994, GENETICS, V136, P1013; McKusick V.A., 1994, MENDELIAN INHERITANC; METZENBERG AB, 1991, GENETICS, V128, P143; NELIS E, IN PRESS EUR J HUM G; OOSUMI T, 1995, NATURE, V378, P672, DOI 10.1038/378672a0; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P92; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; REISECKER F, 1994, NEUROLOGY, V44, P753, DOI 10.1212/WNL.44.4.753; ROA BB, 1994, ADV HUM GENET, V22, P117; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1995, LAB MED INT, V12, P22; Robertson H.M., 1993, Insect Molecular Biology, V2, P125, DOI 10.1111/j.1365-2583.1993.tb00132.x; ROBERTSON HM, 1993, NATURE, V362, P241, DOI 10.1038/362241a0; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; Sambrook J., 1989, MOL CLONING LAB MANU; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SMIT AFA, IN PRESS P NATL ACAD; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmerman V, 1996, HUM GENET, V97, P26, DOI 10.1007/BF00218828; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; WISE CA, 1993, AM J HUM GENET, V53, P853; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	65	261	264	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					288	297		10.1038/ng0396-288			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	WOS:A1996TY18300018	8589720				2022-01-24	
J	TORRONI, A; LOTT, MT; CABELL, MF; CHEN, YS; LAVERGNE, L; WALLACE, DC				TORRONI, A; LOTT, MT; CABELL, MF; CHEN, YS; LAVERGNE, L; WALLACE, DC			MTDNA AND THE ORIGIN OF CAUCASIANS - IDENTIFICATION OF ANCIENT CAUCASIAN-SPECIFIC HAPLOGROUPS, ONE OF WHICH IS PRONE TO A RECURRENT SOMATIC DUPLICATION IN THE D-LOOP REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; ENDONUCLEASE CLEAVAGE PATTERNS; HEREDITARY OPTIC NEUROPATHY; BASE PAIR RECOGNITION; PAPUA-NEW-GUINEA; RESTRICTION ENZYMES; NONCODING REGION; POPULATION-DATA; HUMAN-EVOLUTION; COMPLEX-I	mtDNA sequence variation was examined in 175 Caucasians from the United States and Canada by PCR amplification and high-resolution restriction-endonuclease analysis. The majority of the Caucasian mtDNAs were subsumed within four mtDNA lineages (haplogroups) defined by mutations that are rarely seen in Africans and Mongoloids. The sequence divergence of these haplogroups indicates that they arose early in Caucasian radiation and gave raise to modern European mtDNAs. Although ancient, none of these haplogroups is old enough to be compatible with a Neanderthal origin, suggesting that Home sapiens sapiens displaced H. s. neanderthaliensis, rather than mixed with it. The mtDNAs of one of these haplogroups have a unique homoplasmic insertion between nucleotide pair (np) 573 and np 574, within the D-loop control region. This insertion makes these mtDNAs prone to a somatic mutation that duplicates a 270-bp portion of the D-loop region between np 309 and np 572. This finding suggests that certain nonpathogenic mtDNA mutations could predispose individuals to mtDNA rearrangements.	EMORY UNIV, SCH MED, DEPT MED & MOLEC GENET, ATLANTA, GA 30322 USA; MINIST SECURITE PUBL, DIRECT EXPERTISES JUDICLARES, MONTREAL, PQ, CANADA				Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478; Lott, Marie/0000-0003-2035-479X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM046915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021328] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM46915] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21328] Funding Source: Medline		Ammerman Albert, 1984, NEOLITHIC TRANSITION; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BARYOSEF O, 1993, SCI AM, V268, P94, DOI 10.1038/scientificamerican0493-94; BENERECETTI ASS, 1988, ANN HUM GENET, V52, P39, DOI 10.1111/j.1469-1809.1988.tb01076.x; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, AM J HUM GENET, V39, P502; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; BREGA A, IN PRESS GENE GEOGR; BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67; BROWN MD, 1992, GENETICS, V130, P163; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; De Benedictis G, 1989, Gene Geogr, V3, P33; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; DIONNE FT, 1991, MED SCI SPORT EXER, V23, P177; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1990, AM J HUM GENET, V46, P828; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Kumar S, 1993, MEGA MOL EVOLUTIONAR; MIGNOTTE F, 1990, EUR J BIOCHEM, V194, P561, DOI 10.1111/j.1432-1033.1990.tb15653.x; MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221; NEI M, 1983, GENETICS, V105, P207; PASSARINO G, 1993, AM J HUM GENET, V53, P609; PIAZZA A, 1993, SCIENCE, V260, P1767, DOI 10.1126/science.8511584; RIGAUD JP, 1990, WORLD 18000 BP; RITTE U, 1993, HUM BIOL, V65, P359; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SARTORIS S, 1988, ANN HUM GENET, V52, P327, DOI 10.1111/j.1469-1809.1988.tb01112.x; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SCOZZARI R, 1994, HUM BIOL, V66, P1; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SEMINO O, 1991, ANN HUM GENET, V55, P123, DOI 10.1111/j.1469-1809.1991.tb00405.x; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1986, COLD SPRING HARB SYM, V51, P433, DOI 10.1101/SQB.1986.051.01.052; SWOFFORD D, 1992, PHYLOGENETIC ANAL US; THORNE AG, 1992, SCI AM, V266, P76, DOI 10.1038/scientificamerican0492-76; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TORRONI A, 1990, INT J ANTHR, V5, P97; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WALLACE DC, 1993, GENOME PRIORITY REPO, V1, P727; WOLPOFF MH, 1989, HUMAN REVOLUTION, P62; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	67	261	266	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					760	776					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	WOS:A1994PJ02700020	7942855				2022-01-24	
J	LEDERBERG, EM; LEDERBERG, J				LEDERBERG, EM; LEDERBERG, J			GENETIC STUDIES OF LYSOGENICITY IN ESCHERICHIA-COLI	GENETICS			English	Article																	ADAMS MH, 1950, METH MED RES, V2, P1; ANDERSON ES, 1951, J HYG-CAMBRIDGE, V49, P458, DOI 10.1017/S0022172400066778; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BOYD JSK, 1951, J PATHOL BACTERIOL, V63, P445, DOI 10.1002/path.1700630311; BURNET F. M., 1936, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V14, P27, DOI 10.1038/icb.1936.3; BURNET FM, 1945, VIRUS ORGANISM; CAVALLI LL, 1949, NATURE, V164, P1057, DOI 10.1038/1641057c0; DAVIS BD, 1950, EXPERIENTIA, V6, P41, DOI 10.1007/BF02174810; DELBRUCK M, 1950, VIRUSES 1950; DHERELLE FD, 1926, BACTERIOPHAGE ITS BE, P237; Fredericq P., 1948, REV BELGE PATH    S4, V19, P1; HAYES W, 1952, NATURE, V169, P118, DOI 10.1038/169118b0; LEDERBERG EM, 1952, GENETICS, V37, P469; LEDERBERG J, 1951, SCIENCE, V114, P68, DOI 10.1126/science.114.2951.68; LEDERBERG J, 1950, METH MED RES, V3, P5; LEDERBERG J, 1952, GENETICS, V37, P720; LEDERBERG J, 1949, P NATL ACAD SCI USA, V35, P178, DOI 10.1073/pnas.35.4.178; LEDERBERG J, 1952, J BACTERIOL, V63, P399, DOI 10.1128/JB.63.3.399-406.1952; LEDERBERG J, 1951, COLD SPRING HARBOR S, V16, P414; LEDERBERG J, 1951, GENETICS 20TH CENTUR; Lominski I, 1938, CR SOC BIOL, V129, P151; LWOFF A, 1950, ANN I PASTEUR PARIS, V79, P815; LWOFF A, 1950, ANN I PASTEUR PARIS, V78, P711; NICOLLE P, 1951, ANN I PASTEUR PARIS, V81, P614; Schiff F, 1940, J IMMUNOL, V39, P361; SONNEBORN TM, 1945, AM NAT, V79, P318, DOI 10.1086/281268; SONNEBORN TM, 1950, HEREDITY, V4, P11, DOI 10.1038/hdy.1950.2; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; TATUM EL, 1945, P NATL ACAD SCI USA, V31, P215, DOI 10.1073/pnas.31.8.215; WAHL R, 1952, ANN I PASTEUR PARIS, V82, P29; WEIGLE JJ, 1951, J BACTERIOL, V62, P301, DOI 10.1128/JB.62.3.301-318.1951; WILLIAMS SH, 1948, J HYG CAMB, V46, P82; WILLIAMSSMITH HW, 1948, J HYG, V46, P74	33	261	265	1	16	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1953	38	1					51	64					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW856	WOS:A1953XW85600004	17247421				2022-01-24	
J	Jarvik, GP; Amendola, LM; Berg, JS; Brothers, K; Clayton, EW; Chung, W; Evans, BJ; Evans, JP; Fullerton, SM; Gallego, CJ; Garrison, NA; Gray, SW; Holm, IA; Kullo, IJ; Lehmann, LS; McCarty, C; Prows, CA; Rehm, HL; Sharp, RR; Salama, J; Sanderson, S; Van Driest, SL; Williams, MS; Wolf, SM; Wolf, WA; Burke, W				Jarvik, Gail P.; Amendola, Laura M.; Berg, Jonathan S.; Brothers, Kyle; Clayton, Ellen W.; Chung, Wendy; Evans, Barbara J.; Evans, James P.; Fullerton, Stephanie M.; Gallego, Carlos J.; Garrison, Nanibaa' A.; Gray, Stacy W.; Holm, Ingrid A.; Kullo, Iftikhar J.; Lehmann, Lisa Soleymani; McCarty, Cathy; Prows, Cynthia A.; Rehm, Heidi L.; Sharp, Richard R.; Salama, Joseph; Sanderson, Saskia; Van Driest, Sara L.; Williams, Marc S.; Wolf, Susan M.; Wolf, Wendy A.; Burke, Wylie		eMERGE Act-ROR Comm; CERC Comm; CSER Act-ROR Working Grp	Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANAGING INCIDENTAL FINDINGS; ACMG RECOMMENDATIONS; CLINICAL GENOMICS; PATIENT AUTONOMY; WORKING GROUP; CHILDREN; EXOME; BREAST; CANCER; ISSUES	As more research studies incorporate next-generation sequencing (including whole-genome or whole-exome sequencing), investigators and institutional review boards face difficult questions regarding which genomic results to return to research participants and how. An American College of Medical Genetics and Genomics 2013 policy paper suggesting that pathogenic mutations in 56 specified genes should be returned in the clinical setting has raised the question of whether comparable recommendations should be considered in research settings. The Clinical Sequencing Exploratory Research (CSER) Consortium and the Electronic Medical Records and Genomics (eMERGE) Network are multisite research programs that aim to develop practical strategies for addressing questions concerning the return of results in genomic research. CSER and eMERGE committees have identified areas of consensus regarding the return of genomic results to research participants. In most circumstances, if results meet an actionability threshold for return and the research participant has consented to return, genomic results, along with referral for appropriate clinical follow-up, should be offered to participants. However, participants have a right to decline the receipt of genomic results, even when doing so might be viewed as a threat to the participants' health. Research investigators should be prepared to return research results and incidental findings discovered in the course of their research and meeting an actionability threshold, but they have no ethical obligation to actively search for such results. These positions are consistent with the recognition that clinical research is distinct from medical care in both its aims and its guiding moral principles.	[Jarvik, Gail P.; Amendola, Laura M.; Gallego, Carlos J.; Salama, Joseph] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Berg, Jonathan S.; Evans, James P.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Brothers, Kyle] Hudson Alpha Inst Biotechnol, Huntsville, AL 35806 USA; [Brothers, Kyle] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA; [Clayton, Ellen W.; Garrison, Nanibaa' A.; Van Driest, Sara L.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37204 USA; [Clayton, Ellen W.; Garrison, Nanibaa' A.; Van Driest, Sara L.] Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, Nashville, TN 37204 USA; [Chung, Wendy] Columbia Univ, New York, NY 10032 USA; [Evans, Barbara J.] Univ Houston, Ctr Law, Houston, TX 77204 USA; [Fullerton, Stephanie M.; Burke, Wylie] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Gray, Stacy W.; Lehmann, Lisa Soleymani; Rehm, Heidi L.] Brigham & Womens Hosp, Cambridge, MA 02138 USA; [Gray, Stacy W.; Lehmann, Lisa Soleymani; Rehm, Heidi L.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Gray, Stacy W.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Holm, Ingrid A.; Wolf, Wendy A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Holm, Ingrid A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Holm, Ingrid A.; Wolf, Wendy A.] Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Holm, Ingrid A.; Wolf, Wendy A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [McCarty, Cathy] Essentia Inst Rural Hlth, Duluth, MN 55805 USA; [Prows, Cynthia A.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Prows, Cynthia A.] Cincinnati Childrens Hosp Med Ctr, Div Patient Serv, Cincinnati, OH 45229 USA; [Sharp, Richard R.] Mayo Clin, Biomed Eth Program, Rochester, MN 55905 USA; [Sanderson, Saskia] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA 17822 USA; [Wolf, Susan M.] Univ Minnesota, Sch Med, Law Sch, Minneapolis, MN 55455 USA; [Wolf, Susan M.] Univ Minnesota, Consortium Law & Values Hlth Environm & Life Sci, Minneapolis, MN 55455 USA		Jarvik, GP (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	pair@u.washington.edu	Tromp, Gerard/B-2677-2017; Gray, Stacy/AAJ-2956-2020; Jarvik, Gail P/N-6476-2014; Burke, William/C-1203-2012; Fullerton, Stephanie Malia/H-8696-2019	Tromp, Gerard/0000-0002-7761-0806; Gray, Stacy/0000-0001-6948-0143; Jarvik, Gail P/0000-0002-6710-8708; Fullerton, Stephanie Malia/0000-0002-0938-6048; Holm, Ingrid/0000-0003-4712-8821; Rehm, Heidi L./0000-0002-6025-0015; McCarty, Catherine/0000-0003-1089-0142; Connolly, John/0000-0003-4396-1226; Clayton, Ellen/0000-0002-0308-4110; Lynch, John/0000-0001-6457-620X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01HG006507, U01 HG006487, U01 HG007307, U01HG007307, U01HG006500, U01 G006492]; Electronic Medical Records and Genomics (eMERGE) Network [U01HG006375, U01HG006378, U01HG04603, U01HG006828, U01HG006379, U01HG006382]; eMERGE Return of Results awards [R21HG00612, R01 HG006615, R01 HG004500, 1R01CA154517]; Robert Wood Johnson Foundation Investigator AwardRobert Wood Johnson Foundation (RWJF) [69763]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA154517] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000067, UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG007307, U01HG006382, U01HG006500, U01HG006379, U01HG006507, U01HG006380, R01HG004500, U01HG006375, UM1HG007301, U01HG006492, U01HG006378, U01HG007278, R01HG006615, U01HG006487, U01HG004603, U01HG006828] Funding Source: NIH RePORTER	This work was supported by NIH Clinical Sequencing Exploratory Research (CSER) awards U01HG006507, U01 HG006487, U01 HG007307, U01HG007307, U01HG006500, and U01 G006492; Electronic Medical Records and Genomics (eMERGE) Network awards U01HG006375, U01HG006378, U01HG04603, U01HG006828, U01HG006379, and U01HG006382; eMERGE Return of Results awards R21HG00612, R01 HG006615, R01 HG004500, and 1R01CA154517; and Robert Wood Johnson Foundation Investigator Award 69763. All views expressed are those of the authors and do not necessarily reflect the views of the funding agencies, the CSER Consortium, or the eMERGE Network. L.A.H., J.M., C.H., K.S., N.L., S.S., and C.C. are members of the NIH CSER staff team, responsible for scientific program management of the CSER program.	Allyse M, 2013, TRENDS BIOTECHNOL, V31, P439, DOI 10.1016/j.tibtech.2013.04.006; American College of Medical and Genetics, 2014, ACMG UPD REC OPT OUT; Berg JS, 2013, GENET MED, V15, P860, DOI 10.1038/gim.2013.133; Beskow LM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000952; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; Bookman EB, 2006, AM J MED GENET A, V140A, P1033, DOI 10.1002/ajmg.a.31195; Botoseneanu A, 2011, HEALTH EDUC BEHAV, V38, P617, DOI 10.1177/1090198110389711; Buchanan A, 1989, DECIDING OTHERS ETHI; Burke W, 2014, AM J MED GENET C, V166, P105, DOI 10.1002/ajmg.c.31393; Burke W, 2013, GENET MED, V15, P854, DOI 10.1038/gim.2013.113; Clayton EW, 2014, AM J BIOETHICS, V14, P3, DOI 10.1080/15265161.2013.879945; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Evans Barbara J, 2014, Univ Pa J Const Law, V16, P549; Evans BJ, 2013, GENET MED, V15, P915, DOI 10.1038/gim.2013.135; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Goldstein J., 1979, BEST INTERESTS CHILD, VII; Graves KD, 2011, PUBLIC HEALTH GENOM, V14, P178, DOI 10.1159/000324703; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Haga SB, 2013, ADV GENET, V84, P41, DOI 10.1016/B978-0-12-407703-4.00002-5; Holtzman NA, 2013, GENET MED, V15, P750, DOI 10.1038/gim.2013.96; Knoppers BM, 2014, EUR J HUM GENET, V22, P3, DOI 10.1038/ejhg.2013.176; Kohane IS, 2007, SCIENCE, V316, P836, DOI 10.1126/science.1135489; Neumann PJ, 2012, HEALTH ECON, V21, P238, DOI 10.1002/hec.1704; Ormondroyd E, 2007, J Genet Couns, V16, P527, DOI 10.1007/s10897-007-9088-1; Presidential Commission for the Study of Bioethical Issues, 2012, PRIV PROGR WHOL GEN; Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; Richards MPM, 2003, J MED ETHICS, V29, P93, DOI 10.1136/jme.29.2.93; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700; Ross LF, 1998, CHILDREN FAMILIES HL; Shalowitz DI, 2008, PLOS MED, V5, P714, DOI 10.1371/journal.pmed.0050091; Townsend A, 2013, GENET MED, V15, P751, DOI 10.1038/gim.2013.105; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Wendler D, 2007, AM J MED GENET A, V143A, P1733, DOI 10.1002/ajmg.a.31823; WILFOND BS, 1995, AM J HUM GENET, V57, P1233; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23; Yu JH, 2013, GENET MED, V15, P684, DOI 10.1038/gim.2013.35	40	260	261	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					818	826		10.1016/j.ajhg.2014.04.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	WOS:000337331200003	24814192	Green Published, Bronze			2022-01-24	
J	Xue, J; Zhou, X; Zhang, CX; Yu, LL; Fan, HW; Wang, Z; Xu, HJ; Xi, Y; Zhu, ZR; Zhou, WW; Pan, PL; Li, BL; Colbourne, JK; Noda, H; Suetsugu, Y; Kobayashi, T; Zheng, Y; Liu, S; Zhang, R; Liu, Y; Luo, YD; Fang, DM; Chen, Y; Zhan, DL; Lv, XD; Cai, Y; Wang, ZB; Huang, HJ; Cheng, RL; Zhang, XC; Lou, YH; Yu, B; Zhuo, JC; Ye, YX; Zhang, WQ; Shen, ZC; Yang, HM; Wang, J; Wang, J; Bao, YY; Cheng, JA				Xue, Jian; Zhou, Xin; Zhang, Chuan-Xi; Yu, Li-Li; Fan, Hai-Wei; Wang, Zhuo; Xu, Hai-Jun; Xi, Yu; Zhu, Zeng-Rong; Zhou, Wen-Wu; Pan, Peng-Lu; Li, Bao-Ling; Colbourne, John K.; Noda, Hiroaki; Suetsugu, Yoshitaka; Kobayashi, Tetsuya; Zheng, Yuan; Liu, Shanlin; Zhang, Rui; Liu, Yang; Luo, Ya-Dan; Fang, Dong-Ming; Chen, Yan; Zhan, Dong-Liang; Lv, Xiao-Dan; Cai, Yue; Wang, Zhao-Bao; Huang, Hai-Jian; Cheng, Ruo-Lin; Zhang, Xue-Chao; Lou, Yi-Han; Yu, Bing; Zhuo, Ji-Chong; Ye, Yu-Xuan; Zhang, Wen-Qing; Shen, Zhi-Cheng; Yang, Huan-Ming; Wang, Jian; Wang, Jun; Bao, Yan-Yuan; Cheng, Jia-An			Genomes of the rice pest brown planthopper and its endosymbionts reveal complex complementary contributions for host adaptation	GENOME BIOLOGY			English	Article							NILAPARVATA-LUGENS STAL; AMINO-ACIDS; GENE; SEQUENCE; DELPHACIDAE; HEMIPTERA; RESPONSES; DATABASE; TREE; SAP	Background: The brown planthopper, Nilaparvata lugens, the most destructive pest of rice, is a typical monophagous herbivore that feeds exclusively on rice sap, which migrates over long distances. Outbreaks of it have re-occurred approximately every three years in Asia. It has also been used as a model system for ecological studies and for developing effective pest management. To better understand how a monophagous sap-sucking arthropod herbivore has adapted to its exclusive host selection and to provide insights to improve pest control, we analyzed the genomes of the brown planthopper and its two endosymbionts. Results: We describe the 1.14 gigabase planthopper draft genome and the genomes of two microbial endosymbionts that permit the planthopper to forage exclusively on rice fields. Only 40.8% of the 27,571 identified Nilaparvata protein coding genes have detectable shared homology with the proteomes of the other 14 arthropods included in this study, reflecting large-scale gene losses including in evolutionarily conserved gene families and biochemical pathways. These unique genomic features are functionally associated with the animal's exclusive plant host selection. Genes missing from the insect in conserved biochemical pathways that are essential for its survival on the nutritionally imbalanced sap diet are present in the genomes of its microbial endosymbionts, which have evolved to complement the mutualistic nutritional needs of the host. Conclusions: Our study reveals a series of complex adaptations of the brown planthopper involving a variety of biological processes, that result in its highly destructive impact on the exclusive host rice. All these findings highlight potential directions for effective pest control of the planthopper.	[Xue, Jian; Zhang, Chuan-Xi; Fan, Hai-Wei; Xu, Hai-Jun; Xi, Yu; Zhu, Zeng-Rong; Zhou, Wen-Wu; Pan, Peng-Lu; Li, Bao-Ling; Huang, Hai-Jian; Cheng, Ruo-Lin; Zhang, Xue-Chao; Lou, Yi-Han; Yu, Bing; Zhuo, Ji-Chong; Ye, Yu-Xuan; Shen, Zhi-Cheng; Bao, Yan-Yuan; Cheng, Jia-An] Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Xin; Liu, Shanlin; Zhang, Rui; Liu, Yang; Fang, Dong-Ming; Yang, Huan-Ming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Yu, Li-Li; Wang, Zhuo; Zheng, Yuan; Luo, Ya-Dan; Chen, Yan; Zhan, Dong-Liang; Lv, Xiao-Dan; Cai, Yue; Wang, Zhao-Bao] BGI Shenzhen, BGI Tech, Shenzhen 518083, Guangdong, Peoples R China; [Colbourne, John K.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Noda, Hiroaki; Suetsugu, Yoshitaka; Kobayashi, Tetsuya] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Shen, Zhi-Cheng] Sun Yat Sen Univ, Inst Entomol, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Yang, Huan-Ming; Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Zhou, Xin; Liu, Shanlin; Zhang, Rui] BGI Shenzhen, China Natl GeneBank, Shenzhen 518083, Guangdong, Peoples R China; [Wang, Jian] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China		Zhang, CX (corresponding author), Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China.	chxzhang@zju.edu.cn; wangjian@genomics.cn; wangj@genomics.cn; yybao@zju.edu.cn; jacheng@zju.edu.cn	Zhou, Xin/D-4025-2009; yan, chen/AAS-4603-2021; Zhang, Chuan-Xi/K-7978-2019; Zhou, Xin/AAI-9326-2021; Jian, Xue/M-2381-2019; Wang, Jun/B-9503-2016; Colbourne, John/L-7748-2014; Wang, Jun/C-8434-2016	Zhou, Xin/0000-0002-1407-7952; Zhang, Chuan-Xi/0000-0002-7784-1188; Zhou, Xin/0000-0002-1407-7952; Zhou, Wenwu/0000-0002-0727-8086; Wang, Jun/0000-0002-2113-5874; yu, lili/0000-0003-0435-0385; Colbourne, John/0000-0002-6966-2972; Huang, Haijian/0000-0002-0968-4520; Xu, Hai-Jun/0000-0002-7314-377X; Wang, Jun/0000-0002-8540-8931	National Basic Research Program of China (973 Program)National Basic Research Program of China [2010CB126205]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31272374, 31070136]; BGI-Shenzhen; Chinese Ministry of AgricultureMinistry of Agriculture, China; China National GeneBank-Shenzhen; Key Lab of Genomics; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25292201] Funding Source: KAKEN	This work was supported by grants from the National Basic Research Program of China (973 Program, number 2010CB126205) and the National Science Foundation of China (31272374 and 31070136). Genome sequencing and analysis were also supported by grants from BGI-Shenzhen, Chinese Ministry of Agriculture, Key Lab of Genomics and the China National GeneBank-Shenzhen. We thank Kimiko Yamamoto, Tetsuro Shinoda and Kazuei Mita of the Agrogenomics Research Center, National Institute of Agrobiological Sciences, Japan, for their helpful suggestions for this program.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bottrell DG, 2012, J ASIA-PAC ENTOMOL, V15, P122, DOI 10.1016/j.aspen.2011.09.004; Brisson JA, 2010, INSECT MOL BIOL, V19, P63, DOI 10.1111/j.1365-2583.2009.00935.x; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CAMPBELL BC, 1995, SYST ENTOMOL, V20, P175, DOI 10.1111/j.1365-3113.1995.tb00090.x; CHEN CC, 1981, Z ANGEW ENTOMOL, V91, P321; Chen YH, 2011, J INSECT PHYSIOL, V57, P1375, DOI 10.1016/j.jinsphys.2011.07.002; Cheng J.A., 2009, PLANTHOPPERS NEW THR, P157; CHENG SN, 1979, ACTA ENTOMOL SINICA, V22, P1; CHENIER JVR, 1989, J CHEM ECOL, V15, P1729, DOI 10.1007/BF01012261; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cook Anthea G., 1994, P114; Denno Robert F., 1994, P163; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gould JL, 1998, CURR BIOL, V8, pR731, DOI 10.1016/S0960-9822(98)70461-0; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAYASHI H, 1990, PLANT CELL PHYSIOL, V31, P247; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hongoh Y, 2000, INSECT BIOCHEM MOLEC, V30, P173, DOI 10.1016/S0965-1748(99)00116-2; Hongoh Y, 1997, ZOOL SCI, V14, P581, DOI 10.2108/zsj.14.581; Horgan F, 2009, PLANTHOPPERS NEW THR, P281; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hu DB, 2013, INSECT SCI, V20, P703, DOI 10.1111/j.1744-7917.2012.01571.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; KOYAMA K, 1985, APPL ENTOMOL ZOOL, V20, P424, DOI 10.1303/aez.20.424; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu Zhong-Xian, 2004, Journal of Asia-Pacific Entomology, V7, P317, DOI 10.1016/S1226-8615(08)60233-2; McBride CS, 2007, P NATL ACAD SCI USA, V104, P4996, DOI 10.1073/pnas.0608424104; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Noda H, 2003, INSECT BIOCHEM MOLEC, V33, P649, DOI 10.1016/S0965-1748(03)00056-0; NODA H, 1992, J INVERTEBR PATHOL, V59, P104, DOI 10.1016/0022-2011(92)90119-O; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Perfect T. John, 1994, P282; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Qu LY, 2013, SYMBIOSIS, V61, P47, DOI 10.1007/s13199-013-0256-9; Quinn NL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-404; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; RILEY JR, 1991, ECOL ENTOMOL, V16, P471, DOI 10.1111/j.1365-2311.1991.tb00240.x; Rose MD, 1990, METHODS YEAST GENETI; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; SMITH BH, 1994, ANNU REV ENTOMOL, V39, P351, DOI 10.1146/annurev.en.39.010194.002031; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Suh SO, 2001, MOL BIOL EVOL, V18, P995, DOI 10.1093/oxfordjournals.molbev.a003901; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Visser JH, 1996, ENTOMOL EXP APPL, V80, P35, DOI 10.1007/BF00194719; Wan PJ, 2014, INSECT MOL BIOL, V23, P152, DOI 10.1111/imb.12069; Wang WS, 2010, ACM J EMERG TECH COM, V6, DOI 10.1145/1773814.1773817; Wang Y, 2012, INSECT BIOCHEM MOLEC, V42, P637, DOI 10.1016/j.ibmb.2012.04.009; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WETZEL JM, 1992, J CHEM ECOL, V18, P2083, DOI 10.1007/BF00981929; Wilkes TE, 2010, INSECT MOL BIOL, V19, P59, DOI 10.1111/j.1365-2583.2009.00963.x; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Youn YN, 2002, J ECON ENTOMOL, V95, P269, DOI 10.1603/0022-0493-95.2.269; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; ZEIGLER RS, 2009, PLANTHOPPERS NEW THR, pR5; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; ZHANG ZQ, 1983, ACTA ENTOMOL SINICA, V26, P260	89	260	296	12	143	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2014	15	12							521	10.1186/s13059-014-0521-0			19	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	AW9XX	WOS:000346609500005	25609551	Green Published, gold			2022-01-24	
J	Hunt, M; Kikuchi, T; Sanders, M; Newbold, C; Berriman, M; Otto, TD				Hunt, Martin; Kikuchi, Taisei; Sanders, Mandy; Newbold, Chris; Berriman, Matthew; Otto, Thomas D.			REAPR: a universal tool for genome assembly evaluation	GENOME BIOLOGY			English	Article						Genome assembly; validation; evaluation	DRAFT ASSEMBLIES; SEQUENCE; ARTEMIS; DNA	Methods to reliably assess the accuracy of genome sequence data are lacking. Currently completeness is only described qualitatively and mis-assemblies are overlooked. Here we present REAPR, a tool that precisely identifies errors in genome assemblies without the need for a reference sequence. We have validated REAPR on complete genomes or de novo assemblies from bacteria, malaria and Caenorhabditis elegans, and demonstrate that 86% and 82% of the human and mouse reference genomes are error-free, respectively. When applied to an ongoing genome project, REAPR provides corrected assembly statistics allowing the quantitative comparison of multiple assemblies. REAPR is available at http://www.sanger.ac.uk/resources/software/reapr/.	[Hunt, Martin; Kikuchi, Taisei; Sanders, Mandy; Newbold, Chris; Berriman, Matthew; Otto, Thomas D.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Kikuchi, Taisei] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Parasitol, Miyazaki 8891692, Japan; [Newbold, Chris] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England		Otto, TD (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	tdo@sanger.ac.uk	Berriman, Matthew/A-7618-2011; Otto, Thomas/ABE-7632-2020	Berriman, Matthew/0000-0002-9581-0377; Newbold, Chris/0000-0002-9274-3789; Hunt, Martin/0000-0002-8060-4335; Kikuchi, Taisei/0000-0003-2759-9167; Otto, Thomas/0000-0002-1246-7404	European UnionEuropean Commission; Wellcome TrustWellcome TrustEuropean Commission [098051, 082130/Z/07/Z]; JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24780044]	We acknowledge Bernardo Foth, Adam Reid and Isheng J Tsai for proofreading the manuscript, and J. Tsai for the Brugia pahangi example. Martin Hunt and Thomas Otto were supported by the European Union 7th framework EVIMalaR and Mandy Sanders and Matthew Berriman by the Wellcome Trust (grant number: 098051). Taisei Kikuchi was supported by JSPS KAKENHI (grant number: 24780044). Chris Newbold was supported by the Wellcome Trust (grant number: 082130/Z/07/Z).	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Clark SC, 2013, BIOINFORMATICS, V29, P435, DOI 10.1093/bioinformatics/bts723; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mak HC, 2012, NAT BIOTECHNOL, V30, P1081, DOI 10.1038/nbt.2425; Manske HM, 2009, BIOINFORMATICS, V25, P2434, DOI 10.1093/bioinformatics/btp403; McKay SJ, 2002, BIOINFORMATICS, V18, P1538, DOI 10.1093/bioinformatics/18.11.1538; Narzisi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019175; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; R Development Core Team, 2010, R LANG ENV STAT COMP; Rahman A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r8; Riley MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-252; Salzberg SL, 2012, GENOME RES, V22, P1196; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052210; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	260	261	0	25	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2013	14	5							R47	10.1186/gb-2013-14-5-r47			10	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	234YK	WOS:000325680100007	23710727	Green Accepted, hybrid, Green Published			2022-01-24	
J	Chasman, DI; Schurks, M; Anttila, V; de Vries, B; Schminke, U; Launer, LJ; Terwindt, GM; van den Maagdenberg, AMJM; Fendrich, K; Volzke, H; Ernst, F; Griffiths, LR; Buring, JE; Kallela, M; Freilinger, T; Kubisch, C; Ridker, PM; Palotie, A; Ferrari, MD; Hoffmann, W; Zee, RYL; Kurth, T				Chasman, Daniel I.; Schuerks, Markus; Anttila, Verneri; de Vries, Boukje; Schminke, Ulf; Launer, Lenore J.; Terwindt, Gisela M.; van den Maagdenberg, Arn M. J. M.; Fendrich, Konstanze; Voelzke, Henry; Ernst, Florian; Griffiths, Lyn R.; Buring, Julie E.; Kallela, Mikko; Freilinger, Tobias; Kubisch, Christian; Ridker, Paul M.; Palotie, Aarno; Ferrari, Michel D.; Hoffmann, Wolfgang; Zee, Robert Y. L.; Kurth, Tobias		IHGC	Genome-wide association study reveals three susceptibility loci for common migraine in the general population	NATURE GENETICS			English	Article							RECEPTOR; COHORT; HEALTH; TOOL	Migraine is a common, heterogeneous and heritable neurological disorder. Its pathophysiology is incompletely understood, and its genetic influences at the population level are unknown. In a population-based genome-wide analysis including 5,122 migraineurs and 18,108 non-migraineurs, rs2651899 (1p36.32, PRDM16), rs10166942 (2q37.1, TRPM8) and rs11172113 (12q13.3, LRP1) were among the top seven associations (P < 5 x 10(-6)) with migraine. These SNPs were significant in a meta-analysis among three replication cohorts and met genome-wide significance in a meta-analysis combining the discovery and replication cohorts (rs2651899, odds ratio (OR) = 1.11, P = 3.8 x 10(-9); rs10166942, OR = 0.85, P = 5.5 x 10(-12); and rs11172113, OR = 0.90, P = 4.3 x 10(-9)). The associations at rs2651899 and rs10166942 were specific for migraine compared with non-migraine headache. None of the three SNP associations was preferential for migraine with aura or without aura, nor were any associations specific for migraine features. TRPM8 has been the focus of neuropathic pain models, whereas LRP1 modulates neuronal glutamate signaling, plausibly linking both genes to migraine pathophysiology.	[Chasman, Daniel I.; Schuerks, Markus; Buring, Julie E.; Ridker, Paul M.; Zee, Robert Y. L.; Kurth, Tobias] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Donald W Reynolds Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Schuerks, Markus] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Anttila, Verneri; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Anttila, Verneri; Palotie, Aarno] Univ Helsinki, FIMM, Helsinki, Finland; [de Vries, Boukje; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Schminke, Ulf] Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany; [Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Terwindt, Gisela M.; van den Maagdenberg, Arn M. J. M.; Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Fendrich, Konstanze; Hoffmann, Wolfgang] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Sect Epidemiol Hlth Care & Community Hlth, Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Sect Clin Epidemiol Res, Greifswald, Germany; [Ernst, Florian] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Griffiths, Lyn R.] Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Gold Coast, Qld, Australia; [Kallela, Mikko] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Freilinger, Tobias] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; [Freilinger, Tobias] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Kubisch, Christian] Univ Ulm, Inst Human Genet, Ulm, Germany; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Cent Hosp, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Boston, MA USA; [Kurth, Tobias] INSERM, Neuroepidemiol U708, Paris, France; [Kurth, Tobias] Univ Paris 06, F-75005 Paris, France		Schurks, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA.	markus.schuerks@post.harvard.edu; tobias.kurth@inserm.fr	Ferrari, Michel D./ABE-3758-2021; Hoffmann, Wolfgang/E-6001-2013; Kubisch, Christian/F-1893-2011; Kurth, Tobias/A-9243-2012; van den Maagdenberg, Arn M.J.M./AAE-9052-2019	Ferrari, Michel D./0000-0001-9691-9449; Kubisch, Christian/0000-0003-4220-0978; Kurth, Tobias/0000-0001-7169-2620; Palotie, Aarno/0000-0002-2527-5874; Anttila, Verneri/0000-0002-0073-4675; Griffiths, Lyn/0000-0002-6774-5475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-061836]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-043851, HL-080467, HL-099355]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA-47988]; Donald W. Reynolds Foundation; Leducq FoundationLeducq Foundation; Netherlands Organisation for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [918.56.602]; Spinoza grants; Center for Medical Systems Biology (CMSB) [050-060-409]; Ministry of Health, Welfare and Sport; National Institute of Public Health and the Environment, The NetherlandsNetherlands Government; Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Academy of FinlandAcademy of FinlandEuropean Commission [200923]; Wellcome TrustWellcome TrustEuropean Commission [089062]; European CommunityEuropean Commission [FP7/2007-2013]; European Community (through the SYNSYS Consortium)European Commission [242167]; European Community (through the ENGAGE Consortium)European Commission [201413]; Helsinki University Central Hospital; Finnish Culture FoundationFinnish Cultural Foundation; German Federal Ministry of Education and Research (BMBF) within the National Genome Research NetworkFederal Ministry of Education & Research (BMBF) [EMINet-01GS08120, 01GS08121]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); Center for Molecular Medicine Cologne; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL043851, R01HL080467, RC1HL099355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG007260, ZIAAG007270] Funding Source: NIH RePORTER	This study is supported by a grant from the National Institute of Neurological Disorders and Stroke (NS-061836). The Women's Health Study and the Women's Genome Health Study are supported by grants from the National Heart, Lung, and Blood Institute (HL-043851, HL-080467 and HL-099355) and the National Cancer Institute (CA-47988). Part of the research for this work was supported by grants from the Donald W. Reynolds Foundation and the Leducq Foundation. Genome-wide genotyping and collaborative scientific support was provided by Amgen.; Genotyping in the Genetic Epidemiology of Migraine Study was supported by the Netherlands Organisation for Scientific Research (NWO) VICI (918.56.602) and Spinoza (2009) grants and the Center for Medical Systems Biology (CMSB) established by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO), project no. 050-060-409. The GEM study was supported by the Ministry of Health, Welfare and Sport and the National Institute of Public Health and the Environment, The Netherlands.; SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103 and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. The SHIP authors are grateful to the contribution of A. Teumer, A. Hoffmann and A. Petersmann in generating the SNP data. The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of Siemens AG.; The IHGC study was supported, among others, by the Academy of Finland (200923 to A.P.), the Wellcome Trust (grant number 089062), the European Community's Seventh Framework Programme (FP7/2007-2013) (through the SYNSYS Consortium (grant agreement no. 242167) and the ENGAGE Consortium (grant agreement no. 201413)), the Helsinki University Central Hospital (to M.K.) and the Finnish Culture Foundation (to V.A.). Funding by the German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network (NGFNplus, EMINet-01GS08120 for C.K., 01GS08121 to M. Dichgans), the Deutsche Forschungsgemeinschaft (to C.K.) and the Center for Molecular Medicine Cologne (to C.K.). For a full list of acknowledgements, please see reference 5.	Andreou AP, 2009, EXPERT OPIN INV DRUG, V18, P789, DOI [10.1517/13543780902913792, 10.1517/13543780902913792 ]; Anttila V, 2010, NAT GENET, V42, P869, DOI 10.1038/ng.652; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Biondi David M, 2006, Curr Pain Headache Rep, V10, P167, DOI 10.1007/s11916-006-0042-y; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; Dray A, 2008, BRIT J ANAESTH, V101, P48, DOI 10.1093/bja/aen107; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Haut SR, 2006, LANCET NEUROL, V5, P148, DOI 10.1016/S1474-4422(06)70348-9; Hindorff LA, CATALOG PUBLISHED GE; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/twin.6.5.422; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; SECKERWALKER LM, 1995, BRIT J HAEMATOL, V91, P490, DOI 10.1111/j.1365-2141.1995.tb05329.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394	26	260	266	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					695	U116		10.1038/ng.856			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	WOS:000292184600016	21666692	Green Published, Green Accepted			2022-01-24	
J	Yang, L; Duff, MO; Graveley, BR; Carmichael, GG; Chen, LL				Yang, Li; Duff, Michael O.; Graveley, Brenton R.; Carmichael, Gordon G.; Chen, Ling-Ling			Genomewide characterization of non-polyadenylated RNAs	GENOME BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; MESSENGER-RNAS; NONCODING RNA; POLY(A) TAIL; CHROMATIN; CYCLE; TRANSCRIPTOME; METABOLISM; RESOLUTION; HISTONES	Background: RNAs can be physically classified into poly(A)+ or poly(A)- transcripts according to the presence or absence of a poly(A) tail at their 3' ends. Current deep sequencing approaches largely depend on the enrichment of transcripts with a poly(A) tail, and therefore offer little insight into the nature and expression of transcripts that lack poly(A) tails. Results: We have used deep sequencing to explore the repertoire of both poly(A)+ and poly(A)- RNAs from HeLa cells and H9 human embryonic stem cells (hESCs). Using stringent criteria, we found that while the majority of transcripts are poly(A)+, a significant portion of transcripts are either poly(A)- or bimorphic, being found in both the poly(A)+ and poly(A) populations. Further analyses revealed that many mRNAs may not contain classical long poly(A) tails and such messages are overrepresented in specific functional categories. In addition, we surprisingly found that a few excised introns accumulate in cells and thus constitute a new class of non-polyadenylated long non-coding RNAs. Finally, we have identified a specific subset of poly(A)- histone mRNAs, including two histone H1 variants, that are expressed in undifferentiated hESCs and are rapidly diminished upon differentiation; further, these same histone genes are induced upon reprogramming of fibroblasts to induced pluripotent stem cells. Conclusions: We offer a rich source of data that allows a deeper exploration of the poly(A)- landscape of the eukaryotic transcriptome. The approach we present here also applies to the analysis of the poly(A)- transcriptomes of other organisms.	[Yang, Li; Duff, Michael O.; Graveley, Brenton R.; Carmichael, Gordon G.; Chen, Ling-Ling] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Stem Cell Inst, Farmington, CT 06030 USA; [Chen, Ling-Ling] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China		Chen, LL (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Stem Cell Inst, 263 Farmington Ave, Farmington, CT 06030 USA.	linglingchen@sibcb.ac.cn	Chen, Ling-Ling/AAY-3547-2021; Graveley, Brenton R/C-3108-2013	chen, ling ling/0000-0001-9501-0305; Graveley, Brenton/0000-0001-5777-5892	National Science FoundationNational Science Foundation (NSF) [0925347]; Chinese Academy of SciencesChinese Academy of Sciences [XDA01010206]; National Basic Research Program of ChinaNational Basic Research Program of China [2011CBA01105]; State of Connecticut; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA045382] Funding Source: NIH RePORTER	We thank the UCHC Translational Genomics Core for use of the Illumina Genome Analyzer. H9 and H14 cells were obtained from the WiCell Research Institute and the CT Stem Cell Core Facility. This work was supported by grant 0925347 from the National Science Foundation to GGC, grant XDA01010206 from the "Strategic Priority Research Program" of the Chinese Academy of Sciences, grant 2011CBA01105 from the National Basic Research Program of China, and awards from the State of Connecticut under the Connecticut Stem Cell Research Grants Program to LLC, GGC and BRG. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the State of Connecticut, the Department of Public Health of the State of Connecticut, or Connecticut Innovations, Inc.	Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; Doenecke D, 1997, HISTOCHEM CELL BIOL, V107, P1, DOI 10.1007/s004180050083; Fujii-Yamamoto H, 2005, J BIOL CHEM, V280, P12976, DOI 10.1074/jbc.M412224200; Gu HD, 1999, P NATL ACAD SCI USA, V96, P8943, DOI 10.1073/pnas.96.16.8943; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; KATINAKIS PK, 1980, FEBS LETT, V116, P1, DOI 10.1016/0014-5793(80)80515-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; MANLEY JL, 1989, GENE DEV, V3, P2218, DOI 10.1101/gad.3.12b.2218; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; MILCAREK C, 1974, CELL, V3, P1, DOI 10.1016/0092-8674(74)90030-0; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; SALDITTGEORGIEFF M, 1981, MOL CELL BIOL, V1, P179, DOI 10.1128/MCB.1.2.179; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; [No title captured]	37	260	283	1	41	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2011	12	2							R16	10.1186/gb-2011-12-2-r16			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	748BS	WOS:000289365600012	21324177	Green Published, hybrid			2022-01-24	
J	Taft, RJ; Glazov, EA; Cloonan, N; Simons, C; Stephen, S; Faulkner, GJ; Lassmann, T; Forrest, ARR; Grimmond, SM; Schroder, K; Irvine, K; Arakawa, T; Nakamura, M; Kubosaki, A; Hayashida, K; Kawazu, C; Murata, M; Nishiyori, H; Fukuda, S; Kawai, J; Daub, CO; Hume, DA; Suzuki, H; Orlando, V; Carninci, P; Hayashizaki, Y; Mattick, JS				Taft, Ryan J.; Glazov, Evgeny A.; Cloonan, Nicole; Simons, Cas; Stephen, Stuart; Faulkner, Geoffrey J.; Lassmann, Timo; Forrest, Alistair R. R.; Grimmond, Sean M.; Schroder, Kate; Irvine, Katharine; Arakawa, Takahiro; Nakamura, Mari; Kubosaki, Atsutaka; Hayashida, Kengo; Kawazu, Chika; Murata, Mitsuyoshi; Nishiyori, Hiromi; Fukuda, Shiro; Kawai, Jun; Daub, Carsten O.; Hume, David A.; Suzuki, Harukazu; Orlando, Valerio; Carninci, Piero; Hayashizaki, Yoshihide; Mattick, John S.			Tiny RNAs associated with transcription start sites in animals	NATURE GENETICS			English	Article							ANALYSIS GENE-EXPRESSION; POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; DNA METHYLATION; FACTOR TFIIS; HUMAN-CELLS; GENOME; INITIATION; CLEAVAGE	It has been reported that relatively short RNAs of heterogeneous sizes are derived from sequences near the promoters of eukaryotic genes. In conjunction with the FANTOM4 project, we have identified tiny RNAs with a modal length of 18 nt that map within -60 to +120 nt of transcription start sites (TSSs) in human, chicken and Drosophila. These transcription initiation RNAs (tiRNAs) are derived from sequences on the same strand as the TSS and are preferentially associated with G+C-rich promoters. The 5' ends of tiRNAs show peak density 10-30 nt downstream of TSSs, indicating that they are processed. tiRNAs are generally, although not exclusively, associated with highly expressed transcripts and sites of RNA polymerase II binding. We suggest that tiRNAs may be a general feature of transcription in metazoa and possibly all eukaryotes.	[Lassmann, Timo; Forrest, Alistair R. R.; Arakawa, Takahiro; Nakamura, Mari; Kubosaki, Atsutaka; Hayashida, Kengo; Kawazu, Chika; Murata, Mitsuyoshi; Nishiyori, Hiromi; Fukuda, Shiro; Kawai, Jun; Daub, Carsten O.; Suzuki, Harukazu; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan; [Taft, Ryan J.; Cloonan, Nicole; Simons, Cas; Stephen, Stuart; Faulkner, Geoffrey J.; Grimmond, Sean M.; Schroder, Kate; Irvine, Katharine; Hume, David A.; Mattick, John S.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Glazov, Evgeny A.] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [Forrest, Alistair R. R.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Orlando, Valerio] IRCCS Santa Lucia EBRI, Dulbecco Telethon Inst, Rome, Italy; [Orlando, Valerio] IGB CNR, Dulbecco Telethon Inst, Naples, Italy		Hayashizaki, Y (corresponding author), RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan.	yosihide@gsc.riken.jp; j.mattick@imb.uq.edu.au	Forrest, Alistair/A-6597-2008; Lassmann, Timo/A-8271-2008; Suzuki, Harukazu/N-9553-2015; Daub, Carsten O/A-7436-2010; Grimmond, Sean/K-3246-2019; Stuart, Stephen/I-3380-2012; Schroder, Kate/C-6132-2008; Kawai, Jun/A-6451-2016; Hume, David A/C-7695-2013; Taft, Ryan/B-2945-2010; Cloonan, Nicole/B-5272-2008; Simons, Cas/A-7905-2011; Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012; Irvine, Katharine M/A-5559-2011; Faulkner, Geoffrey J/M-3168-2014; Carninci, Piero/K-1568-2014; Hayashizaki, Yoshihide/N-6590-2015; Glazov, Evgeny A/F-9951-2010; Grimmond, Sean M/J-5304-2016	Forrest, Alistair/0000-0003-4543-1675; Lassmann, Timo/0000-0002-0138-2691; Suzuki, Harukazu/0000-0002-8087-0836; Daub, Carsten O/0000-0002-3295-8729; Grimmond, Sean/0000-0002-8102-7998; Stuart, Stephen/0000-0001-5141-640X; Schroder, Kate/0000-0001-9261-3805; Cloonan, Nicole/0000-0001-7802-6647; Simons, Cas/0000-0003-3147-8042; Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527; Irvine, Katharine M/0000-0002-6716-1605; Faulkner, Geoffrey J/0000-0001-5769-4494; Carninci, Piero/0000-0001-7202-7243; Grimmond, Sean M/0000-0002-8102-7998; Hume, David/0000-0002-2615-1478; Fukuda, Shiro/0000-0002-0065-662X	US National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF); University of Queensland Postdoctoral Research FellowshipUniversity of Queensland; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [ID 428261]; Australian NHMRC FellowshipNational Health and Medical Research Council of Australia [455857]; TelethonFondazione Telethon [TCP00094]; Associazione Italiana Riecrca sul Cancro (AIRC)Fondazione AIRC per la ricerca sul cancro; Compagnia San PaoloCompagnia di San Paolo; Australian Research Council Federation FellowshipAustralian Research Council [ID FF0561986]; University of Queensland and the Queensland State Government; Ministry of Education, Culture, Sports, Science and Technology, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Ministry of Education, Culture, Sports, Science and Technology of the Japanese GovernmentMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); RIKEN Frontier Research System, Functional RNA Research Program; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9900991B] Funding Source: researchfish	We thank A. Hasegawa, F. Hori, H. Sano for technical assistance. R. J. T. is supported by a US National Science Foundation Graduate Research Fellowship. N. C. is supported by a University of Queensland Postdoctoral Research Fellowship. A. R. R. F. is supported by a CJ Martin Fellowship from the Australian National Health and Medical Research Council (ID 428261). S. M. G. is supported by Australian NH&MRC Fellowship grant no. 455857. V.O. is supported by Telethon TCP00094, Associazione Italiana Riecrca sul Cancro (AIRC), Compagnia San Paolo. J. S. M. is supported by an Australian Research Council Federation Fellowship (ID FF0561986), the University of Queensland and the Queensland State Government. This work was also supported by grants for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Y.H.), and Research Grant for the RIKEN Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government, the RIKEN Frontier Research System, Functional RNA Research Program (Y.H.). We thank the reviewers for their insights and suggestions.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; FROMONTRACINE M, 1993, NUCLEIC ACIDS RES, V21, P1683, DOI 10.1093/nar/21.7.1683; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lagonigro MS, 2004, PIGM CELL RES, V17, P312; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mellor J, 2008, CURR OPIN GENET DEV, V18, P116, DOI 10.1016/j.gde.2007.12.005; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Pal M, 2001, MOL CELL BIOL, V21, P5815, DOI 10.1128/MCB.21.17.5815-5825.2001; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Prather DA, 2005, MOL CELL BIOL, V25, P2650, DOI 10.1128/MCB.25.7.2650-2659.2005; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tews B, 2007, ONCOGENE, V26, P5010, DOI 10.1038/sj.onc.1210297; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200	47	260	278	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					572	578		10.1038/ng.312			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	WOS:000265575600018	19377478				2022-01-24	
J	Glazov, EA; Cottee, PA; Barris, WC; Moore, RJ; Dalrymple, BP; Tizard, ML				Glazov, Evgeny A.; Cottee, Pauline A.; Barris, Wesley C.; Moore, Robert J.; Dalrymple, Brian P.; Tizard, Mark L.			A microRNA catalog of the developing chicken embryo identified by a deep sequencing approach	GENOME RESEARCH			English	Article							GENOME BROWSER; EXPRESSION; EVOLUTION; CLONING; RNAS	MicroRNA (miRNA) and other types of small regulatory RNAs play a crucial role in the regulation of gene expression in eukaryotes. Several distinct classes of small regulatory RNAs have been discovered in recent years. To extend the repertoire of small regulatory RNAs characterized in chickens we used a deep sequencing approach developed by Solexa (now Illumina Inc.). We sequenced three small RNA libraries prepared from different developmental stages of the chicken embryo (days five, seven, and nine) to produce over 9.5 million short sequence reads. We developed a bioinformatics pipeline to distinguish authentic mature miRNA sequences from other classes of small RNAs and short RNA fragments represented in the sequencing data. Using this approach we detected almost all of the previously known chicken miRNAs and their respective miRNA* sequences. In addition we discovered 449 new chicken miRNAs including 88 miRNA candidates. Of these, 430 miRNAs appear to be specific to the avian lineage. Another six new miRNAs had evidence of evolutionary conservation in at least one vertebrate species outside of the bird lineage. The remaining 13 putative miRNAs appear to represent chicken orthologs of known vertebrate miRNAs. We discovered 39 additional putative miRNA candidates originating from miRNA generating intronic sequences known as mirtrons.	[Cottee, Pauline A.; Moore, Robert J.; Tizard, Mark L.] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Glazov, Evgeny A.; Barris, Wesley C.; Dalrymple, Brian P.] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia		Tizard, ML (corresponding author), CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia.	mark.tizard@csiro.au	Moore, Robert J./D-8352-2011; Glazov, Evgeny A/F-9951-2010; Dalrymple, Brian P/F-8721-2010; Tizard, Mark L/B-6610-2011	Moore, Robert J./0000-0002-0776-5861; Dalrymple, Brian P/0000-0003-3891-5233; Tizard, Mark L/0000-0001-8421-2497			Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519	34	260	583	2	29	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUN	2008	18	6					957	964		10.1101/gr.074740.107			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	307YT	WOS:000256356200013	18469162	Bronze, Green Published			2022-01-24	
J	Lee, C; Iafrate, AJ; Brothman, AR				Lee, Charles; Iafrate, A. John; Brothman, Arthur R.			Copy number variations and clinical cytogenetic diagnosis of constitutional disorders	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SEGMENTAL ANEUPLOIDY; WHOLE-GENOME; REARRANGEMENTS; GENE; MICROARRAY; DELETION; POLYMORPHISM; RETARDATION; IMBALANCE	The recent appreciation of widespread copy number variation in the genomes of healthy human beings has presented a significant challenge to clinical cytogeneticists who wish to use genome-wide array comparative genomic hybridization (CGH) assays for clinical diagnostic purposes. Clinical cytogeneticists need to differentiate between copy number variants (CNVs) that are likely to be pathogenic and CNVs that are less likely to contribute to an affected individual's clinical presentation. Unfortunately, our knowledge of the phenotypic effects of most CNVs is minimal, leading to the classification of many CNVs as genomic imbalances of unknown clinical significance. This has caused many laboratories to resist the use of higher-resolution genome-wide array CGH assays for clinical purposes. Ironically, the accumulation and annotation of such array CGH data can lead to the rapid identification of pathogenic CNVs and the definition of new genomic syndromes that, in turn, are useful for accurate clinical genetic diagnoses.	[Lee, Charles; Iafrate, A. John] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lee, Charles; Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Brothman, Arthur R.] Univ Utah, Dept Pediat, Salt Lake City, UT 84132 USA; [Brothman, Arthur R.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84132 USA; [Brothman, Arthur R.] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA		Lee, C (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	clee@rics.bwh.harvard.edu					Bejjani BA, 2006, J MOL DIAGN, V8, P528, DOI 10.2353/jmoldx.2006.060029; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flint J, 2003, CURR OPIN GENET DEV, V13, P310, DOI 10.1016/S0959-437X(03)00049-2; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Hansson K, 2007, AM J MED GENET A, V143A, P1354, DOI 10.1002/ajmg.a.31783; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; LINDSLEY DL, 1972, GENETICS, V71, P157; Martin CL, 2002, J MED GENET, V39, P734, DOI 10.1136/jmg.39.10.734; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SCHAFFER LG, 2005, ISCN 2005 INT SYSTEM, pCH7; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Veltman JA, 2006, J MOL DIAGN, V8, P534, DOI 10.2353/jmoldx.2006.060131; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; WANG Y, 2005, NUCLEIC ACIDS RES, V38, P183, DOI DOI 10.1039/NAR/GNI177	37	260	285	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S48	S54		10.1038/ng2092			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	WOS:000253974400009	17597782				2022-01-24	
J	Rice, G; Newman, WG; Dean, J; Patrick, T; Parmar, R; Flintoff, K; Robins, P; Harvey, S; Hollis, T; O'Hara, A; Herrick, AL; Bowden, AP; Perrino, FW; Lindahl, T; Barnes, DE; Crow, YJ				Rice, Gillian; Newman, William G.; Dean, John; Patrick, Teresa; Parmar, Rekha; Flintoff, Kim; Robins, Peter; Harvey, Scott; Hollis, Thomas; O'Hara, Ann; Herrick, Ariane L.; Bowden, Andrew P.; Perrino, Fred W.; Lindahl, Tomas; Barnes, Deborah E.; Crow, Yanick J.			Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECOMBINANT PROTEINS; EXONUCLEASE TREX1; INTERFERON-ALPHA; CELL-DEATH; ERYTHEMATOSUS; DNA; IDENTIFICATION; INFECTION; CATALYSIS; LOCUS	TREX1 constitutes the major 3'-> 5' DNA exonuclease activity measured in mammalian cells. Recently, biallelic mutations in TREX1 have been shown to cause Aicardi-Goutieres syndrome at the AGS1 locus. Interestingly, Aicardi-Goutieres syndrome shows overlap with systemic lupus erythematosus at both clinical and pathological levels. Here, we report a heterozygous TREX1 mutation causing familial chilblain lupus. Additionally, we describe a de novo heterozygous mutation, affecting a critical catalytic residue in TREX1, that results in typical Aicardi-Goutieres syndrome.	St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, DNA Lab, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; St Marys Hosp, Acad Unit Med Genet, Manchester, NH USA; Natl Hlth Serv Grampian, Dept Med Genet, Aberdeen, Scotland; Royal Aberdeen Childrens Hosp, Dept Paediat Neurol, Aberdeen, Scotland; Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms, Herts, England; Wake Forest Univ, Dept Biochem, Winston Salem, NC 27109 USA; Hope Hosp, Rheumat Dis Ctr, Salford M6 8HD, Lancs, England; Rochdale Royal Infirm, Dept Rheumatol, Rochdale, England; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England		Crow, YJ (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Level 9 Wellcome Trust Benner Bldg, Leeds LS9 7TF, W Yorkshire, England.	Yanickcrow@mac.com	Crow, Yanick J/N-6120-2014; Rice, Gillian I/G-3128-2015	Crow, Yanick J/0000-0001-7211-7564; Rice, Gillian I/0000-0002-4223-0571; Herrick, Ariane/0000-0003-4941-7926; Newman, William/0000-0002-6382-4678; Dean, John/0000-0003-3841-0841	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM069962] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM069962, GM069962] Funding Source: Medline		Aicardi J, 2000, NEUROPEDIATRICS, V31, P113, DOI 10.1055/s-2000-7533; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cohen PL, 2006, SPRINGER SEMIN IMMUN, V28, P145, DOI 10.1007/s00281-006-0038-z; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2000, AM J HUM GENET, V67, P213, DOI 10.1086/302955; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; Dale RC, 2000, NEUROPEDIATRICS, V31, P155, DOI 10.1055/s-2000-7492; De Laet C, 2005, NEUROPEDIATRICS, V36, P399, DOI 10.1055/s-2005-873058; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Perrino FW, 2004, ADV ENZYME REGUL, V44, P37, DOI 10.1016/j.advenzreg.2003.11.010; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Rasmussen M, 2005, NEUROPEDIATRICS, V36, P40, DOI 10.1055/s-2004-830532; TOLMIE JL, 1995, J MED GENET, V32, P881, DOI 10.1136/jmg.32.11.881; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	23	260	270	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					811	815		10.1086/513443			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	WOS:000245465200022	17357087	Bronze, Green Published			2022-01-24	
J	Cichon, S; Martin, L; Hennies, HC; Mueller, F; Van Driessche, K; Karpushova, A; Stevens, W; Colombo, R; Renne, T; Drouet, C; Bork, K; Nothen, MM				Cichon, Sven; Martin, Ludovic; Hennies, Hans Christian; Mueller, Felicitas; Van Driessche, Karen; Karpushova, Anna; Stevens, Wim; Colombo, Roberto; Renne, Thomas; Drouet, Christian; Bork, Konrad; Noethen, Markus M.			Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORMAL C1-INHIBITOR; FRENCH-CANADIANS; C1 INHIBITOR; HUMAN GENOME; MUTATIONS; GENE; POPULATIONS; ACTIVATION; PLASMA; SYSTEM	Hereditary angioedema (HAE) is characterized clinically by recurrent acute skin swelling, abdominal pain, and potentially life-threatening laryngeal edema. Three forms of HAE have been described. The classic forms, HAE types I and II, occur as a consequence of mutations in the C1-inhibitor gene. In contrast to HAE types I and II, HAE type III has been observed exclusively in women, where it appears to be correlated with conditions of high estrogen levels - for example, pregnancy or the use of oral contraceptives. A recent report proposed two missense mutations (c.1032C -> A and c. 1032C -> G) in F12, the gene encoding human coagulation factor XII (FXII, or Hageman factor) as a possible cause of HAE type III. Here, we report the occurrence of the c.1032C -> A (p.Thr328Lys) mutation in an HAE type III - affected family of French origin. Investigation of the F12 gene in a large German family did not reveal a coding mutation. Haplotype analysis with use of microsatellite markers is compatible with locus heterogeneity in HAE type III. To shed more light on the pathogenic relevance of the HAE type III-associated p. Thr328Lys mutation, we compared FXII activity and plasma levels in patients carrying the mutation with that of healthy control individuals. Our data strongly suggest that p. Thr328Lys is a gain-of-function mutation that markedly increases FXII amidolytic activity but that does not alter FXII plasma levels. We conclude that enhanced FXII enzymatic plasma activity in female mutation carriers leads to enhanced kinin production, which results in angioedema. Transcription of F12 is positively regulated by estrogens, which may explain why only women are affected with HAE type III. The results of our study represent an important step toward an understanding of the molecular processes involved in HAE type III and provide diagnostic and possibly new therapeutic opportunities.	Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; Hop Porte Madeleine, Dept Dermatol, Orleans, France; Univ Cologne, Cologne Ctr Genom, D-5000 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-5000 Cologne 41, Germany; Univ Wurzburg, Inst Clin Chem & Pathobiochem, D-97070 Wurzburg, Germany; Univ Antwerp, Dept Immunol, B-2020 Antwerp, Belgium; Univ Sacred Heart, Lab Human Mol Biol & Genet, I-20123 Milan, Italy; Univ Grenoble 1, Immunol Lab, Grenoble, France; CHU Grenoble, F-38043 Grenoble, France; Univ Mainz, Dept Dermatol, D-6500 Mainz, Germany		Cichon, S (corresponding author), Univ Bonn, Life & Brain Ctr, Dept Genom, Sigmund Freud Str 25, D-53127 Bonn, Germany.	sven.cichon@uni-bonn.de	Cichon, Sven/H-8803-2013; Hennies, Hans C/G-9424-2014; , DDDD/J-8775-2019; DROUET, Christian/AAE-5682-2020; Nothen, Markus/B-2027-2009; Cichon, Sven/B-9618-2014	Cichon, Sven/0000-0002-9475-086X; Hennies, Hans C/0000-0001-7210-2389; , DDDD/0000-0003-1318-4278; DROUET, Christian/0000-0003-1318-4278; Nothen, Markus/0000-0002-8770-2464; Cichon, Sven/0000-0002-9475-086X			Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Binkley KE, 2000, J ALLERGY CLIN IMMUN, V106, P546; Bork K, 2006, BRIT J DERMATOL, V154, P542, DOI 10.1111/j.1365-2133.2005.07048.x; Bork K, 2000, LANCET, V356, P213, DOI 10.1016/S0140-6736(00)02483-1; Bowen B, 2001, CLIN IMMUNOL, V98, P157, DOI 10.1006/clim.2000.4947; Cicardi M, 1999, AM J MED, V106, P650, DOI 10.1016/S0002-9343(99)00123-0; Citarella F, 1996, EUR J BIOCHEM, V238, P240, DOI 10.1111/j.1432-1033.1996.0240q.x; COLMAN RW, 1984, J CLIN INVEST, V73, P1249, DOI 10.1172/JCI111326; Dewald G, 2006, BIOCHEM BIOPH RES CO, V343, P1286, DOI 10.1016/j.bbrc.2006.03.092; FARSETTI A, 1995, ENDOCRINOLOGY, V136, P5076, DOI 10.1210/en.136.11.5076; Gupta S, 2004, ALLERGY, V59, P557, DOI 10.1111/j.1398-9995.2004.00428.x; HOJIMA Y, 1984, BLOOD, V63, P1453; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Labuda M, 1996, AM J HUM GENET, V59, P633; Luria SE, 1943, GENETICS, V28, P491; Martin L, 2001, J ALLERGY CLIN IMMUN, V107, P747, DOI 10.1067/mai.2001.114242; Nussberger J, 2002, NEW ENGL J MED, V347, P621, DOI 10.1056/NEJM200208223470820; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; REICH DE, 1999, MICROSATELLITES EVOL, P129; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Tosi M, 1998, IMMUNOBIOLOGY, V199, P358, DOI 10.1016/S0171-2985(98)80040-5; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	27	260	263	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1098	1104		10.1086/509899			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	WOS:000242131600011	17186468	Green Published, Bronze			2022-01-24	
J	Vella, A; Cooper, JD; Lowe, CE; Walker, N; Nutland, S; Widmer, B; Jones, R; Ring, SM; McArdle, W; Pembrey, ME; Strachan, DP; Dunger, DB; Twells, RCJ; Clayton, DG; Todd, JA				Vella, A; Cooper, JD; Lowe, CE; Walker, N; Nutland, S; Widmer, B; Jones, R; Ring, SM; McArdle, W; Pembrey, ME; Strachan, DP; Dunger, DB; Twells, RCJ; Clayton, DG; Todd, JA			Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYMPHOID TYROSINE PHOSPHATASE; ALPHA-CHAIN GENE; COMMON DISEASE; GENOME ASSOCIATION; T-CELLS; SUSCEPTIBILITY; EPIDEMIOLOGY; VARIANTS; IL-2	As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex. We employed a tag single-nucleotide polymorphism ( tag SNP) approach in large T1D sample collections consisting of 7,457 cases and controls and 725 multiplex families. Tag SNPs were analyzed using a multilocus test to provide a regional test for association. We found strong statistical evidence in the case-control collection (P = 6.5 x 10(-8)) for a T1D locus in the CD25 region of chromosome 10p15 and replicated the association in the family collection (P = 7.3 x 10(-3); combined P = 1.3 x 10(-10)). These results illustrate the utility of tag SNPs in a chromosome-regional test of disease association and justify future fine mapping of the causal variant in the region.	Univ Cambridge, Cambridge Inst Med Res, Addenbrookes Hosp,Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2XY, England; Univ Bristol, Dept Community Based Med, Bristol, Avon, England; UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1E 6BT, England; St George Hosp, Sch Med, Dept Community Hlth Sci, London, England; Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England		Todd, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Addenbrookes Hosp,Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Wellcome Trust Med Res Council Bldg,Hills Rd, Cambridge CB2 2XY, England.	john.todd@cimr.cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Dunger, Professor David/0000-0002-2566-9304; Walker, Neil/0000-0001-9796-7688	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0000934] Funding Source: Medline		Anjos S, 2004, MOL GENET METAB, V81, P187, DOI 10.1016/j.ymgme.2003.11.010; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Breslow N., 1980, STAT METHODS CANC RE, V1; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Clayton D, 1993, STAT MODELS EPIDEMIO; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Fan RZ, 2003, AM J HUM GENET, V72, P850, DOI 10.1086/373966; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Hirschhorn Joel N, 2003, Pediatr Diabetes, V4, P87, DOI 10.1034/j.1399-5448.2001.00013.x; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2005, NAT GENET, V37, P110, DOI 10.1038/ng0205-110; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; TOLEDANO MB, 1990, P NATL ACAD SCI USA, V87, P1830, DOI 10.1073/pnas.87.5.1830; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vella A, 2004, DIABETES, V53, P1158, DOI 10.2337/diabetes.53.4.1158; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392	35	260	271	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					773	779		10.1086/429843			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	WOS:000228198300005	15776395	Green Published, Bronze			2022-01-24	
J	Wang, E; Ding, YC; Flodman, P; Kidd, JR; Kidd, KK; Grady, DL; Ryder, OA; Spence, MA; Swanson, JM; Moyzis, RK				Wang, E; Ding, YC; Flodman, P; Kidd, JR; Kidd, KK; Grady, DL; Ryder, OA; Spence, MA; Swanson, JM; Moyzis, RK			The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; 7-REPEAT ALLELE; POSITIVE SELECTION; PROMOTER REGION; NOVELTY SEEKING; HUMAN GENOME; POLYMORPHISM; ASSOCIATION; ATTENTION; EVOLUTION	Associations of the seven-repeat (7R) allele of the human dopamine receptor D4 (DRD4) gene with both the personality trait of novelty seeking and attention deficit/hyperactivity disorder have been reported. Recently, on the basis of the unusual DNA sequence organization of the DRD4 7R 48-bp tandem repeat ( VNTR), we proposed that the 7R allele originated as a rare mutational event that increased to high frequency by positive selection. We now have resequenced the entire DRD4 locus from 103 individuals homozygous for 2R, 4R, or 7R variants of the VNTR, a method developed to directly estimate haplotype diversity. DNA from individuals of African, European, Asian, North and South American, and Pacific Island ancestry were used. 4R/4R homozygotes exhibit little linkage disequilibrium (LD) over the region examined, with more polymorphisms observed in DNA samples from African individuals. In contrast, the evidence for strong LD surrounding the 7R allele is dramatic, with all 7R/7R individuals ( including those from Africa) exhibiting the same alleles at most polymorphic sites. By intra-allelic comparison at 18 high-heterozygosity sites spanning the locus, we estimate that the 7R allele arose prior to the upper Paleolithic era (similar to40,000-50,000 years ago). Further, the pattern of recombination at these polymorphic sites is the pattern expected for selection acting at the 7R VNTR itself, rather than at an adjacent site. We propose a model for selection at the DRD4 locus consistent with these observed LD patterns and with the known biochemical and physiological differences between receptor variants.	Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Child Dev Ctr, Irvine, CA USA; Univ Calif Irvine, Dept Pediat, Orange, CA 92668 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA		Moyzis, RK (corresponding author), Univ Calif Irvine, Coll Med, Dept Biol Chem, Sprague Hall, Irvine, CA 92697 USA.	rmoyzis@uci.edu			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH060660] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH60660, R01 MH060660] Funding Source: Medline		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Betzig L., 1993, SOCIAL STRATIFICATIO; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Buss D.M., 1999, EVOLUTIONARY PSYCHOL; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Darwin C., 1871, P475; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Fay JC, 2000, GENETICS, V155, P1405; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FU YX, 1993, GENETICS, V133, P693; Grady DL, 2003, MOL PSYCHIATR, V8, P536, DOI 10.1038/sj.mp.4001350; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; HARTMAN T, 1993, ATTENTION DEFICIT DI; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jensen PS, 1997, J AM ACAD CHILD PSY, V36, P1672, DOI 10.1097/00004583-199712000-00015; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/01213011-199910000-00003; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langley K, 2004, AM J PSYCHIAT, V161, P133, DOI 10.1176/appi.ajp.161.1.133; LEUNG PWL, IN PRESS AM J MED GE; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; Maynard Smith J., 1982, pi; McCracken JT, 2000, MOL PSYCHIATR, V5, P531, DOI 10.1038/sj.mp.4000770; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Okuyama Y, 2000, MOL PSYCHIATR, V5, P64, DOI 10.1038/sj.mp.4000563; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ronai Z, 2001, MOL PSYCHIATR, V6, P35, DOI 10.1038/sj.mp.4000832; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Swanson J, 2000, P NATL ACAD SCI USA, V97, P4754, DOI 10.1073/pnas.080070897; Swanson J, 2001, CLIN NEUROSCI RES, V1, P207, DOI 10.1016/S1566-2772(01)00007-X; Swanson WJ, 2003, CURR OPIN GENET DEV, V13, P617, DOI 10.1016/j.gde.2003.10.007; TAJIMA F, 1989, GENETICS, V123, P585; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Volkow ND, 2003, AM J PSYCHIAT, V160, P1909, DOI 10.1176/appi.ajp.160.11.1909	59	260	262	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					931	944		10.1086/420854			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	WOS:000220926100013	15077199	Green Published, Bronze			2022-01-24	
J	Versteeg, R; van Schaik, BDC; van Batenburg, MF; Roos, M; Monajemi, R; Caron, H; Bussemaker, HJ; van Kampen, AHC				Versteeg, R; van Schaik, BDC; van Batenburg, MF; Roos, M; Monajemi, R; Caron, H; Bussemaker, HJ; van Kampen, AHC			The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes	GENOME RESEARCH			English	Article							CHROMOSOMAL DOMAINS; HUMAN GENOME; INTEGRATION	The chromosomal gene expression profiles established by the Human Transcriptome Map (HTM) revealed a clustering of highly expressed genes in about 30 domains, called ridges. To physically characterize ridges, we constructed a new HTM based oil the draft human genome sequence (HTMseq). Expression of 25,003 genes can be analyzed online in a multitude of tissues (http://bioinfo.amc.uva.nl/HTMseq). Ridges are found to be very gene-dense domains with a high GC content, a high SINE repeat density, and a low LINE repeat density. Genes in ridges have significantly shorter introns than genes Outside of ridges. The HTMseq also identifies a significant Clustering of weakly expressed genes in domains with fully opposite characteristics (antiridges). Both types of domains are open to tissue-specific expression regulation, but the maximal expression levels in ridges are considerably higher than in antiridges. Ridges are therefore an integral part of a higher order structure in the genome related to transcriptional regulation.	Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Bioinformat, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Paediat Oncol EKZ, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1012 WX Amsterdam, Netherlands; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA		Versteeg, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1100 DE Amsterdam, Netherlands.	R.Versteeg@AMC.UVA.NL	Roos, Marco/C-5842-2008; Versteeg, Rogier/AAQ-1765-2020	Monajemi, Ramin/0000-0002-4277-6523; van Schaik, Barbera/0000-0002-5568-8127; Versteeg, Rogier/0000-0001-7172-0388; Roos, Marco/0000-0002-8691-772X	NLM NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [P20 LM007276, LM007276] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [P20LM007276] Funding Source: NIH RePORTER		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Fujii T, 2002, CANCER RES, V62, P3340; Lal A, 1999, CANCER RES, V59, P5403; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Press W.H., 1997, NUMERICAL RECIPES C; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0	15	260	264	0	10	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	SEP	2003	13	9					1998	2004		10.1101/gr.1649303			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	717JL	WOS:000185085300003	12915492	Green Published, Bronze			2022-01-24	
J	Hansen, JJ; Durr, A; Cournu-Rebeix, I; Georgopoulos, C; Ang, D; Nielsen, MN; Davoine, CS; Brice, A; Fontaine, B; Gregersen, N; Bross, P				Hansen, JJ; Durr, A; Cournu-Rebeix, I; Georgopoulos, C; Ang, D; Nielsen, MN; Davoine, CS; Brice, A; Fontaine, B; Gregersen, N; Bross, P			Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ESCHERICHIA-COLI; PROTEINS	SPG13, an autosomal dominant form of pure hereditary spastic paraplegia, was recently mapped to chromosome 2q24-34 in a French family. Here we present genetic data indicating that SPG13 is associated with a mutation, in the gene encoding the human mitochondrial chaperonin Hsp60, that results in the V72I substitution. A complementation assay showed that wild-type HSP60 (also known as "HSPD1"), but not HSP60 (V72I), together with the co-chaperonin HSP10 (also known as "HSPE1"), can support growth of Escherichia coli cells in which the homologous chromosomal groESgroEL chaperonin genes have been deleted. Taken together, our data strongly indicate that the V72I variation is the first disease-causing mutation that has been identified in HSP60.	Arhus Univ Hosp, Res Unit Mol Med, Aarhus, Denmark; Fac Hlth Sci, Aarhus, Denmark; Grp Hosp Pitie Salpetriere, Federat Neurol, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, INSERM, U289, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, Dept Genet Cytogenet & Embryol, F-75634 Paris, France; Fac Med, INSERM, U546, Paris, France; Ctr Med Univ Geneva, CH-1211 Geneva, Switzerland		Bross, P (corresponding author), Skejby Sygehus, Res Unit Mol Med, DK-8200 Aarhus N, Denmark.		Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019; Bross, Peter/B-7219-2013	brice, alexis/0000-0002-0941-3990; Bross, Peter/0000-0001-9526-8525			BROSS P, 1995, J BIOL CHEM, V270, P10284, DOI 10.1074/jbc.270.17.10284; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4; Castanie HP, 1997, ANAL BIOCHEM, V254, P150, DOI 10.1006/abio.1997.2423; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fontaine B, 2000, AM J HUM GENET, V66, P702, DOI 10.1086/302776; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Richardson A, 2001, J BIOL CHEM, V276, P4981, DOI 10.1074/jbc.M008628200; Slavotinek AM, 2001, TRENDS GENET, V17, P528, DOI 10.1016/S0168-9525(01)02413-1; Tallaksen CME, 2001, CURR OPIN NEUROL, V14, P457, DOI 10.1097/00019052-200108000-00005; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758	13	260	269	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1328	1332		10.1086/339935			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	WOS:000175012400022	11898127	Bronze, Green Published			2022-01-24	
J	Sun, C; Sklaetsky, H; Birren, B; Devon, K; Tang, ZL; Silber, S; Oates, R; Page, DC				Sun, C; Sklaetsky, H; Birren, B; Devon, K; Tang, ZL; Silber, S; Oates, R; Page, DC			An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HUMAN DNA; LONG ARM; CLONES; MICRODELETIONS; POLYMORPHISMS; LOCALIZATION; EXPRESSION; SEQUENCES; DELETIONS	In humans, deletion of any one of three Y-chromosomal regions-AZFa. AZFb or AZFc-disrupts spermatogenesis, causing infertility in otherwise healthy men(1-5). Although candidate genes have been identified in all three regions(3,6-8), no case of spermatogenic failure has been traced to a point mutation in a Y-linked gene, or to a deletion of a single Y-linked gene. We sequenced the AZFa region of the Y chromosome and identified two functional genes previously described: USP9Y(also known as DFFRY) and DBY (refs 7,8). Screening of the two genes in 576 infertile and 96 fertile men revealed several sequence variants, most of which appear to be heritable and of little functional consequence. We found one de novo mutation in USP9Y: a 4-bp deletion in a splice-donor site, causing an exon to be skipped and protein truncation. This mutation was present in a man with nonobstructive azoospermia (that is, no sperm was detected in semen), but absent in his fertile brother, suggesting that the USP9Y mutation caused spermatogenic failure. We also identified a single-gene deletion associated with spermatogenic failure, again involving USP9Y, by re-analysing a published study.	MIT, Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO USA; Boston Univ, Sch Med, Dept Urol, Boston, MA 02118 USA		Page, DC (corresponding author), MIT, Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA.			Oates, Robert/0000-0003-2330-6697			ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AndreuttiZaugg C, 1997, CANCER RES, V57, P3288; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; Grimaldi P, 1998, MOL HUM REPROD, V4, P1116, DOI 10.1093/molehr/4.12.1116; JONES MH, 1994, GENOMICS, V24, P266, DOI 10.1006/geno.1994.1615; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; LAHN BT, SCIENCE, V286, P99; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; NELSON DL, 1991, P NATL ACAD SCI USA, V88, P6157, DOI 10.1073/pnas.88.14.6157; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Pryor JL, 1997, NEW ENGL J MED, V336, P534, DOI 10.1056/NEJM199702203360802; QURESHI SJ, 1996, MOL HUM REPROD, V2, P275; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Sargent CA, 1999, J MED GENET, V36, P670; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769	24	260	281	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					429	432		10.1038/70539			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	WOS:000084023900018	10581029				2022-01-24	
J	duSart, D; Cancilla, MR; Earle, E; Mao, JI; Saffery, R; Tainton, KM; Kalitsis, P; Martyn, J; Barry, AE; Choo, KHA				duSart, D; Cancilla, MR; Earle, E; Mao, JI; Saffery, R; Tainton, KM; Kalitsis, P; Martyn, J; Barry, AE; Choo, KHA			A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA	NATURE GENETICS			English	Article							SUPERNUMERARY MARKER CHROMOSOMES; PROTEIN CENP-C; ANTICENTROMERE ANTIBODIES; SACCHAROMYCES-CEREVISIAE; KINETOCHORE CENTROMERE; INSITU HYBRIDIZATION; HUMAN AUTOANTIBODIES; MAMMALIAN-CELLS; FISSION YEAST; PHYSICAL MAP	We recently described a human marker chromosome containing a functional neo-centromere that binds anticentromere antibodies, but is devoid of centromeric alpha-satellite repeats and derived from a hitherto non-centromeric: region of chromosome 10q25. Chromosome walking using cloned single-copy DNA from this region enabled us to identify the antibody-binding domain of this centromere. Extensive restriction mapping indicates that this domain has an identical genomic organization to the corresponding normal chromosomal region, suggesting a mechanism for the origin of this centromere through the activation of a latent centromere that exists within 10q25.	ROYAL CHILDRENS HOSP,MURDOCH INST RES BIRTH DEFECTS,PARKVILLE,VIC 3052,AUSTRALIA; GENOME THERAPEUT CORP,COLLABORAT RES DIV,WALTHAM,MA 02154				Kalitsis, Paul/C-1916-2015	Kalitsis, Paul/0000-0001-5569-0609; Barry, Alyssa/0000-0002-1189-2310; Saffery, Richard/0000-0002-9510-4181			ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALEIXANDRE C, 1987, HUM GENET, V77, P46; ARCHIDIACONO N, 1994, SITU HYBRIDIZATION P, P1; BALDINI A, 1993, HUM GENET, V90, P577; BALDINI A, 1991, CYTOGENET CELL GENET, V58, P1868; BERNAT RL, 1990, J CELL BIOL, V111, P1519, DOI 10.1083/jcb.111.4.1519; BISCHOFF FR, 1990, P NATL ACAD SCI USA, V87, P8617, DOI 10.1073/pnas.87.21.8617; BLENNOW E, 1994, AM J HUM GENET, V54, P877; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; BROWN KE, 1994, HUM MOL GENET, V3, P1227, DOI 10.1093/hmg/3.8.1227; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; BROWN MT, 1995, GENE, V160, P111, DOI 10.1016/0378-1119(95)00163-Z; BROWN W, 1995, TRENDS GENET, V11, P337, DOI 10.1016/S0168-9525(00)89100-3; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; CALLEN DF, 1992, AM J MED GENET, V43, P709, DOI 10.1002/ajmg.1320430412; CHOO KHA, IN PRESS CENTROMERE; CLARKE L, 1985, ANNU REV GENET, V19, P29, DOI 10.1146/annurev.ge.19.120185.000333; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; DASSO M, 1993, TRENDS BIOCHEM SCI, V18, P96, DOI 10.1016/0968-0004(93)90161-F; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; EARNSHAW WC, 1994, FASEB J, V8, P947, DOI 10.1096/fasebj.8.12.8088460; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; FRITZLER MJ, 1980, AM J MED, V69, P520, DOI 10.1016/0002-9343(80)90462-3; GRADY DL, 1992, P NATL ACAD SCI USA, V89, P1695, DOI 10.1073/pnas.89.5.1695; HAAF T, 1994, HUM MOL GENET, V3, P697, DOI 10.1093/hmg/3.5.697; HAAF T, 1992, CELL, V70, P681, DOI 10.1016/0092-8674(92)90436-G; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; HEARTLEIN MW, 1988, MOL CELL BIOL, V8, P3611, DOI 10.1128/MCB.8.9.3611; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KINGWELL B, 1987, CHROMOSOMA, V95, P403, DOI 10.1007/BF00333991; LARIN Z, 1994, HUM MOL GENET, V3, P689, DOI 10.1093/hmg/3.5.689; MAGNANI I, 1993, CLIN GENET, V43, P180; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; MOIR DT, 1994, GENOMICS, V22, P1, DOI 10.1006/geno.1994.1338; MOROI Y, 1981, J CELL BIOL, V90, P254, DOI 10.1083/jcb.90.1.254; Moschonas N. K., 1996, Cytogenetics and Cell Genetics, V72, P99, DOI 10.1159/000134172; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; NELSON M, 1991, NUCLEIC ACIDS RES, V19, P2045, DOI 10.1093/nar/19.suppl.2045; OHASHI H, 1994, AM J HUM GENET, V55, P1202; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; PLUTA AF, 1990, TRENDS BIOCHEM SCI, V15, P181, DOI 10.1016/0968-0004(90)90158-8; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; RAUCH A, 1992, CLIN GENET, V42, P84; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; VERMA RS, 1992, GENOMICS, V14, P113, DOI 10.1016/S0888-7543(05)80291-5; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; WEVRICK R, 1989, P NATL ACAD SCI USA, V86, P9394, DOI 10.1073/pnas.86.23.9394; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Yang CH, 1996, MOL CELL BIOL, V16, P3576; ZHENG CJ, 1994, GENOMICS, V22, P55, DOI 10.1006/geno.1994.1345	65	260	262	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					144	153					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	WOS:A1997XB54300014	9171825				2022-01-24	
J	Lee, MP; Hu, RJ; Johnson, LA; Feinberg, AP				Lee, MP; Hu, RJ; Johnson, LA; Feinberg, AP			Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements	NATURE GENETICS			English	Article							FACTOR-II GENE; WILMS-TUMOR; IGF2; H19; RELAXATION; EXPRESSION; DNA	Genomic imprinting is an epigenetic chromosomal modification in the gamete or zygote causing preferential expression of a specific parental allele in somatic cells of the offspring. We and others have identified three imprinted human genes on 11p15.5, IGF2 (refs 1-4), H19 (refs 1,5), and p57(KIP2) (ref. 6), although the latter gene is separated by 700 kb from the other two, and it is unclear whether there are other imprinted genes within this large interval. We previously mapped an embryonal tumour suppressor gene to this region(7), as well as five balanced germline chromosomal rearrangement breakpoints from patients with Beckwith-Wiedemann syndrome (BWS)(8), a condition characterized by prenatal overgrowth and cancer. We isolated the upstream exons of the previously identified gene KVLQT1, which causes the familial cardiac defect long-QT (LQT) syndrome. We found that KVLQT1 spans much of the interval between p57(KIP2) and IGF2, and that it is also imprinted. We demonstrated that the gene is disrupted by chromosomal chromosomal translocation in an embryonal rhabdoid tumour. Furthermore, the lack of parent-of-origin effect in LQT syndrome appears to be due to relative lack of imprinting in the affected tissue, cardiac muscle, representing a novel mechanism for variable penetrance of a human disease gene.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205				Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA054358, CA54358] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R37CA054358, R01CA054358] Funding Source: NIH RePORTER		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Chung WY, 1996, HUM MOL GENET, V5, P1101, DOI 10.1093/hmg/5.8.1101; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; FEINBERG AP, 1994, J CELL SCI S, V18, P7; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; HATADA H, 1996, NAT GENET, V14, P171; Hoovers JMN, 1995, P NATL ACAD SCI USA, V92, P12456, DOI 10.1073/pnas.92.26.12456; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; Mannens M., 1994, European Journal of Human Genetics, V2, P3; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REIK W, 1994, HUM MOL GENET, V3, P1297, DOI 10.1093/hmg/3.8.1297; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; THOMPSON JS, IN PRESS CANC RES; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	28	260	274	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					181	185		10.1038/ng0297-181			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	WOS:A1997WF08700019	9020845				2022-01-24	
J	Gauguier, D; Froguel, P; Parent, V; Bernard, C; Bihoreau, MT; Portha, B; James, MR; Penicaud, L; Lathrop, M; Ktorza, A				Gauguier, D; Froguel, P; Parent, V; Bernard, C; Bihoreau, MT; Portha, B; James, MR; Penicaud, L; Lathrop, M; Ktorza, A			Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat	NATURE GENETICS			English	Article							SPONTANEOUSLY HYPERTENSIVE RAT; BLOOD-PRESSURE; MELLITUS; ENDOCRINE; ETIOLOGY; LINKAGE; TWINS; MAP	Goto-Kakizaki (GK) rats are a well characterized model for non-insulin dependent diabetes mellitus (NIDDM). We have used a combination of physiological and genetic studies to identify quantitative trait loci (QTLs) responsible for the control of glucose homeostasis and insulin secretion in a F-2 cohort bred from spontaneously diabetic GK rats. The genetic dissection of NIDDM allowed us to map up to six independently segregating loci predisposing to hyperglycaemia, glucose intolerance or altered insulin secretion, and a seventh locus implicated in body weight. QTLs implicated in glucose tolerance and adiposity map to the same region of rat chromosome 1, and may indicate the influence of a single locus. Our study demonstrates that distinct combinations of genetic loci are responsible for different physiological characteristics associated with the diabetic phenotype in the GK rat, and it constitutes an important step for directing the search for the genetic factors involved in human NIDDM.	ST LOUIS HOSP,INSERM,U358,F-75010 PARIS,FRANCE; INST PASTEUR,CNRS,EP 10,F-59019 LILLE,FRANCE; UNIV PARIS 07,PHYSIOPATHOL NUTR LAB,CNRS,URA 307,F-75005 PARIS,FRANCE		Gauguier, D (corresponding author), WELLCOME TRUST CTR HUMAN GENET,WINDMILL RD,OXFORD OX3 7BN,ENGLAND.		Portha, Bernard/AAW-3021-2021; Gauguier, Dominique/G-2190-2016; FROGUEL, Philippe/O-6799-2017	Gauguier, Dominique/0000-0001-6156-9530; FROGUEL, Philippe/0000-0003-2972-0784	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ABDELHALIM SM, 1994, DIABETES, V43, P2811; AKABAYASHI A, 1994, MOL BRAIN RES, V21, P55, DOI 10.1016/0169-328X(94)90377-8; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; COOK DL, 1992, INT TXB DIABETES MEL, P89; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DENG YL, 1992, NAT GENET, V1, P267, DOI 10.1038/ng0792-267; DUBAY C, 1993, NAT GENET, V3, P354, DOI 10.1038/ng0493-354; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; GAUGUIER D, 1994, DIABETES, V43, P220, DOI 10.2337/diabetes.43.2.220; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; GLASER B, 1994, NAT GENET, V7, P185, DOI 10.1038/ng0694-185; GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80; GOTO Y, 1988, LESSONS ANIMAL DIABE, V2, P490; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; KING H, 1988, BAILLIERE CLIN ENDOC, V2, P291, DOI 10.1016/S0950-351X(88)80033-8; LEIBOWITZ SF, 1991, BRAIN RES BULL, V27, P333, DOI 10.1016/0361-9230(91)90121-Y; LINDPAINTNER K, 1993, J HYPERTENS, V11, P19, DOI 10.1097/00004872-199301000-00004; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; ROSEN KM, 1993, ENDOCRINOLOGY, V133, P168; SAMANI NJ, 1993, J CLIN INVEST, V92, P1099, DOI 10.1172/JCI116616; SERIKAWA T, 1992, GENETICS, V131, P701; SHEIKH SP, 1988, AM J PHYSIOL, V255, pG46, DOI 10.1152/ajpgi.1988.255.1.G46; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; TAYLOR R, 1989, BRIT MED BULL, V45, P73, DOI 10.1093/oxfordjournals.bmb.a072322; TAYLOR SI, 1991, J CLIN ENDOCR METAB, V73, P1158, DOI 10.1210/jcem-73-6-1158; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Wallum BJ, 1992, INT TXB DIABETES MEL, P285; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477	35	260	263	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					38	43		10.1038/ng0196-38			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	WOS:A1996TM55500012	8528248				2022-01-24	
J	TURELLI, M; ORR, HA				TURELLI, M; ORR, HA			THE DOMINANCE THEORY OF HALDANES RULE	GENETICS			English	Article							DROSOPHILA-MELANOGASTER; ZYGOTIC LETHALS; EVOLUTION; CELLS; CHROMOSOMES; POPULATIONS; SPECIATION; MUTATIONS; SEX	''HALDANE's rule'' states that, if species hybrids of one sex only are inviable or sterile, the afflicted sex is much more likely to be heterogametic (XY) than homogametic (XX). We show that most or all of the phenomena associated with HALDANE's rule can be explained by the simple hypothesis that alleles decreasing hybrid fitness are partially recessive. Under this hypothesis, the XY sex suffers more than the XX because X-linked alleles causing postzygotic isolation tend to have greater cumulative effects when hemizygous than when heterozygous, even though the XX sex carries twice as many such alleles. The dominance hypothesis can also account for the ''large X effect,'' the disproportionate effect of the X chromosome on hybrid inviability/sterility. In addition, the dominance theory is consistent with: the long temporal lag between the evolution of heterogametic and homogametic postzygotic isolation, the frequency of exceptions to HALDANE's rule, puzzling Drosophila experiments in which ''unbalanced'' hybrid females, who carry two X chromosomes from the same species, remain fertile whereas F-1 hybrid males are sterile, and the absence of cases of HALDANE's rule for hybrid inviability in mammals. We discuss several novel predictions that could lead to rejection of the dominance theory.	UNIV CALIF DAVIS,EVOLUT & ECOL SECT,DAVIS,CA 95616; UNIV ROCHESTER,DEPT BIOL,ROCHESTER,NY 14627		TURELLI, M (corresponding author), UNIV CALIF DAVIS,CTR POPULAT BIOL,DAVIS,CA 95616, USA.						ASHBURNER M, 1989, DROSOPHILA LABORATOR; BIDDLE FG, 1994, GENOME, V37, P198, DOI 10.1139/g94-027; BREEUWER JAJ, 1995, IN PRESS EVOLUTION; CABOT EL, 1994, GENETICS, V137, P175; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; CHRISTIE P, 1984, J HERED, V75, P510, DOI 10.1093/oxfordjournals.jhered.a110004; Coyne J.A., 1989, P180; COYNE JA, 1985, NATURE, V314, P736, DOI 10.1038/314736a0; COYNE JA, 1989, EVOLUTION, V43, P362, DOI 10.1111/j.1558-5646.1989.tb04233.x; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; DAVIS AW, 1994, GENETICS, V137, P191; Dobzhansky T., 1937, GENETICS ORIGIN SPEC; GARCIABELLIDO A, 1983, GENETICS, V103, P235; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; Haldane J. B. S., 1963, Journal of Genetics, V58, P237, DOI 10.1007/BF02986143; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Huxley J, 1940, NEW SYSTEMATICS, P185; JOHNSON NA, 1993, GENETICS, V135, P443; KACSER H, 1981, GENETICS, V97, P639; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KRATZER PG, 1981, P NATL ACAD SCI-BIOL, V78, P3093, DOI 10.1073/pnas.78.5.3093; Lawrence PA, 1992, MAKING FLY; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MIGEON BR, 1994, TRENDS GENET, V10, P230, DOI 10.1016/0168-9525(94)90169-4; Muller HJ., 1942, BIOL S, V6, P71; MURPHY C, 1974, DEV BIOL, V39, P23, DOI 10.1016/S0012-1606(74)80005-9; ORR HA, 1995, GENETICS, V139, P1805; ORR HA, 1993, EVOLUTION, V47, P1606, DOI [10.2307/2410171, 10.1111/j.1558-5646.1993.tb02179.x]; ORR HA, 1993, NATURE, V361, P532, DOI 10.1038/361532a0; RIPOLL P, 1977, GENETICS, V86, P357; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; TAKAGI N, 1974, EXP CELL RES, V86, P127, DOI 10.1016/0014-4827(74)90657-0; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Wright S., 1969, EVOLUTION GENETICS P; WU CI, 1994, ANNU REV GENET, V28, P283, DOI 10.1146/annurev.ge.28.120194.001435; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534	37	260	263	1	28	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	MAY	1995	140	1					389	402					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QV521	WOS:A1995QV52100032	7635302				2022-01-24	
J	ROSENZWEIG, RF; SHARP, RR; TREVES, DS; ADAMS, J				ROSENZWEIG, RF; SHARP, RR; TREVES, DS; ADAMS, J			MICROBIAL EVOLUTION IN A SIMPLE UNSTRUCTURED ENVIRONMENT - GENETIC DIFFERENTIATION IN ESCHERICHIA-COLI	GENETICS			English	Article								Populations of Escherichia coli initiated with a single clone and maintained for long periods in glucose-limited continuous culture, become polymorphic. In one population, three clones were isolated and by means of reconstruction experiments were shown to be maintained in stable polymorphism, although they exhibited substantial differences in maximum specific growth rates and in glucose uptake kinetics. Analysis of these three clones revealed that their stable coexistence could be explained by differential patterns of the secretion and uptake of two alternative metabolites acetate and glycerol. Regulatory (constitutive and null) mutations in acetyl-coenzyme A synthetase accounted for different patterns of acetate secretion and uptake seen. Altered patterns in glycerol uptake are most likely explained by mutations which result in quantitative differences in the induction of the glycerol regulon and/or structural changes in glycerol kinase that reduce allosteric inhibition by effector molecules associated with glycolysis. The evolution of resource partitioning, and consequent polymorphisms which arise may illustrate incipient processes of speciation in asexual organisms.	UNIV MICHIGAN, DEPT BIOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT CHEM, ANN ARBOR, MI 48109 USA						NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM030959] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM30959] Funding Source: Medline		ADAMS J, 1992, CURR GENET, V22, P13, DOI 10.1007/BF00351736; ATWOOD KC, 1951, COLD SPRING HARB SYM, V16, P345, DOI 10.1101/SQB.1951.016.01.026; BAJPAI R, 1987, ANN NY ACAD SCI, V506, P446, DOI 10.1111/j.1749-6632.1987.tb23840.x; Bergmeyer H.L., 1983, METHODS ENZYMATIC AN; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; CLAASSEN PAM, 1986, J BACTERIOL, V168, P791, DOI 10.1128/jb.168.2.791-794.1986; COLLINS SH, 1976, J BACTERIOL, V126, P1232, DOI 10.1128/JB.126.3.1232-1244.1976; COUTTS DAP, 1987, J APPL BACTERIOL, V62, P251, DOI 10.1111/j.1365-2672.1987.tb02406.x; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; DAVISON BH, 1986, BIOTECHNOL BIOENG, V28, P1127, DOI 10.1002/bit.260280802; DEBOER M, 1986, J BACTERIOL, V167, P393, DOI 10.1128/jb.167.1.393-395.1986; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.es.21.110190.002105; ELMANSI EMT, 1989, J GEN MICROBIOL, V135, P2875; FIESCHKO J, 1986, CHEM ENG COMMUN, V45, P229, DOI 10.1080/00986448608911387; FOX DK, 1986, J BIOL CHEM, V261, P3487; FOX DK, 1986, J BIOL CHEM, V261, P3498; FREEDBERG WB, 1973, J BACTERIOL, V115, P816, DOI 10.1128/JB.115.3.816-823.1973; Gause G.F., 1934, STRUGGLE EXISTENCE; GOTTSCHAL JC, 1980, ARCH MICROBIOL, V126, P33, DOI 10.1007/BF00421888; GOTTSCHAL JC, 1979, ARCH MICROBIOL, V121, P241, DOI 10.1007/BF00425062; GOTTSCHAL JC, 1982, BIOTECHNOL BIOENG, V24, P1403, DOI 10.1002/bit.260240612; GOTTSCHAL JC, 1986, BACTERIA NATURE, P261; GOTTSCHALE G, 1979, BACTERIAL METABOLISM; HARDER W, 1982, PHILOS T ROY SOC B, V297, P459, DOI 10.1098/rstb.1982.0055; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HELLING RB, 1987, GENETICS, V116, P349; HELLING RB, 1990, MOL GEN GENET, V223, P508, DOI 10.1007/BF00264460; HEMPFLING WP, 1975, J BACTERIOL, V123, P1076, DOI 10.1128/JB.123.3.1076-1087.1975; HOFLE MG, 1982, ARCH MICROBIOL, V133, P289, DOI 10.1007/BF00521292; HOFLE MG, 1983, APPL ENVIRON MICROB, V46, P1045; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; IUCHI S, 1990, J BACTERIOL, V172, P179, DOI 10.1128/JB.172.1.179-184.1990; JOHNSTON JR, 1977, FEMS MICROBIOL LETT, V2, P313, DOI 10.1111/j.1574-6968.1977.tb00968.x; Kimura M., 1983, NEUTRAL THEORY MOL E; KISTLER WA, 1971, J BACTERIOL, V108, P1224, DOI 10.1128/JB.108.3.1224-1234.1971; KOPLOVE HM, 1978, J BACTERIOL, V134, P992, DOI 10.1128/JB.134.3.992-1001.1978; Kubitschek HE, 1970, INTRO RES CONTINUOUS; KURLANDZKA A, 1991, MOL BIOL EVOL, V8, P261; LANDWALL P, 1977, J GEN MICROBIOL, V103, P353, DOI 10.1099/00221287-103-2-353; LENSKI RE, 1986, J THEOR BIOL, V122, P83, DOI 10.1016/S0022-5193(86)80226-0; LEVINE SM, 1980, J BACTERIOL, V143, P1081, DOI 10.1128/JB.143.2.1081-1085.1980; LEWONTIN Richard C, 1974, GENETIC BASIS EVOLUT; Lin E.C.C., 1984, CELL MEMBRANE, P109; LIN ECC, 1987, ESCHERICHIA COLI SAL, V1, P244; LULI GW, 1990, APPL ENVIRON MICROB, V56, P1004, DOI 10.1128/AEM.56.4.1004-1011.1990; MAJEWSKI RA, 1990, BIOTECHNOL BIOENG, V35, P732, DOI 10.1002/bit.260350711; MCDONALD JF, 1983, ANNU REV ECOL SYST, V14, P77, DOI 10.1146/annurev.es.14.110183.000453; MEGEE RD, 1972, CAN J MICROBIOL, V18, P1733, DOI 10.1139/m72-269; MODI RI, 1991, EVOLUTION, V45, P656, DOI 10.1111/j.1558-5646.1991.tb04336.x; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; NOVOTNY MJ, 1985, J BACTERIOL, V162, P810, DOI 10.1128/JB.162.2.810-816.1985; Painter PR., 1986, THE MICROBIAL WORLD; PAVLOU S, 1990, BIOTECHNOL BIOENG, V35, P224, DOI 10.1002/bit.260350303; POSTMA PW, 1984, J BACTERIOL, V158, P351, DOI 10.1128/JB.158.1.351-353.1984; POSTMA PW, 1987, ESCHERICHIA COLI SAL, V1, P127; POWELL EO, 1958, J GEN MICROBIOL, V18, P259, DOI 10.1099/00221287-18-1-259; Reanney DC, 1983, MICROBES THEIR NATUR, V34, P379; REPASKE DR, 1981, J BACTERIOL, V145, P1196, DOI 10.1128/JB.145.3.1196-1208.1981; SENIOR E, 1976, NATURE, V263, P476, DOI 10.1038/263476a0; Silverstein R.M., 1991, SPECTROMETRIC IDENTI; SLATER JH, 1978, COMPANION MICROBIOLO, P181; SMIRNOVA GV, 1988, MICROBIOLOGY+, V57, P446; SMIRNOVA GV, 1985, MICROBIOLOGY+, V54, P205; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; SWEET G, 1990, J BACTERIOL, V172, P424, DOI 10.1128/JB.172.1.424-430.1990; Tempest DW, 1987, ESCHERICHIA COLI SAL, P797; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; WILKINSON TG, 1974, BIOTECHNOL BIOENG, V16, P41, DOI 10.1002/bit.260160105; YEOH HT, 1968, CAN J MICROBIOL, V14, P491, DOI 10.1139/m68-083; Zeikus J G., 1983, MICROBES THEIR NATUR, P423; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970; [No title captured]; [No title captured], DOI DOI 10.1007/3540116982_1; [No title captured]; [No title captured], DOI DOI 10.1126/SCIENCE.192.4238.463)	77	260	262	0	29	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	AUG	1994	137	4					903	917					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NX912	WOS:A1994NX91200003	7982572				2022-01-24	
J	TATSUMI, K; MIYAI, K; NOTOMI, T; KAIBE, K; AMINO, N; MIZUNO, Y; KOHNO, H				TATSUMI, K; MIYAI, K; NOTOMI, T; KAIBE, K; AMINO, N; MIZUNO, Y; KOHNO, H			CRETINISM WITH COMBINED HORMONE DEFICIENCY CAUSED BY A MUTATION IN THE PIT1 GENE	NATURE GENETICS			English	Article							THYROID-HORMONE; TRANSCRIPTION FACTOR; BETA-SUBUNIT; DNA-BINDING; POU-DOMAIN; RESISTANCE; RECEPTOR; REGION; SRY	Cretinism is marked by irreversible mental and growth retardation. We describe here an entirely new case of cretinism showing combined pituitary hormone deficiencies of thyrotropin, growth hormone and prolactin that appears to be caused by homozygosity for a nonsense mutation in the gene for the pituitary specific transcription activator, Pit-1/GHF-1 (designated PIT1 in humans for pituitary specific factor 1). This is the first report in humans of a defect in a transcription activator causing deficiency of multiple target genes.	FUKUOKA HIGASHI NATL HOSP,FUKUOKA,JAPAN; FUKUOKA CHILDRENS HOSP,FUKUOKA,JAPAN		TATSUMI, K (corresponding author), OSAKA UNIV,SCH MED,DEPT LAB MED,SUITA,OSAKA 565,JAPAN.						ASHIDA N, IN PRESS SCREENING, V1; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BRAVERMAN LD, 1991, WERNER INGBARS THYRO; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHATTERJEE VKK, 1991, J CLIN INVEST, V87, P1977; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; DACOUVOUTETAKIS C, 1990, AM J HUM GENET, V46, P988; DeGroot LJ, 1989, ENDOCRINOLOGY; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Green MC., 1989, GENETIC VARIANTS STR, P12; HATA N, 1985, CLIN CHEM, V31, P750; HAYASHIZAKI Y, 1990, J CLIN ENDOCR METAB, V71, P792, DOI 10.1210/jcem-71-4-792; HAYASHIZAKI Y, 1989, EMBO J, V8, P2291, DOI 10.1002/j.1460-2075.1989.tb08355.x; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; IEIRI T, 1991, J CLIN INVEST, V88, P1901, DOI 10.1172/JCI115513; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; KOHNO H, 1980, ARCH DIS CHILD, V55, P725, DOI 10.1136/adc.55.9.725; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MIYAI K, 1971, NEW ENGL J MED, V285, P1043, DOI 10.1056/NEJM197111042851902; MIYAI K, 1988, PROGR ENDOCRINOLOGY, P545; MORI R, 1991, JPN J HUM GENET, V36, P313, DOI 10.1007/BF01883604; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NOGUCHI T, 1988, PROG NEUROBIOL, V31, P149, DOI 10.1016/0301-0082(88)90030-5; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; SAKURAI A, 1989, P NATL ACAD SCI USA, V86, P8977, DOI 10.1073/pnas.86.22.8977; TAKEDA K, 1991, J CLIN INVEST, V87, P496, DOI 10.1172/JCI115023; TATSUMI K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P231, DOI 10.1016/0167-4781(92)90494-K; THEILL LE, 1989, NATURE, V342, P945, DOI 10.1038/342945a0; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; USALA SJ, 1990, BIOCHEM BIOPH RES CO, V171, P575, DOI 10.1016/0006-291X(90)91185-U; USALA SJ, 1991, J CLIN ENDOCR METAB, V72, P32, DOI 10.1210/jcem-72-1-32; USALA SJ, 1991, MOL ENDOCRINOL, V5, P327, DOI 10.1210/mend-5-3-327; USALA SJ, 1990, J CLIN INVEST, V85, P93, DOI 10.1172/JCI114438; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0	46	260	267	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					56	58		10.1038/ng0492-56			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	WOS:A1992JC97800013	1302000				2022-01-24	
J	BAIRD, PA; ANDERSON, TW; NEWCOMBE, HB; LOWRY, RB				BAIRD, PA; ANDERSON, TW; NEWCOMBE, HB; LOWRY, RB			GENETIC-DISORDERS IN CHILDREN AND YOUNG-ADULTS - A POPULATION STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALGARY,CALGARY T2N 1N4,ALBERTA,CANADA; UNIV BRITISH COLUMBIA,DEPT HLTH CARE & EPIDEMIOL,VANCOUVER V6T 1W5,BC,CANADA; ALBERTA CHILDRENS PROV GEN HOSP,RES INST,CALGARY T2T 5C7,ALBERTA,CANADA		BAIRD, PA (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,226-6174 UNIV BLVD,VANCOUVER V6T 1W5,BC,CANADA.						BAIRD PA, 1985, AM J MENT DEF, V89, P323; BAIRD PA, 1987, CAN MED ASSOC J, V136, P109; BAIRD PA, 1981, AM J HUM GENET, V33, P470; BAIRD PA, 1987, J PEDIATR-US, V110, P849, DOI 10.1016/S0022-3476(87)80395-5; BAIRD PA, 1968, BRIT J PREV SOC MED, V22, P81; BAIRD PA, 1983, AM J MED GENET, V16, P49, DOI 10.1002/ajmg.1320160109; CZEIZEL A, 1984, MUTAT RES, V128, P73, DOI 10.1016/0027-5107(84)90049-6; HAMERTON JL, 1975, CLIN GENET, V8, P223; JACOBS PA, 1977, AM J EPIDEMIOL, V105, P180, DOI 10.1093/oxfordjournals.aje.a112374; LEUNG TJ, 1985, AM J MED GENET, V21, P43; LOWRY RB, 1975, CAN J PUBLIC HEALTH, V66, P322; LOWRY RB, 1977, TERATOLOGY, V16, P277, DOI 10.1002/tera.1420160306; LOWRY RB, 1986, GENET EPIDEMIOL, V3, P455, DOI 10.1002/gepi.1370030609; LOWRY RB, 1972, CAN MED ASSOC J, V106, P1299; LOWRY RB, 1976, TERATOLOGY, V14, P29, DOI 10.1002/tera.1420140105; MYRIANTHOPOULOS N C, 1974, Birth Defects Original Article Series, V10, P1; RENWICK DHG, 1968, BRIT J PREV SOC MED, V22, P61; SEARLE AG, 1986, J MED GENET, V23, P220, DOI 10.1136/jmg.23.3.220; SPOUGE D, 1985, TERATOLOGY, V32, P171, DOI 10.1002/tera.1420320204; TRIMBLE BK, 1977, CAN J GENET CYTOL, V19, P375, DOI 10.1139/g77-041; TRIMBLE BK, 1978, AM J MED GENET, V2, P1, DOI 10.1002/ajmg.1320020102; TRIMBLE BK, 1974, ANN HUM GENET, V38, P199, DOI 10.1111/j.1469-1809.1974.tb01951.x; Vogel F, 1986, HUMAN GENETICS PROBL; WILSON RD, 1985, AM J MED GENET, V21, P153, DOI 10.1002/ajmg.1320210123; 1986, UNSCEAR REPORT GENET; 1982, UNSCEAR IONIZING RAD; 1977, UNSCEAR SOURCES EFFE; 1966, 17TH GEN ASS OFF R S, V16; 1981, 1981 MIN HLTH DIV VI	29	260	275	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					677	693					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	WOS:A1988N143800003	3358420				2022-01-24	
J	LEDERBERG, J				LEDERBERG, J			GENE RECOMBINATION AND LINKED SEGREGATIONS IN ESCHERICHIA-COLI	GENETICS			English	Article																	ANDERSON EH, 1946, P NATL ACAD SCI USA, V32, P120, DOI 10.1073/pnas.32.5.120; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BOIVIN A, 1946, HELV CHIM ACTA, V29, P1338, DOI 10.1002/hlca.19460290560; BRAUN AC, 1946, J BACTERIOL, V52, P695, DOI 10.1128/JB.52.6.695-702.1946; DEMEREC M, 1945, GENETICS, V30, P119; DIENES L, 1946, S QUANT BIOL, V11, P51; Dobzhansky TH, 1941, GENETICS ORIGIN SPEC; Gray CH, 1944, P NATL ACAD SCI USA, V30, P404, DOI 10.1073/pnas.30.12.404; LEDERBERG G, 1947, THESIS YALE U; LEDERBERG J, 1946, J BIOL CHEM, V165, P381; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; LEDERBERG J, 1946, COLD SPRING HARB SYM, V11, P113; LURIA SE, 1947, BACTERIOL REV, V11, P1; MULLER HJ, 1947, PROC R SOC SER B-BIO, V134, P1, DOI 10.1098/rspb.1947.0001; Roepke RR, 1944, J BACTERIOL, V48, P401, DOI 10.1128/JB.48.4.401-412.1944; RYAN FJ, 1946, P NATL ACAD SCI USA, V32, P163, DOI 10.1073/pnas.32.6.163; RYAN FJ, 1946, COLD SPRING HARB SYM, V11, P215; Steinberg AG, 1944, GENETICS, V29, P83; TATUM EL, 1946, COLD SPRING HARB SYM, V11, P278; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; TATUM EL, 1945, P NATL ACAD SCI USA, V31, P215, DOI 10.1073/pnas.31.8.215; WINKLER HANS, 1932, BIOL ZENTRALBL, V52, P163	22	260	262	0	7	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1947	32	5					505	525					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU206	WOS:A1947UU20600006	17247259				2022-01-24	
J	Wright, S				Wright, S			The results of crosses between inbred strains of guinea pigs, differing in number of digits	GENETICS			English	Article									Univ Chicago, Chicago, IL USA								BERNSTEIN F, 1929, HDB VERERB, V1, P1; Castle W E, 1921, Science, V54, P223, DOI 10.1126/science.54.1393.223; CASTLE WE, 1906, PUB CARNEGIE I WASHI, V49; SEREBROVSKY AS, 1928, Z INDUKT ABSTAMM VER, V48, P229; Wright S, 1934, GENETICS, V19, P0506; WRIGHT S, 1922, USDA B, V1090, P37; Wright S, 1922, USDA AGR B, V1121	7	260	263	0	4	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	NOV	1934	19	6					0537	0551					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V23RJ	WOS:000201599900003	17246736				2022-01-24	
J	Haldane, JBS; Waddington, CH				Haldane, JBS; Waddington, CH			Inbreeding and linkage	GENETICS			English	Article									John Innes Hort Inst, London, England								Jennings HS, 1916, GENETICS, V1, P53; Jennings HS, 1917, GENETICS, V2, P97; Robbins RB, 1918, GENETICS, V3, P375; Wright S, 1921, GENETICS, V6, P124; Wright S, 1921, GENETICS, V6, P111	5	260	266	0	9	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	JUL	1931	16	4					0357	0374					18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V23QP	WOS:000201597900006	17246626				2022-01-24	
J	Schumacher, FR; Al Olama, AA; Berndt, SI; Benlloch, S; Ahmed, M; Saunders, EJ; Dadaev, T; Leongamornlert, D; Anokian, E; Cieza-Borrella, C; Goh, C; Brook, MN; Sheng, X; Fachal, L; Dennis, J; Tyrer, J; Muir, K; Lophatananon, A; Stevens, VL; Gapstur, SM; Carter, BD; Tangen, CM; Goodman, PJ; Thompson, IM; Batra, J; Chambers, S; Moya, L; Clements, J; Horvath, L; Tilley, W; Risbridger, GP; Gronberg, H; Aly, M; Nordstrom, T; Pharoah, P; Pashayan, N; Schleutker, J; Tammela, TLJ; Sipeky, C; Auvinen, A; Albanes, D; Weinstein, S; Wolk, A; Hakansson, N; West, CML; Dunning, AM; Burnet, N; Mucci, LA; Giovannucci, E; Andriole, GL; Cussenot, O; Cancel-Tassin, G; Koutros, S; Freeman, LEB; Sorensen, KD; Orntoft, TF; Borre, M; Maehle, L; Grindedal, EM; Neal, DE; Donovan, JL; Hamdy, FC; Martin, RM; Travis, RC; Key, TJ; Hamilton, RJ; Fleshner, NE; Finelli, A; Ingles, SA; Stern, MC; Rosenstein, BS; Kerns, SL; Ostrer, H; Lu, YJ; Zhang, HW; Feng, NH; Mao, XY; Guo, X; Wang, GM; Sun, Z; Giles, GG; Southey, MC; MacInnis, RJ; FitzGerald, LM; Kibel, AS; Drake, BF; Vega, A; Gomez-Caamano, A; Szulkin, R; Eklund, M; Kogevinas, M; Llorca, J; Castano-Vinyals, G; Penney, KL; Stampfer, M; Park, JY; Sellers, TA; Lin, HY; Stanford, JL; Cybulski, C; Wokolorczyk, D; Lubinski, J; Ostrander, EA; Geybels, MS; Nordestgaard, BG; Nielsen, SF; Weischer, M; Bisbjerg, R; Roder, MA; Iversen, P; Brenner, H; Cuk, K; Holleczek, B; Maier, C; Luedeke, M; Schnoeller, T; Kim, J; Logothetis, CJ; John, EM; Teixeira, MR; Paulo, P; Cardoso, M; Neuhausen, SL; Steele, L; Ding, YC; De Ruyck, K; De Meerleer, G; Ost, P; Razack, A; Lim, J; Teo, SH; Lin, DW; Newcomb, LF; Lessel, D; Gamulin, M; Kulis, T; Kaneva, R; Usmani, N; Singhal, S; Slavov, C; Mitev, V; Parliament, M; Claessens, F; Joniau, S; Van den Broeck, T; Larkin, S; Townsend, PA; Aukim-Hastie, C; Dominguez, MG; Castelao, JE; Martinez, ME; Roobol, MJ; Jenster, G; van Schaik, RHN; Menegaux, F; Truong, T; Koudou, YA; Xu, JF; Khaw, KT; Cannon-Albright, L; Pandha, H; Michael, A; Thibodeau, SN; McDonnell, SK; Schaid, DJ; Lindstrom, S; Turman, C; Ma, J; Hunter, DJ; Riboli, E; Siddiq, A; Canzian, F; Kolonel, LN; Le Marchand, L; Hoover, RN; Machiela, MJ; Cui, ZX; Kraft, P; Conti, DV; Easton, DF; Wiklund, F; Chanock, SJ; Henderson, BE; Kote-Jarai, Z; Haiman, CA; Eeles, RA				Schumacher, Fredrick R.; Al Olama, Ali Amin; Berndt, Sonja I.; Benlloch, Sara; Ahmed, Mahbubl; Saunders, Edward J.; Dadaev, Tokhir; Leongamornlert, Daniel; Anokian, Ezequiel; Cieza-Borrella, Clara; Goh, Chee; Brook, Mark N.; Sheng, Xin; Fachal, Laura; Dennis, Joe; Tyrer, Jonathan; Muir, Kenneth; Lophatananon, Artitaya; Stevens, Victoria L.; Gapstur, Susan M.; Carter, Brian D.; Tangen, Catherine M.; Goodman, Phyllis J.; Thompson, Ian M., Jr.; Batra, Jyotsna; Chambers, Suzanne; Moya, Leire; Clements, Judith; Horvath, Lisa; Tilley, Wayne; Risbridger, Gail P.; Gronberg, Henrik; Aly, Markus; Nordstrom, Tobias; Pharoah, Paul; Pashayan, Nora; Schleutker, Johanna; Tammela, Teuvo L. J.; Sipeky, Csilla; Auvinen, Anssi; Albanes, Demetrius; Weinstein, Stephanie; Wolk, Alicja; Hakansson, Niclas; West, Catharine M. L.; Dunning, Alison M.; Burnet, Neil; Mucci, Lorelei A.; Giovannucci, Edward; Andriole, Gerald L.; Cussenot, Olivier; Cancel-Tassin, Geraldine; Koutros, Stella; Freeman, Laura E. Beane; Sorensen, Karina Dalsgaard; Orntoft, Torben Falck; Borre, Michael; Maehle, Lovise; Grindedal, Eli Marie; Neal, David E.; Donovan, Jenny L.; Hamdy, Freddie C.; Martin, Richard M.; Travis, Ruth C.; Key, Tim J.; Hamilton, Robert J.; Fleshner, Neil E.; Finelli, Antonio; Ingles, Sue Ann; Stern, Mariana C.; Rosenstein, Barry S.; Kerns, Sarah L.; Ostrer, Harry; Lu, Yong-Jie; Zhang, Hong-Wei; Feng, Ninghan; Mao, Xueying; Guo, Xin; Wang, Guomin; Sun, Zan; Giles, Graham G.; Southey, Melissa C.; MacInnis, Robert J.; FitzGerald, Liesel M.; Kibel, Adam S.; Drake, Bettina F.; Vega, Ana; Gomez-Caamano, Antonio; Szulkin, Robert; Eklund, Martin; Kogevinas, Manolis; Llorca, Javier; Castano-Vinyals, Gemma; Penney, Kathryn L.; Stampfer, Meir; Park, Jong Y.; Sellers, Thomas A.; Lin, Hui-Yi; Stanford, Janet L.; Cybulski, Cezary; Wokolorczyk, Dominika; Lubinski, Jan; Ostrander, Elaine A.; Geybels, Milan S.; Nordestgaard, Borge G.; Nielsen, Sune F.; Weischer, Maren; Bisbjerg, Rasmus; Roder, Martin Andreas; Iversen, Peter; Brenner, Hermann; Cuk, Katarina; Holleczek, Bernd; Maier, Christiane; Luedeke, Manuel; Schnoeller, Thomas; Kim, Jeri; Logothetis, Christopher J.; John, Esther M.; Teixeira, Manuel R.; Paulo, Paula; Cardoso, Marta; Neuhausen, Susan L.; Steele, Linda; Ding, Yuan Chun; De Ruyck, Kim; De Meerleer, Gert; Ost, Piet; Razack, Azad; Lim, Jasmine; Teo, Soo-Hwang; Lin, Daniel W.; Newcomb, Lisa F.; Lessel, Davor; Gamulin, Marija; Kulis, Tomislav; Kaneva, Radka; Usmani, Nawaid; Singhal, Sandeep; Slavov, Chavdar; Mitev, Vanio; Parliament, Matthew; Claessens, Frank; Joniau, Steven; Van den Broeck, Thomas; Larkin, Samantha; Townsend, Paul A.; Aukim-Hastie, Claire; Dominguez, Manuela Gago; Castelao, Jose Esteban; Martinez, Maria Elena; Roobol, Monique J.; Jenster, Guido; van Schaik, Ron H. N.; Menegaux, Florence; Truong, Therese; Koudou, Yves Akoli; Xu, Jianfeng; Khaw, Kay-Tee; Cannon-Albright, Lisa; Pandha, Hardev; Michael, Agnieszka; Thibodeau, Stephen N.; McDonnell, Shannon K.; Schaid, Daniel J.; Lindstrom, Sara; Turman, Constance; Ma, Jing; Hunter, David J.; Riboli, Elio; Siddiq, Afshan; Canzian, Federico; Kolonel, Laurence N.; Le Marchand, Loic; Hoover, Robert N.; Machiela, Mitchell J.; Cui, Zuxi; Kraft, Peter; Conti, David V.; Easton, Douglas F.; Wiklund, Fredrik; Chanock, Stephen J.; Henderson, Brian E.; Kote-Jarai, Zsofia; Haiman, Christopher A.; Eeles, Rosalind A.		Profile Study; APCB; IMPACT Study; Canary PASS Investigators; Breast Prostate Canc Cohort Consor; PRACTICAL Prostate Canc As; Canc Prostate Sweden CAPS; Prostate Canc Genome-wide As; Genetic Assoc Mech Oncology GAME-	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE LOCI; RISK; GENE; METAANALYSIS; VARIANTS; PATHWAY; IDENTIFICATION; CONSORTIUM; PREDICTION	Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data from a custom high-density array of 46,939 PrCa cases and 27,910 controls of European ancestry with previously genotyped data of 32,255 PrCa cases and 33,202 controls of European ancestry. Our analysis identified 62 novel loci associated (P < 5.0 x 10(-8)) with PrCa and one locus significantly associated with early-onset PrCa (<= 55 years). Our findings include missense variants rs1800057 (odds ratio (OR) = 1.16; P = 8.2 x 10(-9); G>C, p.Pro1054Arg) in ATM and rs2066827 (OR = 1.06; P = 2.3 x 10(-9); T>G, p.Val109Gly) in CDKN1B. The combination of all loci captured 28.4% of the PrCa familial relative risk, and a polygenic risk score conferred an elevated PrCa risk for men in the ninetieth to ninety-ninth percentiles (relative risk = 2.69; 95% confidence interval (CI): 2.55-2.82) and first percentile (relative risk = 5.71; 95% CI: 5.04-6.48) risk stratum compared with the population average. These findings improve risk prediction, enhance fine-mapping, and provide insight into the underlying biology of PrCa1.	[Schumacher, Fredrick R.; Cui, Zuxi] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Schumacher, Fredrick R.] Univ Hosp, Seidman Canc Ctr, Cleveland, OH USA; [Al Olama, Ali Amin; Benlloch, Sara; Dennis, Joe; Tyrer, Jonathan; Pharoah, Paul; Easton, Douglas F.] Univ Cambridge, Strangeways Res Lab, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Al Olama, Ali Amin] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Berndt, Sonja I.; Albanes, Demetrius; Weinstein, Stephanie; Koutros, Stella; Freeman, Laura E. Beane; Finelli, Antonio; Rosenstein, Barry S.; Ostrer, Harry; Zhang, Hong-Wei; Gamulin, Marija; Hoover, Robert N.; Machiela, Mitchell J.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Benlloch, Sara; Ahmed, Mahbubl; Saunders, Edward J.; Dadaev, Tokhir; Leongamornlert, Daniel; Anokian, Ezequiel; Cieza-Borrella, Clara; Goh, Chee; Brook, Mark N.; Kote-Jarai, Zsofia; Eeles, Rosalind A.] Inst Canc Res, London, England; [Sheng, Xin; Ingles, Sue Ann; Stern, Mariana C.; Conti, David V.; Henderson, Brian E.; Haiman, Christopher A.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Fachal, Laura] Fdn Publ Galega Med Xenom SERGAS, CIBERER, Grp Med Xenom, IDIS, Santiago De Compostela, Spain; [Fachal, Laura; Pharoah, Paul; Pashayan, Nora; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Strangeways Lab, Cambridge, England; [Muir, Kenneth; Lophatananon, Artitaya] Univ Manchester, Div Populat Hlth, Hlth Serv Res & Primary Care, Manchester, Lancs, England; [Muir, Kenneth; Lophatananon, Artitaya] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Stevens, Victoria L.; Gapstur, Susan M.; Carter, Brian D.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Tangen, Catherine M.; Goodman, Phyllis J.] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Thompson, Ian M., Jr.] CHRISTUS Santa Rosa Hosp Med Ctr, San Antonio, TX USA; [Batra, Jyotsna; Moya, Leire; Clements, Judith] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Batra, Jyotsna; Moya, Leire; Clements, Judith] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Batra, Jyotsna; Moya, Leire; Clements, Judith] Australian Prostate Canc Res Ctr Qld, Translat Res Inst, Brisbane, Qld, Australia; [Chambers, Suzanne] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia; [Chambers, Suzanne] Canc Council Queensland, Fortitude Valley, Qld, Australia; [Horvath, Lisa] Chris OBrien Lifehouse COBLH, Camperdown, NSW, Australia; [Horvath, Lisa] Garvan Inst Med Res, Sydney, NSW, Australia; [Tilley, Wayne] Univ Adelaide, Dame Roma Mitchell Canc Res Ctr, Adelaide, SA, Australia; [Risbridger, Gail P.] Monash Univ, Dept Anat & Dev Biol, Prostate Canc Res Program, Monash Biomed Discovery Inst Canc Program, Clayton, Vic, Australia; [Risbridger, Gail P.] Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic, Australia; [Gronberg, Henrik; Nordstrom, Tobias; Eklund, Martin; Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Aly, Markus] Karolinska Univ Hosp, Dept Urol, Stockholm, Sweden; [Aly, Markus] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Nordstrom, Tobias] Karolinska Inst, Danderyds Hosp, Dept Clin Sci, Stockholm, Sweden; [Pashayan, Nora] UCL, Dept Appl Hlth Res, London, England; [Schleutker, Johanna; Sipeky, Csilla] Univ Turku, Inst Biomed, Turku, Finland; [Schleutker, Johanna] Turku Univ Hosp, Dept Med Genet, Tyks Microbiol & Genet, Turku, Finland; [Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Auvinen, Anssi] Univ Tampere, Sch Hlth Sci, Dept Epidemiol, Tampere, Finland; [Wolk, Alicja; Hakansson, Niclas] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, Stockholm, Sweden; [Wolk, Alicja] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [West, Catharine M. L.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Canc Res Ctr, Div Canc Sci, Manchester, Lancs, England; [West, Catharine M. L.] Univ Manchester, Christie NHS Fdn Trust, Manchester, Lancs, England; [Burnet, Neil] Univ Cambridge, Cambridge Univ Hosp NHS Fdn Trust, Ctr Oncol, Dept Oncol, Cambridge, England; [Mucci, Lorelei A.; Giovannucci, Edward] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Andriole, Gerald L.; Drake, Bettina F.] Washington Univ, Sch Med, St Louis, MO USA; [Cussenot, Olivier; Cancel-Tassin, Geraldine] UPMC, Sorbonne Univ, Tenon Hosp, GRC ONCOTYPE URO 5, Paris, France; [Cussenot, Olivier; Cancel-Tassin, Geraldine] Tenon Hosp, CeRePP, Paris, France; [Sorensen, Karina Dalsgaard; Orntoft, Torben Falck] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark; [Sorensen, Karina Dalsgaard; Orntoft, Torben Falck; Borre, Michael] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Borre, Michael] Aarhus Univ Hosp, Dept Urol, Aarhus, Denmark; [Maehle, Lovise; Grindedal, Eli Marie] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge, England; [Neal, David E.] Canc Res UK, Cambridge Res Inst, Cambridge, England; [Neal, David E.; Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Neal, David E.; Hamdy, Freddie C.] Univ Oxford, John Radcliffe Hosp, Fac Med Sci, Oxford, England; [Donovan, Jenny L.; Martin, Richard M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Travis, Ruth C.; Key, Tim J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Hamilton, Robert J.; Fleshner, Neil E.] Princess Margaret Canc Ctr, Dept Surg Oncol, Toronto, ON, Canada; [Finelli, Antonio] Princess Margaret Canc Ctr, Div Urol, Toronto, ON, Canada; [Rosenstein, Barry S.] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA; [Rosenstein, Barry S.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kerns, Sarah L.] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Ostrer, Harry] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Lu, Yong-Jie; Mao, Xueying] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Zhang, Hong-Wei] Second Mil Med Univ, Shanghai, Peoples R China; [Feng, Ninghan] Nanjing Med Univ, Wuxi Hosp 2, Wuxi, Peoples R China; [Guo, Xin] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China; [Wang, Guomin] Fudan Univ, Zhongshan Hosp, Dept Urol, Med Coll, Shanghai, Peoples R China; [Sun, Zan] China Med Univ, Peoples Hosp, Peoples Hosp Liaoning Prov, Shenyang, Peoples R China; [Giles, Graham G.; MacInnis, Robert J.; FitzGerald, Liesel M.] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic, Australia; [Giles, Graham G.; MacInnis, Robert J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostati, Melbourne, Vic, Australia; [Southey, Melissa C.] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic, Australia; [FitzGerald, Liesel M.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Kibel, Adam S.] Brigham & Womens Hosp, Div Urol Surg, 75 Francis St, Boston, MA 02115 USA; [Vega, Ana] Fdn Publ Galega Med Xenomica SERGAS, Grp Med Xenom, CIBERER, IDIS, Santiago De Compostela, Spain; [Gomez-Caamano, Antonio] SERGAS, Dept Radiat Oncol, Complexo Hosp Univ Santiago, Santiago De Compostela, Spain; [Szulkin, Robert] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med, Huddinge, Sweden; [Szulkin, Robert] Scandinavian Dev Serv, Danderyd, Sweden; [Kogevinas, Manolis; Castano-Vinyals, Gemma] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis; Llorca, Javier; Castano-Vinyals, Gemma] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Kogevinas, Manolis; Castano-Vinyals, Gemma] Hosp del Mar, Res Inst, IMIM, Barcelona, Spain; [Kogevinas, Manolis; Castano-Vinyals, Gemma] Univ Pompeu Fabra, Barcelona, Spain; [Llorca, Javier] Univ Cantabria, IDIVAL, Santander, Spain; [Penney, Kathryn L.; Stampfer, Meir; Ma, Jing] Brigham & Womens Hosp, Dept Med, Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Penney, Kathryn L.; Stampfer, Meir; Ma, Jing] Harvard Med Sch, Boston, MA USA; [Park, Jong Y.; Sellers, Thomas A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Lin, Hui-Yi] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA USA; [Stanford, Janet L.; Geybels, Milan S.; Lin, Daniel W.; Newcomb, Lisa F.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Cybulski, Cezary; Wokolorczyk, Dominika; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Ostrander, Elaine A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Nordestgaard, Borge G.; Nielsen, Sune F.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nordestgaard, Borge G.; Nielsen, Sune F.; Weischer, Maren] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark; [Bisbjerg, Rasmus] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Urol, Herlev, Denmark; [Roder, Martin Andreas; Iversen, Peter] Copenhagen Univ Hosp, Rigshosp, Dept Urol, Copenhagen Prostate Canc Ctr, Copenhagen, Denmark; [Brenner, Hermann; Cuk, Katarina] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Maier, Christiane; Luedeke, Manuel] Univ Hosp Ulm, Inst Human Genet, Ulm, Germany; [Schnoeller, Thomas] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Kim, Jeri; Logothetis, Christopher J.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA USA; [Teixeira, Manuel R.; Paulo, Paula; Cardoso, Marta] Portuguese Oncol Inst Porto, Dept Genet, Porto, Portugal; [Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, Porto, Portugal; [Neuhausen, Susan L.; Steele, Linda; Ding, Yuan Chun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [De Ruyck, Kim; De Meerleer, Gert] Univ Ghent, Fac Med & Hlth Sci, Basic Med Sci, Ghent, Belgium; [Ost, Piet] Ghent Univ Hosp, Dept Radiotherapy, Ghent, Belgium; [Razack, Azad; Lim, Jasmine] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia; [Teo, Soo-Hwang] Subang Jaya Med Ctr, Outpatient Ctr, CRM, Selangor, Malaysia; [Lin, Daniel W.; Newcomb, Lisa F.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Lessel, Davor] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Gamulin, Marija] Univ Hosp Ctr Zagreb, Div Med Oncol, Urogenital Unit, Dept Oncol, Zagreb, Croatia; [Kulis, Tomislav] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Urol, Zagreb, Croatia; [Kaneva, Radka; Mitev, Vanio] Med Univ Sofia, Dept Med Chem & Biochem, Mol Med Ctr, Sofia, Bulgaria; [Usmani, Nawaid; Singhal, Sandeep; Parliament, Matthew] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada; [Usmani, Nawaid; Singhal, Sandeep; Parliament, Matthew] Cross Canc Inst, Div Radiat Oncol, Edmonton, AB, Canada; [Slavov, Chavdar] Med Univ Sofia, Dept Urol, Sofia, Bulgaria; [Slavov, Chavdar] Med Univ Sofia, Alexandrovska Univ Hosp, Sofia, Bulgaria; [Claessens, Frank; Van den Broeck, Thomas] Katholieke Univ Leuven, Dept Cellular & Mol Med, Mol Endocrinol Lab, Leuven, Belgium; [Joniau, Steven; Van den Broeck, Thomas] Univ Hosp Leuven, Dept Urol, Leuven, Belgium; [Larkin, Samantha] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England; [Townsend, Paul A.] Univ Manchester, Div Canc Sci,Hlth Innovat Manchester, Manchester Canc Res Ctr,NIHR Manchester Biomed Re, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Aukim-Hastie, Claire; Pandha, Hardev; Michael, Agnieszka] Univ Surrey, Guildford, Surrey, England; [Dominguez, Manuela Gago] Galician Fdn Genom Med, Genom Med Grp,SERGAS, Inst Invest Sanitaria Santiago de Compostela IDIS, Complejo Hosp Univ Santiago,Serv Galego Saude, Santiago De Compostela, Spain; [Dominguez, Manuela Gago] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Castelao, Jose Esteban] Complexo Hosp Univ Vigo, Inst Invest Biomed Galicia IISGS, CHUVI Hosp, Genet Oncol Unit, Vigo, Spain; [Martinez, Maria Elena] Univ Calif San Diego, Moores Canc Ctr, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Roobol, Monique J.; Jenster, Guido] Erasmus Univ, Med Ctr, Dept Urol, Rotterdam, Netherlands; [van Schaik, Ron H. N.] Erasmus Univ, Med Ctr, Dept Clin Chem, Rotterdam, Netherlands; [Menegaux, Florence; Truong, Therese; Koudou, Yves Akoli] Univ Paris Saclay, Univ Paris Sud, INSERM, Canc & Environm Grp,Ctr Res Epidemiol & Populat H, Villejuif, France; [Xu, Jianfeng] NorthShore Univ HealthSyst, Program Personalized Canc Care, Evanston, IL USA; [Khaw, Kay-Tee] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Cannon-Albright, Lisa] Univ Utah, Sch Med, Dept Med, Div Genet Epidemiol, Salt Lake City, UT USA; [Cannon-Albright, Lisa] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Thibodeau, Stephen N.; Schaid, Daniel J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [McDonnell, Shannon K.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Lindstrom, Sara] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Turman, Constance; Hunter, David J.; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA USA; [Riboli, Elio] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Siddiq, Afshan] Queen Mary Univ London, Genom England, London, England; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Epidemiol Program, Honolulu, HI 96822 USA; Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH USA; Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH USA; [Genetic Assoc Mech Oncology GAME-] Geisel Sch Med, Norris Cotton Canc Ctr, Lebanon, NH USA; [Schumacher, Fredrick R.; Al Olama, Ali Amin; Berndt, Sonja I.; Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, London, England		Schumacher, FR (corresponding author), Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA.; Schumacher, FR (corresponding author), Univ Hosp, Seidman Canc Ctr, Cleveland, OH USA.; Al Olama, AA (corresponding author), Univ Cambridge, Strangeways Res Lab, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England.; Al Olama, AA (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.; Eeles, RA (corresponding author), Inst Canc Res, London, England.; Schumacher, FR; Al Olama, AA; Eeles, RA (corresponding author), Royal Marsden NHS Fdn Trust, London, England.	frs2@case.edu; aa461@medschl.cam.ac.uk; ros.eeles@icr.ac.uk	van Schaik, Ron H.N./G-6816-2013; Menegaux, Florence/H-4261-2018; Feng, Ninghan/ABA-8996-2021; Townsend, Paul/AAF-8234-2020; Pharoah, Paul/V-6658-2019; Auvinen, Anssi/AAD-9311-2020; Kaneva, Radka P/V-6535-2017; Auvinen, Anssi/AAL-2111-2020; Brenner, Hermann/B-4627-2017; Nordestgaard, Borge Gronne/ABF-1310-2020; Brenner, Hermann/ABE-6383-2020; Kulis, Tomislav/AAF-5565-2020; Risbridger, Gail P/B-8655-2008; Razack, Azad HA/B-8152-2009; Chambers, Suzanne K/H-5957-2012; Machiela, Mitchell J/H-7335-2019; Castano-Vinyals, Gemma/N-3885-2019; JASMINE, LIM/F-7404-2015; Feng, ninghan/ABB-3726-2021; Vega, Ana/R-4758-2019; Joniau, Steven/K-7655-2013; Lessel, Davor/ABD-6088-2021; Kogevinas, Manolis/C-3918-2017; Khaw, Kay-Tee/AAZ-3209-2021; Schumacher, Fredrick/R-6043-2019; truong, therese/A-2837-2013; Weinstein, Stephanie J/P-1627-2017; Koutros, Stella/W-5788-2019; Kaneva, Radka/AAT-5322-2021; Llorca, Javier/F-7371-2011; Burnet, Neil/L-1025-2019; Gago-Dominguez, Manuela/AAP-6611-2021; Castano-Vinyals, Gemma/H-7021-2017; Drake, Bettina/O-2072-2019; Fachal, Laura/N-5560-2014; Teixeira, Manuel/E-4885-2011; Teo, Soo-hwang/H-2353-2014; Roder, M. Andreas/H-7701-2019; /F-1441-2016; West, Catharine/J-4152-2012; Claessens, Frank/M-8565-2016	Menegaux, Florence/0000-0003-3363-6411; Pharoah, Paul/0000-0001-8494-732X; Kaneva, Radka P/0000-0002-1437-1393; Auvinen, Anssi/0000-0003-1125-4818; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Risbridger, Gail P/0000-0003-3089-4028; Razack, Azad HA/0000-0002-4237-6511; Chambers, Suzanne K/0000-0003-2369-6111; Machiela, Mitchell J/0000-0001-6538-9705; Castano-Vinyals, Gemma/0000-0003-4468-1816; JASMINE, LIM/0000-0002-7501-1834; Joniau, Steven/0000-0003-3195-9890; Kogevinas, Manolis/0000-0002-9605-0461; Schumacher, Fredrick/0000-0002-3073-7463; truong, therese/0000-0002-2943-6786; Weinstein, Stephanie J/0000-0002-3834-1535; Koutros, Stella/0000-0001-5294-5485; Llorca, Javier/0000-0001-8569-861X; Castano-Vinyals, Gemma/0000-0003-4468-1816; Drake, Bettina/0000-0001-9340-5848; Fachal, Laura/0000-0002-7256-9752; Teixeira, Manuel/0000-0002-4896-5982; Roder, M. Andreas/0000-0002-0019-5333; Eeles, Rosalind/0000-0002-3698-6241; /0000-0001-8387-2127; Mitev, Vanyo/0000-0001-7528-590X; Lin, Hui-Yi/0000-0002-3307-5549; Brook, Mark/0000-0002-8969-2378; Cieza-Borrella, Clara/0000-0003-2739-1040; Riboli, Elio/0000-0001-6795-6080; Saunders, Ed/0000-0003-4343-3570; McDonnell, Shannon/0000-0001-6201-369X; Townsend, Paul/0000-0001-8956-9508; Horvath, Lisa/0000-0001-6842-9223; De Ruyck, Kim/0000-0001-9921-644X; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Siddiq, Afshan/0000-0002-9110-1434; Hamdy, Freddie/0000-0003-2627-2154; cussenot, olivier/0000-0002-9912-0533; batra, Jyotsna/0000-0003-4646-6247; Southey, Melissa/0000-0002-6313-9005; Kraft, Peter/0000-0002-4472-8103; Tilley, Wayne/0000-0003-1893-2626; Lubinski, Jan/0000-0003-2931-3003; Michael, Agnieszka/0000-0002-7262-6227; Carter, Brian/0000-0003-1166-6521; BURNET, NEIL/0000-0001-9692-706X; Cardoso, Marta/0000-0002-3633-1659; Borre, Michael/0000-0002-1519-9185; Martin, Richard/0000-0002-7992-7719; Canzian, Federico/0000-0002-4261-4583; Pashayan, Nora/0000-0003-0843-2468; Schleutker, Johanna/0000-0002-1863-0305; Gomez-Caamano, Antonio/0000-0002-9773-4590; Sorensen, Karina Dalsgaard/0000-0002-4902-5490; West, Catharine/0000-0002-0839-3449; Lessel, Davor/0000-0003-4496-244X; Claessens, Frank/0000-0002-8676-7709	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U19 CA 148537, X01HG007492, HHSN268201200008I]; NIH NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01 CA188392]; European Community's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175)]; Cancer Research UKCancer Research UK [C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565, C5047/A7357, C1287/A16563, C5047/A3354, C16913/A6135]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA128978]; Post-Cancer GWAS Initiative [1U19 CA148537, 1U19 CA148065, 1U19 CA148112]; Department of DefenseUnited States Department of Defense [W81XWH-10-1-0341]; Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure; Breast Cancer Research Foundation; Ovarian Cancer Research Fund; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); European Commission's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175)]; NIH Cancer Post-Cancer GWAS initiativeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 U19 CA 148537-01]; Institute of Cancer Research; Everyman Campaign; Prostate Cancer Research Foundation; Prostate Research Campaign UK (now Prostate Action); Orchid Cancer Appeal; National Cancer Research Network UK; National Cancer Research Institute (NCRI) UK; NIHRNational Institute for Health Research (NIHR); Royal Marsden NHS Foundation TrustRoyal Society of New ZealandMarsden Fund (NZ); National Health and Medical Research Council, AustraliaNational Health and Medical Research Council of Australia [126402, 209057, 251533, 396414, 450104, 504700, 504702, 504715, 623204, 940394, 614296]; VicHealth; Cancer Council VictoriaCanadian Institutes of Health Research (CIHR)Cancer Council Victoria; Prostate Cancer Foundation of Australia; Whitten Foundation, PricewaterhouseCoopers; Tattersall's; Intramural Program of the National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01-CA98233, U01-CA98710, U01-CA98216, U01-CA98758]; Swedish Cancer Foundation [09-0677, 11484, 12-823]; Cancer Risk Prediction Center (CRisP); Linneus Centre grant - Swedish Research Council [ID 70867902]; wedish Research CouncilSwedish Research Council Formas [K2010 70X-20430-04-3, 2014-2269]; Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH; Cancer Research UKCancer Research UK [16565, 21332, 16491, 16561, 14136, 15007, 19169, 10118, 17528] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1000143, G0401527, MR/N003284/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0510-10096, NF-SI-0512-10114, NF-SI-0509-10242, NF-SI-0513-10121] Funding Source: researchfish; The Danish Cancer SocietyDanish Cancer Society [R130-A8313, R130-A8338] Funding Source: researchfish; The Francis Crick Institute [10119] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N003284/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [UG1CA189974, UM1CA182883, K05CA175147, U01CA188392, ZIACP010152, K07CA187546] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [ZIAHG200325] Funding Source: NIH RePORTER	We pay tribute to Brian Henderson for his vision and leadership; he was a driving force behind the OncoArray project and he unfortunately passed away before seeing its fruition. We also thank the individuals who participated in these studies enabling this work.r Genotyping of the OncoArray was funded by the US National Institutes of Health (NIH) (U19 CA 148537 for the ELLIPSE project and X01HG007492 to the Center for Inherited Disease Research (CIDR) under contract no. HHSN268201200008I. Additional analytical support was provided by NIH NCI U01 CA188392 (to F.A.S.).r Funding for the iCOGS infrastructure came from the European Community's Seventh Framework Programme under grant agreement no. 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, and C8197/A16565), the NIH (CA128978) and Post-Cancer GWAS Initiative (1U19 CA148537, 1U19 CA148065, and 1U19 CA148112; the GAME-ON initiative), the Department of Defense (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund.r This work was supported by the Canadian Institutes of Health Research; the European Commission's Seventh Framework Programme grant agreement no. 223175 (HEALTH-F2-2009-223175); Cancer Research UK grants C5047/A7357, C1287/A10118, C1287/A16563, C5047/A3354, C5047/A10692, and C16913/A6135; and NIH Cancer Post-Cancer GWAS initiative grant no. 1 U19 CA 148537-01 (the GAME-ON initiative).r We also thank the following for funding support: the Institute of Cancer Research and the Everyman Campaign, the Prostate Cancer Research Foundation, Prostate Research Campaign UK (now Prostate Action), the Orchid Cancer Appeal, the National Cancer Research Network UK, and the National Cancer Research Institute (NCRI) UK. We are grateful for the support of NIHR funding to the NIHR Biomedical Research Centre at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust.r The Prostate Cancer Program of Cancer Council Victoria also acknowledges grant support from the National Health and Medical Research Council, Australia (126402, 209057, 251533, 396414, 450104, 504700, 504702, 504715, 623204, 940394, and 614296), VicHealth, Cancer Council Victoria, the Prostate Cancer Foundation of Australia, the Whitten Foundation, PricewaterhouseCoopers, and Tattersall's. E.A.O., D.M.K., and E.M.K. acknowledge the Intramural Program of the National Human Genome Research Institute for support.r The BPC3 was supported by the NIH, National Cancer Institute (cooperative agreements U01-CA98233 to D.J.H., U01-CA98710 to S.M.G., U01-CA98216 to E.R., and U01-CA98758 to B.E.H., and the Intramural Research Program of the NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics).r The CAPS GWAS study was supported by the Swedish Cancer Foundation (grant nos. 09-0677, 11484, and 12-823), the Cancer Risk Prediction Center (CRisP; http://ki.se/en/meb/crisp/), a Linneus Centre grant (contract ID 70867902) financed by the Swedish Research Council, and the Swedish Research Council (grant nos. K2010 70X-20430-04-3, and 2014-2269).r PEGASUS was supported by the Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH.r A full description of funding and acknowledgements can be found in the Supplementary Note.	Al Olama AA, 2015, CANCER EPIDEM BIOMAR, V24, P1121, DOI 10.1158/1055-9965.EPI-14-0317; Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Al Olama AA, 2013, HUM MOL GENET, V22, P408, DOI 10.1093/hmg/dds425; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Albright F, 2015, PROSTATE, V75, P390, DOI 10.1002/pros.22925; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Altekruse SF, 2010, CANCER EPIDEM BIOMAR, V19, P1460, DOI 10.1158/1055-9965.EPI-09-1310; Amos CI, 2017, CANCER EPIDEM BIOMAR, V26, P126, DOI 10.1158/1055-9965.EPI-16-0106; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basta J, 2015, TRANSL RES, V165, P36, DOI 10.1016/j.trsl.2014.05.003; Bunker CH, 2002, CANCER EPIDEM BIOMAR, V11, P726; Cuzick J, 2014, LANCET ONCOL, V15, pE484, DOI 10.1016/S1470-2045(14)70211-6; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles R, 2014, NAT REV UROL, V11, P18, DOI 10.1038/nrurol.2013.266; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Ghadirian P, 1997, INT J CANCER, V70, P679, DOI 10.1002/(SICI)1097-0215(19970317)70:6<679::AID-IJC9>3.3.CO;2-3; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kicinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027130; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Kudo T, 2012, CANCER RES, V72, P2901, DOI 10.1158/0008-5472.CAN-12-0572; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Leongamornlert D, 2014, BRIT J CANCER, V110, P1663, DOI 10.1038/bjc.2014.30; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Matikainen MP, 2001, CANCER CAUSE CONTROL, V12, P223, DOI 10.1023/A:1011283123610; McDermott DF, 2013, CANCER MED-US, V2, P662, DOI 10.1002/cam4.106; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Meyer A, 2007, RADIOTHER ONCOL, V83, P283, DOI 10.1016/j.radonc.2007.04.029; Romero P, 2005, GENOME BIOL, V6; Sanchez-Huertas C, 2015, CURR BIOL, V25, pR294, DOI 10.1016/j.cub.2015.02.006; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Stanford JL, 2001, EPIDEMIOL REV, V23, P19, DOI 10.1093/oxfordjournals.epirev.a000789; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang ML, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9469; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yee DS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-162; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001	64	259	262	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2018	50	7					928	+		10.1038/s41588-018-0142-8			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GL5QU	WOS:000437224400007	29892016	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Lozupone, CA; Stombaugh, J; Gonzalez, A; Ackermann, G; Wendel, D; Vazquez-Baeza, Y; Jansson, JK; Gordon, JI; Knight, R				Lozupone, Catherine A.; Stombaugh, Jesse; Gonzalez, Antonio; Ackermann, Gail; Wendel, Doug; Vazquez-Baeza, Yoshiki; Jansson, Janet K.; Gordon, Jeffrey I.; Knight, Rob			Meta-analyses of studies of the human microbiota	GENOME RESEARCH			English	Article							HUMAN GUT MICROBIOME; INTESTINAL MICROBIOTA; BODY HABITATS; DIVERSITY; TWINS; DISEASE; ENTEROTYPES; PATTERNS; BACTERIA; DELIVERY	Our body habitat-associated microbial communities are of intense research interest because of their influence on human health. Because many studies of the microbiota are based on the same bacterial 16S ribosomal RNA (rRNA) gene target, they can, in principle, be compared to determine the relative importance of different disease/physiologic/developmental states. However, differences in experimental protocols used may produce variation that outweighs biological differences. By comparing 16S rRNA gene sequences generated from diverse studies of the human microbiota using the QIIME database, we found that variation in composition of the microbiota across different body sites was consistently larger than technical variability across studies. However, samples from different studies of the Western adult fecal microbiota generally clustered by study, and the 16S rRNA target region, DNA extraction technique, and sequencing platform produced systematic biases in observed diversity that could obscure biologically meaningful compositional differences. In contrast, systematic compositional differences in the fecal microbiota that occurred with age and between Western and more agrarian cultures were great enough to outweigh technical variation. Furthermore, individuals with ileal Crohn's disease and in their third trimester of pregnancy often resembled infants from different studies more than controls from the same study, indicating parallel compositional attributes of these distinct developmental/physiological/disease states. Together, these results show that cross-study comparisons of human microbiota are valuable when the studied parameter has a large effect size, but studies of more subtle effects on the human microbiota require carefully selected control populations and standardized protocols.	[Lozupone, Catherine A.] Univ Colorado, Div Biomed Informat & Personalized Med, Dept Med, Aurora, CO 80045 USA; [Stombaugh, Jesse; Gonzalez, Antonio; Ackermann, Gail; Wendel, Doug; Vazquez-Baeza, Yoshiki; Knight, Rob] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA		Knight, R (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.	rob.knight@colorado.edu	Jansson, Janet/H-5478-2018; Knight, Rob/D-1299-2010; Gonzalez, Antonio/A-6421-2018; Lozupone, Catherine/AAD-9317-2020	Jansson, Janet/0000-0002-5487-4315; Stombaugh, Jesse/0000-0001-9631-0748; Knight, Rob/0000-0002-0975-9019	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01DK090285]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Crohns and Colitis Foundation of America; Howard Hughes Medical InstituteHoward Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K01DK090285] Funding Source: NIH RePORTER	C.L. was supported by the National Institutes of Health (K01DK090285). This work was supported in part by the National Institutes of Health, the Crohns and Colitis Foundation of America, and the Howard Hughes Medical Institute.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; BOVE JM, 1993, CLIN INFECT DIS, V17, pS10, DOI 10.1093/clinids/17.Supplement_1.S10; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; O'Sullivan O, 2011, J APPL MICROBIOL, V111, P467, DOI 10.1111/j.1365-2672.2011.05067.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ratan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055089; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	49	259	268	2	150	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2013	23	10					1704	1714		10.1101/gr.151803.112			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	228QQ	WOS:000325202100012	23861384	hybrid, Green Published, Green Submitted			2022-01-24	
J	Wang, C; Li, YL; Shi, L; Ren, J; Patti, M; Wang, T; de Oliveira, JRM; Sobrido, MJ; Quintans, B; Baquero, M; Cui, XN; Zhang, XY; Wang, LQ; Xu, HB; Wang, JH; Yao, J; Dai, XH; Liu, J; Zhang, L; Ma, HY; Gao, Y; Ma, XX; Feng, SL; Liu, MG; Wang, QK; Forster, IC; Zhang, X; Liu, JY				Wang, Cheng; Li, Yulei; Shi, Lei; Ren, Jie; Patti, Monica; Wang, Tao; de Oliveira, Joao R. M.; Sobrido, Maria-Jesus; Quintans, Beatriz; Baquero, Miguel; Cui, Xiaoniu; Zhang, Xiang-Yang; Wang, Lianqing; Xu, Haibo; Wang, Junhan; Yao, Jing; Dai, Xiaohua; Liu, Juan; Zhang, Lu; Ma, Hongying; Gao, Yong; Ma, Xixiang; Feng, Shenglei; Liu, Mugen; Wang, Qing K.; Forster, Ian C.; Zhang, Xue; Liu, Jing-Yu			Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis	NATURE GENETICS			English	Article							TRANSPORT; DISEASE; IDENTIFICATION; BRAIN	Familial idiopathic basal ganglia calcification (IBGC) is a genetic condition with a wide spectrum of neuropsychiatric symptoms, including parkinsonism and dementia. Here, we identified mutations in SLC20A2, encoding the type III sodium-dependent phosphate transporter 2 (PiT2), in IBGC-affected families of varied ancestry, and we observed significantly impaired phosphate transport activity for all assayed PiT2 mutants in Xenopus laevis oocytes. Our results implicate altered phosphate homeostasis in the etiology of IBGC.	[Wang, Cheng; Li, Yulei; Ren, Jie; Cui, Xiaoniu; Zhang, Xiang-Yang; Yao, Jing; Dai, Xiaohua; Liu, Juan; Zhang, Lu; Ma, Hongying; Gao, Yong; Ma, Xixiang; Feng, Shenglei; Liu, Mugen; Wang, Qing K.; Liu, Jing-Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Wang, Cheng; Li, Yulei; Ren, Jie; Cui, Xiaoniu; Zhang, Xiang-Yang; Yao, Jing; Dai, Xiaohua; Liu, Juan; Zhang, Lu; Ma, Hongying; Gao, Yong; Ma, Xixiang; Feng, Shenglei; Liu, Mugen; Wang, Qing K.; Liu, Jing-Yu] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Shi, Lei; Wang, Lianqing; Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, McKusick Zhang Ctr Genet Med, Beijing 100730, Peoples R China; [Shi, Lei; Wang, Lianqing; Zhang, Xue] Peking Union Med Coll, Beijing 100021, Peoples R China; [Patti, Monica; Forster, Ian C.] Univ Zurich, Inst Physiol, Zurich Ctr Integrated Human Physiol, Zurich, Switzerland; [de Oliveira, Joao R. M.] Univ Fed Pernambuco, Keizo Asami Lab, Dept Neuropsychiat, Recife, PE, Brazil; [Wang, Tao] Union Hosp HUST, Dept Neurol, Wuhan, Peoples R China; [Sobrido, Maria-Jesus; Quintans, Beatriz] Clin Hosp Santiago de Compostela, Fdn Publ Galega Med Xenom, Serv Galego Saude SERGAS, Santiago De Compostela, Spain; [Sobrido, Maria-Jesus; Quintans, Beatriz] Inst Hlth Carlos III, Ctr Network Res Rare Dis CIBERER, Barcelona, Spain; [Baquero, Miguel] Univ Valencia, Hosp Univ & Politecn La Fe, Serv Neurol, Dept Med, Valencia, Spain; [Xu, Haibo] Union Hosp HUST, Dept Radiol, Wuhan, Peoples R China; [Wang, Junhan] Hosp HUST, Dept Clin Lab, Wuhan, Peoples R China		Liu, JY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China.	xuezhang@pumc.edu.cn; liujy@mail.hust.edu.cn	Wang, Lianqing/AAX-5278-2020	Wang, Lianqing/0000-0002-7161-4718; Wang, Cheng/0000-0002-7822-259X; Forster, Ian/0000-0003-3087-9952	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670736, 30972655, 30730097, 31021091, 30871386]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT1006]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; John Simon Guggenheim Memorial Foundation; Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Institute of Health Carlos IIIInstituto de Salud Carlos III; FEDER fundsEuropean Commission	We would like to thank all the family members for their enthusiastic participation in the study. X. Z. would like to thank K. Hong, Q. Liu, Z. Wu, W. Xia, C. Zhang and L. Zou for clinical support. J. R. M. d. O. would like to thank R. Lemos and D. Oliveira for technical support. This study was mainly supported by the National Natural Science Foundation of China (30670736 and 30972655 to J.-Y. L. and 30730097 and 31021091 to X. Z.) and by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT; IRT1006 to X. Z.). I. C. F. is supported by the Swiss National Science Foundation. M. L. is supported by the National Natural Science Foundation of China (30871386). J. R. M. d. O. is supported by the John Simon Guggenheim Memorial Foundation and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico M.-J. S. and B. Q. are supported by research contracts from the Institute of Health Carlos III and by FEDER funds. The study was approved by the ethics committees of HUST and Peking Union Medical College. Written informed consent was obtained from all participants or their legal guardians.	Bottger P, 2002, J BIOL CHEM, V277, P42741, DOI 10.1074/jbc.M207096200; Dai XH, 2010, AM J MED GENET B, V153B, P1305, DOI 10.1002/ajmg.b.31102; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; Kendrick J, 2011, ADV CHRONIC KIDNEY D, V18, P113, DOI 10.1053/j.ackd.2010.12.003; Lagrue E, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-91; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; Oliveira JRM, 2004, NEUROLOGY, V63, P2165, DOI 10.1212/01.WNL.0000145601.88274.88; Prie D, 2010, NEW ENGL J MED, V362, P2399, DOI 10.1056/NEJMra0904186; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI 10.1056/NEJMoa0912923; Villa-Bellosta R, 2009, AM J PHYSIOL-RENAL, V296, pF691, DOI 10.1152/ajprenal.90623.2008; Wider C, 2009, J NEUROL, V256, P839, DOI 10.1007/s00415-009-5025-6	15	259	272	5	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					254	256		10.1038/ng.1077			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	WOS:000300843600008	22327515				2022-01-24	
J	Salzberg, SL; Sommer, DD; Schatz, MC; Phillippy, AM; Rabinowicz, PD; Tsuge, S; Furutani, A; Ochiai, H; Delcher, AL; Kelley, D; Madupu, R; Puiu, D; Radune, D; Shumway, M; Trapnell, C; Aparna, G; Jha, G; Pandey, A; Patil, PB; Ishihara, H; Meyer, DF; Szurek, B; Verdier, V; Koebnik, R; Dow, JM; Ryan, RP; Hirata, H; Tsuyumu, S; Lee, SW; Ronald, PC; Sonti, RV; Van Sluys, MA; Leach, JE; White, FF; Bogdanove, AJ				Salzberg, Steven L.; Sommer, Daniel D.; Schatz, Michael C.; Phillippy, Adam M.; Rabinowicz, Pablo D.; Tsuge, Seiji; Furutani, Ayako; Ochiai, Hirokazu; Delcher, Arthur L.; Kelley, David; Madupu, Ramana; Puiu, Daniela; Radune, Diana; Shumway, Martin; Trapnell, Cole; Aparna, Gudlur; Jha, Gopaljee; Pandey, Alok; Patil, Prabhu B.; Ishihara, Hiromichi; Meyer, Damien F.; Szurek, Boris; Verdier, Valerie; Koebnik, Ralf; Dow, J. Maxwell; Ryan, Robert P.; Hirata, Hisae; Tsuyumu, Shinji; Lee, Sang Won; Ronald, Pamela C.; Sonti, Ramesh V.; Van Sluys, Marie-Anne; Leach, Jan E.; White, Frank F.; Bogdanove, Adam J.			Genome sequence and rapid evolution of the rice pathogen Xanthomonas oryzae pv. oryzae PXO99(A)	BMC GENOMICS			English	Article							BACTERIAL-BLIGHT RESISTANCE; INSERTION SEQUENCES; DISEASE RESISTANCE; GENE; DIVERSITY; CAMPESTRIS; PATHOVARS; ALIGNMENT; ORIGIN	Background: Xanthomonas oryzae pv. oryzae causes bacterial blight of rice (Oryza sativa L.), a major disease that constrains production of this staple crop in many parts of the world. We report here on the complete genome sequence of strain PXO99(A) and its comparison to two previously sequenced strains, KACC10331 and MAFF311018, which are highly similar to one another. Results: The PXO99(A) genome is a single circular chromosome of 5,240,075 bp, considerably longer than the genomes of the other strains (4,941,439 bp and 4,940,217 bp, respectively), and it contains 5083 protein-coding genes, including 87 not found in KACC10331 or MAFF311018. PXO99(A) contains a greater number of virulence-associated transcription activator-like effector genes and has at least ten major chromosomal rearrangements relative to KACC10331 and MAFF311018. PXO99(A) contains numerous copies of diverse insertion sequence elements, members of which are associated with 7 out of 10 of the major rearrangements. A rapidly-evolving CRISPR (clustered regularly interspersed short palindromic repeats) region contains evidence of dozens of phage infections unique to the PXO99(A) lineage. PXO99(A) also contains a unique, near-perfect tandem repeat of 212 kilobases close to the replication terminus. Conclusion: Our results provide striking evidence of genome plasticity and rapid evolution within Xanthomonas oryzae pv. oryzae. The comparisons point to sources of genomic variation and candidates for strain-specific adaptations of this pathogen that help to explain the extraordinary diversity of Xanthomonas oryzae pv. oryzae genotypes and races that have been isolated from around the world.	[Salzberg, Steven L.; Sommer, Daniel D.; Schatz, Michael C.; Phillippy, Adam M.; Delcher, Arthur L.; Kelley, David; Puiu, Daniela; Trapnell, Cole] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Rabinowicz, Pablo D.; Madupu, Ramana; Radune, Diana; Shumway, Martin] Inst Genom Res, Rockville, MD 20850 USA; [Rabinowicz, Pablo D.] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA; [Tsuge, Seiji; Furutani, Ayako] Kyoto Prefectural Univ, Plant Pathol Lab, Sakyo Ku, Kyoto 6068522, Japan; [Furutani, Ayako; Ochiai, Hirokazu] Natl Inst Agrobiol Sci, Dept Genet Resources, Tsukuba, Ibaraki 3058602, Japan; [Aparna, Gudlur; Pandey, Alok; Patil, Prabhu B.; Sonti, Ramesh V.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Jha, Gopaljee; Leach, Jan E.] CSIR, Inst Himalayan Bioresource Technol, Palampur, Himachal Prades, India; [Ishihara, Hiromichi] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Trapnell, Cole; Meyer, Damien F.; Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol, Ames, IA USA; [Szurek, Boris; Verdier, Valerie; Koebnik, Ralf] Inst Rech Dev, F-34090 Montpellier, France; [Dow, J. Maxwell; Ryan, Robert P.; Tsuyumu, Shinji] Natl Univ Ireland Univ Coll Cork, BioSci Inst, BIOMERIT Res Ctr, Cork, Ireland; [Hirata, Hisae] Shizuoka Univ, Grad Sch Nat Sci & Technol, Suruga Ku, Shizuoka 4228017, Japan; [Lee, Sang Won; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Van Sluys, Marie-Anne] IB USP, Dept Bot, Sao Paulo, SP, Brazil; [White, Frank F.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA		Salzberg, SL (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	salzberg@umd.edu; dsommer@umiacs.umd.edu; mschatz@umiacs.umd.edu; amp@umiacs.umd.edu; prabinowicz@som.umaryland.edu; s_tsuge@kpu.ac.jp; a9920614@kpu.ac.jp; ochiaih@nias.affrc.go.jp; adelcher@umiacs.umd.edu; dakelley@umiacs.umd.edu; rmadupu@jcvi.org; dpuiu@umiacs.umd.edu; dbushman@jcvi.org; shumwaym@ncbi.nlm.nih.gov; cole@cs.umd.edu; aparna@ccmb.res.in; jmsgopal@yahoo.co.in; alok@ccmb.res.in; prabhubpatil@gmail.com; hiromichi.ishihara@colostate.edu; dfmeyer@iastate.edu; boris.szurek@mpl.ird.fr; valerie.verdier@mpl.ird.fr; koebnik@mpl.ird.fr; m.dow@ucc.ie; r.ryan@ucc.ie; hisaeh@agr.shizuoka.ac.jp; tsuyumu@agr.shizuoka.ac.jp; drlee@ucdavis.edu; pcronald@ucdavis.edu; sonti@ccmb.res.in; mavsluys2004@yahoo.com; jan.leach@colostate.edu; fwhite@ksu.edu; ajbog@iastate.edu	Sriariyanun, Malinee/B-6767-2016; MEYER, Damien F/G-2607-2013; Van Sluys, Marie-Anne/A-8483-2012; Patil, Prabhu/B-4070-2010; Jha, Gopaljee/Y-8411-2018; Bogdanove, Adam/ABE-6252-2020; Salzberg, Steven/Q-6514-2019; Koebnik, Ralf/J-5627-2014; Verdier, Valerie/K-1004-2016; Salzberg, Steven L/F-6162-2011; Schatz, Michael/L-2690-2019; Ronald, Pamela/AAK-7664-2020; Gudlur, Aparna/J-9646-2015; Phillippy, Adam M/U-5731-2018	Sriariyanun, Malinee/0000-0002-3088-9256; MEYER, Damien F/0000-0003-2735-176X; Van Sluys, Marie-Anne/0000-0002-6506-2734; Jha, Gopaljee/0000-0002-3965-3135; Salzberg, Steven/0000-0002-8859-7432; Koebnik, Ralf/0000-0002-4419-0542; Verdier, Valerie/0000-0001-5425-9454; Salzberg, Steven L/0000-0002-8859-7432; Schatz, Michael/0000-0002-4118-4446; Gudlur, Aparna/0000-0001-8753-183X; Phillippy, Adam M/0000-0003-2983-8934; Szurek, Boris/0000-0002-1808-7082; Dow, Max/0000-0001-8245-2294; Patil, Prabhu/0000-0003-2720-1059; Ryan, Rober/0000-0002-7353-0913; Pandey, Alok/0000-0001-5634-5911	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM006845] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM083873, R01 GM083873, R01 GM083873-05] Funding Source: Medline; NLM NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01 LM006845-09, R01 LM006845] Funding Source: Medline		Adhikari TB, 1999, PHYTOPATHOLOGY, V89, P687, DOI 10.1094/PHYTO.1999.89.8.687; ADHIKARI TB, 1995, APPL ENVIRON MICROB, V61, P966, DOI 10.1128/AEM.61.3.966-971.1995; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DEFEYTER R, 1993, MOL PLANT MICROBE IN, V6, P225, DOI 10.1094/MPMI-6-225; Eisen JA, 2000, GENOME BIOL, V1; Gagnevin L, 1997, APPL ENVIRON MICROB, V63, P246, DOI 10.1128/AEM.63.1.246-253.1997; Gu K, 2004, THEOR APPL GENET, V108, P800, DOI 10.1007/s00122-003-1491-x; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hayward A. C., 1993, Xanthomonas., P1; Iyer AS, 2004, MOL PLANT MICROBE IN, V17, P1348, DOI 10.1094/MPMI.2004.17.12.1348; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LEACH JE, 1990, MOL PLANT MICROBE IN, V3, P238, DOI 10.1094/MPMI-3-238; LEACH JE, 1995, CURR OPIN BIOTECH, V6, P298, DOI 10.1016/0958-1669(95)80051-4; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; MEW TW, 1992, PLANT DIS, V76, P1029, DOI 10.1094/PD-76-1029; Monteiro-Vitorello CB, 2005, OMICS, V9, P146, DOI 10.1089/omi.2005.9.146; *NCBI, NCBI TRAC ARCH; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; Ou S. H, 1985, RICE DIS, P380; Ronald P, 2002, SCIENCE, V296, P58, DOI 10.1126/science.1071337; Salzberg SL, 2004, PLOS BIOL, V2, P1273, DOI 10.1371/journal.pbio.0020285; Salzberg SL, 1998, GENE, V217, P57, DOI 10.1016/S0378-1119(98)00374-6; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; ZHANG Q, 2007, GENETICS IMPROVEMENT, P377	39	259	580	3	70	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAY 1	2008	9								204	10.1186/1471-2164-9-204			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	315ZN	WOS:000256918800001	18452608	gold, Green Published, Green Accepted			2022-01-24	
J	Foll, M; Gaggiotti, O				Foll, Matthieu; Gaggiotti, Oscar			Identifying the environmental factors that determine the genetic structure of Populations	GENETICS			English	Article							DNA-SEQUENCE VARIATION; PARTIAL MANTEL TESTS; DIVERSITY; DIFFERENTIATION; INFERENCE; PATTERNS; PROGRAM; ORIGIN; REGION; LOCI	The study of population genetic structure is a fundamental problem in population biology because it helps us obtain a deeper understanding of the evolutionary process. One of the issues most assiduously studied in this context is the assessment of the relative importance of environmental factors (geographic distance, language, temperature, altitude, etc.) on the genetic structure of populations. The most widely used method to address this question is the multivariate Mantel test, a nonparametric method that calculates a correlation coefficient between a dependent matrix of pairwise population genetic distances and one or more independent matrices of environmental differences. Here we present a hierarchical Bayesian method that estimates F-ST values for each local population and relates them to environmental factors using a generalized linear model. The method is demonstrated by applying it to two data sets, a data set for a population of the argan tree and a human data set comprising 51 populations distributed worldwide. We also carry out a simulation study to investigate the performance of the method and find that it can correctly identify the factors that play a role in the structuring of genetic diversity under a wide range of scenarios.	CNRS, Lab Ecol Alpine, LECA, UMR 5553, F-38041 Grenoble 09, France		Gaggiotti, O (corresponding author), CNRS, Lab Ecol Alpine, LECA, UMR 5553, BP 53, F-38041 Grenoble 09, France.	oscar.gaggiotti@ujf-grenoble.fr	Gaggiotti, Oscar E/G-2459-2010; Foll, Matthieu/A-8561-2014	Gaggiotti, Oscar E/0000-0003-1827-1493; Foll, Matthieu/0000-0001-9006-8436			Amos W, 2006, P NATL ACAD SCI USA, V103, P820, DOI 10.1073/pnas.0507991103; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; Balding DJ, 2002, J R STAT SOC B, V64, P737; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Brooks SP, 2003, J R STAT SOC B, V65, P3, DOI 10.1111/1467-9868.03711; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; CHEVERUD JM, 1989, SYST ZOOL, V38, P201, DOI 10.2307/2992282; Currat M, 2004, MOL ECOL NOTES, V4, P139, DOI 10.1046/j.1471-8286.2003.00582.x; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; EXCOFFIER L, 2001, HDB STAT GENETICS, P00271, DOI DOI 10.1002/9780470061619CH29; Falush D, 2003, GENETICS, V164, P1567; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gaggiotti OE, 2004, MOL ECOL, V13, P811, DOI 10.1046/j.1365-294X.2003.02028.x; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Holsinger KE, 1999, HEREDITAS, V130, P245, DOI 10.1111/j.1601-5223.1999.00245.x; Hunley K, 2005, P NATL ACAD SCI USA, V102, P1312, DOI 10.1073/pnas.0409301102; Legendre P, 2000, J STAT COMPUT SIM, V67, P37, DOI 10.1080/00949650008812035; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.1890/0012-9658(2002)083[1131:SCMISE]2.0.CO;2; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; PIAZZA A, 1981, P NATL ACAD SCI-BIOL, V78, P2638, DOI 10.1073/pnas.78.4.2638; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; Rousset F, 2002, EVOLUTION, V56, P1874; Smit J, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-4; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SOKAL RR, 1992, P NATL ACAD SCI USA, V89, P7669, DOI 10.1073/pnas.89.16.7669; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197; [No title captured]	36	259	264	1	70	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2006	174	2					875	891		10.1534/genetics.106.059451			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	102GJ	WOS:000241798700027	16951078	Bronze, Green Published			2022-01-24	
J	Calvo, S; Jain, M; Xie, XH; Sheth, SA; Chang, B; Goldberger, OA; Spinazzola, A; Zeviani, M; Carr, SA; Mootha, VK				Calvo, S; Jain, M; Xie, XH; Sheth, SA; Chang, B; Goldberger, OA; Spinazzola, A; Zeviani, M; Carr, SA; Mootha, VK			Systematic identification of human mitochondrial disease genes through integrative genomics	NATURE GENETICS			English	Article							RESPIRATORY-CHAIN DISORDERS; HETEROGENEITY; PROTEINS; SEQUENCE; LOCUS; PROTEOME; DATABASE; MUSCLE; MOUSE	The majority of inherited mitochondrial disorders are due to mutations not in the mitochondrial genome ( mtDNA) but rather in the nuclear genes encoding proteins targeted to this organelle. Elucidation of the molecular basis for these disorders is limited because only half(1,2) of the estimated 1,500 mitochondrial proteins(3) have been identified. To systematically expand this catalog, we experimentally and computationally generated eight genome-scale data sets, each designed to provide clues as to mitochondrial localization: targeting sequence prediction, protein domain enrichment, presence of cis-regulatory motifs, yeast homology, ancestry, tandem-mass spectrometry, coexpression and transcriptional induction during mitochondrial biogenesis. Through an integrated analysis we expand the collection to 1,080 genes, which includes 368 novel predictions with a 10% estimated false prediction rate. By combining this expanded inventory with genetic intervals linked to disease, we have identified candidate genes for eight mitochondrial disorders, leading to the discovery of mutations in MPV17 that result in hepatic mtDNA depletion syndrome(4). The integrative approach promises to better define the role of mitochondria in both rare and common human diseases.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02446 USA; Natl Neurol Inst C Besta, Unite Mol Neurogenet, I-20126 Milan, Italy		Mootha, VK (corresponding author), MIT, Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	vamsi@hms.harvard.edu	Zeviani, Massimo/AAU-2632-2021; Carr, Steven A./AAH-8366-2019; Zeviani, Massimo/K-2891-2014; Spinazzola, Antonella/P-5791-2019; Spinazzola, Antonella/P-5298-2017	Zeviani, Massimo/0000-0002-9067-5508; Spinazzola, Antonella/0000-0003-4242-8091; Spinazzola, Antonella/0000-0003-4242-8091; Xie, Xiaohui/0000-0002-5479-6345			Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Basel-Vanagaite L, 2004, NEUROLOGY, V62, P87, DOI 10.1212/01.WNL.0000101680.49036.69; Christodoulou K, 2001, NEUROGENETICS, V3, P127, DOI 10.1007/s100480100112; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Rotig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Seyda A, 2001, AM J HUM GENET, V68, P386, DOI 10.1086/318196; Shoubridge EA, 2001, SEMIN NEUROL, V21, P261, DOI 10.1055/s-2001-17943; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Steinmuller R, 1998, EUR J HUM GENET, V6, P201, DOI 10.1038/sj.ejhg.5200180; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Zeviani Massimo, 2004, Suppl Clin Neurophysiol, V57, P304; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	30	259	267	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					576	582		10.1038/ng1776			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	WOS:000237147500021	16582907				2022-01-24	
J	Schmidt, S; Hauser, MA; Scott, WK; Postel, EA; Agarwal, A; Gallins, P; Wong, F; Chen, YS; Spencer, K; Schnetz-Boutaud, N; Haines, JL; Pericak-Vance, MA				Schmidt, S; Hauser, MA; Scott, WK; Postel, EA; Agarwal, A; Gallins, P; Wong, F; Chen, YS; Spencer, K; Schnetz-Boutaud, N; Haines, JL; Pericak-Vance, MA			Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; GENETIC ASSOCIATION; GENOMEWIDE-SCAN; CHOROIDAL NEOVASCULARIZATION; LINKAGE DISEQUILIBRIUM; GEOGRAPHIC ATROPHY; PARENTAL GENOTYPES; EXTENDED FAMILIES; CHROMOSOME 10Q26; GRADING SYSTEM	We used iterative association mapping to identify a susceptibility gene for age-related macular degeneration (AMD) on chromosome 10q26, which is one of the most consistently implicated linkage regions for this disorder. We employed linkage analysis methods, followed by family-based and case-control association analyses, using two independent data sets. To identify statistically the most likely AMD-susceptibility allele, we used the Genotype-IBD Sharing Test (GIST) and conditional haplotype analysis. To incorporate the two most important known AMD risk factors-smoking and the Y402H variant of the complement factor H gene (CFH) - we used logistic regression modeling to test for gene-gene and gene-environment interactions in the case-control data set and used the ordered-subset analysis to account for genetic linkage heterogeneity in the family-based data set. Our results strongly implicate a coding change (Ala69Ser) in the LOC387715 gene as the second major identified AMD-susceptibility allele, confirming earlier suggestions. This variant's effect on AMD is statistically independent of CFH and is of similar magnitude to the effect of Y402H. The overall effect is driven primarily by a strong association in smokers, since we observed significant evidence for a statistical interaction between the LOC387715 variant and a history of cigarette smoking. This gene-environment interaction is supported by statistically independent family-based and case-control analysis methods. We estimate that CFH, LOC387715, and cigarette smoking together explain 61% of the population-attributable risk (PAR) of AMD. The adjusted PAR percentage estimates are 20% for smoking, 36% for LOC387715, and 43% for CFH. We demonstrate, for the first time, that a genetic susceptibility coupled with a modifiable lifestyle factor such as cigarette smoking confers a significantly higher risk of AMD than either factor alone.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Eye Ctr, Durham, NC 27710 USA; Vanderbilt Univ, Med Ctr, Dept Ophthalmol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA		Schmidt, S (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA.	silke.schmidt@duke.edu	Haines, Jonathan/C-3374-2012; Scott, William/A-7593-2009	Haines, Jonathan/0000-0002-4351-4728; Scott, William/0000-0001-9336-6404	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR 00095, M01 RR000095] Funding Source: Medline; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY015216, U10 EY012118, R03 EY015216, R01 EY012118, EY12118] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG11268, P60 AG011268] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000095] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012118, R03EY015216, U10EY012118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P60AG011268] Funding Source: NIH RePORTER		Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kenealy SJ, 2004, MOL VIS, V10, P57; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klaver CCW, 2001, INVEST OPHTH VIS SCI, V42, P2237; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Martin ER, 2003, AM J HUM GENET, V73, P1016, DOI 10.1086/378779; North BV, 2005, HUM HERED, V59, P79, DOI 10.1159/000085222; Oliveira SA, 2005, AM J HUM GENET, V77, P252, DOI 10.1086/432588; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; SCHMIDT M, 2005, STAT APPL GENET MOL, P4; Schmidt S, 2000, MOL VIS, V6, P287; SCOTT WK, 2005, AM SOC HUM GEN 55 AN; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Xu H, 2005, BIOINFORMATICS, V21, P4181, DOI 10.1093/bioinformatics/bti682; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	44	259	265	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					852	864		10.1086/503822			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	WOS:000236756200010	16642439	Green Published, Bronze			2022-01-24	
J	Carlson, MRJ; Zhang, B; Fang, ZX; Mischel, PS; Horvath, S; Nelson, SF				Carlson, MRJ; Zhang, B; Fang, ZX; Mischel, PS; Horvath, S; Nelson, SF			Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks	BMC GENOMICS			English	Article							SACCHAROMYCES-CEREVISIAE; ORGANIZATION; CELLS	Background: Genes and proteins are organized into functional modular networks in which the network context of a gene or protein has implications for cellular function. Highly connected hub proteins, largely responsible for maintaining network connectivity, have been found to be much more likely to be essential for yeast survival. Results: Here we investigate the properties of weighted gene co-expression networks formed from multiple microarray datasets. The constructed networks approximate scale-free topology, but this is not universal across all datasets. We show strong positive correlations between gene connectivity within the whole network and gene essentiality as well as gene sequence conservation. We demonstrate the preservation of a modular structure of the networks formed, and demonstrate that, within some of these modules, it is possible to observe a strong correlation between connectivity and essentiality or between connectivity and conservation within the modules particularly within modules containing larger numbers of essential genes. Conclusion: Application of these techniques can allow a finer scale prediction of relative gene importance for a particular process within a group of similarly expressed genes.	Univ Calif Los Angeles, Gonda Goldschmied Neurosci & Genet Res Ctr, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Rosetta Inpharmat LLC, Seattle, WA 98109 USA; Canc Prevent Inst, Dayton, OH 45439 USA; Wright State Univ, Sch Med, Dept Community Hlth, Dayton, OH 45435 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA		Nelson, SF (corresponding author), Univ Calif Los Angeles, Gonda Goldschmied Neurosci & Genet Res Ctr, David Geffen Sch Med, Dept Human Genet, 695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	mrjcarlson@mednet.ucla.edu; binzhang.ucla@gmail.com; fang@CancerPreventionInstitute.org; pmischel@mednet.ucla.edu; shorvath@mednet.ucla.edu; snelson@ucla.edu	Nelson, Stanley F/D-4771-2009; Fang, Zhongxiang/A-8988-2019	Nelson, Stanley F/0000-0002-2082-3114; Fang, Zhongxiang/0000-0002-9902-3426	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA009056] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [5T32CA09056, U01 CA881273, T32 CA009056] Funding Source: Medline		Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Batagelj V, 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Csanyi G, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016122; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Haggarty SJ, 2003, J AM CHEM SOC, V125, P10543, DOI 10.1021/ja035413p; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Pereira-Leal JB, 2005, MOL BIOL EVOL, V22, P421, DOI 10.1093/molbev/msi024; PROVERO P, 2002, CONDMAT0207345, V2; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rung J, 2002, BIOINFORMATICS, V18, pS202, DOI 10.1093/bioinformatics/18.suppl_2.S202; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Wagner A, 2002, GENOME RES, V12, P309, DOI 10.1101/gr.193902; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; PAJEK ALGORITHM; VERSION 7 NEUROSPORA; GEN TOPOLOGICAL OVER; DYNAMIC TREE CUT ALG	38	259	263	1	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAR 3	2006	7								40	10.1186/1471-2164-7-40			15	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	025OE	WOS:000236275000001	16515682	Green Published, gold			2022-01-24	
J	Clark, HF; Gurney, AL; Abaya, E; Baker, K; Baldwin, D; Brush, J; Chen, J; Chow, B; Chui, C; Crowley, C; Currell, B; Deuel, B; Dowd, P; Eaton, D; Foster, J; Grimaldi, C; Gu, QM; Hass, PE; Heldens, S; Huang, A; Kim, HS; Klimowski, L; Jin, YS; Johnson, S; Lee, J; Lewis, L; Liao, DZ; Mark, M; Robbie, E; Sanchez, C; Schoenfeld, J; Seshagiri, S; Simmons, L; Singh, J; Smith, V; Stinson, J; Vagts, A; Vandlen, R; Watanabe, C; Wieand, D; Woods, K; Xie, MH; Yansura, D; Yi, S; Yu, GY; Yuan, J; Zhang, M; Zhang, ZM; Goddard, A; Wood, WI; Godowski, P				Clark, HF; Gurney, AL; Abaya, E; Baker, K; Baldwin, D; Brush, J; Chen, J; Chow, B; Chui, C; Crowley, C; Currell, B; Deuel, B; Dowd, P; Eaton, D; Foster, J; Grimaldi, C; Gu, QM; Hass, PE; Heldens, S; Huang, A; Kim, HS; Klimowski, L; Jin, YS; Johnson, S; Lee, J; Lewis, L; Liao, DZ; Mark, M; Robbie, E; Sanchez, C; Schoenfeld, J; Seshagiri, S; Simmons, L; Singh, J; Smith, V; Stinson, J; Vagts, A; Vandlen, R; Watanabe, C; Wieand, D; Woods, K; Xie, MH; Yansura, D; Yi, S; Yu, GY; Yuan, J; Zhang, M; Zhang, ZM; Goddard, A; Wood, WI; Godowski, P			The Secreted Protein Discovery Initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: A bioinformatics assessment	GENOME RESEARCH			English	Article							I CYTOKINE RECEPTOR; GROWTH-FACTOR; FACTOR FAMILY; IDENTIFICATION; LIGAND; ANGIOGENESIS; INFLAMMATION; RESPONSES; SIGNALS; MEMBERS	A large-scale effort, termed the Secreted Protein Discovery Initiative (SPDI), was undertaken to identify novel secreted and transmembrane proteins. In the first of several approaches, a biological signal sequence trap in yeast cells was utilized to identify cDNA clones encoding putative secreted proteins. A second strategy utilized various algorithms that recognize features such as the hydrophobic properties of signal sequences to identify putative proteins encoded by expressed sequence tags (ESTs) from human cDNA libraries. A third approach surveyed ESTs for protein sequence similarity to a set of known receptors and their ligands with the BLAST algorithm. Finally, both signal-sequence prediction algorithms and BLAST were used to identify single exons of potential genes from within human genomic sequence. The isolation of full-length cDNA clones for each of these candidate genes resulted in the identification of >1000 novel proteins. A total of 256 of these cDNAs are still novel, including variants and novel genes, per the most recent GenBank release version. The success of this large-scale effort was assessed by a bioinformatics analysis of the proteins through predictions of protein domains, subcellular localizations, and possible functional roles. The SPDI collection should facilitate efforts to better understand intercellular communication, may lead to new understandings of human diseases, and provides potential opportunities for the development of therapeutics.	Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; Genentech Inc, Dept Biol Mol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA		Clark, HF (corresponding author), Genentech Inc, Dept Bioinformat, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	hclark@gene.com		Seshagiri, Somasekar/0000-0003-4272-6443			Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Armant MA, 2002, GENOME BIOL, V3; Baker D, 2000, PARTY POLIT, V6, P249, DOI 10.1177/1354068800006002012; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Danielsen AJ, 2002, GROWTH FACTORS, V20, P1, DOI 10.1080/08977190290022185; Dedhar S, 1999, Curr Opin Hematol, V6, P37, DOI 10.1097/00062752-199901000-00007; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Flavell RA, 2002, CURR TOP MICROBIOL, V266, P1; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Ghilardi N, 2002, J BIOL CHEM, V277, P16831, DOI 10.1074/jbc.M201140200; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Gurney AL, 1999, CURR BIOL, V9, P215, DOI 10.1016/S0960-9822(99)80093-1; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Klein RD, 1996, P NATL ACAD SCI USA, V93, P7108, DOI 10.1073/pnas.93.14.7108; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Onuffer JJ, 2002, TRENDS PHARMACOL SCI, V23, P459, DOI 10.1016/S0165-6147(02)02064-3; Ornitz DM, 2001, GENOME BIOL, V2; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Schooltink H, 2002, J INTERF CYTOK RES, V22, P505, DOI 10.1089/10799900252981981; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3; Williamson AR, 1999, DRUG DISCOV TODAY, V4, P115, DOI 10.1016/S1359-6446(99)01303-3; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Yamamoto S, 1999, IMMUNOL TODAY, V20, P278, DOI 10.1016/S0167-5699(99)01464-4; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zhang ZM, 2003, BIOINFORMATICS, V19, P307, DOI 10.1093/bioinformatics/19.2.307	42	259	1210	0	16	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2003	13	10					2265	2270		10.1101/gr.1293003			6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	731GR	WOS:000185876400008	12975309	Bronze, Green Published			2022-01-24	
J	Fabrizio, P; Liou, LL; Moy, VN; Diaspro, A; SelverstoneValentine, J; Gralla, EB; Longo, VD				Fabrizio, P; Liou, LL; Moy, VN; Diaspro, A; SelverstoneValentine, J; Gralla, EB; Longo, VD			SOD2 functions downstream of Sch9 to extend longevity in yeast	GENETICS			English	Article							LACKING SUPEROXIDE-DISMUTASE; SACCHAROMYCES-CEREVISIAE; STATIONARY-PHASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; STRESS RESISTANCE; SUBCELLULAR-DISTRIBUTION; GENE-EXPRESSION; FAMILY MEMBER; RAT-LIVER	Signal transduction pathways inactivated during periods of starvation are implicated in the regulation of longevity in organisms ranging from yeast to mammals, but the mechanisms responsible for life-span extension are poorly understood. Chronological life-span extension in S. cerevisiae cyr1 and sch9 mutants is mediated by the stress-resistance proteins Msn2/Msn4 and Rim15. Here we show that mitochondrial superoxide dismutase (Sod2) is required for survival extension in yeast. Deletion of SOD2 abolishes life-span extension in sch9Delta mutants and decreases survival in cyr1:mTn mutants. The overexpression of Sods-mitochondrial Sod2 and cytosolic CuZnSod (Sod1)-delays the age-dependent reversible inactivation of mitochondrial aconitase, a superoxide-sensitive enzyme, and extends survival by 30%. Deletion of the RAS2 gene, which functions upstream of CYR1, also doubles the mean life span by a mechanism that requires Msn2/4 and Sod2. These findings link mutations that extend chronological life span in S. cerevisiae to superoxide dismutases and suggest that the induction of other stress-resistance genes regulated by Msn2/4 and Rim15 is required for maximum longevity extension.	Univ So Calif, Ctr Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Sci Biol, Los Angeles, CA 90089 USA; Univ So Calif, Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Genoa, Dept Phys, I-16146 Genoa, Italy		Longo, VD (corresponding author), Univ So Calif, Ctr Biol Sci, 3715 McClintock Ave, Los Angeles, CA 90089 USA.		Diaspro, Alberto/E-7833-2010	Diaspro, Alberto/0000-0002-4916-5928; fabrizio, paola/0000-0002-1144-7727	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-08761-10] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK-46828] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK046828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG008761] Funding Source: NIH RePORTER		Ashrafi K, 1999, P NATL ACAD SCI USA, V96, P9100, DOI 10.1073/pnas.96.16.9100; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Cherkasova V, 2000, J MOL BIOL, V300, P433, DOI 10.1006/jmbi.2000.3880; Do TQ, 1996, P NATL ACAD SCI USA, V93, P7534, DOI 10.1073/pnas.93.15.7534; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; FlatteryOBrien JA, 1997, MOL MICROBIOL, V23, P303, DOI 10.1046/j.1365-2958.1997.2121581.x; Flint DH, 1996, CHEM REV, V96, P2315, DOI 10.1021/cr950041r; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GELLER BL, 1984, METHOD ENZYMOL, V105, P105; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; GRANOT D, 1991, P NATL ACAD SCI USA, V88, P5724, DOI 10.1073/pnas.88.13.5724; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LIU XF, 1992, J BIOL CHEM, V267, P18298; Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; Longo VD, 1999, NEUROBIOL AGING, V20, P479, DOI 10.1016/S0197-4580(99)00089-5; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; MIKUS MD, 1982, GENETICS, V101, P369; Morano KA, 1999, EMBO J, V18, P5953, DOI 10.1093/emboj/18.21.5953; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; MUELLER DM, 1988, J BIOL CHEM, V263, P5634; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; RACKER E, 1950, BIOCHIM BIOPHYS ACTA, V4, P211, DOI 10.1016/0006-3002(50)90026-6; Roberts RL, 1997, CELL, V89, P1055, DOI 10.1016/S0092-8674(00)80293-7; RUIS H, 1995, BIOESSAYS, V17, P959, DOI 10.1002/bies.950171109; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Zambrano MM, 1996, CELL, V86, P181, DOI 10.1016/S0092-8674(00)80089-6	59	259	268	1	24	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	JAN	2003	163	1					35	46					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	646MW	WOS:000181039700004	12586694				2022-01-24	
J	Broeckel, U; Hengstenberg, C; Mayer, B; Holmer, S; Martin, LJ; Comuzzie, AG; Blangero, J; Nurnberg, P; Reis, A; Riegger, GAJ; Jacob, HJ; Schunkert, H				Broeckel, U; Hengstenberg, C; Mayer, B; Holmer, S; Martin, LJ; Comuzzie, AG; Blangero, J; Nurnberg, P; Reis, A; Riegger, GAJ; Jacob, HJ; Schunkert, H			A comprehensive linkage analysis for myocardial infarction and its related risk factors	NATURE GENETICS			English	Article							CORONARY-HEART-DISEASE; SUSCEPTIBILITY LOCUS; GENETIC-LINKAGE; PAIR ANALYSIS; CHROMOSOME; HYPERTENSION; ASSOCIATION; MAPS	Coronary artery disease and myocardial infarction (MI) are leading causes of death in the western world. Numerous studies have shown that risk factors such as diabetes mellitus, arterial hypertension and hypercholesterolemia contribute to the development of the disease. Although each risk factor by itself is partly under genetic control, a positive family history is an independent predictor, which suggests that there are additional susceptibility genes(1). We have scanned the whole genome in 513 families to identify chromosomal regions linked to myocardial infarction and related risk factors that are known to be under genetic control. Here we show, by using variance component analysis and incorporating risk factors, that risk of myocardial infarction maps to a single region on chromosome 14 with a significant lod score of 3.9 (pointwise P=0.00015, genome-wide P<0.05), providing evidence of a principal MI locus. To characterize this locus we analyzed each risk factor by itself. Serum concentrations of lipoprotein (a) show linkage to both the apolipoprotein (a) locus (lod score 26.99) and a new locus on chromosome 1 (lod score 3.8). There is suggestive linkage for diabetes mellitus on chromosome 6 (lod score 2.96), for hypertension on chromosomes 1 and 6, for high-density and low-density lipoprotein cholesterol on chromosomes 1 and 17, and for triglyceride concentrations on chromosome 9. Although some of these risk factors overlap with previously identified loci, none overlaps with the newly identified susceptibility locus for myocardial infarction and coronary artery disease.	Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany; Med Coll Wisconsin, Dept Cardiovasc Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Max Delbruck Ctr Mol Med, Zentrum Genkartierung, Berlin, Germany; Univ Erlangen Nurnberg, Inst Humangenet, D-8520 Erlangen, Germany; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA		Schunkert, H (corresponding author), Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany.	jacob@mcw.edu; heribert.schunkert@klinik.uni-regensburg.de	Reis, Andre/D-2309-2009; Blangero, John/ABA-7175-2021; Hengstenberg, Christian/U-5485-2019; Martin, Lisa/E-2425-2016	Reis, Andre/0000-0002-6301-6363; Martin, Lisa/0000-0001-8702-9946			Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Comuzzie AG, 1999, GENET EPIDEMIOL, V17, pS109; Dahlen GH, 1998, J INTERN MED, V244, P417; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; LOBEL H, 1993, CIRCULATION, V88, P2524; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; THOMPSON EA, 1993, 243 U WASH DEP STAT; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5	27	259	266	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					210	214		10.1038/ng827			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	WOS:000173708700024	11818963				2022-01-24	
J	Miller, CR; Joyce, P; Waits, LP				Miller, CR; Joyce, P; Waits, LP			Assessing allelic dropout and genotype reliability using maximum likelihood	GENETICS			English	Article							GENETIC DIVERSITY; DNA; MICROSATELLITES; SAMPLES; TRACKING	A growing number of population genetic studies utilize nuclear DNA microsatellite data from museum specimens and noninvasive sources. Genotyping errors are elevated in these low quantity DNA sources, potentially, compromising the power and accuracy of the data. The most conservative method for addressing this problem is effective, but requires extensive replication of individual genotypes. In search of a more efficient method, we developed a maximum-likelihood approach that minimizes errors by estimating genotype reliability and strategically directing replication at loci most likely to harbor errors. The model assumes that false and contaminant alleles can be removed from the dataset and that the allelic dropout rate is even across loci. Simulations demonstrate that the proposed method marks a vast improvement in efficiency while maintaining accuracy. When allelic dropout rates are low (0-30%), the reduction in the number of PCR replicates is typically 40-50%. The model is robust to moderate violations of the even dropout rate assumption. For datasets that contain false and contaminant alleles, a replication strategy is proposed. Our current model addresses only allelic dropout, the most prevalent source of genotyping error. However, the developed likelihood framework can incorporate additional error-generating processes as they become more clearly understood.	Univ Idaho, Coll Nat Resources, Dept Fish & Wildlife, Moscow, ID 83844 USA; Univ Idaho, Div Stat, Dept Math, Moscow, ID 83844 USA		Miller, CR (corresponding author), Univ Idaho, Coll Nat Resources, Dept Fish & Wildlife, Moscow, ID 83844 USA.	mill8560@uidaho.edu		Waits, Lisette/0000-0002-1323-0812			Bouzat JL, 1998, AM NAT, V152, P1, DOI 10.1086/286145; Ernest HB, 2000, MOL ECOL, V9, P433, DOI 10.1046/j.1365-294x.2000.00890.x; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; GERLOFF U, 1995, MOL ECOL, V4, P515, DOI 10.1111/j.1365-294X.1995.tb00247.x; Goossens B, 1998, MOL ECOL, V7, P1237, DOI 10.1046/j.1365-294x.1998.00407.x; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; Miller LM, 1997, GENETICS, V147, P1249; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.1890/1051-0761(2000)010[0283:EAAUND]2.0.CO;2; MORIN PA, 1994, MOL ECOL, V3, P469, DOI 10.1111/j.1365-294X.1994.tb00125.x; Mundy NI, 1997, P ROY SOC B-BIOL SCI, V264, P869, DOI 10.1098/rspb.1997.0121; NAVIDI W, 1992, AM J HUM GENET, V50, P347; Palsboll PJ, 1997, NATURE, V388, P767, DOI 10.1038/42005; Reed JZ, 1997, MOL ECOL, V6, P225, DOI 10.1046/j.1365-294X.1997.00175.x; Roy MS, 1996, CONSERV BIOL, V10, P1413, DOI 10.1046/j.1523-1739.1996.10051413.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1046/j.1365-294X.1997.00251.x; Tessier N, 1999, MOL ECOL, V8, P169, DOI 10.1046/j.1365-294X.1999.00547.x; Waits JL, 2000, ANIM CONSERV, V3, P191, DOI 10.1017/S1367943000000901; Woods JG, 1999, WILDLIFE SOC B, V27, P616	22	259	265	0	24	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JAN	2002	160	1					357	366					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	516TY	WOS:000173573900033	11805071				2022-01-24	
J	Wallace, RH; Scheffer, IE; Barnett, S; Richards, M; Dibbens, L; Desai, RR; Lerman-Sagie, T; Lev, D; Mazarib, A; Brand, N; Ben-Zeev, B; Goikhman, I; Singh, R; Kremmidiotis, G; Gardner, A; Sutherland, GR; George, AL; Mulley, JC; Berkovic, SF				Wallace, RH; Scheffer, IE; Barnett, S; Richards, M; Dibbens, L; Desai, RR; Lerman-Sagie, T; Lev, D; Mazarib, A; Brand, N; Ben-Zeev, B; Goikhman, I; Singh, R; Kremmidiotis, G; Gardner, A; Sutherland, GR; George, AL; Mulley, JC; Berkovic, SF			Neuronal sodium-channel alpha 1-subunit mutations in generalized epilepsy with febrile seizures plus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS; MAPS; ORGANIZATION	Generalized epilepsy with febrile seizures plus (GEFS+) is a familial epilepsy syndrome characterized by the presence of febrile and afebrile seizures. The first gene, GEFS1, was mapped to chromosome 19q and was identified as the sodium-channel beta1-subunit, SCN1B. A second locus on chromosome 2q, GEFS2, was recently identified as the sodium-channel alpha1-subunit, SCN1A. Single-stranded conformation analysis (SSCA) of SCN1A was performed in 53 unrelated index cases to estimate the frequency of mutations in patients with GEFS+. No mutations were found in 17 isolated cases of GEFS+. Three novel SCN1A mutations-D188V, V1353L, and I1656M-were found in 36 familial cases; of the remaining 33 families, 3 had mutations in SCN1B. On the basis of SSCA, the combined frequency of SCN1A and SCN1B mutations in familial cases of GEFS+ was found to be 17%.	Womens & Childrens Hosp, Ctr Med Genet, Dept Cytogenet & Mol Genet, N Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Dept Genet, Adelaide, SA, Australia; Univ Melbourne, Austin & Repatriat Med Ctr, Heidelberg, Vic, Australia; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Dept Pharmacol, Nashville, TN 37212 USA; Wolfson Med Ctr, Metab Neurogenet Clin, Holon, Israel; Tel Aviv Sourasky Med Ctr, Dept Neurol, Tel Aviv, Israel; Chaim Sheba Med Ctr, Dept Pediat Neurol, Ramat Gan, Israel; Carmel Hosp, Dept Pediat, Haifa, Israel		Wallace, RH (corresponding author), Bion Womens & Childrens Hosp Res Facil, 28 Dalgliesh St, Thebarton, SA 5031, Australia.		Sutherland, Grant Robert/D-2606-2012; Scheffer, Ingrid E/G-1668-2013; Lerman-Sagie, Tally/AAY-7598-2021	Scheffer, Ingrid E/0000-0002-2311-2174; Lerman-Sagie, Tally/0000-0001-6641-6875; Wallace, Robyn/0000-0001-6141-3317; Dibbens, Leanne/0000-0002-5824-3342; Berkovic, Samuel/0000-0003-4580-841X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS032387, R01NS032387] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS032387, NS 32387, R37 NS032387] Funding Source: Medline		Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Bendahhou S, 1999, J NEUROSCI, V19, P4762; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Kuhn FJP, 1999, J GEN PHYSIOL, V114, P167, DOI 10.1085/jgp.114.2.167; Lopes-Cendes I, 2000, AM J HUM GENET, V66, P698, DOI 10.1086/302768; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Peiffer A, 1999, ANN NEUROL, V46, P671, DOI 10.1002/1531-8249(199910)46:4<671::AID-ANA20>3.0.CO;2-5; Plummer NW, 1998, GENOMICS, V54, P287, DOI 10.1006/geno.1998.5550; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Scheffer IE, 2000, ANN NEUROL, V47, P840, DOI 10.1002/1531-8249(200006)47:6<840::AID-ANA28>3.0.CO;2-V; Singh R, 1999, ANN NEUROL, V45, P75, DOI 10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236	16	259	275	1	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					859	865		10.1086/319516			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	WOS:000167666000007	11254444	Bronze, Green Published			2022-01-24	
J	Morahan, G; Huang, DX; Ymer, SI; Cancilla, MR; Stephen, K; Dabadghao, P; Werther, G; Tait, BD; Harrison, LC; Colman, PG				Morahan, G; Huang, DX; Ymer, SI; Cancilla, MR; Stephen, K; Dabadghao, P; Werther, G; Tait, BD; Harrison, LC; Colman, PG			Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele	NATURE GENETICS			English	Article							DISTAL CHROMOSOME 2Q; GENETIC SUSCEPTIBILITY; INSULIN; CELLS; CYTOKINE; MELLITUS; IDDM; TH2	Type 1 diabetes (T1D; or insulin-dependent diabetes mellitus, IDDM) is an autoimmune disease with both genetic and environmental components. In addition to the human leukocyte antigen (HLA) complex, the single major genetic contributor of susceptibility(1), an unknown number of other unidentified genes are required to mediate disease. Although many loci conferring susceptibility to T1D have been mapped(2), their identification has proven problematic(3) due to the complex nature of this disease. Our strategy for finding T1D susceptibility genes has been to test for human homologues of loci implicated in diabetes-prone NOD (non-obese diabetic) mice, together with application of biologically relevant stratification methods(4). We report here a new susceptibility locus, IDDM18 located near the interleukin-12 (IL-12)p40 gene, IL12B. Significant bias in transmission of IL12B alleles was observed in affected sibpairs and was confirmed in an independent cohort of simplex families. A single base change in the 3' UTR showed strong linkage disequilibrium with the T1D susceptibility locus. The IL12B 3' UTR alleles showed different levers of expression in cell lines. Variation in IL-12p40 production may influence T-cell responses crucial for either mediating or protecting against this and other autoimmune diseases.	Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; Royal Childrens Hosp, Dept Endocrinol, Melbourne, Vic, Australia; Royal Melbourne Hosp, Australian Red Cross Blood Serv, Victorian Transplantat & Immunogenet Serv, Rotary Bone Marrow Res Ctr, Melbourne, Vic, Australia		Morahan, G (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Parkville, Vic, Australia.	morahan@wehi.edu.au	Morahan, Grant/T-7501-2019; Werther, George/B-3784-2012	Colman, Peter/0000-0001-8718-6175			Adorini L, 1996, ANN NY ACAD SCI, V795, P208, DOI 10.1111/j.1749-6632.1996.tb52670.x; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; DEGLIESPOSTI MA, 1993, HUM IMMUNOL, V38, P3, DOI 10.1016/0198-8859(93)90514-2; Fu J, 1998, DIABETOLOGIA, V41, P228, DOI 10.1007/s001250050894; GERMANN T, 1993, EUR J IMMUNOL, V23, P1762, DOI 10.1002/eji.1830230805; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HUANG D, IN PRESS GENES IMMUN; JOHNSON KJ, 1992, GENOMICS, V14, P745, DOI 10.1016/S0888-7543(05)80178-8; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Larsen ZM, 1999, AUTOIMMUNITY, V31, P35, DOI 10.3109/08916939908993857; LECAM A, 1995, EUR J BIOCHEM, V231, P620; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; ROBINSON WP, 1993, GENET EPIDEMIOL, V10, P273, DOI 10.1002/gepi.1370100502; Sambrook J, 1989, MOL CLONING; She JX, 1998, CURR OPIN IMMUNOL, V10, P682, DOI 10.1016/S0952-7915(98)80089-7; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Szelachowska M, 1997, HORM METAB RES, V29, P168, DOI 10.1055/s-2007-979014; Trembleau S, 1997, EUR J IMMUNOL, V27, P2330, DOI 10.1002/eji.1830270930; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; WARRINGTON JA, 1994, GENOMICS, V24, P395, DOI 10.1006/geno.1994.1636; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOLF SF, 1991, J IMMUNOL, V146, P3074; YOUNES RN, 1994, SHOCK S, V1, P2; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	29	259	268	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2001	27	2					218	221		10.1038/84872			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	WOS:000166839200027	11175794				2022-01-24	
J	Myung, K; Datta, A; Chen, C; Kolodner, RD				Myung, K; Datta, A; Chen, C; Kolodner, RD			SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination	NATURE GENETICS			English	Article							WERNERS-SYNDROME GENES; DNA HELICASE; BLOOMS-SYNDROME; REPLICATION; INTERACTS; PROTEINS; PRODUCT	The Escherichia coli gene recQ was identified as a RecF recombination pathway gene(1). The gene SGS1, encoding the only RecQ-like DNA helicase in Saccharomyces cerevisiae, was identified by mutations that suppress the top3 slow-growth phenotype(2,3). Relatively little is known about the function of Sgs1p because single mutations in SCSI do not generally cause strong phenotypes. Mutations in genes encoding RecQ-like DNA helicases such as the Bloom and Werner syndrome genes, BLM and WRN, have been suggested to cause increased genome instability(4,5). But the exact DNA metabolic defect that might underlie such genome instability has remained unclear. To better understand the cellular role of the RecQ-like DNA helicases, sgs1 mutations were analyzed for their effect on genome rearrangements(6,7). Mutations in SGS1 increased the rate of accumulating gross chromosomal rearrangements (GCRs), including translocations and deletions containing extended regions of imperfect homology at their breakpoints. sgs1 mutations also increased the rate of recombination between DNA sequences that had 91% sequence homology. Epistasis analysis showed that Sgs1p is redundant with DNA mismatch repair (MMR) for suppressing GCRs and for suppressing recombination between divergent DNA sequences. This suggests that defects in the suppression of rearrangements involving divergent, repeated sequences may underlie the genome instability seen in BLM and WRN patients and in cancer cases associated with defects in these genes.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA		Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.		Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM50006, GM26017] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37GM026017, R01GM026017, R01GM050006] Funding Source: NIH RePORTER		Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Calin G, 1998, CANCER RES, V58, P3777; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen YL, 1998, T NONFERR METAL SOC, V8, P5; Datta A, 1996, MOL CELL BIOL, V16, P1085; Davey S, 1998, MOL CELL BIOL, V18, P2721, DOI 10.1128/MCB.18.5.2721; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Frei C, 2000, GENE DEV, V14, P81; FUKUCHI K, 1990, HUM GENET, V84, P249; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; German J, 1998, GENETIC BASIS HUMAN, P301; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; MONNAT RJ, 1992, GENOMICS, V13, P777, DOI 10.1016/0888-7543(92)90153-J; Moser MJ, 1999, HUM MUTAT, V13, P271, DOI 10.1002/(SICI)1098-1004(1999)13:4<271::AID-HUMU2>3.3.CO;2-H; NAKAYAMA H, 1984, MOL GEN GENET, V195, P475; Ng SW, 1999, NUCLEIC ACIDS RES, V27, P993, DOI 10.1093/nar/27.4.993; Nicholson A, 2000, GENETICS, V154, P133; SALK D, 1985, ADV EXP MED BIOL, V190, P541; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SHIRAISHI Y, 1983, CANCER GENET CYTOGEN, V9, P129, DOI 10.1016/0165-4608(83)90033-X; Watt PM, 1996, GENETICS, V144, P935; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	30	259	261	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					113	116		10.1038/83673			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	WOS:000166187900027	11138010				2022-01-24	
J	Soderlund, C; Humphray, S; Dunham, A; French, L				Soderlund, C; Humphray, S; Dunham, A; French, L			Contigs built with fingerprints, markers, and FPCV4.7	GENOME RESEARCH			English	Article							PHYSICAL MAP; HUMAN GENOME; CHROMOSOME; CLONES; STRATEGY; SYSTEM	Contigs have been assembled, and over 2800 clones selected for sequencing for human chromosomes 9, 10 and 13. Using the FPC (FingerPrinted Contig) software, the contigs are assembled with markers and complete digest fingerprints, and the contigs are ordered and localised by a global Framework. Publicly available resources have been used, such as, the 1998 International Gene Map for the framework and the GSC Human PAC fingerprint database for the majority of the fingerprints. Additional markers and fingerprints are generated in-house to supplement this data. To support the scale up of building maps, FPC V4.7 has been extended to use markers with the fingerprints for assembly of contigs, new clones and markers can be automatically added to existing contigs, and poorly assembled contigs are marked accordingly. To test the automatic assembly, a simulated complete digest of 110 Mb of concatenated human sequence was used to create datasets with varying coverage, length of clones, and types of error. When no error was introduced and a tolerance of 7 was used in assembly, the largest contig with no false positive overlaps has 9534 clones with 32 out-of-order clones, that is, the starting coordinates of adjacent clones are in the wrong order. This paper describes the new Features in FPC, the scenario for building the maps of chromosomes 9, 10 and 13, and the results From the simulation.	Clemson Univ, Genom Inst, Clemson, SC 29634 USA; Sanger Ctr, Cambridge CB10 1SA, England		Soderlund, C (corresponding author), Clemson Univ, Genom Inst, Clemson, SC 29634 USA.	cari@cs.clemson.edu			Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Cao YC, 1999, GENOME RES, V9, P763; CARRANO AV, 1989, GENOMICS, V4, P129, DOI 10.1016/0888-7543(89)90291-7; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Ding Y, 1999, GENOMICS, V56, P237, DOI 10.1006/geno.1998.5734; DURBIN R, 1994, COMPUTATIONAL METHOD, P7821; Gregory SG, 1997, GENOME RES, V7, P1162, DOI 10.1101/gr.7.12.1162; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; HUMPHRAY S, IN PRESS GENOMIC PRO; Klein PE, 2000, GENOME RES, V10, P789, DOI 10.1101/gr.10.6.789; LANDER E S, 1988, Genomics, V2, P231; Mahairas GG, 1999, P NATL ACAD SCI USA, V96, P9739, DOI 10.1073/pnas.96.17.9739; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Mungall AJ, 1997, DNA SEQUENCE, V8, P151, DOI 10.3109/10425179709034066; Niederfuhr A, 1998, GENOMICS, V53, P155, DOI 10.1006/geno.1998.5486; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; Osoegawa K, 2000, GENOME RES, V10, P116; Slonim D, 1997, J COMPUT BIOL, V4, P487, DOI 10.1089/cmb.1997.4.487; Soderlund C, 1995, COMPUT APPL BIOSCI, V11, P645; Soderlund C, 1998, BIOINFORMATICS, V14, P538, DOI 10.1093/bioinformatics/14.6.538; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SODERLUND C, 1997, GUIDE HUMAN GENOME C, P151; SOEDA E, 1995, GENOMICS, V25, P73, DOI 10.1016/0888-7543(95)80111-X; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218; SULSTON J, 1989, COMPUT APPL BIOSCI, V5, P101; SULSTON J, 1988, COMPUT APPL BIOSCI, V4, P125; Taylor K, 1996, GENOME RES, V6, P235, DOI 10.1101/gr.6.4.235; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; Zhu H, 1999, GENOME RES, V9, P739	30	259	265	0	6	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2000	10	11					1772	1787		10.1101/gr.GR-1375R			16	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	374VH	WOS:000165364700015	11076862	Bronze, Green Published			2022-01-24	
J	Allison, DB; Neale, MC; Zannolli, R; Schork, NJ; Amos, CI; Blangero, J				Allison, DB; Neale, MC; Zannolli, R; Schork, NJ; Amos, CI; Blangero, J			Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSESSING GENETIC-LINKAGE; DISCORDANT SIB PAIRS; MATRIX MIXED MODELS; FAMILIES; MULTIVARIATE; SELECTION; PEDIGREES; POWER; DISTRIBUTIONS; EFFICIENCY	Detection of linkage to genes for quantitative traits remains a challenging task. Recently, variance components (VC) techniques have emerged as among the more powerful of available methods. As often implemented, such techniques require assumptions about the phenotypic distribution. Usually, multivariate normality is assumed. However, several factors may lead to markedly nonnormal phenotypic data, including (a) the presence of a major gene (not necessarily linked to the markers under study), (b) some types of gene x environment interaction, (c) use of a dichotomous phenotype (i.e., affected vs, unaffected), (d) nonnormality of the population within-genotype (residual) distribution, and (e) selective (extreme) sampling. Using simulation, we have investigated, for sib-pair studies, the robustness of the likelihood-ratio test for a VC quantitative-trait locus-detection procedure to violations of normality that are due to these factors. Results showed (d) that some types of nonnormality, such as leptokurtosis, produced type I error rates in excess of the nominal, or alpha, levels whereas others did not; and (b) that the degree of type I error-rate inflation appears to be directly related to the residual sibling correlation. Potential solutions to this problem are discussed. Investigators contemplating use of this VC procedure are encouraged to provide evidence that their trait data are normally distributed, to employ a procedure that allows for nonnormal data, or to consider implementation of permutation tests.	Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10032 USA; Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA; Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychol, Richmond, VA USA; Univ Siena, Policlin LeScotte, Dept Pediat, I-53100 Siena, Italy; Case Western Reserve Univ, Dept Biostat & Epidemiol, Cleveland, OH 44106 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA		Allison, DB (corresponding author), Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, Obes Res Ctr, 1090 Amsterdam Ave,14th Floor, New York, NY 10032 USA.		Neale, Michael C/B-1418-2008; Neale, Michael/AAD-5056-2020; Blangero, John/ABA-7175-2021	Schork, Nicholas/0000-0003-0920-5013; Allison, David/0000-0003-3566-9399	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK47256, DK51716, DK26687] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R29DK047256, R01DK051716, P30DK026687] Funding Source: NIH RePORTER		Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Allison DB, 1998, HUM HERED, V48, P97, DOI 10.1159/000022788; Allison DB, 1997, BEHAV GENET, V27, P401, DOI 10.1023/A:1025696232582; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; Amos CI, 1997, GENET EPIDEMIOL, V14, P743, DOI 10.1002/(SICI)1098-2272(1997)14:6<743::AID-GEPI30>3.0.CO;2-O; ASTEMBORSKI JA, 1985, AM J MED GENET, V21, P741, DOI 10.1002/ajmg.1320210417; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BEATY TH, 1987, GENET EPIDEMIOL, V4, P203, DOI 10.1002/gepi.1370040305; BEATY TH, 1987, GENET EPIDEMIOL, V4, P211, DOI 10.1002/gepi.1370040306; BENTLER PM, 1991, P 23 S INT INT FDN N, P463; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BOX GEP, 1953, BIOMETRIKA, V40, P318, DOI 10.1093/biomet/40.3-4.318; CHERNOFF H, 1954, ANN MATH STAT, V25, P579, DOI 10.1214/aoms/1177728726; Christiaens GCML, 1997, OBSTET GYNECOL, V90, P546, DOI 10.1016/S0029-7844(97)00349-9; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; CRAWFORD DHG, 1993, HEPATOLOGY, V17, P833, DOI 10.1002/hep.1840170514; de Andrade M, 1997, GENET EPIDEMIOL, V14, P773, DOI 10.1002/(SICI)1098-2272(1997)14:6<773::AID-GEPI35>3.0.CO;2-L; Dolan CV, 1998, BEHAV GENET, V28, P197, DOI 10.1023/A:1021423214032; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; ELSTON RC, IN PRESS GENET EPIDE; EVANS M, 1993, STAT DISTRIBUTIONS, P92; FOUTZ RV, 1977, ANN STAT, V5, P1183, DOI 10.1214/aos/1176344003; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; GEORGE VT, 1988, COMMUN STAT-THEOR M, V17, P2933, DOI 10.1080/03610928808829781; GOLDBERGER J, 1994, AM J CARDIOL, V73, P43, DOI 10.1016/0002-9149(94)90725-0; Good P., 1994, PERMUTATION TESTS PR; Guerra R, 1999, HUM HERED, V49, P146, DOI 10.1159/000022863; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOPPER JL, 1983, AM J EPIDEMIOL, V117, P344, DOI 10.1093/oxfordjournals.aje.a113547; HU LT, 1992, PSYCHOL BULL, V112, P351, DOI 10.1037//0033-2909.112.2.351; ITURRIA SJ, IN PRESS GENET EPIDE; KEITH RA, 1983, CLIN PHARMACOL THER, V34, P521, DOI 10.1038/clpt.1983.208; KRUGLYAK L, 1995, GENETICS, V139, P1421; LANDER ES, 1989, GENETICS, V121, P185; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Little RJA., 1987, STAT ANAL MISSING DA; MATTHYSSE S, 1979, P NATL ACAD SCI USA, V76, P2862, DOI 10.1073/pnas.76.6.2862; MICCERI T, 1989, PSYCHOL BULL, V105, P156, DOI 10.1037/0033-2909.105.1.156; MOTUM PI, 1993, AM J HEMATOL, V43, P37, DOI 10.1002/ajh.2830430109; [National Center for Health Statistics . Centers for Disease Control and Prevention USDoHaHS Statistics NCfH], 1997, NAT HLTH NUTR EX SUR; NEALE MC, 1992, NATO ASI SERIES D, V47; NEALE MC, 1997, MX STAT MODELING; NEALE MC, IN PRESS L ERLBAUM; POONI HS, 1976, HEREDITY, V36, P215, DOI 10.1038/hdy.1976.26; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 1996, AM J HUM GENET, V58, P836; SCHORK N, 1989, AM J HUM GENET, V45, P803; SCHORK N, 1991, GENET EPIDEMIOL, V8, P29, DOI 10.1002/gepi.1370080104; Schork N J, 1996, Stat Methods Med Res, V5, P155, DOI 10.1177/096228029600500204; SCHORK NJ, 1990, STAT MED, V9, P301, DOI 10.1002/sim.4780090313; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SCHORK NJ, 1992, GENET EPIDEMIOL, V9, P73, DOI 10.1002/gepi.1370090202; SCHORK NJ, 1990, GENET EPIDEMIOL, V7, P427, DOI 10.1002/gepi.1370070605; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Wan Y, 1997, ANN HUM GENET, V61, P79; Wang J, 1998, ANN HUM GENET, V62, P349, DOI 10.1046/j.1469-1809.1998.6240349.x; White H, 1994, ESTIMATION INFERENCE; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Wilcox R., 1997, INTRO ROBUST ESTIMAT; Williams JT, 1999, GENET EPIDEMIOL, V16, P113, DOI 10.1002/(SICI)1098-2272(1999)16:2<113::AID-GEPI1>3.0.CO;2-6; Wright FA, 1997, AM J HUM GENET, V60, P740; Wright FA, 1997, GENETICS, V146, P417; [No title captured]	69	259	261	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					531	544		10.1086/302487			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	WOS:000081836900028	10417295	Green Published, Bronze			2022-01-24	
J	de Winter, JP; Waisfisz, Q; Rooimans, MA; van Berkel, CGM; Bosnoyan-Collins, L; Alon, N; Carreau, M; Bender, O; Demuth, I; Schindler, D; Pronk, JC; Arwert, F; Hoehn, H; Digweed, M; Buchwald, M; Joenje, H				de Winter, JP; Waisfisz, Q; Rooimans, MA; van Berkel, CGM; Bosnoyan-Collins, L; Alon, N; Carreau, M; Bender, O; Demuth, I; Schindler, D; Pronk, JC; Arwert, F; Hoehn, H; Digweed, M; Buchwald, M; Joenje, H			The Fanconi anaemia group G gene FANCG is identical with XRCC9	NATURE GENETICS			English	Article							CHROMOSOMAL INSTABILITY; ANEMIA GENES; COMPLEMENTATION; SUSCEPTIBILITY; SENSITIVITY; UV40; MICE; FAA	Fanconi anemia (FA) is an autosomal recessive disease with diverse clinical symptoms including developmental anomalies, bone marrow failure and early occurrence of malignancies'. In addition to spontaneous chromosome instability, FA cells exhibit cell cycle disturbances and hypersensitivity to crosslinking agents(1). Eight complementation groups (A-H) have been distinguished(2), each group possibly representing a distinct FA gene(3). The genes mutated in patients of complementation groups A (FANCA; refs 4,5) and C (FANCC; ref. 6) have been identified, and FANCD has been mapped to chromosome band 3p22-26 (ref. 7). An additional FA gene has recently been mapped to chromosome 9p (ref. 8). Here we report the identification of the gene mutated in group G, FANCG, on the basis of complementation of an FA-G cell line and the presence of pathogenic mutations in four FA-C patients. We identified the gene as human XRCC9, a gene which has been shown to complement the MMC-sensitive Chinese hamster mutant UV40, and is suspected to be involved in DNA post-replication repair or cell cycle checkpoint control(9,10). The gene is localized to chromosome band 9p13 (ref. 9), corresponding with a known localization of an FA gene.	Free Univ Amsterdam, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands; Hosp Sick Children, Program Genet & Genomic Biol, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Humboldt Univ, Inst Human Genet, D-13353 Berlin, Germany; Univ Wurzburg, Inst Human Genet, D-8700 Wurzburg, Germany		Joenje, H (corresponding author), Free Univ Amsterdam, Dept Human Genet, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	h.joenje.humgen@med.vu.nl	Demuth, Ilja/ABD-5352-2021	Demuth, Ilja/0000-0002-4340-2523; Carreau, Madeleine/0000-0002-0582-6114	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL050131] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL50131] Funding Source: Medline		Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1998, GENETIC BASIS HUMAN, P317; Auerbach Arleen D., 1997, Current Opinion in Pediatrics, V9, P600, DOI 10.1097/00008480-199712000-00010; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; Busch DB, 1996, MUTAT RES-DNA REPAIR, V363, P209, DOI 10.1016/0921-8777(96)00014-6; Carreau M, 1998, MOL MED TODAY, V4, P201, DOI 10.1016/S1357-4310(98)01243-X; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Hoatlin ME, 1998, BLOOD, V91, P1418, DOI 10.1182/blood.V91.4.1418; ISHIDA R, 1982, CANCER RES, V42, P4000; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kupfer GM, 1997, NAT GENET, V17, P487, DOI 10.1038/ng1297-487; Levran O, 1997, P NATL ACAD SCI USA, V94, P13051, DOI 10.1073/pnas.94.24.13051; Liu N, 1997, P NATL ACAD SCI USA, V94, P9232, DOI 10.1073/pnas.94.17.9232; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; MOSHELL AN, 1981, IN VITRO CELL DEV B, V17, P299; Saar K, 1998, EUR J HUM GENET, V6, P501, DOI 10.1038/sj.ejhg.5200241; SAVOV A, 1992, NUCLEIC ACIDS RES, V20, P6741, DOI 10.1093/nar/20.24.6741; SCHINDLER D, 1988, AM J HUM GENET, V43, P429; SEYSCHAB H, 1995, BLOOD, V85, P2233, DOI 10.1182/blood.V85.8.2233.bloodjournal8582233; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Whitney MA, 1996, BLOOD, V88, P49	25	259	262	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					281	283		10.1038/3093			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	WOS:000076698100023	9806548				2022-01-24	
J	Bullido, MJ; Artiga, MJ; Recuero, M; Sastre, I; Garcia, MA; Aldudo, J; Lendon, C; Han, SW; Morris, JC; Frank, A; Vazquez, J; Goate, A; Valdivieso, F				Bullido, MJ; Artiga, MJ; Recuero, M; Sastre, I; Garcia, MA; Aldudo, J; Lendon, C; Han, SW; Morris, JC; Frank, A; Vazquez, J; Goate, A; Valdivieso, F			A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia	NATURE GENETICS			English	Article							APOLIPOPROTEIN-E; TYPE-4 ALLELE; DISEASE; FREQUENCY; RNA	The epsilon 4 allele of the apolipoprotein E gene (APOE) has been associated with an increased risk of developing Alzheimer's disease (AD; refs 1,2). However, it is apparent that the APOE epsilon 4 allele alone is neither necessary nor sufficient to cause the disease(3-5). We have recently found three new polymorphisms within the APOE transcriptional regulatory region (M.J.A. et al., manuscript submitted) and now establish an association between one of these polymorphisms (-491A/T) and dementia as observed in Cases Alzheimer's disease, in two independent clinical populations. The results suggest that homozygosity of a common variant (-491A) is associated with increased risk for AD, and that this association is independent of APOE epsilon 4 status. In vitro studies suggest that the -491A/T polymorphism may increase risk for AD by altering the level of ApoE protein expression.	Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol & Genet, St Louis, MO 63110 USA; Univ Autonoma Madrid, Hosp La Paz, Serv Neurol, Madrid 28034, Spain		Valdivieso, F (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain.	fvaldivieso@cbm.uam.es	Morris, John C/A-1686-2012; Bullido, Maria/C-8509-2014; Garcia, Ana Frank/I-5159-2015; Vazquez, Jesus/B-7697-2015	Bullido, Maria/0000-0002-6477-1117; Garcia, Ana Frank/0000-0003-3858-9116; Vazquez, Jesus/0000-0003-1461-5092; Goate, Alison/0000-0002-0576-2472; Aldudo, Jesus/0000-0002-7098-4709	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG05681, AG00634] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005681] Funding Source: NIH RePORTER		BENNETT C, 1995, AM J MED GENET, V60, P1, DOI 10.1002/ajmg.1320600102; Berg Leonard, 1994, P9; Blesa R, 1996, ANN NEUROL, V39, P548, DOI 10.1002/ana.410390419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Garcia MA, 1996, J NEUROSCI, V16, P7550; Higuchi R., 1990, PCR PROTOCOLS GUIDE, P177; HIXSON JE, 1990, J LIPID RES, V31, P545; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; Lendon CL, 1997, NEUROSCI LETT, V222, P187, DOI 10.1016/S0304-3940(97)13381-X; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; Muros M, 1996, ATHEROSCLEROSIS, V121, P13, DOI 10.1016/0021-9150(95)06643-8; PAYAMI H, 1993, LANCET, V342, P738; Relkin NR, 1996, LANCET, V347, P1091, DOI 10.1016/S0140-6736(96)90284-6; SANTANA MA, 1996, J NEUROL S2, V243, P591; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Taddei K, 1997, NEUROSCI LETT, V223, P29, DOI 10.1016/S0304-3940(97)13394-8; YAMADA T, 1995, J NEUROL SCI, V129, P56, DOI 10.1016/0022-510X(94)00249-N	20	259	266	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1998	18	1					69	71		10.1038/ng0198-69			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	WOS:000071259600025	9425904				2022-01-24	
J	Xiao, S; Nalabolu, SR; Aster, JC; Ma, JL; Abruzzo, L; Jaffe, ES; Stone, R; Weissman, SM; Hudson, TJ; Fletcher, JA				Xiao, S; Nalabolu, SR; Aster, JC; Ma, JL; Abruzzo, L; Jaffe, ES; Stone, R; Weissman, SM; Hudson, TJ; Fletcher, JA			FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome	NATURE GENETICS			English	Article							FIBROBLAST GROWTH-FACTOR; T-CELL; CHROMOSOMAL TRANSLOCATIONS; LYMPHOBLASTIC LYMPHOMA; RECEPTOR; EOSINOPHILIA; ABERRATIONS; MALIGNANCY; ACTIVATION; MUTATIONS	Various histological subtypes of leukaemia and lymphoma are associated with diagnostic chromosome translocations(1-4), and substantial strides have been made in determining the specific oncogenes targetted by those translocations. We report the cloning of a novel fusion oncogene associated with a unique leukaemia/lymphoma syndrome. Patients afflicted with this syndrome present with lymphoblastic lymphoma and a myeloproliferative disorder, often accompanied by pronounced peripheral eosinophilia and/or prominent eosinophilic infiltrates in the affected bone marrow, which generally progress to full-blown acute myelogenous leukaemia within a year of diagnosis(5-9). A specific chromosome translocation, t(8;13)(p11;q11-12), is found in both lymphoma and myeloid leukaemia cells from these patients, supporting bi-lineage differentiation from a transformed stem cell(6-8). We find that the 8p11 translocation breakpoints, in each of four patients, interrupt intron 8 of the fibroblast growth factor receptor 1 gene (FGFR1). These translocations are associated with aberrant transcripts in which four predicted zinc-finger domains, contributed by a novel and widely expressed chromosome-13 gene (ZNF198), are fused to the FGFR1 tyrosine-kinase domain. Transient expression studies show that the ZNF198-FGFR1 fusion transcript directs the synthesis of an approximately 87-kD polypeptide, localizing predominantly to the cytoplasm. Our studies demonstrate an FGFR1 oncogenic role and suggest a tumorigenic mechanism in which ZNF198-FGFR1 activation results from ZNF198 zinc-finger-mediated homodimerization.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Yale Univ, Sch Med, New Haven, CT 06536 USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02142 USA; Univ Maryland, Med Ctr, Dept Pathol, Baltimore, MD 21201 USA; NCI, Hematopathol Sect, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA		Xiao, S (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Jaffe, Elaine S/G-8984-2014	Jaffe, Elaine S/0000-0003-4632-0301	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA72791] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA072791] Funding Source: NIH RePORTER		ABRUZZO LV, 1992, AM J SURG PATHOL, V16, P236, DOI 10.1097/00000478-199203000-00003; Aster JC, 1997, J BIOL CHEM, V272, P11336; AVRAHAM H, 1994, BLOOD, V83, P2126; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; CROCE CM, 1993, SEMIN ONCOL, V20, P31; DIB A, 1995, ONCOGENE, V10, P995; FAGAN K, 1993, CANCER GENET CYTOGEN, V65, P71, DOI 10.1016/0165-4608(93)90062-Q; FLETCHER JA, 1991, NEW ENGL J MED, V324, P436, DOI 10.1056/NEJM199102143240702; GABBIANELLI M, 1990, SCIENCE, V249, P1561, DOI 10.1126/science.2218497; GABRILOVE JL, 1994, BLOOD, V83, P907; INHORN RC, 1995, BLOOD, V85, P1881, DOI 10.1182/blood.V85.7.1881.bloodjournal8571881; ITOH N, 1990, BIOCHEM BIOPH RES CO, V169, P680, DOI 10.1016/0006-291X(90)90384-Y; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MACDONALD D, 1995, LEUKEMIA, V9, P1628; NAEEM R, 1995, GENE CHROMOSOME CANC, V12, P148, DOI 10.1002/gcc.2870120210; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; OFFIT K, 1991, HEMATOL ONCOL CLIN N, V5, P853, DOI 10.1016/S0889-8588(18)30389-7; PARIMOO S, 1993, NUCLEIC ACIDS RES, V21, P4422, DOI 10.1093/nar/21.18.4422; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RODRIGUES GA, 1993, MOL CELL BIOL, V13, P6711, DOI 10.1128/MCB.13.11.6711; ROWLEY JD, 1990, CANCER RES, V50, P3816; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Tong Q, 1997, J BIOL CHEM, V272, P9043; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Verdier AS, 1997, GENOMICS, V40, P151, DOI 10.1006/geno.1996.4492; WILSON EL, 1991, BLOOD, V77, P954; XIAO S, 1995, AM J PATHOL, V147, P896	30	259	270	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					84	87		10.1038/ng0198-84			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	WOS:000071259600029	9425908				2022-01-24	
J	Ober, C; Weitkamp, LR; Cox, N; Dytch, H; Kostyu, D; Elias, S				Ober, C; Weitkamp, LR; Cox, N; Dytch, H; Kostyu, D; Elias, S			HLA and mate choice in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY TYPES; MATING PREFERENCES; MOUSE STRAINS; MICE; HUTTERITES; ISOLATE; RECOGNITION; COMPLEX; LOCUS	Evidence from studies in rodents suggests that mate selection is influenced by major-histocompatibility-complex haplotypes, with preferences for dissimilar partners. This study was initiated to determine whether avoidance of a mate with the same HLA haplotype as one's own might be occurring in the Hutterites, a North American reproductive isolate of European ancestry, notable for their large sibships, communal lifestyle, and limited number of five-locus HLA haplotypes (HLA-A, -B, -C, -DR, and -DQ). HLA haplotypes were known for 411 Hutterite couples. The number of couples expected to match for a haplotype was calculated in two ways: first, from population genotype frequencies, with account being taken of the nonrandom mating pattern with respect to colony lineages, and, second, from computer simulations using conservative founder assumptions and the exact genealogy of the 411 couples. We observed fewer matches for HLA haplotypes between spouses than expected (first method, P =.005; second method, P =.020-.067). Among couples who did match for a haplotype, the matched haplotype was inherited from the mother in 29 cases and from the father in 50 cases (P =.018). These results are consistent with the conclusion that Hutterite mate choice is influenced by HLA haplotypes, with an avoidance of spouses with haplotypes that are the same as one's own.	UNIV CHICAGO, DEPT MED, CHICAGO, IL 60637 USA; UNIV ROCHESTER, MED CTR, DEPT PSYCHIAT, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, MED CTR, DIV GENET, ROCHESTER, NY 14642 USA; DUKE UNIV, MED CTR, DEPT IMMUNOL, DURHAM, NC 27706 USA; BAYLOR COLL MED, DEPT OBSTET & GYNECOL, HOUSTON, TX 77030 USA		Ober, C (corresponding author), UNIV CHICAGO, CTR MED GENET, DEPT OBSTET & GYNECOL, 924 E 57TH ST, CHICAGO, IL 60637 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD021244] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD021244, HD21244] Funding Source: Medline		BEAUCHAMP GK, 1985, P NATL ACAD SCI USA, V82, P4186, DOI 10.1073/pnas.82.12.4186; Bleibtreu H., 1964, THESIS HARVARD U CAM; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; DAWSON DV, 1995, GENET EPIDEMIOL, V12, P47, DOI 10.1002/gepi.1370120106; EGID K, 1989, ANIM BEHAV, V38, P548, DOI 10.1016/S0003-3472(89)80051-X; GILBERT AN, 1986, J COMP PSYCHOL, V100, P262, DOI 10.1037/0735-7036.100.3.262; Hostetler John A., 1974, HUTTERITE SOC; JIN K, 1995, BIOMETRICS, V51, P1064, DOI 10.2307/2533005; KOSTYU DD, 1989, AM J HUM GENET, V45, P261; KOSTYU DD, 1993, HUM IMMUNOL, V37, P135, DOI 10.1016/0198-8859(93)90178-4; MANGE AP, 1964, HUM BIOL, V36, P104; MARTIN AO, 1970, AM J PHYS ANTHROPOL, V32, P351, DOI 10.1002/ajpa.1330320305; OBER C, 1992, AM J HUM GENET, V50, P6; OBER C, 1995, PLACENTA, V16, P569, DOI 10.1016/0143-4004(95)90026-8; OBRIEN E, 1987, MAMMALIAN DISPERSAL, P193; POLLACK MS, 1982, IMMUNOGENETICS, V15, P579; PORTER RH, 1990, CHEM SIGNAL, V5, P289; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; ROSENBERG LT, 1983, IMMUNOGENETICS, V17, P89, DOI 10.1007/BF00364292; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; VOGEL F, 1996, HUMAN GENETICS; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1979, J EXP MED, V150, P755, DOI 10.1084/jem.150.4.755; YAMAZAKI K, 1990, CHEM SIGNAL, V5, P255; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818; YAMAZAKI K, 1978, IMMUNOGENETICS, V6, P253, DOI 10.1007/BF01563915	28	259	272	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					497	504		10.1086/515511			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	WOS:A1997XY52300006	9326314	Green Published, Bronze			2022-01-24	
J	Tajima, F				Tajima, F			The amount of DNA polymorphism maintained in a finite population when the neutral mutation rate varies among sites	GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; NUCLEOTIDE-SEQUENCES; DIVERGENCE	The expectations of the average number of nucleotide differences per site (pi), the proportion of segregating site (s), the minimum number of mutations per site (s*) and some other quantities were derived under the finite site models with and without rate variation among sites, where the finite site models include Jukes and Canter's model, the equal-input model and Kimura's model. As a model of rate variation, the gamma distribution was used. The results indicate that if distribution parameter alpha is small, the effect of rate variation on these quantities are substantial, so that the estimates of a based on the infinite site model are substantially underestimated, where theta = 4N upsilon, N is the effective population size and upsilon is the mutation rate per site per generation. New methods for estimating theta are also presented, which are based on the finite site models with and without rate variation. Using these methods, underestimation can be corrected.			Tajima, F (corresponding author), UNIV TOKYO, GRAD SCH SCI, DEPT BIOL SCI, BUNKYO KU, HONGO 7-3-1, TOKYO 113, JAPAN.						BERTORELLE G, 1995, MOL BIOL EVOL, V12, P887; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FU YX, 1994, GENETICS, V136, P685; FU YX, 1993, GENETICS, V133, P693; FU YX, 1994, GENETICS, V138, P1375; GOLDING GB, 1983, MOL BIOL EVOL, V1, P125; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1991, PHILOS T ROY SOC B, V333, P409, DOI 10.1098/rstb.1991.0091; HORAI S, 1990, AM J HUM GENET, V46, P828; JUKS TH, 1969, MAMMALIAN PROTEIN ME, P21; KIMURA M, 1969, GENETICS, V61, P893; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura M., 1983, NEUTRAL THEORY MOL E; KUHNER MK, 1995, GENETICS, V140, P1421; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; ROGERS A, 1992, MOL BIOL EVOL, V9, P1181; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1982, J MOL EVOL, V18, P115, DOI 10.1007/BF01810830; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; WAKELEY J, 1993, J MOL EVOL, V37, P613; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	27	259	269	0	17	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	1996	143	3					1457	1465					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU742	WOS:A1996UU74200036	8807315				2022-01-24	
J	RUBINSZTEIN, DC; AMOS, W; LEGGO, J; GOODBURN, S; JAIN, S; LI, SH; MARGOLIS, RL; ROSS, CA; FERGUSONSMITH, MA				RUBINSZTEIN, DC; AMOS, W; LEGGO, J; GOODBURN, S; JAIN, S; LI, SH; MARGOLIS, RL; ROSS, CA; FERGUSONSMITH, MA			MICROSATELLITE EVOLUTION - EVIDENCE FOR DIRECTIONALITY AND VARIATION IN RATE BETWEEN SPECIES	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; TRINUCLEOTIDE CAG REPEAT; HUNTINGTONS-DISEASE; LOCUS; EXPANSION; LENGTH; GENE; MUTATION; ONSET; AGE	Microsatellite DNA sequences are rapidly becoming the dominant source of nuclear genetic markers for a wide range of applications, from genome mapping to forensic testing to population studies. If misinterpretation is to be avoided, it is vital that we understand fully the way in which microsatellite sequences evolve. We have therefore compared allele length distributions for 42 microsatellites in humans with their homologues in a range of related primates. We find a highly significant trend for the loci to be longer in humans, showing that microsatellites can evolve directionally and at different rates in closely related species.	UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 2QQ,ENGLAND; ADDENBROOKES HOSP,DEPT CLIN GENET,CAMBRIDGE CB2 2QQ,ENGLAND; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,MOLEC NEUROBIOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,ENGLAND		RUBINSZTEIN, DC (corresponding author), ADDENBROOKES NHS TRUST,GENET MOLEC LAB,E ANGLIAN REG GENET SERV,BOX 158,HILLS RD,CAMBRIDGE CB2 2QQ,ENGLAND.		Rubinsztein, David C/C-3472-2011		NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH050763] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH50763] Funding Source: Medline		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BANCHS I, 1994, HUM MUTAT, V3, P365, DOI 10.1002/humu.1380030407; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; COLEMAN MP, 1991, GENOMICS, V11, P991, DOI 10.1016/0888-7543(91)90024-9; DEKA R, 1994, GENOMICS, V22, P226, DOI 10.1006/geno.1994.1369; DOVER GA, 1993, CURR OPIN GENET DEV, V3, P902, DOI 10.1016/0959-437X(93)90012-E; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FARRER LA, 1992, AM J HUM GENET, V50, P528; FU YH, CELL, V67, P1047; GRAY IC, 1991, P ROY SOC B-BIOL SCI, V243, P241, DOI 10.1098/rspb.1991.0038; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDWICK LJ, 1993, HUM MOL GENET, V2, P1755, DOI 10.1093/hmg/2.10.1755; HUGNOT JP, 1991, NUCLEIC ACIDS RES, V19, P3159, DOI 10.1093/nar/19.11.3159; JANSEN G, 1994, AM J HUM GENET, V54, P575; JANSEN G, 1992, GENOMICS, V13, P509, DOI 10.1016/0888-7543(92)90118-C; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; JODICE C, 1994, AM J HUM GENET, V54, P959; Jones Michael H., 1992, Human Molecular Genetics, V1, P131, DOI 10.1093/hmg/1.2.131; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOLDE R, 1994, NAT GENET, V6, P9; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P220; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MOORE BJ, 1991, NUCLEIC ACIDS RES, V20, P929; NAPLER JR, 1967, HDB LIVING PRIMATES; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OUDET C, 1992, J MED GENET, V30, P300; PASCHEN W, 1994, GENOMICS, V20, P435, DOI 10.1006/geno.1994.1198; PORTER CJ, 1992, NUCLEIC ACIDS RES, V20, P1429, DOI 10.1093/nar/20.6.1429; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; ROUX AF, 1993, HUM MOL GENET, V2, P821, DOI 10.1093/hmg/2.6.821-a; RUBINSZTEIN DC, 1994, BRIT J PSYCHIAT, V164, P851, DOI 10.1192/bjp.164.6.851; RUBLNSZTEIN DC, 1994, NAT GENET, V7, P525; SLIERENDREGT BL, 1993, TISSUE ANTIGENS, V42, P55, DOI 10.1111/j.1399-0039.1993.tb02237.x; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STANIER P, 1991, NUCLEIC ACIDS RES, V19, P4793, DOI 10.1093/nar/19.17.4793; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; TSAI YC, 1995, J UROLOGY, V153, P1697, DOI 10.1016/S0022-5347(01)67507-4; VALDES AM, 1993, GENETICS, V133, P737; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; WEBER JL, 1993, HUM MOL GENET, V8, P1123; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213	46	259	263	0	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					337	343		10.1038/ng0795-337			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	WOS:A1995RG38600019	7670473				2022-01-24	
J	MOLL, RH; LONNQUIST, JH; FORTUNO, JV; JOHNSON, EC				MOLL, RH; LONNQUIST, JH; FORTUNO, JV; JOHNSON, EC			RELATIONSHIP OF HETEROSIS AND GENETIC DIVERGENCE IN MAIZE	GENETICS			English	Article																	ANDERSON E, 1958, ANN MISSOURI BOTAN G, V35, P255; BROWN WL, 1953, 8 P ANN HYBR CORN IN, V8, P11; BROWN WL, 1953, TROP AGR, V30, P141; East EM, 1936, GENETICS, V21, P375; EAST EM, 1912, PLANT IND B, V243, P1; HAYES H. K., 1939, JOUR AMER SOC AGRON, V31, P710; JOHNSON I. J., 1940, JOUR AMER SOC AGRON, V32, P479; Mangelsdorf, 1952, RACES MAIZE MEXICO; MOLL R. H., 1962, CROP SCI, V2, P197, DOI 10.2135/cropsci1962.0011183X000200030005x; PATERNIANI E., 1963, Crop science, V3, P504, DOI 10.2135/cropsci1963.0011183X000300060014x; RICHEY FD, 1922, J AM SOC AGRON, V14, P1; WU SHAO-KWEI, 1939, JOUR AMER SOC AGRON, V31, P131	12	259	274	0	3	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1965	52	1					139	+					1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	66033	WOS:A19656603300012	17248265				2022-01-24	
J	Wong, VK; Baker, S; Pickard, DJ; Parkhill, J; Page, AJ; Feasey, NA; Kingsley, RA; Thomson, NR; Keanel, JA; Weill, FX; Edwards, DJ; Hawkey, J; Harris, SR; Mather, AE; Cain, AK; Hadfield, J; Hart, PJ; Thieu, NTV; Klemm, EJ; Glinos, DA; Breiman, RF; Watson, CH; Kariuki, S; Gordon, MA; Heyderman, RS; Okoro, C; Jacobs, J; Lunguya, O; Edmunds, WJ; Msefula, C; Chabalgoity, JA; Kama, M; Jenkins, K; Dutta, S; Marks, F; Campos, J; Thompson, C; Obaro, S; MacLennan, CA; Dolecek, C; Keddy, KH; Smith, AM; Parry, CM; Karkey, A; Mulholland, EK; Campbell, JI; Dongol, S; Basnyat, B; Dufour, M; Bandaranayake, D; Naseri, TT; Singh, SP; Hatta, M; Newton, P; Onsare, RS; Isaia, L; Dance, D; Davong, V; Thwaites, G; Wijedoru, L; Crump, JA; De Pinna, E; Nair, S; Nilles, EJ; Thanh, DP; Turner, P; Soeng, S; Valcanis, M; Powling, J; Dimovski, K; Hogg, G; Farrar, J; Holt, KE; Dougan, G				Wong, Vanessa K.; Baker, Stephen; Pickard, Derek J.; Parkhill, Julian; Page, Andrew J.; Feasey, Nicholas A.; Kingsley, Robert A.; Thomson, Nicholas R.; Keanel, Jacqueline A.; Weill, Francois-Xavier; Edwards, David J.; Hawkey, Jane; Harris, Simon R.; Mather, Alison E.; Cain, Amy K.; Hadfield, James; Hart, Peter J.; Nga Tran Vu Thieu; Klemm, Elizabeth J.; Glinos, Dafni A.; Breiman, Robert F.; Watson, Conall H.; Kariuki, Samuel; Gordon, Melita A.; Heyderman, Robert S.; Okoro, Chinyere; Jacobs, Jan; Lunguya, Octavie; Edmunds, W. John; Msefula, Chisorno; Chabalgoity, Jose A.; Kama, Mike; Jenkins, Kylie; Dutta, Shanta; Marks, Florian; Campos, Josefina; Thompson, Corinne; Obaro, Stephen; MacLennan, Calman A.; Dolecek, Christiane; Keddy, Karen H.; Smith, Anthony M.; Parry, Christopher M.; Karkey, Abhilasha; Mulholland, E. Kim; Campbell, James I.; Dongol, Sabina; Basnyat, Buddha; Dufour, Muriel; Bandaranayake, Don; Naseri, Take Toleafoa; Singh, Shalini Pravin; Hatta, Mochammad; Newton, Paul; Onsare, Robert S.; Isaia, Lupeoletalalei; Dance, David; Davong, Viengmon; Thwaites, Guy; Wijedoru, Lalith; Crump, John A.; De Pinna, Elizabeth; Nair, Satheesh; Nilles, Eric J.; Duy Pham Thanh; Turner, Paul; Soeng, Sona; Valcanis, Mary; Powling, Joan; Dimovski, Karolina; Hogg, Geoff; Farrar, Jeremy; Holt, Kathryn E.; Dougan, Gordon			Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events	NATURE GENETICS			English	Article							ENTERICA SEROVAR TYPHI; ANTIBIOTIC-RESISTANCE; INTERACTIVE TREE; INCHI1 PLASMIDS; FEVER; MUTATIONS; EVOLUTION; ANNOTATION; POPULATION; PARATYPHI	The emergence of multidrug-resistant (MDR) typhoid is a major global health threat affecting many countries where the disease is endemic. Here whole-genome sequence analysis of 1,832 Salmonella enterica serovar Typhi (S. Typhi) identifies a single dominant MDR lineage, H58, that has emerged and spread throughout Asia and Africa over the last 30 years. Our analysis identifies numerous transmissions of H58, including multiple transfers from Asia to Africa and an ongoing, unrecognized MDR epidemic within Africa itself. Notably, our analysis indicates that H58 lineages are displacing antibiotic-sensitive isolates, transforming the global population structure of this pathogen. H58 isolates can harbor a complex MDR element residing either on transmissible IncHI1 plasmids or within multiple chromosomal integration sites. We also identify new mutations that define the H58 lineage. This phylogeographical analysis provides a framework to facilitate global management of MDR typhoid and is applicable to similar MDR lineages emerging in other bacterial species.	[Wong, Vanessa K.; Pickard, Derek J.; Page, Andrew J.; Kingsley, Robert A.; Keanel, Jacqueline A.; Mather, Alison E.; Cain, Amy K.; Hadfield, James; Klemm, Elizabeth J.; Glinos, Dafni A.; Okoro, Chinyere; MacLennan, Calman A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Wong, Vanessa K.] Univ Cambridge, Hosp Natl Hlth Serv NHS Fdn Trust, Addenbrookes Hosp, Dept Microbiol, Cambridge, England; [Baker, Stephen; Nga Tran Vu Thieu; Thompson, Corinne; Thwaites, Guy] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Baker, Stephen; Thompson, Corinne; Dolecek, Christiane; Newton, Paul; Dance, David; Thwaites, Guy; Turner, Paul; Farrar, Jeremy] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Baker, Stephen; Thomson, Nicholas R.; Mulholland, E. Kim] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Feasey, Nicholas A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kingsley, Robert A.] Inst Food Res, Norwich, Norfolk, England; [Weill, Francois-Xavier] Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Edwards, David J.; Hawkey, Jane] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Hawkey, Jane] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia; [MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England; [Breiman, Robert F.; Kariuki, Samuel] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Breiman, Robert F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Breiman, Robert F.] Emory Global Hlth Inst, Atlanta, GA USA; [Watson, Conall H.; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Ctr Math Modelling Infect Dis, London WC1, England; [Gordon, Melita A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Katholieke Univ KU Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Lunguya, Octavie] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Lunguya, Octavie] Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO; [Msefula, Chisorno] Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; [Chabalgoity, Jose A.] Inst Higiene, Facultad Medicina, Dept Desarrollo Biotecnol, Montevideo, Uruguay; [Kama, Mike] Minist Hlth, Suva, Fiji; [Jenkins, Kylie] Fiji Hlth Sector Support Program, Suva, Fiji; [Dutta, Shanta] Natl Inst Cholera & Enter Dis, Kolkata, India; [Marks, Florian] Int Vaccine Inst, Dept Epidemiol, Seoul, South Korea; [Campos, Josefina] Carlos G Malbran Inst, ANLIS, Enteropathogen Div, Buenos Aires, DF, Argentina; [Obaro, Stephen] Univ Nebraska, Med Ctr, Div Pediat Infect Dis, Omaha, NE 68182 USA; [Obaro, Stephen] Univ Abuja, Teaching Hosp, Abuja, Nigeria; [Obaro, Stephen] Bingham Univ, Karu, Nigeria; [MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Keddy, Karen H.; Smith, Anthony M.] Univ Witwatersrand, Ctr Enter Dis, Natl Inst Communicable Dis, Div Natl Hlth Lab Serv, Johannesburg, South Africa; [Parry, Christopher M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Parry, Christopher M.] Nagasaki Univ, Grad Sch Trop Med & Global Hlth, Nagasaki 852, Japan; [Dongol, Sabina; Basnyat, Buddha] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Patan Acad Hlth Sci, Kathmandu, Nepal; [Mulholland, E. Kim] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Dufour, Muriel] Inst Environm Sci & Res Ltd ESR, Enter & Leptospira Reference Lab, Porirua, New Zealand; [Bandaranayake, Don] Inst Environm Sci & Res, Natl Ctr Biosecur & Infect Dis, Porirua, New Zealand; [Singh, Shalini Pravin] WHO, Ctr Communicable Dis Control, Natl Influenza Ctr, Suva, Fiji; [Hatta, Mochammad] Hasanuddin Univ, Dept Microbiol, Makassar, Indonesia; [Newton, Paul; Dance, David; Davong, Viengmon] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Wellcome Trust Res Unit, Viangchan, Laos; [Wijedoru, Lalith; Turner, Paul] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Wijedoru, Lalith] Chelsea & Westminster Hosp, Paediat Emergency Med, London, England; [Crump, John A.] Univ Otago, Ctr Int Hlth & Otago Int Hlth Res Network, Dunedin Sch Med, Dunedin, New Zealand; [De Pinna, Elizabeth; Nair, Satheesh] Publ Hlth England, Salmonella Reference Serv, London, England; [Nilles, Eric J.] WHO, Div Pacific Tech Support, Emerging Dis Surveillance & Response, Suva, Fiji; [Turner, Paul; Soeng, Sona] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [Valcanis, Mary; Powling, Joan; Dimovski, Karolina; Hogg, Geoff] Univ Melbourne, Microbiol Diagnost Unit, Dept Microbiol & Immunol, Doherty Inst Infect & Immun,Publ Hlth Lab, Melbourne, Vic, Australia		Wong, VK (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	vw1@sanger.ac.uk	MacLennan, Calman A/L-9343-2014; Pham, Thanh Duy/AAX-3845-2020; Crump, John A./AAZ-6412-2020; Hatta, Mochammad/D-3742-2019; Msefula, Chisomo/AAY-9107-2020; Nilles, Eric/ABA-4757-2021; Hawkey, Jane/AAE-3443-2021; Holt, Kathryn E/A-8108-2012; Thomson, Nicholas R/P-5988-2014; Keddy, Karen Helena/AAZ-2189-2020; Parkhill, Julian/G-4703-2011; Crump, John A./AAZ-6289-2020; Thwaites, Guy E/R-4993-2019; Gordon, Melita/F-5563-2012	MacLennan, Calman A/0000-0001-9694-0846; Pham, Thanh Duy/0000-0001-7029-9210; Crump, John A./0000-0002-4529-102X; Hatta, Mochammad/0000-0002-8456-4203; Nilles, Eric/0000-0001-7044-5257; Hawkey, Jane/0000-0001-9661-5293; Holt, Kathryn E/0000-0003-3949-2471; Thomson, Nicholas R/0000-0002-4432-8505; Keddy, Karen Helena/0000-0001-8640-2235; Parkhill, Julian/0000-0002-7069-5958; Crump, John A./0000-0002-4529-102X; Thwaites, Guy E/0000-0002-2858-2087; Feasey, Nicholas/0000-0003-4041-1405; Gordon, Melita/0000-0002-0629-0884; Weill, Francois-Xavier/0000-0001-9941-5799; Okoro, Chinyere/0000-0002-2466-304X; Keane, Jacqueline A./0000-0003-0739-6848; Turner, Paul/0000-0002-1013-7815; Page, Andrew/0000-0001-6919-6062; Msefula, Chisomo/0000-0003-2304-886X; Newton, Paul/0000-0002-4608-6431; Heyderman, Robert/0000-0003-4573-449X; Nair, Satheesh/0000-0002-7297-1485; Marks, Florian/0000-0002-6043-7170; Farrar, Jeremy/0000-0002-2700-623X; Baker, Stephen/0000-0003-1308-5755; Kingsley, Robert/0000-0002-0194-6485; Dufour, Muriel/0000-0003-3638-4918; Glinos, Dafni/0000-0001-5556-0222; Campos, Josefina/0000-0003-1409-0441; Dance, David/0000-0001-9189-7244; Watson, Conall/0000-0002-2469-791X; Cain, Amy/0000-0002-4230-6572	Wellcome TrustWellcome TrustEuropean Commission; Wellcome Trust awardWellcome Trust [098051]; Wellcome Trust research fellowshipWellcome Trust [WT092152MA]; Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme [101113/Z/13/Z]; Wellcome Trust Mahidol University Oxford Tropical Medicine Research ProgrammeWellcome Trust; Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant)Wellcome Trust; European Society for Paediatric Infectious Diseases; University of Oxford-Li Ka Shing Global Health Foundation; Wellcome TrustWellcome TrustEuropean Commission [089275/H/091Z]; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [1061409]; Victorian Life Sciences Computation Initiative (VLSCI) [VR0082]; Clinical Research Fellowship from GlaxoSmithKline; UK Medical Research Council PhD studentshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Institut PasteurEuropean Commission; Institut de Veille Sanitaire; French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence)French National Research Agency (ANR) [ANR-10-LABX-62-IBEID]; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/J003999/1, G1100100/1]; Society in Science; Branco Weiss Fellowship; antibiotic resistance surveillance project in the Democratic Republic of the Congo; Belgian Directorate General of Development Cooperation [2.01]; Institute of Tropical Medicine (Antwerp, Belgium) [2.01]; Bill and Melinda Gates FoundationBill & Melinda Gates Foundation; US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program [R01 TW009237]; UK Biotechnology and Biological Sciences Research Council (BBSRC)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J010367/1]; UK BBSRC Zoonoses in Emerging Livestock Systems awardsUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L017679, BB/L018926, BB/L018845]; US National Institutes of Health grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AI099525-02]; Royal SocietyRoyal Society of LondonEuropean Commission [100087/Z/12/Z]; National Institute of Allergy and Infectious Diseases of the US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI097493]; Div Of Molecular and Cellular BioscienceNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [1330800] Funding Source: National Science Foundation; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R01TW009237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI099525, U01AI062563, R01AI097493] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L018926/1, BB/L018845/1, BB/J010367/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1100100, 1263989, G9818340] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J010367/1, BB/L018926/1, BB/L018845/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9818340] Funding Source: UKRI	This work was supported by the Wellcome Trust. We would like to thank the members of the Pathogen Informatics Team and the core sequencing teams at the Wellcome Trust Sanger Institute (Cambridge, UK). We are grateful to D. Harris for his superb work in managing the sequence data. We also thank L. Fabre for her excellent technical assistance.; This work was supported by a number of organizations. The authors affiliated with the Wellcome Trust Sanger Institute were funded by Wellcome Trust award 098051; N.A.F. was supported by Wellcome Trust research fellowship WT092152MA. N.A.F., R.S.H. and this work were supported by a strategic award from the Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme (101113/Z/13/Z). C.M.P. was funded by the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant), the European Society for Paediatric Infectious Diseases and the University of Oxford-Li Ka Shing Global Health Foundation. D.D., P.N. and V.D. were supported by the Wellcome Trust (core grant 089275/H/091Z). K.E.H. was supported by the National Health and Medical Research Council of Australia (fellowship 1061409) and the Victorian Life Sciences Computation Initiative (VLSCI; grant VR0082). C.A.M. was supported by a Clinical Research Fellowship from GlaxoSmithKline, and P.J.H. was supported by a UK Medical Research Council PhD studentship. This work forms part of a European Union Framework Programme 7 Marie Curie Actions Industry Academia Partnerships and Pathways (LAPP) Consortium Programme, entitled GENDRIVAX (Genome-Driven Vaccine Development for Bacterial Infections), involving the Wellcome Trust Sanger Institute, KEMRI Nairobi and the Novartis Vaccines Institute for Global Health. The authors affiliated with the Institut Pasteur were funded by the Institut Pasteur, the Institut de Veille Sanitaire and the French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence, grant ANR-10-LABX-62-IBEID). C.H.W. was supported by the UK Medical Research Council (MR/J003999/1). CO. was supported by Society in Science and the Branco Weiss Fellowship, administered by ETH Zurich. A.K.C. was supported by the UK Medical Research Council (G1100100/1). J.J. was supported by the antibiotic resistance surveillance project in the Democratic Republic of the Congo, funded by project 2.01 of the Third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine (Antwerp, Belgium). F.M. was supported by a research grant from the Bill and Melinda Gates Foundation. The findings and conclusions contained within this publication are those of the authors and do not necessarily reflect positions or policies of the Bill and Melinda Gates Foundation. J.A. Crump was supported by the joint US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program (R01 TW009237), the UK Biotechnology and Biological Sciences Research Council (BBSRC; BB/J010367/1) and UK BBSRC Zoonoses in Emerging Livestock Systems awards BB/L017679, BB/L018926 and BB/L018845. S.K. was supported by US National Institutes of Health grant R01 AI099525-02. S.B. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). S.O. was supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R01 AI097493). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. C.D.; was supported by the University of Oxford-Li Ka Shing Global Health Foundation.	ANDERSON ES, 1975, J HYG-CAMBRIDGE, V74, P289, DOI 10.1017/S0022172400024360; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Baker S, 2013, ELIFE, V2, DOI 10.7554/eLife.01229; Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Baucheron S, 2005, ANTIMICROB AGENTS CH, V49, P862, DOI 10.1128/AAC.49.2.862-863.2005; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; BODHIDATTA L, 1987, REV INFECT DIS, V9, P841; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Bwakura-Dangarembizi M, 2014, NEW ENGL J MED, V370, P41, DOI 10.1056/NEJMoa1214901; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chiou CS, 2014, ANTIMICROB AGENTS CH, V58, P6501, DOI 10.1128/AAC.03608-14; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Fraser A, 2007, VACCINE, V25, P7848, DOI 10.1016/j.vaccine.2007.08.027; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Gomes C, 2013, MICROB DRUG RESIST, V19, P88, DOI 10.1089/mdr.2012.0036; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Haanpera M, 2005, ANTIMICROB AGENTS CH, V49, P457, DOI 10.1128/AAC.49.1.457-460.2005; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hendriksen RS, 2015, J CLIN MICROBIOL, V53, P262, DOI 10.1128/JCM.02026-14; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Holt KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001490; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Hooper D C, 1993, Drugs, V45 Suppl 3, P8; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Keddy KH, 2010, EMERG INFECT DIS, V16, P879, DOI 10.3201/eid1605.091917; Khan MI, 2010, EXPERT REV VACCINES, V9, P485, DOI 10.1586/ERV.10.43; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lawhon SD, 2003, MOL MICROBIOL, V48, P1633, DOI 10.1046/j.1365-2958.2003.03535.x; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lutterloh E, 2012, CLIN INFECT DIS, V54, P1100, DOI 10.1093/cid/cis012; Marvig RL, 2012, ANTIMICROB AGENTS CH, V56, P4519, DOI 10.1128/AAC.00630-12; Menezes GA, 2012, CLIN MICROBIOL INFEC, V18, P239, DOI 10.1111/j.1469-0691.2011.03546.x; Mirza SH, 1996, J MED MICROBIOL, V44, P317, DOI 10.1099/00222615-44-5-317; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; OLARTE J, 1973, ANTIMICROB AGENTS CH, V4, P597, DOI 10.1128/AAC.4.6.597; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Phan MD, 2009, ANTIMICROB AGENTS CH, V53, P716, DOI 10.1128/AAC.00645-08; Phoba MF, 2012, EMERG INFECT DIS, V18, P1692, DOI 10.3201/eid1810.120525; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Song YJ, 2010, J ANTIMICROB CHEMOTH, V65, P1631, DOI 10.1093/jac/dkq175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	73	258	261	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					632	639		10.1038/ng.3281			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	WOS:000355386500014	25961941	Green Accepted, Green Submitted			2022-01-24	
J	Heinzen, EL; Swoboda, KJ; Hitomi, Y; Gurrieri, F; Nicole, S; de Vries, B; Tiziano, FD; Fontaine, B; Walley, NM; Heavin, S; Panagiotakaki, E; Fiori, S; Abiusi, E; Di Pietro, L; Sweney, MT; Newcomb, TM; Viollet, L; Huff, C; Jorde, LB; Reyna, SP; Murphy, KJ; Shianna, KV; Gumbs, CE; Little, L; Silver, K; Ptacek, LJ; Haan, J; Ferrari, MD; Bye, AM; Herkes, GK; Whitelaw, CM; Webb, D; Lynch, BJ; Uldall, P; King, MD; Scheffer, IE; Neri, G; Arzimanoglou, A; van den Maagdenberg, AMJM; Sisodiya, SM; Mikati, MA; Goldstein, DB				Heinzen, Erin L.; Swoboda, Kathryn J.; Hitomi, Yuki; Gurrieri, Fiorella; Nicole, Sophie; de Vries, Boukje; Tiziano, F. Danilo; Fontaine, Bertrand; Walley, Nicole M.; Heavin, Sinead; Panagiotakaki, Eleni; Fiori, Stefania; Abiusi, Emanuela; Di Pietro, Lorena; Sweney, Matthew T.; Newcomb, Tara M.; Viollet, Louis; Huff, Chad; Jorde, Lynn B.; Reyna, Sandra P.; Murphy, Kelley J.; Shianna, Kevin V.; Gumbs, Curtis E.; Little, Latasha; Silver, Kenneth; Ptacek, Louis J.; Haan, Joost; Ferrari, Michel D.; Bye, Ann M.; Herkes, Geoffrey K.; Whitelaw, Charlotte M.; Webb, David; Lynch, Bryan J.; Uldall, Peter; King, Mary D.; Scheffer, Ingrid E.; Neri, Giovanni; Arzimanoglou, Alexis; van den Maagdenberg, Arn M. J. M.; Sisodiya, Sanjay M.; Mikati, Mohamad A.; Goldstein, David B.		European Alternating Hemiplegia; Biobanca Registro Clinico; European Network Res Alternating	De novo mutations in ATP1A3 cause alternating hemiplegia of childhood	NATURE GENETICS			English	Article							ONSET DYSTONIA-PARKINSONISM; GENE MUTATION; MIGRAINE; PUMP; PATHOPHYSIOLOGY; GENOMES	Alternating hemiplegia of childhood (AHC) is a rare, severe neurodevelopmental syndrome characterized by recurrent hemiplegic episodes and distinct neurological manifestations. AHC is usually a sporadic disorder and has unknown etiology. We used exome sequencing of seven patients with AHC and their unaffected parents to identify de novo nonsynonymous mutations in ATP1A3 in all seven individuals. In a subsequent sequence analysis of ATP1A3 in 98 other patients with AHC, we found that ATP1A3 mutations were likely to be responsible for at least 74% of the cases; we also identified one inherited mutation in a case of familial AHC. Notably, most AHC cases are caused by one of seven recurrent ATP1A3 mutations, one of which was observed in 36 patients. Unlike ATP1A3 mutations that cause rapid-onset dystonia-parkinsonism, AHC-causing mutations in this gene caused consistent reductions in ATPase activity without affecting the level of protein expression. This work identifies de novo ATP1A3 mutations as the primary cause of AHC and offers insight into disease pathophysiology by expanding the spectrum of phenotypes associated with mutations in ATP1A3.	[Heinzen, Erin L.; Hitomi, Yuki; Walley, Nicole M.; Shianna, Kevin V.; Gumbs, Curtis E.; Little, Latasha; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Heinzen, Erin L.; Shianna, Kevin V.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Swoboda, Kathryn J.; Sweney, Matthew T.; Newcomb, Tara M.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Swoboda, Kathryn J.; Viollet, Louis; Reyna, Sandra P.; Murphy, Kelley J.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Gurrieri, Fiorella; Tiziano, F. Danilo; Fiori, Stefania; Abiusi, Emanuela; Di Pietro, Lorena; Neri, Giovanni] Univ Cattolica Sacro Cuore, Inst Med Genet, Policlin A Gemelli, Rome, Italy; [Nicole, Sophie; Fontaine, Bertrand] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Nicole, Sophie; Fontaine, Bertrand] INSERM, U975, Paris, France; [Nicole, Sophie; Fontaine, Bertrand] CNRS, UMR7225, Paris, France; [de Vries, Boukje; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Fontaine, Bertrand] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, F-75634 Paris, France; [Fontaine, Bertrand] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Canalopathies Musculaires, F-75634 Paris, France; [Heavin, Sinead; Scheffer, Ingrid E.] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic, Australia; [Panagiotakaki, Eleni; Arzimanoglou, Alexis] Univ Hosp Lyon HCL, Woman Mother Child Hosp, Epilepsy Sleep & Pediat Neurophysiol Dept, Lyon, France; [Huff, Chad; Jorde, Lynn B.] Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT USA; [Silver, Kenneth] Univ Chicago, Dept Neurol, Comer Childrens Hosp, Chicago, IL 60637 USA; [Silver, Kenneth] Univ Chicago, Dept Pediat, Comer Childrens Hosp, Chicago, IL 60637 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Ptacek, Louis J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Haan, Joost] Rijnland Hosp, Dept Neurol, Leiderdorp, Netherlands; [Haan, Joost; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Bye, Ann M.] Sydney Childrens Hosp, Dept Paediat Neurol, Randwick, NSW, Australia; [Herkes, Geoffrey K.; Whitelaw, Charlotte M.] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Whitelaw, Charlotte M.] Univ Sydney, No Clin Sch, Sydney, NSW 2006, Australia; [Webb, David] Our Ladys Childrens Hosp, Dublin, Ireland; [Lynch, Bryan J.; King, Mary D.] Childrens Univ Hosp, Dublin, Ireland; [Uldall, Peter] Univ Copenhagen, Rigshosp, Dept Paediat & Adolescent Med, DK-2100 Copenhagen, Denmark; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Scheffer, Ingrid E.] Florey Neurosci Inst, Melbourne, Vic, Australia; [Arzimanoglou, Alexis] CNRS, INSERM, U1028, Lyon, France; [Arzimanoglou, Alexis] CNRS, UMR 5292, Lyon, France; [Sisodiya, Sanjay M.] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Mikati, Mohamad A.] Duke Univ, Med Ctr, Div Pediat Neurol, Durham, NC USA; [Mikati, Mohamad A.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Goldstein, David B.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA		Goldstein, DB (corresponding author), Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA.	mohamad.mikati@dm.duke.edu; d.goldstein@dm.duke.edu	Nevsimalova, Sona/H-3533-2017; Tiziano, Francesco Danilo D/A-7260-2010; Herkes, Geoffrey/ABC-7464-2020; Granata, Tiziana/J-9012-2016; Di Pietro, Lorena/Z-3179-2019; Scheffer, Ingrid E/G-1668-2013; Abiusi, Emanuela/H-6743-2018; Goldstein, David/AAY-8125-2020; Ferrari, Michel D./ABE-3758-2021; Stagnaro, Michela/AAZ-6525-2020; Hitomi, Yuki/V-8236-2019; Gurrieri, Fiorella/K-3214-2016; Panagiotakaki, Eleni/AAN-1067-2020; Kemlink, David/F-9567-2017; Bassi, Maria Teresa T/A-3517-2014; Casari, Giorgio/J-3070-2018; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Nardocci, Nardo/AAB-9903-2019; Vigevano, Federico/K-9466-2016; NICOLE, Sophie/N-4348-2018	Nevsimalova, Sona/0000-0003-0083-3742; Tiziano, Francesco Danilo D/0000-0002-5545-6158; Herkes, Geoffrey/0000-0002-4491-8441; Granata, Tiziana/0000-0002-0170-6836; Di Pietro, Lorena/0000-0001-5723-2169; Scheffer, Ingrid E/0000-0002-2311-2174; Ferrari, Michel D./0000-0001-9691-9449; Gurrieri, Fiorella/0000-0002-6775-5972; Kemlink, David/0000-0003-1398-5796; Bassi, Maria Teresa T/0000-0002-8236-1197; Casari, Giorgio/0000-0002-0115-8980; Nardocci, Nardo/0000-0001-5863-5592; Webb, David/0000-0002-0762-8277; Vigevano, Federico/0000-0001-7513-0051; DE GRANDIS, ELISA/0000-0002-9733-9216; Crawley, Francis P./0000-0002-6893-5916; Swoboda, Kathryn/0000-0002-4593-6342; Arzimanoglou, Alexis/0000-0002-7233-2771; Panagiotakaki, Eleni/0000-0003-2611-0227; Abiusi, Emanuela/0000-0001-9028-012X; NICOLE, Sophie/0000-0001-8793-7928; Mikati, Mohamad/0000-0003-0363-8715; martinelli boneschi, filippo/0000-0002-9955-1368; Zucca, Claudio/0000-0001-7621-2542	Italian Patient Association for Alternating Hemiplegia (AISEA Onlus); Center for Human Genome Variation; Center for HIV/AIDS Vaccine Immunology; Joseph and Kathleen Bryan Alzheimer's Disease Research Center from the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Disease [UO1AIO67854]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG028377]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC2NS070344, 1RC2NS070342-01]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [RC2MH089915]; AHCF; ENRAH for SMEs Consortium under the European Commission Sixth Framework Programme; Institut National de la Sante et de la Recherche MedicaleInstitut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche ScientifiqueCentre National de la Recherche Scientifique (CNRS); University Pierre and Marie Curie; Association Francaise Contre les MyopathiesAssociation Francaise contre les Myopathies; Association Francaise de l'Hemiplegie Alternante; AISEA Onlus; Wellcome TrustWellcome TrustEuropean Commission [084730]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025764]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1T32HL105321-01]; University of Luxembourg Institute for Systems Biology Program; Center for Medical Systems Biology established in The Netherlands Genomics Initiative and The Netherlands Organisation for Scientific Research [050-060-409]; Contrat d'Interface from Assistance Publique-Hopitaux de Paris; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025764] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL105321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [RC2MH089915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC2NS070344, RC2NS070342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028377] Funding Source: NIH RePORTER	We thank the Italian Patient Association for Alternating Hemiplegia (AISEA Onlus) for coordinating and funding the project I.B.AHC Biobank and Clinical Registry for Alternating Hemiplegia. Specifically, we thank M.T. Bassi and E. Tenderini for preparing all of the samples from AHC-affected individuals for analysis. Many thanks also to the Scientific Institute E. Medea, which hosts the I.B.AHC Biobank according to the I.B.AHC protocol.; The following individuals contributed next-generation sequenced control samples to this study: D. Attix, E. Behr, R. Brown, J. Burke, D. Daskalakis, V. Dixon, Z. Farfel, R. Gbadegesin, A. Holden, E. Holtzman, J. Hoover-Fong, C. Hulette, S. Kerns, D. Lancet, D. Levy, N. Liang, W. Lowe, P. Lugar, D. Marchuk, J. McEvoy, J. Milner, H. Oster, R. Ottman, S. Palmer, E. Pras, V. Shashi, N. Sobriera, D. Valle, K. Welsh-Bohmer and M. Winn, as well as the MURDOCK study community registry. Funding for the collection and sequencing of control samples was provided by the Center for Human Genome Variation, the Center for HIV/AIDS Vaccine Immunology and the Joseph and Kathleen Bryan Alzheimer's Disease Research Center under grants from the National Institutes of Health (NIH), including the National Institute of Allergy and Infectious Disease (UO1AIO67854); the National Institute on Aging (P30 AG028377); the National Institute of Neurological Disorders and Stroke (RC2NS070344 and 1RC2NS070342-01) and the National Institute of Mental Health (RC2MH089915).; This study was funded in part by grants from the AHCF (to K.J.S., S.P.R. and T.M.N.); the ENRAH for SMEs Consortium under the European Commission Sixth Framework Programme; the Institut National de la Sante et de la Recherche Medicale (to S.N. and B.F.); the Centre National de la Recherche Scientifique (to S.N. and B.F.); the University Pierre and Marie Curie (to S.N. and B.F.); the Association Francaise Contre les Myopathies (to S.N. and B.F.); the Association Francaise de l'Hemiplegie Alternante (to S.N., A.M.J.M.v.d.M. and B.d.V.); AISEA Onlus (to F.G. and G.N.); the Center for Human Genome Variation; the Wellcome Trust (084730 to S.M.S.); the National Center for Research Resources (UL1RR025764 to the University of Utah Center for Clinical and Translational Sciences; K.J.S.); the NIH (1T32HL105321-01 to C.H.); the University of Luxembourg Institute for Systems Biology Program (to C.H.) and the Center for Medical Systems Biology established in The Netherlands Genomics Initiative and The Netherlands Organisation for Scientific Research (project 050-060-409 to A.M.J.M.v.d.M. and M.D.F.). S.N. is a recipient of a Contrat d'Interface from Assistance Publique-Hopitaux de Paris.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; BOURGEOIS M, 1993, J PEDIATR-US, V122, P673, DOI 10.1016/S0022-3476(06)80003-X; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Ge DL, 2011, BIOINFORMATICS, V27, P1998, DOI 10.1093/bioinformatics/btr317; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kamm C, 2008, NEUROLOGY, V70, P1501, DOI 10.1212/01.wnl.0000310431.41036.e0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MIKATI MA, 1992, NEUROLOGY, V42, P2251, DOI 10.1212/WNL.42.12.2251; Mikati MA, 2000, PEDIATR NEUROL, V23, P134, DOI 10.1016/S0887-8994(00)00157-0; Neville BGR, 2007, DEV MED CHILD NEUROL, V49, P777, DOI 10.1111/j.1469-8749.2007.00777.x; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Panagiotakaki E, 2010, BRAIN, V133, P3598, DOI 10.1093/brain/awq295; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Rho JM, 1998, J CHILD NEUROL, V13, P39, DOI 10.1177/088307389801300107; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Svetel M, 2010, J NEUROL, V257, P472, DOI 10.1007/s00415-009-5385-y; Sweney MT, 2009, PEDIATRICS, V123, pe534, DOI 10.1542/peds.2008-2027; Swoboda KJ, 2004, ANN NEUROL, V55, P884, DOI 10.1002/ana.20134; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; VERRETT S, 1971, PEDIATRICS, V47, P675; Zhu M., AM J HUM GE IN PRESS	29	258	278	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2012	44	9					1030	+		10.1038/ng.2358			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	WOS:000308491200015	22842232	Green Accepted, Green Submitted			2022-01-24	
J	Wen, WQ; Cho, YS; Zheng, W; Dorajoo, R; Kato, N; Qi, L; Chen, CH; Delahanty, RJ; Okada, Y; Tabara, Y; Gu, DF; Zhu, DL; Haiman, CA; Mo, ZN; Gao, YT; Saw, SM; Go, MJ; Takeuchi, F; Chang, LC; Kokubo, Y; Liang, J; Hao, M; Le Marchand, L; Zhang, Y; Hu, YL; Wong, TY; Long, JR; Han, BG; Kubo, M; Yamamoto, K; Su, MH; Miki, T; Henderson, BE; Song, HD; Tan, AH; He, J; Ng, DPK; Cai, QY; Tsunoda, T; Tsai, FJ; Iwai, N; Chen, GK; Shi, JJ; Xu, JF; Sim, XL; Xiang, YB; Maeda, S; Ong, RTH; Li, C; Nakamura, Y; Aung, T; Kamatani, N; Liu, JJ; Lu, W; Yokota, M; Seielstad, M; Fann, CSJ; Wu, JY; Lee, JY; Hu, FB; Tanaka, T; Tai, ES; Shu, XO				Wen, Wanqing; Cho, Yoon-Shin; Zheng, Wei; Dorajoo, Rajkumar; Kato, Norihiro; Qi, Lu; Chen, Chien-Hsiun; Delahanty, Ryan J.; Okada, Yukinori; Tabara, Yasuharu; Gu, Dongfeng; Zhu, Dingliang; Haiman, Christopher A.; Mo, Zengnan; Gao, Yu-Tang; Saw, Seang-Mei; Go, Min-Jin; Takeuchi, Fumihiko; Chang, Li-Ching; Kokubo, Yoshihiro; Liang, Jun; Hao, Mei; Le Marchand, Loic; Zhang, Yi; Hu, Yanling; Wong, Tien-Yin; Long, Jirong; Han, Bok-Ghee; Kubo, Michiaki; Yamamoto, Ken; Su, Mei-Hsin; Miki, Tetsuro; Henderson, Brian E.; Song, Huaidong; Tan, Aihua; He, Jiang; Ng, Daniel P-K; Cai, Qiuyin; Tsunoda, Tatsuhiko; Tsai, Fuu-Jen; Iwai, Naoharu; Chen, Gary K.; Shi, Jiajun; Xu, Jianfeng; Sim, Xueling; Xiang, Yong-Bing; Maeda, Shiro; Ong, Rick T. H.; Li, Chun; Nakamura, Yusuke; Aung, Tin; Kamatani, Naoyuki; Liu, Jian-Jun; Lu, Wei; Yokota, Mitsuhiro; Seielstad, Mark; Fann, Cathy S. J.; Wu, Jer-Yuarn; Lee, Jong-Young; Hu, Frank B.; Tanaka, Toshihiro; Tai, E. Shyong; Shu, Xiao-Ou		Genetic Invest ANthropometric Tria	Meta-analysis identifies common variants associated with body mass index in east Asians	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ADULT OBESITY; RISK LOCI; FTO GENE; POPULATIONS; SNP; DATABASE; TRAITS; CDKAL1; MC4R	Multiple genetic loci associated with obesity or body mass index (BMI) have been identified through genome-wide association studies conducted predominantly in populations of European ancestry. We performed a meta-analysis of associations between BMI and approximately 2.4 million SNPs in 27,715 east Asians, which was followed by in silico and de novo replication studies in 37,691 and 17,642 additional east Asians, respectively. We identified ten BMI-associated loci at genome-wide significance (P < 5.0 x 10(-8)), including seven previously identified loci (FTO, SEC16B, MC4R, GIPR-QPCTL, ADCY3-DNAJC27, BDNF and MAP2K5) and three novel loci in or near the CDKAL1, PCSK1 and GP2 genes. Three additional loci nearly reached the genome-wide significance threshold, including two previously identified loci in the GNPDA2 and TFAP2B genes and a newly identified signal near PAX6, all of which were associated with BMI with P < 5.0 x 10(-7). Findings from this study may shed light on new pathways involved in obesity and demonstrate the value of conducting genetic studies in non-European populations.	[Wen, Wanqing; Zheng, Wei; Delahanty, Ryan J.; Long, Jirong; Cai, Qiuyin; Shi, Jiajun; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA; [Wen, Wanqing; Zheng, Wei; Delahanty, Ryan J.; Long, Jirong; Cai, Qiuyin; Shi, Jiajun; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Wen, Wanqing; Zheng, Wei; Delahanty, Ryan J.; Long, Jirong; Cai, Qiuyin; Shi, Jiajun; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Cho, Yoon-Shin; Go, Min-Jin; Han, Bok-Ghee; Lee, Jong-Young] Natl Inst Hlth, Ctr Genome Sci, Cheongwon Gun, South Korea; [Cho, Yoon-Shin] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea; [Dorajoo, Rajkumar; Ong, Rick T. H.; Liu, Jian-Jun; Seielstad, Mark] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Dorajoo, Rajkumar] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, Hammersmith Hosp, London, England; [Kato, Norihiro; Takeuchi, Fumihiko] Natl Ctr Global Hlth & Med, Res Inst, Dept Gene Diagnost & Therapeut, Tokyo, Japan; [Qi, Lu; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chen, Chien-Hsiun; Chang, Li-Ching; Su, Mei-Hsin; Fann, Cathy S. J.; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chien-Hsiun; Tsai, Fuu-Jen; Wu, Jer-Yuarn] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Okada, Yukinori; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, CGM, Yokohama, Kanagawa, Japan; [Okada, Yukinori] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Tabara, Yasuharu] Ehime Univ, Grad Sch Med, Dept Basic Med Res & Educ, Toon, Japan; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhu, Dingliang; Zhang, Yi] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhu, Dingliang] Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhu, Dingliang; Zhang, Yi] Sino French Res Ctr Life Sci & Genom, Shanghai, Peoples R China; [Zhu, Dingliang] Shanghai Key Lab Vasc Biol, Shanghai, Peoples R China; [Haiman, Christopher A.; Henderson, Brian E.; Chen, Gary K.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Peoples R China; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Saw, Seang-Mei; Ng, Daniel P-K; Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Liang, Jun] Southeast Univ, Affiliated Hosp, Cent Hosp Xuzhou, Dept Endocrinol, Xuzhou, Peoples R China; [Hao, Mei; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Epidemiol Program, Honolulu, HI 96813 USA; [Hu, Yanling] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Peoples R China; [Wong, Tien-Yin; Aung, Tin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tien-Yin; Aung, Tin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Wong, Tien-Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Kubo, Michiaki] RIKEN, CGM, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Div Genome Anal, Fukuoka 812, Japan; [Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon, Japan; [Song, Huaidong] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Mol Med Ctr, Shanghai Inst Endocrinol,Ruijin Hosp, Shanghai 200030, Peoples R China; [Tan, Aihua] Guangxi Med Univ, Affiliated Hosp 1, Ctr Metab Dis & Diabet, Nanning, Peoples R China; [Tsunoda, Tatsuhiko] RIKEN, CGM, Lab Med Informat, Yokohama, Kanagawa, Japan; [Iwai, Naoharu] Natl Cerebral & Cardiovasc Ctr, Dept Genom Med, Suita, Osaka, Japan; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Sim, Xueling] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Maeda, Shiro] RIKEN, CGM, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Ong, Rick T. H.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Li, Chun] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan; [Lu, Wei] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi 464, Japan; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Tanaka, Toshihiro] RIKEN, CGM, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore		Shu, XO (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA.	xiao-ou.shu@vanderbilt.edu	Chen, Chien Hsiun/Q-3826-2018; Zheng, Wei/O-3351-2013; Wu, Jer-Yuarn/S-7010-2018; Liu, Jianjun/AAK-4989-2020; Li, Chun/R-1095-2019; Tanaka, Toshihiro/J-9310-2014; Sim, Xueling/AAZ-6652-2020; Wong, Tien Y/AAC-9724-2020; Tsunoda, Tatsuhiko/K-2061-2014; Fann, Cathy SJ/F-9410-2010; Tsai, Fuu-Jen/J-4140-2015; Kubo, Michiaki/N-7947-2015; Tai, E Shyong/J-9831-2013; Lee, Jong-Young/M-6319-2013; Li, Chun/B-8388-2012; Seielstad, Mark/T-7841-2019; He, Jiang/AAF-5303-2020	Zheng, Wei/0000-0003-1226-070X; Liu, Jianjun/0000-0002-3255-3019; Li, Chun/0000-0002-8819-2443; Tanaka, Toshihiro/0000-0001-6201-9784; Sim, Xueling/0000-0002-1233-7642; Wong, Tien Y/0000-0002-8448-1264; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Lee, Jong-Young/0000-0002-0092-9958; He, Jiang/0000-0002-8286-9652; Seielstad, Mark/0000-0001-5783-1401; Dorajoo, Rajkumar/0000-0001-6608-2051; SHI, JIAJUN/0000-0001-5194-0009; Long, Jirong/0000-0002-7433-9766; Tai, E Shyong/0000-0003-2929-8966	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 CA064277, R37 CA070867, R01 CA090899, R01 CA118229, R01 CA092585, R01 CA122756]; Ingram professorship funds; Allen Foundation; Vanderbilt Clinical and Translational Science Award (CTSA) [1 UL1 RR024975]; National Center for Research Resources (NCRR) at NIH; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 CA064277, R01 CA118229, R01 CA092585, HL071981]; Korea Centers for Disease Control and Prevention [4845-301, 4851-302, 4851-307]; Biomedical Research Council of Singapore (BMRC)Agency for Science Technology & Research (ASTAR) [05/1/36/19/413, 03/1/27/18/216]; National Medical Research Council of Singapore (NMRC)National Medical Research Council, Singapore [NMRC/1174/2008]; NMRCNational Medical Research Council, Singapore [NMRC/CSA/008/2009, NMRC/0796/2003, NMRC/STaR/0003/2008, NMRC/0975/2005]; Japan Science Technology AgencyJapan Science & Technology Agency (JST); Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation Organization (NIBIO)National Institute of Biomedical Innovation; National Center for Global Health and Medicine (NCGM); American Heart AssociationAmerican Heart Association; Boston Obesity Nutrition Research Center [DK46200]; National Heart, Lung, and Blood Institute at NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL072507, HL087263, HL090682]; BMRCAgency for Science Technology & Research (ASTAR) [06/1/21/19/466, 09/1/35/19/616, 08/1/35/19/550]; Centre for Molecular Epidemiology at National University of SingaporeNational University of Singapore; Chinese National Key Program for Basic Research [973:2004CB518603]; Chinese National High Tech ProgramNational High Technology Research and Development Program of China [863:2009AA022703]; National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA063464, CA054281, CA132839]; NIH Genes, Environment and Health Initiative (GEI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HG004726]; GEI [HG04424]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA063464, R01CA064277, R01CA148667, R01CA090899, R01CA132839, R01CA092585, R01CA124558, R01CA054281, R01CA122756, P30CA071789, R01CA063464, R37CA054281, R01CA118229, R37CA070867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024975, KL2RR024977, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071981, U01HL072507, R01HL090682, R01HL087263] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004446, U01HG004424, U01HG004726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK046200] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21390209] Funding Source: KAKEN	The Shanghai Genome Wide Associations Studies (SGWAS) would like to thank the dedicated investigators and staff members from the research teams at Vanderbilt University, the Shanghai Cancer Institute and the Shanghai Institute of Preventive Medicine and, most of all, the study participants for their contributions to this work. Genotyping assays and statistical analyses for the SGWAS were primarily supported by grants from the US National Institutes of Health (NIH; R01 CA064277, R37 CA070867, R01 CA090899, R01 CA118229, R01 CA092585 and R01 CA122756), as well as by Ingram professorship funds, Allen Foundation funds and a Vanderbilt Clinical and Translational Science Award (CTSA; 1 UL1 RR024975) from the National Center for Research Resources (NCRR) at the NIH. NIH grants provided support for the participating studies, including the Shanghai Breast Cancer Study (R01 CA064277), the Shanghai Breast Cancer Survival Study (R01 CA118229) and the Shanghai Endometrial Cancer Study (R01 CA092585). The KARE project was supported by grants from the Korea Centers for Disease Control and Prevention (4845-301, 4851-302 and 4851-307). The Singapore Prospective Study Program (SP2) was funded through grants from the Biomedical Research Council of Singapore (BMRC; 05/1/36/19/413 and 03/1/27/18/216) and the National Medical Research Council of Singapore (NMRC; NMRC/1174/2008). E. S. T. also received support from the NMRC through a clinician scientist award (NMRC/CSA/008/2009). The Singapore Malay Eye Study (SiMES) was funded by the NMRC (NMRC/0796/2003 and NMRC/STaR/0003/2008) and the BMRC (09/1/35/19/616). The CAGE Network Studies were supported by grants for the Core Research for Evolutional Science and Technology (CREST) from the Japan Science Technology Agency, the Program for Promotion of Fundamental Studies in Health Sciences, the National Institute of Biomedical Innovation Organization (NIBIO) and the National Center for Global Health and Medicine (NCGM). L. Q. is supported by a grant from the NIH (HL071981), an American Heart Association Scientist Development Award and the Boston Obesity Nutrition Research Center (DK46200). The Genetic Epidemiology Network of Salt Sensitivity (GenSalt) is supported by research grants from the National Heart, Lung, and Blood Institute at the NIH (HL072507, HL087263 and HL090682). SINDI was funded by grants from the BMRC (09/1/35/19/616 and 08/1/35/19/550) and the NMRC (NMRC/STaR/0003/2008). SCORM was funded by the NMRC (NMRC/0975/2005), the BMRC (06/1/21/19/466) and the Centre for Molecular Epidemiology at the National University of Singapore. The SIH was supported by the Chinese National Key Program for Basic Research (973:2004CB518603) and the Chinese National High Tech Program (863:2009AA022703). The MEC was supported by grants from the National Cancer Institute (NCI; CA063464, CA054281 and CA132839) and from the NIH Genes, Environment and Health Initiative (GEI; HG004726). Assistance with genotype cleaning for the MEC Japanese prostate cancer study was provided by the Gene Environment Association Studies (GENEVA) Coordinating Center (HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Funding support for genotyping, which was performed at the Broad Institute of MIT and Harvard University, was provided by the GEI (HG04424).	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Okada Y., 2012, NAT GENET       0212, DOI 10.1038ng.1086; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Winkler C, 2010, DIABETES, V59, P2063, DOI 10.2337/db10-0099; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	35	258	270	0	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					307	U112		10.1038/ng.1087			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	WOS:000300843600017	22344219	Green Accepted			2022-01-24	
J	Freeman, JD; Warren, RL; Webb, JR; Nelson, BH; Holt, RA				Freeman, J. Douglas; Warren, Rene L.; Webb, John R.; Nelson, Brad H.; Holt, Robert A.			Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing	GENOME RESEARCH			English	Article							D-J DIVERSITY; V(D)J RECOMBINATION; GENES; SELECTION; LYMPHOCYTES; MECHANISM; RESPONSES; HEALTHY; REGIONS; HIV	T-cell receptor (TCR) genomic loci undergo somatic V(D)J recombination, plus the addition/subtraction of nontemplated bases at recombination junctions, in order to generate the repertoire of structurally diverse T cells necessary for antigen recognition. TCR beta subunits can be unambiguously identified by their hypervariable CDR3 (Complement Determining Region 3) sequence. This is the site of V(D) J recombination encoding the principal site of antigen contact. The complexity and dynamics of the T-cell repertoire remain unknown because the potential repertoire size has made conventional sequence analysis intractable. Here, we use 5'-RACE, Illumina sequencing, and a novel short read assembly strategy to sample CDR3(beta) diversity in human T lymphocytes from peripheral blood. Assembly of 40.5 million short reads identified 33,664 distinct TCR beta clonotypes and provides precise measurements of CDR3(beta) length diversity, usage of nontemplated bases, sequence convergence, and preferences for TRBV (T-cell receptor beta variable gene) and TRBJ (T-cell receptor beta joining gene) gene usage and pairing. CDR3 length between conserved residues of TRBV and TRBJ ranged from 21 to 81 nucleotides (nt). TRBV gene usage ranged from 0.01% for TRBV17 to 24.6% for TRBV20-1. TRBJ gene usage ranged from 1.6% for TRBJ2-6 to 17.2% for TRBJ2-1. We identified 1573 examples of convergence where the same amino acid translation was specified by distinct CDR3(beta) nucleotide sequences. Direct sequence-based immunoprofiling will likely prove to be a useful tool for understanding repertoire dynamics in response to immune challenge, without a priori knowledge of antigen.	[Freeman, J. Douglas; Warren, Rene L.; Holt, Robert A.] Michael Smith Genome Sci Ctr, BC Canc Agcy, Vancouver, BC V5Z 1L3, Canada; [Webb, John R.; Nelson, Brad H.] Deeley Res Ctr, BC Canc Agcy, Victoria, BC V8R 6V5, Canada		Holt, RA (corresponding author), Michael Smith Genome Sci Ctr, BC Canc Agcy, Vancouver, BC V5Z 1L3, Canada.	rholt@bcgsc.ca	Nelson, Brad H/K-2622-2014; Holt, Robert A/C-3303-2009; Warren, Rene/R-7681-2016	Holt, Robert A/0000-0002-7259-1247; Nelson, Brad/0000-0002-4445-5539; Warren, Rene/0000-0002-9890-2293	Genome Canada and Genome British Columbia; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Fred Hutchinson Cancer Research Centre, Seattle, WA	This work was funded by Genome Canada and Genome British Columbia. R. A. H. is a Michael Smith Foundation for Health Research scholar. We thank Martin Krzywinski for generating Figure 4 using the Circos software package (Krzywinski et al. 2009). The melanoma-specific T-cell clone DES M26 was kindly provided by Cassian Yee, Fred Hutchinson Cancer Research Centre, Seattle, WA.	Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Boria I, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-50; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; EVEN J, 1995, RES IMMUNOL, V146, P65, DOI 10.1016/0923-2494(96)80240-9; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Folch G, 2000, EXP CLIN IMMUNOGENET, V17, P42, DOI 10.1159/000019123; Fuschiotti P, 2007, MOL IMMUNOL, V44, P3380, DOI 10.1016/j.molimm.2007.02.017; GELLERT M, 1992, ANNU REV GENET, V26, P425, DOI 10.1146/annurev.ge.26.120192.002233; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GORSKI J, 1994, J IMMUNOL, V152, P5109; HALL MA, 1995, HUM IMMUNOL, V43, P207, DOI 10.1016/0198-8859(95)00013-T; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Manfras BJ, 1999, HUM IMMUNOL, V60, P1090, DOI 10.1016/S0198-8859(99)00099-3; Murphy K., 2007, JANEWAYS IMMUNOBIOLO, V7th; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Peters DG, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e39; ROLDAN EQ, 1995, IMMUNOGENETICS, V41, P91; ROSENBERG WMC, 1992, EUR J IMMUNOL, V22, P541, DOI 10.1002/eji.1830220237; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Warren RL, 2009, BIOINFORMATICS, V25, P458, DOI 10.1093/bioinformatics/btp010	33	258	266	0	17	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2009	19	10					1817	1824		10.1101/gr.092924.109			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	501NX	WOS:000270389700014	19541912	Green Published, Bronze			2022-01-24	
J	Stankiewicz, P; Sen, P; Bhatt, SS; Storer, M; Xia, ZL; Bejjani, BA; Ou, ZS; Wiszniewska, J; Driscoll, DJ; Bolivar, J; Bauer, M; Zackai, EH; McDonald-McGinn, D; Nowaczyk, MMJ; Murray, M; Shaikh, TH; Martin, V; Tyreman, M; Simonic, I; Willatt, L; Paterson, J; Mehta, S; Rajan, D; Fitzgerald, T; Gribble, S; Prigmore, E; Patel, A; Shaffer, LG; Carter, NP; Cheung, SW; Langston, C; Shaw-Smith, C				Stankiewicz, Pawel; Sen, Partha; Bhatt, Samarth S.; Storer, Mekayla; Xia, Zhilian; Bejjani, Bassem A.; Ou, Zhishuo; Wiszniewska, Joanna; Driscoll, Daniel J.; Bolivar, Juan; Bauer, Mislen; Zackai, Elaine H.; McDonald-McGinn, Donna; Nowaczyk, Malgorzata M. J.; Murray, Mitzi; Shaikh, Tamim H.; Martin, Vicki; Tyreman, Matthew; Simonic, Ingrid; Willatt, Lionel; Paterson, Joan; Mehta, Sarju; Rajan, Diana; Fitzgerald, Tomas; Gribble, Susan; Prigmore, Elena; Patel, Ankita; Shaffer, Lisa G.; Carter, Nigel P.; Cheung, Sau Wai; Langston, Claire; Shaw-Smith, Charles			Genomic and Genic Deletions of the FOX Gene Cluster on 16q24.1 and Inactivating Mutations of FOXF1 Cause Alveolar Capillary Dysplasia and Other Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PULMONARY VEINS; LUNG; MISALIGNMENT; EXPRESSION; VESSELS; HAPLOINSUFFICIENCY; HYPERTENSION; SURVIVAL; DEFECTS	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV) is a rare, neonatally lethal developmental disorder of the lung with defining histologic abnormalities typically associated with multiple congenital anomalies (MCA). Using array CGH analysis, we have identified six overlapping microdeletions encompassing the FOX transcription factor gene cluster in chromosome 16q24.1q24.2 in patients with ACD/MPV and MCA. Subsequently, we have identified four different heterozygous mutations (frameshift, nonsense, and no-stop) in the candidate FOXF1 gene in unrelated patients with sporadic ACD/MPV and MCA. Custom-designed, high-resolution microarray analysis of additional ACD/MPV samples revealed one microdeletion harboring FOXF1 and two distinct microdeletions upstream of FOXF1, implicating a position effect. DNA sequence analysis revealed that in six of nine deletions, both breakpoints occurred in the portions of Alu elements showing eight to 43 base pairs of perfect microhomology, suggesting replication error Microhomology-Mediated Break-Induced Replication (MMBIR)/Fork Stalling and Template Switching (FoSTeS) as a mechanism of their formation. In contrast to the association of point mutations in FOXF1 with bowel malrotation, microdeletions of FOXF1 were associated with hypoplastic left heart syndrome and gastrointestinal atresias, probably due to haploinsufficiency for the neighboring FOXC2 and FOXL1 genes. These differences reveal the phenotypic consequences of gene alterations in cis.	[Stankiewicz, Pawel; Bhatt, Samarth S.; Xia, Zhilian; Ou, Zhishuo; Wiszniewska, Joanna; Patel, Ankita; Cheung, Sau Wai] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stankiewicz, Pawel] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Sen, Partha] Baylor Coll Med, Dept Pediat Nutr, Houston, TX 77030 USA; [Storer, Mekayla; Martin, Vicki; Shaw-Smith, Charles] Inst Child Hlth, London WC1N 1EH, England; [Storer, Mekayla; Martin, Vicki; Rajan, Diana; Fitzgerald, Tomas; Gribble, Susan; Prigmore, Elena; Carter, Nigel P.; Shaw-Smith, Charles] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Bejjani, Bassem A.; Shaffer, Lisa G.] Signature Genom Labs LLC, Spokane, WA 99207 USA; [Driscoll, Daniel J.] Univ Florida, Div Pediat Genet & Metab, Coll Med, Gainesville, FL 32610 USA; [Bolivar, Juan] Miami Childrens Hosp, Dept Cardiol, Miami, FL 33155 USA; [Bauer, Mislen] Miami Childrens Hosp, Dept Genet, Miami, FL 33155 USA; [Zackai, Elaine H.; McDonald-McGinn, Donna; Shaikh, Tamim H.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Nowaczyk, Malgorzata M. J.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 3K9, Canada; [Murray, Mitzi] Univ Washington, Dept Med Genet, Seattle, WA 98195 USA; [Tyreman, Matthew; Simonic, Ingrid; Willatt, Lionel; Paterson, Joan; Mehta, Sarju] Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 0QQ, England; [Langston, Claire] Baylor Coll Med, Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA		Stankiewicz, P (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	pawels@bcm.edu	Bhatt, Samarth/H-2892-2019; McDonald-McGinn, Donna/L-8643-2019; Stankiewicz, Pawel/AAP-7906-2021	Bhatt, Samarth/0000-0001-5706-4572; Stankiewicz, Pawel/0000-0002-6456-7490; /0000-0003-4077-250X; Storer, Mekayla/0000-0003-0242-1418; Britt, Allison/0000-0001-6601-0453; Fitzgerald, Tomas/0000-0002-2370-8496	Polish Ministry of Science and Higher EducationMinistry of Science and Higher Education, Poland [R13-0005-04/2008]; National Association of Rare Disorders (NORD); Wellcome TrustWellcome TrustEuropean Commission; National Institute for Health Research (NIHR), UKNational Institute for Health Research (NIHR); Addenbrooke's Charitable Trust; Tracheo-Oesophageal Fistula	The authors thank all of the families who participated in this study and the Alveolar Capillary Dysplasia Association, the parent organization, for help in recruitment of patients. We thank A.L. Beaudet, J.W. Belmont, M. Jamrich, M. Justice, J.R. Lupski, F.J. Probst, D. Scott, and M. Shinawi for helpful discussion. P. Sen would like to thank M. Haymond for support and encouragement. We acknowledge J. Rosenfeld for collecting clinical information on the patients and helping with data collection. P.St. was supported in part by grant R13-0005-04/2008 from the Polish Ministry of Science and Higher Education. Part of this study was supported by a National Association of Rare Disorders (NORD) grant to P. Sen. We thank T.F. Beck for technical assistance. M.S., V.M., D.R., T.F., S.G., E.P., N.RC., and C.S.-S. are funded by the Wellcome Trust; C.S.-S. is the recipient of a Wellcome Trust Intermediate Clinical Fellowship. M.T., I.S., L.W., J.P., and S.M. gratefully acknowledge funding from the Biomedical Research Centre Grant from the National Institute for Health Research (NIHR), UK. C.S.-S., V.M., and M.S. gratefully acknowledge additional funding from the Addenbrooke's Charitable Trust and Tracheo-Oesophageal Fistula Support, the UK patient support group for patients with esophageal atresia and tracheo-esophageal fistula. C.S.-S. thanks N. Conte, A. Bradley, R. Hennekam, and P. Scambler for helpful discussion; and C. Hall, H. Martin, and B. Treacy for technical assistance. Some authors are based in the Department of Molecular and Human Genetics at Baylor College of Medicine (BCM), which offers extensive genetic laboratory testing, including use of arrays for genomic copy number analysis, and derives revenue from this activity. B.A.B. and L.G.S. have ownership and sit on the Members' Board of Signature Genomic Laboratories, LLC. The UK authors declare no competing interest.	Ahmed Sheikh, 2008, Pediatr Crit Care Med, V9, pe43, DOI 10.1097/PCC.0b013e31818e383e; Al-Hathlol K, 2000, EARLY HUM DEV, V57, P85, DOI 10.1016/S0378-3782(99)00065-1; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Bell R, 2001, HUM GENET, V108, P546, DOI 10.1007/s004390100528; BOGGS S, 1994, J PEDIATR-US, V124, P125, DOI 10.1016/S0022-3476(94)70267-5; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; Chang VWH, 2001, GENE, V267, P201, DOI 10.1016/S0378-1119(01)00400-0; Eulmesekian P, 2005, J PERINAT MED, V33, P347, DOI 10.1515/JPM.2005.067; Fukamachi H, 2001, BIOCHEM BIOPH RES CO, V280, P1069, DOI 10.1006/bbrc.2001.4247; Fukuda K, 2003, DEV BIOL, V255, P278, DOI 10.1016/S0012-1606(02)00088-X; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Gutierrez C, 2000, PEDIATR DEVEL PATHOL, V3, P271, DOI 10.1007/s100249910035; Hellqvist M, 1996, J BIOL CHEM, V271, P4482; Iida K, 1997, DEVELOPMENT, V124, P4627; Kalinichenko VV, 2004, AM J PHYSIOL-LUNG C, V286, pL521, DOI 10.1152/ajplung.00212.2003; Kalinichenko VV, 2001, DEV BIOL, V235, P489, DOI 10.1006/dbio.2001.0322; Kalinichenko VV, 2001, AM J PHYSIOL-LUNG C, V280, pL695, DOI 10.1152/ajplung.2001.280.4.L695; Kanzaki-Kato N, 2005, CARDIOVASC RES, V65, P711, DOI 10.1016/j.cardiores.2004.10.017; Kohlhase J, 2000, AM J MED GENET, V91, P190, DOI 10.1002/(SICI)1096-8628(20000320)91:3<190::AID-AJMG6>3.0.CO;2-I; LANGSTON C, 1991, Pediatric Pathology, V11, P163; Licht C, 2004, EUR J PEDIATR, V163, P181, DOI 10.1007/s00431-003-1385-6; Lim L, 2002, AM J PHYSIOL-LUNG C, V282, pL1012, DOI 10.1152/ajplung.00371.2001; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Michalsky MP, 2005, J PEDIATR SURG, V40, P1100, DOI 10.1016/j.jpedsurg.2005.03.067; Ou Z, 2008, GENET MED, V10, P278, DOI 10.1097/GIM.0b013e31816b4420; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Rabah R, 2001, PEDIATR DEVEL PATHOL, V4, P167, DOI 10.1007/s100240010125; Sen P, 2004, J PEDIATR-US, V145, P646, DOI 10.1016/j.jpeds.2004.06.081; Shaw-Smith C, 2006, J MED GENET, V43, P545, DOI 10.1136/jmg.2005.038158; SIMOS TE, 1993, APPL MATH LETT, V6, P9, DOI 10.1016/0893-9659(93)90090-A; Steinhorn RH, 1997, J PEDIATR-US, V130, P417, DOI 10.1016/S0022-3476(97)70203-8; Takano-Maruyama M, 2006, AM J PHYSIOL-GASTR L, V291, pG163, DOI 10.1152/ajpgi.00019.2006; Tseng HT, 2004, DEVELOPMENT, V131, P3637, DOI 10.1242/dev.01234; Vassal HB, 1998, J MED GENET, V35, P58, DOI 10.1136/jmg.35.1.58; WAGENVOORT CA, 1986, HUM PATHOL, V17, P727, DOI 10.1016/S0046-8177(86)80182-4	38	258	270	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					780	791		10.1016/j.ajhg.2009.05.005			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458SC	WOS:000267042800008	19500772	hybrid, Green Published			2022-01-24	
J	Stamatoyannopoulos, JA; Adzhubei, I; Thurman, RE; Kryukov, GV; Mirkin, SM; Sunyaev, SR				Stamatoyannopoulos, John A.; Adzhubei, Ivan; Thurman, Robert E.; Kryukov, Gregory V.; Mirkin, Sergei M.; Sunyaev, Shamil R.			Human mutation rate associated with DNA replication timing	NATURE GENETICS			English	Article							HUMAN-CHROMOSOMES; GENOME; DISEASE; REGIONS	Eukaryotic DNA replication is highly stratified, with different genomic regions shown to replicate at characteristic times during S phase. Here we observe that mutation rate, as reflected in recent evolutionary divergence and human nucleotide diversity, is markedly increased in later-replicating regions of the human genome. All classes of substitutions are affected, suggesting a generalized mechanism involving replication time-dependent DNA damage. This correlation between mutation rate and regionally stratified replication timing may have substantial evolutionary implications.	[Stamatoyannopoulos, John A.; Thurman, Robert E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.; Thurman, Robert E.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Adzhubei, Ivan; Kryukov, Gregory V.; Sunyaev, Shamil R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Mirkin, Sergei M.] Tufts Univ, Dept Biol, Medford, MA 02155 USA		Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@u.washington.edu; ssunyaev@rics.bwh.harvard.edu	Mirkin, Sergei/A-7310-2010; Kryukov, Gregory V/A-9592-2008; Mirkin, Sergei/AAR-7226-2020	Mirkin, Sergei/0000-0003-4576-7582; Kryukov, Gregory/0000-0002-6131-9483; Adzhubey, Ivan/0000-0002-1483-9259	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54HG003042, R01GM071852];  [R01GM078598];  [R01MH084676];  [U54LM008748];  [R01GM60987]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG004592, R01HG003042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM060987, R01GM078598, R01GM071852, R01GM071923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH084676] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [U54LM008748] Funding Source: NIH RePORTER	We thank A. Kondrashov, M. Przeworski and J. Cameron for helpful discussions. This work was supported by US National Institutes of Health grants U54HG003042 and R01GM071852 to J.A.S.; R01GM078598, R01MH084676 and U54LM008748 to S. R. S. and R01GM60987 to S. M. M.	Chuang JH, 2004, PLOS BIOL, V2, P253, DOI 10.1371/journal.pbio.0020029; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Jeon Y, 2005, P NATL ACAD SCI USA, V102, P6419, DOI 10.1073/pnas.0405088102; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Tyekucheva S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r76; Watanabe Y, 2002, HUM MOL GENET, V11, P13, DOI 10.1093/hmg/11.1.13; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264	15	258	262	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					393	395		10.1038/ng.363			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	WOS:000264659000010	19287383	Green Accepted			2022-01-24	
J	Yu, XW; Ng, CP; Habacher, H; Roy, S				Yu, Xianwen; Ng, Chee Peng; Habacher, Hermann; Roy, Sudipto			Foxj1 transcription factors are master regulators of the motile ciliogenic program	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; AIRWAY EPITHELIAL-CELLS; PROTEIN-KINASE-A; ZEBRAFISH EMBRYO; HEDGEHOG ACTIVITY; KUPFFERS VESICLE; SONIC-HEDGEHOG; FACTOR HFH-4; NEURAL-TUBE; FACTOR RFX3	Motile cilia induce fluid movement through their rhythmic beating activity. In mammals, the transcription factor Foxj1 has been implicated in motile cilia formation. Here we show that a zebrafish Foxj1 homolog, foxj1a, is a target of Hedgehog signaling in the floor plate. Loss of Foxj1a compromises the assembly of motile cilia that decorate floor plate cells. Besides the floor plate, foxj1a is expressed in Kupffer's vesicle and pronephric ducts, where it also promotes ciliary differentiation. We show that Foxj1a activates a constellation of genes essential for motile cilia formation and function, and that its activity is sufficient for ectopic development of cilia that resemble motile cilia. We also document that a paralogous gene, foxj1b, is expressed in the otic vesicle and seems to regulate motile cilia formation in this tissue. Our findings identify a dedicated master regulatory role for Foxj1 in the transcriptional program that controls the production of motile cilia.	[Yu, Xianwen; Ng, Chee Peng; Habacher, Hermann; Roy, Sudipto] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore; [Roy, Sudipto] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore		Roy, S (corresponding author), Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, 61 Biopolis Dr, Singapore 138673, Singapore.	sudipto@imcb.a-star.edu.sg	Yu, Xianwen/Q-2646-2019		Institute of Molecular and Cell Biology; Agency for Science, Technology and Research of SingaporeAgency for Science Technology & Research (ASTAR)	We wish to thank J. Briscoe for discussion, M. Ma for the plasmid containing zebrafish cetn2 cDNA, C. X. Goh for technical assistance, S. Choksi for advice on ChIP and S. Choksi and other members of our laboratory for their comments on the manuscript. This work was funded by the Institute of Molecular and Cell Biology and the Agency for Science, Technology and Research of Singapore. S. R. is an adjunct faculty member in the Department of Biological Sciences, National University of Singapore.	Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; AMOS WB, 1985, CELL MOTIL CYTOSKEL, V5, P239, DOI 10.1002/cm.970050306; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Chen WB, 2001, DEVELOPMENT, V128, P2385; Choi VM, 2006, GENE EXPR PATTERNS, V6, P443, DOI 10.1016/j.modgep.2005.11.007; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Huang T, 2003, J CELL SCI, V116, P4935, DOI 10.1242/jcs.00830; Ikeda T, 2005, FEBS LETT, V579, P819, DOI 10.1016/j.febslet.2004.12.070; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Majumdar A, 2000, DEVELOPMENT, V127, P2089; Odenthal J, 2000, DEV BIOL, V219, P350, DOI 10.1006/dbio.1999.9589; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Pelletier GJ, 1998, AM J PHYSIOL-LUNG C, V274, pL351, DOI 10.1152/ajplung.1998.274.3.L351; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Xu J, 2006, GENETICS, V174, P735, DOI 10.1534/genetics.106.061523; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	44	258	264	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1445	1453		10.1038/ng.263			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	WOS:000261215900021	19011630				2022-01-24	
J	Loi, S; Haibe-Kains, B; Desmedt, C; Wirapati, P; Lallemand, F; Tutt, AM; Gillet, C; Ellis, P; Ryder, K; Reid, JF; Daidone, MG; Pierotti, MA; Berns, EM; Jansen, PHM; Foekens, JA; Delorenzi, M; Bontempi, G; Piccart, MJ; Sotiriou, C				Loi, Sherene; Haibe-Kains, Benjamin; Desmedt, Christine; Wirapati, Pratyaksha; Lallemand, Francoise; Tutt, Andrew M.; Gillet, Cheryl; Ellis, Paul; Ryder, Kenneth; Reid, James F.; Daidone, Maria G.; Pierotti, Marco A.; Berns, Els Mjj; Jansen, Maurice P. H. M.; Foekens, John A.; Delorenzi, Mauro; Bontempi, Gianluca; Piccart, Martine J.; Sotiriou, Christos			Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen	BMC GENOMICS			English	Article							CLASSIFICATION; CARCINOMAS; GENES; GRADE	Background: Estrogen receptor positive (ER+) breast cancers (BC) are heterogeneous with regard to their clinical behavior and response to therapies. The ER is currently the best predictor of response to the anti-estrogen agent tamoxifen, yet up to 30-40% of ER+ BC will relapse despite tamoxifen treatment. New prognostic biomarkers and further biological understanding of tamoxifen resistance are required. We used gene expression profiling to develop an outcome-based predictor using a training set of 255 ER+ BC samples from women treated with adjuvant tamoxifen monotherapy. We used clusters of highly correlated genes to develop our predictor to facilitate both signature stability and biological interpretation. Independent validation was performed using 362 tamoxifen-treated ER+ BC samples obtained from multiple institutions and treated with tamoxifen only in the adjuvant and metastatic settings. Results: We developed a gene classifier consisting of 181 genes belonging to 13 biological clusters. In the independent set of adjuvantly-treated samples, it was able to define two distinct prognostic groups (HR 2.01 95% CI: 1.29-3.13; p = 0.002). Six of the 13 gene clusters represented pathways involved in cell cycle and proliferation. In 112 metastatic breast cancer patients treated with tamoxifen, one of the classifier components suggesting a cellular inflammatory mechanism was significantly predictive of response. Conclusion: We have developed a gene classifier that can predict clinical outcome in tamoxifen-treated ER+ BC patients. Whilst our study emphasizes the important role of proliferation genes in prognosis, our approach proposes other genes and pathways that may elucidate further mechanisms that influence clinical outcome and prediction of response to tamoxifen.	[Loi, Sherene; Haibe-Kains, Benjamin; Desmedt, Christine; Lallemand, Francoise; Piccart, Martine J.; Sotiriou, Christos] Inst Jules Bordet, Funct Genom Unit, B-1000 Brussels, Belgium; [Loi, Sherene] Peter MacCallum Canc Inst, Melbourne, Vic, Australia; [Haibe-Kains, Benjamin; Bontempi, Gianluca] Univ Libre Bruxelles, Machine Learning Grp, Brussels, Belgium; [Wirapati, Pratyaksha; Delorenzi, Mauro] Swiss Inst Canc Res, NCCR Mol Oncol, Epalinges, Switzerland; [Wirapati, Pratyaksha; Delorenzi, Mauro] Swiss Inst Bioinformat, Epalinges, Switzerland; [Tutt, Andrew M.; Gillet, Cheryl; Ellis, Paul; Ryder, Kenneth] Guys Hosp, London SE1 9RT, England; [Reid, James F.; Pierotti, Marco A.] Fdn Ist FIRC Oncol Mol IFOM, Milan, Italy; [Berns, Els Mjj; Jansen, Maurice P. H. M.; Foekens, John A.] Erasmus MC Daniel JNI, Rotterdam, Netherlands; [Reid, James F.; Daidone, Maria G.; Pierotti, Marco A.] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol, Milan, Italy		Sotiriou, C (corresponding author), Inst Jules Bordet, Funct Genom Unit, B-1000 Brussels, Belgium.	sherene.loi@petermac.org; bhaibeka@ulb.ac.be; christine.desmedt@bordet.be; Pratyaksha.Wirapati@unil.ch; francoise.lallemand@bordet.be; andrew.tutt@icr.org.uk; cheryl.gillet@cancer.org.uk; paul.ellis@gstt.sthames.nhs.uk; kenneth.ryder@cancer.org.uk; james.reid@ifom-ieo-campus.it; mariagrazia.daidone@istitutotumori.mi.it; marco.pierotti@istitutotumori.mi.it; p.berns@erasmus.nl; m.p.h.m.jansen@erasmusmc.nl; j.foekens@erasmusmc.nl; Mauro.Delorenzi@isb-sib.ch; gbonte@ulb.ac.be; martine.piccart@bordet.be; christos.sotiriou@bordet.be	Pierotti, Marco Alessandro/AAC-4728-2022; Bontempi, Gianluca/J-7121-2012; Loi, Sherene/H-1979-2016; Reid, James/G-2496-2010; Desmedt, Christine/P-7438-2017; Bontempi, Gianluca/ABE-4365-2020; Haibe-Kains, Benjamin/D-3702-2011; Daidone, Maria Grazia/E-9232-2017	Pierotti, Marco Alessandro/0000-0002-7431-8332; Bontempi, Gianluca/0000-0001-8621-316X; Loi, Sherene/0000-0001-6137-9171; Desmedt, Christine/0000-0002-5223-5579; Bontempi, Gianluca/0000-0001-8621-316X; Haibe-Kains, Benjamin/0000-0002-7684-0079; Daidone, Maria Grazia/0000-0002-4786-1321; Reid, James/0000-0001-6997-2850			Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; COCHRAN W. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P102; Davis CA, 2006, BIOINFORMATICS, V22, P2356, DOI 10.1093/bioinformatics/btl400; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; HAIBEKAINS B, 2008, STUDIES COMPUTATIONA; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Liu LT, 2003, ONCOGENE, V22, P8263, DOI 10.1038/sj.onc.1207157; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Park MY, 2007, BIOSTATISTICS, V8, P212, DOI 10.1093/biostatistics/kxl002; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Praz V, 2004, NUCLEIC ACIDS RES, V32, pD542, DOI 10.1093/nar/gkh107; Reid JF, 2005, JNCI-J NATL CANCER I, V97, P927, DOI 10.1093/jnci/dji153; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; *SYST I, ING PATHW AN; *TEAM RCD, R PROJ STAT COMP; Turner S, 2004, J THEOR BIOL, V229, P101, DOI 10.1016/j.jtbi.2004.03.008	24	258	263	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAY 22	2008	9								239	10.1186/1471-2164-9-239			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	310RV	WOS:000256548700001	18498629	Green Published, gold			2022-01-24	
J	Lu, C; Kulkarni, K; Souret, FF; MuthuValliappan, R; Tej, SS; Poethig, RS; Henderson, IR; Jacobsen, SE; Wang, WZ; Green, PJ; Meyers, BC				Lu, Cheng; Kulkarni, Karthik; Souret, Frederic F.; MuthuValliappan, Ramesh; Tej, Shivakundan Singh; Poethig, R. Scott; Henderson, Ian R.; Jacobsen, Steven E.; Wang, Wenzhong; Green, Pamela J.; Meyers, Blake C.			MicroRNAs and other small RNAs enriched in the Arabidopsis RNA-dependent RNA polymerase-2 mutant	GENOME RESEARCH			English	Article							TRANS-ACTING SIRNAS; PLANT MICRORNAS; A-LYRATA; S-LOCUS; THALIANA; GENES; MIRNA; BIOGENESIS; TARGETS; IDENTIFICATION	The Arabidopsis genome contains a highly complex and abundant population of small RNAs, and many of the endogenous siRNAs are dependent on RNA-Dependent RNA Polymerase 2 (RDR2) for their biogenesis. By analyzing an rdr2 loss-of-function mutant using two different parallel sequencing technologies, MPSS and 454, we characterized the complement of miRNAs expressed in Arabidopsis inflorescence to considerable depth. Nearly all known miRNAs were enriched in this mutant and we identified 13 new miRNAs, all of which were relatively low abundance and constitute new families. Trans-acting siRNAs (ta-siRNAs) were even more highly enriched. Computational and gel blot analyses suggested that the minimal number of miRNAs in Arabidopsis is similar to 155. The size profile of small RNAs in rdr2 reflected enrichment of 21-nt miRNAs and other classes of siRNAs like ta-siRNAs, and a significant reduction in 24-nt heterochromatic siRNAs. Other classes of small RNAs were found to be RDR2-independent, particularly those derived from long inverted repeats and a subset of tandem repeats. The small RNA populations in other Arabidopsis small RNA biogenesis mutants were also examined; a dcl2/3/4 triple mutant showed a similar pattern to rdr2, whereas dcl1-7 and rdr6 showed reductions in miRNAs and ta-siRNAs consistent with their activities in the biogenesis of these types of small RNAs. Deep sequencing of mutants provides a genetic approach for the dissection and characterization of diverse small RNA populations and the identification of low abundance miRNAs.	Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19711 USA; Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA		Green, PJ (corresponding author), Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19711 USA.	green@dbi.udel.edu; meyers@dbi.udel.edu	Henderson, Ian/A-2174-2012; Meyers, Blake C/B-6535-2012	Meyers, Blake C/0000-0003-3436-6097; Henderson, Ian/0000-0001-5066-1489	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20 RR16472-04, P20 RR016472] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM60398, R01 GM051893, GM51893, R37 GM060398, R01 GM060398, R56 GM051893] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37GM060398, R56GM051893, R01GM060398, R01GM051893] Funding Source: NIH RePORTER		Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brenner S, 2000, P NATL ACAD SCI USA, V97, P1665, DOI 10.1073/pnas.97.4.1665; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; May BP, 2005, PLOS GENET, V1, P705, DOI 10.1371/journal.pgen.0010079; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; REDEI GP, 1975, ANNU REV GENET, V9, P111, DOI 10.1146/annurev.ge.09.120175.000551; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wortman JR, 2003, PLANT PHYSIOL, V132, P461, DOI 10.1104/pp.103.022251; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X	57	258	373	2	27	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	WOODBURY	500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA	1088-9051			GENOME RES	Genome Res.	OCT	2006	16	10					1276	1288		10.1101/gr.5530106			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	090OE	WOS:000240959800012	16954541	Green Published, Bronze			2022-01-24	
J	Hay, A; Tsiantis, M				Hay, Angela; Tsiantis, Miltos			The genetic basis for differences in leaf form between Arabidopsis thaliana and its wild relative Cardamine hirsuta	NATURE GENETICS			English	Article							ROUGH-SHEATH2 GENE; LATERAL ORGANS; HOMEOBOX GENE; EXPRESSION; LEAVES; ASYMMETRIC-LEAVES1; EFFICIENT; IDENTITY; PROTEIN; SYSTEM	A key question in biology is how differences in gene function or regulation produce new morphologies during evolution. Here we investigate the genetic basis for differences in leaf form between two closely related plant species, Arabidopsis thaliana and Cardamine hirsuta. We report that in C. hirsuta, class I KNOTTED1-like homeobox (KNOX) proteins are required in the leaf to delay cellular differentiation and produce a dissected leaf form, in contrast to A. thaliana, in which KNOX exclusion from leaves results in a simple leaf form. These differences in KNOX expression arise through changes in the activity of upstream gene regulatory sequences. The function of ASYMMETRIC LEAVES1/ROUGHSHEATH2/PHANTASTICA (ARP) proteins to repress KNOX expression is conserved between the two species, but in C. hirsuta the ARP-KNOX regulatory module controls new developmental processes in the leaf. Thus, evolutionary tinkering with KNOX regulation, constrained by ARP function, may have produced diverse leaf forms by modulating growth and differentiation patterns in developing leaf primordia.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England		Tsiantis, M (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	miltos.tsiantis@plants.ox.ac.uk					Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2003, PLANT PHYSIOL, V131, P1671, DOI 10.1104/pp.102.017434; Kim JY, 2003, DEVELOPMENT, V130, P4351, DOI 10.1242/dev.00618; Kim M, 2003, NATURE, V424, P438, DOI 10.1038/nature01820; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Ori N, 2000, DEVELOPMENT, V127, P5523; Scanlon MJ, 1996, DEVELOPMENT, V122, P1683; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; SMITH LG, 1992, DEVELOPMENT, V116, P21; Theodoris G, 2003, P NATL ACAD SCI USA, V100, P6837, DOI 10.1073/pnas.1132113100; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622	26	258	278	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2006	38	8					942	947		10.1038/ng1835			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	WOS:000239325700026	16823378				2022-01-24	
J	Selinger, DW; Saxena, RM; Cheung, KJ; Church, GM; Rosenow, C				Selinger, DW; Saxena, RM; Cheung, KJ; Church, GM; Rosenow, C			Global RNA half-life analysis in Escherichia coli reveals positional patterns of transcript degradation	GENOME RESEARCH			English	Article							CELL-DIVISION GENES; MESSENGER-RNA; EXPRESSION DATA; DCW CLUSTER; TDC OPERON; STABILITY; BACTERIA; K-12; RIFAMPICIN; INHIBITION	Subgenic-resolution oligonucleotide microarrays were used to study global RNA degradation in wild-type Escherichia coli MG1655. RNA chemical half-lives were measured for 1036 open reading frames (ORFs) and for 329 known and predicted operons. The half-life of total mRNA was 6.8 min under the conditions tested. We also observed significant relationships between gene functional assignments and transcript stability. Unexpectedly, transcription of a single operon (tdcABCDEFG) was relatively rifampicin-insensitive and showed significant increases 2.5 min after rifampicin addition. This supports a novel mechanism of transcription for the tdc operon, whose promoter lacks any recognizable sigma binding sites. Probe by probe analysis of all known and predicted operons showed that the 5' ends of operons degrade, on average, more quickly than the rest of the transcript, with stability increasing in a 3' direction, supporting and further generalizing the current model of a net 5' to 3' directionality of degradation. Hierarchical clustering analysis of operon degradation patterns revealed that this pattern predominates but is not exclusive. We found a weak but highly significant correlation between the degradation of adjacent operon regions, suggesting that stability is determined by a combination of local and operon-wide stability determinants. The 16 ORF dcw gene cluster, which has a complex promoter structure and a partially characterized degradation pattern, was studied at high resolution, allowing a detailed and integrated description of its abundance and degradation. We discuss the application of subgenic resolution DNA microarray analysis to study global mechanisms of RNA transcription and processing.	Affymetrix Inc, Santa Clara, CA 95051 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA		Rosenow, C (corresponding author), Affymetrix Inc, Santa Clara, CA 95051 USA.			church, george/0000-0001-6232-9969			Aach J, 2000, GENOME RES, V10, P431, DOI 10.1101/gr.10.4.431; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cam K, 1996, NUCLEIC ACIDS RES, V24, P3065, DOI 10.1093/nar/24.15.3065; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; de la Fuente A, 2001, BIOCHIMIE, V83, P109, DOI 10.1016/S0300-9084(00)01212-8; Dewar SJ, 2000, FEMS MICROBIOL LETT, V187, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Flardh K, 1998, MOL MICROBIOL, V30, P305, DOI 10.1046/j.1365-2958.1998.01064.x; Flardh K, 1997, MOL MICROBIOL, V24, P927, DOI 10.1046/j.1365-2958.1997.4001762.x; Goldenberg D, 1996, MOL MICROBIOL, V19, P241, DOI 10.1046/j.1365-2958.1996.363898.x; Grunberg-Manago M, 1999, ANNU REV GENET, V33, P193, DOI 10.1146/annurev.genet.33.1.193; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; LAM LT, 2001, GENOME BIOL, V2; Li C., 2001, GENOME BIOL, V2; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mengin-Lecreulx D, 1998, J BACTERIOL, V180, P4406, DOI 10.1128/JB.180.17.4406-4412.1998; Mohanty BK, 1999, MOL MICROBIOL, V34, P1094, DOI 10.1046/j.1365-2958.1999.01673.x; NILSSON G, 1984, NATURE, V312, P75, DOI 10.1038/312075a0; Rauhut R, 1999, FEMS MICROBIOL REV, V23, P353, DOI 10.1111/j.1574-6976.1999.tb00404.x; Regnier P, 2000, BIOESSAYS, V22, P235; Rosenow C, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.22.e112; Salgado H, 2001, NUCLEIC ACIDS RES, V29, P72, DOI 10.1093/nar/29.1.72; Sarkar N, 1997, ANNU REV BIOCHEM, V66, P173, DOI 10.1146/annurev.biochem.66.1.173; Sawers G, 2001, MOL MICROBIOL, V39, P1285, DOI 10.1046/j.1365-2958.2001.02316.x; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; TJADEN B, 2002, BIOINFORMATICS S, V18, P337; Vicente M, 1998, CELL MOL LIFE SCI, V54, P317, DOI 10.1007/s000180050158; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wegrzyn A, 1998, FEBS LETT, V440, P172, DOI 10.1016/S0014-5793(98)01449-5; WU YF, 1995, MOL GEN GENET, V247, P764, DOI 10.1007/BF00290409	35	258	262	0	24	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	FEB	2003	13	2					216	223		10.1101/gr.912603			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	642TY	WOS:000180821900008	12566399	Bronze, Green Published			2022-01-24	
J	Schubeler, D; Scalzo, D; Kooperberg, C; van Steensel, B; Delrow, J; Groudine, M				Schubeler, D; Scalzo, D; Kooperberg, C; van Steensel, B; Delrow, J; Groudine, M			Genome-wide DNA replication profile for Drosophila melanogaster: a link between transcription and replication timing	NATURE GENETICS			English	Article							MAMMALIAN-CELLS; GENE-EXPRESSION; HETEROCHROMATIN; ORGANIZATION; ASSOCIATION; REGION; LOCUS	Replication of the genome before mitotic cell division is a highly regulated process that ensures the fidelity of DNA duplication. DNA replication initiates at specific locations, termed origins of replication, and progresses in a defined temporal order during the S phase of the cell cycle. The relationship between replication timing and gene expression has been the subject of some speculation(1). A recent genome-wide analysis in Saccharomyces cerevisiae showed no association between replication timing and gene expression(2). In higher eukaryotes, the limited number of genomic loci analyzed has not permitted a firm conclusion regarding this association. To explore the relationship between DNA replication and gene expression in higher eukaryotes, we developed a strategy to measure the timing of DNA replication for thousands of genes in a single DNA array hybridization experiment. Using this approach, we generated a genome-wide map of replication timing for Drosophila melanogaster. Moreover, by surveying over 40% of all D. melanogaster genes, we found a strong correlation between DNA replication early in S phase and transcriptional activity. As this correlation does not exist in S. cerevisiae, this interplay between DNA replication and transcription may be a unique characteristic of higher eukaryotes.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Netherlands Canc Inst, Amsterdam, Netherlands; Fred Hutchinson Canc Res Ctr, DNA Array Facil, Seattle, WA 98104 USA; Univ Washington, Dept Radiat Oncol, Seattle, WA USA		Schubeler, D (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.						Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; CAIZZI R, 1993, GENETICS, V133, P335; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(02)01451-4; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; DePamphilis ML, 1999, BIOESSAYS, V21, P5, DOI 10.1002/(SICI)1521-1878(199901)21:1<5::AID-BIES2>3.0.CO;2-6; DOLFINI S, 1970, EXPERIENTIA, V26, P1020, DOI 10.1007/BF02114171; EBERL DF, 1993, GENETICS, V134, P277; Fan J., 1996, LOCAL POLYNOMIAL MOD; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; HANSEN RS, 1995, HUM MOL GENET, V4, P813; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; JAKUBCZAK JL, 1992, GENETICS, V131, P129; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kooperberg C, 2002, J COMPUT BIOL, V9, P55, DOI 10.1089/10665270252833190; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; Sullivan B, 2001, J CELL BIOL, V154, P683, DOI 10.1083/jcb.200103001; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; WAKIMOTO BT, 1990, GENETICS, V125, P141; YANG YH, 2001, MICROARRAYS OPTICAL	25	258	266	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					438	442		10.1038/ng1005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	WOS:000179034800023	12355067				2022-01-24	
J	Lipkin, SM; Moens, PB; Wang, V; Lenzi, M; Shanmugarajah, D; Gilgeous, A; Thomas, J; Cheng, J; Touchman, JW; Green, ED; Schwartzberg, P; Collins, FS; Cohen, PE				Lipkin, SM; Moens, PB; Wang, V; Lenzi, M; Shanmugarajah, D; Gilgeous, A; Thomas, J; Cheng, J; Touchman, JW; Green, ED; Schwartzberg, P; Collins, FS; Cohen, PE			Meiotic arrest and aneuploidy in MLH3-deficient mice	NATURE GENETICS			English	Article							DNA MISMATCH REPAIR; CROSSING-OVER; MUTS HOMOLOG; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; MEIOSIS; GENE; RECOMBINATION; MLH1; MSH5	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis(1,2). The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2-6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process. Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors(2,3), and two others, Msh4 and Msh5, have specific roles in meiosis(4-10). Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice(2,3,11-14). To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice 15. Here we show that Mlh3(-/-) mice are viable but sterile. Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization. Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92697 USA; NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; York Univ, Dept Biol, N York, ON M3J 1P3, Canada; Albert Einstein Coll Med, Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; NHGRI, Transgen & Knockout Core Facil, Bethesda, MD 20892 USA		Cohen, PE (corresponding author), Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92697 USA.		wang, vicky/AAO-6474-2020		NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [Z01HG000123, ZIAHG000123] Funding Source: NIH RePORTER		Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Edelmann W, 2000, CANCER RES, V60, P803; Ellsworth RE, 2000, P NATL ACAD SCI USA, V97, P1172, DOI 10.1073/pnas.97.3.1172; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Green ED, 2001, NAT REV GENET, V2, P573, DOI 10.1038/35084503; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Her CT, 1999, MAMM GENOME, V10, P1054, DOI 10.1007/s003359901161; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; Kneitz B, 2000, GENE DEV, V14, P1085; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Moens PB, 2002, J CELL SCI, V115, P1611; Osoegawa K, 2000, GENOME RES, V10, P116; PaquisFlucklinger V, 1997, GENOMICS, V44, P188, DOI 10.1006/geno.1997.4857; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Touchman JW, 2000, GENOME RES, V10, P165, DOI 10.1101/gr.10.2.165; Wang DH, 1996, CANCER LETT, V100, P31, DOI 10.1016/0304-3835(95)04068-4; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395	29	258	270	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					385	390		10.1038/ng931			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	WOS:000177147100013	12091911				2022-01-24	
J	Jain, AN; Tokuyasu, TA; Snijders, AM; Segraves, R; Albertson, DG; Pinkel, D				Jain, AN; Tokuyasu, TA; Snijders, AM; Segraves, R; Albertson, DG; Pinkel, D			Fully automatic quantification of microarray image data	GENOME RESEARCH			English	Article							EXPRESSION	DNA microarrays are now widely used to measure expression levels and DNA copy number in biological samples. Ratios of relative abundance of nucleic acids are derived from images of regular arrays of spots containing target genetic material to which fluorescently labeled samples are hybridized. Whereas there are a number of methods in use for the quantification of images, many of the software systems in wide use either encourage or require extensive human interaction at the level of individual spots on arrays. We present a fully automatic system for microarray image quantification. The system automatically locates both subarray grids and individual spots, requiring no user identification of any image coordinates. Ratios are computed based on explicit segmentation of each spot. On a typical image of 6000 spots, the entire process takes less than 20 sec. We present a quantitative assessment of performance on multiple replicates of genome-wide array-based comparative genomic hybridization experiments. By explicitly identifying the pixels in each spot, the system yields more accurate estimates of ratios than systems assuming spot circularity. The software, called UCSF spot, runs on Windows platforms and is available free of charge for academic use.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA		Jain, AN (corresponding author), Univ Calif San Francisco, Ctr Canc, Box 0128, San Francisco, CA 94143 USA.				NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA089520, R01CA083040, P01CA064602] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA89520, CA83040, P50 CA089520, CA64602, P01 CA064602] Funding Source: Medline		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; *AX INSTR INC, 2001, GEN PRO 3 0; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754	6	258	263	0	10	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	FEB	2002	12	2					325	332		10.1101/gr.210902			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	518VY	WOS:000173689600013	11827952	Bronze, Green Published			2022-01-24	
J	Pennarun, G; Escudier, E; Chapelin, C; Bridoux, AM; Cacheux, V; Roger, G; Clement, A; Goossens, M; Amselem, S; Duriez, B				Pennarun, G; Escudier, E; Chapelin, C; Bridoux, AM; Cacheux, V; Roger, G; Clement, A; Goossens, M; Amselem, S; Duriez, B			Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OUTER-ARM DYNEIN; HEAVY-CHAIN GENES; INTERMEDIATE-CHAIN; IMMOTILE-CILIA; LIGHT-CHAIN; MOLECULAR ANALYSIS; BINDING SITES; PROTEIN; IDENTIFICATION; EXPRESSION	Primary ciliary dyskinesia (PCD) is a group of heterogeneous disorders of unknown origin, usually inherited as an autosomal recessive trait. Its phenotype is characterized by axonemal abnormalities of respiratory cilia and sperm tails leading to bronchiectasis and sinusitis, which are sometimes associated with situs inversus (Kartagener syndrome) and male sterility. The main ciliary defect in PCD is an absence of dynein arms. We have isolated the first gene involved in PCD, using a candidate-gene approach developed on the basis of documented abnormalities of immotile strains of Chlamydomonas reinhardtii, which carry axonemal ultrastructural defects reminiscent of PCD. Taking advantage of the evolutionary conservation of genes encoding axonemal proteins, we have isolated a human sequence (DNAI1) related to IC78, a C. reinhardtii gene encoding a dynein intermediate chain in which mutations are associated with the absence of outer dynein arms. DNAI1 is highly expressed in trachea and testis and is composed of 20 exons located at 9p13-p21. Two loss-of-function mutations of DNAI1 have been identified in a patient with PCD characterized by immotile respiratory cilia lacking outer dynein arms. In addition, we excluded linkage between this gene and similar PCD phenotypes in five other affected families, providing a clear demonstration of locus heterogeneity. These data reveal the critical role of DNAI1 in the development of human axonemal structures and open up new means for identification of additional genes involved in related developmental defects.	Hop Henri Mondor, INSERM, U468, F-94010 Creteil, France; Assistance Publ Hop Paris, Grp Hosp Pitie Salpetriere, Serv Histol Embryol, Paris, France; Assistance Publ Hop Paris, Serv Otorhinolaryngol, Paris, France; Assistance Publ Hop Paris, Hop Armand Trousseau, Serv Pneumol Pediat, Paris, France		Amselem, S (corresponding author), Hop Henri Mondor, INSERM, U468, 51 Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	amselem@im3.inserm.fr	Duriez, Benedicte/Z-4690-2019; Pennarun, Gaelle/AAX-6579-2021; Olcese, Chiara/L-6081-2014	Pennarun, Gaelle/0000-0001-9881-9345			AFZELIUS B A, 1976, Science (Washington D C), V193, P317; AFZELIUS BA, 1985, CRC CR REV BIOCH MOL, V19, P63, DOI 10.3109/10409238509086788; Andrews KL, 1996, MOL BIOL CELL, V7, P71, DOI 10.1091/mbc.7.1.71; ASAI DJ, 1994, J CELL SCI, V107, P839; Blair DF, 1992, CURR OPIN GENET DEV, V2, P756, DOI 10.1016/S0959-437X(05)80136-4; CHAO J, 1982, AM REV RESPIR DIS, V126, P302; Chapelin C, 1997, FEBS LETT, V412, P325, DOI 10.1016/S0014-5793(97)00800-4; Chaplin JA, 1997, MOL ECOL, V6, P155, DOI 10.1046/j.1365-294X.1997.00168.x; Crackower MA, 1999, GENOMICS, V55, P257, DOI 10.1006/geno.1998.5665; ESCUDIER E, 1990, AM REV RESPIR DIS, V142, P674, DOI 10.1164/ajrccm/142.3.674; GIBBONS BH, 1994, MOL BIOL CELL, V5, P57, DOI 10.1091/mbc.5.1.57; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cellbio.10.1.339; Kastury K, 1997, J CLIN ENDOCR METAB, V82, P3047, DOI 10.1210/jc.82.9.3047; KING SM, 1991, J BIOL CHEM, V266, P8401; KING SM, 1995, J CELL BIOL, V131, P399, DOI 10.1083/jcb.131.2.399; LEDIZET M, 1995, MOL BIOL CELL, V6, P713, DOI 10.1091/mbc.6.6.713; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; LEMIEUX N, 1992, CYTOGENET CELL GENET, V59, P311, DOI 10.1159/000133277; Milisav I, 1996, MAMM GENOME, V7, P667, DOI 10.1007/s003359900202; MITCHELL DR, 1991, J CELL BIOL, V113, P835, DOI 10.1083/jcb.113.4.835; Myster SH, 1997, MOL BIOL CELL, V8, P607, DOI 10.1091/mbc.8.4.607; NARAYAN D, 1994, J MED GENET, V31, P493, DOI 10.1136/jmg.31.6.493; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neesen J, 1997, GENE, V200, P193, DOI 10.1016/S0378-1119(97)00417-4; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Ogawa K, 1996, MOL BIOL CELL, V7, P1895, DOI 10.1091/mbc.7.12.1895; OGAWA K, 1995, MOL BIOL CELL, V6, P685, DOI 10.1091/mbc.6.6.685; OGAWA K, 1991, NATURE, V352, P643, DOI 10.1038/352643a0; PASCHAL BM, 1992, J CELL BIOL, V118, P1133, DOI 10.1083/jcb.118.5.1133; Perrone CA, 1998, MOL BIOL CELL, V9, P3351, DOI 10.1091/mbc.9.12.3351; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Porter ME, 1996, GENETICS, V144, P569; PORTER ME, 1994, J CELL BIOL, V126, P1495, DOI 10.1083/jcb.126.6.1495; Porter ME, 1996, CURR OPIN CELL BIOL, V8, P10, DOI 10.1016/S0955-0674(96)80042-1; RASMUSSON K, 1994, MOL BIOL CELL, V5, P45, DOI 10.1091/mbc.5.1.45; ROSSMAN CM, 1980, CHEST, V78, P580, DOI 10.1378/chest.78.4.580; Rupp G, 1996, J CELL BIOL, V135, P1853, DOI 10.1083/jcb.135.6.1853; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAKIBARA H, 1991, J CELL BIOL, V113, P615, DOI 10.1083/jcb.113.3.615; SAKAKIBARA H, 1993, J CELL BIOL, V122, P653, DOI 10.1083/jcb.122.3.653; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; STURGESS JM, 1986, AM J MED GENET, V25, P149, DOI 10.1002/ajmg.1320250117; TANAKA Y, 1995, J CELL SCI, V108, P1883; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VALLEE R, 1993, P NATL ACAD SCI USA, V90, P8769, DOI 10.1073/pnas.90.19.8769; Vaughan KT, 1996, GENOMICS, V36, P29, DOI 10.1006/geno.1996.0422; WILKERSON CG, 1995, J CELL BIOL, V129, P169, DOI 10.1083/jcb.129.1.169; WILKERSON CG, 1994, J CELL SCI, V107, P497; WITMAN G B, 1992, Current Opinion in Cell Biology, V4, P74; Witt M, 1999, AM J HUM GENET, V64, P313, DOI 10.1086/302203; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335	53	258	267	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1508	1519		10.1086/302683			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	WOS:000084282500005	10577904	Bronze, Green Published			2022-01-24	
J	Kirchman, PA; Kim, S; Lai, CY; Jazwinski, SM				Kirchman, PA; Kim, S; Lai, CY; Jazwinski, SM			Interorganelle signaling is a determinant of longevity in Saccharomyces cerevisiae	GENETICS			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; OXIDATIVE STRESS; CALORIC RESTRICTION; GENE-EXPRESSION; FAMILY MEMBER; IN-VIVO; YEAST; TRANSCRIPTION; MUTATION	Replicative capacity, which is the number of times an individual cell divides, is the measure of longevity in the yeast Saccharomyces cerevisiae. In this study, a process that involves signaling from the mitochondrion to the nucleus, called retrograde regulation, is shown to determine yeast longevity, and its induction resulted in postponed senescence. Activation of retrograde regulation, by genetic and environmental means, correlated with increased replicative capacity in four different S. cerevisiae strains. Deletion of a gene required for the retrograde response, RTG2, eliminated the increased replicative capacity. RAS2, a gene previously shown to influence longevity in yeast, interacts with retrograde regulation in setting yeast longevity. The molecular mechanism of aging elucidated here parallels the results of genetic studies of aging in nematodes and fruit flies, as well as the caloric restriction paradigm in mammals, and it underscores the importance of metabolic regulation in aging, suggesting a general applicability.	Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA		Jazwinski, SM (corresponding author), Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, 1901 Perdido St,Box P7-2, New Orleans, LA 70112 USA.		Kirchman, Paul/AAE-9589-2019				Ausubel FM., 1994, CURRENT PROTOCOLS MO; Brierley EJ, 1997, MOL CELL BIOCHEM, V174, P325, DOI 10.1023/A:1006847319162; CALLEJA M, 1993, J BIOL CHEM, V268, P18891; CHELSTOWSKA A, 1995, J BIOL CHEM, V270, P18141, DOI 10.1074/jbc.270.30.18141; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; DORMAN JB, 1995, GENETICS, V141, P1399; DUDAS SP, 1995, J GERONTOL A-BIOL, V50, pB117, DOI 10.1093/gerona/50A.3.B117; EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Finch C.E., 1990, LONGEVITY SENESCENCE; FRAENKEL DG, 1985, P NATL ACAD SCI USA, V82, P4740, DOI 10.1073/pnas.82.14.4740; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gancedo C., 1989, YEASTS, P205; GOLDRING ES, 1970, J MOL BIOL, V52, P323, DOI 10.1016/0022-2836(70)90033-1; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Heydari AR, 1996, DEV GENET, V18, P114, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;114::AID-DVG4&gt;3.0.CO;2-C; HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909; JAZWINSKI SM, 1993, GENETICA, V91, P35, DOI 10.1007/BF01435986; Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54; JAZWINSKI SM, 1989, EXP GERONTOL, V24, P423; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Khazaeli AA, 1997, J GERONTOL A-BIOL, V52, pB48, DOI 10.1093/gerona/52A.1.B48; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; KOONIN EV, 1994, TRENDS BIOCHEM SCI, V19, P156, DOI 10.1016/0968-0004(94)90275-5; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LINNANE AW, 1992, AGING-CLIN EXP RES, V4, P267, DOI 10.1007/BF03324106; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Liu HP, 1996, GENETICS, V144, P967; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x; MASORO EJ, 1995, EXP GERONTOL, V30, P291, DOI 10.1016/0531-5565(94)00028-2; Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I; Murakami S, 1996, GENETICS, V143, P1207; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PAHLAVANI MA, 1994, MODULATION AGING PRO, P143; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; POHLEY HJ, 1987, MECH AGEING DEV, V38, P231, DOI 10.1016/0047-6374(87)90092-3; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; REAUME SE, 1949, ARCH BIOCHEM, V22, P331; RICHARDSON A, 1994, GENETICS EVOLUTION A, P226; ROMAN H, 1956, COLD SPRING HARB SYM, V21, P175, DOI 10.1101/SQB.1956.021.01.015; Rothermel BA, 1997, J BIOL CHEM, V272, P19801, DOI 10.1074/jbc.272.32.19801; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Shama S, 1998, EXP CELL RES, V245, P379, DOI 10.1006/excr.1998.4279; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SMALL WC, 1995, BIOCHEMISTRY-US, V34, P5569, DOI 10.1021/bi00016a031; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; SPEVAK W, 1983, MOL CELL BIOL, V3, P1545, DOI 10.1128/MCB.3.9.1545; SUN JY, 1994, J BIOL CHEM, V269, P18638; SZEKELY E, 1984, MOL CELL BIOL, V4, P939, DOI 10.1128/MCB.4.5.939; TATCHELL K, 1984, NATURE, V309, P523, DOI 10.1038/309523a0; TATCHELL K, 1985, P NATL ACAD SCI USA, V82, P3785, DOI 10.1073/pnas.82.11.3785; TATCHELL K, 1993, SIGNAL TRANSDUCTION, P147; Tengan CH, 1997, MUTAT RES-FUND MOL M, V379, P1, DOI 10.1016/S0027-5107(97)00076-6; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VANREMMEN H, 1994, HDB PHYSL AGING, P171; Velot C, 1996, GENETICS, V144, P893; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	76	258	262	1	16	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	MAY	1999	152	1					179	190					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	194XB	WOS:000080219100015	10224252				2022-01-24	
J	Belin, V; Cusin, V; Viot, G; Girlich, D; Toutain, A; Moncla, A; Vekemans, M; Le Merrer, M; Munnich, A; Cormier-Daire, V				Belin, V; Cusin, V; Viot, G; Girlich, D; Toutain, A; Moncla, A; Vekemans, M; Le Merrer, M; Munnich, A; Cormier-Daire, V			SHOX mutations in dyschondrosteosis (Leri-Weill syndrome)	NATURE GENETICS			English	Article							LOCI; MAP	Dyschondrosteosis(1) (DCS) is an autosomal dominant(2) form of mesomelic dysplasia with deformity of the forearm (Madelung deformity; ref. 3). Based on the observation of XY translocations (p22,q12; refs 4-6) in DCS patients, we tested the pseudoautosomal region in eight families with DCS and showed linkage of the DCS gene to a microsatellite DNA marker at the DXYS233 locus (Zmax=6.26 at theta=0). The short stature homeobox-containing gene(7,8) (SHOX), involved in idiopathic growth retardation and possibly Turner short stature, maps to this region and was therefore regarded as a strong candidate gene in DCS. Here, we report large-scale deletions tin seven families) and a nonsense mutation tin one family) of SHOX in patients with DCS and show that Langer mesomelic dwarfism(9) results from homozygous mutations at the DCS locus.	Hop Enfants Malad, INSERM U393, Dept Genet, Paris, France; Hop Enfants Malad, INSERM U393, Unite Rech Handicaps Genet Enfant, Paris, France; Hop Clocheville, Serv Genet, Tours, France; Hop Enfants La Timone, Dept Genet, Marseille, France		Munnich, A (corresponding author), Hop Enfants Malad, INSERM U393, Dept Genet, Paris, France.		; cormier-daire, valerie/H-6520-2017	Girlich, Delphine/0000-0002-7698-2798; Toutain, Annick/0000-0002-5999-5300; cormier-daire, valerie/0000-0002-2839-9856			BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; CASTILLO S, 1985, CYTOGENET CELL GENET, V40, P601; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; ESPERITU C, 1975, AM J DIS CHILD, V129, P375; Guichet A, 1997, CLIN DYSMORPHOL, V6, P341, DOI 10.1097/00019605-199710000-00007; LERI A, 1929, B MEM SOC MED HOP P, V35, P1491; LICHTENSTEIN JR, 1980, J MED GENET, V17, P41, DOI 10.1136/jmg.17.1.41; Madelung V, 1878, ARCH KLIN CHIR, V23, P395; OGATA T, 1992, J MED GENET, V29, P624, DOI 10.1136/jmg.29.9.624; PFEIFFER RA, 1980, CYTOGENET CELL GENET, V26, P150, DOI 10.1159/000131436; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; TOUTAIN A, 1991, ANN PEDIATR-PARIS, V38, P37	14	258	264	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					67	69		10.1038/ng0198-67			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	WOS:000073346700020	9590292				2022-01-24	
J	Gill, KS; Gill, BS; Endo, TR; Boyko, EV				Gill, KS; Gill, BS; Endo, TR; Boyko, EV			Identification and high-density mapping of gene-rich regions in chromosome group 5 of wheat	GENETICS			English	Article							PHYSICAL MAP; COMMON WHEAT; HUMAN GENOME; HOMOLOGOUS RECOMBINATION; LINKAGE MAP; BANDS; ARM; SYSTEM; TOMATO	The distribution of genes and recombination in the wheat genome was studied by comparing physical maps with the genetic linkage maps. The physical maps were generated by mapping 80 DNA and two phenotypic markers on an array of 65 deletion lines for homoeologous group 5 chromosomes. The genetic maps were constructed for chromosome 5B in wheat and 5D in Triticum tauschii. No marker mapped in the proximal 20% chromosome region surrounding the centromere. More than 60% of the long arm markers were present in three major clusters that physically encompassed <18% of the arm. Because 48% of the markers were cDNA clones and the distributions of the CDNA and genomic clones were similar, the marker distribution may represent the distribution of genes. The gene clusters were identified and allocated to very small chromosome regions because of a higher number of deletions in their surrounding regions. The recombination was suppressed in the centromeric regions and mainly occurred in the gene-rich regions. The bp/cM estimates varied from 118 kb for gene-rich regions to 22 Mb for gene-poor regions. The wheat genes present in these clusters are, therefore, amenable to molecular manipulations parallel to the plants with smaller genomes like rice.	KYOTO UNIV,FAC AGR,GENET LAB,KYOTO 606,JAPAN		Gill, KS (corresponding author), KANSAS STATE UNIV,DEPT PLANT PATHOL,WHEAT GENET RESOURCE CTR,4307 THROCKMORTON HALL,MANHATTAN,KS 66506, USA.						AISSANI B, 1991, GENE, V106, P173, DOI 10.1016/0378-1119(91)90197-J; Anderson JA, 1992, THEOR APPL GENET, V83, P1035, DOI 10.1007/BF00232969; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; BENNETZEN JL, 1993, TRENDS GENET, V9, P259, DOI 10.1016/0168-9525(93)90001-X; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; BOLLAG RJ, 1989, ANNU REV GENET, V23, P199, DOI 10.1146/annurev.ge.23.120189.001215; BURR B, 1988, GENETICS, V118, P519; CURTIS CA, 1991, THEOR APPL GENET, V81, P245, DOI 10.1007/BF00215730; DELANEY DE, 1995, THEOR APPL GENET, V91, P780, DOI 10.1007/BF00220959; DELANEY DE, 1995, THEOR APPL GENET, V91, P568, DOI 10.1007/BF00223281; DUJON B, 1994, NATURE, V369, P371, DOI 10.1038/369371a0; DVORAK J, 1984, GENETICS, V106, P325; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; ENDO TR, 1988, J HERED, V79, P366, DOI 10.1093/oxfordjournals.jhered.a110529; ENDO TR, 1996, IN PRESS J HERED; GALIBA G, 1995, THEOR APPL GENET, V90, P1174, DOI 10.1007/BF00222940; GANAL MW, 1989, MOL GEN GENET, V215, P395, DOI 10.1007/BF00427035; GAUDET AM, 1990, EUKARYOTIC NUCL MOL, P118; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; GILL KS, 1993, GENETICS, V134, P1231; GILL KS, 1994, BIOESSAYS, V16, P841, DOI 10.1002/bies.950161111; GILL KS, 1993, CHROMOSOMA, V102, P374, DOI 10.1007/BF00360401; GILL KS, 1991, GENOME, V34, P362, DOI 10.1139/g91-058; GILL KS, 1994, PLANT GENOME, V2, P64; HOHMANN U, 1994, MOL GEN GENET, V245, P644, DOI 10.1007/BF00282228; KOTA RS, 1988, GENETICS, V120, P1085; KOTA RS, 1993, GENOME, V36, P548, DOI 10.1139/g93-075; KURATA N, 1994, NAT GENET, V8, P365, DOI 10.1038/ng1294-365; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LUKASZEWSKI AJ, 1995, GENETICS, V140, P1069; MICKELSONYOUNG L, 1995, THEOR APPL GENET, V90, P18007; MOUCHIROUD D, 1991, GENE, V100, P181, DOI 10.1016/0378-1119(91)90364-H; NARANJO T, 1987, GENOME, V29, P873, DOI 10.1139/g87-149; NASUDA S, 1992, THESIS KYOTO U JAPAN; NILSSON NO, 1993, TRENDS GENET, V9, P344, DOI 10.1016/0168-9525(93)90038-J; RICK CM, 1971, STADLER S, V1, P153; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SEARS ER, 1954, RES B U MISSOURI AGR, V572; SEGAL G, 1992, MOL GEN GENET, V231, P179, DOI 10.1007/BF00279789; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; STEINMETZ M, 1987, TRENDS GENET, V3, P7, DOI 10.1016/0168-9525(87)90154-5; SUMNER AT, 1993, J MOL EVOL, V37, P117, DOI 10.1007/BF02407346; TANKSELY SD, 1993, GENETIC MAPS; TSUJIMOTO H, 1985, JPN J GENET, V60, P565, DOI 10.1266/jjg.60.565; UMEHARA Y, 1995, MOL BREEDING, V1, P79, DOI 10.1007/BF01682091; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; WERNER JE, 1992, P NATL ACAD SCI USA, V89, P11307, DOI 10.1073/pnas.89.23.11307; YUNIS JJ, 1977, CHROMOSOMA, V61, P335, DOI 10.1007/BF00288617; ZHANG HB, 1994, MOL GEN GENET, V244, P613, DOI 10.1007/BF00282751	49	258	269	0	3	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JUN	1996	143	2					1001	1012					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN684	WOS:A1996UN68400033	8725245				2022-01-24	
J	Kolman, CJ; Sambuughin, N; Bermingham, E				Kolman, CJ; Sambuughin, N; Bermingham, E			Mitochondrial DNA analysis of mongolian populations and implications for the origin of New World founders	GENETICS			English	Article							DIFFERENTIATION; SEQUENCES; REGION; POLYMORPHISM; MIGRATIONS; AFFINITIES; AMERICA; GENOME	High levels of mitochondrial DNA (mtDNA) diversity were determined for Mongolian populations, represented by the Mongol-speaking Khalkha and Dariganga. Although 103 samples were collected across Mongolia, low levels of genetic substructuring were detected, reflecting the nomadic lifestyle and relatively recent ethnic differentiation of Mongolian populations, mtDNA control region I sequence and seven additional mtDNA polymorphisms were assayed to allo iv extensive comparison with previous human population studies. Based on a comparative analysis, we propose that indigenous populations in east Central Asia represent the closest genetic link between Old and New World populations. Utilizing restriction/deletion polymorphisms, Mongolian populations were found to carry all four New World founding haplogroups as defined by WALLACE and coworkers. The ubiquitous presence of the four New World haplogroups in the Americas but narrow distribution across Asia weakens support for GREENBERG and coworkers' theory of New World colonization via three independent migrations. The statistical and geographic scarcity of New World haplogroups in Asia makes it improbable that the same four haplotypes would be drawn from one geographic region three independent times. Instead, it is likely that founder effects manifest throughout Asia and the Americas are responsible for differences in mtDNA haplotype frequencies observed in these regions.	SMITHSONIAN TROP RES INST, BALBOA, PANAMA; MONGOLIA MED UNIV, NATL CTR ANTROPOL, ULAANBAATAR, MONGOLIA								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BADAMKHATAN S, 1987, ETHNOGRAPHY MONGOLIA, V1; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BALLINGER SW, 1992, GENETICS, V130, P139; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; BATSURI J, 1986, THESIS NI VAVILOV I; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; DEREVIANKO AP, 1969, ARCTIC ANTHROPOL, V6, P119; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; EXCOFFIER L, 1992, GENETICS, V131, P479; Fiedel S. J., 1992, PREHISTORY AM; GINTHER C, 1993, DNA FINGERPRINTING S; GONGOR D, 1970, KHALKHA MONGOLIANS I; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HALL WW, 1994, AIDS RES HUM RETROV, V10, P443; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1990, AM J HUM GENET, V46, P828; LAIRMORE MD, 1990, P NATL ACAD SCI USA, V87, P8840, DOI 10.1073/pnas.87.22.8840; MADDISON DR, 1992, SYST BIOL, V41, P111, DOI 10.2307/2992510; MALONEY EM, 1992, J INFECT DIS, V166, P100, DOI 10.1093/infdis/166.1.100; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; NEEL JV, 1994, P NATL ACAD SCI USA, V91, P10737, DOI 10.1073/pnas.91.22.10737; NEI M, 1981, GENETICS, V97, P145; NEI M, 1974, GENETICS, V76, P379; NEI M, 1993, MOL BIOL EVOL, V10, P927; SAMBUUGHIN N, 1992, GENETIKA+, V28, P136; SAMBUUGHIN N, 1991, GENETIKA+, V27, P2137; SAMBUUGHIN N, 1992, THESIS NI VAVILOV I; SANTOS M, 1994, HUM BIOL, V66, P963; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; Swofford DL, 1989, PAUP PHYLOGENETIC AN; SZATHMARY EJE, 1994, METHOD THEORY INVEST, P00117; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TUMEN D, 1992, THESIS ML LOMONOSOV; Turner C G 2nd, 1984, Acta Anthropogenet, V8, P23; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	46	258	277	0	12	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	1996	142	4					1321	1334					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UD844	WOS:A1996UD84400022	8846908				2022-01-24	
J	ADLKOFER, K; MARTINI, R; AGUZZI, A; ZIELASEK, J; TOYKA, KV; SUTER, U				ADLKOFER, K; MARTINI, R; AGUZZI, A; ZIELASEK, J; TOYKA, KV; SUTER, U			HYPERMYELINATION AND DEMYELINATING PERIPHERAL NEUROPATHY IN PMP22-DEFICIENT MICE	NATURE GENETICS			English	Article							TOOTH DISEASE TYPE-1A; TREMBLER-J MOUSE; ARREST-SPECIFIC GENE; MYELIN PROTEIN; POINT MUTATION; SCHWANN-CELLS; HEREDITARY NEUROPATHY; PRESSURE PALSIES; NERVOUS-SYSTEM; PMP22 GENE	Peripheral myelin protein PMP22 has been suggested to have a role in peripheral nerve myelination and cell proliferation. Defects at the PMP22 locus are associated with peripheral neuropathies such as Charcot-Marie-Tooth disease type 1A. We now demonstrate that mice devoid of Pmp22 are retarded in the onset of myelination and develop abundant sausage-like hypermyelination structures (tomacula) at a young age followed by severe demyelination, axonal loss and functional impairment. Mice carrying one functional copy of Pmp22 are less affected but they also exhibit focal tomacula comparable to the morphological features in hereditary neuropathy with liability to pressure palsies (HNPP). We conclude that Pmp22 is required for the correct development of peripheral nerves, the maintenance of axons and the determination of myelin thickness and stability.	ETH HONGGERBERG,DEPT CELL BIOL,CH-8093 ZURICH,SWITZERLAND; ETH HONGGERBERG,DEPT NEUROBIOL,CH-8093 ZURICH,SWITZERLAND; UNIV ZURICH HOSP,INST NEUROPATHOL,CH-8091 ZURICH,SWITZERLAND; UNIV WURZBURG,DEPT NEUROL,D-97080 WURZBURG,GERMANY				Aguzzi, Adriano/A-3351-2008; Suter, Ueli/A-1624-2010	Aguzzi, Adriano/0000-0002-0344-6708; Martini, Rudolf/0000-0002-5463-5592			AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; BAECHER D, IN PRESS J NEUROSCI; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHANCE PF, 1994, HUM MOL GENET, V3, P323; COLLELO RJ, 1994, J NEUROSCI, V14, P2594; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dyck PJ, 1993, PERIPHERAL NEUROPATH, P1094; DYCK PJ, 1984, PERIPHERAL NEUROPATH, P760; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HENRY EW, 1983, J NEUROPATH EXP NEUR, V42, P688, DOI 10.1097/00005072-198311000-00008; LOW PA, 1977, J NEUROL NEUROSUR PS, V40, P434, DOI 10.1136/jnnp.40.5.434; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1995, J NEUROSCI, V15, P4488; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MEIER C, 1982, J NEUROL, V228, P73, DOI 10.1007/BF00313754; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; NICHOLSON GA, 1994, NAT GENET, V6, P263, DOI 10.1038/ng0394-263; PAREEK S, 1993, J BIOL CHEM, V268, P10372; PARMANTIER E, 1995, EUR J NEUROSCI, V7, P1080, DOI 10.1111/j.1460-9568.1995.tb01095.x; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Peters A., 1991, FINE STRUCTURE NERVO, P212; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; RUFFNER H, 1993, P NATL ACAD SCI USA, V90, P11503, DOI 10.1073/pnas.90.24.11503; SHINE HD, 1992, J NEUROCHEM, V58, P342, DOI 10.1111/j.1471-4159.1992.tb09316.x; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1995, J ANAT, V186, P483; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1995, ANNU REV NEUROSCI, V18, P45, DOI 10.1146/annurev.neuro.18.1.45; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SUTER U, 1995, J NEUROSCI RES, V40, P145, DOI 10.1002/jnr.490400202; SUTER U, 1994, J BIOL CHEM, V269, P25795; TAYLOR V, IN PRESS J BIOL CHEM; THOMAS FP, 1994, ACTA NEUROPATHOL, V87, P91; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; UNCINI A, 1995, MUSCLE NERVE, V18, P628, DOI 10.1002/mus.880180610; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VALENTIJN LJ, 1995, HUM MUTAT, V5, P76, DOI 10.1002/humu.1380050110; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; Windebank A, 1993, PERIPHERAL NEUROPATH, V2, P1137; ZOIDL G, 1995, EMBO J, V14, P1122, DOI 10.1002/j.1460-2075.1995.tb07095.x	53	258	260	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					274	280		10.1038/ng1195-274			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	WOS:A1995TC63900015	7581450				2022-01-24	
J	NAROD, SA; FORD, D; DEVILEE, P; BARKARDOTTIR, RB; LYNCH, HT; SMITH, SA; PONDER, BAJ; WEBER, BL; GARBER, JE; BIRCH, JM; CORNELIS, RS; KELSELL, DP; SPURR, NK; SMYTH, E; HAITES, N; SOBOL, H; BIGNON, YJ; CHANGCLAUDE, J; HAMANN, U; LINDBLOM, A; BORG, A; PIVER, MS; GALLION, HH; STRUEWING, JP; WHITTEMORE, A; TONIN, P; GOLDGAR, DE; EASTON, DF; MILNER, B; ALLAN, L; SIMARD, J; ROMMENS, J; MCGILLIVRAY, B; GREEN, R; IVES, E; BOYD, N; ROSEN, B; COLE, D; MORGAN, K; MOSLEHI, R; PONDER, B; PETO, J; SMITH, S; STRATTON, M; DICIOCCIO, RA; GALLION, H; SANTIBANEZKOREF, MS; TEARE, MD; EVANS, DG; STOPPALYONNET, D; LALLE, P; BONAITI, C; ESSIOUX, L; GIRODET, C; MAUGARDLOUBOUTIN, C; NICOLLEAU, G; LONGY, M; TOULOUSE, C; HORSTEIN, I; BIRNBAUM, D; EISINGER, F; KARENGUEVEN, F; NOGUCHI, T; HARDOUIN, A; RIO, P; MACHELARDROUMAGNAC, M; NOGUES, C; COHENHAGUENAUER, O; LORTHOLARY, A; BAY, JO; ARASON, A; BARKDARDOTTIR, RB; EGILSSON, V; BISHOP, DT; KELSELL, D; MURDAY, VA; SOLOMON, E; SPURR, N; TURNER, G; LENOIR, G; FEUNTEUN, J; LYNCH, H; LYNCH, J; WATSON, P; CONWAY, T; BONNARDEL, C; SEROVA, O; TORCHARD, D; LARSSON, C; VASEN, H; VANLEEUWEN, I; CORNELISSE, CJ; STEEL, M; PORTER, D; COHEN, BB; CAROTHERS, A; CANNONALBRIGHT, LA; GOLDGAR, D; SKOLNICK, M; BECHER, H; JOHANNSSON, O; WEBER, B; COLLINS, F; BOEHNKE, M; GARBER, J; LI, F				NAROD, SA; FORD, D; DEVILEE, P; BARKARDOTTIR, RB; LYNCH, HT; SMITH, SA; PONDER, BAJ; WEBER, BL; GARBER, JE; BIRCH, JM; CORNELIS, RS; KELSELL, DP; SPURR, NK; SMYTH, E; HAITES, N; SOBOL, H; BIGNON, YJ; CHANGCLAUDE, J; HAMANN, U; LINDBLOM, A; BORG, A; PIVER, MS; GALLION, HH; STRUEWING, JP; WHITTEMORE, A; TONIN, P; GOLDGAR, DE; EASTON, DF; MILNER, B; ALLAN, L; SIMARD, J; ROMMENS, J; MCGILLIVRAY, B; GREEN, R; IVES, E; BOYD, N; ROSEN, B; COLE, D; MORGAN, K; MOSLEHI, R; PONDER, B; PETO, J; SMITH, S; STRATTON, M; DICIOCCIO, RA; GALLION, H; SANTIBANEZKOREF, MS; TEARE, MD; EVANS, DG; STOPPALYONNET, D; LALLE, P; BONAITI, C; ESSIOUX, L; GIRODET, C; MAUGARDLOUBOUTIN, C; NICOLLEAU, G; LONGY, M; TOULOUSE, C; HORSTEIN, I; BIRNBAUM, D; EISINGER, F; KARENGUEVEN, F; NOGUCHI, T; HARDOUIN, A; RIO, P; MACHELARDROUMAGNAC, M; NOGUES, C; COHENHAGUENAUER, O; LORTHOLARY, A; BAY, JO; ARASON, A; BARKDARDOTTIR, RB; EGILSSON, V; BISHOP, DT; KELSELL, D; MURDAY, VA; SOLOMON, E; SPURR, N; TURNER, G; LENOIR, G; FEUNTEUN, J; LYNCH, H; LYNCH, J; WATSON, P; CONWAY, T; BONNARDEL, C; SEROVA, O; TORCHARD, D; LARSSON, C; VASEN, H; VANLEEUWEN, I; CORNELISSE, CJ; STEEL, M; PORTER, D; COHEN, BB; CAROTHERS, A; CANNONALBRIGHT, LA; GOLDGAR, D; SKOLNICK, M; BECHER, H; JOHANNSSON, O; WEBER, B; COLLINS, F; BOEHNKE, M; GARBER, J; LI, F			AN EVALUATION OF GENETIC-HETEROGENEITY IN 145 BREAST-CANCER OVARIAN-CANCER FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRCA1 REGION; ALLELE LOSS; CHROMOSOME-17Q21; SUSCEPTIBILITY; LINKAGE; ONSET; MAPS; INTERVAL; MARKERS; RISKS	The breast-ovary cancer-family syndrome is a dominant predisposition to cancer of the breast and ovaries which has been mapped to chromosome region 17q12-q21. The majority, but not all, of breast-ovary cancer families show linkage to this susceptibility locus, designated BRCA1. We report here the results of a linkage analysis of 145 families with both breast and ovarian cancer. These families contain either a total of three or more cases of early-onset (before age 60 years) breast cancer or ovarian cancer. All families contained at least one case of ovarian cancer, Overall, an estimated 76% of the 145 families are linked to the BRCA1 locus. None of 13 families with cases of male breast cancer appear to be linked, but it is estimated that 92% (95% confidence interval 76%-100%) of families with no male breast cancer and with two or more ovarian cancers are linked to BRCA1. These data suggest that the breast-ovarian cancer-family syndrome is genetically heterogeneous. However, the large majority of families with early-onset breast cancer and with two or more cases of ovarian cancer are likely to be due to BRCA1 mutations.	MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; INST CANC RES,EPIDEMIOL SECT,SUTTON,SURREY,ENGLAND; LEIDEN UNIV,DEPT PATHOL,LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT HUMAN GENET,LEIDEN,NETHERLANDS; UNIV HOSP ICELAND,DEPT PATHOL,REYKJAVIK,ICELAND; CREIGHTON UNIV,SCH MED,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE 68178; UNIV CAMBRIDGE,DEPT PATHOL,HUMAN CANC GENET RES GRP,CANC RES CAMPAIGN,CAMBRIDGE,ENGLAND; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; UNIV MANCHESTER,PEDIAT & FAMILIAL CANC RES GRP,CANC RES CAMPAIGN,MANCHESTER,LANCS,ENGLAND; IMPERIAL CANC RES FUND,HUMAN GENET RESOURCES LAB,POTTERS BAR,HERTS,ENGLAND; WESTERN GEN HOSP,HUMAN GENET UNIT,MRC,EDINBURGH,MIDLOTHIAN,SCOTLAND; UNIV ABERDEEN,DEPT MOLEC & CELL BIOL,ABERDEEN,SCOTLAND; INST J PAOLI I CALMETTES,DEPT ONCOL GENET,MARSEILLE,FRANCE; CTR JEAN PERRIN,MOLEC ONCOL LAB,CLERMONT FERRAND,FRANCE; GERMAN CANC RES CTR,DIV EPIDEMIOL,HEIDELBERG,GERMANY; KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN; UNIV LUND HOSP,LUND,SWEDEN; ROSWELL PK CANC INST,BUFFALO,NY; NIH,GENET EPIDEMIOL BRANCH,BETHESDA,MD; STANFORD UNIV,SCH MED,DIV EPIDEMIOL,STANFORD,CA; UNIV UTAH,GENET EPIDEMIOL GRP,SALT LAKE CITY,UT				Struewing, Jeffery P/C-3221-2008; Kelsell, David P/F-8767-2011; Narod, Steven A/AAA-6112-2022; , bignon/Y-3243-2019; Becher, Heiko/ABI-1234-2020; Feunteun, Jean/AAZ-1267-2020; LALLE, Philippe/G-7734-2018; Struewing, Jeffery P/I-7502-2013	Struewing, Jeffery P/0000-0002-4848-3334; Bishop, Tim/0000-0002-8752-8785; Kelsell, David/0000-0002-9910-7144			AMOS CI, 1992, JAMA-J AM MED ASSOC, V268, P1896, DOI 10.1001/jama.268.14.1896; ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BEWTRA C, 1992, INT J GYNECOL PATHOL, V11, P180, DOI 10.1097/00004347-199207000-00003; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; BULLER RE, 1993, GYNECOL ONCOL, V51, P160, DOI 10.1006/gyno.1993.1265; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; CORNELIS RS, 1993, ONCOGENE, V8, P781; EASTON D, 1993, CANCER SURV, V18, P95; EASTON DF, 1993, AM J HUM GENET, V52, P678; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FOULKES W, 1991, LANCET, V338, P444, DOI 10.1016/0140-6736(91)91065-3; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; GOLDGAR DE, 1993, AM J HUM GENET, V52, P743; GREGGI S, 1990, GYNECOL ONCOL, V39, P300, DOI 10.1016/0090-8258(90)90256-K; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JOLLY KW, 1994, ONCOGENE, V9, P97; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LYNCH HT, 1993, ARCH INTERN MED, V153, P1979; NAROD S, 1994, LANCET, V343, P236, DOI 10.1016/S0140-6736(94)91021-9; NAROD S, 1993, CLIN INVEST MED, V16, P314; NAROD SA, 1994, CANCER-AM CANCER SOC, V74, P2341, DOI 10.1002/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z; NAROD SA, 1991, LANCET, V338, P82; OTT J, 1985, ANAL HUMAN GENETIC L; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P582; SAITO H, 1993, CANCER RES, V53, P3382; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; SMITH SA, 1994, GENE CHROMOSOME CANC, V10, P71, DOI 10.1002/gcc.2870100112; SMITH SA, 1993, AM J HUM GENET, V52, P767; SOBOL H, 1992, HUM GENET, V89, P381; STEICHENGERSDOR.E, 1994, AM J HUM GENET, V55, P870; STRATTON MR, 1994, NAT GENET, V7, P103, DOI 10.1038/ng0594-103; TONIN P, 1994, HUM MOL GENET, V3, P1679, DOI 10.1093/hmg/3.9.1679; VARESCO L, 1992, GENE CHROMOSOME CANC, V4, P84, DOI 10.1002/gcc.2870040113; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a	39	258	260	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					254	264					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	WOS:A1995QC10100033	7825586				2022-01-24	
J	BOULET, L; KARPATI, G; SHOUBRIDGE, EA				BOULET, L; KARPATI, G; SHOUBRIDGE, EA			DISTRIBUTION AND THRESHOLD EXPRESSION OF THE TRANS RNALYS MUTATION IN SKELETAL-MUSCLE OF PATIENTS WITH MYOCLONIC EPILEPSY AND RAGGED-RED FIBERS (MERRF)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL ENCEPHALOMYOPATHY MERRF; KEARNS-SAYRE SYNDROME; RESPIRATORY-CHAIN; DNA MUTATION; HELA-CELLS; DISEASE; GENOMES; SEGREGATION; SEQUENCE; MYOPATHY	We investigated the distribution and expression of mutant mtDNAs carrying the A-to-G mutation at position 8344 in the tRNA(Lys) gene in the skeletal muscle of four patients with myoclonus epilepsy and ragged-red fibers (MERRF). The proportion of mutant genomes was greater than 80% of total mtDNAs in muscle samples of all patients and was associated with a decrease in the activity of cytochrome c oxidase (COX). The vast majority of myoblasts, cloned from the satellite-cell population in the same muscles, were homoplasmic for the mutation. The overall proportion of mutant mtDNAs in this population was similar to that in differentiated muscle, suggesting that the ratio of mutant to wild-type mtDNAs in skeletal muscle is determined either in the ovum or during early development and changes little with age. Translation of all mtDNA-encoded genes was severely depressed in homoplasmic mutant myoblast clones but not in heteroplasmic or wild-type clones. The threshold for biochemical expression of the mutation was determined in heteroplasmic myotubes formed by fusion of different proportions of mutant and wild-type myoblasts. The magnitude of the decrease in translation in myotubes containing mutant mtDNAs was protein specific. Complex I and IV subunits were more affected than complex V subunits, and there was a rough correlation with both protein size and number of lysine residues. Approximately 15% wild-type mtDNAs restored translation and COX activity to near normal levels. These results show that the A-to-G substitution in tRNA(Lys) is a functionally recessive mutation that can be rescued by intraorganellar complementation with a small proportion of wild-type mtDNAs and explain the steep threshold for expression of the MERRF clinical phenotype.	MCGILL UNIV,MONTREAL NEUROL INST,3801 UNIV ST,MONTREAL H3A 2B4,QUEBEC,CANADA; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2T5,QUEBEC,CANADA		SHOUBRIDGE, EA (corresponding author), MCGILL UNIV,MONTREAL NEUROL INST,3801 UNIV ST,MONTREAL H3A 2B4,QUEBEC,CANADA.						ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; Attardi G, 1979, Methods Enzymol, V56, P66; ATTARDI G, 1990, BIOCHEM SOC T, V18, P509, DOI 10.1042/bst0180509; BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H; BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; DEZAMAROCZY M, 1981, NATURE, V292, P75, DOI 10.1038/292075a0; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; HAM RG, 1988, IN VITRO CELL DEV B, V24, P833; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; MANZANET R, 1986, MYOLOGY, P285; MATSUOKA T, 1991, J NEUROL SCI, V106, P193, DOI 10.1016/0022-510X(91)90257-8; MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4; MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6; NOER AS, 1991, AM J HUM GENET, V49, P715; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; RICH A, 1976, ANNU REV BIOCHEM, V45, P805, DOI 10.1146/annurev.bi.45.070176.004105; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z; SHIH KD, 1991, BIOCHEM BIOPH RES CO, V174, P1109, DOI 10.1016/0006-291X(91)91535-K; SHMOOKLERREIS RJ, 1983, J BIOL CHEM, V258, P9078; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SMITH CA, 1971, J MOL BIOL, V59, P255, DOI 10.1016/0022-2836(71)90050-7; Srere PA, 1969, METHODS ENZYMOLOGY, P3; TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WEBSTER C, 1988, EXP CELL RES, V174, P252, DOI 10.1016/0014-4827(88)90159-0; Wharton D.C., 1967, METHOD ENZYMOL, V10, P245; YONEDA M, 1991, PROG NEUROPATH, V7, P169; ZEVIANI M, 1991, AM J HUM GENET, V48, P203	40	258	260	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1187	1200					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	WOS:A1992KC99500002	1334369				2022-01-24	
J	GREENBERG, F; GUZZETTA, V; DEOCALUNA, RM; MAGENIS, RE; SMITH, ACM; RICHTER, SF; KONDO, I; DOBYNS, WB; PATEL, PI; LUPSKI, JR				GREENBERG, F; GUZZETTA, V; DEOCALUNA, RM; MAGENIS, RE; SMITH, ACM; RICHTER, SF; KONDO, I; DOBYNS, WB; PATEL, PI; LUPSKI, JR			MOLECULAR ANALYSIS OF THE SMITH-MAGENIS SYNDROME - A POSSIBLE CONTIGUOUS-GENE SYNDROME ASSOCIATED WITH DEL(17)(P11.2)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH DISEASE; PRADER-WILLI SYNDROME; NEUROPATHY TYPE-I; INTERSTITIAL DELETION; SHORT ARM; PERICENTROMERIC REGION; HEREDITARY MOTOR; CHROMOSOME-17; LINKAGE; MARKERS	We undertook clinical evaluation (32 cases) and molecular evaluation (31 cases) of unrelated patients affected with Smith-Magenis syndrome (SMS) associated with an interstitial deletion of band p11.2 of chromosome 17. Patients were evaluated both clinically and electrophysiologically for peripheral neuropathy, since markers showing close linkage to one form of Charcot-Marie-Tooth disease (CMT1A) map to this chromosomal region. The common clinical findings were broad flat midface with brachycephaly, broad nasal bridge, brachydactyly, speech delay, and hoarse, deep voice. Fifty-five percent of the patients showed clinical signs (e.g., decreased or absent deep tendon reflexes, pes planus or pes cavus, decreased sensitivity to pain, and decreased leg muscle mass) suggestive of peripheral neuropathy. However, unlike patients with CMT1A, these patients demonstrated normal nerve conduction velocities. Self-destructive behaviors, primarily onychotillomania and polyembolokoilamania, were observed in 67% of the patients, and significant symptoms of sleep disturbance were observed in 62%. The absence of REM sleep was demonstrated by polysomnography in two patients. Southern analysis indicated that most patients were deleted for five 17p11.2 markers - FG1 (D17S446), 1516 (D17S258), pYNM67-R5 (D17S29), pA10-41 (D17S71), and pS6.1-HN2 (D17S445) - thus defining a region which appears to be critical to SMS. The deletion was determined to be of paternal origin in nine patients and of maternal origin in six patients. The apparent random parental origin of deletion documented in 15 patients suggests that genomic imprinting does not play a role in the expression of the SMS clinical phenotype. Our findings suggest that SMS is likely a contiguous-gene deletion syndrome which comprises characteristic clinical features, developmental delay, clinical signs of peripheral neuropathy, abnormal sleep function, and specific behavioral anomalies.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,T-905,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,TEXAS CHILDRENS HOSP,HOUSTON,TX 77030; OREGON HLTH SCI UNIV,DEPT MOLEC GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,CHILD DEV REHABIL CTR,PORTLAND,OR 97201; CHILDRENS HOSP,DENVER,CO 80218; UNIV ARIZONA,DEPT PEDIAT,TUCSON,AZ 85721; UNIV RYUKYUS,DEPT HUMAN ECOL & GENET,NAHA,OKINAWA 903,JAPAN; INDIANA UNIV,SCH MED,DEPT NEUROL,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT MOLEC GENET,INDIANAPOLIS,IN 46202		LUPSKI, JR (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,T-905,HOUSTON,TX 77030, USA.		Dobyns, William/AAI-2768-2020; Dobyns, William/ABC-6525-2021; Patel, Pragna/H-9129-2017	Dobyns, William/0000-0002-7681-2844; Patel, Pragna/0000-0003-3584-1072	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027042] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR-00188] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD24064-02] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-27042] Funding Source: Medline		BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BURD L, 1990, AM J MED GENET, V37, P97, DOI 10.1002/ajmg.1320370122; CHANCE PF, 1990, AM J HUM GENET, V47, P915; COLLEY AF, 1990, J PAEDIATR CHILD H, V26, P17, DOI 10.1111/j.1440-1754.1990.tb02372.x; COLVER GB, 1987, BRIT J DERMATOL, V117, P397, DOI 10.1111/j.1365-2133.1987.tb04150.x; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1987, AM J HUM GENET, V40, P212; FRANCO B, 1990, NUCLEIC ACIDS RES, V18, P7196, DOI 10.1093/nar/18.23.7196-a; FRANCO B, 1991, HUM GENET, V87, P269, DOI 10.1007/BF00200903; GUZZETTA V, 1991, GENOMICS, V9, P31, DOI 10.1016/0888-7543(91)90217-3; HALL JG, 1990, AM J HUM GENET, V46, P857; HAMILL MA, 1988, ANN GENET-PARIS, V31, P36; HOBSON JA, 1990, J NEUROSCI, V10, P371; IVENS A, 1990, HUM GENET, V84, P473; Kimura J., 1989, ELECTRODIAGNOSIS DIS; LEDBETTER DH, 1989, METABOLIC BASIS INHE, P343; LOCKWOOD D, 1988, J MED GENET, V25, P732, DOI 10.1136/jmg.25.11.732; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MAGENIS RE, 1986, AM J MED GENET, V24, P415, DOI 10.1002/ajmg.1320240304; MCALPINE PJ, 1990, GENOMICS, V7, P408, DOI 10.1016/0888-7543(90)90175-T; MIDDLETONPRICE HR, 1990, AM J HUM GENET, V46, P92; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; PATEL PI, 1990, AM J HUM GENET, V47, P926; PATEL PI, 1990, AM J HUM GENET, V46, P801; PATIL SR, 1984, HUM GENET, V67, P237, DOI 10.1007/BF00273011; POPP DW, 1987, AM J MED GENET, V26, P493, DOI 10.1002/ajmg.1320260228; RAEYMAEKERS P, 1989, AM J HUM GENET, V45, P953; RAY R, 1990, NUCLEIC ACIDS RES, V18, P4958, DOI 10.1093/nar/18.16.4958; SAIT MA, 1985, DERMATOLOGICA, V171, P200, DOI 10.1159/000249420; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHRANDERSTUMPEL C, 1990, CLIN GENET, V37, P148; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; Smith Ann., 1982, AM J HUM GENET, V34, pA410; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; TANDAN R, 1990, NEUROLOGY, V40, P773, DOI 10.1212/WNL.40.5.773; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X	47	258	263	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1207	1218					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	WOS:A1991GU67200008	1746552				2022-01-24	
J	Ford, CB; Shah, RR; Maeda, MK; Gagneux, S; Murray, MB; Cohen, T; Johnston, JC; Gardy, J; Lipsitch, M; Fortune, SM				Ford, Christopher B.; Shah, Rupal R.; Maeda, Midori Kato; Gagneux, Sebastien; Murray, Megan B.; Cohen, Ted; Johnston, James C.; Gardy, Jennifer; Lipsitch, Marc; Fortune, Sarah M.			Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis	NATURE GENETICS			English	Article							BEIJING-GENOTYPE; WESTERN CAPE; PROBABILITY-DISTRIBUTION; ANTIBIOTIC-RESISTANCE; SOUTH-AFRICA; STRAINS; MUTANTS; ACQUISITION; INFECTION; EVOLUTION	A key question in tuberculosis control is why some strains of M. tuberculosis are preferentially associated with resistance to multiple drugs. We demonstrate that M. tuberculosis strains from lineage 2 (East Asian lineage and Beijing sublineage) acquire drug resistances in vitro more rapidly than M. tuberculosis strains from lineage 4 (Euro-American lineage) and that this higher rate can be attributed to a higher mutation rate. Moreover, the in vitro mutation rate correlates well with the bacterial mutation rate in humans as determined by whole-genome sequencing of clinical isolates. Finally, using a stochastic mathematical model, we demonstrate that the observed differences in mutation rate predict a substantially higher probability that patients infected with a drug-susceptible lineage 2 strain will harbor multidrug-resistant bacteria at the time of diagnosis. These data suggest that interventions to prevent the emergence of drug-resistant tuberculosis should target bacterial as well as treatment-related risk factors.	[Ford, Christopher B.; Shah, Rupal R.; Lipsitch, Marc; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Maeda, Midori Kato] Univ Calif San Francisco, Curry Int TB Ctr, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Murray, Megan B.; Cohen, Ted] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cohen, Ted] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Cohen, Ted; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Johnston, James C.; Gardy, Jennifer] British Columbia Ctr Dis Control, Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada; [Gardy, Jennifer] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Fortune, Sarah M.] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Fortune, Sarah M.] Broad Inst MIT & Harvard, Cambridge, MA USA		Fortune, SM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu	Gagneux, Sebastien/ABE-7909-2020	Cohen, Ted/0000-0002-8091-7198; Gagneux, Sebastien/0000-0001-7783-9048; Lipsitch, Marc/0000-0003-1504-9213	Director's Office of the US National Institutes of Health [DP2 0D001378]; National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19 AI076217]; US National Institutes of Health Models of Infectious Disease Agent Study programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 U54 GM088558]; Howard Hughes Medical Institute Physician Scientist Early Career AwardHoward Hughes Medical Institute; Harvard University Graduate School of Arts and Sciences; Doris Duke Charitable Foundation Clinical Scientist Development AwardAmerican Heart AssociationDoris Duke Charitable Foundation (DDCF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI076217, T32AI007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM088558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD001378] Funding Source: NIH RePORTER	This work was supported by a New Innovator's Award (DP2 0D001378) from the Director's Office of the US National Institutes of Health (S. M. F.), by a subcontract from the National Institute of Allergy and Infectious Diseases (U19 AI076217 to S. M. F. and M. B. M.), by the US National Institutes of Health Models of Infectious Disease Agent Study program, through cooperative agreement 1 U54 GM088558 (M. L.), by a Howard Hughes Medical Institute Physician Scientist Early Career Award (S. M. F.), by a Merit Fellowship from the Harvard University Graduate School of Arts and Sciences (C. B. F.) and by a Doris Duke Charitable Foundation Clinical Scientist Development Award (S. M. F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases or the US National Institutes of Health.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Blazquez J, 2003, CLIN INFECT DIS, V37, P1201, DOI 10.1086/378810; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Bradford WZ, 1996, LANCET, V348, P928, DOI 10.1016/S0140-6736(96)03027-9; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Colijn C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018327; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fallow A, 2010, J BACTERIOL, V192, P2228, DOI 10.1128/JB.01597-09; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Hall LMC, 2006, MICROBIOL-SGM, V152, P2505, DOI 10.1099/mic.0.29079-0; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huang HY, 2010, J CLIN MICROBIOL, V48, P4474, DOI 10.1128/JCM.00930-10; Huet G, 2009, J BIOL CHEM, V284, P27101, DOI 10.1074/jbc.M109.041939; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Johnson R, 2010, INT J TUBERC LUNG D, V14, P119; Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12; Kimura M, 1971, Journal Molec Evol, V1, P1, DOI 10.1007/BF01659390; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Luria SE, 1943, GENETICS, V28, P491; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Migliori G. B., 2007, EUROSURVEILLANCE, V12; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schmalstieg AM, 2012, ANTIMICROB AGENTS CH, V56, P4806, DOI 10.1128/AAC.05546-11; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; STEWART FM, 1994, GENETICS, V137, P1139; STEWART FM, 1990, GENETICS, V124, P175; Streicher EM, 2004, J CLIN MICROBIOL, V42, P891, DOI 10.1128/JCM.42.2.891-894.2004; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Vadwai V, 2012, TUBERCULOSIS, V92, P264, DOI 10.1016/j.tube.2012.01.002; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; Weyer K, 1998, LAB SERVICES TUBER 2, VWHO/TB/98.258; Williams K, 2012, ANTIMICROB AGENTS CH, V56, P3114, DOI 10.1128/AAC.00384-12	72	257	263	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2013	45	7					784	+		10.1038/ng.2656			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	WOS:000321005200013	23749189	Green Accepted, Green Submitted			2022-01-24	
J	Levesque, CA; Brouwer, H; Cano, L; Hamilton, JP; Holt, C; Huitema, E; Raffaele, S; Robideau, GP; Thines, M; Win, J; Zerillo, MM; Beakes, GW; Boore, JL; Busam, D; Dumas, B; Ferriera, S; Fuerstenberg, SI; Gachon, CMM; Gaulin, E; Govers, F; Grenville-Briggs, L; Horner, N; Hostetler, J; Jiang, RHY; Johnson, J; Krajaejun, T; Lin, HN; Meijer, HJG; Moore, B; Morris, P; Phuntmart, V; Puiu, D; Shetty, J; Stajich, JE; Tripathy, S; Wawra, S; van West, P; Whitty, BR; Coutinho, PM; Henrissat, B; Martin, F; Thomas, PD; Tyler, BM; De Vries, RP; Kamoun, S; Yandell, M; Tisserat, N; Buell, CR				Levesque, C. Andre; Brouwer, Henk; Cano, Liliana; Hamilton, John P.; Holt, Carson; Huitema, Edgar; Raffaele, Sylvain; Robideau, Gregg P.; Thines, Marco; Win, Joe; Zerillo, Marcelo M.; Beakes, Gordon W.; Boore, Jeffrey L.; Busam, Dana; Dumas, Bernard; Ferriera, Steve; Fuerstenberg, Susan I.; Gachon, Claire M. M.; Gaulin, Elodie; Govers, Francine; Grenville-Briggs, Laura; Horner, Neil; Hostetler, Jessica; Jiang, Rays H. Y.; Johnson, Justin; Krajaejun, Theerapong; Lin, Haining; Meijer, Harold J. G.; Moore, Barry; Morris, Paul; Phuntmart, Vipaporn; Puiu, Daniela; Shetty, Jyoti; Stajich, Jason E.; Tripathy, Sucheta; Wawra, Stephan; van West, Pieter; Whitty, Brett R.; Coutinho, Pedro M.; Henrissat, Bernard; Martin, Frank; Thomas, Paul D.; Tyler, Brett M.; De Vries, Ronald P.; Kamoun, Sophien; Yandell, Mark; Tisserat, Ned; Buell, C. Robin			Genome sequence of the necrotrophic plant pathogen Pythium ultimum reveals original pathogenicity mechanisms and effector repertoire	GENOME BIOLOGY			English	Article							OOMYCETE PHYTOPHTHORA-INFESTANS; POTATO FAMINE PATHOGEN; PROTEIN FAMILIES; MITOCHONDRIAL GENOME; PLEIOTROPIC DRUG; GENE FAMILY; ARABIDOPSIS-THALIANA; CADHERIN SUPERFAMILY; MICROBE INTERACTIONS; MOLECULAR EVOLUTION	Background: Pythium ultimum is a ubiquitous oomycete plant pathogen responsible for a variety of diseases on a broad range of crop and ornamental species. Results: The P. ultimum genome (42.8 Mb) encodes 15,290 genes and has extensive sequence similarity and synteny with related Phytophthora species, including the potato blight pathogen Phytophthora infestans. Whole transcriptome sequencing revealed expression of 86% of genes, with detectable differential expression of suites of genes under abiotic stress and in the presence of a host. The predicted proteome includes a large repertoire of proteins involved in plant pathogen interactions, although, surprisingly, the P. ultimum genome does not encode any classical RXLR effectors and relatively few Crinkler genes in comparison to related phytopathogenic oomycetes. A lower number of enzymes involved in carbohydrate metabolism were present compared to Phytophthora species, with the notable absence of cutinases, suggesting a significant difference in virulence mechanisms between P. ultimum and more host-specific oomycete species. Although we observed a high degree of orthology with Phytophthora genomes, there were novel features of the P. ultimum proteome, including an expansion of genes involved in proteolysis and genes unique to Pythium. We identified a small gene family of cadherins, proteins involved in cell adhesion, the first report of these in a genome outside the metazoans. Conclusions: Access to the P. ultimum genome has revealed not only core pathogenic mechanisms within the oomycetes but also lineage-specific genes associated with the alternative virulence and lifestyles found within the pythiaceous lineages compared to the Peronosporaceae.	[Hamilton, John P.; Lin, Haining; Whitty, Brett R.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Levesque, C. Andre; Robideau, Gregg P.] Agr & Agri Food Canada, Ottawa, ON K1A 0C6, Canada; [Levesque, C. Andre; Robideau, Gregg P.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Brouwer, Henk; De Vries, Ronald P.] Fungal Biodivers Ctr, CBS KNAW, NL-3584 CT Utrecht, Netherlands; [Cano, Liliana; Huitema, Edgar; Raffaele, Sylvain; Win, Joe; Kamoun, Sophien] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Holt, Carson; Moore, Barry; Yandell, Mark] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Thines, Marco] Biodivers & Climate Res Ctr, D-60325 Frankfurt, Germany; [Thines, Marco] Goethe Univ Frankfurt, Dept Biol Sci, Inst Ecol Evolut & Divers, D-60323 Frankfurt, Germany; [Zerillo, Marcelo M.; Tisserat, Ned] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Beakes, Gordon W.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Boore, Jeffrey L.; Fuerstenberg, Susan I.] Genome Project Solut, Hercules, CA 94547 USA; [Busam, Dana; Ferriera, Steve; Hostetler, Jessica; Johnson, Justin; Puiu, Daniela; Shetty, Jyoti] J Craig Venter Inst, Rockville, MD 20850 USA; [Dumas, Bernard; Gaulin, Elodie] Univ Toulouse, CNRS, UMR5546, F-31326 Castanet Tolosan, France; [Gachon, Claire M. M.] Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Govers, Francine; Meijer, Harold J. G.] Wageningen Univ, Phytopathol Lab, NL-16708 PB Wageningen, Netherlands; [Govers, Francine] CBSG, NL-6700 AB Wageningen, Netherlands; [Grenville-Briggs, Laura; Horner, Neil; Wawra, Stephan; van West, Pieter] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Jiang, Rays H. Y.] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Krajaejun, Theerapong] Mahidol Univ, Dept Pathol, Fac Med, Ramathibodi Hosp, Bangkok 10400, Thailand; [Morris, Paul; Phuntmart, Vipaporn] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Stajich, Jason E.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Tripathy, Sucheta; Tyler, Brett M.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille I & II, CNRS, UMR6098, F-13288 Marseille, France; [Martin, Frank] USDA ARS, Salinias, CA 93905 USA; [Thomas, Paul D.] SRI Int, Evolutionary Syst Biol, Menlo Pk, CA 94025 USA		Buell, CR (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	buell@msu.edu	Raffaele, Sylvain/K-6673-2019; Win, Joe/H-2557-2014; Stajich, Jason Eric/C-7297-2008; de Vries, Ronald P./F-8125-2011; Gachon, Claire/C-2787-2009; Huitema, Edgar/G-3760-2011; Krajaejun, Theerapong/P-2550-2017; zerillo, marcelo m./M-4159-2016; Thines, Marco/H-1685-2011; Kamoun, Sophien/B-3529-2009; Hamilton, John P/G-1379-2016; Tripathy, Sucheta/N-3097-2019; Wawra, Stephan/D-2781-2013; Govers, Francine/A-5616-2009; Whitty, Brett/P-3231-2019; Cano, Liliana M/O-7041-2016; Meijer, Harold/S-3891-2019; Grenville-Briggs, Laura/B-3386-2013; Grenville-Briggs, Laura J/C-3419-2014; Meijer, Harold/G-5703-2012; Henrissat, Bernard/J-2475-2012; Dumas, Bernard/D-1751-2009; Raffaele, Sylvain/F-7187-2012	Raffaele, Sylvain/0000-0002-2442-9632; Win, Joe/0000-0002-9851-2404; Stajich, Jason Eric/0000-0002-7591-0020; de Vries, Ronald P./0000-0002-4363-1123; Huitema, Edgar/0000-0002-5766-0830; Krajaejun, Theerapong/0000-0003-0545-3765; zerillo, marcelo m./0000-0001-9671-2894; Kamoun, Sophien/0000-0002-0290-0315; Hamilton, John P/0000-0002-8682-5526; Tripathy, Sucheta/0000-0003-0611-8088; Wawra, Stephan/0000-0001-8555-1618; Govers, Francine/0000-0001-5311-929X; Whitty, Brett/0000-0001-5776-5424; Cano, Liliana M/0000-0002-7996-4181; Meijer, Harold/0000-0002-0883-219X; Grenville-Briggs, Laura J/0000-0001-5910-3651; Henrissat, Bernard/0000-0002-3434-8588; Dumas, Bernard/0000-0002-4138-3533; Raffaele, Sylvain/0000-0002-2442-9632; Buell, C Robin/0000-0002-6727-4677; Horner, Neil/0000-0002-0550-4537; Morris, Paul/0000-0002-2989-041X; van West, Pieter/0000-0002-0767-6017; Thomas, Paul/0000-0002-9074-3507; Gaulin, Elodie/0000-0003-0572-8749; Gachon, Claire/0000-0002-3702-7472	US Department of Agriculture (USDA) National Institute of Food and AgricultureUnited States Department of Agriculture (USDA) [2007-35600-17774, 2007-35600-18886]; NIH/NHGRIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [5R01HG004694]; National Research Initiative of the USDA CSREESUnited States Department of Agriculture (USDA)National Institute of Food and Agriculture [2007-35600-18530]; National Science FoundationNational Science Foundation (NSF) [MCB-0731969]; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); European CommissionEuropean CommissionEuropean Commission Joint Research Centre [MIEF-CT-2006-022837, PERG03-GA-2008-230865]; Dutch Ministry of Agriculture, Nature and Food Quality; Max-Planck SocietyMax Planck SocietyFoundation CELLEX; German Science Foundation (DFG)German Research Foundation (DFG); Landesstiftung Baden-Wurttemberg; Hesse's Ministry of Higher Education, Research, and the Arts; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NCRR 1 S10 RR17214-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR017214] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG004694] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E006795/1] Funding Source: researchfish; Natural Environment Research CouncilUK Research & Innovation (UKRI)Natural Environment Research Council (NERC) [NE/F012578/1, dml010007] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E006795/1] Funding Source: UKRI; NERCUK Research & Innovation (UKRI)Natural Environment Research Council (NERC) [NE/F012578/1, dml010007] Funding Source: UKRI	Funding for the work was provided by the US Department of Agriculture (USDA) National Institute of Food and Agriculture Microbial Genome Sequencing Program to CRB and NT (2007-35600-17774 and 2007-35600-18886). The MAKER genome annotation pipeline is funded by NIH/NHGRI 5R01HG004694 to MY. Analysis of the genome was funded in part by grants to BMT from the National Research Initiative of the USDA CSREES #2007-35600-18530 and from the National Science Foundation #MCB-0731969. CAL and GPR are supported by the NSERC Discovery and Network programs. CMMG is the recipient of a Marie Curie Intra-European Fellowship (MIEF-CT-2006-022837) and a European Reintegration Grant (PERG03-GA-2008-230865) from the European Commission. HB is supported by the Dutch Ministry of Agriculture, Nature and Food Quality through a FES program. MT acknowledges support by the Max-Planck Society, the German Science Foundation (DFG), the Landesstiftung Baden-Wurttemberg and the LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz research program of Hesse's Ministry of Higher Education, Research, and the Arts. An allocation of computer time from the Center for High Performance Computing at the University of Utah is gratefully acknowledged. The computational resources for annotating the genome were provided by the National Institutes of Health (grant # NCRR 1 S10 RR17214-01) on the Arches Metacluster, administered by the University of Utah Center for High Performance Computing. We want to thank the Canadian Collection of Fungal Cultures (CCFC/DAOM) for supplying and maintaining the culture for this study. We acknowledge the assistance of Nicole Desaulniers for culturing and DNA extractions as well as Jason Miller and Brian Walenz of the J Craig Venter Institute in assembly of the P. ultimum genome. We want to thank George Mahuku for sharing results on resistance of beans before publication.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AGNIHOTRI VP, 1967, CAN J MICROBIOL, V13, P1509, DOI 10.1139/m67-199; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Avila-Adame C, 2006, CURR GENET, V49, P39, DOI 10.1007/s00294-005-0016-3; Bailey TL, 1994, P 2 INT C INT SYST M; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; BAKER CJ, 1978, PHYTOPATHOLOGY, V68, P1577, DOI 10.1094/Phyto-68-1577; Bangyeekhun E, 2001, J INVERTEBR PATHOL, V77, P206, DOI 10.1006/jipa.2001.5019; Barr DJS, 1996, CAN J BOT, V74, P753, DOI 10.1139/b96-094; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Belbahri L, 2008, GENE, V408, P1, DOI 10.1016/j.gene.2007.10.019; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2009, J EXP BOT, V60, P1133, DOI 10.1093/jxb/ern353; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; BLASCHEK W, 1992, CARBOHYD RES, V231, P293, DOI 10.1016/0008-6215(92)84026-O; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boudjeko T, 2006, PLANTA, V223, P271, DOI 10.1007/s00425-005-0090-2; Bouzidi MF, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-110; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Brunner F, 2002, PHYTOCHEMISTRY, V59, P689, DOI 10.1016/S0031-9422(02)00045-6; Buckeridge MS, 2000, PLANT PHYSIOL BIOCH, V38, P141, DOI 10.1016/S0981-9428(00)00162-5; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Campion C, 1998, CAN J MICROBIOL, V44, P221, DOI 10.1139/cjm-44-3-221; Campion C, 1997, EUR J PLANT PATHOL, V103, P725, DOI 10.1023/A:1008657319518; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cao LH, 2005, FEMS MICROBIOL LETT, V251, P203, DOI 10.1016/j.femsle.2005.08.004; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; CHERIF M, 1993, CAN J MICROBIOL, V39, P213, DOI 10.1139/m93-030; CHERIF M, 1991, PHYSIOL MOL PLANT P, V39, P353, DOI 10.1016/0885-5765(91)90017-C; Cheung F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-542; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; COHEN Y, 1986, ANNU REV PHYTOPATHOL, V24, P311, DOI 10.1146/annurev.py.24.090186.001523; Connolly MS, 2005, CURR GENET, V48, P356, DOI 10.1007/s00294-005-0015-4; COOK RJ, 1980, PLANT DIS, V64, P102, DOI 10.1094/PD-64-1061; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Coutinho PM, 2009, FUNGAL GENET BIOL, V46, pS161, DOI 10.1016/j.fgb.2008.07.020; DAVIDSE LC, 1988, FUNGICIDE RESISTANCE, P63; Denisov G, 2008, BIOINFORMATICS, V24, P1035, DOI 10.1093/bioinformatics/btn074; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; DOBLIN MS, 2003, PLANT CELL WALL ANN, V8, P183; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; DRESCHLER C, 1946, PLANT DIS REP, V30, P226; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Erwin D.C., 1996, PHYTOPHTHORA DIS WOR; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Feyereisen R., 2000, GENOME BIOL, V1, pR, DOI [10.1186/gb-2000-1-6-reviews3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FRANCIS DM, 1993, CURR GENET, V24, P100, DOI 10.1007/BF00324672; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GAMS KW, 1998, CBS COURSE MYCOLOGY; Gaulin E, 2002, J CELL SCI, V115, P4565, DOI 10.1242/jcs.00138; Gaulin E, 2006, PLANT CELL, V18, P1766, DOI 10.1105/tpc.105.038687; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gotesson A, 2002, MOL PLANT MICROBE IN, V15, P907, DOI 10.1094/MPMI.2002.15.9.907; Grayburn WS, 2004, MYCOLOGIA, V96, P981, DOI 10.2307/3762082; Grenville-Briggs LJ, 2008, PLANT CELL, V20, P720, DOI 10.1105/tpc.107.052043; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hein I, 2009, MOL PLANT PATHOL, V10, P547, DOI [10.1111/J.1364-3703.2009.00547.X, 10.1111/j.1364-3703.2009.00547.x]; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jiang RHY, 2006, MOL PLANT MICROBE IN, V19, P1311, DOI 10.1094/MPMI-19-1311; Jiang RHY, 2006, MOL BIOL EVOL, V23, P338, DOI 10.1093/molbev/msj039; Judelson HS, 2006, MOL PLANT PATHOL, V7, P17, DOI [10.1111/J.1364-3703.2005.00313.X, 10.1111/j.1364-3703.2004.00256.x-i1]; Judelson HS, 1998, GENOME, V41, P605, DOI 10.1139/gen-41-4-605; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kolaczkowski M, 1998, MICROB DRUG RESIST, V4, P143, DOI 10.1089/mdr.1998.4.143; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARKIN RP, 1995, PHYTOPATHOLOGY, V85, P430, DOI 10.1094/Phyto-85-430; Latijnhouwers M, 2003, TRENDS MICROBIOL, V11, P462, DOI 10.1016/j.tim.2003.08.002; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lewis SE, 2002, GENOME BIOL, V3; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin FN, 2000, MYCOLOGIA, V92, P711, DOI 10.2307/3761428; Martin FN, 1999, CRIT REV PLANT SCI, V18, P111, DOI 10.1016/S0735-2689(99)00389-5; Martin FN, 2007, CURR GENET, V51, P285, DOI 10.1007/s00294-007-0121-6; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1337, DOI 10.1094/MPMI-19-1337; Mendoza L, 1996, J MYCOL MED, V6, P151; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; MOORE LD, 1968, PHYTOPATHOLOGY, V58, P833; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Munoz CI, 1998, CURR GENET, V33, P225, DOI 10.1007/s002940050330; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Panabieres F, 1997, MYCOL RES, V101, P1459, DOI 10.1017/S0953756297004413; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; PANTHER Classification System, PANTHER CLASS SYST; Plaats-Niterink A. J. Van der, 1981, Studies in Mycology; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Rosso ML, 2008, CROP SCI, V48, P2215, DOI 10.2135/cropsci2008.01.0035; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SAUNDERS GA, 1988, J INVERTEBR PATHOL, V52, P360, DOI 10.1016/0022-2011(88)90148-6; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; Snowdon A. L., 1990, COLOUR ATLAS POSTHAR, VI, P302, DOI DOI 10.1017/S0014479700018573; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Staszczak M, 2008, FUNGAL GENET BIOL, V45, P328, DOI 10.1016/j.fgb.2007.10.017; SUMNER DR, 1990, PLANT DIS, V74, P704, DOI 10.1094/PD-74-0704; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; THOMAS PD, BMC BIOINFORMATICS, V11, P312; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Torto TA, 2002, CURR GENET, V40, P385, DOI 10.1007/s00294-002-0272-4; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Torto-Alalibo T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-46; Tsui CKM, 2009, MOL PHYLOGENET EVOL, V50, P129, DOI 10.1016/j.ympev.2008.09.027; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogel G, 1998, PLANT J, V13, P673, DOI 10.1046/j.1365-313X.1998.00064.x; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WANG MC, 1980, EXP MYCOL, V4, P269, DOI 10.1016/0147-5975(80)90031-6; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Wu CH, 2008, MOL PLANT MICROBE IN, V21, P480, DOI 10.1094/MPMI-21-4-0480; Yan HZ, 2005, FUNGAL GENET BIOL, V42, P339, DOI 10.1016/j.fgb.2005.01.003; Yandell M, 2006, PLOS COMPUT BIOL, V2, P113, DOI 10.1371/journal.pcbi.0020015; Yang DE, 2005, MOL GENET GENOMICS, V274, P229, DOI 10.1007/s00438-005-0016-5; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; ZEVENHUI.LP, 1970, J GEN MICROBIOL, V61, P183, DOI 10.1099/00221287-61-2-183	161	257	271	1	64	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2010	11	7							R73	10.1186/gb-2010-11-7-r73			22	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	674UT	WOS:000283776300004	20626842	Green Published, Green Submitted, hybrid			2022-01-24	
J	Coffee, B; Keith, K; Albizua, I; Malone, T; Mowrey, J; Sherman, SL; Warren, ST				Coffee, Bradford; Keith, Krayton; Albizua, Igor; Malone, Tamika; Mowrey, Julie; Sherman, Stephanie L.; Warren, Stephen T.			Incidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-ABNORMALITIES; KLINEFELTER-SYNDROME; CYTOGENETIC SURVEY; FAMILY EXPERIENCES; CGG REPEAT; GENE; DIAGNOSIS; CHILDREN; IDENTIFICATION; PREVALENCE	Fragile X syndrome (FXS) results from a CGG-repeat expansion that triggers hypermethylation and silencing of the FMR1 gene. FXS is referred to as the most common form of inherited intellectual disability, yet its true incidence has never been measured directly by large population screening. Here, we developed an inexpensive and high-throughput assay to quantitatively assess FMR1 methylation in DNA isolated from the dried blood spots of 36,124 deidentified newborn mates. This assay displays 100% specificity and 100% sensitivity for detecting FMR1 methylation, Successfully distinguishing normal males from males with full-mutation FXS. Furthermore, the assay can detect excess FMR1 methylation in 82% of females with full mutations, although the methylation did not correlate with intellectual disability. With amelogenin PCR used for detecting the presence of a Y chromosome, this assay can also detect males with Klinefelter syndrome (KS) (47, XXY). We identified 64 males with FMR1 methylation and, after confirmatory testing, found seven to have full-mutation FXS and 57 to have KS. Because the precise incidence of KS is known, we used our observed KS incidence as a sentinel to assess ascertainment quality and showed that our KS incidence of 1 in 633 newborn males was not significantly different from the literature incidence of 1 in 5 76 (p = 0.79). The seven FXS males revealed an FXS incidence in males of 1 in 5161 (95% confidence interval of 1 in 10,653-1 in 2500), consistent with some earlier indirect estimates. Given the trials now underway for possible FXS treatments, this method could be used in newborn or infant screening as a way of ensuring early interventions for FXS.	[Coffee, Bradford; Keith, Krayton; Albizua, Igor; Malone, Tamika; Mowrey, Julie; Sherman, Stephanie L.; Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA		Warren, ST (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	swarren@emory.edu	Warren, Stephen T/A-2498-2012		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD020521, HD024064]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [AAMC MM-0937-06/06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD020521, R01HD020521] Funding Source: NIH RePORTER	We thank Kasinathan Muraliclharan for assistance in assay development, Elizabeth Franco and M. Ramachandran from the Georgia Public Health Laboratory Newborn Screening Program for their critical assistance, and Fuping Zhang for technical assistance. We also thank Michael Friez and Roger Stephenson for providing DNA samples from phenotyped full-mutation females. This work was supported by National Institutes of Health grants HD020521 and HD024064 and by Centers for Disease Control and Prevention grant AAMC MM-0937-06/06 (to S.T.W.).	Abramsky L, 1997, PRENATAL DIAG, V17, P363, DOI 10.1002/(SICI)1097-0223(199704)17:4<363::AID-PD79>3.0.CO;2-O; Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Bailey DB, 2003, PEDIATRICS, V111, P407, DOI 10.1542/peds.111.2.407; Bailey DB, 2000, J DEV BEHAV PEDIATR, V21, P315, DOI 10.1097/00004703-200010000-00001; Bailey DB, 2008, PEDIATRICS, V121, pE693, DOI 10.1542/peds.2007-0820; BUCKTON KE, 1980, ANN HUM GENET, V43, P227, DOI 10.1111/j.1469-1809.1980.tb01556.x; Carmichael B, 1999, J INTELL DISABIL RES, V43, P47, DOI 10.1046/j.1365-2788.1999.43120157.x; Chang S, 2008, NAT CHEM BIOL, V4, P256, DOI 10.1038/nchembio.78; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Crawford DC, 2002, AM J MED GENET, V110, P226, DOI 10.1002/ajmg.10427; Eberhart DE, 1996, SOMAT CELL MOLEC GEN, V22, P435, DOI 10.1007/BF02369435; Fernandez LS, 2009, ORG LETT, V11, P329, DOI 10.1021/ol802506n; Freeman SB, 2007, PUBLIC HEALTH REP, V122, P62, DOI 10.1177/003335490712200109; FREUND LS, 1993, PEDIATRICS, V91, P321; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gurian EA, 2006, PEDIATRICS, V117, P1915, DOI 10.1542/peds.2005-2294; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; HAMERTON JL, 1975, CLIN GENET, V8, P223; HANSTEEN IL, 1982, CLIN GENET, V21, P309; IDZELENE IP, 1978, GENETIKA+, V14, P2193; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; KIRCHGESSNER CU, 1995, J MED GENET, V32, P925, DOI 10.1136/jmg.32.12.925; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; LIN CC, 1976, HUM GENET, V31, P315, DOI 10.1007/BF00270861; MAEDA T, 1991, JPN J HUM GENET, V36, P117, DOI 10.1007/BF01876812; Morris JK, 2008, EUR J HUM GENET, V16, P163, DOI 10.1038/sj.ejhg.5201956; Nelson RM, 2001, PEDIATRICS, V107, P1451; NIELSEN J, 1982, HUM GENET, V61, P98, DOI 10.1007/BF00274195; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Nygren AOH, 2008, J MOL DIAGN, V10, P496, DOI 10.2353/jmoldx.2008.080053; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Rife M, 2003, GENET TEST, V7, P339, DOI 10.1089/109065703322783725; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; Saul RA, 2008, GENET MED, V10, P714, DOI 10.1097/GIM.0b013e3181862a76; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Strom CM, 2007, GENET MED, V9, P199, DOI 10.1097/GIM.0b013e31803d3ac9; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Visootsak J, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-42; WEBB TP, 1986, J MED GENET, V23, P396, DOI 10.1136/jmg.23.5.396; Youings SA, 2000, J MED GENET, V37, P415, DOI 10.1136/jmg.37.6.415; PEDIATRICS, V106, P1494	51	257	272	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					503	514		10.1016/j.ajhg.2009.09.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	WOS:000270836000007	19804849	Bronze, Green Published			2022-01-24	
J	Gudmundsson, J; Sulem, P; Gudbjartsson, DF; Blondal, T; Gylfason, A; Agnarsson, BA; Benediktsdottir, KR; Magnusdottir, DN; Orlygsdottir, G; Jakobsdottir, M; Stacey, SN; Sigurdsson, A; Wahlfors, T; Tammela, T; Breyer, JP; McReynolds, KM; Bradley, KM; Saez, B; Godino, J; Navarrete, S; Fuertes, F; Murillo, L; Polo, E; Aben, KK; van Oort, IM; Suarez, BK; Helfand, BT; Kan, DH; Zanon, C; Frigge, ML; Kristjansson, K; Gulcher, JR; Einarsson, GV; Jonsson, E; Catalona, WJ; Mayordomo, JI; Kiemeney, LA; Smith, JR; Schleutker, J; Barkardottir, RB; Kong, A; Thorsteinsdottir, U; Rafnar, T; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Blondal, Thorarinn; Gylfason, Arnaldur; Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Magnusdottir, Droplaug N.; Orlygsdottir, Gudbjorg; Jakobsdottir, Margret; Stacey, Simon N.; Sigurdsson, Asgeir; Wahlfors, Tiina; Tammela, Teuvo; Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Saez, Berta; Godino, Javier; Navarrete, Sebastian; Fuertes, Fernando; Murillo, Laura; Polo, Eduardo; Aben, Katja K.; van Oort, Inge M.; Suarez, Brian K.; Helfand, Brian T.; Kan, Donghui; Zanon, Carlo; Frigge, Michael L.; Kristjansson, Kristleifur; Gulcher, Jeffrey R.; Einarsson, Gudmundur V.; Jonsson, Eirikur; Catalona, William J.; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Smith, Jeffrey R.; Schleutker, Johanna; Barkardottir, Rosa B.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari			Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility	NATURE GENETICS			English	Article							SEQUENCE VARIANTS; COLORECTAL-CANCER; MULTIPLE LOCI; RISK; GENE; 8Q24; SCAN	We report a prostate cancer genome-wide association follow-on study. We discovered four variants associated with susceptibility to prostate cancer in several European populations: rs10934853[A] (OR = 1.12, P = 2.9 x 10(-10)) on 3q21.3; two moderately correlated (r(2) = 0.07) variants, rs16902094[G] (OR = 1.21, P = 6.2 x 10(-15)) and rs445114[T] (OR = 1.14, P = 4.7 x 10(-1)0), on 8q24.21; and rs8102476[C] (OR = 1.12, P = 1.6 x 10(-11)) on 19q13.2. We also refined a previous association signal on 11q13 with the SNP rs11228565[A] (OR = 1.23, P = 6.7 x 10(-12)). In a multivariate analysis using 22 prostate cancer risk variants typed in the Icelandic population, we estimated that carriers in the top 1.3% of the risk distribution are at a 2.5 times greater risk of developing the disease than members of the general population.	[Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Blondal, Thorarinn; Gylfason, Arnaldur; Magnusdottir, Droplaug N.; Orlygsdottir, Gudbjorg; Jakobsdottir, Margret; Stacey, Simon N.; Sigurdsson, Asgeir; Zanon, Carlo; Frigge, Michael L.; Kristjansson, Kristleifur; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Barkardottir, Rosa B.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Wahlfors, Tiina; Schleutker, Johanna] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Wahlfors, Tiina; Schleutker, Johanna] Tampere Univ Hosp, Tampere, Finland; [Tammela, Teuvo] Univ Tampere, Dept Urol, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Smith, Jeffrey R.] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Saez, Berta; Godino, Javier; Mayordomo, Jose I.] Hlth Sci Inst Aragon, Zaragoza, Spain; [Saez, Berta; Mayordomo, Jose I.] Nanotechnol Inst Aragon, Zaragoza, Spain; [Navarrete, Sebastian; Fuertes, Fernando] Univ Zaragoza, Div Radiat Oncol, Lozano Blesa Univ Hosp, Zaragoza, Spain; [Murillo, Laura] Reina Sofia Hosp, Div Med Oncol, Tudela, Spain; [Polo, Eduardo] Ernest Lluch Hosp, Div Med Oncol, Calatayud, Spain; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Aben, Katja K.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol Biostat & Hlth Technol Assessment, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Oort, Inge M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Suarez, Brian K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Helfand, Brian T.; Kan, Donghui; Catalona, William J.] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zanon, Carlo] Univ Turin, Mol Genet Lab, Inst Canc Res & Treatment, Sch Med, Candiolo, Italy; [Einarsson, Gudmundur V.; Jonsson, Eirikur] Landspitali Univ Hosp, Dept Urol, Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Zaragoza, Div Med Oncol, Univ Hosp, Zaragoza, Spain; [Smith, Jeffrey R.] Vet Affairs Tennessee Valley Healthcare Syst, Med Res Serv, Nashville, TN USA		Stefansson, K (corresponding author), deCODE Genet, Reykjavik, Iceland.	julius@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; van Oort, Inge/AAD-1197-2020; Aben, Katja KH/G-9686-2016; Godino, Javier/M-3753-2018; Kiemeney, Lambertus A./D-3357-2009; van Oort, Inge/L-4554-2015; Mayordomo, Jose/K-3453-2013; Smith, Jeff/C-3484-2012; Wahlfors, Tiina/U-7635-2018	van Oort, Inge/0000-0002-8002-1869; Aben, Katja KH/0000-0002-0214-2147; Godino, Javier/0000-0002-5653-2722; Kiemeney, Lambertus A./0000-0002-2368-1326; van Oort, Inge/0000-0002-8002-1869; Wahlfors, Tiina/0000-0002-3910-796X; Saez, Berta/0000-0003-0753-1165; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Schleutker, Johanna/0000-0002-1863-0305	European UnionEuropean Commission [202059, 218071]; V Foundation; US Department of Veterans AffairsUS Department of Veterans Affairs; Academy of FinlandAcademy of FinlandEuropean Commission; Sigrid Juselius FoundationSigrid Juselius Foundation; Pirkanmaa Hospital District, Tampere University Hospital; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA090386] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025741] Funding Source: NIH RePORTER	We thank the individuals who participated in the study and whose contribution made this work possible. This project was funded in part by contract number 202059 PROMARK) from the Seventh Framework Program of the European Union to deCODE Genetics T. R. and L. A. K.), in part by FP7-MC-IAPP Grant agreement no. 218071 CancerGene) to deCODE Genetics, in part by a V Foundation award and US Department of Veterans Affairs grants to J. R. S., and in part by Academy of Finland, Sigrid Juselius Foundation, Finnish Cancer Organisations and the Competitive Research Funding of the Pirkanmaa Hospital District, Tampere University Hospital, to J. S.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; KOTEJARAI Z, 2008, CANCER EPIDEM BIOMAR, V17, P2901; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	31	257	261	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1122	U104		10.1038/ng.448			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	WOS:000270330400017	19767754	Green Accepted			2022-01-24	
J	Cordeddu, V; Di Schiavi, E; Pennacchio, LA; Ma'ayan, A; Sarkozy, A; Fodale, V; Cecchetti, S; Cardinale, A; Martin, J; Schackwitz, W; Lipzen, A; Zampino, G; Mazzanti, L; Digilio, MC; Martinelli, S; Flex, E; Lepri, F; Bartholdi, D; Kutsche, K; Ferrero, GB; Anichini, C; Selicorni, A; Rossi, C; Tenconi, R; Zenker, M; Merlo, D; Dallapiccola, B; Iyengar, R; Bazzicalupo, P; Gelb, BD; Tartaglia, M				Cordeddu, Viviana; Di Schiavi, Elia; Pennacchio, Len A.; Ma'ayan, Avi; Sarkozy, Anna; Fodale, Valentina; Cecchetti, Serena; Cardinale, Alessio; Martin, Joel; Schackwitz, Wendy; Lipzen, Anna; Zampino, Giuseppe; Mazzanti, Laura; Digilio, Maria C.; Martinelli, Simone; Flex, Elisabetta; Lepri, Francesca; Bartholdi, Deborah; Kutsche, Kerstin; Ferrero, Giovanni B.; Anichini, Cecilia; Selicorni, Angelo; Rossi, Cesare; Tenconi, Romano; Zenker, Martin; Merlo, Daniela; Dallapiccola, Bruno; Iyengar, Ravi; Bazzicalupo, Paolo; Gelb, Bruce D.; Tartaglia, Marco			Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair	NATURE GENETICS			English	Article							INTERACTION DATABASE; C-ELEGANS; RAS; PTPN11; PHOSPHATASE; NETWORK; SUR-8	N-myristoylation is a common form of co-translational protein fatty acylation resulting from the attachment of myristate to a required N-terminal glycine residue(1,2). We show that aberrantly acquired N-myristoylation of SHOC2, a leucine-rich repeat-containing protein that positively modulates RAS-MAPK signal flow(3-6), underlies a clinically distinctive condition of the neuro-cardio-facial-cutaneous disorders family. Twenty-five subjects with a relatively consistent phenotype previously termed Noonan-like syndrome with loose anagen hair (MIM607721)(7) shared the 4A>G missense change in SHOC2 (producing an S2G amino acid substitution) that introduces an N-myristoylation site, resulting in aberrant targeting of SHOC2 to the plasma membrane and impaired translocation to the nucleus upon growth factor stimulation. Expression of SHOC2(S2G) in vitro enhanced MAPK activation in a cell typespecific fashion. Induction of SHOC2(S2G) in Caenorhabditis elegans engendered protruding vulva, a neomorphic phenotype previously associated with aberrant signaling. These results document the first example of an acquired N-terminal lipid modification of a protein causing human disease.	[Cordeddu, Viviana; Fodale, Valentina; Martinelli, Simone; Flex, Elisabetta; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Di Schiavi, Elia; Bazzicalupo, Paolo] CNR, Ist Genet & Biofis A Buzzati Traverso, Naples, Italy; [Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Pennacchio, Len A.; Martin, Joel; Schackwitz, Wendy; Lipzen, Anna] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Ma'ayan, Avi; Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, SBCNY, New York, NY USA; [Sarkozy, Anna; Lepri, Francesca; Dallapiccola, Bruno] San Giovanni Rotondo & Ist Mendel, Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Rome, Italy; [Fodale, Valentina; Dallapiccola, Bruno] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Cecchetti, Serena; Merlo, Daniela] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Cardinale, Alessio; Merlo, Daniela] IRCCS San Raffaele Pisana, Rome, Italy; [Zampino, Giuseppe] Univ Cattolica Sacro Cuore, Ist Clin Pediat, Rome, Italy; [Mazzanti, Laura] Univ Bologna, Dipartimento Pediat, Bologna, Italy; [Digilio, Maria C.] Bambino Gesu Pediat Hosp, Sez Genet Med, Rome, Italy; [Bartholdi, Deborah] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Kutsche, Kerstin] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Ferrero, Giovanni B.] Univ Turin, Dipartimento Pediat, Turin, Italy; [Anichini, Cecilia] Univ Siena, Dipartimento Pediat Ostetr & Med Riproduz, I-53100 Siena, Italy; [Selicorni, Angelo] Fdn Policlin Milano, IRCCS, Clin Pediat 1, Milan, Italy; [Rossi, Cesare] St Orsola Marcello Malpighi Hosp, Unita Operat Genet Med, Bologna, Italy; [Tenconi, Romano] Univ Padua, Dipartimento Pediat, I-35128 Padua, Italy; [Zenker, Martin] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-8520 Erlangen, Germany; [Gelb, Bruce D.] Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genom Sci, New York, NY USA		Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	bruce.gelb@mssm.edu; mtartaglia@iss.it	Lepri, Francesca Romana/AAA-6115-2020; Rossi, Cesare/AAC-2083-2022; Tartaglia, Marco/K-2955-2018; cordeddu, viviana/A-5612-2016; Flex, Elisabetta/A-5958-2017; Martinelli, Simone/J-9432-2018; Ferrero, Giovanni Battista/K-5265-2018; Ma'ayan, Avi/AAG-3131-2019; Cecchetti, Serena/N-1061-2015; Zampino, Giuseppe/AAC-2152-2019; cordeddu, viviana/J-2272-2014; Digilio, Maria Cristina/AAI-2434-2019; Merlo, Daniela/K-7986-2016; Di Schiavi, Elia/B-8046-2015; Dallapiccola, Bruno/K-8692-2016	Rossi, Cesare/0000-0003-1826-615X; Tartaglia, Marco/0000-0001-7736-9672; cordeddu, viviana/0000-0001-7159-7383; Flex, Elisabetta/0000-0002-6802-1356; Martinelli, Simone/0000-0002-5843-419X; Ferrero, Giovanni Battista/0000-0002-3793-5788; Ma'ayan, Avi/0000-0002-6904-1017; Cecchetti, Serena/0000-0002-3601-176X; Di Schiavi, Elia/0000-0002-8179-6666; Martin, Joel/0000-0001-9511-6441; mazzanti, laura/0000-0002-7670-6494; Schackwitz, Wendy/0000-0002-3013-9180; Lepri, Francesca Romana/0000-0001-5331-0473; Dallapiccola, Bruno/0000-0002-5031-1013; Pennacchio, Len/0000-0002-8748-3732	TelethonItalyFondazione Telethon [GGP07115]; Convenzione Italia- USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL71207, HD01294, HL074728]; SBCNY [P50GM071558]; German Research Foundation ( DFG)German Research Foundation (DFG) [ZE 524/ 4- 1]; IRCCS- CSS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD001294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071207, P50HL074728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM054508, P50GM071558] Funding Source: NIH RePORTER	We are indebted to the affected individuals and families who participated in the study, the physicians who referred the subjects, A. Fire ( Stanford University School of Medicine, Stanford, California) and J. D. McGhee ( University of Calgary, Calgary, Canada) for plasmids, and C. Ramoni, S. Venanzi and T. Squatriti ( Istituto Superiore di Sanita`, Rome, Italy) and the Open Laboratory ( IGB- CNR, Naples, Italy) for experimental support. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center ( University of Minnesota, Minneapolis, Minnesota), funded by the US National Institutes of Health ( NIH) National Center for Research Resources. We also thank M. C. Silengo ( Universita` di Torino, Turin, Italy), S. Spranger ( Praxis fuer Humangenetik, Bremen, Germany), I. M. Gaspar ( Egas Moniz Hospital, Lisbon, Portugal) and D. R. Bertola ( HC/ FMUSP, Sa ~ o Paulo, Brazil) for their contribution in DNA sampling and valuable clinical assistance. This research was funded by grants from TelethonItaly ( GGP07115) and ` Convenzione Italia- USA- malattie rare' to M. T., the NIH ( HL71207, HD01294 and HL074728) to B. D. G., SBCNY ( P50GM071558) to A. M. and R. I. the German Research Foundation ( DFG) ( ZE 524/ 4- 1) to M. Z. and IRCCS- CSS ( Ricerca Corrente 2009) to F. L.	ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [10.1007/BF01386390, DOI 10.1007/BF01386390]; Duerr Janet S, 2006, WormBook, P1; Eisenmann DM, 2000, GENETICS, V156, P1097; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kishore RS, 2002, DEV BIOL, V241, P339, DOI 10.1006/dbio.2001.0513; Li WQ, 2000, GENE DEV, V14, P895; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Mazzanti L, 2003, AM J MED GENET A, V118A, P279, DOI 10.1002/ajmg.a.10923; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Sarkozy A., 2009, V17, P55; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M., 2009, V17, P20; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; TOSTI A, 1991, DERMATOLOGICA, V182, P247; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; VACHON L, 1987, MOL PHARMACOL, V31, P159; VANDERBURGT I, 1994, AM J MED GENET, V53, P187, DOI 10.1002/ajmg.1320530213; VORON DA, 1976, AM J MED, V60, P447, DOI 10.1016/0002-9343(76)90764-6; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239	36	257	268	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1022	U95		10.1038/ng.425			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	WOS:000269382100016	19684605	Green Accepted, Green Published			2022-01-24	
J	Zhong, SQ; Dekkers, JCM; Fernando, RL; Jannink, JL				Zhong, Shengqiang; Dekkers, Jack C. M.; Fernando, Rohan L.; Jannink, Jean-Luc			Factors Affecting Accuracy From Genomic Selection in Populations Derived From Multiple Inbred Lines: A Barley Case Study	GENETICS			English	Article							MARKER-ASSISTED SELECTION; QUANTITATIVE TRAITS; BREEDING VALUE; IMPROVEMENT; DENSITY; PROGENY; CROSSES; MAIZE; POWER; LOCI	We compared the accuracies of four genomic-selection prediction methods as affected by marker density, level of linkage disequilibrium (LD), quantitative trail. locus (QTL) number, sample size, and level of replication in populations generated front multiple inbred lines. Marker data on 42 two-row spring barley inbred lines were used to simulate high and low LD populations from multiple inbred line crosses: the first included many small full-sib families and the second was derived from five generations of random mating. True breeding values (TBV) were simulated oil the basis of 20 or 80 additive QTL. Methods used to derive genomic estimated breeding values (GEBV) were random regression best linear unbiased prediction (RR-BLUP), Bayes-B, a Bayesian shrinkage regression method, and BLUP front a mixed model analysis using a relationship matrix calculated from marker data. Using the best methods, accuracies of GEBV were comparable to accuracies front phenotype for predicting TBV without requiring the time and expense of field evaluation. We identified a trade-off between a method's ability to capture marker-QTL vs. marker-based relatedness of individuals. The Bayesian shrinkage regression method primarily captured LD, the BLUP methods captured relationships, while Bayes-B captured both. Under most of the study scenarios, mixed-model analysis using a marker-derived relationship matrix (BLUP) was more accurate than methods that directly estimated marker effects, suggesting that relationship information was more valuable than LD information. When markers were in strong LD with large-effect QTL, or when predictions were made on individuals several generations removed from the training data set, however, the ranking of method performance was reversed and BLUP had the lowest accuracy.	[Jannink, Jean-Luc] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Zhong, Shengqiang] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Dekkers, Jack C. M.; Fernando, Rohan L.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Dekkers, Jack C. M.; Fernando, Rohan L.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA 50011 USA		Jannink, JL (corresponding author), USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.	jean-luc.jannink@ars.usda.gov	Zhong, Shengqiang/E-3816-2010	Jannink, Jean-Luc/0000-0003-4849-628X	U. S. Department of Agriculture-Cooperative State Research, Education, and Extension Service-National Research Initiative grantUnited States Department of Agriculture (USDA) [2006-55606-16722]	Patrick Hayes and Peter Szucs mapped DArT and SNP markers on the OWB mapping population used in this research. Timothy J. Close, Stefano Lonardi, and Yonghui Wu developed the SNP map. We thank two anonymous reviewers for their constructive comments. This research was supported by U. S. Department of Agriculture-Cooperative State Research, Education, and Extension Service-National Research Initiative grant no. 2006-55606-16722, "Barley Coordinated Agricultural Project: Leveraging Genomics, Genetics, and Breeding for Gene Discovery and Barley Improvement."	Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Calus MPL, 2007, J ANIM BREED GENET, V124, P362, DOI 10.1111/j.1439-0388.2007.00691.x; Falconer D, 1996, INTRO QUANTITATIVE G INTRO QUANTITATIVE G; GODDARD ME, 2008, GENETICA IN PRESS; HAMER D, 2007, GENETICS, V177, P2389; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Jansen RC, 2007, HDB STAT GENETICS, P589; KNAPP SJ, 1990, GENETICS, V126, P769; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; LANDE R, 1990, GENETICS, V124, P743; Meuwissen THE, 2001, GENETICS, V157, P1819; Moreau L, 1999, THEOR APPL GENET, V98, P234, DOI 10.1007/s001220051063; Piyasatian N, 2007, THEOR APPL GENET, V115, P665, DOI 10.1007/s00122-007-0597-y; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; ter Braak CJF, 2005, GENETICS, V170, P1435, DOI 10.1534/genetics.105.040469; VanRaden PM, 2007, POULTRY SCI, V86, P374; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Verhoeven KJF, 2006, HEREDITY, V96, P139, DOI 10.1038/sj.hdy.6800763; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Xu SZ, 2003, GENETICS, V163, P789; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zenger KR, 2007, ANIM GENET, V38, P7, DOI 10.1111/j.1365-2052.2006.01543.x; Zhong SQ, 2007, GENETICS, V177, P567, DOI 10.1534/genetics.107.075358	25	257	273	0	43	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	1943-2631			GENETICS	Genetics	MAY	2009	182	1					355	364		10.1534/genetics.108.098277			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499IX	WOS:000270213800030	19299342	Green Published, Bronze			2022-01-24	
J	Yamaguchi-Kabata, Y; Nakazono, K; Takahashi, A; Saito, S; Hosono, N; Kubo, M; Nakamura, Y; Kamatani, N				Yamaguchi-Kabata, Yumi; Nakazono, Kazuyuki; Takahashi, Atsushi; Saito, Susumu; Hosono, Naoya; Kubo, Michiaki; Nakamura, Yusuke; Kamatani, Naoyuki			Japanese Population Structure, Based on SNP Genotypes from 7003 Individuals Compared to Other Ethnic Groups: Effects on Population-Based Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DNA VARIATION; GENE; STRATIFICATION; POLYMORPHISM; SELECTION; PATTERNS; ORIGINS; ASIA; MAP	Because population stratification can cause spurious associations in case-control Studies, understanding the population structure is important. Here, we examined Japanese population structure by "Eigenanalysis," using the genotypes for 140,387 SNPs in 7003 Japanese individuals, along with 60 European, 60 African, and 90 East-Asian individuals, in the HapMap project. Most Japanese individuals fell into two main clusters, Hondo and Ryukyu; the Hondo cluster includes most of the individuals from the main islands in Japan, and the Ryukyu cluster includes most of the individuals from Okinawa. The SNPs with the greatest frequency differences between the Hondo and Ryukyu clusters were found in the HLA region in chromosome 6. The nonsynonymous SNPs with the greatest frequency differences between the Hondo and Ryukyu clusters were the Val/Ala polymorphism (rs3827760) in the EDAR gene, associated with hair thickness, and the Gly/Ala polymorphism (rs17822931) in the ABCC11 gene, associated with ear-wax type. Genetic differentiation was observed, even among different regions in Honshu Island, the largest island of Japan. Simulation studies showed that the inclusion of different proportions of individuals from different regions of Japan in case and control groups can lead to an inflated rate of false-positive results when the sample sizes are large.	[Yamaguchi-Kabata, Yumi; Nakazono, Kazuyuki; Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Inst Phys & Chem Res, Ctr Genom Med, Lab Stat Anal,Minato Ku, Tokyo 1088639, Japan; [Nakamura, Yusuke] RIKEN, Inst Phys & Chem Res, Ctr Genom Med, Lab Genotyping,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kamatani, Naoyuki] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo 1620054, Japan		Yamaguchi-Kabata, Y (corresponding author), RIKEN, Inst Phys & Chem Res, Ctr Genom Med, Lab Stat Anal,Minato Ku, 4-6-1 Shirokane Dai, Tokyo 1088639, Japan.	yyamaguc@src.riken.jp	Kubo, Michiaki/N-7947-2015				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bannai M, 2000, TISSUE ANTIGENS, V55, P128, DOI 10.1034/j.1399-0039.2000.550204.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Horai S, 1996, AM J HUM GENET, V59, P579; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nakamura T, 2005, J HUM GENET, V50, P53, DOI 10.1007/s10038-004-0220-x; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peacock E, 2005, PHARMACOGENOMICS, V6, P439, DOI 10.1517/14622416.6.4.439; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733; [No title captured]	37	257	261	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					445	456		10.1016/j.ajhg.2008.08.019			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	WOS:000260239200002	18817904	Green Published, Bronze			2022-01-24	
J	McGowan, KA; Li, JZ; Park, CY; Beaudry, V; Tabor, HK; Sabnis, AJ; Zhang, W; Fuchs, H; de Angelis, MH; Myers, RM; Attardi, LD; Barsh, GS				McGowan, Kelly A.; Li, Jun Z.; Park, Christopher Y.; Beaudry, Veronica; Tabor, Holly K.; Sabnis, Amit J.; Zhang, Weibin; Fuchs, Helmut; de Angelis, Martin Hrabe; Myers, Richard M.; Attardi, Laura D.; Barsh, Gregory S.			Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects	NATURE GENETICS			English	Article							DIAMOND-BLACKFAN ANEMIA; PROTEIN S19; P53-DEPENDENT CHECKPOINT; DROSOPHILA-MELANOGASTER; CRE RECOMBINASE; MOUSE; MICE; GENE; PROLIFERATION; P53	Mutations in genes encoding ribosomal proteins cause the Minute phenotype in Drosophila and mice, and Diamond-Blackfan syndrome in humans. Here we report two mouse dark skin (Dsk) loci caused by mutations in Rps19 (ribosomal protein S19) and Rps20 (ribosomal protein S20). We identify a common pathophysiologic program in which p53 stabilization stimulates Kit ligand expression, and, consequently, epidermal melanocytosis via a paracrine mechanism. Accumulation of p53 also causes reduced body size and erythrocyte count. These results provide a mechanistic explanation for the diverse collection of phenotypes that accompany reduced dosage of genes encoding ribosomal proteins, and have implications for understanding normal human variation and human disease.	[McGowan, Kelly A.; Li, Jun Z.; Tabor, Holly K.; Sabnis, Amit J.; Zhang, Weibin; Myers, Richard M.; Attardi, Laura D.; Barsh, Gregory S.] Stanford Univ, Div Radiat & Canc Biol, Dept Genet, Stanford, CA 94305 USA; [Li, Jun Z.; Tabor, Holly K.; Myers, Richard M.] Stanford Univ, Stanford Human Genome Ctr, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Park, Christopher Y.] Stanford Univ, Dept Pathol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Beaudry, Veronica; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; [Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA		Barsh, GS (corresponding author), Stanford Univ, Div Radiat & Canc Biol, Dept Genet, Stanford, CA 94305 USA.	gbarsh@stanford.edu	Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012	Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Sabnis, Amit/0000-0002-2061-5139; Li, Jun/0000-0001-6727-0812	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM068882] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM068882] Funding Source: Medline		Alizadeh A, 2008, PIGM CELL MELANOMA R, V21, P63, DOI 10.1111/j.1755-148X.2007.00425.x; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Angelini M, 2007, HUM MOL GENET, V16, P1720, DOI 10.1093/hmg/ddm120; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; Chan EL, 2007, MOL CARCINOGEN, V46, P49, DOI 10.1002/mc.20192; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Flygare J, 2007, BLOOD, V109, P3152, DOI 10.1182/blood-2006-09-001222; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matsson H, 2006, BLOOD CELL MOL DIS, V36, P259, DOI 10.1016/j.bcmd.2005.12.002; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; MAYER TC, 1973, DEV BIOL, V34, P39, DOI 10.1016/0012-1606(73)90337-0; MCCULLOC.EA, 1965, BLOOD-J HEMATOL, V26, P399, DOI 10.1182/blood.V26.4.399.399; Miyake K, 2008, STEM CELLS, V26, P323, DOI 10.1634/stemcells.2007-0569; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schultz J, 1929, GENETICS, V14, P366; SJALANDER A, 1995, HUM HERED, V45, P144, DOI 10.1159/000154275; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147	50	257	262	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					963	970		10.1038/ng.188			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	WOS:000258026900012	18641651	Green Accepted			2022-01-24	
J	Kooner, JS; Chambers, JC; Aguilar-Salinas, CA; Hinds, DA; Hyde, CL; Warnes, GR; Perez, FJG; Frazer, KA; Elliott, P; Scott, J; Milos, PM; Cox, DR; Thompson, JF				Kooner, Jaspal S.; Chambers, John C.; Aguilar-Salinas, Carlos A.; Hinds, David A.; Hyde, Craig L.; Warnes, Gregory R.; Gomez Perez, Francisco J.; Frazer, Kelly A.; Elliott, Paul; Scott, James; Milos, Patrice M.; Cox, David R.; Thompson, John F.			Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides	NATURE GENETICS			English	Article							GENE; OBESITY; CHREBP; HDL	We tested over 267,000 SNPs in 1,005 Northern Europeans and 248,000 in 1,006 Indian Asians for association with triglycerides and HDL cholesterol, with replication in 10,536 subjects. We found association of a nonsynonymous SNP (rs3812316, G771C, Gln241His) in MLXIPL with plasma triglyceride levels (combined P = 1.4 x 10(-10)). MLXIPL coordinates transcriptional regulation of enzymes that channel glycolytic end-products into lipogenesis and energy storage, making MLXIPL a plausible 'thrifty gene'.	[Kooner, Jaspal S.; Scott, James] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Chambers, John C.; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London SW7 2AZ, England; [Aguilar-Salinas, Carlos A.; Gomez Perez, Francisco J.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [Hinds, David A.; Frazer, Kelly A.; Cox, David R.] Perlegen Sci Inc, Mountain View, CA 94043 USA; [Hyde, Craig L.; Warnes, Gregory R.; Milos, Patrice M.] Pfizer Global Res & Dev, Groton, CT 06340 USA		Scott, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.	j.scott@imperial.ac.uk	Salinas, Carlos A Aguilar/AAL-4491-2020	Hinds, David/0000-0002-4911-803X; Elliott, Paul/0000-0002-7511-5684; Thompson, John/0000-0001-8568-3311; Frazer, Kelly/0000-0002-6060-8902	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0700931, G0601966] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700931, G0601966] Funding Source: Medline		Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Fisher RA., 1925, STAT METHODS RES WOR; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Ordovas JM, 2002, CARDIOVASC DRUG THER, V16, P273, DOI 10.1023/A:1021769523568; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	15	257	262	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					149	151		10.1038/ng.2007.61			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	WOS:000252732900010	18193046				2022-01-24	
J	Bieda, M; Xu, XQ; Singer, MA; Green, R; Farnham, PJ				Bieda, M; Xu, XQ; Singer, MA; Green, R; Farnham, PJ			Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome	GENOME RESEARCH			English	Article							GROWTH-REGULATION; CHROMATIN IMMUNOPRECIPITATION; HISTONE DEACETYLASE; BINDING-SITES; C-MYC; TRANSCRIPTION; TARGETS; IDENTIFICATION; ACTIVATION; PRB	The E2F family of transcription factors regulates basic cellular processes. Here, we take an unbiased approach towards identifying E2F1 target genes by examining localization of E2F1-binding sites using high-density oligonucleotide tiling arrays. To begin, we developed a statistically-based methodology for analysis of ChIP-chip data obtained from arrays that represent 30 Mb of the human genome. Using this methodology, we identified regions bound by E2F1, MYC, and RNA Polymerase II (POLR2A). We found a large number of binding sites for all three factors; extrapolation suggests there may be similar to 20,000-30,000 E2F1- and MYC-binding sites and similar to 12,000-17,000 active promoters in HeLa cells. In contrast to our results for MYC, we find that the majority of E2F1- binding sites (> 80%) are located in core promoters and that 50% of the sites overlap transcription starts. Only a small fraction of E2F1 sites possess the canonical binding motif. Surprisingly, we found that similar to 30% of genes in the 30-Mb region possessed an E2F1 binding site in a core promoter and E2F1 was bound near to 83% of POLR2A-bound sites. To determine if these results were representative of the entire human genome, we performed ChIP-chip analyses of similar to 24,000 promoters and confirmed that greater than 20% of the promoters were bound by E2F1. Our results suggest that E2F1 is recruited to promoters via a method distinct from recognition of the known consensus site and point toward a new understanding of E2F1 as a factor that contributes to the regulation of a large fraction of human genes.	Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; NimbleGen Syst Inc, Madison, WI 53711 USA		Bieda, M (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.			Farnham, Peggy/0000-0003-4469-7914	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG003129] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA45250] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG003129, R01 HG003129] Funding Source: Medline		Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; Blau J, 1996, MOL CELL BIOL, V16, P2044; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ERDOS P, 1970, J ANAL MATH, V23, P103, DOI 10.1007/BF02795493; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; HSIAO KM, 1994, GENE DEV, V8, P1526, DOI 10.1101/gad.8.13.1526; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; Muller M J, 2001, Obes Rev, V2, P15; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Oberley MJ, 2003, J BIOL CHEM, V278, P42466, DOI 10.1074/jbc.M307733200; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Pearson A, 1997, ONCOGENE, V15, P2643, DOI 10.1038/sj.onc.1201451; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; SLANSKY JE, 1993, MOL CELL BIOL, V13, P7201; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; SLANSKY JE, 1993, ROLE TRANSCRIPTION F; Stekel D, 2003, MICROARRAY BIOINFORM; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; WATERMAN MS, 1987, P NATL ACAD SCI USA, V84, P1239, DOI 10.1073/pnas.84.5.1239; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666	46	257	266	0	2	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2006	16	5					595	605		10.1101/gr.4887606			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	038LF	WOS:000237220600005	16606705	Green Published, Bronze			2022-01-24	
J	Giorgini, F; Guidetti, P; Nguyen, QV; Bennett, SC; Muchowski, PJ				Giorgini, F; Guidetti, P; Nguyen, QV; Bennett, SC; Muchowski, PJ			A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease	NATURE GENETICS			English	Article							INCLUSION-BODY FORMATION; MUTANT HUNTINGTIN; POLYGLUTAMINE AGGREGATION; QUINOLINIC ACID; IN-VIVO; TOXICITY; MODEL; BRAIN; INHIBITION; EXPANSIONS	Huntington disease is a fatal neurodegenerative disorder caused by expansion of a polyglutamine tract in the protein huntingtin (Htt)(1), which leads to its aggregation in nuclear and cytoplasmic inclusion bodies(2). We recently identified 52 loss-of-function mutations in yeast genes that enhance the toxicity of a mutant Htt fragment(3). Here we report the results from a genome-wide loss-of-function suppressor screen in which we identified 28 gene deletions that suppress toxicity of a mutant Htt fragment. The suppressors are known or predicted to have roles in vesicle transport, vacuolar degradation, transcription and prion-like aggregation. Among the most potent suppressors was Bna4 ( kynurenine 3-monooxygenase), an enzyme in the kynurenine pathway of tryptophan degradation that has been linked directly to the pathophysiology of Huntington disease in humans by a mechanism that may involve reactive oxygen species(4). This finding is suggestive of a conserved mechanism of polyglutamine toxicity from yeast to humans and identifies new candidate therapeutic targets for the treatment of Huntington disease.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Catonsville, MD 21228 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Univ Washington, Ctr Neurogenet & Neurotherapeut, Seattle, WA 98195 USA		Muchowski, PJ (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	mucho@u.washington.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS047237] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047237] Funding Source: NIH RePORTER		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Goda K, 1999, ADV EXP MED BIOL, V467, P397; Guidetti P, 2000, NEUROSCI LETT, V283, P233, DOI 10.1016/S0304-3940(00)00956-3; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 1999, EUR J NEUROSCI, V11, P3857, DOI 10.1046/j.1460-9568.1999.00806.x; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallory MJ, 2003, J BIOL CHEM, V278, P44727, DOI 10.1074/jbc.M308632200; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moroni F, 1999, ADV EXP MED BIOL, V467, P199; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Perez-Severiano F, 2004, NEUROCHEM RES, V29, P729, DOI 10.1023/B:NERE.0000018843.83770.4b; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Richter A, 2003, EUR J PHARMACOL, V478, P47, DOI 10.1016/j.ejphar.2003.08.038; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Ryu JK, 2004, EXP NEUROL, V187, P150, DOI 10.1016/j.expneurol.2004.01.006; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	30	257	262	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					526	531		10.1038/ng1542			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	WOS:000228862300023	15806102	Green Accepted			2022-01-24	
J	Vega, H; Waisfisz, Q; Gordillo, M; Sakai, N; Yanagihara, I; Yamada, M; van Gosliga, D; Kayserili, H; Xu, CZ; Ozono, K; Jabs, EW; Inui, K; Joenje, H				Vega, H; Waisfisz, Q; Gordillo, M; Sakai, N; Yanagihara, I; Yamada, M; van Gosliga, D; Kayserili, H; Xu, CZ; Ozono, K; Jabs, EW; Inui, K; Joenje, H			Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion	NATURE GENETICS			English	Article							SYNDROME FIBROBLASTS; DNA-REPLICATION; ACETYLTRANSFERASE; ABNORMALITIES	Roberts syndrome is an autosomal recessive disorder characterized by craniofacial anomalies, tetraphocomelia and loss of cohesion at heterochromatic regions of centromeres and the Y chromosome. We identified mutations in a new human gene, ESCO2, associated with Roberts syndrome in 15 kindreds. The ESCO2 protein product is a member of a conserved protein family that is required for the establishment of sister chromatid cohesion during S phase and has putative acetyltransferase activity.	Univ Nacl Colombia, Inst Genet, Bogota, Colombia; Osaka Univ, Grad Sch Med, Dept Dev Med Pediat D5, Suita, Osaka 5650871, Japan; Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Osaka Med Ctr Maternal & Child Hlth, Dept Dev Infect Dis, Res Inst, Osaka 5941101, Japan; Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34390 Istanbul, Turkey		Vega, H (corresponding author), Univ Nacl Colombia, Inst Genet, Ciudad Univ, Bogota, Colombia.	hhvegaf@unal.edu.co; ejabs1@jhem.jhmi.edu		Jabs, Ethylin/0000-0001-8983-5466	TelethonFondazione Telethon [GTF04002] Funding Source: Medline		Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; BURNS MA, 1989, MUTAT RES, V216, P243, DOI 10.1016/0165-1161(89)90049-6; GERMAN J, 1979, CLIN GENET, V16, P441; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Hoque MT, 2002, J BIOL CHEM, V277, P42306, DOI 10.1074/jbc.M206836200; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; JABS EW, 1991, CHROMOSOMA, V100, P251, DOI 10.1007/BF00344159; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; TOMKINS D, 1979, AM J MED GENET, V4, P17, DOI 10.1002/ajmg.1320040104; TOMKINS DJ, 1984, AM J HUM GENET, V36, P1332; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; VANDENBERG DJ, 1993, AM J MED GENET, V47, P1104, DOI 10.1002/ajmg.1320470735; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018	15	257	269	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					468	470		10.1038/ng1548			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	WOS:000228862300014	15821733				2022-01-24	
J	Palanichamy, MG; Sun, C; Agrawal, S; Bandelt, HJ; Kong, QP; Khan, F; Wang, CY; Chaudhuri, TK; Palla, V; Zhang, YP				Palanichamy, MG; Sun, C; Agrawal, S; Bandelt, HJ; Kong, QP; Khan, F; Wang, CY; Chaudhuri, TK; Palla, V; Zhang, YP			Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: Implications for the peopling of South Asia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CODING REGION SNPS; GENOME VARIATION; GENETIC-EVIDENCE; WEST; POPULATION; LINEAGES; HISTORY; PHYLOGEOGRAPHY; POLYMORPHISMS; DISPERSAL	To resolve the phylogeny of the autochthonous mitochondrial DNA (mtDNA) haplogroups of India and determine the relationship between the Indian and western Eurasian mtDNA pools more precisely, a diverse subset of 75 macrohaplogroup N lineages was chosen for complete sequencing from a collection of >1800 control-region sequences sampled across India. We identified five new autochthonous haplogroups (R7, R8, R30, R31, and N5) and fully characterized the autochthonous haplogroups (R5, R6, N1d, U2a, U2b, and U2c) that were previously described only by first hypervariable segment (HVS-I) sequencing and coding-region restriction-fragment-length polymorphism analysis. Our findings demonstrate that the Indian mtDNA pool, even when restricted to macrohaplogroup N, harbors at least as many deepest-branching lineages as the western Eurasian mtDNA pool. Moreover, the distribution of the earliest branches within haplogroups M, N, and R across Eurasia and Oceania provides additional evidence for a three-founder-mtDNA scenario and a single migration route out of Africa.	Chinese Acad Sci, Kunming Inst Zool, Lab Cellular & Mol Evolut, Kunming 650223, Yunnan, Peoples R China; Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; Sanjay Gandhi Postgrad Inst Med Sci, Dept Med Genet, Lucknow, Uttar Pradesh, India; Univ Hamburg, Fachbereich Math, Hamburg, Germany; N Bengal Univ, Dept Zool, Siliguri W Bengal, India; Sri Venkateswara Univ, Dept Anthropol, Tirupati 517502, Andhra Pradesh, India		Zhang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Lab Cellular & Mol Evolut, Kunming 650223, Yunnan, Peoples R China.	zhangyp1@263.net.cn	Sun, Chang/I-6326-2012				Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Allard Marc W, 2004, Leg Med (Tokyo), V6, P11, DOI 10.1016/j.legalmed.2003.08.004; Allard MW, 2002, J FORENSIC SCI, V47, P1215; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BAIG M, IN PRESS ANN HUM GEN; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Brandstatter A, 2003, INT J LEGAL MED, V117, P291, DOI 10.1007/s00414-003-0395-2; Bulayeva K, 2003, HUM BIOL, V75, P837, DOI 10.1353/hub.2004.0003; Cann RL, 2001, SCIENCE, V291, P1742, DOI 10.1126/science.1058948; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Crimi Marco, 2002, Hum Mutat, V20, P409, DOI 10.1002/humu.9079; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derbeneva OA, 2002, RUSS J GENET+, V38, P1316, DOI 10.1023/A:1021111530654; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster L, 2002, P NATL ACAD SCI USA, V99, P13950, DOI 10.1073/pnas.202400499; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Hedges SB, 2000, NATURE, V408, P652, DOI 10.1038/35047193; Herrnstadt, 2002, AM J HUM GENET, V71, P448; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kaur I, 2002, HUM BIOL, V74, P819; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T., 2000, ARCHAEOGENETICS DNA, P267; Kong QP, 2004, J HUM GENET, V49, P414, DOI 10.1007/s10038-004-0170-3; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; KONG QP, 2003, AM J HUM GENET, V75, P157; LOOGVALI EL, 2004, MOL BIOL EVOL; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; McElreavey K, 2002, Community Genet, V5, P153, DOI 10.1159/000066328; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Oppenheimer S, 2003, OUT EDEN PEOPLING WO; Passarino G, 1996, AM J HUM GENET, V59, P927; Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Renfrew, 2003, EXAMINING FARMING LA, P215; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rocha H, 1999, AM J HUM GENET, V65, P1457, DOI 10.1086/302641; Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703; Roy S, 2003, ANN HUM BIOL, V30, P443, DOI 10.1080/0301446031000111410; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; TAYLOR RW, 2002, NUCLEIC ACIDS RES, V29, pE85; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511	56	257	267	4	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					966	978		10.1086/425871			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	WOS:000224866400003	15467980	Green Published, Bronze			2022-01-24	
J	Serre, D; Paabo, SP				Serre, D; Paabo, SP			Evidence for gradients of human genetic diversity within and among continents	GENOME RESEARCH			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; MTDNA; HISTORY; RACE; INFERENCE; EVOLUTION; PATTERNS; ORIGINS; EUROPE	Genetic variation in humans is sometimes described as being discontinuous among continents or among groups of individuals, and by some this has been interpreted as genetic Support for "races." A recent Study in which >350 microsatellites were studied in a global sample of humans showed that they Could be grouped according to their continental origin, and this was widely interpreted as evidence for a discrete distribution of human genetic diversity. Here, we investigate how Study design can influence Such conclusions. Our results show that when individuals are sampled homogeneously from around the globe, the pattern seen is one of gradients of allele frequencies that extend over the entire world, rather than discrete clusters. Therefore, there is no reason to assume that major genetic discontinuities exist between different continents or "races".	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany		Serre, D (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	serre@eva.mpg.de; paabo@eva.mpg.de					Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; BOWCOCK A, 1991, GENOMICS, V11, P491, DOI 10.1016/0888-7543(91)90170-J; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Boyd W.C, 1950, GENETICS RACES MAN; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cann HM, 2002, SCIENCE, V296, P261; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; Excoffier L, 2003, SCIENCE, V300; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kayser M, 2003, GENOME RES, V13, P624, DOI 10.1101/gr.463003; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; King MC, 2002, SCIENCE, V298, P2342, DOI 10.1126/science.1080373; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lewontin R. C., 1972, EVOLUTIONARY BIOL, V6, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LIVINGSTONE FB, 1962, CURR ANTHROPOL, V3, P279, DOI 10.1086/200290; Manni F, 2002, HUM BIOL, V74, P645, DOI 10.1353/hub.2002.0054; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Nei M, 1996, MOL BIOL EVOL, V13, P170, DOI 10.1093/oxfordjournals.molbev.a025553; Owens K, 1999, SCIENCE, V286, P451, DOI 10.1126/science.286.5439.451; Paabo S, 2003, NATURE, V421, P409, DOI 10.1038/nature01400; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; PerezLezaun A, 1997, HUM GENET, V99, P1; Phimister EG, 2003, NEW ENGL J MED, V348, P1081, DOI 10.1056/NEJMp030028; Pritchard JK, 2000, GENETICS, V155, P945; RISCH N, 2002, GENOME BIOL, V3; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; SAHI T, 1994, SCAND J GASTROENTERO, V29, P7, DOI 10.3109/00365529409091740; SOKAL RR, 1990, AM NAT, V135, P157, DOI 10.1086/285037; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Williams MA, 2001, CRIT CARE MED, V29, pA82; WRIGHT S, 1969, EVOLUTION GENETICS P, V2, P1	50	257	263	4	38	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	SEP	2004	14	9					1679	1685		10.1101/gr.2529604			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	851HJ	WOS:000223675900001	15342553	Green Published, Bronze			2022-01-24	
J	Ryder, E; Blows, F; Ashburner, M; Bautista-Llacer, R; Coulson, D; Drummond, J; Webster, J; Gubb, D; Gunton, N; Johnson, G; O'Kane, CJ; Huen, D; Sharma, P; Asztalos, Z; Baisch, H; Schulze, J; Kube, M; Kittlaus, K; Reuter, G; Maroy, P; Szidonya, J; Rasmuson-Lestander, A; Ekstrom, K; Dickson, B; Hugentobler, C; Stocker, H; Hafen, E; Lepesant, JA; Pflugfelder, G; Heisenberg, M; Mechler, B; Serras, F; Corominas, M; Schneuwly, S; Preat, T; Roote, J; Russell, S				Ryder, E; Blows, F; Ashburner, M; Bautista-Llacer, R; Coulson, D; Drummond, J; Webster, J; Gubb, D; Gunton, N; Johnson, G; O'Kane, CJ; Huen, D; Sharma, P; Asztalos, Z; Baisch, H; Schulze, J; Kube, M; Kittlaus, K; Reuter, G; Maroy, P; Szidonya, J; Rasmuson-Lestander, A; Ekstrom, K; Dickson, B; Hugentobler, C; Stocker, H; Hafen, E; Lepesant, JA; Pflugfelder, G; Heisenberg, M; Mechler, B; Serras, F; Corominas, M; Schneuwly, S; Preat, T; Roote, J; Russell, S			The DrosDel collection: A set of P-element insertions for generating custom chromosomal aberrations in Drosophila melanogaster	GENETICS			English	Article							GENE ACTIVITY; REQUIREMENTS; SEQUENCE; GENOME; REGION; DNA	We describe a collection of P-element insertions that have considerable utility for generating custom chromosomal aberrations in Drosophila melanogaster. We have mobilized a pair of engineered P elements, p{RS3} and p{RS5}, to collect 3243 lines unambiguously mapped to the Drosophila genome sequence. The collection contains, on average, an element every 35 kb. We demonstrate the utility of the collection for generating custom chromosomal deletions that have their end points mapped, with base-pair resolution, to the genome sequence. The collection was generated in an isogenic strain, thus affording a uniform background for screens where sensitivity to genetic background is high. The entire collection, along with a computational and genetic toolbox for designing and generating custom deletions, is publicly available. Using the collection it is theoretically possible to generate >12,000 deletions between 1 bp and 1 Mb in size by simple eye color selection. In addition, a further 37,000 deletions, selectable by molecular screening, may be generated. We are now rising the collection to generate a second-generation deficiency kit that is precisely mapped to the genome sequence.	Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Univ Halle Wittenberg, Inst Genet, D-06120 Halle An Der Saale, Germany; Umea Univ, Dept Biol Mol, S-90187 Umea, Sweden; Univ Szeged, Dept Genet & Mol Biol, H-6726 Szeged, Hungary; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Inst Jacques Monod, CNRS, FR-75251 Paris, France; Johannes Gutenberg Univ Mainz, Inst Genet, D-55128 Mainz, Germany; Univ Wurzburg, Lehrstuhl Genet, D-97074 Wurzburg, Germany; Deutsch Krebsforschungszentrum, Dept Dev Genet, D-69120 Heidelberg, Germany; Univ Barcelona, Fac Biol, Dept Genet, Barcelona 08028, Spain; Univ Regensburg, Inst Zool, D-93040 Regensburg, Germany; CNRS, F-91190 Gif Sur Yvette, France		Russell, S (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	s.russell@gen.cam.ac.uk	O'Kane, Cahir J/C-4413-2011; Stoecker, Horst/F-8382-2012; Ryder, Edward/AAK-1243-2021; Russell, Steve/A-4072-2011; O'Kane, Cahir/Q-6681-2019; Dickson, Barry/AAE-7632-2019; Corominas, Montserrat/K-6528-2012; Gubb, David/F-9793-2011; Serras, Florenci/L-2353-2014; Huen, David/F-3676-2014; Pflugfelder, Gert/ABG-9562-2021	Stoecker, Horst/0000-0002-3282-3664; Ryder, Edward/0000-0002-1799-9899; Russell, Steve/0000-0003-0546-3031; O'Kane, Cahir/0000-0002-3488-2078; Dickson, Barry/0000-0003-0715-892X; Corominas, Montserrat/0000-0002-0724-8346; Serras, Florenci/0000-0003-1184-5386; Huen, David/0000-0002-9900-2297; Preat, Thomas/0000-0001-9976-1763	Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [G18877] Funding Source: Medline		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashburner M, 1999, GENETICS, V153, P179; Ashburner M., 1989, DROSOPHILA LAB HDB; Bridges CB, 1916, GENETICS, V1, P1; Casella, 1999, MONTE CARLO STAT MET; CELNIKER SE, 2002, GENOME BIOL, V0003; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Golic KG, 1996, GENETICS, V144, P1693; Gray YHM, 1996, GENETICS, V144, P1601; GUBB D, 1988, DROSOPHILA PRACTICAL, P109; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; Huet F, 2002, P NATL ACAD SCI USA, V99, P9948, DOI 10.1073/pnas.142310099; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; KAISER K, 1990, P NATL ACAD SCI USA, V87, P1686, DOI 10.1073/pnas.87.5.1686; Karess RE, 1985, DNA CLONING PRACTICA, VII, P121; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; LINDSLEY DL, 1972, GENETICS, V71, P157; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; MERRILL PT, 1988, DEVELOPMENT, V104, P495; Mohr SE, 2002, GENETICS, V162, P165; MULLINS MC, 1989, GENE DEV, V3, P729, DOI 10.1101/gad.3.5.729; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; Schultz J, 1929, GENETICS, V14, P366; Spradling AC, 1999, GENETICS, V153, P135; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; ZUSMAN SB, 1985, DEV BIOL, V111, P359, DOI 10.1016/0012-1606(85)90490-7	31	257	263	0	16	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUN	2004	167	2					797	813		10.1534/genetics.104.026658			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	837QN	WOS:000222650500020	15238529	Green Published, Green Accepted, Bronze			2022-01-24	
J	Rise, ML; von Schalburg, KR; Brown, GD; Mawer, MA; Devlin, RH; Kuipers, N; Busby, M; Beetz-Sargent, M; Alberto, R; Gibbs, AR; Hunt, P; Shukin, R; Zeznik, JA; Nelson, C; Jones, SRM; Smailus, DE; Jones, SJM; Schein, JE; Marra, MA; Butterfield, YSN; Stott, JM; Ng, SHS; Davidson, WS; Koop, BF				Rise, ML; von Schalburg, KR; Brown, GD; Mawer, MA; Devlin, RH; Kuipers, N; Busby, M; Beetz-Sargent, M; Alberto, R; Gibbs, AR; Hunt, P; Shukin, R; Zeznik, JA; Nelson, C; Jones, SRM; Smailus, DE; Jones, SJM; Schein, JE; Marra, MA; Butterfield, YSN; Stott, JM; Ng, SHS; Davidson, WS; Koop, BF			Development and application of a salmonid EST database and cDNA microarray: Data mining and interspecific hybridization characteristics	GENOME RESEARCH			English	Article							WINTER FLOUNDER; RAINBOW-TROUT; FISH; GENE; EVOLUTION; METABOLISM; EXPRESSION; ATLANTIC; SEQUENCE; DUPLICATIONS	We report 80,388 ESTs from 23 Atlantic salmon (Salmo salar) cDNA libraries (61,819 ESTs), 6 rainbow trout (Oncorhynchus mykiss) cDNA libraries (14,544 ESTs), 2 chinook salmon (Oncorhynchus tshawytscha) cDNA libraries (1317 ESTs), 2 sockeye salmon (Oncorhynchus nerka) cDNA libraries (1243 ESTs), and 2 lake whitefish (Coregonus clupeaformis) cDNA libraries (1465 ESTs). The majority of these are 3 sequences, allowing discrimination between paralogs arising from a recent genome duplication in the salmonid lineage. Sequence assembly reveals 28,710 different S. Salar, 8981 O. mykiss, 1085 O. tshawytscha, 520 O. nerka, and 1176 C clupeaformis Putative transcripts. We annotate the submitted portion of our EST database by molecular function. Higher- and lower-molecular-weight fractions of libraries are shown to contain distinct gene sets, and higher rates of gene discovery are associated with higher-molecular weight libraries. Pyloric caecum library group annotations indicate this organ may function in redox control and as a barrier against systemic uptake of xenobiotics. A microarray is described, containing 7356 salmonid elements representing 3557 different cDNAs. Analyses of cross-species hybridizations to this cDNA microarray indicate that this resource may be used for Studies involving all salmonids.	Univ Victoria, Ctr Biomed Res, Victoria, BC V8W 3N5, Canada; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Fisheries & Oceans Canada, Aquaculture Div, W Vancouver, BC V7V 1N6, Canada; Vancouver Gen Hosp, Prostate Ctr, Array Facil, Vancouver, BC V6H 3Z6, Canada; Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada		Koop, BF (corresponding author), Univ Victoria, Ctr Biomed Res, Victoria, BC V8W 3N5, Canada.	bkoop@uvic.ca	Marra, Marco A/B-5987-2008; Koop, Ben F./A-8151-2008; Alberto, Roger/S-6405-2019; Jones, Steven J/C-3621-2009; Schein, Jacquie E/G-3674-2015; Jones, Simon/C-2485-2012	Marra, Marco A/0000-0001-7146-7175; Koop, Ben F./0000-0003-0045-5200; Alberto, Roger/0000-0001-5978-3394; Jones, Steven J/0000-0003-3394-2208; Jones, Simon/0000-0002-8800-9653			Allendorf F.W., 1984, P1; Allendorf FW, 1997, GENETICS, V145, P1083; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson Theodore, 1996, NEW STAT ANAL DATA; Bailey GS, 1996, ENVIRON HEALTH PERSP, V104, P5, DOI 10.2307/3432693; BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; Basu N, 2002, GENE, V295, P173, DOI 10.1016/S0378-1119(02)00687-X; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; BOOKE HE, 1968, J FISH RES BOARD CAN, V25, P1667, DOI 10.1139/f68-149; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BUDDINGTON RK, 1986, P NATL ACAD SCI USA, V83, P8012, DOI 10.1073/pnas.83.20.8012; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; COE IR, 1995, MOL CELL ENDOCRINOL, V115, P113, DOI 10.1016/0303-7207(95)03675-W; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; Davey GC, 2001, GENE, V263, P121, DOI 10.1016/S0378-1119(00)00587-4; Deplancke B, 2002, CURR OPIN CLIN NUTR, V5, P85, DOI 10.1097/00075197-200201000-00015; DEVLIN RH, 1993, CAN J FISH AQUAT SCI, V50, P1738, DOI 10.1139/f93-195; Devlin RH, 2001, NATURE, V409, P781, DOI 10.1038/35057314; Douglas SE, 1999, MAR BIOTECHNOL, V1, P458, DOI 10.1007/PL00011802; Douglas SE, 1999, J APPL ICHTHYOL, V15, P80, DOI 10.1046/j.1439-0426.1999.00117.x; Douglas SE, 1998, J MAR BIOTECHNOL, V6, P214; Eshel R, 2001, CELL IMMUNOL, V213, P141, DOI 10.1006/cimm.2001.1872; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Faillace MP, 2002, J COMP NEUROL, V451, P127, DOI 10.1002/cne.10333; Gregory TR, 2002, ANIMAL GENOME SIZE D; HOLLAND PWH, 1994, DEVELOPMENT, P125; Katchamart S, 2002, ENVIRON TOXICOL CHEM, V21, P2445, DOI 10.1897/1551-5028(2002)021<2445:EOXEOT>2.0.CO;2; KIDO Y, 1991, P NATL ACAD SCI USA, V88, P2326, DOI 10.1073/pnas.88.6.2326; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Madigou T, 2002, MOL REPROD DEV, V63, P151, DOI 10.1002/mrd.90006; Nelson J. S., 1994, FISHES WORLD; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; OHNO S, 1965, CYTOGENETICS, V4, P117, DOI 10.1159/000129849; Ohno S., 1970, EVOLUTION GENE DUPLI; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Phillips R, 2001, BIOL REV, V76, P1, DOI 10.1017/S1464793100005613; Phillips Ruth B., 1997, P145, DOI 10.1016/B978-012417540-2/50011-7; Rabinovich GA, 2002, BBA-GEN SUBJECTS, V1572, P274, DOI 10.1016/S0304-4165(02)00314-8; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Shum BP, 2001, J IMMUNOL, V166, P3297, DOI 10.4049/jimmunol.166.5.3297; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; SMITH GR, 1989, FISHERIES, V14, P4, DOI 10.1577/1548-8446(1989)014<0004:TCASNO>2.0.CO;2; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Stearley R.F., 1993, P622; Tipsmark CK, 2002, J EXP ZOOL, V293, P106, DOI 10.1002/jez.10118; Vinogradov AE, 1998, CYTOMETRY, V31, P100, DOI 10.1002/(SICI)1097-0320(19980201)31:2<100::AID-CYTO5>3.0.CO;2-Q; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Zhang CB, 2001, J COMP PHYSIOL B, V171, P161, DOI 10.1007/s003600000170	50	257	271	0	43	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAR	2004	14	3					478	490		10.1101/gr.1687304			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	780PB	WOS:000189389100017	14962987	Green Published, Bronze			2022-01-24	
J	Hu, W; Yan, Q; Shen, DK; Liu, F; Zhu, ZD; Song, HD; Xu, XR; Wang, ZJ; Rong, YP; Zeng, LC; Wu, J; Zhang, X; Wang, JJ; Xu, XN; Wang, SY; Fu, G; Zhang, XL; Wang, ZQ; Brindley, PJ; McManus, DP; Xue, CL; Feng, Z; Chen, Z; Han, ZG				Hu, W; Yan, Q; Shen, DK; Liu, F; Zhu, ZD; Song, HD; Xu, XR; Wang, ZJ; Rong, YP; Zeng, LC; Wu, J; Zhang, X; Wang, JJ; Xu, XN; Wang, SY; Fu, G; Zhang, XL; Wang, ZQ; Brindley, PJ; McManus, DP; Xue, CL; Feng, Z; Chen, Z; Han, ZG			Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource	NATURE GENETICS			English	Article							COMPARATIVE GENOMICS; SEX DETERMINATION; SEQUENCE; EXPRESSION; MANSONI; PROTEIN; CLONING; HOST	Schistosoma japonicum causes schistosomiasis in humans and livestock in the Asia-Pacific region. Knowledge of the genome of this parasite should improve understanding of schistosome-host interactions, biomedical aspects of schistosomiasis and invertebrate evolution. We assigned 43,707 expressed sequence tags ( ESTs) derived from adult S. japonicum and their eggs to 13,131 gene clusters. Of these, 35% shared no similarity with known genes and 75% had not been reported previously in schistosomes. Notably, S. japonicum encoded mammalian-like receptors for insulin, progesterone, cytokines and neuropeptides, suggesting that host hormones, or endogenous parasite homologs, could orchestrate schistosome development and maturation and that schistosomes modulate anti-parasite immune responses through inhibitors, molecular mimicry and other evasion strategies.	Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Ctr Dis Control & Prevent, Inst Parasit Dis, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Dept Parasitol, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Rui Jin Hosp, State Key Lab Med Genom, Shanghai 200025, Peoples R China; Tulane Univ, Hlth Sci Ctr, Dept Trop Med, New Orleans, LA 70112 USA; Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Australian Ctr Int Hlth & Nutr, Brisbane, Qld 4029, Australia		Han, ZG (corresponding author), Chinese Natl Human Genome Ctr Shanghai, 351 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	hanzg@chgc.sh.cn	Song, Huai-Dong/G-8961-2011; McManus, Don/AAC-5394-2020; HU, Wei/F-1004-2012; McManus, Donald P./G-2678-2013	McManus, Don/0000-0001-6443-1449; Brindley, Paul J./0000-0003-1765-0002; Han, Ze-Guang/0000-0002-1018-1752			Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Boag PR, 2001, ADV PARASIT, V50, P153, DOI 10.1016/S0065-308X(01)50031-7; Bostic JR, 1996, MOL BIOCHEM PARASIT, V79, P79, DOI 10.1016/0166-6851(96)02640-0; Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4; BUEDING E, 1982, J PARASITOL, V68, P208, DOI 10.2307/3281177; CAMACHO M, 1995, J PARASITOL, V81, P637, DOI 10.2307/3283866; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; de Mendonca RL, 2000, PARASITOL TODAY, V16, P233, DOI 10.1016/S0169-4758(00)01641-0; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GORMAN M, 1993, CELL, V72, P39, DOI 10.1016/0092-8674(93)90048-U; Halton DW, 1997, INT J PARASITOL, V27, P693, DOI 10.1016/S0020-7519(97)00011-8; Hoffmann KF, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-8-research0041; Holland PWH, 1999, NATURE, V402, pC41, DOI 10.1038/35011536; Imase A, 2001, PARASITOLOGY, V123, P163, DOI 10.1017/S0031182001008198; Johnston DA, 1999, BIOESSAYS, V21, P131, DOI 10.1002/(SICI)1521-1878(199902)21:2<131::AID-BIES7>3.0.CO;2-I; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kuwabara PE, 1998, DEV BIOL, V204, P251, DOI 10.1006/dbio.1998.9062; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le TH, 2002, TRENDS PARASITOL, V18, P206, DOI 10.1016/S1471-4922(02)02252-3; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Lum DH, 2000, GENE DEV, V14, P3153; Mei HP, 1997, EXP PARASITOL, V86, P69, DOI 10.1006/expr.1997.4150; Morand S, 2000, PARASITOLOGY, V120, P45, DOI 10.1017/S0031182099005235; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; PULTZ MA, 1995, DEVELOPMENT, V121, P99; Ravindran B, 2001, TRENDS PARASITOL, V17, P70, DOI 10.1016/S1471-4922(00)01835-3; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Salzet M, 2000, PARASITOL TODAY, V16, P536, DOI 10.1016/S0169-4758(00)01787-7; Santos TM, 1999, MOL BIOCHEM PARASIT, V103, P79, DOI 10.1016/S0166-6851(99)00100-0; Skelly PJ, 1996, P NATL ACAD SCI USA, V93, P3642, DOI 10.1073/pnas.93.8.3642; SKELLY PJ, 1994, J BIOL CHEM, V269, P4247; Sokol SB, 2000, GENE DEV, V14, P901; Thornton JW, 2000, ANNU REV GENOM HUM G, V1, P41, DOI 10.1146/annurev.genom.1.1.41; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xu XR, 2001, P NATL ACAD SCI USA, V98, P15089, DOI 10.1073/pnas.241522398	46	257	292	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					139	147		10.1038/ng1236			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	WOS:000185625300010	12973349				2022-01-24	
J	Kivisild, T; Rootsi, S; Metspalu, M; Mastana, S; Kaldma, K; Parik, J; Metspalu, E; Adojaan, M; Tolk, HV; Stepanov, V; Golge, M; Usanga, E; Papiha, SS; Cinnioglu, C; King, R; Cavalli-Sforza, L; Underhill, PA; Villems, R				Kivisild, T; Rootsi, S; Metspalu, M; Mastana, S; Kaldma, K; Parik, J; Metspalu, E; Adojaan, M; Tolk, HV; Stepanov, V; Golge, M; Usanga, E; Papiha, SS; Cinnioglu, C; King, R; Cavalli-Sforza, L; Underhill, PA; Villems, R			The genetic heritage of the earliest settlers persists both in Indian tribal and caste populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA LINEAGES; Y-CHROMOSOME HAPLOTYPES; HOMO-SAPIENS SAPIENS; SEQUENCE VARIATION; ADMIXTURE PROPORTIONS; MTDNA VARIATION; 9-BP DELETION; MODERN HUMANS; SOUTH-INDIA; ORIGINS	Two tribal groups from southern India-the Chenchus and Koyas-were analyzed for variation in mitochondrial DNA (mtDNA), the Y chromosome, and one autosomal locus and were compared with six caste groups from different parts of India, as well as with western and central Asians. In mtDNA phylogenetic analyses, the Chenchus and Koyas coalesce at Indian-specific branches of haplogroups M and N that cover populations of different social rank from all over the subcontinent. Coalescence times suggest early late Pleistocene settlement of southern Asia and suggest that there has not been total replacement of these settlers by later migrations. H, L, and R2 are the major Indian Y-chromosomal haplogroups that occur both in castes and in tribal populations and are rarely found outside the subcontinent. Haplogroup R1a, previously associated with the putative Indo-Aryan invasion, was found at its highest frequency in Punjab but also at a relatively high frequency (26%) in the Chenchu tribe. This finding, together with the higher R1a-associated short tandem repeat diversity in India and Iran compared with Europe and central Asia, suggests that southern and western Asia might be the source of this haplogroup. Haplotype frequencies of the MX1 locus of chromosome 21 distinguish Koyas and Chenchus, along with Indian caste groups, from European and eastern Asian populations. Taken together, these results show that Indian tribal and caste populations derive largely from the same genetic heritage of Pleistocene southern and western Asians and have received limited gene flow from external regions since the Holocene. The phylogeography of the primal mtDNA and Y-chromosome founders suggests that these southern Asian Pleistocene coastal settlers from Africa would have provided the inocula for the subsequent differentiation of the distinctive eastern and western Eurasian gene pools.	Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Newcastle Upon Tyne, Dept Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Kuwait Univ, Dept Med Lab Sci, Sulibikhat, Kuwait; Univ Kiel, Dept Physiol, Kiel, Germany; Inst Med Genet, Tomsk, Russia; Univ Loughborough, Dept Human Sci, Loughborough, Leics, England; Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia		Kivisild, T (corresponding author), Estonian Bioctr, Riia 23, EE-51010 Tartu, Estonia.		Stepanov, Vadim A./N-7657-2014; Metspalu, Mait/G-8671-2015; Kivisild, Toomas/P-5889-2017; Stepanov, Vadim A/G-4320-2013; Mastana, Sarabjit/A-1405-2011	Metspalu, Mait/0000-0003-3099-9161; Kivisild, Toomas/0000-0002-6297-7808; Stepanov, Vadim A/0000-0002-5166-331X; Mastana, Sarabjit/0000-0002-9553-4886	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM28428, P01 GM028428, GM55273] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01GM028428] Funding Source: NIH RePORTER		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Bhattacharyya NP, 1999, GENOME RES, V9, P711; Bhowmick P. K., 1992, CHENCHUS FORESTS PLA; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; Chikhi L, 2001, GENETICS, V158, P1347; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Edwin D, 2002, CURR SCI INDIA, V83, P158; Ellis N, 2002, GENOME RES, V12, P339; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Forster P, 1996, AM J HUM GENET, V59, P935; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kivisild T., 2000, ARCHAEOGENETICS DNA, P267; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Majumder PP, 2001, EUR J HUM GENET, V9, P794, DOI 10.1038/sj.ejhg.5200705; Majumder PP, 2001, GENOME RES, V11, P931, DOI 10.1101/gr.192401; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Nebel A, 2002, AM J HUM GENET, V70, P1594, DOI 10.1086/340669; Nebel A, 2001, AM J HUM GENET, V69, P1095, DOI 10.1086/324070; NEI M, 1993, MOL BIOL EVOL, V10, P927; Papiha SS, 1996, HUM BIOL, V68, P607; Passarino G, 1996, ANN HUM BIOL, V23, P121, DOI 10.1080/03014469600004342; Passarino G, 2001, HUM IMMUNOL, V62, P922, DOI 10.1016/S0198-8859(01)00291-9; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Raitio M, 2001, GENOME RES, V11, P471, DOI 10.1101/gr.156301; Ramana GV, 2001, EUR J HUM GENET, V9, P695, DOI 10.1038/sj.ejhg.5200708; Redd AJ, 2002, CURR BIOL, V12, P673, DOI 10.1016/S0960-9822(02)00789-3; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Saillard J, 2000, HUM BIOL, V72, P1065; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sambrook J., 1989, MOL CLONING LAB MANU; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shouse B, 2001, SCIENCE, V294, P988, DOI 10.1126/science.294.5544.988; Shriver MD, 1997, AM J HUM GENET, V60, P957; SINGH KS, 1997, PEOPLE INDIA, V3; Soodyall H, 1996, AM J HUM GENET, V58, P595; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; TARN W, 1951, GREEKS BACTR INDIA; Thangaraj K, 1999, ELECTROPHORESIS, V20, P1743, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1743::AID-ELPS1743>3.0.CO;2-V; THURIN M, 1999, CAMBRIDGE ENCY HUNTE, P252; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; WALTER H, 1991, ANTHR INDIENS; Watkins WS, 1999, AM J PHYS ANTHROPOL, V109, P147, DOI 10.1002/(SICI)1096-8644(199906)109:2<147::AID-AJPA1>3.3.CO;2-3; Weale ME, 2001, HUM GENET, V109, P659, DOI 10.1007/s00439-001-0627-9; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zerjal T, 1999, GENOMIC DIVERSITY, P91	82	257	271	0	36	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					313	332		10.1086/346068			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	WOS:000180680000012	12536373	Bronze, Green Published			2022-01-24	
J	Richard, G; Smith, LE; Bailey, RA; Itin, P; Hohl, D; Epstein, EH; DiGiovanna, JJ; Compton, JG; Bale, SJ				Richard, G; Smith, LE; Bailey, RA; Itin, P; Hohl, D; Epstein, EH; DiGiovanna, JJ; Compton, JG; Bale, SJ			Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis	NATURE GENETICS			English	Article							GAP JUNCTION PROTEINS; MOLECULAR-CLONING; EXPRESSION; SKIN; EPIDERMIS; DEAFNESS; FAMILY; MODULATION; LINKAGE	Erythrokeratodermia variabilis (EKV, OMIM 133200) is an autosomal dominant genodermatosis with considerable intra- and interfamilial variability(1). It has a disfiguring phenotype characterized by the independent occurrence of two morphologic features: transient figurate red patches and localized or generalized hyperkeratosis (Fig. 1). Both features can be triggered by external factors such as trauma to the skin. After initial linkage to the RH locus on 1p (refs 2,3). EKV was mapped to an an interval of 2.6 cM on 1p34-p35. and a candidate gene (GJA4) encoding the gap junction protein alpha-4 (connexin 31. Cx31) was excluded by sequence analysis(4). Evidence in mouse suggesting that the EKV region harbours a cluster of epidermally expressed connexin genes(5,6) led us to characterize the human homologues of GJB3 (encoding Cx31) and GJB5 (encoding Cx31.1). GJB3, GJB5 and GJA4 were localized to a 1.1-Mb YAC in the candidate interval. We detected heterozygous missense mutations in GJB3 in four EKV families leading to substitution of a conserved glycine by charged residues (G12R and G12D). or change of a cysteine (C865). These mutations are predicted to interfere with normal Cx31 structure and function, possibly due to a dominant inhibitory effect. Our results implicate Cx31 in the pathogenesis of EKV, and provide evidence that intercellular communication mediated by Cx31 is crucial for epidermal differentiation and response to external factors.	NIAMSD, Genet Studies Sect, Skin Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Basel, Dept Dermatol, Basel, Switzerland; Beaumont Hosp, Dept Dermatol, Lausanne, Switzerland; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Dermatol, San Francisco, CA 94143 USA; Brown Univ, Rhode Isl Hosp, Dept Dermatol, Div Dermatopharmacol, Providence, RI 02903 USA		Bale, SJ (corresponding author), NIAMSD, Genet Studies Sect, Skin Biol Lab, NIH, Bethesda, MD 20892 USA.						BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BRISSETTE JL, 1994, P NATL ACAD SCI USA, V91, P6453, DOI 10.1073/pnas.91.14.6453; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; BUTTERWECK A, 1994, EUR J CELL BIOL, V65, P152; DACOSTA SM, 1925, ACTA DERM-VENEREOL, V6, P255; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Deschenes SM, 1997, J NEUROSCI, V17, P9077; GOLIGER JA, 1994, DEV DYNAM, V200, P1, DOI 10.1002/aja.1002000102; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; GUO HM, 1992, J INVEST DERMATOL, V99, P460, DOI 10.1111/1523-1747.ep12616154; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; HENNEMANN H, 1992, EUR J CELL BIOL, V57, P51; HENNEMANN H, 1992, J BIOL CHEM, V267, P17225; HOH JH, 1991, J BIOL CHEM, V266, P6524; ITIN P, 1992, HAUTARZT, V43, P500; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; Larson DM, 1997, AM J PHYSIOL-CELL PH, V272, pC405, DOI 10.1152/ajpcell.1997.272.2.C405; MasgrauPeya E, 1997, J HISTOCHEM CYTOCHEM, V45, P1207, DOI 10.1177/002215549704500904; REED KE, 1993, J CLIN INVEST, V91, P997, DOI 10.1172/JCI116321; Richard G, 1997, J INVEST DERMATOL, V109, P666, DOI 10.1111/1523-1747.ep12337713; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; RISEK B, 1992, DEVELOPMENT, V116, P639; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466; VANDERSCHROEFF JG, 1984, HUM GENET, V68, P165, DOI 10.1007/BF00279308; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Yeager M, 1996, CURR OPIN STRUC BIOL, V6, P183, DOI 10.1016/S0959-440X(96)80073-X; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	30	257	274	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					366	369		10.1038/3840			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	WOS:000077199600024	9843209				2022-01-24	
J	Majamaa, K; Moilanen, JS; Uimonen, S; Remes, AM; Salmela, PI; Karppa, M; Majamaa-Voltti, KAM; Rusanen, H; Sorri, M; Peuhkurinen, KJ; Hassinen, IE				Majamaa, K; Moilanen, JS; Uimonen, S; Remes, AM; Salmela, PI; Karppa, M; Majamaa-Voltti, KAM; Rusanen, H; Sorri, M; Peuhkurinen, KJ; Hassinen, IE			Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: Prevalence of the mutation in an adult population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER RNALEU(UUR) GENE; DIABETES-MELLITUS; POINT MUTATION; DNA; DISEASES; PHENOTYPE; ENCEPHALOPATHY; MYOPATHY; GENOTYPE; FINLAND	Mitochondrial diseases are characterized by considerable clinical variability and are most often caused by mutations in mtDNA. Because of the phenotypic variability, epidemiological studies of the frequency of these disorders have been difficult to perform. We studied the prevalence of the mtDNA mutation at nucleotide 3243 in an adult population of 245,201 individuals. This mutation is the most common molecular etiology of MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes), one of the clinical entities among the mitochondrial disorders. Patients with diabetes mellitus, sensorineural hearing impairment, epilepsy, occipital brain infarct, ophthalmoplegia, cerebral white-matter disease, basal-ganglia calcifications, hypertrophic cardiomyopathy, or ataxia were ascertained on the basis of defined clinical criteria and family-history data. A total of 615 patients were identified, and 480 samples were examined for the mutation. The mutation was found in 11 pedigrees, and its frequency was calculated to be greater than or equal to 16.3/100,000 in the adult population (95% confidence interval 11.3-21.4/100,000). The mutation had arisen in the population at least nine times, as determined by mtDNA haplotyping. Clinical evaluation of the probands revealed a syndrome that most frequently consisted of hearing impairment, cognitive decline, and short stature. The high prevalence of the common MELAS mutation in the adult population suggests that mitochondrial disorders constitute one of the largest diagnostic categories of neurogenetic diseases.	Oulu Univ, Dept Neurol, FIN-90220 Oulu, Finland; Oulu Univ, Dept Biochem Med, FIN-90220 Oulu, Finland; Oulu Univ, Dept Otorhinolaryngol, FIN-90220 Oulu, Finland; Oulu Univ, Dept Internal Med, FIN-90220 Oulu, Finland		Majamaa, K (corresponding author), Oulu Univ, Dept Neurol, Kajaanintie 52 A, FIN-90220 Oulu, Finland.		Majamaa, Kari/A-1344-2012; Moilanen, Jukka S/G-2604-2012	Moilanen, Jukka S/0000-0002-8041-3205; Majamaa, Kari/0000-0002-9070-3791			DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Hutchin TP, 1997, GENETICS, V145, P771; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; Liu VWS, 1997, HUM MUTAT, V9, P265, DOI 10.1002/(SICI)1098-1004(1997)9:3<265::AID-HUMU8>3.0.CO;2-6; Maassen JA, 1996, DIABETOLOGIA, V39, P375; Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331; MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873; MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5; MORTEN KJ, 1995, HUM MOL GENET, V4, P1689; *NAWH NAT RES DEV, 1994, HEALTH, V2; NORIO R, 1973, ANN CLIN RES, V5, P109; PASSARINO G, 1993, AM J HUM GENET, V53, P609; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; Shoffner JM, 1996, LANCET, V348, P1283, DOI 10.1016/S0140-6736(96)09138-6; Smith ML, 1997, J CLIN ENDOCR METAB, V82, P2826, DOI 10.1210/jc.82.9.2826; Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013; SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525; Torroni A, 1996, GENETICS, V144, P1835; Tully G, 1996, GENOMICS, V34, P107, DOI 10.1006/geno.1996.0247; WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Wong LJC, 1997, CLIN CHEM, V43, P1241	29	257	269	0	21	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					447	454		10.1086/301959			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	WOS:000075360800020	9683591	Green Published, Bronze			2022-01-24	
J	Verhoeven, K; Van Laer, L; Kirschhofer, K; Legan, PK; Hughes, DC; Schatteman, I; Verstreken, M; Van Hauwe, P; Coucke, P; Chen, A; Smith, RJH; Somers, T; Offeciers, FE; Van de Heyning, P; Richardson, GP; Wachtler, F; Kimberling, WT; Willems, PJ; Govaerts, PJ; Van Camp, G				Verhoeven, K; Van Laer, L; Kirschhofer, K; Legan, PK; Hughes, DC; Schatteman, I; Verstreken, M; Van Hauwe, P; Coucke, P; Chen, A; Smith, RJH; Somers, T; Offeciers, FE; Van de Heyning, P; Richardson, GP; Wachtler, F; Kimberling, WT; Willems, PJ; Govaerts, PJ; Van Camp, G			Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment	NATURE GENETICS			English	Article							TAMM-HORSFALL PROTEIN; MEMBRANE-PROTEIN; SEQUENCE; GRANULE; GP-2; GLYCOPROTEIN; HOMOLOGY; RECEPTOR; PANCREAS	The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. alpha-tectorin is one of the major non-collagenous components of the tectorial membrane(1,2). Recently, the gene encoding mouse alpha-tectorin (Tecta) was mapped to a region of mouse chromosome 9, which shows evolutionary conservation with human chromosome 11q (ref. 3), where linkage was found in two families, one Belgian (DFNA12; ref. 4) and the other, Austrian (DFNA8; unpublished data), with autosomal dominant non-syndromic hearing impairment. We determined the complete sequence and the intron-exon structure of the human TECTA gene. In both families, mutation analysis revealed missense mutations which replace conserved amino-acid residues within the zona pellucida domain of TECTA. These findings indicate that mutations in TECTA are responsible for hearing impairment in these families, and implicate a new type of protein in the pathogenesis of hearing impairment.	Univ Instelling Antwerp, Dept Med Genet, B-2610 Wilrijk, Belgium; Univ Instelling Antwerp, Dept Otorhinolaryngol, B-2610 Wilrijk, Belgium; Univ Hosp Vienna, Clin Otorhinol, A-1090 Vienna, Austria; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; St Augustinus Hosp, Dept Otolaryngol, B-2610 Wilrijk, Belgium; Univ Iowa Hosp & Clin, Dept Otolaryngol, Iowa City, IA 52242 USA; Univ Vienna, Inst Histol & Embryol, A-1090 Vienna, Austria; Boys Town Natl Res Hosp, Omaha, NE 68131 USA		Van Camp, G (corresponding author), Univ Instelling Antwerp, Dept Med Genet, Universiteitsplein 1, B-2610 Wilrijk, Belgium.	gvcamp@uia.ua.ac.be	Coucke, Paul J/AAO-2954-2020; Van Camp, Guy/F-3386-2013; Heyning, Paul H Vande/I-8278-2017; Hughes, David/AAB-9237-2019	Coucke, Paul J/0000-0001-7119-586X; Van Camp, Guy/0000-0001-5105-9000; Heyning, Paul H Vande/0000-0002-8424-3717; Hughes, David/0000-0002-4539-3093; Smith, Richard/0000-0003-1201-6731; Legan, P. Kevin/0000-0002-7403-6415			BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Brown DD, 1996, P NATL ACAD SCI USA, V93, P1924, DOI 10.1073/pnas.93.5.1924; DURKIN ME, 1988, J CELL BIOL, V107, P2749, DOI 10.1083/jcb.107.6.2749; FUKUOKA SI, 1992, P NATL ACAD SCI USA, V89, P1189, DOI 10.1073/pnas.89.4.1189; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; GOVAERTS PJ, IN PRESS AM J OTOL; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; HOOPS TC, 1991, J BIOL CHEM, V266, P4257; Hughes DC, 1998, GENOMICS, V48, P46, DOI 10.1006/geno.1997.5159; KRAWCZAK M, 1992, HUM GENET, V90, P41; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; LERACH H, 1990, GENOME ANAL, V1, P39; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PRASADAN K, 1995, BBA-GENE STRUCT EXPR, V1260, P328, DOI 10.1016/0167-4781(94)00240-4; RICHARDSON GP, 1987, HEARING RES, V25, P45, DOI 10.1016/0378-5955(87)90078-5; SULIK KK, 1995, HEREDITARY HEARING L, pCH4; Verhoeven K, 1997, AM J HUM GENET, V60, P1168; Wong SME, 1996, GENE, V171, P311, DOI 10.1016/0378-1119(96)00065-0; Yu Heron, 1994, Gene Expression, V4, P63	20	257	274	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					60	62		10.1038/ng0598-60			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	WOS:000073346700018	9590290				2022-01-24	
J	Henske, EP; Scheithauer, BW; Short, MP; Wollmann, R; Nahmias, J; Hornigold, N; vanSlegtenhorst, M; Welsh, CT; Kwiatkowski, DJ				Henske, EP; Scheithauer, BW; Short, MP; Wollmann, R; Nahmias, J; Hornigold, N; vanSlegtenhorst, M; Welsh, CT; Kwiatkowski, DJ			Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE MAP; INTERNATIONAL WORKSHOP; GROWTH SUPPRESSOR; HUMAN 9Q34.1; REGION; GENE; HETEROZYGOSITY; TSC1; CHROMOSOME-9; 16P13	Tuberous sclerosis (TSC) is an autosomal dominant disorder characterized by seizures, mental retardation, and hamartomatous lesions. Although hamartomas can occur in almost any organ, they are most common in the brain, kidney, heart, and skin. Allelic loss or loss of heterozygosity (LOH) in TSC lesions has previously been reported on chromosomes 16p13 and 9q34, the locations of the TSC2 and TSC1 genes, respectively, suggesting that the TSC genes act as tumor-suppressor genes. In our study, 87 lesions from 47 TSC patients were analyzed for LOH in the TSC1 and TSC2 chromosomal regions. Three findings resulted hem this analysis, First, we confirmed that the TSC1 critical region is distal to D9S149. Second, we found LOH more frequently on chromosome 16p13 than on 9q34. Of the 28 patients with angiomyolipomas or rhabdomyomas, 16p13 LOH was detected in lesions from 12 (57%) of 21 informative patients, while 9q34 LOH was detected in lesions from only 1 patient (4%). This could indicate that TSC2 tumors are more likely than TSC1 tumors to require surgical resection or that TSC2 is more common than TSC1 in out patient population. It is also possible that small regions of 9q34 LOH were missed. Lastly, LOH was found in 56% of renal angiomyolipomas and cardiac rhabdomyomas but in only 4% of TSC brain lesions. This suggests that brain lesions can result from different pathogenic mechanisms than kidney and heart lesions.	BRIGHAM & WOMENS HOSP, DIV EXPT MED, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA; MAYO CLIN, DEPT PATHOL, ROCHESTER, MN USA; UNIV CHICAGO, MED CTR, SECT NEUROPATHOL, CHICAGO, IL 60637 USA; UCL, MRC, HUMAN BIOCHEM GENET UNIT, LONDON, ENGLAND; UCL, DEPT GENET & BIOMETRY, LONDON, ENGLAND; ERASMUS UNIV ROTTERDAM, ROTTERDAM, NETHERLANDS; UNIV UTAH, DEPT PATHOL, SALT LAKE CITY, UT USA						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS01571, NS31535] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS001571, R01NS031535] Funding Source: NIH RePORTER		CARBONARA C, 1994, HUM MOL GENET, V3, P1829, DOI 10.1093/hmg/3.10.1829; Carbonara C, 1996, GENE CHROMOSOME CANC, V15, P18, DOI 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; GREEN AJ, 1994, HUM MOL GENET, V3, P1833, DOI 10.1093/hmg/3.10.1833; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HENSKE EP, 1995, GENOMICS, V28, P105, DOI 10.1006/geno.1995.1113; HENSKE EP, 1995, GENE CHROMOSOME CANC, V13, P295, DOI 10.1002/gcc.2870130411; HENSKE EP, 1993, GENOMICS, V17, P587, DOI 10.1006/geno.1993.1376; HIROSE T, 1995, ACTA NEUROPATHOL, V90, P387; KWIATKOWSKI DJ, 1994, ARCH DERMATOL, V130, P348, DOI 10.1001/archderm.130.3.348; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; MURRELL J, 1995, GENOMICS, V25, P59, DOI 10.1016/0888-7543(95)80109-Y; NAYLOR SL, 1994, CYTOGENET CELL GENET, V65, P2; NELLIST M, 1993, CELL, V75, P1305; NORTHRUP H, 1992, AM J HUM GENET, V51, P709; POVEY S, 1994, ANN HUM GENET, V58, P107, DOI 10.1111/j.1469-1809.1994.tb01881.x; POVEY S, 1994, ANN HUM GENET, V58, P177, DOI 10.1111/j.1469-1809.1994.tb01887.x; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; SHEN Y, 1994, GENOMICS, V22, P68, DOI 10.1006/geno.1994.1346; SNAREY A, 1994, AM J HUM GENET, V55, P365; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; [No title captured]; [No title captured]	25	257	263	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					400	406					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	WOS:A1996VM28800016	8755927				2022-01-24	
J	Bestor, TH; Tycko, B				Bestor, TH; Tycko, B			Creation of genomic methylation patterns	NATURE GENETICS			English	Article							DNA METHYLATION; GENE-REGULATION; METHYLTRANSFERASE; EVOLUTION	There are two biological properties of genomic methylation patterns that can be regarded as established. First, methylation of 5'-CpG-3' dinucleotides within promoters represses transcription, often to undetectable levels. Second, in most cases methylation patterns are subject to clonal inheritance. These properties suit methylation patterns for a number of biological roles, although none of the current hypotheses can be regarded as proved or disproved. One hypothesis suggests that the activity of parasitic sequence elements is repressed by selective methylation. Features of invasive sequences that might allow their identification and inactivation are discussed in terms of the genome defense hypothesis. Identification of the cues that direct de novo methylation may reveal the biological role (or roles) of genomic methylation patterns.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032		Bestor, TH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,701 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA060610, R01CA060765] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA60765, CA60610] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GMOO616] Funding Source: Medline		ASHBURNER M, 1992, DROSOPHILA LAB HDB, V303; ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; BESTOR T, 1987, NUCLEIC ACIDS RES, V15, P3835, DOI 10.1093/nar/15.9.3835; BESTOR TH, 1993, CURR BIOL, V3, P384, DOI 10.1016/0960-9822(93)90209-7; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; BESTOR TH, 1995, GENOMIC IMPRINTING C; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CHALLITA PM, 1994, P NATL ACAD SCI USA, V91, P2567, DOI 10.1073/pnas.91.7.2567; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; CHESNOKOV IN, 1995, J BIOL CHEM, V270, P18539, DOI 10.1074/jbc.270.31.18539; CLEAVER JE, 1994, CELL, V76, P1, DOI 10.1016/0092-8674(94)90165-1; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; DUHL D, 1994, NAT GENET, V7, P220; ENGELS WR, 1994, SCIENCE, V263, P1623, DOI 10.1126/science.8128250; FINNEGAN J, 1994, BIO-TECHNOL, V12, P883, DOI 10.1038/nbt0994-883; FLAVELL RB, 1994, P NATL ACAD SCI USA, V91, P3490, DOI 10.1073/pnas.91.9.3490; GOYON C, 1994, J MOL BIOL, V240, P42, DOI 10.1006/jmbi.1994.1416; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; JAENISCH R, 1985, P NATL ACAD SCI USA, V82, P1451, DOI 10.1073/pnas.82.5.1451; JENTSCH F, 1986, EMBO J, V5, P181; JUE K, 1995, BIOL REPROD, V53, P561, DOI 10.1095/biolreprod53.3.561; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; KRICKER MC, 1992, P NATL ACAD SCI USA, V89, P1075, DOI 10.1073/pnas.89.3.1075; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, COLD SPRING HARB SYM, V58, P297, DOI 10.1101/SQB.1993.058.01.035; LU M, 1991, J BIOL CHEM, V266, P2531; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MATZKE AJM, 1994, MOL GEN GENET, V244, P219, DOI 10.1007/BF00285449; MATZKE MA, 1995, TRENDS GENET, V11, P1, DOI 10.1016/S0168-9525(00)88973-8; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; MUMMANENI P, 1993, J BIOL CHEM, V268, P552; NEUMANN B, 1994, NAT GENET, V9, P451; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; TAYLOR JH, 1984, MOL CELL BIOCHEM, V61, P99; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; YANG AS, 1995, NUCLEIC ACIDS RES, V23, P1380, DOI 10.1093/nar/23.8.1380; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	51	257	263	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					363	367		10.1038/ng0496-363			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	WOS:A1996UC55300013	8630488				2022-01-24	
J	MCLEAN, WHI; RUGG, EL; LUNNY, DP; MORLEY, SM; LANE, EB; SWENSSON, O; DOPPINGHEPENSTAL, PJC; GRIFFITHS, WAD; EADY, RAJ; HIGGINS, C; NAVSARIA, HA; LEIGH, IM; STRACHAN, T; KUNKELER, L; MUNRO, CS				MCLEAN, WHI; RUGG, EL; LUNNY, DP; MORLEY, SM; LANE, EB; SWENSSON, O; DOPPINGHEPENSTAL, PJC; GRIFFITHS, WAD; EADY, RAJ; HIGGINS, C; NAVSARIA, HA; LEIGH, IM; STRACHAN, T; KUNKELER, L; MUNRO, CS			KERATIN-16 AND KERATIN-17 MUTATIONS CAUSE PACHYONYCHIA-CONGENITA	NATURE GENETICS			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; EPIDERMOLYSIS-BULLOSA SIMPLEX; INTERMEDIATE FILAMENTS; HAIR-FOLLICLES; COILED-COIL; EXPRESSION; CELLS; GENES; CYTOKERATIN; PATTERNS	Pachyonychia congenita (PC) is a group of autosomal dominant disorders characterized by dystrophic nails and other ectodermal aberrations. A gene for Jackson-Lawler PC was recently mapped to the type I keratin cluster on 17q. Here, we show that a heterozygous missense mutation in the helix initiation motif of K17 (Asn92Asp) cosegregates with the disease in this kindred. We also show that Jadassohn-Lewandowsky PC is caused by a heterozygous missense mutation in the helix initiation peptide of K16 (Leu130Pro). The known expression patterns of these keratins in epidermal structures correlates with the specific abnormalities observed in each form of PC.	UNITED MED & DENT SCH, ST THOMAS HOSP, ST JOHNS INST DERMATOL, LONDON SE1 7EH, ENGLAND; ROYAL LONDON HOSP, COLL MED, EXPTL DERMATOL LABS, LONDON E1 6BL, ENGLAND; UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND; SO GEN HOSP, DEPT DERMATOL, GLASGOW G51 4TF, LANARK, SCOTLAND		MCLEAN, WHI (corresponding author), UNIV DUNDEE, INST MED SCI, DEPT ANAT & PHYSIOL, CANC RES CAMPAIGN LABS, CELL STRUCT RES GRP, DUNDEE DD1 4HN, SCOTLAND.		McLean, William HI/C-6352-2009	McLean, William Henry Irwin/0000-0001-5539-5757	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; COLLIN C, 1992, EXP CELL RES, V202, P132, DOI 10.1016/0014-4827(92)90412-2; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HEID HW, 1988, DIFFERENTIATION, V37, P215, DOI 10.1111/j.1432-0436.1988.tb00724.x; HOROVITZ A, 1992, J MOL BIOL, V227, P560, DOI 10.1016/0022-2836(92)90907-2; JACKSON ADM, 1951, ANN EUGENIC, V16, P142, DOI 10.1111/j.1469-1809.1951.tb02468.x; JADASSOHN J, 1906, JACOBS IKONOGRAPHIA, V1, P29; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; KREMER H, 1994, J INVEST DERMATOL, V103, P286, DOI 10.1111/1523-1747.ep12394414; LANE EB, 1991, ANN NY ACAD SCI, V642, P197; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANE EB, 1994, CURR OPIN GENET DEV, V4, P412, DOI 10.1016/0959-437X(94)90030-2; LANGBEIN L, 1993, DIFFERENTIATION, V55, P57, DOI 10.1111/j.1432-0436.1993.tb00033.x; MCKUSICK VA, 1994, OMIM LINE MENDELIAN; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1994, J INVEST DERMATOL, V103, P277, DOI 10.1111/1523-1747.ep12394307; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; MOLL R, 1982, J CELL BIOL, V95, P285, DOI 10.1083/jcb.95.1.285; MOLL R, 1982, DIFFERENTIATION, V23, P170, DOI 10.1111/j.1432-0436.1982.tb01280.x; MUNRO CS, 1994, J MED GENET, V31, P675, DOI 10.1136/jmg.31.9.675; QUINLAN RA, 1994, INTERMEDIATE FILAMEN; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROMANO V, 1987, CYTOGENET CELL GENET, V46, P683; ROMANO V, 1988, CYTOGENET CELL GENET, V48, P148, DOI 10.1159/000132612; ROSENBERG M, 1988, MOL CELL BIOL, V8, P722, DOI 10.1128/MCB.8.2.722; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; ROTHNAGEL JA, 1994, NAT GENET, V7, P485, DOI 10.1038/ng0894-485; SERRANO L, 1992, J MOL BIOL, V227, P544, DOI 10.1016/0022-2836(92)90906-Z; SMEDTS F, 1990, AM J PATHOL, V136, P657; SMEDTS F, 1992, AM J PATHOL, V140, P601; STARK HJ, 1987, DIFFERENTIATION, V35, P236, DOI 10.1111/j.1432-0436.1987.tb00174.x; STEINERT PM, 1990, J BIOL CHEM, V265, P8766; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STOOF TJ, 1994, KERATINOCYTE HDB, P365; TROYANOVSKY SM, 1989, J CELL SCI, V93, P419; TROYANOVSKY SM, 1992, EUR J CELL BIOL, V59, P127; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; WETZELS RHW, 1991, AM J PATHOL, V138, P751; WILSON CL, 1994, BRIT J DERMATOL, V131, P191	48	257	279	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1995	9	3					273	278		10.1038/ng0395-273			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	WOS:A1995QL23200017	7539673				2022-01-24	
J	MULLAN, M; HOULDEN, H; WINDELSPECHT, M; FIDANI, L; LOMBARDI, C; DIAZ, P; ROSSOR, M; CROOK, R; HARDY, J; DUFF, K; CRAWFORD, F				MULLAN, M; HOULDEN, H; WINDELSPECHT, M; FIDANI, L; LOMBARDI, C; DIAZ, P; ROSSOR, M; CROOK, R; HARDY, J; DUFF, K; CRAWFORD, F			A LOCUS FOR FAMILIAL EARLY-ONSET ALZHEIMERS-DISEASE ON THE LONG ARM OF CHROMOSOME 14, PROXIMAL TO THE ALPHA-1-ANTICHYMOTRYPSIN GENE	NATURE GENETICS			English	Article							PROTEIN; MUTATION	Although mutations in the beta-amyloid precursor protein gene (APP) on chromosome 21 cause some cases of early-onset Alzheimer's disease (AD), most cases evidently do not have mutations in APP. We analysed ten early-onset families for linkage to APP and markers elsewhere in the genome. One family (F172) was consistent with linkage to chromosome 21 and was subsequently found to have an APP Val to Ile mutation. Of the others, all but one were consistent with linkage to markers in the middle long arm of chromosome 14. However, no family showed independent evidence of linkage with two point analysis and only one showed independent evidence of linkage on multipoint analysis. Therefore, we cannot rule out heterogeneity at these loci although tests for heterogeneity were not significant.	ST MARYS HOSP,SCH MED,DEPT BIOCHEM,LONDON W2 1PG,ENGLAND; ST MARYS HOSP,SCH MED,DEPT NEUROL,LONDON W2 1PG,ENGLAND		MULLAN, M (corresponding author), UNIV S FLORIDA,CTR PSYCHIAT,ALZHEIMERS DIS RES LABS,3515 E FLETCHER AVE,TAMPA,FL 33613, USA.		Rossor, Martin/C-1598-2008; Hardy, John/C-2451-2009; Houlden, Henry/C-1532-2008	Hardy, John/0000-0002-3122-0423; Houlden, Henry/0000-0002-2866-7777; Duff, Karen/0000-0002-6177-868X; Rossor, Martin/0000-0001-8215-3120; Mullan, Michael/0000-0002-1473-7527			ABE K, 1991, NEUROSCI LETT, V125, P169, DOI 10.1016/0304-3940(91)90019-P; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; COX DW, 1990, CYTOGENET CELL GENET, V55, P183, DOI 10.1159/000133010; FIDANI L, 1992, HUM MOL GENET, V1, P165, DOI 10.1093/hmg/1.3.165; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLENNER GG, 1989, J NEUROL SCI, V94, P1, DOI 10.1016/0022-510X(89)90214-1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HARLIN MCC, 1991, NATURE, V353, P844; LATHROP GM, 1990, AM J HUM GENET S, V47, pA188; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Ott J, 1991, ANAL HUMAN GENETIC L; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEITKAMP LR, 1983, AM J HUM GENET, V35, P443; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729	20	257	261	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					340	342		10.1038/ng1292-340			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	WOS:A1992KB49500022	1303291				2022-01-24	
J	BRILES, WE; MCGIBBON, WH; IRWIN, MR				BRILES, WE; MCGIBBON, WH; IRWIN, MR			ON MULTIPLE ALLELES EFFECTING CELLULAR ANTIGENS IN THE CHICKEN	GENETICS			English	Article																	Boyd WC, 1940, J HERED, V31, P135, DOI 10.1093/oxfordjournals.jhered.a104861; DUNN LC, 1945, GENETICS, V30, P543; Ehrlich P, 1900, BERL KLIN WSCHR, V37, P453; FISCHER RA, 1944, CITED INDIRECTLY; FISHER RA, 1946, NATURE, V157, P48, DOI 10.1038/157048b0; GREEN MM, 1949, P NATL ACAD SCI USA, V35, P586, DOI 10.1073/pnas.35.10.586; Kozelka AW, 1933, J IMMUNOL, V24, P519; Landsteiner K, 1932, P SOC EXP BIOL MED, V30, P209; Landsteiner K., 1901, WIENER KLIN WOCHENST, P1132; Landsteiner K., 1900, ZENTRALBL BAKTERIOL, V27, P357; LANDSTEINER K., 1924, P SOC EXP BIOL MED, V22, P100; Landsteiner K, 1945, SPECIFICITY SEROLOGI; LAUGHNAN JR, 1949, P NATL ACAD SCI USA, V35, P167, DOI 10.1073/pnas.35.4.167; LEWIS EB, 1948, GENETICS, V33, P113; LEWIS EB, 1945, GENETICS, V30, P137; MCGIBBON WH, 1945, GENETICS, V30, P252; McGibbon WH, 1944, GENETICS, V29, P407; Miller RA, 1938, ANAT REC, V70, P155, DOI 10.1002/ar.1090700204; PERLMAN E, 1946, J EXP MED, V84, P235, DOI 10.1084/jem.84.3.235; RACE RR, 1949, HEREDITY, V3, P205, DOI 10.1038/hdy.1949.12; Race RR, 1944, NATURE, V153, P771, DOI 10.1038/153771b0; SANGER R, 1947, NATURE, V160, P505, DOI 10.1038/160505a0; STEPHENS SG, 1948, GENETICS, V33, P191; STORMONT C, 1945, GENETICS, V30, P25; STORMONT C, 1951, IN PRESS GENETICS, V36; Thomsen O, 1936, HEREDITAS, V22, P129; Thomsen O, 1934, HEREDITAS, V19, P243; Todd C, 1930, P R SOC LOND B-CONTA, V106, P20, DOI 10.1098/rspb.1930.0009; Todd C, 1935, PROC R SOC SER B-BIO, V117, P358, DOI 10.1098/rspb.1935.0034; Todd C, 1910, J Hyg (Lond), V10, P185; TODD C, 1931, P ROY SOC B, V107, P197; WALSH RJ, 1947, NATURE, V160, P504, DOI 10.1038/160504b0; Wiener Alexander S., 1943, PROC SOC EXP BIOL AND MED, V54, P316; Wiener AS, 1944, SCIENCE, V100, P595, DOI 10.1126/science.100.2609.595; Wiener AS, 1943, P SOC EXP BIOL MED, V53, P167, DOI 10.3181/00379727-53-14234; WIENER AS, 1949, AM J CLIN PATHOL, V19, P621; WIENER AS, 1949, AM J CLIN PATHOL, V19, P779; Wiener AS, 1934, J GENET, V29, P1, DOI 10.1007/BF02981779; WIENER AS, 1949, 8TH P INT C GEN, P500; YU CP, 1948, J GENET, V49, P46, DOI 10.1007/BF02986382	40	257	267	0	3	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1950	35	6					633	652					20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW843	WOS:A1950XW84300004	14793708				2022-01-24	
J	Yang, JH; Liu, DY; Wang, XW; Ji, CM; Cheng, F; Liu, BN; Hu, ZY; Chen, S; Pental, D; Ju, YH; Yao, P; Li, XM; Xie, K; Zhang, JH; Wang, JL; Liu, F; Ma, WW; Shopan, J; Zheng, HK; Mackenzie, SA; Zhang, MF				Yang, Jinghua; Liu, Dongyuan; Wang, Xiaowu; Ji, Changmian; Cheng, Feng; Liu, Baoning; Hu, Zhongyuan; Chen, Sheng; Pental, Deepak; Ju, Youhui; Yao, Pu; Li, Xuming; Xie, Kun; Zhang, Jianhui; Wang, Jianlin; Liu, Fan; Ma, Weiwei; Shopan, Jannat; Zheng, Hongkun; Mackenzie, Sally A.; Zhang, Mingfang			The genome sequence of allopolyploid Brassica juncea and analysis of differential homoeolog gene expression influencing selection	NATURE GENETICS			English	Article							EVOLUTION; REVEALS; POLYPLOIDY; DIVERSITY; OLERACEA; DATABASE; ORIGIN	The Brassica genus encompasses three diploid and three allopolyploid genomes, but a clear understanding of the evolution of agriculturally important traits via polyploidy is lacking. We assembled an allopolyploid Brassica juncea genome by shotgun and single-molecule reads integrated to genomic and genetic maps. We discovered that the A subgenomes of B. juncea and Brassica napus each had independent origins. Results suggested that A subgenomes of B. juncea were of monophyletic origin and evolved into vegetable-use and oil-use subvarieties. Homoeolog expression dominance occurs between subgenomes of allopolyploid B. juncea, in which differentially expressed genes display more selection potential than neutral genes. Homoeolog expression dominance in B. juncea has facilitated selection of glucosinolate and lipid metabolism genes in subvarieties used as vegetables and for oil production. These homoeolog expression dominance relationships among Brassicaceae genomes have contributed to selection response, predicting the directional effects of selection in a polyploid crop genome.	[Yang, Jinghua; Hu, Zhongyuan; Ma, Weiwei; Shopan, Jannat; Zhang, Mingfang] Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou, Zhejiang, Peoples R China; [Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang] Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Peoples R China; [Yang, Jinghua; Hu, Zhongyuan; Zhang, Mingfang] Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou, Zhejiang, Peoples R China; [Liu, Dongyuan; Ji, Changmian; Liu, Baoning; Ju, Youhui; Yao, Pu; Li, Xuming; Xie, Kun; Zhang, Jianhui; Zheng, Hongkun] Biomarker Technol Corp, Beijing, Peoples R China; [Wang, Xiaowu; Cheng, Feng] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China; [Chen, Sheng] Univ Western Australia, Sch Plant Biol M084, Perth, WA, Australia; [Chen, Sheng] Univ Western Australia, UWA Inst Agr, Perth, WA, Australia; [Pental, Deepak] Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, New Delhi, India; [Wang, Jianlin] Tibet Univ, Agr & Anim Husb Coll, Coll Plant Sci & Technol, Linzhi, Peoples R China; [Liu, Fan] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Beijing, Peoples R China; [Yang, Jinghua; Liu, Dongyuan; Wang, Xiaowu; Ji, Changmian; Cheng, Feng; Mackenzie, Sally A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA		Zhang, MF (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou, Zhejiang, Peoples R China.; Zhang, MF (corresponding author), Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Peoples R China.; Zhang, MF (corresponding author), Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou, Zhejiang, Peoples R China.; Mackenzie, SA (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA.	sally.mackenzie@unl.edu; mfzhang@zju.edu.cn	Chen, Sheng/B-1340-2011; Wang, Xiaowu/L-2579-2019; Zhang, Jianhui/K-8793-2019; Yang, Jinghua/G-9164-2016	Chen, Sheng/0000-0002-5238-3432; Zhang, Jianhui/0000-0002-6362-4027; Li, Xuming/0000-0002-5049-9706; Ji, Changmian/0000-0001-8781-4063	Science and Technology Program of Zhejiang Province [2015C32046]; Ear-marked Special Fund from Ministry of Agriculture [09162130135252]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31372063]	We thank X.H. Qi for the construction of F<INF>2</INF> population for genetic mapping, and L.J. Fan for the flow cytometry analysis. This work was supported by grants from Science and Technology Program of Zhejiang Province (2015C32046), Ear-marked Special Fund from Ministry of Agriculture (09162130135252) and the National Natural Science Foundation of China (31372063).	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Bottley A, 2006, PLANT J, V47, P897, DOI 10.1111/j.1365-313X.2006.02841.x; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chang PL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r125; Chen S, 2013, J HERED, V104, P416, DOI 10.1093/jhered/est015; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Flagel L, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-16; Grover CE, 2012, NEW PHYTOL, V196, P966, DOI 10.1111/j.1469-8137.2012.04365.x; Hinata K., 1980, OPERA BOT, V55, P1, DOI [DOI 10.1016/B978-1-891127-79-3.50001-9, 10.1016/b978-1-891127-79-3.50001-9]; Institute of Archaeology of Chinese Academy of Science, 1963, SPEC ISS ARCH; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0161, 10.1199/tab.0133]; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Michael TP, 2015, CURR OPIN PLANT BIOL, V24, P71, DOI 10.1016/j.pbi.2015.02.002; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nagaharu U., 1935, JPN J BOT, V7, P389, DOI DOI 10.1038/35036519; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Warwick SI, 2006, PLANT SYST EVOL, V259, P249, DOI 10.1007/s00606-006-0421-1; Warwick SI, 2011, PLANT GENET GENOMICS, V9, P33, DOI 10.1007/978-1-4419-7118-0_2; Ye YN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-769; Zhang DW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00957; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zou J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2343-1	35	256	280	19	185	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1225	1232		10.1038/ng.3657			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	WOS:000384391600018	27595476	hybrid	Y	N	2022-01-24	
J	Hwang, EY; Song, QJ; Jia, GF; Specht, JE; Hyten, DL; Costa, J; Cregan, PB				Hwang, Eun-Young; Song, Qijian; Jia, Gaofeng; Specht, James E.; Hyten, David L.; Costa, Jose; Cregan, Perry B.			A genome-wide association study of seed protein and oil content in soybean	BMC GENOMICS			English	Article						GWAS; Glycine max; Seed protein and oil content; Single nucleotide polymorphism; Linkage disequilibrium	GENETIC-LINKAGE MAP; QUANTITATIVE TRAIT LOCI; AGRONOMIC TRAITS; GROUP-I; QTL; TOLERANCE; POLYMORPHISMS; ARCHITECTURE; POPULATIONS; HAPLOTYPE	Background: Association analysis is an alternative to conventional family-based methods to detect the location of gene(s) or quantitative trait loci (QTL) and provides relatively high resolution in terms of defining the genome position of a gene or QTL. Seed protein and oil concentration are quantitative traits which are determined by the interaction among many genes with small to moderate genetic effects and their interaction with the environment. In this study, a genome-wide association study (GWAS) was performed to identify quantitative trait loci (QTL) controlling seed protein and oil concentration in 298 soybean germplasm accessions exhibiting a wide range of seed protein and oil content. Results: A total of 55,159 single nucleotide polymorphisms (SNPs) were genotyped using various methods including Illumina Infinium and GoldenGate assays and 31,954 markers with minor allele frequency >0.10 were used to estimate linkage disequilibrium (LD) in heterochromatic and euchromatic regions. In euchromatic regions, the mean LD (r(2)) rapidly declined to 0.2 within 360 Kbp, whereas the mean LD declined to 0.2 at 9,600 Kbp in heterochromatic regions. The GWAS results identified 40 SNPs in 17 different genomic regions significantly associated with seed protein. Of these, the five SNPs with the highest associations and seven adjacent SNPs were located in the 27.6-30.0 Mbp region of Gm20. A major seed protein QTL has been previously mapped to the same location and potential candidate genes have recently been identified in this region. The GWAS results also detected 25 SNPs in 13 different genomic regions associated with seed oil. Of these markers, seven SNPs had a significant association with both protein and oil. Conclusions: This research indicated that GWAS not only identified most of the previously reported QTL controlling seed protein and oil, but also resulted in narrower genomic regions than the regions reported as containing these QTL. The narrower GWAS-defined genome regions will allow more precise marker-assisted allele selection and will expedite positional cloning of the causal gene(s).	[Hwang, Eun-Young; Costa, Jose] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Song, Qijian; Jia, Gaofeng; Hyten, David L.; Cregan, Perry B.] ARS, USDA, Soybean Genom & Improvement Lab, Beltsville, MD 20705 USA; [Specht, James E.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA		Cregan, PB (corresponding author), ARS, USDA, Soybean Genom & Improvement Lab, Beltsville, MD 20705 USA.	perry.cregan@ars.usda.gov		Hyten, David/0000-0001-6324-9389; Costa, Jose/0000-0003-2051-6226	National Science FoundationNational Science Foundation (NSF) [IOS 0822258]; United Soybean Board Project [8265]	We thank the National Science Foundation (IOS 0822258) and the United Soybean Board Project #8265 for funding to support this work.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bao XU, 1989, JILIN AGR SCI, V39, P5; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bhosale SU, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-32; Bolon YT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-41; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; BRIM CA, 1979, CROP SCI, V19, P494, DOI 10.2135/cropsci1979.0011183X001900040016x; Brummer EC, 1997, CROP SCI, V37, P370, DOI 10.2135/cropsci1997.0011183X003700020011x; Campbell CR, 1992, RES SER B USDA, V368, P21; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Chung J, 2003, CROP SCI, V43, P1053, DOI 10.2135/cropsci2003.1053; Cober ER, 2000, CROP SCI, V40, P39, DOI 10.2135/cropsci2000.40139x; Cregan PB, 1999, CROP SCI, V39, P1464, DOI 10.2135/cropsci1999.3951464x; DIERS BW, 1992, THEOR APPL GENET, V83, P608, DOI 10.1007/BF00226905; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Hao DR, 2012, EUPHYTICA, V186, P919, DOI 10.1007/s10681-012-0697-x; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hyten DL, 2008, THEOR APPL GENET, V116, P945, DOI 10.1007/s00122-008-0726-2; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Keim P., 1988, Soybean Genetics Newsletter, V15, P150; Kim JS, 2005, GENETICS, V171, P1963, DOI 10.1534/genetics.105.048215; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Lee SH, 1996, THEOR APPL GENET, V93, P649, DOI 10.1007/BF00224058; Mamidi S, 2011, PLANT GENOME-US, V4, P154, DOI 10.3835/plantgenome2011.04.0011; Mandel JR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003378; Mansur LM, 1996, CROP SCI, V36, P1327, DOI 10.2135/cropsci1996.0011183X003600050042x; Nichols DM, 2006, CROP SCI, V46, P834, DOI 10.2135/cropsci2005.05-0168; Niedziela A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-67; Orf JH, 1999, CROP SCI, V39, P1642, DOI 10.2135/cropsci1999.3961642x; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1139/G06-112; RUBEL G, 1994, J AM OIL CHEM SOC, V71, P1057, DOI 10.1007/BF02675896; Sebolt AM, 2000, CROP SCI, V40, P1438, DOI 10.2135/cropsci2000.4051438x; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Song QJ, 2010, CROP SCI, V50, P1950, DOI 10.2135/cropsci2009.10.0607; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Stombaugh SK, 2004, CROP SCI, V44, P2101, DOI 10.2135/cropsci2004.2101; Tajuddin T, 2003, BREEDING SCI, V53, P133, DOI 10.1270/jsbbs.53.133; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Urbany C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-7; Visioni A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-424; Wilcox J.R., 1987, SOYBEANS IMPROVEMENT, P211; Wilcox JR, 1998, CROP SCI, V38, P1536, DOI 10.2135/cropsci1998.0011183X003800060021x; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Wilson RF., 2004, SOYBEANS IMPROVEMENT, V3, P621, DOI [10.2134/agronmonogr16.3ed.c13, DOI 10.2134/AGR0NM0N0GR16.3ED.C13]; Xu B, 1985, SOYBEAN SCI, V3, P327; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang XB, 2013, PLANT MOL BIOL REP, V31, P594, DOI 10.1007/s11105-012-0526-3; Zhao Q, 2002, GENOME RES, V12, P817, DOI 10.1101/gr.48902; Zhu YL, 2003, GENETICS, V163, P1123	59	256	280	5	112	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JAN 2	2014	15								1	10.1186/1471-2164-15-1			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	288LX	WOS:000329614600001	24382143	Green Published, gold			2022-01-24	
J	Sartori, R; Schirwis, E; Blaauw, B; Bortolanza, S; Zhao, JH; Enzo, E; Stantzou, A; Mouisel, E; Toniolo, L; Ferry, A; Stricker, S; Goldberg, AL; Dupont, S; Piccolo, S; Amthor, H; Sandri, M				Sartori, Roberta; Schirwis, Elija; Blaauw, Bert; Bortolanza, Sergia; Zhao, Jinghui; Enzo, Elena; Stantzou, Amalia; Mouisel, Etienne; Toniolo, Luana; Ferry, Arnaud; Stricker, Sigmar; Goldberg, Alfred L.; Dupont, Sirio; Piccolo, Stefano; Amthor, Helge; Sandri, Marco			BMP signaling controls muscle mass	NATURE GENETICS			English	Article							TGF-BETA-SUPERFAMILY; SKELETAL-MUSCLE; UBIQUITIN LIGASES; ATROPHY; MICE; IDENTIFICATION; HYPERTROPHY; DENERVATION; RECEPTORS; PROMOTER	Cell size is determined by the balance between protein synthesis and degradation. This equilibrium is affected by hormones, nutrients, energy levels, mechanical stress and cytokines. Mutations that inactivate myostatin lead to excessive muscle growth in animals and humans, but the signals and pathways responsible for this hypertrophy remain largely unknown. Here we show that bone morphogenetic protein (BMP) signaling, acting through Smad1, Smad5 and Smad8 (Smad1/5/8), is the fundamental hypertrophic signal in mice. Inhibition of BMP signaling causes muscle atrophy, abolishes the hypertrophic phenotype of myostatin-deficient mice and strongly exacerbates the effects of denervation and fasting. BMP-Smad1/5/8 signaling negatively regulates a gene (Fbxo30) that encodes a ubiquitin ligase required for muscle loss, which we named muscle ubiquitin ligase of the SCF complex in atrophy-1 (MUSA1). Collectively, these data identify a critical role for the BMP pathway in adult muscle maintenance, growth and atrophy.	[Sartori, Roberta; Bortolanza, Sergia; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Sartori, Roberta; Blaauw, Bert; Bortolanza, Sergia; Enzo, Elena; Toniolo, Luana; Dupont, Sirio; Piccolo, Stefano; Sandri, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Schirwis, Elija; Stantzou, Amalia; Mouisel, Etienne; Ferry, Arnaud; Amthor, Helge] Univ Paris 06, Inst Myol,UMR, Unite Mixte 76,Assoc Inst Myol, CNRS UMR 7215,INSERM U974, Paris, France; [Schirwis, Elija; Stantzou, Amalia; Amthor, Helge] Univ Versailles St Quentin En Yvelines, UFR Unite Format & Rech Sci Sante, Montigny Le Bretonneux, France; [Schirwis, Elija] Max Delbruck Ctr Mol Med, Berlin, Germany; [Zhao, Jinghui; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Stricker, Sigmar] Max Planck Inst Mol Genet, Dev & Dis Grp, D-14195 Berlin, Germany; [Amthor, Helge] Univ Paris 05, CHU Necker Enfants Malad, Serv Genet Med, Paris, France; [Sandri, Marco] CNR, Inst Neurosci, Padua, Italy; [Sandri, Marco] McGill Univ, Dept Med, Montreal, PQ, Canada		Sandri, M (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy.	stefano.piccolo@unipd.it; helge.amthor@uvsq.fr; marco.sandri@unipd.it	blaauw, bert/A-7614-2014; ferry, arnaud/D-2816-2019; Toniolo, Luana/B-9647-2014; Dupont, Sirio/AAP-8133-2021; Stricker, Sigmar/B-9169-2009	blaauw, bert/0000-0002-3893-1463; Toniolo, Luana/0000-0001-7160-5638; Stricker, Sigmar/0000-0002-7174-5363; Mouisel, Etienne/0000-0002-4676-5709; ferry, arnaud/0000-0002-6050-4556; BLAAUW, BERT/0000-0002-4167-5106; Enzo, Elena/0000-0001-9768-6368; Sartori, Roberta/0000-0002-2763-9838; Stantzou, Amalia/0000-0002-4903-6384; Dupont, Sirio/0000-0002-6869-1966	Telethon ItalyFondazione Telethon [TCP04009]; European Research Council (ERC)European Research Council (ERC)European Commission [282310-MyoPHAGY]; European Union (MYOAGE)European Commission [223576]; Leducq FoundationLeducq Foundation; Italian Ministry of Education (MiUR)Ministry of Education, Universities and Research (MIUR); Associazione Italiana per la Ricerca sul CancroFondazione AIRC per la ricerca sul cancro Funding Source: Custom	We gratefully acknowledge the critical reading of K. Dyar. We thank S.-J. Lee (Johns Hopkins University School of Medicine) for the kind gift of Mstn-/-mice and S. J. Burden (Skirball Institute, New York University Medical School) for the gift of MLC1f-Cre mice. HA-Skp1, Flag-Cul1 and Flag-Roc1 were kindly provided by S. H. Lecker. We acknowledge C. Beley and G. Precigout for AAV production. This work was supported by Telethon Italy (TCP04009), by the European Research Council (ERC; 282310-MyoPHAGY), by the European Union (MYOAGE, contract 223576 of Framework Programme 7), by the Leducq Foundation and by the Italian Ministry of Education (MiUR; PRIN 2010/2011) to M. S., by Associazione Italiana per la Ricerca sul Cancro (AIRC) Investigator grants to S. P. and S. D. and by a Comitato Promotore Telethon Grant, the AIRC Special Program Molecular Clinical Oncology" 5 per Mille," HSFP, Excellence-IIT and Epigenetics Flagship project CNR-MiUR grants to S. P., by the Association Francaise contre les Myopathies to H. A., E. S., A. S. and A. F., by the Agence Nationale de la Recherche to H. A. (ANR-12-BSV1-0038) and by the Deutsche Forschungsgemeinschaft and the Universite Franco-Allemand (as part of the MyoGrad International Graduate School for Myology GK 1631/1 and CDFA-06-11) to S. S., H. A., A. S. and E. S. E. E. is the recipient of a CARIPARO Foundation PhD fellowship.	Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Gomes AV, 2012, FASEB J, V26, P2986, DOI 10.1096/fj.12-204495; Hirner S, 2008, J MOL BIOL, V379, P666, DOI 10.1016/j.jmb.2008.03.049; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krause C, 2011, INT J BIOCHEM CELL B, V43, P478, DOI 10.1016/j.biocel.2011.01.007; Le Goff C, 2012, NAT GENET, V44, P85, DOI 10.1038/ng.1016; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Mouisel E, 2010, MUSCLE NERVE, V41, P809, DOI 10.1002/mus.21624; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sartorelli Vittorio, 2004, Sci STKE, V2004, pre11, DOI 10.1126/stke.2442004re11; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Winbanks CE, 2013, J CELL BIOL, V203, P345, DOI 10.1083/jcb.201211134; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	34	256	265	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2013	45	11					1309	+		10.1038/ng.2772			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	244JL	WOS:000326384100011	24076600				2022-01-24	
J	Cowper-Sal-lari, R; Zhang, XY; Wright, JB; Bailey, SD; Cole, MD; Eeckhoute, J; Moore, JH; Lupien, M				Cowper-Sal-lari, Richard; Zhang, Xiaoyang; Wright, Jason B.; Bailey, Swneke D.; Cole, Michael D.; Eeckhoute, Jerome; Moore, Jason H.; Lupien, Mathieu			Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EPIGENETIC SIGNATURES; SUSCEPTIBILITY; ENHANCERS; DISTINCT; DEFINES; PROMOTERS; RS6983267; PROTEINS; DYNAMICS	Genome-wide association studies (GWAS) have identified thousands of SNPs that are associated with human traits and diseases. But, because the vast majority of these SNPs are located in non-coding regions of the genome, the mechanisms by which they promote disease risk have remained elusive. Employing a new methodology that combines cistromics, epigenomics and genotype imputation, we annotate the non-coding regions of the genome in breast cancer cells and systematically identify the functional nature of SNPs associated with breast cancer risk. Our results show that breast cancer risk-associated SNPs are enriched in the cistromes of FOXA1 and ESR1 and the epigenome of histone H3 lysine 4 monomethylation (H3K4me1) in a cancer- and cell type-specific manner. Furthermore, the majority of the risk-associated SNPs modulate the affinity of chromatin for FOXA1 at distal regulatory elements, thereby resulting in allele-specific gene expression, which is exemplified by the effect of the rs4784227 SNP on the TOX3 gene within the 16q12.1 risk locus.	[Bailey, Swneke D.; Lupien, Mathieu] Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Cowper-Sal-lari, Richard; Zhang, Xiaoyang; Wright, Jason B.; Cole, Michael D.; Moore, Jason H.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Genet, Lebanon, NH USA; [Cowper-Sal-lari, Richard; Zhang, Xiaoyang; Moore, Jason H.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Inst Quantitat Biomed Sci, Lebanon, NH USA; [Bailey, Swneke D.; Lupien, Mathieu] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Eeckhoute, Jerome] Univ Lille Nord France, UMR 1011, INSERM, Lille, France; [Eeckhoute, Jerome] Inst Pasteur, F-59019 Lille, France		Lupien, M (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada.	jason.h.moore@dartmouth.edu; mlupien@uhnres.utoronto.ca	Eeckhoute, Jerome/AAN-8219-2021; Moore, Jason H./AAV-9645-2021	Eeckhoute, Jerome/0000-0002-7222-9264; Moore, Jason H./0000-0002-5015-1099; Lupien, Mathieu/0000-0003-0929-9478	US National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [2P30CA023108-32]; American Cancer Society (ACS)American Cancer Society [1RG-82-003-27]; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01LM009012, R01CA155004]; Princess Margaret Hospital Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA080320, P30CA023108, R01CA155004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [F32DK096822] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM009012] Funding Source: NIH RePORTER; Direct For Biological SciencesNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0923008] Funding Source: National Science Foundation	We thank M. Brown, M.L. Freedman and M. Lemaire for discussions, as well as B.G. Neel and R. Marcotte for technical assistance. We acknowledge support from the US National Cancer Institute (NCI; 2P30CA023108-32), the American Cancer Society (ACS; 1RG-82-003-27 to M.L.), the US National Institutes of Health (NIH; R01LM009012 to J.H.M. and R01CA155004 to M.L.) and the Princess Margaret Hospital Foundation (M.L.).	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Grant SFA, 2008, CLIN CHEM, V54, P1116, DOI 10.1373/clinchem.2008.105395; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Magnani L, 2011, TRENDS GENET, V27, P465, DOI 10.1016/j.tig.2011.07.002; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Riaz M, 2012, BREAST CANCER RES TR, V133, P843, DOI 10.1007/s10549-011-1663-3; Ruiz-Narvaez EA, 2010, CANCER EPIDEM BIOMAR, V19, P1320, DOI 10.1158/1055-9965.EPI-09-1250; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Udler MS, 2010, HUM MOL GENET, V19, P2507, DOI 10.1093/hmg/ddq122; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111	47	256	259	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1191	1198		10.1038/ng.2416			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	WOS:000310495800009	23001124	Green Accepted			2022-01-24	
J	So, LH; Ghosh, A; Zong, CH; Sepulveda, LA; Segev, R; Golding, I				So, Lok-Hang; Ghosh, Anandamohan; Zong, Chenghang; Sepulveda, Leonardo A.; Segev, Ronen; Golding, Ido			General properties of transcriptional time series in Escherichia coli	NATURE GENETICS			English	Article							PROTEIN EXPRESSION; SINGLE-CELL; NOISE; MOLECULE; DYNAMICS; REVEALS; STOCHASTICITY; NETWORK; ELONGATION; INITIATION	Gene activity is described by the time series of discrete, stochastic mRNA production events. This transcriptional time series shows intermittent, bursty behavior. One consequence of this temporal intricacy is that gene expression can be tuned by varying different features of the time series. Here we quantify copy-number statistics of mRNA from 20 Escherichia coli promoters using single-molecule fluorescence in situ hybridization in order to characterize the general properties of these transcriptional time series. We find that the degree of burstiness is correlated with gene expression level but is largely independent of other parameters of gene regulation. The observed behavior can be explained by the underlying variation in the duration of bursting events. Using Shannon's mutual information function, we estimate the mutual information transmitted between an outside stimulus, such as the extracellular concentration of inducer molecules, and intracellular levels of mRNA. This suggests that the outside stimulus transmits information reflected in the properties of transcriptional time series.	[So, Lok-Hang; Sepulveda, Leonardo A.; Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [So, Lok-Hang; Zong, Chenghang; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Ghosh, Anandamohan; Segev, Ronen] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ghosh, Anandamohan; Segev, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Sepulveda, Leonardo A.; Golding, Ido] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA		Golding, I (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	igolding@illinois.edu	SEGEV, RONEN/F-1550-2012; Sepulveda, Leonardo A./AAL-3981-2020; Zong, Chenghang/F-3243-2013	Sepulveda, Leonardo A./0000-0003-3602-1009; Segev, Ronen/0000-0002-8109-1076; Zong, Chenghang/0000-0002-8337-8038	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM082837]; National Science FoundationNational Science Foundation (NSF) [082265]; Human Frontier Science ProgramHuman Frontier Science Program [RGY 70/2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM082837] Funding Source: NIH RePORTER	We are grateful to S. Adhya, W. Boos, M. Cashel, V. Chakravartty, L. Chubiz, D. Court, J. Cronan, M. Dreyfus, M. Elowitz, Y. Feng, H. Garcia, T. Hwa, J. Imlay, S. Jang, T. Kuhlman, J. Little, A. van Oudenaarden, A. Raj, C. Rao, R. Milo, V. Shahrezaei, A. Sokac and P. Swain for advice and for providing reagents. We thank members of the Golding laboratory for providing help with experiments. We thank H. Garcia, J. Kondev, R. Phillips, A. Raj, A. Sanchez, S. Sawai and G. Tkacik for commenting on earlier versions of the manuscript. Work in the Golding laboratory was supported by grants from US National Institutes of Health (R01GM082837) and the National Science Foundation (082265, PFC: Center for the Physics of Living Cells). Work in the Segev and Golding laboratories was supported by a joint grant from the Human Frontier Science Program (RGY 70/2008).	Abdel-Hamid AM, 2007, J BACTERIOL, V189, P369, DOI 10.1128/JB.01373-06; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Alon U., 2007, INTRO SYSTEMS BIOL D; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BARKER DF, 1980, J BACTERIOL, V143, P789, DOI 10.1128/JB.143.2.789-800.1980; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Chubb JR, 2010, CURR OPIN GENET DEV, V20, P478, DOI 10.1016/j.gde.2010.06.009; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cox CD, 2008, P NATL ACAD SCI USA, V105, P10809, DOI 10.1073/pnas.0804829105; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fang FC, 2005, P NATL ACAD SCI USA, V102, P4933, DOI 10.1073/pnas.0501417102; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Garcia HG, 2010, TRENDS CELL BIOL, V20, P723, DOI 10.1016/j.tcb.2010.07.002; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2006, CURR BIOL, V16, pR371, DOI 10.1016/j.cub.2006.04.014; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; Michalowski CB, 2005, J BACTERIOL, V187, P6430, DOI 10.1128/JB.187.18.6430-6442.2005; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Neidhardt F. C., 1987, ESCHERICHIA COLI SAL; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Potrykus K, 2006, J BIOL CHEM, V281, P15238, DOI 10.1074/jbc.M601531200; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Sauer R T, 1990, Adv Protein Chem, V40, P1, DOI 10.1016/S0065-3233(08)60286-7; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Simpson ML, 2004, J THEOR BIOL, V229, P383, DOI 10.1016/j.jtbi.2004.04.017; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Singh D, 2009, P NATL ACAD SCI USA, V106, P864, DOI 10.1073/pnas.0810205106; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Tkacik G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031920; TOKESON JPE, 1991, J BACTERIOL, V173, P2319, DOI 10.1128/JB.173.7.2319-2327.1991; van Zon JS, 2006, BIOPHYS J, V91, P4350, DOI 10.1529/biophysj.106.086157; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x; Whitelaw NC, 2010, DEV CELL, V19, P649, DOI 10.1016/j.devcel.2010.11.001; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/NMETH.1482, 10.1038/nmeth.1482]; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	75	256	258	4	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					554	U84		10.1038/ng.821			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	WOS:000291017000012	21532574	Green Accepted			2022-01-24	
J	Kilpivaara, O; Mukherjee, S; Schram, AM; Wadleigh, M; Mullally, A; Ebert, BL; Bass, A; Marubayashi, S; Heguy, A; Garcia-Manero, G; Kantarjian, H; Offit, K; Stone, RM; Gilliland, DG; Klein, RJ; Levine, RL				Kilpivaara, Outi; Mukherjee, Semanti; Schram, Alison M.; Wadleigh, Martha; Mullally, Ann; Ebert, Benjamin L.; Bass, Adam; Marubayashi, Sachie; Heguy, Adriana; Garcia-Manero, Guillermo; Kantarjian, Hagop; Offit, Kenneth; Stone, Richard M.; Gilliland, D. Gary; Klein, Robert J.; Levine, Ross L.			A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; SUSCEPTIBILITY LOCI; ACTIVATING MUTATION; FAMILIAL RISKS; DISORDERS; CLONALITY; DISEASE	Polycythemia vera, essential thrombocythemia and primary myelofibrosis are myeloproliferative neoplasms (MPN) characterized by multilineage clonal hematopoiesis(1-5). Given that the identical somatic activating mutation in the JAK2 tyrosine kinase gene (JAK2(V617F)) is observed in most individuals with polycythemia vera, essential thrombocythemia and primary myelofibrosis(6-10), there likely are additional genetic events that contribute to the pathogenesis of these phenotypically distinct disorders. Moreover, family members of individuals with MPN are at higher risk for the development of MPN, consistent with the existence of MPN predisposition loci(11). We hypothesized that germline variation contributes to MPN predisposition and phenotypic pleiotropy. Genome-wide analysis identified an allele in the JAK2 locus (rs10974944) that predisposes to the development of JAK2(V617F)-positive MPN, as well as three previously unknown MPN modifier loci. We found that JAK2(V617F) is preferentially acquired in cis with the predisposition allele. These data suggest that germline variation is an important contributor to MPN phenotype and predisposition.	[Mukherjee, Semanti; Klein, Robert J.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Kilpivaara, Outi; Schram, Alison M.; Marubayashi, Sachie; Heguy, Adriana; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Mukherjee, Semanti] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [Wadleigh, Martha; Mullally, Ann; Bass, Adam; Stone, Richard M.; Gilliland, D. Gary] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Mullally, Ann; Ebert, Benjamin L.; Gilliland, D. Gary] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Ebert, Benjamin L.; Bass, Adam; Gilliland, D. Gary] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Ebert, Benjamin L.; Bass, Adam; Gilliland, D. Gary] MIT, Cambridge, MA 02139 USA; [Garcia-Manero, Guillermo; Kantarjian, Hagop] Univ Texas Houston, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Gilliland, D. Gary] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Gilliland, D. Gary] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA		Klein, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	kleinr@mskcc.org; leviner@mskcc.org	Klein, Robert/K-1888-2013; levine, ross/AAE-7658-2019	Klein, Robert/0000-0003-3539-5391; Schram, Alison/0000-0002-6070-2413	Wellcome TrustWellcome TrustEuropean Commission [076113]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Starr Cancer Consortium; Myeloproliferative Disorders Foundation; Howard Hughes Medical InstituteHoward Hughes Medical Institute; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF); Kristen Amico Sesselman Leukemia Research Fund; Academy of FinlandAcademy of FinlandEuropean Commission; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA008748]; Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [K08CA134931, P30CA008748, P30CA016672] Funding Source: NIH RePORTER	We would like to acknowledge the subjects who have contributed to our understanding of these disorders. We thank S. Thomas, I. Dolgalev and T. Landers for assistance with high-throughput resequencing, A. Viale for assistance with JAK2 expression analysis, and T. Kirchhoff for advice and suggestions. This study makes use of data generated by the Wellcome Trust Case-Control Consortium; a full list of the investigators who contributed to the generation of the data are available from http://www.wtccc.org.uk and funding was provided by the Wellcome Trust under award 076113. This work was supported by grants from the National Institutes of Health, the Starr Cancer Consortium, the Myeloproliferative Disorders Foundation, the Howard Hughes Medical Institute, the Doris Duke Charitable Foundation and the Kristen Amico Sesselman Leukemia Research Fund. O.K. is supported by a grant from the Academy of Finland. D.G.G. is an Investigator of the Howard Hughes Medical Institute and is a Doris Duke Charitable Foundation Distinguished Clinical Scientist. Work in the laboratory of R.J.K. is supported by Memorial Sloan Kettering Cancer Center through US National Institutes of Health grant P30 CA008748. R. L. L. is an Early Career Award recipient of the Howard Hughes Medical Institute and a Clinical Scientist Development Award recipient of the Doris Duke Charitable Foundation and is the Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center.	ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cario H, 2005, BRIT J HAEMATOL, V130, P800, DOI 10.1111/j.1365-2141.2005.05683.x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; El Kassar Nahed, 1995, British Journal of Haematology, V90, P131; GILLILAND DG, 1991, P NATL ACAD SCI USA, V88, P6848, DOI 10.1073/pnas.88.15.6848; Hemminki K, 2008, INT J CANCER, V123, P1726, DOI 10.1002/ijc.23702; Hemminki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002504; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Pietra D, 2008, BLOOD, V111, P1686, DOI 10.1182/blood-2007-07-101576; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; TSUKAMOTO N, 1994, BRIT J HAEMATOL, V86, P253, DOI 10.1111/j.1365-2141.1994.tb04723.x; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	28	256	262	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2009	41	4					455	459		10.1038/ng.342			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	WOS:000264659000020	19287384	Green Accepted			2022-01-24	
J	Keller, MP; Choi, Y; Wang, P; Davis, DB; Rabaglia, ME; Oler, AT; Stapleton, DS; Argmann, C; Schueler, KL; Edwards, S; Steinberg, HA; Chaibub Neto, E; Kleinhanz, R; Turner, S; Hellerstein, MK; Schadt, EE; Yandell, BS; Kendziorski, C; Attie, AD				Keller, Mark P.; Choi, YounJeong; Wang, Ping; Davis, Dawn Belt; Rabaglia, Mary E.; Oler, Angie T.; Stapleton, Donald S.; Argmann, Carmen; Schueler, Kathy L.; Edwards, Steve; Steinberg, H. Adam; Chaibub Neto, Elias; Kleinhanz, Robert; Turner, Scott; Hellerstein, Marc K.; Schadt, Eric E.; Yandell, Brian S.; Kendziorski, Christina; Attie, Alan D.			A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility	GENOME RESEARCH			English	Article							PANCREATIC BETA-CELL; GENOME-WIDE ASSOCIATION; GROWTH-FACTOR-II; INSULIN-RESISTANCE; IN-VIVO; GLUCAGON-SECRETION; PROLIFERATION RATES; GLUCOSE-INHIBITION; TRANSGENIC MICE; ALPHA-CELLS	Insulin resistance is necessary but not sufficient for the development of type 2 diabetes. Diabetes results when pancreatic beta-cells fail to compensate for insulin resistance by increasing insulin production through an expansion of beta-cell mass or increased insulin secretion. Communication between insulin target tissues and beta-cells may initiate this compensatory response. Correlated changes in gene expression between tissues can provide evidence for such intercellular communication. We profiled gene expression in six tissues of mice from an obesity-induced diabetes-resistant and a diabetes-susceptible strain before and after the onset of diabetes. We studied the correlation structure of mRNA abundance and identified 105 co-expression gene modules. We provide an interactive gene network model showing the correlation structure between the expression modules within and among the six tissues. This resource also provides a searchable database of gene expression profiles for all genes in six tissues in lean and obese diabetes-resistant and diabetes-susceptible mice, at 4 and 10 wk of age. A cell cycle regulatory module in islets predicts diabetes susceptibility. The module predicts islet replication; we found a strong correlation between (H2O)-H-2 incorporation into islet DNA in vivo and the expression pattern of the cell cycle module. This pattern is highly correlated with that of several individual genes in insulin target tissues, including Igf2, which has been shown to promote beta-cell proliferation, suggesting that these genes may provide a link between insulin resistance and beta-cell proliferation.	[Keller, Mark P.; Davis, Dawn Belt; Rabaglia, Mary E.; Oler, Angie T.; Stapleton, Donald S.; Schueler, Kathy L.; Steinberg, H. Adam; Attie, Alan D.] Univ Wisconsin, Dept Chem, Madison, WI 53076 USA; [Choi, YounJeong; Wang, Ping; Yandell, Brian S.; Kendziorski, Christina] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53076 USA; [Choi, YounJeong; Wang, Ping; Chaibub Neto, Elias; Yandell, Brian S.] Univ Wisconsin, Dept Stat, Madison, WI 53076 USA; [Argmann, Carmen; Edwards, Steve; Kleinhanz, Robert; Schadt, Eric E.] Rosetta Inpharmat, Seattle, WA 98109 USA; [Turner, Scott] KineMed, Emeryville, CA 94608 USA; [Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Hellerstein, Marc K.] Univ Calif San Francisco, Dept Med, Div Endocrinol & Metab, San Francisco, CA 94110 USA; [Yandell, Brian S.] Univ Wisconsin, Dept Hort, Madison, WI 53076 USA		Attie, AD (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53076 USA.	adattie@wisc.edu	Davis, Dawn/B-1624-2013; Edwards, Stephen W/G-4482-2011; Longo, Kenneth A/A-5631-2010	Davis, Dawn/0000-0002-0239-4715; Edwards, Stephen/0000-0002-7985-111X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [76274, 58037, 66369, 69430] Funding Source: Medline		Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Burcelin R, 1998, J BIOL CHEM, V273, P8088, DOI 10.1074/jbc.273.14.8088; Busch R, 2004, J IMMUNOL METHODS, V286, P97, DOI 10.1016/j.jim.2003.12.012; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Haluzik M, 2006, CURR OPIN INVEST DR, V7, P306; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Kendziorski CM, 2006, BIOMETRICS, V62, P19, DOI 10.1111/j.1541-0420.2005.00437.x; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Liang Y, 2004, DIABETES, V53, pA134, DOI 10.2337/diabetes.53.2.410; Milo-Landesman Dalit, 2002, Int J Exp Diabetes Res, V3, P69, DOI 10.1080/15604280212526; Mori T, 2002, NEOPLASIA, V4, P268, DOI 10.1038/sj.neo.7900235; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Newton MA, 2006, BAYESIAN INFERENCE FOR GENE EXPRESSION AND PROTEOMICS, P40; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Petrik J, 1999, ENDOCRINOLOGY, V140, P2353, DOI 10.1210/en.140.5.2353; Pierucci D, 2001, DIABETOLOGIA, V44, P1281, DOI 10.1007/s001250100650; R Development Core Team, 2005, R LANG ENV STAT COMP; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shankaran M, 2007, J NEUROSCI RES, V85, P2374, DOI 10.1002/jnr.21389; Shankaran M, 2006, J PHARMACOL EXP THER, V319, P1172, DOI 10.1124/jpet.106.110510; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Vasavada RC, 2007, DIABETES, V56, P57, DOI 10.2337/db06-0517; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Wierup N, 2006, DIABETES, V55, P305, DOI 10.2337/diabetes.55.02.06.db04-1383; Wierup N, 2005, REGUL PEPTIDES, V129, P203, DOI 10.1016/j.regpep.2005.02.016; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan M, 2006, BIOMETRICS, V62, P1089, DOI 10.1111/j.1541-0420.2006.00611.x; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	48	256	261	0	19	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2008	18	5					706	716		10.1101/gr.074914.107			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	295WK	WOS:000255504600003	18347327	Green Published, Bronze			2022-01-24	
J	Peckham, HE; Thurman, RE; Fu, YT; Stamatoyannopoulos, JA; Noble, WS; Struhl, K; Weng, ZP				Peckham, Heather E.; Thurman, Robert E.; Fu, Yutao; Stamatoyannopoulos, John A.; Noble, William Stafford; Struhl, Kevin; Weng, Zhiping			Nucleosome positioning signals in genomic DNA	GENOME RESEARCH			English	Article							IN-VIVO; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL MAPS; SEQUENCE MOTIFS; RNA-POLYMERASE; PHO5 PROMOTER; FREE-ENERGY; HISTONE; YEAST; CORE	Although histones can form nucleosomes on virtually any genomic sequence, DNA sequences show considerable variability in their binding affinity. We have used DNA sequences of Saccharomyces cerevisiae whose nucleosome binding affinities have been experimentally determined (Yuan et al. 2005) to train a support vector machine to identify the nucleosome formation potential of any given sequence of DNA. The DNA sequences whose nucleosome formation potential are most accurately predicted are those that contain strong nucleosome forming or inhibiting signals and are found within nucleosome length stretches of genomic DNA with continuous nucleosome formation or inhibition signals. We have accurately predicted the experimentally determined nucleosome positions across a well-characterized promoter region of S. cerevisiae and identified strong periodicity within 199 center-aligned mononucleosomes studied recently (Segal et al. 2006) despite there being no periodicity information used to train the support vector machine. Our analysis suggests that only a subset of nucleosomes are likely to be positioned by intrinsic sequence signals. This observation is consistent with the available experimental data and is inconsistent with the proposal of a nucleosome positioning code. Finally, we show that intrinsic nucleosome positioning signals are both more inhibitory and more variable in promoter regions than in open reading frames in S. cerevisiae.	Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA		Weng, ZP (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	zhiping@bu.edu			NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01 HG003161, R01 HG003110, R01 HG03110] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM071923] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG003161, R01HG003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM071923] Funding Source: NIH RePORTER		Anselmi C, 1999, J MOL BIOL, V286, P1293, DOI 10.1006/jmbi.1998.2575; Baldi P, 1996, J MOL BIOL, V263, P503, DOI 10.1006/jmbi.1996.0592; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Cao H, 1998, J MOL BIOL, V281, P253, DOI 10.1006/jmbi.1998.1925; CHEN W, 1987, CELL, V50, P1047, DOI 10.1016/0092-8674(87)90171-1; Cohanim AB, 2005, J BIOMOL STRUCT DYN, V22, P687, DOI 10.1080/07391102.2005.10507035; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; DICKERSON RE, 1989, J BIOMOL STRUCT DYN, V6, P627, DOI 10.1080/07391102.1989.10507726; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; Gencheva M, 2006, J MOL BIOL, V361, P216, DOI 10.1016/j.jmb.2006.06.039; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kiyama R, 2002, FEBS LETT, V523, P7, DOI 10.1016/S0014-5793(02)02937-X; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Levitsky VG, 2001, BIOINFORMATICS, V17, P998, DOI 10.1093/bioinformatics/17.11.998; Levitsky VG, 1999, BIOINFORMATICS, V15, P582, DOI 10.1093/bioinformatics/15.7.582; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; LU Q, 1994, J CELL BIOCHEM, V55, P83, DOI 10.1002/jcb.240550110; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Pavlidis P, 2004, BIOINFORMATICS, V20, P586, DOI 10.1093/bioinformatics/btg461; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; RUSSELL DW, 1983, NATURE, V304, P652, DOI 10.1038/304652a0; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; SIVOLOB AV, 1995, J MOL BIOL, V247, P918, DOI 10.1006/jmbi.1994.0190; Stein A, 1999, NUCLEIC ACIDS RES, V27, P848, DOI 10.1093/nar/27.3.848; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Thastrom A, 2004, BIOCHEMISTRY-US, V43, P736, DOI 10.1021/bi0302043; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; THOMA F, 1992, BIOCHIM BIOPHYS ACTA, V1130, P1, DOI 10.1016/0167-4781(92)90455-9; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; Trifonov EN, 1997, MOL BIOL+, V31, P647; Vapnik VN., 1998, STAT LEARNING THEORY; Walter P., 2002, MOL BIOL CELL, V91, P401; Widlund HR, 1997, J MOL BIOL, V267, P807, DOI 10.1006/jmbi.1997.0916; Widlund HR, 1999, J BIOL CHEM, V274, P31847, DOI 10.1074/jbc.274.45.31847; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; WOLFFE AP, 1994, TRENDS BIOCHEM SCI, V19, P240, DOI 10.1016/0968-0004(94)90148-1; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	54	256	265	0	17	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2007	17	8					1170	1177		10.1101/gr.6101007			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	196OL	WOS:000248491800005	17620451	Green Published, Bronze			2022-01-24	
J	Scherer, SW; Lee, C; Birney, E; Altshuler, DM; Eichler, EE; Carter, NP; Hurles, ME; Feuk, L				Scherer, Stephen W.; Lee, Charles; Birney, Ewan; Altshuler, David M.; Eichler, Evan E.; Carter, Nigel P.; Hurles, Matthew E.; Feuk, Lars			Challenges and standards in integrating surveys of structural variation	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN GENETIC-VARIATION; SEGMENTAL DUPLICATIONS; HOMOLOGOUS RECOMBINATION; OLIGONUCLEOTIDE ARRAYS; LINKAGE DISEQUILIBRIUM; EXPRESSION PROFILES; NORMAL INDIVIDUALS; WIDE DETECTION	There has been an explosion of data describing newly recognized structural variants in the human genome. In the flurry of reporting, there has been no standard approach to collecting the data, assessing its quality or describing identified features. This risks becoming a rampant problem, in particular with respect to surveys of copy number variation and their application to disease studies. Here, we consider the challenges in characterizing and documenting genomic structural variants. From this, we derive recommendations for standards to be adopted, with the aim of ensuring the accurate presentation of this form of genetic variation to facilitate ongoing research.	[Scherer, Stephen W.; Feuk, Lars] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Scherer, Stephen W.; Feuk, Lars] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L7, Canada; [Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1SA, England; [Carter, Nigel P.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Altshuler, David M.] Harvard Univ, Board Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Altshuler, David M.] Harvard Univ, MIT, Cambridge, MA 02142 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA		Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, 14th Floor,Toronoto Med Discovery Tower,MaRS Disc, Toronto, ON M5G 1L7, Canada.	steve@genet.sickkids.on.ca	Altshuler, David M/A-4476-2009; Scherer, Stephen W/B-3785-2013	Altshuler, David M/0000-0002-7250-4107; Scherer, Stephen W/0000-0002-8326-1999; Birney, Ewan/0000-0001-8314-8497	Wellcome TrustWellcome TrustEuropean Commission [077008, 077014] Funding Source: Medline		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Budarf ML, 1997, HUM MOL GENET, V6, P1657, DOI 10.1093/hmg/6.10.1657; Burgoon LD, 2006, NAT BIOTECHNOL, V24, P1369, DOI 10.1038/nbt1106-1369; Carson Andrew R., 2006, Human Genomics, V2, P403; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Heim S, 1996, PEDIATR HEMAT ONCOL, V13, pR3, DOI 10.3109/08880019609030800; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; *ISCN, 1985, BIRTH DEFECTS ORIG A, V21, P1; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; RISIN S, 1992, CANCER GENET CYTOGEN, V60, P164, DOI 10.1016/0165-4608(92)90010-6; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	73	256	270	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S7	S15		10.1038/ng2093			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	WOS:000253974400003	17597783	Green Accepted			2022-01-24	
J	Stinear, TP; Seemann, T; Pidot, S; Frigui, W; Reysset, G; Garnier, T; Meurice, G; Simon, D; Bouchier, C; Ma, L; Tichit, M; Porter, JL; Ryan, J; Johnson, PDR; Davies, JK; Jenkin, GA; Small, PLC; Jones, LM; Tekaia, F; Laval, F; Daffe, M; Parkhill, J; Cole, ST				Stinear, Timothy P.; Seemann, Torsten; Pidot, Sacha; Frigui, Wafa; Reysset, Gilles; Garnier, Thierry; Meurice, Guillaume; Simon, David; Bouchier, Christiane; Ma, Laurence; Tichit, Magali; Porter, Jessica L.; Ryan, Janine; Johnson, Paul D. R.; Davies, John K.; Jenkin, Grant A.; Small, Pamela L. C.; Jones, Louis M.; Tekaia, Fredj; Laval, Francoise; Daffe, Mamadou; Parkhill, Julian; Cole, Stewart T.			Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer	GENOME RESEARCH			English	Article							MACROLIDE TOXIN; IDENTIFICATION; TUBERCULOSIS; BIOSYNTHESIS; MARINUM; GROWTH; SEQUENCES; PROTEINS; ANTIGENS; STRAINS	Mycobacterium ukerans is found in aquatic ecosystems and causes Buruli ulcer in humans, a neglected but devastating necrotic disease of subcutaneous tissue that is rampant throughout West and Central Africa. Here, we report the complete 5.8-Mb genome sequence of M. ulcerans and show that it comprises two circular replicons, a chromosome of 5632 kb and a virulence plasmid of 174 kb. The plasmid is required for production of the polyketide toxin mycolactone, which provokes necrosis. Comparisons with the recently completed 6.6-Mb genome of Mycobacterium marinum revealed > 98% nucleotide sequence identity and genome-wide synteny. However, as well as the plasmid, M. ulcerans has accumulated 213 copies of the insertion sequence IS2404, 91 copies of IS2606, 771 pseudogenes, two bacteriophages, and multiple DNA deletions and rearrangements. These data indicate that M. ulcerans has recently evolved via lateral gene transfer and reductive evolution from the generalist, more rapid-growing environmental species M. marinum to become a niche-adapted specialist. Predictions based on genome inspection for the production of modified mycobacterial virulence factors, such as the highly abundant phthiodiolone lipids, were confirmed by structural analyses. Similarly, 11 protein-coding sequences identified as M. ulcerans-specific by comparative genomics were verified as such by PCR screening a diverse collection of 33 strains of M. ulcerans and M. marinum. This work offers significant insight into the biology and evolution of mycobacterial pathogens and is an important component of international efforts to counter Buruli ulcer.	Inst Pasteur, Unite Geneet Mol Bacterienne, F-75725 Paris 15, France; Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic 3800, Australia; Inst Pasteur, Genopole, F-75725 Paris 15, France; Austin Hosp, Dept Infect Dis, Heidelberg, Vic 3084, Australia; Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; Inst Pasteur, Grp Logicels & Banques Donnees, F-75725 Paris 15, France; Inst Pasteur, Unite Genet Mol Levures, F-75725 Paris 15, France; CNRS, IPBS, Dept Mol Mech Mycobacterial Infect, F-31077 Toulouse 14, France; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England		Cole, ST (corresponding author), Inst Pasteur, Unite Geneet Mol Bacterienne, F-75725 Paris 15, France.	stcole@pasteur.fr	Pidot, Sacha/Y-3421-2018; LAUZERAL-VIZCAINO, Francoise/W-8898-2019; Seemann, Torsten/B-2318-2010; Parkhill, Julian/G-4703-2011; Tekaia, Fredj/H-4553-2012	Pidot, Sacha/0000-0003-1202-6614; LAUZERAL-VIZCAINO, Francoise/0000-0002-9741-3252; Seemann, Torsten/0000-0001-6046-610X; Parkhill, Julian/0000-0002-7069-5958; Jones, Louis/0000-0002-3080-9770; Stinear, Timothy/0000-0003-0150-123X; Tekaia, Fredj/0000-0003-1934-2396; FRIGUI, Wafa/0000-0001-5172-7961			ALSOP DG, 1972, AUST NZ J SURG, V41, P317, DOI 10.1111/j.1445-2197.1969.tb06535.x; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; DAFFE M, 1991, RES MICROBIOL, V142, P397, DOI 10.1016/0923-2508(91)90109-N; DAFFE M, 1984, ANN INST PASTEUR MIC, VA135, P191, DOI 10.1016/S0769-2609(84)80002-2; DAFFE M, 1992, J GEN MICROBIOL, V138, P131, DOI 10.1099/00221287-138-1-131; Eisen JA, 2000, GENOME BIOL, V1; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.2005; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.0020108; Kana BD, 2001, J BACTERIOL, V183, P7076, DOI 10.1128/JB.183.24.7076-7086.2001; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; Marsollier L, 2005, CELL MICROBIOL, V7, P935, DOI 10.1111/j.1462-5822.2005.00521.x; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P6296, DOI 10.1128/AEM.70.10.6296-6298.2004; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Matsumoto M, 2001, INT IMMUNOPHARMACOL, V1, P1559, DOI 10.1016/S1567-5769(01)00071-6; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Onwueme KC, 2005, J BACTERIOL, V187, P4760, DOI 10.1128/JB.187.14.4760-4766.2005; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Perez E, 2004, J BIOL CHEM, V279, P42574, DOI 10.1074/jbc.M406246200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Ramakrishnan L, 1997, J BACTERIOL, V179, P5862, DOI 10.1128/jb.179.18.5862-5868.1997; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Rohdich F, 2004, BIOORG CHEM, V32, P292, DOI 10.1016/j.bioorg.2004.05.012; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Stinear T, 1999, J CLIN MICROBIOL, V37, P1018, DOI 10.1128/JCM.37.4.1018-1023.1999; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Stinear TP, 2005, MICROBIOL-SGM, V151, P683, DOI 10.1099/mic.0.27674-0; Stinear TP, 2005, J BACTERIOL, V187, P1668, DOI 10.1128/JB.187.5.1668-1676.2005; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102	37	256	610	0	14	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2007	17	2					192	200		10.1101/gr.5942807			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	132KR	WOS:000243942200008	17210928	Green Published, Bronze			2022-01-24	
J	Kaiser, S; Park, YK; Franklin, JL; Halberg, RB; Yu, M; Jessen, WJ; Freudenberg, J; Chen, XD; Haigis, K; Jegga, AG; Kong, S; Sakthivel, B; Xu, H; Reichling, T; Azhar, M; Boivin, GP; Roberts, RB; Bissahoyo, AC; Gonzales, F; Bloom, GC; Eschrich, S; Carter, SL; Aronow, JE; Kleimeyer, J; Kleimeyer, M; Ramaswamy, V; Settle, SH; Boone, B; Levy, S; Graff, JM; Doetschman, T; Groden, J; Dove, WF; Threadgill, DW; Yeatman, TJ; Coffey, RJ; Aronow, BJ				Kaiser, Sergio; Park, Young-Kyu; Franklin, Jeffrey L.; Halberg, Richard B.; Yu, Ming; Jessen, Walter J.; Freudenberg, Johannes; Chen, Xiaodi; Haigis, Kevin; Jegga, Anil G.; Kong, Sue; Sakthivel, Bhuvaneswari; Xu, Huan; Reichling, Timothy; Azhar, Mohammad; Boivin, Gregory P.; Roberts, Reade B.; Bissahoyo, Anika C.; Gonzales, Fausto; Bloom, Greg C.; Eschrich, Steven; Carter, Scott L.; Aronow, Jeremy E.; Kleimeyer, John; Kleimeyer, Michael; Ramaswamy, Vivek; Settle, Stephen H.; Boone, Braden; Levy, Shawn; Graff, Jonathan M.; Doetschman, Thomas; Groden, Joanna; Dove, William F.; Threadgill, David W.; Yeatman, Timothy J.; Coffey, Robert J., Jr.; Aronow, Bruce J.			Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer	GENOME BIOLOGY			English	Article							RECEPTOR-TYPE-II; COLORECTAL-CANCER; GENE-EXPRESSION; SMALL-INTESTINE; C-MYC; STEM-CELLS; MICE; APC; SMAD3; TUMORIGENESIS	Background: The expression of carcino-embryonic antigen by colorectal cancer is an example of oncogenic activation of embryonic gene expression. Hypothesizing that oncogenesis-recapitulating-ontogenesis may represent a broad programmatic commitment, we compared gene expression patterns of human colorectal cancers ( CRCs) and mouse colon tumor models to those of mouse colon development embryonic days 13.5- 18.5. Results: We report here that 39 colon tumors from four independent mouse models and 100 human CRCs encompassing all clinical stages shared a striking recapitulation of embryonic colon gene expression. Compared to normal adult colon, all mouse and human tumors over-expressed a large cluster of genes highly enriched for functional association to the control of cell cycle progression, proliferation, and migration, including those encoding MYC, AKT2, PLK1 and SPARC. Mouse tumors positive for nuclear beta-catenin shifted the shared embryonic pattern to that of early development. Human and mouse tumors differed from normal embryonic colon by their loss of expression modules enriched for tumor suppressors ( EDNRB, HSPE, KIT and LSPI). Human CRC adenocarcinomas lost an additional suppressor module ( IGFBP4, MAP4KI, PDGFRA, STABI and WNT4). Many human tumor samples also gained expression of a coordinately regulated module associated with advanced malignancy ( ABCCI, FOXO3A, LIF, PIK3RI, PRNP, TNC, TIMP3 and VEGF). Conclusion: Cross-species, developmental, and multi-model gene expression patterning comparisons provide an integrated and versatile framework for definition of transcriptional programs associated with oncogenesis. This approach also provides a general method for identifying pattern-specific biomarkers and therapeutic targets. This delineation and categorization of developmental and non-developmental activator and suppressor gene modules can thus facilitate the formulation of sophisticated hypotheses to evaluate potential synergistic effects of targeting within- and between-modules for next-generation combinatorial therapeutics and improved mouse models.	Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Vanderbilt Univ, Nashville, TN 37232 USA; Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA; Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA; Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Ohio State Univ, Coll Med, Div Human Canc Genet, Columbus, OH 43210 USA; Univ Arizona, Inst Collaborat Biores, Tucson, AZ 85721 USA; Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Harvard Univ, Sch Med,CHIP HST, Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA 02215 USA; Univ Texas, SW Med Ctr Dallas, Dallas, TX 75390 USA		Aronow, BJ (corresponding author), Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA.	bruce.aronow@cchmc.org	Threadgill, David W/N-4425-2013; Eschrich, Steven/K-6848-2013; Jegga, Anil/H-6140-2011; Aronow, Bruce J/F-8438-2012	Threadgill, David W/0000-0003-3538-1635; Eschrich, Steven/0000-0002-9833-2788; Jegga, Anil/0000-0002-4881-7752; Freudenberg, Johannes/0000-0002-5327-4414; Jessen, Walter/0000-0003-3840-4337; Roberts, Reade/0000-0003-2551-3761; Levy, Shawn/0000-0002-1369-5740	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA046413, R01CA079869, U01CA084227, P50CA106991, R37CA063677, R01CA063507, P50CA095103, U01CA084239, U01CA105417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R24DK064403] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01 CA084239, R37 CA63677, U01 CA98013, P50 CA106991, U01 CA84239, U01 CA105417, R01 CA079869, R01 CA063507, R37 CA063677, U01 CA84227, P50 CA095103, R01 CA046413, P50 CA95103] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL07382-28, T32 HL007382] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R24 DK064403, R24 DK 064403] Funding Source: Medline		Abdel-Rahman WM, 2005, ONCOGENE, V24, P1542, DOI 10.1038/sj.onc.1208387; *AFF, TECHN TES AFF; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bissahoyo A, 2005, TOXICOL SCI, V88, P340, DOI 10.1093/toxsci/kfi313; Boivin GP, 2004, COMPARATIVE MED, V54, P15; BOLVIN GP, 2003, GASTROENTEROLOGY, V124, P762; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Byun T, 2005, J CLIN PATHOL, V58, P515, DOI 10.1136/jcp.2004.018598; *CHMC BIO, GENOM TRAF COMP GEN; *CHMC BIO, GATACA GEN ASS AN CL; Cragg RA, 2005, GUT, V54, P469, DOI 10.1136/gut.2004.041962; Engle SJ, 1999, CANCER RES, V59, P3379; Engle SJ, 2002, CANCER RES, V62, P6362; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Giacomini CP, 2005, CANCER RES, V65, P9200, DOI 10.1158/0008-5472.CAN-04-4163; Grady WM, 1999, CANCER RES, V59, P320; Haigis KM, 2004, P NATL ACAD SCI USA, V101, P9769, DOI 10.1073/pnas.0403338101; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Helm J, 2005, CLIN CANCER RES, V11, P2478, DOI 10.1158/1078-0432.CCR-04-1280; Hu M, 2005, CANCER RES, V65, P8715, DOI 10.1158/0008-5472.CAN-05-0700; *ING, IPA ING PATHW AN; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD116, DOI 10.1093/nar/gkl1011; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kaihara T, 2003, J EXP CLIN CANC RES, V22, P117; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Khatri P, 2007, NUCLEIC ACIDS RES, V35, pW206, DOI 10.1093/nar/gkm327; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kim DH, 2003, J BIOCHEM MOL BIOL, V36, P110; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kruhoffer M, 2005, BRIT J CANCER, V92, P2240, DOI 10.1038/sj.bjc.6602621; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Kwong KY, 2005, GENOMICS, V86, P142, DOI 10.1016/j.ygeno.2005.03.012; Lamhonwah AM, 2005, BIOCHEM BIOPH RES CO, V337, P1165, DOI 10.1016/j.bbrc.2005.09.170; LANGSRUD O, ONLINE FISHERS EXTRA; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lepourcelet M, 2005, DEVELOPMENT, V132, P415, DOI 10.1242/dev.01579; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; MGI TJL, MOUSE GENOME INFORM; Mithani SK, 2004, J SURG RES, V117, P296, DOI 10.1016/S0022-4804(03)00335-4; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; *NAT LIB MED, HOM DAT; NUSSE R, 2007, WNT HOMEPAGE WNT TAR; Oving IM, 2002, EUR J CLIN INVEST, V32, P448, DOI 10.1046/j.1365-2362.2002.01004.x; Park YK, 2005, GENESIS, V41, P1, DOI 10.1002/gene.20088; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Plebani M, 1995, INT J BIOL MARKER, V10, P189, DOI 10.1177/172460089501000401; Reichling T, 2005, CANCER RES, V65, P166; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Taketo MM, 2000, CYTOKINE GROWTH F R, V11, P147, DOI 10.1016/S1359-6101(99)00038-6; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; *VUMC, 2006, PROT; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zbar AP, 2004, SURG ONCOL, V13, P45, DOI 10.1016/j.suronc.2004.09.010; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; STANF ONL UN RES GEN; STANMFORD ONLINE UNI	72	256	261	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2007	8	7							R131	10.1186/gb-2007-8-7-r131			26	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	209VP	WOS:000249416400011	17615082	gold, Green Published			2022-01-24	
J	Englbrecht, CC; Schoof, H; Bohm, S				Englbrecht, CC; Schoof, H; Bohm, S			Conservation, diversification and expansion of C2H2 zinc finger proteins in the Arabidopsis thaliana genome	BMC GENOMICS			English	Article							GENE ENCODES; TRANSCRIPTION FACTORS; SUPERMAN PROTEIN; TARGET-SEQUENCE; EXPRESSION; FAMILY; DNA; REPRESSION; EVOLUTION; DOMAIN	Background: The classical C2H2 zinc finger domain is involved in a wide range of functions and can bind to DNA, RNA and proteins. The comparison of zinc finger proteins in several eukaryotes has shown that there is a lot of lineage specific diversification and expansion. Although the number of characterized plant proteins that carry the classical C2H2 zinc finger motifs is growing, a systematic classification and analysis of a plant genome zinc finger gene set is lacking. Results: We found through in silico analysis 176 zinc finger proteins in Arabidopsis thaliana that hence constitute the most abundant family of putative transcriptional regulators in this plant. Only a minority of 33 A. thaliana zinc finger proteins are conserved in other eukaryotes. In contrast, the majority of these proteins ( 81%) are plant specific. They are derived from extensive duplication events and form expanded families. We assigned the proteins to different subgroups and families and focused specifically on the two largest and evolutionarily youngest families (A1 and C1) that are suggested to be primarily involved in transcriptional regulation. The newly defined family A1 ( 24 members) comprises proteins with tandemly arranged zinc finger domains. Family C1 ( 64 members), earlier described as the EPF-family in Petunia, comprises proteins with one isolated or two to five dispersed fingers and a mostly invariant QALGGH motif in the zinc finger helices. Based on the amino acid pattern in these helices we could describe five different signature sequences prevalent in C1 zinc finger domains. We also found a number of non-finger domains that are conserved in these families. Conclusions: Our analysis of the few evolutionarily conserved zinc finger proteins of A. thaliana suggests that most of them could be involved in ancient biological processes like RNA metabolism and chromatin-remodeling. In contrast, the majority of the unique A. thaliana zinc finger proteins are known or suggested to be involved in transcriptional regulation. They exhibit remarkable differences in the features of their zinc finger sequences and zinc finger arrangements compared to animal zinc finger proteins. The different zinc finger helix signatures we found in family C1 may have important implications for the sequence specific DNA recognition and allow inferences about the evolution of the members in this family.	Max Delbruck Ctr Mol Med, Dept Genet Bioinformat & Struct Biol, D-13125 Berlin, Germany; GSF Forschungszentrum Umwelt & Gesundheit, Inst Bioinformat, D-85764 Neuherberg, Germany; Tech Univ Munich, Chair Genome Oriented Bioinformat, Ctr Life & Food Sci, D-85354 Freising Weihenstephan, Germany		Bohm, S (corresponding author), Max Delbruck Ctr Mol Med, Dept Genet Bioinformat & Struct Biol, Robert Rossle Str 10, D-13125 Berlin, Germany.	c.englbrecht@gsf.de; h.schoof@gsf.de; boehm@mdc-berlin.de	Schoof, Heiko/Y-7073-2018	Schoof, Heiko/0000-0002-1527-3752			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Bailey TL, 1994, P 2 INT C INT SYST M; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; *BIOONE, AR BOOK TRANSCR REG; Birve A, 2001, DEVELOPMENT, V128, P3371; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; Chung HR, 2002, EMBO REP, V3, P1158, DOI 10.1093/embo-reports/kvf243; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Colasanti J, 2000, TRENDS BIOCHEM SCI, V25, P236, DOI 10.1016/S0968-0004(00)01542-5; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Dathan N, 2002, NUCLEIC ACIDS RES, V30, P4945, DOI 10.1093/nar/gkf613; Dinkins RD, 2003, PLANT SCI, V165, P33, DOI 10.1016/S0168-9452(03)00123-7; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; FELSENSTEIN J, 1993, PHYLIP VERS 3 5C; Fernandez-Martinez J, 2003, J MOL BIOL, V334, P667, DOI 10.1016/j.jmb.2003.09.072; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Isernia C, 2003, CHEMBIOCHEM, V4, P171, DOI 10.1002/cbic.200390028; Kubo K, 1998, NUCLEIC ACIDS RES, V26, P608, DOI 10.1093/nar/26.2.608; KUHN C, 1995, MOL GEN GENET, V247, P759, DOI 10.1007/BF00290408; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; Mathieu O, 2003, NUCLEIC ACIDS RES, V31, P2424, DOI 10.1093/nar/gkg335; Meissner R, 1997, PLANT MOL BIOL, V33, P615, DOI 10.1023/A:1005746803089; Ohno CK, 2004, DEVELOPMENT, V131, P1111, DOI 10.1242/dev.00991; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Reyes JC, 2002, PLANT PHYSIOL, V130, P1090, DOI 10.1104/pp.006791; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Sakai H, 2000, PLANT CELL, V12, P1607, DOI 10.1105/tpc.12.9.1607; SAKAI H, 1995, NATURE, V378, P199, DOI 10.1038/378199a0; Sakamoto H, 2000, GENE, V248, P23, DOI 10.1016/S0378-1119(00)00133-5; TAGUE BW, 1995, PLANT MOL BIOL, V28, P267, DOI 10.1007/BF00020246; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Takatsuji H, 1996, BIOCHEM BIOPH RES CO, V224, P219, DOI 10.1006/bbrc.1996.1010; Takatsuji H, 1996, J BIOL CHEM, V271, P23368, DOI 10.1074/jbc.271.38.23368; Takeda S, 2004, DEVELOPMENT, V131, P425, DOI 10.1242/dev.00938; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wu KQ, 2003, PLANT J, V34, P241, DOI 10.1046/j.1365-313X.2003.01714.x; Xu T, 2001, P NATL ACAD SCI USA, V98, P2295, DOI 10.1073/pnas.041610098; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Yoshioka K, 2001, J BIOL CHEM, V276, P35802, DOI 10.1074/jbc.M104079200	49	256	353	9	57	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JUL 5	2004	5								39	10.1186/1471-2164-5-39			17	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	839ZU	WOS:000222827600001	15236668	Green Published, Green Accepted, gold			2022-01-24	
J	Liu, G; Parant, JM; Lang, G; Chau, P; Chavez-Reyes, A; El-Naggar, AK; Multani, A; Chang, S; Lozano, G				Liu, G; Parant, JM; Lang, G; Chau, P; Chavez-Reyes, A; El-Naggar, AK; Multani, A; Chang, S; Lozano, G			Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice	NATURE GENETICS			English	Article							P53-DEPENDENT APOPTOSIS; GENETIC INSTABILITY; GENOMIC INSTABILITY; V(D)J RECOMBINATION; P53-DEFICIENT MICE; IN-VIVO; P53; ACTIVATION; GROWTH; RADIATION	The p53 protein integrates multiple upstream signals and functions as a tumor suppressor by activating distinct downstream genes(1-3). At the cellular level, p53 induces apoptosis, cell cycle arrest and senescence. A rare mutant form of p53 with the amino acid substitution R175P, found in human tumors, is completely defective in initiating apoptosis but still induces cell cycle arrest(4,5). To decipher the functional importance of these pathways in spontaneous tumorigenesis, we used homologous recombination to generate mice with mutant p53-R172P ( the mouse equivalent of R175P in humans). Mice inheriting two copies of this mutation (Trp53(515C/515C)) escape the early onset of thymic lymphomas that characterize Trp53-null mice. At 7 months of age, 90% of Trp53-null mice had died, but 85% of Trp53(515C/515C) mice were alive and tumor-free, indicating that p53-dependent apoptosis was not required for suppression of early onset of spontaneous tumors. The lymphomas and sarcomas that eventually developed in Trp53(515C/515C) mice retained a diploid chromosome number, in sharp contrast to aneuploidy observed in tumors and cells from Trp53 null mice. The ability of mutant p53-R172P to induce a partial cell cycle arrest and retain chromosome stability are crucial for suppression of early onset tumorigenesis.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA		Liu, G (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.		Chavez-Reyes, Arturo/ABG-1231-2020	Chavez-Reyes, Arturo/0000-0002-6655-815X; Chau, Gilda/0000-0002-7907-3290			CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donehower LA, 1997, CANCER SURV, V29, P329; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; HARVEY M, 1993, ONCOGENE, V8, P2457; Hundley JE, 1997, MOL CELL BIOL, V17, P723, DOI 10.1128/MCB.17.2.723; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lee Y, 2001, J NEUROSCI, V21, P6687, DOI 10.1523/JNEUROSCI.21-17-06687.2001; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Nacht M, 1998, CELL GROWTH DIFFER, V9, P131; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tlsty TD, 1996, CANCER SURV, V28, P217; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	30	256	259	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					63	68		10.1038/ng1282			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	WOS:000187666800015	14702042	Bronze			2022-01-24	
J	Edwards, SM; Kote-Jarai, Z; Meitz, J; Hamoudi, R; Hope, Q; Osin, P; Jackson, R; Southgate, C; Singh, R; Falconer, A; Dearnaley, DP; Ardern-Jones, A; Murkin, A; Dowe, A; Kelly, J; Williams, S; Oram, R; Stevens, M; Teare, DM; Ponder, BAJ; Gayther, SA; Easton, DF; Eeles, RA				Edwards, SM; Kote-Jarai, Z; Meitz, J; Hamoudi, R; Hope, Q; Osin, P; Jackson, R; Southgate, C; Singh, R; Falconer, A; Dearnaley, DP; Ardern-Jones, A; Murkin, A; Dowe, A; Kelly, J; Williams, S; Oram, R; Stevens, M; Teare, DM; Ponder, BAJ; Gayther, SA; Easton, DF; Eeles, RA		Canc Res UK British Prostate Grp U; British Assoc Urological Surg Sect	Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELIC LOSS; SUSCEPTIBILITY LOCUS; DISTINCT REGIONS; OVARIAN-CANCER; BREAST; FAMILIES; PREDISPOSITION; INDIVIDUALS; PREVALENCE; EXPRESSION	Studies of families with breast cancer have indicated that male carriers of BRCA2 mutations are at increased risk of prostate cancer, particularly at an early age. To evaluate the contribution of BRCA2 mutations to early-onset prostate cancer, we screened the complete coding sequence of BRCA2 for germline mutations, in 263 men with diagnoses of prostate cancer who were less than or equal to55 years of age. Protein-truncating mutations were found in six men (2.3%; 95% confidence interval 0.8%-5.0%), and all of these mutations were clustered outside the ovarian-cancer cluster region. The relative risk of developing prostate cancer by age 56 years from a deleterious germline BRCA2 mutation was 23-fold. Four of the patients with mutations did not have a family history of breast or ovarian cancer. Twenty-two variants of uncertain significance were also identified. These results confirm that BRCA2 is a high-risk prostate-cancer-susceptibility gene and have potential implications for the management of early-onset prostate cancer, in both patients and their relatives.	Inst Canc Res, Translat Canc Genet Team, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Inst Canc Res, Mol Genet Team, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Royal Marsden Natl Hlth Serv Trust Hosp, Sutton, Surrey, England; UCL, Dept Histopathol, London, England; Univ Cambridge, Addenbrookes Hosp, Strangeways Res Lab, Canc Res UK Genet Epidemiol Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Canc Res UK Human Canc Genet Res Grp, Cambridge CB2 2QQ, England		Eeles, RA (corresponding author), Inst Canc Res, Translat Canc Genet Team, Sect Canc Genet, Orchard House,15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	ros@icr.ac.uk	Dearnaley, David P/J-2318-2014; Meitz-Hopkins, Julia/M-3938-2016	Dearnaley, David P/0000-0002-3954-2806; Meitz-Hopkins, Julia/0000-0002-8127-6978; Hamoudi, Rifat/0000-0002-1402-0868; Oram, Richard/0000-0003-3581-8980; Eeles, Rosalind/0000-0002-3698-6241			Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; ARASON A, 1993, AM J HUM GENET, V52, P711; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Connor F, 1997, HUM MOL GENET, V6, P291, DOI 10.1093/hmg/6.2.291; Cooney KA, 1996, CANCER RES, V56, P1142; Edwards SM, 1998, INT J CANCER, V78, P1; Edwards SM, 1997, BRIT J CANCER, V76, P992, DOI 10.1038/bjc.1997.498; Edwards SM, 2001, HUM MUTAT, V17, P220, DOI 10.1002/humu.7; Eeles RA, 1999, PROSTATE CANCER P D, V2, P9, DOI 10.1038/sj.pcan.4500279; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gayther SA, 2000, CANCER RES, V60, P4513; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Healey CS, 2000, NAT GENET, V26, P362, DOI 10.1038/81691; Hubert A, 1999, AM J HUM GENET, V65, P921, DOI 10.1086/302525; Hyytinen ER, 1999, GENE CHROMOSOME CANC, V25, P108, DOI 10.1002/(SICI)1098-2264(199906)25:2<108::AID-GCC6>3.0.CO;2-Y; Johannesdottir G, 1996, CANCER RES, V56, P3663; Lehrer S, 1998, BRIT J CANCER, V78, P771, DOI 10.1038/bjc.1998.576; Melamed J, 1997, CLIN CANCER RES, V3, P1867; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Nastiuk KL, 1999, PROSTATE, V40, P172; PARKIN DM, 1992, IARC SCI PUBLICATION, V120; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Sigurdsson S, 1997, J MOL MED-JMM, V75, P758, DOI 10.1007/s001090050162; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Vezina A, 2000, BRIT J CANCER, V83, P463, DOI 10.1054/bjoc.2000.1249; Wagner TMU, 1999, HUM MOL GENET, V8, P413, DOI 10.1093/hmg/8.3.413; Watanabe M, 1998, ONCOLOGY-BASEL, V55, P569, DOI 10.1159/000011914; Wilkens EP, 1999, PROSTATE, V39, P280; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	36	256	259	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					1	12		10.1086/345310			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	WOS:000180186800001	12474142	Green Published, Bronze			2022-01-24	
J	van Bokhoven, H; Hamel, BCJ; Bamshad, M; Sangiorgi, E; Gurrieri, F; Duijf, PHG; Vanmolkot, KRJ; van Beusekom, E; van Beersum, SEC; Celli, J; Merkx, GFM; Tenconi, R; Fryns, JP; Verloes, A; Newbury-Ecob, RA; Raas-Rotschild, A; Majewski, F; Beemer, FA; Janecke, A; Chitayat, D; Crisponi, G; Kayserili, H; Yates, JRW; Neri, G; Brunner, HG				van Bokhoven, H; Hamel, BCJ; Bamshad, M; Sangiorgi, E; Gurrieri, F; Duijf, PHG; Vanmolkot, KRJ; van Beusekom, E; van Beersum, SEC; Celli, J; Merkx, GFM; Tenconi, R; Fryns, JP; Verloes, A; Newbury-Ecob, RA; Raas-Rotschild, A; Majewski, F; Beemer, FA; Janecke, A; Chitayat, D; Crisponi, G; Kayserili, H; Yates, JRW; Neri, G; Brunner, HG			p63 gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P53 HOMOLOG; MISSENSE MUTATIONS; CELL-LINES; CHROMOSOME; DOMINANT; HOTSPOTS; DEFECTS; CANCER; MAPS; 5-METHYLCYTOSINE	p63 mutations have been associated with EEC syndrome (ectrodactyly, ectodermal dysplasia, and cleft lip/palate), as well as with nonsyndromic split hand-split foot malformation (SHFM). We performed p63 mutation analysis in a sample of 43 individuals and families affected with EEC syndrome, in 35 individuals affected with SHFM, and in three families with the EEC-like condition limb-mammary syndrome (LMS), which is characterized by ectrodactyly, cleft palate, and mammary-gland abnormalities. The results differed for these three conditions. p63 gene mutations were detected in almost all (40/43) individuals affected with EEC syndrome. Apart from a frameshift mutation in exon 13, all other EEC mutations were missense, predominantly involving codons 204, 227, 279, 280, and 304. In contrast, p63 mutations were detected in only a small proportion (4/35) of patients with isolated SHFM. p63 mutations in SHFM included three novel mutations: a missense mutation (K193E), a nonsense mutation (Q634X), and a mutation in the 3' splice site for exon 5. The fourth SHFM mutation (R280H) in this series was also found in a patient with classical EEC syndrome, suggesting partial overlap between the EEC and SHFM mutational spectra. The original family with LMS (van Bokhoven et al. 1999) had no detectable p63 mutation, although it clearly localizes to the p63 locus in 3q27. In two other small kindreds affected with LMS, frameshift mutations were detected in exons 13 and 14, respectively. The combined data show that p63 is the major gene for EEC syndrome, and that it makes a modest contribution to SHFM. There appears to be a genotype-phenotype correlation, in that there is a specific pattern of missense mutations in EEC syndrome that are not generally found in SHFM or LMS.	Univ Nijmegen, Med Ctr, Dept Human Genet, Univ Med Ctr 417, NL-6500 HB Nijmegen, Netherlands; Univ Utah, Hlth Sci Ctr, Dept Pediat, Salt Lake City, UT USA; Shriners Hosp Children, Intermt Unit, Salt Lake City, UT USA; Univ Cattolica Sacro Cuore, Fac Med, Ist Genet Med, Rome, Italy; Univ Padua, Dept Pediat, Clin Genet Serv, Padua, Italy; Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Liege, Wallonia Ctr Human Genet, Liege, Belgium; Bristol Royal Hosp Sick Children, Clin Genet Serv, Bristol, Avon, England; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel; Univ Dusseldorf, Inst Human Genet, D-4000 Dusseldorf, Germany; Univ Utrecht, Med Ctr, Dept Med Genet, Utrecht, Netherlands; Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria; Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; Univ Cagliari, Dipartimento Chim Inorgan & Analit, Monserrato, Italy; Istanbul Fac Med, Dept Pediat, Div Med Genet, Istanbul, Turkey; Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England		van Bokhoven, H (corresponding author), Univ Nijmegen, Med Ctr, Dept Human Genet, Univ Med Ctr 417, POB 9101, NL-6500 HB Nijmegen, Netherlands.	H.vanbokhoven@ANTRG.AZN.NL	Kayserili, Hulya/AAA-5593-2021; Brunner, Han/C-9928-2013; Sangiorgi, Eugenio/AAP-9836-2020; /AAK-8500-2021; Gurrieri, Fiorella/K-3214-2016; van Beusekom, Ellen/AAF-2687-2019; Janecke, Andreas/AAA-5227-2019; van Beersum, Sylvia E.C./P-8653-2015; Duijf, Pascal H.G./E-7110-2012; Bokhoven, J.H.L.M. van van/H-8015-2014; van Bokhoven, Hans/D-8764-2012; VERLOES, Alain/E-7287-2014	Kayserili, Hulya/0000-0003-0376-499X; Sangiorgi, Eugenio/0000-0001-9079-9175; Gurrieri, Fiorella/0000-0002-6775-5972; van Beersum, Sylvia E.C./0000-0002-4552-2908; Duijf, Pascal H.G./0000-0001-8646-9843; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; VERLOES, Alain/0000-0003-4819-0264; Janecke, Andreas/0000-0001-7155-0315			BELLUS GA, 1995, AM J HUM GENET, V56, P368; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chitayat D, 1996, AM J MED GENET, V61, P45, DOI 10.1002/(SICI)1096-8628(19960102)61:1<45::AID-AJMG9>3.0.CO;2-W; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; CZEIZEL AE, 1993, J MED GENET, V30, P593, DOI 10.1136/jmg.30.7.593; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; EVANS JA, 1994, AM J MED GENET, V49, P52, DOI 10.1002/ajmg.1320490111; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Gorlin RJ, 1990, SYNDROMES HEAD NECK; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Hagiwara K, 1999, CANCER RES, V59, P4165; HAQUE MFU, 1993, HUM GENET, V91, P17; HAY RJ, 1976, BRIT J DERMATOL, V94, P277, DOI 10.1111/j.1365-2133.1976.tb04384.x; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; HOLLISTER DW, 1973, J PEDIATR-US, V83, P438, DOI 10.1016/S0022-3476(73)80268-9; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MURRAY JC, 1995, AM J HUM GENET, V57, P227, DOI 10.2134/agronj1965.00021962005700020028x; NUNES ME, 1995, HUM MOL GENET, V4, P2165, DOI 10.1093/hmg/4.11.2165; O'Quinn JR, 1998, AM J HUM GENET, V62, P130, DOI 10.1086/301687; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; PROPPING P, 1993, AM J MED GENET, V45, P642, DOI 10.1002/ajmg.1320450525; RaasRothschild A, 1996, J MED GENET, V33, P996, DOI 10.1136/jmg.33.12.996; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; RODINI ESO, 1990, AM J MED GENET, V37, P42, DOI 10.1002/ajmg.1320370112; Roelfsema NM, 1996, CLIN DYSMORPHOL, V5, P115, DOI 10.1097/00019605-199604000-00003; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHECHTMAN M, 1994, PHILOS PSYCHOL, V7, P3, DOI 10.1080/09515089408573107; Senoo M, 1998, BIOCHEM BIOPH RES CO, V248, P603, DOI 10.1006/bbrc.1998.9013; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; SUIJKERBUIJK RF, 1991, AM J HUM GENET, V48, P269; Tartaglia M, 1997, HUM GENET, V101, P47, DOI 10.1007/s004390050584; TORNALETTI S, 1994, SCIENCE, V263, P1436, DOI 10.1126/science.8128225; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; van Bokhoven H, 1999, AM J HUM GENET, V64, P538, DOI 10.1086/302246; WAYE JS, 1989, CHROMOSOMA, V97, P475, DOI 10.1007/BF00295032; WITTERS I, IN PRESS PRENATAL DI; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	46	256	265	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					481	492		10.1086/323123			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	WOS:000170271400002	11462173	Bronze, Green Published			2022-01-24	
J	Buxbaum, JD; Silverman, JM; Smith, CJ; Kilifarski, M; Reichert, J; Hollander, E; Lawlor, BA; Fitzgerald, M; Greenberg, DA; Davis, KL				Buxbaum, JD; Silverman, JM; Smith, CJ; Kilifarski, M; Reichert, J; Hollander, E; Lawlor, BA; Fitzgerald, M; Greenberg, DA; Davis, KL			Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-LOCUS APPROXIMATIONS; FAMILY-HISTORY; LINKAGE ANALYSES; GENOMIC SCREEN; TWIN; PHENOTYPE; ADEQUACY; DISORDER; POWER; 7Q	Although there is considerable evidence for a strong genetic component to idiopathic autism, several genomewide screens for susceptibility genes have been performed with limited concordance of linked loci, reflecting either numerous genes of weak effect and/or sample heterogeneity. Because decreasing sample heterogeneity would increase the power to identify genes, the effect on evidence for linkage of restricting a sample of autism-affected relative pairs to those with delayed onset (at age >36 mo) of phrase speech (PSD, for phrase speech delay) was studied. In the second stage of a two-stage genome screen for susceptibility loci involving 95 families with two or more individuals with autism or related disorders, a maximal multipoint heterogeneity LOD score (HLOD) of 1.96 and a maximal multipoint nonparametric linkage (NPL) score of 2.39 was seen on chromosome 2q. Restricting the analysis to the subset of families (n = 49) with two or more individuals having a narrow diagnosis of autism and PSD generated a maximal multipoint HLOD score of 2.99 and an NPL score of 3.32. The increased scores in the restricted sample, together with evidence for heterogeneity in the entire sample, indicate that the restricted sample comprises a population that is more genetically homogeneous, which could therefore increase the likelihood of positional cloning of susceptibility loci.	CUNY Mt Sinai Sch Med, Dept Psychiat, Lab Mol Neuropsychiat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Seaver Autism Res Ctr, New York, NY 10029 USA; St James Hosp, Dept Psychiat Elderly, Dublin 8, Ireland; Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland; St Patricks Hosp, Dublin, Ireland		Buxbaum, JD (corresponding author), CUNY Mt Sinai Sch Med, Dept Psychiat, Lab Mol Neuropsychiat, 1 Gustave L Levy Pl,Box 1230, New York, NY 10029 USA.	buxbaj01@doc.mssm.edu	Buxbaum, Joseph D/G-6001-2010; Silverman, Jeremy M./AAO-4268-2020	Buxbaum, Joseph/0000-0001-8898-8313			Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Auranen M, 2000, MOL PSYCHIATR, V5, P320, DOI 10.1038/sj.mp.4000708; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; Bass MP, 2000, AM J HUM GENET, V67, P349; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2000, AM J HUM GENET, V67, P349; Folstein SE, 1999, J CHILD PSYCHOL PSYC, V40, P1117, DOI 10.1017/S0021963099004461; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; *INT MOL GEN STUD, 2000, COLL INT NEUR 22 C B; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lamb JA, 2000, HUM MOL GENET, V9, P861, DOI 10.1093/hmg/9.6.861; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MacLean JE, 1999, J AM ACAD CHILD PSY, V38, P746, DOI 10.1097/00004583-199906000-00023; MORTON NE, 1956, AM J HUM GENET, V8, P80; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; Piven J, 1997, AM J PSYCHIAT, V154, P185; Rapin I, 1998, ANN NEUROL, V43, P7, DOI 10.1002/ana.410430106; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SPIKER D, 1994, AM J MED GENET, V54, P27, DOI 10.1002/ajmg.1320540107; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; VIELAND V, 1992, CYTOGENET CELL GENET, V59, P145, DOI 10.1159/000133229; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155	35	256	264	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1514	1520		10.1086/320588			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	439DB	WOS:000169094600023	11353400	Green Published, Bronze			2022-01-24	
J	Young, WP; Wheeler, PA; Coryell, VH; Keim, P; Thorgaard, GH				Young, WP; Wheeler, PA; Coryell, VH; Keim, P; Thorgaard, GH			A detailed linkage map of rainbow trout produced using doubled haploids	GENETICS			English	Article							RECOMBINANT INBREDS; SALMONID GENOMES; GENETIC-MARKERS; ENZYME LOCI; DNA; FISH; MAIZE; LINES; POLYMORPHISMS; AMPLIFICATION	We report the first detailed genetic linkage map of rainbow trout (Oncorhynchus mykiss). The segregation analysis was performed using 76 doubled haploid rainbow trout produced by androgenesis from a hybrid between the "OSU" and "Arlee" androgenetically derived homozygous lines. Four hundred and seventy-six markers segregated into 31 major linkage groups and 11 small groups (<5 markers/group). The minimum genome size is estimated to be 2627.5 cM in length. The sex-determining locus segregated to a distal position on one of the linkage groups. We analyzed the chromosomal distribution of three classes of markers: (1) amplified fragment length polymorphisms, (2) variable number of tandem repeats, and (3) markers obtained using probes homologous to the 5' or 3' end of salmonid-specific small interspersed nuclear elements. Many of the first class of markers were clustered in regions that appear to correspond to centromeres. The second class of markers were more telomeric in distribution, and the third class were intermediate. Tetrasomic inheritance, apparently related to the tetraploid ancestry of salmonid fishes, was detected at one simple sequence repeat locus and suggested by the presence of one extremely large linkage group that appeared to consist of two smaller groups linked at their tips. The double haploid rainbow trout lines and linkage map present a foundation for further genomic studies.	Washington State Univ, Dept Zool, Pullman, WA 99164 USA; Washington State Univ, Dept Genet & Cell Biol, Pullman, WA 99164 USA; No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA		Thorgaard, GH (corresponding author), Washington State Univ, Dept Zool, Pullman, WA 99164 USA.	thorglab@wsu.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR006654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P01ES004766] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1 RO1-RR06654] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P01 ES04766] Funding Source: Medline		Allendorf F.W., 1984, P1; ALLENDORF FW, 1986, J HERED, V77, P307, DOI 10.1093/oxfordjournals.jhered.a110247; ALLENDORF FW, 1994, HEREDITY, V72, P498, DOI 10.1038/hdy.1994.67; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BUETOW KH, 1991, AM J HUM GENET, V49, P985; BURR B, 1988, GENETICS, V118, P519; BURR B, 1991, TRENDS GENET, V7, P55, DOI 10.1016/0168-9525(91)90232-F; CHO YG, 1994, THEOR APPL GENET, V89, P54, DOI 10.1007/BF00226982; Cummings SA, 1997, CONSERV BIOL, V11, P662, DOI 10.1046/j.1523-1739.1997.95352.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIETRICH WF, 1994, P NATL ACAD SCI USA, V91, P9451, DOI 10.1073/pnas.91.20.9451; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; ESTOUP A, 1993, HEREDITY, V71, P488, DOI 10.1038/hdy.1993.167; Festing MFW, 1979, INBRED STRAINS BIOME; GEORGES M, 1990, GENOMICS, V6, P461, DOI 10.1016/0888-7543(90)90476-B; HOWE HB, 1956, GENETICS, V41, P610; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JOHNSON KR, 1987, GENETICS, V116, P579; JULIER C, 1990, P NATL ACAD SCI USA, V87, P4585, DOI 10.1073/pnas.87.12.4585; Keim P, 1997, CROP SCI, V37, P537, DOI 10.2135/cropsci1997.0011183X003700020038x; KIDO Y, 1991, P NATL ACAD SCI USA, V88, P2326, DOI 10.1073/pnas.88.6.2326; Knapik EW, 1996, DEVELOPMENT, V123, P451; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Lyons LA, 1997, NAT GENET, V15, P47, DOI 10.1038/ng0197-47; MAY B, 1990, GENETIC MAPS; MITCHELLOLDS T, 1995, GENETICS, V140, P1105; MORIZOT DC, 1983, J HERED, V74, P413, DOI 10.1093/oxfordjournals.jhered.a109827; MORIZOT DC, 1977, GENETICS, V86, P645; OHNO S, 1970, T AM FISH SOC, V99, P120, DOI 10.1577/1548-8659(1970)99<120:TEDIGS>2.0.CO;2; OHNO S, 1966, CHROMOSOMA, V18, P455, DOI 10.1007/BF00332549; PARSONS JE, 1985, J HERED, V76, P177, DOI 10.1093/oxfordjournals.jhered.a110060; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; RANA K, 1995, BROODSTOCK MANAGEMEN, P53; SAKAMOTO T, 1994, J FISH BIOL, V44, P1093, DOI 10.1111/j.1095-8649.1994.tb01279.x; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SCHAFER R, 1988, ELECTROPHORESIS, V9, P369, DOI 10.1002/elps.1150090804; SCHEERER PD, 1991, J EXP ZOOL, V260, P382, DOI 10.1002/jez.1402600312; Scribner KT, 1996, CAN J FISH AQUAT SCI, V53, P833, DOI 10.1139/cjfas-53-4-833; SHIN HS, 1985, NATURE, V317, P445, DOI 10.1038/317445a0; Silver L. M., 1995, MOUSE GENETICS CONCE; SPREULI P, 1996, HEREDITY, V76, P317; SPRUELL P, 1994, CAN J FISH AQUAT SCI, V51, P252, DOI 10.1139/f94-311; STADLER DR, 1956, GENETICS, V41, P623; STOSS J, 1983, FISH PHYSIOL, V9, P305; STREISINGER G, 1986, GENETICS, V112, P311; STUBER CW, 1992, GENETICS, V132, P823; TAHIR M, 1994, J HERED, V85, P306, DOI 10.1093/oxfordjournals.jhered.a111464; Takasaki N, 1996, J MOL EVOL, V42, P103, DOI 10.1007/BF02198835; THHORGAARD GH, 1983, COPEIA, P650; Thorgaard G.H., 1988, P363; THORGAARD GH, 1983, GENETICS, V103, P771; THORGAARD GH, 1977, SCIENCE, V196, P900, DOI 10.1126/science.860122; TRAVIS SE, 1996, MOL EVOL, V5, P11; VASSART G, 1987, SCIENCE, V235, P683, DOI 10.1126/science.2880398; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; VUYLSTEKE M, 1997, C STAT PLANT AN GEN; WADA H, 1995, MOL MAR BIOL BIOTECH, V4, P269; WHEELER PA, 1991, AQUACULTURE, V93, P95, DOI 10.1016/0044-8486(91)90208-O; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wolf K., 1985, Z ANGEW ICHTHYOL, V3, P131; WRIGHT JE, 1983, ISOZYMES-CURR T BIOL, V10, P239; Young WP, 1996, J HERED, V87, P77, DOI 10.1093/oxfordjournals.jhered.a022960	63	256	298	0	22	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	FEB	1998	148	2					839	850					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY808	WOS:000072187500026	9504929				2022-01-24	
J	Roberts, SM; Winston, F				Roberts, SM; Winston, F			Essential functional interactions of SAGA, a Saccharomyces cerevisiae complex of Spt, Ada, and Gcn5 proteins, with the Snf/Swi and Srb/mediator complexes	GENETICS			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; YEAST SWI/SNF COMPLEX; PUTATIVE TRANSCRIPTIONAL ADAPTER; ACIDIC ACTIVATION DOMAINS; MULTISUBUNIT COMPLEX; CHROMATIN STRUCTURE; GLUCOSE REPRESSION; SHUTTLE VECTORS; GENE-EXPRESSION	The Saccharomyces cerevisiae transcription factor Spt20/Ada5 was originally identified by mutations that suppress Ty insertion alleles and by mutations that suppress the toxicity caused by Gal4-VP16 overexpression. Here we present evidence for physical associations between Spt20/Ada5 and three other Spt proteins, suggesting that they exist in a complex. A related study demonstrates that this complex also contains the histone acetyltransferase, Gcn5, and Ada2. This complex has been named SAGA (Spt/Ada/Gcn5 acetyltransferase). To identify functions that genetically interact with SAGA, we have screened for mutations that cause lethality in an spt20 Delta/ada5 Delta mutant. Our screen identified mutations in SNF2, SIN4, and GAL11. These mutations affect two known transcription complexes: Snf/Swi, which functions in nucleosome remodeling, and Srb/mediator, which is required for regulated transcription by RNA polymerase II. Systematic analysis has demonstrated that spt20 Delta/ada5 Delta and spt7 Delta mutations cause lethality with every snf/swi and srb/mediator mutation tested. Furthermore, a gcn5 Delta mutation causes severe sickness with snf/swi mutations, but not with srb/mediator mutations. These findings suggest that SAGA has multiple activities and plays critical roles in transcription by RNA polymerase II.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115						NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM045720] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-45720] Funding Source: Medline		ABRAMS E, 1986, MOL CELL BIOL, V6, P3643, DOI 10.1128/MCB.6.11.3643; Ausubel FM, 1988, CURRENT PROTOCOLS MO; BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; BARLEV NA, 1995, J BIOL CHEM, V270, P19337, DOI 10.1074/jbc.270.33.19337; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BOSSIE MA, 1992, MOL BIOL CELL, V3, P875, DOI 10.1091/mbc.3.8.875; Brandl CJ, 1996, J BIOL CHEM, V271, P9298, DOI 10.1074/jbc.271.16.9298; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Cairns BR, 1996, GENE DEV, V10, P2131, DOI 10.1101/gad.10.17.2131; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Candau R, 1996, J BIOL CHEM, V271, P5237; Candau R, 1996, MOL CELL BIOL, V16, P593; CARLSON M, 1984, GENETICS, V107, P19; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; CHEN S, 1993, GENETICS, V134, P701; CHEN SM, 1993, MOL CELL BIOL, V13, P831, DOI 10.1128/MCB.13.2.831; Chiang YC, 1996, J BIOL CHEM, V271, P32359, DOI 10.1074/jbc.271.50.32359; CHOI KY, 1994, CELL, V78, P499; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; EISENMANN DM, 1994, GENETICS, V137, P647; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GANSHEROFF LJ, 1995, GENETICS, V139, P523; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; GUARENTE L, 1995, TRENDS BIOCHEM SCI, V20, P517, DOI 10.1016/S0968-0004(00)89120-3; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; HIMMELFARB HJ, 1990, CELL, V63, P1299, DOI 10.1016/0092-8674(90)90425-E; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Horiuchi J, 1997, MOL CELL BIOL, V17, P3220, DOI 10.1128/MCB.17.6.3220; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; JIANG YW, 1995, GENETICS, V140, P103; JIANG YW, 1992, MOL CELL BIOL, V12, P4503, DOI 10.1128/MCB.12.10.4503; JIANG YW, 1995, GENETICS, V140, P47; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; KRUGER W, 1995, GENE DEV, V9, P2770, DOI 10.1101/gad.9.22.2770; KRUGER W, 1991, MOL CELL BIOL, V11, P4135, DOI 10.1128/MCB.11.8.4135; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Madison JM, 1997, MOL CELL BIOL, V17, P287, DOI 10.1128/MCB.17.1.287; Marcus GA, 1996, MOL CELL BIOL, V16, P3197; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Martens JA, 1996, J BIOL CHEM, V271, P15884, DOI 10.1074/jbc.271.27.15884; MELCHER K, 1995, MOL CELL BIOL, V15, P2839; MENGUS G, 1995, EMBO J, V14, P1520, DOI 10.1002/j.1460-2075.1995.tb07138.x; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; NEIGEBORN L, 1984, GENETICS, V108, P845; NONET ML, 1989, GENETICS, V123, P715; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; PINA B, 1993, MOL CELL BIOL, V13, P5981, DOI 10.1128/MCB.13.10.5981; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Rose MD, 1990, METHODS YEAST GENETI; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SAKAI A, 1990, MOL CELL BIOL, V10, P4130, DOI 10.1128/MCB.10.8.4130; Sakurai H, 1996, P NATL ACAD SCI USA, V93, P9488, DOI 10.1073/pnas.93.18.9488; SALEH A, 1997, J BIOL CHEM, V9, P5571; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; SIKORSKI RS, 1989, GENETICS, V122, P19; SILVERMAN N, 1994, P NATL ACAD SCI USA, V91, P11665, DOI 10.1073/pnas.91.24.11665; SIMCHEN G, 1984, P NATL ACAD SCI-BIOL, V81, P2431, DOI 10.1073/pnas.81.8.2431; Song WJ, 1996, MOL CELL BIOL, V16, P115; SPENCER F, 1988, EUKARYOTIC DNA REPLI, P441; STILLMAN DJ, 1994, GENETICS, V136, P781; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; TREICH I, 1995, MOL CELL BIOL, V15, P4240; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Wilson CJ, 1996, CELL, V84, P235, DOI 10.1016/S0092-8674(00)80978-2; WINSTON F, 1987, GENETICS, V115, P649; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; WINSTON F, 1992, TRANSCRIPTIONAL REGU, P1271; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	98	256	259	0	3	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	OCT	1997	147	2					451	465					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY919	WOS:A1997XY91900009	9335585				2022-01-24	
J	KAY, MA; HOLTERMAN, AX; MEUSE, L; GOWN, A; OCHS, HD; LINSLEY, PS; WILSON, CB				KAY, MA; HOLTERMAN, AX; MEUSE, L; GOWN, A; OCHS, HD; LINSLEY, PS; WILSON, CB			LONG-TERM HEPATIC ADENOVIRUS-MEDIATED GENE-EXPRESSION IN MICE FOLLOWING CTLA4LG ADMINISTRATION	NATURE GENETICS			English	Article							CELL ACTIVATION; RECEPTOR; ANTIGEN; CTLA-4; DELIVERY; THERAPY; LIGAND; SYSTEM; CD28	Recombinant adenovirus vectors are efficient at transferring genes into somatic tissues but are limited for use in clinical gene therapy by immunologic factors that result in the vapid loss of gene expression and inhibit secondary gene transfer. This study demonstrates that systemic coadministration of recombinant adenovirus with soluble CTLA41g, which is known to block co-stimulatory signals between T cells and antigen presenting cells, leads to persistent adenoviral gene expression in mice without longterm immunosuppression. This form of immunotherapy greatly enhances the likelihood that recombinant adenovirus vectors will be useful for human gene therapy.	UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121		KAY, MA (corresponding author), UNIV WASHINGTON,DEPT MED,DIV MED GENET,BOX 357720,SEATTLE,WA 98195, USA.			Kay, Mark/0000-0002-2799-2615	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 17427] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK 49022, DK 47754] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD017427, R01HD017427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK047754, R01DK049022] Funding Source: NIH RePORTER		AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BARR D, 1995, GENE THER, V2, P151; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; ENGLEHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6196; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; INCK BK, 1994, SCIENCE, V265, P1225; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; KAY MA, 1994, TRENDS GENET, V10, P253, DOI 10.1016/0168-9525(94)90173-2; KAY MA, 1994, P NATL ACAD SCI USA, V91, P2353, DOI 10.1073/pnas.91.6.2353; KAY MA, 1995, HEPATOLOGY, V21, P815, DOI 10.1002/hep.1840210331; KAY MA, 1992, HUM GENE THER, V3, P641, DOI 10.1089/hum.1992.3.6-641; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; LENSCHOW DJ, SCIENCE, V257, P789; LEWIS DB, 1994, J EXP MED, V173, P89; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; NGUYEN L, 1994, J IMMUNOL, V152, P478; NONOYAMA S, 1993, J EXP MED, V178, P1097, DOI 10.1084/jem.178.3.1097; NONOYAMA S, 1993, J IMMUNOL, V150, P3817; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; RAWLE FC, 1991, J IMMUNOL, V146, P3977; Rinaldo C R Jr, 1993, Immunodeficiency, V5, P33; SCARIA A, 1995, GENE THER, V2, P295; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; SMITH TAG, 1993, NAT GENET, V5, P397, DOI 10.1038/ng1293-397; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4	33	256	258	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					191	197		10.1038/ng1095-191			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	WOS:A1995RX80600022	7550348				2022-01-24	
J	COOK, GP; TOMLINSON, IM; WALTER, G; RIETHMAN, H; CARTER, NP; BULUWELA, L; WINTER, G; RABBITTS, TH				COOK, GP; TOMLINSON, IM; WALTER, G; RIETHMAN, H; CARTER, NP; BULUWELA, L; WINTER, G; RABBITTS, TH			A MAP OF THE HUMAN-IMMUNOGLOBULIN V-H LOCUS COMPLETED BY ANALYSIS OF THE TELOMERIC REGION OF CHROMOSOME 14Q	NATURE GENETICS			English	Article							HEAVY-CHAIN LOCUS; VARIABLE REGION; ANTIBODY REPERTOIRE; V(H) SEGMENTS; PHYSICAL MAP; 5' EXON; GENE; ORGANIZATION; YEAST; CLONING	Analysis of the telomeric region of chromosome 14q has enabled us to complete a map of the immunoglobulin V-H locus which accounts for almost all V-H segments known to rearrange in B-lymphocytes. The human germline V-H repertoire consists of approximately 50 functional V-H segments - the exact number depending on the haplotype - spanning 1,100 kilobases upstream of the J(H) segments. A yeast artificial chromosome used to map these segments was isolated by its ability to provide telomere activity in yeast, suggesting that the V-H locus may be located within a few kilobases of the 14q telomere. The limited structural diversity encoded by the functional V-H segments demonstrates the importance of combinatorial diversity produced by VDJ joining and the association of heavy and light chains in producing the human antibody repertoire.	MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND; MRC,CTR PROT ENGN,CAMBRIDGE CB2 2QH,CAMBS,ENGLAND; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,ENGLAND				; Rabbitts, Terence/D-6262-2016	Cook, Graham/0000-0003-0223-3652; Rabbitts, Terence/0000-0002-4982-2609			BAER R, 1988, J EXP MED, V167, P2011, DOI 10.1084/jem.167.6.2011; BAER R, 1985, CELL, V43, P705, DOI 10.1016/0092-8674(85)90243-0; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; BRUGGEMANN M, 1989, P NATL ACAD SCI USA, V86, P6709, DOI 10.1073/pnas.86.17.6709; BULUWELA L, 1988, EMBO J, V7, P2003, DOI 10.1002/j.1460-2075.1988.tb03039.x; CARTER NP, 1992, J MED GENET, V29, P299, DOI 10.1136/jmg.29.5.299; CHENG JF, 1989, NUCLEIC ACIDS RES, V17, P6109, DOI 10.1093/nar/17.15.6109; CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; FISCH P, 1992, EUR J IMMUNOL, V22, P2745, DOI 10.1002/eji.1830221042; HALUSKA FG, 1987, P NATL ACAD SCI USA, V84, P6835, DOI 10.1073/pnas.84.19.6835; KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1; MATSUDA F, 1990, EMBO J, V9, P2501, DOI 10.1002/j.1460-2075.1990.tb07429.x; MATSUDA F, 1988, EMBO J, V7, P1047, DOI 10.1002/j.1460-2075.1988.tb02912.x; MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88; MCBRIDE OW, 1982, NUCLEIC ACIDS RES, V10, P8155, DOI 10.1093/nar/10.24.8155; MENGLEGAW L, 1988, P NATL ACAD SCI USA, V85, P9171, DOI 10.1073/pnas.85.23.9171; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; PAVAN WJ, 1990, P NATL ACAD SCI USA, V87, P1300, DOI 10.1073/pnas.87.4.1300; REEVES RH, 1992, METHOD ENZYMOL, V216, P584; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; SASSO EH, 1993, J CLIN INVEST, V91, P2358, DOI 10.1172/JCI116468; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; SHIN EK, 1991, EMBO J, V10, P3641, DOI 10.1002/j.1460-2075.1991.tb04930.x; TOMLINSON IM, 1994, HUM MOL GENET, V3, P853; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; VANDIJK KW, 1993, EUR J IMMUNOL, V23, P832, DOI 10.1002/eji.1830230410; VANDIJK KW, 1992, P NATL ACAD SCI USA, V89, P10430, DOI 10.1073/pnas.89.21.10430; VANES JH, 1992, J IMMUNOL, V149, P2234; WALTER G, 1993, NUCLEIC ACIDS RES, V21, P4524, DOI 10.1093/nar/21.19.4524; WALTER MA, 1990, EMBO J, V9, P3303, DOI 10.1002/j.1460-2075.1990.tb07530.x; WALTER MA, 1991, J EXP MED, V174, P335, DOI 10.1084/jem.174.2.335; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; ZELENETZ AD, 1992, J EXP MED, V176, P1137, DOI 10.1084/jem.176.4.1137	39	256	256	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					162	168		10.1038/ng0694-162			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	WOS:A1994NQ03700016	7920635				2022-01-24	
J	SCHEDL, T; KIMBLE, J				SCHEDL, T; KIMBLE, J			FOG-2, A GERM-LINE-SPECIFIC SEX DETERMINATION GENE REQUIRED FOR HERMAPHRODITE SPERMATOGENESIS IN CAENORHABDITIS-ELEGANS	GENETICS			English	Article									UNIV WISCONSIN,COLL AGR & LIFE SCI,DEPT BIOCHEM,MADISON,WI 53706		SCHEDL, T (corresponding author), UNIV WISCONSIN,GRAD SCH,CELL & MOLEC BIOL LAB,MADISON,WI 53706, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM009554, R01GM031816] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD00630] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM31816, GM09554] Funding Source: Medline		BARTON MK, 1987, GENETICS, V115, P107; BRENNER S, 1974, GENETICS, V77, P71; DONIACH T, 1986, GENETICS, V114, P53; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; DONIACH T, 1986, THESIS MRC LABORATOR; FREUND JE, 1973, MODERN ELEMENTARY ST; GREENWALD IS, 1980, GENETICS, V96, P147; HICKMAN CP, 1973, INTEGRATED PRINCIPLE; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; HODGKIN J, 1984, Journal of Embryology and Experimental Morphology, V83, P103; HODGKIN J, 1987, GENE DEV, V1, P731, DOI 10.1101/gad.1.7.731; HODGKIN J, 1983, MOL GEN GENET, V192, P452, DOI 10.1007/BF00392190; HODGKIN J, 1980, GENETICS, V96, P649; HODGKIN J, 1979, GENETICS, V91, P67; HODGKIN J, 1986, GENETICS, V114, P15; HODGKIN J, 1988, IN PRESS NEMATODE CA; HODGKIN JA, 1977, GENETICS, V86, P275; HORVITZ HR, 1979, MOL GEN GENET, V175, P129, DOI 10.1007/BF00425528; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; KIMBLE J, 1984, DEV BIOL, V105, P189; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; KIMBLE JE, 1988, IN PRESS NEMATODE CA; KIMBLE JE, 1979, DEV BIOL, V87, P286; KLASS M, 1976, DEV BIOL, V52, P1, DOI 10.1016/0012-1606(76)90002-6; MADL JE, 1979, GENETICS, V93, P393; NELSON GA, 1978, DEV BIOL, V66, P386, DOI 10.1016/0012-1606(78)90247-6; SIGURDSON DC, 1984, GENETICS, V108, P331; STERNBERG PW, 1981, DEV BIOL, V88, P147, DOI 10.1016/0012-1606(81)90226-8; STERNBERG PW, 1982, DEV BIOL, V93, P181, DOI 10.1016/0012-1606(82)90251-2; SUDHAUS W, 1974, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V101, P417; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; SWANSON MM, 1984, GENETIC MAPS 1984; TRENT C, 1983, GENETICS, V104, P619; TRIANTAPHYLLOU AC, 1973, ANNU REV PHYTOPATHOL, V11, P441, DOI 10.1146/annurev.py.11.090173.002301; VILLENEUVE AM, 1987, CELL, V48, P25, DOI 10.1016/0092-8674(87)90352-7; WARD S, 1978, GENETICS, V88, P285; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; WATERSTON RH, 1981, GENETICS, V97, P307; WILLS N, 1983, CELL, V33, P575, DOI 10.1016/0092-8674(83)90438-5; 1980, DEV BIOL, V76, P160	40	256	266	0	10	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	MAY	1988	119	1					43	61					19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q6673	WOS:A1988Q667300007	3396865				2022-01-24	
J	GILLIN, FD; ROUFA, DJ; BEAUDET, AL; CASKEY, CT				GILLIN, FD; ROUFA, DJ; BEAUDET, AL; CASKEY, CT			8-AZAGUANINE RESISTANCE IN MAMMALIAN-CELLS .1. HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE	GENETICS			English	Article																	ATKINSON MR, 1965, BIOCHEM J, V94, P64, DOI 10.1042/bj0940064; CASKEY CT, 1964, J BIOL CHEM, V239, P2570; CHU EHY, 1969, GENETICS, V62, P359; CHU EHY, 1968, P NATL ACAD SCI USA, V61, P1306, DOI 10.1073/pnas.61.4.1306; COOPER JEK, 1970, TEX REP BIOL MED, V28, P29; EISENSTA.A, 1965, MUTAT RES, V2, P1, DOI 10.1016/0027-5107(65)90002-3; FORD DK, 1958, J NATL CANCER I, V21, P393; FOWLER AV, 1968, J MOL BIOL, V33, P35, DOI 10.1016/0022-2836(68)90279-9; FREESE E, 1966, RADIAT RES         S, V6, P97; GAREN A, 1968, SCIENCE, V160, P149, DOI 10.1126/science.160.3824.149; GAREN A, 1962, P NATL ACAD SCI USA, V48, P1121, DOI 10.1073/pnas.48.7.1121; HARRIS M, 1971, J CELL PHYSIOL, V78, P177, DOI 10.1002/jcp.1040780204; HAYFLICK L, 1965, TEX REP BIOL MED, VS 23, P285; HENDERSON JF, 1969, AM J HUM GENET, V21, P61; HENDERSON JF, 1967, CANCER RES, V27, P1773; KELLEY WN, 1971, J BIOL CHEM, V246, P2953; KRENITSKY TA, 1969, J BIOL CHEM, V244, P1263; LITTLEFIELD JW, 1963, P NATL ACAD SCI USA, V50, P568, DOI 10.1073/pnas.50.3.568; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luria SE, 1943, GENETICS, V28, P491; MCCOLLISTER RJ, 1964, J BIOL CHEM, V239, P1560; MCDONALD JA, 1971, SCIENCE, V171, P689, DOI 10.1126/science.171.3972.689; MEZGERFREED L, 1972, NATURE-NEW BIOL, V235, P245, DOI 10.1038/newbio235245a0; MORROW J, 1970, GENETICS, V65, P279; MURRAY AW, 1971, ANNU REV BIOCHEM, V40, P811, DOI 10.1146/annurev.bi.40.070171.004115; NAGY M, 1970, BIOCHIM BIOPHYS ACTA, V198, P471, DOI 10.1016/0005-2744(70)90125-7; ROUFA DJ, 1972, FEDERATION ABSTRACTS, V31; RUBIN CS, 1971, P NATL ACAD SCI USA, V68, P1461, DOI 10.1073/pnas.68.7.1461; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; Sherman F, 1970, Symp Soc Exp Biol, V24, P85; STUTTS P, 1963, BIOCHEM PHARMACOL, V12, P97, DOI 10.1016/0006-2952(63)90175-8; SUBAKSHA.H, 1965, EXP CELL RES, V38, P106, DOI 10.1016/0014-4827(65)90432-5; SZYBALSKI W, 1962, 7 NATL CANC I MON, P75; THAKAR JH, 1968, J BACTERIOL, V95, P458, DOI 10.1128/JB.95.2.458-464.1968; WHITFIELD HJ, 1966, J MOL BIOL, V21, P335, DOI 10.1016/0022-2836(66)90103-3; WYNGAARDEN JB, 1959, J BIOL CHEM, V234, P1492; YANOFSKY C, 1963, COLD SPRING HARB SYM, V28, P581, DOI 10.1101/SQB.1963.028.01.078; YANOFSKY C, 1966, COLD SPRING HARB SYM, V31, P151, DOI 10.1101/SQB.1966.031.01.023	38	256	256	0	1	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1972	72	2					239	&					0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O0570	WOS:A1972O057000005	4345996				2022-01-24	
J	Lotta, LA; Gulati, P; Day, FR; Payne, F; Ongen, H; van de Bunt, M; Gaulton, KJ; Eicher, JD; Sharp, SJ; Luan, JA; Rolfe, ED; Stewart, ID; Wheeler, E; Willems, SM; Adams, C; Yaghootkar, H; Forouhi, NG; Khaw, KT; Johnson, AD; Semple, RK; Frayling, T; Perry, JRB; Dermitzakis, E; McCarthy, MI; Barroso, I; Wareham, NJ; Savage, DB; Langenberg, C; O'Rahilly, S; Scott, RA				Lotta, Luca A.; Gulati, Pawan; Day, Felix R.; Payne, Felicity; Ongen, Halit; van de Bunt, Martijn; Gaulton, Kyle J.; Eicher, John D.; Sharp, Stephen J.; Luan, Jian'an; Rolfe, Emanuella De Lucia; Stewart, Isobel D.; Wheeler, Eleanor; Willems, Sara M.; Adams, Claire; Yaghootkar, Hanieh; Forouhi, Nita G.; Khaw, Kay-Tee; Johnson, Andrew D.; Semple, Robert K.; Frayling, Timothy; Perry, John R. B.; Dermitzakis, Emmanouil; McCarthy, Mark I.; Barroso, Ines; Wareham, Nicholas J.; Savage, David B.; Langenberg, Claudia; O'Rahilly, Stephen; Scott, Robert A.		EPIC-InterAct Consortium; Cambridge FPLD1 Consortium	Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance	NATURE GENETICS			English	Article							BODY-FAT DISTRIBUTION; TISSUE EXPANDABILITY; LIPOPROTEIN-LIPASE; METABOLIC SYNDROME; DIABETES-MELLITUS; ABDOMINAL OBESITY; WIDE ASSOCIATION; GENETIC-EVIDENCE; GLYCEMIC TRAITS; ECTOPIC FAT	Insulin resistance is a key mediator of obesity-related cardiometabolic disease, yet the mechanisms underlying this link remain obscure. Using an integrative genomic approach, we identify 53 genomic regions associated with insulin resistance phenotypes (higher fasting insulin levels adjusted for BMI, lower HDL cholesterol levels and higher triglyceride levels) and provide evidence that their link with higher cardiometabolic risk is underpinned by an association with lower adipose mass in peripheral compartments. Using these 53 loci, we show a polygenic contribution to familial partial lipodystrophy type 1, a severe form of insulin resistance, and highlight shared molecular mechanisms in common/mild and rare/severe insulin resistance. Population-level genetic analyses combined with experiments in cellular models implicate CCDC92, DNAH10 and L3MBTL3 as previously unrecognized molecules influencing adipocyte differentiation. Our findings support the notion that limited storage capacity of peripheral adipose tissue is an important etiological component in insulin-resistant cardiometabolic disease and highlight genes and mechanisms underpinning this link.	[Lotta, Luca A.; Day, Felix R.; Sharp, Stephen J.; Luan, Jian'an; Rolfe, Emanuella De Lucia; Stewart, Isobel D.; Willems, Sara M.; Forouhi, Nita G.; Perry, John R. B.; Wareham, Nicholas J.; Langenberg, Claudia; Scott, Robert A.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Gulati, Pawan; Adams, Claire; Semple, Robert K.; Barroso, Ines; Savage, David B.; O'Rahilly, Stephen] Univ Cambridge, Metabol Res Labs, Cambridge, England; [Payne, Felicity; Wheeler, Eleanor; Barroso, Ines] Wellcome Trust Sanger Inst, Hinxton, England; [Ongen, Halit; Dermitzakis, Emmanouil] Univ Geneva, Sch Med, Dept Genet Med & Dev, Geneva, Switzerland; [van de Bunt, Martijn; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [van de Bunt, Martijn; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Gaulton, Kyle J.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Eicher, John D.; Johnson, Andrew D.] NHLBI, Populat Sci Branch, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA; [Yaghootkar, Hanieh; Frayling, Timothy] Univ Exeter, Sch Med, Royal Devon & Exeter Hosp, Genet Complex Traits,Inst Biomed & Clin Sci, Exeter, Devon, England; [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England		Wareham, NJ; Langenberg, C; Scott, RA (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.; Barroso, I; Savage, DB; O'Rahilly, S (corresponding author), Univ Cambridge, Metabol Res Labs, Cambridge, England.; Barroso, I (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	ib1@sanger.ac.uk; nick.wareham@mrc-epid.cam.ac.uk; dbs23@medschl.cam.ac.uk; claudia.langenberg@mrc-epid.cam.ac.uk; so104@medschl.cam.ac.uk; robert.scott@mrc-epid.cam.ac.uk	Grioni, Sara/K-5320-2016; Salamanca-Fernandez, Elena/R-5943-2016; O'Rahilly, Stephen/ABF-6509-2020; Khaw, Kay-Tee/AAZ-3209-2021; Langenberg, Claudia/ABG-9067-2021; Semple, Robert/AAB-2948-2019; Johnson, Andrew D/G-6520-2013; McCarthy, Mark/M-3763-2015; duvnjak, lea/S-8581-2018	Grioni, Sara/0000-0002-5891-8426; Salamanca-Fernandez, Elena/0000-0002-1795-2206; O'Rahilly, Stephen/0000-0003-2199-4449; Langenberg, Claudia/0000-0002-5017-7344; Johnson, Andrew D/0000-0001-6369-5178; Tjonneland, Anne/0000-0003-4385-2097; Savage, David Bousfield/0000-0002-7857-7032; van de Bunt, Martijn/0000-0002-6744-6125; Barroso, Ines/0000-0001-5800-4520; tumino, rosario/0000-0003-2666-414X; Wheeler, Eleanor/0000-0002-8616-6444; Riboli, Elio/0000-0001-6795-6080; Forouhi, Nita/0000-0002-5041-248X; Payne, Felicity/0000-0003-4228-581X; Franks, Paul/0000-0002-0520-7604; Frayling, Timothy/0000-0001-8362-2603; Sacerdote, Carlotta/0000-0002-8008-5096; Gulati, Pawan/0000-0002-0902-8072; Semple, Robert Kenneth/0000-0001-6539-3069; McCarthy, Mark/0000-0002-4393-0510; Ellard, Sian/0000-0002-7620-5526; Overvad, Kim/0000-0001-6429-7921; Ongen, Halit/0000-0002-4197-5790; Lotta, Luca Andrea/0000-0002-2619-5956; duvnjak, lea/0000-0001-8173-5348; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Day, Felix/0000-0003-3789-7651; , Hanieh/0000-0001-9672-9477; Mukhtar, Rasha/0000-0003-0749-6814	UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12015/1, MC_PC_13046, MC_PC_13048, MR/L00002/1]; MRC Metabolic Diseases UnitUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12012/5]; Cambridge NIHR Biomedical Research CentreNational Institute for Health Research (NIHR); EU/EFPIA Innovative Medicines Initiative (EMIF grant ) [115372]; EU FP6 programEuropean Commission [LSHM_CT_2006_037197]; Novo NordiskNovo Nordisk; Wellcome TrustWellcome TrustEuropean Commission [107064, 090532, 098381, WT098051, 095515/Z/11/Z, 100574/Z/12/Z]; University of Oxford; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [ZIAHL006170] Funding Source: NIH RePORTER; Cancer Research UKCancer Research UK [14136] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/L00002/1, MC_UU_12015/2, MC_UU_12015/5, MC_PC_13048, MC_qA137853, MR/N003284/1, MC_UU_12012/5, MC_U106179471, G1000143, G0401527, MC_UU_12012/5/B, MC_UP_A100_1003, MC_U106179472, MC_PC_13046, MC_UU_12015/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10114, NF-SI-0507-10380, NF-SI-0512-10135, CL-2011-18-004, NF-SI-0513-10109] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12015/2, MC_U106179472, MC_UP_A100_1003, MC_UU_12012/5, MC_UU_12015/5, MR/N003284/1, MC_UU_12015/1] Funding Source: UKRI	This study was funded by the UK Medical Research Council through grants MC_UU_12015/1, MC_PC_13046, MC_PC_13048 and MR/L00002/1. This work was supported by the MRC Metabolic Diseases Unit (MC_UU_12012/5) and the Cambridge NIHR Biomedical Research Centre and EU/EFPIA Innovative Medicines Initiative Joint Undertaking (EMIF grant 115372). Funding for the InterAct project was provided by the EU FP6 program (grant LSHM_CT_2006_037197). This work was funded, in part, through an EFSD Rising Star award to R.A.S. supported by Novo Nordisk. D.B.S. is supported by Wellcome Trust grant 107064. M.I.M. is a Wellcome Trust Senior Investigator and is supported by the following grants from the Wellcome Trust: 090532 and 098381. M.v.d.B. is supported by a Novo Nordisk postdoctoral fellowship run in partnership with the University of Oxford. I.B. is supported by Wellcome Trust grant WT098051. S.O'R. acknowledges funding from the Wellcome Trust (Wellcome Trust Senior Investigator Award 095515/Z/11/Z and Wellcome Trust Strategic Award 100574/Z/12/Z).	Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Avila M., 2015, CLIN GENET; Baughman BM, 2016, ACS CHEM BIOL, V11, P722, DOI 10.1021/acschembio.5b00632; Biggs ML, 2010, JAMA-J AM MED ASSOC, V303, P2504, DOI 10.1001/jama.2010.843; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chudasama KK, 2013, AM J HUM GENET, V93, P150, DOI 10.1016/j.ajhg.2013.05.023; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dahlman I, 2016, DIABETES, V65, P433, DOI 10.2337/db15-0828; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Dyment DA, 2013, AM J HUM GENET, V93, P158, DOI 10.1016/j.ajhg.2013.06.005; FDA, 2008, GUID IND DIAB MELL E; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Gray SL, 2006, DIABETES, V55, P2669, DOI 10.2337/db06-0389; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Karpe F, 2015, NAT REV ENDOCRINOL, V11, P90, DOI 10.1038/nrendo.2014.185; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Knowles JW, 2016, J CLIN INVEST, V126, P403, DOI 10.1172/JCI85921; KOZAKI K, 1993, J LIPID RES, V34, P1765; Lane JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112123; LILLIOJA S, 1988, DIABETES METAB REV, V4, P517, DOI 10.1002/dmr.5610040508; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lu YC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10495; MAILLY F, 1995, ARTERIOSCL THROM VAS, V15, P468, DOI 10.1161/01.ATV.15.4.468; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Myocardial IG, 2016, NEW ENGL J MED, V374, P1134, DOI DOI 10.1056/NEJM0A1507652; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Paternoster L, 2011, HUM MOL GENET, V20, P4069, DOI 10.1093/hmg/ddr309; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pinnick KE, 2014, DIABETES, V63, P3785, DOI 10.2337/db14-0385; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Robbins AL, 2015, TRENDS MOL MED, V21, P433, DOI 10.1016/j.molmed.2015.04.004; ROBBINS DC, 1979, METABOLISM, V28, P908, DOI 10.1016/0026-0495(79)90090-8; Ryden M, 2014, J CLIN ENDOCR METAB, V99, pE1870, DOI 10.1210/jc.2014-1526; Salazar MR, 2013, DIABETES VASC DIS RE, V10, P346, DOI 10.1177/1479164113479809; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Scott RA, 2014, DIABETES, V63, P4378, DOI 10.2337/db14-0319; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Semple RK, 2011, ENDOCR REV, V32, P498, DOI 10.1210/er.2010-0020; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Singaraja RR, 2014, J LIPID RES, V55, P1693, DOI 10.1194/jlr.M048710; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yaghootkar H, 2016, DIABETES, V65, P2448, DOI 10.2337/db15-1671; Yaghootkar H, 2014, DIABETES, V63, P4369, DOI 10.2337/db14-0318	77	255	257	4	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					17	26		10.1038/ng.3714			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	WOS:000390976600007	27841877	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Ming, R; VanBuren, R; Wai, CM; Tang, HB; Schatz, MC; Bowers, JE; Lyons, E; Wang, ML; Chen, J; Biggers, E; Zhang, JS; Huang, LX; Zhang, LM; Miao, WJ; Zhang, J; Ye, ZY; Miao, CY; Lin, ZC; Wang, H; Zhou, HY; Yim, WC; Priest, HD; Zheng, CF; Woodhouse, M; Edger, PP; Guyot, R; Guo, HB; Guo, H; Zheng, GY; Singh, R; Sharma, A; Min, XJ; Zheng, Y; Lee, H; Gurtowski, J; Sedlazeck, FJ; Harkess, A; McKain, MR; Liao, ZY; Fang, JP; Liu, J; Zhang, XD; Zhang, Q; Hu, WC; Qin, Y; Wang, K; Chen, LY; Shirley, N; Lin, YR; Liu, LY; Hernandez, AG; Wright, CL; Bulone, V; Tuskan, GA; Heath, K; Zee, F; Moore, PH; Sunkar, R; Leebens-Mack, JH; Mockler, T; Bennetzen, JL; Freeling, M; Sankoff, D; Paterson, AH; Zhu, XG; Yang, XH; Smith, JAC; Cushman, JC; Paull, RE; Yu, QY				Ming, Ray; VanBuren, Robert; Wai, Ching Man; Tang, Haibao; Schatz, Michael C.; Bowers, John E.; Lyons, Eric; Wang, Ming-Li; Chen, Jung; Biggers, Eric; Zhang, Jisen; Huang, Lixian; Zhang, Lingmao; Miao, Wenjing; Zhang, Jian; Ye, Zhangyao; Miao, Chenyong; Lin, Zhicong; Wang, Hao; Zhou, Hongye; Yim, Won C.; Priest, Henry D.; Zheng, Chunfang; Woodhouse, Margaret; Edger, Patrick P.; Guyot, Romain; Guo, Hao-Bo; Guo, Hong; Zheng, Guangyong; Singh, Ratnesh; Sharma, Anupma; Min, Xiangjia; Zheng, Yun; Lee, Hayan; Gurtowski, James; Sedlazeck, Fritz J.; Harkess, Alex; McKain, Michael R.; Liao, Zhenyang; Fang, Jingping; Liu, Juan; Zhang, Xiaodan; Zhang, Qing; Hu, Weichang; Qin, Yuan; Wang, Kai; Chen, Li-Yu; Shirley, Neil; Lin, Yann-Rong; Liu, Li-Yu; Hernandez, Alvaro G.; Wright, Chris L.; Bulone, Vincent; Tuskan, Gerald A.; Heath, Katy; Zee, Francis; Moore, Paul H.; Sunkar, Ramanjulu; Leebens-Mack, James H.; Mockler, Todd; Bennetzen, Jeffrey L.; Freeling, Michael; Sankoff, David; Paterson, Andrew H.; Zhu, Xinguang; Yang, Xiaohan; Smith, J. Andrew C.; Cushman, John C.; Paull, Robert E.; Yu, Qingyi			The pineapple genome and the evolution of CAM photosynthesis	NATURE GENETICS			English	Article							CRASSULACEAN ACID METABOLISM; EXPRESSION ANALYSIS; GENE; SEQUENCE; PLANTS; IDENTIFICATION; ARABIDOPSIS; DIVERGENCE; C-4; DIVERSIFICATION	Pineapple (Ananas comosus (L.) Merr.) is the most economically valuable crop possessing crassulacean acid metabolism (CAM), a photosynthetic carbon assimilation pathway with high water-use efficiency, and the second most important tropical fruit. We sequenced the genomes of pineapple varieties F153 and MD2 and a wild pineapple relative, Ananas bracteatus accession CB5. The pineapple genome has one fewer ancient whole-genome duplication event than sequenced grass genomes and a conserved karyotype with seven chromosomes from before the. duplication event. The pineapple lineage has transitioned from C-3 photosynthesis to CAM, with CAM-related genes exhibiting a diel expression pattern in photosynthetic tissues. CAM pathway genes were enriched with cis-regulatory elements associated with the regulation of circadian clock genes, providing the first cis-regulatory link between CAM and circadian clock regulation. Pineapple CAM photosynthesis evolved by the reconfiguration of pathways in C-3 plants, through the regulatory neofunctionalization of preexisting genes and not through the acquisition of neofunctionalized genes via whole-genome or tandem gene duplication.	[Ming, Ray; VanBuren, Robert; Wai, Ching Man; Tang, Haibao; Zhang, Jisen; Huang, Lixian; Zhang, Lingmao; Miao, Wenjing; Zhang, Jian; Ye, Zhangyao; Miao, Chenyong; Lin, Zhicong; Liao, Zhenyang; Fang, Jingping; Liu, Juan; Zhang, Xiaodan; Zhang, Qing; Hu, Weichang; Qin, Yuan; Wang, Kai; Chen, Li-Yu] Fujian Agr & Forestry Univ, Fujian Agr & Forestry Univ & Univ Illinois Urbana, Fuzhou, Peoples R China; [Ming, Ray; VanBuren, Robert; Wai, Ching Man; Tang, Haibao; Zhang, Jisen; Huang, Lixian; Zhang, Lingmao; Miao, Wenjing; Zhang, Jian; Ye, Zhangyao; Miao, Chenyong; Lin, Zhicong; Liao, Zhenyang; Fang, Jingping; Liu, Juan; Zhang, Xiaodan; Zhang, Qing; Hu, Weichang; Qin, Yuan; Wang, Kai; Chen, Li-Yu] Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou, Peoples R China; [Ming, Ray; VanBuren, Robert; Wai, Ching Man; Heath, Katy] Univ Illinois, Dept Plant Biol, Urbana, IL USA; [VanBuren, Robert; Priest, Henry D.; McKain, Michael R.; Mockler, Todd] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Tang, Haibao; Lyons, Eric] Univ Arizona, iPlant Collaborat, Tucson, AZ USA; [Schatz, Michael C.; Biggers, Eric; Lee, Hayan; Gurtowski, James; Sedlazeck, Fritz J.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Bowers, John E.; Wang, Hao; Zhou, Hongye; Harkess, Alex; Leebens-Mack, James H.; Bennetzen, Jeffrey L.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Wang, Ming-Li; Moore, Paul H.] Hawaii Agr Res Ctr, Kunia, HI USA; [Chen, Jung; Paull, Robert E.] Univ Hawaii, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Yim, Won C.; Cushman, John C.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Zheng, Chunfang; Sankoff, David] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Woodhouse, Margaret; Edger, Patrick P.; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Guyot, Romain] IRD, Divers Adaptat & Dev Plantes, Montpellier, France; [Guo, Hao-Bo; Guo, Hong] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA; [Zheng, Guangyong; Zhu, Xinguang] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Gesell Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Singh, Ratnesh; Sharma, Anupma; Yu, Qingyi] Texas A&M Univ Syst, Dept Plant Pathol & Microbiol, Texas A&M AgriLife Res, Dallas, TX USA; [Min, Xiangjia] Youngstown State Univ, Dept Biol Sci, Youngstown, OH 44555 USA; [Zheng, Yun] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Peoples R China; [Shirley, Neil; Bulone, Vincent] Univ Adelaide, Sch Agr Food & Wine, Australian Res Council ARC Ctr Excellence Plant C, Adelaide, SA, Australia; [Lin, Yann-Rong; Liu, Li-Yu] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan; [Hernandez, Alvaro G.; Wright, Chris L.] Univ Illinois, WM Keck Ctr, Urbana, IL USA; [Tuskan, Gerald A.; Yang, Xiaohan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Zee, Francis] USDA ARS, Pacific Basin Agr Res Ctr, Hilo, HI USA; [Sunkar, Ramanjulu] Oklahoma State Univ, Dept Biochem & Mol Biol, Noble Res Ctr, Stillwater, OK 74078 USA; [Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Smith, J. Andrew C.] Univ Oxford, Dept Plant Sci, Oxford, England		Ming, R (corresponding author), Fujian Agr & Forestry Univ, Fujian Agr & Forestry Univ & Univ Illinois Urbana, Fuzhou, Peoples R China.	rming@life.uiuc.edu; qyu@ag.tamu.edu	LIN, Yann-rong/AAI-4096-2020; Edger, Patrick/ABE-6442-2020; Bulone, Vincent/D-7469-2013; Miao, Chenyong/L-6403-2019; guyot, romain/AAE-2262-2021; Sedlazeck, Fritz J/E-4548-2018; Tang, Haibao/A-6715-2011; Yang, Xiaohan/A-6975-2011; Yim, Won Cheol/K-9100-2016; Bowers, John/B-9245-2009; Zheng, Yun/I-7011-2012; Mockler, Todd C/L-2609-2013; Yu, Qingyi/E-8899-2019; guyot, romain/M-1118-2015; Bowers, John/AAD-7601-2019; Schatz, Michael/L-2690-2019; Yang, Xiaohan/AAM-2449-2020; Edger, Patrick/AAP-3846-2021; Leebens-Mack, James/AAF-6770-2019; Wang, Kai/A-2143-2011; Zheng, Yun/AAS-1149-2021; Tuskan, Gerald/A-6225-2011; Bulone, Vincent/C-8492-2019; Smith, J.A.C./M-3338-2014; Guo, Hao-Bo/B-7486-2009; Singh, Ratnesh/I-1392-2015; Min, Xiangjia/O-9509-2014	LIN, Yann-rong/0000-0001-6833-8276; guyot, romain/0000-0002-7016-7485; Sedlazeck, Fritz J/0000-0001-6040-2691; Tang, Haibao/0000-0002-3460-8570; Yang, Xiaohan/0000-0001-5207-4210; Yim, Won Cheol/0000-0002-7489-0435; Bowers, John/0000-0001-8984-9796; Zheng, Yun/0000-0003-4292-9806; Mockler, Todd C/0000-0002-0462-5775; Yu, Qingyi/0000-0001-5393-5764; guyot, romain/0000-0002-7016-7485; Schatz, Michael/0000-0002-4118-4446; Yang, Xiaohan/0000-0001-5207-4210; Leebens-Mack, James/0000-0003-4811-2231; Wang, Kai/0000-0002-1074-0438; Zheng, Yun/0000-0003-4292-9806; Tuskan, Gerald/0000-0003-0106-1289; Bulone, Vincent/0000-0003-2809-4160; Smith, J.A.C./0000-0001-9188-0258; Guo, Hao-Bo/0000-0003-1321-1758; chen, li yu/0000-0002-5199-6237; Lyons, Eric/0000-0002-3348-8845; Zhang, Xiaodan/0000-0001-8192-0666; Singh, Ratnesh/0000-0001-5647-3390; Zhang, Jian/0000-0002-0790-4462; Zhou, Hongye/0000-0003-4373-8083; Shirley, Neil/0000-0001-8114-9891; Bowers, John/0000-0001-5693-2796; Liu, Li-yu/0000-0001-6997-8101; Min, Xiangjia/0000-0001-7978-0596; Miao, Chenyong/0000-0002-0904-3707	Fujian Agriculture and Forestry University; USDA T-START grant through the University of Hawaii; University of Illinois at Urbana-Champaign; Fujian provincial government; US National Science Foundation (NSF) Plant Genome ProgramNational Science Foundation (NSF) [0922545]; NSFNational Science Foundation (NSF) [DBI-1401572, IOS-1444567]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HG006677]; US NSFNational Science Foundation (NSF) [DBI-1350041, DBI-1265383]; US Department of Energy, Office of Science, Genomic Science ProgramUnited States Department of Energy (DOE) [DE-SC0008834]; Direct For Biological SciencesNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [1442199] Funding Source: National Science Foundation; Division Of Integrative Organismal SystemsNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [1401572, 0922742] Funding Source: National Science Foundation; Div Of Biological InfrastructureNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [1627442] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG006677] Funding Source: NIH RePORTER	We thank R. Kai and C. Mayo Riley for maintaining the pineapple plants and the collection of leaf tissues; M. Conway at Dole Plantation for assistance in time-course leaf sample collection; G. Sanewski for providing the MD2 pedigree; and M. Cushman for providing clarifying comments on the manuscript. This project is supported by funding from the Fujian Agriculture and Forestry University to R. M.; a USDA T-START grant through the University of Hawaii to Q.Y., R.M., P.H.M. and R.E.P.; and funding from the University of Illinois at Urbana-Champaign to R.M. H.T. is supported by the 100 Talent Plan award from the Fujian provincial government. Analyses of the pineapple genome are supported by the following funding sources: US National Science Foundation (NSF) Plant Genome Program grant 0922545 to R.M., P.H.M. and Q.Y. and NSF grant DBI-1401572 to R.V.; NSF grant IOS-1444567 to J.H.L.-M.; and US National Institutes of Health award R01-HG006677 and US NSF awards DBI-1350041 and DBI-1265383 to M.C.S. W.C.Y., H.-B.G., H.G., G.A.T., X.Y. and J.C.C. acknowledge support from the US Department of Energy, Office of Science, Genomic Science Program, under award DE-SC0008834.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Antony E, 2008, J EXP BOT, V59, P1895, DOI 10.1093/jxb/ern077; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bartholomew D. P., 2002, PINEAPPLE BOT PRODUC; Beauman F., 2006, PINEAPPLE KING FRUIT; Borland AM, 2014, TRENDS PLANT SCI, V19, P327, DOI 10.1016/j.tplants.2014.01.006; BREWBAKER JL, 1967, AM J BOT, V54, P611, DOI 10.2307/2440666; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; CARNAL NW, 1983, PLANT PHYSIOL, V71, P150, DOI 10.1104/pp.71.1.150; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Christin PA, 2014, J EXP BOT, V65, P3609, DOI 10.1093/jxb/eru087; Clement C. R., 2010, Diversity, V2, P72; Collins, 1960, PINEAPPLE BOT CULTIV; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; DITTRICH P, 1973, PLANT PHYSIOL, V52, P357, DOI 10.1104/pp.52.4.357; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Edwards EJ, 2012, INT J PLANT SCI, V173, P724, DOI 10.1086/666098; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Holtum JAM, 2005, FUNCT PLANT BIOL, V32, P429, DOI 10.1071/FP04189; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiao YN, 2014, PLANT CELL, V26, P2792, DOI 10.1105/tpc.114.127597; KENYON WH, 1985, PLANT PHYSIOL, V77, P183, DOI 10.1104/pp.77.1.183; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kramer EM, 1998, GENETICS, V149, P765; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; McRae SR, 2002, FUNCT PLANT BIOL, V29, P717, DOI 10.1071/PP01227; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Mirarab S., 2015, RES COMPUTATIONAL MO, P177; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; NOBEL PS, 1991, NEW PHYTOL, V119, P183, DOI 10.1111/j.1469-8137.1991.tb01022.x; OSMOND CB, 1978, ANNU REV PLANT PHYS, V29, P379, DOI 10.1146/annurev.pp.29.060178.002115; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Silvera K, 2010, FUNCT PLANT BIOL, V37, P995, DOI 10.1071/FP10084; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VanBuren R., 2011, Tropical Plant Biology, V4, P228, DOI 10.1007/s12042-011-9084-3; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4311; Wang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r68; Woodhouse MR, 2011, PLANT CELL, V23, P4241, DOI 10.1105/tpc.111.093567; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang XH, 2015, NEW PHYTOL, V207, P491, DOI 10.1111/nph.13393; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	66	255	276	20	187	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1435	+		10.1038/ng.3435			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	WOS:000365813200015	26523774	hybrid, Green Accepted, Green Submitted, Green Published			2022-01-24	
J	Maller, JB; McVean, G; Byrnes, J; Vukcevic, D; Palin, K; Su, Z; Howson, JMM; Auton, A; Myers, S; Morris, A; Pirinen, M; Brown, MA; Burton, PR; Caulfield, MJ; Compston, A; Farrall, M; Hall, AS; Hattersley, AT; Hill, AVS; Mathew, CG; Pembrey, M; Satsangi, J; Stratton, MR; Worthington, J; Craddock, N; Hurles, M; Ouwehand, W; Parkes, M; Rahman, N; Duncanson, A; Todd, JA; Kwiatkowski, DP; Samani, NJ; Gough, SCL; McCarthy, MI; Deloukas, P; Donnelly, P				Maller, Julian B.; McVean, Gilean; Byrnes, Jake; Vukcevic, Damjan; Palin, Kimmo; Su, Zhan; Howson, Joanna M. M.; Auton, Adam; Myers, Simon; Morris, Andrew; Pirinen, Matti; Brown, Matthew A.; Burton, Paul R.; Caulfield, Mark J.; Compston, Alastair; Farrall, Martin; Hall, Alistair S.; Hattersley, Andrew T.; Hill, Adrian V. S.; Mathew, Christopher G.; Pembrey, Marcus; Satsangi, Jack; Stratton, Michael R.; Worthington, Jane; Craddock, Nick; Hurles, Matthew; Ouwehand, Willem; Parkes, Miles; Rahman, Nazneen; Duncanson, Audrey; Todd, John A.; Kwiatkowski, Dominic P.; Samani, Nilesh J.; Gough, Stephen C. L.; McCarthy, Mark I.; Deloukas, Panagiotis; Donnelly, Peter		Wellcome Trust Case Control Consor	Bayesian refinement of association signals for 14 loci in 3 common diseases	NATURE GENETICS			English	Article								To further investigate susceptibility loci identified by genome-wide association studies, we genotyped 5,500 SNPs across 14 associated regions in 8,000 samples from a control group and 3 diseases: type 2 diabetes (T2D), coronary artery disease (CAD) and Graves' disease. We defined, using Bayes theorem, credible sets of SNPs that were 95% likely, based on posterior probability, to contain the causal disease-associated SNPs. In 3 of the 14 regions, TCF7L2 (T2D), CTLA4 (Graves' disease) and CDKN2A-CDKN2B (T2D), much of the posterior probability rested on a single SNP, and, in 4 other regions (CDKN2A-CDKN2B (CAD) and CDKAL1, FTO and HHEX (T2D)), the 95% sets were small, thereby excluding most SNPs as potentially causal. Very few SNPs in our credible sets had annotated functions, illustrating the limitations in understanding the mechanisms underlying susceptibility to common diseases. Our results also show the value of more detailed mapping to target sequences for functional studies.	[Maller, Julian B.; McVean, Gilean; Byrnes, Jake; Vukcevic, Damjan; Su, Zhan; Auton, Adam; Myers, Simon; Morris, Andrew; Pirinen, Matti; Farrall, Martin; Hill, Adrian V. S.; Kwiatkowski, Dominic P.; McCarthy, Mark I.; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Maller, Julian B.; McVean, Gilean; Myers, Simon; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Palin, Kimmo; Stratton, Michael R.; Hurles, Matthew; Ouwehand, Willem; Kwiatkowski, Dominic P.; Deloukas, Panagiotis] Wellcome Trust Sanger Inst, Cambridge, England; [Howson, Joanna M. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Howson, Joanna M. M.; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge, England; [Brown, Matthew A.] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Burton, Paul R.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Burton, Paul R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London, England; [Compston, Alastair] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Hall, Alistair S.] Univ Leeds, LIGHT, MCRC, Leeds, W Yorkshire, England; [Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Mathew, Christopher G.] Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Pembrey, Marcus] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Worthington, Jane] Univ Manchester, Arthritis Res UK Epidemiol Unit, Manchester, Lancs, England; [Craddock, Nick] Cardiff Univ, Sch Med, Ctr Neuropsychiat Genet & Genom, MRC, Cardiff, S Glam, Wales; [Ouwehand, Willem] Univ Cambridge, Dept Haematol, Cambridge, England; [Ouwehand, Willem] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge, England; [Parkes, Miles] Addenbrookes Hosp, Inflammatory Bowel Dis Genet Res Grp, Cambridge, England; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Samani, Nilesh J.] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Glenfield Gen Hosp, Leicester Natl Inst Hlth Res NIHR, Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Gough, Stephen C. L.; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford, England; [Gough, Stephen C. L.; McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England		Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	donnelly@well.ox.ac.uk	Deloukas, Panos/B-2922-2013; Todd, John A/A-3542-2010; Palin, Kimmo/ABG-5710-2020; eyre, stephen/K-3776-2017; Dominiczak, Anna F/P-9390-2017; Myers, Simon R/A-6792-2015; Brown, Matthew A/E-5749-2010; Worthington, Jane/M-9770-2014; Hall, Alistair/K-1953-2019; Burton, Paul R/H-7527-2016; Mathew, Christopher G/G-3434-2015; Rahman, Nazneen/D-2802-2013; McCarthy, Mark/M-3763-2015	Deloukas, Panos/0000-0001-9251-070X; Todd, John A/0000-0003-2740-8148; Palin, Kimmo/0000-0002-4621-6128; eyre, stephen/0000-0002-1251-6974; Dominiczak, Anna F/0000-0003-4913-3608; Myers, Simon R/0000-0002-2585-9626; Brown, Matthew A/0000-0003-0538-8211; Worthington, Jane/0000-0003-0544-042X; Mathew, Christopher G/0000-0003-4178-1838; Weedon, Michael/0000-0002-6174-6135; Howson, Joanna/0000-0001-7618-0050; Hall, Alistair/0000-0003-0306-7887; Zeggini, Eleftheria/0000-0003-4238-659X; Pirinen, Matti/0000-0002-1664-1350; McVean, Gil/0000-0002-5012-4162; Lango Allen, Hana/0000-0002-7803-8688; Harrison, Pille/0000-0003-4117-6910; Ouwehand, Willem/0000-0002-7744-1790; Walker, Neil/0000-0001-9796-7688; Hattersley, Andrew/0000-0001-5620-473X; Donnelly, Peter/0000-0001-9495-3408; Wain, Louise/0000-0003-4951-1867; Wallace, Chris/0000-0001-9755-1703; Hocking / Mennie, Lynne J/0000-0002-2414-2826; Maller, Julian/0000-0002-1565-9559; Vukcevic, Damjan/0000-0001-7780-9586; Rahman, Nazneen/0000-0003-4376-0440; Parkes, Miles/0000-0002-6467-0631; McCarthy, Mark/0000-0002-4393-0510; bennett, amanda/0000-0003-2140-8710; Newman, William/0000-0002-6382-4678; Kwiatkowski, Dominic/0000-0002-5023-0176; Mentzer, Alexander/0000-0002-4502-2209; Munroe, Patricia/0000-0002-4176-2947; Caulfield, Mark/0000-0001-9295-3594; Burren, Oliver/0000-0002-3388-5760; Lindgren, Cecilia/0000-0002-4903-9374	Wellcome TrustWellcome TrustEuropean Commission; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory; NIHR Biomedical Research Centers; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600329, G0800759, G19/9, G1100226, G0800675, G9521010] Funding Source: UKRI; British Heart FoundationBritish Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600329, G0801418B, G9521010, G0800759, G19/9, G1100226, G0800675, G0600718B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10275, NF-SI-0508-10335, NF-SI-0611-10219] Funding Source: researchfish; Chief Scientist Office [ETM/137, ETM/75, CZB/4/540] Funding Source: researchfish	We are grateful to D. Altshuler and colleagues at the Broad Institute for provision of SNP discovery information in some of our fine-mapping regions. We acknowledge the many physicians, research fellows and research nurses who contributed to the various case collections and the collection teams and senior management of the UK Blood Services responsible for the UK Blood Services Collection. The principal funder of the project was the Wellcome Trust. For the 1958 Birth Cohort, venous blood collection was funded by the UK Medical Research Council, and cell line production and DNA extraction and processing were funded by the Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory. Many of the authors of this paper received funding from the NIHR Biomedical Research Centers.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639	7	255	257	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1294	1301		10.1038/ng.2435			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	WOS:000311713200005	23104008	Green Accepted, Green Published			2022-01-24	
J	Olcaydu, D; Harutyunyan, A; Jager, R; Berg, T; Gisslinger, B; Pabinger, I; Gisslinger, H; Kralovics, R				Olcaydu, Damla; Harutyunyan, Ashot; Jaeger, Roland; Berg, Tiina; Gisslinger, Bettina; Pabinger, Ingrid; Gisslinger, Heinz; Kralovics, Robert			A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms	NATURE GENETICS			English	Article							TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ACTIVATING MUTATION; MYELOID METAPLASIA; GENETIC-VARIATION; DISORDERS; MYELOFIBROSIS; HETEROGENEITY; CANCER; TUMORS	Genome-wide association studies have identified a number of new disease susceptibility loci that represent haplotypes defined by numerous SNPs. SNPs within a disease-associated haplotype are thought to influence either the expression of genes or the sequence of the proteins they encode. In a series of investigations of the JAK2 gene in myeloproliferative neoplasms, we uncovered a new property of haplotypes that can explain their disease association. We observed a nonrandom distribution of the somatic JAK2(V617F) oncogenic mutation between two parental alleles of the JAK2 gene. We identified a haplotype that preferentially acquires JAK2(V617F) and confers susceptibility to myeloproliferative neoplasms. One interpretation of our results is that a certain combination of SNPs may render haplotypes differentially susceptible to somatic mutagenesis. Thus, disease susceptibility loci may harbor somatic mutations that have a role in disease pathogenesis.	[Olcaydu, Damla; Harutyunyan, Ashot; Jaeger, Roland; Berg, Tiina; Kralovics, Robert] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Gisslinger, Bettina; Pabinger, Ingrid; Gisslinger, Heinz; Kralovics, Robert] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Blood Coagulat, Vienna, Austria		Kralovics, R (corresponding author), Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria.	robert.kralovics@cemm.oeaw.ac.at	Harutyunyan, Ashot S/M-3528-2014	Harutyunyan, Ashot S/0000-0002-9050-9315; Kralovics, Robert/0000-0002-6997-8539; Jager, Roland/0000-0003-4530-1344	Austrian Academy of Sciences; Austrian Science FundAustrian Science Fund (FWF) [P20033-B11]; Medical University of Vienna	The study was supported by funding from the Austrian Academy of Sciences, Austrian Science Fund (FWF, P20033-B11) and the Initiative for Cancer Research of the Medical University of Vienna. We thank C. Ay and N. Bachhofner for help with sample collection and T. Burkard for advice on statistical analysis. We thank H. Pickersgill for help with the manuscript.	Agaiwy A, 2008, AM J SURG PATHOL, V32, P1553, DOI 10.1097/PAS.0b013e31817587ea; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Laghi L, 2001, BRIT J CANCER, V84, P196, DOI 10.1054/bjoc.2000.1560; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LEVI S, 1991, CANCER RES, V51, P3497; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li S, 2008, BLOOD, V111, P3863, DOI 10.1182/blood-2007-09-111971; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Mechanic LE, 2007, CANCER EPIDEM BIOMAR, V16, P214, DOI 10.1158/1055-9965.EPI-06-0790; Moskaluk CA, 1997, CANCER RES, V57, P2140; Pardanani A, 2008, BLOOD, V111, P2785, DOI 10.1182/blood-2007-06-095703; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; SOZZI G, 1995, CANCER RES, V55, P135	22	255	263	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					450	454		10.1038/ng.341			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	WOS:000264659000019	19287385				2022-01-24	
J	Chuck, G; Meeley, R; Irish, E; Sakai, H; Hake, S				Chuck, George; Meeley, Robert; Irish, Erin; Sakai, Hajime; Hake, Sarah			The maize tasselseed4 microRNA controls sex determination and meristem cell fate by targeting Tasselseed6/indeterminate spikelet1	NATURE GENETICS			English	Article							FLORAL ORGAN IDENTITY; GENES; EXPRESSION; MUTANTS; PROTEIN; BOUNDARY; APETALA2; ENCODES; DOMAIN	In maize ( Zea mays), sex determination occurs through abortion of female carpels in the tassel and arrest of male stamens in the ear. The Tasselseed6 ( Ts6) and tasselseed4 ( ts4) mutations permit carpel development in the tassel while increasing meristem branching, showing that sex determination and acquisition of meristem fate share a common pathway. We show that ts4 encodes a mir172 microRNA that targets APETALA2 floral homeotic transcription factors. Three lines of evidence suggest that indeterminate spikelet1 ( ids1), an APETALA2 gene required for spikelet meristem determinacy, is a key target of ts4. First, loss of ids1 suppresses the ts4 sex determination and branching defects. Second, Ts6 mutants phenocopy ts4 and possess mutations in the microRNA binding site of ids1. Finally, IDS1 protein is expressed more broadly in ts4 mutants compared to wild type. Our results demonstrate that sexual identity in maize is acquired by limiting floral growth through negative regulation of the floral homeotic pathway.	Univ Calif Albany, USDA Agr Res Serv, Plant Gene Express Ctr, Albany, CA 94710 USA; Pioneer A DuPont Co, Johnston, IA 50131 USA; Univ Iowa, Dept Sci Biol, Iowa City, IA 52242 USA; Dupont Crop Genet, Wilmington, DE 19880 USA		Chuck, G (corresponding author), Univ Calif Albany, USDA Agr Res Serv, Plant Gene Express Ctr, Albany, CA 94710 USA.	gchuck@nature.berkeley.edu	Irish, Erin/C-7331-2016	Irish, Erin/0000-0003-4244-7938			Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; Irish EE, 1997, AM J BOT, V84, P1502, DOI 10.2307/2446611; IRISH EE, 1994, DEV GENET, V15, P155, DOI 10.1002/dvg.1020150206; JACKSON D, 1994, DEVELOPMENT, V120, P405; JACKSON D, 1991, MOL PLANT PATHOL, P163; Kaplinsky NJ, 2003, DEVELOPMENT, V130, P1149, DOI 10.1242/dev.00336; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; NICKERSON NORTON H., 1959, ANN MISSOURI BOT GARD, V46, P19, DOI 10.2307/2394566; Okamuro JK, 1997, PLANT CELL, V9, P37, DOI 10.1105/tpc.9.1.37; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Phipps IF, 1928, J HERED, V19, P399, DOI 10.1093/oxfordjournals.jhered.a103030; POSTLETHEWAIT SN, 1964, AM J BOT, V51, P238, DOI 10.2307/2440292; Reeves R, 1996, BIOCHEMISTRY-US, V35, P5063, DOI 10.1021/bi952424p; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; VEIT B, 1993, PLANT CELL, V5, P1205, DOI 10.1105/tpc.5.10.1205; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Zhao L, 2007, PLANT J, V51, P840, DOI 10.1111/j.1365-313X.2007.03181.x	26	255	282	5	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1517	1521		10.1038/ng.2007.20			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	WOS:000251267400022	18026103				2022-01-24	
J	Blow, MJ; Grocock, RJ; van Dongen, S; Enright, AJ; Dicks, E; Futreal, PA; Wooster, R; Stratton, MR				Blow, Matthew J.; Grocock, Russell J.; van Dongen, Stijn; Enright, Anton J.; Dicks, Ed; Futreal, P. Andrew; Wooster, Richard; Stratton, Michael R.			RNA editing of human microRNAs	GENOME BIOLOGY			English	Article							NUCLEAR EXPORT; ADENOSINE DEAMINASES; IDENTIFICATION; GENES; INTERFERENCE; BIOGENESIS; EXPRESSION; DICER; ACT	Background: MicroRNAs ( miRNAs) are short RNAs of around 22 nucleotides that regulate gene expression. The primary transcripts of miRNAs contain double-stranded RNA and are therefore potential substrates for adenosine to inosine (A- to- I) RNA editing. Results: We have conducted a survey of RNA editing of miRNAs from ten human tissues by sequence comparison of PCR products derived from matched genomic DNA and total cDNA from the same individual. Six out of 99 ( 6%) miRNA transcripts from which data were obtained were subject to A- to- I editing in at least one tissue. Four out of seven edited adenosines were in the mature miRNA and were predicted to change the target sites in 3' untranslated regions. For a further six miRNAs, we identified A- to- I editing of transcripts derived from the opposite strand of the genome to the annotated miRNA. These miRNAs may have been annotated to the wrong genomic strand. Conclusion: Our results indicate that RNA editing increases the diversity of miRNAs and their targets, and hence may modulate miRNA function.	Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England		Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk	Enright, Anton/F-3094-2011; Blow, Matthew/G-6369-2012	Enright, Anton/0000-0002-6090-3100; Blow, Matthew/0000-0002-8844-9149	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Enright AJ, 2004, GENOME BIOL, V5; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2004, RNA, V10, P171, DOI 10.1261/rna.5191904; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mattocks C, 2000, HUM MUTAT, V16, P437, DOI 10.1002/1098-1004(200011)16:5<437::AID-HUMU9>3.3.CO;2-H; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; RNA EDITING SEQUENCE	42	255	270	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2006	7	4							R27	10.1186/gb-2006-7-4-r27			8	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	054WS	WOS:000238409900010	16594986	hybrid, Green Published			2022-01-24	
J	Dufresne, A; Garczarek, L; Partensky, F				Dufresne, A; Garczarek, L; Partensky, F			Accelerated evolution associated with genome reduction in a free-living prokaryote	GENOME BIOLOGY			English	Article							STRATIFIED WATER COLUMN; CYANOBACTERIUM PROCHLOROCOCCUS; SEQUENCE; MARINE; MUTATIONS; BUCHNERA; SYMBIONT; ECOTYPES; ORIGIN	Background: Three complete genomes of Prochlorococcus species, the smallest and most abundant photosynthetic organism in the ocean, have recently been published. Comparative genome analyses reveal that genome shrinkage has occurred within this genus, associated with a sharp reduction in G+C content. As all examples of genome reduction characterized so far have been restricted to endosymbionts or pathogens, with a host-dependent lifestyle, the observed genome reduction in Prochlorococcus is the first documented example of such a process in a free-living organism. Results: Our results clearly indicate that genome reduction has been accompanied by an increased rate of protein evolution in P. marinus SS120 that is even more pronounced in P. marinus MED4. This acceleration has affected every functional category of protein-coding genes. In contrast, the 16S rRNA gene seems to have evolved clock-like in this genus. We observed that MED4 and SS120 have lost several DNA-repair genes, the absence of which could be related to the mutational bias and the acceleration of amino-acid substitution. Conclusions: We have examined the evolutionary mechanisms involved in this process, which are different from those known from host-dependent organisms. Indeed, most substitutions that have occurred in Prochlorococcus have to be selectively neutral, as the large size of populations imposes low genetic drift and strong purifying selection. We assume that the major driving force behind genome reduction within the Prochlorococcus radiation has been a selective process favoring the adaptation of this organism to its environment. A scenario is proposed for genome evolution in this genus.	CNRS, Biol Stn, UMR 1727, F-29682 Roscoff, France; Univ Paris 06, F-29682 Roscoff, France		Partensky, F (corresponding author), CNRS, Biol Stn, UMR 1727, BP74, F-29682 Roscoff, France.	partensky@sb-roscoff.fr	Partensky, Frederic/B-9194-2018; Partensky, Frederic/AAH-1170-2021	Partensky, Frederic/0000-0003-1274-4050; Partensky, Frederic/0000-0003-1274-4050; Dufresne, Alexis/0000-0001-8231-9098			Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson SGE, 1996, J MOL EVOL, V42, P525, DOI 10.1007/BF02352282; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1016/S0378-1097(02)00934-5; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fuller NJ, 2003, APPL ENVIRON MICROB, V69, P2430, DOI 10.1128/AEM.69.5.2430-2443.2003; Garcia-Pichel F., 2009, ALGOLOG STUD, V109, P213, DOI 10.1127/1864-1318/2003/0109-0213; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Hess WR, 2004, CURR OPIN BIOTECH, V15, P191, DOI 10.1016/j.copbio.2004.03.007; Horst JP, 1999, TRENDS MICROBIOL, V7, P29, DOI 10.1016/S0966-842X(98)01424-3; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Koonin EV, 1996, CURR BIOL, V6, P404, DOI 10.1016/S0960-9822(02)00508-0; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lambert JD, 1998, P NATL ACAD SCI USA, V95, P4458, DOI 10.1073/pnas.95.8.4458; LAWRENCE JG, 1999, ORG PROKARYOTIC GENO, P263; MACKAY WJ, 1994, J BACTERIOL, V176, P3224, DOI 10.1128/jb.176.11.3224-3230.1994; Martin W, 2003, P NATL ACAD SCI USA, V100, P8612, DOI 10.1073/pnas.1633606100; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Nei M., 2000, MOL EVOLUTION PHYLOG; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; PARTENSKY F, 1999, MARINE CYANOBACTERIA, P457; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P83, DOI 10.1093/oxfordjournals.molbev.a026040; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	46	255	267	2	38	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2005	6	2							R14	10.1186/gb-2005-6-2-r14			10	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	897SX	WOS:000227026500010	15693943	Green Published, hybrid			2022-01-24	
J	Rocha, EPC				Rocha, EPC			Codon usage bias from tRNA's point of view: Redundancy, specialization, and efficient decoding for translation optimization	GENOME RESEARCH			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; NATURAL-SELECTION; ADAPTATION INDEX; EVOLUTION; GENOME; DNA; ABUNDANCE; ORGANIZATION; PERSPECTIVE	The selection-mutation-drift theory of codon usage plays a major role in the theory of molecular evolution by explaining the co-evolution of codon usage bias and tRNA content in the framework of translation optimization. Because most Studies have focused only on codon usage, we analyzed the tRNA gene pool of 102 bacterial species. We show that as minimal generation times get shorter, the genomes contain more tRNA genes, but fewer anticodon species. Surprisingly, despite the wide G+C variation of bacterial genomes these anticodons are the same in most genomes. This suggests an optimization of the translation machinery to use a small subset of optimal coclons and anticodons in fast-growing bacteria and in highly expressed genes. As a result, the overrepresented codons in highly expressed genes tend to be the same in very different genomes to match the same most-frequent anticodons. This is particularly important in fast-growing bacteria, which have higher codon usage bias in these genes. Three models were tested to understand the choice of coclons recognized by the same anticodons, all providing significant fit, but under different classes of genes and genomes. Thus, co-evolution of tRNA gene composition and codon usage bias in genomes seen from tRNA's point of view agrees with the selection-mutation-drift theory. However, it Suggests a Much more universal trend in the evolution of anticodon and codon choice than previously thought. It also provides new evidence that a selective force for the optimization of the translation machinery is the maximization of growth.	Inst Pasteur, Unite Genet Genomes Bacteriens, F-75724 Paris 15, France; Univ Paris 06, F-75005 Paris, France		Rocha, EPC (corresponding author), Inst Pasteur, Unite Genet Genomes Bacteriens, F-75724 Paris 15, France.	erocha@pasteur.fr	Rocha, Eduardo/B-7009-2009; Rocha, Eduardo/A-4727-2008	Rocha, Eduardo/0000-0001-7704-822X; 			AKASHI H, 1994, GENETICS, V136, P927; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Berg OG, 1997, J MOL BIOL, V270, P544, DOI 10.1006/jmbi.1997.1142; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BULMER M, 1991, GENETICS, V129, P897; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Chiapello H, 1999, NUCLEIC ACIDS RES, V27, P2848, DOI 10.1093/nar/27.14.2848; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Francino MP, 2001, MOL BIOL EVOL, V18, P1147, DOI 10.1093/oxfordjournals.molbev.a003888; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; GROSJEAN H, 1982, GENE, V18, P199, DOI 10.1016/0378-1119(82)90157-3; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; KANO A, 1991, J MOL BIOL, V221, P387, DOI 10.1016/0022-2836(91)80061-X; Karlin S, 1996, J MOL BIOL, V262, P459, DOI 10.1006/jmbi.1996.0528; Lim VI, 2001, RNA, V7, P942, DOI 10.1017/S135583820100214X; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; McAdams HH, 2004, NAT REV GENET, V5, P169, DOI 10.1038/nrg1292; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Moszer I, 1999, CURR OPIN MICROBIOL, V2, P524, DOI 10.1016/S1369-5274(99)00011-9; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; OSAWA S, 1988, P NATL ACAD SCI USA, V85, P1124, DOI 10.1073/pnas.85.4.1124; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Percudani R, 1999, MOL BIOL EVOL, V16, P1752, DOI 10.1093/oxfordjournals.molbev.a026087; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; SUEOKA N, 1962, P NATL ACAD SCI USA, V48, P582, DOI 10.1073/pnas.48.4.582; Suzuki Y, 2001, BIOINFORMATICS, V17, P660, DOI 10.1093/bioinformatics/17.7.660; THOMAS LK, 1988, P NATL ACAD SCI USA, V85, P4242, DOI 10.1073/pnas.85.12.4242; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xia XH, 1996, GENETICS, V144, P1309; YAMAO F, 1991, NUCLEIC ACIDS RES, V19, P6119, DOI 10.1093/nar/19.22.6119; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Yokoyama Shigeyuki, 1995, P207	61	255	267	2	21	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2004	14	11					2279	2286		10.1101/gr.2896904			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	868LC	WOS:000224914100009	15479947	Bronze, Green Published			2022-01-24	
J	Simpson, MA; Cross, H; Proukakis, C; Priestman, DA; Neville, DCA; Reinkensmeier, G; Wang, H; Wiznitzer, M; Gurtz, K; Verganelaki, A; Pryde, A; Patton, MA; Dwek, RA; Butters, TD; Platt, FM; Crosby, AH				Simpson, MA; Cross, H; Proukakis, C; Priestman, DA; Neville, DCA; Reinkensmeier, G; Wang, H; Wiznitzer, M; Gurtz, K; Verganelaki, A; Pryde, A; Patton, MA; Dwek, RA; Butters, TD; Platt, FM; Crosby, AH			Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase	NATURE GENETICS			English	Article							HUMAN SERUM; GANGLIOSIDES; GLYCOSPHINGOLIPIDS; BIOSYNTHESIS; COMPLEX	We identified an autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness. Assuming a founder effect in a large Old Order Amish pedigree, we carried out a genome-wide screen for linkage and identified a single region of homozygosity on chromosome 2p12-p11.2 spanning 5.1 cM (maximum lod score of 6.84). We sequenced genes in the region and identified a nonsense mutation in SIAT9, which is predicted to result in the premature termination of the GM3 synthase enzyme (also called lactosylceramide alpha-2,3 sialyltransferase). GM3 synthase is a member of the sialyltransferase family and catalyzes the initial step in the biosynthesis of most complex gangliosides from lactosylceramide. Biochemical analysis of plasma glycosphingolipids confirmed that affected individuals lack GM3 synthase activity, as marked by a complete lack of GM3 ganglioside and its biosynthetic derivatives and an increase in lactosylceramide and its alternative derivatives. Although the relationship between defects in ganglioside catabolism and a range of lysosomal storage diseases is well documented, this is the first report, to our knowledge, of a disruption of ganglioside biosynthesis associated with human disease.	Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England; Univ Arizona, Sch Med, Dept Ophthalmol, Tucson, AZ USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Windows Hope Genet Studies, Kimmeridge Trail, OH 44065 USA		Crosby, AH (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Med Genet, Cranmer Terrace, London SW17 0RE, England.	acrosby@sghms.ac.uk	Simpson, Michael/F-4737-2011; proukakis, christos/ABE-3447-2020; Crosby, Andrew H/E-2218-2015; Proukakis, Christos/G-4548-2013; Platt, Frances/G-1004-2010	Simpson, Michael/0000-0002-8539-8753; proukakis, christos/0000-0001-6423-6539; Crosby, Andrew H/0000-0003-3667-9054; Neville, David/0000-0003-2385-8993; Platt, Frances/0000-0001-7614-0403; Verganelaki, Argyro/0000-0001-8748-1078			Datta AK, 2001, J BIOL CHEM, V276, P15200, DOI 10.1074/jbc.M010542200; Gardiner RM, 2000, J NEUROL, V247, P327, DOI 10.1007/s004150050598; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200; IZUMI T, 1993, PEDIATR NEUROL, V9, P293, DOI 10.1016/0887-8994(93)90066-L; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Kobayashi T, 2000, GLYCOCONJUGATE J, V17, P163, DOI 10.1023/A:1026528921085; KUNDU SK, 1985, ARCH BIOCHEM BIOPHYS, V238, P388, DOI 10.1016/0003-9861(85)90179-1; MAX SR, 1974, NEW ENGL J MED, V291, P929, DOI 10.1056/NEJM197410312911802; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Negroni E, 1996, GLYCOCONJUGATE J, V13, P347, DOI 10.1007/BF00731466; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Sandhoff K, 2003, PHILOS T R SOC B, V358, P847, DOI 10.1098/rstb.2003.1265; Schapiro FB, 1998, AM J PHYSIOL-CELL PH, V274, pC319, DOI 10.1152/ajpcell.1998.274.2.C319; SENN HJ, 1992, ATHEROSCLEROSIS, V94, P109, DOI 10.1016/0021-9150(92)90235-9; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yu R K, 1975, Trans Am Neurol Assoc, V100, P261; YU RK, 1987, YALE J BIOL MED, V60, P107; ZEBDA N, 1995, FEBS LETT, V362, P161, DOI 10.1016/0014-5793(95)00234-Z; ZELLER CB, 1992, AM J PHYSIOL, V262, pC1341, DOI 10.1152/ajpcell.1992.262.6.C1341	22	255	263	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1225	1229		10.1038/ng1460			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	WOS:000224832800028	15502825	Bronze			2022-01-24	
J	Xu, SZ				Xu, SZ			Estimating polygenic effects using markers of the entire genome	GENETICS			English	Article							QUANTITATIVE-TRAIT LOCI; L-SHAPED DISTRIBUTION; MONTE-CARLO; SELECTION; MAPS	Molecular markers have been used to map quantitative trait loci. However, they are rarely used to evaluate effects of chromosome segments of the entire genome. The original interval-mapping approach and various modified versions of it may have limited use in evaluating the genetic effects of the entire genome because they require evaluation of multiple models and model selection. Here we present a Bayesian regression method to simultaneously estimate genetic effects associated with markers of the entire genome. With the Bayesian method, we were able to handle situations in which the number of effects is even larger than the number of observations. The key to the success is that we allow each marker effect to have its own variance parameter, which in turn has its own prior distribution so that the variance can be estimated from the data. Under this hierarchical model, we were able to handle a large number of markers and most of the markers may have negligible effects. As a result, it is possible to evaluate the distribution of the marker effects. Using data from the North American Barley Genome Mapping Project in double-haploid barley, we found that the distribution of gene effects follows closely an L-shaped Gamma distribution, which is in contrast to the bell-shaped Gamma distribution when the gene effects were estimated from interval mapping. In addition, we show that the Bayesian method serves as an alternative or even better QTL mapping method because it produces clearer signals for QTL. Similar results were found from simulated data sets of F-2 and backcross (BC) families.	Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA		Xu, SZ (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM55321] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM055321] Funding Source: NIH RePORTER		Ball RD, 2001, GENETICS, V159, P1351; Bost B, 2001, GENETICS, V157, P1773; Bost B, 1999, GENETICS, V153, P2001; BROWMAN KW, 2002, J ROY STAT SOC B, V64, P1; CHURCHILL GA, 1994, GENETICS, V138, P963; EDWARDS MD, 1987, GENETICS, V116, P113; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Hoerl A.E., 1970, TECHNOMETRICS, V12, P68; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; Kao CH, 1999, GENETICS, V152, P1203; LANDER ES, 1989, GENETICS, V121, P185; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackay TFC, 1996, BIOESSAYS, V18, P113, DOI 10.1002/bies.950180207; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Meuwissen THE, 2001, GENETICS, V157, P1819; Otto SP, 2000, GENETICS, V156, P2093; Piepho HP, 2001, GENETICS, V157, P425; Satagopan JM, 1996, GENETICS, V144, P805; Sen S, 2001, GENETICS, V159, P371; Sillanpaa MJ, 1998, GENETICS, V148, P1373; SILLANPAA MJ, 2002, TRENDS GENET, V159, P371; Tinker NA, 1996, CROP SCI, V36, P1053, DOI 10.2135/cropsci1996.0011183X003600040040x; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Yi NJ, 2001, GENETICS, V157, P1759; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	29	255	276	0	21	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	FEB	2003	163	2					789	801					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	653CG	WOS:000181417200030	12618414				2022-01-24	
J	Zhang, JZ; Zhang, YP; Rosenberg, HF				Zhang, JZ; Zhang, YP; Rosenberg, HF			Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey	NATURE GENETICS			English	Article							POSITIVE DARWINIAN SELECTION; RAPID EVOLUTION; SUBSTITUTIONS; FEATURES; PROTEIN; RATES	Although the complete genome sequences of over 50 representative species have revealed the many duplicated genes in all three domains of life(1-4), the roles of gene duplication in organismal adaptation and biodiversity are poorly understood. In addition, the evolutionary forces behind the functional divergence of duplicated genes are often unknown, leading to disagreement on the relative importance of positive Darwinian selection versus relaxation of functional constraints in this process(5-10). The methodology of earlier studies relied largely on DNA sequence analysis but lacked functional assays of duplicated genes, frequently generating contentious results(11,12). Here we use both computational and experimental approaches to address these questions in a study of the pancreatic ribonuclease gene (RNASE1) and its duplicate gene (RNASE1B) in a leaf-eating colobine monkey, douc langur. We show that RNASE1B has evolved rapidly under positive selection for enhanced ribonucleolytic activity in an altered microenvironment, a response to increased demands for the enzyme for digesting bacterial RNA. At the same time, the ability to degrade double-stranded RNA, a non-digestive activity characteristic of primate RNASE1, has been lost in RNASE1B, indicating functional specialization and relaxation of purifying selection. Our findings demonstrate the contribution of gene duplication to organismal adaptation and show the power of combining sequence analysis and functional assays in delineating the molecular basis of adaptive evolution.	NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China		Zhang, JZ (corresponding author), NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.						BARNARD EA, 1969, NATURE, V221, P340, DOI 10.1038/221340a0; BEINTEMA JJ, 1990, MOL BIOL EVOL, V7, P470; BROOKFIELD JFY, 1994, TRENDS GENET, V10, P109, DOI 10.1016/0168-9525(94)90201-1; Charlesworth B, 1999, NATURE, V400, P519, DOI 10.1038/22922; CODE CF, 1968, HDB PHYSL, V3; Delson Eric, 1994, P11; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gaudieri S, 1999, GENOME RES, V9, P541; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; GOODMAN M, 1975, NATURE, V253, P603, DOI 10.1038/253603a0; Hall, 1996, TXB MED PHYSL; Hughes A. L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Kay Robin N. B., 1994, P229; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LI WH, 1983, MOL BIOL EVOL, V1, P94; LI WH, 1997, MOL EVOLUTION, P221; LIBONATI M, 1969, EUR J BIOCHEM, V8, P81, DOI 10.1111/j.1432-1033.1969.tb00498.x; Lynch M, 2000, GENETICS, V154, P459; Makarova KS, 1999, GENOME RES, V9, P608; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; ROSENBERG HF, 1995, J BIOL CHEM, V270, P21539, DOI 10.1074/jbc.270.37.21539; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; TAJIMA F, 1993, GENETICS, V135, P599; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007; [No title captured]	33	255	287	2	55	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					411	415		10.1038/ng852			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	WOS:000174682000019	11925567				2022-01-24	
J	Cuesta, A; Pedrola, L; Sevilla, T; Garcia-Planells, J; Chumillas, MJ; Mayordomo, F; LeGuern, E; Marin, I; Vilchez, JJ; Palau, F				Cuesta, A; Pedrola, L; Sevilla, T; Garcia-Planells, J; Chumillas, MJ; Mayordomo, F; LeGuern, E; Marin, I; Vilchez, JJ; Palau, F			The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease	NATURE GENETICS			English	Article							CMT4A LOCUS; TRANSFERASES	We identified three distinct mutations and six mutant alleles in GDAP1 in three families with axonal Charcot-Marie-Tooth (CMT) neuropathy and vocal cord paresis, which were previously linked to the CMT4A locus on chromosome 8q21.1. These results establish the molecular etiology of CMT4A (MIM 214400) and suggest that it may be associated with both axonal and demyelinating phenotypes.	CSIC, Inst Biomed, Lab Genet & Mol Med, E-46010 Valencia, Spain; Univ Valencia, Hosp La Fe, Dept Neurol, E-46100 Valencia, Spain; Univ Valencia, Hosp La Fe, Dept Clin Neurophysiol, E-46100 Valencia, Spain; Univ Valencia, Hosp La Fe, Dept Pathol, E-46100 Valencia, Spain; Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris, France; Hop La Pitie Salpetriere, Dept Genet Cytogenet & Foetopathol, F-75651 Paris, France; Univ Valencia, Dept Genet, E-46100 Valencia, Spain; Univ Valencia, Inst Cavanilles Biodivers & Biol Evolut, E-46100 Valencia, Spain		Palau, F (corresponding author), CSIC, Inst Biomed, Lab Genet & Mol Med, Jaime Roig 11, E-46010 Valencia, Spain.	fpalau@ibv.csic.es	Palau, Francesc/A-9391-2014; Marin, Ignacio/A-9524-2009; Sevilla, Teresa/L-3292-2017	Palau, Francesc/0000-0002-8635-5421; Marin, Ignacio/0000-0002-1315-8961; Garcia-Planells, Javier/0000-0002-3224-2966; Pedrola, Laia/0000-0002-3031-6124; Vilchez, Juan J/0000-0002-0532-2872			Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; Ben Othmane K, 1998, NEUROGENETICS, V2, P18, DOI 10.1007/s100480050047; BENOTHMANE K, 1995, GENOMICS, V28, P286, DOI 10.1006/geno.1995.1143; Dyck PJ, 1993, PERIPHERAL NEUROPATH, P1094; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HENTATI F, 2001, ACTA MYOL, V20, P25; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lewis RA, 2000, MUSCLE NERVE, V23, P1472, DOI 10.1002/1097-4598(200010)23:10<1472::AID-MUS3>3.0.CO;2-#; Liu H, 1999, J NEUROCHEM, V72, P1781, DOI 10.1046/j.1471-4159.1999.0721781.x; LUPSKI JR, 2001, METABOLIC MOL BASES, P5759; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Salinas AE, 1999, CURR MED CHEM, V6, P279; SEVILLA T, 2001, ACTA MYOL, V20, P49	14	255	263	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					22	25		10.1038/ng798			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	WOS:000173105600007	11743580				2022-01-24	
J	Snel, B; Bork, P; Huynen, MA				Snel, B; Bork, P; Huynen, MA			Genomes in flux: The evolution of archaeal and proteobacterial gene content	GENOME RESEARCH			English	Article							HAEMOPHILUS-INFLUENZAE; UNIVERSAL ANCESTOR; ESCHERICHIA-COLI; PROTEIN FAMILIES; COMMON ANCESTOR; SEQUENCE; PERSPECTIVE; PHYLOGENY	In the course of evolution, genomes are shaped by processes like gene loss, gene duplication, horizontal gene transfer, and gene genesis (the de novo origin of genes). Here we reconstruct the gene content of ancestral Archaea and Proteobacteria and quantify the processes connecting them to their present day representatives based on the distribution of genes in completely sequenced genomes. We estimate that the ancestor of the Proteobacteria contained around 2500 genes, and the ancestor of the Archaea around 2050 genes. Although it is necessary to invoke horizontal gene transfer to explain the content of present day genomes, gene loss, gene genesis, and simple vertical inheritance are quantitatively the most dominant processes in shaping the genome. Together they result in a turnover of gene content such that even the lineage leading from the ancestor of the Proteobacteria to the relatively large genome of Escherichia coli has lost at least 950 genes. Gene loss, unlike the other processes, correlates fairly well with time. This clock-like behavior Suggests that gene loss is under negative selection, while the processes that add genes are under positive selection.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany		Snel, B (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.		Snel, Berend/B-8886-2011; Bork, Peer/F-1813-2013; Huijnen, M.A./H-8051-2014; Huynen, Martijn A/A-1530-2014	Snel, Berend/0000-0002-5804-8547; Bork, Peer/0000-0002-2627-833X; Huynen, Martijn A/0000-0001-6189-5491			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Blanchette M, 1999, J MOL EVOL, V49, P193, DOI 10.1007/PL00006542; BROWN TA, 1999, GENOMES, P329; Bruccoleri RE, 1998, NUCLEIC ACIDS RES, V26, P4482, DOI 10.1093/nar/26.19.4482; Cambillau C, 2000, J BIOL CHEM, V275, P32383, DOI 10.1074/jbc.C000497200; de Rosa R, 1998, MOL BIOL EVOL, V15, P17, DOI 10.1093/oxfordjournals.molbev.a025843; Doolittle WF, 2000, CURR OPIN STRUC BIOL, V10, P355, DOI 10.1016/S0959-440X(00)00096-8; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Gaasterland T, 1998, Microb Comp Genomics, V3, P199; GILLESPIE JH, 1998, POPULATION GENETICS, P32; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Huynen MA, 2000, ADV PROTEIN CHEM, V54, P345, DOI 10.1016/S0065-3233(00)54010-8; Huynen MA, 1999, TRENDS MICROBIOL, V7, P281, DOI 10.1016/S0966-842X(99)01539-5; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Kyrpides N, 1999, J MOL EVOL, V49, P413, DOI 10.1007/PL00006564; Makarova KS, 1999, GENOME RES, V9, P608; Ochman H, 2000, EMBO J, V19, P6637, DOI 10.1093/emboj/19.24.6637; Park J, 1998, BIOINFORMATICS, V14, P144, DOI 10.1093/bioinformatics/14.2.144; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 1996, CURR BIOL, V6, P279, DOI 10.1016/S0960-9822(02)00478-5; Teichmann SA, 1999, J MOL EVOL, V49, P98, DOI 10.1007/PL00006538; Tekaia F, 1999, GENOME RES, V9, P550; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854	35	255	266	0	15	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	JAN	2002	12	1					17	25		10.1101/gr.176501			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	508AN	WOS:000173064900003	11779827	Green Published, Bronze			2022-01-24	
J	Bartel, PL; Roecklein, JA; SenGupta, D; Fields, S				Bartel, PL; Roecklein, JA; SenGupta, D; Fields, S			A protein linkage map of Escherichia coli bacteriophage T7	NATURE GENETICS			English	Article							GENE 2.5 PROTEIN; DNA-POLYMERASE; NUCLEOTIDE-SEQUENCE; HELICASE PROTEINS; 2-HYBRID SYSTEM; RNA-POLYMERASE; YEAST; PURIFICATION; REPLICATION; PRIMASE	Genome sequencing projects are predicting large numbers of novel proteins, whose interactions with other proteins must mediate the function of cellular processes. To analyse these networks, we used the yeast two-hybrid system on a genome-wide scale to identify 25 interactions among the proteins of Escherichia coli bacteriophage T7. Among these is a set of six interactions connecting proteins that function in DNA replication and DNA packaging. Remarkably, two genes, arranged such that one entirely overlaps the other and uses a different reading frame, encode interacting proteins. Several of the interactions reflect intramolecular associations of different domains of the same polypeptide, suggesting that the two-hybrid assay may be useful in the analysis of protein folding. This global approach to protein-protein interactions may be applicable to the analysis of more complex genomes whose sequences are becoming available.	UNIV WASHINGTON,MARKEY MOLEC MED CTR,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,MARKEY MOLEC MED CTR,DEPT MED,SEATTLE,WA 98195; SUNY STONY BROOK,DEPT MOLEC GENET & MICROBIOL,STONY BROOK,NY 11794; SUNY STONY BROOK,GRAD PROGRAM MOLEC & CELLULAR BIOL,STONY BROOK,NY 11794						NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA28146] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA028146] Funding Source: NIH RePORTER		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BENDIXEN C, 1994, NUCLEIC ACIDS RES, V22, P1778, DOI 10.1093/nar/22.9.1778; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; CASJENS S, 1989, VIROLOGY, V171, P588, DOI 10.1016/0042-6822(89)90628-4; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; KIM YT, 1992, J BIOL CHEM, V267, P15032; KIM YT, 1992, J BIOL CHEM, V267, P15022; LANCY ED, 1989, J BACTERIOL, V171, P5581, DOI 10.1128/jb.171.10.5581-5586.1989; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MATSUOKATO H, 1981, VIROLOGY, V109, P157; MOFFATT BA, 1987, CELL, V49, P221, DOI 10.1016/0092-8674(87)90563-0; MOONEY PQ, 1980, NUCLEIC ACIDS RES, V8, P3043, DOI 10.1093/nar/8.13.3043; NAKAI H, 1986, J BIOL CHEM, V261, P5208; NAKAI H, 1988, J BIOL CHEM, V263, P9818; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PRINTEN JA, 1994, GENETICS, V138, P609; RAHMSDORF HJ, 1974, P NATL ACAD SCI USA, V71, P586, DOI 10.1073/pnas.71.2.586; ROEDER GS, 1977, VIROLOGY, V76, P263, DOI 10.1016/0042-6822(77)90302-6; Schiestl Robert H., 1993, Methods (Orlando), V5, P79, DOI 10.1006/meth.1993.1011; Sherman F., 1986, METHODS YEAST GENETI; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SPOEREL N, 1979, NATURE, V278, P30, DOI 10.1038/278030a0; Steven A. C., 1986, ELECT MICROSCOPY PRO, P1; STUDIER FW, 1981, J MOL BIOL, V153, P493, DOI 10.1016/0022-2836(81)90404-6	35	255	269	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					72	77		10.1038/ng0196-72			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	WOS:A1996TM55500017	8528255				2022-01-24	
J	CLUTTERBUCK, AJ				CLUTTERBUCK, AJ			A MUTATIONAL ANALYSIS OF CONIDIAL DEVELOPMENT IN ASPERGILLUS-NIDULANS	GENETICS			English	Article																	BAINBRIDGE BW, 1964, THESIS U SHEFFIELD; BRODY S, 1967, P NATL ACAD SCI USA, V58, P923, DOI 10.1073/pnas.58.3.923; CLUTTERB.AJ, 1969, J GEN MICROBIOL, V55, P291, DOI 10.1099/00221287-55-2-291; CLUTTERBUCK AJ, 1968, HEREDITY, V23, P165; CLUTTERBUCK AJ, 1968, ASPERGILLUS NEWSL, V9, P14; CLUTTERBUCK AJ, 1968, ASPERGILLUS NEWSL, V9, P26; CUTTERBUCK AJ, 1966, ASPERGILLUS NEWSL, V7, P12; DORN GL, 1967, GENETICS, V56, P619; EPSTEIN RH, 1963, COLD SPRING HARB SYM, V28, P375, DOI 10.1101/SQB.1963.028.01.053; GARNJOBST L, 1967, GENETICS, V57, P579; GRUNEBERG H, 1952, GENETICS MOUSE; HADORN E, 1955, DEVELOPMENTAL GENETI; HALVORSON HO, 1966, ANNU REV MICROBIOL, V20, P169, DOI 10.1146/annurev.mi.20.100166.001125; HAWTHORNE DC, 1964, GENETICS, V50, P829; MACKINTOSH ME, 1963, GENET RES, V4, P320, DOI 10.1017/S0016672300003670; MCCULLY KS, 1965, GENET RES, V6, P352, DOI 10.1017/S0016672300004249; MORTON AG, 1961, PROC R SOC SER B-BIO, V153, P548, DOI 10.1098/rspb.1961.0018; PATEMAN JA, 1967, BIOCHEM J, V104, P103, DOI 10.1042/bj1040103; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; RAPER K. B., 1953, Journal of the Elisha Mitchell Scientific Society, V69, P1; ROBERTS CF, 1964, GENET RES, V5, P211, DOI 10.1017/S001667230000118X; Romano AH., 1966, FUNGI ADV TREATISE, P181; SIDDIQI OH, 1962, GENET RES, V3, P303, DOI 10.1017/S0016672300035072; SINHA U, 1967, GENET RES, V10, P261, DOI 10.1017/S0016672300011022; SINHA U, 1967, THESIS U GLASGOW; Thom C, 1945, MANUAL ASPERGILLI; TURIAN G, 1966, FUNGI, V2, P339; YUILL E, 1938, BRIT MYCOL SOC T, V22, P194	28	255	272	0	9	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1969	63	2					317	+					1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F3746	WOS:A1969F374600006	5366214				2022-01-24	
J	Ionita-Laza, I; McCallum, K; Xu, B; Buxbaum, JD				Ionita-Laza, Iuliana; McCallum, Kenneth; Xu, Bin; Buxbaum, Joseph D.			A spectral approach integrating functional genomic annotations for coding and noncoding variants	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; ESTIMATING RELATIVE RISKS; INTELLECTUAL DISABILITY; GENETIC-VARIANTS; WHOLE-GENOME; EXOME; AUTISM; SCHIZOPHRENIA; PATTERNS; NETWORK	Over the past few years, substantial effort has been put into the functional annotation of variation in human genome sequences. Such annotations can have a critical role in identifying putatively causal variants for a disease or trait among the abundant natural variation that occurs at a locus of interest. The main challenges in using these various annotations include their large numbers and their diversity. Here we develop an unsupervised approach to integrate these different annotations into one measure of functional importance (Eigen) that, unlike most existing methods, is not based on any labeled training data. We show that the resulting meta-score has better discriminatory ability using disease-associated and putatively benign variants from published studies (in both coding and noncoding regions) than the recently proposed CADD score. Across varied scenarios, the Eigen score performs generally better than any single individual annotation, representing a powerful single functional score that can be incorporated in fine-mapping studies.	[Ionita-Laza, Iuliana; McCallum, Kenneth] Columbia Univ, Dept Biostat, New York, NY USA; [Xu, Bin] Columbia Univ, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA		Ionita-Laza, I (corresponding author), Columbia Univ, Dept Biostat, New York, NY USA.	ii2135@columbia.edu	Buxbaum, Joseph D/G-6001-2010	Buxbaum, Joseph/0000-0001-8898-8313	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH095797, R01 MH100233]; Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH095797] Funding Source: NIH RePORTER	This research was supported by US National Institutes of Health grants R01 MH095797 and R01 MH100233 and by the Seaver Foundation. All analyses were conducted on the Minerva HPC complex at the Icahn School of Medicine at Mount Sinai.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Capanu M, 2008, STAT MED, V27, P1973, DOI 10.1002/sim.3196; Capanu M, 2011, BIOMETRICS, V67, P371, DOI 10.1111/j.1541-0420.2010.01469.x; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0089-z; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Ko A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4983; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	46	254	256	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					214	220		10.1038/ng.3477			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	WOS:000369043900021	26727659	Green Accepted			2022-01-24	
J	Rahbari, R; Wuster, A; Lindsay, SJ; Hardwick, RJ; Alexandrov, LB; Al Turki, S; Dominiczak, A; Morris, A; Porteous, D; Smith, B; Stratton, MR; Hurles, ME				Rahbari, Raheleh; Wuster, Arthur; Lindsay, Sarah J.; Hardwick, Robert J.; Alexandrov, Ludmil B.; Al Turki, Saeed; Dominiczak, Anna; Morris, Andrew; Porteous, David; Smith, Blair; Stratton, Michael R.; Hurles, Matthew E.		UK10K Consortium	Timing, rates and spectra of human germline mutation	NATURE GENETICS			English	Article							HUMAN-DISEASE; GONADAL MOSAICISM; RECURRENCE RISK; AGE; INHERITANCE; EVOLUTION; VARIANTS; PATTERNS; GENETICS; GENOMES	Germline mutations are a driving force behind genome evolution and genetic disease. We investigated genome-wide mutation rates and spectra in multi-sibling families. The mutation rate increased with paternal age in all families, but the number of additional mutations per year differed by more than twofold between families. Meta-analysis of 6,570 mutations showed that germline methylation influences mutation rates. In contrast to somatic mutations, we found remarkable consistency in germline mutation spectra between the sexes and at different paternal ages. In parental germ line, 3.8% of mutations were mosaic, resulting in 1.3% of mutations being shared by siblings. The number of these shared mutations varied significantly between families. Our data suggest that the mutation rate per cell division is higher during both early embryogenesis and differentiation of primordial germ cells but is reduced substantially during post-pubertal spermatogenesis. These findings have important consequences for the recurrence risks of disorders caused by de novo mutations.	[Rahbari, Raheleh; Wuster, Arthur; Lindsay, Sarah J.; Hardwick, Robert J.; Alexandrov, Ludmil B.; Al Turki, Saeed; Stratton, Michael R.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton, England; [Wuster, Arthur] Genentech Inc, Dept Human Genet, San Francisco, CA 94080 USA; [Wuster, Arthur] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Dominiczak, Anna] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Morris, Andrew; Smith, Blair] Univ Dundee, Med Res Inst, Dundee, Scotland; [Porteous, David] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland		Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	meh@sanger.ac.uk	Porteous, David/AAA-3446-2021; Zheng, Houfeng/K-4424-2012; Alexandrov, Ludmil/AAS-1454-2021; Smith, Blair H/G-2834-2012; Jamshidi, Yalda/AAL-1377-2020; McQuillin, Andrew/C-1623-2008; Dominiczak, Anna F/P-9390-2017; Soler Artigas, Maria/L-6529-2013	Porteous, David/0000-0003-1249-6106; Zheng, Houfeng/0000-0001-5681-8598; Alexandrov, Ludmil/0000-0003-3596-4515; Smith, Blair H/0000-0002-5362-9430; Jamshidi, Yalda/0000-0003-0151-6482; McQuillin, Andrew/0000-0003-1567-2240; Dominiczak, Anna F/0000-0003-4913-3608; Futema, Marta/0000-0002-2120-2088; Soler Artigas, Maria/0000-0002-3213-1107; Wilson, Scott/0000-0002-0357-1373; Schmidts, Miriam/0000-0002-1714-6749; Wain, Louise/0000-0003-4951-1867; Swerdlow, Harold/0000-0002-9510-160X; Kilpinen, Helena/0000-0001-6692-6154; Lindsay, Sarah/0000-0002-0965-3070; Wuster, Arthur/0000-0003-4162-5931; Bochukova, Elena/0000-0003-0275-1548; Rahbari, Raheleh/0000-0002-1839-7785; Farooqi, Sadaf/0000-0001-7609-3504; Kelly, Kirsten/0000-0003-4234-543X; MacArthur, Daniel/0000-0002-5771-2290	Wellcome TrustWellcome TrustEuropean Commission [WT098051, WT091310]; Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_PC_15018, MR/N005813/1, MC_UU_12012/5/B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0510-10268] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N005813/1] Funding Source: UKRI	We thank D. Conrad and A. Ramu for their responsive development of the DeNovoGear software and A. Campbell and S. Kerr for their support in identifying relevant families. This research was funded by the Wellcome Trust (grant WT098051). Generation Scotland has received core funding from the Chief Scientist Office of the Scottish Government Health Directorates CZD/16/6 and the Scottish Funding Council HR03006. This study makes use of data generated by the UK10K Consortium, derived from samples from ALSPAC and TwinsUK. A full list of the investigators who contributed to the generation of the data is available from http://www.uk10k.org. Funding for UK10K was provided by the Wellcome Trust under award WT091310. Data can be accessed at the European Genome-phenome Archive (EGA) under accessions EGAS00001000108 and EGAS00001000090.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anazi S, 2014, CLIN GENET, V85, P278, DOI 10.1111/cge.12156; Bachetti T, 2014, PEDIATR PULM, V49, pE45, DOI 10.1002/ppul.22790; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Campbell IM, 2014, AM J HUM GENET, V95, P345, DOI 10.1016/j.ajhg.2014.08.010; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Coticchio G., 2013, OOGENESIS; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dhamija R, 2014, AM J MED GENET A, V164, P2356, DOI 10.1002/ajmg.a.36621; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Liu G, 2014, MOL VIS, V20, P15; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Momand JR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103440; Muller F., 1987, DEV STAGES HUMAN EMB; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sayres MAW, 2011, BIOESSAYS, V33, P938, DOI 10.1002/bies.201100091; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schaibley VM, 2013, GENOME RES, V23, P1974, DOI 10.1101/gr.154971.113; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Tajir M, 2013, GENE, V518, P476, DOI 10.1016/j.gene.2012.12.105; Venn O, 2014, SCIENCE, V344, P1272, DOI 10.1126/science.344.6189.1272; Voet T, 2011, CYTOGENET GENOME RES, V133, P160, DOI 10.1159/000324235; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030	36	254	262	8	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					126	133		10.1038/ng.3469			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	WOS:000369043900009	26656846	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Lawrenson, T; Shorinola, O; Stacey, N; Li, CD; Ostergaard, L; Patron, N; Uauy, C; Harwood, W				Lawrenson, Tom; Shorinola, Oluwaseyi; Stacey, Nicola; Li, Chengdao; Ostergaard, Lars; Patron, Nicola; Uauy, Cristobal; Harwood, Wendy			Induction of targeted, heritable mutations in barley and Brassica oleracea using RNA-guided Cas9 nuclease	GENOME BIOLOGY			English	Article						Genome editing; CRISPR/Cas9; Barley; Brassica; PM19; GA4; Crops; Mutations; Breeding; Off-target	CRISPR/CAS9 SYSTEM; GENOME MODIFICATION; POD SHATTER; ARABIDOPSIS; SPECIFICITY; DNA; GENERATION; MULTIPLEX; DELETIONS; GENES	Background: The RNA-guided Cas9 system represents a flexible approach for genome editing in plants. This method can create specific mutations that knock-out or alter target gene function. It provides a valuable tool for plant research and offers opportunities for crop improvement. Results: We investigate the use and target specificity requirements of RNA-guided Cas9 genome editing in barley (Hordeum vulgare) and Brassica oleracea by targeting multicopy genes. In barley, we target two copies of HvPM19 and observe Cas9-induced mutations in the first generation of 23 % and 10 % of the lines, respectively. In B. oleracea, targeting of BolC. GA4. a leads to Cas9-induced mutations in 10 % of first generation plants screened. In addition, a phenotypic screen identifies T-0 plants with the expected dwarf phenotype associated with knock-out of the target gene. In both barley and B. oleracea stable Cas9-induced mutations are transmitted to T-2 plants independently of the T-DNA construct. We observe off-target activity in both species, despite the presence of at least one mismatch between the single guide RNA and the non-target gene sequences. In barley, a transgene-free plant has concurrent mutations in the target and non-target copies of HvPM19. Conclusions: We demonstrate the use of RNA-guided Cas9 to generate mutations in target genes of both barley and B. oleracea and show stable transmission of these mutations thus establishing the potential for rapid characterisation of gene function in these species. In addition, the off-target effects reported offer both potential difficulties and specific opportunities to target members of multigene families in crops.	[Lawrenson, Tom; Shorinola, Oluwaseyi; Stacey, Nicola; Ostergaard, Lars; Uauy, Cristobal; Harwood, Wendy] John Innes Ctr, Colney NR4 7UH, Herts, England; [Li, Chengdao] Murdoch Univ, Western Barley Genet Alliance, Murdoch, WA 6150, Australia; [Patron, Nicola] Sainsbury Lab, Colney NR4 7UH, Herts, England		Uauy, C (corresponding author), John Innes Ctr, Norwich Res Pk, Colney NR4 7UH, Herts, England.	cristobal.uauy@jic.ac.uk; wendy.harwood@jic.ac.uk	Uauy, Cristobal/T-4382-2019; Patron, Nicola J/D-8778-2014; Ostergaard, Lars/AAA-3020-2020	Uauy, Cristobal/0000-0002-9814-1770; Patron, Nicola J/0000-0002-8389-1851; Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X; Harwood, Wendy/0000-0002-4323-9009; Shorinola, Oluwaseyi/0000-0003-3516-303X	UK Biotechnology and Biological Sciences Research Council (BBSRC)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004553/1]; BBSRC and Engineering and Physics Research Council (EPSRC) Synthetic Biology Research Centre awardUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [BB/L014130/1]; John Innes Centre Innovation fund; John Innes Foundation; Gatsby Charitable Foundation; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/J/000C0628, BB/I01800X/1, BB/M018164/1, BBS/E/T/000PR6193, BBS/E/T/000PR5885, BB/L014130/1, BB/J533055/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I01800X/1, BBS/E/J/00000613, BB/J533055/1, BB/M018164/1, BBS/E/J/000C0628, BB/L014130/1, BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish	This work was supported by the Institute Strategic Programme grant BB/J004553/1 from the UK Biotechnology and Biological Sciences Research Council (BBSRC), the BBSRC and Engineering and Physics Research Council (EPSRC) Synthetic Biology Research Centre award (BB/L014130/1), by the John Innes Centre Innovation fund, the John Innes Foundation and the Gatsby Charitable Foundation.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI [10.1016/j.pbi.2005.01.001, 10.1016/j.gde.2015.11.003]; Arnaud N, 2010, GENE DEV, V24, P2127, DOI 10.1101/gad.593410; Barrero JM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0665-6; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Borrill P, 2015, NEW PHYTOL, V208, P1008, DOI 10.1111/nph.13533; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Engler C, 2014, ACS SYNTH BIOL, V3, P839, DOI 10.1021/sb4001504; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Girin T, 2010, PLANT J, V63, P329, DOI 10.1111/j.1365-313X.2010.04244.x; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hartung F, 2014, PLANT J, V78, P742, DOI 10.1111/tpj.12413; Harwood WA, 2014, METHODS MOL BIOL, V1099, P251, DOI 10.1007/978-1-62703-715-0_20; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Ostergaard L, 2006, PLANT BIOTECHNOL J, V4, P45, DOI 10.1111/j.1467-7652.2005.00156.x; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ranford JC, 2002, J EXP BOT, V53, P147, DOI 10.1093/jexbot/53.366.147; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sparrow PAC, 2006, METH MOL B, V343, P417; Sparrow PACHN, 2015, METHODS MOL BIOL, V1223, P287, DOI 10.1007/978-1-4939-1695-5_23; Spence J, 1996, J MICROSC-OXFORD, V181, P195, DOI 10.1046/j.1365-2818.1996.111391.x; The International Wheat Genome Sequencing Consortium, 2014, SCIENCE, V345; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Weng H, 2004, PLANT MOL BIOL REP, V22, P289, DOI 10.1007/BF02773139; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	48	254	273	6	153	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	NOV 30	2015	16									10.1186/s13059-015-0826-7			13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	CX3BM	WOS:000365570500001	26616834	Green Published, gold			2022-01-24	
J	Elsik, CG; Worley, KC; Bennett, AK; Beye, M; Camara, F; Childers, CP; de Graaf, DC; Debyser, G; Deng, JX; Devreese, B; Elhaik, E; Evans, JD; Foster, LJ; Graur, D; Guigo, R; Hoff, KJ; Holder, ME; Hudson, ME; Hunt, GJ; Jiang, HY; Joshi, V; Khetani, RS; Kosarev, P; Kovar, CL; Ma, J; Maleszka, R; Moritz, RFA; Munoz-Torres, MC; Murphy, TD; Muzny, DM; Newsham, IF; Reese, JT; Robertson, HM; Robinson, GE; Rueppell, O; Solovyev, V; Stanke, M; Stolle, E; Tsuruda, JM; Van Vaerenbergh, M; Waterhouse, RM; Weaver, DB; Whitfield, CW; Wu, YQ; Zdobnov, EM; Zhang, L; Zhu, DH; Gibbs, RA				Elsik, Christine G.; Worley, Kim C.; Bennett, Anna K.; Beye, Martin; Camara, Francisco; Childers, Christopher P.; de Graaf, Dirk C.; Debyser, Griet; Deng, Jixin; Devreese, Bart; Elhaik, Eran; Evans, Jay D.; Foster, Leonard J.; Graur, Dan; Guigo, Roderic; Hoff, Katharina Jasmin; Holder, Michael E.; Hudson, Matthew E.; Hunt, Greg J.; Jiang, Huaiyang; Joshi, Vandita; Khetani, Radhika S.; Kosarev, Peter; Kovar, Christie L.; Ma, Jian; Maleszka, Ryszard; Moritz, Robin F. A.; Munoz-Torres, Monica C.; Murphy, Terence D.; Muzny, Donna M.; Newsham, Irene F.; Reese, Justin T.; Robertson, Hugh M.; Robinson, Gene E.; Rueppell, Olav; Solovyev, Victor; Stanke, Mario; Stolle, Eckart; Tsuruda, Jennifer M.; Van Vaerenbergh, Matthias; Waterhouse, Robert M.; Weaver, Daniel B.; Whitfield, Charles W.; Wu, Yuanqing; Zdobnov, Evgeny M.; Zhang, Lan; Zhu, Dianhui; Gibbs, Richard A.		HGSC Prod Teams; Honey Bee Genome Sequencing Consor	Finding the missing honey bee genes: lessons learned from a genome upgrade	BMC GENOMICS			English	Article						Apis mellifera; GC content; Gene annotation; Gene prediction; Genome assembly; Genome improvement; Genome sequencing; Repetitive DNA; Transcriptome	APIS-MELLIFERA; CLASSIFICATION-SYSTEM; DOMAIN DATABASE; TANDEM REPEATS; DRAFT GENOME; ANNOTATION; EVOLUTION; SEQUENCE; EXPRESSION; PREDICTION	Background: The first generation of genome sequence assemblies and annotations have had a significant impact upon our understanding of the biology of the sequenced species, the phylogenetic relationships among species, the study of populations within and across species, and have informed the biology of humans. As only a few Metazoan genomes are approaching finished quality (human, mouse, fly and worm), there is room for improvement of most genome assemblies. The honey bee (Apis mellifera) genome, published in 2006, was noted for its bimodal GC content distribution that affected the quality of the assembly in some regions and for fewer genes in the initial gene set (OGSv1.0) compared to what would be expected based on other sequenced insect genomes. Results: Here, we report an improved honey bee genome assembly (Amel_4.5) with a new gene annotation set (OGSv3.2), and show that the honey bee genome contains a number of genes similar to that of other insect genomes, contrary to what was suggested in OGSv1.0. The new genome assembly is more contiguous and complete and the new gene set includes similar to 5000 more protein-coding genes, 50% more than previously reported. About 1/6 of the additional genes were due to improvements to the assembly, and the remaining were inferred based on new RNAseq and protein data. Conclusions: Lessons learned from this genome upgrade have important implications for future genome sequencing projects. Furthermore, the improvements significantly enhance genomic resources for the honey bee, a key model for social behavior and essential to global ecology through pollination.	[Elsik, Christine G.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Elsik, Christine G.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Elsik, Christine G.] Univ Missouri, MU Informat Inst, Columbia, MO 65211 USA; [Elsik, Christine G.; Bennett, Anna K.; Childers, Christopher P.; Munoz-Torres, Monica C.; Reese, Justin T.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Worley, Kim C.; Deng, Jixin; Holder, Michael E.; Joshi, Vandita; Kovar, Christie L.; Muzny, Donna M.; Newsham, Irene F.; Wu, Yuanqing; Zhang, Lan; Zhu, Dianhui; Gibbs, Richard A.; HGSC Prod Teams] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Beye, Martin] Univ Dusseldorf, Inst Evolutionary Genet, D-40225 Dusseldorf, Germany; [Camara, Francisco; Guigo, Roderic] Univ Pompeu Fabra, Ctr Genom Regulat, E-08003 Barcelona, Catalonia, Spain; [Childers, Christopher P.; Reese, Justin T.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [de Graaf, Dirk C.; Van Vaerenbergh, Matthias] Univ Ghent, Lab Zoophysiol, B-9000 Ghent, Belgium; [Debyser, Griet; Devreese, Bart] Univ Ghent, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Elhaik, Eran] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; [Evans, Jay D.] USDA ARS, BARC E, Bee Res Lab, Beltsville, MD 20705 USA; [Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Graur, Dan] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Hoff, Katharina Jasmin; Stanke, Mario] Ernst Moritz Arndt Univ Greifswald, Inst Math & Comp Sci, D-17487 Greifswald, Germany; [Hudson, Matthew E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Hudson, Matthew E.; Ma, Jian] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Hunt, Greg J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Jiang, Huaiyang] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Khetani, Radhika S.] Univ Illinois, Roy J Carver Biotechnol Ctr, High Performance Biol Comp HPCBio, Urbana, IL 61801 USA; [Kosarev, Peter] Softberry Inc, Mt Kisco, NY 10549 USA; [Ma, Jian] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Maleszka, Ryszard] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Moritz, Robin F. A.; Stolle, Eckart] Univ Halle Wittenberg, Inst Zool, D-06099 Halle, Saale, Germany; [Munoz-Torres, Monica C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Murphy, Terence D.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Robinson, Gene E.] Univ Illinois, Inst Genom Biol, Dept Entomol, Neurosci Program, Urbana, IL 61801 USA; [Rueppell, Olav] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Solovyev, Victor] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Tsuruda, Jennifer M.] Clemson Univ, Clemson, SC 29634 USA; [Waterhouse, Robert M.; Zdobnov, Evgeny M.] Univ Geneva, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, CMU, CH-1211 Geneva, Switzerland; [Weaver, Daniel B.] Genformatic, Austin, TX 78731 USA; [Whitfield, Charles W.] Univ Illinois, Dept Entomol, Neurosci Program, Program Ecol & Evolutionary Biol, Urbana, IL 61801 USA		Elsik, CG (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	elsikc@missouri.edu; kworley@bcm.edu	Stanke, Mario/P-7876-2019; Guigo, Roderic/D-1303-2010; Kalra, D.K./H-6661-2019; Rueppell, Olav/G-2679-2010; Devreese, Bart/K-2841-2019; Hoff, Katharina/AAX-8809-2021; Maleszka, Ryszard/A-6078-2008; Elsik, Christine G/C-4120-2017; Ma, Jian/A-9838-2008; Stolle, Eckart/G-3780-2011; Hudson, Matthew E/A-4438-2008; Moritz, Robin FA/K-6053-2012; Elhaik, Eran/H-6838-2019; Zdobnov, Evgeny M/K-1133-2012; Waterhouse, Robert M/A-1858-2010; Evans, Jay D/C-8408-2012; Ferreira, Francisco Camara/G-9841-2015; Devreese, Bart/B-2011-2009; Zdobnov, Evgeny/AAB-2745-2022; wu, yuanqing/G-6563-2016	Stanke, Mario/0000-0001-8696-0384; Guigo, Roderic/0000-0002-5738-4477; Kalra, D.K./0000-0001-5254-4067; Rueppell, Olav/0000-0001-5370-4229; Devreese, Bart/0000-0002-9764-2581; Maleszka, Ryszard/0000-0003-1855-555X; Elsik, Christine G/0000-0002-4248-7713; Ma, Jian/0000-0002-4202-5834; Stolle, Eckart/0000-0001-7638-4061; Hudson, Matthew E/0000-0002-4737-0936; Moritz, Robin FA/0000-0003-0791-887X; Elhaik, Eran/0000-0003-4795-1084; Waterhouse, Robert M/0000-0003-4199-9052; Evans, Jay D/0000-0002-0036-4651; Ferreira, Francisco Camara/0000-0002-1971-5466; Devreese, Bart/0000-0002-9764-2581; Zdobnov, Evgeny/0000-0002-5178-1498; Cree, Simone/0000-0002-7349-422X; Worley, Kim/0000-0002-0282-1000; Khetani, Radhika/0000-0003-2430-2970; Childers, Anna/0000-0002-0747-8539; wu, yuanqing/0000-0002-8286-8078; Solovyev, Victor/0000-0001-8885-493X; Childers, Chris/0000-0002-1253-5550	National Human Genome Research Institute, National Institutes of Health (NHGRI, NIH) [U54 HG003273]; USDA National Institute of Food Agriculture [2010-65205-20407]; Clare Luce Booth Fellowship at Georgetown University; Direct For Biological SciencesNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [1262575] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003273] Funding Source: NIH RePORTER	Funding for the project was provided by a grant to RG from the National Human Genome Research Institute, National Institutes of Health (NHGRI, NIH) U54 HG003273. Contributions from members of the CGE lab were supported by Agriculture and Food Research Initiative Competitive grant no. 2010-65205-20407 from the USDA National Institute of Food Agriculture. AKB was supported by a Clare Luce Booth Fellowship at Georgetown University. The authors are grateful for the HGSC sequence production teams (Patil, S., Gubbala, S., Aqrawi, P., Arias, F., Bess, C., Blankenburg, K. B., Brocchini, M., Buhay, C., Challis, D., Chang, K., Chen, D., Coleman, P., Drummond, J., English, A., Evani, U., Francisco, L., Fu, Q., Goodspeed, R., Haessly, T. H., Hale, W., Han, H., Holder, M., Hu, Y., Jackson, L., Jakkamsetti, A., Jayaseelan, J. C., Kakkar, N., Kalra, D., Kandadi, H., Lee, S., Li, H., Liu, Y., Macmil, S., Mandapat, C. M., Mata, R., Mathew, T., Matskevitch, T., Munidasa, M., Nagaswamy, U., Najjar, R., Nguyen, N., Niu, J., Opheim, D., Palculict, T., Paul, S., Pellon, M., Perales, L., Pham, C., Pham, P., Pu, L.-L., Qi, S., Qu, J., Ren, Y., Ruth, R.T., Saada, N., Sabo, A., San Lucas, F., Sershen, C., Shafer, J., Shah, N., Shelton, R., Song, X.-Z., Tabassum, N., Tang, L., Taylor, A., Taylor, M., Velamala, V., Wan, Z., Wang, L., Wang, Y., Warren, J., Weissenberger, G., Wilczek-Boney, K. B., Yao, J., Yin, B., Yu, J., Zhang, J., Zhang, L., Zhou, C., Zhu, D., Zhu, Y., and Zou, X.), and the input of other members of the HGSC genome assembly team.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ament SA, 2011, J EXP BIOL, V214, P3808, DOI 10.1242/jeb.060244; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Begna D, 2012, J PROTEOME RES, V11, P1317, DOI 10.1021/pr200974a; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chan MMY, 2010, INSECT MOL BIOL, V19, P653, DOI 10.1111/j.1365-2583.2010.01022.x; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chan QWT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-290; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Eckalbar WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-49; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elhaik E, 2013, ISRN BIOINFORMATICS, V2013; Elhaik E, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq532; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt263, 10.1093/nar/gkt1223]; Florea L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021400; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Foret S, 2012, P NATL ACAD SCI USA, V109, P4968, DOI 10.1073/pnas.1202392109; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; GMACHL M, 1995, J BIOL CHEM, V270, P12704, DOI 10.1074/jbc.270.21.12704; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Harris R.S, 2007, IMPROVED PAIRWISE AL; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalendar R, 2004, GENETICS, V166, P1437, DOI 10.1534/genetics.166.3.1437; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Kapitonov VV, 2009, GENE, V448, P207, DOI 10.1016/j.gene.2009.07.019; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Keller O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-278; Kent CF, 2012, P NATL ACAD SCI USA, V109, P18012, DOI 10.1073/pnas.1208094109; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Ladoukakis E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r118; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Lees J, 2012, NUCLEIC ACIDS RES, V40, pD465, DOI 10.1093/nar/gkr1181; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li-Byarlay H, 2013, P NATL ACAD SCI USA, V110, P12750, DOI 10.1073/pnas.1310735110; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; OVCHINNIKOV YA, 1980, BIOORG KHIM+, V6, P359; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Parra G, 2003, GENOME RES, V13, P108, DOI 10.1101/gr.871403; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quesneville H, 2003, J MOL EVOL, V57, pS50, DOI 10.1007/s00239-003-0007-2; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simola DF, 2013, GENOME RES, V23, P1235, DOI 10.1101/gr.155408.113; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Solovyev V, 2002, CURRENT TOPICS COMPU, P201; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; van Baren MJ, 2007, CURR PROTOC BIOINFOR; Van Vaerenbergh MDG, 2014, J PROTEOMIC IN PRESS; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Witte CP, 2001, P NATL ACAD SCI USA, V98, P13778, DOI 10.1073/pnas.241341898; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zayed A, 2012, ANNU REV GENET, V46, P591, DOI 10.1146/annurev-genet-110711-155517; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; [No title captured]	108	254	259	1	91	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JAN 30	2014	15								86	10.1186/1471-2164-15-86			29	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	AA5DT	WOS:000331116900002	24479613	Green Published, Green Accepted, Green Submitted, gold			2022-01-24	
J	Piazza, R; Valletta, S; Winkelmann, N; Redaelli, S; Spinelli, R; Pirola, A; Antolini, L; Mologni, L; Donadoni, C; Papaemmanuil, E; Schnittger, S; Kim, DW; Boultwood, J; Rossi, F; Gaipa, G; De Martini, GP; Di Celle, PF; Jang, HG; Fantin, V; Bignell, GR; Magistroni, V; Haferlach, T; Pogliani, EM; Campbell, PJ; Chase, AJ; Tapper, WJ; Cross, NCP; Gambacorti-Passerini, C				Piazza, Rocco; Valletta, Simona; Winkelmann, Nils; Redaelli, Sara; Spinelli, Roberta; Pirola, Alessandra; Antolini, Laura; Mologni, Luca; Donadoni, Carla; Papaemmanuil, Elli; Schnittger, Susanne; Kim, Dong-Wook; Boultwood, Jacqueline; Rossi, Fabio; Gaipa, Giuseppe; De Martini, Greta P.; Di Celle, Paola Francia; Jang, Hyun Gyung; Fantin, Valeria; Bignell, Graham R.; Magistroni, Vera; Haferlach, Torsten; Pogliani, Enrico Maria; Campbell, Peter J.; Chase, Andrew J.; Tapper, William J.; Cross, Nicholas C. P.; Gambacorti-Passerini, Carlo			Recurrent SETBP1 mutations in atypical chronic myeloid leukemia	NATURE GENETICS			English	Article							SCHINZEL-GIEDION SYNDROME; MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS; DIFFERENTIAL EXPRESSION; RNA-SEQ; TUMOR-SUPPRESSOR; SELF-RENEWAL; GENOME; PROTEIN; FUSION; DISORDERS	Atypical chronic myeloid leukemia (aCML) shares clinical and laboratory features with CML, but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and identified somatic alterations of SETBP1 (encoding a p.Gly870Ser alteration) in two cases. Targeted resequencing of 70 aCMLs, 574 diverse hematological malignancies and 344 cancer cell lines identified SETBP1 mutations in 24 cases, including 17 of 70 aCMLs (24.3%; 95% confidence interval (CI) = 16-35%). Most mutations (92%) were located between codons 858 and 871 and were identical to changes seen in individuals with Schinzel-Giedion syndrome. Individuals with mutations had higher white blood cell counts (P = 0.008) and worse prognosis (P = 0.01). The p.Gly870Ser alteration abrogated a site for ubiquitination, and cells exogenously expressing this mutant exhibited higher amounts of SETBP1 and SET protein, lower PP2A activity and higher proliferation rates relative to those expressing the wild-type protein. In summary, mutated SETBP1 represents a newly discovered oncogene present in aCML and closely related diseases.	[Piazza, Rocco; Valletta, Simona; Redaelli, Sara; Spinelli, Roberta; Pirola, Alessandra; Antolini, Laura; Mologni, Luca; Donadoni, Carla; De Martini, Greta P.; Magistroni, Vera; Pogliani, Enrico Maria; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Winkelmann, Nils; Chase, Andrew J.; Tapper, William J.; Cross, Nicholas C. P.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Winkelmann, Nils] Univ Klinikum Jena, Klin Innere Med 2, Jena, Germany; [Papaemmanuil, Elli; Bignell, Graham R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Schnittger, Susanne; Haferlach, Torsten] MLL, Munich, Germany; [Kim, Dong-Wook] Catholic Univ, Dept Hematol, Seoul, South Korea; [Boultwood, Jacqueline] John Radcliffe Hosp, Leukaemia & Lymphoma Res Mol Hematol Unit, Oxford OX3 9DU, England; [Rossi, Fabio] San Gerardo Hosp, Immunotransfus Unit, Monza, Italy; [Gaipa, Giuseppe] Univ Milano Bicocca, Pediat Clin, M Tettamanti Res Ctr, Monza, Italy; [Di Celle, Paola Francia] Azienda Ospeda San Giovanni Battista Torino, Lab Oncol Mol, Ctr Ric Med Sperimentale CeRMS, Turin, Italy; [Jang, Hyun Gyung; Fantin, Valeria] Agios Pharmaceut, Cambridge, MA USA; [Pogliani, Enrico Maria] San Gerardo Hosp, Hematol Unit, Monza, Italy; [Chase, Andrew J.; Tapper, William J.; Cross, Nicholas C. P.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Gambacorti-Passerini, Carlo] San Gerardo Hosp, Hematol & Clin Res Unit, Monza, Italy		Gambacorti-Passerini, C (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	carlo.gambacorti@unimib.it	redaelli, sara/I-5146-2012; Antolini, Laura/C-6115-2018; Mologni, Luca/AAC-1065-2022; Cross, Nicholas C P/B-4817-2009; Magistroni, Vera/AAA-5582-2020	redaelli, sara/0000-0003-0166-1188; Mologni, Luca/0000-0002-6365-5149; Cross, Nicholas C P/0000-0001-5481-2555; Magistroni, Vera/0000-0002-7334-9401; Rocco, Piazza/0000-0003-4198-9620; Tapper, William/0000-0002-5896-1889; Boultwood, Jacqueline/0000-0002-4330-2928; Chase, Andrew/0000-0001-6617-9953; Gaipa, Giuseppe/0000-0002-1006-5946; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X	Associazione Italiana per la Ricerca sul Cancro (AIRC)Fondazione AIRC per la ricerca sul cancro [IG-10092]; Programmi di ricerca di Rilevante Interesse Nazionale (PRIN) programMinistry of Education, Universities and Research (MIUR) [20084XBENM_004]; Fondazione CariploFondazione Cariplo [2009-2667]; Lombardy RegionRegione Lombardia [ID-16871, ID14546A]; Lombardy Region (FSE Dote Ricercatori) [16-AR]; Leukaemia and Lymphoma Research (UK); Korea Research FoundationKorea Research Foundation [R21-2007-000-10041-0]; Mildred Scheel Stiftung fuer Krebsforschung (Deutsche Krebshilfe, Germany) [109590]	We kindly acknowledge the contributions of S. Mori in the preparation of this manuscript, M. Viltadi for technical help, G. Cazzaniga (Tettamanti Foundation, San Gerardo Hospital) for the MIGR1-EGFP plasmid and C. Cecchetti, Z. Sortino and C. Rizzo for clinical sample management. We thank M. Vogel for her critical reading of the manuscript. This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) 2010 (IG-10092 to C. G.-P.); Programmi di ricerca di Rilevante Interesse Nazionale (PRIN) program (20084XBENM_004 to R. P.); Fondazione Cariplo (2009-2667 to C. G.-P.); the Lombardy Region (ID-16871 and ID14546A to C. G.-P. and FSE Dote Ricercatori 16-AR to S. R.); Leukaemia and Lymphoma Research (UK) grants (to N.C.P.C. and J.B.); the Basic Research Program of the Korea Research Foundation (R21-2007-000-10041-0 to D.-W.K.) (2007); and Mildred Scheel Stiftung fuer Krebsforschung (Deutsche Krebshilfe, Germany, grant 109590 to N.W.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cristobal I, 2010, BLOOD, V115, P615, DOI 10.1182/blood-2009-06-227363; Cross NCP, 2012, ONCOTARGET, V3, P3; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ernst T, 2010, HAEMATOL-HEMATOL J, V95, P1473, DOI 10.3324/haematol.2010.021808; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Godley LA, 2012, NEW ENGL J MED, V366, P1152, DOI 10.1056/NEJMe1200409; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldman JM, 2010, SEMIN HEMATOL, V47, P302, DOI 10.1053/j.seminhematol.2010.07.001; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurzrock R, 2001, J CLIN ONCOL, V19, P2915, DOI 10.1200/JCO.2001.19.11.2915; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Lehman AM, 2008, AM J MED GENET A, V146A, P1299, DOI 10.1002/ajmg.a.32277; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Manfredini R, 2005, STEM CELLS, V23, P496, DOI 10.1634/stemcells.2004-0265; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Marubini E, 1995, ANAL SURVIVAL DATA C; Minakuchi M, 2001, EUR J BIOCHEM, V268, P1340, DOI 10.1046/j.1432-1327.2001.02000.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUNDY GR, 1991, CIBA F SYMP, V157, P137; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; NOWELL PC, 1960, SCIENCE, V132, P1497; Oakley K, 2012, BLOOD, V119, P6099, DOI 10.1182/blood-2011-10-388710; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Piazza R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks394; Rebora P, 2010, AM J EPIDEMIOL, V172, P1028, DOI 10.1093/aje/kwq262; Reiter A, 2009, HAEMATOL-HEMATOL J, V94, P1634, DOI 10.3324/haematol.2009.014001; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Score J, 2012, BLOOD, V119, P1208, DOI 10.1182/blood-2011-07-367243; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wolfe DA., 1979, INTRO THEORY NONPARA; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2	52	254	259	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					18	U41		10.1038/ng.2495			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	WOS:000312838800008	23222956	Green Accepted			2022-01-24	
J	Albers, CA; Paul, DS; Schulze, H; Freson, K; Stephens, JC; Smethurst, PA; Jolley, JD; Cvejic, A; Kostadima, M; Bertone, P; Breuning, MH; Debili, N; Deloukas, P; Favier, R; Fiedler, J; Hobbs, CM; Huang, N; Hurles, ME; Kiddle, G; Krapels, I; Nurden, P; Ruivenkamp, CAL; Sambrook, JG; Smith, K; Stemple, DL; Strauss, G; Thys, C; van Geet, C; Newbury-Ecob, R; Ouwehand, WH; Ghevaert, C				Albers, Cornelis A.; Paul, Dirk S.; Schulze, Harald; Freson, Kathleen; Stephens, Jonathan C.; Smethurst, Peter A.; Jolley, Jennifer D.; Cvejic, Ana; Kostadima, Myrto; Bertone, Paul; Breuning, Martijn H.; Debili, Najet; Deloukas, Panos; Favier, Remi; Fiedler, Janine; Hobbs, Catherine M.; Huang, Ni; Hurles, Matthew E.; Kiddle, Graham; Krapels, Ingrid; Nurden, Paquita; Ruivenkamp, Claudia A. L.; Sambrook, Jennifer G.; Smith, Kenneth; Stemple, Derek L.; Strauss, Gabriele; Thys, Chantal; van Geet, Chris; Newbury-Ecob, Ruth; Ouwehand, Willem H.; Ghevaert, Cedric			Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome	NATURE GENETICS			English	Article							DEVELOPMENTAL DISORDER; THROMBOCYTOPENIA; BINDING; COMPONENT; GENE; EXPRESSION	The exon-junction complex (EJC) performs essential RNA processing tasks(1-5). Here, we describe the first human disorder, thrombocytopenia with absent radii (TAR)(6), caused by deficiency in one of the four EJC subunits. Compound inheritance of a rare null allele and one of two low-frequency SNPs in the regulatory regions of RBM8A, encoding the Y14 subunit of EJC, causes TAR. We found that this inheritance mechanism explained 53 of 55 cases (P < 5 x 10(-228)) of the rare congenital malformation syndrome. Of the 53 cases with this inheritance pattern, 51 carried a submicroscopic deletion of 1q21.1 that has previously been associated with TAR(7), and two carried a truncation or frameshift null mutation in RBM8A. We show that the two regulatory SNPs result in diminished RBM8A transcription in vitro and that Y14 expression is reduced in platelets from individuals with TAR. Our data implicate Y14 insufficiency and, presumably, an EJC defect as the cause of TAR syndrome.	[Albers, Cornelis A.; Stephens, Jonathan C.; Smethurst, Peter A.; Jolley, Jennifer D.; Cvejic, Ana; Hobbs, Catherine M.; Kiddle, Graham; Sambrook, Jennifer G.; Ouwehand, Willem H.; Ghevaert, Cedric] Univ Cambridge, Dept Haematol, Cambridge, England; [Albers, Cornelis A.; Stephens, Jonathan C.; Smethurst, Peter A.; Jolley, Jennifer D.; Cvejic, Ana; Hobbs, Catherine M.; Kiddle, Graham; Sambrook, Jennifer G.; Ouwehand, Willem H.; Ghevaert, Cedric] Natl Hlth Serv NHS Blood & Transplant, Cambridge, England; [Albers, Cornelis A.; Paul, Dirk S.; Cvejic, Ana; Deloukas, Panos; Huang, Ni; Hurles, Matthew E.; Stemple, Derek L.; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Schulze, Harald] Charite, Inst Transfus Med, D-13353 Berlin, Germany; [Schulze, Harald; Fiedler, Janine] Charite, Lab Pediat Mol Biol, D-13353 Berlin, Germany; [Freson, Kathleen; Thys, Chantal; van Geet, Chris] Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Kostadima, Myrto; Bertone, Paul] EBI, EMBL, Cambridge, England; [Breuning, Martijn H.; Ruivenkamp, Claudia A. L.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Debili, Najet; Favier, Remi] INSERM, U790, Villejuif, France; [Fiedler, Janine] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Krapels, Ingrid] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Nurden, Paquita] Hop Xavier Arnozan, Ctr Reference Pathol Plaquettaires, Hematol Lab, Pessac, France; [Smith, Kenneth; Newbury-Ecob, Ruth] Univ Bristol, Div Child Hlth, Bristol, Avon, England; [Smith, Kenneth; Newbury-Ecob, Ruth] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; [Strauss, Gabriele] Charite, Dept Pediat Oncol & Hematol, D-13353 Berlin, Germany; [van Geet, Chris] Univ Ziekenhuis Leuven, Dept Pediat, Louvain, Belgium		Albers, CA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.	caa@sanger.ac.uk; cg348@cam.ac.uk	Paul, Dirk S./H-3469-2019; Albers, Kees/A-4170-2015; Deloukas, Panos/B-2922-2013; Bertone, Paul/Z-3734-2019; Bertone, Paul/A-6600-2013	Paul, Dirk S./0000-0002-8230-0116; Albers, Kees/0000-0003-4115-3727; Deloukas, Panos/0000-0001-9251-070X; Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Kostadima, Myrto Areti/0000-0002-1818-4050; freson, kathleen/0000-0002-4381-2442; Ghevaert, Cedric/0000-0002-9251-0934; Stephens, Jonathan/0000-0003-2020-9330; Cvejic, Ana/0000-0003-3204-9311; Ouwehand, Willem/0000-0002-7744-1790	National Institutes for Health Research (NIHR) [RP-PG-0310-1002, RBAG096]; British Heart FoundationBritish Heart Foundation [FS/09/039, RG/09/12/28096]; Wellcome TrustWellcome TrustEuropean Commission [WT-082597/Z/07/Z, WT-084183/2/07/2, WT091310]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SCHU1421/3-1]; Sanitatsrat Dr. Emil Alexander Hubner-und-Gemahlin-Stiftung [T114/17644/2008/sm]; Excellentie Financiering KULeuvenKU Leuven [EF/05/013]; Fonds Wetenschappelijk Onderzoek-VlaanderenFWO [G.0490.10N, G.0743.09]; Research Council of the University of Leuven (Onderzoeksraad-K.U. Leuven) [GOA/2009/13]; Marie-Curie NetSim Initial Training Network [EC-215820]; Gis-Maladies Rares, Diagnostic Differentiel des Purpuras Thrombopeniques Idiopathiques Chroniques et des Thrombopenies Congenitales (DIATROC); INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission [ANR-08-GENO-028-03]; British Heart FoundationBritish Heart Foundation [FS/09/039/27788, RG/08/014/24067, RG/09/012/28096] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0310-1002] Funding Source: researchfish	We thank C. Langford and P. Ellis for performing the enrichment for the exome sequencing, S. Balasubramaniam for assistance with data processing and the Wellcome Trust Sanger Institute sequencing core for sequencing. We thank V. Mooser from GlaxoSmithKline, G. Waeber and P. Vollenweider from CoLaus and J. Durham, C. Scott and colleagues at the Sanger Institute for providing access to their collection of whole-exome sequencing data for the CoLaus cohort<SUP>12</SUP>. We thank R. Durbin, B. Gottgens and I. Palacios for comments on the manuscript. This study makes use of data generated by the UK10K Consortium, which were derived from samples from the TwinsUK cohort. A full list of the investigators who contributed to the generation of the data is available from their website (see URLs). The study was supported by grants from the National Institutes for Health Research (NIHR; RP-PG-0310-1002 to C.G., G.K., P.A.S. and W.H.O.), the British Heart Foundation (FS/09/039 to C.G. and RG/09/12/28096 to C.A.A.), project grants from the Wellcome Trust (WT-082597/Z/07/Z to A.C. and WT-084183/2/07/2 to J.C.S.), grants by the Deutsche Forschungsgemeinschaft (SCHU1421/3-1 to H.S.) and the Sanitatsrat Dr. Emil Alexander Hubner-und-Gemahlin-Stiftung (T114/17644/2008/sm to H.S.), by the Excellentie Financiering KULeuven (EF/05/013), by research grants from the Fonds Wetenschappelijk Onderzoek-Vlaanderen (G.0490.10N and G.0743.09) and by a grant from the Research Council of the University of Leuven (Onderzoeksraad-K.U. Leuven; GOA/2009/13 to C.T., K.F. and C.v.G.). The project made use of NHS Blood and Transplant donors from the Cambridge BioResource (see URLs). This local resource for genotype-phenotype association studies is supported by a grant from the NIHR to the Cambridge Biomedical Research Centre (RBAG096 to J.C.S. and J.D.J.). D.S.P. and M.K. were supported by a Marie-Curie NetSim Initial Training Network grant (EC-215820). The French cases were collected with support from the Gis-Maladies Rares, Diagnostic Differentiel des Purpuras Thrombopeniques Idiopathiques Chroniques et des Thrombopenies Congenitales (DIATROC) program and INSERM (ANR-08-GENO-028-03). Funding for UK10K was provided by the Wellcome Trust (WT091310).	Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Geddis AE, 2006, SEMIN HEMATOL, V43, P196, DOI 10.1053/j.seminhematol.2006.04.003; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Greenhalgh KL, 2002, J MED GENET, V39, P876, DOI 10.1136/jmg.39.12.876; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; HALL JG, 1969, MEDICINE, V48, P411, DOI 10.1097/00005792-196948060-00001; Haremaki T, 2010, DEV DYNAM, V239, P1977, DOI 10.1002/dvdy.22330; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; PERKINS AS, 1991, DEVELOPMENT, V111, P479; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salicioni AM, 2000, GENOMICS, V69, P54, DOI 10.1006/geno.2000.6315; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	36	254	259	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					435	U248		10.1038/ng.1083			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	WOS:000302130600019	22366785	Green Accepted			2022-01-24	
J	Turnbull, C; Rapley, EA; Seal, S; Pernet, D; Renwick, A; Hughes, D; Ricketts, M; Linger, R; Nsengimana, J; Deloukas, P; Huddart, RA; Bishop, DT; Easton, DF; Stratton, MR; Rahman, N				Turnbull, Clare; Rapley, Elizabeth A.; Seal, Sheila; Pernet, David; Renwick, Anthony; Hughes, Deborah; Ricketts, Michelle; Linger, Rachel; Nsengimana, Jeremie; Deloukas, Panagiotis; Huddart, Robert A.; Bishop, D. Timothy; Easton, Douglas F.; Stratton, Michael R.; Rahman, Nazneen		UK Testicular Canc Collaboration	Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; TELOMERE DYSFUNCTION; SUSCEPTIBILITY LOCI; SEX REVERSAL; 5P15.33; TUMORS; RISK; GENE; INSTABILITY	We conducted a genome-wide association study for testicular germ cell tumor, genotyping 298,782 SNPs in 979 affected individuals and 4,947 controls from the UK and replicating associations in a further 664 cases and 3,456 controls. We identified three new susceptibility loci, two of which include genes that are involved in telomere regulation. We identified two independent signals within the TERT-CLPTM1L locus on chromosome 5, which has previously been associated with multiple other cancers (rs4635969, OR = 1.54, P = 1.14 x 10(-23); rs2736100, OR = 1.33, P = 7.55 x 10(-15)). We also identified a locus on chromosome 12 (rs2900333, OR = 1.27, P = 6.16 x 10(-10)) that contains ATF7IP, a regulator of TERT expression. Finally, we identified a locus on chromosome 9 (rs755383, OR = 1.37, P = 1.12 x 10(-23)), containing the sex determination gene DMRT1, which has been linked to teratoma susceptibility in mice.	[Turnbull, Clare; Rapley, Elizabeth A.; Seal, Sheila; Pernet, David; Renwick, Anthony; Hughes, Deborah; Ricketts, Michelle; Linger, Rachel; Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Surrey, England; [Nsengimana, Jeremie; Bishop, D. Timothy] Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England; [Deloukas, Panagiotis; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton, England; [Huddart, Robert A.] Inst Canc Res, Acad Radiotherapy Unit, Sutton, Surrey, England; [Easton, Douglas F.] Strangeways Res Lab, Genet Epidemiol Unit, Canc Res UK, Cambridge CB1 4RN, England		Turnbull, C (corresponding author), Inst Canc Res, Sect Canc Genet, Surrey, England.	clare.turnbull@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Turnbull, Clare/AAA-6596-2019; Nsengimana, Jeremie/AAP-3185-2020; Deloukas, Panos/B-2922-2013; Rahman, Nazneen/D-2802-2013	Deloukas, Panos/0000-0001-9251-070X; Bishop, Tim/0000-0002-8752-8785; huddart, robert/0000-0003-3604-1990; Rahman, Nazneen/0000-0003-4376-0440; Turnbull, Clare/0000-0002-1734-5772	National Health Service; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0000934]; Wellcome TrustWellcome TrustEuropean Commission [068545/Z/02]; Institute of Cancer Research; Cancer Research UKCancer Research UK; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934, G0700491] Funding Source: UKRI; Cancer Research UKCancer Research UK [10589, 11022, 10118] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700491] Funding Source: researchfish	We thank subjects with TGCT and the clinicians involved in their care for participation in this study. We also thank D. Dudakia, J. Pugh, H. McDonald and J. Marke for recruitment of subjects and database entry for the TGCT collections. We acknowledge National Health Service funding to the National Institute for Health Research Biomedical Research Centre. We acknowledge use of DNA from the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. C.T. is a Medical Research Council Clinical Research Fellow. D.F.E. is a Principal Research Fellow of Cancer Research UK. The study was supported by the Institute of Cancer Research, Cancer Research UK and the Wellcome Trust.	Barbaro M, 2009, EUR J HUM GENET, V17, P1439, DOI 10.1038/ejhg.2009.70; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; FERLAY J, 2002, IARC CANCERBASE, V5; Fernandez-Garcia I, 2008, J THORAC ONCOL, V3, P1085, DOI 10.1097/JTO.0b013e3181886713; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Horvath A, 2009, CANCER RES, V69, P5301, DOI 10.1158/0008-5472.CAN-09-0884; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Liu LF, 2009, J BIOL CHEM, V284, P5165, DOI 10.1074/jbc.M807098200; Livadas S, 2003, CANCER GENET CYTOGEN, V143, P174, DOI 10.1016/S0165-4608(02)00849-X; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rashid HH, 2004, UROL ONCOL-SEMIN ORI, V22, P285, DOI 10.1016/S1078-1439(03)00177-7; Schrader M, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-32; Schrader M, 2002, ONCOL REP, V9, P1097; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Zhang A, 2002, INT J CANCER, V101, P427, DOI 10.1002/ijc.10627	30	254	262	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2010	42	7					604	U178		10.1038/ng.607			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	WOS:000279242400013	20543847	Green Accepted			2022-01-24	
J	Benko, S; Fantes, JA; Amiel, J; Kleinjan, DJ; Thomas, S; Ramsay, J; Jamshidi, N; Essafi, A; Heaney, S; Gordon, CT; McBride, D; Golzio, C; Fisher, M; Perry, P; Abadie, V; Ayuso, C; Holder-Espinasse, M; Kilpatrick, N; Lees, MM; Picard, A; Temple, IK; Thomas, P; Vazquez, MP; Vekemans, M; Roest Crollius, H; Hastie, ND; Munnich, A; Etchevers, HC; Pelet, A; Farlie, PG; FitzPatrick, DR; Lyonnet, S				Benko, Sabina; Fantes, Judy A.; Amiel, Jeanne; Kleinjan, Dirk-Jan; Thomas, Sophie; Ramsay, Jacqueline; Jamshidi, Negar; Essafi, Abdelkader; Heaney, Simon; Gordon, Christopher T.; McBride, David; Golzio, Christelle; Fisher, Malcolm; Perry, Paul; Abadie, Veronique; Ayuso, Carmen; Holder-Espinasse, Muriel; Kilpatrick, Nicky; Lees, Melissa M.; Picard, Arnaud; Temple, I. Karen; Thomas, Paul; Vazquez, Marie-Paule; Vekemans, Michel; Roest Crollius, Hugues; Hastie, Nicholas D.; Munnich, Arnold; Etchevers, Heather C.; Pelet, Anna; Farlie, Peter G.; FitzPatrick, David R.; Lyonnet, Stanislas			Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence	NATURE GENETICS			English	Article							GENE-EXPRESSION; UPSTREAM; DOWNSTREAM; MECHANISMS; DISTINCT	Pierre Robin sequence (PRS) is an important subgroup of cleft palate. We report several lines of evidence for the existence of a 17q24 locus underlying PRS, including linkage analysis results, a clustering of translocation breakpoints 1.06-1.23 Mb upstream of SOX9, and microdeletions both similar to 1.5 Mb centromeric and similar to 1.5 Mb telomeric of SOX9. We have also identified a heterozygous point mutation in an evolutionarily conserved region of DNA with in vitro and in vivo features of a developmental enhancer. This enhancer is centromeric to the breakpoint cluster and maps within one of the microdeletion regions. The mutation abrogates the in vitro enhancer function and alters binding of the transcription factor MSX1 as compared to the wild-type sequence. In the developing mouse mandible, the 3-Mb region bounded by the microdeletions shows a regionally specific chromatin decompaction in cells expressing Sox9. Some cases of PRS may thus result from developmental misexpression of SOX9 due to disruption of very-long-range cis-regulatory elements.	[Fantes, Judy A.; Kleinjan, Dirk-Jan; Ramsay, Jacqueline; Essafi, Abdelkader; Heaney, Simon; McBride, David; Fisher, Malcolm; Perry, Paul; Hastie, Nicholas D.; FitzPatrick, David R.] MRC HGU, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Benko, Sabina; Amiel, Jeanne; Thomas, Sophie; Golzio, Christelle; Vekemans, Michel; Munnich, Arnold; Etchevers, Heather C.; Pelet, Anna; Lyonnet, Stanislas] Hop Necker Enfants Malad, INSERM, U 781, Paris, France; [Amiel, Jeanne; Vekemans, Michel; Munnich, Arnold; Lyonnet, Stanislas] Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France; [Jamshidi, Negar; Gordon, Christopher T.; Kilpatrick, Nicky; Thomas, Paul; Farlie, Peter G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Abadie, Veronique; Vekemans, Michel; Munnich, Arnold; Lyonnet, Stanislas] Univ Paris 05, Fac Med, Paris, France; [Abadie, Veronique] Hop Necker Enfants Malad, AP HP, Serv Pediat, Paris, France; [Ayuso, Carmen] Fdn Jimenez Diaz, Ciberer Madrid, Spain; [Holder-Espinasse, Muriel] CHRU Lille, Hop Jeanne Flandre, Lille, France; [Lees, Melissa M.] Great Ormond St Hosp Sick Children, N Thames Reg Genet Serv, London, England; [Picard, Arnaud; Vazquez, Marie-Paule] Hop Enfants Armand Trousseau, AP HP, Serv Chirurg Maxillofacial & Chirurg Plast, Paris, France; [Picard, Arnaud; Vazquez, Marie-Paule] Univ Paris 06, UFR Med Pierre & Marie Curie, Paris, France; [Temple, I. Karen] Univ Southampton, Div Human Genet, Wessex Clin Genet Acad Grp, Southampton, Hants, England; [Roest Crollius, Hugues] Ecole Normale Super, CNRS, Dept Biol, UMR 8541, Paris, France		FitzPatrick, DR (corresponding author), MRC HGU, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.	david.fitzpatrick@hgu.mrc.ac.uk; stanislas.lyonnet@inserm.fr	Thomas, Paul Q/K-4497-2012; Jamshidi, Negar/J-6136-2019; FitzPatrick, David R/C-7301-2013; Etchevers, Heather C./B-5813-2012; amiel, jeanne/H-3501-2017; Lyonnet, Stanislas/H-5483-2017; Essafi, Abdelkader/A-6602-2009; temple, isabel K/K-2391-2015; Gordon, Chris/F-1267-2017; THOMAS, Sophie/F-4492-2017	Etchevers, Heather C./0000-0003-0201-3799; amiel, jeanne/0000-0001-5973-4728; Lyonnet, Stanislas/0000-0001-5426-9417; Gordon, Chris/0000-0002-9300-8399; THOMAS, Sophie/0000-0002-8569-3277; ROEST CROLLIUS, Hugues/0000-0002-8209-173X; Temple, Isabel Karen/0000-0002-6045-1781; PELET, Anastella/0000-0002-8353-1725; Fisher, Malcolm/0000-0003-1074-8103; Golzio, Christelle/0000-0002-4420-3921; Benko, Sabina/0000-0001-6130-7944; Ayuso, Carmen/0000-0002-9242-7065; FitzPatrick, David R./0000-0003-4861-969X	Agence Nationale de la RechercheFrench National Research Agency (ANR)European Commission; Fondation pour la Recherche Medicale (FRM)Fondation pour la Recherche Medicale; MRC (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); National Health and Medical Research Council (Australia)National Health and Medical Research Council of Australia; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS039818]; FRMFondation pour la Recherche Medicale; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U127527180, MC_U127561093] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U127561093, MC_U127527180] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039818] Funding Source: NIH RePORTER	We are grateful to the affected individuals and their families who participated in this study, to the Associations Francaises du Syndrome de Robin, to the Centres de References Anomalies Cranio-Faciales Rares (AP-HP, Necker and Trousseau hospitals), and to C. Ozilou, G. Staub and G. Guedu-Molina for assistance. We thank T. Attie-Bitach, G. Couly and L. Legeai-Mallet (Necker) and V. van Heyningen and R. Hill (MRC HGU) for useful discussion. This study was underwritten by grants from the Agence Nationale de la Recherche (ERARE grant CraniRare), EUROCRAN FP5, the Fondation pour la Recherche Medicale (FRM), the MRC (UK) and the National Health and Medical Research Council (Australia). S. T. was supported in part by grant NS039818 from the US National Institutes of Health and S. B. by the FRM.	Ahituv N, 2005, HUM MOL GENET, V14, P3057, DOI 10.1093/hmg/ddi338; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Andelfinger G, 2002, AM J HUM GENET, V71, P663, DOI 10.1086/342360; Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bien-Willner GA, 2007, HUM MOL GENET, V16, P1143, DOI 10.1093/hmg/ddm061; Cai JL, 2005, HUM MOL GENET, V14, P903, DOI 10.1093/hmg/ddi083; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Etchevers HC, 2006, ADV EXP MED BIOL, V589, P213; Holder-Espinasse M, 2001, J PEDIATR-US, V139, P588, DOI 10.1067/mpd.2001.117784; Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005; Jakobsen LP, 2007, J MED GENET, V44, P381, DOI 10.1136/jmg.2006.046177; Jamshidi N, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010157; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Robin P, 1994, Plast Reconstr Surg, V93, P1301; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Suzuki T, 2006, DEV GROWTH DIFFER, V48, P477, DOI 10.1111/j.1440-169x.2006.00886.x; Velagaleti GVN, 2005, AM J HUM GENET, V76, P652, DOI 10.1086/429252; VINTINER GM, 1991, AM J MED GENET, V41, P44, DOI 10.1002/ajmg.1320410113; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	30	254	264	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					359	364		10.1038/ng.329			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	WOS:000263640200019	19234473				2022-01-24	
J	Ridker, PM; Pare, G; Parker, A; Zee, RYL; Danik, JS; Buring, JE; Kwiatkowski, D; Cook, NR; Miletich, JP; Chasman, DI				Ridker, Paul M.; Pare, Guillaume; Parker, Alex; Zee, Robert Y. L.; Danik, Jacqueline S.; Buring, Julie E.; Kwiatkowski, David; Cook, Nancy R.; Miletich, Joseph P.; Chasman, Daniel I.			Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: The women's genome health study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-E GENOTYPES; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; GENE POLYMORPHISMS; SOLUBLE RECEPTOR; CRP LEVELS; RISK; INTERLEUKIN-6; EVENTS; LEPTIN	Although elevated levels of C-reactive protein (CRP) independently predict increased risk of development of metabolic syndrome, diabetes, myocardial infarction, and stroke, comprehensive analysis of the influence of genetic variation on CRP is not available. To address this issue, we performed a genome-wide association study among 6345 apparently healthy women in which we evaluated 336,108 SNPs as potential determinants of plasma CRP concentration. Overall, seven loci that associate with plasma CRP at levels achieving genome-wide statistical significance were found (range of p values for lead SNPs within the seven loci: 1.9 x 10(-8) to 6.2 x 10(-28)). Two of these loci (GCKR and HNF1A) are suspected or known to be associated with maturity-onset diabetes of the young, one is a gene-desert region on 12q23.2, and the remaining four loci are in or near the leptin receptor protein gene, the apolipoprotein E gene, the interleukin-6 receptor protein gene, or the CRP gene itself. The protein products of six of these seven loci are directly involved in metabolic syndrome, insulin resistance, beta cell function, weight homeostasis, and/or premature atherothrombosis. Thus, common variation in several genes involved in metabolic and inflammatory regulation have significant effects on CRP levels, consistent with CRP's identification as a useful biomarker of risk for incident vascular disease and diabetes.	[Ridker, Paul M.; Pare, Guillaume; Zee, Robert Y. L.; Danik, Jacqueline S.; Buring, Julie E.; Cook, Nancy R.; Chasman, Daniel I.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Ridker, Paul M.; Zee, Robert Y. L.; Danik, Jacqueline S.; Kwiatkowski, David; Cook, Nancy R.; Chasman, Daniel I.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02115 USA; [Parker, Alex; Miletich, Joseph P.] Amgen Inc, Cambridge, MA 02139 USA		Ridker, PM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA.	pridker@partners.org	Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760; Venkatasubramanian, Siddharth/0000-0002-5860-0768			Austin MA, 2004, ANN HUM GENET, V68, P179, DOI 10.1046/j.1529-8817.2004.00078.x; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Chasman DI, 2006, GENES IMMUN, V7, P211, DOI 10.1038/sj.gene.6364289; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Garcia-Herrero CM, 2007, DIABETOLOGIA, V50, P325, DOI 10.1007/s00125-006-0542-7; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016; Judson R, 2004, ATHEROSCLEROSIS, V177, P345, DOI 10.1016/j.atherosclerosis.2004.07.012; Kado S, 1999, ACTA DIABETOL, V36, P67, DOI 10.1007/s005920050147; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sima A, 2007, CLIN CHEM LAB MED, V45, P1149, DOI 10.1515/CCLM.2007.258; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; TONIATTI C, 1990, EMBO J, V9, P4467, DOI 10.1002/j.1460-2075.1990.tb07897.x; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Zhang YY, 2007, ATHEROSCLEROSIS, V191, P121, DOI 10.1016/j.atherosclerosis.2006.02.043	33	254	256	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1185	1192		10.1016/j.ajhg.2008.03.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	WOS:000255923600019	18439548	Green Published, Bronze			2022-01-24	
J	Owusu-Ansah, E; Yavari, A; Mandal, S; Banerjee, U				Owusu-Ansah, Edward; Yavari, Amir; Mandal, Sudip; Banerjee, Utpal			Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR FOXO3A; DROSOPHILA EYE; OXIDATIVE STRESS; PROLIFERATION; APOPTOSIS; OXYGEN; JNK; SUPEROXIDE; ACTIVATION; EXPRESSION	During electron transport, the mitochondrion generates ATP and reactive oxygen species (ROS), a group of partially reduced and highly reactive metabolites of oxygen(1). In this in vivo genetic analysis in Drosophila melanogaster, we establish that disruption of complex I of the mitochondrial electron transport chain specifically retards the cell cycle during the G1-S transition. The mechanism involves a specific signaling cascade initiated by ROS and transduced by ASK-1, JNK, FOXO and the Drosophila p27 homolog, Dacapo. On the basis of our data combined with previous analyses of the system(2), we conclude that mitochondrial dysfunction activates at least two retrograde signals to specifically enforce a G1-S cell cycle checkpoint. One such signal involves an increase in AMP production and downregulation of cyclin E protein; another independent pathway involves increased ROS and upregulation of Dacapo. Thus, our results indicate that the mitochondrion can use AMP and ROS at sublethal concentrations as independent signaling molecules to modulate cell cycle progression.	[Owusu-Ansah, Edward; Yavari, Amir; Mandal, Sudip; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA		Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu		Mandal, Sudip/0000-0002-2211-483X	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01 EY008152, R01-EY00852] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY008152] Funding Source: NIH RePORTER		Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; EDWARD EOA, 2008, NAT PROTOC; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Karim FD, 1998, DEVELOPMENT, V125, P1; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kuzin B, 1996, CELL, V87, P639, DOI 10.1016/S0092-8674(00)81384-7; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Newsome TP, 2000, DEVELOPMENT, V127, P851; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; WOLFF T, 1991, DEVELOPMENT, V113, P841; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188	28	254	257	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					356	361		10.1038/ng.2007.50			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	WOS:000253548400029	18246068				2022-01-24	
J	Wittkopp, PJ; Haerum, BK; Clark, AG				Wittkopp, Patricia J.; Haerum, Belinda K.; Clark, Andrew G.			Regulatory changes underlying expression differences within and between Drosophila species	NATURE GENETICS			English	Article							GENE-EXPRESSION; INTERSPECIFIC HYBRIDS; MELANOGASTER; EVOLUTION; CIS; TRANS	Differences in gene expression are an important source of phenotypic variation, and can be caused by changes in cis and/or trans regulation. cis-regulatory variants alter allele-specific expression, whereas trans-regulatory variants influence expression of both alleles in a diploid cell. Because of this difference, we hypothesize that natural selection may favor one type of change over the other. Here, we investigate contributions of cis- and trans-regulatory changes to variable intra- and interspecific gene expression using four strains of Drosophila melanogaster, three strains of D. simulans and a total of 78 genes. We show that cis- regulatory changes account for a greater proportion of the expression differences observed between rather than within species. These data are inconsistent with a neutral model assuming equal probabilities of fixation for cis- and trans-regulatory polymorphisms, suggesting that natural selection influences the molecular mechanisms underlying divergent gene expression. Specifically, cis- regulatory changes seem to accumulate preferentially over time.	[Wittkopp, Patricia J.; Haerum, Belinda K.; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Wittkopp, Patricia J.; Haerum, Belinda K.] Univ Michigan, Dept Mol Cellular & Dev Biol, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA		Wittkopp, PJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	wittkopp@umich.edu		Clark, Andrew/0000-0001-7159-8511			Akritas MG, 1996, ASTROPHYS J, V470, P706, DOI 10.1086/177901; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Osada N, 2006, MOL BIOL EVOL, V23, P1585, DOI 10.1093/molbev/msl023; Powell J.R., 1997, PROGR PROSPECTS EVOL; Ranz JM, 2004, GENOME RES, V14, P373, DOI 10.1101/gr.2019804; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wittkopp PJ, 2006, GENETICS, V173, P1817, DOI 10.1534/genetics.105.054684; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wittkopp PJ, 2005, CELL MOL LIFE SCI, V62, P1779, DOI 10.1007/s00018-005-5064-9; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	24	254	257	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					346	350		10.1038/ng.77			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	WOS:000253548400027	18278046				2022-01-24	
J	Kleefstra, T; Brunner, HG; Amiel, J; Oudakker, AR; Nillesen, WM; Magee, A; Genevieve, D; Cormier-Daire, V; van Esch, H; Fryns, JP; Hamel, BCJ; Sistermans, EA; de Vries, BBA; van Bokhoven, H				Kleefstra, Tjitske; Brunner, Han G.; Amiel, Jeanne; Oudakker, Astrid R.; Nillesen, Willy M.; Magee, Alex; Genevieve, David; Cormier-Daire, Valerie; van Esch, Hilde; Fryns, Jean-Pierre; Hamel, Ben C. J.; Sistermans, Erik A.; de Vries, Bert B. A.; van Bokhoven, Hans			Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; DEPENDENT PROBE AMPLIFICATION; HISTONE LYSINE METHYLATION; CHROMOSOME 9Q; GENE; METHYLTRANSFERASE; G9A; REARRANGEMENTS; FEATURES; PATIENT	A clinically recognizable 9q subtelomeric deletion syndrome has recently been established. Common features seen in these patients are severe mental retardation, hypotonia, brachycephaly, flat face with hypertelorism, synophrys, anteverted nares, cupid bow or tented upper lip, everted lower lip, prognathism, macroglossia, conotruncal heart defects, and behavioral problems. The minimal critical region responsible for this 9q subtelomeric deletion (9q(-)) syndrome has been estimated to be < 1 Mb and comprises the euchromatin histone methyl transferase 1 gene (EHMT1). Previous studies suggested that haploinsufficiency for EHMT1 is causative for 9q subtelomeric deletion syndrome. We have performed a comprehensive mutation analysis of the EHMT1 gene in 23 patients with clinical presentations reminiscent of 9q subtelomeric deletion syndrome. This analysis revealed three additional microdeletions that comprise the EHMT1 gene, including one interstitial deletion that reduces the critical region for this syndrome. Most importantly, we identified two de novo mutations-a nonsense mutation and a frameshift mutation-in the EHMT1 gene in patients with a typical 9q(-) phenotype. These results establish that haploinsufficiency of EHMT1 is causative for 9q subtelomeric deletion syndrome.	Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; Belfast City Hosp, Reg Genet Serv, Belfast BT9 7AD, Antrim, North Ireland; Hop Necker Enfants Malad, Dept Human Genet, Paris, France		Kleefstra, T (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Human Genet, 849,POB 9101, NL-6500 HB Nijmegen, Netherlands.	T.Kleefstra@antrg.umcn.nl	Bokhoven, J.H.L.M. van van/H-8015-2014; amiel, jeanne/H-3501-2017; Van+Esch, Hilde/AAU-5688-2020; van Bokhoven, Hans/D-8764-2012; Sistermans, Erik/B-1109-2009; Oudakker, Astrid/AAB-7890-2019; Kleefstra, Tjitske/G-2619-2012; Brunner, Han/C-9928-2013; cormier-daire, valerie/H-6520-2017	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; amiel, jeanne/0000-0001-5973-4728; Sistermans, Erik/0000-0001-7187-4563; cormier-daire, valerie/0000-0002-2839-9856			Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Harada N, 2004, J HUM GENET, V49, P440, DOI 10.1007/s10038-004-0166-z; Harada N, 2004, J MED GENET, V41, P130, DOI 10.1136/jmg.2003.014639; Iwakoshi M, 2004, AM J MED GENET A, V126A, P278, DOI 10.1002/ajmg.a.20602; Kleefstra T, 2006, AM J MED GENET A, V140A, P618, DOI 10.1002/ajmg.a.31123; Kleefstra T, 2005, J MED GENET, V42, P299, DOI 10.1136/jmg.2004.028464; Kleefstra T, 2004, J MED GENET, V41, P394, DOI 10.1136/jmg.2003.016972; Koolen DA, 2004, J MED GENET, V41, P892, DOI 10.1136/jmg.2004.023671; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lugtenberg D, 2006, AM J HUM GENET, V78, P265, DOI 10.1086/500306; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Neas KR, 2005, AM J MED GENET A, V132A, P425, DOI 10.1002/ajmg.a.30496; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; RAVNAN JB, 2005, J MED GENET; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Shoichet SA, 2003, AM J HUM GENET, V73, P1341, DOI 10.1086/380309; Stewart DR, 2004, AM J MED GENET A, V128A, P340, DOI 10.1002/ajmg.a.30136; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Xin ZH, 2003, J BIOL CHEM, V278, P14996, DOI 10.1074/jbc.M211753200; Yatsenko SA, 2005, J MED GENET, V42, P328, DOI 10.1136/jmg.2004.028258	28	254	263	0	17	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					370	377		10.1086/505693			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	WOS:000239040400019	16826528	Green Published, Bronze			2022-01-24	
J	Squazzo, SL; O'Geen, H; Komashko, VM; Krig, SR; Jin, VX; Jang, SW; Margueron, R; Reinberg, D; Green, R; Farnham, PJ				Squazzo, Sharon L.; O'Geen, Henriette; Komashko, Vitalina M.; Krig, Sheryl R.; Jin, Victor X.; Jang, Sung-wook; Margueron, Raphael; Reinberg, Danny; Green, Roland; Farnham, Peggy J.			Suz12 binds to silenced regions of the genome in a cell-type-specific manner	GENOME RESEARCH			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; METHYLATION; H3; CANCER; EZH2; LYSINE-27; ENHANCER; EXPRESSION; REQUIRES; GENES	Suzl2 is a component of the Polycomb group complexes 2, 3, and 4 (PRC 2/ 3/ 4). These complexes are critical for proper embryonic development, but very few target genes have been identified in either mouse or human cells. Using a variety of ChIP-chip approaches, we have identified a large set of Suz12 target genes in five different human and mouse cell lines. Interestingly, we found that Suz12 target promoters are cell type specific, with transcription factors and homeobox proteins predominating in embryonal cells and glycoproteins and immunoglobulin-related proteins predominating in adult tumors. We have also characterized the localization of other components of the PRC complex with Suz12 and investigated the overall relationship between Suz12 binding and markers of active versus inactive chromatin, using both promoter arrays and custom tiling arrays. Surprisingly, we find that the PRC complexes can be localized to discrete binding sites or spread through large regions of the mouse and human genomes. Finally, we have shown that some Suz12 target genes are bound by OCT4 in embryonal cells and suggest that OCT4 maintains stem cell self-renewal, in part, by recruiting PRC complexes to certain genes that promote differentiation.	Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; NimbleGen Syst Inc, Madison, WI 53711 USA; Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst, Div Nucle Acids Enzymol, Piscataway, NJ 08854 USA; Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA		Farnham, PJ (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	pjfarnham@ucdavis.edu	Margueron, Raphael F/B-9996-2015	Margueron, Raphael F/0000-0002-9093-7977; Reinberg, Danny/0000-0003-4288-2016; Farnham, Peggy/0000-0003-4469-7914	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA45250] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG003129, R01 HG003129] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R56 DK067889, R01 DK067889, DK067889] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG003129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R56DK067889, R01DK067889] Funding Source: NIH RePORTER		Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fox CA, 2005, J BIOL CHEM, V280, P8629, DOI 10.1074/jbc.R400033200; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Oberley MJ, 2003, J BIOL CHEM, V278, P42466, DOI 10.1074/jbc.M307733200; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Raaphorst FM, 2005, HUM MOL GENET, V14, pR93, DOI 10.1093/hmg/ddi111; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	31	254	263	0	8	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2006	16	7					890	900		10.1101/gr.5306606			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	059DB	WOS:000238712400009	16751344	Bronze, Green Published			2022-01-24	
J	Carlson, CS; Aldred, SF; Lee, PK; Tracy, RP; Schwartz, SM; Rieder, M; Liu, KA; Williams, OD; Iribarren, C; Lewis, EC; Fornage, M; Boerwinkle, E; Gross, M; Jaquish, C; Nickerson, DA; Myers, RM; Siscovick, DS; Reiner, AP				Carlson, CS; Aldred, SF; Lee, PK; Tracy, RP; Schwartz, SM; Rieder, M; Liu, KA; Williams, OD; Iribarren, C; Lewis, EC; Fornage, M; Boerwinkle, E; Gross, M; Jaquish, C; Nickerson, DA; Myers, RM; Siscovick, DS; Reiner, AP			Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOVASCULAR-DISEASE; HAPLOTYPE RECONSTRUCTION; RISK-FACTORS; INFLAMMATION; GENE; MARKERS; PREDICTION; RECRUITMENT; PHASE	Elevated plasma levels of C- reactive protein ( CRP), an inflammation- sensitive marker, have emerged as an important predictor of future cardiovascular disease and metabolic abnormalities in apparently healthy men and women. Here, we performed a systematic survey of common nucleotide variation across the genomic region encompassing the CRP gene locus. Of the common single- nucleotide polymorphisms ( SNPs) identified, several in the CRP promoter region are strongly associated with CRP levels in a large cohort study of cardiovascular risk in European American and African American young adults. We also demonstrate the functional importance of these SNPs in vitro.	Univ Washington, Ctr Hlth Sci, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Vermont, Burlington, VT USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; Kaiser Permanente, Div Res, Oakland, CA USA; Univ Texas, Houston, TX USA; Univ Minnesota, Minneapolis, MN USA; NHLBI, Bethesda, MD 20892 USA		Carlson, CS (corresponding author), Univ Washington, Ctr Hlth Sci, Dept Genome Sci, Room K-322,1705 NE Pacific St, Seattle, WA 98195 USA.	csc47@u.washington.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [N01HC045134, N01HC005187, N01HC095095, N01HC048047, N01HC048048, N01HC048049, N01HC048050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL048050, R29HL048048, R01HL048049, U01HL066642, R01HL071017, R01HL048048, U01HL066682] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL66682, N01HC48047, N01HC05187, N01-HC-48048, HL66642, U01 HL066682, N01-HC-05187, HL71017, N01-HC-48047, N01HC48049, N01-HC-95095, N01-HC-48050, N01HC95095, N01-HC-48049, N01HC48048, R01 HL071017, U01 HL066642, N01HC48050, N01 HC045134] Funding Source: Medline		Abernethy TJ, 1941, J EXP MED, V73, P173, DOI 10.1084/jem.73.2.173; Albert MA, 2004, AM J CARDIOL, V93, P1238, DOI 10.1016/j.amjcard.2004.01.067; Anand SS, 2004, ARTERIOSCL THROM VAS, V24, P1509, DOI 10.1161/01.ATV.0000135845.95890.4e; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Friedman J, 2008, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7; Hackam DG, 2003, JAMA-J AM MED ASSOC, V290, P932, DOI 10.1001/jama.290.7.932; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Kleemann R, 2004, BLOOD, V103, P4188, DOI 10.1182/blood-2003-11-3791; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; LI SP, 1990, J BIOL CHEM, V265, P4136; MacGregor AJ, 2004, CLIN CHEM, V50, P130, DOI 10.1373/clinchem.2003.028258; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Retterstol L, 2003, ATHEROSCLEROSIS, V169, P279, DOI 10.1016/S0021-9150(03)00192-8; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; SHINE B, 1981, CLIN CHIM ACTA, V117, P13, DOI 10.1016/0009-8981(81)90005-X; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Szalai AJ, 2002, GENES IMMUN, V3, P14, DOI 10.1038/sj.gene.6363820; SZALAI AJ, IN PRESS J MOL MED; TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561; Watkins Laurence O, 2004, Rev Cardiovasc Med, V5 Suppl 3, pS3; Wener MH, 2000, J RHEUMATOL, V27, P2351; Wolford JK, 2003, MOL GENET METAB, V78, P136, DOI 10.1016/S1096-7192(02)00230-5; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	37	254	260	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					64	77		10.1086/431366			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	WOS:000229794500006	15897982	Bronze, Green Published			2022-01-24	
J	Hollox, EJ; Armour, JAL; Barber, JCK				Hollox, EJ; Armour, JAL; Barber, JCK			Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME REGION 8P23.1; HUMAN-GENOME; SEGMENTAL DUPLICATIONS; HOST-DEFENSE; PEPTIDE; VARIANT; HYBRIDIZATION; POLYMORPHISMS; POPULATIONS; EXPRESSION	Using a combination of multiplex amplifiable probe hybridization and semiquantitative fluorescence in situ hybridization (SQ-FISH), we analyzed DNA copy number variation across chromosome band 8p23.1, a region that is frequently involved in chromosomal rearrangements. We show that a cluster of at least three antimicrobial beta-defensin genes (DEFB4, DEFB103, and DEFB104) at 8p23.1 are polymorphic in copy number, with a repeat unit greater than or equal to 240 kb long. Individuals have 2 - 12 copies of this repeat per diploid genome. By segregation, microsatellite dosage, and SQ-FISH chromosomal signal intensity ratio analyses, we deduce that individual chromosomes can have one to eight copies of this repeat unit. Chromosomes with seven or eight copies of this repeat unit are identifiable by cytogenetic analysis as a previously described 8p23.1 euchromatic variant. Analysis of RNA from different individuals by semiquantitative reverse-transcriptase polymerase chain reaction shows a significant correlation between genomic copy number of DEFB4 and levels of its messenger RNA ( mRNA) transcript. The peptides encoded by these genes are potent antimicrobial agents, especially effective against clinically important pathogens, such as Pseudomonas aeruginosa and Staphylococcus aureus, and DEFB4 has been shown to act as a cytokine linking the innate and adaptive immune responses. Therefore, a copy number polymorphism involving these genes, which is reflected in mRNA expression levels, is likely to have important consequences for immune system function.	Univ Nottingham, Inst Genet, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England; Salisbury Dist Hosp, Salisbury, England; Southampton Univ Hosp Trust, Div Human Genet, Southampton, Hants, England		Hollox, EJ (corresponding author), Univ Nottingham, Inst Genet, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England.			Armour, John/0000-0002-8558-8506; Hollox, Edward/0000-0002-0115-2298			Armour JAL, 2000, NUCLEIC ACIDS RES, V28, P605, DOI 10.1093/nar/28.2.605; Ausubel F., 1997, SHORT PROTOCOLS MOL; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Barber JCK, 1998, J MED GENET, V35, P491, DOI 10.1136/jmg.35.6.491; Barber JCK, 1999, HUM GENET, V104, P211, DOI 10.1007/s004390050938; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Engelen JJM, 2000, AM J MED GENET, V91, P18, DOI 10.1002/(SICI)1096-8628(20000306)91:1<18::AID-AJMG3>3.3.CO;2-V; Fan YS, 2001, AM J MED GENET, V103, P231, DOI 10.1002/ajmg.1534; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Giglio S, 2002, AM J HUM GENET, V71, P276, DOI 10.1086/341610; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gu X, 1999, MOL BIOL EVOL, V16, P147, DOI 10.1093/oxfordjournals.molbev.a026097; Harada N, 2002, AM J MED GENET, V111, P285, DOI 10.1002/ajmg.10584; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hollox EJ, 2002, J MED GENET, V39, P790, DOI 10.1136/jmg.39.11.790; Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Jurevic RJ, 2002, GENET TEST, V6, P261, DOI 10.1089/10906570260471787; Kennedy SJ, 2001, AM J MED GENET, V104, P79, DOI 10.1002/1096-8628(20011115)104:1<79::AID-AJMG1598>3.0.CO;2-T; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Liu L, 1998, GENE, V222, P237, DOI 10.1016/S0378-1119(98)00480-6; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Mars WM, 1995, J BIOL CHEM, V270, P30371, DOI 10.1074/jbc.270.51.30371; Morrison GM, 2003, MOL BIOL EVOL, V20, P460, DOI 10.1093/molbev/msg060; MURPHY LD, 1990, BIOCHEMISTRY-US, V29, P10351, DOI 10.1021/bi00497a009; O'Malley DP, 1999, PRENATAL DIAG, V19, P183; Pehlivan T, 1999, AM J MED GENET, V83, P201, DOI 10.1002/(SICI)1096-8628(19990319)83:3<201::AID-AJMG11>3.3.CO;2-M; Pramanik S, 2002, AM J HUM GENET, V71, P1342, DOI 10.1086/344713; Robledo R, 2002, GENOMICS, V80, P585, DOI 10.1006/geno.2002.7014; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Singh PK, 1999, P NATL ACAD SCI USA, V96, P2569; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Siniscalco M, 2000, TRENDS GENET, V16, P435, DOI 10.1016/S0168-9525(00)02101-6; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Tsai CH, 2002, J MED GENET, V39, P769, DOI 10.1136/jmg.39.10.769; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yu CE, 2002, AM J HUM GENET, V71, P100, DOI 10.1086/341291; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	46	254	261	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					591	600		10.1086/378157			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	WOS:000185134000011	12916016	Bronze, Green Published			2022-01-24	
J	Haug, K; Warnstedt, M; Alekov, AK; Sander, T; Ramirez, A; Poser, B; Maljevic, S; Hebeisen, S; Kubisch, C; Rebstock, J; Horvath, S; Hallmann, K; Dullinger, JS; Rau, B; Haverkamp, F; Beyenburg, S; Schulz, H; Janz, D; Giese, B; Muller-Newen, G; Propping, P; Elger, CE; Fahlke, C; Lerche, H; Heils, A				Haug, K; Warnstedt, M; Alekov, AK; Sander, T; Ramirez, A; Poser, B; Maljevic, S; Hebeisen, S; Kubisch, C; Rebstock, J; Horvath, S; Hallmann, K; Dullinger, JS; Rau, B; Haverkamp, F; Beyenburg, S; Schulz, H; Janz, D; Giese, B; Muller-Newen, G; Propping, P; Elger, CE; Fahlke, C; Lerche, H; Heils, A			RETRACTED: Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies (Retracted article. See vol 41, pg. 1043, 2009)	NATURE GENETICS			English	Article; Retracted Publication							POSTSYNAPTIC INHIBITION; ION CHANNELS; NEURONS; GABA; GAMMA-2-SUBUNIT; CONDUCTANCE; HIPPOCAMPUS; POTASSIUM; MOUSE; CELLS	Idiopathic generalized epilepsy (IGE) is an inherited neurological disorder affecting about 0.4% of the world's population. Mutations in ten genes causing distinct forms of idiopathic epilepsy have been identified so far(1-7), but the genetic basis of many IGE subtypes is still unknown. Here we report a gene associated with the four most common IGE subtypes: childhood and juvenile absence epilepsy (CAE and JAE), juvenile myoclonic epilepsy (JME), and epilepsy with grand mal seizures on awakening (EGMA; ref. 8). We identified three different heterozygous mutations in the chloride-channel gene CLCN2 in three unrelated families with IGE. These mutations result in (i) a premature stop codon (M200fsX231), (ii) an atypical splicing (del74-117) and (iii) a single amino-acid substitution (G715E). All mutations produce functional alterations that provide distinct explanations for their pathogenic phenotypes. M200fsX231 and del74-117 cause a loss of function of ClC-2 channels and are expected to lower the transmembrane chloride gradient essential for GABAergic inhibition. G715E alters voltage-dependent gating, which may cause membrane depolarization and hyperexcitability.	Univ Klinikum Bonn, Inst Humangenet, D-53111 Bonn, Germany; Ctr Estudios Cient, Valdivia, Chile; Rhein Westfal TH Aachen, Inst Biochem, D-52057 Aachen, Germany; Univ Klinikum Bonn, Klinikum Padiatrie, D-59113 Bonn, Germany; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; Univ Klinikum Bonn, Klin Epileptol, D-53105 Bonn, Germany; Humboldt Univ, Virchow Klinikum, Klinikum Charite, Arbeitsgrp Epilepsie Genet,Neurol Klin, D-13353 Berlin, Germany; Univ Ulm, Abt Angew Physiol & Neurol, D-89069 Ulm, Germany; Rhein Westfal TH Aachen, Lehr & Forschungsgebeit Physiol, D-52057 Aachen, Germany		Heils, A (corresponding author), Univ Klinikum Bonn, Inst Humangenet, Wilhelmstr 31, D-53111 Bonn, Germany.	holger.lerche@medizin.uni-ulm.de; armin.heils@ukb.uni-bonn.de	Alekov, Alexi/ABE-4170-2020; Kubisch, Christian/F-1893-2011; Ramirez, Alfredo/S-5126-2019; Fahlke, Christoph/G-3635-2013	Kubisch, Christian/0000-0003-4220-0978; Ramirez, Alfredo/0000-0003-4991-763X; Fahlke, Christoph/0000-0001-8602-9952; Alekov, Alexi/0000-0001-6362-7247; Maljevic, Snezana/0000-0003-1876-5872			[Anonymous], 1989, EPILEPSIA, V30, P389; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/ng0501-46; Berkovic SF, 2001, EPILEPSIA, V42, P16, DOI 10.1046/j.1528-1157.2001.0420s5016.x; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; CID LP, 1995, HUM MOL GENET, V4, P407, DOI 10.1093/hmg/4.3.407; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Kaila K, 1997, J NEUROSCI, V17, P7662; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lerche H, 2001, AM J MED GENET, V106, P146, DOI 10.1002/ajmg.1582; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; Mladinic M, 1999, P ROY SOC B-BIOL SCI, V266, P1207, DOI 10.1098/rspb.1999.0764; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; Sander T, 2000, HUM MOL GENET, V9, P1465, DOI 10.1093/hmg/9.10.1465; Serratosa JM, 1999, EPILEPSIA, V40, P12, DOI 10.1111/j.1528-1157.1999.tb00893.x; Sik A, 2000, NEUROSCIENCE, V101, P51, DOI 10.1016/S0306-4522(00)00360-2; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Steinlein OK, 2000, CURR OPIN GENET DEV, V10, P286, DOI 10.1016/S0959-437X(00)00079-4; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259	30	254	273	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					527	532		10.1038/ng1121			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	WOS:000181928600027	12612585	Bronze			2022-01-24	
J	Digilio, MC; Conti, E; Sarkozy, A; Mingarelli, R; Dottorini, T; Marino, B; Pizzuti, A; Dallapiccola, B				Digilio, MC; Conti, E; Sarkozy, A; Mingarelli, R; Dottorini, T; Marino, B; Pizzuti, A; Dallapiccola, B			Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEOPARD-SYNDROME; LENTIGINOSIS; FEATURES; FAMILY	Multiple-lentigines (ML)/LEOPARD (multiple (l) under bar entigines, (e) under bar lectrocardiographic-conduction abnormalities, (o) under bar cular hypertelorism, (p) under bar ulmonary stenosis, (a) under bar bnormal genitalia, (r) under bar etardation of growth, and sensorineural (d) under bar eafness) syndrome is an autosomal dominant condition-characterized by lentigines and cafe' au lait spots, facial anomalies, cardiac defects-that shares several clinical features with Noonan syndrome (NS). We screened nine patients with ML/LEOPARD syndrome (including a mother-daughter pair) and two children with NS who had multiple cafe' au lait spots, for mutations in the NS gene, PTPN11, and found, in 10 of 11 patients, one of two new missense mutations, in exon 7 or exon 12. Both mutations affect the PTPN11 phosphotyrosine phosphatase domain, which is involved in <30% of the NS PTPN11 mutations. The study demonstrates that ML/LEOPARD syndrome and NS are allelic disorders. The detected mutations suggest that distinct molecular and pathogenetic mechanisms cause the peculiar cutaneous manifestations of the ML/LEOPARD-syndrome subtype of NS.	Univ Roma La Sapienza, Ist CSS Mendel, I-00198 Rome, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, Med Genet Sect, I-00198 Rome, Italy; Univ Roma La Sapienza, Inst Pediat, Div Pediat Cardiol, I-00198 Rome, Italy; Bambino Gesu Pediat Hosp, Ist Ricovero & Cura & Carattere Sci, Div Med Genet, San Giovanni Rotondo, Italy; Casa Sollievo Sofferenza Hosp, Ist Ricovero & Cura & Carattere Sci, San Giovanni Rotondo, Italy		Pizzuti, A (corresponding author), Univ Roma La Sapienza, Ist CSS Mendel, Viale Regina Margherita 261, I-00198 Rome, Italy.	a.pizzuti@css-mendel.it	Digilio, Maria Cristina/AAI-2434-2019; Dallapiccola, Bruno/K-8692-2016	Dallapiccola, Bruno/0000-0002-5031-1013; PIZZUTI, Antonio/0000-0003-3245-1925			AHLBOM BE, 1995, CLIN GENET, V48, P85; ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; BLIEDEN LC, 1983, PEDIATR CARDIOL, V4, P168, DOI 10.1007/BF02076346; CARNEY JA, 1986, ARCH DERMATOL, V122, P790, DOI 10.1001/archderm.122.7.790; Coppin BD, 1997, J MED GENET, V34, P582, DOI 10.1136/jmg.34.7.582; DOCIU I, 1976, BRIT J DERMATOL, V94, P39, DOI 10.1111/j.1365-2133.1976.tb04339.x; GORLIN JR, 1990, SYNDROMES HEAD NECK, P461; GORLIN RJ, 1969, AM J DIS CHILD, V117, P652, DOI 10.1001/archpedi.1969.02100030654006; JAMIESON CR, 1994, NAT GENET, V8, P357, DOI 10.1038/ng1294-357; Legius E, 1998, EUR J HUM GENET, V6, P32, DOI 10.1038/sj.ejhg.5200150; Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0; MENDEZ HMM, 1985, AM J MED GENET, V21, P493, DOI 10.1002/ajmg.1320210312; Noonan JA, 1999, J PEDIATR-US, V135, P667, DOI 10.1016/S0022-3476(99)70082-X; PIPKIN AC, 1950, J HERED, V41, P79, DOI 10.1093/oxfordjournals.jhered.a106092; SCHIEVINK WI, 1995, NEW ENGL J MED, V332, P576, DOI 10.1056/NEJM199503023320905; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; VORON DA, 1976, AM J MED, V60, P447, DOI 10.1016/0002-9343(76)90764-6; WATSON GH, 1967, ARCH DIS CHILD, V42, P303, DOI 10.1136/adc.42.223.303; Wu R, 1996, HUM MUTAT, V8, P51, DOI 10.1002/(SICI)1098-1004(1996)8:1<51::AID-HUMU7>3.3.CO;2-Z	20	254	275	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					389	394		10.1086/341528			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	WOS:000176977700016	12058348	Bronze, Green Published			2022-01-24	
J	Kikuchi, S; Hata, M; Fukumoto, K; Yamane, Y; Matsui, T; Tamura, A; Yonemura, S; Yamagishi, H; Keppler, D; Tsukita, S; Tsukita, S				Kikuchi, S; Hata, M; Fukumoto, K; Yamane, Y; Matsui, T; Tamura, A; Yonemura, S; Yamagishi, H; Keppler, D; Tsukita, S; Tsukita, S			Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes	NATURE GENETICS			English	Article							MULTIDRUG-RESISTANCE PROTEIN; DUBIN-JOHNSON-SYNDROME; EZRIN/RADIXIN/MOESIN ERM PROTEINS; EXPORT PUMP; CELL-ADHESION; DRUG-RESISTANCE; CDNA CLONING; GENE; MOESIN; FAMILY	The ezrin-radixin-moesin (ERM) family of proteins crosslink actin filaments and integral membrane proteins(1-3). Radixin (encoded by Rdx) is the dominant ERM protein in the liver of wildtype mice(4,5) and is concentrated at bile canalicular membranes (BCMs)(5). Here we show that Rdx(-/-) mice are normal at birth, but their serum concentrations of conjugated bilirubin begin to increase gradually around 4 weeks, and they show mild liver injury after 8 weeks. This phenotype is similar to human conjugated hyperbilirubinemia in Dubin-Johnson syndrome(6,7), which is caused by mutations in the multidrug resistance protein 2 (MRP2, gene symbol ABCC2)(8-11), although this syndrome is not associated with overt liver injury. In wildtype mice, Mrp2 concentrates at BCMs to secrete conjugated bilirubin into bile(8,11,12). In the BCMs of Rdx(-/-) mice, Mrp2 is decreased compared with other BCM proteins such as dipeptidyl peptidase IV (CD26) and P-glycoproteins. In vitro binding studies show that radixin associates directly with the carboxy-terminal cytoplasmic domain of human MRP2. These findings indicate that radixin is required for secretion of conjugated bilirubin through its support of Mrp2 localization at BCMs.	Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Prefectural Univ Med, Dept Surg, Kamigyo Ku, Kyoto 6028566, Japan; KAN Res Inst, Shimogyo Ku, Kyoto 6008815, Japan; RIKEN, Ctr Dev Biol, Lab Cellular Morphogenesis, Chuo Ku, Kobe, Hyogo 6500047, Japan; Deutsch Krebsforschungszentrum, Div Tumor Biochem, D-69120 Heidelberg, Germany; Kyoto Univ, Coll Med Technol, Sakyo Ku, Kyoto 6068507, Japan		Tsukita, S (corresponding author), Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.	atsukita@mfour.med.kyoto-u.ac.jp	Keppler, Dietrich/A-5528-2013	Keppler, Dietrich/0000-0003-2964-2333; Kikuchi, Shojiro/0000-0002-6217-8352			Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Buchler M, 1996, J BIOL CHEM, V271, P15091; CHILDS S, 1995, CANCER RES, V55, P2029; Cui YH, 1999, MOL PHARMACOL, V55, P929; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; DUBIN IN, 1954, MEDICINE, V33, P155, DOI 10.1097/00005792-195409000-00001; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Kartenbeck J, 1996, HEPATOLOGY, V23, P1061; Keitel V, 2000, HEPATOLOGY, V32, P1317, DOI 10.1053/jhep.2000.19791; Kocher O, 1999, LAB INVEST, V79, P1161; Kondo T, 1997, J CELL BIOL, V139, P749, DOI 10.1083/jcb.139.3.749; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Nies AT, 1998, HEPATOLOGY, V28, P1332, DOI 10.1002/hep.510280523; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Paulusma CC, 1997, HEPATOLOGY, V25, P1539, DOI 10.1002/hep.510250635; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; SATO N, 1992, J CELL SCI, V103, P131; SPRINZ H, 1954, ANN INTERN MED, V41, P952, DOI 10.7326/0003-4819-41-5-952; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	30	254	262	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					320	325		10.1038/ng905			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	WOS:000176494100024	12068294				2022-01-24	
J	Wu, LF; Hughes, TR; Davierwala, AP; Robinson, MD; Stoughton, R; Altschuler, SJ				Wu, LF; Hughes, TR; Davierwala, AP; Robinson, MD; Stoughton, R; Altschuler, SJ			Large-scale prediction of Saccharomyces cerevisiae gene function using overlapping transcriptional clusters	NATURE GENETICS			English	Article							CELL NUCLEAR ANTIGEN; EXPRESSION PROFILES; RIBOSOME BIOGENESIS; PROTEIN FUNCTION; GENOME; YEAST; SEQUENCE; DATABASE; IDENTIFICATION; REPLICATION	Genome sequencing has led to the discovery of tens of thousands of potential new genes. Six years after the sequencing of the well-studied yeast Saccharomyces cerevisiae and the discovery that its genome encodes 6,000 predicted proteins, more than 2,000 have not yet been characterized experimentally, and determining their functions seems far from a trivial task. One crucial constraint is the generation of useful hypotheses about protein function. Using a new approach to interpret microarray data, we assign likely cellular functions with confidence values to these new yeast proteins. We perform extensive genome-wide validations of our predictions and offer visualization methods for exploration of the large numbers of functional predictions. We identify potential new members of many existing functional categories including 285 candidate proteins involved in transcription, processing and transport of non-coding RNA molecules. We present experimental validation confirming the involvement of several of these proteins in ribosomal RNA processing. Our methodology can be applied to a variety of genomics data types and organisms.	Rosetta Inpharmat, Kirkland, WA USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada		Altschuler, SJ (corresponding author), Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA.	saltschuler@cgr.harvard.edu	Robinson, Mark D./O-2254-2019; Robinson, Mark D/A-6432-2015	Robinson, Mark D./0000-0002-3048-5518; Robinson, Mark D/0000-0002-3048-5518			Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ball CA, 2000, NUCLEIC ACIDS RES, V28, P77, DOI 10.1093/nar/28.1.77; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen C, 1999, MOL CELL BIOL, V19, P7801; CHENG Y, 1995, SCIENCE, V267, P1807, DOI 10.1126/science.7534442; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Goffeau A., 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Goldstein DR, 2002, STAT SINICA, V12, P219; Hartigan JA, 1975, CLUSTERING ALGORITHM; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/ng0501-21; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; King RD, 2000, YEAST, V17, P283, DOI 10.1002/1097-0061(200012)17:4<283::AID-YEA52>3.0.CO;2-F; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Prosperi E, 1997, Prog Cell Cycle Res, V3, P193; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shatkay H, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P317; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; 1909, SCIENCE, V282, P2012	41	254	266	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					255	265		10.1038/ng906			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	WOS:000176494100012	12089522				2022-01-24	
J	Lin, YP; Ma, WL; Benchimol, S				Lin, YP; Ma, WL; Benchimol, S			Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; GROWTH SUPPRESSION; ADAPTER MOLECULE; CELL-DEATH; INTERACTS; TRANSFORMATION; IDENTIFICATION; INHIBITION; MOTIF; RIP	The p53 tumour suppressor promotes cell-cycle arrest or apoptosis in response to cellular stress, such as DNA damage and oncogenesis. This role of p53 is important for its tumour-suppression function(1) and depends, at least in part, on its ability to bind to specific DNA sequences and activate the transcription of target genes(2-4). The pathway through which p53 promotes apoptosis is not fully understood. Here we describe a new gene regulated by p53 that encodes a predicted protein of 915 amino acids in mice (910 amino acids in humans), which we have named Pidd. The mouse Pidd cDNA contains a p53 consensus DNA binding sequence upstream of the Pidd-coding region. This sequence element bound to p53 and conferred p53-dependent inducibility on a heterologous reporter gene. Moreover, Pidd RNA was induced by ionizing radiation in a p53-dependent manner and the basal level of Pidd RNA was dependent on Trp53 status. Overexpression of Pidd inhibited cell growth in a p53-like manner by inducing apoptosis. Antisense inhibition of Pidd expression attenuated p53-mediated apoptosis. Our data suggest that Pidd is an effector of p53-dependent apoptosis.	Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada		Benchimol, S (corresponding author), Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, 500 Sherbourne St, Toronto, ON, Canada.						Ahmad M, 1997, CANCER RES, V57, P615; BARRY ELR, 1993, BIOTECHNIQUES, V15, P1018; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FU L, 1966, EMBO J, V15, P4392; JOHNSON P, 1993, MOL CELL BIOL, V13, P1456, DOI 10.1128/MCB.13.3.1456; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIN YP, 1995, MOL CELL BIOL, V15, P6045; Mathews DH, 1999, RNA, V5, P1458, DOI 10.1017/S1355838299991148; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; SLINGERLAND JM, 1993, EMBO J, V12, P1029, DOI 10.1002/j.1460-2075.1993.tb05744.x; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1	26	254	262	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					122	125		10.1038/79102			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000033	10973264				2022-01-24	
J	Matsuo, K; Owens, JM; Tonko, M; Elliott, C; Chambers, TJ; Wagner, EF				Matsuo, K; Owens, JM; Tonko, M; Elliott, C; Chambers, TJ; Wagner, EF			Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation	NATURE GENETICS			English	Article							TERMINAL TRANSACTIVATION DOMAIN; ACTIVATION DOMAINS; BINDING PROTEIN; CELL-GROWTH; FRA-1 GENE; TRANSFORMATION; LIGAND; CYTOKINE; REQUIRES; MOUSE	Osteoclasts are bone-resorbing cells derived from haematopoietic precursors of the monocyte-macrophage lineage. Mice lacking Fos (encoding c-Fos) develop osteopetrosis due to an early differentiation block in the osteoclast lineage(1-3), c-Fos is a component of the dimeric transcription factor activator protein-1 (Ap-1), which is composed mainly of Fos (c-Fos, FosB, Fra-1 and Fra-2) and Jun proteins (c-Jun, JunB and JunD). Unlike Fra-1 (encoded by Fos/1), c-Fos contains transactivation domains required for oncogenesis and cellular transformation(4-6). The mechanism by which c-Fos exerts its specific function in osteoclast differentiation is not understood. Here we show by retroviral-gene transfer that all four Fos proteins, hut not the Jun proteins, rescue the differentiation block in vitro. Structure-function analysis demonstrated that the major carboxy-terminal transactivation domains of c-Fos and FosB are dispensable and that Fra-1 (which lacks transactivation domains(4,7)) has the highest rescue activity. Moreover, a transgene expressing Fra-1 rescues the osteopetrosis of c-fos-mutant mice in vivo. The osteoclast differentiation factor Rankl (also known as TRANCE, CUE and OPGL; refs 8-11) induces transcription of Fos/1 in a c-fos-dependent manner, thereby establishing a link between Rank signalling and the expression of Ap-1 proteins in osteoclast differentiation.	Res Inst Mol Pathol, A-1030 Vienna, Austria; St George Hosp, Sch Med, Dept Histopathol, London, England		Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Elliott, Candace/F-1860-2011; Matsuo, Koichi/K-5695-2012	Elliott, Candace/0000-0002-9174-0244; Matsuo, Koichi/0000-0002-1490-8955; Wagner, Erwin F/0000-0001-7872-0196			Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; BROWN HJ, 1995, EMBO J, V14, P124, DOI 10.1002/j.1460-2075.1995.tb06982.x; CHAMBERS TJ, 1993, P NATL ACAD SCI USA, V90, P5578, DOI 10.1073/pnas.90.12.5578; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Funk M, 1997, MOL CELL BIOL, V17, P537, DOI 10.1128/MCB.17.2.537; GIUS D, 1990, MOL CELL BIOL, V10, P4243, DOI 10.1128/MCB.10.8.4243; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; JOOSS KU, 1994, EMBO J, V13, P1467, DOI 10.1002/j.1460-2075.1994.tb06401.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LIVAK KJ, 1995, PCR METH APPL, V4, P357; METZ R, 1994, MOL CELL BIOL, V14, P6021, DOI 10.1128/MCB.14.9.6021; METZ R, 1994, EMBO J, V13, P3832, DOI 10.1002/j.1460-2075.1994.tb06694.x; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; OLIVIERO S, 1992, GENE DEV, V6, P1799, DOI 10.1101/gad.6.9.1799; Owens JM, 1999, J CELL PHYSIOL, V179, P170, DOI 10.1002/(SICI)1097-4652(199905)179:2<170::AID-JCP7>3.0.CO;2-K; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; Schreiber M, 1997, ONCOGENE, V15, P1171, DOI 10.1038/sj.onc.1201460; SUTHERLAND JA, 1992, GENE DEV, V6, P1810, DOI 10.1101/gad.6.9.1810; WANG SJ, 1992, J OPT SOC AM B, V9, P360, DOI 10.1364/JOSAB.9.000360; WISDOM R, 1992, GENE DEV, V6, P667, DOI 10.1101/gad.6.4.667; WISDOM R, 1993, MOL CELL BIOL, V13, P7429, DOI 10.1128/MCB.13.12.7429; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; WRIGHTON C, 1993, MOL CELL BIOL, V13, P4657, DOI 10.1128/MCB.13.8.4657; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	30	254	259	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2000	24	2					184	187		10.1038/72855			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	280LQ	WOS:000085104600022	10655067				2022-01-24	
J	Duggirala, R; Blangero, J; Almasy, L; Dyer, TD; Williams, KL; Leach, RJ; O'Connell, P; Stern, MP				Duggirala, R; Blangero, J; Almasy, L; Dyer, TD; Williams, KL; Leach, RJ; O'Connell, P; Stern, MP			Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SULFONYLUREA RECEPTOR GENE; MAJOR SUSCEPTIBILITY LOCUS; ACID-BINDING PROTEIN; GENOME DATA-BASE; INSULIN-RESISTANCE; QUANTITATIVE TRAITS; CARDIOVASCULAR RISK; EXTENDED PEDIGREES; SAN-ANTONIO; NIDDM	Since little is known about chromosomal locations harboring type 2 diabetes-susceptibility genes, we conducted a genomewide scan for such genes in a Mexican American population. We used data from 27 low-income extended Mexican American pedigrees consisting of 440 individuals for whom genotypic data are available for 379 markers. We used a variance-components technique to conduct multipoint linkage analyses for two phenotypes: type 2 diabetes (a discrete trait) and age at onset of diabetes (a truncated quantitative trait). For the multipoint analyses, a subset of 295 markers was selected on the basis of optimal spacing and informativeness. We found significant evidence that a susceptibility locus near the marker D10S587 on chromosome 10q influences age at onset of diabetes (LOD score 3.75) and is also linked with type 2 diabetes itself (LOD score 2.88). This susceptibility locus explains 63.8% +/- 9.9% (P = .000016) of the total phenotypic variation in age at onset of diabetes and 65.7% +/- 10.9% (P = .000135) of the total variation in liability to type 2 diabetes. Weaker evidence was found for linkage of diabetes and of age at onset to regions on chromosomes 3p, 4q, and 9p. In conclusion, our strongest evidence for linkage to both age at onset of diabetes and type 2 diabetes itself in the Mexican American population was for a region on chromosome 10q.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA		Duggirala, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78284 USA.		Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019	Leach, Robin/0000-0002-3201-5579	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK42273, DK47482, DK44297] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK042273, R01DK047482, R29DK044297] Funding Source: NIH RePORTER		Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BAIER LJ, 1995, J CLIN INVEST, V95, P1281, DOI 10.1172/JCI117778; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; BROSSEAU JD, 1979, AM J PUBLIC HEALTH, V69, P1277, DOI 10.2105/AJPH.69.12.1277; CANNINGS C, 1977, CLIN GENET, V12, P208; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; CNATOR A, 1997, EXTENDING SAS SURVIV; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Davis S, 1996, AM J HUM GENET, V58, P867; Diehl A K, 1989, Adv Intern Med, V34, P73; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Duggirala R, 1996, AM J HUM GENET, V59, P694; Dyke B., 1996, PEDSYS PEDIGREE DATA; ELBEIN S, 1997, DIABETES S1, V57, pA51; Elbein SC, 1997, J NUTR, V127, pS1891, DOI 10.1093/jn/127.9.1891S; Elston RC, 1998, AM J HUM GENET, V63, P931, DOI 10.1086/302073; ELSTON RC, 1974, AM J HUM GENET, V26, P13; Farrall M, 1997, AM J HUM GENET, V60, P735; Fasman KH, 1996, NUCLEIC ACIDS RES, V24, P57, DOI 10.1093/nar/24.1.57; FASMAN KH, 1994, NUCLEIC ACIDS RES, V22, P3462, DOI 10.1093/nar/22.17.3462; FROUGEL P, 1992, NATURE, V356, P162; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Ghosh S, 1996, DIABETES, V45, P1, DOI 10.2337/diabetes.45.1.1; Green P., 1990, DOCUMENTATION CRIMAP; Greenberg DA, 1996, AM J HUM GENET, V58, P892; Greenberg DA, 1997, AM J HUM GENET, V60, P738; Hani E, 1997, DIABETES, V46, P688, DOI 10.2337/diabetes.46.4.688; Hani EH, 1997, DIABETES, V46, P1225, DOI 10.2337/diab.46.7.1225; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HANSON RL, 1995, AM J HUM GENET, V57, P160; Hanson RL, 1997, DIABETES S1, V46, pA51; Inoue H, 1996, DIABETES, V45, P825, DOI 10.2337/diabetes.45.6.825; Kahn CR, 1996, ANNU REV MED, V47, P509; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kong A, 1997, NAT GENET, V17, P148, DOI 10.1038/ng1097-148; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lindner T, 1997, DIABETES, V46, P1227, DOI 10.2337/diab.46.7.1227; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; MCCARTHY M, 1997, DIABETES S1, V46, pA52; MCCARTHY MI, 1994, DIABETOLOGIA, V37, P959, DOI 10.1007/s001250050205; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MENDELL NR, 1974, BIOMETRICS, V30, P41, DOI 10.2307/2529616; MITCHELL BD, 1995, DIABETES, V44, P1046, DOI 10.2337/diabetes.44.9.1046; Mitchell BD, 1998, DIABETES, V47, pA170; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; OCONNELL P, 1994, GENOMICS, V24, P557, DOI 10.1006/geno.1994.1666; Ohta Y, 1998, DIABETES, V47, P476, DOI 10.2337/diabetes.47.3.476; PILLAY TS, 1995, ADV GENET, V32, P51; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; REWERS M, 1995, NIH PUBLICATION, P179; Sakul H, 1998, DIABETES, V47, pA71; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Serjeantson S, 1984, DIABETES MELLITUS RE, P23; Stern MP, 1996, DIABETES, V45, P563, DOI 10.2337/diabetes.45.5.563; STERN MP, 1984, AM J EPIDEMIOL, V120, P834, DOI 10.1093/oxfordjournals.aje.a113956; STERN MP, 1990, DIABETES METAB REV, V6, P29, DOI 10.1002/dmr.5610060102; Stern MP, 1996, GENOME RES, V6, P724, DOI 10.1101/gr.6.8.724; STIRLING B, 1995, DIABETOLOGIA, V38, P1479, DOI 10.1007/BF00400610; Suarez BK, 1994, GENETIC APPROACHES M, P23; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; Verge CF, 1998, DIABETES, V47, pA220; WEISS KM, 1984, YEARB PHYS ANTHROPOL, V27, P153; *WHO, 1985, WHO TECH REP SER, V277, P1; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Zimmet P, 1979, Diabetes Care, V2, P144, DOI 10.2337/diacare.2.2.144	73	254	267	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1127	1140		10.1086/302316			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	WOS:000079632900024	10090898	Green Published, Bronze			2022-01-24	
J	Gibbs, M; Stanford, JL; McIndoe, RA; Jarvik, GP; Kolb, S; Goode, EL; Chakrabarti, L; Schuster, EF; Buckley, VA; Miller, EL; Brandzel, S; Li, S; Hood, L; Ostrander, EA				Gibbs, M; Stanford, JL; McIndoe, RA; Jarvik, GP; Kolb, S; Goode, EL; Chakrabarti, L; Schuster, EF; Buckley, VA; Miller, EL; Brandzel, S; Li, S; Hood, L; Ostrander, EA			Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LINKAGE ANALYSIS; FAMILY HISTORY; ALLELIC LOSS; OLIGODENDROGLIAL TUMORS; BREAST-CANCER; RISK; NEUROBLASTOMA; GENE; HETEROZYGOSITY	Combining data from a genomic screen in 70 families with a high risk for prostate cancer (PC) with data from candidate-region mapping in these families and an additional 71 families, we have localized a potential hereditary PC-susceptibility locus to chromosome 1p36. Because an excess of cases of primary brain cancer (BC) have been observed in some studies of families with a high risk for PC, and because loss of heterozygosity at 1p36 is frequently observed in BC, we further evaluated 12 families with both a history of PC and a blood relative with primary BC. The overall LOD score in these 12 families was 3.22 at a recombination fraction (theta) of .06, with marker D1S507. On the basis of an a priori hypothesis, this group was stratified by age at diagnosis of PC. In the younger age group (mean age at diagnosis <66 years), a maximum two-point LOD score of 3.65 at theta = .0 was observed, with D1S407. This linkage was rejected in both early- and late-onset families without a history of BC (LOD scores -7.12 and -6.03, respectively, at theta = .0). After exclusion of 3 of the 12 families that had better evidence of linkage to previously described PC-susceptibility loci, linkage to the 1p36 region was suggested by a two-point LOD score of 4.74 at theta = .0, with marker D1S407. We conclude that a significant proportion of these families with both a high risk for PC and a family member with BC show linkage to the 1p36 region.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA		Ostrander, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N,D2-190, Seattle, WA 98109 USA.		Jarvik, Gail P/N-6476-2014; Chakrabarti, Lisa/G-4236-2011	Jarvik, Gail P/0000-0002-6710-8708; , lisa/0000-0001-7213-6837; McIndoe, Richard/0000-0002-3040-3631; Ostrander, Elaine/0000-0001-6075-9738; Kolb, Suzanne/0000-0002-6443-644X	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA56678] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA056678] Funding Source: NIH RePORTER		Airewele G, 1998, J NATL CANCER I, V90, P543, DOI 10.1093/jnci/90.7.543; BELLO MJ, 1995, INT J CANCER, V64, P207; BELLO MJ, 1994, INT J CANCER, V57, P172, DOI 10.1002/ijc.2910570207; BELLO MJ, 1995, CANCER GENET CYTOGEN, V83, P160, DOI 10.1016/0165-4608(95)00064-V; BELLO MJ, 1994, GENE CHROMOSOME CANC, V9, P296, DOI 10.1002/gcc.2870090411; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; BOVA GS, 1993, CANCER RES, V53, P3869; CANNONALBRIGHT L, 1995, NAT GENET, V9, P336, DOI 10.1038/ng0495-336; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Cher ML, 1996, CANCER RES, V56, P3091; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gronberg H, 1997, CANCER RES, V57, P4707; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Gronberg H, 1997, JAMA-J AM MED ASSOC, V278, P1251, DOI 10.1001/jama.278.15.1251; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; ISAACS SD, 1995, J NATL CANCER I, V87, P991, DOI 10.1093/jnci/87.13.991; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; KRAUS JA, 1995, J NEUROPATH EXP NEUR, V54, P91, DOI 10.1097/00005072-199501000-00011; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Laniado ME, 1998, JAMA-J AM MED ASSOC, V279, P507, DOI 10.1001/jama.279.7.507; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOVE RR, 1985, J CHRON DIS, V38, P289, DOI 10.1016/0021-9681(85)90074-8; MARIS JM, 1995, CANCER RES, V55, P4664; MARTINSSON T, 1995, CANCER RES, V55, P5681; MASSENKEIL G, 1994, ANTICANCER RES, V14, P2785; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; Ott J, 1991, ANAL HUMAN GENETIC L; RANSOM DT, 1992, GENE CHROMOSOME CANC, V5, P357, DOI 10.1002/gcc.2870050412; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RUDDON RW, 1981, CANC BIOL; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; SCHLICHT W, 1994, ANXIETY STRESS COPIN, V6, P275, DOI 10.1080/10615809408248802; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; STANFORD JL, IN PRESS NCI PUBL; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; VanRoy N, 1997, CANCER GENET CYTOGEN, V97, P135, DOI 10.1016/S0165-4608(96)00362-7; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Williams BJ, 1996, J UROLOGY, V155, P720, DOI 10.1016/S0022-5347(01)66509-1; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	48	254	261	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					776	787		10.1086/302287			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	WOS:000079204700015	10053012	Bronze, Green Published			2022-01-24	
J	HOWELL, N; KUBACKA, I; XU, M; MCCULLOUGH, DA				HOWELL, N; KUBACKA, I; XU, M; MCCULLOUGH, DA			LEBER HEREDITARY OPTIC NEUROPATHY - INVOLVEMENT OF THE MITOCHONDRIAL NDI GENE AND EVIDENCE FOR AN INTRAGENIC SUPPRESSOR MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; NADH DEHYDROGENASE; READING FRAMES; DNA MUTATION; ORGANIZATION; GENOME; SUBUNIT; NEURORETINOPATHY; HETEROGENEITY; VERTEBRATES	A large Queensland family has an extreme form of Leber hereditary optic neuropathy (LHON) in which several neurological abnormalities and an infantile encephalopathy are present in addition to the characteristic ophthalmological changes. Sequence analysis of the seven mitochondrial genes encoding subunits of respiratory chain complex I (NADH-ubiquinone oxidoreductase) reveals two novel features of the etiology of this mitochondrial genetic disease. The first conclusion from these studies is that the ophthalmological and neurological deficits in this family are produced by a mutation at nucleotide 4160 of the ND1 gene. This nucleotide alteration results in the substitution of proline for the highly conserved leucine residue at position 285 of the ND1 protein. Secondary-structure analysis predicts that the proline replacement disrupts a small alpha helix in a hydrophilic loop. All nine family members analyzed were homoplasmic for this mutation. The second major result from these studies is that the members of one branch of this family carry, at nucleotide 4136 of the same gene, a second mutation, also homoplasmic, which produces a cysteine-for-tyrosine replacement at position 277. The clinical and biochemical phenotypes of the family members indicate that this second nucleotide substitution may function as an intragenic suppressor mutation which ameliorates the neurological abnormalities and complex I deficiency.			HOWELL, N (corresponding author), UNIV TEXAS, MED BRANCH, DEPT RADIAT THERAPY, DIV BIOL, GALVESTON, TX 77550 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD08315] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM33683] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD008315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM033683] Funding Source: NIH RePORTER		ADAMS JH, 1966, BRAIN, V89, P15, DOI 10.1093/brain/89.1.15; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BOER PH, 1988, EMBO J, V7, P3501, DOI 10.1002/j.1460-2075.1988.tb03226.x; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; BROWN TA, 1983, EMBO J, V2, P427, DOI 10.1002/j.1460-2075.1983.tb01440.x; BRUYN GW, 1964, J NEUROL SCI, V1, P59, DOI 10.1016/0022-510X(64)90054-1; BURGER G, 1985, J MOL BIOL, V186, P231, DOI 10.1016/0022-2836(85)90100-7; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CUMMINGS DJ, 1988, CURR GENET, V14, P253, DOI 10.1007/BF00376746; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; EARLEY FGP, 1987, FEBS LETT, V219, P108, DOI 10.1016/0014-5793(87)81200-0; FRIEDRICH T, 1990, FEBS LETT, V265, P37, DOI 10.1016/0014-5793(90)80878-M; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GARNIER J, 1990, PREDICTION PROTEIN S, P417; HENSGENS LAM, 1984, NUCLEIC ACIDS RES, V12, P7327, DOI 10.1093/nar/12.19.7327; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1990, AM J HUM GENET, V47, P629; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; KOHCHI T, 1988, J MOL BIOL, V203, P353, DOI 10.1016/0022-2836(88)90004-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEES F, 1964, J NEUROL NEUROSUR PS, V27, P415, DOI 10.1136/jnnp.27.5.415; LUNDSGARD R, 1944, ACTA OPHTHALMOL S3, V21, P3; MONDELLI M, 1990, ACTA NEUROL SCAND, V81, P349; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; PALAN A, 1989, DOC OPHTHALMOL, V71, P77, DOI 10.1007/BF00155135; PARKER WD, 1989, NEW ENGL J MED, V320, P1331, DOI 10.1056/NEJM198905183202007; PRITCHARD AE, 1990, NUCLEIC ACIDS RES, V18, P163, DOI 10.1093/nar/18.1.163; RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1; ROE BA, 1985, J BIOL CHEM, V260, P9759; ROSE FC, 1970, BRIT J OPHTHALMOL, V54, P388, DOI 10.1136/bjo.54.6.388; SEEDORFF T, 1985, ACTA OPHTHALMOL, V63, P135; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WEERDT CJD, 1971, ACTA NEUROL SCAND, V47, P541, DOI 10.1111/j.1600-0404.1971.tb07507.x	41	254	257	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					935	942					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	WOS:A1991FK89700012	2018041				2022-01-24	
J	DEMEREC, M; FANO, U				DEMEREC, M; FANO, U			BACTERIOPHAGE-RESISTANT MUTANTS IN ESCHERICHIA-COLI	GENETICS			English	Article																	BAIL O, 1923, Z IMMUNITATSFORSCH, V38, P57; Burnet FM, 1929, J PATHOL BACTERIOL, V32, P15, DOI 10.1002/path.1700320104; BURNET FM, 1936, J PATH BACT, V36, P299; Delbruck M., 1942, ARCH BIOCHEM, V1, P111; Gratia A, 1921, J EXP MED, V34, P115, DOI 10.1084/jem.34.1.115; Hershey AD, 1943, J IMMUNOL, V46, P267; KALMANSON G., 1939, JOUR GEN PHYSIOL, V23, P203, DOI 10.1085/jgp.23.2.203; Luria SE, 1943, GENETICS, V28, P491	8	254	256	1	10	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1945	30	2					119	&					0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW821	WOS:A1945XW82100002	17247150				2022-01-24	
J	Dobzhansky, T; Wright, S				Dobzhansky, T; Wright, S			Genetics of natural populations. X. Dispersion rates in Drosophila pseudoobscura	GENETICS			English	Article									Columbia Univ, New York, NY USA; Univ Chicago, Chicago, IL USA								Dobzhansky T, 1941, GENETICS, V26, P23; Jackson CHN, 1940, ANN EUGENIC, V10, P332, DOI 10.1111/j.1469-1809.1940.tb02259.x; TIMOFEEFF-RESSOVSKY N. W., 1940, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V79, P28; TIMOFEEFFRESSOV.NW, 1940, Z INDUKT ABSTAMMUNGS, V79, P35; TIMOFEEFFRESSOV.NW, 1940, Z A V, V79, P114; Wright S, 1943, GENETICS, V28, P114; Wright S, 1942, GENETICS, V27, P0363	7	254	254	0	15	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	JUL	1943	28	4					304	340					37	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V22WH	WOS:000201545100005	17247091				2022-01-24	
J	Blakely, CM; Watkins, TBK; Wu, W; Gini, B; Chabon, JJ; McCoach, CE; McGranahan, N; Wilson, GA; Birkbak, NJ; Olivas, VR; Rotow, J; Maynard, A; Wang, V; Gubens, MA; Banks, KC; Lanman, RB; Caulin, AF; St John, J; Cordero, AR; Giannikopoulos, P; Simmons, AD; Mack, PC; Gandara, DR; Husain, H; Doebele, RC; Riess, JW; Diehn, M; Swanton, C; Bivona, TG				Blakely, Collin M.; Watkins, Thomas B. K.; Wu, Wei; Gini, Beatrice; Chabon, Jacob J.; McCoach, Caroline E.; McGranahan, Nicholas; Wilson, Gareth A.; Birkbak, Nicolai J.; Olivas, Victor R.; Rotow, Julia; Maynard, Ashley; Wang, Victoria; Gubens, Matthew A.; Banks, Kimberly C.; Lanman, Richard B.; Caulin, Aleah F.; St John, John; Cordero, Anibal R.; Giannikopoulos, Petros; Simmons, Andrew D.; Mack, Philip C.; Gandara, David R.; Husain, Hatim; Doebele, Robert C.; Riess, Jonathan W.; Diehn, Maximilian; Swanton, Charles; Bivona, Trever G.			Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers	NATURE GENETICS			English	Article							CIRCULATING TUMOR DNA; ACQUIRED-RESISTANCE; MET AMPLIFICATION; MUTATIONS; HETEROGENEITY; ACTIVATION; EXPRESSION; INHIBITOR; AZD9291; CELLS	A widespread approach to modern cancer therapy is to identify a single oncogenic driver gene and target its mutant-protein product (for example, EGFR-inhibitor treatment in EGFR-mutant lung cancers). However, genetically driven resistance to targeted therapy limits patient survival. Through genomic analysis of 1,122 EGFR-mutant lung cancer cell-free DNA samples and whole-exome analysis of seven longitudinally collected tumor samples from a patient with EGFR-mutant lung cancer, we identified critical co-occurring oncogenic events present in most advanced-stage EGFR-mutant lung cancers. We defined new pathways limiting EGFR-inhibitor response, including WNT/beta-catenin alterations and cell-cycle-gene (CDK4 and CDK6) mutations. Tumor genomic complexity increases with EGFR-inhibitor treatment, and co-occurring alterations in CTNNB1 and PIK3CA exhibit nonredundant functions that cooperatively promote tumor metastasis or limit EGFR-inhibitor response. This study calls for revisiting the prevailing single-gene driver-oncogene view and links clinical outcomes to co-occurring genetic alterations in patients with advanced-stage EGFR-mutant lung cancer.	[Blakely, Collin M.; Wu, Wei; Gini, Beatrice; Olivas, Victor R.; Rotow, Julia; Maynard, Ashley; Wang, Victoria; Gubens, Matthew A.; Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Blakely, Collin M.; Wu, Wei; Gini, Beatrice; Olivas, Victor R.; Rotow, Julia; Maynard, Ashley; Wang, Victoria; Gubens, Matthew A.; Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Watkins, Thomas B. K.; McGranahan, Nicholas; Wilson, Gareth A.; Birkbak, Nicolai J.; Swanton, Charles] UCL Canc Inst, Canc Res UK Lung Canc Ctr Excellence, Francis Crick Inst, London, England; [Chabon, Jacob J.; Diehn, Maximilian] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA USA; [McCoach, Caroline E.; Doebele, Robert C.] Univ Colorado, Div Med Oncol, Dept Med, Aurora, CO USA; [Banks, Kimberly C.; Lanman, Richard B.] Guardant Hlth Inc, Redwood City, CA USA; [Caulin, Aleah F.; St John, John; Cordero, Anibal R.; Giannikopoulos, Petros] Driver Inc, San Francisco, CA USA; [Simmons, Andrew D.] Clovis Oncol Inc, Boulder, CO USA; [Mack, Philip C.; Gandara, David R.; Riess, Jonathan W.] Univ Calif Davis, Canc Ctr, Sacramento, CA 95817 USA; [Husain, Hatim] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA		Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Bivona, TG (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Swanton, C (corresponding author), UCL Canc Inst, Canc Res UK Lung Canc Ctr Excellence, Francis Crick Inst, London, England.	charles.swanton@crick.ac.uk; trever.bivona@ucsf.edu	McGranahan, Nicholas/ABD-6561-2021; Lanman, Richard B/D-8290-2016; Doebele, Robert C./I-8230-2019; wu, wei/J-2797-2019	McGranahan, Nicholas/0000-0001-9537-4045; Lanman, Richard B/0000-0001-8122-4329; Doebele, Robert C./0000-0001-6728-6857; Birkbak, Nicolai/0000-0003-1613-9587; Maynard, Ashley/0000-0002-3588-3080; WU, WEI/0000-0002-6556-067X; Swanton, Charles/0000-0002-4299-3018; Banks, Kimberly/0000-0002-1290-3114; Diehn, Maximilian/0000-0003-2032-0581	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NCI-R01CA169338, NCI-DP2CA174497]; Pew Charitable Trust; Stewart Foundation; Searle Foundation; AACR; Lung Cancer Research Foundation; Cancer Research UKCancer Research UK [20466, 19310, 17786] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/P014712/1] Funding Source: researchfish; Rosetrees TrustRosetrees Trust [M391, M445, M179, M231-CD1, M640] Funding Source: researchfish; The Francis Crick Institute [A1278, VEG 108844, 10485, 10172, 10170, 10169, 10467, 10174, C60895/A23896, 10359, C28575/A25223] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/P014712/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U54CA224081, P50CA058187, DP2CA174497, R01CA211052, R01CA204302, U01CA217882, R01CA169338] Funding Source: NIH RePORTER	The authors acknowledge funding support from the NIH (NCI-R01CA169338, NIH Director's New Innovator Award NCI-DP2CA174497), the Pew Charitable Trust, Stewart Foundation, and Searle Foundation (to T.G.B.), and the AACR and Lung Cancer Research Foundation (C.M.B.). The authors thank J. Blakely for artwork and A. Sabnis, R. Okimoto, A. Tulpule, and M. Hutchinson for critical review and input on the manuscript. The authors acknowledge the following researchers for providing plasmids through Addgene: E. Campeau (University of Massachusetts Medical School); H. Land and J. Morgenstern (Imperial Cancer Research Fund); B. Weinberg (Whitehead Institute for Biomedical Research); J. Zhao (Dana-Farber Cancer Institute, Harvard Medical School); and E. Fearon (University of Michigan School of Medicine).	Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Canale M, 2017, CLIN CANCER RES, V23, P2195, DOI 10.1158/1078-0432.CCR-16-0966; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Dorantes-Heredia R, 2016, TRANSL LUNG CANCER R, V5, P401, DOI 10.21037/tlcr.2016.07.10; Eberlein CA, 2015, CANCER RES, V75, P2489, DOI 10.1158/0008-5472.CAN-14-3167; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Ho CC, 2017, J THORAC ONCOL, V12, P567, DOI 10.1016/j.jtho.2016.11.2231; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Okimoto RA, 2017, NAT GENET, V49, P87, DOI 10.1038/ng.3728; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Ou SHI, 2016, LUNG CANCER, V98, P59, DOI 10.1016/j.lungcan.2016.05.015; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Politi K, 2010, DIS MODEL MECH, V3, P111, DOI 10.1242/dmm.003681; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson JC, 2016, CLIN CANCER RES, V22, P5772, DOI 10.1158/1078-0432.CCR-16-1231; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Trejo CL, 2013, CANCER RES, V73, P6448, DOI 10.1158/0008-5472.CAN-13-0681; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; VanderLaan PA, 2017, LUNG CANCER, V106, P17, DOI 10.1016/j.lungcan.2017.01.011; Villaflor V, 2016, ONCOTARGET, V7, P66880, DOI 10.18632/oncotarget.11801; Wang XY, 1999, EXP CELL RES, V250, P253, DOI 10.1006/excr.1999.4529; Yu HA, 2014, ANN ONCOL, V25, P423, DOI 10.1093/annonc/mdt573; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	37	253	259	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2017	49	12					1693	+		10.1038/ng.3990			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FO0XY	WOS:000416480600008	29106415	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Fontebasso, AM; Papillon-Cavanagh, S; Schwartzentruber, J; Nikbakht, H; Gerges, N; Fisett, PO; Bechet, D; Faury, D; De Jay, N; Ramkissoon, LA; Corcoran, A; Jones, DTW; Sturm, D; Johann, P; Tomita, T; Goldman, S; Nagib, M; Bendel, A; Goumnerova, L; Bowers, DC; Leonard, JR; Rubin, JB; Alden, T; Browd, S; Geyer, JR; Leary, S; Jallo, G; Cohen, K; Gupta, N; Prados, MD; Carret, AS; Ellezam, B; Crevier, L; Klekner, A; Bognar, L; Hauser, P; Garami, M; Myseros, J; Dong, ZF; Siege, PM; Malkin, HL; Ligon, AH; Albrecht, S; Pfister, SM; Ligon, KL; Majewski, J; Jabado, N; Kieran, MW				Fontebasso, Adam M.; Papillon-Cavanagh, Simon; Schwartzentruber, Jeremy; Nikbakht, Hamid; Gerges, Noha; Fisett, Pierre-Olivier; Bechet, Denise; Faury, Damien; De Jay, Nicolas; Ramkissoon, Lori A.; Corcoran, Aoife; Jones, David T. W.; Sturm, Dominik; Johann, Pascal; Tomita, Tadanori; Goldman, Stewart; Nagib, Mahmoud; Bendel, Anne; Goumnerova, Liliana; Bowers, Daniel C.; Leonard, Jeffrey R.; Rubin, Joshua B.; Alden, Tord; Browd, Samuel; Geyer, J. Russell; Leary, Sarah; Jallo, George; Cohen, Kenneth; Gupta, Nalin; Prados, Michael D.; Carret, Anne-Sophie; Ellezam, Benjamin; Crevier, Louis; Klekner, Almos; Bognar, Laszlo; Hauser, Peter; Garami, Miklos; Myseros, John; Dong, Zhifeng; Siege, Peter M.; Malkin, Hay Ley; Ligon, Azra H.; Albrecht, Steffen; Pfister, Stefan M.; Ligon, Keith L.; Majewski, Jacek; Jabado, Nada; Kieran, Mark W.			Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma	NATURE GENETICS			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; INTRINSIC PONTINE GLIOMAS; BMP RECEPTOR; HISTONE H3.3; I RECEPTOR; GLIOBLASTOMA; GENES; MOUSE; ALK2; SUBGROUPS	Pediatric midline high-grade astrocytomas (mHGAs) are incurable with few treatment targets identified. Most tumors harbor mutations encoding p.Lys27Met in histone H3 variants. In 40 treatment-naive mHGAs, 39 analyzed by whole-exome sequencing, we find additional somatic mutations specific to tumor location. Gain-of-function mutations in ACVR1 occur in tumors of the pons in conjunction with histone H3.1 p.Lys27Met substitution, whereas FGFR1 mutations or fusions occur in thalamic tumors associated with histone H3.3 p.Lys27Met substitution. Hyperactivation of the bone morphogenetic protein (BMP)-ACVR1 developmental pathway in mHGAs harboring ACVR1 mutations led to increased levels of phosphorylated SMAD1, SMAD5 and SMAD8 and upregulation of BMP downstream early-response genes in tumor cells. Global DNA methylation profiles were significantly associated with the p.Lys27Met alteration, regardless of the mutant histone H3 variant and irrespective of tumor location, supporting the role of this substitution in driving the epigenetic phenotype. This work considerably expands the number of potential treatment targets and further justifies pretreatment biopsy in pediatric mHGA as a means to orient therapeutic efforts in this disease.	[Fontebasso, Adam M.; Jabado, Nada] McGill Univ, Montreal Childrens Hosp, Div Expt Med, Montreal, PQ H3H 1P3, Canada; [Fontebasso, Adam M.; Jabado, Nada] McGill Univ, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Papillon-Cavanagh, Simon; Nikbakht, Hamid; Gerges, Noha; Bechet, Denise; Faury, Damien; De Jay, Nicolas; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Schwartzentruber, Jeremy] Wellcome Trust Sanger Inst, Hinxton, England; [Fisett, Pierre-Olivier; Albrecht, Steffen] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Faury, Damien] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Ramkissoon, Lori A.; Corcoran, Aoife; Ligon, Azra H.; Ligon, Keith L.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Dept Med Oncol, Boston, MA 02115 USA; [Jones, David T. W.; Sturm, Dominik; Johann, Pascal; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Tomita, Tadanori; Alden, Tord] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Neurol Surg, Chicago, IL 60611 USA; [Goldman, Stewart] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat Hematol Oncol, Chicago, IL 60611 USA; [Nagib, Mahmoud] Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Bendel, Anne] Childrens Hosp & Clin Minnesota, Dept Pediat Hematol Oncol, Minneapolis, MN USA; [Goumnerova, Liliana] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Goumnerova, Liliana; Ligon, Azra H.; Ligon, Keith L.] Harvard Univ, Sch Med, Boston, MA USA; [Bowers, Daniel C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat Hematol Oncol, St Louis, MO USA; [Browd, Samuel] Seattle Childrens Hosp, Dept Neurosurg, Seattle, WA USA; [Geyer, J. Russell; Leary, Sarah] Seattle Childrens Hosp, Canc & Blood Disorders Ctr, Seattle, WA USA; [Jallo, George] Johns Hopkins Univ Hosp, Dept Neurol Surg, Baltimore, MD 21287 USA; [Cohen, Kenneth] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Pediat Hematol Oncol, Baltimore, MD USA; [Prados, Michael D.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Carret, Anne-Sophie] Univ Montreal, CHU St Justine, Dept Hematol Oncol, Montreal, PQ, Canada; [Ellezam, Benjamin] Univ Montreal, CHU St Justine, Dept Pathol, Montreal, PQ, Canada; [Crevier, Louis] Univ Montreal, CHU St Justine, Dept Neurosurg, Montreal, PQ, Canada; [Klekner, Almos; Bognar, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Neurosurg, Debrecen, Hungary; [Hauser, Peter; Garami, Miklos] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Myseros, John] Childrens Natl Med Ctr, Dept Neurosurg, Washington, DC 20010 USA; [Dong, Zhifeng; Siege, Peter M.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Malkin, Hay Ley] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Ligon, Azra H.; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Kieran, Mark W.] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA		Ligon, KL (corresponding author), Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Dept Med Oncol, Boston, MA 02115 USA.	keith_ligon@dfci.harvard.edu; jacek.majewski@mcgill.ca; nada.jabado@mcgill.ca; mark_kieran@dfci.harvard.edu	Sturm, Dominik/AAL-3689-2020; Johann, Pascal David/AAT-9368-2021; Pfister, Stefan M/F-6860-2013; Garami, Miklos/AAK-5680-2021; Papillon-Cavanagh, Simon/AAS-8749-2020; Jones, David T. W./Z-1963-2019; Jabado, Nada/AAN-4026-2020; Prados, Michael/N-5220-2019; Jones, David TW/G-9588-2013	Sturm, Dominik/0000-0003-0250-1696; Pfister, Stefan M/0000-0002-5447-5322; Papillon-Cavanagh, Simon/0000-0002-0372-2266; Jones, David TW/0000-0002-2036-5141; Schwartzentruber, Jeremy/0000-0002-6183-2092; Bowers, Daniel/0000-0002-3947-2481; Kieran, Mark/0000-0003-2184-7692; Leary, Sarah/0000-0003-0225-6184; Nikbakht, Hamid/0000-0003-0209-5667	Genome CanadaGenome Canada; McGill University; Montreal Children's Hospital Foundation; Hungarian Scientific Research Fund (OTKA)Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [T-04639]; National Research and Development Fund (NKFP) [1A/002/2004]; TAMOP [-4.2.2A-11/1/KONV-2012-0025]; NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA142536]; Zach Carson DIPG Fund at Dana-Farber Cancer Institute (DFCI); Mikey Czech Foundation; Maria Foundation; CIHRCanadian Institutes of Health Research (CIHR); Cedars Cancer Institute; McGill Integrated Cancer Research Training Program; Genome Quebec; Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR); Chercheur Clinicien Senior Award; Ellie Kavalieros Fund (DFCI); Caroline Fund (DFCI); Ryan Harvey DIPG Fund (DFCI); Stop&Shop Pediatric Brain Tumor Program (DFCI); Pediatric Brain Tumor Clinical and Research Fund (DFCI); CIHR Systems Biology Training Program at McGill University; T.D.Trust/Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA142536, P30CA060553] Funding Source: NIH RePORTER	The authors would like to express their sincere gratitude toward all staff at the McGill University and Genome Quebec Innovation Centre for excellent technical expertise, library preparation and sequencing. The authors are very grateful to J.-J. Lebrun (McGill University) for primer sequences and materials for SMAD signaling studies. This work was performed within the context of the I-CHANGE (International Childhood Astrocytoma Integrated Genomics and Epigenomics) Consortium and was supported by funding from Genome Canada, Genome Quebec, the Institute for Cancer Research of the Canadian Institutes for Health Research (CIHR), McGill University and the Montreal Children's Hospital Foundation. This work was also supported by Hungarian Scientific Research Fund (OTKA) contract T-04639: National Research and Development Fund (NKFP) contract 1A/002/2004 (P.H.and M.G.) and TAMOP-4.2.2A-11/1/KONV-2012-0025 (A.K. and LB.). N.J.is a member of the Penny Cole laboratory and the recipient of a Chercheur Clinicien Senior Award. J.Majewski holds a Canada Research Chair (tier 2). L.G., K.L.L. and M.W.K. are supported by NCI P01CA142536. We acknowledge the support of the Zach Carson DIPG Fund at the Dana-Farber Cancer Institute (DFCI), the Ellie Kavalieros Fund (DFCI), the Mikey Czech Foundation, the Prayer From Maria Foundation, the Hope for Caroline Fund (DFCI), the Ryan Harvey DIPG Fund (DFCI), the Stop&Shop Pediatric Brain Tumor Program (DFCI) and the Pediatric Brain Tumor Clinical and Research Fund (DFCI). A.M.F.is supported by a studentship from CIHR, as well as by an award from the CIHR Systems Biology Training Program at McGill University. D.B. is supported by a studentship from the T.D. Trust/Montreal Children's Hospital Foundation, and N. Gerges is supported by a studentship from the Cedars Cancer Institute. N.D.J. is supported by an award from the McGill Integrated Cancer Research Training Program.	Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; Fukuda T, 2008, BIOCHEM BIOPH RES CO, V377, P905, DOI 10.1016/j.bbrc.2008.10.093; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kishigami S, 2004, DEV BIOL, V276, P185, DOI 10.1016/j.ydbio.2004.08.042; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lahti L, 2012, DEVELOPMENT, V139, P894, DOI 10.1242/dev.071936; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611	22	253	261	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					462	466		10.1038/ng.2950			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	WOS:000335422900012	24705250	Green Accepted			2022-01-24	
J	Simon, MM; Greenaway, S; White, JK; Fuchs, H; Gailus-Durner, V; Wells, S; Sorg, T; Wong, K; Bedu, E; Cartwright, EJ; Dacquin, R; Djebali, S; Estabel, J; Graw, J; Ingham, NJ; Jackson, IJ; Lengeling, A; Mandillo, S; Marvel, J; Meziane, H; Preitner, F; Puk, O; Roux, M; Adams, DJ; Atkins, S; Ayadi, A; Becker, L; Blake, A; Brooker, D; Cater, H; Champy, MF; Combe, R; Danecek, P; di Fenza, A; Gates, H; Gerdin, AK; Golini, E; Hancock, JM; Hans, W; Holter, SM; Hough, T; Jurdic, P; Keane, TM; Morgan, H; Muller, W; Neff, F; Nicholson, G; Pasche, B; Roberson, LA; Rozman, J; Sanderson, M; Santos, L; Selloum, M; Shannon, C; Southwell, A; Tocchini-Valentini, GP; Vancollie, VE; Westerberg, H; Wurst, W; Zi, M; Yalcin, B; Ramirez-Solis, R; Steel, KP; Mallon, AM; de Angelis, MH; Herault, Y; Brown, SDM				Simon, Michelle M.; Greenaway, Simon; White, Jacqueline K.; Fuchs, Helmut; Gailus-Durner, Valerie; Wells, Sara; Sorg, Tania; Wong, Kim; Bedu, Elodie; Cartwright, Elizabeth J.; Dacquin, Romain; Djebali, Sophia; Estabel, Jeanne; Graw, Jochen; Ingham, Neil J.; Jackson, Ian J.; Lengeling, Andreas; Mandillo, Silvia; Marvel, Jacqueline; Meziane, Hamid; Preitner, Frederic; Puk, Oliver; Roux, Michel; Adams, David J.; Atkins, Sarah; Ayadi, Abdel; Becker, Lore; Blake, Andrew; Brooker, Debra; Cater, Heather; Champy, Marie-France; Combe, Roy; Danecek, Petr; di Fenza, Armida; Gates, Hilary; Gerdin, Anna-Karin; Golini, Elisabetta; Hancock, John M.; Hans, Wolfgang; Hoelter, Sabine M.; Hough, Tertius; Jurdic, Pierre; Keane, Thomas M.; Morgan, Hugh; Mueller, Werner; Neff, Frauke; Nicholson, George; Pasche, Bastian; Roberson, Laura-Anne; Rozman, Jan; Sanderson, Mark; Santos, Luis; Selloum, Mohammed; Shannon, Carl; Southwell, Anne; Tocchini-Valentini, Glauco P.; Vancollie, Valerie E.; Westerberg, Henrik; Wurst, Wolfgang; Zi, Min; Yalcin, Binnaz; Ramirez-Solis, Ramiro; Steel, Karen P.; Mallon, Ann-Marie; de Angelis, Martin Hrabe; Herault, Yann; Brown, Steve D. M.			A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains	GENOME BIOLOGY			English	Article						Mouse inbred lines; sequence variation; mouse phenotyping; gene knockout; C57BL/6	GENE; RESOURCE; EUROPHENOME; DATABASE; LINES; WIDE; CRB1	Background: The mouse inbred line C57BL/6J is widely used in mouse genetics and its genome has been incorporated into many genetic reference populations. More recently large initiatives such as the International Knockout Mouse Consortium (IKMC) are using the C57BL/6N mouse strain to generate null alleles for all mouse genes. Hence both strains are now widely used in mouse genetics studies. Here we perform a comprehensive genomic and phenotypic analysis of the two strains to identify differences that may influence their underlying genetic mechanisms. Results: We undertake genome sequence comparisons of C57BL/6J and C57BL/6N to identify SNPs, indels and structural variants, with a focus on identifying all coding variants. We annotate 34 SNPs and 2 indels that distinguish C57BL/6J and C57BL/6N coding sequences, as well as 15 structural variants that overlap a gene. In parallel we assess the comparative phenotypes of the two inbred lines utilizing the EMPReSSslim phenotyping pipeline, a broad based assessment encompassing diverse biological systems. We perform additional secondary phenotyping assessments to explore other phenotype domains and to elaborate phenotype differences identified in the primary assessment. We uncover significant phenotypic differences between the two lines, replicated across multiple centers, in a number of physiological, biochemical and behavioral systems. Conclusions: Comparison of C57BL/6J and C57BL/6N demonstrates a range of phenotypic differences that have the potential to impact upon penetrance and expressivity of mutational effects in these strains. Moreover, the sequence variants we identify provide a set of candidate genes for the phenotypic differences observed between the two strains.	[Simon, Michelle M.; Greenaway, Simon; Wells, Sara; Atkins, Sarah; Blake, Andrew; Brooker, Debra; Cater, Heather; di Fenza, Armida; Gates, Hilary; Hancock, John M.; Hough, Tertius; Morgan, Hugh; Nicholson, George; Santos, Luis; Southwell, Anne; Westerberg, Henrik; Mallon, Ann-Marie; Brown, Steve D. M.] Med Res Council Harwell, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; [Simon, Michelle M.; Greenaway, Simon; Wells, Sara; Atkins, Sarah; Blake, Andrew; Brooker, Debra; Cater, Heather; di Fenza, Armida; Gates, Hilary; Hancock, John M.; Hough, Tertius; Morgan, Hugh; Nicholson, George; Santos, Luis; Southwell, Anne; Westerberg, Henrik; Mallon, Ann-Marie; Brown, Steve D. M.] Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England; [White, Jacqueline K.; Wong, Kim; Estabel, Jeanne; Ingham, Neil J.; Adams, David J.; Danecek, Petr; Gerdin, Anna-Karin; Keane, Thomas M.; Roberson, Laura-Anne; Sanderson, Mark; Shannon, Carl; Vancollie, Valerie E.; Ramirez-Solis, Ramiro; Steel, Karen P.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Fuchs, Helmut; Gailus-Durner, Valerie; Becker, Lore; Hans, Wolfgang; Hoelter, Sabine M.; Rozman, Jan; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; [Fuchs, Helmut; Gailus-Durner, Valerie; Becker, Lore; Hans, Wolfgang; Hoelter, Sabine M.; Rozman, Jan; de Angelis, Martin Hrabe] German Mouse Clin, D-85764 Neuherberg, Germany; [Graw, Jochen; Puk, Oliver; Wurst, Wolfgang] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, D-85764 Neuherberg, Germany; [Neff, Frauke] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Pathol, D-85764 Neuherberg, Germany; [Sorg, Tania; Bedu, Elodie; Meziane, Hamid; Roux, Michel; Ayadi, Abdel; Champy, Marie-France; Combe, Roy; Selloum, Mohammed; Yalcin, Binnaz; Herault, Yann] INSERM, CNRS, IGBMC, Inst Clin Souris,ICS MCI,PHENOMIN,GIE CERBM, F-67404 Illkirch Graffenstaden, France; [Cartwright, Elizabeth J.; Zi, Min] Univ Manchester, Fac Med & Human Sci, Manchester MN13 9PT, Lancs, England; [Mueller, Werner] Univ Manchester, Fac Life Sci, Oxford MN13 9PT, England; [Dacquin, Romain; Djebali, Sophia; Marvel, Jacqueline; Jurdic, Pierre] AniRA ImmOs Phenotyping Facil, SFR Biosci Lyon Gerland, UMS3444 US8, F-69007 Lyon, France; [Jackson, Ian J.] Univ Edinburgh, Western Gen Hosp, MRC, Human Genet Unit,IGMM, Edinburgh EH4 2XU, Midlothian, Scotland; [Lengeling, Andreas] Univ Edinburgh, Roslin Inst, Infect & Immun Div, Roslin EH25 9RG, Midlothian, Scotland; [Mandillo, Silvia; Golini, Elisabetta; Tocchini-Valentini, Glauco P.] CNR, Cell Biol & Neurobiol Inst, Monterotondo Scala, I-00015 Monterotondo Scala, Italy; [Preitner, Frederic] Helmholtz Ctr Infect Res, Dept Infect Genet, D-38124 Braunschweig, Germany; [Pasche, Bastian] Univ Hosp Bern, Mouse Metab Facil, Cardiomet Ctr, CH-1015 Lausanne, Switzerland; [Pasche, Bastian; Yalcin, Binnaz] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Wurst, Wolfgang] Tech Univ Munich, Chair Dev Genet, D-80333 Munich, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen, D-80336 Munich, Germany		Brown, SDM (corresponding author), Med Res Council Harwell, Mammalian Genet Unit, Harwell Sci Campus, Didcot OX11 0RD, Oxon, England.	s.brown@har.mrc.ac.uk	Mandillo, Silvia/AAW-1363-2020; DJEBALI, SOPHIA/A-1798-2017; de Angelis, Martin Hrabe/F-5531-2012; marvel, jacqueline/H-8638-2014; Golini, Elisabetta/AAX-2849-2020; Yalcin, Binnaz/P-5482-2016; Mandillo, Silvia/E-6503-2019; Roux, Michel J/A-3213-2009; Gailus-Durner, Valerie/M-7337-2014; Holter, Sabine M./N-5868-2014; Herault, Yann/B-5500-2012; Becker, Lore/E-3717-2010; Graw, Jochen/D-9336-2013; Muller, Werner/B-9044-2008; Fuchs, Helmut/M-7347-2014; Hancock, John/A-2442-2009; Becker, Lore/AAJ-1203-2020; Yalcin, Binnaz/ABB-7735-2020; Rozman, Jan/A-2540-2010; , Elisabetta/D-9095-2015	DJEBALI, SOPHIA/0000-0002-0567-5387; de Angelis, Martin Hrabe/0000-0002-7898-2353; marvel, jacqueline/0000-0001-6241-459X; Yalcin, Binnaz/0000-0002-1924-6807; Mandillo, Silvia/0000-0002-4869-0974; Roux, Michel J/0000-0002-5812-5215; Holter, Sabine M./0000-0003-4878-5241; Herault, Yann/0000-0001-7049-6900; Muller, Werner/0000-0002-1297-9725; Fuchs, Helmut/0000-0002-5143-2677; Hancock, John/0000-0003-2991-2217; Becker, Lore/0000-0002-6890-4984; Yalcin, Binnaz/0000-0002-1924-6807; Rozman, Jan/0000-0002-8035-8904; Santos, Luis/0000-0001-6403-4902; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Graw, Jochen/0000-0003-0298-9660; , Elisabetta/0000-0002-9323-7124; Cartwright, Elizabeth/0000-0002-6836-7795; Cater, Heather/0000-0002-8696-6070; Jackson, Ian/0000-0001-6526-0688; Wong, Kim/0000-0002-0984-1477; SELLOUM, MOHAMMED/0000-0003-4057-3519; Wurst, Wolfgang/0000-0003-4422-7410; Keane, Thomas/0000-0001-7532-6898	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [LSHG-CT-2006-037188 EUMODIC, LSHG-CT-2007-037445]; Wellcome TrustWellcome TrustEuropean Commission [098051]; EMBO Long-Term FellowshipEuropean Molecular Biology Organization (EMBO); Agence Nationale de la RechercheFrench National Research Agency (ANR)European Commission; French state aid [ANR-10-INBS-07]; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/D/20231759] Funding Source: researchfish; Cancer Research UKCancer Research UK [13031] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U142684175, G1002082, G0800024, MC_UP_1502/1, MC_U142684171, G0300212, MC_U127561112, MC_qA137918, MC_U142684172, MC_PC_U127561112] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/D/20231759] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U127561112, MC_qA137918, MC_U142684171, MC_U142684175, G1002082, G0300212, MC_PC_U127561112, G0800024, MC_U142684172, MC_UP_1502/1] Funding Source: UKRI	The project was funded by the European Commission contract numbers LSHG-CT-2006-037188 EUMODIC and LSHG-CT-2007-037445, and also supported by the Wellcome Trust (grant number 098051). We gratefully acknowledge the contribution of all contributors to the EUMODIC project; a list can be found in the paper by Morgan et al. [19]. We thank the Genomics Services group at the Wellcome Trust Centre for Human Genetics, University of Oxford, for running the Sequenom assays. Binnaz Yalcin is supported by an EMBO Long-Term Fellowship and the Agence Nationale de la Recherche. The ICS was also supported by the French state aid managed by the National Agency for Research under the program of future investments (PHENOMIN, ANR-10-INBS-07).	Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Gates H, 2011, METHODS, V53, P394, DOI 10.1016/j.ymeth.2010.12.017; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Mallon AM, 2008, NUCLEIC ACIDS RES, V36, pD715, DOI 10.1093/nar/gkm728; Manske HM, 2009, GENOME RES, V19, P2125, DOI 10.1101/gr.093443.109; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Morgan H, 2010, NUCLEIC ACIDS RES, V38, pD577, DOI 10.1093/nar/gkp1007; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tucci V, 2006, MAMM GENOME, V17, P1113, DOI 10.1007/s00335-006-0075-x; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILLIAMS RW, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8; Wong K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r128; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18	36	253	253	0	31	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2013	14	7							R82	10.1186/gb-2013-14-7-r82			22	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	268UA	WOS:000328194900014	23902802	Green Published, hybrid			2022-01-24	
J	Katiyar, A; Smita, S; Lenka, SK; Rajwanshi, R; Chinnusamy, V; Bansal, KC				Katiyar, Amit; Smita, Shuchi; Lenka, Sangram Keshari; Rajwanshi, Ravi; Chinnusamy, Viswanathan; Bansal, Kailash Chander			Genome-wide classification and expression analysis of MYB transcription factor families in rice and Arabidopsis	BMC GENOMICS			English	Article							R2R3-MYB GENE FAMILY; DNA-BINDING DOMAIN; C-MYB; CELL-CYCLE; NUCLEOTIDE-SEQUENCE; DROUGHT STRESS; PROTEIN; TOLERANCE; REGULATOR; DATABASE	Background: The MYB gene family comprises one of the richest groups of transcription factors in plants. Plant MYB proteins are characterized by a highly conserved MYB DNA-binding domain. MYB proteins are classified into four major groups namely, 1R-MYB, 2R-MYB, 3R-MYB and 4R-MYB based on the number and position of MYB repeats. MYB transcription factors are involved in plant development, secondary metabolism, hormone signal transduction, disease resistance and abiotic stress tolerance. A comparative analysis of MYB family genes in rice and Arabidopsis will help reveal the evolution and function of MYB genes in plants. Results: A genome-wide analysis identified at least 155 and 197 MYB genes in rice and Arabidopsis, respectively. Gene structure analysis revealed that MYB family genes possess relatively more number of introns in the middle as compared with C-and N-terminal regions of the predicted genes. Intronless MYB-genes are highly conserved both in rice and Arabidopsis. MYB genes encoding R2R3 repeat MYB proteins retained conserved gene structure with three exons and two introns, whereas genes encoding R1R2R3 repeat containing proteins consist of six exons and five introns. The splicing pattern is similar among R1R2R3 MYB genes in Arabidopsis. In contrast, variation in splicing pattern was observed among R1R2R3 MYB members of rice. Consensus motif analysis of 1kb upstream region (5' to translation initiation codon) of MYB gene ORFs led to the identification of conserved and over-represented cis-motifs in both rice and Arabidopsis. Real-time quantitative RT-PCR analysis showed that several members of MYBs are up-regulated by various abiotic stresses both in rice and Arabidopsis. Conclusion: A comprehensive genome-wide analysis of chromosomal distribution, tandem repeats and phylogenetic relationship of MYB family genes in rice and Arabidopsis suggested their evolution via duplication. Genome-wide comparative analysis of MYB genes and their expression analysis identified several MYBs with potential role in development and stress response of plants.	[Katiyar, Amit; Smita, Shuchi; Lenka, Sangram Keshari; Rajwanshi, Ravi; Bansal, Kailash Chander] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Katiyar, Amit; Smita, Shuchi; Bansal, Kailash Chander] Indian Agr Res Inst Campus, Natl Bur Plant Genet Resources, New Delhi 110012, India; [Lenka, Sangram Keshari] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Rajwanshi, Ravi] Assam Univ, Dept Biotechnol, Silchar 788011, Assam, India; [Chinnusamy, Viswanathan] Indian Agr Res Inst, Div Plant Physiol, New Delhi 110012, India		Bansal, KC (corresponding author), Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India.	kailashbansal@hotmail.com	Chinnusamy, Viswanathan/B-9079-2009; Rajwanshi, Ravi/B-9228-2013; Katiyar, Amit/AAV-1748-2021; smita, shuchi/L-2280-2019; Lenka, Sangram K./A-5830-2009	Chinnusamy, Viswanathan/0000-0003-2174-9064; Rajwanshi, Ravi/0000-0002-0568-5681; Lenka, Sangram K./0000-0002-0121-2430	Indian Council of Agricultural Research (ICAR)Indian Council of Agricultural Research (ICAR); National Initiative on Climate Resilient Agriculture (NICRA); University Grants Commission (UGC)University Grants Commission, India; Council of Scientific and Industrial Research (CSIR)Council of Scientific & Industrial Research (CSIR) - India; Department of Biotechnology (DBT), Govt. of IndiaDepartment of Biotechnology (DBT) India	We thank Indian Council of Agricultural Research (ICAR) for supporting this work through the ICAR-sponsored Network Project on Transgenics in Crops (NPTC) and National Initiative on Climate Resilient Agriculture (NICRA). SKL gratefully acknowledge University Grants Commission (UGC) and Council of Scientific and Industrial Research (CSIR) for CSIR-UGC Junior and Senior Research Fellowship Grant. SS and RR acknowledge the senior research and research associate fellowship grant by Department of Biotechnology (DBT), Govt. of India, respectively. We thank Cathie Martin, John Innes Centre, Norwich Research Park, Colney, Norwich, UK, for her valuable suggestions on the data analysis and manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Araki S, 2004, J BIOL CHEM, V279, P32979, DOI 10.1074/jbc.M403171200; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Braun E. L., 1999, Maize Genetics Cooperation Newsletter, P26; Chen RM, 2005, PLANT SCI, V169, P1146, DOI 10.1016/j.plantsci.2005.07.018; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cominelli E, 2009, CELL RES, V19, P1231, DOI 10.1038/cr.2009.123; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Ding Z, 2008, CELL RES, V18, P1047, DOI [10.1038/cr.2008.280, DOI 10.1038/CR.2008.280]; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Haga N, 2007, DEVELOPMENT, V134, P1101, DOI 10.1242/dev.02801; Hemm MR, 2001, TRENDS PLANT SCI, V6, P135, DOI 10.1016/S1360-1385(01)01915-X; Higginson T, 2003, PLANT J, V35, P177, DOI 10.1046/j.1365-313X.2003.01791.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ito M, 2005, J PLANT RES, V118, P61, DOI 10.1007/s10265-005-0192-8; Ito M, 2001, PLANT CELL, V13, P1891, DOI 10.1105/tpc.13.8.1891; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P69, DOI 10.1007/s10142-007-0052-9; Jia L, 2004, PLANT PHYSIOL, V134, P575, DOI 10.1104/pp.103.027201; Jiang CH, 2004, GENE, V326, P13, DOI 10.1016/j.gene.2003.09.049; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; KANEIISHII C, 1990, J BIOL CHEM, V265, P19990; Karamysheva ZN, 2004, J BIOL CHEM, V279, P47799, DOI 10.1074/jbc.M407938200; Kaundal R, 2010, PLANT PHYSIOL, V154, P36, DOI 10.1104/pp.110.156851; Kim JH, 2008, PLANT J, V54, P1015, DOI 10.1111/j.1365-313X.2008.03476.x; Kirik V, 2005, DEVELOPMENT, V132, P1477, DOI 10.1242/dev.01708; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Kranz H, 2000, PLANT J, V21, P231, DOI 10.1046/j.1365-313x.2000.00666.x; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lee MM, 2001, DEVELOPMENT, V128, P1539; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Lenka SK, 2009, PLANT MOL BIOL, V69, P261, DOI 10.1007/s11103-008-9423-4; Li JG, 2006, J EXP BOT, V57, P1263, DOI 10.1093/jxb/erj094; Lipsick JS, 1996, ONCOGENE, V13, P223; Lu SX, 2009, PLANT PHYSIOL, V150, P834, DOI 10.1104/pp.108.133272; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pasquali G, 2008, PLANT CELL REP, V27, P1677, DOI 10.1007/s00299-008-0587-9; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Pesch M, 2009, CURR OPIN PLANT BIOL, V12, P587, DOI 10.1016/j.pbi.2009.07.015; Poole Rebecca L., 2007, V406, P179; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Rabinowicz PD, 1999, GENETICS, V153, P427; RAMACHANDRAN S, 1994, CURR OPIN GENET DEV, V4, P642, DOI 10.1016/0959-437X(94)90129-Q; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Romero I, 1998, PLANT J, V14, P273, DOI 10.1046/j.1365-313X.1998.00113.x; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; SHINOZAKI K, 1992, PLANT MOL BIOL, V19, P493, DOI 10.1007/BF00023398; Simon M, 2007, DEV BIOL, V311, P566, DOI 10.1016/j.ydbio.2007.09.001; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WALKER JC, 1993, PLANT J, V3, P451, DOI 10.1046/j.1365-313X.1993.t01-23-00999.x; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yuan QP, 2005, PLANT PHYSIOL, V138, P17, DOI 10.1104/pp.104.059063; Zeng HZ, 2007, NUCLEIC ACIDS RES, V35, pD879, DOI 10.1093/nar/gkl814; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	85	253	288	36	173	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	OCT 10	2012	13								544	10.1186/1471-2164-13-544			19	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	085WT	WOS:000314645700001	23050870	Green Published, gold			2022-01-24	
J	Bonnefond, A; Clement, N; Fawcett, K; Yengo, L; Vaillant, E; Guillaume, JL; Dechaume, A; Payne, F; Roussel, R; Czernichow, S; Hercberg, S; Hadjadj, S; Balkau, B; Marre, M; Lantieri, O; Langenberg, C; Bouatia-Naji, N; Charpentier, G; Vaxillaire, M; Rocheleau, G; Wareham, NJ; Sladek, R; McCarthy, MI; Dina, C; Barroso, I; Jockers, R; Froguel, P				Bonnefond, Amelie; Clement, Nathalie; Fawcett, Katherine; Yengo, Loic; Vaillant, Emmanuel; Guillaume, Jean-Luc; Dechaume, Aurelie; Payne, Felicity; Roussel, Ronan; Czernichow, Sebastien; Hercberg, Serge; Hadjadj, Samy; Balkau, Beverley; Marre, Michel; Lantieri, Olivier; Langenberg, Claudia; Bouatia-Naji, Nabila; Charpentier, Guillaume; Vaxillaire, Martine; Rocheleau, Ghislain; Wareham, Nicholas J.; Sladek, Robert; McCarthy, Mark I.; Dina, Christian; Barroso, Ines; Jockers, Ralf; Froguel, Philippe		Meta-Anal Glucose Insulin-Related	Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; GENERAL-POPULATION; RISK; DISEASES; EXCESS; LOCI	Genome-wide association studies have revealed that common noncoding variants in MTNR1B (encoding melatonin receptor 1B, also known as MT2) increase type 2 diabetes (T2D) risk(1,2). Although the strongest association signal was highly significant (P < 1 x 10(-20)), its contribution to T2D risk was modest (odds ratio (OR) of similar to 1.10-1.15)(1-3). We performed large-scale exon resequencing in 7,632 Europeans, including 2,186 individuals with T2D, and identified 40 nonsynonymous variants, including 36 very rare variants (minor allele frequency (MAF) < 0.1%), associated with T2D (OR = 3.31, 95% confidence interval (CI) = 1.78-6.18; P = 1.64 x 10(-4)). A four-tiered functional investigation of all 40 mutants revealed that 14 were nonfunctional and rare (MAF < 1%), and 4 were very rare with complete loss of melatonin binding and signaling capabilities. Among the very rare variants, the partial-or total-loss-of-function variants but not the neutral ones contributed to T2D (OR = 5.67, CI = 2.17-14.82; P = 4.09 x 10(-4)). Genotyping the four complete loss-of-function variants in 11,854 additional individuals revealed their association with T2D risk (8,153 individuals with T2D and 10,100 controls; OR = 3.88, CI = 1.49-10.07; P = 5.37 x 10(-3)). This study establishes a firm functional link between MTNR1B and T2D risk.	[Bonnefond, Amelie; Yengo, Loic; Vaillant, Emmanuel; Dechaume, Aurelie; Bouatia-Naji, Nabila; Vaxillaire, Martine; Froguel, Philippe] Lille Pasteur Inst, CNRS, Unite Mixte Rech UMR 8199, Lille, France; [Bonnefond, Amelie; Yengo, Loic; Vaillant, Emmanuel; Dechaume, Aurelie; Bouatia-Naji, Nabila; Vaxillaire, Martine; Froguel, Philippe] Lille Nord France Univ, Ecole Doctorale Biol Sante, Lille, France; [Guillaume, Jean-Luc; Jockers, Ralf] Inst Cochin, INSERM, U1016, Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] CNRS, UMR 8104, Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] Paris Descartes Univ, Dept Med, Paris, France; [Fawcett, Katherine; Payne, Felicity; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Roussel, Ronan; Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Roussel, Ronan; Marre, Michel] Univ Paris 07, INSERM, U695, Paris, France; [Czernichow, Sebastien] Ambroise Pare Hosp, AP HP, Dept Nutr, Boulogne, France; [Czernichow, Sebastien] Univ Versailles Saint Quentin, Unite Format & Rech UFR Sci Sante, Boulogne, France; [Hercberg, Serge] Univ Paris 13, Ctr Rech Nutr Humaine, Inst Natl Rech Agron, INSERM,U557,U1125, Bobigny, France; [Hercberg, Serge] Avicenne Hosp, AP HP, Dept Publ Hlth, Bobigny, France; [Hadjadj, Samy] Ctr Hosp Univ Poitiers, Dept Endocrinol & Diabetol, Poitiers, France; [Hadjadj, Samy] Clin Invest Ctr Poitiers Biotheque CIC0802, INSERM, U927, Poitiers, France; [Balkau, Beverley] Ctr Res Epidemiol & Populat Hlth, INSERM, U780, Villejuif, France; [Balkau, Beverley] Univ Paris 11, Orsay, France; [Lantieri, Olivier] Inst Interreg Sante IRSA, La Riche, France; [Langenberg, Claudia] Univ Cambridge, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Dept Endocrinol & Diabetol, Essonnes, France; [Rocheleau, Ghislain] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Rocheleau, Ghislain] Prognomix, Montreal, PQ, Canada; [Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Dina, Christian] Inst Thorax, INSERM, U915, Nantes, France; [Dina, Christian] CNRS, Equipe Rech Labellisee 3147, Nantes, France; [Dina, Christian] Univ Nantes, Dept Biol Med & Hlth, Nantes, France; [Barroso, Ines] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, Sch Publ Hlth, Hammersmith Hosp, London, England		Froguel, P (corresponding author), Lille Pasteur Inst, CNRS, Unite Mixte Rech UMR 8199, Lille, France.	ralf.jockers@inserm.fr; p.froguel@imperial.ac.uk	Bonnefond, Amelie/O-2784-2017; Langenberg, Claudia/ABG-9067-2021; Dina, Christian R/D-3535-2015; FROGUEL, Philippe/O-6799-2017; BOUATIA-NAJI, NABILA/D-5863-2013; Yengo, Loic/D-2692-2017; Sladek, Robert/R-2391-2019; Jockers, Ralf/Q-2100-2019; Serge, Hercberg/F-3038-2017; HERCBERG, Serge/B-4429-2008; Jockers, Ralf/P-2272-2017; McCarthy, Mark/M-3763-2015	Bonnefond, Amelie/0000-0001-9976-3005; Langenberg, Claudia/0000-0002-5017-7344; Dina, Christian R/0000-0002-7722-7348; FROGUEL, Philippe/0000-0003-2972-0784; Yengo, Loic/0000-0002-4272-9305; Sladek, Robert/0000-0002-2730-1204; Jockers, Ralf/0000-0002-4354-1750; Serge, Hercberg/0000-0002-3168-1350; HERCBERG, Serge/0000-0002-3168-1350; Jockers, Ralf/0000-0002-4354-1750; McCarthy, Mark/0000-0002-4393-0510; Barroso, Ines/0000-0001-5800-4520; Bouatia-Naji, Nabila/0000-0001-5424-2134; Fawcett, Katherine/0000-0002-6675-2112; Marre, Michel/0000-0002-3071-1837; Payne, Felicity/0000-0003-4228-581X	French Agence Nationale de la RechercheFrench National Research Agency (ANR) [ANR-08-GENOPAT, ANR-11-blanc 'MLT2D', ANR-11-META 'MELA-BETES']; Contrat de Projects Etat-Region Nord-Pas-De-Calais (CPER)Region Hauts-de-France; Societe Francophone du Diabete; Fondation Recherche Medicale; InsermInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; CNRSCentre National de la Recherche Scientifique (CNRS)European Commission; Wellcome TrustWellcome TrustEuropean Commission [077016/Z/05/Z]; UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; MRC Centre for Obesity and Related Metabolic DiseasesUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600717B, MC_U106179471] Funding Source: researchfish	We are sincerely indebted to all participants in the genetic study. We thank M. Deweirder and F. Allegaert for their technical assistance and their invaluable management of DNA samples and B. Gardiola-Lemaitre for her invaluable advice. This study was supported by the French Agence Nationale de la Recherche (ANR-08-GENOPAT to P. F. and ANR-11-blanc 'MLT2D' and ANR-11-META 'MELA-BETES' to R. J. and P. F.), the Contrat de Projects Etat-Region Nord-Pas-De-Calais (CPER 2007-2013 'Axe Cardio-Diabete' to P. F.), the Societe Francophone du Diabete (to A. B.), the Fondation Recherche Medicale ('Equipe FRM' to R. J.), Inserm and CNRS. I. B. acknowledges funding from the Wellcome Trust (077016/Z/05/Z) and from the UK National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre and the MRC Centre for Obesity and Related Metabolic Diseases.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Andersson EA, 2010, DIABETES, V59, P1539, DOI 10.2337/db09-1757; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Downes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012646; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Dubovsky SL, 2009, EXPERT OPIN INV DRUG, V18, P1533, DOI 10.1517/13543780903292634; Hadjadj S, 2008, DIABETES CARE, V31, P1847, DOI 10.2337/dc07-2079; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Meyre D, 2004, DIABETES, V53, P803, DOI 10.2337/diabetes.53.3.803; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Peschke E, 2010, BEST PRACT RES CL EN, V24, P829, DOI 10.1016/j.beem.2010.09.001; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Syddall HE, 2005, INT J EPIDEMIOL, V34, P1234, DOI 10.1093/ije/dyi127; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x	29	253	256	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					297	U98		10.1038/ng.1053			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	WOS:000300843600015	22286214	Green Accepted			2022-01-24	
J	Burroughs, AM; Ando, Y; de Hoon, MJL; Tomaru, Y; Nishibu, T; Ukekawa, R; Funakoshi, T; Kurokawa, T; Suzuki, H; Hayashizaki, Y; Daub, CO				Burroughs, A. Maxwell; Ando, Yoshinari; de Hoon, Michiel J. L.; Tomaru, Yasuhiro; Nishibu, Takahiro; Ukekawa, Ryo; Funakoshi, Taku; Kurokawa, Tsutomu; Suzuki, Harukazu; Hayashizaki, Yoshihide; Daub, Carsten O.			A comprehensive survey of 3 ' animal miRNA modification events and a possible role for 3 ' adenylation in modulating miRNA targeting effectiveness	GENOME RESEARCH			English	Article							CYTOPLASMIC POLY(A) POLYMERASE; EMBRYONIC STEM-CELLS; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; MICRORNAS; RNA; EXPRESSION; FAMILY; POLYADENYLATION; IDENTIFICATION	Animal microRNA sequences are subject to 3' nucleotide addition. Through detailed analysis of deep-sequenced short RNA data sets, we show adenylation and uridylation of miRNA is globally present and conserved across Drosophila and vertebrates. To better understand 3' adenylation function, we deep-sequenced RNA after knockdown of nucleotidyltransferase enzymes. The PAPD4 nucleotidyltransferase adenylates a wide range of miRNA loci, but adenylation does not appear to affect miRNA stability on a genome-wide scale. Adenine addition appears to reduce effectiveness of miRNA targeting of mRNA transcripts while deep-sequencing of RNA bound to immunoprecipitated Argonaute (AGO) subfamily proteins EIF2C1-EIF2C3 revealed substantial reduction of adenine addition in miRNA associated with EIF2C2 and EIF2C3. Our findings show 3' addition events are widespread and conserved across animals, PAPD4 is a primary miRNA adenylating enzyme, and suggest a role for 3' adenine addition in modulating miRNA effectiveness, possibly through interfering with incorporation into the RNA-induced silencing complex (RISC), a regulatory role that would complement the role of miRNA uridylation in blocking DICER1 uptake.	[Burroughs, A. Maxwell; Ando, Yoshinari; de Hoon, Michiel J. L.; Tomaru, Yasuhiro; Suzuki, Harukazu; Hayashizaki, Yoshihide; Daub, Carsten O.] RIKEN Yokohama Inst, OSC, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Tomaru, Yasuhiro; Hayashizaki, Yoshihide] Yokohama City Univ, Int Grad Sch Arts & Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Nishibu, Takahiro; Ukekawa, Ryo; Funakoshi, Taku; Kurokawa, Tsutomu] Wako Pure Chem Ind Ltd, Chuo Ku, Osaka 5408605, Japan		Burroughs, AM (corresponding author), RIKEN Yokohama Inst, OSC, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	burrough@gsc.riken.jp; yando@gsc.riken.jp	Hayashizaki, Yoshihide/N-6590-2015; Daub, Carsten O/A-7436-2010; Ando, Yoshinari/AAK-5668-2020; Suzuki, Harukazu/N-9553-2015; de Hoon, Michiel/A-6443-2013	Daub, Carsten O/0000-0002-3295-8729; Ando, Yoshinari/0000-0002-8128-6201; Suzuki, Harukazu/0000-0002-8087-0836; Burroughs, A. Max/0000-0002-2229-8771; Ando, Yukio/0000-0001-7115-9105	MEXTMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	This work was supported by a research grant for the Omics Science Center from the MEXT to Y.H.	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Benoit P, 2008, DEVELOPMENT, V135, P1969, DOI 10.1242/dev.021444; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kwak JE, 2008, P NATL ACAD SCI USA, V105, P14644, DOI 10.1073/pnas.0803185105; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2009, NUCLEIC ACIDS RES, V37, P1878, DOI 10.1093/nar/gkp031; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; MULJO SA, 2009, WILEY INTERDISCIP RE, V2, P148; Nakanishi T, 2006, DEV BIOL, V289, P115, DOI 10.1016/j.ydbio.2005.10.017; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Severin J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r39; Suh N, 2006, P NATL ACAD SCI USA, V103, P15108, DOI 10.1073/pnas.0607050103; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tomaru Y, 2009, NUCLEIC ACIDS RES, V37, P1049, DOI 10.1093/nar/gkn1028; Trippe R, 1998, NUCLEIC ACIDS RES, V26, P3119, DOI 10.1093/nar/26.13.3119; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733	58	253	262	0	23	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	OCT	2010	20	10					1398	1410		10.1101/gr.106054.110			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	656XS	WOS:000282375000010	20719920	Green Published, Bronze			2022-01-24	
J	Raubeson, LA; Peery, R; Chumley, TW; Dziubek, C; Fourcade, HM; Boore, JL; Jansen, RK				Raubeson, Linda A.; Peery, Rhiannon; Chumley, Timothy W.; Dziubek, Chris; Fourcade, H. Matthew; Boore, Jeffrey L.; Jansen, Robert K.			Comparative chloroplast genomics: analyses including new sequences from the angiosperms Nuphar advena and Ranunculus macranthus	BMC GENOMICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; BASAL ANGIOSPERM; CODON USAGE; PLASTID CHROMOSOME; INVERTED REPEAT; PHYLOGENETIC-RELATIONSHIPS; STRUCTURAL FEATURES; GENE ORGANIZATION; LOCAL ALIGNMENT; DNA-SEQUENCES	Background: The number of completely sequenced plastid genomes available is growing rapidly. This array of sequences presents new opportunities to perform comparative analyses. In comparative studies, it is often useful to compare across wide phylogenetic spans and, within angiosperms, to include representatives from basally diverging lineages such as the genomes reported here: Nuphar advena (from a basal-most lineage) and Ranunculus macranthus (a basal eudicot). We report these two new plastid genome sequences and make comparisons (within angiosperms, seed plants, or all photosynthetic lineages) to evaluate features such as the status of ycf15 and ycf68 as protein coding genes, the distribution of simple sequence repeats (SSRs) and longer dispersed repeats (SDR), and patterns of nucleotide composition. Results: The Nuphar [GenBank: NC 008788] and Ranunculus [GenBank: NC 008796] plastid genomes share characteristics of gene content and organization with many other chloroplast genomes. Like other plastid genomes, these genomes are A+T-rich, except for rRNA and tRNA genes. Detailed comparisons of Nuphar with Nymphaea, another Nymphaeaceae, show that more than two-thirds of these genomes exhibit at least 95% sequence identity and that most SSRs are shared. In broader comparisons, SSRs vary among genomes in terms of abundance and length and most contain repeat motifs based on A and T nucleotides. Conclusion: SSR and SDR abundance varies by genome and, for SSRs, is proportional to genome size. Long SDRs are rare in the genomes assessed. SSRs occur less frequently than predicted and, although the majority of the repeat motifs do include A and T nucleotides, the A+T bias in SSRs is less than that predicted from the underlying genomic nucleotide composition. In codon usage third positions show an A+T bias, however variation in codon usage does not correlate with differences in A+T-richness. Thus, although plastome nucleotide composition shows "A+ T richness", an A+T bias is not apparent upon more in-depth analysis, at least in these aspects. The pattern of evolution in the sequences identified as ycf15 and ycf68 is not consistent with them being protein-coding genes. In fact, these regions show no evidence of sequence conservation beyond what is normal for non- coding regions of the IR.	Cent Washington Univ, Ellensburg, WA 98926 USA; Univ Texas, Inst Cellular & Mol Biol, Sect Integrat Biol, Austin, TX 78712 USA; Lawrence Berkeley Natl Lab, DOE Joint Genome Inst, Program Evolut Genom, Walnut Creek, CA 94547 USA		Raubeson, LA (corresponding author), Cent Washington Univ, Ellensburg, WA 98926 USA.	raubeson@cwu.edu; peeryr@cwu.edu; tchumley@mail.utexas.edu; cdz5@hotmail.com; fourcade@bu.edu; JLBoore@Berkeley.edu; jansen@mail.utexas.edu	Jansen, Robert K/F-6272-2011	Peery, Rhiannon/0000-0003-4711-4702			Almeida P, 2004, MOL BIOL EVOL, V21, P1226, DOI 10.1093/molbev/msh108; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Bendich AJ, 2004, PLANT CELL, V16, P1661, DOI 10.1105/tpc.160771; BOOKJANS G, 1984, ANAL BIOCHEM, V141, P244, DOI 10.1016/0003-2697(84)90452-4; Cai ZQ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-77; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Cosner ME, 1997, CURR GENET, V31, P419, DOI 10.1007/s002940050225; Daniell H, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P443, DOI 10.1007/978-1-4020-3166-3_16; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Dechering KJ, 1998, NUCLEIC ACIDS RES, V26, P4056, DOI 10.1093/nar/26.17.4056; Denver DR, 2004, J MOL EVOL, V58, P584, DOI 10.1007/s00239-004-2580-4; Dieringer D, 2003, GENOME RES, V13, P2242, DOI 10.1101/gr.1416703; DOWNIE S, 1992, PLANT MOL SYSTEMATIC, P14; Echols N, 2002, NUCLEIC ACIDS RES, V30, P2515, DOI 10.1093/nar/30.11.2515; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frey JE, 2005, GENETICA, V123, P255, DOI 10.1007/s10709-004-3711-y; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goremykin V, 2003, PLANT SYST EVOL, V242, P119, DOI 10.1007/s00606-003-0056-4; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Howe CJ, 2003, PHILOS T ROY SOC B, V358, P99, DOI 10.1098/rstb.2002.1176; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; JOHNSON LB, 1989, PLANT MOL BIOL, V12, P3, DOI 10.1007/BF00017442; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Kato T, 2000, DNA RES, V7, P323, DOI 10.1093/dnares/7.6.323; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Knight R. D., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-4-research0010, DOI 10.1186/GB-2001-2-4-RESEARCH0010]; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Liu QP, 2005, J GENET, V84, P55, DOI 10.1007/BF02715890; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; MILLIGAN BG, 1989, MOL BIOL EVOL, V6, P355; MOON E, 1987, NUCLEIC ACIDS RES, V15, P611, DOI 10.1093/nar/15.2.611; Morton BR, 1997, P NATL ACAD SCI USA, V94, P11434, DOI 10.1073/pnas.94.21.11434; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; PALMER JD, 1986, METHOD ENZYMOL, V118, P167; Palmer JD., 1991, MOL BIOL PLASTIDS; Perry AS, 2002, J MOL EVOL, V55, P501, DOI 10.1007/s00239-002-2333-y; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Raubeson L., 2005, DIVERSITY EVOLUTION, P45; RAUBESON LA, 1992, BIOCHEM SYST ECOL, V20, P17, DOI 10.1016/0305-1978(92)90067-N; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Rose O, 1998, MOL BIOL EVOL, V15, P613, DOI 10.1093/oxfordjournals.molbev.a025964; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schmitz-Linneweber C, 2002, MOL BIOL EVOL, V19, P1602, DOI 10.1093/oxfordjournals.molbev.a004222; Schmitz-Linneweber C, 2001, PLANT MOL BIOL, V45, P307, DOI 10.1023/A:1006478403810; SHIMADA H, 1991, NUCLEIC ACIDS RES, V19, P983, DOI 10.1093/nar/19.5.983; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Stefanovic S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-35; Sugiura M, 2003, PHOTOSYNTH RES, V76, P371, DOI 10.1023/A:1024913304263; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Wall DP, 2003, J MOL EVOL, V56, P673, DOI 10.1007/s00239-002-2436-8; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zanis MJ, 2002, P NATL ACAD SCI USA, V99, P6848, DOI 10.1073/pnas.092136399	75	253	335	2	34	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JUN 15	2007	8								174	10.1186/1471-2164-8-174			27	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	193KH	WOS:000248272400001	17573971	Green Published, gold			2022-01-24	
J	Odronitz, F; Kollmar, M				Odronitz, Florian; Kollmar, Martin			Drawing the tree of eukaryotic life based on the analysis of 2,269 manually annotated myosins from 328 species	GENOME BIOLOGY			English	Article							GENOME DUPLICATION; EVOLUTION; RECONSTRUCTION; PHYLOGENOMICS; REVEALS	Background: The evolutionary history of organisms is expressed in phylogenetic trees. The most widely used phylogenetic trees describing the evolution of all organisms have been constructed based on single-gene phylogenies that, however, often produce conflicting results. Incongruence between phylogenetic trees can result from the violation of the orthology assumption and stochastic and systematic errors. Results: Here, we have reconstructed the tree of eukaryotic life based on the analysis of 2,269 myosin motor domains from 328 organisms. All sequences were manually annotated and verified, and were grouped into 35 myosin classes, of which 16 have not been proposed previously. The resultant phylogenetic tree confirms some accepted relationships of major taxa and resolves disputed and preliminary classifications. We place the Viridiplantae after the separation of Euglenozoa, Alveolata, and Stramenopiles, we suggest a monophyletic origin of Entamoebidae, Acanthamoebidae, and Dictyosteliida, and provide evidence for the asynchronous evolution of the Mammalia and Fungi. Conclusion: Our analysis of the myosins allowed combining phylogenetic information derived from class-specific trees with the information of myosin class evolution and distribution. This approach is expected to result in superior accuracy compared to single-gene or phylogenomic analyses because the orthology problem is resolved and a strong determinant not depending on any technical uncertainties is incorporated, the class distribution. Combining our analysis of the myosins with high quality analyses of other protein families, for example, that of the kinesins, could help in resolving still questionable dependencies at the origin of eukaryotic life.	[Odronitz, Florian; Kollmar, Martin] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany		Kollmar, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Am Fassberg, D-37077 Gottingen, Germany.	mako@nmr.mpibpc.mpg.de	Kollmar, Martin/AAF-4966-2020	Kollmar, Martin/0000-0002-9768-1855			Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Brown SS, 1997, CURR OPIN CELL BIOL, V9, P44, DOI 10.1016/S0955-0674(97)80150-0; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Doolittle RF, 2005, CURR OPIN STRUC BIOL, V15, P248, DOI 10.1016/j.sbi.2005.04.001; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Fujiwara M, 1997, BIOCHEM BIOPH RES CO, V236, P75, DOI 10.1006/bbrc.1997.6907; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Heintzelman MB, 2001, J PARASITOL, V87, P429, DOI 10.1645/0022-3395(2001)087[0429:MDIA]2.0.CO;2; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hodge T, 2000, J CELL SCI, V113, P3353; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Kollmar M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-183; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Odronitz F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-103; Odronitz F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-300; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reddy ASN, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-7-research0024; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Williams SA, 2005, CELL MOTIL CYTOSKEL, V61, P237, DOI 10.1002/cm.20078; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yumura S, 2003, INT REV CYTOL, V224, P173, DOI 10.1016/S0074-7696(05)24005-6	36	253	256	2	60	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2007	8	9							R196	10.1186/gb-2007-8-9-r196			23	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	247SO	WOS:000252100800022	17877792	Green Published, hybrid			2022-01-24	
J	Locke, DP; Sharp, AJ; McCarroll, SA; McGrath, SD; Newman, TL; Cheng, Z; Schwartz, S; Albertson, DG; Pinkel, D; Altshuler, DM; Eichler, EE				Locke, Devin P.; Sharp, Andrew J.; McCarroll, Steven A.; McGrath, Sean D.; Newman, Tera L.; Cheng, Ze; Schwartz, Stuart; Albertson, Donna G.; Pinkel, Daniel; Altshuler, David M.; Eichler, Evan E.			Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT SEGMENTAL DUPLICATIONS; DELETION POLYMORPHISMS; IDENTIFICATION	Studies of copy-number variation and linkage disequilibrium (LD) have typically excluded complex regions of the genome that are rich in duplications and prone to rearrangement. In an attempt to assess the heritability and LD of copy-number polymorphisms (CNPs) in duplication-rich regions of the genome, we profiled copy-number variation in 130 putative "rearrangement hotspot regions" among 269 individuals of European, Yoruba, Chinese, and Japanese ancestry analyzed by the International HapMap Consortium. Eighty-four hotspot regions, corresponding to 257 bacterial artificial chromosome (BAC) probes, showed evidence of copy-number differences. Despite a predisposing genetic architecture, no polymorphism was ever observed in the remaining 46 "rearrangement hotspots," and we suggest these represent excellent candidate sites for pathogenic rearrangements. We used a combination of BAC-based and high-density customized oligonucleotide arrays to resolve the molecular basis of structural rearrangements. For common variants (frequency > 10%), we observed a distinct bias against copy-number losses, suggesting that deletions are subject to purifying selection. Heritability estimates did not differ significantly from 1.0 among the majority (30 of 34) of loci analyzed, consistent with normal Mendelian inheritance. Some of the CNPs in duplication-rich regions showed strong LD with nearby single-nucleotide polymorphisms (SNPs) and were observed to segregate on ancestral SNP haplotypes. However, LD with the best available SNP markers was weaker than has been reported for deletion polymorphisms in less complex regions of the genome. These observations may be accounted for by a low density of SNP data in duplicated regions, challenges in mapping and typing the CNPs, and the possibility that CNPs in these regions have rearranged on multiple haplotype backgrounds. Our results underscore the need for complete maps of genetic variation in duplication-rich regions of the genome.	Univ Washington, Dept Gen Sci, Sch Med, Seattle, WA 98195 USA; Howard Hughes Med Inst, Seattle, WA USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA USA; MIT, Cambridge, MA 02139 USA; Univ Chicago, Dept Genet, Chicago, IL 60637 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA		Eichler, EE (corresponding author), Univ Washington, Dept Gen Sci, Sch Med, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Sharp, Andrew/A-5783-2008; Altshuler, David M/A-4476-2009; McCarroll, Steven A/A-8433-2009; McGrath, Sean/AAT-3540-2020	Altshuler, David M/0000-0002-7250-4107; McGrath, Sean/0000-0001-9064-8449; Locke, Devin/0000-0002-2527-0475	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD043569] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002385] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG002385, R01 HG002385] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD043569, R01 HD043569] Funding Source: Medline		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Fisher, 1930, GENETICAL THEORY NAT; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wirtenberger M, 2006, AM J HUM GENET, V78, P520, DOI 10.1086/500793	20	253	256	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					275	290		10.1086/505653			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	WOS:000239040400009	16826518	Bronze, Green Published			2022-01-24	
J	Blomme, T; Vandepoele, K; De Bodt, S; Simillion, C; Maere, S; Van de Peer, Y				Blomme, Tine; Vandepoele, Klaas; De Bodt, Stefanie; Simillion, Cedric; Maere, Steven; Van de Peer, Yves			The gain and loss of genes during 600 million years of vertebrate evolution	GENOME BIOLOGY			English	Article							WHOLE-GENOME DUPLICATION; HOX CLUSTERS; 2 ROUNDS; SEQUENCE; FAMILIES; AGE; NEOFUNCTIONALIZATION; SUBFUNCTIONALIZATION; SENSITIVITY; EXPANSION	Background: Gene duplication is assumed to have played a crucial role in the evolution of vertebrate organisms. Apart from a continuous mode of duplication, two or three whole genome duplication events have been proposed during the evolution of vertebrates, one or two at the dawn of vertebrate evolution, and an additional one in the fish lineage, not shared with land vertebrates. Here, we have studied gene gain and loss in seven different vertebrate genomes, spanning an evolutionary period of about 600 million years. Results: We show that: first, the majority of duplicated genes in extant vertebrate genomes are ancient and were created at times that coincide with proposed whole genome duplication events; second, there exist significant differences in gene retention for different functional categories of genes between fishes and land vertebrates; third, there seems to be a considerable bias in gene retention of regulatory genes towards the mode of gene duplication ( whole genome duplication events compared to smaller-scale events), which is in accordance with the so-called gene balance hypothesis; and fourth, that ancient duplicates that have survived for many hundreds of millions of years can still be lost. Conclusion: Based on phylogenetic analyses, we show that both the mode of duplication and the functional class the duplicated genes belong to have been of major importance for the evolution of the vertebrates. In particular, we provide evidence that massive gene duplication ( probably as a consequence of entire genome duplications) at the dawn of vertebrate evolution might have been particularly important for the evolution of complex vertebrates.	State Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium		Van de Peer, Y (corresponding author), State Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk, B-9052 Ghent, Belgium.	yves.vandepeer@psb.ugent.be	Maere, Steven G.G./P-5640-2014; Van de Peer, Yves/D-4388-2009; Van de Peer, Yves/AAE-7666-2019; Vandepoele, Klaas/E-7514-2010	Maere, Steven G.G./0000-0002-5341-136X; Van de Peer, Yves/0000-0003-4327-3730; Van de Peer, Yves/0000-0003-4327-3730; Vandepoele, Klaas/0000-0003-4790-2725; Simillion, Cedric/0000-0002-2026-6741			Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Aburomia Rami, 2003, Journal of Structural and Functional Genomics, V3, P45, DOI 10.1023/A:1022648729770; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Aparicio S, 1997, NAT GENET, V16, P79, DOI 10.1038/ng0597-79; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Davis JC, 2005, TRENDS GENET, V21, P548, DOI 10.1016/j.tig.2005.07.008; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Force A, 1999, GENETICS, V151, P1531; FREELING M, IN PRESS GENOME RES; Friedman R, 2001, GENOME RES, V11, P1842, DOI 10.1101/gr.200601; Garcia-Fernandez Jordi, 1996, International Journal of Developmental Biology, V40, p71S; *GEN ONT CONS, 2004, NUCLEIC ACIDS RES, pD258; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibson TJ, 2000, BIOCHEM SOC T, V28, P259, DOI 10.1042/bst0280259; Gu X, 2003, GENETICA, V118, P133, DOI 10.1023/A:1024197424306; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hedges SB, 2003, TRENDS GENET, V19, P200, DOI 10.1016/S0168-9525(03)00053-2; Hedges SB, 2002, SCIENCE, V297, P1283; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holland Peter W. H., 2003, Journal of Structural and Functional Genomics, V3, P75, DOI 10.1023/A:1022656931587; Holland PWH, 1997, CURR BIOL, V7, pR570, DOI 10.1016/S0960-9822(06)00284-3; HOLLAND PWH, 1994, DEVELOPMENT, P125; Hughes AL, 1999, J MOL EVOL, V48, P565, DOI 10.1007/PL00006499; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kondrashov FA, 2006, J THEOR BIOL, V239, P141, DOI 10.1016/j.jtbi.2005.08.033; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Larhammar D, 2002, GENOME RES, V12, P1910, DOI 10.1101/gr.445702; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Lundin Lars-Gustav, 2003, Journal of Structural and Functional Genomics, V3, P53, DOI 10.1023/A:1022600813840; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Malaga-Trillo E, 2001, AM ZOOL, V41, P676, DOI 10.1668/0003-1569(2001)041[0676:GDAAEO]2.0.CO;2; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Naruse K, 2000, GENETICS, V154, P1773; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohno S., 1970, EVOLUTION GENE DUPLI; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Panopoulou G, 2003, GENOME RES, V13, P1056, DOI 10.1101/gr.874803; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Shiu SH, 2006, P NATL ACAD SCI USA, V103, P2232, DOI 10.1073/pnas.0510388103; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van de Peer Yves, 2005, P329, DOI 10.1016/B978-012301463-4/50008-5; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Volff JN, 2003, TRENDS GENET, V19, P674, DOI 10.1016/j.tig.2003.10.006; Wang YF, 2000, J MOL EVOL, V51, P88, DOI 10.1007/s002390010069; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384	64	253	263	1	26	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2006	7	5							R43	10.1186/gb-2006-7-5-r43			12	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	059DG	WOS:000238712900018	16723033	Green Published, hybrid			2022-01-24	
J	Gibon, Y; Usadel, B; Blaesing, OE; Kamlage, B; Hoehne, M; Trethewey, R; Stitt, M				Gibon, Yves; Usadel, Bjoern; Blaesing, Oliver E.; Kamlage, Beate; Hoehne, Melanie; Trethewey, Richard; Stitt, Mark			Integration of metabolite with transcript and enzyme activity profiling during diurnal cycles in Arabidopsis rosettes	GENOME BIOLOGY			English	Article							MASS-SPECTROMETRY; NITRATE UPTAKE; GENE; METABOLOMICS; PLANTS; TOBACCO; SUGAR; LIGHT; TOOL; VISUALIZATION	Background: Genome-wide transcript profiling and analyses of enzyme activities from central carbon and nitrogen metabolism show that transcript levels undergo marked and rapid changes during diurnal cycles and after transfer to darkness, whereas changes in activities are smaller and delayed. In the starchless pgm mutant, where sugars are depleted every night, there are accentuated diurnal changes in transcript levels. Enzyme activities in this mutant do not show larger diurnal changes; instead, they shift towards the levels found in the wild type after several days of darkness. This indicates that enzyme activities change slowly, integrating the changes in transcript levels over several diurnal cycles. Results: To generalize this conclusion, 137 metabolites were profiled using gas and liquid chromatography coupled to mass spectroscopy. The amplitudes of the diurnal changes in metabolite levels in pgm were ( with the exception of sugars) similar or smaller than in the wild type. The average levels shifted towards those found after several days of darkness in the wild type. Examples include increased levels of amino acids due to protein degradation, decreased levels of fatty acids, increased tocopherol and decreased myo-inositol. Many metabolite-transcript correlations were found and the proportion of transcripts correlated with sugars increased dramatically in the starchless mutant. Conclusion: Rapid diurnal changes in transcript levels are integrated over time to generate quasi-stable changes across large sectors of metabolism. This implies that correlations between metabolites and transcripts are due to regulation of gene expression by metabolites, rather than metabolites being changed as a consequence of a change in gene expression.	Max Planck Inst Mol Physiol, D-14476 Potsdam, Germany; Metanom GmbH, D-10589 Berlin, Germany		Gibon, Y (corresponding author), Max Planck Inst Mol Physiol, Sci Pk Golm,Muhlenberg, D-14476 Potsdam, Germany.	gibon@mpimp-golm.mpg.de	Usadel, Bjorn/E-1932-2011; Gibon, Yves/B-9919-2011	Usadel, Bjorn/0000-0003-0921-8041; Gibon, Yves/0000-0001-8161-1089; Stitt, Mark/0000-0002-4900-1763			Batagelj V, 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; FREHR M, 2005, BIOCHEM SOC T, V33, P287; Gergov M, 2003, J CHROMATOGR B, V795, P41, DOI 10.1016/S1570-0232(03)00498-7; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Gibon Y, 2002, PLANT J, V30, P221, DOI 10.1046/j.1365-313X.2001.01278.x; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Horak Christine E, 2002, Funct Integr Genomics, V2, P171; Hsieh MH, 2005, PLANT PHYSIOL, V138, P641, DOI 10.1104/pp.104.058735; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Kopka J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-109; Krishnan P, 2005, J EXP BOT, V56, P255, DOI 10.1093/jxb/eri010; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Matt P, 2001, PLANT CELL ENVIRON, V24, P177, DOI 10.1111/j.1365-3040.2001.00676.x; Matt P, 2001, PLANT CELL ENVIRON, V24, P1119, DOI 10.1046/j.1365-3040.2001.00771.x; Meyer C, 2001, PLANT NITROGEN, P37; Mijalski T, 2005, P NATL ACAD SCI USA, V102, P8621, DOI 10.1073/pnas.0407672102; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Morgenthal K, 2005, METABOLOMICS, V1, P109, DOI 10.1007/s11306-005-4430-9; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; NEUHAUS HE, 1989, PLANTA, V178, P110, DOI 10.1007/BF00392534; Niessen WMA, 2003, J CHROMATOGR A, V1000, P413, DOI 10.1016/S0021-9673(03)00506-5; Nikiforova VJ, 2005, J EXP BOT, V56, P1887, DOI 10.1093/jxb/eri179; Oresic Matej, 2004, Appl Bioinformatics, V3, P205; Peck SC, 2005, PLANT PHYSIOL, V138, P591, DOI 10.1104/pp.105.060285; Ratcliffe RG, 2001, ANNU REV PLANT PHYS, V52, P499, DOI 10.1146/annurev.arplant.52.1.499; Redman JC, 2004, PLANT J, V38, P545, DOI 10.1111/j.1365-313X.2004.02061.x; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Somerville C, 1996, TRENDS CELL BIOL, V6, P148, DOI 10.1016/0962-8924(96)10002-7; SONNEWALD U, 1991, PLANT J, V1, P95, DOI 10.1111/j.1365-313X.1991.00095.x; Steinhauser D, 2004, BIOINFORMATICS, V20, P3647, DOI 10.1093/bioinformatics/bth398; STITT M, 1989, METHOD ENZYMOL, V174, P518; Stitt M, 2003, CURR OPIN BIOTECH, V14, P136, DOI 10.1016/S0958-1669(03)00023-5; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; STITT M, 1995, ANNU REV PLANT PHYS, V46, P341, DOI 10.1146/annurev.pp.46.060195.002013; Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thimm O, 2006, ANNU PLANT REV, V22, P1; Urbanczyk-Wochniak E, 2005, PLANTA, V221, P891, DOI 10.1007/s00425-005-1483-y; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; von Roepenack-Lahaye E, 2004, PLANT PHYSIOL, V134, P548, DOI 10.1104/pp.103.032714; WILLMITZER L, 1988, TRENDS GENET, V4, P13, DOI 10.1016/0168-9525(88)90122-9	59	253	257	2	68	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2006	7	8							R76	10.1186/gb-2006-7-8-r76			23	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	095QN	WOS:000241322800021	16916443	hybrid, Green Published			2022-01-24	
J	Schmidt, LS; Nickerson, ML; Warren, MB; Glenn, GM; Toro, JR; Merino, MJ; Turner, ML; Choyke, PL; Sharma, N; Peterson, J; Morrison, P; Maher, ER; Walther, MM; Zbar, B; Linehan, WM				Schmidt, LS; Nickerson, ML; Warren, MB; Glenn, GM; Toro, JR; Merino, MJ; Turner, ML; Choyke, PL; Sharma, N; Peterson, J; Morrison, P; Maher, ER; Walther, MM; Zbar, B; Linehan, WM			Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL-CELL CARCINOMA; GERMAN-SHEPHERD DOG; NIHON RAT MODEL; SPONTANEOUS PNEUMOTHORAX; INTESTINAL POLYPOSIS; NODULAR DERMATOFIBROSIS; PERIFOLLICULAR FIBROMAS; KIDNEY NEOPLASIA; MESSENGER-RNA; GENE	Birt-Hogg-Dube syndrome (BHD), a genodermatosis characterized by multiple hamartomas of the hair follicle (fibrofolliculoma), predisposes individuals to an increased risk of developing renal neoplasms and spontaneous pneumothorax. Previously, we localized the BHD locus (also known as FLCN) to chromosome 17p11.2 by linkage analysis and subsequently identified germline mutations in a novel gene in probands from eight of the nine families with BHD in our screening panel. Affected members of five of the families inherited an insertion/deletion of a cytosine in a C-8 tract in exon 11. This mutation was also identified by exon 11 screening in probands from 22 of 52 additional families with BHD and therefore represents a hypermutable "hotspot" for mutation in BHD. Here, we screened the remaining 30 families from this large BHD cohort by direct sequence analysis and identified germline BHD mutations in 84% (51/61) of all families with BHD recruited to our study. Mutations were located along the entire length of the coding region, including 16 insertion/deletion, 3 nonsense, and 3 splice-site mutations. The majority of BHD mutations were predicted to truncate the BHD protein, folliculin. Among patients with a mutation in the exon 11 hotspot, significantly fewer renal tumors were observed in patients with the C-deletion than those with the C-insertion mutation. Coding-sequence mutations were not found, however, in probands from two large families with BHD whose affected members shared their family's BHD-affected haplotype. Of the 53 families with BHD whose members inherited either a germline mutation or the affected haplotype, 24 (45%) had at least one member with renal neoplasms. Three families classified with familial renal oncocytoma were identified with BHD mutations, which represents the first disease gene associated with this rare form of renal neoplasm. This study expands the BHD-mutation spectrum and evaluates genotype-phenotype correlations among families with BHD.	NCI, Immunobiol Lab, Ctr Canc Res, Frederick, MD 21702 USA; Sci Applicat Int Corp Frederick Inc, Basic Res Program, Frederick, MD USA; NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA; NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Belfast City Hosp Trust, Belfast, Antrim, North Ireland; Univ Birmingham, Inst Biomed Res, Sect Med & Mol Genet, Birmingham, W Midlands, England		Schmidt, LS (corresponding author), NCI, Immunobiol Lab, Ctr Canc Res, Bldg 560,Room 12-69, Frederick, MD 21702 USA.	schmidtl@ncifcrf.gov	MAHER, EAMONN R/A-9507-2008	MAHER, EAMONN R/0000-0002-6226-6918; Sharma, Nirmala/0000-0001-9781-880X	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01SC006659, Z01SC009392, ZIDBC010688, Z01BC010688, Z01BC010696, ZIASC009392, ZIABC010696] Funding Source: NIH RePORTER; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [N01-C0-12400] Funding Source: Medline		BINET O, 1986, ANN DERMATOL VENER, V113, P928; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Chung JY, 1996, INT J DERMATOL, V35, P365, DOI 10.1111/j.1365-4362.1996.tb03642.x; Hino O, 2001, JPN J CANCER RES, V92, P1147, DOI 10.1111/j.1349-7006.2001.tb02133.x; HORNSTEIN OP, 1975, ARCH DERMATOL FORSCH, V253, P161, DOI 10.1007/BF00582068; HORNSTEIN OP, 1976, HUM GENET, V33, P193; Jonasdottir TJ, 2000, P NATL ACAD SCI USA, V97, P4132, DOI 10.1073/pnas.070053397; Khoo SK, 2002, J MED GENET, V39, P906, DOI 10.1136/jmg.39.12.906; Khoo SK, 2001, ONCOGENE, V20, P5239, DOI 10.1038/sj.onc.1204703; Le Guyadec T, 1998, ANN DERMATOL VENER, V125, P717; Lindor NM, 2001, INT J DERMATOL, V40, P653, DOI 10.1046/j.1365-4362.2001.01287-4.x; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Liu V, 2000, J AM ACAD DERMATOL, V43, P1120, DOI 10.1067/mjd.2000.109288; LIUM B, 1985, VET PATHOL, V22, P447, DOI 10.1177/030098588502200503; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Okimoto K, 2000, JPN J CANCER RES, V91, P1096, DOI 10.1111/j.1349-7006.2000.tb00890.x; Pavlovich CP, 2005, J UROLOGY, V173, P1482, DOI 10.1097/01.ju.0000154629.45832.30; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; RONGIOLETTI F, 1989, CLIN EXP DERMATOL, V14, P72, DOI 10.1111/j.1365-2230.1989.tb00890.x; ROTH JS, 1993, J AM ACAD DERMATOL, V29, P1055, DOI 10.1016/S0190-9622(08)82049-X; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tickoo SK, 1999, AM J SURG PATHOL, V23, P1094, DOI 10.1097/00000478-199909000-00013; Toro JR, 1999, ARCH DERMATOL, V135, P1195, DOI 10.1001/archderm.135.10.1195; VOCKE C, IN PRESS J NATL CANC; Warren MB, 2004, MODERN PATHOL, V17, P998, DOI 10.1038/modpathol.3800152; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393	29	253	262	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					1023	1033		10.1086/430842			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	WOS:000229047900008	15852235	Green Published, Bronze			2022-01-24	
J	Sheen, VL; Ganesh, VS; Topcu, M; Sebire, G; Bodell, A; Hill, RS; Grant, PE; Shugart, YY; Imitola, J; Khoury, SJ; Guerrini, R; Walsh, CA				Sheen, VL; Ganesh, VS; Topcu, M; Sebire, G; Bodell, A; Hill, RS; Grant, PE; Shugart, YY; Imitola, J; Khoury, SJ; Guerrini, R; Walsh, CA			Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex	NATURE GENETICS			English	Article							NUCLEOTIDE-EXCHANGE PROTEINS; ADP-RIBOSYLATION FACTORS; TRANS-GOLGI NETWORK; BREFELDIN-A; PERIVENTRICULAR HETEROTOPIA; NEURONAL MIGRATION; CORTICAL SIZE; CELL-ADHESION; GROWTH; BIG2	Disruption of human neural precursor proliferation can give rise to a small brain ( microcephaly), and failure of neurons to migrate properly can lead to an abnormal arrest of cerebral cortical neurons in proliferative zones near the lateral ventricles (periventricular heterotopia). Here we show that an autosomal recessive condition characterized by microcephaly and periventricular heterotopia 1 maps to chromosome 20 and is caused by mutations in the gene ADP-ribosylation factor guanine nucleotide-exchange factor-2 (ARFGEF2). By northern-blot analysis, we found that mouse Arfgef2 mRNA levels are highest during embryonic periods of ongoing neuronal proliferation and migration, and by in situ hybridization, we found that the mRNA is widely distributed throughout the embryonic central nervous system (CNS). ARFGEF2 encodes the large (>200 kDa) brefeldin A (BFA)-inhibited GEF2 protein (BIG2), which is required for vesicle and membrane trafficking from the trans-Golgi network (TGN). Inhibition of BIG2 by BFA, or by a dominant negative ARFGEF2 cDNA, decreases cell proliferation in vitro, suggesting a cell-autonomous regulation of neural expansion. Inhibition of BIG2 also disturbed the intracellular localization of such molecules as E-cadherin and beta-catenin by preventing their transport from the Golgi apparatus to the cell surface. Our findings show that vesicle trafficking is an important regulator of proliferation and migration during human cerebral cortical development.	Harvard Univ, Sch Med, Div Neurogenet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurol,Beth Israel Diaconess Med Ctr, Boston, MA 02115 USA; Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Pediat Neurol, TR-06100 Ankara, Turkey; Univ Sherbrooke, CHU Fleurimont, Dept Pediat Neurol, Sherbrooke, PQ J1H 5N4, Canada; Harvard Univ, Sch Med, Athinoula A Marinos Ctr Biomed Imaging, Massachusetts Gen Hosp,Dept Pediat Neuroradiol, Boston, MA 02114 USA; Johns Hopkins Med Sch, Dept Pediat Epidemiol, Baltimore, MD 21205 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA; Univ Pisa, Div Child Neurol & Psychiat, Epilepsy Neurophysiol & Neurogenet Unit, I-56018 Pisa, Italy; IRCCS Fdn Stella Maris, I-56018 Pisa, Italy; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA		Walsh, CA (corresponding author), Harvard Univ, Sch Med, Div Neurogenet, Boston, MA 02115 USA.			YAO, YIN/0000-0003-3053-8429; Guerrini, Renzo/0000-0002-7272-7079; khoury, samia/0000-0003-3198-6063; Walsh, Christopher/0000-0002-0156-2238	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH063886] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08 MH063886] Funding Source: Medline		Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bonifacino JS, 2003, CELL, V112, P141, DOI 10.1016/S0092-8674(03)00038-2; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Jareb M, 1997, J NEUROSCI, V17, P8955; KLYMKOWSKY MW, 1995, CELL, V83, P5, DOI 10.1016/0092-8674(95)90226-0; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Pacheco-Rodriguez G, 2002, METHOD ENZYMOL, V345, P397; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Ruthel G, 1999, J NEUROBIOL, V39, P97, DOI 10.1002/(SICI)1097-4695(199904)39:1<97::AID-NEU8>3.0.CO;2-Z; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SHEEN VL, 1994, EXP NEUROL, V130, P67, DOI 10.1006/exnr.1994.1186; Sheen VL, 2003, NEUROLOGY, V60, P1108, DOI 10.1212/01.WNL.0000055898.00349.02; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Sheen VL, 1999, EXP NEUROL, V158, P47, DOI 10.1006/exnr.1999.7104; Sheen Volney L, 2003, Curr Neurol Neurosci Rep, V3, P433, DOI 10.1007/s11910-003-0027-8; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567	30	253	261	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					69	76		10.1038/ng1276			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	WOS:000187666800016	14647276	Bronze			2022-01-24	
J	Hashimshony, T; Zhang, JM; Keshet, I; Bustin, M; Cedar, H				Hashimshony, T; Zhang, JM; Keshet, I; Bustin, M; Cedar, H			The role of DNA methylation in setting up chromatin structure during development	NATURE GENETICS			English	Article							H3 LYSINE-4 METHYLATION; MOUSE EMBRYO; HISTONE H1; BINDING; TRANSCRIPTION; COMPLEX	DNA methylation inhibits gene expression in animal cells, probably by affecting chromatin structure. Biochemical studies suggest that this process may be mediated by methyl-specific binding proteins that recruit enzymatic machinery capable of locally altering histone modification(1). To test whether DNA methylation actually has a role in the assembly of chromatin during normal development, we used cell transfection and a transgene construct genetically programmed to be either methylated or unmethylated in all cell types of the mouse(2). Chromatin immunoprecipitation (ChIP) analysis shows that the presence of DNA methylation brings about the deacetylation of histone H4 and methylation of Lys9 of histone H3 (H3 Lys9) and prevents methylation of Lys4 of histone H3 (H3 Lys4), thus generating a structure identical to that of methylated sequences in the genome. These results indicate that the methylation pattern established in early embryogenesis is profoundly important in setting up the structural profile of the genome.	Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Expt Med & Canc Res, IL-91120 Jerusalem, Israel; NCI, Prot Sect, Mol Carcinogenesis Lab, Div Basic Sci,NIH, Bethesda, MD 20892 USA		Cedar, H (corresponding author), Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, POB 12272, IL-91120 Jerusalem, Israel.	cedar@md2.huji.ac.il	Bustin, Michael/G-6155-2015	Bustin, Michael/0000-0002-5147-7242	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01BC004496, ZIABC004496] Funding Source: NIH RePORTER		BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; BUSTIN M, 1989, METHOD ENZYMOL, V170, P214; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; FUKS F, 2002, J BIOL CHEM; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; MONK M, 1987, DEVELOPMENT, V99, P371; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; RENZ M, 1975, P NATL ACAD SCI USA, V72, P733, DOI 10.1073/pnas.72.2.733; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200	24	253	263	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2003	34	2					187	192		10.1038/ng1158			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	WOS:000183200500025	12740577				2022-01-24	
J	Jones, B; Jones, EL; Bonney, SA; Patel, HN; Mensenkamp, AR; Eichenbaum-Voline, S; Rudling, M; Myrdal, U; Annesi, G; Naik, S; Meadovvs, N; Quattrone, A; Islam, SA; Naoumova, RP; Angelin, B; Infante, R; Levy, E; Roy, CC; Freemont, PS; Scott, J; Shoulders, CC				Jones, B; Jones, EL; Bonney, SA; Patel, HN; Mensenkamp, AR; Eichenbaum-Voline, S; Rudling, M; Myrdal, U; Annesi, G; Naik, S; Meadovvs, N; Quattrone, A; Islam, SA; Naoumova, RP; Angelin, B; Infante, R; Levy, E; Roy, CC; Freemont, PS; Scott, J; Shoulders, CC			Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders	NATURE GENETICS			English	Article							CHYLOMICRON RETENTION DISEASE; ENDOPLASMIC-RETICULUM; ANDERSONS-DISEASE; APOPROTEIN-B; TRANSPORT; PROTEINS; COAT; BINDING; EXPORT	Dietary fat is an important source of nutrition. Here we identify eight mutations in SARA2 that are associated with three severe disorders of fat malabsorption. The Sar1 family of proteins initiates the intracellular transport of proteins in COPII (coat protein)-coated vesicles. Our data suggest that chylomicrons, which vastly exceed the size of typical COPII vesicles, are selectively recruited by the COPII machinery for transport through the secretory pathways of the cell.	Univ London Imperial Coll Sci Technol & Med, Genom & Mol Med Grp, MRC, Ctr Clin Sci, London, England; Huddinge Univ Hosp, Ctr Metab & Endocrinol, Karolinska Inst, Stockholm, Sweden; Huddinge Univ Hosp, Ctr Nutr & Toxicol, Karolinska Inst, Stockholm, Sweden; Cent Hosp Vasteras, Dept Paediat, Vasteras, Sweden; CNR, Inst Neurol Sci, Piano Lago Of Mangone, Consenza, Italy; Barts & London, Dept Adult & Paediat Gastroenterol, Queen Marys Sch Med & Dent, London, England; Univ London Imperial Coll Sci Technol & Med, Struct Bioinformat Grp, London, England; INSERM, Ctr Rech, Paris 12, France; Univ Montreal, Ctr Rech, Hop St Justine, Montreal, PQ H3C 3J7, Canada; Univ London Imperial Coll Sci Technol & Med, Ctr Struct Biol, Dept Sci Biol, London, England; Univ London Imperial Coll Sci Technol & Med, Genet & Genom Res Inst, London, England		Scott, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Genom & Mol Med Grp, MRC, Ctr Clin Sci, London, England.		Annesi, Grazia/AAX-5732-2020; Mensenkamp, Arjen/L-4520-2015; QUATTRONE, Aldo/A-6734-2016	Mensenkamp, Arjen/0000-0003-3805-877X; QUATTRONE, Aldo/0000-0003-2001-957X; Freemont, Paul/0000-0002-5658-8486			Aguglia U, 2000, ANN NEUROL, V47, P260, DOI 10.1002/1531-8249(200002)47:2<260::AID-ANA21>3.3.CO;2-M; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; BOUMA ME, 1986, J CLIN INVEST, V78, P398, DOI 10.1172/JCI112590; Dannoura AH, 1999, ARTERIOSCL THROM VAS, V19, P2494, DOI 10.1161/01.ATV.19.10.2494; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; NEMETH A, 1995, EUR J CLIN INVEST, V25, P271, DOI 10.1111/j.1365-2362.1995.tb01559.x; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; ROY CC, 1987, GASTROENTEROLOGY, V92, P390, DOI 10.1016/0016-5085(87)90133-8; Saito Y, 1998, J BIOCHEM-TOKYO, V124, P816, DOI 10.1093/oxfordjournals.jbchem.a022185; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153	15	253	259	0	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					29	31		10.1038/ng1145			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	WOS:000182667900012	12692552				2022-01-24	
J	Stewart, SA; Ben-Porath, I; Carey, VJ; O'Connor, BF; Hahn, WC; Weinberg, RA				Stewart, SA; Ben-Porath, I; Carey, VJ; O'Connor, BF; Hahn, WC; Weinberg, RA			Erosion of the telomeric single-strand overhang at replicative senescence	NATURE GENETICS			English	Article							NORMAL HUMAN-CELLS; HUMAN FIBROBLASTS; LIFE-SPAN; IN-VITRO; HUMAN-CHROMOSOMES; VIVO; END; LOOP	Cultured primary human cells inevitably enter a state of replicative senescence for which the specific molecular trigger is unknown. We show that the single-strand telomeric overhang, a key component of telomere structure, is eroded at senescence. Expression of telomerase prevents overhang loss, suggesting that this enzyme prevents senescence by maintaining proper telomere structure. In contrast, progressive overhang loss occurs in cells that avoid senescence through the inactivation of p53 and Rb, indicating that overhang erosion is the result of continuous cell division and not a consequence of senescence. We thus provide evidence for a specific molecular alteration in telomere structure at senescence and suggest that this change, rather than overall telomere length, serves to trigger this state.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Channing Lab, Boston, MA 02115 USA		Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Stewart, Sheila A/C-5213-2012				ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1973, AM J MED SCI, V265, P432, DOI 10.1097/00000441-197306000-00001; HENDERSON ER, 1989, MOL CELL BIOL, V9, P345, DOI 10.1128/MCB.9.1.345; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; KARSEDER J, 2002, SCIENCE, V295, P2446; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Stansel RM, 2001, EMBO J, V20, P5532; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	28	253	265	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					492	496		10.1038/ng1127			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	WOS:000181928600020	12652299	Bronze			2022-01-24	
J	Nolin, SL; Brown, WT; Glicksman, A; Houck, GE; Gargano, AD; Sullivan, A; Biancalana, V; Brondum-Nielsen, K; Hjalgrim, H; Holinski-Feder, E; Kooy, F; Longshore, J; Macpherson, J; Mandel, JL; Matthijs, G; Rousseau, F; Steinbach, P; Vaisanen, ML; von Koskull, H; Sherman, SL				Nolin, SL; Brown, WT; Glicksman, A; Houck, GE; Gargano, AD; Sullivan, A; Biancalana, V; Brondum-Nielsen, K; Hjalgrim, H; Holinski-Feder, E; Kooy, F; Longshore, J; Macpherson, J; Mandel, JL; Matthijs, G; Rousseau, F; Steinbach, P; Vaisanen, ML; von Koskull, H; Sherman, SL			Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FMR1 GENE; CLINICAL PHENOTYPE; DELETION; INSTABILITY; MUTATION; IDENTIFICATION; METHYLATION; POPULATION; PREVALENCE; DIAGNOSIS	The CGG repeat in the 5 untranslated region of the fragile X mental retardation 1 gene (FMR1) exhibits remarkable instability upon transmission from mothers with premutation alleles. A collaboration of 13 laboratories in eight countries was established to examine four issues concerning FMR1 CGG-repeat instability among females with premutation (similar to55-200 repeats) and intermediate (similar to46-60 repeats) alleles. Our central findings were as follows: (1) The smallest premutation alleles that expanded to a full mutation (>200 repeats) in one generation contained 59 repeats; sequence analysis of the 59-repeat alleles from these two females revealed no AGG interruptions within the FMR1 CGG repeat. (2) When we corrected for ascertainment and recalculated the risks of expansion to a full mutation, we found that the risks for premutation alleles with <100 repeats were lower than those previously published. (3) When we examined the possible influence of sex of offspring on transmission of a full mutation-by analysis of 567 prenatal fragile X studies of 448 mothers with premutation and full-mutation alleles-we found no significant differences in the proportion of full-mutation alleles in male or female fetuses. (4) When we examined 136 transmissions of intermediate alleles from 92 mothers with no family history of fragile X, we found that, in contrast to the instability observed in families with fragile X, most (99/136 [72.8%]) transmissions of intermediate alleles were stable. The unstable transmissions (37/136 [27.2%]) in these families included both expansions and contractions in repeat size. The instability increased with the larger intermediate alleles (19% for 49-54 repeats, 30.9% for 55-59, and 80% for 60-65 repeats). These studies should allow improved risk assessments for genetic counseling of women with premutation or intermediate-size alleles.	New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Fac Med Strasbourg, Lab Diagnost Genet, Strasbourg, France; Ctr Hosp Reg Univ, Strasbourg, France; John F Kennedy Inst, DK-2600 Glostrup, Denmark; Univ Munich, Abt Med Genet, Munich, Germany; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Greenwood Genet Ctr, Greenwood, SC 29646 USA; Wessex Reg Genet Lab, Salisbury, Wilts, England; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Laval, Quebec City, PQ, Canada; Univ Ulm, Abt Humangenet, Ulm, Germany; Oulu Univ Hosp, Dept Clin Genet, Oulu, Finland; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland		Nolin, SL (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Human Genet, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.		Kooy, Frank/F-5276-2014; Biancalana, Valerie/O-2351-2016; Mandel, Jean Louis/Q-2668-2016	Kooy, Frank/0000-0003-2024-0485; Matthijs, Gert/0000-0001-6710-1912; Mandel, Jean Louis/0000-0002-0535-6589	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD029909, HD29909] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD029909] Funding Source: NIH RePORTER		Ashley-Koch AE, 1998, AM J HUM GENET, V63, P776, DOI 10.1086/302018; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Brown WT, 1996, AM J MED GENET, V64, P287, DOI 10.1002/(SICI)1096-8628(19960809)64:2<287::AID-AJMG11>3.0.CO;2-B; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Crawford DC, 2002, AM J MED GENET, V110, P226, DOI 10.1002/ajmg.10427; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GU YH, 1994, HUM MOL GENET, V3, P1705, DOI 10.1093/hmg/3.9.1705; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; HIRST M, 1995, AM J HUM GENET, V56, P67; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LEVINSON G, 1994, AM J MED GENET, V51, P527, DOI 10.1002/ajmg.1320510448; LOESCH DZ, 1995, AM J HUM GENET, V57, P1408; MEIJER H, 1994, HUM MOL GENET, V3, P615; Murray A, 1996, HUM MOL GENET, V5, P727, DOI 10.1093/hmg/5.6.727; Nolin SL, 1996, AM J HUM GENET, V59, P1252; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Parvari R, 1999, AM J MED GENET, V83, P302, DOI 10.1002/(SICI)1096-8628(19990402)83:4<302::AID-AJMG13>3.0.CO;2-P; Pesso R, 2000, PRENATAL DIAG, V20, P611, DOI 10.1002/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; QUAN F, 1995, AM J HUM GENET, V56, P1042; Rousseau F., 1994, American Journal of Human Genetics, V55, pA240; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; Sullivan AK, 2002, AM J HUM GENET, V70, P1532, DOI 10.1086/340846; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Toledano-Alhadef H, 2001, AM J HUM GENET, V69, P351, DOI 10.1086/321974; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; VAISANEN ML, 1994, HUM GENET, V93, P143; VANDENOUWELAND AMW, 1994, HUM MOL GENET, V3, P1823, DOI 10.1093/hmg/3.10.1823; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VITS L, 1994, HUM GENET, V94, P523, DOI 10.1007/BF00211019; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1992, AM J HUM GENET, V50, P968; ZHONG N, 1995, AM J HUM GENET, V57, P351	39	253	261	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					454	464		10.1086/367713			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	WOS:000180680000025	12529854	Green Published, Bronze			2022-01-24	
J	Richard, G; Rouan, F; Willoughby, CE; Brown, N; Chung, P; Ryynanen, M; Jabs, EW; Bale, SJ; DiGiovanna, JJ; Uitto, J; Russell, L				Richard, G; Rouan, F; Willoughby, CE; Brown, N; Chung, P; Ryynanen, M; Jabs, EW; Bale, SJ; DiGiovanna, JJ; Uitto, J; Russell, L			Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GAP JUNCTION PROTEINS; KID-SYNDROME; ERYTHROKERATODERMIA VARIABILIS; CHANNELS; CELLS; KERATODERMA; EXPRESSION; FAMILY; GENE	Keratitis-ichthyosis-deafness syndrome (KID) is a rare ectodermal dysplasia characterized by vascularizing keratitis, profound sensorineural hearing loss (SNHL), and progressive erythrokeratoderma, a clinical triad that indicates a failure in development and differentiation of multiple stratifying epithelia. Here, we provide compelling evidence that KID is caused by heterozygous missense mutations in the connexin-26 gene, GJB2. In each of 10 patients with KID, we identified a point mutation leading to substitution of conserved residues in the cytoplasmic amino terminus or first extracellular domain of Cx26. One of these mutations was detected in six unrelated sporadic case subjects and also segregated in one family with vertical transmission of KID. These results indicate the presence of a common, recurrent mutation and establish its autosomal dominant nature. Cx26 and the closely related Cx30 showed differential expression in epidermal, adnexal, and corneal epithelia but were not significantly altered in lesional skin. However, mutant Cx26 was incapable of inducing intercellular coupling in vitro, which indicates its functional impairment. Our data reveal striking genotype-phenotype correlations and demonstrate that dominant GJB2 mutations can disturb the gap junction system of one or several ectodermal epithelia, thereby producing multiple phenotypes: nonsyndromic SNHL, syndromic SNHL with palmoplantar keratoderma, and KID. Decreased host defense and increased carcinogenic potential in KID illustrate that gap junction communication plays not only a crucial role in epithelial homeostasis and differentiation but also in immune response and epidermal carcinogenesis.	Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, BLSB, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; Univ Liverpool, Dept Med, Expt Ophthalmol Unit, Liverpool L69 3BX, Merseyside, England; Oulu Univ Hosp, Dept Obstet & Gynecol, Oulu, Finland; Johns Hopkins Univ Hosp, Dept Pediat Med & Plast Surg, Inst Med Genet, Baltimore, MD 21287 USA; NIAMSD, Genet Studies Sect, NIH, Bethesda, MD 20892 USA; GeneDx, Rockville, MD USA; Brown Univ, Rhode Isl Hosp, Dept Dermatol, Providence, RI 02903 USA; Montreal Childrens Hosp, Div Med Genet, Montreal, PQ H3H 1P3, Canada		Richard, G (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, BLSB, Suite 450,233 S 10th St, Philadelphia, PA 19107 USA.			Willoughby, Colin/0000-0002-1246-4166; Jabs, Ethylin/0000-0001-8983-5466	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K08AR002141, P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P01-AR38923, K08-AR02141, P01 AR038923, K08 AR002141] Funding Source: Medline		Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; CaceresRios H, 1996, PEDIATR DERMATOL, V13, P105; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; GROB JJ, 1987, ARCH DERMATOL, V123, P777, DOI 10.1001/archderm.123.6.777; Hu J, 1997, J CLIN INVEST, V99, P2312, DOI 10.1172/JCI119410; KAMIBAYASHI Y, 1995, CARCINOGENESIS, V16, P1287, DOI 10.1093/carcin/16.6.1287; Kelsell DP, 2001, AM J HUM GENET, V68, P559, DOI 10.1086/318803; Kone-Paut I, 1998, PEDIATR DERMATOL, V15, P219, DOI 10.1046/j.1525-1470.1998.1998015219.x; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; LEGRAND J, 1982, J FR OPHTALMOL, V5, P441; Macari F, 2000, AM J HUM GENET, V67, P1296; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Martin PEM, 1999, HUM MOL GENET, V8, P2369, DOI 10.1093/hmg/8.13.2369; Matic M, 1997, DIFFERENTIATION, V61, P251, DOI 10.1046/j.1432-0436.1997.6140251.x; MESNIL M, 1995, CANCER RES, V55, P629; NAZZARO V, 1990, J AM ACAD DERMATOL, V23, P385, DOI 10.1016/0190-9622(90)70229-B; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Ratkay-Traub I, 2001, EXP EYE RES, V73, P291, DOI 10.1006/exer.2001.1040; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Richard G, 2001, Adv Dermatol, V17, P243; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Rouan F, 2001, J CELL SCI, V114, P2105; RUBIN JB, 1992, BIOPHYS J, V62, P183, DOI 10.1016/S0006-3495(92)81804-0; Saez JC, 2000, BRAZ J MED BIOL RES, V33, P447, DOI 10.1590/S0100-879X2000000400011; Sawey MJ, 1996, MOL CARCINOGEN, V17, P49, DOI 10.1002/(SICI)1098-2744(199610)17:2<49::AID-MC1>3.3.CO;2-8; Szymko-Bennett YM, 2002, LARYNGOSCOPE, V112, P272, DOI 10.1097/00005537-200202000-00014; TUPPURAINEN K, 1988, ACTA OPHTHALMOL, V66, P692; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; White TW, 1996, J BIOENERG BIOMEMBR, V28, P339, DOI 10.1007/BF02110110	30	253	275	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1341	1348		10.1086/339986			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	WOS:000175012400024	11912510	Bronze, Green Published			2022-01-24	
J	Grimbacher, B; Schaffer, AA; Holland, SM; Davis, J; Gallin, JI; Malech, HL; Atkinson, TP; Belohradsky, BH; Buckley, RH; Cossu, F; Espanol, T; Garty, BZ; Matamoros, N; Myers, LA; Nelson, RP; Ochs, HD; Renner, ED; Wellinghausen, N; Puck, JM				Grimbacher, B; Schaffer, AA; Holland, SM; Davis, J; Gallin, JI; Malech, HL; Atkinson, TP; Belohradsky, BH; Buckley, RH; Cossu, F; Espanol, T; Garty, BZ; Matamoros, N; Myers, LA; Nelson, RP; Ochs, HD; Renner, ED; Wellinghausen, N; Puck, JM			Genetic linkage of hyper-IgE syndrome to chromosome 4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERFERON-GAMMA PRODUCTION; INFECTION JOBS SYNDROME; HYPERIMMUNOGLOBULIN-E; INTERLEUKIN-4 RECEPTOR; T-CELLS; RECURRENT; DEFICIENCY; ASSOCIATION; CHEMOTAXIS	The hyper-IgE syndrome (HIES) is a rare primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and highly elevated levels of serum IgE. HIES is now recognized as a multisystem disorder, with nonimmunologic abnormalities of the dentition, bones, and connective tissue. HIES can be transmitted as an autosomal dominant trait with variable expressivity. Nineteen kindreds with multiple cases of HIES were scored for clinical and laboratory findings and were genotyped with polymorphic markers in a candidate region on human chromosome 4. Linkage analysis showed a maximum two-point LOD score of 3.61 at recombination fraction of 0 with marker D4S428. Multipoint analysis and simulation testing confirmed that the proximal 4q region contains a disease locus for HIES.	Natl Human Genome Res Inst, Immunol Genet Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NIAID, Computat Biol Branch, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA; NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; Univ Alabama, Dept Pediat, Birmingham, AL USA; Duke Univ, Med Ctr, Dept Pediat & Immunol, Durham, NC USA; Univ S Florida, All Childrens Hosp, Div Clin Immunol & Allergy, St Petersburg, FL 33701 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Hosp Gen Valle Hebron, Immunol Unit, Barcelona, Spain; Hosp Son Dureta, Dept Immunol, Palma de Mallorca, Spain; Osped Microcitemico, Bone Marrow Transplant Unit, Cagliari, Italy; Tel Aviv Univ, Sackler Fac Med, Schneiders Children Med Ctr Israel, IL-69978 Tel Aviv, Israel; Univ Munich, Dr Von Haunerschen Kinderspital, Sect Infect Dis & Clin Immunol, D-80337 Munich, Germany; Univ Ulm, Sect Infect Dis & Clin Immunol, Ulm, Germany		Puck, JM (corresponding author), Natl Human Genome Res Inst, Immunol Genet Sect, Genet & Mol Biol Branch, NIH, Bldg 49,Room 3A14,49 Convent Dr, Bethesda, MD 20892 USA.		Buckley, Rebecca/AAB-1578-2019; Schaffer, Alejandro/N-1222-2019; Renner, Ellen D/R-7168-2016; Schaffer, Alejandro A/F-2902-2012	Renner, Ellen D/0000-0001-9816-8538; Malech, Harry/0000-0001-5874-5775; Cossu, Fausto/0000-0001-5485-2098	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD017427, R37HD017427] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD17427] Funding Source: Medline		Belohradsky B H, 1987, Ergeb Inn Med Kinderheilkd, V55, P1; BLUM R, 1977, J PEDIATR-US, V90, P607, DOI 10.1016/S0022-3476(77)80380-6; Borges WG, 1998, J PEDIATR-US, V133, P303, DOI 10.1016/S0022-3476(98)70243-4; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BUCKLEY R H, 1991, Journal of Allergy and Clinical Immunology, V87, P313, DOI 10.1016/0091-6749(91)91978-3; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; BUCKLEY RH, 1982, ANN ALLERGY, V49, P67; BUCKLEY RH, 1978, IMMUNOL REV, V41, P288, DOI 10.1111/j.1600-065X.1978.tb01469.x; BUCKLEY RH, 1996, IMMUNOLOGIC DISORDER, P413; BUCKLEY RH, 1981, CLIN IMMUNOLOGY UPDA, P147; CLAASSEN JJ, 1991, J ALLERGY CLIN IMMUN, V88, P713, DOI 10.1016/0091-6749(91)90177-P; Cohen M M Jr, 1988, Am J Med Genet Suppl, V4, P99; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVIS SD, 1966, LANCET, V1, P1013; DONABEDIAN H, 1983, MEDICINE, V62, P195, DOI 10.1097/00005792-198307000-00001; DRESKIN SC, 1987, J CLIN INVEST, V79, P1764, DOI 10.1172/JCI113017; DRESKIN SC, 1985, J CLIN INVEST, V75, P26, DOI 10.1172/JCI111683; DRESKIN SC, 1987, J ALLERGY CLIN IMMUN, V80, P746, DOI 10.1016/0091-6749(87)90297-1; Farkas L., 1994, ANTHROPOMETRY HEAD F, P286; GAHR M, 1987, HELV PAEDIATR ACTA, V42, P185; GEHA RS, 1981, J CLIN INVEST, V68, P783, DOI 10.1172/JCI110315; Grimbacher B, 1998, NEW ENGL J MED, V338, P1073; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; GRIMBACHER B, 1999, IN PRESS GENETICS ME; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; HILL HR, 1974, LANCET, V2, P617; HILL HR, 1974, LANCET, V1, P183; Holland SM, 1998, HARRISONS PRINCIPLES, P351; KING CL, 1989, P NATL ACAD SCI USA, V86, P10085, DOI 10.1073/pnas.86.24.10085; KIRCHNER SG, 1985, RADIOLOGY, V156, P362, DOI 10.1148/radiology.156.2.4011897; KRAEMER MJ, 1981, CLIN RES, V29, pA123; KRAEMER MJ, 1982, CLIN IMMUNOL IMMUNOP, V25, P157, DOI 10.1016/0090-1229(82)90178-7; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Ochs H D, 1983, Birth Defects Orig Artic Ser, V19, P57; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1991, ANAL HUMAN GENETIC L, P49; PAGANELLI R, 1991, CLIN EXP IMMUNOL, V84, P28; ROUSSET F, 1991, J ALLERGY CLIN IMMUN, V87, P58, DOI 10.1016/0091-6749(91)90213-8; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P77; VANEPPS DE, 1983, CLIN EXP IMMUNOL, V53, P678; VANSCOY RE, 1975, ANN INTERN MED, V82, P766, DOI 10.7326/0003-4819-82-6-766; VERCELLI D, 1990, J CLIN INVEST, V85, P1666, DOI 10.1172/JCI114618; Weeks DE., 1990, AM J HUM GENET, V47, pA203	46	253	264	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					735	744		10.1086/302547			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	WOS:000082426400018	10441580	Bronze, Green Published			2022-01-24	
J	Comas, D; Calafell, F; Mateu, E; Perez-Lezaun, A; Bosch, E; Martinez-Arias, R; Clarimon, J; Facchini, F; Fiori, G; Luiselli, D; Pettener, D; Bertranpetit, J				Comas, D; Calafell, F; Mateu, E; Perez-Lezaun, A; Bosch, E; Martinez-Arias, R; Clarimon, J; Facchini, F; Fiori, G; Luiselli, D; Pettener, D; Bertranpetit, J			Trading genes along the silk road: mtDNA sequences and the origin of central Asian populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL REGION SEQUENCE; EUROPEAN POPULATIONS; HIGH-ALTITUDE; BODY-WATER; DIVERSITY; POLYMORPHISM; AFRICAN; GENOME; AMERINDS	Central Asia is a vast region at the crossroads of different habitats, cultures, and trade routes. Little is known about the genetics and the history of the population of this region. We present the analysis of mtDNA control-region sequences in samples of the Kazakh, the Uighurs, the lowland Kirghiz, and the highland Kirghiz, which we have used to address both the population history of the region and the possible selective pressures that high altitude has on mtDNA genes. Central Asian mtDNA sequences present features intermediate between European and eastern Asian sequences, in several parameters-such as the frequencies of certain nucleotides, the levels of nudeotide diversity, mean pairwise differences, and genetic distances. Several hypotheses could explain the intermediate position of central Asia between Europe and eastern Asia, but the most plausible would involve extensive levels of admixture between Europeans and eastern Asians in central Asia, possibly enhanced during the Silk Road trade and clearly after the eastern and western Eurasian human groups had diverged. Lowland and highland Kirghiz mtDNA sequences are very similar, and the analysis of molecular variance has revealed that the fraction of mitochondrial genetic variance due to altitude is not significantly different from zero. Thus, it seems unlikely that altitude has exerted a major selective pressure on mitochondrial genes in central Asian populations.	Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Barcelona 08003, Catalonia, Spain; Univ Helsinki, Dept Forens Med, Helsinki, Finland; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Edith Cowan Univ, Ctr Human Genet, Joondalup, WA, Australia; Univ Bologna, Unita Antropol, Dipartimento Biol, Bologna, Italy		Bertranpetit, J (corresponding author), Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Doctor Aiguader 80, Barcelona 08003, Catalonia, Spain.	jaumeb.bertranpetit@cexs.upf.es	Bosch, Elena/N-7603-2019; Bosch, Elena/D-8681-2014; Pettener, Davide/E-1576-2017; Bertranpetit, Jaume/F-8550-2012; Comas, David/D-5382-2014; Calafell, Francesc/C-8595-2014	Bosch, Elena/0000-0003-2848-103X; Bosch, Elena/0000-0003-2848-103X; Bertranpetit, Jaume/0000-0003-0100-0590; Comas, David/0000-0002-5075-0956; Calafell, Francesc/0000-0002-1083-9438; Martinez-Arias, Rosa/0000-0003-4272-1298; Clarimon, Jordi/0000-0002-6824-6942			ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANTHONY DW, 1995, ARCHAEOLOGY, V48, P36; ANTHONY DW, 1991, ANTIQUITY, V65, P22, DOI 10.1017/S0003598X00079278; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; BALLINGER SW, 1992, GENETICS, V130, P139; Bandelt HJ, 1997, AM J HUM GENET, V61, P980, DOI 10.1086/514878; BANDELT HJ, 1995, GENETICS, V141, P743; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; BATTISTINI N, 1995, ANN HUM BIOL, V22, P315, DOI 10.1080/03014469500003982; Bedogni G, 1997, ANN HUM BIOL, V24, P533, DOI 10.1080/03014469700005292; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BOWLES G, 1977, PEOPLES ASIA; CABOT EL, 1988, ESEE EYEBALL SEQUENC; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; Comas D, 1997, HUM GENET, V99, P443, DOI 10.1007/s004390050386; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Efron B., 1982, JACKKNIFE BOOTSTRAP; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier, 1996, ARLEQUIN SOFTWARE EN; EXCOFFIER L, 1992, GENETICS, V131, P479; Facchini F, 1998, AM J HUM BIOL, V10, P241, DOI 10.1002/(SICI)1520-6300(1998)10:2<241::AID-AJHB9>3.0.CO;2-N; Facchini F, 1997, HUM BIOL, V69, P97; FELSENSTEIN J, 1985, EVOLUTION, V35, P785; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Fu YX, 1997, GENETICS, V147, P915; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Handt O, 1998, NUCLEIC ACIDS RES, V26, P126, DOI 10.1093/nar/26.1.126; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Horai S, 1996, AM J HUM GENET, V59, P579; Howell N, 1997, AM J HUM GENET, V61, P986; Howell N, 1996, AM J HUM GENET, V59, P501; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1996, GENETICS, V142, P1321; LUM JK, 1994, HUM BIOL, V66, P567; Macaulay VA, 1997, AM J HUM GENET, V61, P983; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, MOL EVOLUTIONARY GEN; Paabo S, 1996, AM J HUM GENET, V59, P493; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PETTENER D, 1997, ACTA ANDINA, V6, P217; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; PULT I, 1994, BIOL CHEM H-S, V375, P837; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; Richards M, 1996, AM J HUM GENET, V59, P185; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruhlen M, 1991, GUIDE WORLDS LANGUAG; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SANTOS M, 1994, HUM BIOL, V66, P963; Sellier J., 1993, ATLAS PEUPLES ORIENT; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Stenico M, 1996, AM J HUM GENET, V59, P1363; TAJIMA F, 1989, GENETICS, V123, P585; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1993, AM J HUM GENET, V53, P591; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Watson E, 1996, AM J HUM GENET, V59, P437	73	253	276	1	42	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1824	1838		10.1086/302133			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	151EL	WOS:000077707700028	9837835	Bronze, Green Published			2022-01-24	
J	Thomas, JT; Kilpatrick, MW; Lin, K; Erlacher, L; Lembessis, P; Costa, T; Tsipouras, P; Luyten, FP				Thomas, JT; Kilpatrick, MW; Lin, K; Erlacher, L; Lembessis, P; Costa, T; Tsipouras, P; Luyten, FP			Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1	NATURE GENETICS			English	Article							FACTOR-BETA SUPERFAMILY; PROTEINS; MEMBER; CHONDRODYSPLASIA; REGULATORS; MOUSE; BMP-7	Chondrodysplasia Grebe type (CGT) is an autosomal recessive disorder characterized by severe limb shortening and dysmorphogenesis. We have identified a causative point mutation in the gene encoding the bone morphogenetic protein (BMP)-like molecule, cartilage-derived morphogenetic protein-1 (CDMP-1). The mutation substitutes a tyrosine for the first of seven highly conserved cysteine residues in the mature active domain of the protein, We demonstrate that the mutation results in a protein that is not secreted and is inactive in vitro. It produces a dominant negative effect by preventing the secretion of other, related BMP family members. We present evidence that this may occur through the formation of heterodimers. The mutation and its proposed mechanism of action provide the first human genetic indication that composite expression patterns of different BMPs dictate limb and digit morphogenesis.	UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06030; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA		Thomas, JT (corresponding author), NIDR,CRANIOFACIAL & SKELETAL DIS BRANCH,NIH,BETHESDA,MD 20892, USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD-22610] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD022610] Funding Source: NIH RePORTER		AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bell Julia, 1951, TREASURY HUMAN INHER, VV; CHANG SC, 1994, J BIOL CHEM, V269, P28227; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Dudley AT, 1997, DEV DYNAM, V208, P349; FENG B, 1985, ACTA GENET SIN, V12, P378; FITCH N, 1978, J MED GENET, V16, P36; GARCIACASTRO JM, 1975, J PEDIATR-US, V87, P948, DOI 10.1016/S0022-3476(75)80915-2; GRAY DJ, 1957, AM J ANAT, V101, P169, DOI 10.1002/aja.1001010202; GREBE H, 1952, FOLIA HERED PATHOL, V2, P23; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Hall B., 1994, BONE, V8, P137; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; JONES CM, 1991, DEVELOPMENT, V111, P531; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KUMAR D, 1984, CLIN GENET, V25, P68; Lin KM, 1996, GENOMICS, V34, P150, DOI 10.1006/geno.1996.0257; LOPEZ AR, 1992, MOL CELL BIOL, V12, P1674, DOI 10.1128/MCB.12.4.1674; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; MASTROBATTISTA JM, 1995, J MED GENET, V32, P851, DOI 10.1136/jmg.32.11.851; QUELCE-SALGADO A., 1964, ACTA GENET STATIST MED [BASEL], V14, P63; SAMPATH TK, 1990, J BIOL CHEM, V265, P13198; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; VENKATARAMAN G, 1995, P NATL ACAD SCI USA, V92, P5406, DOI 10.1073/pnas.92.12.5406; VUKKEVIC S, 1994, J HISTOCHEM CYTOCHEM, V42, P869; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	36	253	268	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					58	64		10.1038/ng0997-58			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	WOS:A1997XU72400018	9288098				2022-01-24	
J	Kas, K; Voz, ML; Roijer, E; Astrom, AK; Meyen, E; Stenman, G; VandeVen, WJM				Kas, K; Voz, ML; Roijer, E; Astrom, AK; Meyen, E; Stenman, G; VandeVen, WJM			Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ENCODING GENE; FUSION; TUMOR; LYMPHOMA; LIBRARY; LAZ3	Pleiomorphic adenoma of the salivary glands is a benign epithelial tumour occurring primarily in the major and minor salivary glands(1). It is by far the most common type of salivary gland tumour. Microscopically, pleiomorphic adenomas show a marked histological diversity with epithelial, myoepithelial and mesenchymal components in a variety of patterns. In addition to a cytogenetic subgroup with normal karyotypes, pleiomorphic adenomas are characterized by recurrent chromosome rearrangements, particularly reciprocal translocations, with breakpoints at 8q12, 3p21, and 12q13-15, in that order of frequency(2,3). The most common abnormality is a reciprocal t(3;8)(p21;q12). We here demonstrate that the t(3;8)(p21;q12) results in promoter swapping between PLAG1, a novel, developmentally regulated zinc finger gene at 8q12, and the constitutively expressed gene for beta-catenin (CTNNB1), a protein interface functioning in the WG/WNT signalling pathway and specification of cell fate during embryogenesis(4). Fusions occur in the 5'-non-coding regions of both genes, exchanging regulatory control elements while preserving the coding sequences. Due to the t(3;8)(p21;q12), PLAG1 is activated and expression levels of CTNNB1 are reduced. Activation of PLAG1 was also observed in an adenoma with a variant translocation t(8;15)(q12;q14). Our results indicate that PLAG1 activation due to promoter swapping is a crucial event in salivary gland tumourigenesis.	CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,MOL ONCOL LAB,B-3000 LOUVAIN,BELGIUM; FLANDERS INTERUNIV INST BIOTECHNOL,B-3000 LOUVAIN,BELGIUM; GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT PATHOL,CANC GENET LAB,S-41345 GOTHENBURG,SWEDEN								ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALTSCHUL SF, 1990, J MOL BIOL, V17, P166; APLAN PD, 1992, BLOOD, V79, P1327; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BULLERDIEK J, 1993, CANCER GENET CYTOGEN, V65, P27, DOI 10.1016/0165-4608(93)90054-P; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; DALLERY E, 1995, ONCOGENE, V10, P2171; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Galieque-Zouitina S, 1996, LEUKEMIA, V10, P579; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KRAUS C, 1994, GENOMICS, V23, P272, DOI 10.1006/geno.1994.1493; LADANYI M, 1994, CANCER RES, V54, P2837; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nollet F, 1996, GENOMICS, V32, P413, DOI 10.1006/geno.1996.0136; ROIJER E, IN PRESS GENES CHROM; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sambrook J., 1989, MOL CLONING LAB MANU; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; SCHOENMAKERS EFPM, 1994, GENOMICS, V20, P210, DOI 10.1006/geno.1994.1155; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Waldron CA., 1991, SURG PATHOLOGY SALIV, P165; WOOD S, 1992, CYTOGENET CELL GENET, V59, P243, DOI 10.1159/000133260; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; [No title captured]	28	253	261	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					170	174		10.1038/ng0297-170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	WOS:A1997WF08700016	9020842				2022-01-24	
J	ROUSSEAU, F; HEITZ, D; TARLETON, J; MACPHERSON, J; MALMGREN, H; DAHL, N; BARNICOAT, A; MATHEW, C; MORNET, E; TEJADA, I; MADDALENA, A; SPIEGEL, R; SCHINZEL, A; MARCOS, JAG; SCHORDERET, DF; SCHAAP, T; MACCIONI, L; RUSSO, S; JACOBS, PA; SCHWARTZ, C; MANDEL, JL				ROUSSEAU, F; HEITZ, D; TARLETON, J; MACPHERSON, J; MALMGREN, H; DAHL, N; BARNICOAT, A; MATHEW, C; MORNET, E; TEJADA, I; MADDALENA, A; SPIEGEL, R; SCHINZEL, A; MARCOS, JAG; SCHORDERET, DF; SCHAAP, T; MACCIONI, L; RUSSO, S; JACOBS, PA; SCHWARTZ, C; MANDEL, JL			A MULTICENTER STUDY ON GENOTYPE-PHENOTYPE CORRELATIONS IN THE FRAGILE-X-SYNDROME, USING DIRECT DIAGNOSIS WITH PROBE STB-12.3 - THE FIRST 2,253 CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; FULL MUTATION; FMR-1 GENE; ABNORMAL METHYLATION; FOUNDER CHROMOSOMES; FETAL TISSUES; DNA; INSTABILITY; REPEAT; EXPRESSION	We report the results of a 14-center collaborative study of genotype-phenotype correlations in 318 fragile X families; these families comprised 2,253 individuals, 1,344 of whom carried a fragile X mutation and 693 of whom had a typical full fragile X mutation. This study demonstrates that direct DNA diagnosis establishes the genotype at the FRAXA-FMR-1 locus. There was a significantly higher prevalence of ''mosaic'' cases among males who carry a full mutation (12%) than among females who carry a full mutation (6%); the mosaic males had a larger expansion than did the mosaic females. Mental status of premutated individuals did not differ from that of those with a normal genotype. Both the abnormal methylation of the FMR-1-EagI site and the size of the expansion were highly correlated with cytogenetics, facial dysmorphism, macroorchidism, and mental retardation (MR). Among female carriers of a full mutation, those with MR had significantly larger expansion than did those without MR. Among 164 independent couples, 3 unrelated husbands carried a premutation that suggests that the prevalence of fragile X premutations in the general population is similar to 0.9% of the X chromosomes. Our data validate the use of direct DNA testing for fragile X diagnosis as well as for carrier identification and support and complete the established relationships among the DNA results and the cytogenetic, physical, and psychological aspects of the disease.	INSERM,U184,CNRS,LGME,STRASBOURG,FRANCE; GREENWOOD GENET CTR,GREENWOOD,SC 29646; WESSEX REG GENET LAB,SALISBURY,WILTS,ENGLAND; UPPSALA UNIV,DEPT MED GENET,UPPSALA,SWEDEN; UPPSALA UNIV,DEPT CLIN GENET,UPPSALA,SWEDEN; UNITED MED & DENT SCH,DIV MED & MOLEC GENET,LONDON,ENGLAND; CTR ETUD BIOL PRENATALE,PARIS,FRANCE; GENET & IVF INST,FAIRFAX,VA 22039; INST MED GENET,ZURICH,SWITZERLAND; HOSP RAMON Y CAJAL,UNIDAD GENET MOLEC,E-28034 MADRID,SPAIN; CHU VAUDOIS,INST MED GENET,CH-1011 LAUSANNE,SWITZERLAND; HADASSAH UNIV HOSP,DEPT HUMAN GENET,IL-91120 JERUSALEM,ISRAEL; IST CLIN & BIOL EVOLUTIVA,CAGLIARI,ITALY; IST CLIN PERFEZIONAMENTO ANAT & ISTOL PATOL,MILAN,ITALY		ROUSSEAU, F (corresponding author), HOP ST FRANCOIS ASSISE,CTR RECH,UNITE RECH GENET HUMAINE & MOLEC,10 RUE ESPINAY,QUEBEC CITY G1L 3L5,PQ,CANADA.		M Isabel, Tejada/E-2394-2012; Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838			DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVRIES BBA, 1993, EUR J HUM GENET, V1, P72; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; FRYNS JP, 1984, HUM GENET, V65, P400, DOI 10.1007/BF00291567; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1991, J MED GENET, V28, P824, DOI 10.1136/jmg.28.12.824; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LAIRD C, 1992, 3RD INT FRAG X C ASP; LEDBETTER DH, 1986, NATURE, V324, P161, DOI 10.1038/324161a0; LOESCH DZ, 1993, AM J HUM GENET, V53, P1064; MACPHERSON J, 1992, AM J MED GENET, V43, P905, DOI 10.1002/ajmg.1320430535; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; NELSON DL, 1993, NAT GENET, V4, P107, DOI 10.1038/ng0693-107; NIELSEN KB, 1983, HUM GENET, V64, P240, DOI 10.1007/BF00279401; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OUDET C, 1993, AM J HUM GENET, V52, P297; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1993, AM J HUM GENET, V52, P884; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SATTLER JM, 1988, ASSESSMENT CHILDRENS; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; TURNER G, 1983, ADV HUM GENET, V13, P83; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBB T, 1990, J MED GENET, V27, P627, DOI 10.1136/jmg.27.10.627; WEBB T, 1989, FRAGILE X SYNDROME, P40; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; WOHRLE D, 1992, AM J HUM GENET, V51, P299; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	38	253	254	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					225	237					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	WOS:A1994NZ33600002	8037202				2022-01-24	
J	MATTHEWS, CH; BORGATO, S; BECKPECCOZ, P; ADAMS, M; TONE, Y; GAMBINO, G; CASAGRANDE, S; TEDESCHINI, G; BENEDETTI, A; CHATTERJEE, VKK				MATTHEWS, CH; BORGATO, S; BECKPECCOZ, P; ADAMS, M; TONE, Y; GAMBINO, G; CASAGRANDE, S; TEDESCHINI, G; BENEDETTI, A; CHATTERJEE, VKK			PRIMARY AMENORRHEA AND INFERTILITY DUE TO A MUTATION IN THE BETA-SUBUNIT OF FOLLICLE-STIMULATING-HORMONE	NATURE GENETICS			English	Article							GENE; GONADOTROPINS; SUBSTITUTION; HYPOGONADISM; FOLLITROPIN; CELLS; SERUM; FSH	We report a woman with primary amenorrhoea and infertility associated with an isolated deficiency of pituitary follicle-stimulating hormone (FSH), but normal luteinizing hormone (LH) secretion. Ovulation was induced by administration of exogenous FSH and resulted in a successful pregnancy. Sequence analysis of the FSHbeta-subunit gene indicated that she is homozygous for a two nucleotide frameshift deletion in the coding sequence. Her mother and son are heterozygous for this mutation. This deletion results in an alteration of amino acid codons 61-86 followed by a premature termination codon. The predicted truncated beta-subunit peptide lacks regions which are important for association with the alpha subunit and for binding to and activation of the FSH receptor. Abnormalities of FSH structure or function might be an under recognised but treatable cause of infertility.	UNIV MILAN, OSPED MAGGIORE, INST ENDOCRINE SCI, IRCCS, I-20122 MILAN, ITALY; UNIV TRIESTE, CATTINARA HOSP, DEPT ENDOCRINOL, I-34100 TRIESTE, ITALY		CHATTERJEE, VKK (corresponding author), UNIV CAMBRIDGE, ADDENBROOKES HOSP, DEPT MED, CAMBRIDGE CB2 2QQ, ENGLAND.			Chatterjee, Vengalil Krishna/0000-0002-2654-8854	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ALANSARI AAK, 1984, FERTIL STERIL, V42, P618; AVRILDUCARNE D, 1990, J GYNECOL OBST BIO R, V19, P881; AZUMA C, 1990, J MOL ENDOCRINOL, V5, P97, DOI 10.1677/jme.0.0050097; BECKPECCOZ P, 1991, J CLIN ENDOCR METAB, V73, P525, DOI 10.1210/jcem-73-3-525; BENEDETTI A, 1991, GIORNALE CLIN MED, V21, P289; CAMPBELL RK, 1991, P NATL ACAD SCI USA, V88, P760, DOI 10.1073/pnas.88.3.760; COLOMA TAS, 1990, J BIOL CHEM, V265, P5037; DACOUVOUTETAKIS C, 1990, AM J HUM GENET, V46, P988; DIAS JA, 1992, TRENDS ENDOCRIN MET, V3, P24, DOI 10.1016/1043-2760(92)90088-I; HAYASHIZAKI Y, 1989, EMBO J, V8, P2291, DOI 10.1002/j.1460-2075.1989.tb08355.x; HSUEH AJW, 1989, RECENT PROG HORM RES, V45, P209; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; JAMESON JL, 1988, MOL ENDOCRINOL, V2, P806, DOI 10.1210/mend-2-9-806; JOCKENHOVEL F, 1989, ACTA ENDOCRINOL-COP, V121, P802, DOI 10.1530/acta.0.1210802; KEENE JL, 1989, J BIOL CHEM, V264, P4769; MARCHBANKS PA, 1989, AM J EPIDEMIOL, V130, P259, DOI 10.1093/oxfordjournals.aje.a115332; MAROULIS GB, 1977, FERTIL STERIL, V28, P818; NIESCHLAG E, 1993, CLIN ENDOCRINOL, V38, P123, DOI 10.1111/j.1365-2265.1993.tb00983.x; PADMANABHAN V, 1987, ENDOCRINOLOGY, V121, P1089, DOI 10.1210/endo-121-3-1089; RABINOWITZ D, 1979, NEW ENGL J MED, V300, P126, DOI 10.1056/NEJM197901183000306; RYAN RJ, 1987, RECENT PROG HORM RES, V43, P383; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VAKHARIA DD, 1991, ENDOCRINOLOGY, V128, P1797, DOI 10.1210/endo-128-4-1797; VAKHARIA DD, 1992, MOL CELL ENDOCRINOL, V85, P89, DOI 10.1016/0303-7207(92)90128-S; WANG C, 1987, J CLIN ENDOCR METAB, V65, P629, DOI 10.1210/jcem-65-4-629; WATKINS PC, 1987, DNA-J MOLEC CELL BIO, V6, P205, DOI 10.1089/dna.1987.6.205; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; WINTERS SJ, 1992, NEW ENGL J MED, V326, P193, DOI 10.1056/NEJM199201163260309	28	253	262	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1993	5	1					83	86		10.1038/ng0993-83			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	WOS:A1993LV56500022	8220432				2022-01-24	
J	Finucane, HK; Reshef, YA; Anttila, V; Slowikowski, K; Gusev, A; Byrnes, A; Gazal, S; Loh, PR; Lareau, C; Shoresh, N; Genovese, G; Saunders, A; Macosko, E; Pollack, S; Perry, JRB; Buenrostro, JD; Bernstein, BE; Raychaudhuri, S; McCarroll, S; Neale, BM; Price, AL				Finucane, Hilary K.; Reshef, Yakir A.; Anttila, Verneri; Slowikowski, Kamil; Gusev, Alexander; Byrnes, Andrea; Gazal, Steven; Loh, Po-Ru; Lareau, Caleb; Shoresh, Noam; Genovese, Giulio; Saunders, Arpiar; Macosko, Evan; Pollack, Samuela; Perry, John R. B.; Buenrostro, Jason D.; Bernstein, Bradley E.; Raychaudhuri, Soumya; McCarroll, Steven; Neale, Benjamin M.; Price, Alkes L.		Brainstorm Consortium	Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; SUSCEPTIBILITY LOCI; COMPLEX TRAITS; RISK LOCI; PARTITIONING HERITABILITY; PREFRONTAL CORTEX; BIPOLAR DISORDER; METAANALYSIS; SCHIZOPHRENIA	We introduce an approach to identify disease-relevant tissues and cell types by analyzing gene expression data together with genome-wide association study (GWAS) summary statistics. Our approach uses stratified linkage disequilibrium (LD) score regression to test whether disease heritability is enriched in regions surrounding genes with the highest specific expression in a given tissue. We applied our approach to gene expression data from several sources together with GWAS summary statistics for 48 diseases and traits (average N = 169,331) and found significant tissue-specific enrichments (false discovery rate (FDR) < 5%) for 34 traits. In our analysis of multiple tissues, we detected a broad range of enrichments that recapitulated known biology. In our brain-specific analysis, significant enrichments included an enrichment of inhibitory over excitatory neurons for bipolar disorder, and excitatory over inhibitory neurons for schizophrenia and body mass index. Our results demonstrate that our polygenic approach is a powerful way to leverage gene expression data for interpreting GWAS signals.	[Finucane, Hilary K.; Anttila, Verneri; Slowikowski, Kamil; Byrnes, Andrea; Lareau, Caleb; Shoresh, Noam; Genovese, Giulio; Buenrostro, Jason D.; Bernstein, Bradley E.; Raychaudhuri, Soumya; McCarroll, Steven; Neale, Benjamin M.; Price, Alkes L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02139 USA; [Finucane, Hilary K.; Gusev, Alexander; Gazal, Steven; Loh, Po-Ru; Pollack, Samuela; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Reshef, Yakir A.] Harvard Univ, Dept Comp Sci, Cambridge, MA 02138 USA; [Anttila, Verneri; Byrnes, Andrea; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Anttila, Verneri; Byrnes, Andrea; Bernstein, Bradley E.; Neale, Benjamin M.] Harvard Med Sch, Boston, MA USA; [Slowikowski, Kamil] Harvard Univ, Bioinformat & Integrat Genom, Cambridge, MA 02138 USA; [Slowikowski, Kamil; Raychaudhuri, Soumya] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA USA; [Lareau, Caleb] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Saunders, Arpiar; Macosko, Evan; McCarroll, Steven] Harvard Med Sch, Dept Genet, Boston, MA USA; [Perry, John R. B.] Univ Cambridge, Sch Clin Med, MRC, Epidemiol Unit,Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England; [Buenrostro, Jason D.] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Raychaudhuri, Soumya] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol, Boston, MA USA; [Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England		Finucane, HK; Price, AL (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Finucane, HK (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.; Finucane, HK; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	finucane@broadinstitute.org; aprice@hsph.harvard.edu	Lareau, Caleb/ABF-9490-2020; Gazal, Steven/AAK-3764-2020; Hansen, Thomas Folkmann/O-5965-2014; Macosko, Evan/X-4664-2019; Slowikowski, Kamil/K-3728-2016	Lareau, Caleb/0000-0003-4179-4807; Hansen, Thomas Folkmann/0000-0001-6703-7762; Slowikowski, Kamil/0000-0002-2843-6370; Reshef, Yakir/0000-0001-6463-4203; Raychaudhuri, Soumya/0000-0002-1901-8265; Gazal, Steven/0000-0003-4510-5730	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH107649, R01 MH109978, U01 CA194393, U01 HG009379]; Fannie and John Hertz Foundation; Eric and Wendy Schmidt; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12015/2] Funding Source: UKRI; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA194393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG009379, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [UH2AR067677, R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH103392, U01MH103365, R21MH103877, P50MH106934, R01MH105898, R21MH105881, R01MH094714, R21MH102791, R01MH109978, U01MH103340, R01MH107649, R01MH105472, U01MH103339, U01MH103346] Funding Source: NIH RePORTER	We are thankful to R. Herbst, E. Hodis, F. Hormozdiari, M. Kanai, T. Pers, S. Riesenfeld, J. Ulirsch and A. Veres for helpful comments. This research was conducted using the UK Biobank Resource (application number: 16549). This research was funded by NIH grants R01 MH107649 (H.K.F., S.G., B.M.N., A.L.P.), R01 MH109978 (A.G., A.L.P.), U01 CA194393 (H.K.F., A.L.P.) and U01 HG009379 (S.R., A.L.P.). H.K. F. was also supported by the Fannie and John Hertz Foundation and by Eric and Wendy Schmidt. Data on neuron types were generated as part of the PsychENCODE Consortium, P. Sklar, Icahn School of Medicine at Mount Sinai), U01MH103365 (F. Vaccarino, Yale University; M. Gerstein, Yale University; S. Weissman, Yale University), U01MH103346 (P. Farnham, University of Southern California; J. A. Knowles, University of Southern California), U01MH103340 (C. Liu, SUNY Upstate Medical University; K. White, University of Chicago), U01MH103339 (N. Sestan, Yale University; M. State, University of California, San Francisco), R21MH109956 (A. Jaffe, Lieber Institute for Brain Development), R21MH105881 (D. Pinto, Icahn School of Medicine at Mount Sinai), R21MH105853 (A. Jaffe, Lieber Institute for Brain Development; D. Weinberger, Lieber Institute for Brain Development), R21MH103877 (S. Dracheva, Icahn School of Medicine at Mount Sinai; S. Akbarian, Icahn School of Medicine at Mount Sinai), R21MH102791 (A. Jaffe, Lieber Institute for Brain Development), R01MH111721 (F. Goes, Johns Hopkins University; T. Hyde, Lieber Institute for Brain Development), R01MH110928 (M. State, University of California, San Francisco; S. Sanders, University of California, San Francisco; J. Willsey, University of California, San Francisco), R01MH110927 (D. Geschwind, University of California, Los Angeles), R01MH110926 (N. Sestan, Yale University), R01MH110921 (P. Sklar, Icahn School of Medicine at Mount Sinai), R01MH110920 (C. Liu, SUNY Upstate Medical University), R01MH110905 (K. White, University of Chicago), R01MH109715 (D. Pinto, Icahn School of Medicine at Mount Sinai), R01MH109677 (P. Roussos, Icahn School of Medicine at Mount Sinai), R01MH105898, (P. Zandi, Johns Hopkins University; T. M. Hyde, Lieber Institute for Brain Development), R01MH094714, (D. Geschwind, University of California, Los Angeles), P50MH106934, (N. Sestan, Yale University), R01MH105472 (G. Crawford, Duke University; P. Sullivan, University of North Carolina).	Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Anttila V, 2016, BIORXIV, DOI [10.1101/048991, DOI 10.1101/048991]; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Backenroth D., 2016, TISSUE SPECIFIC FUNC, DOI [10.1101/069229, DOI 10.1101/069229]; Barbosa IG, 2014, NEUROIMMUNOMODULAT, V21, P117, DOI 10.1159/000356539; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Broedl UC, 2004, CIRC RES, V94, P1554, DOI 10.1161/01.RES.0000130657.00222.39; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cordell HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9019; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Dhirapong A, 2011, HEPATOLOGY, V53, P527, DOI 10.1002/hep.24044; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elamin I, 2013, BEHAV NEUROL, V27, P23, DOI [10.3233/BEN-120295, 10.1155/2013/329375]; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gagliano SA, 2016, ANN CLIN TRANSL NEUR, V3, P924, DOI 10.1002/acn3.369; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hanford LC, 2016, BIPOLAR DISORD, V18, P4, DOI 10.1111/bdi.12362; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI200316146, 10.1172/JCI16146]; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li Y, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw627; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Loh P, 2017, MIXED MODEL ASS BIOB, DOI [10.1101/194944, DOI 10.1101/194944]; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Medic N, 2016, INT J OBESITY, V40, P1177, DOI 10.1038/ijo.2016.42; Muller-Ladner U, 2005, NAT CLIN PRACT RHEUM, V1, P102, DOI 10.1038/ncprheum0047; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Ongen H, 2017, NAT GENET, V49, P1676, DOI 10.1038/ng.3981; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rege S, 2013, AUST NZ J PSYCHIAT, V47, P1136, DOI 10.1177/0004867413499077; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sakai T, 2008, NEUROPATHOLOGY, V28, P143, DOI 10.1111/j.1440-1789.2007.00867.x; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Slowikowski K, 2014, BIOINFORMATICS, V30, P2496, DOI 10.1093/bioinformatics/btu326; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steiner J, 2010, EUR ARCH PSY CLIN N, V260, P509, DOI 10.1007/s00406-010-0098-x; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tfelt-Hansen PC, 2011, HEADACHE, V51, P752, DOI 10.1111/j.1526-4610.2011.01892.x; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Trott DW, 2014, ADV PHYSIOL EDUC, V38, P20, DOI 10.1152/advan.00063.2013; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945; Woo D, 2014, AM J HUM GENET, V94, P511, DOI 10.1016/j.ajhg.2014.02.012; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang J, 2014, HEPATOLOGY, V60, P1708, DOI 10.1002/hep.27313; Zlotnikov-Klionsky Y, 2015, IMMUNITY, V43, P776, DOI 10.1016/j.immuni.2015.08.015	87	252	251	4	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2018	50	4					621	+		10.1038/s41588-018-0081-4			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GC1GR	WOS:000429529300022	29632380	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Paix, A; Folkmann, A; Rasoloson, D; Seydoux, G				Paix, Alexandre; Folkmann, Andrew; Rasoloson, Dominique; Seydoux, Geraldine			High Efficiency, Homology-Directed Genome Editing in Caenorhabditis elegans Using CRISPR-Cas9 Ribonucleoprotein Complexes	GENETICS			English	Article						CRISPR-Cas9; genome editing; homology-directed repair; ribonucleoprotein complexes; C. elegans	GENE INACTIVATION; CRISPR/CAS9; DESIGN; SYSTEM; RNA	Homology-directed repair (HDR) of breaks induced by the RNA-programmed nuclease Cas9 has become a popular method for genome editing in several organisms. Most HDR protocols rely on plasmid-based expression of Cas9 and the gene-specific guide RNAs. Here we report that direct injection of in vitro-assembled Cas9-CRISPR RNA (crRNA) trans-activating crRNA (tracrRNA) ribonucleoprotein complexes into the gonad of Caenorhabditis elegans yields HDR edits at a high frequency. Building on our earlier finding that PCR fragments with 35-base homology are efficient repair templates, we developed an entirely cloning-free protocol for the generation of seamless HDR edits without selection. Combined with the co-CRISPR method, this protocol is sufficiently robust for use with low-efficiency guide RNAs and to generate complex edits, including ORF replacement and simultaneous tagging of two genes with fluorescent proteins.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Paix, Alexandre] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA		Paix, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, PCTB706,725 N Wolfe St, Baltimore, MD 21205 USA.	apaix1@jhmi.edu	Paix, Alexandre/AAL-2673-2020; Paix, Alexandre/E-9137-2011; SEYDOUX, Geraldine/AAA-2005-2020	Paix, Alexandre/0000-0002-8080-7546; Paix, Alexandre/0000-0002-8080-7546; Rasoloson, Dominique/0000-0003-2210-1569; Seydoux, Geraldine/0000-0001-8257-0493	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD37047]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD037047] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P40OD010440] Funding Source: NIH RePORTER	We thank Mike Nonet and Andy Fire for the Cas9::NLS::His bacterial expression plasmid and members of the Seydoux Laboratory for comments on the manuscript. Some strains were provided by or deposited at the Caenorhabditis Genetics Center (CGC), which is funded by the National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440). We also thank WormBase for gene annotations and sequences. This work was supported by National Institutes of Health grant R01HD37047. G.S. is an investigator of the Howard Hughes Medical Institute.	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Chudakov, FLUORESCENT PROTEINS; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dickinson D. J., 2015, GENETICS, V115; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Doench, RATIONAL DESIGN HIGH; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Farboud, DRAMATIC ENHANCEMENT; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Fu BXH, 2014, NUCLEIC ACIDS RES, V42, P13778, DOI 10.1093/nar/gku1102; Gagnon, EFFICIENT MUTAGENESI; Hsu, DNA TARGETING SPECIF; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek, PROGRAMMABLE DUAL RN; Katic I., 2015, CRISPR CAS9 GENOME E; Kelly WG, 1997, GENETICS, V146, P227; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Merritt, 3 UTRS ARE PRIMARY R; Paix, SCALABLE VERSATILE G; Paix A, 2014, GENETICS, V198, P1347, DOI 10.1534/genetics.114.170423; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; van Schendel R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8394; Ward, RAPID PRECISE ENG CA; Ward JD, 2015, GENETICS, V199, P363, DOI 10.1534/genetics.114.172361; Witte H, 2015, DEV GENES EVOL, V225, P55, DOI 10.1007/s00427-014-0486-8; Xu Katic, CRISPR CAS9 GENOME E	32	252	255	1	63	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	SEP	2015	201	1					47	+		10.1534/genetics.115.179382			26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR3BX	WOS:000361206400006	26187122	Green Published, Bronze			2022-01-24	
J	Liao, J; Karnik, R; Gu, HC; Ziller, MJ; Clement, K; Tsankov, AM; Akopian, V; Gifford, CA; Donaghey, J; Galonska, C; Pop, R; Reyon, D; Tsai, SQ; Mallard, W; Joung, JK; Rinn, JL; Gnirke, A; Meissner, A				Liao, Jing; Karnik, Rahul; Gu, Hongcang; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Reyon, Deepak; Tsai, Shengdar Q.; Mallard, William; Joung, J. Keith; Rinn, John L.; Gnirke, Andreas; Meissner, Alexander			Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells	NATURE GENETICS			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; SELF-RENEWAL; HUMAN ES; PLURIPOTENT; EXPRESSION; MAINTENANCE; MUTATIONS; INDUCTION; CPG	DNA methylation is a key epigenetic modification involved in regulating gene expression and maintaining genomic integrity. Here we inactivated all three catalytically active DNA methyltransferases (DNMTs) in human embryonic stem cells (ESCs) using CRISPR/Cas9 genome editing to further investigate the roles and genomic targets of these enzymes. Disruption of DNMT3A or DNMT3B individually as well as of both enzymes in tandem results in viable, pluripotent cell lines with distinct effects on the DNA methylation landscape, as assessed by whole-genome bisulfite sequencing. Surprisingly, in contrast to findings in mouse, deletion of DNMT1 resulted in rapid cell death in human ESCs. To overcome this immediate lethality, we generated a doxycycline-responsive tTA-DNMT1* rescue line and readily obtained homozygous DNMT1-mutant lines. However, doxycycline-mediated repression of exogenous DNMT1* initiates rapid, global loss of DNA methylation, followed by extensive cell death. Our data provide a comprehensive characterization of DNMT-mutant ESCs, including single-base genome-wide maps of the targets of these enzymes.	[Liao, Jing; Karnik, Rahul; Gu, Hongcang; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Mallard, William; Rinn, John L.; Gnirke, Andreas; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Liao, Jing; Karnik, Rahul; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Mallard, William; Rinn, John L.; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA USA; [Liao, Jing; Karnik, Rahul; Ziller, Michael J.; Clement, Kendell; Tsankov, Alexander M.; Akopian, Veronika; Gifford, Casey A.; Donaghey, Julie; Galonska, Christina; Pop, Ramona; Mallard, William; Rinn, John L.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Reyon, Deepak; Tsai, Shengdar Q.; Joung, J. Keith] Massachusetts Gen Hosp, Dept Pathol, Mol Pathol Unit, Charlestown, MA USA		Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu	Tsai, Shengdar Q./G-4600-2012; Clement, Kendell/AAZ-6854-2021	Tsai, Shengdar Q./0000-0001-9161-3993; Galonska, Christina/0000-0002-6920-5608; Gifford, Casey/0000-0002-7757-573X; Karnik, Rahul/0000-0002-0400-635X; Rinn, John/0000-0002-7231-7539; Gu, Hongcang/0000-0002-1439-7606	Human Frontiers Science ProgramHuman Frontier Science Program; US NIH Director's Pioneer Award [DP1 GM105378]; US NIH (National Institute of General Medical Sciences) [P01GM099117]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [DP1GM105378, P01GM099117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA036898] Funding Source: NIH RePORTER	We thank all members of the Meissner laboratory, in particular C. Sindhu for helpful discussion and Z.D. Smith for critical feedback on the manuscript. We thank K. Musunuru (Harvard University) for providing the CRIPSR/Cas9 plasmids and thank Q. Ding from the Musunuru laboratory for technical support. J.L. was supported by a postdoctoral fellowship from the Human Frontiers Science Program. J.K.J. is supported by US NIH Director's Pioneer Award DP1 GM105378. A.M. is a New York Stem Cell Foundation Robertson Investigator. The work was funded by a US NIH (National Institute of General Medical Sciences) grant (P01GM099117) and the New York Stem Cell Foundation.	Barra V, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Giaimo R, 2005, GENE, V351, P73, DOI 10.1016/j.gene.2005.02.015; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gordon CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069486; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Horii T, 2013, INT J MOL SCI, V14, P19774, DOI 10.3390/ijms141019774; Hsiao EC, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt52; Hutnick LK, 2010, J BIOL CHEM, V285, P21082, DOI 10.1074/jbc.M110.125674; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Li L, 2010, BIOPHYS J, V98, P2442, DOI 10.1016/j.bpj.2010.02.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Rao LJ, 2012, STEM CELL REV REP, V8, P1109, DOI 10.1007/s12015-012-9413-4; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Shah MY, 2011, NAT GENET, V43, P289, DOI 10.1038/ng0411-289; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	66	252	263	1	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					469	U64		10.1038/ng.3258			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	WOS:000353635800009	25822089	Green Accepted, Green Submitted			2022-01-24	
J	Reggiori, F; Klionsky, DJ				Reggiori, Fulvio; Klionsky, Daniel J.			Autophagic Processes in Yeast: Mechanism, Machinery and Regulation	GENETICS			English	Article							VACUOLE TARGETING PATHWAY; UNCONVENTIONAL PROTEIN SECRETION; COILED-COIL PROTEIN; ATG1 KINASE COMPLEX; SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; PICHIA-PASTORIS; VESICLE FORMATION; DEGRADATION PATHWAY; CVT PATHWAY	Autophagy refers to a group of processes that involve degradation of cytoplasmic components including cytosol, macromolecular complexes, and organelles, within the vacuole or the lysosome of higher eukaryotes. The various types of autophagy have attracted increasing attention for at least two reasons. First, autophagy provides a compelling example of dynamic rearrangements of subcellular membranes involving issues of protein trafficking and organelle identity, and thus it is fascinating for researchers interested in questions pertinent to basic cell biology. Second, autophagy plays a central role in normal development and cell homeostasis, and, as a result, autophagic dysfunctions are associated with a range of illnesses including cancer, diabetes, myopathies, some types of neurodegeneration, and liver and heart diseases. That said, this review focuses on autophagy in yeast. Many aspects of autophagy are conserved from yeast to human; in particular, this applies to the gene products mediating these pathways as well as some of the signaling cascades regulating it, so that the information we relate is relevant to higher eukaryotes. Indeed, as with many cellular pathways, the initial molecular insights were made possible due to genetic studies in Saccharomyces cerevisiae and other fungi.	[Reggiori, Fulvio] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA		Klionsky, DJ (corresponding author), Univ Michigan, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	klionsky@umich.edu	Reggiori, Fulvio/U-8327-2019	Reggiori, Fulvio/0000-0003-2652-2686	Chemical Science (CW) ECHO [700.59.003]; Earth and Life Sciences (ALW) Open Program [821.02.017]; Deutsche Forschungsgemeinschaft-Netherlands Organization for Scientific Research (NWO) [DN 82-303]; Netherlands Organization for Health Research and Development (ZonMW) VICINetherlands Organization for Health Research and Development [016.130.606]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM053396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM053396] Funding Source: NIH RePORTER	F.R. is supported by Chemical Science (CW) ECHO (700.59.003), Earth and Life Sciences (ALW) Open Program (821.02.017), Deutsche Forschungsgemeinschaft-Netherlands Organization for Scientific Research (NWO) cooperation (DN 82-303), and Netherlands Organization for Health Research and Development (ZonMW) VICI (016.130.606) grants. D.J.K. is supported by National Institutes of Health grant GM053396.	Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; Ano Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1527, DOI 10.1271/bbb.69.1527; Ano Y, 2005, MOL BIOL CELL, V16, P446, DOI 10.1091/mbc.E04-09-0842; Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; Bartholomew CR, 2012, P NATL ACAD SCI USA, V109, P11206, DOI 10.1073/pnas.1200313109; Baskaran S, 2012, MOL CELL, V47, P339, DOI 10.1016/j.molcel.2012.05.027; Baxter BK, 2005, J BIOL CHEM, V280, P39067, DOI 10.1074/jbc.M508064200; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2010, J BIOL CHEM, V285, P23357, DOI 10.1074/jbc.M109.075143; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2003, J BIOL CHEM, V278, P25688, DOI 10.1074/jbc.M210549200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Cao Y, 2008, J CELL BIOL, V182, P703, DOI 10.1083/jcb.200801035; Cao Y, 2009, AUTOPHAGY, V5, P699, DOI 10.4161/auto.5.5.8382; Cebollero E., 2012, INT J CELL BIOL, V2012, P1, DOI DOI 10.1155/2012/182834; Cebollero E, 2012, CURR BIOL, V22, P1545, DOI 10.1016/j.cub.2012.06.029; Chan TF, 2001, J BIOL CHEM, V276, P6463, DOI 10.1074/jbc.M008162200; Chang CY, 2007, MOL BIOL CELL, V18, P919, DOI 10.1091/mbc.E06-08-0683; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cutler NS, 1999, MOL CELL ENDOCRINOL, V155, P135, DOI 10.1016/S0303-7207(99)00121-5; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; Dawaliby R, 2010, MOL BIOL CELL, V21, P4173, DOI 10.1091/mbc.E09-09-0782; Deffieu M, 2009, J BIOL CHEM, V284, P14828, DOI 10.1074/jbc.M109.005181; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dunn WA, 2005, AUTOPHAGY, V1, P75; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Eskelinen EL, 2011, AUTOPHAGY, V7, P935, DOI 10.4161/auto.7.9.15760; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Fujioka Y, 2010, J BIOL CHEM, V285, P1508, DOI 10.1074/jbc.M109.053520; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; He CC, 2008, MOL BIOL CELL, V19, P5506, DOI 10.1091/mbc.E08-05-0544; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; Hoffman M, 1996, GENETICS, V143, P1555; Hong SB, 2011, NAT STRUCT MOL BIOL, V18, P1323, DOI 10.1038/nsmb.2165; Horak J, 2002, J BIOL CHEM, V277, P8248, DOI 10.1074/jbc.M107255200; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Hutchins MU, 1999, J CELL SCI, V112, P4079; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Journo D, 2009, J BIOL CHEM, V284, P35885, DOI 10.1074/jbc.M109.048140; Kabeya Y, 2009, BIOCHEM BIOPH RES CO, V389, P612, DOI 10.1016/j.bbrc.2009.09.034; Kaiser SE, 2012, NAT STRUCT MOL BIOL, V19, P1242, DOI 10.1038/nsmb.2415; Kakuta S, 2012, J BIOL CHEM, V287, P44261, DOI 10.1074/jbc.M112.411454; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Kissova IB, 2009, AUTOPHAGY, V5, P872, DOI 10.4161/auto.9065; Klionsky DJ, 2007, AUTOPHAGY, V3, P413, DOI 10.4161/auto.4377; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Kovacs AL, 2007, AUTOPHAGY, V3, P655, DOI 10.4161/auto.4590; Kraft C, 2008, AUTOPHAGY, V4, P838, DOI 10.4161/auto.6603; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Krick R, 2008, AUTOPHAGY, V4, P896, DOI 10.4161/auto.6801; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Kunz JB, 2004, J BIOL CHEM, V279, P9987, DOI 10.1074/jbc.M307905200; Kvam E, 2005, MOL BIOL CELL, V16, P3987, DOI 10.1091/mbc.E05-04-0290; Kvam E, 2004, J CELL SCI, V117, P4959, DOI 10.1242/jcs.01372; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Lipatova Z, 2012, P NATL ACAD SCI USA, V109, P6981, DOI 10.1073/pnas.1121299109; Liu JJ, 2005, AUTOPHAGY, V1, P146, DOI 10.4161/auto.1.3.2036; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Manjithaya R, 2010, J CELL BIOL, V189, P303, DOI 10.1083/jcb.200909154; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Meiling-Wesse K, 2002, FEBS LETT, V526, P71, DOI 10.1016/S0014-5793(02)03119-8; Mijaljica D, 2012, AUTOPHAGY, V8, P1701, DOI 10.4161/auto.21332; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Monastyrska I, 2005, AUTOPHAGY, V1, P92, DOI 10.4161/auto.1.2.1832; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nair U, 2010, J BIOL CHEM, V285, P11476, DOI 10.1074/jbc.M109.080374; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Nazarko TY, 2007, MOL BIOL CELL, V18, P106, DOI 10.1091/mbc.E06-06-0554; Nazarko VY, 2011, AUTOPHAGY, V7, P375, DOI 10.4161/auto.7.4.14369; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Obara Keisuke, 2011, Int J Cell Biol, V2011, P713435, DOI 10.1155/2011/713435; Oda MN, 1996, J CELL BIOL, V132, P999, DOI 10.1083/jcb.132.6.999; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Oku M, 2003, EMBO J, V22, P3231, DOI 10.1093/emboj/cdg331; Oku M, 2006, AUTOPHAGY, V2, P272, DOI 10.4161/auto.3135; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Polupanov AS, 2011, CELL BIOL INT, V35, P311, DOI 10.1042/CBI20100547; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Reggiori F, 2005, MOL BIOL CELL, V16, P5843, DOI 10.1091/mbc.E05-07-0629; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; Reggiori F, 2006, CURR TOP DEV BIOL, V74, P1, DOI 10.1016/S0070-2153(06)74001-7; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Rieter E., 2013, J CELL SCI IN PRESS; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Sattler T, 2000, J CELL BIOL, V151, P529, DOI 10.1083/jcb.151.3.529; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stasyk OV, 2006, AUTOPHAGY, V2, P30, DOI 10.4161/auto.2226; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Taylor R, 2012, AUTOPHAGY, V8, P1300, DOI 10.4161/auto.20681; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Till A., 2012, INT J CELL BIOL, V2012; TITORENKO VI, 1995, J BACTERIOL, V177, P357, DOI 10.1128/jb.177.2.357-363.1995; Tucker KA, 2003, J BIOL CHEM, V278, P48445, DOI 10.1074/jbc.M309238200; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; TUTTLE DL, 1995, J CELL SCI, V108, P25; Umekawa M, 2012, J BIOL CHEM, V287, P16300, DOI 10.1074/jbc.M112.344952; Uttenweiler Andreas, 2008, V445, P245, DOI 10.1007/978-1-59745-157-4_16; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; van Zutphen T, 2008, AUTOPHAGY, V4, P63, DOI 10.4161/auto.5076; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wang K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371591; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Watanabe Y, 2012, J BIOL CHEM, V287, P31681, DOI 10.1074/jbc.M112.397570; Watanabe Y, 2010, J BIOL CHEM, V285, P30026, DOI 10.1074/jbc.M110.143545; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamaguchi M, 2012, NAT STRUCT MOL BIOL, V19, P1250, DOI 10.1038/nsmb.2451; Yamaguchi M, 2012, STRUCTURE, V20, P1244, DOI 10.1016/j.str.2012.04.018; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yamashita SI, 2006, J CELL BIOL, V173, P709, DOI 10.1083/jcb.200512142; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	211	252	261	0	38	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	1943-2631			GENETICS	Genetics	JUN	2013	194	2					341	361		10.1534/genetics.112.149013			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	156IG	WOS:000319814700005	23733851	Bronze, Green Published			2022-01-24	
J	Antoniou, AC; Wang, XS; Fredericksen, ZS; McGuffog, L; Tarrell, R; Sinilnikova, OM; Healey, S; Morrison, J; Kartsonaki, C; Lesnick, T; Ghoussaini, M; Barrowdale, D; Peock, S; Cook, M; Oliver, C; Frost, D; Eccles, D; Evans, DG; Eeles, R; Izatt, L; Chu, C; Douglas, F; Paterson, J; Stoppa-Lyonnet, D; Houdayer, C; Mazoyer, S; Giraud, S; Lasset, C; Remenieras, A; Caron, O; Hardouin, A; Berthet, P; Hogervorst, FBL; Rookus, MA; Jager, A; van den Ouweland, A; Hoogerbrugge, N; van der Luijt, RB; Meijers-Heijboer, H; Garcia, EBG; Devilee, P; Vreeswijk, MPG; Lubinski, J; Jakubowska, A; Gronwald, J; Huzarski, T; Byrski, T; Gorski, B; Cybulski, C; Spurdle, AB; Holland, H; Goldgar, DE; John, EM; Hopper, JL; Southey, M; Buys, SS; Daly, MB; Terry, MB; Schmutzler, RK; Wappenschmidt, B; Engel, C; Meindl, A; Preisler-Adams, S; Arnold, N; Niederacher, D; Sutter, C; Domchek, SM; Nathanson, KL; Rebbeck, T; Blum, JL; Piedmonte, M; Rodriguez, GC; Wakeley, K; Boggess, JF; Basil, J; Blank, SV; Friedman, E; Kaufman, B; Laitman, Y; Milgrom, R; Andrulis, IL; Glendon, G; Ozcelik, H; Kirchhoff, T; Vijai, J; Gaudet, MM; Altshuler, D; Guiducci, C; Loman, N; Harbst, K; Rantala, J; Ehrencrona, H; Gerdes, AM; Thomassen, M; Sunde, L; Peterlongo, P; Manoukian, S; Bonanni, B; Viel, A; Radice, P; Caldes, T; de la Hoya, M; Singer, CF; Fink-Retter, A; Greene, MH; Mai, PL; Loud, JT; Guidugli, L; Lindor, NM; Hansen, TVO; Nielsen, FC; Blanco, I; Lazaro, C; Garber, J; Ramus, SJ; Gayther, SA; Phelan, C; Narod, S; Szabo, CI; Benitez, J; Osorio, A; Nevanlinna, H; Heikkinen, T; Caligo, MA; Beattie, MS; Hamann, U; Godwin, AK; Montagna, M; Casella, C; Neuhausen, SL; Karlan, BY; Tung, N; Toland, AE; Weitzel, J; Olopade, O; Simard, J; Soucy, P; Rubinstein, WS; Arason, A; Rennert, G; Martin, NG; Montgomery, GW; Chang-Claude, J; Flesch-Janys, D; Brauch, H; Severi, G; Baglietto, L; Cox, A; Cross, SS; Miron, P; Gerty, SM; Tapper, W; Yannoukakos, D; Fountzilas, G; Fasching, PA; Beckmann, MW; Silva, IDS; Peto, J; Lambrechts, D; Paridaens, R; Rudiger, T; Forsti, A; Winqvist, R; Pylkaas, K; Diasio, RB; Lee, AM; Eckel-Passow, J; Vachon, C; Blows, F; Driver, K; Dunning, A; Pharoah, PPD; Offit, K; Pankratz, VS; Hakonarson, H; Chenevix-Trench, G; Easton, DF; Couch, FJ				Antoniou, Antonis C.; Wang, Xianshu; Fredericksen, Zachary S.; McGuffog, Lesley; Tarrell, Robert; Sinilnikova, Olga M.; Healey, Sue; Morrison, Jonathan; Kartsonaki, Christiana; Lesnick, Timothy; Ghoussaini, Maya; Barrowdale, Daniel; Peock, Susan; Cook, Margaret; Oliver, Clare; Frost, Debra; Eccles, Diana; Evans, D. Gareth; Eeles, Ros; Izatt, Louise; Chu, Carol; Douglas, Fiona; Paterson, Joan; Stoppa-Lyonnet, Dominique; Houdayer, Claude; Mazoyer, Sylvie; Giraud, Sophie; Lasset, Christine; Remenieras, Audrey; Caron, Olivier; Hardouin, Agnes; Berthet, Pascaline; Hogervorst, Frans B. L.; Rookus, Matti A.; Jager, Agnes; van den Ouweland, Ans; Hoogerbrugge, Nicoline; van der Luijt, Rob B.; Meijers-Heijboer, Hanne; Garcia, Encarna B. Gomez; Devilee, Peter; Vreeswijk, Maaike P. G.; Lubinski, Jan; Jakubowska, Anna; Gronwald, Jacek; Huzarski, Tomasz; Byrski, Tomasz; Gorski, Bohdan; Cybulski, Cezary; Spurdle, Amanda B.; Holland, Helene; Goldgar, David E.; John, Esther M.; Hopper, John L.; Southey, Melissa; Buys, Saundra S.; Daly, Mary B.; Terry, Mary-Beth; Schmutzler, Rita K.; Wappenschmidt, Barbara; Engel, Christoph; Meindl, Alfons; Preisler-Adams, Sabine; Arnold, Norbert; Niederacher, Dieter; Sutter, Christian; Domchek, Susan M.; Nathanson, Katherine L.; Rebbeck, Timothy; Blum, Joanne L.; Piedmonte, Marion; Rodriguez, Gustavo C.; Wakeley, Katie; Boggess, John F.; Basil, Jack; Blank, Stephanie V.; Friedman, Eitan; Kaufman, Bella; Laitman, Yael; Milgrom, Roni; Andrulis, Irene L.; Glendon, Gord; Ozcelik, Hilmi; Kirchhoff, Tomas; Vijai, Joseph; Gaudet, Mia M.; Altshuler, David; Guiducci, Candace; Loman, Niklas; Harbst, Katja; Rantala, Johanna; Ehrencrona, Hans; Gerdes, Anne-Marie; Thomassen, Mads; Sunde, Lone; Peterlongo, Paolo; Manoukian, Siranoush; Bonanni, Bernardo; Viel, Alessandra; Radice, Paolo; Caldes, Trinidad; de la Hoya, Miguel; Singer, Christian F.; Fink-Retter, Anneliese; Greene, Mark H.; Mai, Phuong L.; Loud, Jennifer T.; Guidugli, Lucia; Lindor, Noralane M.; Hansen, Thomas V. O.; Nielsen, Finn C.; Blanco, Ignacio; Lazaro, Conxi; Garber, Judy; Ramus, Susan J.; Gayther, Simon A.; Phelan, Catherine; Narod, Stephen; Szabo, Csilla I.; Benitez, Javier; Osorio, Ana; Nevanlinna, Heli; Heikkinen, Tuomas; Caligo, Maria A.; Beattie, Mary S.; Hamann, Ute; Godwin, Andrew K.; Montagna, Marco; Casella, Cinzia; Neuhausen, Susan L.; Karlan, Beth Y.; Tung, Nadine; Toland, Amanda E.; Weitzel, Jeffrey; Olopade, Olofunmilayo; Simard, Jacques; Soucy, Penny; Rubinstein, Wendy S.; Arason, Adalgeir; Rennert, Gad; Martin, Nicholas G.; Montgomery, Grant W.; Chang-Claude, Jenny; Flesch-Janys, Dieter; Brauch, Hiltrud; Severi, Gianluca; Baglietto, Laura; Cox, Angela; Cross, Simon S.; Miron, Penelope; Gerty, Sue M.; Tapper, William; Yannoukakos, Drakoulis; Fountzilas, George; Fasching, Peter A.; Beckmann, Matthias W.; Silva, Isabel dos Santos; Peto, Julian; Lambrechts, Diether; Paridaens, Robert; Ruediger, Thomas; Foersti, Asta; Winqvist, Robert; Pylkaes, Katri; Diasio, Robert B.; Lee, Adam M.; Eckel-Passow, Jeanette; Vachon, Celine; Blows, Fiona; Driver, Kristy; Dunning, Alison; Pharoah, Paul P. D.; Offit, Kenneth; Pankratz, V. Shane; Hakonarson, Hakon; Chenevix-Trench, Georgia; Easton, Douglas F.; Couch, Fergus J.		EMBRACE; GEMO Study Collaborators; HEBON; KConFab; SWE-BRCA; MOD SQUAD; GENICA	A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ESTROGEN-RECEPTOR; COMMON VARIANTS; CONFER SUSCEPTIBILITY; OVARIAN-CANCER; NONSENSE; ALLELES; COMPLEX; 2Q35	Germline BRCA1 mutations predispose to breast cancer. To identify genetic modifiers of this risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 mutations who were diagnosed with invasive breast cancer under age 40 and 1,190 BRCA1 carriers without breast cancer diagnosis over age 35. We took forward 96 SNPs for replication in another 5,986 BRCA1 carriers (2,974 individuals with breast cancer and 3,012 unaffected individuals). Five SNPs on 19p13 were associated with breast cancer risk (P-trend = 2.3 x 10(-9) to Ptrend = 3.9 x 10(-7)), two of which showed independent associations (rs8170, hazard ratio (HR) = 1.26, 95% CI 1.17-1.35; rs2363956 HR = 0.84, 95% CI 0.80-0.89). Genotyping these SNPs in 6,800 population-based breast cancer cases and 6,613 controls identified a similar association with estrogen receptor-negative breast cancer (rs2363956 per-allele odds ratio (OR) = 0.83, 95% CI 0.75-0.92, P-trend = 0.0003) and an association with estrogen receptor-positive disease in the opposite direction (OR = 1.07, 95% CI 1.01-1.14, P-trend = 0.016). The five SNPs were also associated with triple-negative breast cancer in a separate study of 2,301 triple-negative cases and 3,949 controls (Ptrend = 1 x 10(-7) to Ptrend = 8 x 10(-5); rs2363956 per-allele OR = 0.80, 95% CI 0.74-0.87, P-trend = 1.1 x 10(-7)).	[Antoniou, Antonis C.; McGuffog, Lesley; Morrison, Jonathan; Kartsonaki, Christiana; Barrowdale, Daniel; Peock, Susan; Cook, Margaret; Oliver, Clare; Frost, Debra; Tung, Nadine; Blows, Fiona; Driver, Kristy; Dunning, Alison; Pharoah, Paul P. D.; Easton, Douglas F.; EMBRACE] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Wang, Xianshu; Guidugli, Lucia; Szabo, Csilla I.; Toland, Amanda E.; Couch, Fergus J.] Dept Lab Med & Pathol, Mayo Clin, Rochester, MN USA; [Fredericksen, Zachary S.; Tarrell, Robert; Lesnick, Timothy; Weitzel, Jeffrey; Eckel-Passow, Jeanette; Vachon, Celine; Pankratz, V. Shane] Dept Hlth Sci Res, Mayo Clin, Rochester, MN USA; [Sinilnikova, Olga M.; Giraud, Sophie; Olopade, Olofunmilayo] Univ Lyon Ctr Leon Berard, Ctr Hosp, Unit Mixte Genet Constitutionnelle Canc Frequents, Lyon, France; [Sinilnikova, Olga M.; Mazoyer, Sylvie; Simard, Jacques] Univ Lyon, Ctr Leon Berard, CNRS, Equipe Labellisee LIGUE 2008, Lyon, France; [Healey, Sue; Ghoussaini, Maya; Spurdle, Amanda B.; Holland, Helene; Simard, Jacques; Chenevix-Trench, Georgia] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Eccles, Diana; Gerty, Sue M.; Tapper, William] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Evans, D. Gareth] Cent Manchester Univ Hosp, Manchester Acad Hlth Sci Ctr, NHSFT, Manchester, Lancs, England; [Eeles, Ros] Inst Canc Res & Royal Marsden NHS Fdn, Oncogenet Team, Sutton, Surrey, England; [Izatt, Louise; Soucy, Penny] Guys & St Thomas NHS Fdn Trust, Clin Genet, London, England; [Chu, Carol] Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Douglas, Fiona] Newcastle Tyne Hosp NHS Trust, Ctr Life, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; Addenbrookes Hosp, Dept Clin Genet, E Anglian Reg Genet Serv, Cambridge, England; [Stoppa-Lyonnet, Dominique; Houdayer, Claude] Univ Paris 05, Inst Curie, INSERM U509, Serv Genet Oncolog, Paris, France; [Lasset, Christine] Univ Lyon 1, CNRS, UMR5558, F-69365 Lyon, France; [Lasset, Christine] Ctr Leon Berard, Unit Prevent & Epidemiol Genet, Lyon, France; [Remenieras, Audrey] Inst Cancerol Gustave Roussy, Dept Genet, Villejuif, France; [Caron, Olivier] Inst Cancerol Gustave Roussy, Dept Med, Consultat Genet, Villejuif, France; [Hardouin, Agnes; Berthet, Pascaline; Miron, Penelope] Ctr Francois Baclesse, F-14021 Caen, France; [GEMO Study Collaborators] Federat Natl Ctr Lutte Contre Canc, Grp Genet & Canc, Canc Genet Network, GEMO Study, Paris, France; [Hogervorst, Frans B. L.] Netherlands Canc Inst, Family Canc Clin, Amsterdam, Netherlands; [Rookus, Matti A.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Jager, Agnes] Erasmus Univ, Med Ctr, Rotterdam Family Canc Clin, Dept Clin Genet, Rotterdam, Netherlands; [van den Ouweland, Ans] Rotterdam Family Canc Clin, Erasmus Univ Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Meijers-Heijboer, Hanne] Vrije Univ Amsterdam, Dept Clin Genet, Amsterdam, Netherlands; [Garcia, Encarna B. Gomez] Maastricht Univ, Med Ctr, Dept Clin Genet, Sch Oncol & Dev Biol, Maastricht, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Vreeswijk, Maaike P. G.] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands; [Lubinski, Jan; Jakubowska, Anna; Gronwald, Jacek; Huzarski, Tomasz; Byrski, Tomasz; Gorski, Bohdan; Cybulski, Cezary] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [KConFab] Peter MacCallum Canc Inst, Kathleen Cuningham Fdn Consortium Res Familial Br, kConFab, Melbourne, Vic 3000, Australia; [Goldgar, David E.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [John, Esther M.] Stanford Univ, Sch Med, Canc Prevent Inst Calif, Stanford, CA USA; [Hopper, John L.; Southey, Melissa] Univ Melbourne, Melbourne, Vic, Australia; [Buys, Saundra S.] Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, Salt Lake City, UT USA; [Daly, Mary B.; Godwin, Andrew K.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Terry, Mary-Beth] Columbia Univ, New York, NY USA; [Schmutzler, Rita K.; Wappenschmidt, Barbara] Univ Cologne, Dept Obstet & Gynaecol, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.; Wappenschmidt, Barbara] Univ Cologne, CIO, Cologne, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Meindl, Alfons] Tech Univ Munich, Dept Obstet & Gynaecol, Div Tumor Genet, Klinikum Rechts Isar, Munich, Germany; [Preisler-Adams, Sabine] Univ Munster, Inst Human Genet, Munster, Germany; [Arnold, Norbert] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Obstet & Gynaecol, Kiel, Germany; [Niederacher, Dieter] Univ Dusseldorf, Univ Hosp Dusseldorf, Div Mol Genet, Dept Obstet & Gynaecol, Dusseldorf, Germany; [Sutter, Christian] Heidelberg Univ, Div Mol Diagnost, Inst Human Genet, Heidelberg, Germany; [Domchek, Susan M.; Nathanson, Katherine L.; Rebbeck, Timothy] Univ Penn, Philadelphia, PA 19104 USA; [Blum, Joanne L.] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA; [Piedmonte, Marion] Roswell Pk Canc Inst, Gynecol Oncol Grp Stat & Data Ctr, Buffalo, NY 14263 USA; [Rodriguez, Gustavo C.] Northshore Univ Hlth Syst, Evanston NW Healthcare, Evanston, IL USA; [Wakeley, Katie] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA; [Boggess, John F.] Univ N Carolina, Chapel Hill, NC USA; [Basil, Jack] St Elizabeth Hosp, Edgewood, KY USA; [Blank, Stephanie V.] NYU, Sch Med, New York, NY USA; [Friedman, Eitan; Laitman, Yael; Milgrom, Roni] Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Tel Hashomer, Israel; [Kaufman, Bella] Inst Oncol, Sheba Med Ctr, Tel Hashomer, Israel; [Andrulis, Irene L.; Glendon, Gord] Ontario Canc Inst, Ontario Canc Genet Network, Toronto, ON M4X 1K9, Canada; [Ozcelik, Hilmi] Samuel Lunenfeld Res Inst, Fred Litwin Ctr Canc Genet, Toronto, ON, Canada; [Andrulis, Irene L.; Offit, Kenneth] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kirchhoff, Tomas; Vijai, Joseph] Mem Hosp, Clin Genet Serv, New York, NY USA; [Kirchhoff, Tomas; Vijai, Joseph] Sloan Kettering Inst, Canc Biol & Genet Program, Mem Sloan Kettering Canc Ctr, New York, NY USA; [Gaudet, Mia M.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Gaudet, Mia M.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, New York, NY USA; [Altshuler, David; Guiducci, Candace] Broad Inst Harvard, Cambridge, MA USA; [Altshuler, David; Guiducci, Candace] MIT, Cambridge, MA 02139 USA; [Loman, Niklas; Harbst, Katja] Lund Univ, Dept Oncol, Lund, Sweden; [Rantala, Johanna] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Ehrencrona, Hans] Uppsala Univ, Dept Genet & Pathol Rudbeck Lab, Uppsala, Sweden; [Gerdes, Anne-Marie] Dept Clin Genet, Copenhagen, Denmark; [Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Sunde, Lone] Aalborg & Aarhus Univ, Dept Clin Genet, Aalborg, Denmark; [Peterlongo, Paolo; Radice, Paolo] Fdn Inst Ricovero Cura Carattere Sci, Unit Genet Susceptibil Canc, Dept Expt Oncol & Mol Med, Ist Nazl Tumori, Milan, Italy; [Peterlongo, Paolo; Radice, Paolo] Fdn Ist Fdn Italiana Ricera Cancro FIRC Oncol Mol, IFOM, Milan, Italy; [Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Dept Prevent & Predict Med, Milan, Italy; [Bonanni, Bernardo; de la Hoya, Miguel] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Viel, Alessandra] Ctr Riferimento Oncol, Div Expt Oncol, IRCCS, I-33081 Aviano, PN, Italy; [Caldes, Trinidad] Hosp Clin San Carlos, Madrid, Spain; [Singer, Christian F.; Fink-Retter, Anneliese] Med Univ Vienna, Dept Obstet Gynecol, Vienna, Austria; [Greene, Mark H.; Mai, Phuong L.; Loud, Jennifer T.] Natl Canc Inst, Div Canc Epidemiol & Genet, Clin Genet Branch, Bethesda, MD USA; [Lindor, Noralane M.] Mayo Clin Rochester, Rochester, MN USA; [Hansen, Thomas V. O.; Nielsen, Finn C.] Copenhagen Univ Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Blanco, Ignacio; Lazaro, Conxi] Gran Via Hosp, Catalan Inst Oncol, Hereditary Canc Program, Barcelona, Spain; [Garber, Judy] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ramus, Susan J.; Gayther, Simon A.] UCL, Dept Gynecol Oncol, EGA, London, England; [Phelan, Catherine] Res Inst, Womens Coll, Toronto, ON, Canada; [Narod, Stephen] H Lee Moffitt Canc Ctr & Res Inst, Dept Epidemiol & Genet, Tampa, FL USA; [Benitez, Javier; Osorio, Ana] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Madrid, Spain; [Nevanlinna, Heli; Heikkinen, Tuomas] Univ Helsinki, Ctr Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Caligo, Maria A.] Univ Pisa, Dept Oncol, Div Surg Mol & Ultrastructural Pathol, Pisa, Italy; [Beattie, Mary S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Beattie, Mary S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Beattie, Mary S.] Univ Calif San Francisco, Canc Risk Program, Helen Diller Family Canc Ctr, San Francisco, CA 94143 USA; [Hamann, Ute; Foersti, Asta] German Canc Res Ctr, Heidelberg, Germany; [Montagna, Marco; Casella, Cinzia] Ist Oncol Veneto IRCCS, Immunol & Mol Oncol Unit, Padua, Italy; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Karlan, Beth Y.] Canc Res Inst, Samuel Oschin Canc Inst, Div Gynecol Oncol, Cedars Sinai Med Ctr, Los Angeles, CA USA; [Karlan, Beth Y.] Univ Calif Los Angeles, Dept Obstet & Gynecol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Tung, Nadine] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Toland, Amanda E.] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Weitzel, Jeffrey] City Hope Canc Ctr, Div Clin Canc Genet, Duarte, CA USA; [Olopade, Olofunmilayo] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Simard, Jacques] Univ Quebec, Ctr Hosp, Canc Genom Lab, Quebec City, PQ, Canada; [Simard, Jacques] Univ Laval, Ctr Rech Ctr Hosp Univ Quebec CHUQ, Quebec City, PQ G1K 7P4, Canada; [Rubinstein, Wendy S.] Northshore Univ Hlth Syst, Evanston, IL USA; [Arason, Adalgeir] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Rennert, Gad] Queensland Inst Med Res, QIMR GWAS Collect, Brisbane, Qld 4006, Australia; [Martin, Nicholas G.; Montgomery, Grant W.] B Rappaport Fac Med Techn, Haifa, Israel; [Martin, Nicholas G.; Montgomery, Grant W.] Carmel Hosp, Dept Commun Med & Epidemiol, Clalit Hlth Serv Natl Canc Control Ctr, Haifa, Israel; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Severi, Gianluca; Baglietto, Laura] Canc Epidemiol Ctr, MCCS, Melbourne, Australia; [Cox, Angela] Univ Sheffield, Dept Oncol, Fac Med Dent & Hlth, Inst Canc Studies, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Fac Med Dent & Hlth, Sheffield, S Yorkshire, England; [Miron, Penelope] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab Inst Radioisotopes & Radiodiagno, Athens, Greece; [Fountzilas, George] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Med Oncol, Thessaloniki, Greece; [Fountzilas, George] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Med Oncol, Thessaloniki, Greece; [Fasching, Peter A.] Calif State Univ Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90032 USA; [Beckmann, Matthias W.] Univers Hosp Erlangen, Dept Gynecol & Obstet, Erlangen, Germany; [Silva, Isabel dos Santos; Peto, Julian] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Cancer Res UK Epidemiol & Genet Grp, London WC1, England; [Lambrechts, Diether] VRC, VIB, Leuven, Belgium; [Paridaens, Robert] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium; [Ruediger, Thomas] Inst Pathol, Stadt Klinikum Karlsruhe, Karlsruhe, Germany; [Foersti, Asta] Lund Univ, Ctr Primary Hlth Care Res, Lund, Sweden; [Winqvist, Robert; Pylkaes, Katri] Univ Oulu, Dept Clin Genet & Biocenter Oulu, Canc Genet Lab, Oulu Univ Hosp, Oulu, Finland; [Diasio, Robert B.; Lee, Adam M.] Mayo Clin, Dept Pharmacol, Rochester, MN USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA		Couch, FJ (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England.	couch.fergus@mayo.edu	Chenevix-Trench, Georgia/AAV-2014-2020; Baglietto, Laura/AAB-9051-2019; Arnold, Norbert/E-3012-2010; Jakubowska, Anna/O-8050-2014; Bonanni, Bernardo/AAM-7928-2020; Blanco, Ignacio/D-2565-2013; Sunde, Lone/H-7402-2013; Fasching, Peter/ABH-9912-2020; Blanco, Ignacio/AAN-5426-2021; de la Hoya, MIguel/Z-2911-2019; Hansen, Thomas v. O./J-9361-2014; Severi, Gianluca/Q-1824-2019; Lambrechts, Diether/AAJ-3167-2020; Montgomery, Grant W/B-7148-2008; Verdrengh, Evelien/H-4571-2012; Spurdle, Amanda B/A-4978-2011; BYRSKI, Tomasz/I-2844-2014; Caligo, Adelaide Maria/K-4289-2018; Ozcelik, Hilmi/A-3952-2011; Joseph, Vijai/J-9158-2013; Gronwald, Jacek/A-4576-2017; Eccles, Diana/K-6327-2019; Ehrencrona, Hans/Q-4621-2019; Fountzilas, George/ABF-2139-2020; Severi, Gianluca/H-3774-2018; Ramus, Susan/AAG-8352-2019; Pharoah, Paul/V-6658-2019; GARCIA, CONXI LAZARO/Q-2410-2016; Toland, Amanda Ewart/E-4202-2011; Mazoyer, Sylvie/N-7559-2017; Viel, Alessandra/J-7116-2018; Peterlongo, Paolo/Q-4717-2018; Tobias, Edward/D-4246-2009; Sunde, Lone/AAG-7303-2019; Fink, Rainer H/C-5333-2008; Andrulis, Irene L./E-7267-2013; manoukian, siranoush/E-7132-2017; Osorio, Ana/I-4324-2014; Hoogerbrugge, Nicoline/O-1016-2013; Huzarski, Tomasz/AAQ-2161-2021; jager, agnes/V-6381-2017; Nielsen, Finn Cilius/AAA-4926-2020; Ehrencrona, Hans/M-5619-2014; montagna, marco/E-2225-2012; Altshuler, David M/A-4476-2009; Radice, Paolo/O-3119-2013	Chenevix-Trench, Georgia/0000-0002-1878-2587; Arnold, Norbert/0000-0003-4523-8808; Jakubowska, Anna/0000-0002-5650-0501; Blanco, Ignacio/0000-0002-7414-7481; Blanco, Ignacio/0000-0002-7414-7481; Hansen, Thomas v. O./0000-0003-4635-2653; Severi, Gianluca/0000-0001-7157-419X; Montgomery, Grant W/0000-0002-4140-8139; Spurdle, Amanda B/0000-0003-1337-7897; BYRSKI, Tomasz/0000-0001-9181-5026; Caligo, Adelaide Maria/0000-0003-0589-1829; Joseph, Vijai/0000-0002-7933-151X; Gronwald, Jacek/0000-0002-3643-2871; Eccles, Diana/0000-0002-9935-3169; Ehrencrona, Hans/0000-0002-5589-3622; Severi, Gianluca/0000-0001-7157-419X; Ramus, Susan/0000-0003-0005-7798; Pharoah, Paul/0000-0001-8494-732X; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Viel, Alessandra/0000-0003-2804-0840; Peterlongo, Paolo/0000-0001-6951-6855; Tobias, Edward/0000-0003-2649-7695; Sunde, Lone/0000-0002-8479-165X; Fink, Rainer H/0000-0002-6896-4266; manoukian, siranoush/0000-0002-6034-7562; Osorio, Ana/0000-0001-8124-3984; Hoogerbrugge, Nicoline/0000-0003-2393-8141; Huzarski, Tomasz/0000-0003-3857-4854; jager, agnes/0000-0002-7713-1450; Ehrencrona, Hans/0000-0002-5589-3622; montagna, marco/0000-0002-4929-2150; Altshuler, David M/0000-0002-7250-4107; Durocher, Francine/0000-0001-8012-4641; Evans, Gareth/0000-0002-8482-5784; Martin, Nicholas/0000-0003-4069-8020; van der Luijt, Rob/0000-0002-0018-1089; Eeles, Rosalind/0000-0002-3698-6241; Baglietto, Laura/0000-0002-8193-7529; de la Hoya, Miguel/0000-0002-8113-1410; Yannoukakos, Drakoulis/0000-0001-7509-3510; Pylkas, Katri/0000-0002-2449-0521; Cox, Angela/0000-0002-5138-1099; Barrowdale, Daniel/0000-0003-1661-3939; Mazoyer, Sylvie/0000-0002-2135-0160; Gerdes, Anne-Marie/0000-0002-0328-3320; dos Santos Silva, Isabel/0000-0002-6596-8798; Nathanson, Katherine/0000-0002-6740-0901; Lubinski, Jan/0000-0003-2931-3003; Tapper, William/0000-0002-5896-1889; Engel, Christoph/0000-0002-7247-282X; Gomez-Garcia, Encarna/0000-0003-4999-8847; Nevanlinna, Heli/0000-0002-0916-2976; Simard, Jacques/0000-0001-6906-3390; Kirchhoff, Tomas/0000-0002-9055-2364; Thorne, Heather/0000-0003-3610-2511; Southey, Melissa/0000-0002-6313-9005; Dunning, Alison Margaret/0000-0001-6651-7166; Brauch, Hiltrud/0000-0001-7531-2736; Radice, Paolo/0000-0001-6298-4111; Lambrechts, Diether/0000-0002-3429-302X; Cross, Simon/0000-0003-2044-1754; Winqvist, Robert/0000-0003-0932-9104; Heikkinen, Tuomas/0000-0003-1154-6204; Houdayer, Claude/0000-0002-5190-0389	Breast Cancer Research Foundation (BCRF); US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA128978]; Cancer Research UKCancer Research UK; Cancer Research UKCancer Research UK [11174, 11022, 10118] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801875] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA089393, U01CA069417, U01CA113916, U01CA069631, U01CA069398, U01CA069638, R01CA074415, P50CA116201, R01CA128978, R01CA122340, RC4CA153828] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000043] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0801875] Funding Source: UKRI	Financial support for this study was provided by the Breast Cancer Research Foundation (BCRF), Susan G. Komen for the Cure and US National Institutes of Health grant CA128978 to F. J. C. and by Cancer Research UK to D. F. E. and A. C. A. A. C. A. is a Cancer Research UK Senior Cancer Research Fellow and D. F. E. is a Cancer Research UK Principal Research Fellow. The authors thank Cancer Genetic Markers of Susceptability (CGEMS) and Wellcome Trust Case Control Consortium (WTCCC) for provision of genotype data from controls. Study specific acknowledgments listed in Supplementary Note.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Antoniou AC, 2009, HUM MOL GENET, V18, P4442, DOI 10.1093/hmg/ddp372; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; BOOS DD, 1992, AM STAT, V46, P327, DOI 10.2307/2685328; Buisson M, 2006, HUM MUTAT, V27, P1024, DOI 10.1002/humu.20384; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Milne RL, 2008, CLIN CANCER RES, V14, P2861, DOI 10.1158/1078-0432.CCR-07-4436; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Simchoni S, 2006, P NATL ACAD SCI USA, V103, P3770, DOI 10.1073/pnas.0511301103; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thompson DJ, 2008, CANCER EPIDEM BIOMAR, V17, P3490, DOI 10.1158/1055-9965.EPI-08-0734; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	32	252	258	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					885	+		10.1038/ng.669			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	WOS:000282276600020	20852631	Green Accepted, Green Published			2022-01-24	
J	Anttila, V; Stefansson, H; Kallela, M; Todt, U; Terwindt, GM; Calafato, MS; Nyholt, DR; Dimas, AS; Freilinger, T; Muller-Myhsok, B; Artto, V; Inouye, M; Alakurtti, K; Kaunisto, MA; Hamalainen, E; de Vries, B; Stam, AH; Weller, CM; Heinze, A; Heinze-Kuhn, K; Goebel, I; Borck, G; Gobel, H; Steinberg, S; Wolf, C; Bjornsson, A; Gudmundsson, G; Kirchmann, M; Hauge, A; Werge, T; Schoenen, J; Eriksson, JG; Hagen, K; Stovner, L; Wichmann, E; Meitinger, T; Alexander, M; Moebus, S; Schreiber, S; Aulchenko, YS; Breteler, MMB; Uitterlinden, AG; Hofman, A; van Duijn, CM; Tikka-Kleemola, P; Vepsalainen; Lucae, S; Tozzi, F; Muglia, P; Barrett, J; Kaprio, J; Farkkila, M; Peltonen, L; Stefansson, K; Zwart, JA; Ferrari, MD; Olesen, J; Daly, M; Wessman, M; van den Maagdenberg, AMJM; Dichgans, M; Kubisch, C; Dermitzakis, ET; Frants, RR; Palotie, A				Anttila, Verneri; Stefansson, Hreinn; Kallela, Mikko; Todt, Unda; Terwindt, Gisela M.; Calafato, M. Stella; Nyholt, Dale R.; Dimas, Antigone S.; Freilinger, Tobias; Mueller-Myhsok, Bertram; Artto, Ville; Inouye, Michael; Alakurtti, Kirsi; Kaunisto, Mari A.; Haemaelaeinen, Eija; de Vries, Boukje; Stam, Anine H.; Weller, Claudia M.; Heinze, Axel; Heinze-Kuhn, Katja; Goebel, Ingrid; Borck, Guntram; Goebel, Hartmut; Steinberg, Stacy; Wolf, Christiane; Bjoernsson, Asgeir; Gudmundsson, Gretar; Kirchmann, Malene; Hauge, Anne; Werge, Thomas; Schoenen, Jean; Eriksson, Johan G.; Hagen, Knut; Stovner, Lars; Wichmann, Erich; Meitinger, Thomas; Alexander, Michael; Moebus, Susanne; Schreiber, Stefan; Aulchenko, Yurii S.; Breteler, Monique M. B.; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.; Tikka-Kleemola, Paevi; Vepsaelaeinen, Salli; Lucae, Susanne; Tozzi, Federica; Muglia, Pierandrea; Barrett, Jeffrey; Kaprio, Jaakko; Faerkkilae, Markus; Peltonen, Leena; Stefansson, Kari; Zwart, John-Anker; Ferrari, Michel D.; Olesen, Jes; Daly, Mark; Wessman, Maija; van den Maagdenberg, Arn M. J. M.; Dichgans, Martin; Kubisch, Christian; Dermitzakis, Emmanouil T.; Frants, Rune R.; Palotie, Aarno		Int Headache Genetics Consortium	Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1	NATURE GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; LYMPHOBLASTOID CELL-LINES; EPISODIC ATAXIA; SPREADING DEPRESSION; GENE-EXPRESSION; CONFERS RISK; GLUTAMATE; MUTATION; INVOLVEMENT; MECHANISMS	Migraine is a common episodic neurological disorder, typically presenting with recurrent attacks of severe headache and autonomic dysfunction. Apart from rare monogenic subtypes, no genetic or molecular markers for migraine have been convincingly established. We identified the minor allele of rs1835740 on chromosome 8q22.1 to be associated with migraine (P = 5.38 x 10(-9), odds ratio = 1.23, 95% CI 1.150-1.324) in a genome-wide association study of 2,731 migraine cases ascertained from three European headache clinics and 10,747 population-matched controls. The association was replicated in 3,202 cases and 40,062 controls for an overall meta-analysis P value of 1.69 x 10(-11) (odds ratio = 1.18, 95% CI 1.127-1.244). rs1835740 is located between MTDH (astrocyte elevated gene 1, also known as AEG-1) and PGCP (encoding plasma glutamate carboxypeptidase). In an expression quantitative trait study in lymphoblastoid cell lines, transcript levels of the MTDH were found to have a significant correlation to rs1835740 (P = 3.96 x 10(-5), permuted threshold for genome-wide significance 7.7 x 10(-5)). To our knowledge, our data establish rs1835740 as the first genetic risk factor for migraine.	[Anttila, Verneri; Inouye, Michael; Alakurtti, Kirsi; Barrett, Jeffrey] Wellcome Trust Sanger Inst, Cambridge, England; [Anttila, Verneri; Alakurtti, Kirsi; Kaunisto, Mari A.; Haemaelaeinen, Eija; Kaprio, Jaakko; Peltonen, Leena; Wessman, Maija; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Stefansson, Hreinn; Steinberg, Stacy; Bjoernsson, Asgeir; Stefansson, Kari] DeCODE genet, Dept Populat Genom, Reykjavik, Iceland; [Kallela, Mikko; Artto, Ville; Vepsaelaeinen, Salli; Faerkkilae, Markus] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Goebel, Ingrid; Borck, Guntram] Univ Cologne, Inst Human Genet, Cologne, Germany; [Todt, Unda; Goebel, Ingrid; Borck, Guntram] Univ Cologne, Inst Genet, D-5000 Cologne, Germany; [Todt, Unda; Goebel, Ingrid; Borck, Guntram] Univ Cologne, Ctr Mol Med Cologne, D-5000 Cologne, Germany; [Terwindt, Gisela M.; Stam, Anine H.; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Calafato, M. Stella] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Cambridge Biomed Res Ctr, Nat Inst Hlth Res, Cambridge, England; [Nyholt, Dale R.] Queensland Inst Med Res, Neurogenet Lab, Brisbane, Qld 4006, Australia; [Dimas, Antigone S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Dimas, Antigone S.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, Geneva, Switzerland; [Freilinger, Tobias] Univ Munich, Dept Neurol, Klinikum Grosshadern, Munich, Germany; [Freilinger, Tobias; Dichgans, Martin] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Mueller-Myhsok, Bertram; Wolf, Christiane; Lucae, Susanne] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Inouye, Michael; de Vries, Boukje; Weller, Claudia M.; van den Maagdenberg, Arn M. J. M.; Frants, Rune R.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Kaunisto, Mari A.] Folkhalsan Res Ctr, Helsinki, Finland; [Heinze, Axel; Heinze-Kuhn, Katja; Goebel, Hartmut] Kiel Pain & Headache Ctr, Kiel, Germany; [Gudmundsson, Gretar] Landspitali Univ Hosp, Dept Neurol, Reykjavik, Iceland; [Kirchmann, Malene; Hauge, Anne; Olesen, Jes] Danish Headache Ctr, Glostrup, Denmark; [Kirchmann, Malene; Hauge, Anne] Glostrup Cty Hosp, Dept Neurol, Glostrup, Denmark; [Werge, Thomas] Univ Copenhagen, Research Inst Biol Psychiat, Roskilde, Denmark; [Schoenen, Jean] Univ Liege, Headache Res Unit, Dept Neurol, B-4000 Liege, Belgium; [Schoenen, Jean] Univ Liege, GIGA, B-4000 Liege, Belgium; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Dept Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.; Kaprio, Jaakko] Nat Inst Hlth & Welf, Helsinki, Finland; [Hagen, Knut; Stovner, Lars; Zwart, John-Anker] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Wichmann, Erich] Inst Epidemiol, Helmholtz Ctr Munich, Neuherberg, Germany; [Wichmann, Erich] Univ Munich, Inst Med Informationsverarbeitung, Munich, Germany; [Meitinger, Thomas] Inst Human Genet, Helmholtz Ctr Munich, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Klinikum Rechts Isar, Munich, Germany; [Alexander, Michael] Univ Bonn, Dept Genom, Life & Brain Ctr, D-5300 Bonn, Germany; [Alexander, Michael] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Schreiber, Stefan] Univ Kiel, Dept Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Dept Internal Med 1, Kiel, Germany; [Aulchenko, Yurii S.; Breteler, Monique M. B.; Hofman, Albert; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Tikka-Kleemola, Paevi] Univ Helsinki, Res Program Mol Med, Helsinki, Finland; [Tozzi, Federica; Muglia, Pierandrea] GlaxoSmithKline Res & Dev Ltd, Verona, Italy; [Muglia, Pierandrea] Univ Toronto, Dept Psychiat, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Peltonen, Leena; Palotie, Aarno] Broad Inst & Harvard, Boston, MA USA; [Zwart, John-Anker] Oslo Univ Hosp & Univ, Dept Neurol, Oslo, Norway; [Kubisch, Christian] Univ Cologne, Cologne Excellence Cluster Cellular Stress Resp, Cologne, Germany; [Kubisch, Christian] Univ Ulm, Inst Human Genet, Ulm, Germany; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Cent Hosp, Dept Med Genet, Helsinki, Finland		Anttila, V (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	verneri.anttila@sanger.ac.uk; aarno.palotie@sanger.ac.uk	Borck, Guntram/F-1868-2015; Stovner, Lars Jacob/D-5025-2014; Meitinger, Thomas/O-1318-2015; Tozzi, Federica/AAP-5462-2021; Breteler, Monique M.B./J-5058-2014; Ferrari, Michel D./ABE-3758-2021; Nyholt, Dale R/J-3174-2017; Daly, Mark J/B-2453-2017; Muller-Myhsok, Bertram/A-3289-2013; Gobel, Hartmut/AAE-4719-2020; Stefansson, Kari/AAE-7187-2019; Kaprio, Jaakko/A-1820-2008; Dermitzakis, Emmanouil/B-7687-2013; Kubisch, Christian/F-1893-2011; Aulchenko, Yurii/M-8270-2013; Werge, Thomas/G-7263-2012; Muglia, Pierandrea/ABD-9235-2020; van den Maagdenberg, Arn M.J.M./AAE-9052-2019	Tozzi, Federica/0000-0002-3536-2920; Breteler, Monique M.B./0000-0002-0626-9305; Ferrari, Michel D./0000-0001-9691-9449; Nyholt, Dale R/0000-0001-7159-3040; Daly, Mark J/0000-0002-0949-8752; Kaprio, Jaakko/0000-0002-3716-2455; Kubisch, Christian/0000-0003-4220-0978; Aulchenko, Yurii/0000-0002-7899-1575; Muglia, Pierandrea/0000-0002-3973-8606; Anttila, Verneri/0000-0002-0073-4675; Palotie, Aarno/0000-0002-2527-5874; Meitinger, Thomas/0000-0002-8838-8403; Stefansson, Hreinn/0000-0002-9331-6666; Eriksson, Johan/0000-0002-2516-2060; Olesen, Jes/0000-0002-6712-2702; Van Duijn, Cornelia/0000-0002-2374-9204; Inouye, Michael/0000-0001-9413-6520; Kaunisto, Mari/0000-0002-6946-9195	Wellcome TrustWellcome TrustEuropean Commission [WT089062]; Academy of FinlandAcademy of FinlandEuropean Commission [200923, 00213]; Helsinki University Central Hospital; Academy of Finland Center of Excellence for Complex Disease GeneticsAcademy of Finland; EuroHead projectEuropean Commission [LSM-CT-2004-504837]; Helsinki Biomedical Graduate School; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Finnish Neurology Foundation; Biomedicum Helsinki Foundation; Cambridge Biomedical Research CentreGeneral Electric; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [339462, 613674]; Australian Research CouncilAustralian Research Council [FT0991022]; German Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01GS08121]; German National Genome Research Network; Center for Molecular Medicine Cologne; Heinz Nixdorf Foundation; Netherlands Organization for the Health Research and DevelopmentNetherlands Organization for Health Research and Development [90700217]; Netherlands Organisation for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [918.56.602]; Spinoza; Center for Medical Systems Biology (CMSB) [050-060-409, 050-060-810, 175.010.2005.011, 911-03-012]; National Center for Research Resources (US)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); Helmholtz Center MunichHelmholtz Association; German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC Health); Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development; Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Ministry for Health, Welfare and Sports; European Commission (DG XII)European CommissionEuropean Commission Joint Research Centre; Municipality of Rotterdam; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)	We wish to thank all individuals in the respective cohorts for their generous participation. This work was supported by the Wellcome Trust (grant number WT089062) and, among others, by the Academy of Finland (200923 to AP, 00213 to M. W.); the Helsinki University Central Hospital (to M. Kallela., M. F., V. Artto and S. V.); the Academy of Finland Center of Excellence for Complex Disease Genetics; the EuroHead project (LSM-CT-2004-504837); the Helsinki Biomedical Graduate School (to V. Anttila, P. T.-K.); the Finnish Cultural Foundation (to V. Anttila); the Finnish Neurology Foundation, Biomedicum Helsinki Foundation (to V. Anttila, P. T.-K. and V. Artto); the Cambridge Biomedical Research Centre (to S. C.); the Australian National Health and Medical Research Council Fellowship (339462 and 613674) and the Australian Research Council Future Fellowship (FT0991022) schemes (to D. R. N.); the German Federal Ministry of Education and Research (BMBF) (grant 01GS08121 to M. Dichgans, along with support to H. E. W. in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus) for the Heinz Nixdorf Recall study, and to C. K. (EMINet -01GS08120) for the National Genome Research Network (Germany; NGFN-1 and NGFN-Plus)); the Center for Molecular Medicine Cologne (to C. K.); the Heinz Nixdorf Foundation for the Heinz Nixdorf Recall study, Deutsche Forschungsgemeinschaft (DFG; to C. K. and H. G.); the Netherlands Organization for the Health Research and Development (ZonMw) no. 90700217 (to G. M. T.) and to the Rotterdam Study (RIDE1 and RIDE2); the Netherlands Organisation for Scientific Research (NWO) VICI (918.56.602) and Spinoza (2009) grants (to M. D. F.); and the Center for Medical Systems Biology (CMSB) established by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO), project no. 050-060-409 (to C. M. v. D., R. R. F., M. D. F. and A. M. J. M. v. d. M.) and project nos. 050-060-810 and 175.010.2005.011, 911-03-012 (to the Rotterdam Study). We thank the Health 2000 study for providing Finnish control genotypes. The Broad Institute Center for Genotyping and Analysis is supported by a grant from the National Center for Research Resources (US). The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria and is supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII) and the Municipality of Rotterdam. We wish to thank S. Hunt, R. Gwillian, P. Whittaker, S. Potter and A. Tashakkori-Ghanbarian, as well as P. Marin-Garcia, for their invaluable help with this study. Finally, we wish to collectively thank everyone who has contributed to the collection, genotyping and analysis of the individual cohorts.	Boycott HE, 2008, GLIA, V56, P998, DOI 10.1002/glia.20673; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; de Vries B, 2009, ARCH NEUROL-CHICAGO, V66, P97, DOI 10.1001/archneurol.2008.535; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Frankel WN, 2009, TRENDS GENET, V25, P361, DOI 10.1016/j.tig.2009.07.001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hanna MG, 2006, NAT CLIN PRACT NEURO, V2, P252, DOI 10.1038/ncpneuro0178; Hindorff LA, CATALOG PUBLISHED GE; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Martin MV, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-62; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Noch E, 2009, CANCER BIOL THER, V8, P1791, DOI 10.4161/cbt.8.19.9762; Nyholt DR, 2008, HUM MOL GENET, V17, P3318, DOI 10.1093/hmg/ddn227; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2006, EUR J NEUROL, V13, P333, DOI 10.1111/j.1468-1331.2006.01184.x; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027	39	252	258	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					869	+		10.1038/ng.652			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	WOS:000282276600017	20802479	Green Accepted			2022-01-24	
J	Potocki, L; Bi, WM; Treadwell-Deering, D; Carvalho, CMB; Eifert, A; Friedman, EM; Glaze, D; Krull, K; Lee, JA; Lewis, RA; Mendoza-Londono, R; Robbins-Furman, P; Shaw, C; Shi, X; Weissenberger, G; Withers, M; Yatsenko, SA; Zackai, EH; Stankiewicz, P; Lupski, JR				Potocki, Lorraine; Bi, Weimin; Treadwell-Deering, Diane; Carvalho, Claudia M. B.; Eifert, Anna; Friedman, Ellen M.; Glaze, Daniel; Krull, Kevin; Lee, Jennifer A.; Lewis, Richard Alan; Mendoza-Londono, Roberto; Robbins-Furman, Patricia; Shaw, Chad; Shi, Xin; Weissenberger, George; Withers, Marjorie; Yatsenko, Svetlana A.; Zackai, Elaine H.; Stankiewicz, Pawel; Lupski, James R.			Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS-SYNDROME; TOOTH DISEASE TYPE-1A; SUPERNUMERARY MARKER CHROMOSOME; PELIZAEUS-MERZBACHER-DISEASE; GENOME ARCHITECTURE; HOMOLOGOUS RECOMBINATION; PROXIMAL 17P; SEGMENTAL DUPLICATIONS; MOLECULAR-MECHANISM; TANDEM DUPLICATION	The duplication 17p11.2 syndrome, associated with dup(17)(p11.2p11.2), is a recently recognized syndrome of multiple congenital anomalies and mental retardation and is the first predicted reciprocal microduplication syndrome described the homologous recombination reciprocal of the Smith-Magenis syndrome (SMS) microdeletion (del(17)(p11.2p11.2)). We previously described seven subjects with dup( 17)( p11.2p11.2) and noted their relatively mild phenotype compared with that of individuals with SMS. Here, we molecularly analyzed 28 additional patients, using multiple independent assays, and also report the phenotypic characteristics obtained from extensive multidisciplinary clinical study of a subset of these patients. Whereas the majority of subjects (22 of 35) harbor the homologous recombination reciprocal product of the common SMS microdeletion (similar to 3.7 Mb), 13 subjects (similar to 37%) have nonrecurrent duplications ranging in size from 1.3 to 15.2 Mb. Molecular studies suggest potential mechanistic differences between nonrecurrent duplications and nonrecurrent genomic deletions. Clinical features observed in patients with the common dup( 17)( p11.2p11.2) are distinct from those seen with SMS and include infantile hypotonia, failure to thrive, mental retardation, autistic features, sleep apnea, and structural cardiovascular anomalies. We narrow the critical region to a 1.3-Mb genomic interval that contains the dosage-sensitive RAI1 gene. Our results refine the critical region for Potocki-Lupski syndrome, provide information to assist in clinical diagnosis and management, and lend further support for the concept that genomic architecture incites genomic instability.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Speech Language & Learning, Houston, TX 77030 USA; Baylor Coll Med, Dept Otolaryngol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Allied Hlth, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Univ Toronto, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5S 1A1, Canada; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA		Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Room 604B,Baylor Plaza 1, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Krull, Kevin R/N-3882-2018; Stankiewicz, Pawel/AAP-7906-2021; Warfield, Simon/B-3352-2009	Krull, Kevin R/0000-0002-0476-7001; Stankiewicz, Pawel/0000-0002-6456-7490; Warfield, Simon/0000-0002-7659-3880; Shaw, Chad/0000-0001-7267-5398; Mendoza-Londono, Roberto/0000-0003-3542-8106	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR000188, M01RR00188] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08 HD01149, P01 HD039420, P01 HD39420, HD2406407] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD001149, P01HD039420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000188] Funding Source: NIH RePORTER		Aldred C, 2004, J CHILD PSYCHOL PSYC, V45, P1420, DOI 10.1111/j.1469-7610.2004.00338.x; Arcos-Burgos M, 2004, AM J HUM GENET, V75, P998, DOI 10.1086/426154; Balarin MAS, 1999, AM J MED GENET, V82, P183, DOI 10.1002/(SICI)1096-8628(19990115)82:2<183::AID-AJMG16>3.0.CO;2-H; Barber G, 2004, CALL CENT MAG, V17, P10; Bartlett CW, 2005, AM J HUM GENET, V76, P688, DOI 10.1086/429345; Bi W, 2006, AM J MED GENET A, V140A, P2454, DOI 10.1002/ajmg.a.31510; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Brown A, 1996, AM J MED GENET, V63, P373, DOI 10.1002/(SICI)1096-8628(19960517)63:2<373::AID-AJMG9>3.0.CO;2-U; CHEN KS, 1995, AM J HUM GENET, V56, P175; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; DOCHERTY Z, 1983, J MED GENET, V20, P138, DOI 10.1136/jmg.20.2.138; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Goldman AM, 2006, J CHILD NEUROL, V21, P93, DOI 10.1177/08830738060210021201; Goldstein DR, 2006, TRANSPL IMMUNOL, V17, P11, DOI 10.1016/j.trim.2006.09.012; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.0.CO;2-1; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; KOZMA C, 1991, AM J MED GENET, V41, P446, DOI 10.1002/ajmg.1320410413; Lee BH, 2006, J HIGH ENERGY PHYS; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Madduri N, 2006, J DEV BEHAV PEDIATR, V27, P188, DOI 10.1097/00004703-200606000-00002; MAGENIS RE, 1986, AM J MED GENET, V24, P415, DOI 10.1002/ajmg.1320240304; MATISE TC, 1994, AM J HUM GENET, V54, P1110; Mendrzyk F, 2006, GENE CHROMOSOME CANC, V45, P401, DOI 10.1002/gcc.20304; Moog U, 2004, GENET COUNSEL, V15, P73; MULLEN E, 1995, MULLEN SCLAES EARLY; Ogdie MN, 2004, AM J HUM GENET, V75, P661, DOI 10.1086/424387; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Potocki L, 2000, J MED GENET, V37, P428, DOI 10.1136/jmg.37.6.428; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Roa BB, 1996, HUM GENET, V97, P642; Sattler, 1986, STANFORDBINET INTELL; Schneider MC, 2000, AM J MED GENET, V94, P296, DOI 10.1002/1096-8628(20001002)94:4<296::AID-AJMG6>3.0.CO;2-B; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Shaw CJ, 2004, J MED GENET, V41, P113, DOI 10.1136/jmg.2003.012831; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Shaw CJ, 2004, HUM GENET, V115, P1, DOI 10.1007/s00439-004-1119-5; Shaw CJ, 2004, AM J MED GENET A, V124A, P173, DOI 10.1002/ajmg.a.20355; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Sparrow S., 1984, VINELAND ADAPTIVE BE; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2001, CLIN GENET, V60, P336, DOI 10.1034/j.1399-0004.2001.600503.x; Stankiewicz P, 2001, GENOME RES, V11, P1205, DOI 10.1101/gr.181101; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TRILOCHAN S, 2006, GENET MED, V8, P719; Vlangos CN, 2005, AM J MED GENET A, V132A, P278, DOI 10.1002/ajmg.a.30461; Walz K, 2004, HUM MOL GENET, V13, P367, DOI 10.1093/hmg/ddh044; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Yatsenko SA, 2005, AM J MED GENET A, V138A, P175, DOI 10.1002/ajmg.a.30948; Zhao Q, 1998, GENOMICS, V49, P394, DOI 10.1006/geno.1998.5285; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	72	252	253	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					633	649		10.1086/512864			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	WOS:000245465200005	17357070	Green Published, Bronze			2022-01-24	
J	Syrris, P; Ward, D; Evans, A; Asimaki, A; Gandjbakhch, E; Sen-Chowdhry, S; McKenna, WJ				Syrris, Petros; Ward, Deirdre; Evans, Alison; Asimaki, Angeliki; Gandjbakhch, Estelle; Sen-Chowdhry, Srijita; McKenna, William J.			Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLAKOPHILIN-2 MUTATIONS; RECESSIVE MUTATION; WOOLLY HAIR; CARDIOMYOPATHY; PLAKOGLOBIN; IDENTIFICATION; DIAGNOSIS; FAMILIES; DELETION; CADHERIN	Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited myocardial disorder associated with arrhythmias, heart failure, and sudden death. To date, mutations in four genes encoding major desmosomal proteins (plakoglobin, desmoplakin, plakophilin-2, and desmoglein-2) have been implicated in the pathogenesis of ARVD/C. We screened 77 probands with ARVD/C for mutations in desmocollin-2 (DSC2), a gene coding for a desmosomal cadherin. Two heterozygous mutations-a deletion and an insertion-were identified in four probands. Both mutations result in frameshifts and premature truncation of the desmocollin-2 protein. For the first time, we have identified mutations in desmocollin-2 in patients with ARVD/C, a finding that is consistent with the hypothesis that ARVD/C is a disease of the desmosome.	UCL Hosp Trust, Heart Hosp, London W1G 8PH, England; UCL, Dept Med, London, England		McKenna, WJ (corresponding author), UCL Hosp Trust, Heart Hosp, 16-18 Westmoreland St, London W1G 8PH, England.	william.mckenna@uclh.org	SYRRIS, PETROS/C-1703-2008; McKenna, William J/C-3243-2008; ASIMAKI, ANGELIKI/J-7140-2016	SYRRIS, PETROS/0000-0002-2363-8758; McKenna, William J/0000-0001-7994-2460; ASIMAKI, ANGELIKI/0000-0001-9886-6870			Alcalai R, 2003, J AM COLL CARDIOL, V42, P319, DOI 10.1016/S0735-1097(03)00628-4; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Bauce B, 2005, EUR HEART J, V26, P1666, DOI 10.1093/eurheartj/ehi341; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Corrado D, 2000, CIRCULATION, V101, pE101, DOI 10.1161/01.CIR.101.11.e101; Corrado D, 2000, HEART, V83, P588, DOI 10.1136/heart.83.5.588; Dalal D, 2006, CIRCULATION, V113, P1641, DOI 10.1161/CIRCULATIONAHA.105.568642; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Greenwood MD, 1997, GENOMICS, V44, P330, DOI 10.1006/geno.1997.4894; Hamid MS, 2002, J AM COLL CARDIOL, V40, P1445, DOI 10.1016/S0735-1097(02)02307-0; Hashimoto T, 1997, J INVEST DERMATOL, V109, P127, DOI 10.1111/1523-1747.ep12319025; Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7; Hunt DM, 2001, EUR J HUM GENET, V9, P197, DOI 10.1038/sj.ejhg.5200605; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Moss C, 2004, J INVEST DERMATOL, V123, P607, DOI 10.1111/j.0022-202X.2004.23311.x; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Norman M, 2005, CIRCULATION, V112, P636, DOI 10.1161/CIRCULATIONAHA.104.532234; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Protonotarios N, 2001, J AM COLL CARDIOL, V38, P1477, DOI 10.1016/S0735-1097(01)01568-6; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; Syrris P, 2006, CIRCULATION, V113, P356, DOI 10.1161/CIRCULATIONAHA.105.561654; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; TROYANOVSKY SM, 1994, P NATL ACAD SCI USA, V91, P10790, DOI 10.1073/pnas.91.23.10790; van Tintelen JP, 2006, CIRCULATION, V113, P1650, DOI 10.1161/CIRCULATIONAHA.105.609719	37	252	258	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					978	984		10.1086/509122			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	WOS:000241667400020	17033975	Green Published, Bronze			2022-01-24	
J	Ioshikhes, IP; Albert, I; Zanton, SJ; Pugh, BF				Ioshikhes, Ilya P.; Albert, Istvan; Zanton, Sara J.; Pugh, B. Franklin			Nucleosome positions predicted through comparative genomics	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MULTIPLE ALIGNMENT; PROMOTER REGIONS; DNA PATTERN; YEAST; IDENTIFICATION; SEQUENCES; GENES; SITES; CORE	DNA sequence has long been recognized as an important contributor to nucleosome positioning, which has the potential to regulate access to genes. The extent to which the nucleosomal architecture at promoters is delineated by the underlying sequence is now being worked out. Here we use comparative genomics to report a genome-wide map of nucleosome positioning sequences (NPSs) located in the vicinity of all Saccharomyces cerevisiae genes. We find that the underlying DNA sequence provides a very good predictor of nucleosome locations that have been experimentally mapped to a small fraction of the genome. Notably, distinct classes of genes possess characteristic arrangements of NPSs that may be important for their regulation. In particular, genes that have a relatively compact NPS arrangement over the promoter region tend to have a TATA box buried in an NPS and tend to be highly regulated by chromatin modifying and remodeling factors.	Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; Penn State Univ, Huck Inst Life Sci, Bioinformat Consulting Ctr, University Pk, PA 16802 USA		Pugh, BF (corresponding author), Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu	Albert, Istvan/J-3734-2015	Albert, Istvan/0000-0001-8366-984X	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM59055, R01 GM059055] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM059055] Funding Source: NIH RePORTER		Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bolshoy A, 1996, COMPUT APPL BIOSCI, V12, P383; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cohanim AB, 2005, J BIOMOL STRUCT DYN, V22, P687, DOI 10.1080/07391102.2005.10507035; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes I, 1999, P NATL ACAD SCI USA, V96, P2891, DOI 10.1073/pnas.96.6.2891; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Widom J, 1996, J MOL BIOL, V259, P579, DOI 10.1006/jmbi.1996.0341; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	21	252	260	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1210	1215		10.1038/ng1878			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	WOS:000241251100023	16964265				2022-01-24	
J	Lalani, SR; Safiullah, AM; Fernbach, SD; Harutyunyan, KG; Thaller, C; Peterson, LE; McPherson, JD; Gibbs, RA; White, LD; Hefner, M; Davenport, SLH; Graham, JM; Bacino, CA; Glass, NL; Towbin, JA; Craigen, WJ; Neish, SR; Lin, AE; Belmont, JW				Lalani, SR; Safiullah, AM; Fernbach, SD; Harutyunyan, KG; Thaller, C; Peterson, LE; McPherson, JD; Gibbs, RA; White, LD; Hefner, M; Davenport, SLH; Graham, JM; Bacino, CA; Glass, NL; Towbin, JA; Craigen, WJ; Neish, SR; Lin, AE; Belmont, JW			Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE ANOMALIES; CHOANAL ATRESIA; HEART-DISEASE; ASSOCIATION; CRITERIA; COMPLEX; METHYLATION; DELETION; CHILD	CHARGE syndrome is a well-established multiple-malformation syndrome with distinctive consensus diagnostic criteria. Characteristic associated anomalies include ocular coloboma, choanal atresia, cranial nerve defects, distinctive external and inner ear abnormalities, hearing loss, cardiovascular malformations, urogenital anomalies, and growth retardation. Recently, mutations of the chromodomain helicase DNA-binding protein gene CHD7 were reported to be a major cause of CHARGE syndrome. We sequenced the CHD7 gene in 110 individuals who had received the clinical diagnosis of CHARGE syndrome, and we detected mutations in 64 ( 58%). Mutations were distributed throughout the coding exons and conserved splice sites of CHD7. Of the 64 mutations, 47 ( 73%) predicted premature truncation of the protein. These included nonsense and frameshift mutations, which most likely lead to haploinsufficiency. Phenotypically, the mutation-positive group was more likely to exhibit cardiovascular malformations ( 54 of 59 in the mutation-positive group vs. 30 of 42 in the mutation-negative group; P = .014), coloboma of the eye ( 55 of 62 in the mutation-positive group vs. 30 of 43 in the mutation-negative group; P = .022) and facial asymmetry, often caused by seventh cranial nerve abnormalities ( 36 of 56 in the mutation-positive group vs. 13 of 39 in the mutation-negative group; P = .004) Mouse embryo whole-mount and section in situ hybridization showed the expression of Chd7 in the outflow tract of the heart, optic vesicle, facioacoustic preganglion complex, brain, olfactory pit, and mandibular component of the first branchial arch. Microarray gene-expression analysis showed a signature pattern of gene-expression differences that distinguished the individuals with CHARGE syndrome with CHD7 mutation from the controls. We conclude that cardiovascular malformations, coloboma, and facial asymmetry are common findings in CHARGE syndrome caused by CHD7 mutation.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; St Louis Univ, Dept Pediat, St Louis, MO 63103 USA; Sensory Genet NeuroDev, Bloomington, MN USA; Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Dept Pediat,Med Genet Inst, Los Angeles, CA USA; Massachusetts Gen Hosp Children, Genet & Teratol Unit, Boston, MA 02114 USA		Belmont, JW (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,T826, Houston, TX 77030 USA.	jbelmont@bcm.tmc.edu	Graham, John M./J-1429-2019; Belmont, John/AAH-6084-2021; Neish, Steven/AAJ-7974-2021; Towbin, Jeffrey A./J-5595-2019; Lalani, Seema/AAI-5090-2020; McPherson, John D/D-2633-2017; Belmont, John W/AAI-2494-2019	Towbin, Jeffrey A./0000-0002-6585-714X; McPherson, John D/0000-0001-8049-9347; Belmont, John W/0000-0001-7409-3578; Peterson, Leif/0000-0002-1187-0883	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD022657, R01HD039056] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD22657, P01 HD022657, R01HD39056, R01 HD039056] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM08243, T32 GM008243] Funding Source: Medline		Amiel J, 2001, AM J MED GENET, V99, P124, DOI 10.1002/1096-8628(20010301)99:2<124::AID-AJMG1114>3.0.CO;2-9; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; BLAKE KD, 1989, INT J CARDIOL, V25, P339, DOI 10.1016/0167-5273(89)90225-8; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; CLEMENTI M, 1991, AM J MED GENET, V41, P246, DOI 10.1002/ajmg.1320410223; De Krijger RR, 1999, PEDIATR DEVEL PATHOL, V2, P577, DOI 10.1007/s100249900165; Devriendt K, 1998, CLIN GENET, V53, P408; Feng Q, 2001, GENE DEV, V15, P827; Graham JM, 2001, AM J MED GENET, V99, P120, DOI 10.1002/1096-8628(2000)9999:999<00::AID-AJMG1132>3.0.CO;2-J; HALL BD, 1979, J PEDIATR-US, V95, P395, DOI 10.1016/S0022-3476(79)80513-2; HITTNER HM, 1979, J PEDIAT OPHTH STRAB, V16, P122; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Issekutz KA, 2005, AM J MED GENET A, V133A, P309, DOI 10.1002/ajmg.a.30560; Kaufman, 1992, ATLAS MOUSE DEV; Lalani SR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-8; Lalani SR, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.017640; Lalani SR, 2003, AM J MED GENET A, V118A, P260, DOI 10.1002/ajmg.a.20002; Lee Wang-Tso, 1995, Journal of the Formosan Medical Association, V94, P60; Lev D, 2000, J MED GENET, V37, P231, DOI 10.1136/jmg.37.3.231; LUBINSKY MS, 1994, AM J MED GENET, V49, P21, DOI 10.1002/ajmg.1320490106; Mitchell J A, 1985, Ophthalmic Paediatr Genet, V6, P271; NORTH KN, 1995, AM J MED GENET, V57, P610, DOI 10.1002/ajmg.1320570419; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Sanlaville D, 2002, CLIN GENET, V61, P135, DOI 10.1034/j.1399-0004.2002.610208.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Studer M, 2001, DEVELOPMENT, V128, P3707; Tellier AL, 1996, CLIN GENET, V50, P548; Tellier AL, 1998, AM J MED GENET, V76, P402, DOI 10.1002/(SICI)1096-8628(19980413)76:5<402::AID-AJMG7>3.0.CO;2-O; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Verloes A, 2005, AM J MED GENET A, V133A, P306, DOI 10.1002/ajmg.a.30559; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wilkinson DG, 1992, IN SITU HYBRIDIZATIO; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	36	252	263	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					303	314		10.1086/500273			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	WOS:000236744900011	16400610	Green Published, Bronze			2022-01-24	
J	Bienengraeber, M; Olson, TM; Selivanov, VA; Kathmann, EC; O'Cochlain, F; Gao, F; Karger, AB; Ballew, JD; Hodgson, DM; Zingman, LV; Pang, YP; Alekseev, AE; Terzic, A				Bienengraeber, M; Olson, TM; Selivanov, VA; Kathmann, EC; O'Cochlain, F; Gao, F; Karger, AB; Ballew, JD; Hodgson, DM; Zingman, LV; Pang, YP; Alekseev, AE; Terzic, A			ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic K-ATP channel gating	NATURE GENETICS			English	Article							SULFONYLUREA RECEPTOR; HEART-FAILURE; KIR6.2; TRAFFICKING; GENE; SUR1	Stress tolerance of the heart requires high-fidelity metabolic sensing by ATP-sensitive potassium (K-ATP) channels that adjust membrane potential dependent functions to match cellular energetic demand. Scanning of genomic DNA from individuals with heart failure and rhythm disturbances due to idiopathic dilated cardiomyopathy identified two mutations in ABCC9, which encodes the regulatory SUR2A subunit of the cardiac K-ATP channel. These missense and frameshift mutations mapped to evolutionarily conserved domains adjacent to the catalytic ATPase pocket within SUR2A. Mutant SUR2A proteins showed aberrant redistribution of conformations in the intrinsic ATP hydrolytic cycle, translating into abnormal K-ATP channel phenotypes with compromised metabolic signal decoding. Defective catalysis-mediated pore regulation is thus a mechanism for channel dysfunction and susceptibility to dilated cardiomyopathy.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Dept Med, Coll Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Pediat Cardiol, Dept Pediat & Adolescent Med, Coll Med, Rochester, MN 55905 USA		Terzic, A (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Dept Med, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	terzic.andre@mayo.edu	Alekseev, Alexey/I-5346-2013	Pang, Yuan-Ping/0000-0003-0838-2560; Olson, Timothy/0000-0003-2716-9423; Selivanov, Vitaly/0000-0002-7937-9249; Karger, Amy/0000-0002-2781-3824; Zingman, Leonid/0000-0002-7566-4616	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL071225-02, R01 HL071225-01, R01 HL071225] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071225] Funding Source: NIH RePORTER		Abraham MR, 2002, J BIOL CHEM, V277, P24427, DOI 10.1074/jbc.M201777200; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chien KR, 2003, NAT MED, V9, P508, DOI 10.1038/nm0503-508; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Hodgson DM, 2003, EMBO J, V22, P1732, DOI 10.1093/emboj/cdg192; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsushita K, 2002, CIRC RES, V90, P554, DOI 10.1161/01.RES.0000012666.42782.30; Nestorowicz A, 1997, DIABETES, V46, P1743, DOI 10.2337/diabetes.46.11.1743; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199; Zingman LV, 2002, J BIOL CHEM, V277, P14206, DOI 10.1074/jbc.M109452200; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	29	252	261	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					382	387		10.1038/ng1329			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	WOS:000220647200022	15034580	Bronze, Green Accepted			2022-01-24	
J	Ensenauer, RE; Adeyinka, A; Flynn, HC; Michels, VV; Lindor, NM; Dawson, DB; Thorland, EC; Lorentz, CP; Goldstein, JL; McDonald, MT; Smith, WE; Simon-Fayard, E; Alexander, AA; Kulharya, AS; Ketterling, RP; Clark, RD; Jalal, SM				Ensenauer, RE; Adeyinka, A; Flynn, HC; Michels, VV; Lindor, NM; Dawson, DB; Thorland, EC; Lorentz, CP; Goldstein, JL; McDonald, MT; Smith, WE; Simon-Fayard, E; Alexander, AA; Kulharya, AS; Ketterling, RP; Clark, RD; Jalal, SM			Microduplication 22q11.2, an emerging syndrome: Clinical, cytogenetic, and molecular analysis of thirteen patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAT-EYE SYNDROME; LOW-COPY REPEATS; CARDIO-FACIAL SYNDROME; INTERSTITIAL DUPLICATION; GENOMIC DISORDERS; DELETION SYNDROME; TANDEM DUPLICATION; CHROMOSOME 22Q11; PROXIMAL 22Q; MECHANISMS	Chromosome 22, particularly band 22q11.2, is predisposed to rearrangements due to misalignments of low-copy repeats (LCRs). DiGeorge/velocardiofacial syndrome (DG/VCFS) is a common disorder resulting from microdeletion within the same band. Although both deletion and duplication are expected to occur in equal proportions as reciprocal events caused by LCR-mediated rearrangements, very few microduplications have been identified. We have identified 13 cases of microduplication 22q11.2, primarily by interphase fluorescence in situ hybridization (FISH). The size of the duplications, determined by FISH probes from bacterial artificial chromosomes and P-1 artificial chromosomes, range from 3-4 Mb to 6 Mb, and the exchange points seem to involve an LCR. Molecular analysis based on 15 short tandem repeats confirmed the size of the duplications and indicated that at least 1 of 15 loci has three alleles present. The patients' phenotypes ranged from mild to severe, sharing a tendency for velopharyngeal insufficiency with DG/VCFS but having other distinctive characteristics, as well. Although the present series of patients was ascertained because of some overlapping features with DG/VCF syndromes, the microduplication of 22q11.2 appears to be a new syndrome.	Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Cytogenet Lab, Rochester, MN 55905 USA; Mayo Clin, Dept Med Genet, Rochester, MN USA; Mayo Clin, Dept Lab Med & Pathol, Mol Genet Lab, Rochester, MN USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Barbara Bush Childrens Hosp, Maine Med Ctr, Div Genet, Portland, ME USA; Loma Linda Univ, Med Ctr, Dept Pediat, Div Neonatol, Loma Linda, CA USA; Loma Linda Univ, Childrens Hosp, Div Genet, Loma Linda, CA 92350 USA; Desert Pediat Inc, Palm Desert, CA USA; Med Coll Georgia, Dept Pediat & Pathol, Augusta, GA 30912 USA		Jalal, SM (corresponding author), Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Cytogenet Lab, Rochester, MN 55905 USA.	sjalal@mayo.edu		Ketterling, Rhett/0000-0001-6479-7897			Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Collins JE, 1997, GENOME RES, V7, P522, DOI 10.1101/gr.7.5.522; CRIFASI PA, 1995, MAYO CLIN PROC, V70, P1148, DOI 10.4065/70.12.1148; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Emanuel B S, 2001, Adv Pediatr, V48, P39; Fujimoto A, 1996, AM J MED GENET, V62, P300, DOI 10.1002/(SICI)1096-8628(19960329)62:3<300::AID-AJMG19>3.0.CO;2-O; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; Hassed SJ, 2002, AM J HUM GENET, V71, P297; Kato T, 2003, GENET MED, V5, P113, DOI 10.1097/01.GIM.0000056828.03164.30; KNOLL JHM, 1995, AM J MED GENET, V55, P221, DOI 10.1002/ajmg.1320550214; Krepischi-Santos ACV, 2003, AM J MED GENET A, V117A, P41, DOI 10.1002/ajmg.a.10634; LINDSAY EA, 1995, AM J MED GENET, V56, P296, DOI 10.1002/ajmg.1320560316; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; Meins M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e62; Papenhausen PR, 2002, AM J HUM GENET, V71, P302; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; PRASHER VP, 1995, J MED GENET, V32, P306, DOI 10.1136/jmg.32.4.306; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; Rosias PPR, 2001, GENET COUNSEL, V12, P273; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaikh TH, 2001, GENET MED, V3, P6, DOI 10.1097/00125817-200101000-00003; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; TAYLOR KM, 1977, AM J MED GENET, V1, P3, DOI 10.1002/ajmg.1320010103; Thomas JA, 2003, AM J MED GENET A, V119A, P111, DOI 10.1002/ajmg.a.10176; Worthington S, 1997, J MED GENET, V34, P79, DOI 10.1136/jmg.34.1.79	31	252	257	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1027	1040		10.1086/378818			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	WOS:000186493400005	14526392	Green Published, Bronze			2022-01-24	
J	Basu, A; Mukherjee, N; Roy, S; Sengupta, S; Banerjee, S; Chakraborty, M; Dey, B; Roy, M; Roy, B; Bhattacharyya, NP; Roychoudhury, S; Majumder, PP				Basu, A; Mukherjee, N; Roy, S; Sengupta, S; Banerjee, S; Chakraborty, M; Dey, B; Roy, M; Roy, B; Bhattacharyya, NP; Roychoudhury, S; Majumder, PP			Ethnic India: A genomic view, with special reference to peopling and structure	GENOME RESEARCH			English	Article							HIGH-RESOLUTION ANALYSIS; Y-CHROMOSOME HAPLOTYPES; MITOCHONDRIAL; POPULATIONS; POLYMORPHISMS; ASIA; AFFINITIES; DIVERSITY; EVOLUTION; MIGRATION	We report a comprehensive statistical analysis of data on 58 DNA markers (mitochondrial [mt], Y-chromosomal, and autosomal) and sequence data of the mtHVSI from a large number of ethnically diverse populations of India. Our results provide genomic evidence that (1) there is an underlying unity of female lineages in India, indicating that the initial number of female settlers may have been small; (2) the tribal and the caste populations are highly differentiated; (3) the Austro-Asiatic tribals are the earliest settlers in India, providing support to one anthropological hypothesis while refuting some others; (4) a major wave of humans entered India through the northeast; (5) the Tibeto-Burman tribals share considerable genetic commonalities with the Austro-Asiatic tribals, supporting the hypothesis that they may have shared a common habitat in southern China, but the two groups of tribals can be differentiated on the basis of Y-chromosomal haplotypes; (6) the Dravidian tribals were possibly widespread throughout India before the arrival of the Indo-European-speaking nomads, but retreated to southern India to avoid dominance; (7) formation of populations by fission that resulted in founder and drift effects have left their imprints on the genetic structures of contemporary populations; (8) the upper castes show closer genetic affinities with Central Asian populations, although those of southern India are more distant than those of northern India; (9) historical gene flow into India has contributed to a considerable obliteration of genetic histories of contemporary populations so that there is at present no clear congruence of genetic and geographical or sociocultural affinities.	Indian Stat Inst, Anthropol & Human Genet Unit, Kolkata 700108, W Bengal, India; Indian Inst Chem Biol, Human Genet & Genom Dept, Kolkata 700032, W Bengal, India; Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata 700009, W Bengal, India		Majumder, PP (corresponding author), Indian Stat Inst, Anthropol & Human Genet Unit, Kolkata 700108, W Bengal, India.	ppm@isical.ac.in	Roychoudhury, Susanta/AAD-7946-2021; Sengupta, Sanghamitra/AAW-4300-2021				Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beteille A., 1998, INDIAN HUMAN HERITAG, P87; Bhattacharyya NP, 1999, GENOME RES, V9, P711; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cann RL, 2001, SCIENCE, V291, P1742, DOI 10.1126/science.1058948; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Diamond J., 1997, GUNS GERMS STEEL FAT; Ellis N, 2002, GENOME RES, V12, P339; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Grimes Barbara., 1999, ETHNOLOGUE LANGUAGES, V13th; GUHA B, 1935, CENSUS INDIA 1931 3; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; JORDE LB, 1995, AM J HUM GENET, V57, P523; KARVE I, 1961, HINDU SOC INTEREPRET; Keith A., 1936, MAN, V29, P37; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kosambi DD., 1991, CULTURE CIVILISATION; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; MAJUMDAR P, 2000, HAPLOFREQ COMPUTER P; Majumder P. P., 1999, MOL INTERVENTION DIS, P75; Majumder PP, 1999, EUR J HUM GENET, V7, P435, DOI 10.1038/sj.ejhg.5200317; Majumder PP, 1998, EVOL ANTHROPOL, V6, P100, DOI 10.1002/(SICI)1520-6505(1998)6:3<100::AID-EVAN4>3.0.CO;2-I; Meenakshi K., 1995, RECENT PERSPECTIVES, P53; MISRA VN, 1992, MAN ENV, V14, P17; Mukherjee N, 2001, J GENET, V80, P125, DOI 10.1007/BF02717908; Nebel A, 2000, HUM GENET, V107, P630, DOI 10.1007/s004390000426; Nei M., 1987, MOL EVOLUTIONARY GEN; PATTANAYAK DP, 1998, INDIAN HUMAN HERITAG; Pritchard JK, 2000, GENETICS, V155, P945; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; RATNAGAR S, 1995, RECENT PERSPECTIVES, P1; Ray N., 1973, NATL INDIA; RENFREW C, 1992, MAN, V27, P445, DOI 10.2307/2803924; Risley H. H., 1915, PEOPLE INDIA; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar SS, 1958, CULTURAL HERITAGE IN, VI, P17; Schneider S., 2000, ARLEQUIN SOFTWARE PO; Singh KS., 1992, PEOPLE INDIA INTRO; SLATKIN M, 1991, GENETICS, V129, P555; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; THAPAR R, 1995, RECENT PERSPECTIVES, P80; THAPAR R, 2003, EARLY INDIA ORIGINS; Thapar Romila, 1966, HIST INDIA, V1; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Tishkoff SA, 1996, HUM GENET, V97, P759; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096	60	252	260	0	18	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2003	13	10					2277	2290		10.1101/gr.1413403			14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	731GR	WOS:000185876400010	14525929	Green Published, Bronze			2022-01-24	
J	Elkon, R; Linhart, C; Sharan, R; Shamir, R; Shiloh, Y				Elkon, R; Linhart, C; Sharan, R; Shamir, R; Shiloh, Y			Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells	GENOME RESEARCH			English	Article							ELEMENT-BINDING PROTEIN; NF-Y; GENE-EXPRESSION; RETINOBLASTOMA PROTEIN; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; CANCER-CELLS; PROMOTER; E2F; SP1	Dissection of regulatory networks that control gene transcription is one of the greatest challenges of functional genomics. Using human genomic sequences, models for binding sites of known transcription factors, and gene expression data, we demonstrate that the reverse engineering approach, which infers regulatory mechanisms from gene expression patterns, can reveal transcriptional networks in human cells. To date, such methodologies were successfully demonstrated only in prokaryotes and low eukaryotes. We developed computational methods for identifying putative binding sites of transcription factors and for evaluating the statistical significance of their prevalence in a given set of promoters. Focusing on transcriptional mechanisms that control cell cycle progression, our computational analyses revealed eight transcription factors whose binding sites are significantly overrepresented in promoters of genes whose expression is cell-cycle-dependent. The enrichment of some of these factors is specific to certain phases of the cell cycle. In addition, several pairs of these transcription factors show a significant co-occurrence rate in cell-cycle-regulated promoters. Each such pair indicates functional cooperation between its members in regulating the transcriptional program associated with cell cycle progression. The methods presented here are general and can be applied to the analysis of transcriptional networks controlling any biological process.	Tel Aviv Univ, David & Inez Myers Lab Genet Res, Dept Human Genet & Mol Med, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; Int Comp Sci Inst, Berkeley, CA 94704 USA		Shiloh, Y (corresponding author), Tel Aviv Univ, David & Inez Myers Lab Genet Res, Dept Human Genet & Mol Med, Sackler Sch Med, IL-69978 Tel Aviv, Israel.		Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870			Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Chang YC, 2001, MOL CELL BIOL, V21, P1121, DOI 10.1128/MCB.21.4.1121-1131.2001; Cram EJ, 2001, J BIOL CHEM, V276, P22332, DOI 10.1074/jbc.M010539200; Crowe DL, 2000, ANTICANCER RES, V20, P2945; de Borja PF, 2001, EMBO J, V20, P5737; Djaborkhel R, 2000, EXP CELL RES, V261, P250, DOI 10.1006/excr.2000.5047; Elferink CJ, 2001, MOL PHARMACOL, V59, P664, DOI 10.1124/mol.59.4.664; Eto I, 2000, CELL PROLIFERAT, V33, P167, DOI 10.1046/j.1365-2184.2000.00176.x; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Frech K, 1998, In Silico Biol, V1, P29; Halfon MS, 2002, GENOME RES, V12, P1019, DOI 10.1101/gr.228902; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Huang D, 2001, NUCLEIC ACIDS RES, V29, P2810, DOI 10.1093/nar/29.13.2810; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Johansson E, 1998, J BIOL CHEM, V273, P29816, DOI 10.1074/jbc.273.45.29816; Jung MS, 2001, ONCOGENE, V20, P5818, DOI 10.1038/sj.onc.1204748; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Lander ES, 2000, SCIENCE, V287, P1777, DOI 10.1126/science.287.5459.1777; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Martino A, 2001, J IMMUNOL, V166, P1723, DOI 10.4049/jimmunol.166.3.1723; Matuoka K, 1999, EXP CELL RES, V253, P365, DOI 10.1006/excr.1999.4605; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nishikawa NS, 2001, GENES CELLS, V6, P57, DOI 10.1046/j.1365-2443.2001.00395.x; Parisi T, 2002, BIOCHEM BIOPH RES CO, V291, P1138, DOI 10.1006/bbrc.2002.6591; Paskind M, 2000, MAMM GENOME, V11, P1063, DOI 10.1007/s003350010199; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Praz V, 2002, NUCLEIC ACIDS RES, V30, P322, DOI 10.1093/nar/30.1.322; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Recio JA, 2002, ONCOGENE, V21, P1000, DOI 10.1038/sj.onc.1205150; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Saeki K, 1999, BIOCHEM J, V338, P49, DOI 10.1042/0264-6021:3380049; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; vanGinkel PR, 1997, J BIOL CHEM, V272, P18367, DOI 10.1074/jbc.272.29.18367; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu F, 2001, J BIOL CHEM, V276, P28, DOI 10.1074/jbc.M006074200; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677	51	252	259	0	7	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	WOODBURY	500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA	1088-9051			GENOME RES	Genome Res.	MAY	2003	13	5					773	780		10.1101/gr.947203			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	674PQ	WOS:000182645500003	12727897	Green Published, Bronze			2022-01-24	
J	Bennett, CB; Lewis, LK; Karthikeyan, G; Lobachev, KS; Jin, YH; Sterling, JF; Snipe, JR; Resnick, MA				Bennett, CB; Lewis, LK; Karthikeyan, G; Lobachev, KS; Jin, YH; Sterling, JF; Snipe, JR; Resnick, MA			Genes required for ionizing radiation resistance in yeast	NATURE GENETICS			English	Article							PUTATIVE RNA HELICASE; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; CELL-CYCLE; REPAIR; EXPRESSION; PROTEIN; CHECKPOINT; END; RECOMBINATION	The ability of Saccharomyces cerevisiae to tolerate ionizing radiation damage requires many DNA-repair and checkpoint genes, most having human orthologs. A genome-wide screen of diploid mutants homozygous with respect to deletions of 3,670 nonessential genes revealed 107 new loci that influence gamma -ray sensitivity. Many affect replication, recombination and checkpoint functions. Nearly 90% were sensitive to other agents, and most new genes could be assigned to the following functional groups: chromatin remodeling, chromosome segregation, nuclear pore formation, transcription, Golgi/vacuolar activities, ubiquitin-mediated protein degradation, cytokinesis, mitochondrial activity and cell wall maintenance. Over 50% share homology with human genes, including 17 implicated in cancer, indicating that a large set of newly identified human genes may have related roles in the toleration of radiation damage.	NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA		Resnick, MA (corresponding author), NIEHS, Mol Genet Lab, POB 12233, Res Triangle Pk, NC 27709 USA.		resnick, Michael/F-1668-2019	resnick, Michael/0000-0002-8473-7506	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01ES021091] Funding Source: NIH RePORTER		AGUILERA A, 1988, GENETICS, V119, P779; Alper T, 1977, Adv Exp Med Biol, V84, P139; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Bartsch S, 2000, MOL CELL BIOL, V20, P1194, DOI 10.1128/MCB.20.4.1194-1205.2000; BENNETT CB, 1989, RADIAT RES, V120, P102, DOI 10.2307/3577637; Bennett CB, 2001, MOL CELL BIOL, V21, P5359, DOI 10.1128/MCB.21.16.5359-5373.2001; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; COSS RA, 1981, RADIAT RES, V85, P99, DOI 10.2307/3575441; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Fasullo M, 1998, MOL CELL BIOL, V18, P1190, DOI 10.1128/MCB.18.3.1190; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Game JC, 2000, MUTAT RES-FUND MOL M, V451, P277, DOI 10.1016/S0027-5107(00)00055-5; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Hata H, 1998, GENETICS, V148, P571; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; HEUDE M, 1993, GENETICS, V133, P489; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Kerscher O, 2001, GENETICS, V157, P1543; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; LOVETT ST, 1987, GENETICS, V116, P547; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; MOORE CW, 1982, CANCER RES, V42, P929; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nakao K, 2000, INTERNAL MED, V39, P412, DOI 10.2169/internalmedicine.39.412; Negritto MC, 2001, MOL CELL BIOL, V21, P2349, DOI 10.1128/MCB.21.7.2349-2358.2001; Paglin S, 2001, CANCER RES, V61, P439; Perkins EL, 1999, P NATL ACAD SCI USA, V96, P2204, DOI 10.1073/pnas.96.5.2204; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537, DOI 10.1128/MCB.11.9.4537; Resnick MA, 2000, MUTAT RES-FUND MOL M, V451, P1, DOI 10.1016/S0027-5107(00)00036-1; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; THOMAS JH, 1985, GENETICS, V111, P715; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XQ, 1996, NUCLEIC ACIDS RES, V24, P4791, DOI 10.1093/nar/24.23.4791; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WELCH MD, 1994, MOL BIOL CELL, V5, P617, DOI 10.1091/mbc.5.6.617; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu Z, 1999, ENVIRON MOL MUTAGEN, V33, P3, DOI 10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L	50	252	259	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					426	434		10.1038/ng778			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	WOS:000172507500018	11726929				2022-01-24	
J	Broughton, RE; Milam, JE; Roe, BA				Broughton, RE; Milam, JE; Roe, BA			The complete sequence of the zebrafish (Danio rerio) mitochondrial genome and evolutionary patterns in vertebrate mitochondrial DNA	GENOME RESEARCH			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GENE ORDER; REPLICATION; MUTATIONS; NUCLEAR; RNA; ACCUMULATION; ORGANIZATION; POLYMORPHISM; ACCURACY	We describe the complete sequence of the 16,596-nucleotide mitochondrial genome of the zebrafish (Danio rerio); contained are 13 protein genes, 22 tRNAs, 2 rRNAs, and a noncoding control region. Codon usage in protein genes is generally biased toward the available tRNA species but also reflects strand-specific nucleotide frequencies. For 19 of the 20 amino acids, the most frequently used codon ends in either A or C, with A preferred over C for fourfold degenerate codons (the lone exception was AUG: methionine). We show that rates of sequence evolution vary nearly as much within vertebrate classes as between them, yet nucleotide and amino acid composition show directional evolutionary trends, including marked differences between mammals and all other taxa. Birds showed similar compositional characteristics to the other nonmammalian taxa, indicating that the evolutionary trend in mammals is not solely due to metabolic rate and thermoregulatory factors. Complete mitochondrial genomes provide a large character base for phylogenetic analysis and may provide for robust estimates of phylogeny. Phylogenetic analysis of zebrafish and 35 other taxa based oil all protein-coding genes produced trees largely, but not completely, consistent with conventional views of vertebrate evolution. It appears that even with such a large number of nucleotide characters (11,592), limited taxon sampling can lead to problems associated with extensive evolution on long phyletic branches.	Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA		Broughton, RE (corresponding author), Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA.	rbroughton@ou.edu					Babcock CS, 1996, GENETICS, V144, P839; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; BROUGHTON RE, 1994, GENETICS, V138, P179; Brown WM, 1985, MOL EVOLUTIONARY GEN, P95; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DETRICH HW, 1998, ZEBRAFISH BIOL; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; FORAN DR, 1988, NUCLEIC ACIDS RES, V16, P5841, DOI 10.1093/nar/16.13.5841; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Janke A, 1997, MOL BIOL EVOL, V14, P1266, DOI 10.1093/oxfordjournals.molbev.a025736; Kumazawa Y, 1998, GENETICS, V150, P313; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Lynch M, 1997, MOL BIOL EVOL, V14, P914, DOI 10.1093/oxfordjournals.molbev.a025834; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Mindell DP, 1998, P NATL ACAD SCI USA, V95, P10693, DOI 10.1073/pnas.95.18.10693; MITOMAP, 2000, HUM MIT GEN DAT; Murakami M, 1998, ZOOL SCI, V15, P335, DOI 10.2108/zsj.15.335; Naylor GJP, 1998, SYST BIOL, V47, P61, DOI 10.1080/106351598261030; NAYLOR GJP, 1995, NATURE, V373, P565, DOI 10.1038/373565b0; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Penny D, 1999, SYST BIOL, V48, P76, DOI 10.1080/106351599260454; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Rasmussen AS, 1999, J MOL EVOL, V48, P118, DOI 10.1007/PL00006439; ROE BA, 1985, J BIOL CHEM, V260, P9759; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; STEEL M, 1994, APPL MATH LETT, V7, P19, DOI 10.1016/0893-9659(94)90024-8; SULLIVAN J, 1995, MOL BIOL EVOL, V12, P988; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Swofford David L., 1996, P407; TAJIMA F, 1993, GENETICS, V135, P599; Waddell PJ, 1999, SYST BIOL, V48, P119; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0; Xia X, 2000, DATA ANAL MOL BIOL E; Xia XH, 1996, GENETICS, V144, P1309; Zardoya R, 1997, GENETICS, V146, P995; Zardoya R, 1998, P NATL ACAD SCI USA, V95, P14226, DOI 10.1073/pnas.95.24.14226; [No title captured]; [No title captured]	58	252	308	3	24	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2001	11	11					1958	1967		10.1101/gr.156801			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	491QZ	WOS:000172121300021	11691861	Green Published, Bronze			2022-01-24	
J	Ali, RR; Sarra, GM; Stephens, C; de Alwis, M; Bainbridge, JWB; Munro, PM; Fauser, S; Reichell, MB; Kinnon, C; Hunt, DM; Bhattacharya, SS; Thrasher, AJ				Ali, RR; Sarra, GM; Stephens, C; de Alwis, M; Bainbridge, JWB; Munro, PM; Fauser, S; Reichell, MB; Kinnon, C; Hunt, DM; Bhattacharya, SS; Thrasher, AJ			Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy	NATURE GENETICS			English	Article							RDS MUTANT MICE; RETINITIS-PIGMENTOSA; RESCUE; MOUSE; AMPLICONS; VECTOR; ROM-1; DEATH	The gene Prph2 encodes a photoreceptor-specific membrane glycoprotein(1), peripherin-2 (also known as peripherin/rds), which is inserted into the rims of photoreceptor outer segment discs in a complex with rom-1 (ref. 2). The complex is necessary for the stabilization of the discs, which are renewed constantly throughout life, and which contain the visual pigments necessary for photon capture(3). Mutations in Prph2 have been shown to result in a variety of photoreceptor dystrophies, including autosomal dominant retinitis pigmentosa and macular dystrophy(4). A common feature of these diseases is the loss of photoreceptor function, also seen in the retinal degeneration slow (rds or prph2(Rd2/Rd2)) mouse, which is homozygous for a null mutation in Prph2. It is characterized by a complete failure to develop photoreceptor discs and outer segments(5), downregulation of rhodopsin(6,7) and apoptotic loss of photoreceptor cells(8,9). The electroretinograms (ERGs) of Prph2(Rd2/Rd2) mice have greatly diminished a-wave and b-wave amplitudes, which decline to virtually undetectable concentrations by two months(10). Subretinal injection of recombinant adeno-associated virus (AAV) encoding a Prph2 transgene results in stable generation of outer segment structures and formation of new stacks of discs containing both perpherin-2 and rhodopsin, which in many cases are morphologically similar to normal outer segments. Moreover, the re-establishment of the structural integrity of the photoreceptor layer also results in electrophysiological correction. These studies demonstrate for the first time that a complex ultrastructural cell defect can be corrected both morphologically and functionally by in vivo gene transfer.	UCL, Inst Ophthalmol, Dept Mol Genet, London, England; UCL, Inst Child Hlth, Mol Immunol Unit, London, England; Univ Tubingen, Hosp Eye, Tubingen, Germany; Univ Leipzig, Hosp Eye, D-7010 Leipzig, Germany		Ali, RR (corresponding author), UCL, Inst Ophthalmol, Dept Mol Genet, Mortimer St, London, England.	r.ali@ucl.ac.uk	Bhattacharya, Shom/N-2926-2016; Hunt, David M/K-6024-2012; Kinnon, Christine/A-1585-2010	Bhattacharya, Shom/0000-0002-1601-6344; Hunt, David M/0000-0002-9264-3948; Bainbridge, James/0000-0003-1318-8201; Ali, Robin/0000-0003-3126-6517			Ali RR, 1996, HUM MOL GENET, V5, P591, DOI 10.1093/hmg/5.5.591; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; Boursnell MEG, 1997, J INFECT DIS, V175, P16, DOI 10.1093/infdis/175.1.16; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Gregory-Evans K, 1998, TRENDS GENET, V14, P103, DOI 10.1016/S0168-9525(98)01402-4; HILLENKAMP F, 1975, APPL PHYS, V8, P341, DOI 10.1007/BF00898368; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; MOLDAY RS, 1994, PROG RETIN EYE RES, V13, P271, DOI 10.1016/1350-9462(94)90013-2; NIR I, 1990, EXP EYE RES, V51, P257, DOI 10.1016/0014-4835(90)90022-M; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SHALKEN JJ, 1985, BIOCHIM BIOPHYS ACTA, V839, P122; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; Zhang XL, 1999, HUM GENE THER, V10, P2527, DOI 10.1089/10430349950016861; Zhang XL, 1998, J GEN VIROL, V79, P125, DOI 10.1099/0022-1317-79-1-125	18	252	257	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					306	310		10.1038/77068			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	WOS:000087920900019	10888879				2022-01-24	
J	Hamblin, MT; Di Rienzo, A				Hamblin, MT; Di Rienzo, A			Detection of the signature of natural selection in humans: Evidence from the Duffy blood group locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA POLYMORPHISM; NEGATIVE INDIVIDUALS; MOLECULAR EVOLUTION; POSITIVE SELECTION; STATISTICAL TESTS; MITOCHONDRIAL-DNA; GENE; POPULATIONS; MALARIA; RECOMBINATION	The Duffy blood group locus, which encodes a chemokine receptor, is characterized by three alleles-FY*A, FY*B, and FY*O. The frequency of the FY*O allele, which corresponds to the absence of Fy antigen on red blood cells, is at or near fixation in most sub-Saharan African populations but is very rare outside Africa. The F-ST value for the FY*O allele is the highest observed for any allele in humans, providing strong evidence for the action of natural selection at this locus. Homozygosity for the FY*O allele confers complete resistance to vivax malaria, suggesting that this allele has been the target of selection by Plasmodium vivax or some other infectious agent. To characterize the signature of directional selection at this locus, we surveyed DNA sequence variation, both in a 1.9-kb region centered on the FY*O mutation site and in a 1-kb region 5-6 kb away from it, in 17 Italians and in a total of 24 individuals from five sub-Saharan African populations. The level of variation across both regions is two- to threefold lower in the Africans than in the Italians. As a result, the pooled African sample shows a significant departure from the neutral expectation for the number of segregating sites, whereas the Italian sample does not. The FY*O allele occurs on two major haplotypes in three of the five African populations. This finding could be due to recombination, recurrent mutation, population structure, and/or mutation accumulation and drift. Although we are unable to distinguish among these alternative hypotheses, it is likely that the two major haplotypes originated prior to selection on the FY*O mutation.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA		Di Rienzo, A (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	dirienzo@genetics.uchicago.edu			NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG02098-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002098] Funding Source: NIH RePORTER		Aguade M, 1998, GENETICS, V150, P1079; BAILEY WJ, 1991, MOL BIOL EVOL, V8, P155; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; COLUZZI M, 1996, 23 SEM EV BIOL GRAND, P263; FU YX, 1993, GENETICS, V133, P693; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Harinasuta T., 1988, Malaria: principles and practice of malariology. Volume 1., P709; Hill AVS, 1999, EVOLUTION IN HEALTH AND DISEASE, P50; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1987, GENETICS, V116, P153; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Karn RC, 1999, MOL BIOL EVOL, V16, P1192, DOI 10.1093/oxfordjournals.molbev.a026209; Kimura M., 1983, NEUTRAL THEORY MOL E; KREITMAN M, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P204; LIVINGSTONE FB, 1984, HUM BIOL, V56, P413; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Metz EC, 1998, P NATL ACAD SCI USA, V95, P10676, DOI 10.1073/pnas.95.18.10676; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Nachman MW, 1998, GENETICS, V150, P1133; Olsson ML, 1998, BRIT J HAEMATOL, V103, P1184, DOI 10.1046/j.1365-2141.1998.01083.x; Pease JE, 1998, SEMIN IMMUNOL, V10, P169, DOI 10.1006/smim.1998.0129; PRZEWORSKI M, IN PRESS TRENDS GENE; Rozas J, 1997, COMPUT APPL BIOSCI, V13, P307; SIMONSEN KL, 1995, GENETICS, V141, P413; SLATKIN M, 1991, GENETICS, V129, P555; Slatkin M, 1998, GENET RES, V71, P155, DOI 10.1017/S001667239800319X; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Tsaur SC, 1998, MOL BIOL EVOL, V15, P1040, DOI 10.1093/oxfordjournals.molbev.a026002; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Williams TN, 1996, NATURE, V383, P522, DOI 10.1038/383522a0	40	252	260	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1669	1679		10.1086/302879			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	WOS:000088373700020	10762551	Green Published, Bronze			2022-01-24	
J	Kuokkanen, S; Gschwend, M; Rioux, JD; Daly, MJ; Terwilliger, JD; Tienari, PJ; Wikstrom, J; Palo, J; Stein, LD; Hudson, TJ; Lander, ES; Peltonen, L				Kuokkanen, S; Gschwend, M; Rioux, JD; Daly, MJ; Terwilliger, JD; Tienari, PJ; Wikstrom, J; Palo, J; Stein, LD; Hudson, TJ; Lander, ES; Peltonen, L			Genomewide scan of multiple sclerosis in Finnish multiplex families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASIC-PROTEIN GENE; BETA-CHAIN GENES; LINKAGE ANALYSIS; SUSCEPTIBILITY LOCUS; GUIDELINES; FINLAND; COMPLEX; HLA	Multiple sclerosis (MS) is a neurological, demyelinating disorder with a putative autoimmune etiology. It is thought to be a multifactorial disease with a complex mode of inheritance. Here we report the results of a two-stage genomewide scan for loci predisposing to MS. The first stage of the screen, with a low-resolution map, was performed in a selection of 16 pedigrees collected from an isolated Finnish population. Multipoint, nonparametric linkage analysis of the 328 markers did not reveal statistically significant results. However, 10 slightly interesting regions (P = .1-.15) emerged, including our previous findings of the HLA complex on Gp21. and a putative locus on 5p14-p12. Fight of these novel regions were further analyzed by use of denser marker maps, in the second stage of the scan. For the chromosomal regions 4cen, 11tel, and 17q, the statistical significance increased, but not conclusively; for 2q32 and 10q21, the statistical significance did not change. Accordingly, genotyping of the high-density markers in these regions was performed, and the data were analyzed by use of two-point, parametric linkage analysis using the complete pedigree information of the 21 Finnish multiplex families. We detected suggestive evidence for a predisposing locus on chromosomal region 17q22-q24. Several markers on 17q22-q24 yielded positive LOD scores, with the maximum LOD score (Z(max)) occurring with D17S807 (Z(max) = 2.8, theta = .04; dominant model). Interestingly, a suggestive linkage between MS and the markers on 17q22-q24 was also revealed by a recent genomewide scan in MS families from the United Kingdom.	Natl Publ Hlth Inst, Dept Human Mol Genet, FIN-00300 Helsinki, Finland; Inst Biomed, FIN-00300 Helsinki, Finland; Univ Helsinki, Dept Neurol, Helsinki, Finland; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA USA; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA		Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	Leena.Peltonen@ktl.fi	Daly, Mark J/B-2453-2017; Rioux, John D/A-9599-2015; Tienari, Pentti J/A-4893-2012	Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; 	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00098] Funding Source: Medline		BEALL SS, 1989, J NEUROIMMUNOL, V21, P59, DOI 10.1016/0165-5728(89)90159-8; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; EBERS GC, 1981, NEUROLOGY, V31, P1138, DOI 10.1212/WNL.31.9.1138; EOLI M, 1994, J NEUROL, V241, P615, DOI 10.1007/BF00920626; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HILLERT J, 1991, J NEUROIMMUNOL, V31, P141; KINNUNEN E, 1983, ACTA NEUROL SCAND, V67, P255, DOI 10.1111/j.1600-0404.1983.tb04574.x; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LYNCH SG, 1991, ANN NEUROL, V30, P402, DOI 10.1002/ana.410300313; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Ott J, 1991, ANAL HUMAN GENETIC L; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; ROSE J, 1993, LANCET, V341, P1179, DOI 10.1016/0140-6736(93)91003-5; SADOVNICK AD, 1988, AM J MED GENET, V29, P533, DOI 10.1002/ajmg.1320290310; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SEBOUN E, 1989, CELL, V57, P1095, DOI 10.1016/0092-8674(89)90046-9; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Tienari Pentti J., 1993, European Journal of Human Genetics, V1, P257; TIENARI PJ, 1992, LANCET, V340, P987, DOI 10.1016/0140-6736(92)93007-A; TIENARI PJ, 1992, J NEUROL NEUROSUR PS, V55, P883, DOI 10.1136/jnnp.55.10.883; VANDEVYVER C, 1994, J NEUROIMMUNOL, V52, P97, DOI 10.1016/0165-5728(94)90167-8; WIKSTROM J, 1975, ACTA NEUROL SCAND, V51, P173, DOI 10.1111/j.1600-0404.1975.tb07598.x; WOOD NW, 1994, J NEUROL NEUROSUR PS, V57, P1191, DOI 10.1136/jnnp.57.10.1191	36	252	253	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1379	1387		10.1086/301637			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	WOS:000071555900022	9399895	Green Published, Bronze			2022-01-24	
J	Reddy, S; Smith, DBJ; Rich, MM; Leferovich, JM; Reilly, P; Davis, BM; Tran, K; Rayburn, H; Bronson, R; Cros, D; BaliceGordon, RJ; Housman, D				Reddy, S; Smith, DBJ; Rich, MM; Leferovich, JM; Reilly, P; Davis, BM; Tran, K; Rayburn, H; Bronson, R; Cros, D; BaliceGordon, RJ; Housman, D			Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy	NATURE GENETICS			English	Article							UNSTABLE CTG REPEAT; MYOSIN HEAVY-CHAIN; FRAGILE-X SYNDROME; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MDX MOUSE; MESSENGER-RNA; CONTRACTILE PROPERTIES; TRIPLET REPEAT; GENE	Myotonic dystrophy (DM) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3' untranslated region of a putative protein kinase (DMPK). To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient (Dmpk-/-) mice. Dmpk-/- mice develop a late-onset, progressive skeletal myopathy that shares some pathological features with DM. Muscles from mature mice show variation in fibre size, increased fibre degeneration and fibrosis. Adult Dmpk-/- mice show ultrastructural changes in muscle and a 50% decrease in force generation compared to young mice. Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function and suggest that a decrease in DMPK levels may contribute to DM pathology.	MIT,CTR CANC RES,CAMBRIDGE,MA 02138; UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104; TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,BOSTON,MA 02111; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02214						NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P0IAG 1332901] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG013329] Funding Source: NIH RePORTER		ALEU FP, 1964, AM J PATHOL, V45, P221; ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; Bancroft J, 1990, THEORY PRACTICE HIST; BEILHARZ MW, 1992, MOL CELL NEUROSCI, V3, P326, DOI 10.1016/1044-7431(92)90029-2; BELANGER AY, 1983, J NEUROL NEUROSUR PS, V46, P625, DOI 10.1136/jnnp.46.7.625; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; BURKE RE, 1994, MYOLOGY, V1, P464; CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; CASANOVA G, 1979, ACTA NEUROPATHOL, V45, P231, DOI 10.1007/BF00702675; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DUBOWITZ V, 1985, MUSLCE BIOPSY; DUNNE PW, 1995, CELL MOTILITY CYTOSK, V33; FARDEAU M, 1970, MUSCLE DISEASES, P98; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FITZSIMONS RB, 1981, J NEUROL SCI, V52, P367, DOI 10.1016/0022-510X(81)90018-6; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; GAMBKE B, 1984, J BIOL CHEM, V259, P2092; GROUNDS MD, 1992, CELL TISSUE RES, V267, P99, DOI 10.1007/BF00318695; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper PS, 1989, MYOTONIC DYSTROPHY, V2nd; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; Hogan B., 1986, MANIPULATING MOUSE E; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; JOHNSON AG, 1969, ACTA NEUROPATHOL, V12, P218, DOI 10.1007/BF00687646; JOHNSON AG, 1969, ACTA NEUROPATHOL, V12, P183, DOI 10.1007/BF00692505; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOGA R, 1994, BIOCHEM BIOPH RES CO, V202, P577, DOI 10.1006/bbrc.1994.1967; KOIDE R, 1994, NATURE GENET, V6; KOLSHI K, 1995, DEV DYNAMICS, V202, P244; KRAHE R, 1995, GENOMICS, V28; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAEDA M, 1995, J BIOL CHEM, V270, P20246, DOI 10.1074/jbc.270.35.20246; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCCOMAS AJ, 1971, J NEUROL NEUROSUR PS, V34, P132, DOI 10.1136/jnnp.34.2.132; MORGANHUGHES JA, 1994, MYOLOGY, P1610; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; NOVELLI G, 1993, BIOCHEM MED METAB B, V50, P85, DOI 10.1006/bmmb.1993.1049; OBRIEN TA, 1984, DEV MED CHILD NEUROL, V26, P62; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SACCO P, 1992, CLIN SCI, V82, P227, DOI 10.1042/cs0820227; SALVATORI S, 1994, BIOCHEM BIOPH RES CO, V203, P1365, DOI 10.1006/bbrc.1994.2335; SCHIAFFINO S, 1986, MUSCLE NERVE, V9, P51, DOI 10.1002/mus.880090108; SCHOTLAND DL, 1970, J NEUROPATH EXP NEUR, V29, P241; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; SHAW DJ, 1993, GENOMICS, V18, P673, DOI 10.1016/S0888-7543(05)80372-6; TAYLOR RG, 1992, ARCH PHYS MED REHAB, V73, P233; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971; TIMCHENKO L, 1995, P NATL ACAD SCI USA, V92, P5366, DOI 10.1073/pnas.92.12.5366; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; WANG YH, 1994, SCIENCE, V265, P1709; WERNIG A, 1986, PROG NEUROBIOL, V27, P251, DOI 10.1016/0301-0082(86)90023-7	78	252	258	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					325	335		10.1038/ng0796-325			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	WOS:A1996UU28300021	8673132				2022-01-24	
J	TAKAHATA, N				TAKAHATA, N			GENE GENEALOGY IN 3 RELATED POPULATIONS - CONSISTENCY PROBABILITY BETWEEN GENE AND POPULATION TREES	GENETICS			English	Article									UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77225		TAKAHATA, N (corresponding author), NATL INST GENET,MISHIMA,SHIZUOKA 411,JAPAN.						DONNELLY P, 1984, MATH PROC CAMBRIDGE, V95, P349, DOI 10.1017/S0305004100061624; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kingman JFC, 1982, STOCH PROCESS APPL, V13, P235, DOI 10.1016/0304-4149(82)90011-4; NEI M, 1982, EVOL BIOL, V14, P1; Nei M., 1987, MOL EVOLUTIONARY GEN; NEI M, 1985, POPULATION GENETICS, P41; Neigel J.E., 1986, P515; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; SAITOU N, 1986, J MOL EVOL, V24, P189, DOI 10.1007/BF02099966; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1985, GENETICS, V110, P325; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; WATTERSON GA, 1984, THEOR POPUL BIOL, V26, P77, DOI 10.1016/0040-5809(84)90025-X; WATTERSON GA, 1984, THEOR POPUL BIOL, V26, P387, DOI 10.1016/0040-5809(84)90042-X	14	252	252	0	5	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	AUG	1989	122	4					957	966					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AH735	WOS:A1989AH73500023	2759432				2022-01-24	
J	ECKERSON, HW; ROMSON, J; WYTE, C; LADU, BN				ECKERSON, HW; ROMSON, J; WYTE, C; LADU, BN			THE HUMAN-SERUM PARAOXONASE POLYMORPHISM - IDENTIFICATION OF PHENOTYPES BY THEIR RESPONSE TO SALTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ECKERSON, HW (corresponding author), UNIV MICHIGAN,DEPT PHARMACOL,ANN ARBOR,MI 48109, USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-27028] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01GM027028] Funding Source: NIH RePORTER		ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; ALDRIDGE WN, 1975, ENZYME INHIBITORS SU, P176; CARROCIAMPI G, 1981, CAN J PHYSIOL PHARM, V59, P904, DOI 10.1139/y81-138; CLELAND WW, 1963, NATURE, V198, P463, DOI 10.1038/198463a0; ECKERSON HW, 1979, PHARMACOLOGIST, V21, P236; ECKERSON HW, 1981, FED PROC, V40, P724; EIBERG H, 1981, ANN HUM GENET, V45, P323, DOI 10.1111/j.1469-1809.1981.tb00345.x; ERDOES EG, 1961, NATURE, V190, P716, DOI 10.1038/190716a0; FLUGEL M, 1978, KLIN WOCHENSCHR, V56, P911, DOI 10.1007/BF01489217; Geldermacher-Von M.M, 1978, HUM GENET S, V1, P65; GELDMACH.M, 1972, H-S Z PHYSIOL CHEM, V353, P217, DOI 10.1515/bchm2.1972.353.1.217; GELDMACHER M, 1973, H-S Z PHYSIOL CHEM, V354, P337, DOI 10.1515/bchm2.1973.354.1.337; Geldmacher-von Mallinck, 1973, Humangenetik, V17, P331; GELDMACHERVONMALLINCKRODT M, 1979, HUM GENET, V50, P313, DOI 10.1007/BF00399398; KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41; MAIN AR, 1960, BIOCHEM J, V74, P10, DOI 10.1042/bj0740010; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; SIMPSON NE, 1971, AM J HUM GENET, V23, P375; SKRINJAR.M, 1968, BIOCHIM BIOPHYS ACTA, V165, P289, DOI 10.1016/0304-4165(68)90059-7; SOKAL RR, 1966, BIOMETRY PRINCIPLES; Sorensen SPL, 1909, BIOCHEM Z, V21, P131; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; ZECH R, 1974, COMP BIOCHEM PHYSIOL, V48, P427, DOI 10.1016/0305-0491(74)90277-6	23	252	263	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					214	227					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265	WOS:A1983QJ26500005	6301268				2022-01-24	
J	PUKKILA, PJ; PETERSON, J; HERMAN, G; MODRICH, P; MESELSON, M				PUKKILA, PJ; PETERSON, J; HERMAN, G; MODRICH, P; MESELSON, M			EFFECTS OF HIGH-LEVELS OF DNA ADENINE METHYLATION ON METHYL-DIRECTED MISMATCH REPAIR IN ESCHERICHIA-COLI	GENETICS			English	Article									HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,CAMBRIDGE,MA 02138; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710					Modrich, Paul/0000-0001-8708-9885			APPLEYARD RK, 1954, GENETICS, V39, P440; BALE A, 1979, MUTAT RES, V59, P157, DOI 10.1016/0027-5107(79)90153-2; GEIER GE, 1979, J BIOL CHEM, V254, P1408; GELINAS RE, 1977, J MOL BIOL, V114, P169, DOI 10.1016/0022-2836(77)90290-X; GLICKMAN B, 1978, MOL GEN GENET, V163, P307, DOI 10.1007/BF00271960; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; GOMEZEICHELMANN MC, 1977, J MOL BIOL, V117, P621; HERMAN GE, 1981, J BACTERIOL, V145, P644, DOI 10.1128/JB.145.1.644-646.1981; KAISER AD, 1957, VIROLOGY, V4, P509, DOI 10.1016/0042-6822(57)90083-1; KELLENBERGER G, 1960, NATURE, V187, P161, DOI 10.1038/187161a0; LACKS AS, 1982, CELL, V31, P327; LACKS S, 1977, J MOL BIOL, V114, P153, DOI 10.1016/0022-2836(77)90289-3; LIEBERFARB RM, 1970, J BACTERIOL, V104, P363; MANLY KF, 1969, VIROLOGY, V37, P177, DOI 10.1016/0042-6822(69)90197-4; MARINUS MG, 1974, J MOL BIOL, V85, P309, DOI 10.1016/0022-2836(74)90366-0; MARINUS MG, 1973, J BACTERIOL, V114, P1143, DOI 10.1128/JB.114.3.1143-1150.1973; MEIJER M, 1979, P NATL ACAD SCI USA, V76, P580, DOI 10.1073/pnas.76.2.580; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; NATHANS D, 1975, ANN REV BIOCH, V44, P274; RADDING CM, 1978, ANNU REV BIOCHEM, V47, P847, DOI 10.1146/annurev.bi.47.070178.004215; Radman M., 1980, PROGR ENV MUTAGENESI, P121; RYDBERG B, 1978, MUTAT RES, V52, P11, DOI 10.1016/0027-5107(78)90091-X; SUGIMOTO K, 1979, P NATL ACAD SCI USA, V76, P575, DOI 10.1073/pnas.76.2.575; WAGNER R, 1976, P NATL ACAD SCI USA, V73, P4135, DOI 10.1073/pnas.73.11.4135; WILDENBERG J, 1975, P NATL ACAD SCI USA, V72, P2202, DOI 10.1073/pnas.72.6.2202; ZYSKIND JW, 1980, P NATL ACAD SCI-BIOL, V77, P2460, DOI 10.1073/pnas.77.5.2460	26	252	256	0	11	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1983	104	4					571	582					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RB320	WOS:A1983RB32000002	6225697				2022-01-24	
J	BLOCH, DP				BLOCH, DP			A CATALOG OF SPERM HISTONES	GENETICS			English	Article																	ALFERT M, 1956, J BIOPHYS BIOCHEM CY, V2, P109, DOI 10.1083/jcb.2.2.109; ALFERT M, 1958, GES PHYSIOL CHEM COL, V9, P73; ANDO T, 1957, J BIOCHEM-TOKYO, V44, P275, DOI 10.1093/oxfordjournals.jbchem.a126753; ANDO T, 1953, B CHEM SOC JPN, V26, P406; Baerg WJ, 1958, TARANTULA; BARR ML, 1959, SCIENCE, V130, P679, DOI 10.1126/science.130.3377.679; BELETSINA NV, 1964, BIOKHIMIYA, V29, P315; BERLOWIT.L, 1965, P NATL ACAD SCI USA, V54, P476, DOI 10.1073/pnas.54.2.476; BLOCH DP, 1964, J CELL BIOL, V22, P327, DOI 10.1083/jcb.22.2.327; BLOCH DP, 1960, J BIOPHYS BIOCHEM CY, V8, P69, DOI 10.1083/jcb.8.1.69; BLOCH DP, 1960, J BIOPHYS BIOCHEM CY, V7, P515, DOI 10.1083/jcb.7.3.515; BLOCH DP, 1962, J HISTOCHEM CYTOCHEM, V10, P137, DOI 10.1177/10.2.137; BLOCH DP, 1966, PROTOPLASMATOLOGIA, V5, P1; Boveri Th., 1911, Wurzburg Verh physik Ges N F, V41; BROWN DD, 1966, 23 NATL CANC I MON, P297; BURGOS MH, 1955, J BIOPHYS BIOCHEM CY, V1, P287, DOI 10.1083/jcb.1.4.287; CALLANAN MJ, 1957, J BIOL CHEM, V229, P279; CHEVAILLIER P, 1967, J CELL BIOL, V32, P547, DOI 10.1083/jcb.32.3.547; CLAYPOOL CJ, 1967, NATURE, V215, P966, DOI 10.1038/215966a0; Crick F H, 1966, Cold Spring Harb Symp Quant Biol, V31, P1; DALCONTRES GS, 1953, ACTA CIENT VENEZ, V4, P23; DAS CC, 1964, EXP CELL RES, V35, P507, DOI 10.1016/0014-4827(64)90139-9; DAS NK, 1965, J CELL BIOL, V25, P387, DOI 10.1083/jcb.25.2.387; DAS NK, 1967, J CELL BIOL, V35, P455, DOI 10.1083/jcb.35.2.455; DASS CMS, 1958, J BIOPHYS BIOCHEM CY, V4, P129, DOI 10.1083/jcb.4.1.129; DAVIS HS, 1908, B MUSEUM COMP ZOOL, V53, P58; Dunn MS, 1926, J BIOL CHEM, V70, P697; FAMBROUGH DM, 1968, J BIOL CHEM, V243, P4434; FELIX K, 1952, EXPERIENTIA, V8, P312, DOI 10.1007/BF02153309; FELIX K, 1955, AM SCI, V43, P431; FISCHBERG M, 1958, EXP CELL RES      S6, P161; FISCHER H, 1953, Z PHYSIOL CHEM, V293, P176; FRASER RC, 1964, EXP CELL RES, V33, P473, DOI 10.1016/0014-4827(64)90012-6; GALL JG, 1968, P NATL ACAD SCI USA, V60, P553, DOI 10.1073/pnas.60.2.553; GERTSCH WJ, 1949, AMERICAN SPIDERS, P32; GOLDSTEIN L, 1967, CONTROL NUCLEAR A ED, P101; GRASSE PIERRE-P., 1956, ANN SCI NAT ZOOL, V18, P339; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; HAMER D, 1955, BIOL BULL, V108, P35, DOI 10.2307/1538394; HENDERSON SA, 1964, CHROMOSOMA, V15, P345, DOI 10.1007/BF00368137; HENRICKS DM, 1965, EXP CELL RES, V40, P402, DOI 10.1016/0014-4827(65)90273-9; HESS O, 1965, CHROMOSOMA, V16, P222, DOI 10.1007/BF00320950; HIROHATA RYOZO, 1929, JOUR BIOCHEM TOKYO, V10, P251; HNILICA LS, 1963, EXP CELL RES, P367; HUANG RCC, 1964, J MOL BIOL, V8, P54, DOI 10.1016/S0022-2836(64)80148-0; HUGHES-SCHRADER SALLY, 1927, ZEITSCHR WISS BIOL ABT B ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V6, P509; HULTIN T, 1949, ARK KEM MINERAL GEOL, V26, P1; INAFUKU Z, 1951, KYUSHU MEM MED SCI, V2, P33; KAYE JEROME S., 1958, J MORPH, V103, P311, DOI 10.1002/jmor.1051030206; KAYE JS, 1966, J CELL BIOL, V31, P159, DOI 10.1083/jcb.31.1.159; KING TJ, 1956, COLD SPRING HARB SYM, V21, P271, DOI 10.1101/SQB.1956.021.01.022; KONIGSBERGER VV, 1967, REGULATION NUCLEI ED, V10, P51; Kossel A., 1928, PROTAMINES HISTONES; KOSSEL R, 1926, Z PHYSIOL CHEM, V159, P172; KURODA Y, 1951, J BIOCHEM-TOKYO, V38, P115, DOI 10.1093/oxfordjournals.jbchem.a126234; LISITZUIN MA, 1936, Z PHYSIOL CHEM, V238, P54; LISITZUIN MA, 1933, Z PHYSIOL CHEM, V221, P156; MANN T, 1954, BIOCHEMISTRY SEMEN, P9; MEYER GF, 1969, GENETICS, V61, P79; Miescher F., 1897, HISTOCHEMISCHEN PHYS; MONESI V, 1965, EXP CELL RES, V39, P197, DOI 10.1016/0014-4827(65)90023-6; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; MORKOWIN N, 1899, Z PHYSL CHEM, V28, P313; MUCKENTHALER FA, 1964, EXP CELL RES, V35, P531, DOI 10.1016/0014-4827(64)90141-7; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; NEELIN JM, 1964, CAN J BIOCHEM PHYS, V42, P1743, DOI 10.1139/o64-185; NEMER M, 1967, CONTROL NUCLEAR ACTI, P101; OHNO S, 1961, EXP CELL RES, V22, P535, DOI 10.1016/0014-4827(61)90130-6; Painter TS, 1942, P NATL ACAD SCI USA, V28, P311, DOI 10.1073/pnas.28.8.311; PALAU J, 1969, EUR J BIOCHEM, V7, P209, DOI 10.1111/j.1432-1033.1969.tb19593.x; PERROT JEAN-LOUIS, 1930, REV SUISSE ZOOL, V37, P397; RASCH E, 1959, J BIOPHYS BIOCHEM CY, V6, P263, DOI 10.1083/jcb.6.2.263; Schmidt W. J., 1937, DOPPELBRECHUNG KARYO; SETLOW RB, 1967, REGULATION NUCLEIC A, V10, P51; SPEMANN H, 1938, EMBRYONIC DEVELOPMEN, P28; SPIRIN AS, 1965, SCIENCE, V150, P214, DOI 10.1126/science.150.3693.214; SUD BN, 1961, Q J MICROSC SCI, V102, P51; TABER S, 1960, SCIENCE, V131, P1734, DOI 10.1126/science.131.3415.1734; VAUGHN JC, 1966, J CELL BIOL, V31, P257, DOI 10.1083/jcb.31.2.257; VAUGHN JC, 1968, J HISTOCHEM CYTOCHEM, V16, P473, DOI 10.1177/16.7.473; VENDRELY R., 1957, ARCH JULIUS KLAUS STIFT, V32, P538; VENDRELY R, 1966, PROTOPLASMATOLOGIA, V5, P1; WALDSCHMIDTLEIT.E, 1935, MONATSH, V66, P357; WALKER M, 1968, J CELL SCI, V3, P95; Wimsatt WA, 1942, ANAT REC, V83, P299, DOI 10.1002/ar.1090830208; WRIGHT AH, 1957, HANDBOOK SNAKES US C, P202	86	252	255	0	0	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1969	61	1P2S					93	&					0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D5717	WOS:A1969D571700008					2022-01-24	
J	NEEL, JV; SALZANO, FM; KEITER, F; MAYBURYL.D; JUNQUEIRA, PCC				NEEL, JV; SALZANO, FM; KEITER, F; MAYBURYL.D; JUNQUEIRA, PCC			STUDIES ON XAVANTE INDIANS OF BRAZILIAN MATO GROSSO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Salzano, Francisco M/L-7916-2015				Abbie AA, 1953, AM J PHYS ANTHROP-NE, V11, P339, DOI 10.1002/ajpa.1330110310; ABBIE AA, 1960, OCEANIA, V31, P140, DOI 10.1002/j.1834-4461.1960.tb00747.x; ABBIE AA, 1960, MED J AUSTRALIA, V2, P493; ADAMS ARD, 1960, CLINICAL TROPICAL DI; ADELS BR, 1962, AM J DIS CHILD, V103, P255, DOI 10.1001/archpedi.1962.02080020267015; ADELS BR, 1963, AM J HYG, V77, P317, DOI 10.1093/oxfordjournals.aje.a120322; AICHEL OTTO, 1932, ZEITSCHR MORPH U ANTHROP, V31, P1; ARENDS T, 1962, 8 P C INT SOC BLOOD, P379; ARENS L, 1954, S Afr J Clin Sci, V5, P20; ARETAS R. E., 1959, BULL SOC PATHOL EXOT, V52, P404; ARROYAVE G, 1960, AM J TROP MED HYG, V9, P81, DOI 10.4269/ajtmh.1960.9.81; BAKKER A W, 1957, Doc Med Geogr Trop, V9, P1; Barrett M. J., 1953, AUST J DENT, V57, P127; BEST WR, 1962, AM J PHYS ANTHROPOL, V20, P321, DOI 10.1002/ajpa.1330200315; BIRDSELL JB, 1950, COLD SPRING HARB SYM, V15, P259, DOI 10.1101/SQB.1950.015.01.028; BISWAS PC, 1961, 2 INT C HUM GENET, pE105; BLACK FL, 1962, AM J DIS CHILD, V103, P242, DOI 10.1001/archpedi.1962.02080020254011; BLOMBERG R, 1960, CHAVANTE EXPEDITION; BOAS F, 1895, 65 REP M BRIT ASS AD, P523; BOYD M.F., 1949, MALARIOLOGY, P3; BOYD MF, 1949, MALARIOLOGY, P764; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; BOZEMAN FM, 1963, P SOC EXP BIOL MED, V112, P568, DOI 10.3181/00379727-112-28107; BREINL A., 1917, Annals of Tropical Medicine and Parasitology, V10, P427; [Anonymous], 1960, South African Journal of Laboratory and Clinical Medicine, V6, P187; BRONTESTEWART B, 1961, AM J CLIN NUTR, V9, P596, DOI 10.1093/ajcn/9.5.596; BRONTESTEWART B, 1955, LANCET, V2, P1103; Campbell T. D., 1953, AUSTR J DENT, V57, P1; Campbell TD, 1938, AUST J DENT, V42, P121; CARRSAUNDERS AM, 1922, POPULATION PROBLEM L; CASLEY-SMITH J R, 1959, Med J Aust, V46, P627; CASLEY-SMITH J. R., 1959, AUSTRALIAN JOUR EXPTL BIOL AND MED, V37, P481, DOI 10.1038/icb.1959.49; CASLEY-SMITH J. R., 1960, AUSTRALIAN JOUR EXPTL BIOL AND MED SCI, V38, P37, DOI 10.1038/icb.1960.5; CAUSEY OR, 1958, AM J TROP MED HYG, V7, P36, DOI 10.4269/ajtmh.1958.7.36; Chown B, 1955, AM J PHYS ANTHROP-NE, V13, P181, DOI 10.1002/ajpa.1330130202; Chown B, 1953, AM J PHYS ANTHROP-NE, V11, P369, DOI 10.1002/ajpa.1330110312; CLEVE H, 1961, AM J HUM GENET, V13, P372; CLOSE J, 1955, Ann Soc Belg Med Trop (1920), V35, P129; COHEN BM, 1962, AM J HUM GENET, V14, P238; CONNERTY HV, 1961, CLIN CHEM, V7, P37; CONNERTY HV, 1961, CLIN CHEM, V7, P589; COOK RP, 1958, CHOLESTEROL; Coon C.S., 1962, ORIGIN RACES; COUVEE L M, 1962, Trop Geogr Med, V14, P27; COUVEE L. M. J., 1962, TROP AND GEOGR MED, V14, P325; COUVEE L. M. J., 1962, TROP AND GEOGR MED, V14, P314; COWELL A, 1961, HEART FOREST; CRAN JA, 1955, AUSTRALIAN J DENT, V59, P356; CROW JF, 1958, AM ANTHROPOL, V60, P1; Cummins H, 1943, FINGERPRINTS PALMS S; Cummins H, 1935, AM J PHYS ANTHROPOL, V20, P19, DOI 10.1002/ajpa.1330200106; CUMMINS HAROLD, 1941, HUMAN BIOL, V13, P177; Cummins H, 1930, AM J PHYS ANTHROPOL, V15, P123, DOI 10.1002/ajpa.1330150105; Cummins H, 1932, AM J PHYS ANTHROPOL, V17, P229, DOI 10.1002/ajpa.1330170215; CURNOW D. H., 1957, MED JOUR AUSTRALIA II, V44, P608; CURTAIN CC, 1961, AM J TROP MED HYG, V10, P92, DOI 10.4269/ajtmh.1961.10.92; DANOWSKI TS, 1963, METABOLISM, V12, P117; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; DAVIDSON W. S., 1957, Medical Journal of Australia, V2, P601; DAVILA JB, 1950, HANDBOOK SOUTH AMERI, V6, P71; DAVIS R. E., 1957, MED JOUR AUSTRALIA II, V44, P605; de LIMA P E, 1950, Rev Bras Med, V7, P787; DEFREITAS AS, 1955, 1954 REP IND PROT SE; ELLIS FR, 1963, HUM BIOL, V35, P26; FERNANDES JL, 1957, ANN HUM GENET, V22, P16, DOI 10.1111/j.1469-1809.1957.tb01294.x; FINN SB, 1952, 225 NAT AC SCIENC NA, P119; FOX JOHN P., 1959, ARCH INST PASTEUR TUNIS, V36, P449; GABALDON A, 1949, MALARIOLOGY, P764; GAJDUSEK DC, 1959, PEDIATRICS, V23, P121; GAJDUSEK DC, 1955, PEDIATRICS, V16, P819; GEIPEL G, 1935, ANLEITUNG ERBBIOLOGI; GERSHOWITZ H, IN PRESS; GIBLETT ER, 1961, NATURE, V192, P1300, DOI 10.1038/1921300a0; GREY G, 1941, J 2 EXPEDITIONS DISC; HART CWM, 1960, TIWI NORTH AUSTRALIA; HEITHERSAY G, 1959, Med J Aust, V1, P721; HENRY L, 1961, EUGEN QUART, V8, P81, DOI 10.1080/19485565.1961.9987465; HICKS SC, 1933, AUSTRALIAN J EXP BIO, V11, P177; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V46, P229; HUXLEY F, 1957, AFFABLE SAVAGES; JELLIFFE D B, 1953, Doc Med Geogr Trop, V5, P286; JOUBERT SM, 1959, J LAB CLIN MED, V5, P1; JUILLAN M., 1960, Arch. Inst. Pasteur d'Algerie, V38, P151; JUNQUEIRA PC, 1957, ANN HUM GENET, V22, P22, DOI 10.1111/j.1469-1809.1957.tb01295.x; Kean B. H., 1944, AMER JOUR TROP MED, V24, P341; KEAN BH, 1949, ARCH INTERN MED, V83, P355, DOI 10.1001/archinte.1949.00220320109009; KEITER F., 1960, MITTEIL ANTHROPOL GES WIEN, V90, P55; KEITER F, 1957, ARZTL FORSCH, V11, P537; Keiter F, 1954, Z MORPHOL ANTHROPOL, V46, P170; Keiter F, 1950, Z MORPHOL ANTHROPOL, V42, P169; KENDRICK PL, 1961, AM J DIS CHILD, V101, P149, DOI 10.1001/archpedi.1961.04020030013003; KENDRICK PL, IN PRESS; KIDDY CA, 1961, SCIENCE, V134, P615, DOI 10.1126/science.134.3479.615; KLEIN GC, 1962, P SOC EXP BIOL MED, V111, P298, DOI 10.3181/00379727-111-27773; KRITCHEVSKY D, 1958, CHOLESTEROL; KRZYWICKI L, 1934, PRIMITIVE SOCIETY VI; LAPICCIRELLA V, 1962, B WORLD HEALTH ORGAN, V27, P681; LASKER GW, 1960, 5 SEL PAP INT C ANTH; LAYRISSE M, 1958, AM J PHYS ANTHROPOL, V16, P307, DOI 10.1002/ajpa.1330160304; LAYRISSE M, 1963, HUM BIOL, V35, P140; LAYRISSE M, 1962, SOUTHWEST J ANTHROP, V18, P78, DOI 10.1086/soutjanth.18.1.3629125; LAYRISSE M, 1961, SCIENCE, V134, P1077, DOI 10.1126/science.134.3485.1077; LEISSRING JC, 1962, AM J DIS CHILD, V103, P160, DOI 10.1001/archpedi.1962.02080020166009; LEVINE P, 1951, P SOC EXP BIOL MED, V78, P218; LIEKHINGTING, 1960, TROP GEOG MED, V12, P293; LINNET-JEPSEN P, 1958, Acta Genet Stat Med, V8, P164; LIVINGSTONE FB, 1960, AM J PHYS ANTHROPOL, V18, P161, DOI 10.1002/ajpa.1330180302; LOWENSTEIN F, 1961, LANCET, V1, P389; LUYKEN R, 1960, Trop Geogr Med, V12, P145; LUYKEN R, 1960, Trop Geogr Med, V12, P313; LUYKEN R., 1960, TROP GEOGR MED, V12, P233; LUYKEN R, 1958, Trop Geogr Med, V10, P385; MACCLUER JW, 1963, AM J HUM GENET, V15, P191; MANN GV, 1955, BRIT MED J, V2, P1008, DOI 10.1136/bmj.2.4946.1008; MANN I, 1956, AM J OPHTHALMOL, V41, P797, DOI 10.1016/0002-9394(56)91772-X; MANN IDA, 1957, MED JOUR AUSTRALIA II, V44, P610; Manson-Bahr PH., 1960, MANSONS TROPICAL DIS; Mason J.A., 1950, HDB S AM INDIANS, V6, P157; MATHUR KS, 1962, INDIAN J MED RES, V50, P195; MATTOS RB, 1958, ARQUIV BRASIL OFT, V21, P105; MAYBURYLEWIS D, IN PRESS; MENDEZ J, 1962, AM J CLIN NUTR, V10, P403, DOI 10.1093/ajcn/10.5.403; MORTARA G, 1957, FECUNDIDADE MULHER B; Murphy RF, 1960, HEADHUNTERS HERITAGE; NAGEL R, 1963, NATURE, V197, P187, DOI 10.1038/197187a0; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEEL JV, 1958, AM ANTHROPOL, V60, P43; Neel JV, 1954, HUMAN HEREDITY; NEMOTO H, 1960, AM J HUM GENET, V12, P67; NEWMAN MT, 1960, AM J PHYS ANTHROPOL, V18, P45, DOI 10.1002/ajpa.1330180106; NEWMAN MT, 1953, INDIAN TRIBES NORTHE; NYE LJJ, 1937, MED J AUSTRALIA, V2, P1000; OBERG K, 1953, 15 SMITHS INST I SOC; OOMEN H A, 1961, Trop Geogr Med, V13, P321; ORR JB, 1931, 155 GREAT BRIT MED R, P82; OSBORNE RH, 1958, AM J PHYS ANTHROPOL, V16, P187, DOI 10.1002/ajpa.1330160204; PACKER AD, 1961, OCEANIA, V32, P60, DOI 10.1002/j.1834-4461.1961.tb00446.x; PARKER WC, 1961, SCIENCE, V134, P106, DOI 10.1126/science.134.3472.106; PAUL JR, 1952, AM J HYG, V55, P402, DOI 10.1093/oxfordjournals.aje.a119532; PAUL JR, 1955, AM J TROP MED HYG, V4, P512, DOI 10.4269/ajtmh.1955.4.512; POLLITZER WS, 1962, AM J PHYS ANTHROPOL, V20, P33, DOI 10.1002/ajpa.1330200120; POST RH, 1962, EUGEN QUART, V9, P189, DOI 10.1080/19485565.1962.9987526; POST RH, 1962, EUGEN QUART, V9, P131, DOI 10.1080/19485565.1962.9987517; POWELL S J, 1958, S Afr J Lab Clin Med, V4, P273; PRICE WA, 1939, NUTRITION PHYSICAL D; QUEVAL R., 1959, BULL SOC PATHOL EXOT, V52, P385; RACE RR, 1962, BLOOD GROUPS MAN; RANKE KE, 1898, DEUTSCH GES ANTHROPO, V29, P123; RATNOFF OD, 1951, J LAB CLIN MED, V37, P316; REINHARD KR, 1963, JAMA-J AM MED ASSOC, V183, P410, DOI 10.1001/jama.1963.03700060052007; RIBEIRO D, 1957, EDUCACAO CIENCIAS SO, V2, P5; RIGGS JL, 1962, P SOC EXP BIOL MED, V110, P833, DOI 10.3181/00379727-110-27664; RIGGS JL, 1962, J IMMUNOL, V89, P868; SABIN AB, 1962, PEDIATRICS, V29, P105; SABIN AB, 1957, NY ACAD SCI, V5, P113; SALLER K, 1956, LEHRBUCH ANTHROPOLOG; SALZANO FM, 1961, HUM BIOL, V33, P110; SALZANO FM, 1957, AM J PHYS ANTHROPOL, V15, P555, DOI 10.1002/ajpa.1330150407; SALZANO FM, 1961, AM J PHYS ANTHROPOL, V19, P391, DOI 10.1002/ajpa.1330190412; SALZANO FM, 1963, ACTA GENET STAT MED, V13, P1; SCHAAD J D, 1960, Trop Geogr Med, V12, P38; SCHAEFFER M, 1959, AM J TROP MED HYG, V8, P372, DOI 10.4269/ajtmh.1959.8.372; SCHOFIELD F. D., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P332, DOI 10.1016/0035-9203(57)90124-4; SCHULL WJ, IN PRESS; SCHWARTZ C J, 1958, Med J Aust, V2, P84; SCRIMSHAW N, 1961, AM J CLIN NUTR, V9, P206, DOI 10.1093/ajcn/9.2.206; SHAPER AG, 1959, LANCET, V2, P534; SHARP R. LAURISTON, 1940, HUMAN BIOL, V12, P481; SIMMONS RT, 1962, AM J PHYS ANTHROPOL, V20, P303, DOI 10.1002/ajpa.1330200314; SIMOES MT, 1955, 1954 REP IND PROT SE; SMIT AM, 1962, OVER EOSINOFILIE BIJ; SMITHIES O, 1959, ADV PROTEIN CHEM, V14, P65, DOI 10.1016/S0065-3233(08)60609-9; SNYDER MJ, 1962, AM J DIS CHILD, V103, P250, DOI 10.1001/archpedi.1962.02080020262012; SONNET J, 1959, Ann Soc Belg Med Trop (1920), V39, P495; STEGGERDA M, 1950, HANDBOOK SOUTH AMERI, V6, P57; STEINBERG A, 1961, AM J HUM GENET, V13, P205; STEINBERG AG, 1960, NATURE, V185, P324, DOI 10.1038/185324a0; STEWARD JH, 1950, HANDBOOK SOUTH AMERI, V6, P57; STEWARD JH, 1950, HANDBOOK SOUTH AMERI, V6, P71; STEWARD JH, 1946, HANDBOOK SOUTH AMERI, V7; STEWART JH, 1950, HANDBOOK SOUTH AMERI, V6, P157; SUTTON HE, 1960, AM J HUM GENET, V12, P338; SYMUL F, 1950, Ann Soc Belg Med Trop (1920), V30, P295; TABRAH FL, 1962, SCIENCE, V138, P38, DOI 10.1126/science.138.3536.38; TASHIAN RE, 1961, P SOC EXP BIOL MED, V108, P364; THOMPSON M. D., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P77, DOI 10.1016/0035-9203(56)90012-8; TINDALE MB, 1953, HUM BIOL, V25, P169; Vahlquist B., 1958, ADV PEDIATR, V10, P305; van TONGEREN H, 1960, Trop Geogr Med, V12, P208; VANDONGEN R, 1962, MED J AUSTRALIA, V2, P286; VESELL ES, 1962, J GEN PHYSIOL, V45, P553, DOI 10.1085/jgp.45.3.553; WALLACE AFC, 1960, 5 SEL PAP INT C ANTH; WARMER P, 1957, MED J AUSTRALIA, V2, P857; WHEELER AH, 1961, 12 ANN S REC ADV STU; Wilder HH, 1922, AM J PHYS ANTHROPOL, V5, P143, DOI 10.1002/ajpa.1330050210; WILKINSON G. K., 1958, Medical Journal of Australia, V2, P158; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891; 1957, 650 USPHS PUBL SER E; 1950, J IMMUN, V65, P347; [No title captured]; [No title captured]; [No title captured]; 1961, LABORATORY PROCEDURE; [No title captured]	204	252	260	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1964	16	1					52	+					1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2971A	WOS:A19642971A00003	14131874				2022-01-24	
J	Appenzeller, S; Balling, R; Barisic, N; Baulac, S; Caglayan, H; Craiu, D; De Jonghe, P; Depienne, C; Dimova, P; Djemie, T; Gormley, P; Guerrini, R; Helbig, I; Hjalgrim, H; Hoffman-Zacharska, D; Jahn, J; Klein, KM; Koeleman, B; Komarek, V; Krause, R; Kuhlenbaumer, G; Leguern, E; Lehesjoki, AE; Lemke, JR; Lerche, H; Linnankivi, T; Marini, C; May, P; Moller, RS; Muhle, H; Pal, D; Palotie, A; Pendziwiat, M; Robbiano, A; Roelens, F; Rosenow, F; Selmer, K; Serratosa, JM; Sisodiya, S; Stephani, U; Sterbova, K; Striano, P; Suls, A; Talvik, T; von Spiczak, S; Weber, Y; Weckhuysen, S; Zara, F; Abou-Khalil, B; Alldredge, BK; Andermann, E; Andermann, F; Amron, D; Bautista, JF; Berkovic, SF; Bluvstein, J; Boro, A; Cascino, G; Consalvo, D; Crumrine, P; Devinsky, O; Dlugos, D; Epstein, MP; Fiol, M; Fountain, NB; French, J; Friedman, D; Geller, EB; Glauser, T; Glynn, S; Haas, K; Haut, SR; Hayward, J; Helmers, SL; Joshi, S; Kanner, A; Kirsch, HE; Knowlton, RC; Kossoff, EH; Kuperman, R; Kuzniecky, R; Lowenstein, DH; McGuire, SM; Motika, PV; Novotny, EJ; Ottman, R; Paolicchi, JM; Parent, J; Park, K; Poduri, A; Sadleir, L; Scheffer, IE; Shellhaas, RA; Sherr, E; Shih, JJ; Singh, R; Sirven, J; Smith, MC; Sullivan, J; Thio, LL; Venkat, A; Vining, EPG; Von Allmen, GK; Weisenberg, JL; Widdess-Walsh, P; Winawer, MR; Allen, AS; Berkovic, SF; Cassette, P; Delanty, N; Dlugos, D; Eichler, EE; Epstein, MP; Glauser, T; Goldstein, DB; Han, YJ; Heinzen, EL; Johnson, MR; Kuzniecky, R; Lowenstein, DH; Marson, AG; Mefford, HC; Nieh, SE; O'Brien, TJ; Ottman, R; Petrou, S; Petrovski, S; Poduri, A; Ruzzo, EK; Scheffer, IE; Sherr, E				Appenzeller, Silke; Balling, Rudi; Barisic, Nina; Baulac, Stephanie; Caglayan, Hande; Craiu, Dana; De Jonghe, Peter; Depienne, Christel; Dimova, Petia; Djemie, Tania; Gormley, Padhraig; Guerrini, Renzo; Helbig, Ingo; Hjalgrim, Helle; Hoffman-Zacharska, Dorota; Jaehn, Johanna; Klein, Karl Martin; Koeleman, Bobby; Komarek, Vladimir; Krause, Roland; Kuhlenbaeumer, Gregor; Leguern, Eric; Lehesjoki, Anna-Elina; Lemke, Johannes R.; Lerche, Holger; Linnankivi, Tarja; Marini, Carla; May, Patrick; Moller, Rikke S.; Muhle, Hiltrud; Pal, Deb; Palotie, Aarno; Pendziwiat, Manuela; Robbiano, Angela; Roelens, Filip; Rosenow, Felix; Selmer, Kaja; Serratosa, Jose M.; Sisodiya, Sanjay; Stephani, Ulrich; Sterbova, Katalin; Striano, Pasquale; Suls, Arvid; Talvik, Tiina; von Spiczak, Sarah; Weber, Yvonne; Weckhuysen, Sarah; Zara, Federico; Abou-Khalil, Bassel; Alldredge, Brian K.; Andermann, Eva; Andermann, Frederick; Amron, Dina; Bautista, Jocelyn F.; Berkovic, Samuel F.; Bluvstein, Judith; Boro, Alex; Cascino, Gregory; Consalvo, Damian; Crumrine, Patricia; Devinsky, Orrin; Dlugos, Dennis; Epstein, Michael P.; Fiol, Miguel; Fountain, Nathan B.; French, Jacqueline; Friedman, Daniel; Geller, Eric B.; Glauser, Tracy; Glynn, Simon; Haas, Kevin; Haut, Sheryl R.; Hayward, Jean; Helmers, Sandra L.; Joshi, Sucheta; Kanner, Andres; Kirsch, Heidi E.; Knowlton, Robert C.; Kossoff, Eric H.; Kuperman, Rachel; Kuzniecky, Ruben; Lowenstein, Daniel H.; McGuire, Shannon M.; Motika, Paul V.; Novotny, Edward J.; Ottman, Ruth; Paolicchi, Juliann M.; Parent, Jack; Park, Kristen; Poduri, Annapurna; Sadleir, Lynette; Scheffer, Ingrid E.; Shellhaas, Renee A.; Sherr, Elliott; Shih, Jerry J.; Singh, Rani; Sirven, Joseph; Smith, Michael C.; Sullivan, Joe; Thio, Liu Lin; Venkat, Anu; Vining, Eileen P. G.; Von Allmen, Gretchen K.; Weisenberg, Judith L.; Widdess-Walsh, Peter; Winawer, Melodie R.; Allen, Andrew S.; Berkovic, Samuel F.; Cassette, Patrick; Delanty, Norman; Dlugos, Dennis; Eichler, Evan E.; Epstein, Michael P.; Glauser, Tracy; Goldstein, David B.; Han, Yujun; Heinzen, Erin L.; Johnson, Michael R.; Kuzniecky, Ruben; Lowenstein, Daniel H.; Marson, Anthony G.; Mefford, Heather C.; Nieh, Sahar Esmaeeli; O'Brien, Terence J.; Ottman, Ruth; Petrou, Stephen; Petrovski, Slave; Poduri, Annapurna; Ruzzo, Elizabeth K.; Scheffer, Ingrid E.; Sherr, Elliott		EuroEPINOMICS-RES Consortium; EuroEPINOMICS-RES Consortium; Epilepsy Phenome Genome Project; Epi4K Consortium	De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; GRIN2A MUTATIONS; SCHIZOPHRENIA; EPILEPSIES; DYNAMIN-1; PATTERNS; APHASIA; PROTEIN; STXBP1	Emerging evidence indicates that epileptic encephalopathies are genetically highly heterogeneous, underscoring the need for large cohorts of well-characterized individuals to further define the genetic landscape. Through a collaboration between two consortia (EuroEPINOMICS and Epi4K/EPGP), we analyzed exome-sequencing data of 356 trios with the "classical" epileptic encephalopathies, infantile spasms and Lennox Gastaut syndrome, including 264 trios previously analyzed by the Epi4K/EPGP consortium. In this expanded cohort, we find 429 de nova mutations, including de novo mutations in DNM1 in five individuals and de nova mutations in GABBR2, FASN, and RYR3 in two individuals each. Unlike previous studies, this cohort is sufficiently large to show a significant excess of de nova mutations in epileptic encephalopathy probands compared to the general population using a likelihood analysis (p = 8.2 x 10(-4)), supporting a prominent role for de novo mutations in epileptic encephalopathies. We bring statistical evidence that mutations in DNM1 cause epileptic encephalopathy, find suggestive evidence for a role of three additional genes, and show that at least 12% of analyzed individuals have an identifiable causal de novo mutation. Strikingly, 75% of mutations in these probands are predicted to disrupt a protein involved in regulating synaptic transmission, and there is a significant enrichment of de nova mutations in genes in this pathway in the entire cohort as well. These findings emphasize an important role for synaptic dysregulation in epileptic encephalopathies, above and beyond that caused by ion channel dysfunction.					Bautista, Jocelyn F./AAP-6901-2021; Marson, Anthony/AAW-9776-2020; Striano, Pasquale/F-9117-2014; French, Jacqueline A/G-6795-2013; May, Patrick/B-1238-2010; Marini, Carla/AAC-2413-2022; Gormley, Padhraig/L-1949-2018; Ottman, Ruth/O-2371-2013; O'Brien, Terence/L-8102-2013; Helbig, Ingo/G-8467-2018; Zara, Federico/U-3477-2017; Sander-Effron, Samuel/AAX-2231-2020; Scheffer, Ingrid E/G-1668-2013; Suls, Arvid/M-2694-2013; Craiu, Dana/ABE-4886-2020; Novotny, Edward J./ABG-9577-2021; May, Patrick/N-1019-2019; Thio, Liu Lin/A-4318-2008; Selmer, Kaja/AAM-7284-2021; Caglayan, Hande S/A-2368-2016; Effron, Sam Sander/AAF-9758-2021; O'Brien, Terence/AAU-5525-2021; Muhle, Hiltrud/F-5715-2010; Baulac, Stephanie/O-2099-2016; Goldstein, David/AAY-8125-2020; Shellhaas, Renee A/H-6697-2019; Depienne, Christel/AAL-3835-2021; Craiu, Dana/ABC-2986-2020; Stephani, Ulrich/D-1004-2010	Marson, Anthony/0000-0002-6861-8806; Striano, Pasquale/0000-0002-6065-1476; French, Jacqueline A/0000-0003-2242-8027; May, Patrick/0000-0001-8698-3770; Marini, Carla/0000-0002-9212-2691; Gormley, Padhraig/0000-0002-8908-6968; Ottman, Ruth/0000-0001-7074-242X; Helbig, Ingo/0000-0001-8486-0558; Zara, Federico/0000-0001-9744-5222; Scheffer, Ingrid E/0000-0002-2311-2174; Suls, Arvid/0000-0003-0328-198X; May, Patrick/0000-0001-8698-3770; Thio, Liu Lin/0000-0002-9779-7903; Caglayan, Hande S/0000-0001-6402-3306; Baulac, Stephanie/0000-0001-6430-4693; Depienne, Christel/0000-0002-7212-9554; Allen, Andrew/0000-0002-7232-2143	National Institute of Neurological Disorders and Stroke (The Epilepsy Phenome/Genome Project) [NS053998, Epi4K NS077364, NS077274, NS077303, NS077276]; Andrew's Foundation; Finding a Cure for Epilepsy and Seizures; Richard Thalheimer Philanthropic Fund; Eurocores program EuroEPINOMICS-RES of the European Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS077274, U01NS077364, U01NS077303, U01NS053998, U01NS077276] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (The Epilepsy Phenome/Genome Project NS053998; Epi4K NS077364, NS077274, NS077303, and NS077276), The Andrew's Foundation, Finding a Cure for Epilepsy and Seizures, the Richard Thalheimer Philanthropic Fund, and the Eurocores program EuroEPINOMICS-RES of the European Science Foundation. Additional funding sources are summarized in the Supplemental Acknowledgments. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Boumil RM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001046; Carvill GL, 2014, NEUROLOGY, V82, P1245, DOI 10.1212/WNL.0000000000000291; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kodera H, 2013, HUM MUTAT, V34, P1708, DOI 10.1002/humu.22446; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ogiwara I, 2009, NEUROLOGY, V73, P1046, DOI 10.1212/WNL.0b013e3181b9cebc; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; TORRE E, 1994, J BIOL CHEM, V269, P32411; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhu XL, 2014, NAT NEUROSCI, V17, P773, DOI 10.1038/nn.3713	33	251	256	0	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					360	370		10.1016/j.ajhg.2014.08.013			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	WOS:000342654300002		Green Published, Bronze			2022-01-24	
J	Pharoah, PDP; Tsai, YY; Ramus, SJ; Phelan, CM; Goode, EL; Lawrenson, K; Buckley, M; Fridley, BL; Tyrer, JP; Shen, H; Weber, R; Karevan, R; Larson, MC; Song, HL; Tessier, DC; Bacot, F; Vincent, D; Cunningham, JM; Dennis, J; Dicks, E; Katja, KA; Anton-Culver, H; Antonenkova, N; Armasu, SM; Baglietto, L; Bandera, EV; Beckmann, MW; Birrer, MJ; Bloom, G; Bogdanova, N; Brenton, JD; Brinton, LA; Brooks-Wilson, A; Brown, R; Butzow, R; Campbell, I; Carney, ME; Carvalho, RS; Chang-Claude, J; Chen, YA; Chen, ZH; Chow, WH; Cicek, MS; Coetzee, G; Cook, LS; Cramer, DW; Cybulski, C; Dansonka-Mieszkowska, A; Despierre, E; Doherty, JA; Doerk, T; du Bois, A; Duerst, M; Eccles, D; Edwards, R; Ekici, AB; Fasching, PA; Fenstermacher, D; Flanagan, J; Gao, YT; Garcia-Closas, M; Gentry-Maharaj, A; Giles, G; Gjyshi, A; Gore, M; Gronwald, J; Guo, Q; Halle, MK; Harter, P; Hein, A; Heitz, F; Hillemanns, P; Hoatlin, M; Hogdall, E; Hogdall, CK; Hosono, S; Jakubowska, A; Jensen, A; Kalli, KR; Karlan, BY; Kelemen, LE; Kiemeney, LA; Kjaer, SK; Konecny, GE; Krakstad, C; Kupryjanczyk, J; Lambrechts, D; Lambrechts, S; Le, ND; Lee, N; Lee, J; Leminen, A; Lim, BK; Lissowska, J; Lubinski, J; Lundvall, L; Lurie, G; Massuger, LFAG; Matsuo, K; McGuire, V; McLaughlin, JR; Menon, U; Modugno, F; Moysich, KB; Nakanishi, T; Narod, SA; Ness, RB; Nevanlinna, H; Nickels, S; Noushmehr, H; Odunsi, K; Olson, S; Orlow, I; Paul, J; Pejovic, T; Pelttari, LM; Permuth-Wey, J; Pike, MC; Poole, EM; Qu, XT; Risch, HA; Rodriguez-Rodriguez, L; Rossing, MA; Rudolph, A; Runnebaum, I; Rzepecka, IK; Salvesen, HB; Schwaab, I; Severi, G; Shen, H; Shridhar, V; Shu, XO; Sieh, W; Southey, MC; Spellman, P; Tajima, K; Teo, SH; Terry, KL; Thompson, PJ; Timorek, A; Tworoger, SS; van Altena, AM; van den Berg, D; Vergote, I; Vierkant, RA; Vitonis, AF; Wang-Gohrke, S; Wentzensen, N; Whittemore, AS; Wik, E; Winterhoff, B; Woo, YL; Wu, AH; Yang, HP; Zheng, W; Ziogas, A; Zulkifli, F; Goodman, MT; Hall, P; Easton, DF; Pearce, CL; Berchuck, A; Chenevix-Trench, G; Iversen, E; Monteiro, ANA; Gayther, SA; Schildkraut, JM; Sellers, TA				Pharoah, Paul D. P.; Tsai, Ya-Yu; Ramus, Susan J.; Phelan, Catherine M.; Goode, Ellen L.; Lawrenson, Kate; Buckley, Melissa; Fridley, Brooke L.; Tyrer, Jonathan P.; Shen, Howard; Weber, Rachel; Karevan, Rod; Larson, Melissa C.; Song, Honglin; Tessier, Daniel C.; Bacot, Francois; Vincent, Daniel; Cunningham, Julie M.; Dennis, Joe; Dicks, Ed; Aben, Katja K.; Anton-Culver, Hoda; Antonenkova, Natalia; Armasu, Sebastian M.; Baglietto, Laura; Bandera, Elisa V.; Beckmann, Matthias W.; Birrer, Michael J.; Bloom, Greg; Bogdanova, Natalia; Brenton, James D.; Brinton, Louise A.; Brooks-Wilson, Angela; Brown, Robert; Butzow, Ralf; Campbell, Ian; Carney, Michael E.; Carvalho, Renato S.; Chang-Claude, Jenny; Chen, Y. Anne; Chen, Zhihua; Chow, Wong-Ho; Cicek, Mine S.; Coetzee, Gerhard; Cook, Linda S.; Cramer, Daniel W.; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; Despierre, Evelyn; Doherty, Jennifer A.; Doerk, Thilo; du Bois, Andreas; Duerst, Matthias; Eccles, Diana; Edwards, Robert; Ekici, Arif B.; Fasching, Peter A.; Fenstermacher, David; Flanagan, James; Gao, Yu-Tang; Garcia-Closas, Montserrat; Gentry-Maharaj, Aleksandra; Giles, Graham; Gjyshi, Anxhela; Gore, Martin; Gronwald, Jacek; Guo, Qi; Halle, Mari K.; Harter, Philipp; Hein, Alexander; Heitz, Florian; Hillemanns, Peter; Hoatlin, Maureen; Hogdall, Estrid; Hogdall, Claus K.; Hosono, Satoyo; Jakubowska, Anna; Jensen, Allan; Kalli, Kimberly R.; Karlan, Beth Y.; Kelemen, Linda E.; Kiemeney, Lambertus A.; Kjaer, Susanne Kruger; Konecny, Gottfried E.; Krakstad, Camilla; Kupryjanczyk, Jolanta; Lambrechts, Diether; Lambrechts, Sandrina; Le, Nhu D.; Lee, Nathan; Lee, Janet; Leminen, Arto; Lim, Boon Kiong; Lissowska, Jolanta; Lubinski, Jan; Lundvall, Lene; Lurie, Galina; Massuger, Leon F. A. G.; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R.; Menon, Usha; Modugno, Francesmary; Moysich, Kirsten B.; Nakanishi, Toru; Narod, Steven A.; Ness, Roberta B.; Nevanlinna, Heli; Nickels, Stefan; Noushmehr, Houtan; Odunsi, Kunle; Olson, Sara; Orlow, Irene; Paul, James; Pejovic, Tanja; Pelttari, Liisa M.; Permuth-Wey, Jenny; Pike, Malcolm C.; Poole, Elizabeth M.; Qu, Xiaotao; Risch, Harvey A.; Rodriguez-Rodriguez, Lorna; Rossing, Mary Anne; Rudolph, Anja; Runnebaum, Ingo; Rzepecka, Iwona K.; Salvesen, Helga B.; Schwaab, Ira; Severi, Gianluca; Shen, Hui; Shridhar, Vijayalakshmi; Shu, Xiao-Ou; Sieh, Weiva; Southey, Melissa C.; Spellman, Paul; Tajima, Kazuo; Teo, Soo-Hwang; Terry, Kathryn L.; Thompson, Pamela J.; Timorek, Agnieszka; Tworoger, Shelley S.; van Altena, Anne M.; van den Berg, David; Vergote, Ignace; Vierkant, Robert A.; Vitonis, Allison F.; Wang-Gohrke, Shan; Wentzensen, Nicolas; Whittemore, Alice S.; Wik, Elisabeth; Winterhoff, Boris; Woo, Yin Ling; Wu, Anna H.; Yang, Hannah P.; Zheng, Wei; Ziogas, Argyrios; Zulkifli, Famida; Goodman, Marc T.; Hall, Per; Easton, Douglas F.; Pearce, Celeste L.; Berchuck, Andrew; Chenevix-Trench, Georgia; Iversen, Edwin; Monteiro, Alvaro N. A.; Gayther, Simon A.; Schildkraut, Joellen M.; Sellers, Thomas A.		Australian Canc Study; Australian Ovarian Canc Study Grp	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RISK; EXPRESSION; GENE; NEBULETTE; CARCINOMA; 19P13; MYC	Genome-wide association studies (GWAS) have identified four susceptibility loci for epithelial ovarian cancer (EOC), with another two suggestive loci reaching near genome-wide significance. We pooled data from a GWAS conducted in North America with another GWAS from the UK. We selected the top 24,551 SNPs for inclusion on the iCOGS custom genotyping array. We performed follow-up genotyping in 18,174 individuals with EOC (cases) and 26,134 controls from 43 studies from the Ovarian Cancer Association Consortium. We validated the two loci at 3q25 and 17q21 that were previously found to have associations close to genome-wide significance and identified three loci newly associated with risk: two loci associated with all EOC subtypes at 8q21 (rs11782652, P = 5.5 x 10(-9)) and 10p12 (rs1243180, P = 1.8 x 10(-8)) and another locus specific to the serous subtype at 17q12 (rs757210, P = 8.1 x 10(-10)). An integrated molecular analysis of genes and regulatory regions at these loci provided evidence for functional mechanisms underlying susceptibility and implicated CHMP4C in the pathogenesis of ovarian cancer.	[Pharoah, Paul D. P.; Tyrer, Jonathan P.; Song, Honglin; Dicks, Ed; Guo, Qi; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Pharoah, Paul D. P.; Dennis, Joe; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Tsai, Ya-Yu; Phelan, Catherine M.; Buckley, Melissa; Bloom, Greg; Chen, Y. Anne; Chen, Zhihua; Fenstermacher, David; Gjyshi, Anxhela; Permuth-Wey, Jenny; Qu, Xiaotao; Monteiro, Alvaro N. A.; Sellers, Thomas A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Div Populat Sci, Tampa, FL 33682 USA; [Ramus, Susan J.; Lawrenson, Kate; Shen, Howard; Karevan, Rod; Lee, Nathan; Lee, Janet; Pike, Malcolm C.; van den Berg, David; Wu, Anna H.; Pearce, Celeste L.; Gayther, Simon A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Goode, Ellen L.; Fridley, Brooke L.; Cicek, Mine S.; Vierkant, Robert A.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Weber, Rachel; Schildkraut, Joellen M.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Larson, Melissa C.; Armasu, Sebastian M.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Tessier, Daniel C.; Bacot, Francois; Vincent, Daniel] McGill Univ, Ctr Technol, Montreal, PQ, Canada; [Tessier, Daniel C.; Bacot, Francois; Vincent, Daniel] McGill Univ, Montreal, PQ, Canada; [Tessier, Daniel C.; Bacot, Francois; Vincent, Daniel] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Cunningham, Julie M.; Shridhar, Vijayalakshmi] Mayo Clin, Dept Lab Med & Pathol, Div Anat Pathol, Rochester, MN USA; [Aben, Katja K.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Dept Epidemiol, Ctr Canc Genet Res & Prevent, Irvine, CA 92717 USA; [Antonenkova, Natalia] NN Aleksandrov Byelorussian Inst Oncol & Med Radi, Minsk, BELARUS; [Baglietto, Laura; Giles, Graham; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Baglietto, Laura; Giles, Graham; Severi, Gianluca] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Bandera, Elisa V.; Rodriguez-Rodriguez, Lorna] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander] Univ Erlangen Nurnberg, Dept Gynecol & Obstet, Univ Hosp Erlangen, Ctr Comprehens Canc, D-91054 Erlangen, Germany; [Birrer, Michael J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Birrer, Michael J.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Bogdanova, Natalia; Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Brenton, James D.] Li Ka Shing Ctr, Cambridge Res Inst, Cambridge, England; [Brinton, Louise A.; Wentzensen, Nicolas; Yang, Hannah P.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Brown, Robert; Flanagan, James] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Campbell, Ian] Peter MacCallum Canc Ctr, Div Res, Canc Genet Lab, Melbourne, Vic, Australia; [Campbell, Ian] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Carney, Michael E.; Lurie, Galina; Thompson, Pamela J.; Goodman, Marc T.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Chang-Claude, Jenny; Nickels, Stefan; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chow, Wong-Ho] NCI, Div Canc Etiol & Genet, Bethesda, MD 20892 USA; [Coetzee, Gerhard; Noushmehr, Houtan] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Microbiol & Prevent Med, Los Angeles, CA 90033 USA; [Cook, Linda S.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Cramer, Daniel W.; Terry, Kathryn L.; Vitonis, Allison F.] Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Cramer, Daniel W.; Terry, Kathryn L.; Vitonis, Allison F.] Harvard Univ, Sch Med, Boston, MA USA; [Cramer, Daniel W.; Poole, Elizabeth M.; Terry, Kathryn L.; Tworoger, Shelley S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cybulski, Cezary; Gronwald, Jacek; Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr, Dept Mol Pathol, Warsaw, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Inst Oncol, Warsaw, Poland; [Despierre, Evelyn; Lambrechts, Sandrina; Vergote, Ignace] Leuven Canc Inst, Dept Obstet & Gynaecol, Div Gynecol Oncol, Louvain, Belgium; [Doherty, Jennifer A.] Geisel Sch Med Dartmouth, Sect Biostat & Epidemiol, Lebanon, NH USA; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Kliniken Essen Mitte Evang Huyssens Stiftung Knap, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Duerst, Matthias; Runnebaum, Ingo] Jena Univ Hosp, Dept Gynecol, Jena, Germany; [Eccles, Diana] Univ Southampton, Fac Med, Southampton Univ Hosp, Southampton SO9 5NH, Hants, England; [Edwards, Robert; Modugno, Francesmary] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Edwards, Robert] Magee Womens Res Inst, Womens Canc Program, Pittsburgh, PA USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Fasching, Peter A.; Konecny, Gottfried E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Garcia-Closas, Montserrat] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London, England; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Elizabeth Garrett Anderson Inst Womens Hlth, Gynaecol Canc Res Ctr, London, England; [Giles, Graham] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Gore, Martin] Royal Marsden Hosp, Gynecol Oncol Unit, London SW3 6JJ, England; [Halle, Mari K.; Krakstad, Camilla; Salvesen, Helga B.; Wik, Elisabeth] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Halle, Mari K.; Krakstad, Camilla; Salvesen, Helga B.; Wik, Elisabeth] Univ Bergen, Dept Clin Med, Bergen, Norway; [Hillemanns, Peter] Hannover Med Sch, Clin Obstet, Hannover, Germany; [Hillemanns, Peter] Hannover Med Sch, Clin Gynaecol, Hannover, Germany; [Hoatlin, Maureen] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Hogdall, Estrid; Jensen, Allan; Kjaer, Susanne Kruger] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Mol Unit, Copenhagen, Denmark; [Hogdall, Claus K.; Kjaer, Susanne Kruger; Lundvall, Lene] Rigshosp, Dept Obstet & Gynecol, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; [Hosono, Satoyo; Matsuo, Keitaro; Tajima, Kazuo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Kalli, Kimberly R.] Mayo Clin, Dept Med Oncol, Rochester, MN USA; [Karlan, Beth Y.] Cedars Sinai Med Ctr, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kelemen, Linda E.] Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada; [Kelemen, Linda E.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Le, Nhu D.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Lim, Boon Kiong; Woo, Yin Ling] Univ Malaya, Med Ctr, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Massuger, Leon F. A. G.; van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, NL-6525 ED Nijmegen, Netherlands; [McGuire, Valerie; Sieh, Weiva; Whittemore, Alice S.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [McLaughlin, John R.] Univ Toronto, Fac Med, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [McLaughlin, John R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Modugno, Francesmary] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Moysich, Kirsten B.; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Nakanishi, Toru] Aichi Canc Ctr Cent Hosp, Dept Gynecol Oncol, Nagoya, Aichi, Japan; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Ness, Roberta B.] Univ Texas Sch Publ Hlth, Houston, TX USA; [Noushmehr, Houtan; Shen, Hui] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Epigenome Ctr, Los Angeles, CA 90033 USA; [Olson, Sara; Orlow, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Paul, James] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Risch, Harvey A.] Yale Univ, Dept Epidemiol & Publ Hlth, Sch Publ Hlth, New Haven, CT 06520 USA; [Risch, Harvey A.] Yale Univ, Sch Med, New Haven, CT USA; [Rossing, Mary Anne] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rossing, Mary Anne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Schwaab, Ira] Inst Human Genet & Anthropol, Wiesbaden, Germany; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia; [Spellman, Paul] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Teo, Soo-Hwang; Zulkifli, Famida] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Teo, Soo-Hwang; Zulkifli, Famida] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Timorek, Agnieszka] Warsaw Med Univ, Fac Med 2, Dept Obstet Gynecol & Oncol, Warsaw, Poland; [Timorek, Agnieszka] Brodnowski Hosp, Dept Obstet & Gynaecol, Warsaw, Poland; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynaecol, D-89069 Ulm, Germany; [Winterhoff, Boris] Mayo Clin, Dept Obstet & Gynaecol, Rochester, MN USA; [Hall, Per] Karolinska Istitutet, Dept Epidemiol & Biostat, Stockholm, Sweden; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynaecol, Durham, NC USA; [Chenevix-Trench, Georgia] Queensland Inst Med Res, Canc Div, Herston, Qld 4006, Australia; [Iversen, Edwin] Duke Univ, Dept Stat, Durham, NC USA; [Schildkraut, Joellen M.] Duke Canc Inst, Canc Prevent Detect & Control Res Program, Durham, NC USA		Pharoah, PDP (corresponding author), Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England.	paul.pharoah@medschl.cam.ac.uk	Garcia-Closas, Montserrat/AAZ-6930-2021; salvesen, Helga B/C-1187-2017; Menon, Usha/C-4716-2008; Carvalho, Renato/AAK-3890-2020; McLaughlin, John R/E-4577-2013; Fasching, Peter/ABH-9912-2020; Matsuo, Keitaro/H-6758-2019; Jakubowska, Anna/O-8050-2014; Severi, Gianluca/Q-1824-2019; Garcia-Closas, Montserrat/F-3871-2015; Brenton, James D/B-3174-2008; Fridley, Brooke L/D-8315-2015; Woo, Yin Ling/B-5198-2010; Pharoah, Paul/V-6658-2019; Halle, Mari K/AAT-4856-2020; Brinton, Louise A/G-7486-2015; Brooks-Wilson, Angela/E-9399-2012; Coetzee, Gerhard/AAG-8439-2019; Bowtell, David/H-1007-2016; Whittemore, Alice S/F-9925-2014; Dork, Thilo/J-8620-2012; van Altena, Anne M/B-9824-2016; Wik, E./AAA-9105-2020; Eccles, Diana/K-6327-2019; Lambrechts, Diether/AAJ-3167-2020; Bandera, Elisa V/M-4169-2014; Krakstad, Camilla/AAB-5138-2020; Kiemeney, Lambertus A./D-3357-2009; Verdrengh, Evelien/H-4571-2012; Monteiro, Alvaro N. A./A-7566-2009; Severi, Gianluca/H-3774-2018; Zheng, Wei/O-3351-2013; Ramus, Susan/AAG-8352-2019; Narod, Steven A/AAA-6112-2022; Shen, Hui/AAO-4387-2020; coetzee, Gerhard/AAT-6203-2020; Ekici, Arif B/C-3971-2013; Vierkant, Robert/AAP-4927-2020; N, Houtan/C-9692-2013; Wentzensen, Nicolas/AAG-8522-2019; Teo, Soo-hwang/H-2353-2014; Massuger, Leon F.A.G./H-8072-2014; jones, Rob j/N-9379-2017; Van Den Berg, David J/G-8598-2017; Chenevix-Trench, Georgia/AAV-2014-2020; Aben, Katja KH/G-9686-2016; campbell, Ian G/F-6006-2011; Hein, Alexander/F-6999-2010; Bogdanova, Natalia V./Y-2205-2019; Lissowska, Jolanta/AAH-3252-2020; Baglietto, Laura/AAB-9051-2019; Gronwald, Jacek/A-4576-2017	Garcia-Closas, Montserrat/0000-0003-1033-2650; salvesen, Helga B/0000-0002-4438-8831; Menon, Usha/0000-0003-3708-1732; Matsuo, Keitaro/0000-0003-1761-6314; Jakubowska, Anna/0000-0002-5650-0501; Severi, Gianluca/0000-0001-7157-419X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Brenton, James D/0000-0002-5738-6683; Fridley, Brooke L/0000-0001-7739-7956; Woo, Yin Ling/0000-0003-1742-1066; Pharoah, Paul/0000-0001-8494-732X; Brinton, Louise A/0000-0003-3853-8562; Brooks-Wilson, Angela/0000-0003-1009-6408; Bowtell, David/0000-0001-9089-7525; Dork, Thilo/0000-0002-9458-0282; Eccles, Diana/0000-0002-9935-3169; Bandera, Elisa V/0000-0002-8789-2755; Krakstad, Camilla/0000-0002-0174-8139; Kiemeney, Lambertus A./0000-0002-2368-1326; Monteiro, Alvaro N. A./0000-0002-8448-4801; Severi, Gianluca/0000-0001-7157-419X; Zheng, Wei/0000-0003-1226-070X; Ramus, Susan/0000-0003-0005-7798; Ekici, Arif B/0000-0001-6099-7066; Vierkant, Robert/0000-0001-6242-5221; N, Houtan/0000-0003-4051-8114; Van Den Berg, David J/0000-0002-5404-5218; Chenevix-Trench, Georgia/0000-0002-1878-2587; Aben, Katja KH/0000-0002-0214-2147; Hein, Alexander/0000-0003-2601-3398; Lissowska, Jolanta/0000-0003-2695-5799; Gronwald, Jacek/0000-0002-3643-2871; Rzepecka, Iwona Krystyna/0000-0001-7305-6687; Olson, Sara/0000-0003-0182-2754; Kjaer, Susanne/0000-0002-8347-1398; Brown, Robert/0000-0001-7960-5755; Hogdall, Estrid/0000-0003-4689-5658; Heitz, Florian/0000-0002-2412-0352; Dansonka-Mieszkowska, Agnieszka/0000-0002-2482-6523; Giles, Graham/0000-0003-4946-9099; Campbell, Ian/0000-0002-7773-4155; Baglietto, Laura/0000-0002-8193-7529; Flanagan, James/0000-0003-4955-1383; Halle, Mari/0000-0002-2660-8271; Lubinski, Jan/0000-0003-2931-3003; Kupryjanczyk, Jolanta/0000-0001-5820-0214; Pelttari, Liisa/0000-0001-8091-9751; Rudolph, Anja/0000-0001-7520-2035; Southey, Melissa/0000-0002-6313-9005; Nevanlinna, Heli/0000-0002-0916-2976; Dennis, Joe/0000-0003-4591-1214; Orlow, Irene/0000-0001-6234-6961; Paul, James/0000-0001-7367-5816; Coetzee, Gerhard/0000-0001-8820-8364; Weber, Rachel/0000-0001-7119-7734; Hogdall, Claus/0000-0002-5959-8874; Tworoger, Shelley/0000-0002-6986-7046; Shen, Hui/0000-0001-9767-4084; Lambrechts, Diether/0000-0002-3429-302X; Jensen, Allan/0000-0001-8124-4880	European Commission's Seventh Framework ProgrammeEuropean Commission [223175, HEALTH-F22009-223175]; Ovarian Cancer Research Fund; Genetic Associations and Mechanisms in Oncology (GAME-ON); National Cancer Institute Cancer Post-GWAS Initiative [U19-CA148112]; Wellcome TrustWellcome TrustEuropean Commission [076113]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIACP010126, R01CA087538, U19CA148112, R37CA070867, P30CA072720, P30CA008748, R01CA112523, R01CA083918, P50CA136393, R01CA122443, P30CA016672, R01CA149429, P30CA076292] Funding Source: NIH RePORTER; Cancer Research UKCancer Research UK [16561, 15601, 10118, 13086, 15960, 11022] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish	We thank all the individuals who took part in this study and all the researchers, clinicians and technical and administrative staff who made possible the many studies contributing to this work (a full list is provided in the Supplementary Note). The COGS project is funded through a European Commission's Seventh Framework Programme grant (agreement number 223175 - HEALTH-F22009-223175). The Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). The scientific development and funding for this project were supported in part by the Genetic Associations and Mechanisms in Oncology (GAME-ON) and a National Cancer Institute Cancer Post-GWAS Initiative (U19-CA148112). Details of the funding of individual investigators and studies are provided in the Supplementary Note. This study made use of data generated by the Wellcome Trust Case Control consortium; funding for the project was provided by the Wellcome Trust under award 076113. A full list of the investigators who contributed to the generation of the data is available from the website (see URLs). The results published here are based in part on data generated by The Cancer Genome Atlas Pilot Project established by the National Cancer Institute and National Human Genome Research Institute; information about The Cancer Genome Atlas (TCGA) and the investigators and institutions who constitute the TCGA research network can be found on the website (see URLs).	Antoniou Antonis C, 2006, Future Oncol, V2, P257, DOI 10.2217/14796694.2.2.257; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Caudell D, 2008, LEUKEMIA, V22, P678, DOI 10.1038/sj.leu.2405074; Coser VM, 2010, CANCER GENET CYTOGEN, V198, P151, DOI 10.1016/j.cancergencyto.2009.12.013; Elliott KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010858; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hindorff L.A., 2013, CATALOGUE PUBLISHED; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kato N, 2006, MODERN PATHOL, V19, P83, DOI 10.1038/modpathol.3800492; Kato N, 2009, HISTOL HISTOPATHOL, V24, P1479, DOI 10.14670/HH-24.1479; Kim MJ, 2011, CLIN PHARMACOL THER, V89, P571, DOI 10.1038/clpt.2010.353; Lawrenson K, 2010, NEOPLASIA, V12, P317, DOI 10.1593/neo.91948; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nikolova DN, 2009, MOL MED REP, V2, P365, DOI 10.3892/mmr_00000109; Ram R, 2010, J AM COLL CARDIOL, V56, P1503, DOI 10.1016/j.jacc.2010.06.031; Salzman J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001156; Shen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2629; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x	31	251	258	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					362	370		10.1038/ng.2564			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	WOS:000316840600006	23535730	Green Submitted, Green Accepted			2022-01-24	
J	Nikolenko, SI; Korobeynikov, AI; Alekseyev, MA				Nikolenko, Sergey I.; Korobeynikov, Anton I.; Alekseyev, Max A.			BayesHammer: Bayesian clustering for error correction in single-cell sequencing	BMC GENOMICS			English	Article; Proceedings Paper	11th Asia Pacific Bioinformatics Conference (APBC)	JAN 21-24, 2013	Vancouver, CANADA				BACTERIAL GENOMES; MICROBIOME	Error correction of sequenced reads remains a difficult task, especially in single-cell sequencing projects with extremely non-uniform coverage. While existing error correction tools designed for standard (multi-cell) sequencing data usually come up short in single-cell sequencing projects, algorithms actually used for single-cell error correction have been so far very simplistic. We introduce several novel algorithms based on Hamming graphs and Bayesian subclustering in our new error correction tool BAYESHAMMER. While BAYESHAMMER was designed for single-cell sequencing, we demonstrate that it also improves on existing error correction tools for multi-cell sequencing data while working much faster on real-life datasets. We benchmark BAYESHAMMER on both k-mer counts and actual assembly results with the SPADES genome assembler.	[Nikolenko, Sergey I.; Korobeynikov, Anton I.; Alekseyev, Max A.] Acad Univ, Algorithm Biol Lab, St Petersburg, Russia; [Korobeynikov, Anton I.] St Petersburg State Univ, St Petersburg, Russia; [Alekseyev, Max A.] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA		Nikolenko, SI (corresponding author), Acad Univ, Algorithm Biol Lab, St Petersburg, Russia.	sergey@logic.pdmi.ras.ru	Nikolenko, Sergey I/I-7696-2013; Sun, Kun/Q-6479-2018; Nikolenko, Sergey/AAU-3615-2020; Korobeynikov, Anton/D-3555-2009; Alekseyev, Max/D-9362-2016	Nikolenko, Sergey I/0000-0001-7787-2251; Sun, Kun/0000-0002-9883-1616; Nikolenko, Sergey/0000-0001-7787-2251; Korobeynikov, Anton/0000-0002-2937-9259; Alekseyev, Max/0000-0002-5140-8095			Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cormen TH, 2009, INTRO ALGORITHMS; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grindberg RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018565; Gurevich A, 2012, QUAST QUALITY ASSESS; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Medvedev P, 2011, BIOINFORMATICS, V27, pI137, DOI 10.1093/bioinformatics/btr208; Roberts M, 2004, BIOINFORMATICS, V20, P3363, DOI 10.1093/bioinformatics/bth408; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136	15	251	252	2	28	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JAN 21	2013	14			1					S7	10.1186/1471-2164-14-S1-S7			11	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biotechnology & Applied Microbiology; Genetics & Heredity	083NK	WOS:000314471000007	23368723	Green Published, gold, Green Submitted			2022-01-24	
J	Jordan, CT; Cao, L; Roberson, EDO; Pierson, KC; Yang, CF; Joyce, CE; Ryan, C; Duan, SH; Helms, CA; Liu, Y; Chen, YQ; McBride, AA; Hwu, WL; Wu, JY; Chen, YT; Menter, A; Goldbach-Mansky, R; Lowes, MA; Bowcock, AM				Jordan, Catherine T.; Cao, Li; Roberson, Elisha D. O.; Pierson, Katherine C.; Yang, Chi-Fan; Joyce, Cailin E.; Ryan, Caitriona; Duan, Shenghui; Helms, Cynthia A.; Liu, Yin; Chen, Yongqing; McBride, Alison A.; Hwu, Wuh-Liang; Wu, Jer-Yuarn; Chen, Yuan-Tsong; Menter, Alan; Goldbach-Mansky, Raphaela; Lowes, Michelle A.; Bowcock, Anne M.			PSORS2 Is Due to Mutations in CARD14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; GENOME-WIDE ASSOCIATION; PSORIASIS SUSCEPTIBILITY LOCI; IDENTIFICATION; PATHOGENESIS; REGULATOR; PROMOTER; VARIANT; FAMILY; GENES	Psoriasis is a common, immune-mediated genetic disorder of the skin and is associated with arthritis in approximately 30% of cases. Previously, we localized PSORS2 (psoriasis susceptibility locus 2) to chromosomal region 17q25.3-qter after a genome-wide linkage scan in a family of European ancestry with multiple cases of psoriasis and psoriatic arthritis. Linkage to PSORS2 was also observed in a Taiwanese family with multiple psoriasis-affected members. In caspase recruitment domain family, member 14 (CARD14), we identified unique gain-of-function mutations that segregated with psoriasis by using genomic capture and DNA sequencing. The mutations c.349G>A (p.Gly117Ser) (in the family of European descent) and c.349+5G>A (in the Taiwanese family) altered splicing between CARD14 exons 3 and 4. A de novo CARD14 mutation, c.413A>C (p.Glu138Ala), was detected in a child with sporadic, early-onset, generalized pustular psoriasis. CARD14 activates nuclear factor kappa B (NF-kB), and compared with wild-type CARD14, the p.Gly117Ser and p.Glu138Ala substitutions were shown to lead to enhanced NF-kB activation and upregulation of a subset of psoriasis-associated genes in keratinocytes. These genes included chemokine (C-C motif) ligand 20 (CCL20) and interleukin 8 (IL8). CARD14 is localized mainly in the basal and suprabasal layers of healthy skin epidermis, whereas in lesional psoriatic skin, it is reduced in the basal layer and more diffusely upregulated in the suprabasal layers of the epidermis. We propose that, after a triggering event that can include epidermal injury, rare gain-of-function mutations in CARD14 initiate a process that includes inflammatory cell recruitment by keratinocytes. This perpetuates a vicious cycle of epidermal inflammation and regeneration, a cycle which is the hallmark of psoriasis.	[Jordan, Catherine T.; Cao, Li; Roberson, Elisha D. O.; Joyce, Cailin E.; Duan, Shenghui; Helms, Cynthia A.; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA; [Pierson, Katherine C.; Lowes, Michelle A.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10065 USA; [Yang, Chi-Fan; Wu, Jer-Yuarn; Chen, Yuan-Tsong] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Ryan, Caitriona; Menter, Alan] Baylor Univ, Med Ctr, Psoriasis Res Inst, Dallas, TX 75246 USA; [Liu, Yin; Chen, Yongqing; Goldbach-Mansky, Raphaela] NIAMSD, NIH, Bethesda, MD 20892 USA; [McBride, Alison A.] NIAID, NIH, Bethesda, MD 20892 USA; [Hwu, Wuh-Liang] Natl Taiwan Univ Hosp, Dept Pediat & Med Genet, Taipei 100, Taiwan; [Hwu, Wuh-Liang] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan		Bowcock, AM (corresponding author), Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA.	bowcock@genetics.wustl.edu	Roberson, Elisha/ABC-1810-2020; Wu, Jer-Yuarn/S-7010-2018; Goldbach-Mansky, Raphaela/N-5917-2017; Roberson, Elisha D.O./J-1747-2012; Lowes, Michelle A/G-9585-2016	Roberson, Elisha/0000-0001-5921-2399; Roberson, Elisha D.O./0000-0001-5921-2399; Ryan, Caitriona/0000-0003-1915-546X; McBride, Alison/0000-0001-5607-5157; HWU, WUH-LIANG/0000-0001-6690-4879; Bowcock, Anne/0000-0001-8691-9090; Lowes, Michelle A/0000-0003-4256-478X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AR050266, 5RC1AR058681, T32AR007279, T32HL083822, T32GM07200, AR060222, T32HG000045]; National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); Academia SinicaAcademia Sinica - Taiwan; National Science Council (National Clinical Core, National Genotyping Core) of Taiwan; National Psoriasis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL083822] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [T32HG000045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [ZIAAI001145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [T32AR007279, ZIDAR041180, ZIAAR041138, R01AR050266, R01AR060222, ZIEAR041176, RC1AR058681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007200] Funding Source: NIH RePORTER	This research was supported by the following grants from the National Institutes of Health: AR050266 and 5RC1AR058681 (A.M.B.), T32AR007279 (E.D.O.R.), T32HL083822 and T32GM07200 (C.T.J), AR060222 (M.A.L and K.C.P), and T32HG000045 (C.E.J). R.G.M., Y.L., and Y.C. are supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. A.A.M. was supported by the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases. Additional funding came from the Academia Sinica and National Science Council (National Clinical Core, National Genotyping Core) of Taiwan. The authors thank the many individuals with psoriasis and the controls who participated in this study. Mike Lovett provided helpful comments on the manuscript. The authors are indebted to the National Psoriasis Foundation for continuing support during the course of this study.	Abecasis G, 2005, J INVEST DERMATOL, V124, P921, DOI 10.1111/j.0022-202X.2005.23729.x; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hwu WL, 2005, J MED GENET, V42, P152, DOI 10.1136/jmg.2004.018564; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; KAUR P, 1989, J GEN VIROL, V70, P1261, DOI 10.1099/0022-1317-70-5-1261; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nograles KE, 2009, NAT CLIN PRACT RHEUM, V5, P83, DOI 10.1038/ncprheum0987; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Prots I, 2006, ARTHRITIS RHEUM-US, V54, P1491, DOI 10.1002/art.21832; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Singh G, 2006, BIOTECHNIQUES, V41, P177, DOI 10.2144/000112208; Speckman RA, 2003, HUM GENET, V112, P34, DOI 10.1007/s00439-002-0851-y; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Sticherling M, 1999, ACTA DERM-VENEREOL, V79, P4; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Vineis P, 2011, CARCINOGENESIS, V32, P1295, DOI 10.1093/carcin/bgr087; Yang CF, 2008, J INVEST DERMATOL, V128, P1662, DOI 10.1038/jid.2008.1	50	251	261	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					784	795		10.1016/j.ajhg.2012.03.012			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	WOS:000303907500003	22521418	Green Published, Bronze			2022-01-24	
J	Prickett, TD; Agrawal, NS; Wei, XM; Yates, KE; Lin, JC; Wunderlich, JR; Cronin, JC; Cruz, P; Rosenberg, SA; Samuels, Y				Prickett, Todd D.; Agrawal, Neena S.; Wei, Xiaomu; Yates, Kristin E.; Lin, Jimmy C.; Wunderlich, John R.; Cronin, Julia C.; Cruz, Pedro; Rosenberg, Steven A.; Samuels, Yardena		NISC Comparative Sequencing Progra	Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; CANCER; INHIBITOR; KINASES; BREAST; ACTIVATION; RESISTANCE; LAPATINIB; PATHWAYS	Tyrosine phosphorylation is important in signaling pathways underlying tumorigenesis. We performed a mutational analysis of the protein tyrosine kinase (PTK) gene family in cutaneous metastatic melanoma. We identified 30 somatic mutations affecting the kinase domains of 19 PTKs and subsequently evaluated the entire coding regions of the genes encoding these 19 PTKs for somatic mutations in 79 melanoma samples. We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas. We examined seven missense mutations in the most commonly altered PTK gene, ERBB4, and found that they resulted in increased kinase activity and transformation ability. Melanoma cells expressing mutant ERBB4 had reduced cell growth after shRNA-mediated knockdown of ERBB4 or treatment with the ERBB inhibitor lapatinib. These studies could lead to personalized therapeutics specifically targeting the kinases that are mutationally altered in individual melanomas.	[Prickett, Todd D.; Agrawal, Neena S.; Wei, Xiaomu; Yates, Kristin E.; Cronin, Julia C.; Samuels, Yardena] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Lin, Jimmy C.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Wunderlich, John R.; Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Cruz, Pedro] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [NISC Comparative Sequencing Progra] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA		Samuels, Y (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	samuelsy@mail.nih.gov		Samuels, Yardena/0000-0002-3349-7266	National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI); National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZICBC010905, ZIABC010984] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [ZIAHG200337, ZIBHG000196] Funding Source: NIH RePORTER	We thank B. Vogelstein, T. Waldman, D. Bell, P. Meltzer, L. Brody, G. Merlino, S. Gutkind and I. Cardenas-Navia for their helpful comments on the manuscript; members of the NISC Comparative Sequencing Program for generating the sequence data analyzed here; and S. Anderson and M. Kirby for assistance with FACS analysis. This work supported by the Intramural Research Programs of the National Human Genome Research Institute and National Cancer Institute, National Institutes of Health, USA.	Allen LF, 2003, SEMIN ONCOL, V30, P65, DOI 10.1053/j.seminoncol.2003.08.009; Bhangale TR, 2006, NAT GENET, V38, P1457, DOI 10.1038/ng1925; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Chappell DB, 1999, CANCER RES, V59, P59; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Frey MR, 2009, GASTROENTEROLOGY, V136, P217, DOI 10.1053/j.gastro.2008.09.023; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heymach JV, 2006, CLIN CANCER RES, V12, p4441S, DOI 10.1158/1078-0432.CCR-06-0286; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; McHugh LA, 2009, INT J ONCOL, V34, P1155, DOI 10.3892/ijo_00000244; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shih LY, 2004, CLIN CANCER RES, V10, P1326, DOI 10.1158/1078-0432.CCR-0835-03; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774	30	251	254	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1127	U112		10.1038/ng.438			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	WOS:000270330400018	19718025	Green Accepted			2022-01-24	
J	Kanetsky, PA; Mitra, N; Vardhanabhuti, S; Li, MY; Vaughn, DJ; Letrero, R; Ciosek, SL; Doody, DR; Smith, LM; Weaver, J; Albano, A; Chen, C; Starr, JR; Rader, DJ; Godwin, AK; Reilly, MP; Hakonarson, H; Schwartz, SM; Nathanson, KL				Kanetsky, Peter A.; Mitra, Nandita; Vardhanabhuti, Saran; Li, Mingyao; Vaughn, David J.; Letrero, Richard; Ciosek, Stephanie L.; Doody, David R.; Smith, Lauren M.; Weaver, JoEllen; Albano, Anthony; Chen, Chu; Starr, Jacqueline R.; Rader, Daniel J.; Godwin, Andrew K.; Reilly, Muredach P.; Hakonarson, Hakon; Schwartz, Stephen M.; Nathanson, Katherine L.			Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TUMOR SUSCEPTIBILITY; FACTOR-RECEPTOR; PROLIFERATION; PIGMENTATION; ACTIVATION; FERTILITY; MIGRATION; ETIOLOGY; HUMANS	Testicular germ cell tumors (TGCT) have been expected to have a strong underlying genetic component. We conducted a genome-wide scan among 277 TGCT cases and 919 controls and found that seven markers at 12p22 within KITLG (c-KIT ligand) reached genome-wide significance (P < 5.0 x 10 (-8) in discovery). In independent replication, TGCT risk was increased threefold per copy of the major allele at rs3782179 and rs4474514 (OR = 3.08, 95% CI = 2.29-4.13; OR = 3.07, 95% CI 2.29-4.13, respectively). We found associations with rs4324715 and rs6897876 at 5q31.3 near SPRY4 (sprouty 4; P < 5.0 x 10(-6) in discovery). In independent replication, risk of TGCT was increased nearly 40% per copy of the major allele (OR = 1.37, 95% CI = 1.14-1.64; OR = 1.39, 95% CI = 1.16-1.66, respectively). All of the genotypes were associated with both seminoma and nonseminoma TGCT subtypes. These results demonstrate that common genetic variants affect TGCT risk and implicate KITLG and SPRY4 as genes involved in TGCT susceptibility.	[Kanetsky, Peter A.; Mitra, Nandita; Vaughn, David J.; Letrero, Richard; Ciosek, Stephanie L.; Nathanson, Katherine L.] Univ Penn, Sch Med, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA; [Vaughn, David J.] Univ Penn, Sch Med, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA; [Letrero, Richard; Ciosek, Stephanie L.; Smith, Lauren M.; Nathanson, Katherine L.] Univ Penn, Sch Med, Div Med Genet, Dept Med, Philadelphia, PA 19104 USA; [Kanetsky, Peter A.; Mitra, Nandita; Vardhanabhuti, Saran; Li, Mingyao] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Dept Med, Philadelphia, PA 19104 USA; [Doody, David R.; Starr, Jacqueline R.; Schwartz, Stephen M.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Weaver, JoEllen; Godwin, Andrew K.] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Albano, Anthony; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Albano, Anthony; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Chen, Chu; Starr, Jacqueline R.; Schwartz, Stephen M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Starr, Jacqueline R.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA		Nathanson, KL (corresponding author), Univ Penn, Sch Med, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA.	knathans@mail.med.upenn.edu		Doody, David/0000-0003-2291-6493; Nathanson, Katherine/0000-0002-6740-0901; Reilly, Muredach/0000-0002-3035-9386; Starr, Jacqueline/0000-0002-3039-2311	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA085914, R01 CA114478, R01 CA085914-04, R01 CA085914-07, R01 CA085914-05, R01 CA085914-10, R01 CA085914-01, R01 CA085914-03, R01 CA085914-02S1, R01 CA085914-08, P30 CA006927-41, P30 CA006927, R01 CA085914-02, R01 CA085914-09, R01 CA114478-01A2, R01 CA085914-06] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30 ES007033, P30 ES007033-15] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA006927, R01CA114478, R01CA085914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES007033] Funding Source: NIH RePORTER		Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Crockford GP, 2006, HUM MOL GENET, V15, P443, DOI 10.1093/hmg/ddi459; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frolov A, 2003, MOL CANCER THER, V2, P699; Heaney JD, 2008, CANCER RES, V68, P5193, DOI 10.1158/0008-5472.CAN-08-0779; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rapley EA, 2000, NAT GENET, V24, P197, DOI 10.1038/72877; Richiardi L, 2005, CANCER EPIDEM BIOMAR, V14, P2557, DOI 10.1158/1055-9965.EPI-05-0409; Ries L. A. G., 2008, SEER CANC STAT REV 1; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Starr JR, 2005, CANCER EPIDEM BIOMAR, V14, P2183, DOI 10.1158/1055-9965.EPI-04-0749; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Zama AM, 2005, BIOL REPROD, V73, P639, DOI 10.1095/biolreprod.105.042846	30	251	256	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					811	U65		10.1038/ng.393			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	WOS:000267786200011	19483682	Green Accepted			2022-01-24	
J	He, CY; Kraft, P; Chen, C; Buring, JE; Pare, G; Hankinson, SE; Chanock, SJ; Ridker, PM; Hunter, DJ; Chasman, DI				He, Chunyan; Kraft, Peter; Chen, Constance; Buring, Julie E.; Pare, Guillaume; Hankinson, Susan E.; Chanock, Stephen J.; Ridker, Paul M.; Hunter, David J.; Chasman, Daniel I.			Genome-wide association studies identify loci associated with age at menarche and age at natural menopause	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; REPRODUCTIVE FACTORS; LINKAGE ANALYSIS; BREAST-CANCER; SCAN; RISK; REPLICATION; PROTEIN; GENES; TWIN	Age at menarche and age at natural menopause are associated with causes of substantial morbidity and mortality such as breast cancer and cardiovascular disease. We conducted a joint analysis of two genome-wide association studies of these two traits in a total of 17,438 women from the Nurses' Health Study (NHS, N = 2,287) and the Women's Genome Health Study (WGHS, N = 15,151). For age at menarche, we identified ten associated SNPs (P = 1 x 10(-7)-3 x 10(-13)) clustered at 6q21 (in or near the gene LIN28B) and 9q31.2 (in an intergenic region). For age at natural menopause, we identified 13 associated SNPs (P = 1 x 10(-7)-1 x 10(-21)) clustered at 20p12.3 (in the gene MCM8), 19q13.42 (in or near the gene BRSK1), 5q35.2 (in or near genes UIMC1 and HK3) and 6p24.2 (in the gene SYCP2L). These newly identified loci might expand understanding of the biological pathways regulating these two traits.	[He, Chunyan; Kraft, Peter; Chen, Constance; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [He, Chunyan; Kraft, Peter; Chen, Constance; Buring, Julie E.; Hankinson, Susan E.; Ridker, Paul M.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Buring, Julie E.; Pare, Guillaume; Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02115 USA; [Buring, Julie E.; Pare, Guillaume; Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Div Prevent Med, Boston, MA 02115 USA; [Pare, Guillaume; Ridker, Paul M.; Chasman, Daniel I.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Hankinson, Susan E.; Hunter, David J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA; [Chanock, Stephen J.; Hunter, David J.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hunter, David J.] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA		He, CY (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	che@hsph.harvard.edu	Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL 043851, HL69757]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA 047988, CA 40356, U01-CA98233]; Donald W. Reynolds Foundation; Fondation LeducqLeducq Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA098233, R37CA040356, R01CA040356, R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL043851, U19HL069757, U01HL069757] Funding Source: NIH RePORTER	We thank J. Miletich and A. Parker as well as the technical staff at Amgen for their collaboration and scientific support in performing the genotyping for the WGHS. The NHS GWAS was performed as part of the Cancer Genetic Markers of Susceptibility initiative of the NCI. We particularly acknowledge the contributions of R. Hoover, A. Hutchinson, K. Jacobs and G. Thomas. We thank J. Chen for discussion of gene functions. We thank H. Ranu and P. Soule for assistance. The WGHS is supported by HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The NHS is supported by CA 40356 and U01-CA98233 from the National Cancer Institute. We acknowledge the study participants in the NHS and the WGHS for their contribution in making this study possible.	Anderson CA, 2008, J CLIN ENDOCR METAB, V93, P3965, DOI 10.1210/jc.2007-2568; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Cui R, 2006, J EPIDEMIOL, V16, P177, DOI 10.2188/jea.16.177; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; Guo Y, 2006, J CLIN ENDOCR METAB, V91, P1009, DOI 10.1210/jc.2005-2179; He LN, 2007, J GENET, V86, P269, DOI 10.1007/s12041-007-0034-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hooft L, 2008, CLIN ENDOCRINOL, V68, P252, DOI 10.1111/j.1365-2265.2007.03031.x; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kinoshita Y, 2008, MICROSC RES TECHNIQ, V71, P288, DOI 10.1002/jemt.20553; KVALE G, 1992, ACTA ONCOL, V31, P187, DOI 10.3109/02841869209088901; MEYER JM, 1991, AM J MED GENET, V39, P148, DOI 10.1002/ajmg.1320390207; Murabito JM, 2005, FERTIL STERIL, V84, P1674, DOI 10.1016/j.fertnstert.2005.05.046; Murabito JM, 2005, J CLIN ENDOCR METAB, V90, P3427, DOI 10.1210/jc.2005-0181; Paganini-Hill A, 2005, J WOMENS HEALTH, V14, P808, DOI 10.1089/jwh.2005.14.808; Pan F, 2008, HUM GENET, V123, P419, DOI 10.1007/s00439-008-0490-z; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rothenbuhler A, 2006, J CLIN ENDOCR METAB, V91, P3534, DOI 10.1210/jc.2006-0150; Sharma K, 2002, AM J PHYS ANTHROPOL, V117, P327, DOI 10.1002/ajpa.10055; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; van Asselt KM, 2004, AM J HUM GENET, V74, P444, DOI 10.1086/382136; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063	30	251	261	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					724	728		10.1038/ng.385			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	WOS:000266411700023	19448621	Green Accepted, Green Published			2022-01-24	
J	Kornak, U; Reynders, E; Dimopoulou, A; van Reeuwijk, J; Fischer, B; Rajab, A; Budde, B; Nurnberg, P; Foulquier, F; Lefeber, D; Urban, Z; Gruenewald, S; Annaert, W; Brunner, HG; van Bokhoven, H; Wevers, R; Morava, E; Matthijs, G; Van Maldergem, L; Mundlos, S				Kornak, Uwe; Reynders, Ellen; Dimopoulou, Aikaterini; van Reeuwijk, Jeroen; Fischer, Bjoern; Rajab, Anna; Budde, Birgit; Nurnberg, Peter; Foulquier, Francois; Lefeber, Dirk; Urban, Zsolt; Gruenewald, Stephanie; Annaert, Wim; Brunner, Han G.; van Bokhoven, Hans; Wevers, Ron; Morava, Eva; Matthijs, Gert; Van Maldergem, Lionel; Mundlos, Stefan		ARCL Debre-type Study Grp	Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2	NATURE GENETICS			English	Article							CONGENITAL DISORDER; DEFICIENCY REVEALS; COMPLEX-FORMATION; V-ATPASE; DEFECTS; PATHWAY; PH	We identified loss-of-function mutations in ATP6V0A2, encoding the a2 subunit of the V-type H+ ATPase, in several families with autosomal recessive cutis laxa type II or wrinkly skin syndrome. The mutations result in abnormal glycosylation of serum proteins (CDG-II) and cause an impairment of Golgi trafficking in fibroblasts from affected individuals. These results indicate that the a2 subunit of the proton pump has an important role in Golgi function.	[Kornak, Uwe; Dimopoulou, Aikaterini; Fischer, Bjoern; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, Berlin, Germany; [Kornak, Uwe; Dimopoulou, Aikaterini; Fischer, Bjoern; Mundlos, Stefan] Max Planck Inst Mol Genet, Berlin, Germany; [Reynders, Ellen; Annaert, Wim] Katholieke Univ Leuven, Ctr Human Genet, Lab Membrane Trafficking, B-3000 Louvain, Belgium; [Reynders, Ellen; Annaert, Wim] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [van Reeuwijk, Jeroen; Brunner, Han G.; van Bokhoven, Hans] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-3525 GA Nijmegen, Netherlands; [Rajab, Anna] Minist Hlth, Directorate Gen Hlth Affairs, Genet Unit, Muscat 113, Oman; [Budde, Birgit; Nurnberg, Peter] Univ Cologne, CCG, D-50674 Cologne, Germany; [Budde, Birgit; Nurnberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Foulquier, Francois; Matthijs, Gert; Mundlos, Stefan] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Diagnost, B-3000 Louvain, Belgium; [Lefeber, Dirk; Wevers, Ron; Morava, Eva] Univ Med Ctr Nijmegen, Lab Peiat & Neurol, Dept Pediat, NL-6525 GA Nijmegen, Netherlands; [Urban, Zsolt] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Urban, Zsolt] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Gruenewald, Stephanie] Great Ormond St Hosp Children Trust NHS, London WC1N 3JH, England; [Van Maldergem, Lionel] Univ Liege, CHU Sart Tilman, Ctr Genet Humaine, B-4000 Liege, Belgium		Kornak, U (corresponding author), Charite Univ Med Berlin, Inst Med Genet, Berlin, Germany.	uwe.kornak@charite.de	van Reeuwijk, Jeroen/P-8665-2015; Lefeber, Dirk DJ/A-2146-2014; Brunner, Han/C-9928-2013; Nanda, Arti/H-8565-2019; Mundlos, Stefan/ABH-9585-2020; Van Maldergem, Lionel/O-3242-2019; lefeber, dirk/G-5063-2012; van Bokhoven, Hans/D-8764-2012; Fischer-Zirnsak, Bjorn/D-7487-2013; Morava, E./L-4529-2015; Urban, Zsolt/A-2018-2013; FOULQUIER, FRANCOIS/AAI-1182-2021; Wevers, Ron A./H-8116-2014; foulquier, francois/ABE-5886-2020; Bokhoven, J.H.L.M. van van/H-8015-2014; Urban, Zsolt/B-1977-2008; Van Maldergem, Lionel/G-9849-2017; Salih, Mustafa/C-1222-2014	van Reeuwijk, Jeroen/0000-0002-0658-4399; Van Maldergem, Lionel/0000-0001-8880-5214; Fischer-Zirnsak, Bjorn/0000-0002-1075-7571; Urban, Zsolt/0000-0003-3890-1843; Wevers, Ron A./0000-0003-2278-9746; foulquier, francois/0000-0002-6551-3240; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Van Maldergem, Lionel/0000-0001-8880-5214; Quelhas, Dulce/0000-0001-9989-9236; Leao Teles, Elisa/0000-0002-3011-0249; Nanda, Arti/0000-0002-1223-3181; Matthijs, Gert/0000-0001-6710-1912; Budde, Birgit/0000-0001-9385-4168; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Salih, Mustafa/0000-0002-4379-2111; Foulquier, Francois/0000-0001-5084-4015; Dobyns, William/0000-0002-7681-2844			Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Foulquier F, 2007, HUM MOL GENET, V16, P717, DOI 10.1093/hmg/ddl476; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morava E, 2005, EUR J HUM GENET, V13, P414, DOI 10.1038/sj.ejhg.5201361; MORAVA E, IN PRESS EUR J HUM G; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; RAJAB A, IN PRESS AM J MED GE; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	15	251	257	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					32	34		10.1038/ng.2007.45			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	WOS:000252118600015	18157129				2022-01-24	
J	Rosendahl, J; Witt, H; Szmola, R; Bhatia, E; Ozsvari, B; Landt, O; Schulz, HU; Gress, TM; Pfuetzer, R; Loehr, M; Kovacs, P; Blueher, M; Stumvoll, M; Choudhuri, G; Hegyi, P; Morsche, RHT; Drenth, JP; Truninger, K; Macek, M; Puhl, G; Witt, U; Schmidt, H; Buening, C; Ockenga, J; Kage, A; Groneberg, DA; Nickel, R; Berg, T; Wiedenmann, B; Boedeker, H; Keim, V; Moessner, J; Teich, N; Sahin-Toth, M				Rosendahl, Jonas; Witt, Heiko; Szmola, Richard; Bhatia, Eesh; Ozsvari, Bela; Landt, Olfert; Schulz, Hans-Ulrich; Gress, Thomas M.; Pfuetzer, Roland; Loehr, Matthias; Kovacs, Peter; Blueher, Matthias; Stumvoll, Michael; Choudhuri, Gourdas; Hegyi, Peter; Morsche, Rene Hm te; Drenth, Joost P. H.; Truninger, Kaspar; Macek, Milan, Jr.; Puhl, Gero; Witt, Ulrike; Schmidt, Hartmut; Buening, Carsten; Ockenga, Johann; Kage, Andreas; Groneberg, David Alexander; Nickel, Renate; Berg, Thomas; Wiedenmann, Bertram; Boedeker, Hans; Keim, Volker; Moessner, Joachim; Teich, Niels; Sahin-Toth, Miklos			Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis	NATURE GENETICS			English	Article							CATIONIC TRYPSINOGEN GENE; TROPICAL CALCIFIC PANCREATITIS; HEREDITARY PANCREATITIS; MISSENSE MUTATIONS; INHIBITOR GENE; DEGRADATION; PRSS1	Chronic pancreatitis is a persistent inflammatory disease of the pancreas, in which the digestive protease trypsin has a fundamental pathogenetic role. Here we have analyzed the gene encoding the trypsin-degrading enzyme chymotrypsin C (CTRC) in German subjects with idiopathic or hereditary chronic pancreatitis. Two alterations in this gene, p.R254W and p.K247_R254del, were significantly overrepresented in the pancreatitis group, being present in 30 of 901 (3.3%) affected individuals but only 21 of 2,804 (0.7%) controls ( odds ratio (OR)=4.6; confidence interval (CI)=2.6 - 8.0; P=1.3x10(-7)). A replication study identified these two variants in 10 of 348 (2.9%) individuals with alcoholic chronic pancreatitis but only 3 of 432 ( 0.7%) subjects with alcoholic liver disease (OR=4.2; CI=1.2 - 15.5; P=0.02). CTRC variants were also found in 10 of 71 (14.1%) Indian subjects with tropical pancreatitis but only 1 of 84 (1.2%) healthy controls (OR=13.6; CI=1.7 - 109.2; P=0.0028). Functional analysis of the CTRC variants showed impaired activity and/or reduced secretion. The results indicate that loss-of-function alterations in CTRC predispose to pancreatitis by diminishing its protective trypsin-degrading activity.	[Szmola, Richard; Ozsvari, Bela; Sahin-Toth, Miklos] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Rosendahl, Jonas; Boedeker, Hans; Keim, Volker; Moessner, Joachim; Teich, Niels] Univ Leipzig, Dept Gastroenterol & Hepatol, D-04103 Leipzig, Germany; [Witt, Heiko; Berg, Thomas; Boedeker, Hans] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Bhatia, Eesh] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow 226014, Uttar Pradesh, India; [Ozsvari, Bela; Hegyi, Peter] Univ Szeged, Dept Med 1, H-6720 Szeged, Hungary; [Landt, Olfert] TIB MOLBIOL, D-12103 Berlin, Germany; [Schulz, Hans-Ulrich] Otto VonGuericke Univ Magdegurg, Dept Surg, D-39120 Magdeburg, Germany; [Gress, Thomas M.] Univ Marburg, Fac Med, Dept Gastroenterol Endocrinol & Metab, D-35043 Marburg, Germany; [Pfuetzer, Roland] Univ Heidelberg, Med Fac Mannheim, Dept Med 2 Gastroenterol Hepatol Infect Dis, D-68167 Mannheim, Germany; [Loehr, Matthias] Karoliniska Univ Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-14186 Stockholm, Sweden; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res Leipzig, D-04103 Leipzig, Germany; [Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Dept Endocrinol, D-04103 Leipzig, Germany; [Choudhuri, Gourdas] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India; [Morsche, Rene Hm te; Drenth, Joost P. H.] Univ Nijmegen, Med Ctr, Div Gastroenterol & Hepatol, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Truninger, Kaspar] Inselspital Bern, Gastroenterol Clin, CH-3010 Bern, Switzerland; [Macek, Milan, Jr.] Charles Univ Prague, Sch Med 2, CZ-15006 Prague 5, Czech Republic; [Macek, Milan, Jr.] Univ Hosp Motol, Inst Biol & Med Genet Cyst, CZ-15006 Prague 5, Czech Republic; [Puhl, Gero] Dept Surg Charie, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Schmidt, Hartmut] Univ Hosp Munster, D-48149 Munster, Germany; [Buening, Carsten; Ockenga, Johann] Charite Univ Med Berlin, Dept Gastroenterol Hepatol Endocrinol, D-10008 Berlin, Germany; [Kage, Andreas] Charite Univ Med Berlin, Inst Lab Med & Pathobiochem, D-13353 Berlin, Germany; [Groneberg, David Alexander] Charite Univ Med Berlin, Inst Occupat Med, D-12207 Berlin, Germany; [Nickel, Renate] Charite Univ Med Berlin, Dept Pediat, D-13353 Berlin, Germany		Sahin-Toth, M (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, 715 Albany St,Evans St, Boston, MA 02118 USA.	miklos@bu.edu	Groneberg, David/A-5132-2018; Drenth, Joost/V-7436-2019; te Morsche, R/P-9143-2015; Lohr, Matthias/A-3692-2012; Drenth, J.P.H./H-8025-2014; Stumvoll, Michael/ABE-1121-2021; Teich, Niels/AAF-5104-2019	Groneberg, David/0000-0001-8551-6556; Lohr, Matthias/0000-0002-7647-198X; Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Wiedenmann, Bertram/0000-0002-7890-2552; Sahin-Toth, Miklos/0000-0003-4513-9922; Gress, Thomas/0000-0002-9333-5461; Berg, Thomas/0000-0003-0003-6241	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK058088] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK058088-06, R01 DK058088, R01 DK058088-07] Funding Source: Medline		Bhatia E, 2002, GASTROENTEROLOGY, V123, P1020, DOI 10.1053/gast.2002.36028; Boulling A, 2007, EUR J HUM GENET, V15, P936, DOI 10.1038/sj.ejhg.5201873; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; JESSOP NW, 1980, IN VITRO CELL DEV B, V16, P212; Kiraly O, 2007, GUT, V56, P1433, DOI 10.1136/gut.2006.115725; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Schneider A, 2002, GASTROENTEROLOGY, V123, P1026, DOI 10.1053/gast.2002.36059; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Teich N, 1998, HUM MUTAT, V12, P39, DOI 10.1002/(SICI)1098-1004(1998)12:1<39::AID-HUMU6>3.0.CO;2-P; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797	18	251	261	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					78	82		10.1038/ng.2007.44			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	WOS:000252118600021	18059268	Green Accepted			2022-01-24	
J	Pasutto, F; Sticht, H; Hammersen, G; Gillessen-Kaesbach, G; FitzPatrick, DR; Nurnberg, G; Brasch, F; Schirmer-Zimmermann, H; Tolmie, JL; Chitayat, D; Houge, G; Fernandez-Martinez, L; Keating, S; Mortier, G; Hennekam, RCM; von der Wense, A; Slavotinek, A; Meinecke, P; Bitoun, P; Becker, C; Nurnberg, P; Reis, A; Rauch, A				Pasutto, Francesca; Sticht, Heinrich; Hammersen, Gerhard; Gillessen-Kaesbach, Gabriele; FitzPatrick, David R.; Nuernberg, Gudrun; Brasch, Frank; Schirmer-Zimmermann, Heidemarie; Tolmie, John L.; Chitayat, David; Houge, Gunnar; Fernandez-Martinez, Lorena; Keating, Sarah; Mortier, Geert; Hennekam, Raoul C. M.; von der Wense, Axel; Slavotinek, Anne; Meinecke, Peter; Bitoun, Pierre; Becker, Christian; Nuernberg, Peter; Reis, Andre; Rauch, Anita			Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LINKAGE ANALYSIS; PULMONARY HYPOPLASIA; MEMBRANE-PROTEIN; MICROPHTHALMIA; GENES; EXPRESSION; ETIOLOGY; PROGRAM; CHX10	We observed two unrelated consanguineous families with malformation syndromes sharing anophthalmia and distinct eyebrows as common signs, but differing for alveolar capillary dysplasia or complex congenital heart defect in one and diaphragmatic hernia in the other family. Homozygosity mapping revealed linkage to a common locus on chromosome 15, and pathogenic homozygous mutations were identified in STRA6, a member of a large group of "stimulated by retinoic acid" genes encoding novel transmembrane proteins, transcription factors, and secreted signaling molecules or proteins of largely unknown function. Subsequently, homozygous STRA6 mutations were also demonstrated in 3 of 13 patients chosen on the basis of significant phenotypic overlap to the original cases. While a homozygous deletion generating a premature stop codon (p.G50AfsX22) led to absence of the immunoreactive protein in patient's fibroblast culture, structural analysis of three missense mutations (P90L, P293L, and T321P) suggested significant effects on the geometry of the loops connecting the transmembrane helices of STRA6. Two further variations in the C-terminus (T644M and R655C) alter specific functional sites, an SH2-binding motif and a phosphorylation site, respectively. STRA6 mutations thus define a pleiotropic malformation syndrome representing the first human phenotype associated with mutations in a gene from the "STRA" group.	Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; Cnopfs Pediat Hosp, Nurnberg, Germany; Univ Klinikum Schleswig Holstein, Inst Human Genet, Lubeck, Germany; MRC, Human Genet Unit, Med Genet Sect, Edinburgh, Midlothian, Scotland; Univ Cologne, Cologne Ctr Genom, Cologne, Germany; Univ Cologne, Inst Genet, D-5000 Cologne, Germany; RZPD Deutsch Ressourcenzentrum Genomforsch GmbH, Berlin, Germany; Univ Associated Hosp Bremen Mitte, Dept Pathol, Bremen, Germany; Yorkhill Hosp, Glasgow, Lanark, Scotland; Univ Toronto, Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; Univ Toronto, Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium; UCL, Great Ormond St Hosp Children, Inst Child Hlth, London, England; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Altonaer Childrens Hosp, Dept Neonatal & Pediat Intens Care, Hamburg, Germany; Altonaer Kinderkrankenhaus, Abt Med Genet, Hamburg, Germany; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Hosp Jean Verdier, Dept Med Genet, Bondy, France		Rauch, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Schwabachanlage 10, D-91054 Erlangen, Germany.	arauch@humgenet.uni-erlangen.de	Slavotinek, Anne/AAK-6794-2020; FitzPatrick, David R/C-7301-2013; FitzPatrick, David R/B-8311-2008; Mortier, Geert/D-2542-2012; Reis, Andre/D-2309-2009; Rauch, Anita/C-5568-2014	Mortier, Geert/0000-0001-9871-4578; Reis, Andre/0000-0002-6301-6363; Rauch, Anita/0000-0003-2930-3163; Sticht, Heinrich/0000-0001-5644-045X; Bitoun, Pierre/0000-0001-6557-6826; FitzPatrick, David R./0000-0003-4861-969X	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U127561093] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U127561093] Funding Source: UKRI		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; Bar-Yosef U, 2004, HUM GENET, V115, P302, DOI 10.1007/s00439-004-1154-2; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Clark KL, 2006, ANNU REV PHYSIOL, V68, P97, DOI 10.1146/annurev.physiol.68.040104.113828; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Gallot D, 2005, BIRTH DEFECTS RES A, V73, P523, DOI 10.1002/bdra.20151; Greer JJ, 2003, PEDIATR RES, V53, P726, DOI 10.1203/01.PDR.0000062660.12769.E6; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; KAWAGUCHI R, 2007, MEMBRANE RECEPTOR RE; Klaassens M, 2005, AM J HUM GENET, V76, P877, DOI 10.1086/429842; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar VH, 2005, ADV CLIN CHEM, V40, P261, DOI 10.1016/S0065-2423(05)40007-4; Langham MR, 1996, CLIN PERINATOL, V23, P671, DOI 10.1016/S0095-5108(18)30201-X; Lee SYR, 2006, CLIN DYSMORPHOL, V15, P43, DOI 10.1097/01.mcd.0000181604.78252.29; Lurie IW, 2003, GENET COUNSEL, V14, P75; Michalsky MP, 2005, J PEDIATR SURG, V40, P1100, DOI 10.1016/j.jpedsurg.2005.03.067; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sapin V, 2000, MECH DEVELOP, V92, P295, DOI 10.1016/S0925-4773(00)00241-0; Seller MJ, 1996, AM J MED GENET, V62, P227, DOI 10.1002/(SICI)1096-8628(19960329)62:3<227::AID-AJMG5>3.3.CO;2-R; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Slavotinek AM, 2006, EUR J HUM GENET, V14, P999, DOI 10.1038/sj.ejhg.5201652; Smith S A, 1994, Clin Dysmorphol, V3, P287; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Vogt G, 2005, EUR J EPIDEMIOL, V20, P939, DOI 10.1007/s10654-005-2382-z; Zile MH, 2004, EXP BIOL MED, V229, P598, DOI 10.1177/153537020422900703	36	251	258	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					550	560		10.1086/512203			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	WOS:000244403300017	17273977	Green Published, Bronze			2022-01-24	
J	Fang, Y; van Meurs, JBJ; d'Alesio, A; Jhamai, M; Zhao, HY; Rivadeneira, F; Hofman, A; van Leeuwen, JPT; Jehan, F; Pols, HAP; Uitterlinden, AG				Fang, Y; van Meurs, JBJ; d'Alesio, A; Jhamai, M; Zhao, HY; Rivadeneira, F; Hofman, A; van Leeuwen, JPT; Jehan, F; Pols, HAP; Uitterlinden, AG			Promoter and 3 '-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: The Rotterdam study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MINERAL DENSITY; SP1 BINDING-SITE; LINKAGE DISEQUILIBRIUM; I-ALPHA-1 GENE; MESSENGER-RNA; POLYMORPHISMS; ASSOCIATION; WOMEN; SUSCEPTIBILITY; EXPRESSION	Polymorphisms of the vitamin D receptor gene (VDR) have been shown to be associated with several complex diseases, including osteoporosis, but the mechanisms are unknown and study results have been inconsistent. We therefore determined sequence variation across the major relevant parts of VDR, including construction of linkage disequilibrium blocks and identification of haplotype alleles. We analyzed 15 haplotype-tagging SNPs in relation to 937 clinical fractures recorded in 6,148 elderly whites over a follow-up period of 7.4 years. Haplotype alleles of the 5' 1a/1e, 1b promoter region and of the 3' untranslated region (UTR) were strongly associated with increased fracture risk. For the 16% of subjects who had risk genotypes at both regions, their risk increased 48% for clinical fractures (P=.0002), independent of age, sex, height, weight, and bone mineral density. The population-attributable risk varied between 1% and 12% for each block and was 4% for the combined VDR risk genotypes. Functional analysis of the variants demonstrated 53% lower expression of a reporter construct with the 1e/1a promoter risk haplotype (P = 5 x 10(-7)) in two cell lines and 15% lower mRNA level of VDR expression constructs carrying 3'-UTR risk haplotype 1 in five cell lines (P = 2 x 10(-6)). In a further analysis, we showed 30% increased mRNA decay in an osteoblast cell line for the construct carrying the 3'-UTR risk haplotype (P = 2 x 10(-6)). This comprehensive candidate-gene analysis demonstrates that the risk allele of multiple VDR polymorphisms results in lower VDR mRNA levels. This could impact the vitamin D signaling efficiency and might contribute to the increased fracture risk we observed for these risk haplotype alleles.	Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Hop St Vincent de Paul, Inserm U561, F-75674 Paris, France		Uitterlinden, AG (corresponding author), Erasmus MC, Dept Internal Med, Room Ee575,POB 1738, NL-3000 DR Rotterdam, Netherlands.	a.g.uitterlinden@erasmusmc.nl	Jehan, Frederic/P-1568-2014; Rivadeneira, Fernando/O-5385-2015; van Leeuwen, Johannes/D-5015-2014	Jehan, Frederic/0000-0003-1271-6594; Rivadeneira, Fernando/0000-0001-9435-9441; van Leeuwen, Johannes/0000-0002-2282-4006; van Meurs, Joyce/0000-0001-6245-2123			Arai H, 2001, J BONE MINER RES, V16, P1256, DOI 10.1359/jbmr.2001.16.7.1256; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Brown SB, 2000, J CLIN ENDOCR METAB, V85, P868, DOI 10.1210/jc.85.2.868; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; Carling T, 1997, J CLIN ENDOCR METAB, V82, P1772, DOI 10.1210/jc.82.6.1772; Crofts LA, 1998, P NATL ACAD SCI USA, V95, P10529, DOI 10.1073/pnas.95.18.10529; DAME MC, 1985, P NATL ACAD SCI USA, V82, P7825, DOI 10.1073/pnas.82.23.7825; Durrin LK, 1999, BBA-MOL BASIS DIS, V1453, P311, DOI 10.1016/S0925-4439(99)00007-1; Fang RX, 2001, AM J PHYSIOL-GASTR L, V280, pG58, DOI 10.1152/ajpgi.2001.280.1.G58; Fang Y, 2003, J BONE MINER RES, V18, P1632, DOI 10.1359/jbmr.2003.18.9.1632; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; Halsall JA, 2005, PHARMACOGENET GENOM, V15, P349, DOI 10.1097/01213011-200505000-00011; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Ingles SA, 1997, CANCER EPIDEM BIOMAR, V6, P93; Lambert JC, 2003, J MED GENET, V40, P424, DOI 10.1136/jmg.40.6.424; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; MORRISON NA, 1992, P NATL ACAD SCI USA, V89, P6665, DOI 10.1073/pnas.89.15.6665; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Ogunkolade BW, 2002, DIABETES, V51, P2294, DOI 10.2337/diabetes.51.7.2294; SAIJO T, 1991, AM J HUM GENET, V49, P668; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Uitterlinden AG, 1996, J BONE MINER RES, V11, P1241; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; Uitterlinden AG, 2001, J BONE MINER RES, V16, P379, DOI 10.1359/jbmr.2001.16.2.379; Van Der Klift M, 2002, J BONE MINER RES, V17, P1051, DOI 10.1359/jbmr.2002.17.6.1051; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; Yamamoto H, 1999, J BONE MINER RES, V14, P240, DOI 10.1359/jbmr.1999.14.2.240; Young RP, 1996, LANCET, V348, P688, DOI 10.1016/S0140-6736(05)65116-1; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	36	251	266	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					807	823		10.1086/497438			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	WOS:000232569600010	16252240	Green Published, Bronze			2022-01-24	
J	Hilson, P; Allemeersch, J; Altmann, T; Aubourg, S; Avon, A; Beynon, J; Bhalerao, RP; Bitton, F; Caboche, M; Cannoot, B; Chardakov, V; Cognet-Holliger, C; Colot, V; Crowe, M; Darimont, C; Durinck, S; Eickhoff, H; de Longevialle, AF; Farmer, EE; Grant, M; Kuiper, MTR; Lehrach, H; Leon, C; Leyva, A; Lundeberg, J; Lurin, C; Moreau, Y; Nietfeld, W; Paz-Ares, J; Reymond, P; Rouze, P; Sandberg, G; Segura, MD; Serizet, C; Tabrett, A; Taconnat, L; Thareau, V; Van Hummelen, P; Vercruysse, S; Vuylsteke, M; Weingartner, M; Weisbeek, PJ; Wirta, V; Wittink, FRA; Zabeau, M; Small, I				Hilson, P; Allemeersch, J; Altmann, T; Aubourg, S; Avon, A; Beynon, J; Bhalerao, RP; Bitton, F; Caboche, M; Cannoot, B; Chardakov, V; Cognet-Holliger, C; Colot, V; Crowe, M; Darimont, C; Durinck, S; Eickhoff, H; de Longevialle, AF; Farmer, EE; Grant, M; Kuiper, MTR; Lehrach, H; Leon, C; Leyva, A; Lundeberg, J; Lurin, C; Moreau, Y; Nietfeld, W; Paz-Ares, J; Reymond, P; Rouze, P; Sandberg, G; Segura, MD; Serizet, C; Tabrett, A; Taconnat, L; Thareau, V; Van Hummelen, P; Vercruysse, S; Vuylsteke, M; Weingartner, M; Weisbeek, PJ; Wirta, V; Wittink, FRA; Zabeau, M; Small, I			Versatile gene-specific sequence tags for Arabidopsis functional genomics: Trancript profiling and reverse genetics applications	GENOME RESEARCH			English	Article							REPEAT-CONTAINING GENE; ESCHERICHIA-COLI; WIDE EXPRESSION; VACUOLAR ATPASE; MICROARRAY DATA; RESTORER GENE; PLANT-GROWTH; DESIGN; DATABASE; RNA	Microarray transcript profiling and RNA interference are two new technologies crucial for large-scale gene function studies in multicellular eukaryotes. Both rely on sequence-specific hybridization between complementary nucleic acid strands, inciting us to create a collection of gene-specific sequence tags (GSTs) representing at least 21,500 Arabidopsis genes and which are compatible with both approaches. The GSTs were carefully selected to ensure that each of them shared no significant similarity with any other region in the Arabidopsis genome. They were synthesized by PCR amplification from genomic DNA. Spotted microarrays fabricated from the GSTs show good dynamic range, specificity, and sensitivity in transcript profiling experiments. The GSTs have also been transferred to bacterial plasmid vectors via recombinational cloning protocols. These cloned GSTs constitute the ideal starting point for a variety of functional approaches, including reverse genetics. We have subcloned GSTs on a large scale into vectors designed for gene silencing in plant cells. We show that in planta expression of GST hairpin RNA results in the expected phenotypes in silenced Arabidopsis lines. These versatile GST resources provide novel and powerful tools for functional genomics.	Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; UEVE, CNRS, INRA, Unite Rech Genom Vegetale, F-91057 Evry, France; Katholieke Univ Leuven, Fac Engn, Dept Elect Engn, ESAT, B-3001 Heverlee, Belgium; Univ Potsdam, Inst Biochem & Biol Genet, Max Planck Inst Mol Pflanzenphysiol, D-14476 Golm, Germany; Hort Res Int, Warwick CV35 9EF, England; Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; Univ London Imperial Coll Sci Technol & Med, Dept Agr Sci, Ashford TN25 5AH, Kent, England; INRA, Genet & Ameliorat Plantes Stn, F-78026 Versailles, France; John Innes Ctr, CH-1015 Lausanne, Switzerland; Univ Lausanne, Dept Plant Mol Biol, Gene Express Lab, CH-1015 Lausanne, Switzerland; Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, E-28049 Madrid, Spain; AlbaNova Univ Ctr, Royal Inst Technol, KTH, Dept Biotechnol, S-10691 Stockholm, Sweden; Univ Louvain VIB, UZ Gasthuisberg, MicroArray Facil, B-3000 Louvain, Belgium; Univ Utrecht, Dept Mol Genet, NL-3584 CH Utrecht, Netherlands		Hilson, P (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	pierre.hilson@psb.ugent.be; small@evry.inra.fr	/AAD-1735-2020; Small, Ian/AAR-5506-2021; Kuiper, Martin/AAM-7279-2020; Reymond, Philippe/ABG-2852-2020; Reymond, Philippe/ABG-2385-2020; Small, Ian D/C-1168-2008; Farmer, Edward E/H-1635-2011; Leyva, Antonio/C-9040-2013	/0000-0003-3516-4438; Small, Ian/0000-0001-5300-1216; Kuiper, Martin/0000-0002-1171-9876; Reymond, Philippe/0000-0002-3341-6200; Small, Ian D/0000-0001-5300-1216; Leyva, Antonio/0000-0001-7617-0418; Paz-Ares, Javier/0000-0003-0553-9745; Crowe, Mark/0000-0002-9514-2487; Bhalerao, Rishikesh/0000-0003-4384-7036; Altmann, Thomas/0000-0002-3759-360X; Vercruysse, Steven/0000-0002-3136-7353; Moreau, Yves/0000-0002-4647-6560	Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [E18642] Funding Source: Medline		Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An G., 1988, PLANT MOL BIOL MANUA, P1, DOI DOI 10.1007/978-94-009-0951-9; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; AzpirozLeehan R, 1997, TRENDS GENET, V13, P152, DOI 10.1016/S0168-9525(97)01094-9; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Castelli V, 2004, GENOME RES, V14, P406, DOI 10.1101/gr.1515604; Chen H, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-27; CHOI S, 1995, PLANT MOL BIOL REP, V13, P124, DOI 10.1007/BF02668782; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; DESIOIRE S, 2003, EMBO REP, V4, P588; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Ferea TL, 1996, GENETICS, V143, P147; Girke T, 2000, PLANT PHYSIOL, V124, P1570, DOI 10.1104/pp.124.4.1570; Guo YQ, 1996, GENE, V172, P239, DOI 10.1016/0378-1119(96)00057-1; Haas B. J., 2002, GENOME BIOL, V3; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Hilson P, 2003, CURR OPIN PLANT BIOL, V6, P426, DOI 10.1016/S1369-5266(03)00086-4; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; Holloway AJ, 2002, NAT GENET, V32, P481, DOI 10.1038/ng1030; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Hosack D. A., 2003, GENOME BIOL, V4, P1; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; Kim H, 2003, GENOME RES, V13, P327, DOI 10.1101/gr.552003; Knight J, 2001, NATURE, V410, P860, DOI 10.1038/35073680; Komori T, 2004, PLANT J, V37, P315, DOI 10.1046/j.1365-313X.2003.01961.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Li FG, 2001, BIOINFORMATICS, V17, P1067, DOI 10.1093/bioinformatics/17.11.1067; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Nielsen HB, 2003, NUCLEIC ACIDS RES, V31, P3491, DOI 10.1093/nar/gkg622; Parinov S, 1999, PLANT CELL, V11, P2263, DOI 10.1105/tpc.11.12.2263; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Rouillard JM, 2002, BIOINFORMATICS, V18, P486, DOI 10.1093/bioinformatics/18.3.486; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Schaffer R, 2000, CURR OPIN BIOTECH, V11, P162, DOI 10.1016/S0958-1669(00)00084-7; Schiex T., 2001, LNCS, P111; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Speulman E, 1999, PLANT CELL, V11, P1853, DOI 10.1105/tpc.11.10.1853; Sussman MR, 2000, PLANT PHYSIOL, V124, P1465, DOI 10.1104/pp.124.4.1465; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Thareau V, 2003, BIOINFORMATICS, V19, P2191, DOI 10.1093/bioinformatics/btg286; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Van Houdt H, 2003, PLANT PHYSIOL, V131, P245, DOI 10.1104/pp.009407; Varotto C, 2001, NUCLEIC ACIDS RES, V29, P4373, DOI 10.1093/nar/29.21.4373; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wortman JR, 2003, PLANT PHYSIOL, V132, P461, DOI 10.1104/pp.103.022251; Xu D, 2002, BIOINFORMATICS, V18, P1432, DOI 10.1093/bioinformatics/18.11.1432; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhu T, 2000, PLANT PHYSIOL, V124, P1472, DOI 10.1104/pp.124.4.1472	74	251	262	0	21	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2004	14	10B					2176	2189		10.1101/gr.2544504			14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	862TM	WOS:000224514000024	15489341	Bronze, Green Published			2022-01-24	
J	Dos Santos, C; Essioux, L; Teinturier, C; Tauber, M; Goffin, V; Bougneres, P				Dos Santos, C; Essioux, L; Teinturier, C; Tauber, M; Goffin, V; Bougneres, P			A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone	NATURE GENETICS			English	Article							CRYSTAL-STRUCTURE; EXPRESSION; COMPLEX; DIVERSITY; MUTATION; CHILDREN; ISOFORM; HEIGHT; GH	Growth hormone is used to increase height in short children who are not deficient in growth hormone, but its efficacy varies largely across individuals. The genetic factors responsible for this variation are entirely unknown. In two cohorts of short children treated with growth hormone, we found that an isoform of the growth hormone receptor gene that lacks exon 3 (d3-GHR) was associated with 1.7 to 2 times more growth acceleration induced by growth hormone than the full-length isoform (P < 0.0001). In transfection experiments, the transduction of growth hormone signaling through d3-GHR homo- or heterodimers was similar to 30% higher than through full-length GHR homodimers (P < 0.0001). One-half of Europeans are hetero- or homozygous with respect to the allele encoding the d3-GHR isoform, which is dominant over the full-length isoform. These observations suggest that the polymorphism in exon 3 of GHR is important in growth hormone pharmacogenetics.	Univ Paris 05, St Vincent de Paul Hosp, INSERM, U561, F-75014 Paris, France; Univ Paris 05, St Vincent de Paul Hosp, Dept Pediat Endocrinol, F-75014 Paris, France; Childrens Hosp, Unite Endocrinol, Toulouse, France; Univ Paris 05, INSERM, U584, Paris, France		Bougneres, P (corresponding author), Univ Paris 05, St Vincent de Paul Hosp, INSERM, U561, 82 Ave Denfert Rochereau, F-75014 Paris, France.	bougneres@paris5.inserm.fr	GOFFIN, Vincent/G-3322-2013	DOS SANTOS MENGUY, Christine/0000-0002-6748-5183			BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; BRYANT J, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004440; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Frank SJ, 2002, ENDOCRINOLOGY, V143, P2, DOI 10.1210/en.143.1.2; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Hintz RL, 1999, NEW ENGL J MED, V340, P502, DOI 10.1056/NEJM199902183400702; ITHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; KELLY PA, 1993, RECENT PROG HORM RES, V48, P123; LESAGE C, 1991, J PEDIATR-US, V119, P29, DOI 10.1016/S0022-3476(05)81034-0; Ochoa R, 2003, HORM RES, V60, P68, DOI 10.1159/000071873; Pantel J, 2000, J BIOL CHEM, V275, P18664, DOI 10.1074/jbc.M001615200; Pantel J, 2003, J CLIN ENDOCR METAB, V88, P1705, DOI 10.1210/jc.2002-021667; SOBRIER ML, 1993, FEBS LETT, V319, P16, DOI 10.1016/0014-5793(93)80028-S; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Stead JDH, 2000, HUM MOL GENET, V9, P713, DOI 10.1093/hmg/9.5.713; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; URBANEK M, 1993, J BIOL CHEM, V268, P19025	18	251	262	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					720	724		10.1038/ng1379			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	WOS:000222354100022	15208626	Bronze			2022-01-24	
J	Perez-Iratxeta, C; Bork, P; Andrade, MA				Perez-Iratxeta, C; Bork, P; Andrade, MA			Association of genes to genetically inherited diseases using data mining	NATURE GENETICS			English	Article								Although approximately one-quarter of the roughly 4,000 genetically inherited diseases currently recorded in respective databases (LocusLink(1), OMIM2) are already linked to a region of the human genome, about 450 have no known associated gene. Finding disease-related genes requires laborious examination of hundreds of possible candidate genes (sometimes, these are not even annotated; see, for example, refs 3,4). The public availability of the human genome(5) draft sequence has fostered new strategies to map molecular functional features of gene products to complex phenotypic descriptions, such as those of genetically inherited diseases. Owing to recent progress in the systematic annotation of genes using controlled vocabularies 6, we have developed a scoring system for the possible functional relationships of human genes to 455 genetically inherited diseases that have been mapped to chromosomal regions without assignment of a particular gene. In a benchmark of the system with 100 known disease-associated genes, the disease-associated gene was among the 8 best-scoring genes with a 25% chance, and among the best 30 genes with a 50% chance, showing that there is a relationship between the score of a gene and its likelihood of being associated with a particular disease. The scoring also indicates that for some diseases, the chance of identifying the underlying gene is higher.	European Mol Biol Lab, D-69012 Heidelberg, Germany; Max Delbruck Ctr Mol Med, Dept Bioinformat, D-13092 Berlin, Germany		Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.	bork@embl-heidelberg.de	Andrade, Miguel A/B-6565-2008; Bork, Peer/F-1813-2013	Andrade, Miguel A/0000-0001-6650-1711; Bork, Peer/0000-0002-2627-833X			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; PLAITAKIS A, 1993, CAN J NEUROL SCI, V20, P5109; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572; Zimmermann H.J., 1996, FUZZY SET THEORY ITS	11	251	259	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					316	319		10.1038/ng895			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	WOS:000176494100023	12006977				2022-01-24	
J	den Hollander, AI; Heckenlively, JR; van den Born, LI; de Kok, YJM; van der Velde-Visser, SD; Kellner, U; Jurklies, B; van Schooneveld, MJ; Blankenagel, A; Rohrschneider, K; Wissinger, B; Cruysberg, JRM; Deutman, AF; Brunner, HG; Apfeldstedt-Sylla, E; Hoyng, CB; Cremers, FPM				den Hollander, AI; Heckenlively, JR; van den Born, LI; de Kok, YJM; van der Velde-Visser, SD; Kellner, U; Jurklies, B; van Schooneveld, MJ; Blankenagel, A; Rohrschneider, K; Wissinger, B; Cruysberg, JRM; Deutman, AF; Brunner, HG; Apfeldstedt-Sylla, E; Hoyng, CB; Cremers, FPM			Leber congenital amaurosis and retinitis pigmentosa with coats-like exudative vasculopathy are associated with mutations in the crumbs homologue 1 (CRB1) gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CRX; PHENOTYPES	Mutations in the crumbs homologue 1 (CRB1) gene cause a specific form of retinitis pigmentosa (RP) that is designated "RP12" and is characterized by a preserved para-arteriolar retinal pigment epithelium (PPRPE) and by severe loss of vision at age <20 years. Because of the early onset of disease in patients who have RP with PPRPE, we considered CRB1 to be a good candidate gene for Leber congenital amaurosis (LCA). Mutations were detected in 7 (13%) of 52 patients with LCA from the Netherlands, Germany, and the United States. In addition, CRB1 mutations were detected in five of nine patients who had RP with Coats-like exudative vasculopathy, a relatively rare complication of RP that may progress to partial or total retinal detachment. Given that four of five patients had developed the complication in one eye and that not all siblings with RP have the complication, CRB1 mutations should be considered an important risk factor for the Coats-like reaction, although its development may require additional genetic or environmental factors. Although no clear-cut genotype-phenotype correlation could be established, patients with LCA, which is the most severe retinal dystrophy, carry null alleles more frequently than do patients with RP. Our findings suggest that CRB1 mutations are a frequent cause of LCA and are strongly associated with the development of Coats-like exudative vasculopathy in patients with RP.	Univ Med Ctr Nijmegen, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA; Rotterdam Eye Hosp, Rotterdam, Netherlands; Free Univ Berlin, Univ Clin Benjamin Franklin, Dept Ophthalmol, D-1000 Berlin, Germany; Univ Essen Gesamthsch, Augenklin, Essen, Germany; Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands; Heidelberg Univ, Augenklin, Heidelberg, Germany; Univ Tubingen, Augenklin, D-7400 Tubingen, Germany		den Hollander, AI (corresponding author), Univ Med Ctr Nijmegen, Dept Human Genet, POB 9101,Geert Grootepl 10, NL-6500 HB Nijmegen, Netherlands.	A.denHollander@antrg.azn.nl	Cremers, Frans/A-5625-2014; Brunner, Han/C-9928-2013; Hollander, Anneke den/N-4911-2014; Hoyng, C.B./H-8050-2014; Cruysberg, Johannes R. M./D-4313-2009	Cremers, Frans/0000-0002-4954-5592; Cruysberg, Johannes R. M./0000-0002-5330-0774			den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HECKENLIVELY JR, 1982, BRIT J OPHTHALMOL, V66, P26, DOI 10.1136/bjo.66.1.26; KHAN JA, 1988, SURV OPHTHALMOL, V32, P317, DOI 10.1016/0039-6257(88)90094-X; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault I, 2000, EUR J HUM GENET, V8, P578, DOI 10.1038/sj.ejhg.5200503; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; VANDENBORN LI, 1994, AM J OPHTHALMOL, V118, P430, DOI 10.1016/S0002-9394(14)75792-7	22	251	253	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					198	203					6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	WOS:000170108100019	11389483				2022-01-24	
J	Yeh, RF; Lim, LP; Burge, CB				Yeh, RF; Lim, LP; Burge, CB			Computational inference of homologous gene structures in the human genome	GENOME RESEARCH			English	Article							DNA-SEQUENCE; ANNOTATION; DROSOPHILA; IDENTIFICATION; PREDICTION; MOUSE; RECOGNITION; CHROMOSOME; PROGRAM; SEARCH	With the human genome sequence approaching completion, a major challenge is to identify the locations and encoded protein sequences of all human genes. To address this problem we have developed a new gene identification algorithm, GenomeScan, which combines exon-intron and splice signal models with similarity to known protein sequences in an integrated model. Extensive testing shows that GenomeScan can accurately identify the exon-intron structures of genes in finished or draft human genome sequence with a low rate of false-positives. Application of GenomeScan to 2.7 billion bases of human genomic DNA identified at least 20,000-25,000 human genes out of an estimated 30,000-40,000 present in the genome. The results show an accurate and efficient automated approach for identifying genes in higher eukaryotic genomes and provide a first-level annotation of the draft human genome.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA		Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37GM034277] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37 GM034277, R37-GM34277] Funding Source: Medline		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Brenner V, 1997, GENOMICS, V44, P8, DOI 10.1006/geno.1997.4822; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Burge CB, 2001, NAT GENET, V27, P232, DOI 10.1038/85772; BURGE CB, 1997, THESIS STANFORD U CA; Claverie JM, 1997, HUM MOL GENET, V6, P1735, DOI 10.1093/hmg/6.10.1735; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gelfand MS, 1996, P NATL ACAD SCI USA, V93, P9061, DOI 10.1073/pnas.93.17.9061; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Hubbard T, 2000, NATURE, V403, P825, DOI 10.1038/35002770; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Krogh A, 2000, GENOME RES, V10, P523, DOI 10.1101/gr.10.4.523; Kulp D, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P134; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolfsberg TG, 1997, NUCLEIC ACIDS RES, V25, P1626, DOI 10.1093/nar/25.8.1626; Xu Y, 1997, J COMPUT BIOL, V4, P325, DOI 10.1089/cmb.1997.4.325	33	251	260	0	5	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	MAY	2001	11	5					803	816		10.1101/gr.175701			14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	429DW	WOS:000168501600017	11337476	Green Published, Bronze			2022-01-24	
J	Moon, AM; Capecchi, MR				Moon, AM; Capecchi, MR			Fgf8 is required for outgrowth and patterning of the limbs	NATURE GENETICS			English	Article							APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; SONIC-HEDGEHOG; TRANSGENIC MICE; FEEDBACK LOOP; STEM-CELLS; GROWTH; GENE; BUD; INITIATION	The expression pattern and activity of fibroblast growth factor-8 (FGF8) in experimental assays indicate that it has important roles in limb development(1-3), but early embryonic lethality resulting from mutation of Fgf8 in the germ line of mice has prevented direct assessment of these roles(4). Here we report that conditional disruption of Fgf8 in the forelimb of developing mice bypasses embryonic lethality and reveals a requirement for Fgf8 in the formation of the stylopod, anterior zeugopod and autopod. Lack of Fgf8 in the apical ectodermal ridge (AER) alters expression of other Fgf genes, Shh and Bmp2.	Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Human Mol Biol & Genet, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA		Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA.			moon, anne/0000-0002-9090-1093	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD001373] Funding Source: NIH RePORTER		COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Colvin JS, 1999, DEV DYNAM, V216, P72; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Moon AM, 2000, DEVELOPMENT, V127, P989; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; REYNOLDS K, 1991, MECH DEVELOP, V36, P15, DOI 10.1016/0925-4773(91)90068-H; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROGALA EJ, 1974, J MED GENET, V11, P221, DOI 10.1136/jmg.11.3.221; Ros MA, 1996, DEVELOPMENT, V122, P2319; ROWE DA, 1981, J EMBRYOL EXP MORPH, V65, P309; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Tabin CJ, 1998, NATURE, V396, P322, DOI 10.1038/24516; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Vogel A, 1996, DEVELOPMENT, V122, P1737; Wolpert L, 1975, Ciba Found Symp, V0, P95; Xu XL, 1998, DEVELOPMENT, V125, P753	30	251	256	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					455	459		10.1038/82601			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	WOS:000165671700020	11101845	Green Accepted			2022-01-24	
J	Rivera, A; White, K; Stohr, H; Steiner, K; Hemmrich, N; Grimm, T; Jurklies, B; Lorenz, B; Scholl, HPN; Apfelstedt-Sylla, E; Weber, BHF				Rivera, A; White, K; Stohr, H; Steiner, K; Hemmrich, N; Grimm, T; Jurklies, B; Lorenz, B; Scholl, HPN; Apfelstedt-Sylla, E; Weber, BHF			A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUNDUS FLAVIMACULATUS; RETINITIS-PIGMENTOSA; TRANSPORTER GENE; DYSTROPHY; MUTATIONS; ELECTROPHORESIS; CLASSIFICATION; MACULOPATHY; PHENOTYPE; MEMBRANE	Stargardt disease (STGD) is a common autosomal recessive maculopathy of early and young-adult onset and is caused by alterations in the gene encoding the photoreceptor-specific ATP-binding cassette (ABC) transporter (ABCA4). We have studied 144 patients with STGD and 220 unaffected individuals ascertained from the German population, to complete a comprehensive, population-specific survey of the sequence variation in the ABCA4 gene. In addition, we have assessed the proposed role for ABCA4 in age-related macular degeneration (AMD), a common cause of late-onset blindness, by studying 200 affected individuals with late-stage disease. Using a screening strategy based primarily on denaturing gradient gel electrophoresis, me have identified in the three study groups a total of 127 unique alterations, of which 90 have not been previously reported, and have classified 72 as probable pathogenic mutations. Of the 288 STGD chromosomes studied, mutations were identified in 166, resulting in a detection rate of similar to 58%. Eight different alleles account for 61% of the identified disease alleles, and at least one of these, the L541P-A1038V complex allele, appears to be a founder mutation in the German population. When the group with AMD and the control group were analyzed with the same methodology, 18 patients with AMD and 12 controls were found to harbor possible disease-associated alterations. This represents no significant difference between the two groups; however, for detection of modest effects of rare alleles in complex diseases, the analysis of larger cohorts of patients may be required.	Univ Wurzburg, Inst Humangenet, Biozentrum, D-97074 Wurzburg, Germany; Augenklin, Essen, Germany; Univ Regensburg, Klinikum, D-8400 Regensburg, Germany; Univ Tubingen, Augenklin, D-7400 Tubingen, Germany		Weber, BHF (corresponding author), Univ Wurzburg, Inst Humangenet, Biozentrum, Hubland, D-97074 Wurzburg, Germany.			Weber, Bernhard H.F./0000-0002-8808-7723			Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; CIBIS GW, 1980, ARCH OPHTHALMOL-CHIC, V98, P1785; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; DEAN M, 1998, SCIENCE, V279, pA1107; Dryja T. P., 1998, SCIENCE, V279; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504, DOI 10.1001/archopht.117.4.504; FODDE R, 1994, HUM MUTAT, V3, P83, DOI 10.1002/humu.1380030202; KLAVER CCW, 1998, SCIENCE, V279, P1107; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Kniazeva M, 1999, AM J HUM GENET, V64, P1394, DOI 10.1086/302377; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; Lois N, 1999, INVEST OPHTH VIS SCI, V40, P2668; LOPEZ PF, 1990, OPHTHALMOLOGY, V97, P798; MANSOUR AM, 1992, OPHTHALMOLOGICA, V205, P138, DOI 10.1159/000310329; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Papaioannou M, 2000, INVEST OPHTH VIS SCI, V41, P16; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Simonelli F, 2000, INVEST OPHTH VIS SCI, V41, P892; Souied EH, 2000, INVEST OPHTH VIS SCI, V41, P244; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; ZHANG K, 1994, ARCH OPHTHALMOL-CHIC, V112, P759, DOI 10.1001/archopht.1994.01090180057035	38	251	258	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					800	813		10.1086/303090			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	WOS:000089651100004	10958763	Bronze, Green Published			2022-01-24	
J	Colige, A; Sieron, AL; Li, SW; Schwarze, U; Petty, E; Wertelecki, W; Wilcox, W; Krakow, D; Cohn, DH; Reardon, W; Byers, PH; Lapiere, CM; Prockop, DJ; Nusgens, BV				Colige, A; Sieron, AL; Li, SW; Schwarze, U; Petty, E; Wertelecki, W; Wilcox, W; Krakow, D; Cohn, DH; Reardon, W; Byers, PH; Lapiere, CM; Prockop, DJ; Nusgens, BV			Human Ehlers-Danlos syndrome type VIIC and bovine dermatosparaxis are caused by mutations in the procollagen IN-proteinase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE MORPHOGENETIC PROTEIN-1; C-PROTEINASE; N-PROTEINASE; COL5A1 GENE; PHENOTYPE; THROMBOSPONDIN; ACTIVATION; PROPEPTIDE; SEQUENCES; COLLAGEN	Ehlers-Danlos syndrome (EDS) type WC is a recessively inherited connective-tissue disorder, characterized by extreme skin fragility, characteristic facies, joint laxity, droopy skin, umbilical hernia, and blue sclera, Like the animal model dermatosparaxis, EDS type WC results from the absence of activity of procollagen I N-proteinase (pNPI), the enzyme that excises the N-propeptide of type I and type II procollagens. The pNPI enzyme is a metalloproteinase containing properdin repeats and a cysteine-rich domain with similarities to the disintegrin domain of reprolysins. We used bovine cDNA to isolate human pNPI. The human enzyme exists in two forms: a long version similar to the bovine enzyme and a short version that contains the Zn++-binding catalytic site but lacks the entire C-terminal domain in which the properdin repeats are located. We have identified the mutations that cause EDS type WC in the six known affected human individuals and also in one strain of dermatosparactic calf. Five of the individuals with EDS type WC were homozygous for a C-->T transition that results in a premature termination codon, Q225X. Four of these five patients were homozygous at three downstream polymorphic sites. The sixth patient was homozygous for a different transition that results in a premature termination codon, W735X. In the dermatosparactic calf, the mutation is a 17-bp deletion that changes the reading frame of the message. These data provide direct evidence that EDS type WC and dermatosparaxis result from mutations in the pNPI gene.	Univ Liege, CHU Sart Tilman, Lab Connect Tissues Biol, B-4000 Liege, Belgium; Allegheny Univ Hlth Sci, MCP Hahnemann Sch Med, Ctr Gene Therapy, Philadelphia, PA 19102 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ S Alabama, Dept Med Genet, Mobile, AL 36688 USA; Univ Calif Los Angeles, Sch Med,Burns & Allen Cedars Sinai Res Inst, Steven Spielberg Pediat Res Ctr, Ahmanson Dept Pediat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; Great Ormond St Hosp Sick Children, Dept Paediat Genet, London, England		Colige, A (corresponding author), Univ Liege, CHU Sart Tilman, Lab Connect Tissues Biol, B-4000 Liege, Belgium.	LCTB@ulg.ac.be	Sieron, Aleksander L/G-1700-2013	Reardon, Willie/0000-0001-7329-9179; Byers, Peter H./0000-0001-7786-7030; Sieron, Aleksander L./0000-0002-3894-9508	NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [AR 39837, AR 21557] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 22657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R29AR039837, R01AR039837, P01AR021557] Funding Source: NIH RePORTER		BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Colige A, 1997, P NATL ACAD SCI USA, V94, P2374, DOI 10.1073/pnas.94.6.2374; DePaepe A, 1997, AM J HUM GENET, V60, P547; Fujimoto A, 1997, AM J MED GENET, V68, P25, DOI 10.1002/(SICI)1096-8628(19970110)68:1<25::AID-AJMG5>3.0.CO;2-X; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; HANSET R, 1967, ANN MED VET, V7, P451; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; LAPIERE CM, 1971, P NATL ACAD SCI USA, V68, P3054, DOI 10.1073/pnas.68.12.3054; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; LENAERS A, 1971, EUR J BIOCHEM, V23, P533, DOI 10.1111/j.1432-1033.1971.tb01651.x; LEVINSON B, 1993, NAT GENET, V3, P6, DOI 10.1038/ng0193-6; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; NUSGENS BV, 1992, NAT GENET, V1, P214, DOI 10.1038/ng0692-214; PETTY EM, 1993, ARCH DERMATOL, V129, P1310, DOI 10.1001/archderm.129.10.1310; PIERARD GE, 1976, J INVEST DERMATOL, V66, P2, DOI 10.1111/1523-1747.ep12477969; Reardon W, 1995, Clin Dysmorphol, V4, P1; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; SMITH LT, 1992, AM J HUM GENET, V51, P235; Steinmann Beat, 1993, P351; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; TUSZYNSKI GP, 1992, J CELL BIOL, V116, P209, DOI 10.1083/jcb.116.1.209; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WERTELECKI W, 1992, J PEDIATR-US, V121, P558, DOI 10.1016/S0022-3476(05)81144-8	31	251	262	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					308	317		10.1086/302504			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	WOS:000081836900006	10417273	Green Published, Bronze			2022-01-24	
J	HUDSON, RR; BAILEY, K; SKARECKY, D; KWIATOWSKI, J; AYALA, FJ				HUDSON, RR; BAILEY, K; SKARECKY, D; KWIATOWSKI, J; AYALA, FJ			EVIDENCE FOR POSITIVE SELECTION IN THE SUPEROXIDE-DISMUTASE (SOD) REGION OF DROSOPHILA-MELANOGASTER	GENETICS			English	Article							INTRAGENIC RECOMBINATION; NATURAL-POPULATIONS; SEQUENCE-ANALYSIS; DNA POLYMORPHISM; GENE CONVERSION; HISTORY; LOCUS; CU; DIVERGENCE; POLYMERASE	DNA sequence variation in a 1410-bp region including the Cu,Zn Sod locus was examined in 41 homozygous lines of Drosophila melanogaster. Fourteen lines were from Barcelona, Spain, 25 were from California populations and the other two were from laboratory stocks. Two common electromorphs, SODS and SODF, are segregating in the populations. Our sample of 41 lines included 19 Sod(S) and 22 Sod(F) alleles (henceforward referred to as Slow and Fast alleles). All 19 Slow alleles were identical in sequence. Of the 22 Fast alleles sequenced, nine were identical in sequence and are referred to as the Fast A haplotypes. The Slow allele sequence differed from the Fast A haplotype at a single nucleotide site, the site that accounts for the amino acid difference between SODS and SODF. There were nine other haplotypes among the remaining 13 Fast alleles sequenced. The overall level of nucleotide diversity (pi) in this sample is not greatly different than that found at other loci in D. melanogaster. It is concluded that the Slow/Fast polymorphism is a recently arisen polymorphism, not an old balanced polymorphism. The large group of nearly identical haplotypes suggests that a recent mutation, at the Sod locus or tightly linked to it, has increased rapidly in frequency to around 50%, both in California and Spain. The application of a new statistical test demonstrates that the occurrence of such large numbers of haplotypes with SO little variation among them is very unlikely under the usual equilibrium neutral model. We suggest that the high frequency of some haplotypes is due to natural selection at the Sod locus or at a tightly linked locus.			HUDSON, RR (corresponding author), UNIV CALIF IRVINE,DEPT ECOL & EVOLUTIONARY BIOL,IRVINE,CA 92717, USA.		Kwiatowski, Jan/AAI-5026-2020	Kwiatowski, Jan/0000-0003-0748-5912; Skarecky, Douglas/0000-0002-9234-6716	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01GM042397] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM42397] Funding Source: Medline		AYALA FJ, 1972, GENETICS, V70, P113; BEGUN DJ, 1994, GENETICS, V136, P155; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BERRY AJ, 1991, GENETICS, V129, P1111; CEBALLOS I, 1990, ADV EXP MED BIOL, V264, P493; Ceballos-Picot I, 1992, EXS, V62, P89; CHOVNICK A, 1977, CELL, V11, P1, DOI 10.1016/0092-8674(77)90312-9; EANES WF, 1993, P NATL ACAD SCI USA, V90, P7475, DOI 10.1073/pnas.90.16.7475; FU YX, 1993, GENETICS, V133, P693; GILLESPIE JH, 1979, J MOL EVOL, V13, P27, DOI 10.1007/BF01732751; GOLDING GB, 1985, P NATL ACAD SCI USA, V82, P8577, DOI 10.1073/pnas.82.24.8577; GRAF JD, 1986, BIOCHEM GENET, V24, P153, DOI 10.1007/BF00502785; HALE LR, 1991, GENETICS, V129, P103; HARTL DL, 1991, J EVOLUTION BIOL, V4, P519, DOI 10.1046/j.1420-9101.1991.4040519.x; HUDSON RR, 1986, GENETICS, V113, P1057; HUDSON RR, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P23; HUDSON RR, 1988, GENETICS, V120, P831; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; KAPLAN NL, 1989, GENETICS, V123, P887; KAWASAKI ES, 1990, PCR PROTOCOLS GUIDE, P00146; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; KREITMAN M, 1991, GENETICS, V127, P565; KWIATOWSKI J, 1991, MOL BIOL EVOL, V8, P884; KWIATOWSKI J, 1989, NUCLEIC ACIDS RES, V17, P6735, DOI 10.1093/nar/17.16.6735; KWIATOWSKI J, 1989, NUCLEIC ACIDS RES, V17, P1264, DOI 10.1093/nar/17.3.1264; Kwiatowski J, 1992, MOL PHYLOGENET EVOL, V1, P72, DOI 10.1016/1055-7903(92)90037-H; LEE YM, 1985, ARCH BIOCHEM BIOPHYS, V241, P577, DOI 10.1016/0003-9861(85)90583-1; LEE YM, 1981, P NATL ACAD SCI-BIOL, V78, P7052, DOI 10.1073/pnas.78.11.7052; LEE YM, 1985, FEBS LETT, V179, P115, DOI 10.1016/0014-5793(85)80203-9; Maniatis T, 1982, MOLECULAR; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nei M., 1987, MOL EVOLUTIONARY GEN; PENG TX, 1991, GENETICS, V128, P381; PENG TX, 1986, P NATL ACAD SCI USA, V83, P684, DOI 10.1073/pnas.83.3.684; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SEAGER RD, 1982, GENETICS, V102, P467; SETO NOL, 1989, GENE, V75, P85, DOI 10.1016/0378-1119(89)90385-5; SINGH RS, 1982, GENETICS, V101, P235; STEPHENS JC, 1985, MOL BIOL EVOL, V2, P539; STROBECK C, 1987, GENETICS, V117, P149; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1989, GENETICS, V123, P585; TANAKO TS, 1993, MECHANISMS MOL EVOLU, P179; TANIGUCHI N, 1992, ADV CLIN CHEM, V29, P1, DOI 10.1016/S0065-2423(08)60221-8; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	53	251	253	0	7	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	APR	1994	136	4					1329	1340					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NB821	WOS:A1994NB82100012	8013910				2022-01-24	
J	MORAES, CT; RICCI, E; BONILLA, E; DIMAURO, S; SCHON, EA				MORAES, CT; RICCI, E; BONILLA, E; DIMAURO, S; SCHON, EA			THE MITOCHONDRIAL TERT-RNA LEU(UUR) MUTATION IN MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC-ACIDOSIS, AND STROKE-LIKE EPISODES (MELAS) - GENETIC, BIOCHEMICAL, AND MORPHOLOGICAL CORRELATIONS IN SKELETAL-MUSCLE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KEARNS-SAYRE SYNDROME; RAGGED-RED FIBERS; MYOCLONIC EPILEPSY; OXIDASE DEFICIENCY; DNA DELETIONS; DISEASE; MYOPATHIES; GENOMES; IDENTIFICATION; TRANSCRIPTION	Mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) has recently been associated with an A --> G transition at position 3243 within the mitochondrial tRNA(Leu(UUR)) gene. Besides altering the tRNA(Leu(UUR)) sequence, this point mutation lies within a DNA segment responsible for transcription termination of the rRNA genes. We have studied the distribution and expression of mutant mtDNAs in muscle biopsies from MELAS patients. Histochemical, immunohistochemical, and single-fiber PCR analysis showed that ragged-red fibers (RRF) are associated both with high levels of mutant mitochondrial genomes (> 85% mutant mtDNA) and with a partial cytochrome c oxidase deficiency. By quantitative in situ hybridization, the steady-state ratios of mRNAs:rRNAs were found to be similar to controls in six of eight patients studied. In two other patients the relative levels of heavy-strand mRNAs were slightly increased, but a patient with myoclonic epilepsy and RRF also exhibited a similar increase. These results directly correlate the A --> G transition at mtDNA position 3243 with muscle mitochondrial proliferation, partial respiratory-chain impairment, decreased mitochondrially synthesized protein content, and no specific alterations in mitochondrial ratios of mRNAs:rRNAs.	COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, 630 W 168TH ST, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; H HOUSTON MERRITT CLIN RES CTR MUSCULAR DYSTROPHY, NEW YORK, NY USA				Ricci, Enzo/AAC-4448-2020; Moraes, Carlos/AAT-3818-2021	RICCI, Enzo/0000-0003-3092-3597	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS11766, NS28828] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS028828, P01NS011766, P50NS011766] Funding Source: NIH RePORTER		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CHRISTIANSON TW, 1986, P NATL ACAD SCI USA, V83, P6277, DOI 10.1073/pnas.83.17.6277; CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663; CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; Dubowitz V., 1973, MUSCLE BIOPSY MODERN; EVIANI M, 1991, LANCET, V338, P143; GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497; GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E; GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOWELL N, 1991, AM J HUM GENET, V48, P935; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; KARPATI G, 1973, J NEUROL SCI, V19, P133, DOI 10.1016/0022-510X(73)90158-5; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590; KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631; MORAES CT, 1991, CURRENT NEUROLOGY, V11, P83; NELSON I, 1989, NUCLEIC ACIDS RES, V17, P8117, DOI 10.1093/nar/17.20.8117; OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; ROMERO NB, 1989, J NEUROL SCI, V93, P297, DOI 10.1016/0022-510X(89)90199-8; SARKAR G, 1990, NATURE, V343, P27, DOI 10.1038/343027a0; SEIBEL P, 1990, BIOCHEM BIOPH RES CO, V173, P561, DOI 10.1016/S0006-291X(05)80071-3; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SHOFFNER JM, 1990, ADV HUM GENET, V19, P267; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SUDOYO H, 1990, J NEUROL SCI, V98, P185, DOI 10.1016/0022-510X(90)90259-P; TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z; TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; YONEDA M, 1990, BIOCHEM INT, V21, P789	45	251	254	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					934	949					16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	WOS:A1992HR47300007	1315123				2022-01-24	
J	VOWELS, JJ; THOMAS, JH				VOWELS, JJ; THOMAS, JH			GENETIC-ANALYSIS OF CHEMOSENSORY CONTROL OF DAUER FORMATION IN CAENORHABDITIS-ELEGANS	GENETICS			English	Article							DEFECTIVE-MUTANTS; NEMATODE; PHEROMONE; TEMPERATURE; LARVA; FOOD	Dauer larva formation in Caenorhabditis elegans is controlled by chemosensory cells that respond to environmental cues. Genetic interactions among mutations in 23 genes that affect dauer larva formation were investigated. Mutations in seven genes that cause constitutive dauer formation, and mutations in 16 genes that either block dauer formation or result in the formation of abnormal dauers, were analyzed. Double mutants between dauer-constitutive and dauer-defective mutations were constructed and characterized for their capacity to form dauer larvae. Many of the genes could be interpreted to lie in a simple linear epistasis pathway. Three genes, daf-16, daf-18 and daf-20, may affect downstream steps in a branched part of the pathway. Three others genes, daf-2, daf-3 and daf-5, displayed partial or complex epistasis interactions that were difficult to interpret as part of a simple linear pathway. Dauer-defective mutations in nine genes cause structurally defective chemosensory cilia, thereby blocking chemosensation. Mutations in all nine of these genes appear to fall at a single step in the epistasis pathway. Dauer-constitutive mutations in one gene, daf-11, were strongly suppressed for dauer formation by mutations in the nine cilium-structure genes. Mutations in the other six dauer-constitutive genes caused dauer formation despite the absence of functional chemosensory endings. These results suggest that daf-11 is directly involved in chemosensory transduction essential for dauer formation, while the other Daf-c genes play roles downstream of the chemosensory step.			VOWELS, JJ (corresponding author), UNIV WASHINGTON, DEPT GENET, SEATTLE, WA 98195 USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM39868] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM039868] Funding Source: NIH RePORTER		ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CULOTTI JG, 1978, GENETICS, V90, P243; GOLDEN JW, 1985, MOL GEN GENET, V198, P534, DOI 10.1007/BF00332953; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEREFORD LM, 1974, J MOL BIOL, V84, P445, DOI 10.1016/0022-2836(74)90451-3; HERMAN RK, 1984, GENETICS, V108, P165; HORVITZ HR, 1979, MOL GEN GENET, V175, P129, DOI 10.1007/BF00425528; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; RIDDLE DL, 1977, CAENORHABDITIS ELEGA, V9, P101; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; TRENT C, 1983, GENETICS, V104, P619; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	27	251	280	1	9	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JAN	1992	130	1					105	123					19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GX543	WOS:A1992GX54300011	1732156				2022-01-24	
J	HODGKIN, J				HODGKIN, J			MALE PHENOTYPES AND MATING EFFICIENCY IN CAENORHABDITIS-ELEGANS	GENETICS			English	Article											HODGKIN, J (corresponding author), MRC, MOLEC BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND.						BABU P, 1974, MOL GEN GENET, V135, P39, DOI 10.1007/BF00433899; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; COX GN, 1980, GENETICS, V95, P317; CULOTTI JG, 1981, GENETICS, V97, P281; CULOTTI JG, 1978, GENETICS, V90, P243; DUSENBERY DB, 1975, GENETICS, V80, P297; DUSENBERY DB, 1980, NEMATODES BIOL MODEL; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HERMAN RK, 1980, NEMATODES BIOL MODEL; HODGKIN J, 1980, GENETICS, V96, P649; HODGKIN J, 1979, GENETICS, V91, P67; HODGKIN JA, 1977, GENETICS, V86, P275; Hodgkin JA., 1974, THESIS DARWIN COLLEG; HORVITZ HR, 1980, GENETICS, V96, P435; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; WARD S, 1978, GENETICS, V88, P285; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; WARD S, 1977, ANNU REV GENET, V11, P415, DOI 10.1146/annurev.ge.11.120177.002215; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	28	251	441	0	13	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1983	103	1					43	64					22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU908	WOS:A1983PU90800004	17246100				2022-01-24	
J	LAWRENCE, CW; CHRISTENSEN, R				LAWRENCE, CW; CHRISTENSEN, R			UV MUTAGENESIS IN RADIATION-SENSITIVE STRAINS OF YEAST	GENETICS			English	Article									UNIV ROCHESTER,SCH MED & DENT,DEPT RADIAT BIOL & BIOPHYS,ROCHESTER,NY 14642								AVERBECK D, 1970, MOL GEN GENET, V107, P117, DOI 10.1007/BF00333628; BRENDEL M, 1973, MOL GEN GENET, V125, P197, DOI 10.1007/BF00270743; COX B, 1974, MUTAT RES, V26, P257, DOI 10.1016/S0027-5107(74)80023-0; COX BS, 1968, MUTAT RES, V6, P37, DOI 10.1016/0027-5107(68)90101-2; ECKARDT F, 1975, MOL GEN GENET, V136, P261, DOI 10.1007/BF00334021; GAME JC, 1971, MUTAT RES, V12, P328, DOI 10.1016/0027-5107(71)90021-2; GAME JC, 1972, MUTAT RES, V16, P353, DOI 10.1016/0027-5107(72)90203-5; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0165-1218(74)90185-2; Hill R F, 1965, Photochem Photobiol, V4, P563, DOI 10.1111/j.1751-1097.1965.tb09774.x; KOWALSKI S, 1975, MOL GEN GENET, V136, P75, DOI 10.1007/BF00275450; LAWRENCE CW, 1974, J MOL BIOL, V85, P137, DOI 10.1016/0022-2836(74)90134-X; LAWRENCE CW, 1970, GENETICS, V64, pS36; LAWRENCE CW, 1975, GENETICS, V81, pR30; LEMONTT JF, 1972, MOL GEN GENET, V119, P27, DOI 10.1007/BF00270441; LEMONTT JF, 1971, GENETICS, V68, P21; LEMONTT JF, 1971, MUTAT RES, V13, P311, DOI 10.1016/0027-5107(71)90041-8; LEMONTT JF, 1973, GENETICS, V73, P153; MOUSTACCHI E, 1969, MUTAT RES, V7, P171, DOI 10.1016/0027-5107(69)90029-3; MOUSTACCHI E, 1971, MOL GEN GENET, V114, P50; PARRY JM, 1969, MUTAT RES, V8, P545, DOI 10.1016/0027-5107(69)90072-4; PRAKASH L, 1974, GENETICS, V78, P1101; PRAKASH L, 1973, J MOL BIOL, V79, P65, DOI 10.1016/0022-2836(73)90270-2; PRAKASH L, TO BE PUBLISHED; RESNICK MA, 1972, J BACTERIOL, V109, P979, DOI 10.1128/JB.109.3.979-986.1972; RESNICK MA, 1969, GENETICS, V62, P519; SHERMAN F, 1964, BIOCHIM BIOPHYS ACTA, V90, P1, DOI 10.1016/0304-4165(64)90113-8; STEWART JW, 1971, J BIOL CHEM, V246, P7429; STEWART JW, 1972, J MOL BIOL, V68, P83, DOI 10.1016/0022-2836(72)90264-1; UNRAU P, 1971, MOL GEN GENET, V113, P359, DOI 10.1007/BF00272336; WITKIN EM, 1973, GENETICS, V73, P91; WITKIN EVELYN M., 1967, BROOKHAVEN SYMP BIOL, V20, P17; ZAKHAROV IA, 1970, MUTAT RES, V9, P31, DOI 10.1016/0027-5107(70)90068-0; ZIMMERMANN FK, 1968, MOL GEN GENET, V102, P247, DOI 10.1007/BF00385981	33	251	254	0	27	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1976	82	2					207	232					26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BH287	WOS:A1976BH28700005	770231				2022-01-24	
J	Jackman, SD; Vandervalk, BP; Mohamadi, H; Chu, J; Yeo, S; Hammond, SA; Jahesh, G; Khan, H; Coombe, L; Warren, RL; Birol, I				Jackman, Shaun D.; Vandervalk, Benjamin P.; Mohamadi, Hamid; Chu, Justin; Yeo, Sarah; Hammond, S. Austin; Jahesh, Golnaz; Khan, Hamza; Coombe, Lauren; Warren, Rene L.; Birol, Inanc			ABySS 2.0: resource-efficient assembly of large genomes using a Bloom filter	GENOME RESEARCH			English	Article							SEQUENCING DATA; DRAFT GENOMES; LONG READS; LOW MEMORY; LEUKEMIA	The assembly of DNA sequences de novo is fundamental to genomics research. It is the first of many steps toward elucidating and characterizing whole genomes. Downstream applications, including analysis of genomic variation between species, between or within individuals critically depend on robustly assembled sequences. In the span of a single decade, the sequence throughput of leading DNA sequencing instruments has increased drastically, and coupled with established and planned large-scale, personalized medicine initiatives to sequence genomes in the thousands and even millions, the development of efficient, scalable and accurate bioinformatics tools for producing high-quality reference draft genomes is timely. With ABySS 1.0, we originally showed that assembling the human genome using short 50-bp sequencing reads was possible by aggregating the half terabyte of compute memory needed over several computers using a standardized message-passing system (MPI). We present here its redesign, which departs from MPI and instead implements algorithms that employ a Bloom filter, a probabilistic data structure, to represent a de Bruijn graph and reduce memory requirements. We benchmarked ABySS 2.0 human genome assembly using a Genome in a Bottle data set of 250-bp Illumina paired-end and 6-kbp mate-pair libraries from a single individual. Our assembly yielded a NG50 (NGA50) scaffold contiguity of 3.5 (3.0) Mbp using <35 GB of RAM. This is a modest memory requirement by today's standards and is often available on a single computer. We also investigate the use of BioNano Genomics and 10x Genomics' Chromium data to further improve the scaffold NG50 (NGA50) of this assembly to 42 (15) Mbp.	[Jackman, Shaun D.; Vandervalk, Benjamin P.; Mohamadi, Hamid; Chu, Justin; Yeo, Sarah; Hammond, S. Austin; Jahesh, Golnaz; Khan, Hamza; Coombe, Lauren; Warren, Rene L.; Birol, Inanc] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada		Birol, I (corresponding author), British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada.	ibirol@bcgsc.ca	Birol, Inanc/G-5440-2011	Birol, Inanc/0000-0003-0950-7839; Vandervalk, Ben/0000-0002-3082-3476; Hammond, S. Austin/0000-0003-3082-760X; Coombe, Lauren/0000-0002-7518-2326	National Human Genome Research Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG007182]; IntelIntel Corporation; Genome CanadaGenome Canada; Genome British Columbia; British Columbia Cancer Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG007182] Funding Source: NIH RePORTER	We thank Martin Krzywinski for his help with the data visualization in the ideogram and Circos figures. The research presented here was funded by the National Human Genome Research Institute of the National Institutes of Health (under award no. R01HG007182), with additional support provided by Intel, Genome Canada, Genome British Columbia, and the British Columbia Cancer Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding organizations.	Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Bowe Alexander, 2012, Algorithms in Bioinformatics. Proceedings of the12th International Workshop, WABI 2012, P225, DOI 10.1007/978-3-642-33122-0_18; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Chikhi R, 2014, INT C RES COMP MOL B, P35; Chikhi R, 2016, BIOINFORMATICS, V32, P201, DOI 10.1093/bioinformatics/btw279; Chikhi R, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-22; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li DH, 2016, METHODS, V102, P3, DOI 10.1016/j.ymeth.2016.02.020; Li H, 2015, BIOINFORMATICS, V31, P3694, DOI 10.1093/bioinformatics/btv440; Li H, 2015, BIOINFORMATICS, V31, P2885, DOI 10.1093/bioinformatics/btv290; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mohamadi H, 2017, BIOINFORMATICS; Mohamadi H, 2016, BIOINFORMATICS, V32, P3492, DOI 10.1093/bioinformatics/btw397; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Mostovoy Y, 2016, NAT METHODS, V13, P587, DOI [10.1038/NMETH.3865, 10.1038/nmeth.3865]; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; O'Connell J, 2015, BIOINFORMATICS, V31, P2035, DOI 10.1093/bioinformatics/btv057; Paulino D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0663-4; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rizk G, 2013, BIOINFORMATICS, V29, P652, DOI 10.1093/bioinformatics/btt020; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Sahlin K, 2016, BIOINFORMATICS, V32, P1925, DOI 10.1093/bioinformatics/btw064; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Vandervalk BP, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S3-S1; Warren RL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0076-3; Weisenfeld NI, 2014, NAT GENET, V46, P1350, DOI 10.1038/ng.3121; Yeo S., 2017, BIORXIV, DOI [10.1101/100750., DOI 10.1101/100750]; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25	40	250	254	4	33	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2017	27	5					768	777		10.1101/gr.214346.116			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	ET6HP	WOS:000400392400011	28232478	Green Published, Green Submitted, hybrid	Y	N	2022-01-24	
J	Lin, ZW; Li, XR; Shannon, LM; Yeh, CT; Wang, ML; Bai, GH; Peng, Z; Li, JR; Trick, HN; Clemente, TE; Doebley, J; Schnable, PS; Tuinstra, MR; Tesso, TT; White, F; Yu, JM				Lin, Zhongwei; Li, Xianran; Shannon, Laura M.; Yeh, Cheng-Ting; Wang, Ming L.; Bai, Guihua; Peng, Zhao; Li, Jiarui; Trick, Harold N.; Clemente, Thomas E.; Doebley, John; Schnable, Patrick S.; Tuinstra, Mitchell R.; Tesso, Tesfaye T.; White, Frank; Yu, Jianming			Parallel domestication of the Shattering1 genes in cereals	NATURE GENETICS			English	Article							RICE ORYZA-SATIVA; SORGHUM-BICOLOR; WILD-RICE; GENOME; ASSOCIATION; DIVERSITY; EVOLUTION; MARKERS; ORIGIN; MAIZE	A key step during crop domestication is the loss of seed shattering. Here, we show that seed shattering in sorghum is controlled by a single gene, Shattering1 (Sh1), which encodes a YABBY transcription factor. Domesticated sorghums harbor three different mutations at the Sh1 locus. Variants at regulatory sites in the promoter and intronic regions lead to a low level of expression, a 2.2-kb deletion causes a truncated transcript that lacks exons 2 and 3, and a GT-to-GG splice-site variant in the intron 4 results in removal of the exon 4. The distributions of these non-shattering haplotypes among sorghum landraces suggest three independent origins. The function of the rice ortholog (OsSh1) was subsequently validated with a shattering-resistant mutant, and two maize orthologs (ZmSh1-1 and ZmSh1-5.1+ZmSh1-5.2) were verified with a large mapping population. Our results indicate that Sh1 genes for seed shattering were under parallel selection during sorghum, rice and maize domestication.	[Lin, Zhongwei; Li, Xianran; Bai, Guihua; Tesso, Tesfaye T.; Yu, Jianming] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Shannon, Laura M.; Doebley, John] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Yeh, Cheng-Ting; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Yeh, Cheng-Ting; Schnable, Patrick S.] Iowa State Univ, Dept Agron, Ames, IA USA; [Wang, Ming L.] ARS, USDA, Griffin, GA USA; [Bai, Guihua] ARS, USDA, Manhattan, KS USA; [Peng, Zhao; Li, Jiarui; Trick, Harold N.; White, Frank] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Clemente, Thomas E.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; [Tuinstra, Mitchell R.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA		Yu, JM (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	jyu@ksu.edu	Lin, Zhongwei/ABD-9297-2021; Li, Xianran/AAH-1070-2019; Li, Xianran/I-5651-2012; Yu, Jianming/Q-6722-2019; bai, guihua/L-6374-2019; Peng, Zhao/B-2386-2018	Li, Xianran/0000-0002-4252-6911; Yu, Jianming/0000-0001-5326-3099; bai, guihua/0000-0002-1194-319X; Trick, Harold/0000-0001-5255-5575; Schnable, Patrick/0000-0001-9169-5204; Yeh, Cheng-Ting/0000-0002-1392-2018	Agriculture and Food Research Initiative from US Department of Agriculture (USDA) National Institute of Food and Agriculture [2011-03587]; National Science FoundationNational Science Foundation (NSF) [DBI-0820610, DBI-0820619, DBI-1027527]; US Department of EnergyUnited States Department of Energy (DOE) [DE-SC0002259]; USDA-ARSUnited States Department of Agriculture (USDA)USDA Agricultural Research Service; Kansas State University; Kansas State University Center for Sorghum Improvement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007133] Funding Source: NIH RePORTER; Direct For Biological SciencesNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0820619] Funding Source: National Science Foundation	This work was supported by an Agriculture and Food Research Initiative Competitive Grant (2011-03587 to J.Y. and T. T. T.) from the US Department of Agriculture (USDA) National Institute of Food and Agriculture, the Plant Genome Research Program of the National Science Foundation (DBI-0820610 to J.Y., DBI-0820619 to J.D. and DBI-1027527 to P. S. S.), the Plant Feedstock Genomics Program of the US Department of Energy (DE-SC0002259 to J.Y.), the USDA-ARS (M. L. W. and G. B.), the Targeted Excellence Program of Kansas State University and the Kansas State University Center for Sorghum Improvement.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; CUI YX, 1995, THEOR APPL GENET, V90, P787, DOI 10.1007/BF00222013; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; DEWET JMJ, 1967, EVOLUTION, V21, P787, DOI [10.2307/2406774, 10.1111/j.1558-5646.1967.tb03434.x]; DOEBLEY J, 1991, GENETICS, V129, P285; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fukuta Y, 1998, BREEDING SCI, V48, P345; Gu XY, 2005, THEOR APPL GENET, V110, P1108, DOI 10.1007/s00122-005-1939-2; HARLAN J, 1992, CROP MAN; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI 10.1111/j.1558-5646.1973.tb00676.x; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Matsui K, 2004, GENOME, V47, P469, DOI [10.1139/g04-007, 10.1139/G04-007]; Murray SC, 2009, PLANT GENOME-US, V2, P48, DOI 10.3835/plantgenome2008.10.0011; Nalam VJ, 2006, THEOR APPL GENET, V112, P373, DOI 10.1007/s00122-005-0140-y; Onishi K, 2007, GENOME, V50, P757, DOI 10.1139/G07-051; Onishi K, 2007, BREEDING SCI, V57, P7, DOI 10.1270/jsbbs.57.7; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050	30	250	273	2	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					720	U154		10.1038/ng.2281			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	WOS:000304551100023	22581231	Green Accepted, Green Submitted			2022-01-24	
J	Thye, T; Vannberg, FO; Wong, SH; Owusu-Dabo, E; Osei, I; Gyapong, J; Sirugo, G; Sisay-Joof, F; Enimil, A; Chinbuah, MA; Floyd, S; Warndorff, DK; Sichali, L; Malema, S; Crampin, AC; Ngwira, B; Teo, YY; Small, K; Rockett, K; Kwiatkowski, D; Fine, PE; Hill, PC; Newport, M; Lienhardt, C; Adegbola, RA; Corrah, T; Ziegler, A; Morris, AP; Meyer, CG; Horstmann, RD; Hill, AVS				Thye, Thorsten; Vannberg, Fredrik O.; Wong, Sunny H.; Owusu-Dabo, Ellis; Osei, Ivy; Gyapong, John; Sirugo, Giorgio; Sisay-Joof, Fatou; Enimil, Anthony; Chinbuah, Margaret A.; Floyd, Sian; Warndorff, David K.; Sichali, Lifted; Malema, Simon; Crampin, Amelia C.; Ngwira, Bagrey; Teo, Yik Y.; Small, Kerrin; Rockett, Kirk; Kwiatkowski, Dominic; Fine, Paul E.; Hill, Philip C.; Newport, Melanie; Lienhardt, Christian; Adegbola, Richard A.; Corrah, Tumani; Ziegler, Andreas; Morris, Andrew P.; Meyer, Christian G.; Horstmann, Rolf D.; Hill, Adrian V. S.		African TB Genetics Consortium; Wellcome Trust Case Control Consor	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2	NATURE GENETICS			English	Article								We combined two tuberculosis genome-wide association studies from Ghana and The Gambia with subsequent replication in a combined 11,425 individuals. rs4331426, located in a gene-poor region on chromosome 18q11.2, was associated with disease (combined P = 6.8 x 10(-9), odds ratio = 1.19, 95% CI = 1.13-1.27). Our study demonstrates that genome-wide association studies can identify new susceptibility loci for infectious diseases, even in African populations, in which levels of linkage disequilibrium are particularly low.	[Thye, Thorsten; Meyer, Christian G.; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany; [Thye, Thorsten; Ziegler, Andreas] Univ Hosp Schleswig Holstein, Inst Med Biometry & Stat, Lubeck, Germany; [Vannberg, Fredrik O.; Wong, Sunny H.; Teo, Yik Y.; Small, Kerrin; Rockett, Kirk; Kwiatkowski, Dominic; Morris, Andrew P.; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Owusu-Dabo, Ellis; Enimil, Anthony] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Dept Community Hlth, Kumasi, Ghana; [Osei, Ivy; Gyapong, John; Chinbuah, Margaret A.] Ghana Hlth Serv, Hlth Res Unit, Accra, Ghana; [Sirugo, Giorgio; Sisay-Joof, Fatou; Hill, Philip C.; Newport, Melanie; Lienhardt, Christian; Adegbola, Richard A.; Corrah, Tumani] Med Res Ctr Labs, Banjul, Gambia; [Enimil, Anthony] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Floyd, Sian; Crampin, Amelia C.; Fine, Paul E.] London Sch Hyg & Trop Med, London WC1, England; [Warndorff, David K.; Sichali, Lifted; Malema, Simon; Ngwira, Bagrey; Fine, Paul E.] Karonga Prevent Study, Chilumba, Karonga Dist, Malawi		Horstmann, RD (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany.	horstmann@bnitm.de; adrian.hill@well.ox.ac.uk	Lienhardt, Christian/AAU-4969-2021; Wong, Sunny H/N-3754-2015; Enimil, Anthony/AAV-2595-2021; Clark, Taane G./AAM-2570-2020; Sirugo, Giorgio/N-9056-2019; Sirugo, Giorgio/L-1628-2016; Ziegler, Andreas/G-4246-2012	Lienhardt, Christian/0000-0003-0233-893X; Wong, Sunny H/0000-0002-3354-9310; Clark, Taane G./0000-0001-8985-9265; Crampin, Amelia/0000-0002-1513-4330; Gyapong, John/0000-0002-8415-1468; Ziegler, Andreas/0000-0002-8386-5397; Kwiatkowski, Dominic/0000-0002-5023-0176; Small, Kerrin/0000-0003-4566-0005; Newport, Melanie/0000-0002-8946-7525	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U190071468, G19/9] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G19/9, MC_U190071468] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [079828, 076438, 084818] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600718B] Funding Source: researchfish		[Anonymous], 2003, Wkly Epidemiol Rec, V78, P122; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; *WHO, 2009, LANCET, V373, P1145; Ziegler A, 2009, GENET EPIDEMIOL, V33, pS45, DOI 10.1002/gepi.20472	13	250	261	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					739	741		10.1038/ng.639			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	WOS:000281388400005	20694014	Green Submitted, Green Accepted			2022-01-24	
J	Martinez-Estrada, OM; Lettice, LA; Essafi, A; Guadix, JA; Slight, J; Velecela, V; Hall, E; Reichmann, J; Devenney, PS; Hohenstein, P; Hosen, N; Hill, RE; Munoz-Chapuli, R; Hastie, ND				Martinez-Estrada, Ofelia M.; Lettice, Laura A.; Essafi, Abdelkader; Antonio Guadix, Juan; Slight, Joan; Velecela, Victor; Hall, Emma; Reichmann, Judith; Devenney, Paul S.; Hohenstein, Peter; Hosen, Naoki; Hill, Robert E.; Munoz-Chapuli, Ramon; Hastie, Nicholas D.			Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin	NATURE GENETICS			English	Article							WILMS-TUMOR GENE; STEM-CELLS; EXPRESSION; MOUSE; ACTIVATION; EPICARDIUM; RECEPTOR; BIOLOGY; PROTEIN; TOOL	The epicardial epithelial-mesenchymal transition (EMT) is hypothesized to generate cardiovascular progenitor cells that differentiate into various cell types, including coronary smooth muscle and endothelial cells, perivascular and cardiac interstitial fibroblasts and cardiomyocytes. Here we show that an epicardial-specific knockout of the gene encoding Wilms' tumor-1 (Wt1) leads to a reduction in mesenchymal progenitor cells and their derivatives. We show that Wt1 is essential for repression of the epithelial phenotype in epicardial cells and during embryonic stem cell differentiation through direct transcriptional regulation of the genes encoding Snail (Snai1) and E-cadherin (Cdh1), two of the major mediators of EMT. Some mesodermal lineages do not form in Wt1-null embryoid bodies, but this effect is rescued by the expression of Snai1, underscoring the importance of EMT in generating these differentiated cells. These new insights into the molecular mechanisms regulating cardiovascular progenitor cells and EMT will shed light on the pathogenesis of heart diseases and may help the development of cell-based therapies.	[Martinez-Estrada, Ofelia M.; Lettice, Laura A.; Essafi, Abdelkader; Slight, Joan; Velecela, Victor; Hall, Emma; Reichmann, Judith; Devenney, Paul S.; Hohenstein, Peter; Hill, Robert E.; Hastie, Nicholas D.] MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Martinez-Estrada, Ofelia M.; Lettice, Laura A.; Essafi, Abdelkader; Slight, Joan; Velecela, Victor; Hall, Emma; Reichmann, Judith; Devenney, Paul S.; Hohenstein, Peter; Hill, Robert E.; Hastie, Nicholas D.] Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Antonio Guadix, Juan; Munoz-Chapuli, Ramon] Univ Malaga, Dept Anim Biol, Fac Sci, E-29071 Malaga, Spain; [Hosen, Naoki] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Osaka, Japan		Hastie, ND (corresponding author), MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	n.hastie@hgu.mrc.ac.uk	Martinez-Estrada, Ofelia M/V-4733-2017; Munoz-Chapuli, Ramon/K-7306-2014; Hohenstein, Peter/Y-2428-2018	Martinez-Estrada, Ofelia M/0000-0002-1814-1974; Munoz-Chapuli, Ramon/0000-0001-6392-6802; Reichmann, Judith/0000-0003-3288-2856; Hall, Emma/0000-0002-6944-6719; Hohenstein, Peter/0000-0001-8548-4734	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U127527180, MC_U127584494] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U127584494, U.1275.03.013.00001.01, MC_U127527180] Funding Source: Medline		Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Hosono S, 2000, J BIOL CHEM, V275, P10943, DOI 10.1074/jbc.275.15.10943; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mitiku N, 2007, DEV CELL, V13, P897, DOI 10.1016/j.devcel.2007.10.004; Miyoshi Y, 2002, CLIN CANCER RES, V8, P1167; Moore AW, 1999, DEVELOPMENT, V126, P1845; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Spraggon L, 2007, ONCOGENE, V26, P1484, DOI 10.1038/sj.onc.1209922; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129	23	250	257	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					89	U112		10.1038/ng.494			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	WOS:000273055100022	20023660	Green Accepted, Green Submitted, Bronze			2022-01-24	
J	Dieterich, C; Clifton, SW; Schuster, LN; Chinwalla, A; Delehaunty, K; Dinkelacker, I; Fulton, L; Fulton, R; Godfrey, J; Minx, P; Mitreva, M; Roeseler, W; Tian, H; Witte, H; Yang, SP; Wilson, RK; Sommer, RJ				Dieterich, Christoph; Clifton, Sandra W.; Schuster, Lisa N.; Chinwalla, Asif; Delehaunty, Kimberly; Dinkelacker, Iris; Fulton, Lucinda; Fulton, Robert; Godfrey, Jennifer; Minx, Pat; Mitreva, Makedonka; Roeseler, Waltraud; Tian, Huiyu; Witte, Hanh; Yang, Shiaw-Pyng; Wilson, Richard K.; Sommer, Ralf J.			The Pristionchus pacificus genome provides a unique perspective on nematode lifestyle and parasitism	NATURE GENETICS			English	Article							SEQUENCE; GENE; EVOLUTION; CELLULASES; ORTHOLOGS; FAMILIES; BEETLE	Here we present a draft genome sequence of the nematode Pristionchus pacificus, a species that is associated with beetles and is used as a model system in evolutionary biology. With 169 Mb and 23,500 predicted protein-coding genes, the P. pacificus genome is larger than those of Caenorhabditis elegans and the human parasite Brugia malayi. Compared to C. elegans, the P. pacificus genome has more genes encoding cytochrome P450 enzymes, glucosyltransferases, sulfotransferases and ABC transporters, many of which were experimentally validated. The P. pacificus genome contains genes encoding cellulase and diapausin, and cellulase activity is found in P. pacificus secretions, indicating that cellulases can be found in nematodes beyond plant parasites. The relatively higher number of detoxification and degradation enzymes in P. pacificus is consistent with its necromenic lifestyle and might represent a preadaptation for parasitism. Thus, comparative genomics analysis of three ecologically distinct nematodes offers a unique opportunity to investigate the association between genome structure and lifestyle.	[Clifton, Sandra W.; Chinwalla, Asif; Delehaunty, Kimberly; Fulton, Lucinda; Fulton, Robert; Godfrey, Jennifer; Minx, Pat; Mitreva, Makedonka; Yang, Shiaw-Pyng; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Dieterich, Christoph; Schuster, Lisa N.; Dinkelacker, Iris; Roeseler, Waltraud; Tian, Huiyu; Witte, Hanh; Sommer, Ralf J.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany		Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,Forest Pk Blvd, St Louis, MO 63108 USA.	rwilson@wustl.edu; ralf.sommer@tuebingen.mpg.de	Wilson, Richard K./AAF-4139-2019; Dieterich, Christoph/ABF-8459-2021	Wilson, Richard K./0000-0002-1992-1358; Mitreva, Makedonka/0000-0001-9572-3436	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54 HG003079] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003079] Funding Source: NIH RePORTER		Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Allen JE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s9; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Blaxter M, 2007, CELL HOST MICROBE, V2, P211, DOI 10.1016/j.chom.2007.09.008; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Huang XQ, 2006, NUCLEIC ACIDS RES, V34, P201, DOI 10.1093/nar/gkj419; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keen NT, 1998, P NATL ACAD SCI USA, V95, P4789, DOI 10.1073/pnas.95.9.4789; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kiontke Karin, 2005, P1; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mayer WE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-104; Oesch F, 1999, TOXICOLOGY, P83; Poulin R., 2007, EVOLUTIONARY ECOLOGY; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schlager B, 2006, CURR BIOL, V16, P1386, DOI 10.1016/j.cub.2006.06.058; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Srinivasan J, 2002, GENETICS, V162, P129; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tanaka H, 2003, PEPTIDES, V24, P1327, DOI 10.1016/j.peptides.2003.07.021; Tian H, 2008, CURR BIOL, V18, P142, DOI 10.1016/j.cub.2007.12.048; Weischer B, 2000, INTRO NEMATODES; Yi BQ, 2007, DEVELOPMENT, V134, P3111, DOI 10.1242/dev.008375; Zheng M, 2005, NAT GENET, V37, P300, DOI 10.1038/ng1512	37	250	255	4	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1193	1198		10.1038/ng.227			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	WOS:000259651000018	18806794	Green Accepted			2022-01-24	
J	Sulem, P; Gudbjartsson, DF; Stacey, SN; Helgason, A; Rafnar, T; Jakobsdottir, M; Steinberg, S; Gudjonsson, SA; Palsson, A; Thorleifsson, G; Palsson, S; Sigurgeirsson, B; Thorisdottir, K; Ragnarsson, R; Benediktsdottir, KR; Aben, KK; Vermeulen, SH; Goldstein, AM; Tucker, MA; Kiemeney, LA; Olafsson, JH; Gulcher, J; Kong, A; Thorsteinsdottir, U; Stefansson, K				Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Gudjonsson, Sigurjon A.; Palsson, Arnar; Thorleifsson, Gudmar; Palsson, Snaebjoern; Sigurgeirsson, Bardur; Thorisdottir, Kristin; Ragnarsson, Rafn; Benediktsdottir, Kristrun R.; Aben, Katja K.; Vermeulen, Sita H.; Goldstein, Alisa M.; Tucker, Margaret A.; Kiemeney, Lambertus A.; Olafsson, Jon H.; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Two newly identified genetic determinants of pigmentation in Europeans	NATURE GENETICS			English	Article							TYRP1 GENE; POLYMORPHISM; AGOUTI; SKIN; POPULATION; SEQUENCE; ALBINISM; MELANOMA; HUMANS	We present results from a genome-wide association study for variants associated with human pigmentation characteristics among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals. Two coding variants in TPCN2 are associated with hair color, and a variant at the ASIP locus shows strong association with skin sensitivity to sun, freckling and red hair, phenotypic characteristics similar to those affected by well-known mutations in MC1R.	[Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Gudjonsson, Sigurjon A.; Palsson, Arnar; Thorleifsson, Gudmar; Palsson, Snaebjoern; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE genet, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Thorisdottir, Kristin; Benediktsdottir, Kristrun R.; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Thorisdottir, Kristin; Ragnarsson, Rafn] Landspitali Univ Hosp, Dept Plast Surg, IS-101 Reykjavik, Iceland; [Aben, Katja K.; Kiemeney, Lambertus A.] Ctr Comprehens Canc, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K.; Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Goldstein, Alisa M.; Tucker, Margaret A.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Services, Bethesda, MD 20892 USA; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, NL-6500 HB Nijmegen, Netherlands		Gudbjartsson, DF (corresponding author), deCODE genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Aben, Katja KH/G-9686-2016; Tucker, Margaret A/B-4297-2015; Kiemeney, Lambertus A./D-3357-2009; Vermeulen, S.H.H.M./L-4716-2015; Palsson, Snaebjorn/J-9113-2012; Sigurgeirsson, Bardur/AAP-7755-2020; Sigurgeirsson, Bardur/B-6130-2011; Helgason, Agnar/K-1522-2015; Palsson, Arnar/M-2742-2015	Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Palsson, Arnar/0000-0002-6525-8112; Gudbjartsson, Daniel/0000-0002-5222-9857; Palsson, Snaebjorn/0000-0002-4297-3500; Kong, Augustine/0000-0001-8193-5438; Sigurgeirsson, Bardur/0000-0002-9733-9742; Gudjonsson, Sigurjon A./0000-0001-9314-7412	Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01CP005803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [Z01AI000732] Funding Source: NIH RePORTER		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Box NF, 1998, MAMM GENOME, V9, P50, DOI 10.1007/s003359900678; Frudakis T, 2003, GENETICS, V165, P2071; FUKAI K, 1995, NAT GENET, V9, P92, DOI 10.1038/ng0195-92; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; Meziani R, 2005, J DERMATOL SCI, V40, P133, DOI 10.1016/j.jdermsci.2005.08.001; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Schmutz SM, 2007, J HERED, V98, P351, DOI 10.1093/jhered/esm036; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Voisey J, 2002, PIGM CELL RES, V15, P10, DOI 10.1034/j.1600-0749.2002.00039.x	14	250	255	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					835	837		10.1038/ng.160			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	WOS:000257166500016	18488028				2022-01-24	
J	Cong, B; Barrero, LS; Tanksley, SD				Cong, Bin; Barrero, Luz S.; Tanksley, Steven D.			Regulatory change in YABBY-like transcription factor led to evolution of extreme fruit size during tomato domestication	NATURE GENETICS			English	Article							FLOWER DEVELOPMENT; LYCOPERSICON; EXPRESSION; PLANTS; CROSS; RICE; GENE	Plant domestication represents an accelerated form of evolution, resulting in exaggerated changes in the tissues and organs of greatest interest to humans ( for example, seeds, roots and tubers). One of the most extreme cases has been the evolution of tomato fruit. Cultivated tomato plants produce fruit as much as 1,000 times larger than those of their wild progenitors. Quantitative trait mapping studies have shown that a relatively small number of genes were involved in this dramatic transition, and these genes control two processes: cell cycle and organ number determination(1). The key gene in the first process has been isolated and corresponds to fw2.2, a negative regulator of cell division(2,3). However, until now, nothing was known about the molecular basis of the second process. Here, we show that the second major step in the evolution of extreme fruit size was the result of a regulatory change of a YABBY-like transcription factor (fasciated) that controls carpel number during flower and/or fruit development.	[Cong, Bin; Barrero, Luz S.; Tanksley, Steven D.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Cong, Bin; Barrero, Luz S.; Tanksley, Steven D.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA		Tanksley, SD (corresponding author), Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA.	sdt4@cornell.edu					Barrero LS, 2004, THEOR APPL GENET, V109, P669, DOI 10.1007/s00122-004-1676-y; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; ESHED Y, 1995, GENETICS, V141, P1147; Fourquin C, 2005, P NATL ACAD SCI USA, V102, P4649, DOI 10.1073/pnas.0409577102; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Jang S, 2004, PLANT MOL BIOL, V56, P133, DOI 10.1007/s11103-004-2648-y; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lippman Z, 2001, GENETICS, V158, P413; Nesbitt TC, 2002, GENETICS, V162, P365; ROE JL, 1993, CELL, V75, P939, DOI 10.1016/0092-8674(93)90537-Z; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119	17	250	276	13	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					800	804		10.1038/ng.144			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	WOS:000256212000024	18469814				2022-01-24	
J	Edvardson, S; Shaag, A; Kolesnikova, O; Gomori, JM; Tarassov, I; Einbinder, T; Saada, A; Elpeleg, O				Edvardson, Simon; Shaag, Avraham; Kolesnikova, Olga; Gomori, John Moshe; Tarassov, Ivan; Einbinder, Tom; Saada, Ann; Elpeleg, Orly			Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSLATION; DEFICIENCY; MYOPATHY; IMPORT; MTDNA; YEAST	Homozygosity mapping was performed in a consanguineous Sephardic Jewish family with three patients who presented with severe infantile encephalopathy associated with pontocerebellar hypoplasia and multiple mitochondrial respiratory-chain defects. This resulted in the identification of an intronic mutation in RARS2, the gene encoding mitochondrial arginine-transfer RNA (tRNA) synthetase. The mutation was associated with the production of an abnormally short RARS2 transcript and a marked reduction of the mitochondrial tRNA(Arg) transcript in the patients' fibroblasts. We speculate that missplicing mutations in mitochondrial aminoacy1-tRNA synthethase genes preferentially affect the brain because of a tissue-specific vulnerability of the splicing machinery.	Hebrew Univ Jerusalem, Hadassah Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Pediat Neurol Unit, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Radiol, IL-91120 Jerusalem, Israel; Univ Strasbourg 1, CNRS, UMR 7156, Dept Genet Mol & Cellulaire, Strasbourg, France		Elpeleg, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel.	Elpeleg@hadassah.org.il	Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656; Edvardson, Simon/0000-0003-2878-1278; Tarassov, Ivan/0000-0001-8763-6703			Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; de Koning TJ, 1999, NEUROPEDIATRICS, V30, P93, DOI 10.1055/s-2007-973467; Entelis N, 2002, GENET ENG P, V24, P191; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Patel MS, 2006, AM J MED GENET A, V140A, P594, DOI 10.1002/ajmg.a.31095; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; TZAGOLOFF A, 1995, EUR J BIOCHEM, V230, P582; Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	20	250	257	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					857	862		10.1086/521227			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	WOS:000249307600028	17847012	Green Published, Bronze			2022-01-24	
J	Lefebure, T; Stanhope, MJ				Lefebure, Tristan; Stanhope, Michael J.			Evolution of the core and pan-genome of Strepococcus: positive selection, recombination, and genome composition	GENOME BIOLOGY			English	Article							GROUP-A STREPTOCOCCUS; CODON-SUBSTITUTION MODELS; HORIZONTAL GENE-TRANSFER; GROUP-B STREPTOCOCCUS; AMINO-ACID SITES; LIKELIHOOD METHOD; ESCHERICHIA-COLI; HUMAN PATHOGEN; M3 STRAIN; SEQUENCE	Background: The genus Streptococcus is one of the most diverse, and important human and agricultural pathogens. This study employs comparative evolutionary analyses of 26 Streptococcus genomes to yield adaptation to their hosts. Results: Streptococcus genomes exhibit extreme levels of evolutionary plasticity, with high levels of gene gain and loss during species and strain evolution. S. agalactiae has a large pan-genome, with little recombination in its core-genome, while S. pyogenes has a smaller pan-genome and much more recombination of its core-genome, perhaps reflecting the greater habitat, and gene pool, diversity for S. agalactiae compared to S. pyogenes. Core-genome recombination was evident in all lineages (18 to 37% of the core-genome judged to be recombinant), whiled positive selection was mainly observed during species differentiation (from 11 to 34% of the core-genome). Positive selection pressure was unevenly distributed across lineages and biochemical main role categories. S. suis was the lineage with the greatest level of positive selection pressure, the largest number of unique loci selected, and the largest amount of gene gain and loss. Conclusions: Recombination is an important evolutionary force in shaping Streptococcus genomes, not only in the acquistion of significant portions of the genome as lineage specific loci, but also in faciliting rapid evolution of the core-genome. Positive selection, although undoubtedly a slower process, has nonetheless played an important role in adaptation of the core-genome of different Streptococcus species to different hosts.	Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA		Stanhope, MJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	tn17@cornell.edu; mjs297@cornell.edu	Lefebure, Tristan/A-6489-2009	Lefebure, Tristan/0000-0003-3923-8166			Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Anisimova M, 2003, GENETICS, V164, P1229; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Awadalla P, 2003, NAT REV GENET, V4, P50, DOI 10.1038/nrg964; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Benjamini Y, 2001, ANN STAT, V29, P1165; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Bielawski JP, 2004, P NATL ACAD SCI USA, V101, P14824, DOI 10.1073/pnas.0403999101; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Csuros M, 2006, LECT NOTES COMPUT SC, V3909, P206; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Filee J, 2006, MOL BIOL EVOL, V23, P1688, DOI 10.1093/molbev/msl036; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hao WL, 2006, GENOME RES, V16, P636, DOI 10.1101/gr.4746406; Hao WL, 2004, MOL BIOL EVOL, V21, P1294, DOI 10.1093/molbev/msh129; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; Kim YR, 2006, INFECT IMMUN, V74, P2498, DOI 10.1128/IAI.74.4.2498-2502.2006; Kunin V, 2003, GENOME RES, V13, P1589, DOI 10.1101/gr.1092603; Lancefield RC, 1934, J EXP MED, V59, P441, DOI 10.1084/jem.59.4.441; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li ZY, 2003, J INFECT DIS, V188, P1587, DOI 10.1086/379050; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marri PR, 2006, MOL BIOL EVOL, V23, P2379, DOI 10.1093/molbev/msl115; Medigue C, 1999, GENOME RES, V9, P1116, DOI 10.1101/gr.9.11.1116; Mengin-Lecreulx D, 1999, J BACTERIOL, V181, P5909, DOI 10.1128/JB.181.19.5909-5914.1999; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nielsen R, 1998, GENETICS, V148, P929; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI 10.1097/00006454-200302000-00009; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; Ochman H, 2005, P NATL ACAD SCI USA, V102, P6595, DOI 10.1073/pnas.0502035102; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Perrodou E, 2006, NUCLEIC ACIDS RES, V34, pD338, DOI 10.1093/nar/gkj060; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sharkawy A, 2002, CLIN INFECT DIS, V34, P454, DOI 10.1086/338466; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Smith HE, 2001, INFECT IMMUN, V69, P1961, DOI 10.1128/IAI.69.3.1961-1966.2001; SMITH JM, 1992, J MOL EVOL, V34, P126; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Snider LA, 2004, MOL PSYCHIATR, V9, P900, DOI 10.1038/sj.mp.4001542; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Swofford D.L, 2002, PAUP PHYLOGENETIC AN; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Dongen S, 2000, THESIS U UTRECHT NET; Yang KS, 2002, ORG LETT, V4, P1107, DOI 10.1021/ol0173073; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	84	250	255	3	37	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2007	8	5							r71	10.1186/gb-2007-8-5-r71			30	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	175AA	WOS:000246983100009	17475002	Green Published, hybrid			2022-01-24	
J	Parsons, M; Worthey, EA; Ward, PN; Mottram, JC				Parsons, M; Worthey, EA; Ward, PN; Mottram, JC			Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi	BMC GENOMICS			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE PROGRESSION; PLASMODIUM-FALCIPARUM; DEVELOPMENTAL REGULATION; MAXIMUM-LIKELIHOOD; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; FLAGELLAR-LENGTH; PROCYCLIC FORM; CHAGAS-DISEASE	Background: The trypanosomatids Leishmania major, Trypanosoma brucei and Trypanosoma cruzi cause some of the most debilitating diseases of humankind: cutaneous leishmaniasis, African sleeping sickness, and Chagas disease. These protozoa possess complex life cycles that involve development in mammalian and insect hosts, and a tightly coordinated cell cycle ensures propagation of the highly polarized cells. However, the ways in which the parasites respond to their environment and coordinate intracellular processes are poorly understood. As a part of an effort to understand parasite signaling functions, we report the results of a genome-wide analysis of protein kinases (PKs) of these three trypanosomatids. Results: Bioinformatic searches of the trypanosomatid genomes for eukaryotic PKs (ePKs) and atypical PKs (aPKs) revealed a total of 176 PKs in T. brucei, 190 in T. cruzi and 199 in L. major, most of which are orthologous across the three species. This is approximately 30% of the number in the human host and double that of the malaria parasite, Plasmodium falciparum. The representation of various groups of ePKs differs significantly as compared to humans: trypanosomatids lack receptor-linked tyrosine and tyrosine kinase-like kinases, although they do possess dual-specificity kinases. A relative expansion of the CMGC, STE and NEK groups has occurred. A large number of unique ePKs show no strong affinity to any known group. The trypanosomatids possess few ePKs with predicted transmembrane domains, suggesting that receptor ePKs are rare. Accessory Pfam domains, which are frequently present in human ePKs, are uncommon in trypanosomatid ePKs. Conclusion: Trypanosomatids possess a large set of PKs, comprising approximately 2% of each genome, suggesting a key role for phosphorylation in parasite biology. Whilst it was possible to place most of the trypanosomatid ePKs into the seven established groups using bioinformatic analyses, it has not been possible to ascribe function based solely on sequence similarity. Hence the connection of stimuli to protein phosphorylation networks remains enigmatic. The presence of numerous PKs with significant sequence similarity to known drug targets, as well as a large number of unusual kinases that might represent novel targets, strongly argue for functional analysis of these molecules.	Seattle Biomed Res Inst, Seattle, WA 98109 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; Univ Glasgow, Anderson Coll, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland		Parsons, M (corresponding author), Seattle Biomed Res Inst, 307 Westlake Ave N, Seattle, WA 98109 USA.	marilyn.parsons@sbri.org; Elizabeth_Worthey@rosettabio.com; pauline.ward@bbsrc.ac.uk; j.mottram@bio.gla.ac.uk		Mottram, Jeremy/0000-0001-5574-3766; Ward, Pauline/0000-0001-9455-0983	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI031077] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI31077, R01 AI031077-11, R01 AI031077] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ABOAGYEKWARTENG T, 1991, BIOCHEM J, V275, P7, DOI 10.1042/bj2750007; Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Agron PG, 2005, MOL BIOCHEM PARASIT, V142, P121, DOI 10.1016/j.molbiopara.2005.03.007; Alexandre S, 1996, MOL BIOCHEM PARASIT, V77, P173, DOI 10.1016/0166-6851(96)02591-1; Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Angermayr M, 2002, FEBS LETT, V524, P31, DOI 10.1016/S0014-5793(02)02993-9; Barrett C, 1997, COMPUT APPL BIOSCI, V13, P191; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Bengs F, 2005, MOL MICROBIOL, V55, P1606, DOI 10.1111/j.1365-2958.2005.04498.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; BOSSEMEYER D, 1995, FEBS LETT, V369, P57, DOI 10.1016/0014-5793(95)00580-3; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; DELL KR, 1994, MOL BIOCHEM PARASIT, V64, P283, DOI 10.1016/0166-6851(94)00030-1; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Ellis J, 2004, MOL MICROBIOL, V53, P1487, DOI 10.1111/j.1365-2958.2004.04218.x; Force T, 2004, CIRCULATION, V109, P1196, DOI 10.1161/01.CIR.0000118538.21306.A9; GALE M, 1994, J BIOL CHEM, V269, P31659; Garber PM, 2005, TRENDS BIOCHEM SCI, V30, P63, DOI 10.1016/j.tibs.2004.12.004; Garcia-Salcedo JA, 2002, MOL MICROBIOL, V45, P307, DOI 10.1046/j.1365-2958.2002.03019.x; Grant KM, 1998, J BIOL CHEM, V273, P10153, DOI 10.1074/jbc.273.17.10153; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammarton Tansy C, 2003, Prog Cell Cycle Res, V5, P91; Hammarton TC, 2005, MOL MICROBIOL, V56, P104, DOI 10.1111/j.1365-2958.2005.04542.x; Hammarton TC, 2004, J BIOL CHEM, V279, P24757, DOI 10.1074/jbc.M401276200; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hassan P, 2001, MOL BIOCHEM PARASIT, V113, P189, DOI 10.1016/S0166-6851(01)00220-1; Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4; HUA SB, 1994, J CELL BIOCHEM, V54, P20, DOI 10.1002/jcb.240540104; Hua SB, 1997, J BIOL CHEM, V272, P10797, DOI 10.1074/jbc.272.16.10797; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kuhn D, 2005, MOL MICROBIOL, V56, P1169, DOI 10.1111/j.1365-2958.2005.04614.x; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Lejon V, 2005, TROP MED INT HEALTH, V10, P395, DOI 10.1111/j.1365-3156.2005.01403.x; Li Y, 2003, MOL MICROBIOL, V49, P251, DOI 10.1046/j.1365-2958.2003.03575.x; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Mahjoub MR, 2004, MOL BIOL CELL, V15, P5172, DOI 10.1091/mbc.E04-07-0571; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Mottram JC, 1996, MOL MICROBIOL, V22, P573, DOI 10.1046/j.1365-2958.1996.00136.x; MOTTRAM JC, 1995, GENE, V162, P147, DOI 10.1016/0378-1119(95)00350-F; MOTTRAM JC, 1993, J BIOL CHEM, V268, P21044; Muller IB, 2002, MOL BIOL CELL, V13, P3787, DOI 10.1091/mbc.E02-02-0093; Murray HW, 2004, AM J TROP MED HYG, V71, P787, DOI 10.4269/ajtmh.2004.71.787; NAULA C, 2005, IN PRESS BIOCH BIOPH; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Park JH, 2002, MOL BIOCHEM PARASIT, V119, P97, DOI 10.1016/S0166-6851(01)00407-8; PARSONS M, 1991, MOL BIOCHEM PARASIT, V45, P241, DOI 10.1016/0166-6851(91)90091-J; PARSONS M, 1994, MOL BIOCHEM PARASIT, V63, P69, DOI 10.1016/0166-6851(94)90009-4; Parsons M, 2000, PARASITOL TODAY, V16, P56, DOI 10.1016/S0169-4758(99)01590-2; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Portal D, 2003, MOL BIOCHEM PARASIT, V127, P9, DOI 10.1016/S0166-6851(02)00299-2; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sacerdoti-Sierra N, 1997, J BIOL CHEM, V272, P30760, DOI 10.1074/jbc.272.49.30760; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salotra P, 2000, INT J BIOCHEM CELL B, V32, P309, DOI 10.1016/S1357-2725(99)00134-X; Schneider AG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-30; Shalaby T, 2001, EUR J BIOCHEM, V268, P6197, DOI 10.1046/j.0014-2956.2001.02564.x; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2004, MOL BIOL EVOL, V21, P828, DOI 10.1093/molbev/msh077; Spadafora C, 2002, MOL BIOCHEM PARASIT, V124, P23, DOI 10.1016/S0166-6851(02)00156-1; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Therond P, 1996, GENETICS, V142, P1181; Tu XM, 2005, EUKARYOT CELL, V4, P755, DOI 10.1128/EC.4.4.755-764.2005; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Vieira LL, 2002, INT J PARASITOL, V32, P1085, DOI 10.1016/S0020-7519(02)00067-X; WALKER JC, 1990, NATURE, V345, P743, DOI 10.1038/345743a0; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wiese M, 2003, INT J PARASITOL, V33, P1577, DOI 10.1016/S0020-7519(03)00252-2; Wiese M, 2003, EUKARYOT CELL, V2, P769, DOI 10.1128/EC.2.4.769-777.2003; Wiese M, 1998, EMBO J, V17, P2619, DOI 10.1093/emboj/17.9.2619; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; ZHAO Y, 1994, BIOCHEMISTRY-US, V33, P3714, DOI 10.1021/bi00178a031; 2005, PHYML SIMPLE FAST AC; 2005, GENE DB; 2005, PAL2NAL; 2005, KING KINASES GENOME; 2005, PAUP	98	250	256	1	20	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	SEP 15	2005	6								127	10.1186/1471-2164-6-127			19	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	977LD	WOS:000232804400001	16164760	gold, Green Published			2022-01-24	
J	Torto, TA; Li, SA; Styer, A; Huitema, E; Testa, A; Gow, NAR; van West, P; Kamoun, S				Torto, TA; Li, SA; Styer, A; Huitema, E; Testa, A; Gow, NAR; van West, P; Kamoun, S			EST mining and functional expression assays identify extracellular effector proteins from the plant pathogen Phytophthora	GENOME RESEARCH			English	Article							POTATO-VIRUS-X; AVIRULENCE GENE; RESISTANCE; SIGNAL; SEQUENCES; INFESTANS; RECOGNITION; PREDICTION; JUVENILES; SELECTION	Plant pathogenic microbes have the remarkable ability to manipulate biochemical, physiological, and morphological processes in their host plants. These manipulations are achieved through a diverse array of effector molecules that can either promote infection or trigger defense responses. We describe a general functional genomics approach aimed at identifying extracellular effector proteins from plant pathogenic microorganisms by combining data mining of expressed sequence tags (ESTs) with virus-based high-throughput functional expression assays in plants. PexFinder, an algorithm for automated identification of extracellular proteins from EST data sets, was developed and applied to 2147 ESTs from the oomycete plant pathogen Phytophthora infestans. The program identified 261 ESTs (12.2%) corresponding to a set of 142 nonredundant Pex (Phytophthora extracellular protein) cDNAs. Of these, 78 (55%) Pex cDNAs were novel with no significant matches in public databases. Validation of PexFinder was performed using proteomic analysis of secreted protein of A infestans. To identify which of the Pex cDNAs encode effector proteins that manipulate plant processes, high-throughput functional expression assays in plants were performed on, 63 of the identified cDNAs using an Agrobacterium tumefaciens binary vector carrying the potato virus X (PVX) genome. This led to the discovery of two novel necrosis-inducing cDNAs, crn1 and crn2, encoding extracellular proteins that belong to a large and complex protein family in Phytophthora. Further characterization of the crn genes indicated that they are both expressed in P. infestans during colonization of the host plant tomato and that crn2 induced defense-response genes in tomato. Our results indicate that combining data mining using PexFinder with PVX-based functional assays can facilitate the discovery of novel pathogen effector proteins. In principle, this strategy can be applied to a variety of eukaryotic plant pathogens, including oomycetes, fungi, and nematodes.	Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH 44691 USA; Inst Med Sci, Dept Mol & Cell Biol, Foresthill AB25 2ZD, Scotland		Kamoun, S (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH 44691 USA.	kamoun.1@osu.edu	Kamoun, Sophien/B-3529-2009; Huitema, Edgar/G-3760-2011; GOW, Neil/AAS-5323-2021; Testa, Antonino/H-6864-2012	Kamoun, Sophien/0000-0002-0290-0315; Huitema, Edgar/0000-0002-5766-0830; GOW, Neil/0000-0002-2776-5850; Testa, Antonino/0000-0003-3983-2448; van West, Pieter/0000-0002-0767-6017			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Cash P, 1997, ELECTROPHORESIS, V18, P1472, DOI 10.1002/elps.1150180822; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Czernic P, 1996, PLANT MOL BIOL, V31, P255, DOI 10.1007/BF00021788; Dautova M, 2001, NEMATOLOGY, V3, P129, DOI 10.1163/156854101750236259; Fry WE, 1997, PLANT DIS, V81, P1349, DOI 10.1094/PDIS.1997.81.12.1349; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Hahn M, 2001, CURR OPIN PLANT BIOL, V4, P322, DOI 10.1016/S1369-5266(00)00180-1; HAMMONDKOSACK KE, 1995, MOL PLANT MICROBE IN, V8, P181, DOI 10.1094/MPMI-8-0181; HENNIGER H., 1959, Phytopathologische Zeitschrift, V34, P285; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Kamoun S, 2001, CURR OPIN PLANT BIOL, V4, P295, DOI 10.1016/S1369-5266(00)00176-X; KAMOUN S, 1993, MOL PLANT MICROBE IN, V6, P15, DOI 10.1094/MPMI-6-015; Kamoun S, 1999, FUNGAL GENET BIOL, V28, P94, DOI 10.1006/fgbi.1999.1166; Kamoun S, 1999, MOL PLANT MICROBE IN, V12, P459, DOI 10.1094/MPMI.1999.12.5.459; Kamoun S, 2000, FUNGAL PATHOLOGY, P237; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P1028, DOI 10.1094/MPMI.1997.10.8.1028; Karsch-Mizrachi I, 2001, Methods Biochem Anal, V43, P45; Kjemtrup S, 2000, CURR OPIN MICROBIOL, V3, P73, DOI 10.1016/S1369-5274(99)00054-5; Klein RD, 1996, P NATL ACAD SCI USA, V93, P7108, DOI 10.1073/pnas.93.14.7108; Knogge W, 1996, PLANT CELL, V8, P1711, DOI 10.1105/tpc.8.10.1711; Lauge R, 1998, FUNGAL GENET BIOL, V24, P285, DOI 10.1006/fgbi.1998.1076; LONG S, 1988, J BACTERIOL, V170, P4257, DOI 10.1128/jb.170.9.4257-4265.1988; Martin SAM, 2001, FISH PHYSIOL BIOCHEM, V24, P259, DOI 10.1023/A:1014015530045; Menne KML, 2000, BIOINFORMATICS, V16, P741, DOI 10.1093/bioinformatics/16.8.741; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; Parniske M, 2000, CURR OPIN PLANT BIOL, V3, P320, DOI 10.1016/S1369-5266(00)00088-1; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Popeijus M, 2000, NEMATOLOGY, V2, P567, DOI 10.1163/156854100509358; Qutob D, 2000, PLANT PHYSIOL, V123, P243, DOI 10.1104/pp.123.1.243; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; SACKS W, 1995, MOL GEN GENET, V246, P45, DOI 10.1007/BF00290132; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skinner W, 2001, CURR OPIN MICROBIOL, V4, P381, DOI 10.1016/S1369-5274(00)00221-6; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Takken FLW, 2000, PLANT J, V24, P275, DOI 10.1046/j.1365-313x.2000.00866.x; Tampakaki AP, 2000, MOL PLANT MICROBE IN, V13, P1366, DOI 10.1094/MPMI.2000.13.12.1366; TEMPLETON MD, 1994, MOL PLANT MICROBE IN, V7, P320, DOI 10.1094/MPMI-7-0320; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tobias CM, 1999, PLANT J, V17, P41, DOI 10.1046/j.1365-313X.1999.00350.x; UNKLES SE, 1991, GENE, V100, P105, DOI 10.1016/0378-1119(91)90355-F; VANKAN JAL, 1992, PLANT MOL BIOL, V20, P513, DOI 10.1007/BF00040610; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wang XH, 2001, MOL PLANT MICROBE IN, V14, P536, DOI 10.1094/MPMI.2001.14.4.536; Waugh M, 2000, NUCLEIC ACIDS RES, V28, P87, DOI 10.1093/nar/28.1.87; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	58	250	276	0	53	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2003	13	7					1675	1685		10.1101/gr.910003			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	697YC	WOS:000183970000014	12840044	Green Published, Bronze			2022-01-24	
J	Perrotti, D; Cesi, V; Trotta, R; Guerzoni, C; Santilli, G; Campbell, K; Iervolino, A; Condorelli, F; Gambacorti-Passerini, C; Caligiuri, MA; Calabretta, B				Perrotti, D; Cesi, V; Trotta, R; Guerzoni, C; Santilli, G; Campbell, K; Iervolino, A; Condorelli, F; Gambacorti-Passerini, C; Caligiuri, MA; Calabretta, B			BCR-ABL suppresses C/EBP alpha expression through inhibitory action of hnRNP E2	NATURE GENETICS			English	Article							BINDING PROTEIN-ALPHA; CHRONIC MYELOGENOUS LEUKEMIA; RECEPTOR MESSENGER-RNA; KH-DOMAIN PROTEINS; GRANULOCYTIC DIFFERENTIATION; ERYTHROID-DIFFERENTIATION; RIBONUCLEOPROTEIN-K; PU.1 SPI-1; TRANSCRIPTION; TRANSLATION	The arrest of differentiation is a feature of both chronic myelogenous leukemia cells in myeloid blast crisis and myeloid precursors that ectopically express the p210(BCR-ABL) oncoprotein; however, its underlying mechanisms remain poorly understood. Here we show that expression of BCR-ABL in myeloid precursor cells leads to transcriptional suppression of the granulocyte colony-stimulating factor receptor G-CSF-R (encoded by CSF3R), possibly through down-modulation of C/EBPalpha-the principal regulator of granulocytic differentiation. Expression of C/EBPalpha protein is barely detectable in primary marrow cells taken from individuals affected with chronic myeloid leukemia in blast crisis. In contrast, CEBPA RNA is clearly present. Ectopic expression of C/EBPalpha induces granulocytic differentiation of myeloid precursor cells expressing BCR-ABL. Expression of C/EBPalpha is suppressed at the translational level by interaction of the poly(rC)-binding protein hnRNP E2 with CEBPA mRNA, and ectopic expression of hnRNP E2 in myeloid precursor cells down-regulates both C/EBPalpha. and G-CSF-R and leads to rapid cell death on treatment with G-CSF (encoded by CSF3). Our results indicate that BCR-ABL regulates the expression of C/EBPalpha by inducing hnRNP E2-which inhibits the translation of CEBPA mRNA.	Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Univ Modena, Sect Gen Pathol, Dept Biomed Sci, I-41100 Modena, Italy; NCI, I-20133 Milan, Italy; S Gerardo Hosp, Hematol Sect, I-20052 Monza, Italy; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Canc & Leukemia Grp B, Chicago, IL USA		Perrotti, D (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	Danilo.Perrotti@mail.tju.edu	Perrotti, Danilo/E-3852-2011; Condorelli, Fabrizio/J-4726-2016	GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Condorelli, Fabrizio/0000-0002-9943-0857; Trotta, Rossana/0000-0003-4546-2615			Bellon T, 1997, BLOOD, V90, P1828, DOI 10.1182/blood.V90.5.1828; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cambier N, 1998, ONCOGENE, V16, P335, DOI 10.1038/sj.onc.1201490; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Dai ZH, 1998, GENE DEV, V12, P1415, DOI 10.1101/gad.12.10.1415; Elmaagacli AH, 2000, ANN HEMATOL, V79, P424, DOI 10.1007/s002770000169; GAIGER A, 1995, BLOOD, V86, P2371, DOI 10.1182/blood.V86.6.2371.bloodjournal8662371; Gamarnik AV, 1997, RNA, V3, P882; Gordon MY, 1999, J CLIN PATHOL, V52, P719, DOI 10.1136/jcp.52.10.719; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Issaad C, 2000, LEUKEMIA, V14, P662, DOI 10.1038/sj.leu.2401730; KANTARJIAN HM, 1993, BLOOD, V82, P691; KANTARJIAN HM, 1987, AM J MED, V83, P445, DOI 10.1016/0002-9343(87)90754-6; KOZAK M, 1995, P NATL ACAD SCI USA, V92, P2662, DOI 10.1073/pnas.92.7.2662; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LANEUVILLE P, 1991, ONCOGENE, V6, P275; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Perrotti D, 2000, MOL CELL BIOL, V20, P6159, DOI 10.1128/MCB.20.16.6159-6169.2000; Perrotti D, 1998, EMBO J, V17, P4442, DOI 10.1093/emboj/17.15.4442; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; SCOTT LM, 1992, BLOOD, V80, P1725; Silvera D, 1999, J BIOL CHEM, V274, P38163, DOI 10.1074/jbc.274.53.38163; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; STEINMAN RA, 1994, BLOOD, V83, P119; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; TKATCH LS, 1995, J LEUKOCYTE BIOL, V57, P964, DOI 10.1002/jlb.57.6.964; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Ward AC, 2000, LEUKEMIA, V14, P973, DOI 10.1038/sj.leu.2401808; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; WONG KK, 1995, MOL CELL BIOL, V15, P6535; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zou XM, 1999, J BIOL CHEM, V274, P18141, DOI 10.1074/jbc.274.26.18141	50	250	267	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					48	58		10.1038/ng791			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	WOS:000173105600013	11753385				2022-01-24	
J	Zhao, XP; Alvarado, D; Rainier, S; Lemons, R; Hedera, P; Weber, CH; Tukel, T; Apak, M; Heiman-Patterson, T; Ming, L; Bui, M; Fink, JK				Zhao, XP; Alvarado, D; Rainier, S; Lemons, R; Hedera, P; Weber, CH; Tukel, T; Apak, M; Heiman-Patterson, T; Ming, L; Bui, M; Fink, JK			Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia	NATURE GENETICS			English	Article							GUANYLATE-BINDING PROTEIN-1; DYNAMIN; RECEPTOR; ENDOCYTOSIS; IMPAIRMENT; DATABASE; PROGRAMS; FAMILY	The hereditary spastic paraplegias (HSPs; Strumpell-Lorrain syndrome, MIM number 18260) are a diverse class of disorders characterized by insidiously progressive lower-extremity spastic weakness (reviewed in refs. 1-3). Eight autosomal dominant HSP (ADHSP) loci have been identified, the most frequent of which is that linked to the SPG4 locus on chromosome 2p22 (found in -42%)(1), followed by that linked to the SPG3A locus on chromosome 14q11-q21 (in similar to9%)(1). Only SPG4 has been identified(4) as a causative gene in ADHSP. Its protein (spastin) is predicted to participate in the assembly or function of nuclear protein complexes(4). Here we report the identification of mutations in a newly identified GTPase gene, SPG3A, in ADHSP affected individuals.	Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Univ Istanbul, Inst Child Hlth, Div Med Genet, Istanbul, Turkey; Med Coll Penn & Hahnemann Univ, Sch Med, Dept Neurol, Philadelphia, PA USA; Ann Arbor Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48109 USA		Fink, JK (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038713, R01NS033645, R01NS036177] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS33645, R01NS38713, R01NS36177] Funding Source: Medline		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Della Rocca GJ, 1999, J BIOL CHEM, V274, P4749, DOI 10.1074/jbc.274.8.4749; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; Fink JK, 1999, SEMIN NEUROL, V19, P301, DOI 10.1055/s-2008-1040846; FINK JK, 2001, IN PRESS EMERY RIMOI, V4; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hedera P, 2000, NEUROLOGY, V55, P1591, DOI 10.1212/WNL.55.10.1591; Hedera P, 2001, PRENATAL DIAG, V21, P202, DOI 10.1002/1097-0223(200103)21:3<202::AID-PD4>3.0.CO;2-U; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Nicoziani P, 2000, MOL BIOL CELL, V11, P481, DOI 10.1091/mbc.11.2.481; NODA Y, 1993, NEUROSCIENCE, V55, P113, DOI 10.1016/0306-4522(93)90459-S; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; RAINER S, 2001, IN PRESS J MED GENET; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	30	250	265	1	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					326	331		10.1038/ng758			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	WOS:000171911000021	11685207				2022-01-24	
J	Launey, S; Hedgecock, D				Launey, S; Hedgecock, D			High genetic load in the Pacific oyster Crassostrea gigas	GENETICS			English	Article							BIVALVE SPISULA-OVALIS; INBREEDING DEPRESSION; NULL ALLELES; GROWTH-RATE; HETEROZYGOSITY; HETEROSIS; THUNBERG; VIRGINICA; MICROSATELLITES; OVERDOMINANCE	The causes of inbreeding depression and the converse phenomenon of heterosis or hybrid vigor remain poorly understood despite their scientific and agricultural importance. In bivalve molluscs, related phenomena, marker-associated heterosis and distortion of marker segregation ratios, have been widely reported over the past 25 years. A large load of deleterious recessive mutations could explain both phenomena, according to the dominance hypothesis of heterosis. Using inbred lines derived from a natural population of Pacific oysters and classical crossbreeding experiments, we compare the segregation ratios of microsatellite DNA markers at 6 In, and 2-3 months postfertilization in F-2 or F-3 hybrid families. We find evidence for strong and widespread selection against identical-by-descent marker homozygotes. The marker segregation data, when fit to models of selection against linked deleterious recessive mutations and extrapolated to the whole genome, suggest that the wild founders of inbred lines carried a minimum of 8-14 highly deleterious recessive mutations. This evidence for a high genetic load strongly supports the dominance theory of heterosis and inbreeding depression and establishes the oyster as an animal model for understanding the genetic and physiological causes of these economically important phenomena.	Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA		Hedgecock, D (corresponding author), Univ Calif Davis, Bodega Marine Lab, 2099 Westshore Rd, Bodega Bay, CA 94923 USA.	dehedgecock@ucdavis.edu	Hedgecock, Dennis/I-8655-2012	Hedgecock, Dennis/0000-0002-3995-646X			Bayne BL, 1999, J EXP MAR BIOL ECOL, V233, P115, DOI 10.1016/S0022-0981(98)00125-7; BEAUMONT A R, 1991, Journal of Shellfish Research, V10, P1; BEAUMONT AR, 1983, MAR BIOL LETT, V4, P151; Bierne N, 1998, GENETICS, V148, P1893; Bierne N, 2000, GENETICS, V155, P1981; Britten HB, 1996, EVOLUTION, V50, P2158, DOI [10.2307/2410687, 10.1111/j.1558-5646.1996.tb03606.x]; CALLEN DF, 1993, AM J HUM GENET, V52, P922; Crow JF, 1998, GENETICS, V148, P923; David P, 1997, GENETICS, V146, P335; David P, 1997, EVOLUTION, V51, P1318, DOI 10.1111/j.1558-5646.1997.tb03979.x; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; DAVID P, 1995, GENETICS, V139, P1719; David P, 1997, OECOLOGIA, V111, P331, DOI 10.1007/s004420050243; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; FOLTZ DW, 1986, EVOLUTION, V40, P869, DOI 10.1111/j.1558-5646.1986.tb00549.x; Fujio Y., 1982, Tohoku Journal of Agricultural Research, V33, P66; GAFFNEY PM, 1984, AQUACULTURE, V42, P289, DOI 10.1016/0044-8486(84)90108-X; GRIFFING B, 1990, GENETICS, V126, P753; GUO X, 1993, J HERED, V84, P311, DOI 10.1093/oxfordjournals.jhered.a111346; Guo Ximing, 1994, Molecular Marine Biology and Biotechnology, V3, P42; Guo XM, 1996, BIOL BULL-US, V191, P145, DOI 10.2307/1542916; Haldane JBS, 1919, J GENET, V8, P299; Hedgecock D, 1995, AQUACULTURE, V137, P285, DOI 10.1016/0044-8486(95)01105-6; Hedgecock D, 1996, J EXP MAR BIOL ECOL, V203, P49, DOI 10.1016/0022-0981(96)02569-5; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; HEDRICK PW, 1990, HEREDITY, V64, P67, DOI 10.1038/hdy.1990.8; Hu YP, 1996, MOL MAR BIOL BIOTECH, V5, P123; HU YP, 1993, J HERED, V84, P254, DOI 10.1093/oxfordjournals.jhered.a111335; Husband BC, 1996, EVOLUTION, V50, P54, DOI 10.2307/2410780; Huvet A, 2000, ANIM GENET, V31, P71, DOI 10.1111/j.1365-2052.2000.579-5.x; Jones AG, 1998, J HERED, V89, P339, DOI 10.1093/jhered/89.4.339; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Launey S, 1998, THESIS I NATL AGRONO; Leitao A, 2001, AQUACULTURE, V193, P39, DOI 10.1016/S0044-8486(00)00488-9; Leitao A, 1999, MALACOLOGIA, V41, P175; Li G, 1998, CAN J FISH AQUAT SCI, V55, P1025, DOI 10.1139/cjfas-55-4-1025; LONGWELL AC, 1967, CAN J GENET CYTOL, V9, P845, DOI 10.1139/g67-090; Lynch M., 1998, GENETICS ANAL QUANTI; Magoulas A, 1998, ANIM GENET, V29, P69; MCGOLDRICK D, 1997, THESIS U CALIFORNIA; McGoldrick DJ, 1997, GENETICS, V146, P321; McGoldrick DJ, 2000, J SHELLFISH RES, V19, P779; MORTON NE, 1955, AM J HUM GENET, V7, P277; Remington DL, 2000, GENETICS, V155, P337; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SINGH SM, 1978, EVOLUTION, V32, P342, DOI 10.1111/j.1558-5646.1978.tb00650.x; THIRIOTQUIEVREUX C, 1992, GENOME, V35, P39, DOI 10.1139/g92-007; Wada K.T., 1975, Bulletin natn Pearl Res Lab, V19, P2152; Wang ZP, 1999, AQUACULTURE, V173, P347, DOI 10.1016/S0044-8486(98)00457-8; WILKINS NP, 1976, 10TH P EUR S MAR BIO, V1, P549; Williams CG, 1975, SEX EVOLUTION; Zouros E, 1996, GENET RES, V68, P109, DOI 10.1017/S0016672300033991; ZOUROS E, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P135	54	250	273	0	47	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	SEP	2001	159	1					255	265					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476WV	WOS:000171252500021	11560902				2022-01-24	
J	Bacanu, SA; Devlin, B; Roeder, K				Bacanu, SA; Devlin, B; Roeder, K			The power of genomic control	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX HUMAN-DISEASES; LINKAGE DISEQUILIBRIUM; ASSOCIATION; GENE	Although association analysis is a useful tool for uncovering the genetic underpinnings of complex traits, its utility is diminished by population substructure, which can produce spurious association between phenotype and genotype within population-based samples. Because family-based designs are robust against substructure, they have risen to the fore of association analysis. Yet, if population substructure could be ignored, this robustness can come at the price of power. Unfortunately it is rarely evident when population substructure can be ignored. Devlin and Roeder recently have proposed a method, termed "genomic control" (GC), which has the robustness of family-based designs even though it uses population-based data. GC uses the genome itself to determine appropriate corrections for population-based association tests. Using the GC method, we contrast the power of two study designs, family trios (i.e., father, mother, and affected progeny) versus case-control. For analysis of trios, we use the TDT test. When population substructure is absent, we find GC is always more powerful than TDT; furthermore, contrary to previous results, we show that as a disease becomes more prevalent the discrepancy in power becomes more extreme. When population substructure is present, however, the results are more complex: TDT is more powerful when population substructure is substantial, and GC is more powerful otherwise. We also explore general issues of power and implementation of GC within the case-control setting and find that, economically, CC is at least comparable to and often less expensive than family-based methods. Therefore, CC methods should prove a useful complement to family-based methods for the genetic analysis of complex traits.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA		Bacanu, SA (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, 3811 OHara St, Pittsburgh, PA 15213 USA.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Roeder, Kathryn/0000-0002-8869-6254	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R37MH057881, R01MH057881, P01MH056193] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH57881, MH56193] Funding Source: Medline		ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Barnett V., 1978, OUTLIERS STAT DATA; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1993, HUMAN POPULATION GENETICS, P189; CHAMBERS JM, 1991, STAT MODELS; CHASE GR, 1968, BIOMETRIKA, V55, P365, DOI 10.2307/2334877; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; DEVLIN B, 1993, SCIENCE, V259, P748, DOI 10.1126/science.8430323; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DEVLIN B, IN PRESS BIOSTATISTI; EWENS WJ, 1995, AM J HUM GENET, V57, P455; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334; LEEMIS LM, 1995, RELIABILITY PROBABIL; LI CC, 1972, ANN HUM GENET, V33, P23; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P2556, DOI 10.1073/pnas.89.7.2556; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; PUFFETT D, 1994, MUSIC ANAL, V13, P3; Rice J., 1988, MATH STAT DATA ANAL; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROYCHOUDHURY AK, 1988, HUMAN POLYMORPHIC GE; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; *US DHEW, 1980, US DHEW PUBL; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weir BS, 1990, GENETIC DATA ANAL; Wright S., 1969, EVOLUTION GENETICS P, VII	31	250	256	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1933	1944		10.1086/302929			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	WOS:000088373800021	10801388	Green Published, Bronze			2022-01-24	
J	Madsen, LS; Andersson, EC; Jansson, L; Krogsgaard, M; Andersen, CB; Engberg, J; Strominger, JL; Svejgaard, A; Hjorth, JP; Holmdahl, R; Wucherpfennig, KW; Fugger, L				Madsen, LS; Andersson, EC; Jansson, L; Krogsgaard, M; Andersen, CB; Engberg, J; Strominger, JL; Svejgaard, A; Hjorth, JP; Holmdahl, R; Wucherpfennig, KW; Fugger, L			A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor	NATURE GENETICS			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BASIC-PROTEIN PEPTIDE; TRANSGENIC MICE; MYELIN; SUSCEPTIBILITY; EXPRESSION; COMPLEX; SCREEN; LOCI; CD4		Aarhus Univ Hosp, Skejby Sygehus, Dept Clin Immunol, DK-8000 Aarhus, Denmark; Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; Royal Danish Sch Pharm, Dept Pharmacol, DK-2100 Copenhagen, Denmark; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Aarhus Univ, Inst Mol & Struct Biol, Aarhus, Denmark; Univ Lund, Sect Med Inflammat Res, Lund, Sweden; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA		Fugger, L (corresponding author), Aarhus Univ Hosp, Skejby Sygehus, Dept Clin Immunol, DK-8000 Aarhus, Denmark.		Holmdahl, Rikard/AAI-7682-2020				Coraddu F, 1998, NEUROGENETICS, V2, P24, DOI 10.1007/s100480050048; Ebers GC, 1998, SEMIN NEUROL, V18, P295, DOI 10.1055/s-2008-1040880; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Fugger L, 1996, EUR J IMMUNOL, V26, P928, DOI 10.1002/eji.1830260431; FUGGER L, 1994, P NATL ACAD SCI USA, V91, P6151, DOI 10.1073/pnas.91.13.6151; Goverman J, 1999, IMMUNOL REV, V169, P147, DOI 10.1111/j.1600-065X.1999.tb01313.x; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; JANSSON L, 1991, EUR J IMMUNOL, V21, P693, DOI 10.1002/eji.1830210323; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KILLEEN N, 1993, EMBO J, V12, P1547, DOI 10.1002/j.1460-2075.1993.tb05798.x; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; Noseworthy JH, 1999, NATURE, V399, pA40, DOI 10.1038/399a040; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Pearson CI, 1997, J EXP MED, V185, P583, DOI 10.1084/jem.185.4.583; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Sawcer S, 1998, CURR OPIN IMMUNOL, V10, P697, DOI 10.1016/S0952-7915(98)80091-5; Smith A, 1998, PHARM SCI TECHNOL TO, V1, P188, DOI 10.1016/S1461-5347(98)00057-1; Spurkland A, 1997, TISSUE ANTIGENS, V50, P15, DOI 10.1111/j.1399-0039.1997.tb02828.x; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279	30	250	253	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1999	23	3					343	347		10.1038/15525			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	257QC	WOS:000083792200026	10610182				2022-01-24	
J	Coffee, B; Zhang, FP; Warren, ST; Reines, D				Coffee, B; Zhang, FP; Warren, ST; Reines, D			Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells	NATURE GENETICS			English	Article							REPRESS TRANSCRIPTION; DNA METHYLATION; GENE; REGION; DEACETYLASE; EXPRESSION; PROMOTER; YEAST; REACTIVATION; NUCLEOSOME	Mutation of FMR1 results in fragile X mental retardation(1). The most common FMR1 mutation is expansion of a CGG repeat tract at the 5' end of FMR1 (refs 2-4), which leads to cytosine methylation and transcriptional silencing(5,6). Both DNA methylation and histone deacetylation have been associated with transcriptional inactivity(7-9). The finding that the methyl cytosine-binding protein MeCP2 binds to histone deacetylases and represses transcription in vivo(10,11) supports a model in which MeCP2 recruits histone deacetylases to methylated DNA, resulting in histone deacetylation, chromatin condensation and transcriptional silencing(12). Here we demonstrate that the 5' end of FMR1 is associated with acetylated histones H3 and H4 in cells from normal individuals, but acetylation is reduced in cells from fragile X patients. Treatment of fragile X cells with 5-aza-2'-deoxycytidine (5-aza-dC) resulted in reassociation of acetylated histones H3 and H4 with FMR1 and transcriptional reactivation, whereas treatment with trichostatin A (TSA) led to almost complete acetylated histone H4 and little acetylated histone H3 reassociation with FMR1, as well as no detectable transcription. Our results represent the first description of loss of histone acetylation at a specific locus in human disease, and advance understanding of the mechanism of FMR1 transcriptional silencing.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Howard Hughes Med Inst, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA		Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.		excellency, Your/R-2357-2019; Warren, Stephen T/A-2498-2012	excellency, Your/0000-0003-0832-6243; 	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD35576] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD035576] Funding Source: NIH RePORTER		ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Ammerpohl O, 1998, NUCLEIC ACIDS RES, V26, P5256, DOI 10.1093/nar/26.23.5256; ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CHEN EY, 1991, GENOMICS, V10, P792, DOI 10.1016/0888-7543(91)90465-Q; Chiurazzi P, 1998, HUM MOL GENET, V7, P109, DOI 10.1093/hmg/7.1.109; Drouin R, 1997, HUM MOL GENET, V6, P2051, DOI 10.1093/hmg/6.12.2051; Eberhart DE, 1996, SOMAT CELL MOLEC GEN, V22, P435, DOI 10.1007/BF02369435; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Imbert G, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P27; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LIN R, 1989, J CELL BIOL, V108, P1577, DOI 10.1083/jcb.108.5.1577; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; SASAKI T, 1992, MOL CELL BIOL, V12, P3819, DOI 10.1128/MCB.12.9.3819; Schwemmle S, 1997, AM J HUM GENET, V60, P1354, DOI 10.1086/515456; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/S0092-8674(05)80078-9; VanLint C, 1996, GENE EXPRESSION, V5, P245; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	30	250	253	1	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					98	101		10.1038/8807			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	WOS:000080096300032	10319871				2022-01-24	
J	Mangiarini, L; Sathasivam, K; Mahal, A; Mott, R; Seller, M; Bates, GP				Mangiarini, L; Sathasivam, K; Mahal, A; Mott, R; Seller, M; Bates, GP			Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; PALLIDOLUYSIAN ATROPHY DRPLA; ANDROGEN RECEPTOR GENE; TRINUCLEOTIDE REPEAT; ONSET; AGE; EXPANSION; LENGTH; MOSAICISM	Six inherited neurodegenerative diseases are caused by a CAG/polyglutamine expansion, including spinal and bulbar muscular atrophy (SBMA)(1), Huntington's disease (HD)(2), spinocerebellar ataxia type 1 (SCA1)(3), dentatorubral pallidoluysian atrophy (DRPLA)(4,5) Machado-Joseph disease (MJD or SCA3)(6) and SCA2(7-9). Normal and expanded HD allele sizes of 6-39 and 35-121 repeats have been reported(10-13), and the allele distributions for the other diseases are comparable. Intergenerational instability has been described in all cases, and repeats tend to be more unstable on paternal transmission. This may present as larger increases on paternal inheritance as in HD14, or as a tendency to increase on male and decrease on female transmission as in SCA1 (ref.15). Stomatic repeat instability is also appears most pronounced in the CNS16,17. The major exception is the cerebellum, which in HD, DRPLA, SCA1 and MJD has a smaller repeat relative to the other brain regions tested(16-21). Of non-CNS tissues, instability was observed in blood, liver, kidney and colon(16,20,21). A mouse model of CAG repeat instability would be helpful in unravelling its molecular basis although an absence of CAG repeat instability in transgenic mice has so far been reported. These studies include (CAG)(45) in the androgen receptor cDNA(22), (CAG)(44), in the HD cDNA(23), (CAG)(82) in the SCA1 cDNA(24), (CAG)(79) in the SCA3 cDNA and as an isolated (CAC)(79) tract(25).	GUYS HOSP,DIV MED & MOL GENET,LONDON SE1 9RT,ENGLAND; SANGER CTR,HINXTON CB10 1RO,CAMBS,ENGLAND				Longo, Kenneth A/A-5631-2010; Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305; Mott, Richard/0000-0002-1022-9330			ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; BARRON LH, 1993, J MED GENET, V30, P1003, DOI 10.1136/jmg.30.12.1003; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FARRER LA, 1992, AM J HUM GENET, V50, P528; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; *HDCRG, 1993, CELL, V72, P971; Hogan B., 1994, MANIPULATING MOUSE E; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KRAWCZAK M, 1991, AM J HUM GENET, V49, P735; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MANGIARINI L, 1996, CELL, V87, P497; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; SAMPEI K, 1996, NAT GENET, V14, P277; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Takano H, 1996, AM J HUM GENET, V58, P1212; Tanaka F, 1996, J NEUROL SCI, V135, P43, DOI 10.1016/0022-510X(95)00249-2; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; UENO S, 1995, HUM MOL GENET, V4, P663, DOI 10.1093/hmg/4.4.663	30	250	253	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					197	200		10.1038/ng0297-197			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	WOS:A1997WF08700023	9020849				2022-01-24	
J	CHEN, YS; TORRONI, A; EXCOFFIER, L; SANTACHIARABENERECETTI, AS; WALLACE, DC				CHEN, YS; TORRONI, A; EXCOFFIER, L; SANTACHIARABENERECETTI, AS; WALLACE, DC			ANALYSIS OF MTDNA VARIATION IN AFRICAN POPULATIONS REVEALS THE MOST ANCIENT OF ALL HUMAN CONTINENT-SPECIFIC HAPLOGROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; ENDONUCLEASE CLEAVAGE PATTERNS; LENGTH MUTATIONS; HUMAN-EVOLUTION; 9-BP DELETION; POLYMORPHISMS; AFFINITIES; MIGRATIONS; RADIATION; AMERICANS	mtDNA sequence variation was examined in 140 Africans, including Pygmies from Zaire and Central African Republic (C.A.R.) and Mandenkalu, Wolof, and Pular from Senegal. More than 76% of the African mtDNAs (100% of the Pygmies and 67.3% of the Senegalese) formed one major mtDNA cluster (haplogroup L) defined by an African-specific HpaI site gain at nucleotide pair (np) 3592. Additional mutations subdivided haplogroup L into two subhaplogroups, each encompassing both Pygmy and Senegalese mtDNAs. A novel 12-bp homoplasmic insertion in the intergenic region between tRNA(Tyr) and cytochrome oxidase I (COI) genes was also observed in 17.6% of the Pygmies from C.A.R. This insertion is one of the largest observed in human mtDNAs. Another 25% of the Pygmy mtDNAs harbored a 9-bp deletion between the cytochrome oxidase II (COII) and tRNA(Lys) genes, a length polymorphism previously reported in non-African populations. In addition to haplogroup L, other haplogroups were observed in the Senegalese. These haplogroups were more similar to those observed in Europeans and Asians than to haplogroup L mtDNAs, suggesting that the African mtDNAs without the HpaI np 3592 site could be the ancestral types from which European and Asian mtDNAs were derived. Comparison of the intrapopulation sequence divergence in African and non-African populations confirms that African populations exhibit the largest extent of mtDNA variation, a result that further supports the hypothesis that Africans represent the most ancient human group and that all modem humans have a common and recent African origin. The age of the total African variation was estimated to be 101,000-133,000 years before present (YBP), while the age of haplogroup L was estimated at 98,000-130,000 YBP. These values substantially exceed the ages of all Asian- and European-specific mtDNA haplogroups.	EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,ATLANTA,GA 30322; UNIV GENEVA,DEPT ANTHROPOL & ECOL,GENEVA,SWITZERLAND; UNIV PAVIA,DEPT GENET & MICROBIOL,I-27100 PAVIA,ITALY				Excoffier, Laurent/D-3498-2013; Torroni, Antonio/E-1557-2011	Excoffier, Laurent/0000-0002-7507-6494; Torroni, Antonio/0000-0002-4163-4478	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 46915] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM046915] Funding Source: NIH RePORTER		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BROWN MD, 1994, AM J HUM GENET, V55, P410; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; CAVALLISFORZA LL, 1986, AFRICAN PYGMIES, P23; CAVALLISFORZA LL, 1986, ANTHROPOMETRIC DATA, P361; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; GRAVEN L, IN PRESS MOL BIOL EV; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Hiernaux J., 1977, POPULATION STRUCTURE, P187; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; MCDERMOTT F, 1993, NATURE, V363, P252, DOI 10.1038/363252a0; MERRIWETHER DA, 1993, AM J HUM GENET, V53, P833; NEI M, 1983, GENETICS, V105, P207; NEWMAN NJ, 1994, AM J OPHTHALMOL, V118, P158, DOI 10.1016/S0002-9394(14)72895-8; PASSARINO G, 1993, AM J HUM GENET, V53, P609; RITTE U, 1993, HUM BIOL, V65, P359; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SCOZZARI R, 1994, HUM BIOL, V66, P1; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SOODYALL H, 1993, ANN HUM BIOL, V20, P477, DOI 10.1080/03014469300002872; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1989, COLONIZATION PACIFIC, P215; Swofford D.L., 1993, PHYLOGENETIC ANAL US; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1995, AM J HUM GENET, V56, P1234; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TORRONI A, IN PRESS HUM MUTAT; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wallace DC, 1994, HUMAN GENE MAPPING 1, P813; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	46	250	258	0	30	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					133	149					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	WOS:A1995RE62900017	7611282				2022-01-24	
J	LAING, NG; WILTON, SD; AKKARI, PA; DOROSZ, S; BOUNDY, K; KNEEBONE, C; BLUMBERGS, P; WHITE, S; WATKINS, H; LOVE, DR; HAAN, E				LAING, NG; WILTON, SD; AKKARI, PA; DOROSZ, S; BOUNDY, K; KNEEBONE, C; BLUMBERGS, P; WHITE, S; WATKINS, H; LOVE, DR; HAAN, E			A MUTATION IN THE ALPHA-TROPOMYOSIN GENE TPM3 ASSOCIATED WITH AUTOSOMAL-DOMINANT NEMALINE MYOPATHY	NATURE GENETICS			English	Article								Nemaline myopathies are diseases characterized by the presence in muscle fibres of pathognomonic rod bodies. These are composed largely of alpha-actinin and actin. We have identified a missense mutation in the alpha-tropomyosin gene, TPM3, which segregates completely with the disease in a family whose autosomal dominant nemaline myopathy we had previously localized to chromosome 1p13-q25. The mutation substitutes an arginine residue for a highly conserved methionine in a putative actin-binding site near the N terminus of the alpha-tropomyosin. The mutation may strengthen tropomyosin - actin binding, leading to rod body formation, by adding a further basic residue to the postulated actin-binding motif.	CURTIN UNIV TECHNOL, SCH BIOMED SCI, BENTLEY, WA 6102, AUSTRALIA; ROYAL ADELAIDE HOSP, DEPT NEUROL, ADELAIDE, SA 5000, AUSTRALIA; INST MED & VET SCI, ADELAIDE, SA 5000, AUSTRALIA; WOMENS & CHILDRENS HOSP, CTR GENET MED, DEPT MED GENET, ADELAIDE, SA 5006, AUSTRALIA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; UNIV AUCKLAND, SCH BIOL SCI, AUCKLAND, NEW ZEALAND		LAING, NG (corresponding author), UNIV WESTERN AUSTRALIA, AUSTRALIAN NEUROMUSCULAR RES INST, DEPT PATHOL, 4TH FLOOR, A BLOCK, NEDLANDS, WA 6009, AUSTRALIA.			Love, Donald/0000-0003-4669-8769; Laing, Nigel/0000-0001-5111-3732; Wilton, Steve/0000-0002-9400-893X; Watkins, Hugh/0000-0002-5287-9016			AKKARI PA, 1994, CYTOGENET CELL GENET, V65, P265, DOI 10.1159/000133644; BAADER CD, 1993, FEBS LETT, V328, P63, DOI 10.1016/0014-5793(93)80966-X; BEGGS AH, 1992, GENOMICS, V13, P1314, DOI 10.1016/0888-7543(92)90054-V; BODENSTEINER JB, 1994, MUSCLE NERVE, V17, P131, DOI 10.1002/mus.880170202; CHO YJ, 1990, J BIOL CHEM, V265, P538; CLAYTON L, 1988, J MOL BIOL, V201, P507, DOI 10.1016/0022-2836(88)90633-X; CONEN PE, 1963, CAN MED ASSOC J, V89, P983; EYRE H, IN PRESS CYTOGENET C; EYRE HJ, 1993, CYTOGENET CELL GENET, V62, P181, DOI 10.1159/000133467; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GUNNING P, 1990, DEV BIOL, V138, P443, DOI 10.1016/0012-1606(90)90210-A; GUYER M, 1992, SCIENCE, V258, P67; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDY S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P239, DOI 10.1016/0167-4781(92)90087-G; HARDY S, 1991, EUR J BIOCHEM, V202, P431, DOI 10.1111/j.1432-1033.1991.tb16392.x; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HELFMAN DM, 1984, J BIOL CHEM, V259, P4136; HITCHCOCKDEGREGORI SE, 1990, J MOL BIOL, V214, P885, DOI 10.1016/0022-2836(90)90343-K; KARLIK CC, 1984, CELL, V37, P469, DOI 10.1016/0092-8674(84)90377-5; LAING NG, 1992, AM J HUM GENET, V50, P576; MACLEOD AR, 1988, MOL CELL BIOL, V8, P433, DOI 10.1128/MCB.8.1.433; MAK AS, 1980, J BIOL CHEM, V255, P3647; MCALPINE PJ, 1993, GENOME PR R, P11; McKusick V.A., 1992, MENDELIAN INHERITANC; MEEDEL TH, 1993, J BIOL CHEM, V268, P6755; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTT J, 1974, AM J HUM GENET, V26, P588; PRICE HM, 1965, P NATL ACAD SCI USA, V54, P1398, DOI 10.1073/pnas.54.5.1398; RUIZOPAZO N, 1987, J BIOL CHEM, V262, P4755; SHY GM, 1963, BRAIN, V86, P793, DOI 10.1093/brain/86.4.793; TAHVANAINEN E, 1994, J MED GENET, V31, P79, DOI 10.1136/jmg.31.1.79; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WIDADA JS, 1988, NUCLEIC ACIDS RES, V16, P3109, DOI 10.1093/nar/16.7.3109; WILTON SD, 1995, CYTOGENET CELL GENET, V68, P122, DOI 10.1159/000133905; WILTON SD, 1993, AM J MED GENET, V46, P563, DOI 10.1002/ajmg.1320460521; WOLFE SL, 1993, MOL CELL BIOL, P451; YONEZAWA N, 1989, EUR J BIOCHEM, V183, P235, DOI 10.1111/j.1432-1033.1989.tb14918.x	37	250	253	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					75	79		10.1038/ng0195-75			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	WOS:A1995PZ91300018	7704029				2022-01-24	
J	ROMAN, H				ROMAN, H			MITOTIC NONDISJUNCTION IN THE CASE OF INTERCHANGES INVOLVING THE B-TYPE CHROMOSOME IN MAIZE	GENETICS			English	Article																	ANDERSON EG, 1945, GENETICS, V30, P518; Burnham CR, 1932, P NATL ACAD SCI USA, V18, P434, DOI 10.1073/pnas.18.6.434; Clarke AE, 1935, AM J BOT, V22, P711, DOI 10.2307/2436047; DARLINGTON C. D., 1941, JOUR GENETICS, V41, P275, DOI 10.1007/BF02983024; Darlington CD, 1941, PROC R SOC SER B-BIO, V130, P127, DOI 10.1098/rspb.1941.0009; Darlington CD, 1940, J GENET, V39, P351, DOI 10.1007/BF02982848; HASEGAWA NOBUMI, 1934, CYTOLOGIA, V6, P68, DOI 10.1508/cytologia.6.68; Longley AE, 1927, J AGRIC RES, V35, P0769; McCLINTOCK BARBARA, 1933, ZEITSCHR WISS BIOL ABT B ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V19, P191, DOI 10.1007/BF02462870; Metz CW, 1938, AM NAT, V72, P485, DOI 10.1086/280803; Muntzing A, 1944, HEREDITAS, V30, P231; RANDOLPH LF, 1928, CORNELL AGR EXP STA, V117; Rhoades MM, 1940, GENETICS, V25, P483; Schmuck ML, 1934, BIOL BULL-US, V66, P224, DOI 10.2307/1537333; Stadler LJ, 1936, P NATL ACAD SCI USA, V22, P572, DOI 10.1073/pnas.22.10.572; Weatherwax P, 1917, B TORREY BOT CLUB, V44, P483	16	250	260	0	4	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1947	32	4					391	409					19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU205	WOS:A1947UU20500005	17247252				2022-01-24	
J	Klein, CJ; Botuyan, MV; Wu, YH; Ward, CJ; Nicholson, GA; Hammans, S; Hojo, K; Yamanishi, H; Karpf, AR; Wallace, DC; Simon, M; Lander, C; Boardman, LA; Cunningham, JM; Smith, GE; Litchy, WJ; Boes, B; Atkinson, EJ; Middha, S; Dyck, PJB; Parisi, JE; Mer, G; Smith, DI; Dyck, PJ				Klein, Christopher J.; Botuyan, Maria-Victoria; Wu, Yanhong; Ward, Christopher J.; Nicholson, Garth A.; Hammans, Simon; Hojo, Kaori; Yamanishi, Hiromitch; Karpf, Adam R.; Wallace, Douglas C.; Simon, Mariella; Lander, Cecilie; Boardman, Lisa A.; Cunningham, Julie M.; Smith, Glenn E.; Litchy, William J.; Boes, Benjamin; Atkinson, Elizabeth J.; Middha, Sumit; Dyck, P. James B.; Parisi, Joseph E.; Mer, Georges; Smith, David I.; Dyck, Peter J.			Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASE GENE; SERINE PALMITOYLTRANSFERASE; METHYLATION; DEAFNESS; HYPOMETHYLATION; REPLICATION; INSTABILITY; ACTIVATION; NEURONS; BINDING	DNA methyltransferase 1 (DNMT1) is crucial for maintenance of methylation, gene regulation and chromatin stability(1-3). DNA mismatch repair, cell cycle regulation in post-mitotic neurons(4,5) and neurogenesis(6) are influenced by DNA methylation. Here we show that mutations in DNMT1 cause both central and peripheral neurodegeneration in one form of hereditary sensory and autonomic neuropathy with dementia and hearing loss(7,8). Exome sequencing led to the identification of DNMT1 mutation c.1484A>G (p.Tyr495Cys) in two American kindreds and one Japanese kindred and a triple nucleotide change, c.1470-1472TCC>ATA (p.Asp490Glu-Pro491Tyr), in one European kindred. All mutations are within the targeting-sequence domain of DNMT1. These mutations cause premature degradation of mutant proteins, reduced methyltransferase activity and impaired heterochromatin binding during the G2 cell cycle phase leading to global hypomethylation and site-specific hypermethylation. Our study shows that DNMT1 mutations cause the aberrant methylation implicated in complex pathogenesis. The discovered DNMT1 mutations provide a new framework for the study of neurodegenerative diseases.	[Klein, Christopher J.; Litchy, William J.; Dyck, P. James B.; Dyck, Peter J.] Mayo Clin, Dept Neurol, Div Peripheral Nerve Dis, Rochester, MN 55905 USA; [Nicholson, Garth A.] Univ Sydney, Mol Med Lab, Sydney, NSW 2006, Australia; [Hammans, Simon] Southampton Univ Hosp Natl Hlth Serv NHS Trust, Dept Neurol, Southampton, Hants, England; [Yamanishi, Hiromitch] Harima Sanat, Div Psychiat, Hyogo, Japan; [Karpf, Adam R.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Wallace, Douglas C.; Simon, Mariella] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA USA; [Lander, Cecilie] Univ Queensland, Royal Brisbane Hosp, Herston, Qld, Australia; [Boardman, Lisa A.] Mayo Clin, Div Gastroenterol, Rochester, MN USA; [Smith, Glenn E.] Mayo Clin, Div Psychol, Rochester, MN USA; [Boes, Benjamin] Roche Appl Sci Genom Sequencing, Indianapolis, IN USA; [Parisi, Joseph E.] Mayo Clin, Div Neuropathol, Rochester, MN USA		Klein, CJ (corresponding author), Mayo Clin, Dept Neurol, Div Peripheral Nerve Dis, Rochester, MN 55905 USA.	klein.christopher@mayo.edu	Mer, Georges/AAT-4946-2021; Cecilie, Lander/F-8223-2014	Karpf, Adam/0000-0002-0866-0666; Nicholson, Garth/0000-0001-9694-066X; Lander, Cecilie/0000-0002-3548-9550; Klein, Christopher/0000-0002-4012-8856; Simon, Mariella/0000-0002-8200-3277; Middha, Sumit/0000-0003-4135-6268; Smith, Glenn/0000-0003-1506-9484	National Institute of Neurologic Disorders and Strokes (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 (NS065007)]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 (NS36797)]; Muscular Dystrophy AssociationMuscular Dystrophy Association; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 RR024150]; Clinical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS21328, NS070298]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA132878] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036797, K08NS065007, R01NS021328, R01NS070298] Funding Source: NIH RePORTER	This study was supported by the National Institute of Neurologic Disorders and Strokes (NINDS) K08 (NS065007), NINDS R01 (NS36797) and a previous grant from the Muscular Dystrophy Association. The authors wish to thank the Mayo Center for Translational Science Activities (supported by NIH UL1 RR024150) and the Mayo Clinic Bioinformatics Core and Sequencing Core for their excellent assistance. We would also like to thank the support from the Clinical Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567). D. C. W. and M. S. would like to acknowledge the outstanding clinical contributions of J. Platt. Their portion of this work was supported by US National Institutes of Health grants NS21328 and NS070298.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Brooks PJ, 1996, J NEUROSCI, V16, P939; Brown KD, 2007, NAT GENET, V39, P289, DOI 10.1038/ng0307-289; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Golshani Peyman, 2005, Thalamus & Related Systems, V3, P227, DOI 10.1017/S1472928807000222; Guelly C, 2011, AM J HUM GENET, V88, P99, DOI 10.1016/j.ajhg.2010.12.003; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hojo K, 1999, EUR J NEUROL, V6, P357, DOI 10.1046/j.1468-1331.1999.630357.x; Hojo K, 2004, NEUROSCI LETT, V367, P340, DOI 10.1016/j.neulet.2004.06.030; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Klein CJ, 2005, PERIPHERAL NEUROPATH, V2, P1809; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Spada F, 2006, ADV ENZYME REGUL, V46, P224, DOI 10.1016/j.advenzreg.2006.01.011; TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x; Tohgi H, 1999, MOL BRAIN RES, V70, P288, DOI 10.1016/S0169-328X(99)00163-1; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; WRIGHT A, 1995, NEUROLOGY, V45, P560, DOI 10.1212/WNL.45.3.560; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	35	249	265	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2011	43	6					595	U140		10.1038/ng.830			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	WOS:000291017000020	21532572	Green Accepted			2022-01-24	
J	Donati, C; Hiller, NL; Tettelin, H; Muzzi, A; Croucher, NJ; Angiuoli, SV; Oggioni, M; Hotopp, JCD; Hu, FZ; Riley, DR; Covacci, A; Mitchell, TJ; Bentley, SD; Kilian, M; Ehrlich, GD; Rappuoli, R; Moxon, ER; Masignani, V				Donati, Claudio; Hiller, N. Luisa; Tettelin, Herve; Muzzi, Alessandro; Croucher, Nicholas J.; Angiuoli, Samuel V.; Oggioni, Marco; Hotopp, Julie C. Dunning; Hu, Fen Z.; Riley, David R.; Covacci, Antonello; Mitchell, Tim J.; Bentley, Stephen D.; Kilian, Morgens; Ehrlich, Garth D.; Rappuoli, Rino; Moxon, E. Richard; Masignani, Vega			Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species	GENOME BIOLOGY			English	Article							INTRANASAL IMMUNIZATION; MOSAIC GENES; SEQUENCE; RECOMBINATION; DIVERSITY; IDENTIFICATION; EVOLUTION; PATTERNS; PROTEIN; POPULATIONS	Background: Streptococcus pneumoniae is one of the most important causes of microbial diseases in humans. The genomes of 44 diverse strains of S. pneumoniae were analyzed and compared with strains of non-pathogenic streptococci of the Mitis group. Results: Despite evidence of extensive recombination, the S. pneumoniae phylogenetic tree revealed six major lineages. With the exception of serotype 1, the tree correlated poorly with capsular serotype, geographical site of isolation and disease outcome. The distribution of dispensable genes - genes present in more than one strain but not in all strains - was consistent with phylogeny, although horizontal gene transfer events attenuated this correlation in the case of ancient lineages. Homologous recombination, involving short stretches of DNA, was the dominant evolutionary process of the core genome of S. pneumoniae. Genetic exchange occurred both within and across the borders of the species, and S. mitis was the main reservoir of genetic diversity of S. pneumoniae. The pan-genome size of S. pneumoniae increased logarithmically with the number of strains and linearly with the number of polymorphic sites of the sampled genomes, suggesting that acquired genes accumulate proportionately to the age of clones. Most genes associated with pathogenicity were shared by all S. pneumoniae strains, but were also present in S. mitis, S. oralis and S. infantis, indicating that these genes are not sufficient to determine virulence. Conclusions: Genetic exchange with related species sharing the same ecological niche is the main mechanism of evolution of S. pneumoniae. The open pan-genome guarantees the species a quick and economical response to diverse environments.	[Donati, Claudio; Muzzi, Alessandro; Covacci, Antonello; Rappuoli, Rino; Masignani, Vega] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Hiller, N. Luisa; Hu, Fen Z.; Ehrlich, Garth D.] Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Tettelin, Herve; Angiuoli, Samuel V.; Hotopp, Julie C. Dunning; Riley, David R.] Univ Maryland, Inst Genome Sci, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA; [Croucher, Nicholas J.; Bentley, Stephen D.] Sanger Inst, Cambridge CB10 1SA, England; [Oggioni, Marco] Univ Siena, Lab Microbiol Mol & Biotecnol, Dipartimento Biol Mol, Policlin Scotte, I-53100 Siena, Italy; [Mitchell, Tim J.] Univ Glasgow, Div Infect & Immun, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Kilian, Morgens] Aarhus Univ, Inst Med Microbiol & Immunol, DK-8000 Aarhus, Denmark; [Moxon, E. Richard] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Div Med Sci, Headington OX3 9DU, England		Donati, C (corresponding author), Novartis Vaccines & Diagnost, Via Fiorentina 1, I-53100 Siena, Italy.	claudio.donati@novartis.com	Angiuoli, Samuel V/H-7340-2014; Oggioni, Marco Rinaldo/K-3839-2016; Dunning Hotopp, Julie/E-7762-2010; Hiller, N. Luisa/A-3739-2016; Muzzi, Alessandro/J-6200-2012; Donati, Claudio/J-5180-2012; Donati, Claudio/AAF-1246-2020	Oggioni, Marco Rinaldo/0000-0003-4117-793X; Dunning Hotopp, Julie/0000-0003-3862-986X; Hiller, N. Luisa/0000-0001-6572-1368; Ehrlich, Garth/0000-0003-1140-6594; Mitchell, Timothy/0000-0002-8309-5556; Kilian, Mogens/0000-0002-5861-0472; Angiuoli, Samuel/0000-0001-9525-4350; Donati, Claudio/0000-0001-8688-1651; Croucher, Nicholas/0000-0001-6303-8768	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human ServicesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [AI-30071, AI080935]; National Institute of Deafness and other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC04173, DC02148, DC05659]; PATH; University of Maryland; Karen Elise Jensen Foundation; ECEuropean CommissionEuropean Commission Joint Research Centre [HEALTH-F4-2008-222983]; Wellcome TrustWellcome TrustEuropean Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI080935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC005659, R01DC004173, R01DC002148] Funding Source: NIH RePORTER	This project was supported in part by: federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number N01-AI-30071 and grant number AI080935, and the National Institute of Deafness and other Communication Disorders grant numbers DC04173, DC02148, DC05659; funds from PATH, an international nonprofit organization that improves the health of people around the world; University of Maryland, internal funds; the Karen Elise Jensen Foundation; and EC FP7 grant HEALTH-F4-2008-222983. We also would like to acknowledge Luke J Tallon, Kristine M Jones, and Xinyue Liu for genome sequencing; Beth Neuendorf, Diana Radune, Nadia B Fedorova, and Hoda M Khouri for genome closure; and Robert J Dodson and Sean C Daugherty for genome annotation. The Sanger Institute is core funded by the Wellcome Trust. We thank the Sanger Institute Sequencing and Informatics groups for general support. Finally, we would like to thank Annalisa Pantosti for providing early access to the AP200 genome sequences.	Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Baltrus DA, 2008, EVOLUTION, V62, P39, DOI 10.1111/j.1558-5646.2007.00271.x; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Chi F, 2007, INT J MED MICROBIOL, V297, P503, DOI 10.1016/j.ijmm.2007.02.009; Chiavolini D, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-14; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dagerhamn J, 2008, J CLIN MICROBIOL, V46, P863, DOI 10.1128/JCM.01438-07; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Feng J, 2009, GENOME RES, V19, P1214, DOI 10.1101/gr.089342.108; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Friendly M., 2001, VISUALIZING CATEGORI; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Green BA, 2005, INFECT IMMUN, V73, P981, DOI 10.1128/IAI.73.2.981-989.2005; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Hein J., 2005, GENE GENEALOGIES VAR; Henriques-Normark B, 2008, NAT REV MICROBIOL, V6, P827, DOI 10.1038/nrmicro2011; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; KILIAN M, 1995, PEDIATR RES, V38, P182, DOI 10.1203/00006450-199508000-00008; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; LEWONTIN RC, 1964, GENETICS, V49, P49; McVean G, 2002, GENETICS, V160, P1231; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Muzzi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003660; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Overweg K, 2000, INFECT IMMUN, V68, P4180, DOI 10.1128/IAI.68.7.4180-4188.2000; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paton JC, 1996, TRENDS MICROBIOL, V4, P103, DOI 10.1016/0966-842X(96)81526-5; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; R Development Core Team, 2005, R LANG ENV STAT COMP; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEINFORT C, 1989, INFECT IMMUN, V57, P2006, DOI 10.1128/IAI.57.7.2006-2013.1989; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Swiatlo E, 2002, INFECT IMMUN, V70, P412, DOI 10.1128/IAI.70.1.412-415.2002; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msr121; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/oxfordjournals.molbev.a040023]; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; MLST S PNEUMONIAE	71	249	1653	2	41	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2010	11	10							R107	10.1186/gb-2010-11-10-r107			19	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	721TS	WOS:000287378900009	21034474	gold, Green Published			2022-01-24	
J	Weinberg, Z; Wang, JX; Bogue, J; Yang, JY; Corbino, K; Moy, RH; Breaker, RR				Weinberg, Zasha; Wang, Joy X.; Bogue, Jarrod; Yang, Jingying; Corbino, Keith; Moy, Ryan H.; Breaker, Ronald R.			Comparative genomics reveals 104 candidate structured RNAs from bacteria, archaea, and their metagenomes	GENOME BIOLOGY			English	Article							SMALL NONCODING RNAS; COLI HEMOLYSIN OPERON; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; GENE-EXPRESSION; S-ADENOSYLMETHIONINE; SINORHIZOBIUM-MELILOTI; HIGH-THROUGHPUT; HELICOBACTER-PYLORI; SECONDARY STRUCTURE	Background: Structured noncoding RNAs perform many functions that are essential for protein synthesis, RNA processing, and gene regulation. Structured RNAs can be detected by comparative genomics, in which homologous sequences are identified and inspected for mutations that conserve RNA secondary structure. Results: By applying a comparative genomics-based approach to genome and metagenome sequences from bacteria and archaea, we identified 104 candidate structured RNAs and inferred putative functions for many of these. Twelve candidate metabolite-binding RNAs were identified, three of which were validated, including one reported herein that binds the coenzyme S-adenosylmethionine. Newly identified cis-regulatory RNAs are implicated in photosynthesis or nitrogen regulation in cyanobacteria, purine and one-carbon metabolism, stomach infection by Helicobacter, and many other physiological processes. A candidate riboswitch termed crcB is represented in both bacteria and archaea. Another RNA motif may control gene expression from 3'-untranslated regions of mRNAs, which is unusual for bacteria. Many noncoding RNAs that likely act in trans are also revealed, and several of the noncoding RNA candidates are found mostly or exclusively in metagenome DNA sequences. Conclusions: This work greatly expands the variety of highly structured noncoding RNAs known to exist in bacteria and archaea and provides a starting point for biochemical and genetic studies needed to validate their biologic functions. Given the sustained rate of RNA discovery over several similar projects, we expect that far more structured RNAs remain to be discovered from bacterial and archaeal organisms.	[Weinberg, Zasha; Wang, Joy X.; Corbino, Keith; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Weinberg, Zasha; Bogue, Jarrod; Yang, Jingying; Moy, Ryan H.; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA		Weinberg, Z (corresponding author), Yale Univ, Howard Hughes Med Inst, POB 208103, New Haven, CT 06520 USA.	zasha.weinberg@yale.edu; ronald.breaker@yale.edu	Wang, Joy Xin/D-2482-2010; Breaker, Ronald/E-9679-2010	Breaker, Ronald/0000-0002-2165-536X; Moy, Ryan/0000-0002-0507-8590; Weinberg, Zasha/0000-0002-6681-3624	NIH Yale Life Sciences High Performance Computing Center [RR19895-02]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR019895] Funding Source: NIH RePORTER	We thank Nick Carriero and Rob Bjornson for assisting our use of the Yale Life Sciences High Performance Computing Center (NIH grant RR19895-02), Paul Gardner for sharing a list of recently published RNA discovery articless, and Adam Roth, Narisiman Sudarsan, Michelle Meyer, Jonathan Perreault, Jeff Barrick, Zizhen Yao, Elizabeth Tseng, Larry Ruzzo, and Breaker lab members for helpful comments. R. R. B. is a Howard Hughes Medical Institute Investigator.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANTAO VP, 1992, NUCLEIC ACIDS RES, V20, P819, DOI 10.1093/nar/20.4.819; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Arthur DC, 2003, EMBO J, V22, P6346, DOI 10.1093/emboj/cdg607; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2006, CURR OPIN STRUC BIOL, V16, P299, DOI 10.1016/j.sbi.2006.05.001; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Bertram R, 2004, J BACTERIOL, V186, P1362, DOI 10.1128/JB.186.5.1362-1373.2004; BOCHNER BR, 1982, CELL, V29, P929, DOI 10.1016/0092-8674(82)90455-X; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; CARDINEAU GA, 1987, J BIOL CHEM, V262, P3344; Chen S, 2007, APPL ENVIRON MICROB, V73, P1089, DOI 10.1128/AEM.01577-06; Chou HT, 2008, J BACTERIOL, V190, P1966, DOI 10.1128/JB.01804-07; Chugani S, 2007, MICROB PATHOGENESIS, V42, P29, DOI 10.1016/j.micpath.2006.10.004; CITRON M, 1990, CELL, V62, P591, DOI 10.1016/0092-8674(90)90023-8; Connelly JC, 1996, GENES CELLS, V1, P285, DOI 10.1046/j.1365-2443.1996.23024.x; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; del Val C, 2007, MOL MICROBIOL, V66, P1080, DOI 10.1111/j.1365-2958.2007.05978.x; Derzelle S, 2005, APPL ENVIRON MICROB, V71, P8597, DOI 10.1128/AEM.71.12.8597-8605.2005; Diwa A, 2000, GENE DEV, V14, P1249; Duan KM, 1998, FEMS MICROBIOL LETT, V164, P419, DOI 10.1111/j.1574-6968.1998.tb13118.x; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Espinosa-Urgel M, 2001, APPL ENVIRON MICROB, V67, P5219, DOI 10.1128/AEM.67.11.5219-5224.2001; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; Fujita M, 1998, FEMS MICROBIOL LETT, V163, P237, DOI 10.1016/S0378-1097(98)00174-8; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gonzalez N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-167; GUARNEROS G, 1982, P NATL ACAD SCI-BIOL, V79, P238, DOI 10.1073/pnas.79.2.238; Gupta RS, 2004, CRIT REV MICROBIOL, V30, P123, DOI 10.1080/10408410490435133; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; HOBBS M, 1994, MOL MICROBIOL, V12, P855, DOI 10.1111/j.1365-2958.1994.tb01071.x; HURTUBISE Y, 1995, MOL MICROBIOL, V17, P367, DOI 10.1111/j.1365-2958.1995.mmi_17020367.x; Jarrige AC, 2001, EMBO J, V20, P6845, DOI 10.1093/emboj/20.23.6845; Johansen LE, 2003, J BACTERIOL, V185, P5200, DOI 10.1128/JB.185.17.5200-5209.2003; KIM KH, 1986, NUCLEIC ACIDS RES, V14, P8027, DOI 10.1093/nar/14.20.8027; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Kok J, 1996, ANTON LEEUW INT J G, V70, P129, DOI 10.1007/BF00395930; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Leaphart AB, 2006, J BACTERIOL, V188, P1633, DOI 10.1128/JB.188.4.1633-1642.2006; LEE JC, 2003, THESIS U TEXAS AUSTI; Leeds JA, 1997, J BACTERIOL, V179, P3519, DOI 10.1128/jb.179.11.3519-3527.1997; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Leoff C, 2008, J BACTERIOL, V190, P112, DOI 10.1128/JB.01292-07; Liang W, 2007, APPL ENVIRON MICROB, V73, P7482, DOI 10.1128/AEM.01564-07; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Lombardo MJ, 2000, J BACTERIOL, V182, P6287, DOI 10.1128/JB.182.22.6287-6291.2000; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Marchais A, 2009, GENOME RES, V19, P1084, DOI 10.1101/gr.089714.108; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Marolda CL, 1998, J BACTERIOL, V180, P3070, DOI 10.1128/JB.180.12.3070-3079.1998; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; MATTHEAKIS L, 1989, P NATL ACAD SCI USA, V86, P448, DOI 10.1073/pnas.86.2.448; McGowan CC, 2003, MOL MICROBIOL, V48, P1225, DOI 10.1046/j.1365-2958.2003.03500.x; Meyer IM, 2007, BRIEF BIOINFORM, V8, P396, DOI 10.1093/bib/bbm011; Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Muramatsu M, 2007, J BACTERIOL, V189, P2750, DOI 10.1128/JB.01903-06; Muramatsu M, 2006, PLANT CELL PHYSIOL, V47, P878, DOI 10.1093/pcp/pcj060; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08; Nalca Y, 2006, ANTIMICROB AGENTS CH, V50, P1680, DOI 10.1128/AAC.50.5.1680-1688.2006; Narberhaus F, 2009, MOL MICROBIOL, V74, P261, DOI 10.1111/j.1365-2958.2009.06869.x; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nieto JM, 1996, MOL MICROBIOL, V19, P705, DOI 10.1046/j.1365-2958.1996.446951.x; Niven Gordon W., 2008, P293, DOI 10.1007/978-3-540-74921-9_10; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Odenbreit S, 2002, INT J MED MICROBIOL, V292, P247, DOI 10.1078/1438-4221-00204; PACE NR, 1999, RNA WORLD, V2, P113; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Panagiotidis CH, 1998, MOL MICROBIOL, V30, P535, DOI 10.1046/j.1365-2958.1998.01084.x; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Platt MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Ravcheev D. A., 2002, Genetika, V38, P1203; Regulski EE, 2008, MOL MICROBIOL, V68, P918, DOI 10.1111/j.1365-2958.2008.06208.x; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; ROHLMAN CE, 1990, J BACTERIOL, V172, P7200, DOI 10.1128/jb.172.12.7200-7210.1990; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saito S, 2009, GENE, V428, P2, DOI 10.1016/j.gene.2008.09.024; Schattner P, 2002, NUCLEIC ACIDS RES, V30, P2076, DOI 10.1093/nar/30.9.2076; Schlosser A, 1997, J BACTERIOL, V179, P2092, DOI 10.1128/jb.179.6.2092-2095.1997; Seraphin B., 1992, DNA Sequence, V3, P177, DOI 10.3109/10425179209034013; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Sonnleitner E, 2008, MICROBIOL-SGM, V154, P3175, DOI 10.1099/mic.0.2008/019703-0; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sriramulu DD, 2005, PROTEOMICS, V5, P3712, DOI 10.1002/pmic.200401227; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Su ZC, 2006, NUCLEIC ACIDS RES, V34, P1050, DOI 10.1093/nar/gkj496; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Tezuka T, 2009, J BACTERIOL, V191, P4896, DOI 10.1128/JB.00087-09; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; TORRESCABASSA A, 1987, J BACTERIOL, V169, P4525, DOI 10.1128/jb.169.10.4525-4531.1987; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tseng Huei-Hun, 2009, Journal of Bioinformatics and Computational Biology, V7, P373, DOI 10.1142/S0219720009004126; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; UELAND PM, 1982, PHARMACOL REV, V34, P223; Ulve VM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-467; Valverde C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-416; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vitreschak AG, 2004, FEMS MICROBIOL LETT, V234, P357, DOI 10.1016/j.femsle.2004.04.005; Walt A, 2002, J BACTERIOL, V184, P4044, DOI 10.1128/JB.184.14.4044-4047.2002; Wang JX, 2008, MOL CELL, V29, P691, DOI 10.1016/j.molcel.2008.01.012; Wang JX, 2008, BIOCHEM CELL BIOL, V86, P157, DOI 10.1139/O08-008; Wang L, 1998, FEMS MICROBIOL LETT, V165, P201, DOI 10.1016/S0378-1097(98)00264-X; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weinberg Z, 2006, BIOINFORMATICS, V22, P35, DOI 10.1093/bioinformatics/bti743; Weinberg Z, 2008, RNA, V14, P822, DOI 10.1261/rna.988608; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Weinberg Z, 2009, NATURE, V462, P656, DOI 10.1038/nature08586; Welz R, 2007, RNA, V13, P573, DOI 10.1261/rna.407707; WENG ML, 1995, P NATL ACAD SCI USA, V92, P7455, DOI 10.1073/pnas.92.16.7455; Wijayarathna CD, 2001, APPL MICROBIOL BIOT, V55, P466, DOI 10.1007/s002530000533; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Yamanishi Y, 2007, FEBS J, V274, P2262, DOI 10.1111/j.1742-4658.2007.05763.x; YAO Z, 2008, THESIS U WASHINGTON; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1; STOCKHOLM FORMAT	162	249	253	0	39	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2010	11	3							R31	10.1186/gb-2010-11-3-r31			17	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	591NY	WOS:000277309100010	20230605	Green Published, hybrid			2022-01-24	
J	Xu, SH; Yin, XY; Li, SL; Jin, WF; Lou, HY; Yang, L; Gong, XH; Wang, HY; Shen, YP; Pan, XD; He, YG; Yang, YJ; Wang, Y; Fu, WQ; An, Y; Wang, JC; Tan, JZ; Qian, J; Chen, XL; Zhang, X; Sun, YF; Zhang, XJ; Wu, BL; Jin, L				Xu, Shuhua; Yin, Xianyong; Li, Shilin; Jin, Wenfei; Lou, Haiyi; Yang, Ling; Gong, Xiaohong; Wang, Hongyan; Shen, Yiping; Pan, Xuedong; He, Yungang; Yang, Yajun; Wang, Yi; Fu, Wenqing; An, Yu; Wang, Jiucun; Tan, Jingze; Qian, Ji; Chen, Xiaoli; Zhang, Xin; Sun, Yangfei; Zhang, Xuejun; Wu, Bailin; Jin, Li			Genomic Dissection of Population Substructure of Han Chinese and Its Implication in Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE-POLYMORPHISMS; GENETIC-STRUCTURE; WIDE ANALYSIS; BLOOD-PRESSURE; HAPLOTYPE MAP; EAST-ASIA; DISEASE; VARIANTS; PATTERNS; STRATIFICATION	To date, most genome-wide association studies (GWAS) and studies of fine-scale population structure have been conducted primarily on Europeans. Han Chinese, the largest ethnic group in the world, composing 20% of the entire global human population, is largely under-represented in such studies. A well-recognized challenge is the fact that population structure can cause spurious associations in GWAS. In this study, we examined population substructures in a diverse set of over 1700 Han Chinese samples collected from 26 regions across China, each genotyped at similar to 160K single-nucleotide polymorphisms (SNPs). Our results showed that the Han Chinese population is intricately substructured, with the main observed clusters corresponding roughly to northern Han, central Han, and southern Han. However, simulated case-control studies showed that genetic differentiation among these clusters, although very small (F-ST = 0.0002 similar to 0.0009), is sufficient to lead to an inflated rate of false-positive results even when the sample size is moderate. The top two SNPs with the greatest frequency differences between the northern Han and southern Han clusters (F-ST > 0.06) were found in the FADS2 gene, which associates with the fatty acid composition in phospholipids, and in the HLA complex PS gene (HCP5), which associates with HIV infection, psoriasis, and psoriatic arthritis. Ingenuity Pathway Analysis (IPA) showed that most differentiated genes among clusters are involved in cardiac arteriopathy (p < 10(-101)). These signals indicating significant differences among Han Chinese subpopulations should be carefully explained in case they are also detected in association studies, especially when sample sources are diverse.	[Xu, Shuhua; Jin, Wenfei; Lou, Haiyi; Yang, Ling; He, Yungang; Jin, Li] Chinese Acad Sci, Max Planck Soc, MPG, Partner Inst Computat Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Xu, Shuhua; Jin, Wenfei; Lou, Haiyi; Yang, Ling; He, Yungang; Jin, Li] Chinese Acad Sci, Key Lab Computat Biol, MPG, Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Li, Shilin; Gong, Xiaohong; Wang, Hongyan; Shen, Yiping; Pan, Xuedong; Yang, Yajun; Wang, Yi; Fu, Wenqing; An, Yu; Wang, Jiucun; Tan, Jingze; Qian, Ji; Zhang, Xin; Sun, Yangfei; Wu, Bailin; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Li, Shilin; Gong, Xiaohong; Wang, Hongyan; Shen, Yiping; Pan, Xuedong; Yang, Yajun; Wang, Yi; Fu, Wenqing; An, Yu; Wang, Jiucun; Tan, Jingze; Qian, Ji; Zhang, Xin; Sun, Yangfei; Wu, Bailin; Jin, Li] Fudan Univ, MOE, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Li, Shilin; Gong, Xiaohong; Wang, Hongyan; Shen, Yiping; Pan, Xuedong; Yang, Yajun; Wang, Yi; Fu, Wenqing; An, Yu; Wang, Jiucun; Tan, Jingze; Qian, Ji; Zhang, Xin; Sun, Yangfei; Wu, Bailin; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yin, Xianyong; Zhang, Xuejun] Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China; [Yin, Xianyong; Zhang, Xuejun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China; [Shen, Yiping; Chen, Xiaoli; Wu, Bailin] Harvard Univ, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; [Jin, Li] Inst Hlth Sci, CMC, Taizhou 225300, Jiangsu, Peoples R China		Jin, L (corresponding author), Chinese Acad Sci, Max Planck Soc, MPG, Partner Inst Computat Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	ljin007@gmail.com	XU, SHUHUA/D-5345-2009; Jin, Wenfei/V-9944-2019; Jin, Wenfei/H-5330-2011; Chen, Gang/G-2722-2010; Xu, Shuhua/AAH-7620-2020; Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/C-1468-2009; Wang, Jiucun/J-8744-2012; Jin, Li/M-5063-2019	XU, SHUHUA/0000-0002-1975-1002; Jin, Wenfei/0000-0002-0028-3739; Jin, Wenfei/0000-0002-0028-3739; Xu, Shuhua/0000-0002-1975-1002; Jin, Li/0000-0002-4546-2415; Wang, Jiucun/0000-0003-2765-0620; He, Yungang/0000-0002-2931-2871	National Outstanding Youth Science Foundation of China [30625016]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30890034, 30971577]; 863 ProgramNational High Technology Research and Development Program of China [2007AA02Z312]; Shanghai Leading Academic Discipline ProjectShanghai Leading Academic Discipline Project [B111]; Center for Evolutionary Biology; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [09ZRI436400]; Knowledge Innovation Program of Shanghai Institutes for Biological SciencesKnowledge Innovation Program of the Chinese Academy of Sciences; Chinese Academy of SciencesChinese Academy of Sciences [2008KIP311]; SA-SIBS Scholarship Program and the K.C.Wong Education Foundation, Hong Kong	This is a report of a joint effort of three research groups with equal contribution. L.J. is the senior author for the data analysis group, and B.W. and X.J.Z. are the senior authors for two genotyping teams. The authors are grateful to many people in L.J., B.W., and X-J.Z.'s lab for their help in collecting samples. This work was supported by grants from the National Outstanding Youth Science Foundation of China (30625016), the National Science Foundation of China (30890034, 30971577), and the 863 Program (2007AA02Z312). L.J. was also Supported by the Shanghai Leading Academic Discipline Project (B111) and the Center for Evolutionary Biology. S.X. was also supported by the Science and Technology Commission of Shanghai Municipality (09ZRI436400) and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2008KIP311). S.X. gratefully acknowledges the support of the SA-SIBS Scholarship Program and the K.C.Wong Education Foundation, Hong Kong.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brahmachari SK, 2008, J GENET, V87, P3; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cann HM, 2002, SCIENCE, V296, P261; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Cavalli Sforza LL, 1993, HIST GEOGRAPHY HUMAN; Chen R, 1993, Yi Chuan Xue Bao, V20, P389; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Colombo S, 2008, J INFECT DIS, V198, P864, DOI 10.1086/591184; Conen D, 2009, J HYPERTENS, V27, P476, DOI 10.1097/HJH.0b013e32832104c8; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; DU R, 1998, SCI CHINA SER C, V28, P83; Fox AA, 2009, ANESTHESIOLOGY, V110, P738, DOI 10.1097/ALN.0b013e31819c7496; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; *HUGO PAN AS SNP C, 2008, SCIENCE IN PRESS; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shaw GM, 2005, AM J MED GENET A, V138A, P21, DOI 10.1002/ajmg.a.30924; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Xiao CJ, 2000, SCI CHINA SER C, V43, P472; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhao WY, 2007, J HYPERTENS, V25, P1821, DOI 10.1097/HJH.0b013e328244e119	62	249	291	1	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					762	774		10.1016/j.ajhg.2009.10.015			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	WOS:000272797100001	19944404	Green Published, Bronze			2022-01-24	
J	Jaglin, XH; Poirier, K; Saillour, Y; Buhler, E; Tian, GL; Bahi-Buisson, N; Fallet-Bianco, C; Phan-Dinh-Tuy, F; Kong, XP; Bomont, P; Castelnau-Ptakhine, L; Odent, S; Loget, P; Kossorotoff, M; Snoeck, I; Plessis, G; Parent, P; Beldjord, C; Cardoso, C; Represa, A; Flint, J; Keays, DA; Cowan, NJ; Chelly, J				Jaglin, Xavier Hubert; Poirier, Karine; Saillour, Yoann; Buhler, Emmanuelle; Tian, Guoling; Bahi-Buisson, Nadia; Fallet-Bianco, Catherine; Phan-Dinh-Tuy, Francoise; Kong, Xiang Peng; Bomont, Pascale; Castelnau-Ptakhine, Laetitia; Odent, Sylvie; Loget, Philippe; Kossorotoff, Manoelle; Snoeck, Irina; Plessis, Ghislaine; Parent, Philippe; Beldjord, Cherif; Cardoso, Carlos; Represa, Alfonso; Flint, Jonathan; Keays, David Anthony; Cowan, Nicholas Justin; Chelly, Jamel			Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria	NATURE GENETICS			English	Article							ALPHA-TUBULIN; NEURONAL MIGRATION; RNA INTERFERENCE; EXPRESSION; CHAPERONIN; SEQUENCES; SPECTRUM	Polymicrogyria is a relatively common but poorly understood defect of cortical development characterized by numerous small gyri and a thick disorganized cortical plate lacking normal lamination. Here we report de novo mutations in a beta-tubulin gene, TUBB2B, in four individuals and a 27-gestational-week fetus with bilateral asymmetrical polymicrogyria. Neuropathological examination of the fetus revealed an absence of cortical lamination associated with the presence of ectopic neuronal cells in the white matter and in the leptomeningeal spaces due to breaches in the pial basement membrane. In utero RNAi-based inactivation demonstrates that TUBB2B is required for neuronal migration. We also show that two disease-associated mutations lead to impaired formation of tubulin heterodimers. These observations, together with previous data, show that disruption of microtubule-based processes underlies a large spectrum of neuronal migration disorders that includes not only lissencephaly and pachygyria, but also polymicrogyria malformations.	[Tian, Guoling; Kong, Xiang Peng; Cowan, Nicholas Justin] NYU, Dept Biochem, Med Ctr, New York, NY 10016 USA; [Jaglin, Xavier Hubert; Poirier, Karine; Saillour, Yoann; Bahi-Buisson, Nadia; Phan-Dinh-Tuy, Francoise; Castelnau-Ptakhine, Laetitia; Chelly, Jamel] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France; [Jaglin, Xavier Hubert; Poirier, Karine; Saillour, Yoann; Bahi-Buisson, Nadia; Phan-Dinh-Tuy, Francoise; Castelnau-Ptakhine, Laetitia; Chelly, Jamel] INSERM, U567, Paris, France; [Buhler, Emmanuelle] INSERM, U901, Plateforme Postgenom INMED, F-13258 Marseille, France; [Bahi-Buisson, Nadia; Kossorotoff, Manoelle] Hop Necker Enfants Malad, Serv Neurol Pediat, Dept Pediat, AP HP, Paris, France; [Fallet-Bianco, Catherine] Hop St Anne, Serv Anat Pathol, F-75674 Paris, France; [Bomont, Pascale; Cardoso, Carlos; Represa, Alfonso] INSERM, Inst Neurobiol Mediterrane, U901, F-13258 Marseille, France; [Odent, Sylvie] Hop Sud, CHU Rennes, Serv Genet Med, Rennes, France; [Loget, Philippe] CHU Pontchaillou, Dept Anat & Cytopathol, Rennes, France; [Snoeck, Irina] Locatie Juliana Kinderziekenhusi Poliklin, The Hague, Netherlands; [Plessis, Ghislaine] CHU Hop Clemenceau, Serv Genet, Caen, France; [Parent, Philippe] CHU Hop Morvan, Dept Pediat & Genet Med, Brest, France; [Beldjord, Cherif] CHU Hop Cochin, Lab Biochim & Genet Mol, Paris, France; [Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Keays, David Anthony] Inst Mol Pathol, A-1030 Vienna, Austria		Cowan, NJ (corresponding author), NYU, Dept Biochem, Med Ctr, New York, NY 10016 USA.	nicholas.cowan@med.nyu.edu; jamel.chelly@inserm.fr	POIRIER, Karine/N-3009-2018; Bomont, Pascale L/Y-5517-2018; Cardoso, Carlos/M-2767-2019; Cardoso, Carlos/H-4520-2016; Fallet-Bianco, Catherine/AAP-7390-2020; Represa, Alfonso/M-7383-2016; Chelly, Jamel/J-7528-2015	POIRIER, Karine/0000-0002-7928-2906; Bomont, Pascale L/0000-0001-7216-3261; Cardoso, Carlos/0000-0003-1914-9553; Cardoso, Carlos/0000-0003-1914-9553; Represa, Alfonso/0000-0002-5096-8939; Chelly, Jamel/0000-0002-0939-8719; Kong, Xiang-Peng/0000-0001-5773-2681; Flint, Jonathan/0000-0002-9427-4429	AP-HP; INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; FRMFondation pour la Recherche Medicale; ANRFrench National Research Agency (ANR) [A05183KS, ANR-06-NEURO-008-01, RPV06055ASA]; Ministere de l'Enseignement Superieur et de la Recherche,Estonian Research CouncilEuropean Commission; Universite Paris Descartes; EMBOEuropean Molecular Biology Organization (EMBO) [ASTF 66.00-2008]	We thank F. Francis for her helpful comments and critical readings of the manuscript, the subjects and their parents who contributed in this study and all the colleagues who provided clinical and imaging information. We thank R. Guerrini for providing us helpful advice. We are grateful to E. Leguern for allowing K. P. to develop this project and all the members of Cochin Institute genomic platform, Cochin Hospital Cell Bank, and Isabelle Souville for their technical assistance. This work was supported by funding from AP-HP, INSERM, FRM ( funding within the frame of the Programme EQUIPEs FRM 2007) and ANR ( ANR Neuro 2005, project A05183KS and ANR-06-NEURO-008-01 contract number RPV06055ASA). X. H. J. is supported by a PhD fellowship of the Ministere de l'Enseignement Superieur et de la Recherche, by a grant for mobility from Universite Paris Descartes and an EMBO short-term fellowship ( ASTF 66.00-2008) for his work in NYU the Medical Center. K. P. is a post-doctoral researcher supported by FRM ( Fondation pour la Recherche Medicale).	Bahi-Buisson N, 2008, J MED GENET, V45, P647, DOI 10.1136/jmg.2008.058073; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; CLEVELAND DW, 1978, CELL, V15, P1021, DOI 10.1016/0092-8674(78)90286-6; Cowan NJ, 2002, ADV PROTEIN CHEM, V59, P73; Dutcher SK, 2001, CURR OPIN CELL BIOL, V13, P49, DOI 10.1016/S0955-0674(00)00173-3; GAO M, 1992, MOL CELL BIOL, V12, P1330, DOI 10.1128/MCB.12.3.1330; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; LITTLE M, 1988, COMP BIOCHEM PHYS B, V90, P655, DOI 10.1016/0305-0491(88)90320-3; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; TIAN GL, 1995, J BIOL CHEM, V270, P23910, DOI 10.1074/jbc.270.41.23910; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian G, 2008, MOL BIOL CELL, V19, P1152, DOI 10.1091/mbc.E07-09-0861; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	28	249	254	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					746	752		10.1038/ng.380			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	WOS:000266411700027	19465910	Green Accepted, Green Submitted			2022-01-24	
J	Hicks, J; Krasnitz, A; Lakshmi, B; Navin, NE; Riggs, M; Leibu, E; Esposito, D; Alexander, J; Troge, J; Grubor, V; Yoon, S; Wigler, M; Ye, K; Borresen-Dale, AL; Naume, B; Schlicting, E; Norton, L; Hagerstrom, T; Skoog, L; Auer, G; Maner, S; Lundin, P; Zetterberg, A				Hicks, James; Krasnitz, Alexander; Lakshmi, B.; Navin, Nicholas E.; Riggs, Michael; Leibu, Evan; Esposito, Diane; Alexander, Joan; Troge, Jen; Grubor, Vladimir; Yoon, Seungtai; Wigler, Michael; Ye, Kenny; Borresen-Dale, Anne-Lise; Naume, Bjorn; Schlicting, Ellen; Norton, Larry; Hagerstrom, Torsten; Skoog, Lambert; Auer, Gert; Maner, Susanne; Lundin, Par; Zetterberg, Anders			Novel patterns of genome rearrangement and their association with survival in breast cancer	GENOME RESEARCH			English	Article							COPY NUMBER VARIATION; 11Q13 AMPLIFICATION; MICROARRAY ANALYSIS; GENE AMPLIFICATION; PROGNOSTIC-FACTOR; ARRAY-CGH; HYBRIDIZATION; EXPRESSION; TUMORS; CHROMOSOMES	Representational Oligonucleotide Microarray Analysis (ROMA) detects genomic amplifications and deletions with boundaries defined at a resolution of similar to 50 kb. We have used this technique to examine 243 breast tumors from two separate studies for which detailed clinical data were available. The very high resolution of this technology has enabled us to identify three characteristic patterns of genomic copy number variation in diploid tumors and to measure correlations with patient survival. One of these patterns is characterized by multiple closely spaced amplicons, or "firestorms," limited to single chromosome arms. These multiple amplifications are highly correlated with aggressive disease and poor survival even when the rest of the genome is relatively quiet. Analysis of a selected subset of clinical material suggests that a simple genomic calculation, based on the number and proximity of genomic alterations, correlates with life-table estimates of the probability of overall survival in patients with primary breast cancer. Based on this sample, we generate the working hypothesis that copy number profiling might provide information useful in making clinical decisions, especially regarding the use or not of systemic therapies (hormonal therapy, chemotherapy), in the management of operable primary breast cancer with ostensibly good prognosis, for example, small, node-negative, hormone-receptor-positive diploid cases.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Radiumhosp, Rikshosp, Med Ctr, Dept Genet,Inst Canc Res, N-0310 Oslo, Norway; Univ Oslo, Fac Med, N-0316 Oslo, Norway; Radiumhosp, Rikshosp, Med Ctr, Canc Clin, N-0310 Oslo, Norway; Ullevaal Univ Hosp, Dept Surg, N-0407 Oslo, Norway; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden; Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA		Hicks, J (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	hicks@cshl.edu	Ye, Kenny/U-2341-2019	Ye, Kenny/0000-0002-1466-855X; Auer, Gert/0000-0003-3911-0285; Norton, Larry/0000-0003-3701-9250; Wigler, Michael/0000-0003-4396-1971	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA078544] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA078544, R01-CA078544-07] Funding Source: Medline		Ahr A, 2002, LANCET, V359, P131, DOI 10.1016/S0140-6736(02)07337-3; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Albertson DG, 2003, BREAST CANCER RES TR, V78, P289, DOI 10.1023/A:1023025506386; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; BERNS EMJJ, 1995, INT J CANCER, V64, P140, DOI 10.1002/ijc.2910640212; Chunder N, 2004, DIAGN MOL PATHOL, V13, P172, DOI 10.1097/01.pas.0000124337.49401.0b; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Daruwala RS, 2004, P NATL ACAD SCI USA, V101, P16292, DOI 10.1073/pnas.0407247101; DePinho RA, 2004, NAT GENET, V36, P932, DOI 10.1038/ng0904-932; Eden P, 2004, EUR J CANCER, V40, P1837, DOI 10.1016/j.ejca.2004.02.025; FORSSLUND G, 1990, CANCER RES, V50, P4281; Forsslund G, 1996, CANCER, V78, P1748, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1748::AID-CNCR15>3.3.CO;2-U; Garcia MJ, 2005, ONCOGENE, V24, P5235, DOI 10.1038/sj.onc.1208741; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Hellman A, 2002, CANCER CELL, V1, P89, DOI 10.1016/S1535-6108(02)00017-X; Jarvinen TAH, 2003, BREAST CANCER RES TR, V78, P299, DOI 10.1023/A:1023077507295; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI A, 1992, CYTOGENET CELL GENET, V60, P190, DOI 10.1159/000133333; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Knoop AS, 2005, J CLIN ONCOL, V23, P7483, DOI 10.1200/JCO.2005.11.007; Kronenwett U, 2004, CANCER RES, V64, P904, DOI 10.1158/0008-5472.CAN-03-2451; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Madjd Z, 2005, INT J CANCER, V117, P248, DOI 10.1002/ijc.21163; McClintock B, 1938, GENETICS, V23, P315; McClintock B, 1941, GENETICS, V26, P234; Menard S, 2001, ONCOLOGY-BASEL, V61, P67, DOI 10.1159/000055404; Navin N, 2006, BIOINFORMATICS, V22, P2437, DOI 10.1093/bioinformatics/btl273; Nessling M, 2005, CANCER RES, V65, P439; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; RIED T, 1995, CANCER RES, V55, P5415; Ried T, 1997, J MOL MED-JMM, V75, P801, DOI 10.1007/s001090050169; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shuster MI, 2000, GENE CHROMOSOME CANC, V28, P153, DOI 10.1002/(SICI)1098-2264(200006)28:2<153::AID-GCC4>3.3.CO;2-0; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009	48	249	253	0	3	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	WOODBURY	500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA	1088-9051			GENOME RES	Genome Res.	DEC	2006	16	12					1465	1479		10.1101/gr.5460106			15	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	111VF	WOS:000242482600004	17142309	Bronze, Green Published, Green Accepted			2022-01-24	
J	Moreno-Loshuertos, R; Acin-Perez, R; Fernandez-Silva, P; Movilla, N; Perez-Martos, A; de Cordoba, SR; Gallardo, ME; Enriquez, JA				Moreno-Loshuertos, Raquel; Acin-Perez, Rebeca; Fernandez-Silva, Patricio; Movilla, Nieves; Perez-Martos, Acisclo; de Cordoba, Santiago Rodriguez; Gallardo, M. Esther; Enriquez, Jose Antonio			Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants	NATURE GENETICS			English	Article							OXIDATIVE STRESS; RESPIRATORY-FUNCTION; NADH DEHYDROGENASE; MTDNA HAPLOGROUPS; MAMMALIAN-CELLS; MUTATION; GENE; SELECTION; RNA; FIBROBLASTS	Common mitochondrial DNA (mtDNA) haplotypes in humans and mice have been associated with various phenotypes, including learning performance and disease penetrance. Notably, no influence of mtDNA haplotype in cell respiration has been demonstrated. Here, using cell lines carrying four different common mouse mtDNA haplotypes in an identical nuclear background, we show that the similar level of respiration among the cell lines is only apparent and is a consequence of compensatory mechanisms triggered by different production of reactive oxygen species. We observe that the respiration capacity per molecule of mtDNA in cells with the NIH3T3 or NZB mtDNA is lower than in those with the C57BL/6J, CBA/J or BALB/cJ mtDNA. In addition, we have determined the genetic element underlying these differences. Our data provide insight into the molecular basis of the complex phenotypes associated with common mtDNA variants and anticipate a relevant contribution of mtDNA single nucleotide polymorphisms to phenotypic variability in humans.	Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50013 Zaragoza, Spain; CSIC, Ctr Invest Biol, Dept Inmunol, E-28040 Madrid, Spain		Enriquez, JA (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Miguel Servet 177, E-50013 Zaragoza, Spain.	enriquez@unizar.es	Moreno-Loshuertos, Raquel/H-4545-2015; Enriquez, J.A./M-8468-2016; Silva, Patricio Fernandez/U-2256-2017; Acin-Perez, Rebeca/H-6160-2015; Acin-Perez, Rebeca/AAU-4913-2020; de Cordoba, Santiago Rodriguez/K-6727-2014	Enriquez, J.A./0000-0002-3671-2961; Silva, Patricio Fernandez/0000-0001-8971-7355; Acin-Perez, Rebeca/0000-0001-9553-8337; Acin-Perez, Rebeca/0000-0001-9553-8337; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; GALLARDO PEREZ, M. ESTHER/0000-0002-8699-8734; Moreno Loshuertos, Raquel/0000-0002-6600-1618			Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; CHOMYN A, 1994, AM J HUM GENET, V54, P966; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1159/000064724; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Staden R, 2000, Methods Mol Biol, V132, P115; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Tretter L, 2000, J NEUROSCI, V20, P8972; Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133	48	249	256	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1261	1268		10.1038/ng1897			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	WOS:000241592700014	17013393				2022-01-24	
J	Zuchner, S; Noureddine, M; Kennerson, M; Verhoeven, K; Claeys, K; De Jonghe, P; Merory, J; Oliveira, SA; Speer, MC; Stenger, JE; Walizada, G; Zhu, DQ; Pericak-Vance, MA; Nicholson, G; Timmerman, V; Vance, JM				Zuchner, S; Noureddine, M; Kennerson, M; Verhoeven, K; Claeys, K; De Jonghe, P; Merory, J; Oliveira, SA; Speer, MC; Stenger, JE; Walizada, G; Zhu, DQ; Pericak-Vance, MA; Nicholson, G; Timmerman, V; Vance, JM			Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease	NATURE GENETICS			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; NEUROPATHY; IDENTIFICATION; LOCALIZATION; MICROTUBULES; MECHANISM; MUTANT; MAPS; FORM	Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of peripheral neuropathies. Different chromosomal loci have been linked with three autosomal dominant, `intermediate' types of CMT: DI-CMTA(1),DI-CMTB2 and DI-CMTC3. We refined the locus associated with DI-CMTB on chromosome 19p12- 13. 2 to 4.2 Mb in three unrelated families with CMT originating from Australia, Belgium and North America. After screening candidate genes, we identified unique mutations in dynamin 2 (DNM2) in all families. DNM2 belongs to the family of large GTPases and is part of the cellular fusion-fission apparatus(4). In transiently transfected cell lines, mutations of DNM2 substantially diminish binding of DNM2 to membranes by altering the conformation of the beta3/beta4 loop of the pleckstrin homology domain. Additionally, in the Australian and Belgian pedigrees, which carry two different mutations affecting the same amino acid, Lys558, CMT cosegregated with neutropenia, which has not previously been associated with CMT neuropathies.	Duke Univ, Med Ctr, Dept Human Genet, Durham, NC 27710 USA; Rhein Westfal TH Aachen, Univ Hosp, Dept Neuropathol, D-52074 Aachen, Germany; ANZAC Res Inst, Northcott Neurosci Lab, Sydney, NSW, Australia; Concord Hosp, Mol Med Lab, Concord, NSW, Australia; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Heidelberg Repatriat Hosp, Dept Neurol, Heidelberg West, Vic 3081, Australia		Zuchner, S (corresponding author), Duke Univ, Med Ctr, Dept Human Genet, Durham, NC 27710 USA.		Oliveira, Sofia/F-3386-2010	Vance, Jeffery/0000-0003-3815-8199; Claeys, Kristl/0000-0001-9937-443X; Oliveira, Sofia A/0000-0001-7919-4191; Kennerson, Marina/0000-0003-3332-5074; Nicholson, Garth/0000-0001-9694-066X			Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; Kennerson ML, 2001, AM J HUM GENET, V69, P883, DOI 10.1086/323743; Kozlov MM, 1999, BIOPHYS J, V77, P604, DOI 10.1016/S0006-3495(99)76917-1; Lee A, 1999, CURR BIOL, V9, P261, DOI 10.1016/S0960-9822(99)80115-8; Muhlberg AB, 2000, METHODS, V20, P475, DOI 10.1006/meth.2000.0960; SCAIFE R, 1990, J CELL BIOL, V111, P3023, DOI 10.1083/jcb.111.6.3023; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Speer MC, 2002, NEUROGENETICS, V4, P83, DOI 10.1007/s10048-002-0139-3; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Vance JM, 2000, ARCH NEUROL-CHICAGO, V57, P638, DOI 10.1001/archneur.57.5.638; Verhoeven K, 2001, AM J HUM GENET, V69, P889, DOI 10.1086/323742; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zhu DQ, 2003, NEUROGENETICS, V4, P179, DOI 10.1007/s10048-003-0147-y; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	27	249	258	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2005	37	3					289	294		10.1038/ng1514			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	WOS:000227297800020	15731758				2022-01-24	
J	Margulies, EH; Blanchette, M; Haussler, D; Green, ED				Margulies, EH; Blanchette, M; Haussler, D; Green, ED		NISC Comparative Sequencing Progra	Identification and characterization of multi-species conserved sequences	GENOME RESEARCH			English	Article							GENOMIC DNA-SEQUENCES; FACTOR-BINDING SITES; REGULATORY ELEMENTS; NONCODING SEQUENCES; MOUSE GENOME; MULTIPLE ALIGNMENT; MESSENGER-RNA; REGIONS; PREDICTION; DISCOVERY	Comparative sequence analysis has become an essential component of studies aiming to elucidate genome function. The increasing availability of genomic sequences from multiple vertebrates is creating the need for computational methods that can detect highly conserved regions in a robust fashion. Towards that end, we are developing approaches for identifying sequences that are conserved across multiple species; we call these "Multi-species Conserved Sequences" (or MCSs). Here we report two strategies for MCS identification, demonstrating their ability to detect virtually all known actively conserved sequences (specifically, coding sequences) but very little neutrally evolving sequence (specifically, ancestral repeats). Importantly, we find that a substantial fraction of the bases within MCSs (similar to70%) resides within non-coding regions; thus, the majority of sequences conserved across multiple vertebrate species has no known function. Initial characterization of these MCSs has revealed sequences that correspond to clusters of transcription factor-binding sites, non-coding RNA transcripts, and other candidate functional elements. Finally, the ability to detect MCSs represents a valuable metric for assessing the relative contribution of a species' sequence to identifying genomic regions of interest, and our results indicate that the currently available genome sequences are insufficient for the comprehensive identification of MCSs in the human genome.	Natl Ctr Human Genome Res, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Natl Ctr Human Genome Res, NIH Intramural Sequencing Ctr, NISC, NIH, Bethesda, MD 20892 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95964 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95964 USA		Haussler, D (corresponding author), Natl Ctr Human Genome Res, Genome Technol Branch, NIH, Bethesda, MD 20892 USA.	haussler@cse.ucsc.edu; egreen@nhgri.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [Z01HG000196, ZIBHG000196, ZIAHG000060, Z01HG000060] Funding Source: NIH RePORTER		Akker SA, 2001, J MOL ENDOCRINOL, V27, P123, DOI 10.1677/jme.0.0270123; Alexandersson M, 2003, GENOME RES, V13, P496, DOI 10.1101/gr.424203; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; BAILEY TL, 1995, MACH LEARN, V21, P51, DOI 10.1023/A:1022617714621; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Blanchette M, 2003, NUCLEIC ACIDS RES, V31, P3840, DOI 10.1093/nar/gkg606; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; BLANCHETTE M, 2003, 7 ANN INT C RES COMP; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; Bray N, 2003, NUCLEIC ACIDS RES, V31, P3525, DOI 10.1093/nar/gkg623; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chapman MA, 2003, GENOMICS, V81, P249, DOI 10.1016/S0888-7543(03)00005-3; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Dehal P, 2001, SCIENCE, V293, P104, DOI 10.1126/science.1060310; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Elnitski L, 2003, GENOME RES, V13, P64, DOI 10.1101/gr.817703; Etkin LD, 1999, FASEB J, V13, P419, DOI 10.1096/fasebj.13.3.419; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Flicek P, 2003, GENOME RES, V13, P46, DOI 10.1101/gr.830003; Giardine B, 2003, GENOME RES, V13, P732, DOI 10.1101/gr.603103; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Green ED, 2001, NAT REV GENET, V2, P573, DOI 10.1038/35084503; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Kulp D, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P134; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Rogic S, 2001, GENOME RES, V11, P817, DOI 10.1101/gr.147901; ROSKIN K, 2003, 7 ANN INT C RES COMP, P257; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SANKOFF D, 1975, MATH PROGRAM, V9, P240, DOI 10.1007/BF01681346; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Solovyev V., 2001, HDB STAT GENETICS, P83; Spagnoli FM, 2000, J CELL SCI, V113, P3639; Stojanovic N, 1999, NUCLEIC ACIDS RES, V27, P3899, DOI 10.1093/nar/27.19.3899; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Vincent JB, 2002, GENOMICS, V80, P283, DOI 10.1006/geno.2002.6835; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	67	249	258	0	6	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	DEC	2003	13	12					2507	2518		10.1101/gr.1602203			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	749KZ	WOS:000186920200001	14656959	Green Published, Bronze			2022-01-24	
J	Olbrich, H; Fliegauf, M; Hoefele, J; Kispert, A; Otto, E; Volz, A; Wolf, MT; Sasmaz, G; Trauer, U; Reinhardt, R; Sudbrak, R; Antignac, C; Gretz, N; Walz, G; Schermer, B; Benzing, T; Hildebrandt, F; Omran, H				Olbrich, H; Fliegauf, M; Hoefele, J; Kispert, A; Otto, E; Volz, A; Wolf, MT; Sasmaz, G; Trauer, U; Reinhardt, R; Sudbrak, R; Antignac, C; Gretz, N; Walz, G; Schermer, B; Benzing, T; Hildebrandt, F; Omran, H			Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; SENIOR-LOKEN-SYNDROME; FAMILIAL NEPHROPATHY; PROTEIN; PROGRESSION; INTERACTS; LOCUS; IDENTIFICATION; NEPHROCYSTIN; P130(CAS)	Nephronophthisis (NPHP), a group of autosomal recessive cystic kidney disorders, is the most common genetic cause of progressive renal failure in children and young adults(1). NPHP may be associated with Leber congenital amaurosis, tapetoretinal degeneration, cerebellar ataxia, cone-shaped epiphyses, congenital oculomotor apraxia and hepatic fibrosis(2-6). Loci associated with an infantile type of NPHP on 9q22-q31 (NPHP2), juvenile types of NPHP on chromosomes 2q12-q13 (NPHP1) and 1p36 (NPHP4) and an adolescent type of NPHP on 3q21-q22 (NPHP3) have been mapped(7-10). NPHP1 and NPHP4 have been identified(11-13), and interaction of the respective encoded proteins nephrocystin and nephrocystin-4 has been shown(13). Here we report the identification of NPHP3, encoding a novel 1,330-amino acid protein that interacts with nephrocystin. We describe mutations in NPHP3 in families with isolated NPHP and in families with NPHP with associated hepatic fibrosis or tapeto-retinal degeneration. We show that the mouse ortholog Nphp3 is expressed in the node, kidney tubules, retina, respiratory epithelium, liver, biliary tract and neural tissues. In addition, we show that a homozygous missense mutation in Nphp3 is probably responsible for the polycystic kidney disease (pcy) mouse phenotype(14). Interventional studies in the pcy mouse have shown beneficial effects by modification of protein intake and administration of methylprednisolone(15-17), suggesting therapeutic strategies for treating individuals with NPHP3.	Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Hannover Med Sch, Inst Mol Biol, Hannover, Germany; Max Planck Inst Mol Genet, Berlin, Germany; Univ Paris 05, Necker Hosp, Dept Genet, Paris, France; Heidelberg Univ, Klinikum Mannheim, Med Res Ctr, D-68167 Mannheim, Germany; Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; Univ Hosp Freiburg, Clin Res Ctr, D-79106 Freiburg, Germany		Omran, H (corresponding author), Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany.	omran@kikli.ukl.uni-freiburg.de	Volz, Andreas/AAA-6290-2019; Hoefele, Julia/AAB-6448-2020; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; ANTIGNAC, Corinne/H-8945-2017	Hoefele, Julia/0000-0002-7917-7129; Schermer, Bernhard/0000-0002-5194-9000; ANTIGNAC, Corinne/0000-0002-9934-4940; Reinhardt, Richard/0000-0001-9376-2132; Omran, Heymut/0000-0003-0282-6765; Otto, Edgar/0000-0002-2387-9973			ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; AUKEMA HM, 1992, KIDNEY INT, V42, P837, DOI 10.1038/ki.1992.358; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; BOICHIS H, 1973, Q J MED, V42, P221; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Erck C, 2000, NEUROCHEM RES, V25, P5, DOI 10.1023/A:1007523028834; GATTONE VH, 1995, AM J KIDNEY DIS, V25, P302, DOI 10.1016/0272-6386(95)90013-6; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2001, PEDIATR NEPHROL, V16, P168, DOI 10.1007/s004670000518; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; MAINZER F, 1970, AM J MED, V49, P556, DOI 10.1016/S0002-9343(70)80051-1; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Omran H, 2002, J AM SOC NEPHROL, V13, P75, DOI 10.1681/ASN.V13175; Omran H, 2000, AM J HUM GENET, V66, P118, DOI 10.1086/302705; Omran H, 2001, NEPHROL DIAL TRANSPL, V16, P755, DOI 10.1093/ndt/16.4.755; Omran H, 2001, J AM SOC NEPHROL, V12, P107, DOI 10.1681/ASN.V121107; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Schuermann MJ, 2002, AM J HUM GENET, V70, P1240, DOI 10.1086/340317; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; TAKAHASHI H, 1986, J UROLOGY, V135, P1280, DOI 10.1016/S0022-5347(17)46074-5; Tomobe K, 1998, AM J KIDNEY DIS, V31, P55, DOI 10.1053/ajkd.1998.v31.pm9428452; Volz A, 2002, CYTOGENET GENOME RES, V97, P163, DOI 10.1159/000066617	29	249	258	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					455	459		10.1038/ng1216			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	WOS:000184470500026	12872122				2022-01-24	
J	Subramanian, S; Mishra, RK; Singh, L				Subramanian, S; Mishra, RK; Singh, L			Genome-wide analysis of microsatellite repeats in humans: their abundance and density in specific genomic regions	GENOME BIOLOGY			English	Article							SIMPLE SEQUENCE REPEATS; PROTEIN	Background: Simple sequence repeats (SSRs) are found in most organisms, and occupy about 3% of the human genome. Although it is becoming clear that such repeats are important in genomic organization and function and may be associated with disease conditions, their systematic analysis has not been reported. This is the first report examining the distribution and density of simple sequence repeats (1-6 base-pairs ( bp)) in the entire human genome. Results: The densities of SSRs across the human chromosomes were found to be relatively uniform. However, the overall density of SSR was found to be high in chromosome 19. Triplets and hexamers were more predominant in exonic regions compared to intronic and intergenic regions, except for chromosome Y. Comparison of densities of various SSRs revealed that whereas trimers and pentamers showed a similar pattern (500-1,000 bp/Mb) across the chromosomes, di- tetra- and hexa-nucleotide repeats showed patterns of higher ( 2,000-3,000 bp/Mb) density. Repeats of the same nucleotide were found to be higher than other repeat types. Repeats of A, AT, AC, AAT, AAC, AAG, AGC, AAAC, AAAT, AAAG, AAGG, AGAT predominate, whereas repeats of C, CG, ACT, ACG, AACC, AACG, AACT, AAGC, AAGT, ACCC, ACCG, ACCT, CCCG and CCGG are rare. Conclusions: The overall SSR density was comparable in all chromosomes. The density of different repeats, however, showed significant variation. Tri- and hexa-nucleotide repeats are more abundant in exons, whereas other repeats are more abundant in non-coding regions.	Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India		Singh, L (corresponding author), Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	lalji@ccmb.res.in	Mishra, Rakesh K/F-3496-2010	Mishra, Rakesh K/0000-0001-6636-7380; Subramanian, Subbaya/0000-0002-2544-480X			Albanese V, 2001, HUM MOL GENET, V10, P1785, DOI 10.1093/hmg/10.17.1785; Borstnik B, 2002, GENOME RES, V12, P909, DOI 10.1101/gr.138802; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Gur-Arie R, 2000, GENOME RES, V10, P62; JURKA J, 1995, J MOL EVOL, V40, P120, DOI 10.1007/BF00167107; Kashi Y, 1997, TRENDS GENET, V13, P74, DOI 10.1016/S0168-9525(97)01008-1; KUNZLER P, 1995, BIOL CHEM H-S, V376, P201; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larsson J, 2001, P NATL ACAD SCI USA, V98, P6273, DOI 10.1073/pnas.111581298; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Messier W, 1996, NATURE, V381, P483, DOI 10.1038/381483a0; Metzgar D, 2000, GENOME RES, V10, P72; Moxon ER, 1999, SCI AM, V280, P94, DOI 10.1038/scientificamerican0199-94; Primmer CR, 1998, MOL BIOL EVOL, V15, P997, DOI 10.1093/oxfordjournals.molbev.a026015; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; Sinden RR, 2001, NATURE, V411, P757, DOI 10.1038/35081234; SUBRAMANIAN S, 2003, IN PRESS BIOINFORMAT; Thangaraj K, 2003, AM J MED GENET A, V116A, P205, DOI 10.1002/ajmg.a.10865; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; SSRD SIMPE SEQUENCE; GENBANK H SAPIENS SE; DETAILED VIEW EACH R	23	249	275	1	19	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2003	4	2							R13	10.1186/gb-2003-4-2-r13			10	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	675KH	WOS:000182693100009	12620123	Green Published, Bronze			2022-01-24	
J	Collin, GB; Marshall, JD; Ikeda, A; So, WV; Russell-Eggitt, I; Maffei, P; Beck, S; Boerkoel, CF; Sicolo, N; Martin, M; Nishina, PM; Naggert, JK				Collin, GB; Marshall, JD; Ikeda, A; So, WV; Russell-Eggitt, I; Maffei, P; Beck, S; Boerkoel, CF; Sicolo, N; Martin, M; Nishina, PM; Naggert, JK			Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; NATURAL-HISTORY; GENE; INHERITANCE; DYSFUNCTION; DISORDER; LINKAGE; FAMILY	Alstrom syndrome is a homogeneous autosomal recessive disorder that is characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia and neurosensory deficits(1,2). The gene involved in Alstrom syndrome probably interacts with genetic modifiers, as subsets of affected individuals present with additional features such as dilated cardiomyopathy(3), hepatic dysfunction(4), hypothyroidism(5), male hypogonadism, short stature and mild to moderate developmental delay, and with secondary complications normally associated with type 2 diabetes, such as hyperlipidemia and atherosclerosis. Our detection of an uncharacterized transcript, KIAA0328, led us to identify the gene ALMS1, which contains sequence variations, including four frameshift mutations and two nonsense mutations, that segregate with Alstrom syndrome in six unrelated families. ALMS1 is ubiquitously expressed at low levels and does not share significant sequence homology with other genes reported so far. The identification of ALMS1 provides an entry point into a new pathway leading toward the understanding of both Alstrom syndrome and the common diseases that characterize it.	Jackson Lab, Bar Harbor, ME 04609 USA; Hoffmann La Roche Inc, Computat Genom & Genet, Nutley, NJ 07110 USA; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Univ Padua, Ist Semeiot Med, I-35100 Padua, Italy; Inst Nacl Saude, Lisbon, Portugal; Baylor Coll Med, Houston, TX 77030 USA		Naggert, JK (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	jkn@jax.org	Maffei, Pietro/O-1878-2013	Maffei, Pietro/0000-0002-1717-263X; Ikeda, Akihiro/0000-0001-8440-3891			ALSTROM CH, 1959, ACTA PSYCHIAT S S129, V34, P1; CHARLES SJ, 1990, J MED GENET, V27, P590, DOI 10.1136/jmg.27.9.590; Collin GB, 1999, HUM GENET, V105, P474, DOI 10.1007/s004390051133; Collin GB, 1996, GENOMICS, V37, P125, DOI 10.1006/geno.1996.0529; Collin GB, 1997, HUM MOL GENET, V6, P213, DOI 10.1093/hmg/6.2.213; CONNOLLY MB, 1991, AM J MED GENET, V40, P421, DOI 10.1002/ajmg.1320400408; Froguel P, 2001, RECENT PROG HORM RES, V56, P91, DOI 10.1210/rp.56.1.91; GOLDSTEIN JL, 1973, MEDICINE, V52, P53, DOI 10.1097/00005792-197301000-00003; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Inui A, 1999, TRENDS NEUROSCI, V22, P62, DOI 10.1016/S0166-2236(98)01292-2; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; Macari F, 1998, HUM GENET, V103, P658, DOI 10.1007/s004390050887; Marshall JD, 1997, AM J MED GENET, V73, P150, DOI 10.1002/(SICI)1096-8628(19971212)73:2<150::AID-AJMG9>3.0.CO;2-Y; Michaud JL, 1996, J PEDIATR-US, V128, P225, DOI 10.1016/S0022-3476(96)70394-3; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Naggert J, 1997, CURR OPIN GENET DEV, V7, P398, DOI 10.1016/S0959-437X(97)80155-4; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Nishina PM, 1998, GENOMICS, V54, P215, DOI 10.1006/geno.1998.5567; Rastogi P A, 2000, Methods Mol Biol, V132, P47; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116	22	249	259	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					74	78		10.1038/ng867			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	WOS:000175362500018	11941369				2022-01-24	
J	Carvalho-Silva, DR; Santos, FR; Rocha, J; Pena, SDJ				Carvalho-Silva, DR; Santos, FR; Rocha, J; Pena, SDJ			The phylogeography of Brazilian Y-chromosome lineages	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; POPULATION	We examined DNA polymorphisms in the nonrecombining portion of the Y-chromosome to investigate the contribution of distinct patrilineages to the present-day white Brazilian population. Twelve unique-event polymorphisms were typed in 200 unrelated males from four geographical regions of Brazil and in 93 Portuguese males. In our Brazilian sample, the vast majority of Y-chromosomes proved to be of European origin. Indeed, there were no significant differences when the haplogroup frequencies in Brazil and Portugal were compared by means of an exact test of population differentiation. Y-chromosome typing was quite sensitive in the detection of regional immigration events. Distinct footprints of Italian immigration to southern Brazil, migration of Moroccan Jews to the Amazon region, and possible relies of the 17th-century Dutch invasion of northeast Brazil could be seen in the data. In sharp contrast with our mtDNA data in white Brazilians, which showed that greater than or equal to 60% of the matrilineages were Amerindian or African, only 2.5% of the Y-chromosome lineages were from sub-Saharan Africa, and none were Amerindian. Together, these results configure a picture of strong directional mating between European males and Amerindian and African females, which agrees with the known history of the peopling of Brazil since 1500.	Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-30161970 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Biol Geral, BR-30161970 Belo Horizonte, MG, Brazil; Univ Porto, Inst Patol & Imunol Mol, P-4100 Porto, Portugal		Pena, SDJ (corresponding author), Univ Fed Minas Gerais, ICB, Dept Bioquim, Caixa Postal 486, BR-30161970 Belo Horizonte, MG, Brazil.	spena@dcc.ufmg.br	dos Santos, Fabricio Rodrigues/H-2370-2011	dos Santos, Fabricio Rodrigues/0000-0001-9088-1750; rocha, jorge/0000-0001-5460-7615; Carvalho-Silva, Dr D/0000-0001-5662-1840			Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; EXCOFFIER L, 1992, GENETICS, V131, P479; GRINBERG K, 2000, BRASIL 500 ANOS POVO, P125; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; *IBGE I BRAS GEOGR, 2000, BRAS 500 AN POV; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PANDYA A, 1998, THESIS OXFORD U; Pereira L, 2000, INT CONGR SER, P281; Previdere C, 2000, INT CONGR SER, P257; RIBEIRO Darcy, 1995, POVO BRASILEIRO FORM; ROSSER Z, 2000, IN PRESS AM J HUM GE; SANTOS FR, 1993, HUM GENET, V90, P655; SANTOS FR, 1999, DNA PROFILING DNA FI, P133; SCHNEIDER S, 1997, ARLEQUIN VER 1 1 SOF; Semino O, 1996, AM J HUM GENET, V59, P964; Shinka T, 1999, J HUM GENET, V44, P240, DOI 10.1007/s100380050151; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Zerjal T, 1999, GENOMIC DIVERSITY, P91	22	249	262	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					281	286		10.1086/316931			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	WOS:000166399900032	11090340	Green Published, Bronze			2022-01-24	
J	Bjorses, P; Halonen, M; Palvimo, JJ; Kolmer, M; Aaltonen, J; Ellonen, P; Perheentupa, J; Ulmanen, I; Peltonen, L				Bjorses, P; Halonen, M; Palvimo, JJ; Kolmer, M; Aaltonen, J; Ellonen, P; Perheentupa, J; Ulmanen, I; Peltonen, L			Mutations in the AIRE gene: Effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-1 APS1; HUMAN DNA; LOCALIZATION; REGULATOR; DOMAIN; COMMON; EXPRESSION; RECEPTOR; DISEASE; BINDING	Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a monogenic autosomal disease with recessive inheritance. It is characterized by multiple autoimmune endocrinopathies, chronic mucocutaneous candidiasis, and ectodermal dystrophies. The defective gene responsible for this disease was recently isolated, and several different mutations in the novel gene, AIRE, have been identified, by us and by others, in patients with APECED. We have shown that the APECED protein is mainly localized, both in vitro and in vivo, to the cell nucleus, where it forms distinct speckles. This accords with the predicted structural features of the protein, which suggest involvement of AIRE in the regulation of gene transcription. Here, we report the results of mutational analyses of a series of 112 patients with APECED who were from various ethnic backgrounds. A total of 16 different mutations, covering 91% of disease alleles, were observed; of these, 8 were novel. The mutations are spread throughout the coding region of AIRE, yet four evident mutational hotspots were observed. In vitro expression of four different naturally occurring nonsense and missense mutations revealed a dramatically altered subcellular location of the protein in cultured cells. Interestingly, the wild-type APECED protein tethered to the Gal4 DNA-binding domain acted as a strong transcriptional activator of reporter genes in mammalian cells, whereas most of the analyzed mutant polypeptides had lost this capacity.	Univ Helsinki, Inst Biomed, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Inst Biomed, Dept Physiol, Helsinki, Finland; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Helsinki Univ Hosp, Hosp Children & Adolescence, Helsinki, Finland		Peltonen, L (corresponding author), Univ Calif Los Angeles, Sch Med, Gonda Ctr, 695 Charles E Young Dr S, Los Angeles, CA 90024 USA.			Palvimo, Jorma/0000-0003-2373-0578			Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Bjorses P, 1996, AM J HUM GENET, V59, P879; Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547; Blechschmidt K, 1999, GENOME RES, V9, P158; BORDEN KLB, 1995, EMBO J, V14, P5947, DOI 10.1002/j.1460-2075.1995.tb00283.x; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Cao TY, 1997, J CELL SCI, V110, P1563; Engelkamp D, 1996, CURR OPIN GENET DEV, V6, P334, DOI 10.1016/S0959-437X(96)80011-6; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heino M, 1999, HUM MUTAT, V13, P69, DOI 10.1002/(SICI)1098-1004(1999)13:1<69::AID-HUMU8>3.0.CO;2-6; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Mittaz L, 1999, BIOCHEM BIOPH RES CO, V255, P483, DOI 10.1006/bbrc.1999.0223; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Myhre AG, 1998, J CLIN ENDOCR METAB, V83, P4204, DOI 10.1210/jc.83.12.4204; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Pearce SHS, 1998, AM J HUM GENET, V63, P1675, DOI 10.1086/302145; Rinderle C, 1999, HUM MOL GENET, V8, P277, DOI 10.1093/hmg/8.2.277; Rosatelli MC, 1998, HUM GENET, V103, P428, DOI 10.1007/s004390050846; Scott HS, 1998, MOL ENDOCRINOL, V12, P1112, DOI 10.1210/me.12.8.1112; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; SILVER PA, 1984, P NATL ACAD SCI-BIOL, V81, P5951, DOI 10.1073/pnas.81.19.5951; STACEY A, 1990, NUCLEIC ACIDS RES, V18, P2829, DOI 10.1093/nar/18.9.2829; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Wang CY, 1998, HUM GENET, V103, P681, DOI 10.1007/s004390050891; Wang CY, 1999, GENOMICS, V55, P322, DOI 10.1006/geno.1998.5656; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Zakeri H, 1998, BIOTECHNIQUES, V25, P406, DOI 10.2144/98253st01; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	38	249	256	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					378	392		10.1086/302765			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	WOS:000088373100004	10677297	Green Published, Bronze			2022-01-24	
J	Eisen, JA; Heidelberg, JF; White, O; Salzberg, SL				Eisen, Jonathan A.; Heidelberg, John F.; White, Owen; Salzberg, Steven L.			Evidence for symmetric chromosomal inversions around the replication origin in bacteria	GENOME BIOLOGY			English	Article								Background: Whole-genome comparisons can provide great insight into many aspects of biology. Until recently, however, comparisons were mainly possible only between distantly related species. Complete genome sequences are now becoming available from multiple sets of closely related strains or species. Results: By comparing the recently completed genome sequences of Vibrio cholerae, Streptococcus pneumoniae and Mycobacterium tuberculosis to those of closely related species - Escherichia coli, Streptococcus pyogenes and Mycobacterium leprae, respectively - we have identified an unusual and previously unobserved feature of bacterial genome structure. Scatterplots of the conserved sequences (both DNA and protein) between each pair of species produce a distinct X-shaped pattern, which we call an X-alignment. The key feature of these alignments is that they have symmetry around the replication origin and terminus; that is, the distance of a particular conserved feature (DNA or protein) from the replication origin (or terminus) is conserved between closely related pairs of species. Statistically significant X-alignments are also found within some genomes, indicating that there is symmetry about the replication origin for paralogous features as well. Conclusions: The most likely mechanism of generation of X-alignments involves large chromosomal inversions that reverse the genomic sequence symmetrically around the origin of replication. The finding of these X-alignments between many pairs of species suggests that chromosomal inversions around the origin are a common feature of bacterial genome evolution.	[Eisen, Jonathan A.; Heidelberg, John F.; White, Owen; Salzberg, Steven L.] Inst Genom Res, Rockville, MD 20850 USA		Eisen, JA (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	jeisen@tigr.org	Eisen, Jonathan A./H-2706-2019; Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011	Eisen, Jonathan A./0000-0002-0159-2197; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Heidelberg, John/0000-0003-0673-3224	NSFNational Science Foundation (NSF) [IIS-9902923, KDI-9980088]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 LM06845]	We thank S. Eddy, M. A. Riley, T. Read, A. Stoltzfus, M-I Benito and I. Paulsen for helpful comments, suggestions and discussions. S. L. S. was supported in part by NSF grant IIS-9902923 and NIH grant R01 LM06845. S. L. S. and J. A. E were supported in part by NSF grant KDI-9980088. Data for all published complete genome sequences were obtained from the NCBI genomes database [26] or from The Institute for Genomic Research ( TIGR) Microbial Genome Database [27]. The sequences of V. cholerae, S. pneumoniae, and M. tuberculosis (CDC 1551) were determined at TIGR with support from NIH and the NIAID. The M. leprae sequence data were produced by the Pathogen Sequencing Group at the Sanger Centre. Sequencing of M. leprae is funded by the Heiser Program for Research in Leprosy and Tuberculosis of The New York Community Trust and by L'Association Raoul Follereau. The M. tuberculosis CDC 1551 genome sequence was obtained from TIGR. The source of the S. pyogenes genome sequence was the Streptococcal Genome Sequencing Project funded by USPHS/NIH grant AI38406, and was kindly made available by B. A. Roe, S. P. Linn, L. Song, X. Yuan, S. Clifton, R. E. McLaughlin, M. McShan and J. Ferretti, and can be obtained from the website of the Oklahoma University Genome Center [7].	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Force A, 1999, GENETICS, V151, P1531; FRANCOIS V, 1990, MOL MICROBIOL, V4, P537, DOI 10.1111/j.1365-2958.1990.tb00621.x; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; GORDON AJE, 1995, GENETICS, V140, P411; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kaneko T, 1996, DNA Res, V3, P109; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lynch M, 2000, GENETICS, V154, P459; MAHAN MJ, 1991, GENETICS, V129, P1021; MAHAN MJ, 1988, GENETICS, V120, P23; MARSH RC, 1977, P NATL ACAD SCI USA, V74, P2720, DOI 10.1073/pnas.74.7.2720; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; Nadeau JH, 1997, GENETICS, V147, P1259; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Pearson W R, 2000, Methods Mol Biol, V132, P185; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; REBOLLO JE, 1988, P NATL ACAD SCI USA, V85, P9391, DOI 10.1073/pnas.85.24.9391; Salazar L, 1996, MOL MICROBIOL, V20, P283, DOI 10.1111/j.1365-2958.1996.tb02617.x; Salzberg SL, 1998, GENE, V217, P57, DOI 10.1016/S0378-1119(98)00374-6; SCHMID MB, 1983, GENETICS, V105, P539; SEGALL A, 1988, SCIENCE, V241, P1314, DOI 10.1126/science.3045970; SEGALL AM, 1989, GENETICS, V122, P737; Seoighe C, 1999, GENE, V238, P253, DOI 10.1016/S0378-1119(99)00319-4; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Valencia-Morales E, 2000, GENETICS, V154, P971; Wagner A, 1998, BIOESSAYS, V20, P785, DOI 10.1002/(SICI)1521-1878(199810)20:10<785::AID-BIES2>3.3.CO;2-D; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; ZIPKAS D, 1975, P NATL ACAD SCI USA, V72, P1354, DOI 10.1073/pnas.72.4.1354	50	249	254	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2000	1	6											9	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	V12EV	WOS:000207583400010					2022-01-24	
J	Geller, DS; Rodriguez-Soriano, J; Boado, AV; Schifter, S; Bayer, M; Chang, SS; Lifton, RP				Geller, DS; Rodriguez-Soriano, J; Boado, AV; Schifter, S; Bayer, M; Chang, SS; Lifton, RP			Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I	NATURE GENETICS			English	Article							EPITHELIAL SODIUM-CHANNEL; RNA SPLICE JUNCTIONS; BETA-SUBUNIT; ALDOSTERONE; SALT; CORTICOSTERONE; HYPERTENSION	Pseudohypoaldosteronism type I (PHA1) is characterized by neonatal renal salt wasting with dehydration, hypotension, hyperkalaemia and metabolic acidosis, despite elevated aldosterone levels. Two forms of PHA1 exist. An autosomal recessive form features severe disease with manifestations persisting into adulthood(1). This form is caused by toss-of-function mutations in genes encoding subunits of the amiloride-sensitive epithelial sodium channel (ENaC; refs 2,3). Autosomal dominant or sporadic PHA1 is a milder disease that remits with age. Among six dominant and seven sporadic PHA1 kindreds, we have found no ENaC gene mutations, implicating mutations in other genes. As ENaC activity in the kidney is regulated by the steroid hormone aldosterone acting through the mineralocorticoid receptor(4), we have screened the mineralocorticoid receptor gene (MLR) for variants and have identified heterozygous mutations in one sporadic and four dominant kindreds. These include two frameshift mutations tone a de novo mutation), two premature termination codons and one splice donor mutation. These mutations segregate with PHA1 and are not found in unaffected subjects. These findings demonstrate that heterozygous MLR mutations cause PHA1, underscore the important role of mineralocorticoid receptor function in regulation of salt and blood pressure homeostasis in humans and motivate further study of this gene for a potential role in blood pressure variation.	Yale Univ, Sch Med, Dept Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet, New Haven, CT 06510 USA; Hosp Cruces, Dept Pediat, E-48903 Barakaldo, Spain; Glostrup Cty Hosp, Dept Clin Physiol & Nucl Med, DK-2600 Glostrup, Denmark; Charles Univ, Fac Med 1, Dept Pediat, Prague, Czech Republic		Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.						ARAI K, 1995, J CLIN ENDOCR METAB, V80, P814, DOI 10.1210/jc.80.3.814; BAYER M, 1993, ACTA PAEDIATR, V82, P504, DOI 10.1111/j.1651-2227.1993.tb12736.x; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Berger S, 1996, ENDOCR RES, V22, P641, DOI 10.1080/07435809609043758; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; EPPLE HJ, 1995, AM J PHYSIOL-GASTR L, V269, pG42, DOI 10.1152/ajpgi.1995.269.1.G42; GomezSanchez EP, 1996, STEROIDS, V61, P184, DOI 10.1016/0039-128X(96)00010-4; Grunder S, 1997, CURR OPIN NEPHROL HY, V6, P35; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; KOMESAROFF PA, 1994, J CLIN ENDOCR METAB, V79, P27, DOI 10.1210/jc.79.1.27; KOO WWK, 1982, ARCH DIS CHILD, V57, P500, DOI 10.1136/adc.57.7.500; KRAWCZAK M, 1992, HUM GENET, V90, P41; Kuhnle U, 1997, MOL CELL ENDOCRINOL, V133, P77, DOI 10.1016/S0303-7207(97)00149-4; LimTio SS, 1997, ENDOCRINOLOGY, V138, P2537, DOI 10.1210/en.138.6.2537; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; PETERSEN S, 1978, ACTA PAEDIATR SCAND, V67, P255, DOI 10.1111/j.1651-2227.1978.tb16314.x; RODRIGUEZSORIANO J, 1990, PEDIATR NEPHROL, V4, P105, DOI 10.1007/BF00858819; ROSLER A, 1984, J CLIN ENDOCR METAB, V59, P689; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SIPPELL WG, 1980, PEDIATR RES, V14, P39, DOI 10.1203/00006450-198014010-00010; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; ZENNARO MC, 1995, J BIOL CHEM, V270, P21016, DOI 10.1074/jbc.270.36.21016; ZENNARO MC, 1994, J CLIN ENDOCR METAB, V79, P32, DOI 10.1210/jc.79.1.32	24	249	254	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					279	281		10.1038/966			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	WOS:000074565900027	9662404				2022-01-24	
J	PULKKINEN, L; CHRISTIANO, AM; AIRENNE, T; HAAKANA, H; TRYGGVASON, K; UITTO, J				PULKKINEN, L; CHRISTIANO, AM; AIRENNE, T; HAAKANA, H; TRYGGVASON, K; UITTO, J			MUTATIONS IN THE GAMMA-2 CHAIN GENE (LAMC2) OF KALININ/LAMININ-5 IN THE JUNCTIONAL FORMS OF EPIDERMOLYSIS-BULLOSA	NATURE GENETICS			English	Article							BASEMENT-MEMBRANES; MOLECULAR-GENETICS; SKIN DISEASES; VII COLLAGEN; EXPRESSION; LAMININ; LINKAGE; COL7A1; FAMILIES; NIDOGEN	Junctional epidermolysis bullosa (JEB) is an autosomal recessive disorder characterized by blister formation within the dermal-epidermal basement membrane. Genes for the lamina lucida protein, kalinin/laminin 5, have been proposed as candidates for some forms of JEB, based on immunofluorescence analysis recognizing kalinin epitopes. We studied the cDNA of laminin gamma 2 chain for mutations in JEB using heteroduplex analysis. One patient showed a homozygous splice site mutation while another was heterozygous for a deletion-insertion, resulting in a premature termination codon in one allele. Our data implicate mutations in the laminin gamma 2 chain gene (LAMC2) in some forms of JEB.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT DERMATOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT MOLEC BIOL,PHILADELPHIA,PA 19107; UNIV OULU,BIOCTR,SF-90570 OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND								AESCHLIMANN D, 1992, J BIOL CHEM, V267, P11316; ALIMARA L, 1992, J MED GENET, V29, P381, DOI 10.1136/jmg.29.6.381; BONIFAS JM, 1991, SCIENCE, V254, P1201; BURGESON RE, IN PRESS MATRIX BIOL; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHEN YQ, 1994, J INVEST DERMATOL, V102, P205, DOI 10.1111/1523-1747.ep12371763; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1993, ARCH DERMATOL, V129, P1455, DOI 10.1001/archderm.129.11.1455; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DONG W, 1993, HUM MUTAT, V2, P94, DOI 10.1002/humu.1380020206; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cb.07.110191.003015; GRUIS NA, 1992, J INVEST DERMATOL, V99, P528, DOI 10.1111/1523-1747.ep12658066; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; HUMPHRIES MM, 1993, HUM MUTAT, V2, P37, DOI 10.1002/humu.1380020107; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LIN AN, 1992, EPIDERMOLYSIS BULLOS; MARINKOVICH MP, 1993, LAB INVEST, V69, P295; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; MARINKOVICH MP, 1993, ARCH DERMATOL, V129, P1557, DOI 10.1001/archderm.129.12.1557; MARLNKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MAYER LI, 1993, EMBO J, V12, P1879; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; Meneguzzi G, 1992, Exp Dermatol, V1, P221, DOI 10.1111/j.1600-0625.1992.tb00080.x; OLSEN D, 1989, LAB INVEST, V60, P772; OLSEN DR, 1989, J INVEST DERMATOL, V93, P127, DOI 10.1111/1523-1747.ep12277381; OLSEN DR, 1989, AM J HUM GENET, V44, P876; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; RYYNANEN M, 1991, AM J HUM GENET, V49, P797; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TIMPL R, 1986, INT REV EXP PATHOL, V29, P1; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VERLINSKY Y, 1993, PREIMPLANTATION DIAG; VERRANDO P, 1988, BIOCHIM BIOPHYS ACTA, V942, P45, DOI 10.1016/0005-2736(88)90273-8; VERRANDO P, 1991, LAB INVEST, V64, P85; VERRANDO P, IN PRESS EUR J BIOCH	43	249	252	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					293	298		10.1038/ng0394-293			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	WOS:A1994MZ56200018	8012393				2022-01-24	
J	CHAN, CSM; BOTSTEIN, D				CHAN, CSM; BOTSTEIN, D			ISOLATION AND CHARACTERIZATION OF CHROMOSOME-GAIN AND INCREASE-IN-PLOIDY MUTANTS IN YEAST	GENETICS			English	Article							SPINDLE POLE BODY; DNA TOPOISOMERASE-II; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; GENETIC-CONTROL; S-CEREVISIAE; MITOTIC STABILITY; PROTEIN-KINASE; MITOSIS; TRANSFORMATION	We have developed a colony papillation assay for monitoring the copy number of genetically marked chromosomes II and III in Saccharomyces cerevisiae. The unique feature of this assay is that it allows detection of a gain of the marked chromosomes even if there is a gain of the entire set of chromosomes (increase-in-ploidy). This assay was used to screen for chromosome-gain or increase-in-ploidy mutants. Five complementation groups have been defined for recessive mutations that confer an increase-in-ploidy (ipl) phenotype, which, in each case, cosegregates with a temperature-sensitive growth phenotype. Four new alleles of CDC31, which is required for spindle pole body duplication, were also recovered from this screen. Temperature-shift experiments with ipl1 cells show that they suffer severe nondisjunction at 37-degrees. Similar experiments with ipl2 cells show that they gain entire sets of chromosomes and become arrested as unbudded cells at 37-degrees. Molecular cloning and genetic mapping show that IPL1 is a newly identified gene, whereas IPL2 is allelic to BEM2, which is required for normal bud growth.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139						NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM46406, GM45185] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM046406, R01GM045185, R37GM046406] Funding Source: NIH RePORTER		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; ANDREADIS A, 1984, J BIOL CHEM, V259, P8059; BARNES DA, 1986, MOL CELL BIOL, V6, P2828, DOI 10.1128/MCB.6.8.2828; BAUM P, 1988, MOL CELL BIOL, V8, P5386, DOI 10.1128/MCB.8.12.5386; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; BRUENN J, 1970, J BACTERIOL, V102, P548, DOI 10.1128/JB.102.2.548-551.1970; BURKE D, 1989, MOL CELL BIOL, V9, P1049, DOI 10.1128/MCB.9.3.1049; BYERS B, 1981, A BENZON S, V16; CAMPBELL D, 1981, GENETICS, V98, P239; CAMPBELL DA, 1975, GENETICS, V79, P383; CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHENEVERT J, 1992, NATURE, V356, P77, DOI 10.1038/356077a0; ESPOSITO MS, 1982, CURR GENET, V6, P5, DOI 10.1007/BF00397633; Esposito R. E., 1981, MOL BIOL YEAST SACCH, P211; HAARER BK, 1990, J CELL BIOL, V110, P105, DOI 10.1083/jcb.110.1.105; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1973, GENETICS, V74, P267; HARTWELL LH, 1985, GENETICS, V110, P381; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997; HUTTER KJ, 1978, A VAN LEEUW J MICROB, V44, P269, DOI 10.1007/BF00394305; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; KOUPRINA NY, 1988, YEAST, V4, P257, DOI 10.1002/yea.320040404; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LIRAS P, 1978, GENETICS, V88, P651; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; MORTIMER RK, 1989, YEAST, V5, P321, DOI 10.1002/yea.320050503; MORTIMER RK, 1981, MOL BIOL YEAST SACCH, P11; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; PARRY JM, 1976, MUTAT RES, V36, P49, DOI 10.1016/0027-5107(76)90020-8; ROCKMILL B, 1988, GENETICS, V119, P261; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROSE MD, 1987, CELL, V48, P1047, DOI 10.1016/0092-8674(87)90712-4; ROSE MD, 1986, MOL CELL BIOL, V6, P3490, DOI 10.1128/MCB.6.10.3490; SCHATZ PJ, 1988, GENETICS, V120, P681; SCHATZ PJ, 1986, MOL CELL BIOL, V6, P3722, DOI 10.1128/MCB.6.11.3722; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; SCHIESTL RH, 1988, GENETICS, V119, P237; SCHILD D, 1981, GENETICS, V97, P551; SHAFFER B, 1971, GENETICS, V67, P483; SHERMAN F, 1974, METHODS YEAST GENETI; SHERO JH, 1991, GENE DEV, V5, P549, DOI 10.1101/gad.5.4.549; SHORTLE D, 1982, SCIENCE, V217, P371, DOI 10.1126/science.7046050; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; SNYDER M, 1988, CELL, V54, P743, DOI 10.1016/S0092-8674(88)90977-4; SNYDER M, 1991, J CELL BIOL, V114, P515, DOI 10.1083/jcb.114.3.515; SPENCER F, 1990, GENETICS, V124, P237; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; SUROSKY RT, 1985, P NATL ACAD SCI USA, V82, P2106, DOI 10.1073/pnas.82.7.2106; THOMAS JH, 1986, CELL, V44, P65, DOI 10.1016/0092-8674(86)90485-X; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; VALLEN EA, 1992, CELL, V69, P505, DOI 10.1016/0092-8674(92)90451-H; WHITTAKER SG, 1988, MOL GEN GENET, V215, P10, DOI 10.1007/BF00331296; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; WINEY M, 1993, J CELL BIOL, V122, P743, DOI 10.1083/jcb.122.4.743; WINSTON F, 1984, GENETICS, V107, P179; WOOD JS, 1982, MOL CELL BIOL, V2, P1064, DOI 10.1128/MCB.2.9.1064	69	249	254	0	3	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	NOV	1993	135	3					677	691					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MD636	WOS:A1993MD63600007	8293973				2022-01-24	
J	SCHAID, DJ; SOMMER, SS				SCHAID, DJ; SOMMER, SS			GENOTYPE RELATIVE RISKS - METHODS FOR DESIGN AND ANALYSIS OF CANDIDATE-GENE ASSOCIATION STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE; LINKAGE	Design and analysis methods are presented for studying the association of a candidate gene with a disease by using parental data in place of nonrelated controls. This alternative design eliminates spurious differences in allele frequencies between cases and nonrelated controls resulting from different ethnic origins and population stratification for these two groups. We present analysis methods which are based on two genetic relative risks: (1) the relative risk of disease for homozygotes with two copies of the candidate gene versus homozygotes without the candidate gene and (2) the relative risk for heterozygotes with one copy of the candidate gene versus homozygotes without the candidate gene. In addition to estimating the magnitude of these relative risks, likelihood methods allow specific hypotheses to be tested, namely, a test for overall association of the candidate gene with disease, as well as specific genetic hypotheses, such as dominant or recessive inheritance. Two likelihood methods are presented: (1) a likelihood method appropriate when Hardy-Weinberg equilibrium holds and (2) a likelihood method in which we condition on parental genotype data when Hardy-Weinberg equilibrium does not hold. The results for the relative efficiency of these two methods suggest that the conditional approach may at times be preferable, even when equilibrium holds. Sample-size and power calculations are presented for a multitiered design. The purpose of tier 1 is to detect the presence of an abnormal sequence for a postulated candidate gene among a small group of cases. The purpose of tier 2 is to test for association of the abnormal variant with disease, such as by the likelihood methods presented. The purpose of tier 3 is to confirm positive results from tier 2. Results indicate that required sample sizes are smaller when expression of disease is recessive, rather than dominant, and that, for recessive disease and large relative risks, necessary sample sizes may be feasible, even if only a small percentage of the disease can be attributed to the candidate gene.	MAYO CLIN & MAYO FDN,DEPT HLTH SCI RES,BIOSTAT SECT,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905						NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH044276] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL07567] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH44276] Funding Source: Medline		AMOS CI, 1990, AM J HUM GENET, V47, P842; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; LATHROP GM, 1983, TISSUE ANTIGENS, V22, P160, DOI 10.1111/j.1399-0039.1983.tb01183.x; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LI CC, 1978, 1ST COURSE POPULATIO; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Ott J, 1991, ANAL HUMAN GENETIC L; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; SOBELL JL, 1992, GENOMICS, V12, P1, DOI 10.1016/0888-7543(92)90398-C; SOBELL JL, 1993, AM J MED GENET, V48, P28, DOI 10.1002/ajmg.1320480108; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STUART A, 1991, KENDALLS ADV THEORY, V0002; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; [No title captured]	19	249	256	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1114	1126					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	WOS:A1993MC33300016	8213835				2022-01-24	
J	TODA, T; SEGAWA, M; NOMURA, Y; NONAKA, I; MASUDA, K; ISHIHARA, T; SUZUKI, M; TOMITA, I; ORIGUCHI, Y; OHNO, K; MISUGI, N; SASAKI, Y; TAKADA, K; KAWAI, M; OTANI, K; MURAKAMI, T; SAITO, K; FUKUYAMA, Y; SHIMIZU, T; KANAZAWA, I; NAKAMURA, Y				TODA, T; SEGAWA, M; NOMURA, Y; NONAKA, I; MASUDA, K; ISHIHARA, T; SUZUKI, M; TOMITA, I; ORIGUCHI, Y; OHNO, K; MISUGI, N; SASAKI, Y; TAKADA, K; KAWAI, M; OTANI, K; MURAKAMI, T; SAITO, K; FUKUYAMA, Y; SHIMIZU, T; KANAZAWA, I; NAKAMURA, Y			LOCALIZATION OF A GENE FOR FUKUYAMA TYPE CONGENITAL MUSCULAR-DYSTROPHY TO CHROMOSOME 9Q31-33	NATURE GENETICS			English	Article							NERVOUS-SYSTEM INVOLVEMENT; LINKAGE MAP; DNA; ABNORMALITIES; POLYMORPHISM	Fukuyama type congenital muscular dystrophy (FCMD) is an autosomal recessive severe muscular dystrophy associated with an anomaly of the brain. Twenty-one FCMD families, 13 of them with consanguineous marriages, were analysed by genetic linkage analyses with polymorphic microsatellite markers to map the FCMD gene. Significant lod scores were obtained with the markers D9S58 (Z(max)=5.81 at theta=0.06), D9S59 (Z(max)=4.33 at theta=0.02), and HXB (Z(max)=3.28 at theta=0.09) on chromosome 9q31-33. Multipoint analysis placed FCMD between D9S58 and D9S59, with a maximum lod score of 16.93. These markers will be useful for presymptomatic, prenatal and carrier diagnosis of family members carrying FCMD, and they represent important resources for the identification of a gene responsible for FCMD.	UNIV TOKYO, DEPT NEUROL, TOKYO 113, JAPAN; NATL HARA HOSP, DEPT NEUROL & PSYCHIAT, HIROSHIMA, JAPAN; NATL SUZUKA HOSP, DEPT NEUROL, MIE, JAPAN; NATL KAWATANA HOSP, DEPT NEUROL, NAGASAKI, JAPAN; NATL NISHIBEPPU HOSP, DEPT PAEDIAT, OHITO, JAPAN; TOTTORI UNIV, SCH MED, DEPT CHILD NEUROL, TOTTORI 680, JAPAN; KANAGAWA CHILDRENS MED CTR, DEPT PATHOL, KANAGAWA, JAPAN; OSAKA MED CTR, DEPT PAEDIAT NEUROL, OSAKA, JAPAN; RES INST MATERNAL & CHILD HLTH, OSAKA, JAPAN; TOKYO WOMENS MED COLL, DEPT PAEDIAT, TOKYO 162, JAPAN; TEIKYO UNIV, DEPT NEUROL, TOKYO 173, JAPAN; SEGAWA NEUROL CLIN CHILDREN, TOKYO, JAPAN; NATL INST NEUROSCI, NATL CTR NEUROL & PSYCHIAT, TOKYO, JAPAN; NATL HIGASHISAITAMA HOSP, DEPT INTERNAL MED, SAITAMA, JAPAN; KANAGAWA CHILDRENS MED CTR, DEPT ORTHOPAED SURG, KANAGAWA, JAPAN; TOKYO METROPOLITAN INST NEUROSCI, DEPT CLIN NEUROPATHOL, TOKYO, JAPAN; NATL SHIMOSHIZU HOSP, DEPT NEUROL, CHIBA, JAPAN; TOKYO UNIV BRANCH HOSP, DEPT PATHOL, TOKYO, JAPAN		TODA, T (corresponding author), JAPANESE FDN CANC RES, INST CANC, DEPT BIOCHEM, TOKYO 170, JAPAN.			Toda, Tatsushi/0000-0002-0717-1123			ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARIKAWA E, 1991, J NEUROL SCI, V105, P79, DOI 10.1016/0022-510X(91)90122-N; BEGGS AH, 1992, P NATL ACAD SCI USA, V89, P623, DOI 10.1073/pnas.89.2.623; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FARRALL M, 1993, NAT GENET, V5, P107, DOI 10.1038/ng1093-107; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Fukuyama Y., 1960, PEDIAT U TOKYO, V4, P5; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; GOTO M, 1992, NATURE, V355, P735, DOI 10.1038/355735a0; GUYER M, 1992, SCIENCE, V258, P67; Ibraghimov-Beskrovnaya O., 1992, American Journal of Human Genetics, V51, pA130; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MATSUMURA K, 1993, LANCET, V341, P521, DOI 10.1016/0140-6736(93)90279-P; NONAKA I, 1982, MUSCLE NERVE, V5, P102, DOI 10.1002/mus.880050204; OSAWA M, 1978, J TOKYO WOMENS MED C, V48, P112; Ozelius L., 1992, Human Molecular Genetics, V1, P141, DOI 10.1093/hmg/1.2.141-a; OZELIUS LJ, 1992, GENOMICS, V14, P715, DOI 10.1016/S0888-7543(05)80173-9; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; Sambrook J, 1989, MOL CLONING; SANTAVUORI P, 1980, POPULATION STRUCTURE, P647; TAKADA K, 1984, J NEUROPATH EXP NEUR, V43, P395, DOI 10.1097/00005072-198407000-00005; TAKESHITA K, 1977, JPN J HUM GENET, V22, P43, DOI 10.1007/BF01908284; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	32	249	253	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1993	5	3					283	286		10.1038/ng1193-283			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	WOS:A1993MF12200021	8275093				2022-01-24	
J	SCHALLING, M; HUDSON, TJ; BUETOW, KH; HOUSMAN, DE				SCHALLING, M; HUDSON, TJ; BUETOW, KH; HOUSMAN, DE			DIRECT-DETECTION OF NOVEL EXPANDED TRINUCLEOTIDE REPEATS IN THE HUMAN GENOME	NATURE GENETICS			English	Article								Expansion of trinucleotide repeats can give rise to genetic disease. We have developed a technique, repeat expansion detection (RED), that can identify potentially pathological repeat expansion without prior knowledge of chromosomal location. Human genomic DNA is used as a template for a two-step cycling process that generates oligonucleotide multimers when expanded trinucleotide sequences are present at the level found in myotonic dystrophy and fragile-X patients. We have identified at least one new locus exhibiting trinucleotide expansion. Analysis of three families transmitting a long CTG repeat shows that the allele in these families corresponds to a locus on chromosome 18. RED constitutes a powerful tool to identify other diseases caused by this mechanism, particularly diseases associated with anticipation.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; FOX CHASE CANC CTR,PHILADELPHIA,PA 19111				Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P50HG000098, R01HG000299] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P50HG 00098, HG 00299] Funding Source: Medline		ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GUSTAVSON KH, 1986, AM J MED GENET, V23, P581, DOI 10.1002/ajmg.1320230152; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper PS, 1989, MYOTONIC DYSTROPHY, V2nd; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SCHALLING M, 1992, GENE EXPRESSION NEUR, P231; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; 1993, CELL, V72, P1	20	249	252	1	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					135	139		10.1038/ng0693-135			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	WOS:A1993LF81600011	8348150				2022-01-24	
J	CLINE, TW				CLINE, TW			AUTOREGULATORY FUNCTIONING OF A DROSOPHILA GENE-PRODUCT THAT ESTABLISHES AND MAINTAINS THE SEXUALLY DETERMINED STATE	GENETICS			English	Article											CLINE, TW (corresponding author), PRINCETON UNIV, DEPT BIOL, PRINCETON, NJ 08544 USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-23468] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM023468] Funding Source: NIH RePORTER		ACTON AB, 1966, J CELL BIOL, V29, P366, DOI 10.1083/jcb.29.2.366; BAIRATI A, 1966, J MICROSC-PARIS, V5, P265; BAKER BS, 1983, ANNU REV GENET, V17, P345, DOI 10.1146/annurev.ge.17.120183.002021; BELOTE JM, 1982, P NATL ACAD SCI-BIOL, V79, P1568, DOI 10.1073/pnas.79.5.1568; BELOTE JM, 1983, DEV BIOL, V95, P512, DOI 10.1016/0012-1606(83)90054-4; BELOTE JM, 1980, NATURE, V285, P573, DOI 10.1038/285573a0; BELOTE JM, 1980, GENETICS, V96, P165; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; BOWNES M, 1977, ROUX ARCH DEV BIOL, V181, P279, DOI 10.1007/BF00848427; Bridges CB, 1925, AM NAT, V59, P127, DOI 10.1086/280023; BRYANT PJ, 1969, DEV BIOL, V20, P263, DOI 10.1016/0012-1606(69)90015-3; CAPDEVILA MP, 1981, ROUX ARCH DEV BIOL, V190, P339, DOI 10.1007/BF00863271; CAPDEVILA MP, 1978, ROUX ARCH DEV BIOL, V185, P105, DOI 10.1007/BF00848672; CLINE T W, 1983, Genetics, V104, pS16; CLINE T W, 1981, Genetics, V97, pS23; CLINE T W, 1982, Genetics, V100, pS13; CLINE TW, 1979, GENETICS, V91, pS22; CLINE TW, 1978, GENETICS, V90, P683; CLINE TW, 1976, GENETICS, V84, P723; CLINE TW, 1980, GENETICS, V96, P903; CLINE TW, 1983, DEV BIOL, V95, P260, DOI 10.1016/0012-1606(83)90027-1; CLINE TW, 1979, DEV BIOL, V72, P266, DOI 10.1016/0012-1606(79)90117-9; CRICK FHC, 1975, SCIENCE, V189, P340, DOI 10.1126/science.806966; DIDOMENICO BJ, 1982, CELL, V31, P593, DOI 10.1016/0092-8674(82)90315-4; Dobzhansky T, 1934, J GENET, V28, P349, DOI 10.1007/BF02981760; Duncan I., 1982, DEV ORDER ITS ORIGIN, P533; FIELDING CJ, 1967, J EMBRYOL EXP MORPH, V17, P375; FUNG STC, 1957, J EXP ZOOL, V135, P5, DOI 10.1002/jez.1401350103; Garcia-Bellido A., 1978, CLONAL BASIS DEV, P3; GEHRING WJ, 1976, J EMBRYOL EXP MORPH, V35, P607; Geigy R., 1931, Revue Suisse de Zoologie, V38, P187; GILLESPIE NW, 1983, THESIS PRINCETON U P; GOLDBERGER RF, 1974, SCIENCE, V183, P810, DOI 10.1126/science.183.4127.810; HALL JC, 1976, GENETICS BIOLOGY D A, V1, P265; HANNAHALAVA A, 1957, J EXP ZOOL, V134, P533, DOI 10.1002/jez.1401340307; HANSEN U, 1981, CELL, V27, P603, DOI 10.1016/0092-8674(81)90402-5; HAYNIE JL, 1977, ROUX ARCH DEV BIOL, V183, P85, DOI 10.1007/BF00848779; HESS O, 1968, ADV GENET, V14, P171, DOI 10.1016/S0065-2660(08)60427-7; HILDRETH PE, 1965, GENETICS, V51, P659; LAWRENCE PA, 1981, CELL, V26, P3, DOI 10.1016/0092-8674(81)90027-1; LINDSLEY DL, 1972, GENETICS, V71, P157; LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V627; LUCCHESI JC, 1983, DEV GENET, V3, P275; LUCCHESI JC, 1981, CHROMOSOMA, V82, P217, DOI 10.1007/BF00286106; MAHOWALD AP, 1979, DEV BIOL, V69, P118, DOI 10.1016/0012-1606(79)90279-3; MARSH JL, 1978, NATURE, V272, P249, DOI 10.1038/272249a0; MARSHALL T, 1978, GENET RES, V32, P103, DOI 10.1017/S0016672300018590; MORATA G, 1982, AM ZOOL, V22, P57; NEWMAN SM, 1980, DEV BIOL, V68, P533; NICLAS JA, 1983, GENETICS, V103, P617; NIKI Y, 1981, ROUX ARCH DEV BIOL, V190, P1, DOI 10.1007/BF00868697; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OTA T, 1981, GENETICS, V99, P429; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; RIPOLL P, 1980, GENETICS, V94, P135; ROBBINS LG, 1983, GENETICS, V103, P633; ROSELAND CR, 1979, ROUX ARCH DEV BIOL, V186, P235, DOI 10.1007/BF00848591; SANCHEZ L, 1982, ROUX ARCH DEV BIOL, V191, P211, DOI 10.1007/BF00848339; SANCHEZ L, 1983, EMBO J, V2, P485, DOI 10.1002/j.1460-2075.1983.tb01451.x; SANDLER L, 1972, GENETICS, V70, P261; SCHUPBACH T, 1982, DEV BIOL, V89, P117, DOI 10.1016/0012-1606(82)90300-1; SKRIPSKY T, 1982, DEV BIOL, V94, P153, DOI 10.1016/0012-1606(82)90078-1; STEINER E, 1976, ROUX ARCH DEV BIOL, V180, P9, DOI 10.1007/BF00848882; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; STRUHL G, 1982, CELL, V31, P285, DOI 10.1016/0092-8674(82)90428-7; TANAKA A, 1976, GENETICS, V84, P257; TANDLER B, 1968, J CELL BIOL, V38, P329, DOI 10.1083/jcb.38.2.329; TOKUNAGA C, 1962, DEV BIOL, V4, P489, DOI 10.1016/0012-1606(62)90054-4; UCHIDA S, 1981, JPN J GENET, V56, P523, DOI 10.1266/jjg.56.523; UENOYAMA T, 1982, GENETICS, V102, P233; VANDEUSEN EB, 1977, J EMBRYOL EXP MORPH, V37, P173; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X; WIESCHAUS E, 1978, GENETIC MOSAICS CELL, V9, P97; ZALOKAR M, 1980, CELL, V19, P133, DOI 10.1016/0092-8674(80)90394-3	74	249	251	1	13	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1984	107	2					231	277					47	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ST060	WOS:A1984ST06000004	6735170				2022-01-24	
J	LEWIS, JA; WU, CH; BERG, H; LEVINE, JH				LEWIS, JA; WU, CH; BERG, H; LEVINE, JH			THE GENETICS OF LEVAMISOLE RESISTANCE IN THE NEMATODE CAENORHABDITIS-ELEGANS	GENETICS			English	Article									COLUMBIA UNIV, DEPT BIOL SCI, NEW YORK, NY 10027 USA						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12399] Funding Source: Medline		BRENNER S, 1974, GENETICS, V77, P71; BULLOCK MW, 1968, J MED CHEM, V11, P169; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; DUSENBERY DB, 1975, GENETICS, V80, P297; EPSTEIN HF, 1974, J MOL BIOL, V90, P291, DOI 10.1016/0022-2836(74)90374-X; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; HODGKIN JA, 1974, THESIS U CAMBRIDGE E; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; MOERMAN DG, 1979, GENETICS, V91, P95; RAEYMAEKERS AH, 1967, TETRAHEDRON LETT, P1467; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WATERSTON RH, 1978, NATURE, V275, P715, DOI 10.1038/275715a0; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	16	249	273	1	19	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1980	95	4					905	928					24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KX159	WOS:A1980KX15900008	7203008				2022-01-24	
J	SINGH, RS; LEWONTIN, RC; FELTON, AA				SINGH, RS; LEWONTIN, RC; FELTON, AA			GENETIC-HETEROGENEITY WITHIN ELECTROPHORETIC ALLELES OF XANTHINE DEHYDROGENASE IN DROSOPHILA-PSEUDOOBSCURA	GENETICS			English	Article									HARVARD UNIV,MUSEUM COMP ZOOL,CAMBRIDGE,MA 02138								AYALA FJ, 1972, P NATL ACAD SCI USA, V69, P1094, DOI 10.1073/pnas.69.5.1094; BERNSTEIN SC, 1973, P NATL ACAD SCI USA, V70, P3928, DOI 10.1073/pnas.70.12.3928; CANDIDO EPM, 1974, GENETICS, V77, pS9; COBBS G, 1976, GENETICS, V82, P53; COYNE JA, 1976, GENETICS, V84, P593; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; GELBART W, 1976, GENETICS, V84; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HUBBY JL, 1967, GENETICS, V57, P291; HUBBY JL, 1966, GENETICS, V54, P577; JOHNSON GA, TO BE PUBLISHED; JOHNSON GB, 1973, THEOR POPUL BIOL, V4, P209, DOI 10.1016/0040-5809(73)90030-0; KIMURA M, 1964, GENETICS, V49, P725; Kimura M., 1971, THEORETICAL ASPECTS; KING JL, 1975, GENETICS, V79, P681; LEWONTIN RC, 1956, BIOMETRICS, V12, P211, DOI 10.2307/3001762; LEWONTIN RC, 1966, GENETICS, V54, P595; LEWONTIN RC, 1973, GENETICS, V74, P175; LEWONTIN Richard C, 1974, GENETIC BASIS EVOLUT; MARUYAMA T, 1972, GENET RES, V20, P141, DOI 10.1017/S0016672300013665; NARISE S, 1966, BIOCHIM BIOPHYS ACTA, V122, P281, DOI 10.1016/0926-6593(66)90068-3; OHTA T, 1971, GENETICS, V69, P247; PRAKASH S, 1972, GENETICS, V72, P143; PRAKASH S, 1969, GENETICS, V61, P841; PRAKASH S, 1969, P NATL ACAD SCI USA, V62, P778, DOI 10.1073/pnas.62.3.778; PRAKASH S, IN PRESS; SINGH RS, 1975, GENETICS, V80, P637; SINGH RS, 1974, P NATL ACAD SCI USA, V71, P1808, DOI 10.1073/pnas.71.5.1808; YAMAZAKI T, 1972, SCIENCE, V178, P56, DOI 10.1126/science.178.4056.56; [No title captured]	30	249	251	0	0	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1976	84	3					609	629					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CP771	WOS:A1976CP77100013	1001881				2022-01-24	
J	Muller, HJ				Muller, HJ			Genetic variability, twin hybrids and constant hybrids, in a case of balanced lethal factors	GENETICS			English	Article									Rice Inst, Houston, TX USA								Belling J., 1914, Z INDUKT ABSTAMM VER, V12, P303; Bridges CB, 1916, GENETICS, V1, P1; Bridges CB, 1916, GENETICS, V1, P107; CASTLE WE, 1914, AM NAT, V49, P37; CASTLE WE, 1914, CARNEGIE I WASH PUBL, V195; CASTLE WE, 1914, J HERED, V5, P93; Davis BM, 1917, GENETICS, V2, P155; Davis BM, 1916, GENETICS, V1, P197; de Vries H., 1916, Z INDUKT ABSTAMM VER, V16, P239, DOI [10.1007/BF01812791, DOI 10.1007/BF01812791]; De Vries H, 1911, BIOL CENTRALBL, V31, P97; DeVries H, 1918, BOT GAZ, V65, P377, DOI 10.1086/332258; DeVries H, 1917, BOT GAZ, V63, P1, DOI 10.1086/331964; Dexter JS, 1914, AM NAT, V48, P712, DOI 10.1086/279446; Duncan FN, 1915, AM NAT, V49, P575, DOI 10.1086/279502; Emerson RA, 1914, AM NAT, V48, P87, DOI 10.1086/279393; EMERSON RA, 1911, ANN REP NEBR AGR EXP, V25, P59; Federley Harry., 1913, Zeitschrift fuer Induktive Abstammungs und Vererbungslehre Berlin, V9, DOI 10.1007/BF01876667; Frost HB, 1915, AM NAT, V49, P623, DOI 10.1086/279507; GOLDSCHMIDT R, 1913, Z INDUKT ABSTAMM VER, V10, P74; JENNINGS HS, 1917, J WASHINGTON ACAD SC, V7, P281; Morgan TH, 1915, MECH MENDELIAN HERED; Muller HJ, 1917, P NATL ACAD SCI USA, V3, P619, DOI 10.1073/pnas.3.10.619; Muller HJ, 1914, AM NAT, V48, P567, DOI 10.1086/279431; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Pellew C, 1917, J GENET, V6, P317, DOI 10.1007/BF02981874; Saunders ER, 1915, J GENET, V5, P137, DOI 10.1007/BF02985371; Saunders ER, 1911, J GENET, V1, P303, DOI 10.1007/BF02981555; SAUNDERS ER, 1913, Z INDUKT ABSTAMM VER, V10, P297; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Sturtevant AH, 1917, P NATL ACAD SCI USA, V3, P555, DOI 10.1073/pnas.3.9.555	30	249	251	1	8	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	SEP	1918	3	5					422	499					78	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V23LA	WOS:000201583400002	17245914				2022-01-24	
J	Lamke, J; Baurle, I				Laemke, Jorn; Baeurle, Isabel			Epigenetic and chromatin-based mechanisms in environmental stress adaptation and stress memory in plants	GENOME BIOLOGY			English	Article							REMODELING ATPASE BRAHMA; TRANSCRIPTIONAL MEMORY; DNA METHYLATION; TRANSGENERATIONAL INHERITANCE; ACQUIRED THERMOTOLERANCE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; RESPONSES; PROTEIN; DEFENSE	Plants frequently have to weather both biotic and abiotic stressors, and have evolved sophisticated adaptation and defense mechanisms. In recent years, chromatin modifications, nucleosome positioning, and DNA methylation have been recognized as important components in these adaptations. Given their potential epigenetic nature, such modifications may provide a mechanistic basis for a stress memory, enabling plants to respond more efficiently to recurring stress or even to prepare their offspring for potential future assaults. In this review, we discuss both the involvement of chromatin in stress responses and the current evidence on somatic, intergenerational, and transgenerational stress memory.	[Laemke, Jorn; Baeurle, Isabel] Univ Potsdam, Inst Biochem & Biol, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany		Baurle, I (corresponding author), Univ Potsdam, Inst Biochem & Biol, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany.	isabel.baeurle@uni-potsdam.de	Baurle, Isabel/ABD-6356-2021	Baurle, Isabel/0000-0001-5633-8068	Alexander-von-Humboldt-StiftungAlexander von Humboldt Foundation; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [CRC973]; European Research Council (ERC Consolidator Grant)European Research Council (ERC) [725295]; EMBO Young Investigator ProgrammeEuropean Molecular Biology Organization (EMBO)	We would like to thank members of our lab for helpful comments and suggestions. Work in the Baurle lab is supported by funding from the Alexander-von-Humboldt-Stiftung, the Deutsche Forschungsgemeinschaft (CRC973, Project A2), the European Research Council (ERC Consolidator Grant 725295), and the EMBO Young Investigator Programme.	Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114; Asensi-Fabado MA, 2017, BBA-GENE REGUL MECH, V1860, P106, DOI 10.1016/j.bbagrm.2016.07.015; Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Baurle Isabel, 2016, F1000Res, V5, DOI 10.12688/f1000research.7526.1; Bergonzi S, 2013, SCIENCE, V340, P1094, DOI 10.1126/science.1234116; Berry S, 2015, PLANT J, V83, P133, DOI 10.1111/tpj.12869; Bouche F, 2017, PLANT PHYSIOL, V173, P27, DOI 10.1104/pp.16.01322; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Brzezinka K, 2016, ELIFE, V5, DOI 10.7554/eLife.17061; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; Chakrabortee S, 2016, P NATL ACAD SCI USA, V113, P6065, DOI 10.1073/pnas.1604478113; Charng YY, 2006, PLANT PHYSIOL, V140, P1297, DOI 10.1104/pp.105.074898; Charoensawan V, 2015, BIOESSAYS, V37, P748, DOI 10.1002/bies.201400186; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Conrath U, 2015, ANNU REV PHYTOPATHOL, V53, P97, DOI 10.1146/annurev-phyto-080614-120132; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Cortijo S, 2014, SCIENCE, V343, P1145, DOI 10.1126/science.1248127; Crevillen P, 2014, NATURE, V515, P587, DOI 10.1038/nature13722; Crisp PA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501340; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; D'Urso A, 2016, ELIFE, V5, DOI 10.7554/eLife.16691; D'Urso A, 2014, TRENDS GENET, V30, P230, DOI 10.1016/j.tig.2014.04.004; Deleris A, 2016, ANNU REV PHYTOPATHOL, V54, P579, DOI 10.1146/annurev-phyto-080615-100308; Ding Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-229; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1732; Du JM, 2015, NAT REV MOL CELL BIO, V16, P519, DOI 10.1038/nrm4043; Espinas NA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01201; Feng XJ, 2016, P NATL ACAD SCI USA, V113, pE8335, DOI 10.1073/pnas.1610670114; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han SK, 2014, J EXP BOT, V65, P2785, DOI 10.1093/jxb/ert403; Han SK, 2012, PLANT CELL, V24, P4892, DOI 10.1105/tpc.112.105114; Hepworth J, 2015, PLANT PHYSIOL, V168, P1237, DOI 10.1104/pp.15.00496; Hilker M, 2016, BIOL REV, V91, P1118, DOI 10.1111/brv.12215; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Iwasaki M, 2014, P NATL ACAD SCI USA, V111, P8547, DOI 10.1073/pnas.1402275111; Jacob Y, 2011, CURR BIOL, V21, pR20, DOI 10.1016/j.cub.2010.11.052; Jaskiewicz M, 2011, EMBO REP, V12, P50, DOI 10.1038/embor.2010.186; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnson DG, 2013, CELL, V152, P685, DOI 10.1016/j.cell.2013.01.017; Johnson KCM, 2015, PLANT CELL PHYSIOL, V56, P1616, DOI 10.1093/pcp/pcv087; Kim JM, 2012, PLANT CELL PHYSIOL, V53, P847, DOI 10.1093/pcp/pcs053; Kundu S, 2007, GENE DEV, V21, P997, DOI 10.1101/gad.1506607; Lamke J, 2016, EMBO J, V35, P162, DOI 10.15252/embj.201592593; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Lee S, 2016, PLANT CELL, V28, P1640, DOI 10.1105/tpc.16.00012; Light WH, 2013, NUCLEUS-PHILA, V4, P357, DOI 10.4161/nucl.26209; Lin MY, 2014, PLANT PHYSIOL, V164, P2045, DOI 10.1104/pp.113.229609; Liu N, 2014, NUCLEIC ACIDS RES, V42, P5556, DOI 10.1093/nar/gku220; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Majumdar A, 1997, GENE DEV, V11, P1341, DOI 10.1101/gad.11.10.1341; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Meiri D, 2009, PLANT J, V59, P387, DOI 10.1111/j.1365-313X.2009.03878.x; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Mlynarova L, 2007, PLANT J, V51, P874, DOI 10.1111/j.1365-313X.2007.03185.x; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Mozgova I, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.127, 10.1038/nplants.2015.127]; Murgia I, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00745; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ohama N, 2017, TRENDS PLANT SCI, V22, P53, DOI 10.1016/j.tplants.2016.08.015; Para A, 2014, P NATL ACAD SCI USA, V111, P10371, DOI 10.1073/pnas.1404657111; Pecinka A, 2012, PLANT CELL PHYSIOL, V53, P801, DOI 10.1093/pcp/pcs044; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Peirats-Llobet M, 2016, MOL PLANT, V9, P136, DOI 10.1016/j.molp.2015.10.003; Pick T, 2012, PLANT PHYSIOL, V159, P52, DOI 10.1104/pp.111.191841; Pien S, 2008, PLANT CELL, V20, P580, DOI 10.1105/tpc.108.058172; Pieterse CMJ, 2012, PLANT PHYSIOL, V158, P545, DOI 10.1104/pp.112.900430; Ptashne M, 2008, CURR BIOL, V18, pR25, DOI 10.1016/j.cub.2007.11.017; Questa JI, 2016, SCIENCE, V353, P485, DOI 10.1126/science.aaf7354; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roux F, 2011, GENETICS, V188, P1015, DOI 10.1534/genetics.111.128744; Saleh A, 2008, PLANT CELL, V20, P568, DOI 10.1105/tpc.107.056614; Sani E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r59; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Shivaprasad PV, 2012, EMBO J, V31, P257, DOI 10.1038/emboj.2011.458; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Singh P, 2014, PLANT CELL, V26, P2676, DOI 10.1105/tpc.114.123356; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Song ZT, 2015, P NATL ACAD SCI USA, V112, P2900, DOI 10.1073/pnas.1419703112; Stief A, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592316.2014.970430; Stief A, 2014, PLANT CELL, V26, P1792, DOI 10.1105/tpc.114.123851; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Suganuma T, 2013, CURR OPIN CELL BIOL, V25, P322, DOI 10.1016/j.ceb.2013.02.016; Tack J, 2015, P NATL ACAD SCI USA, V112, P6931, DOI 10.1073/pnas.1415181112; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Virlouvet L, 2014, PLANT J, V79, P150, DOI 10.1111/tpj.12548; Vriet C, 2015, CELL MOL LIFE SCI, V72, P1261, DOI 10.1007/s00018-014-1792-z; Walley JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000237; Weigel D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-249; Wibowo A, 2016, ELIFE, V5, DOI 10.7554/eLife.13546; Wu TY, 2013, PLANT PHYSIOL, V161, P2075, DOI 10.1104/pp.112.212589; Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhou CM, 2013, SCIENCE, V340, P1097, DOI 10.1126/science.1234340	104	248	254	17	93	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	JUN 27	2017	18								124	10.1186/s13059-017-1263-6			11	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	EY7FK	WOS:000404154500002	28655328	Green Published, gold	Y	N	2022-01-24	
J	Hendrickson, PG; Dorais, JA; Grow, EJ; Whiddon, JL; Lim, JW; Wike, CL; Weaver, BD; Pflueger, C; Emery, BR; Wilcox, AL; Nix, DA; Peterson, CM; Tapscott, SJ; Carrell, DT; Cairns, BR				Hendrickson, Peter G.; Dorais, Jessie A.; Grow, Edward J.; Whiddon, Jennifer L.; Lim, Jong-Won; Wike, Candice L.; Weaver, Bradley D.; Pflueger, Christian; Emery, Benjamin R.; Wilcox, Aaron L.; Nix, David A.; Peterson, C. Matthew; Tapscott, Stephen J.; Carrell, Douglas T.; Cairns, Bradley R.			Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; MUERV-L; CELL; GENOME; TOTIPOTENCY; EXPRESSION; CHROMATIN; ELEMENTS; PROTEINS; REVEALS	To better understand transcriptional regulation during human oogenesis and preimplantation development, we defined stage-specific transcription, which highlighted the cleavage stage as being highly distinctive. Here, we present multiple lines of evidence that a eutherian-specific multicopy retrogene, DUX4, encodes a transcription factor that activates hundreds of endogenous genes (for example, ZSCAN4, KDM4E and PRAMEF-family genes) and retroviral elements (MERVL/HERVL family) that define the cleavage-specific transcriptional programs in humans and mice. Remarkably, mouse Dux expression is both necessary and sufficient to convert mouse embryonic stem cells (mESCs) into 2-cell-embryo-like ('2C-like') cells, measured here by the reactivation of '2C' genes and repeat elements, the loss of POU5F1 (also known as OCT4) protein and chromocenters, and the conversion of the chromatin landscape (as assessed by transposase-accessible chromatin using sequencing (ATAC-seq)) to a state strongly resembling that of mouse 2C embryos. Thus, we propose mouse DUX and human DUX4 as major drivers of the cleavage or 2C state.	[Hendrickson, Peter G.; Dorais, Jessie A.; Grow, Edward J.; Wike, Candice L.; Weaver, Bradley D.; Pflueger, Christian; Nix, David A.; Cairns, Bradley R.] Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84103 USA; [Hendrickson, Peter G.; Dorais, Jessie A.; Grow, Edward J.; Wike, Candice L.; Weaver, Bradley D.; Pflueger, Christian; Nix, David A.; Cairns, Bradley R.] Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Dorais, Jessie A.; Emery, Benjamin R.; Wilcox, Aaron L.; Peterson, C. Matthew; Carrell, Douglas T.] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA; [Dorais, Jessie A.; Emery, Benjamin R.; Wilcox, Aaron L.; Peterson, C. Matthew; Carrell, Douglas T.] Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT 84112 USA; [Whiddon, Jennifer L.; Lim, Jong-Won; Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA		Cairns, BR (corresponding author), Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84103 USA.; Cairns, BR (corresponding author), Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.; Carrell, DT (corresponding author), Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA.; Carrell, DT (corresponding author), Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT 84112 USA.; Tapscott, SJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	stapscot@fredhutch.org; douglas.carrell@hsc.utah.edu; brad.cairns@hci.utah.edu	Lim, Jong-Won/AAB-3761-2021; Pflueger, Christian/AAD-9877-2020	Pflueger, Christian/0000-0002-5039-2714	HHMIHoward Hughes Medical Institute; Eunice Kennedy Shriver NIH NICHD [K12HD000849]; NIH NIAMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR045203]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS069539]; Friends of FSH Research; National Science Foundation Graduate Research Fellowship ProgramNational Science Foundation (NSF) [DGE-1256082]; University of Washington Interdisciplinary Training in Genome Sciences grant from NHGRI [T32 HG00035]; University of Utah [CA042014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA042014] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR045203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS069539] Funding Source: NIH RePORTER	We thank S. Kuerten (NuGen) for assistance with preparing the RNA-seq libraries, B. Dalley for sequencing services, and T. Parnell for bioinformatic assistance. We give special thanks to M.-E. Torres-Padilla (IGBMC) for generously providing the MERVL::GFP reporter mESC line, and we thank D. Root (Broad Institute) for providing materials. Functional genomics work was supported by HHMI. J.A.D. was further supported by Eunice Kennedy Shriver NIH NICHD K12HD000849. S.J.T. and J.-W.L. were supported by NIH NIAMS R01AR045203, NIH NINDS P01NS069539, and the Friends of FSH Research. J.L.W. was supported by the National Science Foundation Graduate Research Fellowship Program DGE-1256082 and the University of Washington Interdisciplinary Training in Genome Sciences grant T32 HG00035 from NHGRI. Finally, we acknowledge CA042014 for support of the University of Utah core facilities.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Borsos M, 2016, GENE DEV, V30, P611, DOI 10.1101/gad.273805.115; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burglin TR, 2016, CHROMOSOMA, V125, P497, DOI 10.1007/s00412-015-0543-8; Choi YJ, 2017, SCIENCE, V355, DOI 10.1126/science.aag1927; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; De Paepe C, 2014, MOL HUM REPROD, V20, P599, DOI 10.1093/molehr/gau027; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dunwell TL, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0140-y; Eckersley-Maslin MA, 2016, CELL REP, V17, P179, DOI 10.1016/j.celrep.2016.08.087; Eidahl JO, 2016, HUM MOL GENET, V25, P4577, DOI 10.1093/hmg/ddw287; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Gertz J, 2012, GENOME RES, V22, P134, DOI 10.1101/gr.127373.111; Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001; Goke J, 2015, CELL STEM CELL, V16, P135, DOI 10.1016/j.stem.2015.01.005; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Ishiuchi T, 2013, CURR OPIN GENET DEV, V23, P512, DOI 10.1016/j.gde.2013.06.006; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jouhilahti EM, 2016, DEVELOPMENT, V143, P3459, DOI 10.1242/dev.134510; Kalmbach K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925121; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Ko MSH, 2016, CURR TOP DEV BIOL, V120, P103, DOI 10.1016/bs.ctdb.2016.04.004; Leidenroth A, 2012, CHROMOSOMA, V121, P489, DOI 10.1007/s00412-012-0380-y; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Madissoon E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28995; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morgani SM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0549; Niakan K. K., 2012, DEV BIOL, V375, P454; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ribet D, 2008, J VIROL, V82, P1622, DOI 10.1128/JVI.02097-07; Schoorlemmer J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00014; Sun YJ, 2015, GENOME RES, V25, P1703, DOI 10.1101/gr.192542.115; Tohonen V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9207; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yasuda T, 2016, NAT GENET, V48, P569, DOI 10.1038/ng.3535; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang JH, 2016, NAT GENET, V48, P1481, DOI 10.1038/ng.3691; Zhou LQ, 2015, TRENDS CELL BIOL, V25, P82, DOI 10.1016/j.tcb.2014.09.006	50	248	251	8	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2017	49	6					925	+		10.1038/ng.3844			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV8VM	WOS:000402062300017	28459457	Green Accepted	Y	N	2022-01-24	
J	Karner, CM; Chirumamilla, R; Aoki, S; Igarashi, P; Wallingford, JB; Carroll, TJ				Karner, Courtney M.; Chirumamilla, Rani; Aoki, Shigehisa; Igarashi, Peter; Wallingford, John B.; Carroll, Thomas J.			Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis	NATURE GENETICS			English	Article							DROSOPHILA TRACHEAL MORPHOGENESIS; CONVERGENT EXTENSION MOVEMENTS; BETA-CATENIN GENE; TUBE-SIZE CONTROL; CYSTIC KIDNEY; ZEBRAFISH GASTRULATION; TISSUE POLARITY; XENOPUS-LAEVIS; PRIMARY CILIUM; URETERAL BUD	Although many vertebrate organs, such as kidneys, lungs and liver, are composed of epithelial tubules, little is known of the mechanisms that establish the length or diameter of these tubules. In the kidney, defects in the establishment or maintenance of tubule diameter are associated with one of the most common inherited human disorders, polycystic kidney disease. Here we show that attenuation of Wnt9b signaling during kidney morphogenesis affects the planar cell polarity of the epithelium and leads to tubules with significantly increased diameter. Although previous studies showed that polarized cell divisions maintain the diameter of postnatal kidney tubules, we find that cell divisions are randomly oriented during embryonic development. Our data suggest that diameter is established during early morphogenetic stages by convergent extension processes and maintained by polarized cell divisions. Wnt9b, signaling through the non-canonical Rho/Jnk branch of the Wnt pathway, is necessary for both of these processes.	[Karner, Courtney M.; Chirumamilla, Rani; Aoki, Shigehisa; Igarashi, Peter; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA; [Karner, Courtney M.; Chirumamilla, Rani; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Aoki, Shigehisa] Saga Univ, Pathol & Biodef Fac Med, Saga 840, Japan; [Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Wallingford, John B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA		Carroll, TJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA.	thomas.carroll@utsouthwestern.edu		Aoki, Shigehisa/0000-0002-1778-8944; Igarashi, Peter/0000-0001-8698-1185; Karner, Courtney/0000-0003-0387-4486	American Society for Nephrology; American Heart AssociationAmerican Heart Association [0730236N]; Polycystic Kidney Disease Research Foundation; UAB ARPKD Center [5P30DK07403802]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01DK080004]; University of Texas Southwestern O'Brien Kidney Research Core Center [NIH P30DK079328]; National Institute for General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS); March of DimesMarch of Dimes; Burroughs Wellcome FundBurroughs Wellcome Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK079328, R37DK042921, R01DK080004, P30DK074038] Funding Source: NIH RePORTER	We thank O. Cleaver for reading and commenting on this manuscript, L. Avery for help with statistical analysis, J. Zhou (Brigham and Women's and Harvard Medical School) for providing us with antibodies to Pc-1 and Pc-2 and the Pkd1 mutant kidneys, M. Taketo (Kyoto University) for providing the beta-catenin exon 3 flox mice, O. Cabello (J. H. Quillen College of Medicine, East Tennessee State University) for providing us with the Invs mutant kidneys, B. Adams, E. Small, J. Shelton and the Molecular Pathology Core for technical assistance and L. James and M. Princena for the urine albumin studies. This work was supported by grants from the American Society for Nephrology, the American Heart Association (0730236N), the Polycystic Kidney Disease Research Foundation, the UAB ARPKD Center (5P30DK07403802) and the US National Institutes of Health (1R01DK080004) to T. J. C. The work was also supported by the University of Texas Southwestern O'Brien Kidney Research Core Center (NIH P30DK079328). J. B. W. was supported by grants from the National Institute for General Medical Sciences, the March of Dimes and the Burroughs Wellcome Fund.	Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Benzing T, 2007, J AM SOC NEPHROL, V18, P1389, DOI 10.1681/ASN.2006121355; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Concha ML, 1998, DEVELOPMENT, V125, P983; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Djiane A, 2000, DEVELOPMENT, V127, P3091; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goto T, 2005, CURR BIOL, V15, P787, DOI 10.1016/j.cub.2005.03.040; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Ibraghimov-Beskrovnaya O, 2007, CELL CYCLE, V6, P776, DOI 10.4161/cc.6.7.4047; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Jung AC, 2006, CURR BIOL, V16, P1224, DOI 10.1016/j.cub.2006.04.048; Karner C, 2006, SEMIN CELL DEV BIOL, V17, P194, DOI 10.1016/j.semcdb.2006.05.003; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Menezes LFC, 2004, KIDNEY INT, V66, P1345, DOI 10.1111/j.1523-1755.2004.00844.x; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Meyer TN, 2006, DIFFERENTIATION, V74, P638, DOI 10.1111/j.1432-0436.2006.00102.x; Michael L, 2005, KIDNEY INT, V68, P2010, DOI 10.1111/j.1523-1755.2005.00655.x; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; SHIH J, 1992, DEVELOPMENT, V116, P901; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tada M, 2000, DEVELOPMENT, V127, P2227; Thomson RB, 1999, AM J PHYSIOL-RENAL, V277, pF146, DOI 10.1152/ajprenal.1999.277.1.F146; Tong X, 2008, DEV BIOL, V317, P225, DOI 10.1016/j.ydbio.2008.02.040; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2001, INT J DEV BIOL, V45, P225; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	71	248	255	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2009	41	7					793	U46		10.1038/ng.400			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468AS	WOS:000267786200008	19543268	Green Accepted			2022-01-24	
J	Cantagrel, V; Silhavy, JL; Bielas, SL; Swistun, D; Marsh, SE; Bertrand, JY; Audollent, S; Attie-Bitach, T; Holden, KR; Dobyns, WB; Traver, D; Al-Gazali, L; Ali, BR; Lindner, TH; Caspary, T; Otto, EA; Hildebrandt, F; Glass, IA; Logan, CV; Johnson, CA; Bennett, C; Brancati, F; Valente, EM; Woods, CG; Gleeson, JG				Cantagrel, Vincent; Silhavy, Jennifer L.; Bielas, Stephanie L.; Swistun, Dominika; Marsh, Sarah E.; Bertrand, Julien Y.; Audollent, Sophie; Attie-Bitach, Tania; Holden, Kenton R.; Dobyns, William B.; Traver, David; Al-Gazali, Lihadh; Ali, Bassam R.; Lindner, Tom H.; Caspary, Tamara; Otto, Edgar A.; Hildebrandt, Friedhelm; Glass, Ian A.; Logan, Clare V.; Johnson, Colin A.; Bennett, Christopher; Brancati, Francesco; Valente, Enza Maria; Woods, C. Geoffrey; Gleeson, Joseph G.		Int Joubert Syndrome Related Disor	Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME-RELATED DISORDERS; BASAL BODY PROTEIN; MOLAR TOOTH SIGN; SONIC HEDGEHOG; CENTROSOMAL PROTEIN; PROGENITOR POOL; RENAL SYNDROME; CEREBELLUM; FLAGELLAR; EXPANSION	Joubert syndrome US) and related disorders are a group of autosomal-recessive conditions sharing the "molar tooth sign" on axial brain MRI, together with cerebellar vermis hypoplasia, ataxia, and psychomotor delay. JS is suggested to be a disorder of cilia function and is part of a spectrum of disorders involving retinal, renal, digital, oral, hepatic, and cerebral organs. We identified mutations in ARL13B in two families with the classical form of JS. ARL13B belongs to the Ras GTPase family, and in other species is required for ciliogenesis, body axis formation, and renal function. The encoded Arl13b protein was expressed in developing murine cerebellum and localized to the cilia in primary neurons. Overexpression of human wild-type but not patient mutant ARL13B rescued the Arl13b scorpion zebrafish mutant. Thus, ARL13B has an evolutionarily conserved role mediating cilia function in multiple organs.	[Cantagrel, Vincent; Silhavy, Jennifer L.; Bielas, Stephanie L.; Swistun, Dominika; Marsh, Sarah E.; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Neurogenet Lab, La Jolla, CA 92093 USA; [Bertrand, Julien Y.; Traver, David] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Audollent, Sophie; Attie-Bitach, Tania] Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France; [Audollent, Sophie; Attie-Bitach, Tania] Hop Necker Enfants Malad, INSERM, U781, F-75743 Paris 15, France; [Holden, Kenton R.] Greenwood Genet Ctr, Neurosci Sect, Greenwood, SC 29646 USA; [Holden, Kenton R.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Holden, Kenton R.] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Dobyns, William B.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; [Ali, Bassam R.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Lindner, Tom H.] Univ Clin Leipzig, Dept Internal Med 3, Div Nephrol, D-04103 Leipzig, Germany; [Caspary, Tamara] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Glass, Ian A.] Univ Washington, Sch Med, Childrens Hosp Reg Med Ctr, Dept Pediat & Med, Seattle, WA 98105 USA; [Logan, Clare V.; Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Bennett, Christopher] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England; [Brancati, Francesco; Valente, Enza Maria] Mendel Inst Med Genet & Twin Res, Inst Ricovero & Cura Carattere Sci, I-00198 Rome, Italy; [Woods, C. Geoffrey] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England		Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Neurogenet Lab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	woods, christopher g/A-1361-2010; Brancati, Francesco/AAC-3778-2022; Vincent, Cantagrel/H-8698-2017; ATTIE-BITACH, Tania/K-1453-2017; Valente, Enza Maria/G-2942-2017; BERTRAND, Julien/O-3655-2019; Dobyns, William/AAI-2768-2020; Dobyns, William/ABC-6525-2021; Marsh, Sarah/E-9164-2010; Caspary, Tamara/AAH-5625-2020; Ali, Bassam/J-7014-2012	Brancati, Francesco/0000-0003-3624-2354; Vincent, Cantagrel/0000-0002-5180-4848; ATTIE-BITACH, Tania/0000-0002-1155-3626; Valente, Enza Maria/0000-0002-0600-6820; BERTRAND, Julien/0000-0001-6570-4082; Dobyns, William/0000-0002-7681-2844; Caspary, Tamara/0000-0002-6579-7589; Bielas, Stephanie/0000-0003-0567-5632; Marsh, Sarah/0000-0003-4194-043X; Logan, Clare/0000-0003-4323-1602; Ali, Bassam R/0000-0003-1306-6618; Otto, Edgar/0000-0002-2387-9973; Johnson, Colin/0000-0002-2979-8234	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [N01-HG-65403]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-DK068306, R01-DK064614, R01-DK069272]; French Foundation for Medical Research (FRM)Fondation pour la Recherche Medicale; Neuroplasticity of Aging Postdoctoral Training Grant [T32 AG00216]; Cancer Research Institute; US National Institute of Neurological Disease and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Simons Foundation; Burroughs Wellcome Fund AwardBurroughs Wellcome Fund; UCSD Neurosciences Microscopy Core [P30 NS047101]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK064614, R01DK068306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052455, R01NS048453, P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000216] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9826762, G0700073, G9900837] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9900837, G9826762, G0700073] Funding Source: UKRI	We thank the Marshfield Clinic Research Foundation and the US National Heart, Lung, and Blood Institute for genotyping support; the UCSD Neurosciences Microscopy Core for imaging (P30 NS047101); Jeong-Soo Lee (Dana Farber Cancer Institute) for the zebrafish arl13b clone; Mark Lawson (UCSD) for help with Sigma-Plot and statistical analysis; Daniel O'Connor (UCSD) for control DNA samples; and members of the Gleeson laboratory for helpful discussions. Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number N01-HG-65403. F.H. is supported by NIH grants R01-DK068306, ROI-DK064614, and R01-DK069272 and is a Doris Duke Distinguished Clinical Scientist. V.C. was supported by a French Foundation for Medical Research (FRM) fellowship. S.L.B. was supported by the Neuroplasticity of Aging Postdoctoral Training Grant (T32 AG00216). J.Y.B. was supported by the Irvington Institute Fellowship Program of the Cancer Research Institute. This work was supported by grants from the US National Institute of Neurological Disease and Stroke, the Simons Foundation, and the Burroughs Wellcome Fund Award in Translational Research (to J.G.G.). The authors report no conflict of interest.	Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Brancati F, 2007, AM J HUM GENET, V81, P104, DOI 10.1086/519026; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Castori M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027375; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; DELCERRO MP, 1972, J COMP NEUROL, V144, P131, DOI 10.1002/cne.901440202; DELCERRO MP, 1969, ANAT RECORD, V165, P127, DOI 10.1002/ar.1091650202; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Haug K, 2000, AM J MED GENET, V91, P135, DOI 10.1002/(SICI)1096-8628(20000313)91:2<135::AID-AJMG11>3.0.CO;2-1; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KING MD, 1984, ARCH DIS CHILD, V59, P709, DOI 10.1136/adc.59.8.709; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Satran D, 1999, AM J MED GENET, V86, P459; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tisdale EJ, 1999, MOL BIOL CELL, V10, P1837, DOI 10.1091/mbc.10.6.1837; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; VERLOES A, 1989, AM J MED GENET, V32, P227, DOI 10.1002/ajmg.1320320217; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zaki MS, 2008, NEUROLOGY, V70, P556, DOI 10.1212/01.wnl.0000277644.12087.fd; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P3965, DOI 10.1073/pnas.0637349100	60	248	251	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					170	179		10.1016/j.ajhg.2008.06.023			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	WOS:000258418200002	18674751	Bronze, Green Published			2022-01-24	
J	Jaeger, E; Webb, E; Howarth, K; Carvajal-Carmona, L; Rowan, A; Broderick, P; Walther, A; Spain, S; Pittman, A; Kemp, Z; Sullivan, K; Heinimann, K; Lubbe, S; Domingo, E; Barclay, E; Martin, L; Gorman, M; Chandler, I; Vijayakrishnan, J; Wood, W; Papaemmanuil, E; Penegar, S; Qureshi, M; Farrington, S; Tenesa, A; Cazier, JB; Kerr, D; Gray, R; Peto, J; Dunlop, M; Campbell, H; Thomas, H; Houlston, R; Tomlinson, I				Jaeger, Emma; Webb, Emily; Howarth, Kimberley; Carvajal-Carmona, Luis; Rowan, Andrew; Broderick, Peter; Walther, Axel; Spain, Sarah; Pittman, Alan; Kemp, Zoe; Sullivan, Kate; Heinimann, Karl; Lubbe, Steven; Domingo, Enric; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Chandler, Ian; Vijayakrishnan, Jayaram; Wood, Wendy; Papaemmanuil, Elli; Penegar, Steven; Qureshi, Mobshra; Farrington, Susan; Tenesa, Albert; Cazier, Jean-Baptiste; Kerr, David; Gray, Richard; Peto, Julian; Dunlop, Malcolm; Campbell, Harry; Thomas, Huw; Houlston, Richard; Tomlinson, Ian		CORGI Consortium	Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MIXED POLYPOSIS SYNDROME; PROSTATE-CANCER; SUSCEPTIBILITY; SCAN; 8Q24	We mapped a high-penetrance gene (CRAC1; also known as HMPS) associated with colorectal cancer (CRC) in the Ashkenazi population to a 0.6-Mb region on chromosome 15 containing SCG5 (also known as SGNE1), GREM1 and FMN1. We hypothesized that the CRAC1 locus harbored low-penetrance variants that increased CRC risk in the general population. In a large series of colorectal cancer cases and controls, SNPs near GREM1 and SCG5 were strongly associated with increased CRC risk (for rs4779584, P=4.44x10(-14)).	[Jaeger, Emma; Howarth, Kimberley; Carvajal-Carmona, Luis; Rowan, Andrew; Walther, Axel; Spain, Sarah; Kemp, Zoe; Domingo, Enric; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Tomlinson, Ian] Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England; [Webb, Emily; Broderick, Peter; Pittman, Alan; Lubbe, Steven; Chandler, Ian; Vijayakrishnan, Jayaram; Wood, Wendy; Papaemmanuil, Elli; Penegar, Steven; Qureshi, Mobshra] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Carvajal-Carmona, Luis; Tomlinson, Ian] Univ London, Queen Mary Coll, Barts & London Med Sch, Inst Canc, London EC1M 6BQ, England; [Heinimann, Karl] KBW Ctr Biomed, Dept Clin & Biol Sci, Res Grp Human Genet, CH-4058 Basel, Switzerland; [Martin, Lynn] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; [Martin, Lynn] Birmingham Womens Hosp, Dept Med Genet, Birmingham B15 2TG, W Midlands, England; [Farrington, Susan; Dunlop, Malcolm] Univ Edinburgh, Canc Res Ctr, Colon Canc Genet Grp, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan; Dunlop, Malcolm] Western Gen Hosp, UK Med Res Council, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert; Campbell, Harry] Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; [Cazier, Jean-Baptiste] Canc Res UK, London WC2A 3PX, England; [Kerr, David] Univ Oxford, Dept Clin Pharmacol, Radcliffe Infirm, Oxford OX2 6HA, England; [Gray, Richard] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Peto, Julian] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Peto, Julian] Univ London London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London WC1E 7HT, England; [Peto, Julian] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Thomas, Huw] St Marks Hosp, Family Canc Clin & Imperial Coll, Harrow HA1 3UJ, Middx, England		Tomlinson, I (corresponding author), Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England.	richard.houlston@icr.ac.uk; ian.tomlinson@cancer.org.uk	Farrington, Susan M/C-7319-2013; Dunlop, Malcolm G/F-1973-2011; Pittman, Alan/AAP-2534-2020; Carvajal-Carmona, Luis G/B-3882-2010; Lubbe, Steven/L-8261-2013; Cazier, Jean-Baptiste/F-2369-2010; Farrington, Susan M/Q-2710-2019; Pittman, Alan M/D-6231-2012; Domingo, Enric/A-9099-2018; Campbell, Harry/E-2959-2010; Spain, Sarah/G-1968-2010; Lucassen, Anneke/D-7764-2017	Dunlop, Malcolm G/0000-0002-3033-5851; Pittman, Alan/0000-0002-8112-2987; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Lubbe, Steven/0000-0002-7103-6671; Farrington, Susan M/0000-0001-5955-7389; Pittman, Alan M/0000-0002-8112-2987; Domingo, Enric/0000-0003-4390-8767; Campbell, Harry/0000-0002-6169-6262; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Green, Andrew/0000-0002-1077-7417; Houlston, Richard/0000-0002-5268-0242; Gray, Richard/0000-0003-4440-574X; Broderick, Peter/0000-0002-8348-5829; Cazier, Jean-Baptiste/0000-0001-7581-9051; Penegar, Steven/0000-0002-3768-0236; Spain, Sarah/0000-0002-7591-8364; Evans, Gareth/0000-0002-8482-5784; Wood, Wendy/0000-0001-9062-4455; Lucassen, Anneke/0000-0003-3324-4338; Webb, Emily/0000-0002-4019-7456	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U127527198, G0301096] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0301096, MC_U127527198] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Anderson D. R., 2002, MODEL SELECTION MULT; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Tomlinson I, 1999, GASTROENTEROLOGY, V116, P789, DOI 10.1016/S0016-5085(99)70061-2; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Whitelaw SC, 1997, GASTROENTEROLOGY, V112, P327, DOI 10.1053/gast.1997.v112.pm9024286; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	15	248	255	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					26	28		10.1038/ng.2007.41			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	WOS:000252118600013	18084292				2022-01-24	
J	Flynt, AS; Li, N; Thatcher, EJ; Solnica-Krezel, L; Patton, JG				Flynt, Alex S.; Li, Nan; Thatcher, Elizabeth J.; Solnica-Krezel, Lilianna; Patton, James G.			Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate	NATURE GENETICS			English	Article							FLOOR PLATE; EXPRESSION; EMBRYO; GENE; SPECIFICATION; MORPHOGENESIS; INDUCTION; MICRORNAS	Numerous microRNAs ( miRNAs) have been discovered in the genomes of higher eukaryotes, and functional studies indicate that they are important during development. However, little is known concerning the function of individual miRNAs. We approached this problem in zebrafish by combining identification of miRNA expression, functional analyses and experimental validation of potential targets. We show that miR-214 is expressed during early segmentation stages in somites and that varying its expression alters the expression of genes regulated by Hedgehog signaling. Inhibition of miR-214 results in a reduction or loss of slow-muscle cell types. We show that su(fu) mRNA, encoding a negative regulator of Hedgehog signaling, is targeted by miR-214. Through regulation of su( fu), miR-214 enables precise specification of muscle cell types by sharpening cellular responses to Hedgehog.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA		Patton, JG (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	james.g.patton@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008554, R01GM075790] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD007502] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM 008554, R01 GM075790-02, R01 GM075790, T32 GM008554, GM 075790, R01 GM075790-01] Funding Source: Medline		Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Feng XS, 2006, DEV BIOL, V300, P736, DOI 10.1016/j.ydbio.2006.08.056; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Henry CA, 2004, DEV CELL, V7, P917, DOI 10.1016/j.devcel.2004.09.017; Ingham PW, 2005, EXP CELL RES, V306, P336, DOI 10.1016/j.yexcr.2005.03.019; Koudijs MJ, 2005, PLOS GENET, V1, P223, DOI 10.1371/journal.pgen.0010019; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schaffer M, 2005, MECH DEVELOP, V122, P43, DOI 10.1016/j.mod.2004.09.002; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; THISSE C, 1993, DEVELOPMENT, V119, P1203; Topczewska JM, 2001, GENE DEV, V15, P2483, DOI 10.1101/gad.907401; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5	22	248	277	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					259	263		10.1038/ng1953			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	WOS:000244063900026	17220889	Green Accepted			2022-01-24	
J	Gianola, D; Fernando, RL; Stella, A				Gianola, Daniel; Fernando, Rohan L.; Stella, Alessandra			Genomic-assisted prediction of genetic value with semiparametric procedures	GENETICS			English	Article							EFFICIENT ALGORITHM; RELATIONSHIP MATRIX; LARGE PEDIGREES; SELECTION; MODEL; VARIANCE; CLASSIFICATION; IRREDUCIBILITY; INFERENCES; MARKERS	Semiparametric procedures for prediction of total genetic value for quantitative traits, which make use of phenotypic and genomic data simultaneously, are presented. The methods focus on the treatment of massive information provided by, e.g., single-nucleotide polymorphisms. It is argued that standard parametric methods for quantitative genetic analysis cannot handle the multiplicity of potential interactions arising in models with, e.g., hundreds of thousands of markers, and that most of the assumptions required for an orthogonal decomposition of variance are violated in artificial and natural populations. This makes nonparametric procedures attractive. Kernel regression and reproducing kernel Hilbert spaces regression procedures are embedded into standard mixed-effects linear models, retaining additive genetic effects under multivariate normality for operational reasons. Inferential procedures are presented, and some extensions are suggested. An example is presented, illustrating the potential of the methodology. Implementations can be carried out after modification of standard software developed by animal breeders for likelihood-based or Bayesian analysis.	Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA; Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway; Iowa State Univ Sci & Technol, Dept Anim Sci, Ames, IA 50011 USA; Parco Tecnol Padano, I-26900 Lodi, Italy		Gianola, D (corresponding author), Univ Wisconsin, Dept Anim Sci, 1675 Observ Dr, Madison, WI 53706 USA.	gianola@ansci.wisc.edu	Stella, Alessandra/AAY-7322-2020; stella, Alessandra/ABB-1952-2021	stella, Alessandra/0000-0003-2850-3964			AITCHISON J, 1976, BIOMETRIKA, V63, P413, DOI 10.2307/2335719; Chu C.K., 1991, STAT SCI, V4, P404; COCKERHAM CC, 1954, GENETICS, V39, P859; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fernandez SA, 2002, GENET SEL EVOL, V34, P537, DOI [10.1186/1297-9686-34-5-537, 10.1051/gse:2002022]; FERNANDO RL, 1993, THEOR APPL GENET, V87, P89, DOI 10.1007/BF00223750; FERNANDO RL, 1989, GENET SEL EVOL, V21, P467, DOI 10.1051/gse:19890407; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; GIANOLA D, 1986, J ANIM SCI, V63, P217, DOI 10.2527/jas1986.631217x; Gianola D, 2004, GENETICS, V167, P1407, DOI 10.1534/genetics.103.025734; Gianola D, 2003, GENETICS, V163, P347; GIANOLA D, 1982, J ANIM SCI, V54, P1079, DOI 10.2527/jas1982.5451079x; GIANOLA D, 1983, GENET SEL EVOL, V15, P201, DOI 10.1186/1297-9686-15-2-201; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hart JD, 2005, J MULTIVARIATE ANAL, V92, P77, DOI 10.1016/j.jmva.2003.08.005; HENDERSO.CR, 1974, J DAIRY SCI, V57, P963, DOI 10.3168/jds.S0022-0302(74)84993-3; Henderson C. R., 1973, Proceedings of the Animal Breeding and Genetics Symposium in honor of Dr. Jay L. Lush, held July 29, 1972, at Virginia Polytechnic Institute and State University, Blacksburg, Virginia., P10; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; IM S, 1989, GENET SEL EVOL, V21, P399, DOI 10.1051/gse:19890401; Jensen CS, 1999, AM J HUM GENET, V65, P885, DOI 10.1086/302524; JENSEN CS, 1995, INT J HUM-COMPUT ST, V42, P647, DOI 10.1006/ijhc.1995.1029; KEMPTHORNE O, 1954, PROC R SOC SER B-BIO, V143, P103, DOI 10.1098/rspb.1954.0056; Kerr RJ, 1996, J ANIM BREED GENET, V113, P457, DOI 10.1111/j.1439-0388.1996.tb00636.x; KIMELDORF G, 1971, J MATH ANAL APPL, V33, P82, DOI 10.1016/0022-247X(71)90184-3; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LINDLEY DV, 1972, J ROY STAT SOC B, V34, P1; Mallick BK, 2005, J R STAT SOC B, V67, P219, DOI 10.1111/j.1467-9868.2005.00498.x; MARRON JS, 1988, EMPIRICAL EC ECONOME, V13, P187, DOI DOI 10.1007/BF01972448; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Meuwissen THE, 2001, GENETICS, V157, P1819; Nadaraya E., 1964, THEORY PROBAB APPL, V9, P141, DOI [10.1137/1109020, DOI 10.1137/1109020]; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; QUAAS RL, 1980, J ANIM SCI, V51, P1277, DOI 10.2527/jas1981.5161277x; Racine J, 2004, J ECONOMETRICS, V119, P99, DOI 10.1016/S0304-4076(03)00157-X; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; SHEEHAN N, 1993, BIOMETRICS, V49, P163, DOI 10.2307/2532611; Sorensen D, 2001, GENET RES, V77, P83, DOI 10.1017/S0016672300004845; SORENSEN DA, 1983, THEOR APPL GENET, V66, P217, DOI 10.1007/BF00251147; ter Braak CJF, 2005, GENETICS, V170, P1435, DOI 10.1534/genetics.105.040469; VANARENDONK JAM, 1989, THEOR APPL GENET, V78, P735, DOI 10.1007/BF00262571; WANG CS, 1993, GENET SEL EVOL, V25, P41, DOI 10.1051/gse:19930103; WANG CS, 1994, GENET SEL EVOL, V26, P91, DOI 10.1051/gse:19940202; Wang H, 2005, GENETICS, V170, P465, DOI 10.1534/genetics.104.039354; Watson G., 1964, SANKHYA INDIAN J S A, V64, P359, DOI DOI 10.2307/25049340; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wright S, 1934, GENETICS, V19, P0537; Xu SZ, 2003, GENETICS, V163, P789; Yi NJ, 2003, GENETICS, V164, P1129; Zhang YM, 2005, HEREDITY, V95, P96, DOI 10.1038/sj.hdy.6800702; [No title captured]; [No title captured]; [No title captured]	55	248	254	1	27	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	2006	173	3					1761	1776		10.1534/genetics.105.049510			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	071UM	WOS:000239629400047	16648593	Green Published, Bronze			2022-01-24	
J	Becskei, A; Kaufmann, BB; van Oudenaarden, A				Becskei, A; Kaufmann, BB; van Oudenaarden, A			Contributions of low molecule number and chromosomal positioning to stochastic gene expression	NATURE GENETICS			English	Article							CELL-CYCLE; NUCLEAR ARCHITECTURE; NOISE-PROPAGATION; POSITIVE-FEEDBACK; SINGLE-CELL; YEAST; TRANSCRIPTION; NETWORKS; BINDING; FLUCTUATIONS	The presence of low- copy- number regulators and switch- like signal propagation in regulatory networks are expected to increase noise in cellular processes. We developed a noise amplifier that detects fluctuations in the level of low- abundance mRNAs in yeast. The observed fluctuations are not due to the low number of molecules expressed from a gene per se but originate in the random, rare events of gene activation. The frequency of these events and the correlation between stochastic expressions of genes in a single cell depend on the positioning of the genes along the chromosomes. Transcriptional regulators produced by such random expression propagate noise to their target genes.	MIT, Dept Phys, Cambridge, MA 02139 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA		van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Becskei, Attila/0000-0002-9462-0934			Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2004, NAT CELL BIOL, V6, P451, DOI 10.1038/ncb1124; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Holland MJ, 2002, J BIOL CHEM, V277, P14363, DOI 10.1074/jbc.C200101200; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; HORSTHEMKE W, 1992, PHYS REV A, V45, P5492, DOI 10.1103/PhysRevA.45.5492; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Martin DIK, 2001, TRENDS GENET, V17, P444, DOI 10.1016/S0168-9525(01)02368-X; Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pirone JR, 2004, J THEOR BIOL, V226, P111, DOI 10.1016/j.jtbi.2003.08.008; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; T?th J, 1989, MATH MODELS CHEM REA; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thornton BR, 2004, CELL CYCLE, V3, P629; Vashee S, 1998, CURR BIOL, V8, P452, DOI 10.1016/S0960-9822(98)70179-4; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	50	248	251	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					937	944		10.1038/ng1616			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	WOS:000231591900017	16086016				2022-01-24	
J	Zhao, H; Li, RH; Wang, QJ; Yan, QF; Deng, JH; Han, DY; Bai, YD; Young, WY; Guan, MX				Zhao, H; Li, RH; Wang, QJ; Yan, QF; Deng, JH; Han, DY; Bai, YD; Young, WY; Guan, MX			Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large chinese family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; HEREDITARY OPTIC NEUROPATHY; NADH DEHYDROGENASE; A1555G MUTATION; POINT MUTATION; DNA MUTATION; HEARING-LOSS; MTDNA; SUSCEPTIBILITY; IDENTIFICATION	We report here the characterization of a large Chinese family with maternally transmitted aminoglycoside-induced and nonsyndromic deafness. In the absence of aminoglycosides, some matrilineal relatives in this family exhibited late-onset/progressive deafness, with a wide range of severity and age at onset. Notably, the average age at onset of deafness has changed from 55 years ( generation II) to 10 years ( generation IV). Clinical data reveal that the administration of aminoglycosides can induce or worsen deafness in matrilineal relatives. The age at the time of drug administration appears to be correlated with the severity of hearing loss experienced by affected individuals. Sequence analysis of mitochondrial DNA in this pedigree identified a homoplasmic C-to-T transition at position 1494 (C1494T) in the 12S rRNA gene. The C1494T mutation is expected to form a novel U1494-1555A base pair, which is in the same position as the C1494-1555G pair created by the deafness-associated A1555G mutation, at the highly conserved A site of 12S rRNA. Exposure to a high concentration of paromomycin or neomycin caused a variable but significant average increase in doubling time in lymphoblastoid cell lines derived from four symptomatic and two asymptomatic individuals in this family carrying the C1494T mutation when compared to four control cell lines. Furthermore, a significant decrease in the rate of total oxygen consumption was observed in the mutant cell lines. Thus, our data strongly support the idea that the A site of mitochondrial 12S rRNA is the primary target for aminoglycoside-induced deafness. These results also strongly suggest that the nuclear background plays a role in the aminoglycoside ototoxicity and in the development of the deafness phenotype associated with the C1494T mutation in the mitochondrial 12S rRNA gene.	Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Program Human Genet, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Ctr Hearing & Deafness Res, Cincinnati, OH 45229 USA; Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA		Guan, MX (corresponding author), Childrens Hosp, Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	min-xin.guan@chmcc.org		Guan, Min-Xin/0000-0001-5067-6736	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03 DC004958, DC05230, DC04958, R01 DC005230] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS044015, NS44015] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC004958, R01DC005230] Funding Source: NIH RePORTER		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BACINO C, 1995, PHARMACOGENETICS, V5, P165, DOI 10.1097/00008571-199506000-00005; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Casano RAMS, 1999, AM J OTOLARYNG, V20, P151, DOI 10.1016/S0196-0709(99)90062-5; DESTASIO EA, 1990, J MOL BIOL, V212, P127, DOI 10.1016/0022-2836(90)90309-A; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; FISCHELGHODSIAN N, 1995, AM J OTOLARYNG, V16, P403, DOI 10.1016/0196-0709(95)90078-0; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; HOWELL N, 1991, AM J HUM GENET, V48, P935; HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174; Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kogelnik AM, 1998, NUCLEIC ACIDS RES, V26, P112, DOI 10.1093/nar/26.1.112; LI M, 1982, J BIOL CHEM, V257, P5921; Li RH, 2004, AM J MED GENET A, V124A, P113, DOI 10.1002/ajmg.a.20305; Li W, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P415; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Matthijs G, 1996, EUR J HUM GENET, V4, P46; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Morton CC, 2002, HUM MOL GENET, V11, P1229, DOI 10.1093/hmg/11.10.1229; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; NANCE WE, 1975, OTOLARYNG CLIN N AM, V8, P19; NEEFS JM, 1991, NUCLEIC ACIDS RES, V19, P1987, DOI 10.1093/nar/19.suppl.1987; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; PUROHIT P, 1994, NATURE, V370, P659, DOI 10.1038/370659a0; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; ROE BA, 1985, J BIOL CHEM, V260, P9759; SPANGLER EA, 1985, J BIOL CHEM, V260, P6334; Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; Torroni A, 1997, AM J HUM GENET, V60, P1107; Van Camp G, 2000, CLIN GENET, V57, P409, DOI 10.1034/j.1399-0004.2000.570601.x; Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yuan H, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P141; ZIMMERMANN RA, 1990, RIBOSOME, P331; ZWIEB C, 1986, MOL GEN GENET, V203, P256, DOI 10.1007/BF00333963	49	248	318	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					139	152		10.1086/381133			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	WOS:000187723500013	14681830	Green Published, Bronze			2022-01-24	
J	Pailhoux, E; Vigier, B; Chaffaux, S; Servel, N; Taourit, S; Furet, JP; Fellous, M; Grosclaude, F; Cribiu, EP; Cotinot, C; Vaiman, D				Pailhoux, E; Vigier, B; Chaffaux, S; Servel, N; Taourit, S; Furet, JP; Fellous, M; Grosclaude, F; Cribiu, EP; Cotinot, C; Vaiman, D			A 11.7-kb deletion triggers intersexuality and polledness in goats	NATURE GENETICS			English	Article							MAMMALIAN SEX DETERMINATION; SRY; BLEPHAROPHIMOSIS; PTOSIS; REGION; MAP; IDENTIFICATION; TRANSLOCATION; DEFINITION; REVERSAL	Mammalian sex determination is governed by the presence of the sex determining region Y gene (SRY) on the Y chromosome(1). Familial cases of SRY-negative XX sex reversal are rare in humans, often hampering the discovery of new sex-determining genes(2,3). The mouse model is also insufficient to correctly apprehend the sex-determination cascade, as the human pathway is much more sensitive to gene dosage(4-6). Other species might therefore be considered in this respect(7). In goats, the polled intersex syndrome (PIS) mutation associates polledness and intersexuality(8,9). The sex reversal affects exclusively the XX individuals in a recessive manner, whereas the absence of horns is dominant in both sexes. The syndrome is caused by an autosomal gene located at chromosome band 1q43 (ref. 9), shown to be homologous to human chromosome band 3q23 (ref. 10). Through a positional cloning approach, we demonstrate that the mutation underlying PIS is the deletion of a critical 11.7-kb DNA element containing mainly repetitive sequences. This deletion affects the transcription of at least two genes: PISRT1, encoding a 1.5-kb mRNA devoid of open reading frame (ORF), and FOXL2, recently shown to be responsible for blepharophimosis ptosis epicanthus inversus syndrome (BPES) in humans(11). These two genes are located 20 and 200 kb telomeric from the deletion, respectively.	INRA, Ctr Rech, Lab Genet Biochim & Cytogenet, Dept Genet Anim, F-78352 Jouy En Josas, France; INRA, Ctr Rech, Dept Anim Physiol, Lab Biol Dev & Biotechnol, F-78352 Jouy En Josas, France; Inst Pasteur, Human Immunogenet Lab, F-75015 Paris, France		Vaiman, D (corresponding author), INRA, Ctr Rech, Lab Genet Biochim & Cytogenet, Dept Genet Anim, F-78352 Jouy En Josas, France.		Vaiman, Daniel/O-6030-2015	Vaiman, Daniel/0000-0002-1915-0717			AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Asdell S. A., 1944, SCIENCE, V99, P124, DOI 10.1126/science.99.2563.124; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2000, GENOMICS, V68, P296, DOI 10.1006/geno.2000.6304; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIESE K, 1994, P NATL ACAD SCI USA, V91, P3368, DOI 10.1073/pnas.91.8.3368; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KROB G, 1994, EUR J PEDIATR, V153, P2, DOI 10.1007/BF02000779; LAWSON CT, 1995, HUM MOL GENET, V4, P963, DOI 10.1093/hmg/4.5.963; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; Schibler L, 2000, GENOME RES, V10, P311, DOI 10.1101/gr.10.3.311; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Vaiman D, 2000, TRENDS GENET, V16, P488, DOI 10.1016/S0168-9525(00)02126-0; Vaiman D, 1996, MAMM GENOME, V7, P133, DOI 10.1007/s003359900033; Vaiman D, 1996, GENETICS, V144, P279; Vaiman D, 1999, GENOMICS, V56, P31, DOI 10.1006/geno.1998.5691	22	248	258	1	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					453	458		10.1038/ng769			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	WOS:000172507500022	11726932				2022-01-24	
J	Richards, A; Buddles, MR; Donne, RL; Kaplan, BS; Kirk, E; Venning, MC; Tielemans, CL; Goodship, JA; Goodship, THJ				Richards, A; Buddles, MR; Donne, RL; Kaplan, BS; Kirk, E; Venning, MC; Tielemans, CL; Goodship, JA; Goodship, THJ			Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; HEPARIN-BINDING DOMAIN; DEFICIENCY; FAMILY; HYPOCOMPLEMENTEMIA; IDENTIFICATION; HEREDITARY; SECRETION; PROTEINS; DISEASE	Several recent studies have established an association between abnormalities of complement factor H (FH) and the development of hemolytic uremic syndrome (HUS). To identify the relative importance of mutations in FH as a cause of HUS, we have undertaken mutation screening of the FH gene in 19 familial and 31 sporadic patients with FH. Mutations were found in two familial and three sporadic patients, and these clustered in exons 18-20, a domain important for host recognition. Moreover, this study demonstrates that familial HUS is likely to be a heterogeneous condition.	Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Biochem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA; Sydney Childrens Hosp, Dept Med Genet, Randwick, NSW, Australia; Free Univ Brussels, Erasme Hosp, Dept Nephrol, B-1050 Brussels, Belgium		Goodship, THJ (corresponding author), Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	t.h.j.goodship@ncl.ac.uk	Richards, Anna/E-8337-2013; Mohammed, Imran/J-8271-2012	Mohammed, Imran/0000-0002-8412-0768; Kirk, Edwin/0000-0002-4662-0024			Ault BH, 1997, J BIOL CHEM, V272, P25168, DOI 10.1074/jbc.272.40.25168; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Buddles MRH, 2000, AM J HUM GENET, V66, P1721, DOI 10.1086/302877; deVillena FPM, 1996, CYTOGENET CELL GENET, V72, P339; Diaz-Guillen MA, 1999, IMMUNOGENETICS, V49, P549, DOI 10.1007/s002510050534; Fijen CAP, 1996, CLIN EXP IMMUNOL, V105, P511, DOI 10.1046/j.1365-2249.1996.d01-777.x; HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751; LEVY M, 1986, KIDNEY INT, V30, P949, DOI 10.1038/ki.1986.278; Liu Q, 1996, HUM MOL GENET, V5, P107, DOI 10.1093/hmg/5.1.107; LOPEZLARREA C, 1987, BIOCHEM SOC T, V15, P648, DOI 10.1042/bst0150648; Male DA, 2000, MOL IMMUNOL, V37, P41, DOI 10.1016/S0161-5890(00)00024-9; NIELSEN HE, 1989, SCAND J IMMUNOL, V30, P711, DOI 10.1111/j.1365-3083.1989.tb02480.x; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; PICHETTE V, 1994, AM J KIDNEY DIS, V24, P936, DOI 10.1016/S0272-6386(12)81065-1; Prodinger WM, 1998, BIOCHEM J, V331, P41, DOI 10.1042/bj3310041; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; ROODHOOFT AM, 1990, PEDIATR NEPHROL, V4, P597, DOI 10.1007/BF00858631; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; Sanchez-Corral P, 2000, IMMUNOGENETICS, V51, P366, DOI 10.1007/s002510050631; Schmidt BZ, 1999, J BIOL CHEM, V274, P11782, DOI 10.1074/jbc.274.17.11782; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1046/j.1523-1755.1998.00824.x; Ying LH, 1999, AM J HUM GENET, V65, P1538, DOI 10.1086/302673; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4	28	248	253	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					485	490		10.1086/318203			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	WOS:000166524800018	11170896	Green Published, Bronze			2022-01-24	
J	Aksentijevich, I; Torosyan, Y; Samuels, J; Centola, M; Pras, E; Chae, JJ; Oddoux, C; Wood, G; Azzaro, MP; Palumbo, G; Giustolisi, R; Pras, M; Ostrer, H; Kastner, DL				Aksentijevich, I; Torosyan, Y; Samuels, J; Centola, M; Pras, E; Chae, JJ; Oddoux, C; Wood, G; Azzaro, MP; Palumbo, G; Giustolisi, R; Pras, M; Ostrer, H; Kastner, DL			Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH GENE-FREQUENCY; PERIODIC FEVER; ETHNIC-GROUPS; FMF; INHERITANCE; LINKAGE; 12P13	Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis. The FMF gene (MEFV) was cloned recently, and four missense mutations were identified. Here we present data from non-Ashkenazi Jewish and Arab patients in whom we had not originally found mutations and from a new, more ethnically diverse panel. Among 90 symptomatic mutation-positive individuals, 11 mutations accounted for 79% of carrier chromosomes. Of the two mutations that are novel, one alters the same residue (680) as a previously known mutation, and the other (P369S) is located in exon 3. Consistent with another recent report, the E148Q mutation was observed in patients of several ethnicities and on multiple microsatellite haplotypes, but haplotype data indicate an ancestral relationships between non-Jewish Italian and Ashkenazi Jewish patients with FMF and other affected populations. Among similar to 200 anonymous Ashkenazi Jewish DNA samples, the MEFV carrier frequency was 21%, with E148Q the most common mutation. Several lines of evidence indicate reduced penetrance among Ashkenazi Jews, especially for E148Q, P369S, and K695R. Nevertheless, E148Q helps account for recessive inheritance in an Ashkenazi family previously reported as an unusual case of dominantly inherited FMF The presence of three frequent MEFV mutations in multiple Mediterranean populations strongly suggests a heterozygote advantage in this geographic region.	NIAMSD, Genet Sect, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; NYU Med Ctr, Dept Pediat, Human Genet Program, New York, NY 10016 USA; Chaim Sheba Med Ctr, Dept Med C, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Heller Inst Med Res, IL-52621 Tel Hashomer, Israel; Univ Catania, Inst Hematol, Catania, Italy		Aksentijevich, I (corresponding author), NIAMSD, Genet Sect, Arthrit & Rheumatism Branch, NIH, Bldg 10,Room 9N-214, Bethesda, MD 20892 USA.	aksentii@exchange.nih.gov	Palumbo, Giuseppe/W-7072-2019; Aksentijevich, Ivona/AAF-1335-2019	Palumbo, Giuseppe/0000-0003-1859-6319; samuels, jonathan/0000-0002-1513-770X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [Z01AR041083, ZIAAR041083] Funding Source: NIH RePORTER		Akarsu AN, 1997, J MED GENET, V34, P573, DOI 10.1136/jmg.34.7.573; Aksentijevich I, 1997, CELL, V90, P797; Balow JE, 1997, GENOMICS, V44, P280, DOI 10.1006/geno.1997.4860; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 1998, QJM-INT J MED, V91, P603, DOI 10.1093/qjmed/91.9.603; Breda L, 1998, PANMINERVA MED, V40, P157; BRENNERULLMAN A, 1994, AM J MED GENET, V53, P172, DOI 10.1002/ajmg.1320530210; Centola M, 1998, HUM MOL GENET, V7, P1581, DOI 10.1093/hmg/7.10.1581; DANIELS M, 1995, AM J MED GENET, V55, P311, DOI 10.1002/ajmg.1320550313; Gentiloni N, 1992, Minerva Med, V83, P307; GOODMAN RM, 1979, GENETIC DISORDERS JE, P1; Janeway TC, 1908, T ASSOC AM PHYSICIAN, V23, P504; Kastner DL, 1998, HOSP PRACT, V33, P131, DOI 10.3810/hp.1998.04.90; Kronn D, 1998, ARCH INTERN MED, V158, P777, DOI 10.1001/archinte.158.7.777; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Marinone C, 1992, Ann Ital Med Int, V7, P114; McDermott MF, 1998, AM J HUM GENET, V62, P1446, DOI 10.1086/301886; Mulley J, 1998, AM J HUM GENET, V62, P884, DOI 10.1086/301793; Passiu G, 1984, Minerva Med, V75, P1147; PRAS M, 1982, JOHNS HOPKINS MED J, V150, P22; REICH CB, 1970, ARCH INTERN MED, V125, P337, DOI 10.1001/archinte.125.2.337; ROGERS DB, 1989, AM J MED GENET, V34, P168, DOI 10.1002/ajmg.1320340206; ROSENSTEIN ED, 1994, CLIN EXP RHEUMATOL, V12, P96; Samuels J, 1998, MEDICINE, V77, P268, DOI 10.1097/00005792-199807000-00005; SECCHI GC, 1981, PANMINERVA MED, V23, P249; SIEGAL S, 1964, AM J MED, V36, P893, DOI 10.1016/0002-9343(64)90119-6; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; SOHAR E, 1961, ARCH INTERN MED, V107, P529, DOI 10.1001/archinte.1961.03620040055006; YUVAL Y, 1995, AM J MED GENET, V57, P455, DOI 10.1002/ajmg.1320570319	30	248	253	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					949	962		10.1086/302327			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	WOS:000079632900006	10090880	Bronze, Green Published			2022-01-24	
J	Robertson, NG; Lu, L; Heller, S; Merchant, SN; Eavey, RD; McKenna, M; Nadol, JB; Miyamoto, RT; Linthicum, FH; Neto, JFL; Hudspeth, AJ; Seidman, CE; Morton, CC; Seidman, JG				Robertson, NG; Lu, L; Heller, S; Merchant, SN; Eavey, RD; McKenna, M; Nadol, JB; Miyamoto, RT; Linthicum, FH; Neto, JFL; Hudspeth, AJ; Seidman, CE; Morton, CC; Seidman, JG			Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction	NATURE GENETICS			English	Article							SENSORINEURAL HEARING-LOSS; MYOSIN-VIIA GENE; SERINE-PROTEASE ZYMOGEN; TEMPORAL BONE FINDINGS; EXTRACELLULAR-MATRIX; FACTOR-C; DOMAINS; HYBRIDIZATION; PROTEINS; LIMULUS	DFNA9 is an autosomal dominant, nonsyndromic, progressive sensorineural hearing loss with vestibular pathology. Here we report three missense mutations in human COCH (previously described as Coch5b2), a novel cochlear gene, in three unrelated kindreds with DFNA9. All three residues mutated in DFNA9 are conserved in mouse and chicken Coch, and are found in a region containing four conserved cysteines with homology to a domain in factor C, a lipopolysaccharide-binding coagulation factor in Limulus polyphemus. COCH message, found at high levels in human cochlear and vestibular organs, occurs in the chicken inner ear in the regions of the auditory and vestibular nerve fibres, the neural and abneural limbs adjacent to the cochlear sensory epithelium and the stroma of the crista ampullaris of the vestibular labyrinth. These areas correspond to human inner ear structures which show histopathological findings of acidophilic ground substance in DFNA9 patients.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; Indiana Univ, Sch Med, Dept Otolaryngol, Indianapolis, IN 46202 USA; House Ear Inst, Dept Histopathol, Los Angeles, CA 90057 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA		Morton, CC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA.				NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC03402, DC00317] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC003402] Funding Source: NIH RePORTER		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Benson DW, 1996, CIRCULATION, V93, P1791, DOI 10.1161/01.CIR.93.10.1791; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; COLOMBATTI A, 1991, BLOOD, V77, P2305; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Gorlin RJ., 1995, HEREDITARY HEARING L, P9; HALPIN C, 1996, AM J AUDIOL, V5, P105; IWANAGA S, 1992, THROMB RES, V68, P1, DOI 10.1016/0049-3848(92)90124-S; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KHETARPAL U, 1991, ARCH OTOLARYNGOL, V117, P1032; KHETARPAL U, 1993, ARCH OTOLARYNGOL, V119, P106; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Manolis EN, 1996, HUM MOL GENET, V5, P1047, DOI 10.1093/hmg/5.7.1047; MUTA T, 1991, J BIOL CHEM, V266, P6554; NAKAMURA T, 1988, EUR J BIOCHEM, V176, P89, DOI 10.1111/j.1432-1033.1988.tb14254.x; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Robertson NG, 1997, GENOMICS, V46, P345, DOI 10.1006/geno.1997.5067; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scott DA, 1998, NATURE, V391, P32, DOI 10.1038/34079; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; VanCamp G, 1997, AM J HUM GENET, V60, P758; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191	29	248	274	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					299	303		10.1038/3118			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	WOS:000076698100028	9806553				2022-01-24	
J	Hardison, RC; Oeltjen, J; Miller, W				Hardison, RC; Oeltjen, J; Miller, W			Long human-mouse sequence alignments reveal novel regulatory elements: A reason to sequence the mouse genome	GENOME RESEARCH			English	Article							LOCUS-CONTROL REGION; GLOBIN GENE-CLUSTER; HUMAN ALPHA-GLOBIN; CHROMATIN STRUCTURE; INTRAGENIC SEQUENCES; DNA; EXPRESSION; EVOLUTION; CELLS; SITES		PENN STATE UNIV,CTR GENE REGULAT,UNIVERSITY PK,PA 16802; PENN STATE UNIV,DEPT BIOCHEM & MOL BIOL,UNIVERSITY PK,PA 16802; PENN STATE UNIV,DEPT COMP SCI & ENGN,UNIVERSITY PK,PA 16802; BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030				Hardison, Ross C/G-1142-2010	Hardison, Ross C/0000-0003-4084-7516			ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Boguski MS, 1996, CURR OPIN GENET DEV, V6, P683, DOI 10.1016/S0959-437X(96)80020-7; BOGUSKI MS, 1995, TRENDS BIOCHEM SCI, V20, P295, DOI 10.1016/S0968-0004(00)89051-9; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; CATERINA JJ, 1991, P NATL ACAD SCI USA, V88, P1626, DOI 10.1073/pnas.88.5.1626; CHARNAY P, 1984, CELL, V38, P251, DOI 10.1016/0092-8674(84)90547-6; CRADDOCK CF, 1995, EMBO J, V14, P1718, DOI 10.1002/j.1460-2075.1995.tb07161.x; Dembo A., 1994, ANN PROBAB, V22, P2022; Elnitski L, 1997, J BIOL CHEM, V272, P369; FISCHELGHODSIAN N, 1987, NUCLEIC ACIDS RES, V15, P9215, DOI 10.1093/nar/15.22.9215; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; GROSVELD F, 1993, PHILOS T ROY SOC B, V339, P183, DOI 10.1098/rstb.1993.0015; GROUDINE M, 1983, P NATL ACAD SCI-BIOL, V80, P7551, DOI 10.1073/pnas.80.24.7551; Gumucio DL, 1996, MOL PHYLOGENET EVOL, V5, P18, DOI 10.1006/mpev.1996.0004; HARDISON R, 1991, J MOL BIOL, V222, P233, DOI 10.1016/0022-2836(91)90209-O; Himmelmann A, 1996, BLOOD, V87, P1036, DOI 10.1182/blood.V87.3.1036.bloodjournal8731036; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; Jackson JD, 1996, J BIOL CHEM, V271, P11871, DOI 10.1074/jbc.271.20.11871; Jackson JD, 1996, NUCLEIC ACIDS RES, V24, P4327, DOI 10.1093/nar/24.21.4327; JAMESPEDERSON M, 1995, J BIOL CHEM, V270, P3965, DOI 10.1074/jbc.270.8.3965; KOOP BF, 1995, TRENDS GENET, V11, P367, DOI 10.1016/S0168-9525(00)89108-8; KOOP BF, 1994, NAT GENET, V7, P48, DOI 10.1038/ng0594-48; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; LAM L, 1996, J BIOL CHEM, V13, P32421; LAMERDIN JE, 1995, GENOMICS, V25, P547, DOI 10.1016/0888-7543(95)80056-R; Lamerdin JE, 1996, GENOMICS, V34, P399, DOI 10.1006/geno.1996.0303; LI WH, 1990, P NATL ACAD SCI USA, V87, P6703, DOI 10.1073/pnas.87.17.6703; MAKALOWSKI W, 1996, GENOME RES, V6, P8456; MARGOT JB, 1989, J MOL BIOL, V205, P15, DOI 10.1016/0022-2836(89)90362-8; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Muller S, 1996, ONCOGENE, V13, P1955; Oeltjen JC, 1997, GENOME RES, V7, P315, DOI 10.1101/gr.7.4.315; Robbins J, 1996, CARDIOVASC RES, V31, pE2; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Shewchuk BM, 1997, MOL CELL BIOL, V17, P5856, DOI 10.1128/MCB.17.10.5856; SHEWCHUK BM, 1997, THESIS PENNSYLVANIA; SIDERAS P, 1994, J IMMUNOL, V153, P5607; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; YOST SE, 1993, MOL CELL BIOL, V13, P5439, DOI 10.1128/MCB.13.9.5439	43	248	255	0	3	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724	1054-9803			GENOME RES	Genome Res.	OCT	1997	7	10					959	966		10.1101/gr.7.10.959			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	YC515	WOS:A1997YC51500005	9331366	Bronze			2022-01-24	
J	Schuler, GD				Schuler, GD			Sequence mapping by electronic PCR	GENOME RESEARCH			English	Article							HUMAN GENOME; MAP	The highly specific and sensitive PCR provides the basis for sequence-tagged sites (STSs), unique landmarks that have been used widely in the construction of genetic and physical maps of the human genome. Electronic PCR (e-PCR) refers to the process of recovering these unique sites in DNA sequences by searching for subsequences that closely match the PCR primers and have the correct order, orientation, and spacing that they could plausibly prime the amplification of a PCR product of the correct molecular weight. A software tool was developed to provide an efficient implementation of this search strategy and allow the sort of en masse searching that is required for modern genome analysis. Some sample searches were performed to demonstrate a number of factors that can affect the likelihood of obtaining a match. Analysis of one large sequence database record revealed the presence of several microsatellite and gene-based markers and allowed the exact base-pair distances among them to be calculated. This example provides a demonstration of how e-PCR can be used to integrate the growing body of genomic sequence data with existing maps, reveal relationships among markers that existed previously on different maps, and correlate genetic distances with physical distances.			Schuler, GD (corresponding author), NIH,NATL LIB MED,NATL CTR BIOTECHNOL INFORMAT,BETHESDA,MD 20984, USA.						ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; BANGHAM CRM, 1991, PROTOCOLS HUMAN MOL, P1; Benson DA, 1996, NUCLEIC ACIDS RES, V24, P1, DOI 10.1093/nar/24.1.1; CHUMAKOV IM, 1995, NATURE, V377, P175; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Fasman KH, 1996, NUCLEIC ACIDS RES, V24, P57, DOI 10.1093/nar/24.1.57; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SELIG S, 1995, P NATL ACAD SCI USA, V92, P3702, DOI 10.1073/pnas.92.9.3702; SOMMER R, 1989, NUCLEIC ACIDS RES, V17, P6749, DOI 10.1093/nar/17.16.6749; Wootton JC, 1996, METHOD ENZYMOL, V266, P554	16	248	271	1	12	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724	1054-9803			GENOME RES	Genome Res.	MAY	1997	7	5					541	550		10.1101/gr.7.5.541			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	WX931	WOS:A1997WX93100014	9149949	Green Published, Bronze			2022-01-24	
J	Silva, AJ; Frankland, PW; Marowitz, Z; Friedman, E; Lazlo, G; Cioffi, D; Jacks, T; Bourtchuladze, R				Silva, AJ; Frankland, PW; Marowitz, Z; Friedman, E; Lazlo, G; Cioffi, D; Jacks, T; Bourtchuladze, R			A mouse model for the learning and memory deficits associated with neurofibromatosis type I	NATURE GENETICS			English	Article							LONG-TERM POTENTIATION; TARGETED MUTATION; MICE; BEHAVIOR; HIPPOCAMPAL; EXPRESSION; NEURONS; BRAIN; FEAR; NF1	Neurofibromatosis type I (NF1) is one of the most commonly inherited neurological disorders in humans, affecting approximately one in 4,000 individuals(1-3). NF1 results in a complex cluster of developmental and tumour syndromes that include benign neurofibromas, hyperpigmentation of melanocytes and hamartomas of the iris. Some NF1 patients may also show neurologic lesions, such as optic pathway gliomas, dural ectasia and aqueduct stenosis(1-3). Importantly, learning disabilities occur in 30% to 45% of patients with NF1, even in the absence of any apparent neural pathology. The learning disabilities may include a depression in mean IQ scores, visuoperceptual problems and impairments in spatial cognitive abilities(4-9). Spatial learning has been assessed with a variety of cognitive tasks and the most consistent spatial learning deficits have been observed with the Judgement of Line Orientation test(4,7,10,11). It is important to note that some of these deficits could be secondary to developmental abnormalities(1) and other neurological problems, such as poor motor coordination and attentional deficits(9). Previous studies have suggested a role for neurofibromin in brain function. First, the expression of the Nf1 gene is largely restricted to neuronal tissues in the adult(12-14). Second, this GTPase activating protein may act as a negative regulator of neurotrophin-mediated signalling(15). Third, immunohistochemical studies suggest that activation of astrocytes may be common in the brain of NF1 patients(13). Here, we show that the Nf1(+/-) mutation also affects learning and memory in mice. As in humans, the learning and memory deficits of the Nf1(+/-) mice are restricted to specific types of learning, they are not fully penetrant, they can be compensated for with extended training, and they do not involve deficits in simple associative learning.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; MIT, HOWARD HUGHES MED INST, CAMBRIDGE, MA 02139 USA		Silva, AJ (corresponding author), COLD SPRING HARBOR LAB, POB 100, COLD SPRING HARBOR, NY 11724 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494			BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; DATSON MM, 1992, NEURON, V8, P415; EASTON DF, 1993, AM J HUM GENET, V53, P305; ELDRIDGE R, 1989, AM J DIS CHILD, V143, P833, DOI 10.1001/archpedi.1989.02150190083027; Eliason M J, 1988, Neurofibromatosis, V1, P17; ELIASON MJ, 1986, J DEV BEHAV PEDIATR, V7, P175; GUTMANN DH, 1992, ANN NEUROL, V31, P555, DOI 10.1002/ana.410310515; HOFMAN KJ, 1994, J PEDIATR-US, V124, pS1, DOI 10.1016/S0022-3476(05)83163-4; HUSON SM, 1994, NEUROFIBROMATOSES PA, P204; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JOY P, 1995, DEV MED CHILD NEUROL, V37, P906; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NORDLUND M, 1993, J NEUROSCI, V13, P1588; NORDLUND ML, 1995, J NEUROPATH EXP NEUR, V54, P588, DOI 10.1097/00005072-199507000-00013; NORTH K, 1993, J CHILD NEUROL, V8, P395, DOI 10.1177/088307389300800421; NORTH K, 1995, DEV MED CHILD NEUROL, V37, P427, DOI 10.1111/j.1469-8749.1995.tb12026.x; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; RICCARDI VM, 1992, NEUROFIBROMATOSIS PH, P195; SUTHERLAND RJ, 1982, NEUROSCI LETT, V31, P271, DOI 10.1016/0304-3940(82)90032-5; VARNHAGEN CK, 1988, J DEV BEHAV PEDIATR, V9, P257; VOGEL KS, 1995, CELL, V82, P733, DOI 10.1016/0092-8674(95)90470-0; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	30	248	251	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					281	284		10.1038/ng0397-281			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	WOS:A1997WK38600019	9054942				2022-01-24	
J	TENNYSON, CN; KLAMUT, HJ; WORTON, RG				TENNYSON, CN; KLAMUT, HJ; WORTON, RG			THE HUMAN DYSTROPHIN GENE REQUIRES 16 HOURS TO BE TRANSCRIBED AND IS COTRANSCRIPTIONALLY SPLICED	NATURE GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; MESSENGER-RNA; NASCENT TRANSCRIPTS; NONMUSCLE TISSUES; POLY(A) ADDITION; SITE SELECTION; MAJOR PRODUCT; BRAIN; EXPRESSION	The largest known gene is the human dystrophin gene, which has 79 exons spanning at least 2,300 kilobases (kb). Transcript accumulation was monitored from four regions of the gene following induction of expression in muscle cell cultures. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) results indicate that approximately 12 h are required for transcription of 1,770 kb (at an average elongation rate of 2.4 kb min(-1)), extrapolating to a transcription time of 16 h for the complete gene. Accumulation profiles for spliced and total transcript demonstrated that transcripts are spliced at the 5' end before transcription is complete providing strong evidence for cotranscriptional splicing. The rate of transcript accumulation was reduced at the 3' end of the gene relative to the 5' end, perhaps due to premature termination of transcription complexes.	HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5G 1X8,CANADA		TENNYSON, CN (corresponding author), HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO,ON M5G 1X8,CANADA.						ABEI M, 1987, TRENDS GENET, V3, P102; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; BAUREN G, 1994, CELL, V76, P183, DOI 10.1016/0092-8674(94)90182-1; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; BLAU HM, 1985, ADV EXP MED BIOL, V182, P85; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x; COFFEY AJ, 1992, GENOMICS, V12, P474, DOI 10.1016/0888-7543(92)90437-W; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FORD JP, 1978, J VIROL, V28, P795, DOI 10.1128/JVI.28.3.795-801.1978; GALLI G, 1988, P NATL ACAD SCI USA, V85, P2439, DOI 10.1073/pnas.85.8.2439; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LEDERFEIN D, 1993, HUM MOL GENET, V2, P1883, DOI 10.1093/hmg/2.11.1883; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; LEMAIRE MF, 1990, MOL CELL BIOL, V10, P6059, DOI 10.1128/MCB.10.11.6059; LEV AA, 1987, J BIOL CHEM, V262, P15817; LONDON L, 1991, MOL CELL BIOL, V11, P4599, DOI 10.1128/MCB.11.9.4599; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; Maniatis T, 1989, MOL CLONING; MONACO AP, 1992, GENOMICS, V12, P465, DOI 10.1016/0888-7543(92)90436-V; NEVINS JR, 1978, CELL, V15, P1477, DOI 10.1016/0092-8674(78)90071-5; NUDEL U, 1988, NATURE, V331, P635, DOI 10.1038/331635a0; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; SEHGAL PB, 1976, SCIENCE, V194, P431, DOI 10.1126/science.982026; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; SPENCER CA, 1990, ONCOGENE, V5, P777; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; UCKER DS, 1984, J BIOL CHEM, V259, P7416; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WEBER J, 1980, J VIROL, V33, P286, DOI 10.1128/JVI.33.1.286-291.1980; ZEEVI M, 1981, CELL, V26, P39, DOI 10.1016/0092-8674(81)90031-3	42	248	253	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					184	190		10.1038/ng0295-184			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	WOS:A1995QE67200021	7719347				2022-01-24	
J	HOFFMANN, RJ; BOORE, JL; BROWN, WM				HOFFMANN, RJ; BOORE, JL; BROWN, WM			A NOVEL MITOCHONDRIAL GENOME ORGANIZATION FOR THE BLUE MUSSEL, MYTILUS-EDULIS	GENETICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; ISOLEUCINE TRANSFER-RNA; GENE ORGANIZATION; METHIONINE ANTICODON; DIHYDROURIDINE ARM; ESCHERICHIA-COLI; D-LOOP; DNA; INITIATION; EVOLUTION	The sequence of 13.9 kilobases (kb) of the 17.1-kb mitochondrial genome of Mytilus edulis has been determined, and the arrangement of all genes has been deduced. Mytilus mitochondrial DNA (mtDNA) contains 37 genes, all of which are transcribed from the same DNA strand. The gene content of Mytilus is typically metazoan in that it includes genes for large and small ribosomal RNAs, for a complete set of transfer RNAs and for 12 proteins. The protein genes encode the cytochrome b apoenzyme, cytochrome c oxidase (CO) subunits I-III, NADH dehydrogenase (ND) subunits 1-6 and 4L, and ATP synthetase (ATPase) subunit 6. No gene for ATPase subunit 8 could be found. The reading frames for the ND1, COI, and COIII genes contain long extensions relative to those genes in other metazoan mtDNAs. There are 23 tRNA genes, one more than previously found in any metazoan mtDNA. The additional tRNA appears to specify methionine, making Mytilus mtDNA unique in having two tRNA(Met) genes. Five lengthy unassigned intergenic sequences are present, four of which vary in length from 79 to 119 nucleotides and the largest of which is 1.2 kb. The base compositions of these are unremarkable and do not differ significantly from that of the remainder of the mtDNA. The arrangement of genes in Mytilus mtDNA is remarkably unlike that found in any other known metazoan mtDNA.	UNIV MICHIGAN, DEPT BIOL, ANN ARBOR, MI 48109 USA		HOFFMANN, RJ (corresponding author), IOWA STATE UNIV SCI & TECHNOL, DEPT ZOOL & GENET, AMES, IA 50011 USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM30144] Funding Source: Medline		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BATUECAS B, 1988, NUCLEIC ACIDS RES, V16, P6515, DOI 10.1093/nar/16.14.6515; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Brown WM, 1985, MOL EVOLUTIONARY GEN, P95; CANTATORE P, 1989, J BIOL CHEM, V264, P10965; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DEGIORGI C, 1991, MOL BIOL EVOL, V8, P515; DESJARDINS P, 1991, J MOL EVOL, V32, P153, DOI 10.1007/BF02515387; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUBIN DT, 1986, CURR GENET, V10, P701, DOI 10.1007/BF00410919; FISHER C, 1990, P ROY SOC B-BIOL SCI, V242, P149, DOI 10.1098/rspb.1990.0118; FORAN DR, 1988, NUCLEIC ACIDS RES, V16, P5841, DOI 10.1093/nar/16.13.5841; FRANCIS MA, 1982, J BIOL CHEM, V257, P1195; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072; GUPTA R, 1984, J BIOL CHEM, V259, P9461; GUTHRIE C, 1979, BIOCHEMISTRY-US, V18, P3786, DOI 10.1021/bi00584a023; HARADA F, 1974, BIOCHEMISTRY-US, V13, P300, DOI 10.1021/bi00699a011; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; HIMENO H, 1987, GENE, V56, P219; HOEH WR, 1991, SCIENCE, V251, P1488, DOI 10.1126/science.1672472; HSUCHEN CC, 1984, NUCLEIC ACIDS RES, V12, P7771, DOI 10.1093/nar/12.20.7771; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; JOHANSEN S, 1990, NUCLEIC ACIDS RES, V18, P411, DOI 10.1093/nar/18.3.411; KASHDAN MA, 1982, J BIOL CHEM, V257, P1191; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MCCRACKEN A, 1987, CURR GENET, V11, P625, DOI 10.1007/BF00393926; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MORITZ C, 1986, SCIENCE, V233, P1425, DOI 10.1126/science.3018925; MORITZ C, 1987, P NATL ACAD SCI USA, V84, P7183, DOI 10.1073/pnas.84.20.7183; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.es.18.110187.001413; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OKIMOTO R, 1990, EMBO J, V9, P3405, DOI 10.1002/j.1460-2075.1990.tb07542.x; OKIMOTO R, 1990, NUCLEIC ACIDS RES, V18, P6113, DOI 10.1093/nar/18.20.6113; OKIMOTO R, 1991, NUCLEIC ACIDS RES, V19, P1619, DOI 10.1093/nar/19.7.1619; PAABO S, 1991, J MOL EVOL, V33, P426, DOI 10.1007/BF02103134; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; Poinar GO, 1983, NATURAL HIST NEMATOD; ROE BA, 1985, J BIOL CHEM, V260, P9759; SANKOFF D, 1990, METHOD ENZYMOL, V183, P428; SEDEROFF RR, 1984, ADV GENET, V22, P1, DOI 10.1016/S0065-2660(08)60038-3; SKIBINSKI DOF, 1978, EVOLUTION, V32, P354, DOI 10.1111/j.1558-5646.1978.tb00651.x; SKIBINSKI DOF, 1987, P WORLD S SELECTION, V1, P209; SMITH MJ, 1990, J MOL EVOL, V31, P195, DOI 10.1007/BF02109496; SMITH MJ, 1989, GENE, V76, P181, DOI 10.1016/0378-1119(89)90022-X; SNYDER M, 1987, P NATL ACAD SCI USA, V84, P7595, DOI 10.1073/pnas.84.21.7595; SPRINZL M, 1991, NUCLEIC ACIDS RES, V19, P2127, DOI 10.1093/nar/19.suppl.2127; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2971, DOI 10.1093/nar/10.9.2971; UHLENBUSCH I, 1987, CURR GENET, V11, P631, DOI 10.1007/BF00393927; WARRIOR R, 1985, ARCH SCI, V38, P439; WEBER F, 1990, NUCLEIC ACIDS RES, V18, P5027, DOI 10.1093/nar/18.17.5027; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324; WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0; ZEVERING CE, 1991, J MOL EVOL, V33, P431, DOI 10.1007/BF02103135; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	60	248	268	2	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	JUN	1992	131	2					397	412					16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW759	WOS:A1992HW75900015	1386586				2022-01-24	
J	CHRISTIAN, JC; KANG, KW; NORTON, JA				CHRISTIAN, JC; KANG, KW; NORTON, JA			CHOICE OF AN ESTIMATE OF GENETIC VARIANCE FROM TWIN DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV, SCH MED, DEPT MED GENET, INIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, DEPT PSYCHIAT, SECT BIOSTATIST, INDIANAPOLIS, IN 46202 USA								COCHRAN WG, 1951, BIOMETRICS, V7, P17, DOI 10.2307/3001601; HASEMAN JK, 1970, BEHAV GENET, V1, P11, DOI 10.1007/BF01067367; HJORTLAND MC, 1972, THESIS U MINNESOTA; KEMPTHORNE O, 1961, AM J HUM GENET, V13, P320; [No title captured]; [No title captured]	6	248	248	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	2					154	161					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S7582	WOS:A1974S758200004	4856692				2022-01-24	
J	Alvarez, MJ; Shen, Y; Giorgi, FM; Lachmann, A; Ding, BB; Ye, BH; Califano, A				Alvarez, Mariano J.; Shen, Yao; Giorgi, Federico M.; Lachmann, Alexander; Ding, B. Belinda; Ye, B. Hilda; Califano, Andrea			Functional characterization of somatic mutations in cancer using network-based inference of protein activity	NATURE GENETICS			English	Article							GENE SET ENRICHMENT; TRANSCRIPTION FACTOR ACTIVITY; DIFFERENTIAL EXPRESSION; REGULATORY PROGRAMS; SMALL MOLECULES; PATHWAYS; IDENTIFICATION; PROGRESSION; DISEASE	Identifying the multiple dysregulated oncoproteins that contribute to tumorigenesis in a given patient is crucial for developing personalized treatment plans. However, accurate inference of aberrant protein activity in biological samples is still challenging as genetic alterations are only partially predictive and direct measurements of protein activity are generally not feasible. To address this problem we introduce and experimentally validate a new algorithm, virtual inference of protein activity by enriched regulon analysis ( VIPER), for accurate assessment of protein activity from gene expression data. We used VIPER to evaluate the functional relevance of genetic alterations in regulatory proteins across all samples in The Cancer Genome Atlas ( TCGA). In addition to accurately infer aberrant protein activity induced by established mutations, we also identified a fraction of tumors with aberrant activity of druggable oncoproteins despite a lack of mutations, and vice versa. In vitro assays confirmed that VIPER-inferred protein activity outperformed mutational analysis in predicting sensitivity to targeted inhibitors.	[Alvarez, Mariano J.; Shen, Yao; Giorgi, Federico M.; Lachmann, Alexander; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Alvarez, Mariano J.; Shen, Yao] DarwinHealth Inc, New York, NY 11040 USA; [Ding, B. Belinda; Ye, B. Hilda] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Motor Neuron Ctr, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Columbia Initiat Stem Cells, New York, NY 10027 USA		Alvarez, MJ; Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.; Alvarez, MJ (corresponding author), DarwinHealth Inc, New York, NY 11040 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Motor Neuron Ctr, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Columbia Initiat Stem Cells, New York, NY 10027 USA.	malvarez@darwinhealth.com; ac2248@cumc.columbia.edu	Giorgi, Federico M./AAD-5797-2020; Lachmann, Alexander/AAF-1940-2020	Giorgi, Federico M./0000-0002-7325-9908; Lachmann, Alexander/0000-0002-1982-7652; Califano, Andrea/0000-0003-4742-3679	National Institutes of Health (NIH) Roadmap National Centers for Biomedical Computing [5U54CA121852]; NIH Library of Integrated Network-based Cellular Signatures program [1U01CA164184]; National Cancer Institute (NCI) Cancer Target Discovery and Development program [1U01CA168426]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD012351, S10OD021764, R01CA85573]; Lauri Strauss Leukemia Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R35CA197745, U01CA164184, U01CA168426, R01CA085573, U54CA121852, P30CA013330] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD012351, S10OD021764] Funding Source: NIH RePORTER	We thank G. Riekhof for critical insight and help with drafting the manuscript. This work was supported by the National Institutes of Health (NIH) Roadmap National Centers for Biomedical Computing (5U54CA121852), the NIH Library of Integrated Network-based Cellular Signatures program (1U01CA164184), the National Cancer Institute (NCI) Cancer Target Discovery and Development program (1U01CA168426), and the NIH instrumentation grants (S10OD012351 and S10OD021764). Additional support was from NIH (R01CA85573) to B.H.Y. and a fellowship grant from the Lauri Strauss Leukemia Foundation to B.B.D. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI as of January 2011.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Adjibade P, 2014, SEMIN CELL DEV BIOL, V34, P15, DOI 10.1016/j.semcdb.2014.05.013; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alvarez MJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r143; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Benaglia T, 2009, J STAT SOFTW, V32, P1; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Boorsma A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003112; Bozovic A, 2013, CLIN BIOCHEM, V46, P444, DOI 10.1016/j.clinbiochem.2012.09.024; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Dudoit S, 2003, BIOTECHNIQUES, P45; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kundaje A, 2007, ANN NY ACAD SCI, V1115, P178, DOI 10.1196/annals.1407.020; Kushwaha R, 2015, STEM CELLS, V33, P367, DOI 10.1002/stem.1870; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MacConaill LE, 2014, J MOL DIAGN, V16, P660, DOI 10.1016/j.jmoldx.2014.06.004; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; R Development Core team, 2012, R LANG ENV STAT COMP; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rodriguez JA, 2014, SEMIN CANCER BIOL, V27, P11, DOI 10.1016/j.semcancer.2014.03.005; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P264; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wolf-Yadlin A, 2009, CURR OPIN CHEM BIOL, V13, P398, DOI 10.1016/j.cbpa.2009.06.027; Yoruk E, 2011, IEEE ACM T COMPUT BI, V8, P592, DOI 10.1109/TCBB.2010.87	62	247	247	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					838	+		10.1038/ng.3593			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	WOS:000380755100006	27322546	Green Accepted			2022-01-24	
J	Moriyama, T; Nishii, R; Perez-Andreu, V; Yang, WJ; Klussmann, FA; Zhao, XJ; Lin, TN; Hoshitsuki, K; Nersting, J; Kihira, K; Hofmann, U; Komada, Y; Kato, M; McCorkle, R; Li, L; Koh, K; Najera, CR; Kham, SKY; Isobe, T; Chen, ZW; Chiew, EKH; Bhojwani, D; Jeffries, C; Lu, Y; Schwab, M; Inaba, H; Pui, CH; Relling, MV; Manabe, A; Hori, H; Schmiegelow, K; Yeoh, AEJ; Evans, WE; Yang, JJ				Moriyama, Takaya; Nishii, Rina; Perez-Andreu, Virginia; Yang, Wenjian; Klussmann, Federico Antillon; Zhao, Xujie; Lin, Ting-Nien; Hoshitsuki, Keito; Nersting, Jacob; Kihira, Kentaro; Hofmann, Ute; Komada, Yoshihiro; Kato, Motohiro; McCorkle, Robert; Li, Lie; Koh, Katsuyoshi; Najera, Cesar Rolando; Kham, Shirley Kow-Yin; Isobe, Tomoya; Chen, Zhiwei; Chiew, Edwynn Kean-Hui; Bhojwani, Deepa; Jeffries, Cynthia; Lu, Yan; Schwab, Matthias; Inaba, Hiroto; Pui, Ching-Hon; Relling, Mary V.; Manabe, Atsushi; Hori, Hiroki; Schmiegelow, Kjeld; Yeoh, Allen E. J.; Evans, William E.; Yang, Jun J.			NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INFLAMMATORY-BOWEL-DISEASE; S-METHYLTRANSFERASE DEFICIENCY; DNA MISMATCH REPAIR; MAINTENANCE THERAPY; CROHNS-DISEASE; 6-THIOGUANINE NUCLEOTIDES; MERCAPTOPURINE METABOLISM; CATALYTIC-ACTIVITY; DOUBLE-BLIND	Widely used as anticancer and immunosuppressive agents, thiopurines have narrow therapeutic indices owing to frequent toxicities, partly explained by TPMT genetic polymorphisms. Recent studies identified germline NUDT15 variation as another critical determinant of thiopurine intolerance, but the underlying molecular mechanisms and the clinical implications of this pharmacogenetic association remain unknown. In 270 children enrolled in clinical trials for acute lymphoblastic leukemia in Guatemala, Singapore and Japan, we identified four NUDT15 coding variants (p.Arg139Cys, p.Arg139His, p.Val18Ile and p.Val18_Val19insGlyVal) that resulted in 74.4-100% loss of nucleotide diphosphatase activity. Loss-of-function NUDT15 diplotypes were consistently associated with thiopurine intolerance across the three cohorts (P = 0.021, 2.1 x 10(-5) and 0.0054, respectively; meta-analysis P = 4.45 x 10(-8), allelic effect size = -11.5). Mechanistically, NUDT15 inactivated thiopurine metabolites and decreased thiopurine cytotoxicity in vitro, and patients with defective NUDT15 alleles showed excessive levels of thiopurine active metabolites and toxicity. Taken together, these results indicate that a comprehensive pharmacogenetic model integrating NUDT15 variants may inform personalized thiopurine therapy.	[Moriyama, Takaya; Perez-Andreu, Virginia; Yang, Wenjian; Zhao, Xujie; Lin, Ting-Nien; Hoshitsuki, Keito; McCorkle, Robert; Li, Lie; Relling, Mary V.; Evans, William E.; Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Moriyama, Takaya; Kihira, Kentaro; Komada, Yoshihiro; Hori, Hiroki] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie, Japan; [Nishii, Rina] Tokyo Med & Dent Univ, Grad Sch Med, Dept Pediat & Dev Biol, Tokyo, Japan; [Klussmann, Federico Antillon; Najera, Cesar Rolando] Unidad Nacl Oncol Pediat, Guatemala City, Guatemala; [Klussmann, Federico Antillon] Francisco Marroquin Med Sch, Guatemala City, Guatemala; [Hoshitsuki, Keito] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA; [Nersting, Jacob; Schmiegelow, Kjeld] Univ Copenhagen Hosp, Rigshosp, Dept Paediat & Adolescent Med, DK-2100 Copenhagen, Denmark; [Hofmann, Ute; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Hofmann, Ute; Schwab, Matthias] Univ Hosp Tubingen, Dept Clin Pharmacol, Tubingen, Germany; [Kato, Motohiro] Natl Ctr Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Kham, Shirley Kow-Yin; Chiew, Edwynn Kean-Hui; Yeoh, Allen E. J.] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore; [Isobe, Tomoya] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Isobe, Tomoya] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Bhojwani, Deepa] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Jeffries, Cynthia; Lu, Yan] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Schwab, Matthias] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Schwab, Matthias] Univ Tubingen, Dept Biochem & Pharm, Tubingen, Germany; [Inaba, Hiroto; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Schmiegelow, Kjeld] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark; [Yeoh, Allen E. J.] Natl Univ Singapore, Yong Loo Lin Sch Med, VIVA Univ Childrens Canc Ctr, Singapore 117595, Singapore		Yang, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	jun.yang@stjude.org	Nishii, Rina/AAC-4177-2022; Hoshitsuki, Keito/F-9429-2019; Relling, Mary/N-5032-2018; Yang, Jun J./ABG-5646-2020; Pui, Ching-Hon/N-8076-2018; Yeoh, Allen EJ/D-9663-2015; Schwab, Matthias/ABH-7449-2020; McCorkle, Rob/AAH-3759-2019; Inaba, Hiroto/N-3366-2018; Evans, William E./C-2069-2012	Hoshitsuki, Keito/0000-0002-6723-0711; Yang, Jun J./0000-0002-0770-9659; Pui, Ching-Hon/0000-0003-0303-5658; Yeoh, Allen EJ/0000-0002-6454-976X; McCorkle, Rob/0000-0002-5028-8853; Inaba, Hiroto/0000-0003-0605-7342; Evans, William E./0000-0002-9333-5322; Bhojwani, Deepa/0000-0002-7559-7927; Loh, Mignon/0000-0003-4099-4700; Hofmann, Ute/0000-0003-0823-9027; Zhao, Xujie/0000-0001-7213-2270; Kato, Motohiro/0000-0001-5145-1774; Moriyama, Takaya/0000-0001-8864-4174	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA021765, GM115279]; American Lebanese Syrian Associated Charities of St. Jude Children's Research HospitalAmerican Lebanese Syrian Associated Charities (ALSAC); Order of St. Francis Foundation; V Foundation for Cancer Research; Danish Childhood Cancer Foundation; Japanese Ministry of Health; National Medical Research Council (Singapore)National Medical Research Council, Singapore; Children's Cancer Foundation; Viva Foundation for Children with Cancer; Mie Prefecture Study-Abroad Scholarship (Mie, Japan); Robert Bosch Foundation (Stuttgart, Germany); Pediatric Oncology Education Program [CA23944]; Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R25CA023944, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM115279] Funding Source: NIH RePORTER	We thank the patients and parents who participated in the clinical trials included in this study, H. Toyoda at Mie University for his assistance in processing the Japanese Pediatric Leukemia/Lymphoma Study Group samples and C. Smith at St. Jude Children's Research Hospital for querying the 1000 Genomes Project data. This work was supported by the US National Institutes of Health (CA021765 and GM115279), the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital, the Order of St. Francis Foundation, the V Foundation for Cancer Research and the Danish Childhood Cancer Foundation. The Japanese Pediatric Leukemia/Lymphoma Study Group ALL B12 study is supported by the Japanese Ministry of Health, and the MaSpore ALL studies are supported by the National Medical Research Council (Singapore), Children's Cancer Foundation and the Viva Foundation for Children with Cancer. J.J.Y. is an American Society of Hematology Scholar. T.M. is supported by the Mie Prefecture Study-Abroad Scholarship (Mie, Japan). U.H. and M.S. are supported by the Robert Bosch Foundation (Stuttgart, Germany). K.H. is supported by the Pediatric Oncology Education Program grant (CA23944). T.I. is supported by Alex's Lemonade Stand Foundation's pediatric oncology student training (POST) program.	Antillon-Klussmann F, 2010, PEDIATR BLOOD CANCER, V55, P861; Arico M, 2005, Leukemia, V19, P1145, DOI 10.1038/sj.leu.2403783; CANDY S, 1995, GUT, V37, P674, DOI 10.1136/gut.37.5.674; Carter M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8871; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; de Boer NKH, 2007, NAT CLIN PRACT GASTR, V4, P686, DOI 10.1038/ncpgasthep1000; de Jong DJ, 2004, EUR J GASTROEN HEPAT, V16, P207, DOI 10.1097/00042737-200402000-00014; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Ebbesen MS, 2013, J CLIN PHARMACOL, V53, P670, DOI 10.1002/jcph.81; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; Fotoohi AK, 2010, BIOCHEM PHARMACOL, V79, P1211, DOI 10.1016/j.bcp.2010.01.006; Fraser AG, 2002, GUT, V50, P485, DOI 10.1136/gut.50.4.485; Gardiner SJ, 2008, CLIN GASTROENTEROL H, V6, P654, DOI 10.1016/j.cgh.2008.02.032; Goldberg R, 2015, EXPERT REV GASTROENT, V9, P891, DOI 10.1586/17474124.2015.1039987; Hanauer SB, 2004, GASTROENTEROLOGY, V127, P723, DOI 10.1053/j.gastro.2004.06.002; Hedeland RL, 2010, CANCER CHEMOTH PHARM, V66, P485, DOI 10.1007/s00280-009-1184-5; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hindorf U, 2006, ALIMENT PHARM THER, V24, P331, DOI 10.1111/j.1365-2036.2006.02977.x; Hofmann U, 2012, ANAL CHEM, V84, P1294, DOI 10.1021/ac2031699; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Jacobsen JH, 2012, J CHROMATOGR B, V881-82, P115, DOI 10.1016/j.jchromb.2011.11.032; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Kakuta Y, 2016, PHARMACOGENOMICS J, V16, P280, DOI 10.1038/tpj.2015.43; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Kham SKY, 2008, EUR J CLIN PHARMACOL, V64, P373, DOI 10.1007/s00228-007-0426-x; KOREN G, 1990, NEW ENGL J MED, V323, P17, DOI 10.1056/NEJM199007053230104; Krynetskaia NF, 2003, MOL PHARMACOL, V64, P456, DOI 10.1124/mol.64.2.456; KRYNETSKI EY, 1995, P NATL ACAD SCI USA, V92, P949, DOI 10.1073/pnas.92.4.949; Krynetski EY, 2003, CANCER RES, V63, P100; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LENNARD L, 1989, J CLIN ONCOL, V7, P1816, DOI 10.1200/JCO.1989.7.12.1816; LILLEYMAN JS, 1994, LANCET, V343, P1188, DOI 10.1016/S0140-6736(94)92400-7; Maltzman JS, 2003, J CLIN INVEST, V111, P1122, DOI 10.1172/JCI200318384; McLennan AG, 2000, ADV EXP MED BIOL, V486, P115; Meyer JA, 2013, NAT GENET, V45, P290, DOI 10.1038/ng.2558; POSTHUMA EFM, 1995, GUT, V36, P311, DOI 10.1136/gut.36.2.311; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Regueiro M, 2002, J CLIN GASTROENTEROL, V35, P240, DOI 10.1097/00004836-200209000-00008; Reinisch W, 2010, GUT, V59, P752, DOI 10.1136/gut.2009.194159; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Relling MV, 2010, LANCET ONCOL, V11, P507, DOI 10.1016/S1470-2045(10)70097-8; Relling MV, 2006, BLOOD, V107, P843, DOI 10.1182/blood-2005-08-3379; Relling MV, 1999, BLOOD, V93, P2817; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Richards S, 1996, LANCET, V347, P1783; Schmiegelow K, 2009, LEUKEMIA, V23, P557, DOI 10.1038/leu.2008.316; Schmiegelow K, 2014, J PEDIAT HEMATOL ONC, V36, P503, DOI 10.1097/MPH.0000000000000206; Schwab M, 2002, PHARMACOGENETICS, V12, P429, DOI 10.1097/00008571-200208000-00003; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Tai HL, 1996, AM J HUM GENET, V58, P694; Tai HL, 1997, P NATL ACAD SCI USA, V94, P6444, DOI 10.1073/pnas.94.12.6444; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Tanaka Y, 2015, BRIT J HAEMATOL, V171, P109, DOI 10.1111/bjh.13518; Teml A, 2007, CLIN PHARMACOKINET, V46, P187, DOI 10.2165/00003088-200746030-00001; TIDD DM, 1974, CANCER RES, V34, P733; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Vora A, 2013, LANCET ONCOL, V14, P199, DOI 10.1016/S1470-2045(12)70600-9; Xu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8553; Yang JJ, 2015, J CLIN ONCOL, V33, P1235, DOI 10.1200/JCO.2014.59.4671; Yang Jun J, 2013, Methods Mol Biol, V999, P273, DOI 10.1007/978-1-62703-357-2_20; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; Yeoh AEJ, 2012, J CLIN ONCOL, V30, P2384, DOI 10.1200/JCO.2011.40.5936	65	247	264	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					367	+		10.1038/ng.3508			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	WOS:000372908800008	26878724	Green Accepted			2022-01-24	
J	Varshney, GK; Pei, WH; LaFave, MC; Idol, J; Xu, LS; Gallardo, V; Carrington, B; Bishop, K; Jones, M; Li, MY; Harper, U; Huang, SC; Prakash, A; Chen, WB; Sood, R; Ledin, J; Burgess, SM				Varshney, Gaurav K.; Pei, Wuhong; LaFave, Matthew C.; Idol, Jennifer; Xu, Lisha; Gallardo, Viviana; Carrington, Blake; Bishop, Kevin; Jones, MaryPat; Li, Mingyu; Harper, Ursula; Huang, Sunny C.; Prakash, Anupam; Chen, Wenbiao; Sood, Raman; Ledin, Johan; Burgess, Shawn M.			High-throughput gene targeting and phenotyping in zebrafish using CRISPR/Cas9	GENOME RESEARCH			English	Article							CHROMOSOMAL DELETIONS; CAS9 NUCLEASE; DNA CLEAVAGE; GENOME-WIDE; RNA; EXPRESSION; SEQUENCE; INVERSIONS; MUTATIONS; RESOURCE	The use of CRISPR/Cas9 as a genome-editing tool in various model organisms has radically changed targeted mutagenesis. Here, we present a high-throughput targeted mutagenesis pipeline using CRISPR/Cas9 technology in zebrafish that will make possible both saturation mutagenesis of the genome and large-scale phenotyping efforts. We describe a cloning-free single-guide RNA (sgRNA) synthesis, coupled with streamlined mutant identification methods utilizing fluorescent PCR and multiplexed, high-throughput sequencing. We report germline transmission data from 162 loci targeting 83 genes in the zebrafish genome, in which we obtained a 99% success rate for generating mutations and an average germline transmission rate of 28%. We verified 678 unique alleles from 58 genes by high-throughput sequencing. We demonstrate that our method can be used for efficient multiplexed gene targeting. We also demonstrate that phenotyping can be done in the F-1 generation by inbreeding two injected founder fish, significantly reducing animal husbandry and time. This study compares germline transmission data from CRISPR/Cas9 with those of TALENs and ZFNs and shows that efficiency of CRISPR/Cas9 is sixfold more efficient than other techniques. We show that the majority of published "rules" for efficient sgRNA design do not effectively predict germline transmission rates in zebrafish, with the exception of a GG or GA dinucleotide genomic match at the 5' end of the sgRNA. Finally, we show that predicted off-target mutagenesis is of low concern for in vivo genetic studies.	[Varshney, Gaurav K.; Pei, Wuhong; LaFave, Matthew C.; Idol, Jennifer; Xu, Lisha; Gallardo, Viviana; Carrington, Blake; Bishop, Kevin; Huang, Sunny C.; Prakash, Anupam; Sood, Raman; Burgess, Shawn M.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Jones, MaryPat; Harper, Ursula] NHGRI, Canc Genet & Comparat Genom Branch, NIH, Bethesda, MD 20892 USA; [Li, Mingyu; Chen, Wenbiao] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Ledin, Johan] Uppsala Univ, Dept Organismal Biol, Sci Life Lab, SE-75236 Uppsala, Sweden		Burgess, SM (corresponding author), NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA.	burgess@mail.nih.gov	Chen, Wenbiao/ABG-1276-2020	Chen, Wenbiao/0000-0002-0750-8275; Ledin, Johan/0000-0002-7319-7735; Varshney, Gaurav K./0000-0002-0429-1904; LaFave, Matthew/0000-0001-9165-041X; Li, Mingyu/0000-0003-1217-2929; Burgess, Shawn/0000-0003-1147-0596	National Human Genome Research Institute (NHGRI), National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01DK088686]; Science for Life Laboratory, Sweden; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [ZICHG200351, ZICHG200346, ZIAHG000183, ZIAHG200386, ZIGHG200351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK088686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R21GM110311] Funding Source: NIH RePORTER	We thank Colin Huck, Dustin Prebilic, and other staff of the National Institutes of Health zebrafish facility for excellent animal care, Julia Fekecs for illustrations and graphics work, and Robert Blakesley, Alice Young, Baishali Maskeri, and the National Intramural Sequencing Center (NISC) for providing sequence data. This research was supported by the Intramural Research Program of the National Human Genome Research Institute (NHGRI), National Institutes of Health (S.M.B. and R.S.), R01DK088686 (W.C.), and Science for Life Laboratory, Sweden (J.L.).	Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Busch-Nentwich E, 2004, DEVELOPMENT, V131, P943, DOI 10.1242/dev.00961; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis EE, 2014, BBA-MOL BASIS DIS, V1842, P1960, DOI 10.1016/j.bbadis.2014.05.024; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischer S, 2003, DEVELOPMENT, V130, P3515, DOI 10.1242/dev.00537; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Haffter P, 1996, DEVELOPMENT, V123, P1; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/NMETH.2364, 10.1038/nmeth.2364]; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; LaFave MC, 2014, GENETICS, V198, P167, DOI 10.1534/genetics.114.166769; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lim SM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r69; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin M., 2013, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Ota S, 2010, GENESIS, V48, P707, DOI 10.1002/dvg.20682; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Phillips JB, 2011, DIS MODEL MECH, V4, P786, DOI 10.1242/dmm.006429; R Core Team, 2018, R LANG ENV STAT COMP; Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sood R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057239; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; Varshney GK, 2013, NUCLEIC ACIDS RES, V41, pD861, DOI 10.1093/nar/gks946; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yoon C, 1997, DEVELOPMENT, V124, P3157	54	247	259	5	93	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2015	25	7					1030	1042		10.1101/gr.186379.114			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CM0GR	WOS:000357356900010	26048245	Green Published, Green Submitted, hybrid			2022-01-24	
J	Poirier, K; Lebrun, N; Broix, L; Tian, G; Saillour, Y; Boscheron, C; Parrini, E; Valence, S; Saint Pierre, B; Oger, M; Lacombe, D; Genevieve, D; Fontana, E; Darra, F; Cances, C; Barth, M; Bonneau, D; Dalla Bernadina, B; N'Guyen, S; Gitiaux, C; Parent, P; Portes, VD; Pedespan, JM; Legrez, V; Castelnau-Ptakine, L; Nitschke, P; Hieu, T; Masson, C; Zelenika, D; Andrieux, A; Francis, F; Guerrini, R; Cowan, NJ; Bahi-Buisson, N; Chelly, J				Poirier, Karine; Lebrun, Nicolas; Broix, Loic; Tian, Guoling; Saillour, Yoann; Boscheron, Cecile; Parrini, Elena; Valence, Stephanie; Saint Pierre, Benjamin; Oger, Madison; Lacombe, Didier; Genevieve, David; Fontana, Elena; Darra, Franscesca; Cances, Claude; Barth, Magalie; Bonneau, Dominique; Dalla Bernadina, Bernardo; N'Guyen, Sylvie; Gitiaux, Cyril; Parent, Philippe; Portes, Vincent des; Pedespan, Jean Michel; Legrez, Victoire; Castelnau-Ptakine, Laetitia; Nitschke, Patrick; Hieu, Thierry; Masson, Cecile; Zelenika, Diana; Andrieux, Annie; Francis, Fiona; Guerrini, Renzo; Cowan, Nicholas J.; Bahi-Buisson, Nadia; Chelly, Jamel			Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly	NATURE GENETICS			English	Article							NEURONAL MIGRATION DEFECTS; SEVERE INTELLECTUAL DISABILITY; MICROTUBULE-BINDING DOMAIN; DNA-SEQUENCING DATA; GAMMA-TUBULIN; CYTOPLASMIC DYNEIN; KINESIN; PROTEIN; GENE; CHAPERONIN	The genetic causes of malformations of cortical development (MCD) remain largely unknown. Here we report the discovery of multiple pathogenic missense mutations in TUBG1, DYNC1H1 and KIF2A, as well as a single germline mosaic mutation in KIF5C, in subjects with MCD. We found a frequent recurrence of mutations in DYNC1H1, implying that this gene is a major locus for unexplained MCD. We further show that the mutations in KIF5C, KIF2A and DYNC1H1 affect ATP hydrolysis, productive protein folding and microtubule binding, respectively. In addition, we show that suppression of mouse Tubg1 expression in vivo interferes with proper neuronal migration, whereas expression of altered gamma-tubulin proteins in Saccharomyces cerevisiae disrupts normal microtubule behavior. Our data reinforce the importance of centrosomal and microtubule-related proteins in cortical development and strongly suggest that microtubule-dependent mitotic and postmitotic processes are major contributors to the pathogenesis of MCD.	[Poirier, Karine; Lebrun, Nicolas; Broix, Loic; Saillour, Yoann; Valence, Stephanie; Saint Pierre, Benjamin; Oger, Madison; Castelnau-Ptakine, Laetitia; Bahi-Buisson, Nadia; Chelly, Jamel] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France; [Poirier, Karine; Lebrun, Nicolas; Broix, Loic; Saillour, Yoann; Valence, Stephanie; Saint Pierre, Benjamin; Oger, Madison; Castelnau-Ptakine, Laetitia; Bahi-Buisson, Nadia; Chelly, Jamel] INSERM, U1016, Paris, France; [Tian, Guoling; Cowan, Nicholas J.] NYU, Med Ctr, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA; [Boscheron, Cecile; Andrieux, Annie] Univ Grenoble 1, INSERM, Inst Neurosci, U836, Grenoble, France; [Parrini, Elena; Guerrini, Renzo] Univ Florence, A Meyer Childrens Hosp, Pediat Neurol Unit & Labs, Florence, Italy; [Parrini, Elena; Guerrini, Renzo] Stella Maris Fdn, IRCCS, Pisa, Italy; [Lacombe, Didier] CHU Pellegrin, Dept Med Genet, Bordeaux, France; [Genevieve, David] Univ Montpellier I, INSERM, Dept Med Genet, U844, Montpellier, France; [Fontana, Elena; Darra, Franscesca; Dalla Bernadina, Bernardo] Azienda Osped Univ Verona, UOC Neuropsichiatria Infantile, Verona, Italy; [Cances, Claude] CHU Toulouse, Dept Pediat, Toulouse, France; [Barth, Magalie; Bonneau, Dominique] Univ Angers, INSERM, U694, CHU 4, Angers, France; [Barth, Magalie; Bonneau, Dominique; Gitiaux, Cyril] CHU Angers, Serv Genet, Angers, France; [N'Guyen, Sylvie] CHU Nantes, Clin Med Pediat, F-44035 Nantes 01, France; [Gitiaux, Cyril; Bahi-Buisson, Nadia] Univ Paris 05, Hop Necker Enfants Malad, Unite Neurol Pediat, Paris, France; [Parent, Philippe] Serv Pediat & Genet Med, Brest, France; [Portes, Vincent des] Univ Lyon 1, CHU Lyon, Ctr Reference Deficiences Intellectuelles Causes, CNRS,L2C2, Bron, France; [Pedespan, Jean Michel] CHU Pellegrin, Serv Pediat, Bordeaux, France; [Legrez, Victoire] CHU Bicetre, Serv Neuropediat, Le Kremlin Bicetre, France; [Nitschke, Patrick; Hieu, Thierry; Masson, Cecile] Univ Paris 05, Paris, France; [Zelenika, Diana] CNG, Evry, France; [Francis, Fiona] INSERM, Inst Fer Moulin, Paris, France; [Francis, Fiona] Univ Paris 06, Paris, France		Chelly, J (corresponding author), Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France.	nicholas.cowan@nyumc.org; jamel.chelly@inserm.fr	Francis, Fiona/B-5854-2016; POIRIER, Karine/N-3009-2018; Chelly, Jamel/J-7528-2015; ANDRIEUX, ANNIE/B-2134-2017; Bonneau, Dominique/K-6110-2015; lacombe, didier/K-7967-2014; Gitiaux, Cyril/AAB-9102-2020; Parrini, Elena/K-5283-2016; Bahi-Buisson, Nadia/H-5207-2017; DARRA, Francesca/J-7297-2018	POIRIER, Karine/0000-0002-7928-2906; Chelly, Jamel/0000-0002-0939-8719; ANDRIEUX, ANNIE/0000-0002-4022-6405; Guerrini, Renzo/0000-0002-7272-7079; Parrini, Elena/0000-0001-8933-7694; Francis, Fiona/0000-0001-8542-7537; Lacombe, Didier/0000-0002-8956-2207; Bahi-Buisson, Nadia/0000-0002-5352-0929; Gitiaux, Cyril/0000-0002-2190-6843; Fontana, Elena/0000-0002-4553-2452; Bonneau, Dominique/0000-0002-6886-0969; DARRA, Francesca/0000-0002-1062-8438	INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; Fondation pour la Recherche MedicaleFondation pour la Recherche Medicale; Fondation JED; Fondation Maladies Rares; Agence National de RechercheFrench National Research Agency (ANR) [ANR Blanc 1103 01, R11039KK, ANR E-Rare-012-01, E10107KP]; EU-FP7 project GENECODYS [241995]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM097376]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM097376] Funding Source: NIH RePORTER	We are grateful to the patients and their families for their participation. We thank F.J. Fourniol, N. Levy and members of the Chelly lab for their thoughtful comments and help. We thank I. Gibbons and A. Carter (Medical Research Council Laboratory of Molecular Biology) for providing the seryl-tRNA synthetase dynein heavy chain fusion constructs used in the experiments described in this paper. A full-length cDNA encoding human KIF5C was generously provided by F.A. Stephenson (School of Pharmacy, University College London). A full-length cDNA encoding human gamma-tubulin was generously provided by B.R. Oakley (Department of Molecular Biosciences, University of Kansas). We also thank members of the Cochin Hospital Cell Bank, the Centre National de Genotypage, Genoscope, the Paris Descartes Bioinformatics platforms and the Cochin Institute genomic platform for their technical and bioinformatic assistance. This work was supported by funding from INSERM, the Fondation pour la Recherche Medicale (FRM funding within the frame of the programme Equipe FRM; J.C.), the Fondation JED, the Fondation Maladies Rares, the Agence National de Recherche (ANR Blanc 1103 01, project R11039KK; ANR E-Rare-012-01, project E10107KP) and the EU-FP7 project GENECODYS, grant number 241995. This work was also supported by a grant (GM097376 to N.J.C.) from the US National Institutes of Health.	Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bernal C, 2005, ANAL BIOCHEM, V337, P55, DOI 10.1016/j.ab.2004.10.011; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobyns WB, 1999, NEUROLOGY, V53, P270, DOI 10.1212/WNL.53.2.270; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Harms MB, 2012, NEUROLOGY, V78, P1714, DOI 10.1212/WNL.0b013e3182556c05; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kousar R, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-119; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MELKI R, 1993, J CELL BIOL, V122, P1301, DOI 10.1083/jcb.122.6.1301; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Ori-McKenney KM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-26; Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; Poirier K, 2013, EUR J HUM GENET, V21, P381, DOI 10.1038/ejhg.2012.195; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TIAN GL, 1995, NATURE, V375, P250, DOI 10.1038/375250a0; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Tsurusaki Y, 2012, NEUROGENETICS, V13, P327, DOI 10.1007/s10048-012-0337-6; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Weedon MN, 2011, AM J HUM GENET, V89, P308, DOI 10.1016/j.ajhg.2011.07.002; Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542; Wise DO, 2000, GENOMICS, V67, P164, DOI 10.1006/geno.2000.6247; Wynshaw-Boris A, 2010, SEMIN CELL DEV BIOL, V21, P823, DOI 10.1016/j.semcdb.2010.07.008	55	247	260	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					639	+		10.1038/ng.2613			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	WOS:000319563900011	23603762	Green Submitted, Green Accepted			2022-01-24	
J	Bradfield, JP; Taal, HR; Timpson, NJ; Scherag, A; Lecoeur, C; Warrington, NM; Hypponen, E; Holst, C; Valcarcel, B; Thiering, E; Salem, RM; Schumacher, FR; Cousminer, DL; Sleiman, PMA; Zhao, JH; Berkowitz, RI; Vimaleswaran, KS; Jarick, I; Pennell, CE; Evans, DM; St Pourcain, B; Berry, DJ; Mook-Kanamori, DO; Hofman, A; Rivadeneira, F; Uitterlinden, AG; van Duijn, CM; van der Valk, RJP; de Jongste, JC; Postma, DS; Boomsma, DI; Gauderman, WJ; Hassanein, MT; Lindgren, CM; Magi, R; Boreham, CAG; Neville, CE; Moreno, LA; Elliott, P; Pouta, A; Hartikainen, AL; Li, MY; Raitakari, O; Lehtimaki, T; Eriksson, JG; Palotie, A; Dallongeville, J; Das, S; Deloukas, P; McMahon, G; Ring, SM; Kemp, JP; Buxton, JL; Blakemore, AIF; Bustamante, M; Guxens, M; Hirschhorn, JN; Gillman, MW; Kreiner-Moller, E; Bisgaard, H; Gilliland, FD; Heinrich, J; Wheeler, E; Barroso, I; O'Rahilly, S; Meirhaeghe, A; Sorensen, TIA; Power, C; Palmer, LJ; Hinney, A; Widen, E; Farooqi, IS; McCarthy, MI; Froguel, P; Meyre, D; Hebebrand, J; Jarvelin, MR; Jaddoe, VWV; Smith, GD; Hakonarson, H; Grant, SFA				Bradfield, Jonathan P.; Taal, H. Rob; Timpson, Nicholas J.; Scherag, Andre; Lecoeur, Cecile; Warrington, Nicole M.; Hypponen, Elina; Holst, Claus; Valcarcel, Beatriz; Thiering, Elisabeth; Salem, Rany M.; Schumacher, Fredrick R.; Cousminer, Diana L.; Sleiman, Patrick M. A.; Zhao, Jianhua; Berkowitz, Robert I.; Vimaleswaran, Karani S.; Jarick, Ivonne; Pennell, Craig E.; Evans, David M.; St Pourcain, Beate; Berry, Diane J.; Mook-Kanamori, Dennis O.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; van der Valk, Ralf J. P.; de Jongste, Johan C.; Postma, Dirkje S.; Boomsma, Dorret I.; Gauderman, W. James; Hassanein, Mohamed T.; Lindgren, Cecilia M.; Magi, Reedik; Boreham, Colin A. G.; Neville, Charlotte E.; Moreno, Luis A.; Elliott, Paul; Pouta, Anneli; Hartikainen, Anna-Liisa; Li, Mingyao; Raitakari, Olli; Lehtimaki, Terho; Eriksson, Johan G.; Palotie, Aarno; Dallongeville, Jean; Das, Shikta; Deloukas, Panos; McMahon, George; Ring, Susan M.; Kemp, John P.; Buxton, Jessica L.; Blakemore, Alexandra I. F.; Bustamante, Mariona; Guxens, Monica; Hirschhorn, Joel N.; Gillman, Matthew W.; Kreiner-Moller, Eskil; Bisgaard, Hans; Gilliland, Frank D.; Heinrich, Joachim; Wheeler, Eleanor; Barroso, Ines; O'Rahilly, Stephen; Meirhaeghe, Aline; Sorensen, Thorkild I. A.; Power, Chris; Palmer, Lyle J.; Hinney, Anke; Widen, Elisabeth; Farooqi, I. Sadaf; McCarthy, Mark I.; Froguel, Philippe; Meyre, David; Hebebrand, Johannes; Jarvelin, Marjo-Riitta; Jaddoe, Vincent W. V.; Smith, George Davey; Hakonarson, Hakon; Grant, Struan F. A.		Early Growth Genetics EGG Consorti	A genome-wide association meta-analysis identifies new childhood obesity loci	NATURE GENETICS			English	Article							BODY-MASS INDEX; HELICOBACTER-PYLORI; PREVENTION; OVERWEIGHT; BMI	Multiple genetic variants have been associated with adult obesity and a few with severe obesity in childhood; however, less progress has been made in establishing genetic influences on common early-onset obesity. We performed a North American, Australian and European collaborative meta-analysis of 14 studies consisting of 5,530 cases (>= 95th percentile of body mass index (BMI)) and 8,318 controls (<50th percentile of BMI) of European ancestry. Taking forward the eight newly discovered signals yielding association with P < 5 x 10(-6) in nine independent data sets (2,818 cases and 4,083 controls), we observed two loci that yielded genome-wide significant combined P values near OLFM4 at 13q14 (rs9568856; P = 1.82 x 10(-9); odds ratio (OR) = 1.22) and within HOXB5 at 17q21 (rs9299; P = 3.54 x 10(-9); OR = 1.14). Both loci continued to show association when two extreme childhood obesity cohorts were included (2,214 cases and 2,674 controls). These two loci also yielded directionally consistent associations in a previous metaanalysis of adult BMI1.	[Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Hakonarson, Hakon; Grant, Struan F. A.] Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Taal, H. Rob; Mook-Kanamori, Dennis O.; Hofman, Albert; van der Valk, Ralf J. P.; de Jongste, Johan C.; Jaddoe, Vincent W. V.] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Taal, H. Rob; Mook-Kanamori, Dennis O.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Taal, H. Rob; Mook-Kanamori, Dennis O.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Timpson, Nicholas J.; Evans, David M.; St Pourcain, Beate; Kemp, John P.; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Lecoeur, Cecile; Froguel, Philippe; Meyre, David] Univ Lille Nord France, CNRS 8199, Inst Pasteur, Lille, France; [Warrington, Nicole M.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Hypponen, Elina; Vimaleswaran, Karani S.; Berry, Diane J.; Power, Chris] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, MRC Ctr Epidemiol Child Hlth, London, England; [Holst, Claus; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Valcarcel, Beatriz; Elliott, Paul; Das, Shikta; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC Hlth Protect Agcy HPA, Ctr Environm & Hlth,Sch Publ Hlth,Fac Med, London, England; [Thiering, Elisabeth; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Epidemiol 1, Neuherberg, Germany; [Salem, Rany M.; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Salem, Rany M.; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Salem, Rany M.; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Salem, Rany M.; Hirschhorn, Joel N.] Broad Inst, Metab Program, Cambridge, MA USA; [Salem, Rany M.; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Salem, Rany M.; Palotie, Aarno; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Schumacher, Fredrick R.; Gauderman, W. James; Hassanein, Mohamed T.; Gilliland, Frank D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Cousminer, Diana L.; Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Sleiman, Patrick M. A.; Zhao, Jianhua; Hakonarson, Hakon; Grant, Struan F. A.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon; Grant, Struan F. A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Berkowitz, Robert I.] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA 19104 USA; [Berkowitz, Robert I.] Univ Penn, Dept Psychiat, Perelman Sch Med, Ctr Weight & Eating Disorders, Philadelphia, PA 19104 USA; [Jarick, Ivonne] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Mook-Kanamori, Dennis O.] Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [van der Valk, Ralf J. P.] Univ Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Univ Med Ctr Groningen,GRIAC,Res Inst, Groningen, Netherlands; [van der Valk, Ralf J. P.; de Jongste, Johan C.] Erasmus Univ, Div Resp Med, Dept Pediat, Med Ctr,Sophia Childrens Hosp, Rotterdam, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med & TB, GRIAC Res Inst, Groningen, Netherlands; [Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Lindgren, Cecilia M.; Magi, Reedik] Univ Oxford, Genet & Genom Epidemiol Unit, Wellcome Trust Ctr Human Genet, Oxford, England; [Magi, Reedik] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Boreham, Colin A. G.] Univ Coll Dublin, Inst Sport & Hlth, Dublin 2, Ireland; [Neville, Charlotte E.] Queens Univ Belfast, Ctr Publ Hlth, Inst Clin Sci B, Belfast, Antrim, North Ireland; [Moreno, Luis A.] Univ Zaragoza, Growth Exercise Nutr & Dev GENUD Res Grp, Zaragoza, Spain; [Moreno, Luis A.] Univ Zaragoza, Sch Hlth Sci EUCS, Zaragoza, Spain; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu, Finland; [Li, Mingyao] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Raitakari, Olli] Univ Turku, Turku, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, FIN-33101 Tampere, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Palotie, Aarno; Deloukas, Panos; Wheeler, Eleanor; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Univ Cent Hosp, Helsinki, Finland; [Dallongeville, Jean; Meirhaeghe, Aline] Univ Lille Nord France, INSERM, U744, Inst Pasteur Lille, Lille, France; [McMahon, George; Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Buxton, Jessica L.; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Sect Integrat Med, London, England; [Bustamante, Mariona; Guxens, Monica] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Bustamante, Mariona; Guxens, Monica] Hosp Mar Res Inst IMIM, Barcelona, Spain; [Bustamante, Mariona; Guxens, Monica] Consorcio Invest Biomed Red CIBER Epidemiol & Sal, Barcelona, Spain; [Bustamante, Mariona] Ctr Genom Regulat CRG, Genes & Dis Program, Barcelona, Spain; [Bustamante, Mariona] Pompeu Fabra Univ UPF, Barcelona, Spain; [Gillman, Matthew W.] Harvard Univ, Dept Populat Med, Sch Med, Obes Prevent Program, Boston, MA USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Kreiner-Moller, Eskil; Bisgaard, Hans] Univ Copenhagen, Gentofte, Denmark; [Kreiner-Moller, Eskil; Bisgaard, Hans] Copenhagen Univ Hosp, Gentofte, Denmark; [Barroso, Ines; O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Barroso, Ines; O'Rahilly, Stephen; Farooqi, I. Sadaf] Addenbrookes Hosp, NIHR, Cambridge Biomed Res Ctr, Inst Metab Sci, Cambridge, England; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Palmer, Lyle J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Hinney, Anke; Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England; [Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Hakonarson, Hakon; Grant, Struan F. A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA		Grant, SFA (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA.	grants@chop.edu	Hypponen, Elina/B-2596-2014; Timpson, Nicholas John/O-7548-2015; Raitakari, Olli/AAQ-7389-2021; Scherag, Andre/B-3805-2014; Taal, Hendrik R/B-4847-2018; Iniguez, Carmen/AAA-5866-2019; Study, Raine/K-4517-2013; Bisgaard, Hans/N-4761-2016; Rivadeneira, Fernando/O-5385-2015; Meirhaeghe, Aline/E-4663-2015; Meyre, David/D-7315-2011; Blakemore, Alexandra I F/D-2253-2009; Evans, David M/H-6325-2013; Deloukas, Panos/B-2922-2013; Schumacher, Fredrick/R-6043-2019; Price, Thomas/B-7372-2008; Attrill, Lauren/V-1688-2018; FROGUEL, Philippe/O-6799-2017; Kemp, John P./R-3091-2018; Holloway, John W/B-5424-2009; Prokopenko, Inga/H-3241-2014; Buxton, Jessica/L-9849-2019; Guxens, Monica/T-2285-2018; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Pennell, Craig/ABD-6902-2020; Heinrich, Joachim/N-1720-2013; O'Rahilly, Stephen/ABF-6509-2020; Palmer, Lyle John/K-3196-2014; Kronow, Joern/B-1054-2011; Buxton, Jessica L/I-4033-2014; Sunyer, Jordi/G-6909-2014; Davey Smith, George/A-7407-2013; Moreno, Luis/S-1780-2019; Bustamante, Mariona/M-7277-2015; Magi, Reedik/AAJ-9679-2021; Fox, Laura J/C-6249-2016; Bustamante, Mariona/ABB-9142-2021; Thiering, Elisabeth/B-3342-2013; Middeldorp, Christel M/L-7728-2017; Hinney, Anke/D-6953-2011; Warrington, Nicole/P-4868-2014; Palmer, Lyle John/N-1948-2019; Estivill, Xavier/A-3125-2013; McCarthy, Mark/M-3763-2015	Hypponen, Elina/0000-0003-3670-9399; Timpson, Nicholas John/0000-0002-7141-9189; Iniguez, Carmen/0000-0003-3471-4928; Bisgaard, Hans/0000-0003-4131-7592; Rivadeneira, Fernando/0000-0001-9435-9441; Meirhaeghe, Aline/0000-0001-6983-2364; Meyre, David/0000-0003-4850-7444; Blakemore, Alexandra I F/0000-0003-0661-564X; Evans, David M/0000-0003-0663-4621; Deloukas, Panos/0000-0001-9251-070X; Schumacher, Fredrick/0000-0002-3073-7463; Price, Thomas/0000-0001-7356-2109; FROGUEL, Philippe/0000-0003-2972-0784; Kemp, John P./0000-0002-9105-2249; Holloway, John W/0000-0001-9998-0464; Prokopenko, Inga/0000-0003-1624-7457; Guxens, Monica/0000-0002-8624-0333; Pennell, Craig/0000-0002-0937-6165; Heinrich, Joachim/0000-0002-9620-1629; O'Rahilly, Stephen/0000-0003-2199-4449; Palmer, Lyle John/0000-0002-1628-3055; Buxton, Jessica L/0000-0002-0918-9335; Sunyer, Jordi/0000-0002-2602-4110; Davey Smith, George/0000-0002-1407-8314; Moreno, Luis/0000-0003-0454-653X; Bustamante, Mariona/0000-0003-0127-2860; Bustamante, Mariona/0000-0003-0127-2860; Middeldorp, Christel M/0000-0002-6218-0428; Hinney, Anke/0000-0001-5659-0706; Warrington, Nicole/0000-0003-4195-775X; Palmer, Lyle John/0000-0002-1628-3055; Lindgren, Cecilia/0000-0002-4903-9374; Kreiner, Eskil/0000-0003-1204-2438; s, hema/0000-0002-3440-9475; Salem, Rany/0000-0001-8816-6862; Hattersley, Andrew/0000-0001-5620-473X; Geller, Frank/0000-0002-9238-3269; melbye, mads/0000-0001-8264-6785; Karani, Vimal/0000-0002-8485-8930; Estivill, Xavier/0000-0002-0723-2256; Grant, Struan/0000-0003-2025-5302; Palotie, Aarno/0000-0002-2527-5874; Iniguez, Carmen/0000-0002-5156-0732; Elliott, Paul/0000-0002-7511-5684; Wheeler, Eleanor/0000-0002-8616-6444; Farooqi, Sadaf/0000-0001-7609-3504; Magi, Reedik/0000-0002-2964-6011; Zeggini, Eleftheria/0000-0003-4238-659X; Van Duijn, Cornelia/0000-0002-2374-9204; St Pourcain, Beate/0000-0002-4680-3517; Lawlor, Debbie A/0000-0002-6793-2262; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; McCarthy, Mark/0000-0002-4393-0510; Eriksson, Johan/0000-0002-2516-2060; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Scherag, Andre/0000-0002-9406-4704; Barroso, Ines/0000-0001-5800-4520; Lakka, Timo/0000-0002-9199-2871; Thiering, Elisabeth/0000-0002-5429-9584	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801056B, U1475000001, G0400546B, G0600717B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [PHCS/C4/4/016, NF-SI-0508-10082] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600705, G0100103, G0000934, G0601653, G0400546, G0800582, G0900554, G0801056] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050924, R01HD056465] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [RC2HL101651, R01HL087679, RC2HL101543, R01HL061768, R01HL076647, R01HL087680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK075787, U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P01ES009581, P30ES007048, R01ES014447, P01ES011627, R01ES014708, R01ES016535, R03ES014046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [RL1MH083268, R01MH063706] Funding Source: NIH RePORTER; British Heart FoundationBritish Heart Foundation [PG/09/023/26806, PG/1996183/9569, PG/09/023] Funding Source: Medline; CIHRCanadian Institutes of Health Research (CIHR) [MOP-82893] Funding Source: Medline; Department of HealthEuropean Commission [PHCS/C4/4/016] Funding Source: Medline; Diabetes UKDiabetes UK [08/0003775] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601653, G0800582, G0801056, G0400546, G0100103, G0900554, MC_UP_A620_1014, G0000934, G0500539, 74882, G0600705] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL087680, 1RC2HL101543, R01 HL076647, RC2 HL101543, RC2 HL101651, 5R01HL087680, R01 HL061768, 5R01HL076647, 5R01HL061768, 1RC2HL101651, 5R01HL087679-02, R01 HL087679] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD056465-05, R01 HD056465-02, R01 HD056465-04, R01 HD056465-01A1, R24 HD050924, R01 HD056465, R01 HD056465-03] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK075787, U01 DK062418] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30 ES007048, R01 ES014447, 5P30ES007048, 5R01ES014708, 5P01ES011627, 5R01ES014447, R03 ES014046, R01 ES014708, 5P01ES009581, 5R01ES016535, R01 ES016535, 5R03ES014046, P01 ES009581, P01 ES011627] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH063706, 5R01MH63706:02, 1RL1MH083268-01, RL1 MH083268] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R826708-01] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [092731, GR069224, WT088431MA, 068545/Z/02, 090532, 077016/Z/05/Z, 086596/Z/08/Z, 098395, 052515/2/97/2, 083948, 076467] Funding Source: Medline; ORD VA [RD831861-01] Funding Source: Medline		Abdullahi M, 2008, OBES SURG, V18, P1450, DOI 10.1007/s11695-008-9477-z; Arslan E, 2009, EUR J INTERN MED, V20, P695, DOI 10.1016/j.ejim.2009.07.013; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; den Hoed M, 2010, DIABETES, V59, P2980, DOI 10.2337/db10-0370; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Flegal KM, 2002, AM J CLIN NUTR, V75, P761, DOI 10.1093/ajcn/75.4.761; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; Keren D, 2009, OBES SURG, V19, P751, DOI 10.1007/s11695-008-9694-5; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Must A, 2003, NUTR REV, V61, P139, DOI 10.1301/nr.2003.apr.139-142; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	16	247	255	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2012	44	5					526	+		10.1038/ng.2247			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	WOS:000303416300012	22484627	Green Submitted, Green Accepted			2022-01-24	
J	Haber, JE				Haber, James E.			Mating-Type Genes and MAT Switching in Saccharomyces cerevisiae	GENETICS			English	Article							DOUBLE-STRAND-BREAK; ORIGIN RECOGNITION COMPLEX; TRANSCRIPTIONALLY SILENT CHROMATIN; DNA-END-RESECTION; RESOLUTION STRUCTURAL-ANALYSIS; AFFECTING SEXUAL CONJUGATION; REGULATES DONOR PREFERENCE; CYCLE-DEPENDENT REGULATION; ALPHA-SPECIFIC GENES; S PHASE REQUIREMENT	Mating type in Saccharomyces cerevisiae is determined by two nonhomologous alleles, MATa and MAT alpha. These sequences encode regulators of the two different haploid mating types and of the diploids formed by their conjugation. Analysis of the MATa1, MAT alpha 1, and MAT alpha 2 alleles provided one of the earliest models of cell-type specification by transcriptional activators and repressors. Remarkably, homothallic yeast cells can switch their mating type as often as every generation by a highly choreographed, site-specific homologous recombination event that replaces one MAT allele with different DNA sequences encoding the opposite MAT allele. This replacement process involves the participation of two intact but unexpressed copies of mating-type information at the heterochromatic loci, HML alpha and HMRa, which are located at opposite ends of the same chromosome-encoding MAT. The study of MAT switching has yielded important insights into the control of cell lineage, the silencing of gene expression, the formation of heterochromatin, and the regulation of accessibility of the donor sequences. Real-time analysis of MAT switching has provided the most detailed description of the molecular events that occur during the homologous recombinational repair of a programmed double-strand chromosome break.	[Haber, James E.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA		Haber, JE (corresponding author), Brandeis Univ, Rosenstiel Ctr, 415 South St,Mailstop 029, Waltham, MA 02254 USA.	haber@brandeis.edu		Haber, James/0000-0002-1878-0610	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM20056, GM61766, GM76020]; National Science FoundationNational Science Foundation (NSF); Department of EnergyUnited States Department of Energy (DOE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM061766, R01GM076020, R37GM020056, R01GM020056] Funding Source: NIH RePORTER	I am grateful for the helpful comments of Laura Rusche, Scott Holmes, and members of my lab. The part of this work that derives from my own lab has been carried out for more than 30 years by an exceptional contingent of graduate students, postdoctoral fellows, technicians, and Brandeis University undergraduates and has been generously supported, primarily by National Institutes of Health (NIH) grant GM20056, but also by NIH grants GM61766 and GM76020, as well as previous support from the National Science Foundation and the Department of Energy.	ABRAHAM J, 1984, J MOL BIOL, V176, P307, DOI 10.1016/0022-2836(84)90492-3; AMATI BB, 1988, CELL, V54, P967, DOI 10.1016/0092-8674(88)90111-0; Ansari A, 1997, MOL CELL BIOL, V17, P7061, DOI 10.1128/MCB.17.12.7061; Arcangioli B, 1998, EMBO J, V17, P4503, DOI 10.1093/emboj/17.15.4503; Arcangioli B, 2000, EMBO J, V19, P1389, DOI 10.1093/emboj/19.6.1389; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; Astrom SU, 1998, GENETICS, V148, P1021; Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; AXELROD A, 1991, MOL CELL BIOL, V11, P1080, DOI 10.1128/MCB.11.2.1080; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Aylon Y, 2005, CELL CYCLE, V4, P259; Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013; Barsoum E, 2010, GENE DEV, V24, P33, DOI 10.1101/gad.557310; Bi X, 1999, P NATL ACAD SCI USA, V96, P11934, DOI 10.1073/pnas.96.21.11934; Bi X, 2002, GENETICS, V160, P1401; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Bressan DA, 1998, GENETICS, V150, P591; Bressan DA, 2004, J CELL BIOL, V164, P361, DOI 10.1083/jcb.200311063; BRUHN L, 1994, MOL CELL BIOL, V14, P2534, DOI 10.1128/MCB.14.4.2534; Bystricky K, 2009, MOL CELL BIOL, V29, P835, DOI 10.1128/MCB.01009-08; Chant J, 1996, CURR OPIN CELL BIOL, V8, P557, DOI 10.1016/S0955-0674(96)80035-4; Chant J, 1991, CURR OPIN GENET DEV, V1, P342, DOI 10.1016/S0959-437X(05)80298-9; CHENCLELAND TA, 1993, J BIOL CHEM, V268, P23409; Cheng TH, 2000, GENE DEV, V14, P452; Chi MH, 1996, MOL CELL BIOL, V16, P4281; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Coic E, 2006, GENETICS, V173, P1197, DOI 10.1534/genetics.106.055392; Coic E, 2006, MOL CELL BIOL, V26, P5470, DOI 10.1128/MCB.02443-05; Coic E, 2011, GENETICS, V189, P1225, DOI 10.1534/genetics.111.132738; Colaiacovo MP, 1999, GENETICS, V151, P1409; COLLINS I, 1994, MOL CELL BIOL, V14, P3524, DOI 10.1128/MCB.14.5.3524; CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; DeRubertis F, 1996, NATURE, V384, P589; Deryshire MK, 1996, YEAST, V12, P631; Dhillon N, 2009, EMBO J, V28, P2583, DOI 10.1038/emboj.2009.198; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; DUBEY DD, 1991, MOL CELL BIOL, V11, P5346, DOI 10.1128/MCB.11.10.5346; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; ELBLE R, 1991, P NATL ACAD SCI USA, V88, P10966, DOI 10.1073/pnas.88.23.10966; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; FELDMAN JB, 1984, J MOL BIOL, V178, P815, DOI 10.1016/0022-2836(84)90313-9; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FISHERADAMS G, 1995, EMBO J, V14, P1468, DOI 10.1002/j.1460-2075.1995.tb07133.x; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; FOGEL S, 1979, COLD SPRING HARB SYM, V43, P1325, DOI 10.1101/SQB.1979.043.01.152; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; FOX CA, 1993, COLD SPRING HARB SYM, V58, P443, DOI 10.1101/SQB.1993.058.01.051; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; FRIIS J, 1968, GENETICS, V59, P33; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Fung CW, 2009, GENETICS, V181, P1195, DOI 10.1534/genetics.109.100842; Gallagher JEG, 2009, GENETICS, V181, P1477, DOI 10.1534/genetics.108.099663; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0165-1218(74)90185-2; Gartenberg MR, 2009, GENE DEV, V23, P1027, DOI 10.1101/gad.1805309; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Haber James E., 2007, P159; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; HABER JE, 1993, P NATL ACAD SCI USA, V90, P3363, DOI 10.1073/pnas.90.8.3363; HABER JE, 1980, CELL, V20, P519, DOI 10.1016/0092-8674(80)90638-8; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; HABER JE, 1979, GENETICS, V93, P13; Haber JE, 2005, NUCL ACID M, V16, P161; HABER JE, 1992, TRENDS GENET, V8, P446, DOI 10.1016/0168-9525(92)90329-3; HABER JE, 1980, CELL, V22, P277, DOI 10.1016/0092-8674(80)90175-0; HAGEN DC, 1993, MOL CELL BIOL, V13, P6866, DOI 10.1128/MCB.13.11.6866; Hasegawa Y, 2008, RNA, V14, P2333, DOI 10.1261/rna.1016508; HAWTHORNE DC, 1963, GENETICS, V48, P1721; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; HERSCHBACH BM, 1994, NATURE, V370, P309, DOI 10.1038/370309a0; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; HEUDE M, 1993, GENETICS, V133, P489; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hickman MA, 2011, EUKARYOT CELL, V10, P1183, DOI 10.1128/EC.05123-11; Hickman MA, 2010, P NATL ACAD SCI USA, V107, P19384, DOI 10.1073/pnas.1006436107; Hickman MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000710; HICKS J, 1979, NATURE, V282, P478, DOI 10.1038/282478a0; HICKS J, 1984, MOL CELL BIOL, V4, P1278, DOI 10.1128/MCB.4.7.1278; Hicks J, 1977, Brookhaven Symp Biol, P233; Hicks WM, 2011, P NATL ACAD SCI USA, V108, P3108, DOI 10.1073/pnas.1019660108; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Holbeck SL, 1997, GENETICS, V147, P1017; Holmes SG, 1997, GENETICS, V145, P605; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Houston PL, 2006, PLOS GENET, V2, P896, DOI 10.1371/journal.pgen.0020098; Huang L, 1997, MOL CELL BIOL, V17, P6555, DOI 10.1128/MCB.17.11.6555; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Inbar O, 1999, MOL CELL BIOL, V19, P4134; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Ira G, 2006, MOL CELL BIOL, V26, P9424, DOI 10.1128/MCB.01654-06; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jain S, 2009, GENE DEV, V23, P291, DOI 10.1101/gad.1751209; Jambhekar A, 2005, P NATL ACAD SCI USA, V102, P18005, DOI 10.1073/pnas.0509229102; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; JENSEN R, 1983, P NATL ACAD SCI-BIOL, V80, P3035, DOI 10.1073/pnas.80.10.3035; JENSEN RE, 1984, COLD SPRING HARB SYM, V49, P97, DOI 10.1101/SQB.1984.049.01.013; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kaplun L, 2006, ISR MED ASSOC J, V8, P246; Kaplun L, 2003, J BIOL CHEM, V278, P48727, DOI 10.1074/jbc.M308671200; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Kaykov A, 2004, CURR BIOL, V14, P1924, DOI 10.1016/j.cub.2004.10.026; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; KELEHER CA, 1989, MOL CELL BIOL, V9, P5228, DOI 10.1128/MCB.9.11.5228; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; KIMMERLY W, 1988, EMBO J, V7, P2241, DOI 10.1002/j.1460-2075.1988.tb03064.x; Kirchmaier AL, 2006, MOL CELL BIOL, V26, P852, DOI 10.1128/MCB.26.3.852-862.2006; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; KLAR AJS, 1985, GENETICS, V111, P745; KLAR AJS, 1984, NATURE, V310, P744, DOI 10.1038/310744a0; KLAR AJS, 1979, GENETICS, V92, P759; KLAR AJS, 1982, CELL, V28, P551, DOI 10.1016/0092-8674(82)90210-0; KLAR AJS, 1987, CELL, V49, P433, DOI 10.1016/0092-8674(87)90442-9; KLAR AJS, 1979, GENETICS, V93, P37; KLAR AJS, 1980, COLD SPRING HARB SYM, V45, P983, DOI 10.1101/SQB.1981.045.01.114; KLAR AJS, 1993, CURR OPIN GENET DEV, V3, P745, DOI 10.1016/S0959-437X(05)80093-0; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; KOSTRIKEN R, 1983, CELL, V35, P167, DOI 10.1016/0092-8674(83)90219-2; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Laney JD, 2006, MOL CELL BIOL, V26, P371, DOI 10.1128/MCB.26.1.371-380.2006; Laney JD, 2003, GENE DEV, V17, P2259, DOI 10.1101/gad.1115703; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; LAURENSON P, 1991, GENETICS, V129, P685; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; Lee SE, 2002, DNA REPAIR, V1, P27, DOI 10.1016/S1568-7864(01)00003-9; Leung WY, 1997, P NATL ACAD SCI USA, V94, P6851, DOI 10.1073/pnas.94.13.6851; Li FY, 2008, MOL CELL, V30, P325, DOI 10.1016/j.molcel.2008.02.028; Li J, 2012, PLOS GENET, V8, P201, DOI [10.1371/journal.pgen.1002630, 10.1371/journal.pgen.1002692]; Li Q, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000684; LI T, 1995, SCIENCE, V270, P262, DOI 10.1126/science.270.5234.262; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; LIEFSHITZ B, 1995, GENETICS, V140, P1199; LIRAS P, 1978, GENETICS, V88, P651; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Long RM, 2001, J CELL BIOL, V153, P307, DOI 10.1083/jcb.153.2.307; LONG RM, 1997, SCIENCE, V277, P383, DOI DOI 10.1126/science.277.5324.383; Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cb.11.110195.002511; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Lord M, 2002, CURR BIOL, V12, P1347, DOI 10.1016/S0960-9822(02)01042-4; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Lynch PJ, 2010, GENETICS, V185, P113, DOI 10.1534/genetics.109.113100; Lyndaker AM, 2008, GENETICS, V179, P1807, DOI 10.1534/genetics.108.090654; MACKAY V, 1974, GENETICS, V76, P273; MACKAY V, 1974, GENETICS, V76, P255; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Marcand S, 1996, GENE DEV, V10, P1297, DOI 10.1101/gad.10.11.1297; Marrero VA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001007; Martins-Taylor K, 2004, GENETICS, V168, P65, DOI 10.1534/genetics.103.020149; Martins-Taylor K, 2011, GENETICS, V187, P89, DOI 10.1534/genetics.110.123844; McConnell KH, 2006, MOL CELL BIOL, V26, P1955, DOI 10.1128/MCB.26.5.1955-1966.2006; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; MCGILL C, 1989, CELL, V57, P459, DOI 10.1016/0092-8674(89)90921-5; MCGILL CB, 1993, CURR GENET, V23, P305, DOI 10.1007/BF00310891; MCNALLY FJ, 1991, MOL CELL BIOL, V11, P5648, DOI 10.1128/MCB.11.11.5648; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Miele A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000478; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Moreau S, 1999, MOL CELL BIOL, V19, P556; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; NASMYTH K, 1993, CURR OPIN GENET DEV, V3, P286, DOI 10.1016/0959-437X(93)90036-O; NASMYTH K, 1987, CELL, V48, P579, DOI 10.1016/0092-8674(87)90236-4; NASMYTH K, 1987, EMBO J, V6, P243, DOI 10.1002/j.1460-2075.1987.tb04745.x; NASMYTH KA, 1982, ANNU REV GENET, V16, P439, DOI 10.1146/annurev.ge.16.120182.002255; NASMYTH KA, 1980, CELL, V19, P753, DOI 10.1016/S0092-8674(80)80051-1; Naumov G I, 1971, Nauchnye Doki Vyss Shkoly Biol Nauki, V9, P92; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Nickoloff J. A., 2000, DNA DAMAGE REPAIR, V3, P107; NICKOLOFF JA, 1989, J MOL BIOL, V207, P527, DOI 10.1016/0022-2836(89)90462-2; NICKOLOFF JA, 1990, MOL CELL BIOL, V10, P1174, DOI 10.1128/MCB.10.3.1174; NICKOLOFF JA, 1986, P NATL ACAD SCI USA, V83, P7831, DOI 10.1073/pnas.83.20.7831; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Oppikofer M, 2011, EMBO J, V30, P2610, DOI 10.1038/emboj.2011.170; Osborne EA, 2011, P NATL ACAD SCI USA, V108, P1209, DOI 10.1073/pnas.1018742108; Osborne EA, 2009, NAT GENET, V41, P800, DOI 10.1038/ng.402; OSHIMA Y, 1971, GENETICS, V67, P327; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Patterson EE, 2008, GENETICS, V180, P771, DOI 10.1534/genetics.108.091710; PATTERSON HG, 1994, MOL CELL BIOL, V14, P4002, DOI 10.1128/MCB.14.6.4002; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; PLESSIS A, 1992, GENETICS, V130, P451; PORTER SE, 1993, GENETICS, V134, P5; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; RATTRAY AJ, 1995, GENETICS, V139, P45; RAVEH D, 1989, MOL GEN GENET, V220, P33; Ravindra A, 1999, MOL CELL BIOL, V19, P7944; RAY A, 1989, P NATL ACAD SCI USA, V86, P6225, DOI 10.1073/pnas.86.16.6225; RAY BL, 1991, MOL CELL BIOL, V11, P5372, DOI 10.1128/MCB.11.10.5372; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Ren J, 2010, GENETICS, V186, P551, DOI 10.1534/genetics.110.120592; RESNICK MA, 1976, J THEOR BIOL, V59, P97, DOI 10.1016/S0022-5193(76)80025-2; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; RINE J, 1979, GENETICS, V93, P877; RINE J, 1987, GENETICS, V116, P9; Rivier DH, 1992, CURR OPIN GENET DEV, V2, P286, DOI 10.1016/S0959-437X(05)80286-2; RODARTERAMON US, 1972, RADIAT RES, V49, P133, DOI 10.2307/3573378; Rossmann MP, 2011, MOL CELL, V42, P127, DOI 10.1016/j.molcel.2011.03.007; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Ruault M, 2011, J CELL BIOL, V192, P417, DOI 10.1083/jcb.201008007; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Rusche LN, 2009, J CELL PHYSIOL, V219, P525, DOI 10.1002/jcp.21749; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2001, GENE DEV, V15, P955; Safi A, 2008, MOL CELL BIOL, V28, P2567, DOI 10.1128/MCB.01785-07; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Santa Maria J, 1970, I NAC INVEST AGRON C, V30, P1; SCHNELL R, 1986, MOL CELL BIOL, V6, P494, DOI 10.1128/MCB.6.2.494; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Sharp JA, 2005, GENETICS, V171, P885, DOI 10.1534/genetics.105.044719; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; SHEI GJ, 1995, MOL CELL BIOL, V15, P3496; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Sherman JM, 1997, TRENDS GENET, V13, P308, DOI 10.1016/S0168-9525(97)01198-0; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sjostrand JOO, 2002, EUKARYOT CELL, V1, P548, DOI 10.1128/EC.1.4.548-557.2002; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; SMITH DL, 1994, EMBO J, V13, P2378, DOI 10.1002/j.1460-2075.1994.tb06521.x; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; SPRAGUE GF, 1981, NATURE, V289, P250, DOI 10.1038/289250a0; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Stone EM, 1996, J CELL BIOL, V135, P571, DOI 10.1083/jcb.135.3.571; Stone EM, 1998, BIOESSAYS, V20, P30; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; Strathern J. N., 1988, GENETIC RECOMBINATIO, P445; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; STRATHERN JN, 1980, P NATL ACAD SCI-BIOL, V77, P2839, DOI 10.1073/pnas.77.5.2839; STRATHERN JN, 1979, CELL, V18, P309, DOI 10.1016/0092-8674(79)90050-3; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Sun KM, 2002, GENE DEV, V16, P2085, DOI 10.1101/gad.994902; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Szeto L, 1997, GENE DEV, V11, P1899, DOI 10.1101/gad.11.15.1899; Szeto L, 1997, MOL CELL BIOL, V17, P751, DOI 10.1128/MCB.17.2.751; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei Angela, 2005, V264, P140, DOI 10.1002/0470093765.ch10; TAKAHASHI T, 1958, GENETICS, V43, P249; Takahashi YH, 2011, MOL CELL, V42, P118, DOI 10.1016/j.molcel.2011.03.006; TAKANO I, 1967, GENETICS, V57, P875; TAKANO I, 1970, GENETICS, V65, P421; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; TANAKA K, 1984, MOL CELL BIOL, V4, P203, DOI 10.1128/MCB.4.1.203; TATCHELL K, 1981, CELL, V27, P25, DOI 10.1016/0092-8674(81)90357-3; THOMPSON JS, 1994, MOL CELL BIOL, V14, P446, DOI 10.1128/MCB.14.1.446; THOMPSONSTEWART D, 1994, P NATL ACAD SCI USA, V91, P9042, DOI 10.1073/pnas.91.19.9042; THON G, 1993, GENETICS, V134, P1045; Thon G, 1997, GENETICS, V145, P685; THON G, 1994, GENETICS, V138, P29; Toh GWL, 2010, DNA REPAIR, V9, P718, DOI 10.1016/j.dnarep.2010.02.013; Tolstorukov I I, 1973, Nauchnye Doki Vyss Shkoly Biol Nauki, V117, P111; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsukamoto Y, 1996, NUCLEIC ACIDS RES, V24, P2067, DOI 10.1093/nar/24.11.2067; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Valencia-Burton M, 2006, GENETICS, V174, P41, DOI 10.1534/genetics.106.058685; Vandre CL, 2008, GENETICS, V180, P1407, DOI 10.1534/genetics.108.094490; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Wang XR, 2004, GENETICS, V168, P547, DOI 10.1534/genetics.104.028803; WEIFFENBACH B, 1981, MOL CELL BIOL, V1, P522, DOI 10.1128/MCB.1.6.522; WEILER KS, 1992, GENETICS, V132, P929; WEILER KS, 1995, GENETICS, V139, P1495; WEINSTOCK KG, 1990, MOL CELL BIOL, V10, P2882, DOI 10.1128/MCB.10.6.2882; Weiss K, 1997, EMBO J, V16, P4352, DOI 10.1093/emboj/16.14.4352; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Weng YS, 1996, CURR GENET, V29, P335, DOI 10.1007/BF02208614; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; WHITEWAY M, 1987, MOL CELL BIOL, V7, P3713, DOI 10.1128/MCB.7.10.3713; Wilson TE, 2002, GENETICS, V162, P677; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Wu C, 1998, GENE DEV, V12, P1726, DOI 10.1101/gad.12.11.1726; Wu XH, 1997, GENETICS, V147, P399; WU XH, 1995, GENE DEV, V9, P1922, DOI 10.1101/gad.9.15.1922; Wu XH, 1996, CELL, V87, P277, DOI 10.1016/S0092-8674(00)81345-8; Wu XH, 1996, MOL CELL BIOL, V16, P657; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Xu EY, 1999, GENETICS, V153, P25; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Yu JH, 2004, MOL CELL BIOL, V24, P1351, DOI 10.1128/MCB.24.3.1351-1364.2004; Yu Q, 2006, J MOL BIOL, V356, P1082, DOI 10.1016/j.jmb.2005.11.089; Zhang ZM, 1997, MOL CELL BIOL, V17, P5461, DOI 10.1128/MCB.17.9.5461; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou YF, 2006, MOL CELL BIOL, V26, P7806, DOI 10.1128/MCB.01197-06; [No title captured]	345	247	252	1	71	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	MAY	2012	191	1					33	64		10.1534/genetics.111.134577			32	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	009AT	WOS:000308998400004	22555442	Green Published, Bronze			2022-01-24	
J	McCormack, JE; Faircloth, BC; Crawford, NG; Gowaty, PA; Brumfield, RT; Glenn, TC				McCormack, John E.; Faircloth, Brant C.; Crawford, Nicholas G.; Adair Gowaty, Patricia; Brumfield, Robb T.; Glenn, Travis C.			Ultraconserved elements are novel phylogenomic markers that resolve placental mammal phylogeny when combined with species-tree analysis	GENOME RESEARCH			English	Article							MAXIMUM-LIKELIHOOD; EARLY HISTORY; GENOMIC DATA; DIVERSIFICATION; VERTEBRATE; RESOLUTION; ALGORITHMS; REGIONS	Phylogenomics offers the potential to fully resolve the Tree of Life, but increasing genomic coverage also reveals conflicting evolutionary histories among genes, demanding new analytical strategies for elucidating a single history of life. Here, we outline a phylogenomic approach using a novel class of phylogenetic markers derived from ultraconserved elements and flanking DNA. Using species-tree analysis that accounts for discord among hundreds of independent loci, we show that this class of marker is useful for recovering deep-level phylogeny in placental mammals. In broad outline, our phylogeny agrees with recent phylogenomic studies of mammals, including several formerly controversial relationships. Our results also inform two outstanding questions in placental mammal phylogeny involving rapid speciation, where species-tree methods are particularly needed. Contrary to most phylogenomic studies, our study supports a first-diverging placental mammal lineage that includes elephants and tenrecs (Afrotheria). The level of conflict among gene histories is consistent with this basal divergence occurring in or near a phylogenetic "anomaly zone" where a failure to account for coalescent stochasticity will mislead phylogenetic inference. Addressing a long-standing phylogenetic mystery, we find some support from a high genomic coverage data set for a traditional placement of bats (Chiroptera) sister to a clade containing Perissodactyla, Cetartiodactyla, and Carnivora, and not nested within the latter clade, as has been suggested recently, although other results were conflicting. One of the most remarkable findings of our study is that ultraconserved elements and their flanking DNA are a rich source of phylogenetic information with strong potential for application across Amniotes.	[McCormack, John E.; Brumfield, Robb T.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Faircloth, Brant C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Crawford, Nicholas G.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Adair Gowaty, Patricia] Smithsonian Trop Res Inst, Panama City, Panama; [Adair Gowaty, Patricia] Univ Calif Los Angeles, Inst Environm, Los Angeles, CA 90095 USA; [Brumfield, Robb T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA		McCormack, JE (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	mccormack@oxy.edu	McCormack, John/A-6380-2010; Glenn, Travis C/A-2390-2008; Brumfield, Robb T/K-6108-2015; Faircloth, Brant C/Y-3978-2019	McCormack, John/0000-0002-0912-1461; Glenn, Travis C/0000-0001-7725-3637; Brumfield, Robb T/0000-0003-2307-0688; Faircloth, Brant/0000-0002-1943-0217	Amazon Web Services; Harvard FAS Sciences Division Research Computing Group; Direct For Biological SciencesNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [1121797, 0956069] Funding Source: National Science Foundation	We thank M. Springer for sharing the 20-locus mammal data set and J. Mattick for sharing UCE and exon data. SR Hubbell, S. Edwards, J. Degnan, M. Sheehan, M. Alfaro, B. Carstens, and three anonymous reviewers provided helpful comments. One reviewer suggested the point about selection potentially improving the phylogenetic utility of UCEs. H. Hoekstra provided access to the Odyssey cluster supported by the Harvard FAS Sciences Division Research Computing Group to conduct phylogenetic analysis. A research grant from Amazon Web Services (Amazon.com) also supported phylogenetic computation. We thank the many scientists, institutions, and funding agencies that have contributed genomic data available via the UCSC Genome Browser (see complete list at http://genome.ucsc.edu/goldenPath/credits.html and Supplemental Material).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Cannarozzi G, 2007, PLOS COMPUT BIOL, V3, P9, DOI 10.1371/journal.pcbi.0030002; Churakov G, 2009, GENOME RES, V19, P868, DOI 10.1101/gr.090647.108; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2005, EVOLUTION, V59, P24; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hallstrom BM, 2007, MOL BIOL EVOL, V24, P2059, DOI 10.1093/molbev/msm136; Han KL, 2011, SYST BIOL, V60, P375, DOI 10.1093/sysbio/syq100; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Janes DE, 2011, GENOME BIOL EVOL, V3, P102, DOI 10.1093/gbe/evq087; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kenny EM, 2011, DNA RES, V18, P31, DOI 10.1093/dnares/dsq029; Kingman JFC, 1982, STOCH PROCESS APPL, V13, P235, DOI 10.1016/0304-4149(82)90011-4; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Liu L, 2010, BIOINFORMATICS, V26, P962, DOI 10.1093/bioinformatics/btq062; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; McKenna M.C., 1997, CLASSIFICATION MAMMA; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Mossel E, 2005, SCIENCE, V309, P2207, DOI 10.1126/science.1115493; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; Nishihara H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r199; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Nishihara H, 2009, P NATL ACAD SCI USA, V106, P5235, DOI 10.1073/pnas.0809297106; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Nylander JAA, 2004, MRAIC PL PROGRAM DIS; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pollard DA, 2006, PLOS GENET, V2, P1634, DOI 10.1371/journal.pgen.0020173; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Shedlock AM, 2004, TRENDS ECOL EVOL, V19, P545, DOI 10.1016/j.tree.2004.08.002; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Springer MS, 2007, SYST BIOL, V56, P673, DOI 10.1080/10635150701491149; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Stephen S, 2008, MOL BIOL EVOL, V25, P402, DOI 10.1093/molbev/msm268; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wildman DE, 2007, P NATL ACAD SCI USA, V104, P14395, DOI 10.1073/pnas.0704342104; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	66	247	250	0	81	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2012	22	4					746	754		10.1101/gr.125864.111			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	917UJ	WOS:000302203800015	22207614	Bronze, Green Published			2022-01-24	
J	Stamatoyannopoulos, JA; Snyder, M; Hardison, R; Ren, B; Gingeras, T; Gilbert, DM; Groudine, M; Bender, M; Kaul, R; Canfield, T; Giste, E; Johnson, A; Zhang, M; Balasundaram, G; Byron, R; Roach, V; Sabo, PJ; Sandstrom, R; Stehling, AS; Thurman, RE; Weissman, SM; Cayting, P; Hariharan, M; Lian, J; Cheng, Y; Landt, SG; Ma, ZH; Wold, BJ; Dekker, J; Crawford, GE; Keller, CA; Wu, WS; Morrissey, C; Kumar, SA; Mishra, T; Jain, D; Byrska-Bishop, M; Blankenberg, D; Lajoie, BR; Jain, G; Sanyal, A; Chen, KB; Denas, O; Taylor, J; Blobel, GA; Weiss, MJ; Pimkin, M; Deng, WL; Marinov, GK; Williams, BA; Fisher-Aylor, KI; Desalvo, G; Kiralusha, A; Trout, D; Amrhein, H; Mortazavi, A; Edsall, L; McCleary, D; Kuan, S; Shen, Y; Yue, F; Ye, Z; Davis, CA; Zaleski, C; Jha, S; Xue, CH; Dobin, A; Lin, W; Fastuca, M; Wang, HI; Guigo, R; Djebali, S; Lagarde, J; Ryba, T; Sasaki, T; Malladi, VS; Cline, MS; Kirkup, VM; Learned, K; Rosenbloom, KR; Kent, WJ; Feingold, EA; Good, PJ; Pazin, M; Lowdon, RF; Adams, LB				Stamatoyannopoulos, John A.; Snyder, Michael; Hardison, Ross; Ren, Bing; Gingeras, Thomas; Gilbert, David M.; Groudine, Mark; Bender, Michael; Kaul, Rajinder; Canfield, Theresa; Giste, Erica; Johnson, Audra; Zhang, Mia; Balasundaram, Gayathri; Byron, Rachel; Roach, Vaughan; Sabo, Peter J.; Sandstrom, Richard; Stehling, A. Sandra; Thurman, Robert E.; Weissman, Sherman M.; Cayting, Philip; Hariharan, Manoj; Lian, Jin; Cheng, Yong; Landt, Stephen G.; Ma, Zhihai; Wold, Barbara J.; Dekker, Job; Crawford, Gregory E.; Keller, Cheryl A.; Wu, Weisheng; Morrissey, Christopher; Kumar, Swathi A.; Mishra, Tejaswini; Jain, Deepti; Byrska-Bishop, Marta; Blankenberg, Daniel; Lajoie, Bryan R.; Jain, Gaurav; Sanyal, Amartya; Chen, Kaun-Bei; Denas, Olgert; Taylor, James; Blobel, Gerd A.; Weiss, Mitchell J.; Pimkin, Max; Deng, Wulan; Marinov, Georgi K.; Williams, Brian A.; Fisher-Aylor, Katherine I.; Desalvo, Gilberto; Kiralusha, Anthony; Trout, Diane; Amrhein, Henry; Mortazavi, Ali; Edsall, Lee; McCleary, David; Kuan, Samantha; Shen, Yin; Yue, Feng; Ye, Zhen; Davis, Carrie A.; Zaleski, Chris; Jha, Sonali; Xue, Chenghai; Dobin, Alex; Lin, Wei; Fastuca, Meagan; Wang, Huaien; Guigo, Roderic; Djebali, Sarah; Lagarde, Julien; Ryba, Tyrone; Sasaki, Takayo; Malladi, Venkat S.; Cline, Melissa S.; Kirkup, Vanessa M.; Learned, Katrina; Rosenbloom, Kate R.; Kent, W. James; Feingold, Elise A.; Good, Peter J.; Pazin, Michael; Lowdon, Rebecca F.; Adams, Leslie B.		Mouse ENCODE Consortium	An encyclopedia of mouse DNA elements (Mouse ENCODE)	GENOME BIOLOGY			English	Article						ENCODE Project; mouse genome; DNasel hypersensitive sites; histone modifications; transcriptome; transcription factor binding sites; comparative genomics; ChIP-seq; RNA-seq	HUMAN-DISEASE; COMPARATIVE GENOMICS; MODELS	To complement the human Encyclopedia of DNA Elements (ENCODE) project and to enable a broad range of mouse genomics efforts, the Mouse ENCODE Consortium is applying the same experimental pipelines developed for human ENCODE to annotate the mouse genome.	[Stamatoyannopoulos, John A.; Kaul, Rajinder; Canfield, Theresa; Giste, Erica; Johnson, Audra; Roach, Vaughan; Sabo, Peter J.; Sandstrom, Richard; Stehling, A. Sandra; Thurman, Robert E.; Lajoie, Bryan R.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Snyder, Michael; Hariharan, Manoj; Cheng, Yong; Landt, Stephen G.; Ma, Zhihai; Lajoie, Bryan R.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Hardison, Ross; Keller, Cheryl A.; Wu, Weisheng; Morrissey, Christopher; Kumar, Swathi A.; Mishra, Tejaswini; Jain, Deepti; Byrska-Bishop, Marta; Blankenberg, Daniel] Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ren, Bing; Edsall, Lee; McCleary, David; Kuan, Samantha; Shen, Yin; Yue, Feng; Ye, Zhen] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Gingeras, Thomas; Davis, Carrie A.; Zaleski, Chris; Jha, Sonali; Xue, Chenghai; Dobin, Alex; Lin, Wei; Fastuca, Meagan; Wang, Huaien] Cold Spring Harbor Lab, Dept Funct Genom, Cold Spring Harbor, NY 11724 USA; [Groudine, Mark; Sasaki, Takayo] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Groudine, Mark; Bender, Michael; Zhang, Mia; Balasundaram, Gayathri; Byron, Rachel] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Weissman, Sherman M.; Cayting, Philip] Yale Univ, Dept Genet, New Haven, CT 06510 USA; [Cayting, Philip; Lian, Jin] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Cayting, Philip] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Wold, Barbara J.; Marinov, Georgi K.; Fisher-Aylor, Katherine I.; Desalvo, Gilberto; Kiralusha, Anthony; Trout, Diane; Amrhein, Henry] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Dekker, Job; Jain, Gaurav; Sanyal, Amartya] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA USA; [Crawford, Gregory E.; Chen, Kaun-Bei; Denas, Olgert] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Crawford, Gregory E.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Taylor, James] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Blobel, Gerd A.; Weiss, Mitchell J.; Pimkin, Max; Deng, Wulan] Childrens Hosp Philadelphia, Div Hematol, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Mortazavi, Ali] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Guigo, Roderic; Djebali, Sarah; Lagarde, Julien] Ctr Genom Regulat, Div Bioinformat & Genom, Barcelona, Catalunya, Spain; [Malladi, Venkat S.; Cline, Melissa S.; Kirkup, Vanessa M.; Learned, Katrina; Rosenbloom, Kate R.; Kent, W. James] Univ Calif Santa Cruz, Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Feingold, Elise A.; Good, Peter J.; Pazin, Michael; Lowdon, Rebecca F.; Adams, Leslie B.] NHGRI, NIH, Bethesda, MD 20892 USA		Stamatoyannopoulos, JA (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Lin, Wei/AAH-9924-2019; Hardison, Ross C/G-1142-2010; Mishra, Tejaswini/D-3528-2018; Guigo, Roderic/D-1303-2010; Weiss, Mitchell J/W-9814-2018; Byrska-Bishop, Marta/E-7804-2012; SANYAL, AMARTYA/D-7240-2015; Ma, Zhihai/E-7130-2015; Taylor, James/F-1026-2011; Hariharan, Manoj/N-2855-2015; Djebali, Sarah/O-9817-2014; Adams, Leslie/AAZ-9323-2020; Lagarde, Julien/AAI-1686-2020; cheng, yong/I-4270-2012	Lin, Wei/0000-0002-7506-3466; Hardison, Ross C/0000-0003-4084-7516; Mishra, Tejaswini/0000-0001-9931-1260; Guigo, Roderic/0000-0002-5738-4477; Weiss, Mitchell J/0000-0003-2460-3036; SANYAL, AMARTYA/0000-0002-2109-4478; Taylor, James/0000-0001-5079-840X; Hariharan, Manoj/0000-0002-1006-5372; Djebali, Sarah/0000-0002-0599-1267; Adams, Leslie/0000-0003-4956-271X; Lagarde, Julien/0000-0002-0290-7445; Pazin, Michael/0000-0002-7561-3640; Marinov, Georgi/0000-0003-1822-7273; Sandstrom, Richard/0000-0002-3356-1547			Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Cheng Jan-Fang, 2007, Methods Mol Biol, V366, P229; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Hardouin SN, 2000, CLIN GENET, V57, P237, DOI 10.1034/j.1399-0004.2000.570401.x; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Holt BD, 2001, TRENDS CARDIOVAS MED, V11, P82; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Miller W, 2004, ANNU REV GENOM HUM G, V5, P15, DOI 10.1146/annurev.genom.5.061903.180057; Moreno C, 2008, ADV GENET, V60, P655, DOI 10.1016/S0065-2660(07)00423-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Pennacchio LA, 2010, NAT GENET, V42, P557, DOI 10.1038/ng0710-557; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Ryba T, 2011, NAT PROTOC, V6, P870, DOI 10.1038/nprot.2011.328; van Berkum NL, 2009, METHODS MOL BIOL, V567, P189, DOI 10.1007/978-1-60327-414-2_13; Visel A, 2009, GENOMICS, V93, P509, DOI 10.1016/j.ygeno.2009.02.002; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	22	247	250	2	28	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-7596			GENOME BIOL	Genome Biol.		2012	13	8							418	10.1186/gb-2012-13-8-418			5	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	102TR	WOS:000315867500017		Green Published, Green Accepted, Bronze			2022-01-24	
J	Rafnar, T; Gudbjartsson, DF; Sulem, P; Jonasdottir, A; Sigurdsson, A; Jonasdottir, A; Besenbacher, S; Lundin, P; Stacey, SN; Gudmundsson, J; Magnusson, OT; le Roux, L; Orlygsdottir, G; Helgadottir, HT; Johannsdottir, H; Gylfason, A; Tryggvadottir, L; Jonasson, JG; de Juan, A; Ortega, E; Ramon-Cajal, JM; Garcia-Prats, MD; Mayordomo, C; Panadero, A; Rivera, F; Aben, KKH; van Altena, AM; Massuger, LFAG; Aavikko, M; Kujala, PM; Staff, S; Aaltonen, LA; Olafsdottir, K; Bjornsson, J; Kong, A; Salvarsdottir, A; Saemundsson, H; Olafsson, K; Benediktsdottir, KR; Gulcher, J; Masson, G; Kiemeney, LA; Mayordomo, JI; Thorsteinsdottir, U; Stefansson, K				Rafnar, Thorunn; Gudbjartsson, Daniel F.; Sulem, Patrick; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Besenbacher, Soren; Lundin, Par; Stacey, Simon N.; Gudmundsson, Julius; Magnusson, Olafur T.; le Roux, Louise; Orlygsdottir, Gudbjorg; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Gylfason, Arnaldur; Tryggvadottir, Laufey; Jonasson, Jon G.; de Juan, Ana; Ortega, Eugenia; Ramon-Cajal, Jose M.; Garcia-Prats, Maria D.; Mayordomo, Carlos; Panadero, Angeles; Rivera, Fernando; Aben, Katja K. H.; van Altena, Anne M.; Massuger, Leon F. A. G.; Aavikko, Mervi; Kujala, Paula M.; Staff, Synnove; Aaltonen, Lauri A.; Olafsdottir, Kristrun; Bjornsson, Johannes; Kong, Augustine; Salvarsdottir, Anna; Saemundsson, Hafsteinn; Olafsson, Karl; Benediktsdottir, Kristrun R.; Gulcher, Jeffrey; Masson, Gisli; Kiemeney, Lambertus A.; Mayordomo, Jose I.; Thorsteinsdottir, Unnur; Stefansson, Kari			Mutations in BRIP1 confer high risk of ovarian cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; FAMILY-HISTORY; HELICASE BRIP1; BRCA2; GENE; SUSCEPTIBILITY; BACH1; RECOMBINATION; POPULATION	Ovarian cancer causes more deaths than any other gynecologic malignancy in developed countries. Sixteen million sequence variants, identified through whole-genome sequencing of 457 Icelanders, were imputed to 41,675 Icelanders genotyped using SNP chips, as well as to their relatives. Sequence variants were tested for association with ovarian cancer (N of affected individuals = 656). We discovered a rare (0.41% allelic frequency) frameshift mutation, c.2040_2041insTT, in the BRIP1 (FANCJ) gene that confers an increase in ovarian cancer risk (odds ratio (OR) = 8.13, P = 2.8 x 10(-14)). The mutation was also associated with increased risk of cancer in general and reduced lifespan by 3.6 years. In a Spanish population, another frameshift mutation in BRIP1, c.1702_1703del, was seen in 2 out of 144 subjects with ovarian cancer and 1 out of 1,780 control subjects (P = 0.016). This allele was also associated with breast cancer (seen in 6/927 cases; P = 0.0079). Ovarian tumors from heterozygous carriers of the Icelandic mutation show loss of the wild-type allele, indicating that BRIP1 behaves like a classical tumor suppressor gene in ovarian cancer.	[Rafnar, Thorunn; Gudbjartsson, Daniel F.; Sulem, Patrick; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Besenbacher, Soren; Lundin, Par; Stacey, Simon N.; Gudmundsson, Julius; Magnusson, Olafur T.; le Roux, Louise; Orlygsdottir, Gudbjorg; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Gylfason, Arnaldur; Kong, Augustine; Gulcher, Jeffrey; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Tryggvadottir, Laufey; Jonasson, Jon G.] Iceland Canc Registry, Reykjavik, Iceland; [Tryggvadottir, Laufey; Jonasson, Jon G.; Benediktsdottir, Kristrun R.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [de Juan, Ana; Rivera, Fernando] Marques de Valdecilla Univ Hosp, Div Med Oncol, Santander, Spain; [Ortega, Eugenia] Arnau de Vilanova Univ Hosp, Div Med Oncol, Lerida, Spain; [Ramon-Cajal, Jose M.] San Jorge Gen Hosp, Div Gynecol, Huesca, Spain; [Garcia-Prats, Maria D.] San Jorge Gen Hosp, Div Pathol, Huesca, Spain; [Mayordomo, Carlos] Univ Zaragoza, Sch Med, Zaragoza, Spain; [Panadero, Angeles] Ciudad Coria Hosp, Div Med Oncol, Coria, Spain; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Comprehens Canc Ctr Netherlands, Nijmegen, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assesment, NL-6525 ED Nijmegen, Netherlands; [van Altena, Anne M.; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Aavikko, Mervi; Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Genome Scale Biol Res Program, Helsinki, Finland; [Kujala, Paula M.] Univ Tampere, Dept Pathol, Ctr Lab Med, FIN-33101 Tampere, Finland; [Staff, Synnove] Tampere Univ Hosp, Dept Obstet & Gynecol, Tampere, Finland; [Staff, Synnove] Univ Tampere, Inst Biomed Technol, Canc Biol Lab, FIN-33101 Tampere, Finland; [Olafsdottir, Kristrun; Bjornsson, Johannes; Benediktsdottir, Kristrun R.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Salvarsdottir, Anna; Saemundsson, Hafsteinn; Olafsson, Karl] Landspitali Univ Hosp, Dept Obstet & Gynecol, Reykjavik, Iceland; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza, Spain		Rafnar, T (corresponding author), DeCODE Genet, Reykjavik, Iceland.	thorunn.rafnar@decode.is; kstefans@decode.is	Aaltonen, Lauri/A-5375-2010; Stefansson, Kari/AAE-7187-2019; Mayordomo, Jose/K-3453-2013; Aben, Katja KH/G-9686-2016; Massuger, Leon F.A.G./H-8072-2014; Kiemeney, Lambertus A./D-3357-2009; van Altena, Anne M/B-9824-2016	Aaltonen, Lauri/0000-0001-6839-4286; Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Gudbjartsson, Daniel/0000-0002-5222-9857; Besenbacher, Soren/0000-0003-1455-1738; Helgadottir, Hafdis/0000-0003-4352-152X; Kong, Augustine/0000-0001-8193-5438; Staff, Synnove/0000-0001-7280-1673; Tryggvadottir, Laufey/0000-0001-8067-9030; Jonasson, Jon G./0000-0002-2635-5032	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [218071]	This work was partly funded by the European Commission 7<SUP>th</SUP> Framework Programme FP7-MC-IAPP (grant agreement no. 218071 CancerGene).	Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cantor SB, 2011, FUTURE ONCOL, V7, P253, DOI 10.2217/FON.10.191; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GODWIN AK, 1994, AM J HUM GENET, V55, P666; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Malander S, 2006, GYNECOL ONCOL, V101, P238, DOI 10.1016/j.ygyno.2005.10.029; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Rafnar T, 2004, EUR J CANCER, V40, P2788, DOI 10.1016/j.ejca.2004.09.008; Ramus SJ, 2009, MOL ONCOL, V3, P138, DOI 10.1016/j.molonc.2009.02.001; Rubin SC, 1998, AM J OBSTET GYNECOL, V178, P670, DOI 10.1016/S0002-9378(98)70476-4; Sarantaus L, 2000, EUR J HUM GENET, V8, P757, DOI 10.1038/sj.ejhg.5200529; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Sulem P., NAT GENET IN PRESS; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	29	247	249	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2011	43	11					1104	U91		10.1038/ng.955			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	WOS:000296584000014	21964575	Green Submitted			2022-01-24	
J	Murga, M; Bunting, S; Montana, MF; Soria, R; Mulero, F; Canamero, M; Lee, Y; McKinnon, PJ; Nussenzweig, A; Fernandez-Capetillo, O				Murga, Matilde; Bunting, Samuel; Montana, Maria F.; Soria, Rebeca; Mulero, Francisca; Canamero, Marta; Lee, Youngsoo; McKinnon, Peter J.; Nussenzweig, Andre; Fernandez-Capetillo, Oscar			A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging	NATURE GENETICS			English	Article							HEMATOPOIETIC STEM-CELLS; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; CHROMOSOME INSTABILITY; DEFICIENT MICE; GENE ATR; CHECKPOINT; AGE; LEADS; P53	Although DNA damage is considered a driving force for aging, the nature of the damage that arises endogenously remains unclear. Replicative stress, a source of endogenous DNA damage, is prevented primarily by the ATR kinase. We have developed a mouse model of Seckel syndrome characterized by a severe deficiency in ATR. Seckel mice show high levels of replicative stress during embryogenesis, when proliferation is widespread, but this is reduced to marginal amounts in postnatal life. In spite of this decrease, adult Seckel mice show accelerated aging, which is further aggravated in the absence of p53. Together, these results support a model whereby replicative stress, particularly in utero, contributes to the onset of aging in postnatal life, and this is balanced by the replicative stress-limiting role of the checkpoint proteins ATR and p53.	[Murga, Matilde; Montana, Maria F.; Soria, Rebeca; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid, Spain; [Bunting, Samuel; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Mulero, Francisca] CNIO, Mol Imaging Unit, Madrid, Spain; [Canamero, Marta] CNIO, Comparat Pathol Unit, Madrid, Spain; [Lee, Youngsoo; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA		Murga, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid, Spain.	mmurga@cnio.es; ofernandez@cnio.es	Mulero, Francisca/R-2387-2019; Mulero, Francisca M/M-3289-2014; Fernandez-Capetillo, Oscar/H-3508-2015; /AAI-3238-2021; Murga, Matilde/B-3499-2018	Mulero, Francisca/0000-0001-9584-4211; Mulero, Francisca M/0000-0001-9584-4211; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Lee, Youngsoo/0000-0003-4773-6464	Spanish Ministry of ScienceSpanish Government [RYC-2003-002731, CSD200700017, SAF2008-01596]; Fondo de Investigaciones SanitariasInstituto de Salud Carlos III [PI080220]; European Molecular Biology Organization Young Investigator ProgrammeEuropean Molecular Biology Organization (EMBO); European Research CouncilEuropean Research Council (ERC)European Commission [ERC-210520]; Epigenome Network of Excellence; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZICBC009255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037956] Funding Source: NIH RePORTER	We thank M. Serrano and A. Ramiro for critical comments on the manuscript. We also thank S. P. Jackson for his help with the PIKK inhibitors and A. Garcia for cytometry. M. M. is supported by a Ramon y Cajal contract from the Spanish Ministry of Science (RYC-2003-002731) and from a grant from Fondo de Investigaciones Sanitarias (PI080220). Work in O. F.-C.' s laboratory is supported by grants from the Spanish Ministry of Science (RYC-2003-002731, CSD200700017 and SAF2008-01596), European Molecular Biology Organization Young Investigator Programme, European Research Council (ERC-210520) and Epigenome Network of Excellence.	Arnold SR, 1999, PEDIATR DEVEL PATHOL, V2, P180, DOI 10.1007/s100249900107; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bobabilla-Morales L, 2003, AM J MED GENET A, V123A, P148, DOI 10.1002/ajmg.a.20341; BOSCHERINI B, 1981, EUR J PEDIATR, V137, P237, DOI 10.1007/BF00441325; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; BUTLER MG, 1987, AM J MED GENET, V27, P645, DOI 10.1002/ajmg.1320270318; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Casper AM, 2004, AM J HUM GENET, V75, P654, DOI 10.1086/422701; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; EL DW, 1993, CELL, V75, P817; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; FATHIZADEH A, 1979, J AM ACAD DERMATOL, V1, P52, DOI 10.1016/S0190-9622(79)70004-1; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Goodship J, 2000, AM J HUM GENET, V67, P498, DOI 10.1086/303023; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Liu QH, 2000, GENE DEV, V14, P1448; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lombardi G, 2005, J Endocrinol Invest, V28, P99; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; MURPHY DP, 1928, SURG GYNECOL OBSTET, V47, P201; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; SCHMIDT SL, 1987, J COMP NEUROL, V264, P193, DOI 10.1002/cne.902640205; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; SECKEL H, 1960, STUDIES DEV ANTHR IN; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shanske A, 1997, AM J MED GENET, V70, P155, DOI 10.1002/(SICI)1096-8628(19970516)70:2<155::AID-AJMG10>3.0.CO;2-I; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Syrrou M., 1995, Genetic Counseling, V6, P37; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401	50	247	249	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					891	U46		10.1038/ng.420			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	WOS:000268432900012	19620979	Green Accepted			2022-01-24	
